catalogId,name,category,atc5_code,atc5_name,package_moh,administrationNotes,alternativeMedications,atc5_system,contraindications,currency,form,ingredients,lastUpdated,manufacturer_country,manufacturer_name,manufacturers_administration_recommendation,max_price_with_vat,max_retail_price,max_wholesale_price,method,package_barcode,package_name,package_pharmasoft,package_superpharm,package_yarpa,packaging_description,quantity_unit,quantity_value,registrationNumber,registrationValidity,retail_margin,route,schema_version,shelf_life,sideEffect,site,snomed_ct_clinical_code,snomed_ct_clinical_name,snomed_ct_integration_code,snomed_ct_integration_name,status,storage_conditions,strength_unit,strength_value,termsOfIssue,treatmentDescriptions,warnings,filename
0005d4b7-3cd7-485a-9c11-a9ea83b8cdf3,ZAPPA 10,prescription,N05AH03,OLANZAPINE,6860,,,WHO ATC Classification,,ILS,film coated tablets,OLANZAPINE,2025-07-31T14:27:03.877Z,IL,אוניפארם,,94.16343655,79.7995225,59.3305,,,ZAPPA 5MG 30TAB,86148,,13466,BLISTER ALUMINIUM /ALUMINIUM,units,30,146 72 33251 01,valid,34.5,per os,1.4,30,,,,,,,active,,,0,Prescription required,Acute and maintenance treatment of Schizophrenia. Zappa is indicated for the management of the manifestations of psychotic disorders. Zappa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar  Disorder: In patients whose manic episode has responded to Olanzapine treatment Zappa is indicated for the prevention of reccurence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zappa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0005d4b7-3cd7-485a-9c11-a9ea83b8cdf3.json
003aa28e-f07e-4710-8d15-6a6b4c2f5e75,TAMIFLU 30 MG,prescription,J05AH02,OSELTAMIVIR,4190,,,WHO ATC Classification,,ILS,capsules,OSELTAMIVIR AS PHOSPHATE,2025-07-31T09:03:42.677109,IL,רוש,,102.1923596,86.60369839,64.38936683,,7290008140911,TAMIFLU 75MG 10CAP,20106,,25258,BLISTER PVC/PE/PVDC,units,10.0,138 02 31733 00,valid,34.5,per os,1.4,120,,,,,,,,,,0,Prescription required,Treatment of influenza : Treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days.  Prophylaxis of influenza : Post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community.   The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains  and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/003aa28e-f07e-4710-8d15-6a6b4c2f5e75.json
0042d651-47fd-48d1-b135-59ced97b405b,DAPSONE 100MG 100TAB,29C,,,20060,,,,,,tablet,DAPSONE 100MG,2025-07-31T20:10:35.155649,IL,nan,,,,,,,DAPSONE 100MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0042d651-47fd-48d1-b135-59ced97b405b.json
004a3ddc-48dc-4b3a-87bc-922aead77e7f,COSOPT,prescription,S01ED01,TIMOLOL,3827,,,WHO ATC Classification,,ILS,"eye drops, solution","DORZOLAMIDE AS HYDROCHLORIDE/ML, TIMOLOL AS MALEATE/ML",2025-07-31T01:31:52.045057,IL,רפא,,43.85463982,37.164949,27.1277,,7290004997892,COSOPT EYE DROPS 5ML,3577,,17675,DROPER BOTTLE HDPE,units,5.0,141 55 29511 01,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of elevated intraocular pressure (IOP ) in patients with ocular hypertension, open-angle glaucoma, or other secondary open-angle glaucoma when concomitant therapy is appropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/004a3ddc-48dc-4b3a-87bc-922aead77e7f.json
005200b4-b3d4-4566-8783-5d1ec6fab36e,INVEGA 3 MG,prescription,N05AX13,PALIPERIDONE,6191,,,WHO ATC Classification,,ILS,tablets extended release,PALIPERIDONE,2025-07-31T04:11:13.617592,IL,יאנסן סילג,,273.1486652,231.48193,197.0058979,,7290008099356,INVEGA 9MG 28TAB,9292,,88019,BLISTER OPA/ALU/PVC/ALU,units,28.0,139 15 31639 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Invega is indicated for :-treatment of schizophrenia in adults and adolescents (12-17 years).-treatment of schizoaffective disorder in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/005200b4-b3d4-4566-8783-5d1ec6fab36e.json
005c8fcf-a0df-434c-af31-0378a2544730,CYCLOSERINE 250MG 100 CAP,29C,,,20347,,,,,,tablet,CYCLOSERINE 250MG 100 CAP,2025-07-31T20:08:46.134289,IL,nan,,,,,,,CYCLOSERINE 250MG 100 CAP,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/005c8fcf-a0df-434c-af31-0378a2544730.json
00620ab3-8e48-40eb-9b2d-2964592f10b2,SANDOSTATIN ® 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,3721,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE 0.05  MG/ML,2025-07-31T07:59:46.119230,IL,נוברטיס פארמה,,1688.138922,1430.626269,1217.554271,,7298120012734,SANDOSTATIN LAR VIAL 10MG,19742,,62751,AMPOULES GLASS TYPE I,units,1.0,047 03 25697 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery.   Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery  or radiotherapy. Sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery  or in the interim period until radiotherapy becomes fully effective.   Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours:   - Carcinoid tumours with features of the carcinoid syndrome    - VIPomas    - Glucagonomas    - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors  or H2- antagonist therapy    - Insulinomas  for pre-operative control of hypoglycaemia and for maintenance therapy   - GRFomas.   Sandostatin is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/00620ab3-8e48-40eb-9b2d-2964592f10b2.json
00703a00-5643-432f-9256-e8ba4434c7d4,FENTORA ® 100 MCG,prescription,N01AH01,FENTANYL,7615,,,WHO ATC Classification,,ILS,tablets,FENTANYL AS CITRATE,2025-07-31T03:02:52.704989,IL,טבע,,654.576556,554.7259196,472.1071656,,,FENTORA 800MCG 28 BUCCAL TAB,6586,,76300,BLISTER PVC/ALU/POLYAMIDE/PVC,units,28.0,152 90 34050 00,valid,17.5,buccal,1.4,36,,,,,,,,,,0,Prescription required,"Fentora is indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.                                      Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/00703a00-5643-432f-9256-e8ba4434c7d4.json
007837f6-9648-4f23-8e99-0c269db77d28,DERMACOMBIN OINTMENT,prescription,D07CB01,TRIAMCINOLONE AND ANTIBIOTICS,2061,,,WHO ATC Classification,,ILS,ointment,"TRIAMCINOLONE ACETONIDE/G, NEOMYCIN AS SULFATE 2.5 MG/G, GRAMICIDIN 0.25 MG/G, NYSTATIN/G",2025-07-31T01:48:52.992219,IL,תרו,,nan,nan,nan,,7-290000-809120,DERMACOMBIN OINT 15G,4072,,637,TUBE ALUMINIUM,units,15.0,015 28 24536 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,"For the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/007837f6-9648-4f23-8e99-0c269db77d28.json
0097dc09-6d38-48ee-8a4d-83b20028de0f,DESMOPRESSIN TEVA 0.1 MG,prescription,H01BA02,DESMOPRESSIN,6772,,,WHO ATC Classification,,ILS,tablets,DESMOPRESSIN ACETATE 0.1  MG,2025-07-31T01:51:25.468803,IL,טבע,,147.4123874,124.925752,92.8816,,7290102065516,DESMOPRESSIN TEVA 0.2MG 30TAB,4552,,30593,BLISTER OPA/AL/PVC,units,30.0,144 40 33065 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. The treatment must be started befor the age of 65.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0097dc09-6d38-48ee-8a4d-83b20028de0f.json
009e30e5-666c-4da7-aeb9-f657993bfdb7,RIXATHON,prescription,L01XC02,RITUXIMAB,8398,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T07:46:09.163065,IL,סנדוז,,3920.040699,3322.068537,3020.062306,,7290017585413,RIXATHON 500MG/50ML 1 VIAL,18600,,45466,VIAL GLASS TYPE I,units,1.0,162 10 35741 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Rixathon is indicated for the following indications: * Non-Hodgkin’s lymphoma (NHL): Rixathon is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma. Rixathon is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy.Rixathon is indicated for the treatment of patients with CD20 positive diffuse large B-cell non-Hodgkin's lymphoma in combination with CHOP chemotherapy. Rixathon maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.* Chronic lymphocytic leukaemia (CLL):  Rixathon in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including Rixathon or patients refractory to previous Rixathon plus chemotherapy.* Granulomatosis with polyangiitis and Microscopic polyangiitis: Rixathon, in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis (WG) and Microscopic polyangiitis (MPA).*pemphigus vulgaris (PV):Rixathon is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).*Rheumatoid arthritis:Rixathon is indicated, in combination with methotrexate, to reduce signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more TNF antagonist therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/009e30e5-666c-4da7-aeb9-f657993bfdb7.json
00a52cea-8d0d-4aa5-9b75-e2e588b8b11a,OLANZAPINE TEVA ® 7.5 MG,prescription,N05AH03,OLANZAPINE,6816,,,WHO ATC Classification,,ILS,film coated tablets,OLANZAPINE 7.5  MG,2025-07-31T06:05:59.588436,IL,טבע,,236.5842475,200.495125,160.3961,,7290106064393,OLANZAPINE TEVA 7.5MG 56 F.C.TAB,15392,,2393,BLISTER PVC/OPA/AL,units,56.0,145 71 33187 01,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia. Olanzapine Teva®  is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva®  with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/00a52cea-8d0d-4aa5-9b75-e2e588b8b11a.json
00d77393-24cd-438d-86fc-1580902fce6a,ILOMEDINE AMP 0.5 ML,prescription,,,2802,,,,,ILS,injection,ILOMEDINE AMP 0.,2025-07-31T19:12:27.251509,IL,באייר,,464.8024585,393.9004061,335.2343881,,,ILOMEDINE AMP 0.5 ML,9059,,8878,,units,1.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/00d77393-24cd-438d-86fc-1580902fce6a.json
00e0e537-f647-4904-b62c-89c1877a08fa,GEODON IM 20 MG,prescription,N05AE04,ZIPRASIDONE,4506,,,WHO ATC Classification,,ILS,powder for solution for injection,ZIPRASIDONE MESYLATE TRIHYDRATE 40.93   MG,2025-07-31T03:32:27.577021,IL,דקסל פארמה,,485.8262383,411.7171694,350.397591,,7290008095341,GEODON 80MG 60CAPS,7602,,29828,VIAL GLASS TYPE I,units,60.0,125 75 30516 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Rapid control of agitation in patients with schizophrenia, when oral therapy is not appropriate, for a maximum of 3 consecutive days.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/00e0e537-f647-4904-b62c-89c1877a08fa.json
00e4b514-d2d0-476b-a8c4-9e487af07006,REMSIMA 100 MG I.V.,prescription,L04AB02,INFLIXIMAB,7887,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,INFLIXIMAB/VIAL,2025-07-31T07:24:54.272909,IL,פאדאגיס,,2305.677508,1953.96399,1776.3309,,7290012162299,REMSIMA 100 MG 1VIAL 20ML,18552,,52365,VIAL 20 ML GLASS TYPE I,units,1.0,154 60 34158 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"* Rheumatoid arthritis:Remsima, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in:• adult patients with active disease when the response to disease modifying antirheumatic drugs (DMARDs),including methotrexate, has been inadequate.• adult patients with severe, active and progressive disease not previously treated with methotrexate or other DMARDs.In these patient populations, a reduction in the rate of the progression of joint damage, as measured by X ray,has been demonstrated.* Ankylosing spondylitis:Remsima is indicated for treatment of severe, active ankylosing spondylitis, in adult patients who have responded inadequately to conventional therapy.* Psoriatic arthritis:Remsima is indicated for treatment of active and progressive psoriatic arthritis in adult patients when the response to previous DMARD therapy has been inadequate.* Remsima should be administered:• in combination with methotrexate• or alone in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated.Infliximab has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.* Psoriasis:Remsima is indicated for treatment of moderate to severe plaque psoriasis in adult patients who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or psoralen ultra-violet A (PUVA)* Adult Crohn’s disease Remsima is indicated for treatment :•	of moderately to severely active Crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.•	treatment of fistulising, active Crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with conventional treatment (including antibiotics, drainage and immunosuppressive therapy).* Ulcerative colitis•	Remsima is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6 mercaptopurine (6 MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.Paediatric Crohn’s diseaseRemsima is indicated for treatment of severe, active Crohn’s disease in children and adolescents aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition therapy; or who are intolerant to or have contraindications for such therapies. Infliximab has been studied only in combination with conventional immunosuppressive therapy.Paediatric ulcerative colitisRemsima is indicated for treatment of severely active ulcerative colitis in children and adolescents aged 6 to 17 years, who have had an inadequate response to conventional therapy including corticosteroids and 6 MP or AZA, or who are intolerant to or have medical contraindications for such therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/00e4b514-d2d0-476b-a8c4-9e487af07006.json
00f17634-cbd2-4a16-b6c9-513d97cb471b,CHAMPIX 0.5 MG,prescription,N07BA03,VARENICLINE,6236,,,WHO ATC Classification,,ILS,film coated tablets,VARENICLINE AS TARTRATE 0.5  MG,2025-07-31T01:08:30.343653,IL,פיזר,,421.1269894,356.887295,303.7338681,,7290010355747,CHAMPIX 0.5MGX11TAB+1MGX42TAB,3910,,16666,BLISTER ACLAR/PVC/ALUMINIUM,units,53.0,137 66 31510 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Champix is indicated as an aid to smoking cessation treatment adults over 18 years of age.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/00f17634-cbd2-4a16-b6c9-513d97cb471b.json
0109492b-c844-484b-acf3-b9fba9b9469b,PRILIDAN,off-the-counter,N01BB04,PRILOCAINE,5596,,,WHO ATC Classification,,ILS,cream,"PRILOCAINE/, LIDOCAINE/",2025-07-31T12:52:16.476911,IL,הלפרין מדיק,,100.654,85.3,nan,,729001971992,PRILIDAN CREAM 30 GR,,,,TUBE ALUMINIUM,units,30.0,157 87 34381 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Topical anaesthetic for superficial dermal analgesia in connection with insertion of IV catheters, blood sampling and superficial surgical procedures.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0109492b-c844-484b-acf3-b9fba9b9469b.json
0112463d-9fd5-4198-9bb0-83050147383e,ALCOXIDINE,off-the-counter,D08AC02,CHLORHEXIDINE,5543,,,WHO ATC Classification,,ILS,solution - external,"ALCOHOLV/V, CHLORHEXIDINE GLUCONATE 0.5 %W/V",2025-07-31T11:11:29.824961,IL,ויטאמד,,52.474,44.47,nan,,7290008083089,ALCOXIDINE SOL 1 L,127244,,,BOTTLE HDPE,units,1000.0,116 50 28130 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Disinfection of hands and skin,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0112463d-9fd5-4198-9bb0-83050147383e.json
01169ab9-e784-48da-b361-d46ef65e3975,PLEGRIDY 125,prescription,L03AB13,PEGINTERFERON BETA-1A,7632,,,WHO ATC Classification,,ILS,solution for injection,PEGINTERFERON BETA 1A/ 0.5  ML,2025-07-31T06:46:08.058639,IL,מדיסון,,2827.21893,2395.948352,2178.134865,,7290015666091,PLEGRIDY 125MCG/0.5ML 2 PRE FILLED PEN,16978,,4474,PRE-FILLED PEN GLASS TYPE I,units,2.0,155 04 34292 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Plegridy is indicated in adult patients for the treatment of relapsing remitting multiple sclerosis,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/01169ab9-e784-48da-b361-d46ef65e3975.json
0127fcf6-fc24-4e7a-9b12-e951ac83902a,DEPO MEDROL 40 MG/ML,prescription,H02AB04,METHYLPREDNISOLONE,8559,,,WHO ATC Classification,,ILS,suspension for injection,METHYLPREDNISOLONE ACETATE/ML,2025-07-31T05:18:20.188020,IL,דקסל פארמה,,1184.082369,1003.459635,854.0082,,72982006,METHYLPREDNISOLONE MYLAN 1 G 10 VIALS,13973,,59191,VIAL GLASS TYPE I,units,10.0,024 49 21841 00,valid,17.5,"periarticular, i.m, intra-articular, intra-lesional, intrabursal, intrarectal instillation, soft tissues",1.4,60,,,,,,,,,,0,Prescription required,For the treatment of conditions responsive to steroid injection therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0127fcf6-fc24-4e7a-9b12-e951ac83902a.json
0142df2e-b70a-46cf-b859-bcd422e65d24,ABIRATERONE - TRIMA 250 MG,prescription,L02BX03,ABIRATERONE,9389,,,WHO ATC Classification,,ILS,tablets,ABIRATERONE ACETATE,2025-07-30T23:10:11.230636,IL,תרימה,,17160.87617,14543.1154,13221.014,,7290016981414,ABIRATERONE - TRIMA 250 MG 120 TAB,23875,,15853,BOTTLE HDPE,units,120.0,172 37 37264 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Abiraterone Trima 250 mg is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. The treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0142df2e-b70a-46cf-b859-bcd422e65d24.json
0147373c-00eb-4c28-9060-3d5920f37145,SOLUVIT N,prescription,B03BB01,FOLIC ACID,8693,,,WHO ATC Classification,,ILS,powder for solution for infusion,"THIAMINE (VIT B1) MONONITRATE 3.1  MG/VIAL, RIBOFLAVINE 4.9  MG/VIAL, PYRIDOXINE (VIT B6) HYDROCHLORIDE 4.9  MG/VIAL, ASCORBIC ACID AS SODIUM/VIAL, BIOTIN/VIAL, FOLIC ACID 0.4  MG/VIAL, CYANOCOBALAMIN (VIT B12)/VIAL, PANTOTHENIC ACID AS SODIUM/VIAL, NICOTINAMIDE/VIAL",2025-07-31T08:29:08.516693,IL,ניאופרם,,280.993959,238.1304844,202.664242,,7-298120-013007,SOLUVIT N 10 amp,,,,VIAL GLASS TYPE I,units,10.0,102 29 26397 05,valid,17.5,i.v,1.4,18,,,,,,,,,,0,Prescription required,Supplement in intravenous nutrition in order to meet the daily requirments of water soluble vitamins.,תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0147373c-00eb-4c28-9060-3d5920f37145.json
01673163-c1ad-423a-9da4-9e5b9b575b4b,KALITRANS 2.5G 90 EFF.TAB,29C,,,20475,,,,,,tablet,KALITRANS 2.5G 90 EFF.TAB,2025-07-31T20:43:06.445951,IL,nan,,,,,,,KALITRANS 2.5G 90 EFF.TAB,,,,,units,90.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/01673163-c1ad-423a-9da4-9e5b9b575b4b.json
0170222f-bd72-4b0c-bce9-d263aa400875,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,9149,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T03:01:42.914078,IL,פארמהמדיס,,23.84485,20.2075,14.75,,,FENTANYL -PIRAMAL 0.05 MG/ML 5 amp 10ML,,,,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,5.0,148 73 33262 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0170222f-bd72-4b0c-bce9-d263aa400875.json
019739ea-7aeb-401c-a4f9-00fdb1870c12,BAMYXIN EYE OINT 3.5GR,prescription,,,1470,,,,,,tablet,BAMYXIN EYE OINT 3.5GR,2025-07-31T19:00:02.180589,IL,רקח,,,,,,,BAMYXIN EYE OINT 3.5GR,2380,,302,,units,3.5,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/019739ea-7aeb-401c-a4f9-00fdb1870c12.json
01b4d43a-1426-48ac-9611-e08f456ebfa8,FANAPT TABLETS 1 MG,prescription,N05AX14,ILOPERIDONE,6943,,,WHO ATC Classification,,ILS,tablets,ILOPERIDONE,2025-07-31T02:54:07.067717,IL,מגאפארם,,nan,nan,nan,,7290014573062,FANAPT 2MG 60TAB,6506,,43873,BLISTER ALUMINIUM,units,60.0,148 32 33482 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,FANAPT is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/01b4d43a-1426-48ac-9611-e08f456ebfa8.json
01e5bca9-e0fd-4fb4-b8ac-eca044670001,BRINAVESS 20 MG/ML,prescription,C01BG11,VERNAKALANT,8976,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,VERNAKALANT HYDROCHLORIDE/ML,2025-07-31T00:42:39.839470,IL,צמל,,2060.765998,1746.411941,1486.308035,,7290013280619,BRINAVESS 20 MG/ML 25 VIALS,,,,VIAL GLASS TYPE I,units,25.0,148 28 33391 00,valid,17.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults who are hemodynamically stable.- For non-surgery patients: atrial fibrillation ≤ 7 days duration- For post-cardiac surgery patients: atrial fibrillation ≤ 3 days duration,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/01e5bca9-e0fd-4fb4-b8ac-eca044670001.json
01f9f61c-605c-4ed2-8fed-a81d16e0dbd7,HAEMATE-P 1000I.U 1VIAL/15ML,prescription,,,7003,,,,,ILS,injection,HAEMATE-P 1000I.U /,2025-07-31T19:11:37.689954,IL,סי אס אל,,3920.430779,3322.399113,3020.36283,,,HAEMATE-P 1000I.U 1VIAL/15ML,8340,,30797,,units,1.0,,not-registered,10.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/01f9f61c-605c-4ed2-8fed-a81d16e0dbd7.json
0208325e-e289-46bb-b1cf-bccbb2eab288,CELESTONE CHRONODOSE,prescription,H02AB01,BETAMETHASONE,1233,,,WHO ATC Classification,,ILS,suspension for injection,"BETAMETHASONE ACETATE/ML, BETAMETHASONE SODIUM PHOSPHATE 3.945 MG/ML",2025-07-31T01:04:27.828853,IL,אורגנון,,22.13722878,18.76036421,13.6936965,,,CELESTONE CHRONODOSE 1ML 1AMP,3113,,471,AMPOULES GLASS TYPE I,units,1.0,131 43 23009 01,valid,37.0,"i.m, intra-articular, intra-lesional",1.4,18,,,,,,,,,,0,Prescription required,Indicated in the management of conditions known to be responsive to corticosteroid therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0208325e-e289-46bb-b1cf-bccbb2eab288.json
0211d0d6-bf97-46b7-b6da-f0071f5e7bd7,HYDROGEN PEROXIDE 3% LIFE,off-the-counter,D08AX01,HYDROGEN PEROXIDE,3654,,,WHO ATC Classification,,ILS,solution,HYDROGEN PEROXIDEW/W,2025-07-31T12:06:11.811365,IL,פלוריש,,8.496,7.2,nan,,,HYDROGEN   PEROXIDE 3% 50ML,8008,,,BOTTLE POLYETHYLENE,units,50.0,162 73 35786 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,Antiseptic, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0211d0d6-bf97-46b7-b6da-f0071f5e7bd7.json
0212dac7-4150-4af7-adc9-0ee011b85238,XPOVIO 20 MG,prescription,L01XX66,SELINEXOR,8874,,,WHO ATC Classification,,ILS,tablets,SELINEXOR,2025-07-31T10:37:05.267786,IL,ניאופרם,,69630.84838,59009.19617,53644.72379,,7290111092886,XPOVIO 20 MG 32 TAB,24104,,57382,BLISTER PVC/PCTFE/PVC/ALU,units,32.0,167 04 36451 99,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Multiple Myeloma•	Xpovio® in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.•	XPOVIO in combination with dexamethasone is indicated for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least three prior therapies and whose disease is refractory to at least one proteasome inhibitor (PI), at least one immunomodulatory agent (IMiD), and an anti- CD38 monoclonal antibody (mAb).Diffuse Large B-Cell LymphomaXPOVIO is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0212dac7-4150-4af7-adc9-0ee011b85238.json
022c1b88-9e5d-4b98-9bfc-1f55ede1e330,AMANDIN 100,prescription,N04BB01,AMANTADINE,8650,,,WHO ATC Classification,,ILS,film coated tablets,AMANTADINE HEMISULFATE,2025-07-30T23:21:11.579660,IL,מגאפארם,,59.18135505,50.15369295,36.608535,,,AMANDIN 100 MG 100 TAB,,,29269,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,162 30 35338 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Parkinsonian syndromes:Treatment of symptoms of Parkinson’s disease such as rigor, tremor, hypokinesia and akinesia.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/022c1b88-9e5d-4b98-9bfc-1f55ede1e330.json
022c9b4a-5b0a-4791-8e20-920fd3ab4c28,IFO-CELL 2 G,prescription,L01AA06,IFOSFAMIDE,9099,,,WHO ATC Classification,,ILS,solution for infusion,IFOSFAMIDE/,2025-07-31T03:57:46.742363,IL,אמ.בי.איי פארמה,,1301.739534,1103.169145,938.8673578,,7290016369045,IFO-CELL 2 G,,,,VIAL GLASS TYPE I,units,1.0,155 73 34214 00,valid,17.5,i.v,1.4,18,,,,,,,,,,0,Prescription required,"• Testicular tumours For combination chemotherapy in patients with advanced stage II to IV tumours according to the TNM classification (seminomas and non-seminomas), which do not respond or adequately respond to initial chemotherapy.• Cervical cancerPalliative cisplatin/ifosfamide combination chemotherapy (without any other combination partners) of cervical carcinoma, FIGO stage IV B (when curative therapy of the disease is not possible with surgery or radiotherapy) – as an alternative to palliative radiotherapy.• Breast cancerFor palliative therapy in advanced, therapy-refractory or recurrent breast cancer.• Non-small-cell lung cancerFor mono- or combination chemotherapy of patients with inoperable or metastatic tumours.• Small-cell lung cancerFor combination chemotherapy.• Soft-tissue sarcoma (incl. osteosarcoma and rhabdomyosarcoma)For mono- or combination chemotherapy of rhabdomyosarcoma or osteosarcoma after failure of standard therapies. For mono- or combination chemotherapy of other soft-tissue sarcomas after failure of surgery and radiation therapy.• Ewing’s sarcomaFor combination chemotherapy after failure of primary cytostatic therapy.• Non-Hodgkin’s lymphomaFor combination chemotherapy in patients with highly malignant non-Hodgkin’s lymphoma which does not respond, or only insufficiently responds, to the initial therapy. For combination therapy of patients with recurrent tumours.• Hodgkin’s diseaseFor the treatment of patients with primary progressive forms and early relapse of Hodgkin’s disease (duration of complete remission shorter than one year) after failure of primary chemotherapeutic or radiochemotherapeutic treatment – as part of a recognised combination chemotherapy regimen, such as the MINE protocol.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/022c9b4a-5b0a-4791-8e20-920fd3ab4c28.json
02317230-91e9-4fdc-b63f-2b92df2cbced,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,1434,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T10:59:41.280917,IL,טבע,,14.2426,12.07,nan,,7290000800028,ACAMOL 500MG 20TAB,1017,,,BLISTER PVC/ALUMINIUM,units,20.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/02317230-91e9-4fdc-b63f-2b92df2cbced.json
02540e04-65f5-48b3-b3c3-9b4bc070b1df,PREGABALIN DEXCEL 100 MG,prescription,N03AX16,PREGABALIN,8080,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:52:48.660854,IL,דקסל פארמה,,123.5665273,104.717396,77.8568,,,PREGABALIN DEXCEL 75 MG 56 CAPSULES,16992,,58330,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,158 75 34730 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of peripheral and central neuropathic pain in adults.Management of FibromyalgiaTreatment of Generalised Anxiety Disorder (GAD) in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/02540e04-65f5-48b3-b3c3-9b4bc070b1df.json
025461cb-a1eb-4123-8500-150fd41053b2,CLAVENIR 1 G.,prescription,J01CR02,AMOXICILLIN AND ENZYME INHIBITOR,7097,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,"AMOXICILLIN AS SODIUM/VIAL, CLAVULANIC ACID AS POTASSIUM/VIAL",2025-07-31T01:19:22.964021,IL,ביואבניר,,140.413805,118.99475,95.1958,,7290010286065,CLAVENIR 10 VIAL (1.2G),9507,,69752,VIAL GLASS TYPE II,units,10.0,133 73 31216 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Indicated for the treatment of the following infections in adults and children: severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis, and sinusitis when accompanied by severe systemic signs and symptoms), acute exacerbations of chronic bronchitis (adequately diagnosed), community acquired pneumonia. cystitis, pyelonephritis, Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis, bone and joint infections, in particular osteomyelitis, intra-abdominal infections, female genital infections. Prophylaxis against infections associated with major surgical procedures in adults, such as those involving the: gastrointestinal tract, pelvic cavity, head and neck, biliary tract surgery.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/025461cb-a1eb-4123-8500-150fd41053b2.json
02662cd7-8636-45fb-8ac3-076d4468ee4b,KALURIL,prescription,C03EA01,HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS,1579,,,WHO ATC Classification,,ILS,tablets,"AMILORIDE AS HYDROCHLORIDE ANHYDROUS, HYDROCHLOROTHIAZIDE",2025-07-31T04:21:45.767022,IL,טבע,,19.72252,16.714,12.2,,7-290000-803425,KALURIL 30TAB,11186,,11983,BLISTER PVC/ALUMINIUM,units,30.0,117 57 23150 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Hypertension: Kaluril is indicated in the management of hypertension  either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of the disease.   Edema: Edema associated with congestive heart failure and hepatic cirrhosis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/02662cd7-8636-45fb-8ac3-076d4468ee4b.json
026e36b3-b2a4-42ed-b414-6bc261b11aa3,HYDROXYUREA MEDAC 500 MG,29C,L01XX05,HYDROXYCARBAMIDE,20091,,,WHO ATC Classification,,ILS,capsules,HYDROXYCARBAMIDE,2025-07-31T14:48:25.259656,IL,nan,,nan,nan,nan,,7290100819135,HYDROXYUREA 500MG 100CAPS,,,,BLISTER PVDC/ALUMINIUM,units,100.0,168 84 35373 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,Treatment of patient with chronic myeloid leukaemia (CML) in the chronic or accelerated phase of the disease.Treatment of patients with essential thrombocytaemia or polycythaemia vera with a high risk for thrmboembolic complications.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/026e36b3-b2a4-42ed-b414-6bc261b11aa3.json
0274a523-97c0-41d0-b392-6f2956783e21,PACLITAXEL ALBUMIN TEVA,prescription,L01CD01,PACLITAXEL,10079,,,WHO ATC Classification,,ILS,powder for suspension for infusion,PACLITAXEL/VIAL,2025-07-31T06:24:38.298090,IL,טבע,,744.3712256,630.8230725,536.8707,,,PACLITAXEL TEVA 6MG/ML  100MG/16.7ML,,,15928,VIAL GLASS TYPE I,units,1.0,166 86 36321 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Paclitaxel Albumin Teva monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0274a523-97c0-41d0-b392-6f2956783e21.json
0286ccdf-ebae-4d7e-b0d4-2e2b606daaaa,CEFAZOL 1 G.,prescription,J01DB04,CEFAZOLIN,8319,,,WHO ATC Classification,,ILS,powder for solution for injection,CEFAZOLIN AS SODIUM/VIAL,2025-07-31T00:58:59.151451,IL,ויטאמד,,103.0721145,87.3492496,64.94368,,,CEFAZOLIN -VIT 1 GR 10 VIALS,,,17038,VIAL GLASS TYPE III,units,10.0,141 70 31813 00,valid,34.5,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis.  Treatment Respiratory tract:  Respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae)  klebsiella species  haemophilus influenzae  staphylococcus aureus (penicillin-sensitive and penicillin-resistant)  and group A B - hemolytic streptococci.   Cefazolin is effective in the eradication of streptococci from the nasopharynx. However  data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.   Urinary tract:   Infections due to escherichia coli  klebsiella species  proteus mirabilis and some strains of Enterobacter and enterococci.   Skin and skin structure:   -hemolytic beta Infections due to Staphylococcus aureus (penicillin-sensitive and penicillin-resistant)  group A streptococci and other strains of streptococci.   Biliary tract:   Infections due to escherichia coli  various strains of streptococci  proteus mirabilis  klebsiella species and staphylococcus aureus.  Bone and joint :Infections due to staphylococcus aureus.   Genital infections (i.e. prostatitis  epididymitis) due to escherichia coli  proteus mirabilis  klebsiella species and some strains of enterococci.Septicemia due to streptococcus pneumoniae (formerly diplococcus pneumoniae)  staphylococcus aureus (penicillin-sensitive and penicillin-resistant) proteus mirabilis  escherichia coli and klebsiella species.Endocarditis caused by staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group A beta-hemolytic streptococci.   Appropriate culture and susceptibility studies should be performed to determine the susceptibility of the causative organism to cefazolin.Perioperative prophylaxis:   The prophylactic administraton of cefazolin perioperatively (preoperatively  intraoperatively and postoperatively) may reduce the incidence of certain postoperative infectons in patients undergoing surgical procedures (e.g. hysterectomy  gastrointestinal surgery and transurethral prostatectomy) that are classified as contaminated or potentially contaminated. The perioperative use of cefazolin may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g. open-heart surgery and prosthetic arthroplasty).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0286ccdf-ebae-4d7e-b0d4-2e2b606daaaa.json
0294c2b3-5a19-465a-b411-78ec7b294b65,SIMVAXON 10,prescription,C10AA01,SIMVASTATIN,6181,,,WHO ATC Classification,,ILS,caplets,SIMVASTATIN,2025-07-31T08:16:38.443351,IL,דקסל פארמה,,29.3534145,24.875775,18.1575,,,SIMVAXON 40MG 30TAB,19847,,86336,BLISTER ACLAR COATED PVC/ALUMINIUM,units,30.0,132 83 31147 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Coronary Heart Disease :   In patients with coronary heart disease and hypercholesterolemia  Simvaxon is indicated to:    - Reduce the risk of total mortality by reducing coronary death    - Reduce the risk of non-fatal myocardial infarction    - Reduce the risk for undergoing myocardial revascularization procedures    - Reduce the risk of stroke and transient ischemic attacks (TIA's).   Hyperlipidemia:   Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb)  Simvaxon therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia:   Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia):   Simvaxon is indicated for the treatment of patients with hypertriglyceridemia (Fredrickson type IV hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia):  Simvaxon is indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0294c2b3-5a19-465a-b411-78ec7b294b65.json
02bad792-4ed0-4612-9d8b-6eb4202db4c1,OTOMYCIN,29C,S02AA30,"ANTIINFECTIVES, COMBINATIONS",20887,,,WHO ATC Classification,,ILS,drops,"BENZOCAINE, NEOMYCIN AS SULFATE 0.35 %, PHENYLEPHRINE HYDROCHLORIDE 0.25 %, SODIUM PROPIONATE",2025-07-31T15:34:50.592027,IL,nan,,nan,nan,nan,,7290000808253,PHENYLEPHRINE  50MCG/ML INJECTION AGUETTANT FRANCE 10ML,,,,BOTTLE GLASS TYPE III,units,1.0,015 86 24749 00,valid,nan,otic,1.4,18,,,,,,,,,,0,,"Antibacterial, antifungal ear drops.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/02bad792-4ed0-4612-9d8b-6eb4202db4c1.json
02bd14a7-7e7b-49f2-83df-43442872b317,TEVADERM,prescription,D07AC06,DIFLUCORTOLONE,4416,,,WHO ATC Classification,,ILS,cream,"DIFLUCORTOLONE VALERATE 0.1 %, ISOCONAZOLE NITRATE",2025-07-31T09:17:23.039341,IL,טבע,,18.10592,15.344,11.2,,7290008097604,TEVADERM 15GR,20326,,4496,TUBE ALUMINIUM,units,15.0,122 85 30213 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,For the local treatment of inflammatory skin conditions accompanied by secondary fungal infections.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/02bd14a7-7e7b-49f2-83df-43442872b317.json
03003b38-d909-488a-8a50-5a3bf8a68d01,VYEPTI,prescription,N02CD05,EPTINEZUMAB,9347,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,EPTINEZUMAB/,2025-07-31T10:23:31.332603,IL,לנדבק,,5218.413177,4422.384245,4020.349314,,5702150154552,VYEPTI 100MG/ML 1 VIAL,22524,,4558,VIAL GLASS TYPE I,units,1.0,168 65 36769 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,VYEPTI is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/03003b38-d909-488a-8a50-5a3bf8a68d01.json
031e7f9a-d084-4cff-8426-06b90fe3c0db,SIMVASTATIN TEVA ® 40 MG,prescription,C10AA01,SIMVASTATIN,4132,,,WHO ATC Classification,,ILS,tablets,SIMVASTATIN,2025-07-31T08:15:06.869486,IL,טבע,,15.9121938,13.48491,9.843,,,SIMVASTATIN-TEVA 10MG 30TAB,19429,,26873,BLISTER PVC/PE/PVDC/AL,units,30.0,129 18 30737 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia  Simvastatin-teva is indicated to:     Reduce the risk of total mortality by reducing coronary death ;Reduce the risk of non-fatal myocardial infarction ;Reduce the risk for undergoing myocardial revascularization procedures.      Reduce the risk of stroke and transient ischemic attacks (TIA).   Hyperlipidemia: Simvastatin-teva is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvastatin-teva therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios.   Homozygous familial hypercholesterolemia: Simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Simvastatin-teva is indicated for the treatment of patients with hypertriglyceridemia ( Fredrickson type IV  hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia): Simvastatin-teva is also indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/031e7f9a-d084-4cff-8426-06b90fe3c0db.json
03202cf4-cac6-437a-89a3-fc5e5fb3dd3a,DIMETHYL FUMARATE MEDOMIE 120 MG,prescription,N07XX09,DIMETYL FUMARATE,9427,,,WHO ATC Classification,,ILS,capsules delayed release,DIMETHYL FUMARATE,2025-07-31T01:56:58.414340,IL,מדומי פארמה,,669.8656411,567.682772,483.134274,,7290019478003,DIMETHYL FUMARATE MEDOMIE 120 MG 14 CAPS,,,17204,BOTTLE HDPE,units,14.0,170 06 36832 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/03202cf4-cac6-437a-89a3-fc5e5fb3dd3a.json
033c0f7d-69a4-49b2-b959-ab60d15ae6b7,OMVOH 100 MG / ML,prescription,L04AC24,MIRIKIZUMAB,9479,,,WHO ATC Classification,,ILS,solution for injection,MIRIKIZUMAB/,2025-07-31T06:10:11.708939,IL,אלי לילי,,8770.682414,7432.782037,6757.074579,,7290016021394,OMVOH 100 MG/ML 2 PFS,15610,,63091,PRE-FILLED PEN GLASS TYPE I,units,2.0,174 95 37706 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/033c0f7d-69a4-49b2-b959-ab60d15ae6b7.json
0341046e-a1a9-409e-941d-6ca6a3f4aa68,VECTIBIX 20 MG/ML,prescription,L01XC08,PANITUMUMAB,6331,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PANITUMUMAB/,2025-07-31T10:01:31.718447,IL,מדיסון,,1850.113052,1567.892487,1334.376584,,,VECTIBIX 20MG/ML 5ML (100MG) VIAL,22340,,83845,VIAL GLASS TYPE I,units,1.0,142 92 32951 00,valid,17.5,i.v. infusion,1.4,36,,,,,,,,,,0,Prescription required,"In combination with chemotherapy for the treatment of unresectable, advanced or recurrent colorectal cancer (mCRC) with wild-type RAS.Monotherapy for the treatment of patients with metastatic colorectal carcinoma with wild-type RAS after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0341046e-a1a9-409e-941d-6ca6a3f4aa68.json
0345f9ce-9cee-438e-86d8-a5aa323fd9d1,VIEW,off-the-counter,N/A,,5442,,,WHO ATC Classification,,ILS,"eye drops, solution",TETRYZOLINE HYDROCHLORIDE 0.05 %,2025-07-31T13:35:39.385211,IL,ליף-פישר,,19.8948,16.86,nan,,7290102740024,VIEW EYE DROPS 15 ML,,,,BOTTLE LDPE,units,15.0,137 99 31728 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,"For the relief of irritation, burning, reddening or itching of the eye due to allergic or physical causes such as dust, smoke, pollen, sunlight.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0345f9ce-9cee-438e-86d8-a5aa323fd9d1.json
0351c705-c1fd-4e2b-be29-df8bac32b953,COD-GUAIACOL SYRUP 100ML,prescription,,,5063,,,,,,tablet,COD-GUAIACOL SYRUP,2025-07-31T19:03:34.420703,IL,ויטאמד,,,,,,,COD-GUAIACOL SYRUP 100ML,3135,,9412,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0351c705-c1fd-4e2b-be29-df8bac32b953.json
038d951c-8346-4326-bc1a-178efdca33ec,BIVALIRUDIN MEDI-MARKET 250 MG,prescription,B01AE06,BIVALIRUDIN,9619,,,WHO ATC Classification,,ILS,powder for concentrate for solution for injection / infusion,BIVALIRUDIN AS TRIFLUOROACETATE/VIAL,2025-07-31T00:39:45.951496,IL,מדי מרקט,,736.5953311,624.2333591,531.2624333,,7290015842594,BIVALIRUDIN 250 MG POWDER/VIAL,,,,VIAL GLASS TYPE I,units,1.0,171 52 36624 99,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Bivalirudin Medi-Market 250 mg is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/038d951c-8346-4326-bc1a-178efdca33ec.json
0397414f-f9d8-4f1e-b2da-d122f0266005,FLIXERGY NASAL SPRAY,off-the-counter,R01AD08,FLUTICASONE,5561,,,WHO ATC Classification,,ILS,suspension,FLUTICASONE PROPIONATE 0.05 %W/W,2025-07-31T11:56:11.213590,IL,ליף- תרימה,,28.143,23.85,nan,,,FLIXERGY NASAL SPRAY 15 ML(120DOSES),,,,BOTTLE GLASS,units,120.0,161 62 35496 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Self medication:Prophylaxis and treatment of seasonal allergic rhinitis including hay fever in adults.By Physicians order:Prophylaxis and treatment of seasonal allergic rhinitis including hay fever in children of the age of4 years and above and perennial rhinitis in adults and children of the age of 4 years and above., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0397414f-f9d8-4f1e-b2da-d122f0266005.json
03afde9f-5c8f-4ed1-bc36-5c8396f83d1c,DERMOVATE OINTMENT,prescription,D07AD01,CLOBETASOL,261,,,WHO ATC Classification,,ILS,ointment,CLOBETASOL 17- PROPIONATE 0.05 %W/W,2025-07-31T01:49:40.016437,IL,ג.ס.ק,,19.56231494,16.578233,12.1009,,7290008086127,DERMOVATE SCALP APPL SOL 25ML,4082,,649,TUBE ALUMINIUM,units,25.0,027 57 22063 00,valid,37.0,topical,1.4,24,,,,,,,,,,0,Prescription required,"Clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. These include the following:• Psoriasis (excluding widespread plaque psoriasis)• Recalcitrant dermatoses  •Lichen planus• Discoid lupus erythematosus • Other skin conditions which do not respond satisfactorily to less potent steroids.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/03afde9f-5c8f-4ed1-bc36-5c8396f83d1c.json
03cd6404-ee39-4c88-a852-ed91c5f59877,HEMAFER,off-the-counter,B03AB04,FERRIC HYDROXIDE,5514,,,WHO ATC Classification,,ILS,drops,FERRIC HYDROXIDE POLYMALTOSE COMPLEX AS/ML,2025-07-31T12:03:05.075159,IL,ליף-טרי אוף ליף,,60.4632,51.24,nan,,7290106962675,HEMAFER DROPS 50mg/ml 30 ml,,,,BOTTLE GLASS TYPE III,units,30.0,150 66 33806 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,Prevention and treatment of iron deficiency anaemia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/03cd6404-ee39-4c88-a852-ed91c5f59877.json
03e0005a-6a4a-4a28-a11c-79eccae92179,M.I.R. 15,prescription,N02AA01,MORPHINE,1865,,,WHO ATC Classification,,ILS,tablets,MORPHINE SULFATE,2025-07-31T05:03:07.211066,IL,רפא,,55.69267582,47.197185,34.4505,,7290008014076,M.I.R 30MG 20TAB,13465,,8343,BLISTER PVC/ALUMINIUM,units,20.0,033 83 25309 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of moderate to severe pain.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/03e0005a-6a4a-4a28-a11c-79eccae92179.json
03f33255-dd97-4908-9794-0ec972b22fc2,AUGMENTIN SUSPENSION 400 MG/5 ML,prescription,J01CR02,AMOXICILLIN AND ENZYME INHIBITOR,3057,,,WHO ATC Classification,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM SALT 11.4 MG/ML, AMOXICILLIN AS TRIHYDRATE/ML",2025-07-30T23:31:31.264927,IL,ג.ס.ק,,33.16341738,28.104591,20.5143,,7290010140121,AUGMENTIN 500MG 20TAB,1342,,69015,BOTTLE GLASS TYPE III,units,20.0,112 75 29288 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Augmentin is indicated for the treatment of the following infections in adults and children: • Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.• Recurrent tonsillitis",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/03f33255-dd97-4908-9794-0ec972b22fc2.json
04041f48-64ff-486f-8ef4-b638ca7ba732,DERMAX,off-the-counter,,,1799,,,,,ILS,solution,TRICLOSANV/V,2025-07-31T11:29:41.838682,IL,פישר,,49.9966,42.37,nan,,7290000849386,DERMAX 500ML,4078,,,BOTTLE HDPE,units,500.0,022 58 24975 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,For treatment and disinfection of skin infections .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04041f48-64ff-486f-8ef4-b638ca7ba732.json
042c29fe-cbd9-4c7a-ae6a-63b1cbf283d1,FOLIRON,off-the-counter,B03AD01,FERROUS AMINO ACID COMPLEX,5571,,,WHO ATC Classification,,ILS,tablets,"FOLIC ACID 0.4  MG, IRON AS HYDROXIDE POLYMALTOSE COMPLEX",2025-07-31T11:57:21.669985,IL,סם און,,53.5956,45.42,nan,,7290013834294,FOLIRON 0.4 MG/100 MG 30 TAB,,,,BOTTLE HDPE,units,30.0,161 68 34992 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/042c29fe-cbd9-4c7a-ae6a-63b1cbf283d1.json
043649fd-0e1b-494c-bdda-de9b0deceef5,EMEND 125 MG CAPSULES,prescription,A04AD12,APREPITANT,4969,,,WHO ATC Classification,,ILS,capsules,APREPITANT,2025-07-31T02:17:56.413843,IL,מ.ס.ד. ישראל,,166.2533088,140.8926409,112.7141127,,7290006813114,EMEND 1X125MG+2X80MG CAPS,5410,,70091,BLISTER PVC/ALUMINIUM,units,3.0,135 09 31207 13,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Emend in combination with other antiemetic agents  is indicated for the:   - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy  including high-dose cisplatin.  - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/043649fd-0e1b-494c-bdda-de9b0deceef5.json
0441e340-1eb0-4357-a422-b6535923c106,LAMODEX 100 MG DISPERSIBLE/CHEWABLE TABLETS,prescription,N03AX09,LAMOTRIGINE,4722,,,WHO ATC Classification,,ILS,dispersible/chewable tablets,LAMOTRIGINE,2025-07-31T04:33:35.421636,IL,דקסל פארמה,,118.7379342,100.625368,74.8144,,,LAMODEX 200MG 30DISP/CHEW TAB,12354,,68253,BLISTER ACLAR/PVC/ALUMINIUM,units,30.0,129 88 30814 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy • Adults and adolescents aged 13 years and above:   - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.   - Seizures associated with Lennox-Gastaut syndrome. Lamodex is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome. • Children and adolescents aged 2 to 12 years:   - Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.   - Monotherapy of typical absence seizures.Bipolar disorder • Adults aged 18 years and above   - Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamodex is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0441e340-1eb0-4357-a422-b6535923c106.json
0469adfb-fd11-40fd-9417-23a9c14ca2f5,STAMARIL,prescription,J07BL01,"YELLOW FEVER, LIVE ATTENUATED",7530,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,YELLOW FEVER VIRUS STRAIN 17D204 (SUBSTRAIN AB237),2025-07-31T08:39:46.911725,IL,סאנופי אוונטיס,,197.133922,167.0626532,133.6501226,,,STAMARIL 1VIAL,,,61759,VIAL 3 ML GLASS TYPE I,units,1.0,133 30 30951 00,valid,25.0,"i.m, s.c",1.4,36,,,,,,,,,,0,Prescription required,"STAMARIL is indicated for active immunization against yellow fever in persons:•	travelling to, passing through or living in an endemic area,•	travelling to any country that requires an International Certificate of Vaccination for entry(which may or may not depend on the previous itinerary).•	handling potentially infectious materials (e.g. laboratory personnel).See sections 4.2, 4.3 and 4.4 regarding the minimum age for vaccination of children under special circumstances and guidance for vaccination of other specific patient populations.In order to comply with vaccine regulations and to be officially recognized, yellow fever vaccines must be administered in an approved World Health Organization (WHO) vaccination centre and registered on an International Certificate of Vaccination. The validity period of thiscertificate is established according to International Health Regulations (IHR) recommendations, and starts 10 days after primary vaccination and immediately after re-vaccination (see Section 4.2).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0469adfb-fd11-40fd-9417-23a9c14ca2f5.json
0470bb61-d223-47c7-81d0-f59e8702d03a,BACTROBAN NASAL,prescription,R01AX06,MUPIROCIN,976,,,WHO ATC Classification,,ILS,ointment,MUPIROCIN AS CALCIUMW/W,2025-07-31T00:28:28.439547,IL,ג.ס.ק,,29.60566179,25.08954501,18.3135365,,7290008102582,BACTROBAN NASAL 3GR,2371,,20801,TUBE ALUMINIUM,units,3.0,050 85 26431 21,valid,37.0,nasal,1.4,36,,,,,,,,,,0,Prescription required,"The elimination of nasal carriage of staphylococci, including methycillin-resistant staphylococus aureus (MRSA).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0470bb61-d223-47c7-81d0-f59e8702d03a.json
0475316b-5ee1-4cf5-9f22-b5acf45f0fdb,TREVICTA,prescription,N05AX13,PALIPERIDONE,7924,,,WHO ATC Classification,,ILS,extended release suspension for injection,PALIPERIDONE AS PALMITATE/,2025-07-31T09:40:43.587198,IL,יאנסן סילג,,3548.675444,3007.352205,2733.95655,,,TREVICTA E.R SUSP FOR INJ 525MG/2.625ML,20830,,73582,SYRINGE PREFILLED  CYCLIC OLEFIN COPOLYMER,units,1.0,157 43 34606 00,valid,10.0,i.m,1.4,24,,,,,,,,,,0,Prescription required,"TREVICTA, a 3 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly paliperidone palmitate injectable product",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0475316b-5ee1-4cf5-9f22-b5acf45f0fdb.json
04800a5c-b6ff-42e3-a6f4-0ab5ec27a8da,MELODIL 25,prescription,N06AA21,MAPROTILINE,2248,,,WHO ATC Classification,,ILS,tablets,MAPROTILINE HYDROCHLORIDE,2025-07-31T05:09:45.441697,IL,אוניפארם,,14.6657952,12.42864,9.072,,7290000812199,MELODIL 25MG 30TAB,13070,,2563,BLISTER PVC/ALUMINIUM,units,30.0,032 57 22655 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of depressive states and anxiety states associated with depression.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04800a5c-b6ff-42e3-a6f4-0ab5ec27a8da.json
04a063ba-b0aa-4278-8ca6-a84a6685c16a,HYPERHEP B S/D,prescription,J06BB04,HEPATITIS B IMMUNOGLOBULIN,8932,,,WHO ATC Classification,,ILS,solution for injection,HEPATITIS B IMMUNOGLOBULIN/ML,2025-07-31T03:53:20.382499,IL,פאדאגיס,,nan,nan,nan,,,HYPERHEP B S/D 0.5ML,,,,SYRINGE 0.5 ML GLASS TYPE I,units,0.5,127 10 27800 00,valid,nan,i.m,1.4,36,,,,,,,,,,0,Prescription required,"For post-exposure prophylaxis such as: - acute exposure to blood containing HBsAG, - perinatal exposure of infants born to HBsAg-positive mothers, - sexual exposure to HBsAg positive persons, - household exposure to persons with acute HBV infections.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04a063ba-b0aa-4278-8ca6-a84a6685c16a.json
04a9e0b6-288f-4ff0-8c28-ac8fe799381d,DURATEARS,off-the-counter,,,730,,,,,ILS,eye ointment,"MINERAL OIL/G, LANOLIN/G, PETROLATUM/G",2025-07-31T11:34:14.334226,IL,לפידות,,28.2374,23.93,nan,,7290008067690,DURATEARS OINT 3.5GR,4347,,,TUBE ALUMINIUM,units,3.5,109 33 24050 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,Eye dryness.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04a9e0b6-288f-4ff0-8c28-ac8fe799381d.json
04c43b26-6faa-47d0-9e37-a81983c1f0f6,NORLIP,prescription,,,4432,,,,,ILS,tablets,BEZAFIBRATE,2025-07-31T05:51:05.384135,IL,אוניפארם,,31.77653624,26.929268,19.6564,,,NORLIP 200MG 60TAB,14247,,28175,BLISTER PVC/ALUMINIUM,units,60.0,046 05 23778 02,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Norlip is indicated for:•primary hyperlipidaemia types IIa, IIb, III, IV and V (Fredrickson classification) corresponding to groups I, II and III of the European Atherosclerosis Society guidelines – when diet alone or improvements in lifestyle such as increased exercise or weight reduction do not lead to an adequate response. •secondary hyperlipidaemias, e.g. severe hypertriglyceridemias, when sufficient improvement does not occur after correction of the underlying disorder (e.g. diabetes mellitus)",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04c43b26-6faa-47d0-9e37-a81983c1f0f6.json
04dfab05-3dce-493c-b5d2-dd979df119dc,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,6615,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T02:57:43.865219,IL,רפא,,56.36017244,47.762858,34.8634,,,FENTA 12MCG/HOUR 5PATCHES,6408,,14813,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,5.0,148 73 33262 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04dfab05-3dce-493c-b5d2-dd979df119dc.json
04dfafc5-dfe9-4f8d-96c5-1c265a6f9aad,CATAFLAM 50 MG,prescription,M01AB05,DICLOFENAC,3156,,,WHO ATC Classification,,ILS,tablets,DICLOFENAC AS POTASSIUM,2025-07-31T00:57:20.159440,IL,נוברטיס פארמה,,16.74380443,14.1896654,10.35742,,7290008051873,CATAFLAM 50MG 10TAB,3122,,9289,BLISTER PVC/PE/PVDC/AL,units,10.0,069 40 28459 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Management of pain and primary dysmenorrhea, when prompt pain relief is desired.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04dfafc5-dfe9-4f8d-96c5-1c265a6f9aad.json
04e76c33-cbbf-4b6d-88bc-f7e55a668c2f,OXOPURIN 400,prescription,C04AD03,PENTOXIFYLLINE,1779,,,WHO ATC Classification,,ILS,caplets prolonged release,PENTOXIFYLLINE,2025-07-31T06:21:04.023207,IL,דקסל פארמה,,88.72333388,75.189266,55.9028,,7290000806655,OXOPURIN 400MG 100 SR CAPLETS,15280,,7822,BLISTER PVC/ALUMINIUM,units,100.0,011 41 23858 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the improvement of blood flow in the peripheral blood vessels.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04e76c33-cbbf-4b6d-88bc-f7e55a668c2f.json
04eed88b-dfb6-428c-b778-837291be1e31,POLYCUTAN,prescription,D01AC20,COMBINATIONS,2450,,,WHO ATC Classification,,ILS,cream,"CLOTRIMAZOLE, NEOMYCIN SULFATE 0.645 %, DEXAMETHASONE ACETATE 0.044 %",2025-07-31T06:47:18.398349,IL,פאדאגיס,,nan,nan,nan,,7290000857206,POLYCUTAN CREAM 30GR,16561,,8043,TUBE ALUMINIUM,units,30.0,048 52 23172 00,valid,nan,topical,1.4,24,,,,,,,,,,0,Prescription required,Treatment of dermatitis involving also a bacterial and/or fungal infection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/04eed88b-dfb6-428c-b778-837291be1e31.json
05044ea6-d76e-4205-b80d-963c1cd4d62f,SODIUM VALPROATE WOCKHARDT,prescription,N03AG01,VALPROIC ACID,8618,,,WHO ATC Classification,,ILS,solution for injection / infusion,VALPROIC ACID AS SODIUM/ML,2025-07-31T08:26:20.738840,IL,פרופארם,,445.9985357,377.9648776,321.6722363,,,SODIUM VALPROATE WOCKHARDT 100 MG/ML (4 ML) 5 AMP,,,55515,AMPOULES GLASS TYPE I,units,5.0,158 63 34432 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of:•Generalized seizures in the form of absences, myoclonic and tonic-clonic seizures•Partial and secondary generalized seizures.Combination treatment of other forms of seizures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/05044ea6-d76e-4205-b80d-963c1cd4d62f.json
0508bd53-543c-42a1-bf4f-953b021e906e,TUMS ULTRA ASSORTED BERRIES,off-the-counter,A12AA04,CALCIUM CARBONATE,5085,,,WHO ATC Classification,,ILS,chewable tablets,CALCIUM CARBONATE,2025-07-31T13:31:48.533373,IL,ג.ס.ק,,79.9096,67.72,nan,,,TUMS ULTRA 1G ASSORTED 160TAB,20328,,,BOTTLE POLYPROPYLENE,units,160.0,124 55 30280 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,For relief from heartburn and acidity.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0508bd53-543c-42a1-bf4f-953b021e906e.json
051b5355-dd48-445c-96c2-c553365466c4,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,1743,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:31:33.213209,IL,דקסל פארמה,,21.4996,18.22,nan,,,DEXAMOL KID 20TAB,4429,,,BLISTER PVC/ALUMINIUM,units,20.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/051b5355-dd48-445c-96c2-c553365466c4.json
054b869e-63c4-488e-b7be-a9a8d870e87e,DUOTRAV,prescription,S01ED51,"TIMOLOL, COMBINATIONS",8406,,,WHO ATC Classification,,ILS,"eye drops, solution","TRAVOPROST/ML, TIMOLOL AS MALEATE/ML",2025-07-31T09:36:45.441642,IL,SK PHARM(KS KIM),,39.38113863,33.3738463,24.36047175,,729001639250,TRAVOPROST S.K. 2.5ml,20887,,34645,BOTTLE POLYPROPYLENE,units,2.5,144 33 31764 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Decrease of intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/054b869e-63c4-488e-b7be-a9a8d870e87e.json
0555d854-3506-4110-a31e-200abb01b64a,ZINNAT TABLETS 125 MG,prescription,J01DC02,CEFUROXIME,3731,,,WHO ATC Classification,,ILS,tablets,CEFUROXIME AS AXETIL,2025-07-31T10:49:52.369743,IL,סנדוז,,39.76350843,33.69789,24.597,,,ZINNAT 250MG/5ML SUSP 100ML,26087,,36715,BLISTER ALUMINIUM,units,100.0,041 40 25801 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Zinnat is indicated for the treatment of the infections listed below in adults and children from the age of 3 months .• Acute streptococcal tonsillitis and pharyngitis.• Acute bacterial sinusitis.• Acute otitis media.• Acute exacerbations of chronic bronchitis.• Cystitis.• Pyelonephritis.• Uncomplicated skin and soft tissue infections. •Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0555d854-3506-4110-a31e-200abb01b64a.json
055e9c85-2cf3-4e27-ae31-0193de5e4aa2,ACAMOLI ® FORTE 50 MG/ML SYRUP STRAWBERRY FLAVOUR,off-the-counter,N02BE01,PARACETAMOL,1437,,,WHO ATC Classification,,ILS,syrup,PARACETAMOL/,2025-07-31T11:02:02.341418,IL,טבע,,16.1188,13.66,nan,,,ACAMOLI 150MG 12SUPP,1801,,,BOTTLE PET,units,12.0,140 18 31762 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Analgesic, antipyretic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/055e9c85-2cf3-4e27-ae31-0193de5e4aa2.json
056f1088-a679-4ec3-bd51-a1a35732da51,EPIRUBICIN INOVAMED 2MG/ML VIAL 50MG/25ML,prescription,,,7691,,,,,ILS,injection,EPIRUBICIN INOVAMED 2MG/ML VIAL 50MG/,2025-07-31T19:06:00.790968,IL,אינובמד,,275.1245225,233.156375,186.5251,,,EPIRUBICIN INOVAMED 2MG/ML VIAL 50MG/25ML,5588,,58467,,units,1.0,,not-registered,25.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/056f1088-a679-4ec3-bd51-a1a35732da51.json
0576b68e-ef46-48a3-aeb7-36d5d0a2cd55,REMOTIV 250,prescription,,,4889,,,,,ILS,film coated tablets,HYPERICI HERBA EXTRACTUM SICCUM,2025-07-31T07:24:31.588873,IL,רפא,,nan,nan,nan,,7290008012522,REMOTIV 250MG 60 F.C.TAB,18344,,65601,BLISTER PVC/PE/PVDC/AL,units,60.0,130 71 30720 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions. Treatment is recommended for up to 24 weeks.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0576b68e-ef46-48a3-aeb7-36d5d0a2cd55.json
05934eb4-f085-47d4-acc9-6bf9ee35fc65,EPHEDRINE AGUETTANT 3 MG/ML PRE-FILLED SYRINGE,29C,R01AA03,EPHEDRINE,20072,,,WHO ATC Classification,,ILS,solution for injection,EPHEDRINE HYDROCHLORIDE/,2025-07-31T14:29:25.356738,IL,nan,,nan,nan,nan,,,EPHEDRINE 30MG 28TAB,,,,SYRINGE PREFILLED  POLYPROPYLENE,units,28.0,177 79 37046 99,valid,nan,i.v,1.4,36,,,,,,,,,,0,,"Treatment of hypotension from spinal, epidural and general anaesthesia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/05934eb4-f085-47d4-acc9-6bf9ee35fc65.json
05a3e8d4-4d56-45c7-a756-a960cc4fead4,SUPRAMOL 'M' PEDIATRIC SUPPOSITORIES,off-the-counter,N02BE01,PARACETAMOL,2548,,,WHO ATC Classification,,ILS,suppositories,PARACETAMOL,2025-07-31T13:24:20.421391,IL,סם און,,24.2136,20.52,nan,,,SUPRAMOL 500MG 20SUP,19690,,,POUCH PVC/PE,units,20.0,042 50 23368 00,valid,nan,rectal,1.4,48,,,,,,,,,,0,,"Analgesic, antipyretic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/05a3e8d4-4d56-45c7-a756-a960cc4fead4.json
05bc8320-bcc5-4502-bd87-8c74b3b74642,HEMLIBRA 150 MG/ML,prescription,B02BX06,EMICIZUMAB,8447,,,WHO ATC Classification,,ILS,solution for injection,EMICIZUMAB/,2025-07-31T03:43:59.330611,IL,רוש,,31456.03327,26657.6565,24234.23318,,7290014774094,HEMLIBRA 150 MG/ML (105 MG/0.7ML),,,26631,VIAL GLASS TYPE I,units,1.0,161 19 35415 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/05bc8320-bcc5-4502-bd87-8c74b3b74642.json
05c8a37d-d941-4c45-a401-66a325c67564,RIBOMUSTIN 100 MG,prescription,L01AA09,BENDAMUSTINE ,7674,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BENDAMUSTINE  HYDROCHLORIDE/VIAL,2025-07-31T07:34:28.373028,IL,דור שירותים פרמצבטיים,,531.1060487,450.0898718,383.05521,,8718692510647,RIBOMUSTIN 100MG 1VIAL,18518,,67336,VIAL BROWN GLASS,units,1.0,152 40 33966 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"First-line of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotheraphy is not appropiate. Indolent non-Hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen.Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/05c8a37d-d941-4c45-a401-66a325c67564.json
05dce811-5a6c-4696-a937-adf5a5c8f974,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,573,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T12:43:01.379641,IL,ג.ס.ק,,30.5502,25.89,nan,,7290006603036,OTRIVIN MD SPY 10ML 0.05%,15320,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,10.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/05dce811-5a6c-4696-a937-adf5a5c8f974.json
05ebe9be-342b-4542-a027-b77350125001,CINACALCET TRIMA 30 MG,prescription,H05BX01,CINACALCET,7788,,,WHO ATC Classification,,ILS,film coated tablets,CINACALCET AS HYDROCHLORIDE,2025-07-31T01:15:07.062586,IL,תרימה,,2490.261675,2110.39125,1918.5375,,,CINACALCET TRIMA 90 MG 28TAB,9890,,32092,BLISTER PVC/ALUMINIUM,units,28.0,154 44 34241 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet -Trima  may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with:• parathyroid carcinoma.• primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/05ebe9be-342b-4542-a027-b77350125001.json
05f4beab-7ed3-4d69-9204-a2407077233f,ORSERDU 345 MG,prescription,L02BA04,ELACESTRANT,9482,,,WHO ATC Classification,,ILS,film coated tablets,ELACESTRANT AS DIHYDROCHLORIDE,2025-07-31T06:17:21.934616,IL,סטמליין ישראל,,16373.13833,13875.54157,12614.1287,,7290019908074,ORSERDU 86 MG 30 TAB,,,,BOTTLE HDPE,units,30.0,176 11 37712 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Orserdu is indicated for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/05f4beab-7ed3-4d69-9204-a2407077233f.json
06001e5e-4e26-4a4b-a506-0e8c39fe9d74,OLANZAPINE ODT TEVA ® 10 MG,prescription,N05AH03,OLANZAPINE,6817,,,WHO ATC Classification,,ILS,tablets orodispersible,OLANZAPINE,2025-07-31T06:05:14.492761,IL,טבע,,143.4005325,121.525875,97.2207,,7290106063143,OLANZAPINE  TEVA 10MG 28 F.C.TAB,15393,,2396,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,157 16 34591 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia. Olanza ODT Teva is indicated for the management  of the manifestations of psychotic disorders.Olanza ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanza ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanza ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06001e5e-4e26-4a4b-a506-0e8c39fe9d74.json
0600efc2-47f8-4b87-8102-b98f8c39476d,EXEMASIN - VIT,prescription,L02BG06,EXEMESTANE,8400,,,WHO ATC Classification,,ILS,film coated tablets,EXEMESTANE,2025-07-31T02:48:54.324728,IL,ויטאמד,,301.1369853,255.200835,217.1922,,,EXEMASIN - VIT 30 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,156 62 34456 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Exemasin-VIT is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone.Exemasin-VIT is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies. Exemasin-VIT is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0600efc2-47f8-4b87-8102-b98f8c39476d.json
0607824a-efb7-4fa7-984f-5adc2b07f201,TEPKINLY 4 MG / 0.8 ML,prescription,,,9472,,,,,ILS,solution for injection,EPCORITAMAB/ML,2025-07-31T09:13:34.410605,IL,אב-וי,,36008.37031,30515.56942,27741.42674,,8054083027029,TEPKINLY 48MG  1 VIAL,,,17436,VIAL GLASS TYPE I,units,1.0,176 07 37755 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"TEPKINLY is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B cell lymphoma after two or more lines of systemic therapy.Tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0607824a-efb7-4fa7-984f-5adc2b07f201.json
060f2727-89e9-412b-b3c8-20be1526e1ed,PEMETREXED TARO 100 MG,prescription,L01BA04,PEMETREXED,8477,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,PEMETREXED/VIAL,2025-07-31T06:33:00.192362,IL,תרו,,4932.985268,4180.49599,3800.4509,,7290017164151,PEMETREXED TARO 500 MG VIAL,,,68644,VIAL GLASS TYPE I,units,1.0,163 33 35358 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,1.Pemetrexed Taro in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. 2.Pemetrexed Taro in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. 3.Pemetrexed Taro is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.4.Pemetrexed Taro is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/060f2727-89e9-412b-b3c8-20be1526e1ed.json
0614f11a-00cc-487c-91b4-88e0c9b3935d,WELLBUTRIN XR 150 MG,prescription,N07BA02,BUPROPION,6241,,,WHO ATC Classification,,ILS,modified release tablets,BUPROPION HYDROCHLORIDE,2025-07-31T10:26:02.992526,IL,ג.ס.ק,,100.8479005,85.46432625,63.54225,,7290010140374,WELLBUTRIN XR 300MG 30 TABLETS,23068,,78653,BOTTLE HDPE,units,30.0,140 05 31653 00,valid,34.5,per os,1.4,18,,,,,,,,,,0,Prescription required,"Wellbutrin XR is indicated for the treatment of major depressive episodes.Following satisfactory response, continuation with Wellbutrin XR therapy is effective in preventingrelapse.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0614f11a-00cc-487c-91b4-88e0c9b3935d.json
06328967-b0d9-4766-821b-1047f74b0e11,TACROCEL 0.5 MG,prescription,L04AD02,TACROLIMUS,7080,,,WHO ATC Classification,,ILS,capsules,TACROLIMUS AS MONOHYDRATE 0.5  MG,2025-07-31T08:57:59.138556,IL,פאדאגיס,,1752.945433,1485.546978,1264.2953,,,TACROCEL 5 MG 50 CAPSULES,20747,,38114,BLISTER PVC/PE/PVDC/AL,units,50.0,148 54 33452 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in liver kidney or heart allograft recipients.Treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06328967-b0d9-4766-821b-1047f74b0e11.json
065d1be8-0e4b-423d-b6e3-50335d7c2e1d,AMBRISENTAN S.K. 10 MG,prescription,C02KX02,AMBRISENTAN,8984,,,WHO ATC Classification,,ILS,film coated tablets,AMBRISENTAN,2025-07-30T23:21:32.476031,IL,טבע,,4039.989548,3423.719956,3112.472687,,,AMBRISENTAN TEVA 10 MG 30TAB,17583,,74872,BLISTER PVC/PE/PVDC/AL,units,30.0,176 63 36826 99,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"AMBRISENTAN S.K. is indicated for treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment with tadalafil.Efficacy has been  shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/065d1be8-0e4b-423d-b6e3-50335d7c2e1d.json
065f415e-21ea-441c-916e-a1823e6cbdc5,TERLIPRESSIN ALTAN 1 MG,prescription,H01BA04,TERLIPRESSIN,9000,,,WHO ATC Classification,,ILS,solution for injection,TERLIPRESSIN AS ACETATE 0.1 MG/ML,2025-07-31T09:16:08.930809,IL,פרופארם,,1029.069,872.0924119,742.206308,,8470007050452,TERLIPRESSIN ALTAN 1 MG / 8.5 ML,,,71631,AMPOULES GLASS TYPE I,units,5.0,164 13 35448 00,valid,17.5,i.v,1.4,18,,,,,,,,,,0,Prescription required,Bleeding oesophageal varices. Treatment of type I hepatorenal syndrome,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/065f415e-21ea-441c-916e-a1823e6cbdc5.json
06670f74-4ffc-4e12-8788-98053192d5df,RAVICTI 1.1 G/ML,prescription,A16AX09,GLYCEROL PHENYLBUTYRATE,8691,,,WHO ATC Classification,,ILS,liquid,GLYCEROL PHENYLBUTYRATE 1.1 G /,2025-07-31T07:17:22.593923,IL,מדיסון,,955.0231073,809.3416523,688.8014063,,,RAVICTI 1.1 G/ML 25 ML,18574,,64852,BOTTLE GLASS TYPE II,units,25.0,162 79 35361 03,valid,17.5,"gastroenteral, oral",1.4,36,,,,,,,,,,0,Prescription required,"RAVICTI is indicated for use as adjunctive therapy  for chronic management of adult and paediatric patients &#8805;2 months of age with urea cycle disorders (UCDs) including deficiencies of carbamoyl phosphate-synthase-I (CPS), ornithine carbamoyltransferase (OTC), argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL), arginase I (ARG) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (HHH) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.   RAVICTI must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06670f74-4ffc-4e12-8788-98053192d5df.json
06687af0-a947-40cf-8532-f353400d875a,IBUPRO  FORTE 400,off-the-counter,M01AE01,IBUPROFEN,5447,,,WHO ATC Classification,,ILS,caplets,IBUPROFEN,2025-07-31T12:08:47.353890,IL,ליף-דקסון,,33.9014,28.73,nan,,,IBUPRO FORTE 400MG 30 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,30.0,127 97 30763 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. For the relief of mild to moderate pain and treatment of primary dysmenorrhea.For the treatment of pain associated with migraine.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06687af0-a947-40cf-8532-f353400d875a.json
06745c9b-2c0d-4470-b9ca-e78137ad391c,STRATTERA 4 MG/ML ORAL SOLUTION,prescription,N06BA09,ATOMOXETINE,8358,,,WHO ATC Classification,,ILS,solution  (oral),ATOMOXETINE/,2025-07-31T08:45:30.773116,IL,אלי לילי,,378.7391794,320.9654205,273.16206,,7290016021059,STRATTERA 4 MG/ML ORAL SOL 3 BOTTLES 100ML,9861,,24189,BOTTLE GLASS TYPE III,units,3.0,158 61 35026 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD. Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06745c9b-2c0d-4470-b9ca-e78137ad391c.json
0692010e-f2e0-46d8-a24c-0cbcd1c64f8f,CELLUSPAN,prescription,,,1794,,,,,ILS,"eye drops, solution",HYDROXYETHYLCELLULOSE 1.4 %,2025-07-31T01:05:04.219543,IL,פישר,,22.600067,19.1526,13.98,,7290000849522,CELLUSPAN EYE DROPS 10ML,3114,,476,BOTTLE LDPE,units,10.0,058 77 23763 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Diagnostic agent.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0692010e-f2e0-46d8-a24c-0cbcd1c64f8f.json
06aaa080-fdca-4eb3-b730-84002ed71f22,TOPITRIM 100 MG,prescription,N03AX11,TOPIRAMATE,6028,,,WHO ATC Classification,,ILS,tablets,TOPIRAMATE,2025-07-31T09:26:28.026633,IL,תרימה,,57.92099974,49.085593,35.8289,,,TOPITRIM 25MG 60TAB,20606,,72912,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,136 65 31516 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topitim is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topitrim is indicated in adults for the prevention of migraines. The use of Topitrim in the acute treatment of migraine has not been studied.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06aaa080-fdca-4eb3-b730-84002ed71f22.json
06c369f0-0f1e-4c1c-a951-7642131797b3,VESOXX,prescription,G04BD04,OXYBUTYNIN,9262,,,WHO ATC Classification,,ILS,solution for intravesical,OXYBUTYNIN HYDROCHLORIDE/,2025-07-31T10:09:52.918941,IL,פרופארם,,9299.08344,7880.579537,7164.163215,,,VESOXX 1MG/1ML (10MG/10ML) 100 SYRINGE PREFILLED,,,17138,SYRINGE PREFILLED  POLYPROPYLENE,units,100.0,174 61 37610 99,valid,10.0,intravesical,1.4,36,,,,,,,,,,0,Prescription required,"Vesoxx is indicated for the suppression of neurogenic detrusor overactivity (NDO) in children from 6 years of age and adults, who are managing bladder emptying by clean intermittent catheterization (CIC), if they cannot be adequately managed by oral anticholinergic treatment due to lack of efficacy and/or intolerable side effects..",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06c369f0-0f1e-4c1c-a951-7642131797b3.json
06c70c29-bdb0-43b5-92e9-d2c8b2a3aea3,ACAMOLI ® FORTE 50 MG/ML SYRUP STRAWBERRY FLAVOUR,off-the-counter,N02BE01,PARACETAMOL,5295,,,WHO ATC Classification,,ILS,syrup,PARACETAMOL/,2025-07-31T11:02:54.131213,IL,טבע,,38.9282,32.99,nan,,,ACAMOLI SYR FOR BIG KIDS STRAB 100ML,,,,BOTTLE PET,units,100.0,140 18 31762 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Analgesic, antipyretic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06c70c29-bdb0-43b5-92e9-d2c8b2a3aea3.json
06deaaf8-d882-42b4-aa98-dd86d2d4cb08,ETORICOXIB DEXCEL 120 MG,prescription,M01AH05,ETORICOXIB,8181,,,WHO ATC Classification,,ILS,tablets,ETORICOXIB,2025-07-31T02:41:28.746147,IL,דקסל פארמה,,45.16670944,38.27687241,27.93932293,,,ETORICOXIB DEXCEL 90 MG 14 tabs,5629,,74263,BLISTER ALUMINIUM /ALUMINIUM,units,14.0,160 18 34751 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06deaaf8-d882-42b4-aa98-dd86d2d4cb08.json
06e7d832-d1a0-4dec-b02b-50311258094c,EPIVIR 150 MG,prescription,J05AF05,LAMIVUDINE,3291,,,WHO ATC Classification,,ILS,film coated tablets,LAMIVUDINE,2025-07-31T02:28:38.556668,IL,ג.ס.ק,,341.0487578,289.0243838,245.978199,,7290008085502,EPIVIR 150MG 60TAB,5081,,9442,BOTTLE HDPE,units,60.0,102 54 28844 22,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Epivir is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06e7d832-d1a0-4dec-b02b-50311258094c.json
06fe4d25-4254-4d0b-a337-5d39642a4032,PIOGLITAZONE TEVA 45 MG,prescription,A10BG03,PIOGLITAZONE,9584,,,WHO ATC Classification,,ILS,tablets,PIOGLITAZONE AS HYDROCHLORIDE,2025-07-31T06:43:52.616569,IL,טבע,,151.0019832,127.9677881,102.3742305,,,PIOGLITAZONE TEVA 45 MG,,,17331,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,165 42 36345 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Pioglitazone Teva is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.Pioglitazone Teva is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/06fe4d25-4254-4d0b-a337-5d39642a4032.json
0707ce30-04f3-46bf-9406-8768c4f4b739,VICTOZA,prescription,A10BX07,LIRAGLUTIDE,6292,,,WHO ATC Classification,,ILS,solution for injection,LIRAGLUTIDE/ML,2025-07-31T10:13:24.482532,IL,נובו נורדיסק,,432.5521911,366.5696698,311.974187,,7290008126755,VICTOZA  6MG/ML 3ML 2 PRE FILLED PEN,22304,,83834,PRE-FILLED PEN GLASS TYPE I,units,2.0,143 07 32987 00,valid,17.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Victoza is indicated for: • Treatment of adults, adolescents and children aged 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:  1. As monotherapy when metformin is considered inappropriate due to intolerance or contraindications  2. In addition to other medicinal products for the treatment of diabetes. • To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0707ce30-04f3-46bf-9406-8768c4f4b739.json
0709655f-680c-4d01-ae4e-52ed155436ae,CEFOVIT FORTE 500,prescription,J01DB01,CEFALEXIN,8562,,,WHO ATC Classification,,ILS,capsules,CEFALEXIN AS MONOHYDRATE,2025-07-31T01:00:18.304854,IL,ויטאמד,,30.06876,25.482,18.6,,,CEFOVIT FORTE 500 MG 20 CAPS,,,2438,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,026 85 25146 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of infections caused by cephalexin susceptible microorganisms.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0709655f-680c-4d01-ae4e-52ed155436ae.json
0714fb9c-278c-4bca-a2c8-c5d012062845,HYSONE4 ALPHARM AUSTRALIA,29C,,,20850,,,,,,tablet,HYSONE4 ALPHARM AUSTRALIA,2025-07-31T20:36:48.592736,IL,nan,,,,,,,HYSONE4 ALPHARM AUSTRALIA,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0714fb9c-278c-4bca-a2c8-c5d012062845.json
073d24ae-7538-4bf6-bc14-bcc66899c792,PITRIYA-T,off-the-counter,D01AE15,TERBINAFINE,5613,,,WHO ATC Classification,,ILS,cream,TERBINAFINE HYDROCHLORIDEW/W,2025-07-31T12:48:33.556011,IL,תרו יבוא,,50.327,42.65,nan,,,PITRIYA-T CREAM 15 G,,,,TUBE LAMINATED,units,15.0,166 65 36323 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum) Microsporum canis and Epidemophyton floccosum. Yeast infections of the skin principally those caused by the genus Candida (e.g. candida albicans). Pityriasis (tinea versicolor) due to pityrosporum orbiculare (also known as malassezia furfur). For the treatment of plantar-type tinea pedis (Moccasin type).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/073d24ae-7538-4bf6-bc14-bcc66899c792.json
075362fd-b650-4d9a-8357-a27662853959,AREXVY,prescription,,,9516,,,,,ILS,powder and suspension for suspension for injection,RSVPREF3 ANTIGEN/VIAL,2025-07-31T00:24:51.352728,IL,ג.ס.ק,,1030.596046,873.3865181,743.307675,,7290014547742,AREXVY 163 MCG/ VIAL 1 VIAL,,,16117,VIAL GLASS TYPE I,units,1.0,175 37 37768 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,Arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/075362fd-b650-4d9a-8357-a27662853959.json
075a1204-32eb-40b7-a2a2-8c231b7d0270,TRUVADA,prescription,J05AF07,TENOFOVIR DISOPROXIL,4972,,,WHO ATC Classification,,ILS,film coated tablets,"EMTRICITABINE, TENOFOVIR DISOPROXIL AS FUMARATE",2025-07-31T09:47:36.452222,IL,גיליאד,,2203.263857,1867.17276,1589.0832,,7290006401625,TRUVADA 30TAB,20584,,69621,BOTTLE HDPE,units,30.0,134 42 31125 23,valid,17.5,per os,1.4,42,,,,,,,,,,0,Prescription required,Truvada is indicated in combination with other anti-retroviral medicinal products for the treatment of HIV-1 infected adults over 18 years of age.Truvada is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection in adults at high risk .,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/075a1204-32eb-40b7-a2a2-8c231b7d0270.json
076ab8f9-4f3c-4c77-997c-c7a735c93ddd,SEROQUEL 100 MG,prescription,N05AH04,QUETIAPINE,4129,,,WHO ATC Classification,,ILS,film coated tablets,QUETIAPINE AS FUMARATE,2025-07-31T08:06:21.856319,IL,צמל,,54.01189928,45.772796,33.4108,,,SEROQUEL 100MG 30TAB,19419,,25351,BLISTER PVC/ALUMINIUM,units,30.0,109 40 29314 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of schizophrenia.   Treatment of manic episodes associated with bipolar disorder. Treatment of major depressive episodes in bipolar disorders.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/076ab8f9-4f3c-4c77-997c-c7a735c93ddd.json
076bdc8a-6248-4400-8000-f8edbfc44be3,RIZALT  RPD 10 MG WAFERS,prescription,N02CC04,RIZATRIPTAN,3834,,,WHO ATC Classification,,ILS,tablets soluble in mouth,RIZATRIPTAN AS BENZOATE,2025-07-31T07:46:51.839257,IL,אורגנון,,112.0170101,94.9296696,70.57968,,,RIZALT RPD 10MG 6 WAFER,18274,,9761,BLISTER PVC/PVDC/ALUMINIUM,units,6.0,112 38 29510 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/076bdc8a-6248-4400-8000-f8edbfc44be3.json
07a37cb9-ffaa-4f53-a31b-5a20ea86279d,DACARBAZINE MEDAC 1000 MG,prescription,L01AX04,DACARBAZINE,7441,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,DACARBAZINE AS CITRATE/VIAL,2025-07-31T01:38:37.426049,IL,צמל,,185.3819825,157.103375,125.6827,,,DACARBAZINE MEDAC 500MG VIAL,4524,,86831,VIAL GLASS,units,1.0,134 90 31172 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. Further indications for dacarbazine as part of a combination chemotherapy in advanced Hodgkin's disease as a second line.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/07a37cb9-ffaa-4f53-a31b-5a20ea86279d.json
07deae07-1942-4622-84cf-2fd7b82c15db,FUROSEMIDE BAXTER 20 MG/2 ML,prescription,C03CA01,FUROSEMIDE,8991,,,WHO ATC Classification,,ILS,solution for injection,FUROSEMIDE/ML,2025-07-31T03:22:50.436094,IL,מרגלית,,15.51936,13.152,9.6,,7290001942505,FUROSEMIDE BAXTER 20 MG/2 ML 5 AMPS,,,59056,AMPOULES GLASS TYPE I,units,5.0,157 93 34378 00,valid,37.0,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,"Furosemide baxter 20mg/2 ml Injection is a potent diuretic indicated for use when a prompt and effective diuresis is required. The Furosemide baxter 20 mg/2 ml injection is appropriate for use in emergencies or when oral therapy is not feasible. Indications include cardiac, pulmonary, hepatic and renal oedema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/07deae07-1942-4622-84cf-2fd7b82c15db.json
07e51da5-e8a6-4553-a39b-84f6a54305fe,ISADERM VETERINARY,prescription,,,6478,,,,,ILS,gel,"BETAMETHASONE AS VALERATE 0.1 %, FUSIDIC ACID AS HEMIHYDRATE 0.5 %",2025-07-31T03:23:34.064638,IL,טבע,,15.03438,12.741,9.3,,5701170099003,FUSID 40MG 30TAB,6442,,84637,TUBE ALUMINIUM,units,30.0,082 41 92173 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,"For the topical treatment of surface pyoderma in dogs such as acute moist dermatitis (""hot spots"") and intertrigo (skin fold dermatitis) in dogs.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/07e51da5-e8a6-4553-a39b-84f6a54305fe.json
0835d5a8-e9ce-41ba-83e8-ea25f9933e76,RIVAROXABAN DEXCEL 2.5 MG,prescription,B01AF01,RIVAROXABAN,9392,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN 2.5  MG,2025-07-31T07:42:54.191780,IL,דקסל פארמה,,301.1194655,255.1859877,217.179564,,7290015912945,RIVAROXABAN DEXCEL 2.5 MG 56 TAB,18707,,16653,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,172 92 36481 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Rivaroxaban Dexcel 2.5 mg, co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers.Rivaroxaban Dexcel 2.5 mg, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0835d5a8-e9ce-41ba-83e8-ea25f9933e76.json
086f9b11-9e87-4402-9cf4-de493841de21,MEROAVENIR  1G  10VIALS,prescription,,,8278,,,,,ILS,injection,MEROAVENIR 1G S,2025-07-31T19:18:09.512302,IL,ביואבניר,,960.8428362,814.27359,692.9988,,,MEROAVENIR  1G  10VIALS,,,51366,,units,10.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/086f9b11-9e87-4402-9cf4-de493841de21.json
088db102-0ce5-476c-ae63-272a421340f7,LUMYKRAS,prescription,L01XX73,SOTORASIB,9221,,,WHO ATC Classification,,ILS,film coated tablets,SOTORASIB,2025-07-31T04:59:11.584441,IL,מדיסון,,33400.18224,28305.24044,25732.03676,,8715131024918,LUMYKRAS 120 MG 240 TAB,,,,BLISTER ALU-PVC/PE/PVDC ,units,240.0,169 95 37013 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"LUMYKRAS is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an approved test, who have received at least one prior systemic therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/088db102-0ce5-476c-ae63-272a421340f7.json
08a379fb-29d5-41ef-8acc-ff51bcaa0ab5,ALLERGYX,off-the-counter,,,5067,,,,,ILS,tablets,LORATADINE,2025-07-31T11:12:30.716184,IL,טבע,,60.4986,51.27,nan,,729000802626,ALLERGYX 10MG 20TAB,1980,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,124 58 30421 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of symptoms of allergy in seasonal allergic rhinitis, perennial allergic rhinitis, chronic urticaria.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/08a379fb-29d5-41ef-8acc-ff51bcaa0ab5.json
08a60b88-abdf-4da2-be7a-9360c04a4231,CELCOX 100 MG,prescription,M01AH01,CELECOXIB,3884,,,WHO ATC Classification,,ILS,capsules,CELECOXIB,2025-07-31T01:04:17.344459,IL,תרימה,,24.77778986,20.998127,15.3271,,7-290008-075749,CELCOX 200MG 10CAPS,3707,,27394,BLISTER PVC/ALUMINIUM,units,10.0,134 40 30074 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of inflammation and pain in osteoarthritis (OA) and rheumatoid arthritis (RA).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/08a60b88-abdf-4da2-be7a-9360c04a4231.json
08c24817-8cf5-4402-b7a8-7037a97e3a74,CANDOR 16,prescription,C09CA06,CANDESARTAN,7324,,,WHO ATC Classification,,ILS,tablets,CANDESARTAN CILEXETIL,2025-07-31T00:52:15.480622,IL,אוניפארם,,33.5274757,28.413115,20.7395,,,CANDOR 16MG 28TAB,9686,,48772,BLISTER PVC/ALUMINIUM,units,28.0,150 71 33815 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Hypertension. Treatment of patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction < or = 40 % ) as add-on therapy to ACE inhibitors or when ACE inhibitors are not tolerated,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/08c24817-8cf5-4402-b7a8-7037a97e3a74.json
08c63dc7-e2e9-4b90-a4cb-d6817d3015c3,OCALIVA 10 MG,prescription,A05AA04,OBETICHOLIC ACID ,8469,,,WHO ATC Classification,,ILS,film coated tablets,OBETICHOLIC ACID,2025-07-31T06:00:02.379489,IL,ניאופרם,,13127.68334,11125.15587,10113.77806,,,OCALIVA 5 MG 30 TAB,15505,,54992,BOTTLE POLYETHYLENE,units,30.0,160 33 35218 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,OCALIVA is indicated for the treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/08c63dc7-e2e9-4b90-a4cb-d6817d3015c3.json
08e8747b-7dfc-4104-a128-e16f881c7607,BEZAFIBRATE MEDOMIE,prescription,C10AB02,BEZAFIBRATE,4048,,,WHO ATC Classification,,ILS,tablets sustained release,BEZAFIBRATE,2025-07-31T00:35:03.515709,IL,מדיסון,,36.79882746,31.185447,22.7631,,,BEZAFIBRATE 400MG 30 SR TAB,2211,,33469,BLISTER PVC/ALUMINIUM,units,30.0,176 67 37746 99,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Bezafibrate Medomie is indicated as an adjunct to diet and other non- pharmacological treatment (e.g. exercise, weight reduction) for the following: - Treatment of severe hypertriglyceridaemia",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/08e8747b-7dfc-4104-a128-e16f881c7607.json
08f15bba-adcd-41af-9d4f-bafcb5f42676,RHINOLAST,prescription,R01AC03,AZELASTINE,4557,,,WHO ATC Classification,,ILS,nasal solution,AZELASTINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T07:33:16.374667,IL,מגאפארם,,31.66279813,26.83288097,19.5860445,,,RHINOLAST SPRAY 0.1% 10ML,18311,,51962,BOTTLE GLASS,units,10.0,118 44 29866 00,valid,37.0,nasal,1.4,36,,,,,,,,,,0,Prescription required,Treatment of seasonal allergic rhinitis and perennial allergic rhinitis for adults and children 6 years and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/08f15bba-adcd-41af-9d4f-bafcb5f42676.json
08f19d5b-b4fa-48c9-a19d-d490cf09d268,LYSODREN,prescription,L01XX23,MITOTANE,20099,,,WHO ATC Classification,,ILS,tablets,MITOTANE,2025-07-31T05:02:14.617456,IL,כ.צ.ט,,2865.271451,2428.196253,2207.451139,,,LYSODREN 500MG 100TAB,,,35699,BOTTLE HDPE,units,100.0,166 52 35626 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Symptomatic treatment of advanced (unresectable, metastatic or relapsed) adrenal cortical carcinoma (ACC).",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/08f19d5b-b4fa-48c9-a19d-d490cf09d268.json
090bd132-b844-430e-baa9-f113ce5a5e6f,LIXIANA15 MG,prescription,B01AF03,EDOXABAN,8518,,,WHO ATC Classification,,ILS,film coated tablets,EDOXABAN AS TOSYLATE,2025-07-31T04:51:36.897686,IL,מדיסון,,119.8724859,101.5868569,75.52926167,,,LIXIANA 15 MG 10 TAB,12606,,73223,BLISTER PVC/ALUMINIUM,units,10.0,166 82 36013 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"• Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with  one or more risk factors, such as congestive heart failure, hypertension, age &#8805; 75 years,diabetes mellitus, prior stroke or transient ischaemic attack (TIA).• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/090bd132-b844-430e-baa9-f113ce5a5e6f.json
090e209c-8dca-472e-a23e-063cf4ad10d6,OMR-IGG-AM 5 %,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",6425,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML MG/ML",2025-07-31T06:09:45.327041,IL,אומריקס,,3163.527229,2680.955398,2437.23218,,,OMR-IGG-AM 5% SOLUTION FOR INJECTION 200ML,15050,,51047,BOTTLE GLASS TYPE I,units,200.0,127 54 30698 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Replacement therapy     * PRIMARY immunodeficiency (patients with PRIMARY defective antibody synthesis such as agammaglobulinemia OR hypogammaglobulinemia)     * Myeloma OR chronic Lymphocytic Leukemia (CLL) with severe secondary hypogammaglobulinemia AND recurrent infections.     * Children with congenital AIDS AND recurrent infections    - Immunomodulation     * Idiopathic Thrombocytopenic Purpura (ITP)     * Guillain Barre Syndrome     * Kawasaki Disease    - Allogenic Bone Marrow Transplantation,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/090e209c-8dca-472e-a23e-063cf4ad10d6.json
093607a6-b5f1-42a7-8abd-3ce024d2ade7,METABOLASE VETERINARY,29C,,,20323,,,,,ILS,solution for injection,"THIOCTIC ACID 0.2 MG/ML, CYANOCOBALAMIN (VIT B12) 0.03 MG/ML, GLYCINE 1.5 MG/ML, ASPARTIC ACID 1.5 MG/ML, GLUTAMIC ACID 1.5 MG/ML, FRUCTOSE/ML, SORBITOL/ML, PYRIDOXINE (VIT B6) HYDROCHLORIDE 0.15 MG/ML, L- ORNITHINE AS HYDROCHLORIDE 1.20 MG/ML, L- LYSINE AS HYDROCHLORIDE 0.50 MG/ML, L- CITRULLINE 1.20 MG/ML, L-CARNITINE AS HYDROCHLORIDE 5.00 MG/ML, L-ARGININE 2.40 MG/ML, D, L-ACETYLMETHIONINE 20.00 MG/ML",2025-07-31T14:03:35.491342,IL,nan,,nan,nan,nan,,,CARNITINE 1G 10TAB,,,,BOTTLE GLASS TYPE II,units,10.0,082 87 92329 00,valid,nan,"s.c, i.v, intra-peritoneal",1.4,24,,,,,,,,,,0,,"Supplement  of vitamins, amino acid and sugars",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/093607a6-b5f1-42a7-8abd-3ce024d2ade7.json
093d3202-21c8-4f90-951c-670ad2f163bc,TOPITRIM 100 MG,prescription,N03AX11,TOPIRAMATE,6030,,,WHO ATC Classification,,ILS,tablets,TOPIRAMATE,2025-07-31T09:26:05.901467,IL,תרימה,,149.81929,126.9655,101.5724,,,TOPITRIM 100MG 60TAB,20608,,72914,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,136 65 31516 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topitim is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topitrim is indicated in adults for the prevention of migraines. The use of Topitrim in the acute treatment of migraine has not been studied.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/093d3202-21c8-4f90-951c-670ad2f163bc.json
0954a165-456a-4aa0-9903-f613f26e1fe1,DACOGEN,prescription,L01BC08,DECITABINE,6562,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,DECITABINE/VIAL,2025-07-31T01:39:10.265942,IL,יאנסן סילג,,5009.994634,4245.758164,3859.780149,,7290014577145,DACOGEN 50 MG/VIAL 1X20ML VIAL,4522,,86391,VIAL GLASS TYPE I,units,1.0,143 65 31633 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Dacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and Intermediate-1, Intermediate-2 and High-Risk International Prognostic Scoring System groups.Dacogen is indicated for the treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0954a165-456a-4aa0-9903-f613f26e1fe1.json
095b4484-6fa8-4f56-bed0-a33ff8adc560,RIVAROXABAN S.K. 10 MG,prescription,B01AF01,RIVAROXABAN,9330,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:43:15.913643,IL,SK PHARM(KS KIM),,270.578248,229.3036,195.152,,,RIVAROXABAN S.K. 10 MG 30 TAB,18698,,8621,BLISTER ALU-PVC/PE/PVDC ,units,30.0,170 37 36327 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/095b4484-6fa8-4f56-bed0-a33ff8adc560.json
09602b41-7a23-4e13-a1b0-6c7075a96be1,XATRAL SR 5 MG,prescription,G04CA01,ALFUZOSIN,3643,,,WHO ATC Classification,,ILS,tablets sustained release,ALFUZOSIN HYDROCHLORIDE,2025-07-31T10:30:52.994136,IL,סאנופי אוונטיס,,46.48556997,39.39455258,28.75514787,,,XATRAL SR 5MG 56TAB,24064,,85259,BLISTER PVC/ALUMINIUM,units,56.0,110 16 29084 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09602b41-7a23-4e13-a1b0-6c7075a96be1.json
096c99bd-73b2-400a-979b-1af32cb6c148,RISPERIDEX 1 MG,prescription,N05AX08,RISPERIDONE,8049,,,WHO ATC Classification,,ILS,tablets,RISPERIDONE,2025-07-31T07:39:35.621405,IL,דקסל פארמה,,104.4948227,88.5549345,65.8401,,7290010577439,RISPERIDEX 4MG 30TAB,18567,,16282,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,134 54 31353 00,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/096c99bd-73b2-400a-979b-1af32cb6c148.json
09702bd2-6433-42f3-8e63-0ff8185b769a,INOTYOL,off-the-counter,,,73,,,,,ILS,ointment,"ICHTHAMMOL 1.474 G /, ZINC OXIDE 14.763 G /, HAMAMELIS 0.984 G /, BENZOIN SIAM 0.1 G /, TITANIUM DIOXIDE 5.905 G /",2025-07-31T12:10:14.783339,IL,פאדאגיס,,46.0554,39.03,nan,,7298074130003,INOTYOL OINT 50GR,9033,,,TUBE ,units,50.0,022 26 21121 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Local treatment of eczema, feet ulcers, mild burns and skin irritations.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09702bd2-6433-42f3-8e63-0ff8185b769a.json
0994d7fa-77c8-44f7-8bf4-314888650c73,MILN-AVENIR 25 MG,prescription,N06AX17,MILNACIPRAN,9103,,,WHO ATC Classification,,ILS,capsules,MILNACIPRAN AS HYDROCHLORIDE,2025-07-31T05:24:21.022854,IL,ביואבניר,,70.2838297,59.56257019,44.2844388,,,MILN-AVENIR 50 MG 56 CAPS,,,73194,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,169 70 36192 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0994d7fa-77c8-44f7-8bf4-314888650c73.json
09a0ebfa-1e2d-4fe2-bbb3-dd2b22d750e4,BOSULIF 100 MG,prescription,L01XE14,BOSUTINIB,7662,,,WHO ATC Classification,,ILS,film coated tablets,BOSUTINIB AS MONOHYDRATE,2025-07-31T00:41:08.240152,IL,פיזר,,11343.47852,9613.117817,8739.198016,,7290013592224,BOSULIF 500 MG 28 F.C.TAB,2576,,70005,BLISTER PVC/ALUMINIUM,units,28.0,152 88 34014 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Bosulif is indicated for the treatment of adult patients with:• newly diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukaemia (Ph+ CML).• chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukaemia (Ph+ CML) previously treated with one or more tyrosine kinase inhibitor(s) [TKI(s)] and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09a0ebfa-1e2d-4fe2-bbb3-dd2b22d750e4.json
09a38798-ff9d-473e-8ba9-19337fafcf0f,TRILEPTIN 300 MG,prescription,N03AF02,OXCARBAZEPINE,3581,,,WHO ATC Classification,,ILS,film coated tablets,OXCARBAZEPINE,2025-07-31T09:42:58.338001,IL,נוברטיס פארמה,,55.83544612,47.31817678,34.53881517,,7290001173992,TRILEPTIN 300MG 50TAB,20210,,75885,BLISTER PVC/PE/PVDC/AL,units,50.0,106 80 28707 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of primary generalised tonic-clonic seizures and partial seizures with or without secondary generalization.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09a38798-ff9d-473e-8ba9-19337fafcf0f.json
09a67636-d70d-4188-a107-24590753b59f,ZAPPA ODT 10,prescription,N05AH03,OLANZAPINE,7299,,,WHO ATC Classification,,ILS,tablets orodispersible,OLANZAPINE,2025-07-31T10:43:40.122943,IL,אוניפארם,,142.7783728,120.998621,89.9618,,,ZAPPA ODT 10MG 30 O.D.TAB,26185,,47262,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,150 21 33756 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia. Zappa ODT is indicated for the management of the manifestations of psychotic disorders. Zappa ODT is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Zappa ODT is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zappa ODT with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09a67636-d70d-4188-a107-24590753b59f.json
09a79c64-7be7-4806-b2e2-28ea6e866dbe,LITAK 10,prescription,L01BB04,CLADRIBINE,7962,,,WHO ATC Classification,,ILS,solution for injection / infusion,CLADRIBINE/,2025-07-31T04:49:56.323585,IL,פרופארם,,1516.992654,1285.587052,1094.11664,,7290006412621,LITAK 10  1VIAL 10mg/5ML,12346,,55139,VIAL GLASS TYPE I,units,1.0,119 99 30038 00,valid,17.5,"i.v, s.c",1.4,48,,,,,,,,,,0,Prescription required,Hairy cell leukemia. Chronic lymphocytic leukemia. Second line treatment for low grade Non-Hodgkin's lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09a79c64-7be7-4806-b2e2-28ea6e866dbe.json
09acf7e7-0216-474e-9d6a-9a9512e0e042,PLUVICTO,prescription,V10XX05,LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN ,9237,,,WHO ATC Classification,,ILS,solution for injection / infusion,LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN 1000 MBQ/ML,2025-07-31T06:46:36.809094,IL,נוברטיס פארמה,,105074.0861,89045.83967,80950.76333,,7290019217695,PLUVICTO SOL FOR INJ / INF 1VIAL,,,17429,VIAL GLASS TYPE I,units,1.0,172 79 37413 99,valid,10.0,i.v,1.4,5,,,,,,,,,,0,Prescription required,Pluvicto is indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy or who are not medically suitable for taxanes.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09acf7e7-0216-474e-9d6a-9a9512e0e042.json
09b5aba1-2b3b-46a1-9354-a334b5a3902c,FYCOMPA 10 MG FILM COATED TABLETS,prescription,N03AX22,PERAMPANEL,7264,,,WHO ATC Classification,,ILS,film coated tablets,PERAMPANEL AS ANHYDROUS,2025-07-31T03:24:44.281448,IL,אסיי,,394.4072219,334.2434232,284.4624879,,,FYCOMPA 6MG 28 F.C TAB,6531,,51058,BLISTER PVC/ALUMINIUM,units,28.0,150 50 33794 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.Fycompa is indicated for the adjunctive treatment of primary generalised tonic clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalized epilepsy (IGE).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09b5aba1-2b3b-46a1-9354-a334b5a3902c.json
09c84b03-3681-4e9c-96df-19f371ee1a96,BRINTELLIX 10 MG,prescription,N06AX26,VORTIOXETINE,7726,,,WHO ATC Classification,,ILS,film coated tablets,VORTIOXETINE AS HYDROBROMIDE,2025-07-31T00:43:00.831264,IL,לנדבק,,173.3727667,146.92608,117.540864,,,BRINTELLIX 15MG 28F.C.TAB,2588,,85111,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,153 73 34155 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Brintellix is indicated for the treatment of major depressive episodes in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09c84b03-3681-4e9c-96df-19f371ee1a96.json
09f3899d-4dd7-4b20-9fee-e5a2965f6e3a,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,3960,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:23:36.260807,IL,רקיט בנקיזר,,29.7714,25.23,nan,,7290000852973,STREPSILS PLUS 24 LOZ,19245,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/09f3899d-4dd7-4b20-9fee-e5a2965f6e3a.json
0a018370-5550-4a6b-b340-068ea729cf45,BELARA,prescription,G03AA01,ETYNODIOL AND ESTROGEN,4963,,,WHO ATC Classification,,ILS,film coated tablets,"ETHINYLESTRADIOL 0.03  MG, CHLORMADINONE ACETATE",2025-07-31T00:30:01.002256,IL,ליברה,,117.2444678,99.35972293,73.87339995,,7290008872218,BELARA 3X21TAB,2418,,61869,BLISTER PVC/PVDC/ALUMINIUM,units,63.0,127 34 30410 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral hormonal contraceptive.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a018370-5550-4a6b-b340-068ea729cf45.json
0a10adff-e676-4d7b-95b5-83309f04c490,ONPATTRO 2 MG/ML,off-the-counter,N07XX12,PATISIRAN,5204,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PATISIRAN  AS SODIUM/,2025-07-31T13:18:36.841672,IL,מגאפארם,,22.479,19.05,nan,,,SIRAN 200MG EFFERVESCENT 20TAB,19855,,,VIAL GLASS TYPE I,units,20.0,165 33 36108 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,,Onpattro is indicated for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a10adff-e676-4d7b-95b5-83309f04c490.json
0a2645d2-294c-4293-91cf-3945b791a122,ABIPLATIN TEVA,prescription,L01XA01,CISPLATIN,8844,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,CISPLATIN/ML,2025-07-30T23:10:06.208330,IL,טבע,,120.5978232,102.2015496,75.98628225,,7-290000-850115,ABIPLATIN TEVA 1MG/1ML 50MG 1 VIAL,,,35134,VIAL GLASS TYPE I,units,1.0,031 30 25429 05,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Palliative therapy to be employed either alone, or more commonly in established combination therapy with orher approved chemotherapeutic agents and in patients with metastatic testicular tumor and metastatic ovarian tumor who have alreasy received appropriate surgical and/or radiotherapeutic procedures and in patients with advanced bladder cancer.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a2645d2-294c-4293-91cf-3945b791a122.json
0a2d05d3-5287-4cf7-ba0d-3444acb6def5,DULOX TEVA 30 MG,prescription,N06AX21,DULOXETINE,8915,,,WHO ATC Classification,,ILS,gastro resistant capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T02:05:36.023170,IL,טבע,,70.737047,59.94665,44.57,,,DULOX TEVA 30 MG 30 CAPS,,,70647,BLISTER AL/OPA/AL/PVC,units,30.0,166 98 35976 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Dulox Teva is indicated for:- The treatment of major depressive episodes. - The management of neuropathic pain associated with diabetic peripheral neuropathy. - The treatment of generalized anxiety disorder (GAD).- The management of fibromyalgia. - The management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. This has been established in studies in patients with chronic low ‎back pain (CLBP) and chronic pain due to osteoarthritis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a2d05d3-5287-4cf7-ba0d-3444acb6def5.json
0a402b4e-6f7f-429a-9afe-b6bc03114400,LAEVOLAC,off-the-counter,A06AD11,LACTULOSE,5178,,,WHO ATC Classification,,ILS,solution  (oral),LACTULOSE/ML,2025-07-31T12:16:52.239598,IL,מגאפארם,,66.1862,56.09,nan,,9088880170823,LAEVOLAC 500ML,12218,,,BOTTLE PET,units,500.0,115 98 29714 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Constipation. Acute and chronic hepatic encephalopathy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a402b4e-6f7f-429a-9afe-b6bc03114400.json
0a5958ac-8758-4cd2-a709-4443fe3ecfb0,IDEFIRIX 11 MG,prescription,L04AA41,IMLIFIDASE,9441,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,IMLIFIDASE/VIAL,2025-07-31T03:57:09.162404,IL,מדיסון,,1502985.025,1273716.179,1157923.799,,,IDEFIRIX 11 MG/VIAL 2 VIALS,,,,VIAL GLASS TYPE I,units,2.0,169 35 37017 00,valid,10.0,i.v,1.4,18,,,,,,,,,,0,Prescription required,Idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. The use of Idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a5958ac-8758-4cd2-a709-4443fe3ecfb0.json
0a6c0e0a-02b3-4c51-8670-3b9e063cb83d,DIMETHYL FUMARATE MEDOMIE 120 MG,prescription,N07XX09,DIMETYL FUMARATE,9428,,,WHO ATC Classification,,ILS,capsules delayed release,DIMETHYL FUMARATE,2025-07-31T01:57:09.216214,IL,מדומי פארמה,,2491.803221,2111.697645,1919.725132,,7290019478003,DIMETHYL FUMARATE MEDOMIE 240 MG 60 CAPS,,,17176,BOTTLE HDPE,units,60.0,170 06 36832 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a6c0e0a-02b3-4c51-8670-3b9e063cb83d.json
0a794244-a00d-44dd-8965-74f2e900217b,ONCASPAR 750 U/ML,prescription,L01XX24,PEGASPARGASE,8866,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,PEGASPARGASE 3750 U/VIAL,2025-07-31T06:11:29.568085,IL,צמל,,7830.394254,6635.927629,6032.661481,,7290100819036,ONCASPAR 750 U/ML 1 VIAL 5 ML,,,86966,VIAL GLASS TYPE I,units,1.0,165 21 36198 00,valid,10.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (ALL) in paediatric patients from birth to 18 years, and adult patients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a794244-a00d-44dd-8965-74f2e900217b.json
0a7d1578-a444-45f9-8747-caeae7e04763,REAGILA 1.5,prescription,N05AX15,CARIPRAZINE,8589,,,WHO ATC Classification,,ILS,"capsule, hard",CARIPRAZINE AS HYDROCHLORIDE 1.5  MG,2025-07-31T07:18:04.890130,IL,דקסל פארמה,,319.1221479,270.4425102,230.1638385,,,REAGILA 3 MG 30CAPS,17045,,3610,BLISTER PVC/PE/PVDC/AL,units,30.0,163 54 35920 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,-Reagila is indicated for the:•	Treatment of schizophrenia in adult patients.•	Acute treatment of manic or mixed episodes associated with bipolar I disorder in adult.•	Treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults.•	Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a7d1578-a444-45f9-8747-caeae7e04763.json
0a83dd0a-42dd-4991-a430-0781af8ee9e7,FULVESTRANT EVER PHARMA 250 MG,prescription,L02BA03,FULVESTRANT,9301,,,WHO ATC Classification,,ILS,solution for injection,FULVESTRANT/,2025-07-31T03:22:02.139857,IL,פארמלוג'יק,,486.730825,412.48375,351.05,,,FULVESTRANT EVER PHARMA 250 MG SYRINGE PREFILLED,,,38150,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,170 44 36279 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"FULVESTRANT EVER PHARMA 250 MG is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:* not previously treated with endocrine therapy,or* with disease relapse on or after adjuvant endocrine therapy,or* disease progression on endocrine therapy.Combination Therapy with Palbociclib: FULVESTRANT EVER PHARMA 250 MG is indicated for the treatment of HR-positive, human epidermal growth factor receptor 2 (HER2)- negative advanced or metastatic breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a83dd0a-42dd-4991-a430-0781af8ee9e7.json
0a87e2a8-0e5c-4bf1-8929-52b06f5dc106,TEMODAL 100 MG,prescription,L01AX03,TEMOZOLOMIDE,4195,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T09:12:02.872196,IL,מ.ס.ד. ישראל,,2505.715923,2123.48807,1930.4437,,7290008121972,TEMODAL 250MG 5CAP,20749,,38957,SACHET POLYETHYLENE,units,5.0,120 30 30116 23,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a87e2a8-0e5c-4bf1-8929-52b06f5dc106.json
0a8caef0-a087-49e2-a1b8-447ad8133548,TUMS SMOOTHIES EX PEPPERMINT,off-the-counter,A02AC01,CALCIUM CARBONATE,795,,,WHO ATC Classification,,ILS,chewable tablets,CALCIUM CARBONATE,2025-07-31T13:30:46.726681,IL,ג.ס.ק,,17.6528,14.96,nan,,7290010140497,TUMS MINT 500MG 3*12 ROLL,20520,,,BOTTLE POLYPROPYLENE,units,36.0,134 94 31175 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For relief from heartburn and acidity,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0a8caef0-a087-49e2-a1b8-447ad8133548.json
0aa15aa3-ad86-48bf-ac4c-7b5b193d1108,LMD IN SODIUM CHLORIDE 500ML   FLEXIBLE PVC CONTAINERS,29C,,,20946,,,,,,tablet,LMD IN SODIUM CHLORIDE FLEXIBLE PVC CONTAINERS,2025-07-31T20:49:01.666503,IL,nan,,,,,,,LMD IN SODIUM CHLORIDE 500ML   FLEXIBLE PVC CONTAINERS,,,,,units,1.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0aa15aa3-ad86-48bf-ac4c-7b5b193d1108.json
0aa37967-2ba5-478b-ab32-478a2e6c4000,ALPRALID 0.25,prescription,N05BA12,ALPRAZOLAM,3286,,,WHO ATC Classification,,ILS,tablets,ALPRAZOLAM 0.25   MG,2025-07-30T23:20:34.857964,IL,כ.צ.ט,,15.689103,13.29585,9.705,,,ALPRALID 0.50MG 30TAB,1144,,9495,BLISTER PVC/ALUMINIUM,units,30.0,137 10 28371 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of symptoms of tension and anxiety, anxiety accompanied by depression and in panic states with or without phobia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0aa37967-2ba5-478b-ab32-478a2e6c4000.json
0ab38bae-e1ec-4980-8282-4aa6d473b07d,CERTICAN ® 0.25 MG TABLETS,prescription,L04AA18,EVEROLIMUS,4842,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS 0.25   MG,2025-07-31T01:07:43.535753,IL,נוברטיס פארמה,,1114.568211,944.549373,803.8718068,,,CERTICAN 0.75MG 60 TAB,3792,,13352,BLISTER PVC/PA/ALUMINIUM,units,60.0,132 60 31066 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Kidney and heart transplantationCertican ® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in adult patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0ab38bae-e1ec-4980-8282-4aa6d473b07d.json
0acd2c58-39eb-40d3-87c2-f4eeeda9c0b8,PHENERGAN 50 MG/2 ML,29C,R06AD02,PROMETHAZINE,20796,,,WHO ATC Classification,,ILS,solution for injection,PROMETHAZINE AS HYDROCHLORIDE/,2025-07-31T15:41:30.668541,IL,nan,,nan,nan,nan,,7290018609873,PROMETHAZINE 25MG/1ML 5VIAL(2ML),,,,AMPOULES GLASS TYPE I,units,5.0,167 08 35764 00,valid,nan,"i.m, i.v",1.4,36,,,,,,,,,,0,,"Phenergan is indicated :As symptomatic treatment for allergic conditions of the upper respiratory tract and skin including allergic rhinitis, urticaria and anaphylactic reactions to drugs and foreign proteins.For sedation and treatment of insomnia in adults.As an adjunct in preoperative sedation in surgery and obstetrics.As a paediatric sedative. For prevention and control of nausea and vomiting associated with certain types of anaesthesia and surgery.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0acd2c58-39eb-40d3-87c2-f4eeeda9c0b8.json
0acec6e6-7f10-4613-bd90-b2c2346564ff,VANCOAVENIR 1 G,prescription,A07AA09,VANCOMYCIN,4864,,,WHO ATC Classification,,ILS,powder for solution for injection,VANCOMYCIN AS HYDROCHLORIDE/VIAL,2025-07-31T09:59:09.915176,IL,דקסל פארמה,,33.81458386,28.656427,20.9171,,7290010287147,VANCOMYCIN MYLAN 500MG/VIAL,22280,,29145,VIAL GLASS TYPE I,units,1.0,153 18 34020 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci.It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside.Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. Vancomycin hydrochloride is not effective orally when administered for other types of infection.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0acec6e6-7f10-4613-bd90-b2c2346564ff.json
0af06252-8288-4d05-a17a-5af13d0be7cd,CHILDREN'S ADVIL GRAPE FLAVOR,off-the-counter,M01AE01,IBUPROFEN,5448,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T12:08:35.465978,IL,ליף-דקסון,,24.4024,20.68,nan,,305730171304,IBUPRO 200MG 30 CAPLETS,,,,BOTTLE PLASTIC,units,30.0,122 43 30111 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0af06252-8288-4d05-a17a-5af13d0be7cd.json
0af157ae-7991-43e0-ad6f-62058814feb2,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4902,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:23:36.004245,IL,מדיסון,,3723.497418,3155.506427,2868.642206,,8715131005863,ARANESP 500MCG PREFILLED PEN 1X1ML,9492,,65755,PRE-FILLED PEN GLASS TYPE I,units,1.0,124 46 30400 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0af157ae-7991-43e0-ad6f-62058814feb2.json
0afa4e0c-d91c-438e-88d3-39a0c318e723,DAIVOBET,prescription,D05AX52,"CALCIPOTRIOL, COMBINATIONS",4704,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS DIPROPIONATE 0.5 MG/G, CALCIPOTRIOL AS HYDRATE/G",2025-07-31T01:39:31.471204,IL,דקסל פארמה,,129.9051085,110.0890799,81.850617,,,DAIVOBET OINT 60GR,4463,,10346,TUBE ALUMINIUM,units,60.0,127 60 30600 00,valid,34.5,dermal,1.4,24,,,,,,,,,,0,Prescription required,Topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0afa4e0c-d91c-438e-88d3-39a0c318e723.json
0b00aa66-3506-4776-962a-1f13a94d4f48,ADAKVEO 10 MG/ML,prescription,B06AX01,CRIZANLIZUMAB,8757,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,CRIZANLIZUMAB/ML,2025-07-30T23:14:10.000329,IL,נוברטיס פארמה,,nan,nan,nan,,,ADAKVEO 10 MG/ML 10ml 1 vial,17314,,41018,VIAL GLASS TYPE I,units,1.0,168 71 36562 00,valid,nan,i.v,1.4,24,,,,,,,,,,0,Prescription required,ADAKVEO is indicated to reduce the frequency of vasoocclusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b00aa66-3506-4776-962a-1f13a94d4f48.json
0b17afb3-e381-4ef4-852e-8fdcbbab3b51,BONJESTA,29C,R06AA09,DOXYLAMINE,20619,,,WHO ATC Classification,,ILS,tablets extended release,"DOXYLAMINE SUCCINATE, PYRIDOXINE (VIT B6) HYDROCHLORIDE",2025-07-31T15:43:05.533519,IL,nan,,nan,nan,nan,,7290100819074,PYRIDOXINE 100MG/3ML INJ,,,,BLISTER OPA/AL/PVC,units,1.0,167 52 36428 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,BONJESTA is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.Limitations of UseBONJESTA has not been studied in women with hyperemesis gravidarum.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b17afb3-e381-4ef4-852e-8fdcbbab3b51.json
0b21c559-3068-4b00-9c9c-7efcd3f3e1c3,KONAKION MM PAEDIATRIC 2 MG/0.2 ML,prescription,B02BA01,PHYTOMENADIONE,3677,,,WHO ATC Classification,,ILS,solution for injection,PHYTOMENADIONE/ML,2025-07-31T04:29:11.252046,IL,צמל,,42.83413492,36.30011595,26.496435,,7290013280480,KONAKION PED 2MG/0.2ML 5VIALS,11077,,33843,AMPOULES GLASS TYPE I,units,5.0,105 47 28944 00,valid,37.0,"i.m, i.v, per os",1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis and treatment of haemorrhoagic disease of the newborn.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b21c559-3068-4b00-9c9c-7efcd3f3e1c3.json
0b2305b3-4086-4bde-91d5-dc3779543168,REMODULIN 2.5 MG/ML,prescription,B01AC21,TREPROSTINIL,6722,,,WHO ATC Classification,,ILS,solution for injection,TREPROSTINIL AS SODIUM 2.5 MG/ML,2025-07-31T07:24:08.569865,IL,רפא,,15698.12655,13303.49767,12094.08879,,7290008107389,REMODULIN 2.5MG/ML VIAL 1X20ML,,,60208,VIAL 20 ML GLASS TYPE I,units,1.0,126 57 30563 00,valid,10.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,Remodulin is indicated as a continuous subcutaneous infusion or  intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders.   Pulmonary hypertension associated with congenital systemic to pulmonary shunts.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b2305b3-4086-4bde-91d5-dc3779543168.json
0b2596dc-bb0b-45de-b9a4-ed84d2978471,FRAGMIN 2500 I.U /0.2 ML,prescription,B01AB04,DALTEPARIN,4371,,,WHO ATC Classification,,ILS,solution for injection,DALTEPARIN SODIUM/ 0.2  ML,2025-07-31T03:19:57.114022,IL,פיזר,,133.1719436,112.8575844,83.90898467,,7290013592880,FRAGMIN 2500UI/0.2ML 10INJ,6325,,23322,SYRINGE GLASS TYPE I,units,10.0,123 11 26544 00,valid,34.5,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,Prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. Treatment of acute deep venous thrombosis and/or pulmonary embolism. Unstable coronary artery disease. Thromboprophylaxis in conjunction with surgery.   Prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency  respiratory insufficiency and severe infections.Cancer patients : Treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b2596dc-bb0b-45de-b9a4-ed84d2978471.json
0b29d5f4-84ff-47d6-badb-0fdabb95d0ca,LIPITOR 10 MG,prescription,C10AA05,ATORVASTATIN,4563,,,WHO ATC Classification,,ILS,film coated tablets,ATORVASTATIN AS CALCIUM,2025-07-31T04:48:30.819358,IL,דקסל פארמה,,65.84528738,55.801091,41.4878,,,LIPITOR 80MG 30TAB,12483,,68417,BLISTER PVC/OPA/AL,units,30.0,126 04 30587 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol  LDL- cholesterol  apolipoprotein B  and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Lipitor is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable.   Pediatric patients (10-17 years of age) :   Atorvastatin is indicated as an adjunct to diet to reduce total -C  LDL-C  and apo B levels in boys and postmenarchal girls  10 to 17 years of age  with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:   1. LDL-C remains >or = 190 mg/dl or   2. LDL-C remains > or = 160 mg/dl and:    there is a positive family history of premature cardiovascular disease or    two or more other CVD risk factors are present in the pediatric patient.   Prevention of cardiovascular and/or cerebrovascular event sush as MI or stroke  as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor.   In patients with clinically evident coronary heart disease  Lipitor is indicated to :    Reduce the risk of non-fatal myocardial infarction.    Reduce the risk of fatal and non fatal stroke.    Reduce the risk for revascularization procedures.    Reduce the risk of hospitalization for CHF.    Reduce the risk of angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b29d5f4-84ff-47d6-badb-0fdabb95d0ca.json
0b346365-6e3b-46d8-a442-2a949138ca6f,LERCANAPRIL TEVA 10 /10,prescription,C09BB02,ENALAPRIL AND LERCANIDIPINE,8681,,,WHO ATC Classification,,ILS,film coated tablets,"LERCANIDIPINE HYDROCHLORIDE, ENALAPRIL MALEATE",2025-07-31T04:40:32.531206,IL,טבע,,36.17287994,30.654983,22.3759,,,LERCANAPRIL TEVA 10 MG /20 MG 30 TAB,,,56613,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,164 44 35533 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under Lercanidipine monotherapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b346365-6e3b-46d8-a442-2a949138ca6f.json
0b55e1ce-2c58-42ad-a019-1cf2f2656c9d,ALCOHOL 70%  FLORIS,off-the-counter,D08AX08,ETHANOL,3597,,,WHO ATC Classification,,ILS,solution,ALCOHOLV/V,2025-07-31T11:09:34.656512,IL,פלוריש,,20.0836,17.02,nan,,,ALCOHOL 70% 200ML,1425,,,BOTTLE HDPE,units,200.0,057 39 27018 00,valid,nan,topical,1.4,48,,,,,,,,,,0,,Antiseptic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b55e1ce-2c58-42ad-a019-1cf2f2656c9d.json
0b6a451f-ff3e-4910-be2f-64f53ab73b78,PROPOFOL-LIPURO 1%,prescription,N01AX10,PROPOFOL,8289,,,WHO ATC Classification,,ILS,emulsion for injection or infusion,PROPOFOL/ML,2025-07-31T07:02:38.303623,IL,לפידות,,49.46565635,41.92004775,30.598575,,4030539048033,PROPOFOL - LIPURO 1 % 20ml 5 AMP,16799,,78927,AMPOULES GLASS TYPE I,units,5.0,127 87 30672 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Propofol-Lipuro 1% is a short-acting intravenous general anaesthetic for• induction and maintenance of general anaesthesia in adults and children > 1 month• sedation of ventilated patients >16 years of age in the intensive care unit• sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 1 month.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b6a451f-ff3e-4910-be2f-64f53ab73b78.json
0b6ddda3-6c20-44b3-981a-7424bcce67e9,AGISTEN ALOEVERA CREAM,off-the-counter,D01AC01,CLOTRIMAZOLE,5634,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T11:07:51.626360,IL,פאדאגיס,,31.69357949,26.85896686,nan,,7290004850432,AGISTEN PASTE 30GR,,,,TUBE ALUMINIUM,units,30.0,043 17 22461 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as Malassezia furfur, as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b6ddda3-6c20-44b3-981a-7424bcce67e9.json
0b730306-e9b9-4784-b9cd-1ba64aa8f3f1,QUETIAPINE SANDOZ ® 300 MG PRT,prescription,N05AH04,QUETIAPINE,8838,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:10:48.520676,IL,סנדוז,,122.873282,104.1299,77.42,,,QUETIAPINE SANDOZ  300 MG  30 PRT,17357,,70537,BLISTER PVC/PCTFE/AL,units,30.0,166 04 35778 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Sandoz PRT is indicated for the treatment of Schizophrenia. Quetiapine Sandoz PRT is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Sandoz PRT. Quetiapine Sandoz PRT  is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for the treatment of major depressive episodes in bipolar disorder. Quetiapine Sandoz PRT is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy . Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Sandoz PRT.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b730306-e9b9-4784-b9cd-1ba64aa8f3f1.json
0b7f4f0a-8800-409e-a12f-0ac75d1a5169,FLUCONAZOLE BAXTER 2 MG/ML,prescription,J02AC01,FLUCONAZOLE,8990,,,WHO ATC Classification,,ILS,solution for infusion,FLUCONAZOLE/,2025-07-31T03:11:22.079416,IL,מרגלית,,69.13899601,58.5923695,43.5631,,7290001942574,FLUCONAZOLE BAXTER 2 MG/ML 1 BOTTLE  (200MG/100ML),,,59057,BOTTLE GLASS TYPE II,units,100.0,159 70 34451 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:•         Cryptococcal meningitis.•         Coccidioidomycosis. Invasive candidiasis.•         Mucosal candidiasis (including oropharyngeal candidiasis, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis).•         Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene topical treatment are insufficient.Fluconazole is indicated in adults for the prophylaxis of:•         Relapse of cryptococcal meningitis in patients with high risk of recurrence.•         Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•         Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Haematopoetic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b7f4f0a-8800-409e-a12f-0ac75d1a5169.json
0b81bcd2-e540-4ea0-bf36-af30a266ba09,KALSINUS,prescription,R01BA02,PSEUDOEPHEDRINE,7433,,,WHO ATC Classification,,ILS,tablets,PSEUDOEPHEDRINE HYDROCHLORIDE,2025-07-31T04:21:35.631864,IL,סם און,,23.18915704,19.651828,14.3444,,7290013834010,KALSINUS 60MG 20 F.C.TAB,11242,,37127,BLISTER PVC/ALUMINIUM,units,20.0,148 21 33484 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Symptomatic treatment of nasal congestion, to relieve eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b81bcd2-e540-4ea0-bf36-af30a266ba09.json
0b9cd9fa-4905-4c8c-bb46-34ed561f2dff,ALCOHOL 70%  FLORIS,off-the-counter,D08AX08,ETHANOL,5078,,,WHO ATC Classification,,ILS,solution,ALCOHOLV/V,2025-07-31T11:09:12.126170,IL,ויטאמד,,12.2012,10.34,nan,,,ALCOHOL 70% 100ML,1892,,,BOTTLE HDPE,units,100.0,057 39 27018 00,valid,nan,topical,1.4,48,,,,,,,,,,0,,Antiseptic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0b9cd9fa-4905-4c8c-bb46-34ed561f2dff.json
0ba24e03-03f8-4e77-a36a-088d3e398528,TERBULIN SYRUP,prescription,R03CC03,TERBUTALINE,3131,,,WHO ATC Classification,,ILS,syrup,TERBUTALINE SULFATE/,2025-07-31T09:14:28.943779,IL,ויטאמד,,10.798888,9.1516,6.68,,7-290008-068826,TERBULIN SYRUP 115ML,20129,,9272,BOTTLE PET,units,115.0,065 68 28095 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Bronchodilator for the treatment of acute attacks of Asthma.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0ba24e03-03f8-4e77-a36a-088d3e398528.json
0ba2c157-9987-42f2-b1db-68a75e4fc6f7,BOSULIF 100 MG,prescription,L01XE14,BOSUTINIB,7661,,,WHO ATC Classification,,ILS,film coated tablets,BOSUTINIB AS MONOHYDRATE,2025-07-31T00:40:57.530313,IL,פיזר,,2315.344103,1962.156107,1783.778279,,7290013592224,BOSULIF 100 MG 28 F.C.TAB,2575,,70002,BLISTER PVC/ALUMINIUM,units,28.0,152 88 34014 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Bosulif is indicated for the treatment of adult patients with:• newly diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukaemia (Ph+ CML).• chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukaemia (Ph+ CML) previously treated with one or more tyrosine kinase inhibitor(s) [TKI(s)] and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0ba2c157-9987-42f2-b1db-68a75e4fc6f7.json
0bb7191c-f455-487d-91a7-d217ebe49ce3,TYSABRI,prescription,L04AA23,NATALIZUMAB,6128,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,NATALIZUMAB/,2025-07-31T09:49:40.300959,IL,מדיסון,,6285.064791,5326.326331,4842.114846,,7290008128377,TYSABRI 300MG/15ML CONCENTRATE FOR SOL. FOR INF.,20680,,16991,VIAL GLASS TYPE I,units,1.0,136 45 31505 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis . To delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. The safety and efficacy of Tysabri beyond two years are unknown. Because Tysabri increases the risk of progressive multifocal leukoencephalopathy (PML), an opportunistic viral infection of the brain that usually leads to death or severe disability. Tysabri is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, alternate multiple sclerosis therapies. Safety and efficacy in patients with chronic progressive multiple sclerosis have not been studied.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0bb7191c-f455-487d-91a7-d217ebe49ce3.json
0bcbda9c-26e5-4951-84b9-9aff6847abd9,FEMOSTON 1/10 MG,prescription,G03FB08,DYDROGESTERONE AND ESTROGEN,8388,,,WHO ATC Classification,,ILS,film coated tablets,"DYDROGESTERONE, ESTRADIOL AS HEMIHYDRATE, ESTRADIOL AS HEMIHYDRATE",2025-07-31T02:56:49.608162,IL,אבוט,,64.38129967,54.56042588,40.5653724,,8002660031433,FEMOSTON 1/10 MG 28 tab,,,48834,BLISTER PVC/ALUMINIUM,units,28.0,161 66 35128 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hormone replacement therapy (HRT) for estrogen deficiency symptoms in menopausal women at least 6 months since last menses.Prevention of osteoporosis in postmenopausal women at high risk of future fractures. Femoston 1/10 should only be used in patients who are intolerant of other products, approved for the prevention of osteoporosis or for whom these products are contra-indicated.Femoston is indicated for women with an intact uterus.Experience with treatment of women older than 65 years is limited.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0bcbda9c-26e5-4951-84b9-9aff6847abd9.json
0bd1d736-9130-4ce9-b6cc-399e612d6785,HYDROAGISTEN CREAM,prescription,D07AA02,HYDROCORTISONE,2395,,,WHO ATC Classification,,ILS,cream,"CLOTRIMAZOLE, HYDROCORTISONE ACETATE",2025-07-31T03:52:41.357597,IL,פאדאגיס,,33.62004638,28.491566,20.7967635,,,HYDROAGISTEN CR 15GR,8243,,7968,TUBE ALUMINIUM,units,15.0,042 82 24888 00,valid,37.0,dermal,1.4,24,,,,,,,,,,0,Prescription required,Skin inflammation involving fungal infection,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0bd1d736-9130-4ce9-b6cc-399e612d6785.json
0bd7d6b2-ebb3-481e-a966-de44ecd325cc,QUININE SULFATE 300 MG,prescription,P01BC01,QUININE,1970,,,WHO ATC Classification,,ILS,tablets,QUININE SULFATE,2025-07-31T07:12:42.686499,IL,רקח,,31.75293388,26.909266,19.6418,,7290008089357,QUININE SULFATE 20TAB,17008,,7166,SECURITAINER POLYPROPYLENE,units,20.0,118 10 22176 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antimalarial.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0bd7d6b2-ebb3-481e-a966-de44ecd325cc.json
0bdce3fc-7155-47c6-a407-aad69dc73953,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8033,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:53:42.193115,IL,יאנסן סילג,,13039.06554,11050.05603,10045.50548,,7640111932642,UPTRAVI ® 600 MCG 60 TAB,21127,,22559,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0bdce3fc-7155-47c6-a407-aad69dc73953.json
0be31cd5-0480-4ef3-9b7f-4fc3f0753e6a,KEVZARA 150 MG,prescription,L04AC14,SARILUMAB,8119,,,WHO ATC Classification,,ILS,solution for injection,SARILUMAB 131.6  MG /,2025-07-31T04:26:06.730156,IL,סאנופי אוונטיס,,4571.240986,3873.933212,3521.757465,,,KEVZARA 200 MG SOL FOR INJ 2 SYR,11276,,64839,PRE-FILLED PEN GLASS TYPE I,units,2.0,160 37 35260 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Kevzara in combination with methotrexate (MTX) is indicated for the treatment of moderately to severely active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (DMARDs). Kevzara can be given as monotherapy in case of intolerance to MTX or when treatment with MTX is inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0be31cd5-0480-4ef3-9b7f-4fc3f0753e6a.json
0bf22605-0d9a-4a1d-b387-9259e0475e55,MAGNESIUM SULFATE 50 % W/V INOVAMED,prescription,A12CC02,MAGNESIUM SULFATE,8749,,,WHO ATC Classification,,ILS,solution for injection / concentrate for solution for inj/inf,MAGNESIUM SULFATE AS HEPTAHYDRATE/,2025-07-31T05:04:44.555141,IL,אינובמד,,156.9933233,133.0451951,106.4361561,,7290104530517,MAGNESIUM SULFATE 50 %  INOVAMED 10 AMP,17114,,60203,AMPOULES POLYPROPYLENE,units,10.0,164 55 35842 00,valid,25.0,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Magnesium Sulfate 50%w/v Inovamed  is indicated for:1.  the treatment of Magnesium deficiency in hypomagnesaemia. 2. the prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutrition. 3. the control and prevention of seizures in severe pre-eclampsia.  4. the control and prevention of recurrent seizures in eclampsia, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0bf22605-0d9a-4a1d-b387-9259e0475e55.json
0bfb2b07-425c-44b2-95b9-7e0a8accf79c,ANAESTHETIC,off-the-counter,S02DA30,COMBINATIONS,2933,,,WHO ATC Classification,,ILS,drops,"TETRACAINE HYDROCHLORIDE 0.5 %W/W, PHENAZONEW/W",2025-07-31T11:13:04.692911,IL,ויטאמד,,17.75,15.04,nan,,7290008084871,ANAESTHETIC EAR DRPS10ML,1134,,,BOTTLE LDPE,units,10.0,063 15 28051 00,valid,nan,otic,1.4,24,,,,,,,,,,0,,"For the relief of pain in acute otitis media and the external, auditory canal.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0bfb2b07-425c-44b2-95b9-7e0a8accf79c.json
0bfb8e35-1d73-45fc-ac31-9a127805b8db,STIMOPEG,prescription,L03AA13,PEGFILGRASTIM,9432,,,WHO ATC Classification,,ILS,solution for injection,PEGFILGRASTIM/ML,2025-07-31T08:44:14.272277,IL,צמל,,3269.259689,2770.559182,2518.690165,,7290100819067,STIMOPEG 10MG/ML 1 PFS 0.6 ML,,,1485,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,173 06 37317 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy, given at intervals of 14 days or more, for malignancy. (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0bfb8e35-1d73-45fc-ac31-9a127805b8db.json
0c06d09b-8676-451a-8c53-e03bde683d27,NAVELBINE 20 MG,prescription,L01CA04,VINORELBINE,6500,,,WHO ATC Classification,,ILS,capsules,VINORELBINE AS TARTRATE,2025-07-31T05:40:40.206321,IL,פאדאגיס,,322.3508109,273.1786654,232.4924812,,7290010137039,NAVELBINE 30MG 1CAPSULE,14417,,63503,BLISTER PVC/PVDC/ALUMINIUM,units,1.0,130 90 30910 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of non small cell lung cancer. For the treatment of advanced breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0c06d09b-8676-451a-8c53-e03bde683d27.json
0c0f300a-8f34-47b6-9904-5978fa8da240,ARIPLY 10,prescription,N05AX12,ARIPIPRAZOLE,7347,,,WHO ATC Classification,,ILS,tablets,ARIPIPRAZOLE,2025-07-30T23:27:27.201339,IL,אוניפארם,,384.7271292,326.03994,277.4808,,,ARIPLY 30MG 28TAB,9645,,40688,BLISTER PVC/ALUMINIUM,units,28.0,149 03 33529 01,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,"Ariply is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.Ariply  is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD). Efficacy was established in two 6-week trials in adults with MDD who had an inadequate response to antidepressant therapy during the current episode.Ariply  is indicated for the treatment of irritability associated with autistic disorder. Efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0c0f300a-8f34-47b6-9904-5978fa8da240.json
0c195c48-5cdd-4af2-bb2d-3f5c23f8c8ac,REPHENIDATE LA 10 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,9143,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:26:12.334911,IL,דקסל פארמה,,77.92893605,66.04147123,49.1014656,,,REPHENIDATE LA 20 MG 30 CAPS,18681,,41266,BLISTER ACLAR/ALUMINIUM,units,30.0,170 55 37007 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention deficit hyperactivity disorder (ADHD),תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0c195c48-5cdd-4af2-bb2d-3f5c23f8c8ac.json
0c2f5e87-163a-4e46-ac8b-63da410cb130,TAF 25 % VETERINARY,prescription,,,3233,,,,,ILS,solution  (oral),THIAMPHENICOL/ML,2025-07-31T06:39:35.778946,IL,ויטאמד,,14.9874986,12.70127,9.271,,,PHENICOL 0.5% 10ML,16111,,9375,BOTTLE POLYETHYLENE,units,10.0,142 30 92419 00,valid,37.0,per os in drinking water,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of bacterial diseases of the respiratory and intestinal system, caused especially by Gram-positive and Gram-negative micro-organisms, mycoplasmas and clamydiae in broilers.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0c2f5e87-163a-4e46-ac8b-63da410cb130.json
0c31e03c-92e8-47db-8018-276dbe3147b3,YASMIN,prescription,G03AA12,DROSPIRENONE AND ESTROGEN,4400,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ETHINYLESTRADIOL 0.03   MG",2025-07-31T10:38:52.618976,IL,באייר,,34.50933089,29.24519697,21.3468591,,7-298074-040876,YASMIN  1X21TAB,25004,,3913,BLISTER PVC/ALUMINIUM,units,21.0,122 02 30220 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraception.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0c31e03c-92e8-47db-8018-276dbe3147b3.json
0c3258fe-538a-41fe-807c-f94e20577733,DERMASIL,off-the-counter,D01BA02,TERBINAFINE,5557,,,WHO ATC Classification,,ILS,cream,TERBINAFINE HYDROCHLORIDE,2025-07-31T11:29:18.706187,IL,ליף-רפא,,54.3626,46.07,nan,,7290103439651,DERMASIL 1% CREAM 30GR,,,,TUBE ALUMINIUM,units,30.0,134 74 31484 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidemophyton floccosum. Yeast infections of the skin, principally those caused by the genus Candida (e.g. candida albicans). Pityriasis (tinea versicolor due to pityrosporum orbiculare (also known as malassezia furfur).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0c3258fe-538a-41fe-807c-f94e20577733.json
0c5e54ad-2122-40bc-9f80-8901dac0738f,NICOTINELL LOZENGES 1 MG,off-the-counter,,,2500,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:29:36.443587,IL,ג.ס.ק,,98.294,83.3,nan,,,NICOTINEL TTS 10 7S,14479,,,BLISTER PVC/PE/PVDC/AL,units,7.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0c5e54ad-2122-40bc-9f80-8901dac0738f.json
0c7d03ed-683f-4e9a-bf13-e142b36c4ca9,CEFTRIAXONE-VIT,prescription,J01DD04,CEFTRIAXONE,8248,,,WHO ATC Classification,,ILS,powder for solution for injection,CEFTRIAXONE AS DISODIUM HEMIHEPTAHYDRATE 1.0 G/VIAL,2025-07-31T01:02:47.402202,IL,ויטאמד,,262.6035425,222.545375,178.0363,,7290015793087,CEFTRIAXONE-VIT  1GR/VIAL  10 VIAL,129282,,17057,VIAL GLASS TYPE III,units,10.0,159 42 34699 00,valid,25.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Ceftriaxone VIT  is indicated for the treatment of the following infections in adults andchildren including term neonates (from birth):-Bacterial Meningitis- Community acquired pneumonia-Hospital acquired pneumonia-Acute otitis media-Intra-abdominal infections-Complicated urinary tract infections (including pyelonephritis)-Infections of bones and joints-Complicated skin and soft tissue infections-Gonorrhoea-Syphilis-Bacterial endocarditisCeftriaxone VIT may be used:-  For treatment of acute exacerbations of chronic obstructive pulmonary diseasein adults- For treatment of disseminated Lyme borreliosis (early (stage II) and late (stageIII) in adults and children including neonates from 15 days of age.- For pre-operative prophylaxis of surgical site infections-In the management of neutropenic patients with fever that is suspected to be dueto a ceftriaxone – susceptible  bacterial infection- In the treatment of patients with bacteraemia that occurs in association with, oris suspected to be associated with, any of the infections listed aboveCeftriaxone VIT should be co-administered with other antibacterial agents whenever thepossible range of causative bacteria would not fall within its spectrum.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0c7d03ed-683f-4e9a-bf13-e142b36c4ca9.json
0caa9a66-a434-475f-baae-0d7135dc3767,DERMOSTAMIN GEL,off-the-counter,D04AA13,DIMETINDENE,5610,,,WHO ATC Classification,,ILS,gel,DIMETINDENE MALEATE 0.1 %W/W,2025-07-31T11:30:05.438700,IL,ליף- תרימה,,30.0546,25.47,nan,,,DERMOSTAMIN GEL 30gr,,,,TUBE ALUMINIUM,units,30.0,162 15 35946 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0caa9a66-a434-475f-baae-0d7135dc3767.json
0cadd55e-285c-475f-89fe-39baa93bf665,VIA-AVENIR 100 MG,prescription,G04BE03,SILDENAFIL,8264,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:11:38.684596,IL,ביואבניר,,187.2596575,158.694625,126.9557,,7290010286911,VIA AVENIR 25MG  8TABS,,,55870,BLISTER PVC/PVDC/ALUMINIUM,units,8.0,147 72 33415 01,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0cadd55e-285c-475f-89fe-39baa93bf665.json
0cb386d6-b588-4f3a-b375-18ee770aea5a,SALAZOPIRIN 500MG 100TAB,prescription,,,1226,,,,,ILS,tablet,SALAZOPIRIN 500MG,2025-07-31T19:30:49.421489,IL,פיזר,,66.55961432,56.40645533,41.937885,,,SALAZOPIRIN 500MG 100TAB,19002,,1936,,units,100.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0cb386d6-b588-4f3a-b375-18ee770aea5a.json
0cc6a85a-8229-4148-bc3e-219e883d1d10,CURATANE 10 MG,prescription,,,4018,,,,,ILS,capsules soft gelatin,ISOTRETINOIN,2025-07-31T01:35:50.872328,IL,תרו יבוא,,107.1851159,90.834844,67.5352,,,CURATANE 20MG 30CAP,3705,,27306,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,136 12 30295 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of severe cystic acne that does not respond to other treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0cc6a85a-8229-4148-bc3e-219e883d1d10.json
0cce489e-f632-4a32-8360-97167885e693,CIPRAMIL 20 MG TABLETS,prescription,N06AB04,CITALOPRAM,6498,,,WHO ATC Classification,,ILS,film coated tablets,CITALOPRAM AS HYDROBROMIDE,2025-07-31T01:16:14.235782,IL,לנדבק,,49.65888046,42.083797,30.7181,,,CIPRAMIL 40MG 28TAB,3995,,2692,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,102 51 28198 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of states of depression and panic disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0cce489e-f632-4a32-8360-97167885e693.json
0cd3e2d3-2bf9-4008-b0ea-e74b4e1701f2,DEPALEPT SYRUP,prescription,N03AG01,VALPROIC ACID,2315,,,WHO ATC Classification,,ILS,syrup,VALPROIC ACID AS SODIUM/ML  ML,2025-07-31T01:47:08.588283,IL,כ.צ.ט,,34.13741888,28.930016,21.1168,,7290008005104,DEPALEPT SYR 110ML,4339,,590,BOTTLE GLASS TYPE III,units,110.0,033 72 22644 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0cd3e2d3-2bf9-4008-b0ea-e74b4e1701f2.json
0cf48feb-81a3-46a3-9ef4-dc51d5a8eafd,FUCITHALMIC VISCOUS EYE DROPS,prescription,S01AA13,FUSIDIC ACID,2622,,,WHO ATC Classification,,ILS,"eye drops, suspension",FUSIDIC ACIDW/W,2025-07-31T03:21:18.199247,IL,דקסל פארמה,,45.63304409,38.67207299,28.2277905,,7-290005-680656,FUCITHALMIC VISCOUS EYE DROPS 5GR (GEL),6010,,8638,TUBE LAMINATED PE,units,5.0,057 82 26772 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Treatment of external eye infections caused by microorganisms sensitive to the preparation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0cf48feb-81a3-46a3-9ef4-dc51d5a8eafd.json
0d0dc7eb-e109-4a0f-bea3-639f0341369d,DASATINIB TEVA 100 MG,prescription,L01XE06,DASATINIB,9178,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB AS MONOHYDRATE,2025-07-31T01:42:59.428664,IL,טבע,,6252.333003,5298.587291,4816.897537,,,DASATINIB TEVA 100 MG 30 TAB,,,37031,BLISTER OPA/ALU/PVC/ALU,units,30.0,169 90 36435 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with : * Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase. * Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate. * Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d0dc7eb-e109-4a0f-bea3-639f0341369d.json
0d11305f-5839-4e89-9b99-06d2096fc8b3,LIDOCAINE B.BRAUN 1 %,prescription,D04AB01,LIDOCAINE,9108,,,WHO ATC Classification,,ILS,solution for injection,LIDOCAINE HYDROCHLORIDE MONOHYDRATE/ML,2025-07-31T04:46:21.292043,IL,לפידות,,101.7301897,86.2120252,64.09816,,,LIDOCAINE B.BRAUN 1 % 10 ML 20 AMP,,,55817,AMPOULES LDPE,units,20.0,156 33 34107 00,valid,34.5,"i.m, epidural, s.c, intradermal, submucosal, spinal, perineural, i.v regional anaesthesia",1.4,24,,,,,,,,,,0,Prescription required,Local and regional anaesthesia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d11305f-5839-4e89-9b99-06d2096fc8b3.json
0d1f9904-2a45-4e39-a6a1-48a734248b7e,RAPAMUNE 1 MG TABLETS,prescription,L04AA10,SIROLIMUS,4804,,,WHO ATC Classification,,ILS,coated tablets,SIROLIMUS,2025-07-31T07:16:40.419909,IL,פיזר,,559.0625932,473.7818797,403.218621,,72900064011731,RAPAMUNE 1MG 30TAB,18331,,11944,BLISTER PVC/PE/ALUMINIUM,units,30.0,131 73 30909 22,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. It is recommended that Rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. Rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d1f9904-2a45-4e39-a6a1-48a734248b7e.json
0d200c4d-e73c-4863-a103-b606af63f56f,CELLCEPT 250 MG,prescription,L04AA06,MYCOPHENOLIC ACID,3669,,,WHO ATC Classification,,ILS,capsules,MYCOPHENOLATE MOFETIL,2025-07-31T01:04:38.186336,IL,רוש,,321.3999896,272.3728725,231.8067,,7290008140188,CELLCEPT 250MG 100CAPS,3390,,33840,BLISTER PVC/ALUMINIUM,units,100.0,111 34 29434 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. Cellcept should be used concomitantly with cyclosporin and corticosteroids.Allogenic hepatic transplant.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d200c4d-e73c-4863-a103-b606af63f56f.json
0d25db19-39fa-4589-9ce6-e7c521b95b21,GUTRON 2.5MG 20TAB,29C,,,3803,,,,,,tablet,GUTRON 2.5MG,2025-07-31T20:33:21.664060,IL,nan,,,,,,,GUTRON 2.5MG 20TAB,,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d25db19-39fa-4589-9ce6-e7c521b95b21.json
0d2781fd-ea7d-426d-98a8-a3193adf863a,DUPLEX 10/160,prescription,C09CA03,VALSARTAN,9181,,,WHO ATC Classification,,ILS,coated tablets,"VALSARTAN, AMLODIPINE AS BESILATE",2025-07-31T02:08:36.204640,IL,אוניפארם,,110.7706242,93.87341036,69.79435714,,,DUPLEX 5/80 30 TABS,,,36970,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,153 26 34298 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of essential hypertension. Duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d2781fd-ea7d-426d-98a8-a3193adf863a.json
0d4b98b2-d849-4151-af6f-2da4393dce34,NEO-MEDROL ACNE 25ML,prescription,,,100,,,,,,tablet,NEO-MEDROL ACNE,2025-07-31T19:22:06.747105,IL,פיזר,,,,,,,NEO-MEDROL ACNE 25ML,14071,,1453,,units,25.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d4b98b2-d849-4151-af6f-2da4393dce34.json
0d67438c-ce87-484a-9bdb-a3cc4af91c6a,CRUSIA,prescription,B01AB05,ENOXAPARIN,8444,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/,2025-07-31T01:34:06.906693,IL,צמל,,70.1460872,59.44583925,44.19765,,,CRUSIA 100MG/ML 2 SYR,10629,,55142,SYRINGE 0.5 ML GLASS TYPE I,units,2.0,162 88 35673 00,valid,34.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Crusia is indicated in adults for:•Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery.•Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism.•Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE ikely to require thrombolytic therapy or surgery. Prevention of thrombus formation in extra corporeal circulation during haemodialysis.•Acute coronary syndrome:-Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid.-Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d67438c-ce87-484a-9bdb-a3cc4af91c6a.json
0d7b46f7-092d-4fce-bca3-050a118712df,GARDASIL 9,prescription,J07BM03,"PAPILLOMAVIRUS (HUMAN TYPES 6, 11, 16, 18, 31, 33, 45, 52, 58)",8254,,,WHO ATC Classification,,ILS,suspension for injection,"HPV TYPE 58 L1 PROTEIN/ 0.5  ML, HPV TYPE 52 L1 PROTEIN/ 0.5  ML, HPV TYPE 45 L1 PROTEIN/ 0.5  ML, HPV TYPE 33 L1 PROTEIN/ 0.5  ML, HPV TYPE 31 L1 PROTEIN/ 0.5  ML, HPV TYPE 18 L1 PROTEIN/ 0.5  ML, HPV TYPE 16 L1 PROTEIN/ 0.5  ML, HPV TYPE 11 L1 PROTEIN/ 0.5  ML, HPV TYPE 6 L1 PROTEIN/ 0.5  ML",2025-07-31T03:27:49.169901,IL,מ.ס.ד. ישראל,,657.2213454,556.9672666,474.014695,,,GARDASIL 9 1 SYRINGE,,,25957,SYRINGE GLASS TYPE I,units,1.0,157 58 34548 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Gardasil 9 is indicated for active immunisation of individuals at the age of 9-45 years old against the following HPV diseases:•	Premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine HPV types•	Genital warts (Condyloma acuminata) caused by specific HPV types.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d7b46f7-092d-4fce-bca3-050a118712df.json
0d80bcfb-b4ab-41c0-8081-73f47b12a95b,IG VENA,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",8653,,,WHO ATC Classification,,ILS,solution for infusion,HUMAN NORMAL IMMUNOGLOBULIN/ML,2025-07-31T03:58:18.506363,IL,קמהדע,,3163.527229,2680.955398,2437.23218,,,IG VENA 1VIAL 5% 200ML,,,40763,VIAL GLASS TYPE I,units,200.0,164 11 35926 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, and children and adolescents (0-18 years) in:• Primary immunodeficiency syndromes (PID) with impaired antibody production• Secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)* or serum IgG level of <4 g/l*  PSAF  =  failure  to  mount  at  least  a  2-fold  rise  in  IgG  antibody  titre  to  pneumococcal polysaccharide and polypeptide antigen vaccines.Immunomodulation in adults, and children and adolescents (0-18 years) in:• Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count• Guillain Barré syndrome• Kawasaki disease (in conjunction with acetylsalicylic acid)• Chronic inflammatory demyelinating poliradiculoneuropathy (CIDP)• Multifocal motor neuropathy (MMN)",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d80bcfb-b4ab-41c0-8081-73f47b12a95b.json
0d80bdef-3ce6-4ccf-9468-781e03e6f652,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,3481,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:32:23.920827,IL,דקסל פארמה,,13.8296,11.72,nan,,,DEXAMOL SINUS NIGHT 20 CAPLETS,4046,,,BLISTER PVC/ALUMINIUM,units,20.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d80bdef-3ce6-4ccf-9468-781e03e6f652.json
0d928790-011e-4ea1-b3c7-b08ebdc8deac,INDOCID 100MG 12SUPP,29C,,,20461,,,,,,suppository,INDOCID 100MG 12SUPP,2025-07-31T20:38:23.127249,IL,nan,,,,,,,INDOCID 100MG 12SUPP,,,,,units,12.0,,not-registered,,rectal,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0d928790-011e-4ea1-b3c7-b08ebdc8deac.json
0da93f75-9007-411f-9664-aeffba0ff341,PIOGLITAZONE INOVAMED 15,prescription,A10BG03,PIOGLITAZONE,8918,,,WHO ATC Classification,,ILS,tablets,PIOGLITAZONE AS HYDROCHLORIDE,2025-07-31T06:43:20.755797,IL,אינובמד,,132.6480042,112.4135679,83.5788609,,7290104530869,PIOGLITAZONE INOVAMED 30MG 30TAB,17476,,72747,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,167 54 35972 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0da93f75-9007-411f-9664-aeffba0ff341.json
0dad36cb-819a-49b0-a25e-d0f83a392780,FLUCANOL 100,prescription,J02AC01,FLUCONAZOLE,6607,,,WHO ATC Classification,,ILS,capsules,FLUCONAZOLE,2025-07-31T03:10:50.814461,IL,רפא,,49.435628,41.8946,30.58,,7290008012423,FLUCANOL 50MG 7CAPSULES,6155,,57191,BLISTER PVC/PVDC/ALUMINIUM,units,7.0,128 37 30644 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:• Cryptococcal meningitis.• Coccidioidomycosis.• Invasive candidiasis.• Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.• Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.• Candidal balanitis when local therapy is not appropriate.• Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.• Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:• Relapse of cryptococcal meningitis in patients with high risk of recurrence.• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.• To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).• Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis and cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0dad36cb-819a-49b0-a25e-d0f83a392780.json
0dad6690-b6b7-4819-bc64-156446c5988c,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4551,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:23:46.813754,IL,מדיסון,,1566.411136,1327.467123,1129.759254,,8715131005863,ARANESP 50MCG 4 PREFILLED SYR 0.5ML,9485,,29745,PRE-FILLED PEN GLASS TYPE I,units,4.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0dad6690-b6b7-4819-bc64-156446c5988c.json
0db8150e-15fa-45ce-84c6-49ed511f77f0,XADAGO 100 MG,prescription,N04BD03,SAFINAMIDE,8885,,,WHO ATC Classification,,ILS,film coated tablets,SAFINAMIDE AS METHANESULFONATE,2025-07-31T10:26:48.591556,IL,מדיסון,,410.67719,348.0315325,296.1970489,,,XADAGO 50 MG 30 TAB,24095,,7104,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,164 64 35607 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Xadago is indicated for the treatment of adult patients with idiopathic Parkinson’s disease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0db8150e-15fa-45ce-84c6-49ed511f77f0.json
0dbb5f7a-cff3-41cf-87fe-f90bbfa98b47,FUROSEMIDE S.A.L.F 250 MG/25 ML,prescription,C03CA01,FUROSEMIDE,9423,,,WHO ATC Classification,,ILS,solution for infusion,FUROSEMIDE/ML,2025-07-31T03:23:23.602960,IL,רז פרמהצפטי,,64.25095647,54.44996553,40.48324575,,7290018490181,FUROSEMIDE S.A.L.F 250 MG/25 ML 5 VIALS,6643,,70837,VIAL GLASS TYPE I,units,5.0,166 77 35843 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Furosemide is a potent diuretic indicated for use when a prompt and effective diuresis is required.Furosemide is appropriate for use in emergencies or where oral therapy is not feasible. The indications include cardiac, pulmonary, hepatic and renal oedema",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0dbb5f7a-cff3-41cf-87fe-f90bbfa98b47.json
0dce3b27-086e-4f2b-9d0c-21b9ac8b5690,NUVIGIL 150 MG,prescription,N06BA07,MODAFINIL,7880,,,WHO ATC Classification,,ILS,tablets,ARMODAFINIL,2025-07-31T05:58:48.371382,IL,טבע,,nan,nan,nan,,,NUVIGIL 250 MG 30TAB,14597,,51370,BLISTER PVC/ALUMINIUM,units,30.0,155 84 34389 06,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,"Nuvigil is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0dce3b27-086e-4f2b-9d0c-21b9ac8b5690.json
0dd3a1da-0f69-4828-b4f9-389a3441e64e,KAMRAB,prescription,J06BB05,RABIES IMMUNOGLOBULIN,6888,,,WHO ATC Classification,,ILS,solution for injection,HUMAN-RABIES IMMUNOGLOBULIN/ML,2025-07-31T04:22:39.373046,IL,קמהדע,,1508.397007,1278.302605,1087.917111,,7290008072250,KAMRAB 150IU/ML 1VIAL/2ML,,,,VIAL GLASS TYPE I,units,2.0,138 88 31771 00,valid,17.5,i.m,1.4,30,,,,,,,,,,0,Prescription required,"KamRAB IM is indicated for passive, transient post-exposure prevention of rabies infection when given immediately to individuals in cases of contact with rabid or possibly rabid animal.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0dd3a1da-0f69-4828-b4f9-389a3441e64e.json
0ddc0ea3-0265-4244-80bc-a4a8be6d87b5,PAN-CEFTRIAXONE 1 GR10 VIAL,prescription,,,7966,,,,,ILS,injection,PAN-CEFTRIAXONE 1 GR,2025-07-31T19:27:35.694541,IL,פארמלוג'יק,,262.6035425,222.545375,178.0363,,,PAN-CEFTRIAXONE 1 GR10 VIAL,16714,,59635,,units,10.0,,not-registered,25.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0ddc0ea3-0265-4244-80bc-a4a8be6d87b5.json
0de4951f-4b76-4f80-9a0a-2fc81d9e8907,ACTIQ 1200 MCG,prescription,N02AB03,FENTANYL,6122,,,WHO ATC Classification,,ILS,compressed tablet on a handle,FENTANYL AS CITRATE/DOSE,2025-07-31T00:07:22.500711,IL,טבע,,732.6051529,620.8518521,528.384555,,7290106061019,ACTIQ 200MCG 30 COMPRESSED TAB,9269,,86429,BLISTER PVC/ACLAR,units,30.0,138 25 31575 00,valid,17.5,oral transmucosal,1.4,36,,,,,,,,,,0,Prescription required,Actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0de4951f-4b76-4f80-9a0a-2fc81d9e8907.json
0e036969-6db5-45cd-ad43-324a41ee134e,KORSUVA,prescription,V03AX04,DIFELIKEFALIN,9216,,,WHO ATC Classification,,ILS,solution for injection,DIFELIKEFALIN AS ACETATE/,2025-07-31T04:29:22.174875,IL,כ.צ.ט,,2188.891647,1854.993004,1578.71745,,,KORSUVA 50mcg/ml 12 vial,,,,VIAL GLASS TYPE I,units,12.0,173 72 37475 99,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Korsuva is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0e036969-6db5-45cd-ad43-324a41ee134e.json
0e0ff341-82a2-4d3f-bf37-0d5dc76c39e9,ASTONIN H 100MCG 100TAB,29C,,,20040,,,,,,tablet,ASTONIN H 100MCG,2025-07-31T19:58:04.661799,IL,nan,,,,,,,ASTONIN H 100MCG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0e0ff341-82a2-4d3f-bf37-0d5dc76c39e9.json
0e204fff-71e3-48e8-bff2-f075b2c75708,DEXILANT 30 MG,29C,A02BC06,DEXLANSOPRAZOLE,20858,,,WHO ATC Classification,,ILS,modified release capsules,DEXLANSOPRAZOLE,2025-07-31T14:59:03.264901,IL,nan,,nan,nan,nan,,,LANSOPRAZOLE15 MG  28TAB ORODISPERSIBLE  TEVA UK,,,,BLISTER PVC/PE/PCTFE/AL,units,28.0,155 45 34383 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Dexilant 30 is indicated in adults and in adolescents aged 12 to 17 years for the following:• Maintenance of healed erosive reflux oesophagitis and maintenance of relief of heartburn• Short-term treatment of heartburn and acid regurgitation associated with symptomatic non-erosive gastro-oesophageal reflux disease (GORD).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0e204fff-71e3-48e8-bff2-f075b2c75708.json
0eadcddf-e1e6-417f-86c0-eb02bce305a8,TEPADINA 100 MG,prescription,L01AC01,THIOTEPA,7761,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,THIOTEPA/VIAL,2025-07-31T09:12:47.880916,IL,אמ.בי.איי פארמה,,2654.351586,2249.450597,2044.955088,,7290014257528,TEPADINA 100MG VIAL,,,84871,VIAL GLASS TYPE I,units,1.0,154 18 34230 03,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"TEPADINA is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;2.  when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0eadcddf-e1e6-417f-86c0-eb02bce305a8.json
0ee6973f-1fa5-4ed7-8f09-048be16e1699,BALVERSA 3 MG,prescription,L01EX16,ERDAFITINIB,8488,,,WHO ATC Classification,,ILS,film coated tablets,ERDAFITINIB,2025-07-30T23:34:03.669777,IL,יאנסן סילג,,nan,nan,nan,,7290014577572,BALVERSA 3 MG 56 TAB,2746,,430,BOTTLE HDPE,units,56.0,165 77 36132 00,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,"BALVERSA is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has:- Susceptible FGFR3 or FGFR2 genetiic alterations, and- Progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0ee6973f-1fa5-4ed7-8f09-048be16e1699.json
0eed2e98-f877-472b-a4a3-8c34c95ed7ca,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5089,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:00:38.985261,IL,טבע,,51.33,43.5,nan,,7290000800028,ACAMOL TSIN.LIQUI.GEL 30D+10N CAPSULE,1896,,,BLISTER PVC/ALUMINIUM,units,40.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0eed2e98-f877-472b-a4a3-8c34c95ed7ca.json
0eefb8df-45d7-4e21-b92e-37e2677efc8c,PUREGON SOLUTION FOR INJECTION,prescription,G03GA06,FOLLITROPIN BETA,4733,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN BETA/,2025-07-31T07:07:10.163327,IL,אורגנון,,443.3794883,375.7453457,319.783273,,7290006537096,PUREGON  300UI/0.36ML CARTRIDGE,16663,,60464,CARTRIDGE GLASS TYPE I,units,1.0,130 52 30898 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Puregon is indicated for the treatment of female infertility in the following clinical situations: Anovulation (including polycystic ovarian disease, PCOD) in women who have beenunresponsive to treatment with clomiphene citrate. Controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)]. In the male : Deficient spermatogenesis due to hypogonadotrophic hypogonadism.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0eefb8df-45d7-4e21-b92e-37e2677efc8c.json
0efc2d16-4e18-4df5-b526-4a52c1a78d47,ZEMPLAR 1 MICROGRAM,prescription,H05BX02,PARICALCITOL,6649,,,WHO ATC Classification,,ILS,"capsule, soft",PARICALCITOL,2025-07-31T10:45:44.615632,IL,אב-וי,,512.6626941,434.4599296,369.7531315,,,ZEMPLAR 1MCG 28 CAPSULES,26154,,83855,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,141 12 31816 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0efc2d16-4e18-4df5-b526-4a52c1a78d47.json
0f0a5009-89b6-435c-81b4-327847e31530,LYNPARZA 100 MG,prescription,L01XX46,,8453,,,WHO ATC Classification,,ILS,film coated tablets,OLAPARIB,2025-07-31T05:00:51.547721,IL,אסטראזנקה,,9930.66975,8415.822197,7650.747451,,7290013075734,LYNPARZA 100 MG 56 TAB,12552,,27551,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,161 63 35469 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Ovarian cancer:Lynparza is indicated as monotherapy for the: •           maintenance treatment of adult patients with advanced (FIGO stages III and IV) BRCA1/2- mutated (germline and/or somatic) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. •           Maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete response or partial response) to platinum-based chemotherapy.First-line Maintenance Treatment of Advanced Ovarian Cancer in Combination with BevacizumabLynparza is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either:• a deleterious or suspected deleterious BRCA mutation, and/or• genomic instability Breast cancer:Germline BRCA-mutated HER2-negative Metastatic Breast CancerLynparza is indicated in patients with deleterious or suspected deleterious gBRCAm, HER2-negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. Patients with hormone receptor (HR)- positive breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy.Adjuvant Treatment of Germline BRCA-mutated HER2-negative High Risk Early Breast Cancer Lynparza is indicated for the adjuvant treatment of adult patients with deleterious or suspected deleterious gBRCAm human epidermal growth factor receptor 2 (HER2)-negative high risk early breast cancer who have been treated with neoadjuvant or adjuvant chemotherapy. Adenocarcinoma of the pancreas:First-line Maintenance Treatment of Germline BRCA-mutated Metastatic Pancreatic AdenocarcinomaLynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen.Prostate cancer:•	germline or somatic BRCA1/2 or ATM- mutated metastatic castration-resistant prostate cancer Lynparza is indicated for the treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA1/2 or ATM- mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with enzalutamide or abiraterone.•	Lynparza is indicated in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with deleterious or suspected deleterious HRR-mutated (HRRm) metastatic castration-resistant prostate cancer (mCRPC). Select patients for therapy based on an approved companion diagnostic for Lynparza",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0f0a5009-89b6-435c-81b4-327847e31530.json
0f1fd100-beb1-4197-be68-99dc172a576c,BRAFTOVI 75 MG,prescription,L01XE46,ENCORAFENIB,8752,,,WHO ATC Classification,,ILS,hard gelatin capsules,ENCORAFENIB,2025-07-30T23:42:25.955056,IL,מדיסון,,30284.04185,25664.44339,23331.31217,,,BRAFTOVI 75 MG 180CAPS,2645,,25964,BOTTLE HDPE,units,180.0,167 76 35722 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"BRAF V600E or V600K Mutation-Positive Unresectable or Metastatic MelanomaEncorafenib is a kinase inhibitor indicated, in combination with binimetinib, for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation.BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (CRC)Encorafenib is indicated in combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAF V600E mutation, as detected by an approved test after prior therapy.BRAF V600E Mutation-Positive metastatic non-small cell lung cancer (NSCLC)Encorafenib is a kinase inhibitor indicated, in combination with binimetinib, for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) adenocarcinoma with a BRAF V600E mutation, as detected by an approved test.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0f1fd100-beb1-4197-be68-99dc172a576c.json
0f26a6d6-cfca-433e-baac-eaff28e7b6d1,KALINOR RETARD 600 MG,prescription,A12BA01,POTASSIUM CHLORIDE,9146,,,WHO ATC Classification,,ILS,capsules prolonged release,POTASSIUM CHLORIDE,2025-07-31T04:21:24.768235,IL,טרוסטפארם,,81.91452046,69.41908823,51.612705,,,KALINOR RETARD 600 MG SR 100 CAPS,,,2444,BOTTLE GLASS TYPE III,units,100.0,170 46 36674 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prevention of hypokalemia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0f26a6d6-cfca-433e-baac-eaff28e7b6d1.json
0f46e861-cf44-425c-9897-14dfcdbaa151,EPREX/PROTECS 10000 IU/1ML 6 SYRINGES,prescription,,,4569,,,,,ILS,tablet,EPREX/PROTECS 10000 IU/ 6 SYRINGES,2025-07-31T19:06:22.911603,IL,יאנסן סילג,,2365.062168,2004.289973,1705.7787,,,EPREX/PROTECS 10000 IU/1ML 6 SYRINGES,5462,,86985,,units,6.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0f46e861-cf44-425c-9897-14dfcdbaa151.json
0f7662ea-ffc5-4ebe-9f77-949afa7a8069,KEYTRUDA 100 MG/4 ML,prescription,L01FF02,PEMBROLIZUMAB,7918,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PEMBROLIZUMAB/ML,2025-07-31T04:26:12.159334,IL,מ.ס.ד. ישראל,,12933.47552,10960.57296,9964.157237,,7290006813794,KEYTRUDA 100 MG/4 ML,,,12898,VIAL GLASS TYPE I,units,1.0,154 38 34448 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Melanoma• KEYTRUDA is indicated for the treatment of adult and pediatric (12 years and older) patients with unresectable or metastatic melanoma.•KEYTRUDA is indicated for the adjuvant treatment of adult and pediatric (12 years and older) patients with Stage IIB, IIC, or III melanoma following complete resection.Non-Small Cell Lung Cancer• KEYTRUDA, in combination with pemetrexed and carboplatin, is indicated for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC) negative for EGFR or ALK genomic tumor aberrations.• KEYTRUDA, in combination with carboplatin and either paclitaxel or paclitaxel protein-bound , is indicated for the first-line treatment of patients with metastatic squamous NSCLC.• KEYTRUDA, as a single agent, is indicated for the treatment of patients with metastatic NSCLC whose tumors express PD-L1 [Tumor Proportion Score (TPS) &#8805;50%)] as determined by a validated test. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on or after platinum-containing chemotherapy and an approved therapy for these aberrations prior to receiving KEYTRUDA .• KEYTRUDA, as a single agent, is indicated for the treatment of patients with advanced NSCLC whose tumors express PD-L1 as determined by a validated test, with disease progression on or after platinum containing chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on approved therapy for these aberrations prior to receiving KEYTRUDA .• KEYTRUDA , as a single agent, is indicated as adjuvant treatment following resection and platinum-based chemotherapy for adult patients with Stage IB (T2a &#8805;4 cm), II, or IIIA NSCLC.• KEYTRUDA, in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment, is indicated for the treatment of resectable NSCLC at high risk of recurrence in adults (for selection criteria, see section 14 CLINICAL STUDIES).Head and Neck Cancer• KEYTRUDA, in combination with platinum and fluorouracil (FU), is indicated for the first-line treatment of patients with metastatic or with unresectable, recurrent head and neck squamous cell carcinoma (HNSCC).• KEYTRUDA, as a single agent, is indicated for the first-line treatment of patients with metastatic or with unresectable, recurrent HNSCC whose tumors express PD-L1 [Combined Positive Score (CPS) &#8805;1] as determined by a validated test .• KEYTRUDA, as a single agent, is indicated for the treatment of patients with recurrent or metastatic HNSCC with disease progression on or after platinum-containing chemotherapy..Classical Hodgkin Lymphoma• KEYTRUDA is indicated for the treatment of adult patients with relapsed or refractory classical Hodgkin lymphoma (cHL).• KEYTRUDA is indicated for the treatment of pediatric patients with refractory cHL, or cHL that has relapsed after 2 or more lines of therapyPrimary Mediastinal large B-Cell Lymphoma KEYTRUDA is indicated for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or who have relapsed after 2 or more prior lines of therapy.Limitation of Use: KEYTRUDA is not recommended for treatment of patients with PMBCL who require urgent cytoreductive therapy.Urothelial Cancer• KEYTRUDA, as a single agent, is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin-containing chemotherapy and whose tumors express PD-L1 (CPS &#8805;10)  as determined by a validated test, or in patients who are not eligible for any platinum-containing chemotherapy regardless of PD-L1 status. • KEYTRUDA, as a single agent, is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.• KEYTRUDA, as a single agent, is indicated for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors who are ineligible for or have elected not to undergo cystectomy.• KEYTRUDA, in combination with enfortumab vedotin, is indicated for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer.Microsatellite Instability-High CancerKEYTRUDA is indicated for the treatment of adult and pediatric patients with unresectable or metastatic, microsatellite instability-high (MSI H) or mismatch repair deficient (dMMR). • solid tumors that have progressed following prior systemic treatment and who have no satisfactory alternative treatment options,or• colorectal cancer that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.Limitation of Use: The safety and effectiveness of KEYTRUDA in pediatric patients with MSI H central nervous system cancers have not been established. Gastric Cancer• KEYTRUDA, in combination with trastuzumab, fluoropyrimidine and platinum-containing chemotherapy, is indicated for the first-line treatment of locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction (GEJ) adenocarcinoma in adults whose tumors express PD-L1 with a CPS &#8805;1 as determined by a validated test.• KEYTRUDA, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors express PD-L1 with a CPS &#8805;1 as determined by a validated test.Cervical Cancer• KEYTRUDA, in combination with chemoradiotherapy (CRT), is indicated for the treatment of patients with FIGO 2014 Stage III-IVA cervical cancer.• KEYTRUDA, in combination with chemotherapy, with or without bevacizumab, is indicated for the treatment of patients with persistent, recurrent, or metastatic cervical cancer whose tumors express PD-L1 (CPS &#8805;1) as determined by a validated test. • KEYTRUDA, as a single agent, is indicated for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy whose tumors express PD-L1 (CPS &#8805;1) as determined by a validated test.Biliary Tract CancerKEYTRUDA, in combination with gemcitabine and cisplatin, is indicated for the treatment of patients with locally advanced unresectable or metastatic biliary tract cancer (BTC).Merkel Cell CarcinomaKEYTRUDA is indicated for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma (MCC).Renal Cell Carcinoma• KEYTRUDA, in combination with axitinib, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC).• KEYTRUDA, in combination with lenvatinib, is indicated for the first-line treatment of adult patients with advanced RCC.• KEYTRUDA is indicated for the adjuvant treatment of patients with RCC at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions.Esophageal Cancer• KEYTRUDA is indicated for the treatment of patients with locally advanced or metastatic esophageal or gastroesophageal junction (GEJ) (Siewert type I) carcinoma that is not amenable to surgical resection or definitive chemoradiation in combination with platinum- and fluoropyrimidine-based chemotherapy.• KEYTRUDA is indicated for the treatment of patients with recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus whose tumors express PD-L1 (CPS &#8805;10) as determined by a validated test, with disease progression after one or more prior lines of systemic therapy.Cutaneous Squamous Cell CarcinomaKEYTRUDA is indicated for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC that is not curable by surgery or radiationMicrosatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer (CRC)KEYTRUDA is indicated for the first-line treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer (CRC).Tumor Mutational Burden-High CancerKEYTRUDA is indicated for the treatment of adult and pediatric patients with unresectable or metastatic tumor mutational burden-high (TMB-H) [&#8805;10 mutations/megabase (mut/Mb)] solid tumors, as determined by a validated test, that have progressed following prior treatment and who have no satisfactory alternative treatment options.Limitations of Use: The safety and effectiveness of KEYTRUDA in pediatric patients with TMB-H central nervous system cancers have not been established.Triple Negative Breast Cancer• KEYTRUDA, in combination with chemotherapy, is indicated for the treatment of patients with locally recurrent unresectable or metastatic triple negative breast cancer (TNBC) whose tumors express PD-L1 (CPS &#8805;10) as determined by a validated test• KEYTRUDA is indicated for the treatment of patients with high risk early stage triple negative breast cancer (TNBC) in combination with chemotherapy as neoadjuvant treatment, and then continued as a single agent as adjuvant treatment after surgery.Endometrial carcinoma• KEYTRUDA, in combination with carboplatin and paclitaxel, followed by KEYTRUDA as a single agent, for the treatment of adult patients with primary advanced or recurrent pMMR endometrial carcinoma at least 12 months from prior adjuvant chemotherapy, and dMMR endometrial carcinoma regardless of prior adjuvant treatment.• KEYTRUDA, in combination with lenvatinib, is indicated for the treatment of advanced or recurrent endometrial carcinoma in adults who have disease progression on or following prior treatment with a platinum containing therapy and who are not candidates for curative surgery or radiation.Malignant Pleural MesotheliomaKEYTRUDA, in combination with pemetrexed and platinum chemotherapy, is indicated for the first line treatment of adults with unresectable non-epithelioid malignant pleural mesothelioma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0f7662ea-ffc5-4ebe-9f77-949afa7a8069.json
0f840925-593a-4895-b829-c755f31a9485,IOPAMIRO 300,prescription,V08AB04,IOPAMIDOL,2916,,,WHO ATC Classification,,ILS,solution for injection,IOPAMIDOL 612.4  MG/ML,2025-07-31T06:25:47.829700,IL,כ.צ.ט,,27.93290808,23.671956,17.2788,,,PAMID 2.5MG 30TAB,16075,,9034,BOTTLE GLASS TYPE I,units,30.0,020 40 24483 11,valid,37.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"X-ray contrast medium in neuroradiology, angiography, urography, ct scanning, arthrography and fistulography",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0f840925-593a-4895-b829-c755f31a9485.json
0f9baeaf-9310-4739-a76f-e07a40360c37,AMBIEN CR 6.25 MG,prescription,N05CF02,ZOLPIDEM,9345,,,WHO ATC Classification,,ILS,tablets extended release,ZOLPIDEM TARTRATE 6.25   MG,2025-07-30T23:21:21.578975,IL,סאנופי אוונטיס,,nan,nan,nan,,7290012711053,AMBIEN CR 6.25MG 14TAB,23383,,89037,BLISTER PVC/ALUMINIUM,units,14.0,142 05 31833 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the short-term treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance  (as measured by wake time after sleep onset).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0f9baeaf-9310-4739-a76f-e07a40360c37.json
0fcd2b7c-9021-4c73-9740-77a18f51f5b9,VELTASSA 16.8 G,prescription,V03AE09,PATIROMER CALCIUM ,9061,,,WHO ATC Classification,,ILS,powder for oral suspension,PATIROMER AS SORBITEX CALCIUM 16.8 G,2025-07-31T10:03:17.294566,IL,כ.צ.ט,,1256.734344,1065.029153,906.4077895,,,VELTASSA 16.8 G 30 SACHETS,,,78949,SACHET ALUMINIUM,units,30.0,161 53 35492 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Veltassa is indicated for the treatment of hyperkalaemia in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0fcd2b7c-9021-4c73-9740-77a18f51f5b9.json
0fea5f36-a458-4fd9-9866-323482926e5c,LOPI-CARE TABLETS,off-the-counter,A07DA03,LOPERAMIDE,5390,,,WHO ATC Classification,,ILS,tablets,LOPERAMIDE HYDROCHLORIDE,2025-07-31T12:21:42.044370,IL,מכבי קאר,,21.9952,18.64,nan,,7290008091176,LOPI-CARE  10 TABLETS,,,,BLISTER PVC/ALUMINIUM,units,10.0,135 81 31537 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Control and symptomatic relief of acute diarrhea in adults, adolescents and children aged 6 years and older.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0fea5f36-a458-4fd9-9866-323482926e5c.json
0ff08ff6-31a3-4597-80fb-5abe0dbcb05b,ONDANSETRON BAXTER 2 MG/ML,prescription,A04AA01,ONDANSETRON,8992,,,WHO ATC Classification,,ILS,solution for injection,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE/ML,2025-07-31T06:11:56.822897,IL,מרגלית,,217.707345,184.49775,147.5982,,7290001942536,ONDANSETRON BAXTER 2 MG/ML 5 AMPS,,,59058,AMPOULES GLASS TYPE I,units,5.0,159 95 34421 00,valid,25.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Adults: Odnasetron Baxter is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Odnasetron Baxter is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV).Paediatric Population: Odnasetron Baxter is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged 6 months, and for the prevention and treatment of PONV in children aged 2 years.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0ff08ff6-31a3-4597-80fb-5abe0dbcb05b.json
0ff85eb0-9aff-4a06-85bd-1feb027cbdd2,OMRI-HEP-B 5 % IV,prescription,,,7450,,,,,ILS,solution for injection,HUMAN IMMUNOGLOBULIN/,2025-07-31T06:10:01.209663,IL,אומריקס,,16409.24039,13906.13654,12641.94231,,7290004961800,OMRI-HEP-B VIAL 5G/100ML,53706,,3271,VIAL GLASS TYPE II,units,100.0,122 31 30076 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Passive immunization for the prevention of Hepatitis B virus re-infection after liver transplantation.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/0ff85eb0-9aff-4a06-85bd-1feb027cbdd2.json
10042cd6-ce40-4c6a-821e-70db33228ef7,RIVAROXABAN DEXCEL 10 MG,prescription,B01AF01,RIVAROXABAN,9393,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:42:27.934019,IL,דקסל פארמה,,270.578248,229.3036,195.152,,7290015912952,RIVAROXABAN DEXCEL 10 MG 30 TAB,18708,,16667,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,172 93 36479 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), adults (following completion of at least 6 months therapy for DVT or PE).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10042cd6-ce40-4c6a-821e-70db33228ef7.json
1010b5d8-0e7f-4a37-9008-1ae938f705ec,XENICAL,prescription,A08AB01,ORLISTAT,4166,,,WHO ATC Classification,,ILS,capsules,ORLISTAT,2025-07-31T10:33:04.942044,IL,צמל,,287.5248847,243.6651674,207.3746105,,,XENICAL 120MG 84CAP,24022,,51546,BLISTER PVC/PVDC,units,84.0,114 32 29627 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m2, or overweight patients (BMI > 28 kg/m2) with associated risk factors.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1010b5d8-0e7f-4a37-9008-1ae938f705ec.json
101bfac6-2f58-4605-9bbd-435c5b42effe,VALSARTAN DEXCEL 160,prescription,C09CA03,VALSARTAN,7017,,,WHO ATC Classification,,ILS,film coated tablets,VALSARTAN,2025-07-31T09:56:52.502455,IL,דקסל פארמה,,28.10184278,23.815121,17.3833,,,VALSARTAN DEXCEL 80MG 28TAB,22348,,34572,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,147 21 33427 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Valsartan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan significantly reduced hospitalisations for heart failure. There is no evidence that Valsartan provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.For treatment of hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/101bfac6-2f58-4605-9bbd-435c5b42effe.json
1030942f-1f63-4f17-96f1-026131bb72eb,ATACAND ® 16 MG,prescription,C09CA06,CANDESARTAN,6430,,,WHO ATC Classification,,ILS,tablets,CANDESARTAN CILEXETIL,2025-07-30T23:28:51.604863,IL,צמל,,24.02073608,20.356556,14.8588,,,ATACAND 8MG 28TAB,9320,,80922,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,109 10 29185 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Hypertension. Treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ACE inhibitors or when ACE inhibitors are not tolerated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1030942f-1f63-4f17-96f1-026131bb72eb.json
103ea40e-fc05-4506-9462-073879dced23,FLEBOGAMMA 5 % DIF,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7146,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T03:07:06.367290,IL,מדיצ'י,,179.7458653,152.3270113,121.861609,,,FLEBOGAMMA 5% 10ML VIAL,,,,BOTTLE GLASS TYPE II,units,10.0,121 04 29877 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Replacement therapy in:Primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- Wiskott Aldrich syndromeMyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.Children with congenital AIDS and recurrent infections.Immunomodulation :Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.Guillain Barré Syndrome.Kawasaki disease.Allogeneic bone marrow transplantation",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/103ea40e-fc05-4506-9462-073879dced23.json
103ec66e-b83e-4888-9271-7929453720a5,VASODIP COMBO 20,prescription,C09AA02,ENALAPRIL,6358,,,WHO ATC Classification,,ILS,tablets,"LERCANIDIPINE HYDROCHLORIDE, ENALAPRIL MALEATE",2025-07-31T10:00:34.759462,IL,דקסל פארמה,,36.17287994,30.654983,22.3759,,,VASODIP COMBO 20 30TAB,22306,,84551,BLISTER PA/ALUMINIUM/PVC,units,30.0,141 05 31727 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under Enalapril monotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/103ec66e-b83e-4888-9271-7929453720a5.json
104cdeba-8d96-44e5-9ac6-25055d3112cc,EMPRESSIN 40IU/2ML,29C,,,20835,,,,,,tablet,EMPRESSIN 40IU/,2025-07-31T20:20:54.185438,IL,nan,,,,,,,EMPRESSIN 40IU/2ML,,,,,units,10.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/104cdeba-8d96-44e5-9ac6-25055d3112cc.json
1089ca32-bb22-4eeb-979d-839055f6e4ef,CONTROLOC I.V.,prescription,A02BC02,PANTOPRAZOLE,6026,,,WHO ATC Classification,,ILS,powder for solution for injection,PANTOPRAZOLE AS SODIUM/VIAL,2025-07-31T01:29:40.063296,IL,טקדה,,23.92131518,20.272301,14.7973,,7298074020502,CONTROLOC I.V.  40MG/VIAL,3928,,22893,VIAL GLASS TYPE I,units,1.0,129 41 30772 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of duodenal ulcer, gastric ulcer, moderate and severe forms of reflux oesophagitis. Zollinger Ellison Syndrome.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1089ca32-bb22-4eeb-979d-839055f6e4ef.json
109a7ad7-baee-49fa-863d-cf58ce079759,MEROPENEM / ANFARM 1 G,prescription,J01DH02,MEROPENEM,8067,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,MEROPENEM AS TRIHYDRATE/VIAL,2025-07-31T05:14:25.132541,IL,SK PHARM(KS KIM),,960.8428362,814.27359,692.9988,,2802860602015,MEROPENEM / ANFARM 1 G 10 VIALS,13767,,49076,VIAL GLASS TYPE III,units,10.0,150 54 33679 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary  infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological  infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis -Septicemia. Meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/109a7ad7-baee-49fa-863d-cf58ce079759.json
10a883e8-20b1-4d54-89d9-c48ad3af67a7,AMBIEN CR 6.25 MG,prescription,N05CF02,ZOLPIDEM,9346,,,WHO ATC Classification,,ILS,tablets extended release,ZOLPIDEM TARTRATE 6.25   MG,2025-07-30T23:21:16.592166,IL,סאנופי אוונטיס,,nan,nan,nan,,7290012711053,AMBIEN CR 12.5 MG 14 TAB,23384,,89038,BLISTER PVC/ALUMINIUM,units,14.0,142 05 31833 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the short-term treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance  (as measured by wake time after sleep onset).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10a883e8-20b1-4d54-89d9-c48ad3af67a7.json
10a9c648-96d1-4d7a-9f04-d2e8cafaae19,EVIANA,prescription,G03CA53,"ESTRADIOL, COMBINATIONS",6239,,,WHO ATC Classification,,ILS,film coated tablets,"ESTRADIOL AS HEMIHYDRATE 0.5   MG, NORETHISTERONE ACETATE 0.1   MG",2025-07-31T02:45:22.798091,IL,נובו נורדיסק,,nan,nan,nan,,7290008126946,EVIANA 28 TAB,5479,,78487,BOTTLE POLYPROPYLENE,units,28.0,139 85 31685 00,valid,nan,per os,1.4,30,,,,,,,,,,0,Prescription required,Eviana is indicated for women who have a uterus for the:  Treatment of moderate to severe vasomotor symptoms associated with menopause.   Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis  therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered .The experience treating women older than 65 years is limited .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10a9c648-96d1-4d7a-9f04-d2e8cafaae19.json
10cc3006-7927-4cb2-8f7c-717c061332f7,FOLEX 400,off-the-counter,B03AD02,FERROUS FUMARATE,5210,,,WHO ATC Classification,,ILS,tablets,"FOLIC ACID, FERROUS AS FUMARATE",2025-07-31T11:56:34.480645,IL,רפא,,29.3466,24.87,nan,,,FOLEX 400MG  30 TAB,6391,,,BLISTER PVC/ALUMINIUM,units,30.0,142 40 33082 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the prevention and treatment of iron deficiency anemia and for maintaining the level of folic acid particular in pregnancy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10cc3006-7927-4cb2-8f7c-717c061332f7.json
10cd8002-ed64-4ecb-8f22-d616c8a7d4e2,ESTROFEM 1 MG,prescription,G03CA03,ESTRADIOL,3867,,,WHO ATC Classification,,ILS,film coated tablets,ESTRADIOL AS HEMIHYDRATE,2025-07-31T02:38:40.725545,IL,נובו נורדיסק,,18.7109398,15.85672935,11.574255,,7290008126410,ESTROFEM 1MG 28TAB,5160,,24680,DISPENSER PACK POLYPROPYLENE,units,28.0,117 54 29845 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women. Prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. Estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.The experience treating women older than 65 years is limited.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10cd8002-ed64-4ecb-8f22-d616c8a7d4e2.json
10ce146f-543b-4f35-8c1e-76b4c6dca052,MABTHERA 10 MG/ML I.V,prescription,L01XC02,RITUXIMAB,7851,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T05:03:27.951996,IL,רוש,,7294.85384,6182.0798,5620.072546,,7290008140119,MABTHERA 1400 MG S.C. VIAL,13804,,10299,VIAL GLASS TYPE I,units,1.0,112 51 29472 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"MabThera is indicated for the following indications: * Non-Hodgkin’s lymphoma (NHL)MabThera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma.MabThera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy MabThera is indicated for the treatment of patients with CD20 positive diffuse large B-cell non-Hodgkin's lymphoma in combination with CHOP chemotherapy. MabThera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * Chronic lymphocytic leukaemia (CLL)MabThera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including MabThera or patients refractory to previous MabThera plus chemotherapy.* Rheumatoid arthritisMabThera is indicated, in combination with methotrexate, to reduce signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more TNF antagonist therapies.* Granulomatosis with polyangiitis and Microscopic polyangiitisMabThera, in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis (WG) and Microscopic polyangiitis (MPA). *Pemphigus vulgarisMabThera is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10ce146f-543b-4f35-8c1e-76b4c6dca052.json
10cfa606-315a-4479-ad0e-16b0781169f6,IMITREX INJECTION,prescription,N02CC01,SUMATRIPTAN,4088,,,WHO ATC Classification,,ILS,solution for injection,SUMATRIPTAN AS SUCCINATE/ 0.5  ML,2025-07-31T04:02:10.840091,IL,ג.ס.ק,,74.56758826,63.19287421,46.9835496,,7290008085953,IMITREX NASAL SPRAY 20MGx2,9171,,23365,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,055 92 26920 00,valid,34.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache.Imitrex should only be used where there is a clear diagnosis of migraine or cluster headache.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10cfa606-315a-4479-ad0e-16b0781169f6.json
10d1fd7c-769b-4a26-beb4-174ec2f5f0c0,APO-GO,prescription,N04BC07,APOMORPHINE,4763,,,WHO ATC Classification,,ILS,solution for injection / infusion,APOMORPHINE HYDROCHLORIDE/ML,2025-07-31T00:21:29.950239,IL,טבע,,nan,nan,nan,,5-017807-103693,APO-GO 10MG/ML 5AMPX2ML,1960,,63825,AMPOULES GLASS TYPE I,units,5.0,128 26 30682 00,valid,nan,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson's disease which are not sufficiently controlled by oral anti-Parkinson medication.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10d1fd7c-769b-4a26-beb4-174ec2f5f0c0.json
10d91563-6381-434c-9914-85c55a4ed352,DICLOVIT,off-the-counter,M02AA15,DICLOFENAC,5061,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T11:33:17.447557,IL,ויטאמד,,64.01,54.25,nan,,7290008106313,DICLOVIT 1%100 GR,4156,,,TUBE ALUMINIUM,units,100.0,111 42 29399 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications:Local treatment of pain, inflammation and swelling due to: • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order:• Pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10d91563-6381-434c-9914-85c55a4ed352.json
10dbc7d8-7265-4ff2-abe4-4d166b863f08,FUCICORT CREAM,prescription,D07CC01,BETAMETHASONE AND ANTIBIOTICS,2568,,,WHO ATC Classification,,ILS,cream,"FUSIDIC ACID, BETAMETHASONE AS VALERATE 0.1 %",2025-07-31T03:20:46.096753,IL,דקסל פארמה,,45.41986751,38.49141485,28.09592325,,,FUCICORT CREAM 15GR,6329,,8552,TUBE ALUMINIUM,units,15.0,056 30 26527 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,Treatment of eczematous dermatoses when secondary bacterial infection is confirmed.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10dbc7d8-7265-4ff2-abe4-4d166b863f08.json
10e6a470-b1fd-4ffb-938d-5934830f22ee,AMGEVITA ®,prescription,L04AB04,ADALIMUMAB,9433,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/,2025-07-31T00:18:21.943773,IL,מדיסון,,2331.675847,1975.996569,1796.360517,,,AMGEVITA 40MG/0.8ML 2 PENS,,,66057,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,165 56 36181 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid arthritisAMGEVITA in combination with methotrexate is indicated for:• The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.• The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.AMGEVITA can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.Axial spondyloarthritisAnkylosing spondylitis (AS):AMGEVITA is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Axial spondyloarthritis without radiographic evidence of AS:AMGEVITA is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels, who have had an inadequate response to, or are intolerant to, non - steroidal anti-inflammatory drugs.Psoriatic arthritisAMGEVITA is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate.Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease to improve physical function.PsoriasisAMGEVITA is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.Hidradenitis suppurativa (HS)AMGEVITA is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult patients with an inadequate response to conventional systemic HS therapy.Crohn’s diseaseAMGEVITA is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. AMGEVITA is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.Ulcerative colitisAMGEVITA is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6- mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.UveitisAMGEVITA is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroidsparing, or in whom corticosteroid treatment is inappropriate.Intestinal Behcet's diseaseAmgevita is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10e6a470-b1fd-4ffb-938d-5934830f22ee.json
10f69847-60fb-4b03-8302-f91cfb27a85f,ALKASOLVE TABLETS,off-the-counter,,,1986,,,,,ILS,tablets,"POTASSIUM CITRATE, SODIUM CITRATE",2025-07-31T11:11:40.133543,IL,סם און,,114.9084,97.38,nan,,7290008066303,ALKASOLVE 180TAB,1198,,,BOTTLE HDPE,units,180.0,028 09 21247 00,valid,nan,per os,1.4,30,,,,,,,,,,0,,Urinary alkalizer.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10f69847-60fb-4b03-8302-f91cfb27a85f.json
10fb98c4-8472-44ec-91c1-398488f5d266,PRIMOLUT-NOR,prescription,G03DC02,NORETHISTERONE,8701,,,WHO ATC Classification,,ILS,tablets,NORETHISTERONE ACETATE,2025-07-31T06:57:05.706075,IL,באייר,,22.54102715,19.10256623,13.943479,,7290015876063,PRIMOLUT-NOR 5 MG 30 TAB,,,57700,BLISTER PVC/ALUMINIUM,units,30.0,122 29 24814 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Oral progestron for: Dysfunctional bleeding, primary and secondary amenorrhea,  premenstrual syndrome, timing of mensturation and endometriosis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10fb98c4-8472-44ec-91c1-398488f5d266.json
10fd1ccb-01e2-43b1-b2c3-5ccfe0678d40,ZENALB 20,prescription,B05AA01,ALBUMIN,6900,,,WHO ATC Classification,,ILS,solution for infusion,ALBUMIN HUMAN/ML,2025-07-31T10:46:23.918361,IL,קמהדע,,175.9130352,149.07885,119.26308,,7290011225063,ZENALB 20% SOLUTION IV INF. 50ML,,,87777,BOTTLE GLASS TYPE II,units,50.0,137 74 31656 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"For restoration and maintenance of circulation blood volume where volume deficiency has been demonstrated and use of a colloid, is appropriate.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/10fd1ccb-01e2-43b1-b2c3-5ccfe0678d40.json
111b7498-fb51-47da-ac3c-0eefe4d82f22,HUMULIN N,prescription,A10AC01,INSULIN (HUMAN),734,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN (HUMAN)/ML,2025-07-31T03:50:55.449702,IL,אלי לילי,,111.0172727,94.08243863,69.9497685,,7290008139816,HUMULIN NPH 10ML,9003,,7040,VIAL GLASS TYPE I,units,10.0,054 12 22715 22,valid,34.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/111b7498-fb51-47da-ac3c-0eefe4d82f22.json
1131aeff-c08f-4131-8289-5e20ac01ee44,ACCOFIL 300 MCG/0.5 ML,prescription,L03AA02,FILGRASTIM,8438,,,WHO ATC Classification,,ILS,solution for injection / infusion,FILGRASTIM/ 0.5  ML,2025-07-31T00:05:19.653422,IL,צמל,,167.9440789,142.3254969,113.8603976,,,ACCOFIL 300 MCG/0.5 ML 1 PFS,,,,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,160 35 34790 00,valid,25.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"ACCOFIL is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia.The safety and efficacy of ACCOFIL are similar in adults and children receiving cytotoxic chemotherapy.ACCOFIL is indicated for the mobilisation of peripheral blood progenitor cells (PBPCs).In patients, children or adults with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of less or equal to 0.5 x 109 /L, and a history of severe or recurrent infections, long term administration of ACCOFIL is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.ACCOFIL is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 x 109 /L) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1131aeff-c08f-4131-8289-5e20ac01ee44.json
11424ea4-906d-4559-b728-3ae26b0fe305,ZINNAT TABLETS 125 MG,prescription,J01DC02,CEFUROXIME,307,,,WHO ATC Classification,,ILS,tablets,CEFUROXIME AS AXETIL,2025-07-31T10:49:29.767844,IL,סנדוז,,22.92888444,19.431258,14.1834,,,ZINNAT 250MG 10TAB,26060,,7882,BLISTER ALUMINIUM,units,10.0,041 40 25801 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Zinnat is indicated for the treatment of the infections listed below in adults and children from the age of 3 months .• Acute streptococcal tonsillitis and pharyngitis.• Acute bacterial sinusitis.• Acute otitis media.• Acute exacerbations of chronic bronchitis.• Cystitis.• Pyelonephritis.• Uncomplicated skin and soft tissue infections. •Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/11424ea4-906d-4559-b728-3ae26b0fe305.json
114298be-2c95-4730-bd6f-f08b4da8d2ea,UTROGESTAN 100,prescription,G03DA04,PROGESTERONE,2902,,,WHO ATC Classification,,ILS,capsules,PROGESTERONE,2025-07-31T09:55:43.599533,IL,כ.צ.ט,,32.77737184,27.777435,20.2755,,,UTROGESTAN 100MG 30 VAG CAPS,21011,,9009,BLISTER PVC/ALUMINIUM,units,30.0,132 44 26341 11,valid,37.0,"per os, vaginal",1.4,36,,,,,,,,,,0,Prescription required,"Vaginal or oral addministration: Disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).Vaginal administration: Progesterone substitution for ovary deprived women in situation of total progesterone deficiency. Supplementation of the luteal phase during in vitro fertilization cycles. Supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. In cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. For all other progesterone indications, in the case of : Adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/114298be-2c95-4730-bd6f-f08b4da8d2ea.json
11499815-2494-45e6-9700-e8a5de27d6a8,SOLODENT ALCOHOL FREE MOUTHWASH,off-the-counter,A01AB03,CHLORHEXIDINE,5566,,,WHO ATC Classification,,ILS,solution,CHLORHEXIDINE GLUCONATE 0.2 %W/V,2025-07-31T13:19:33.133543,IL,ליף-פלוריש,,26.1252,22.14,nan,,,SOLODENT MOUTHWASH 0.2%  300ML,,,,BOTTLE PET,units,300.0,172 54 37476 99,valid,nan,local oral,1.4,24,,,,,,,,,,0,,"Antibacterial solution for the disinfection of the mouth:1) As an aid to maintaining oral hygiene. 2) As an aid in the treatment and prevention of gingivitis. 3) Inhibition of formation of dental plaque. 4) For use in aphtous ulceration and oral candidal infections (e.g., denture stomatitis and thrush). 5) For use in a post- periodontal surgery or treatment regimen to promote gingival healing.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/11499815-2494-45e6-9700-e8a5de27d6a8.json
117bd44c-6529-4009-b284-e28dae958d7f,TEMO 100 MG,prescription,L01AX03,TEMOZOLOMIDE,6794,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T09:11:04.418690,IL,פאדאגיס,,300.518329,254.67655,216.746,,7298074050721,TEMO 20 MG 5CAPS,20702,,32093,BOTTLE GLASS TYPE III,units,5.0,145 26 33258 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/117bd44c-6529-4009-b284-e28dae958d7f.json
1189730b-9b0c-4273-b5b2-e1a4804956b3,PENTASA SLOW RELEASE GRANULES 4 G.,prescription,A07EC02,MESALAZINE,6966,,,WHO ATC Classification,,ILS,granules,MESALAZINE,2025-07-31T06:35:09.101928,IL,פרינג,,177.6365903,150.53949,120.431592,,7640128547228,PENTASA  1GR 60 SR TABLETS,9430,,24200,SACHET POLYESTER/ALUMINIUM/POLYETHYLENE,units,60.0,157 47 34816 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate ulcerative colitis or crohn's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1189730b-9b0c-4273-b5b2-e1a4804956b3.json
11ab2bb5-ee5b-4943-ab75-0ffbe08e3004,TUMS SMOOTHIES EX PEPPERMINT,off-the-counter,A02AC01,CALCIUM CARBONATE,5235,,,WHO ATC Classification,,ILS,chewable tablets,CALCIUM CARBONATE,2025-07-31T13:31:37.451134,IL,ג.ס.ק,,35.6596,30.22,nan,,7290010140497,TUMS SMOOTHIES EX TROPICAL FRUIT 750MG 60 TABS,20653,,,BOTTLE POLYPROPYLENE,units,60.0,134 94 31175 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For relief from heartburn and acidity,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/11ab2bb5-ee5b-4943-ab75-0ffbe08e3004.json
11ae7813-c8b5-4a6f-a118-457fadea246c,COLUMVI,29C,L01FX28,GLOFITAMAB,21017,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,GLOFITAMAB/,2025-07-31T14:10:20.110646,IL,nan,,nan,nan,nan,,7290014774278,COLUMVI 1MG/ML VIAL 2.5ML,,,,VIAL GLASS TYPE I,units,2.5,176 69 37772 00,valid,nan,i.v,1.4,30,,,,,,,,,,0,,"Columvi is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B cell lymphoma after two or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/11ae7813-c8b5-4a6f-a118-457fadea246c.json
11b5b264-c2c8-49f7-807e-93930c4de8aa,FOMICYT 2 G.,prescription,J01XX01,FOSFOMYCIN,9459,,,WHO ATC Classification,,ILS,powder for solution for infusion,FOSFOMYCIN AS SODIUM/VIAL,2025-07-31T03:15:58.498691,IL,צמל,,1853.765572,1570.987843,1337.01093,,,FOMICYT 8 G. 10 VIALS,,,19096,VIAL GLASS TYPE I,units,10.0,173 51 37318 99,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveConsideration should be given to official guidance on the appropriate use of antibacterial agents.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/11b5b264-c2c8-49f7-807e-93930c4de8aa.json
11d11ece-7e96-49b2-8b25-297ed96d578e,PARSABIV,prescription,H05BX04,ETELCALCETIDE,8122,,,WHO ATC Classification,,ILS,solution for injection,ETELCALCETIDE AS HYDROCHLORIDE/,2025-07-31T06:29:50.908149,IL,מדיסון,,810.0325224,686.4682699,584.2283148,,8715131020538,PARSABIV 5 MG/1 ML 6 VIALS,10310,,5362,VIAL GLASS TYPE I,units,6.0,161 94 35289 00,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,Parsabiv is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/11d11ece-7e96-49b2-8b25-297ed96d578e.json
11df469f-3c64-4a17-8c35-b75d372ce524,FENTAMED 100 MCG,prescription,N01AH01,FENTANYL,9365,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE MICRONIZED,2025-07-31T02:59:58.008677,IL,אינובמד,,1032.394278,874.910405,744.6046,,7290104531170,FENTAMED 400 MCG 30 TAB SUBLINGUAL,23636,,5040,BLISTER PA/AL/PVC//ALU/PET,units,30.0,173 43 36706 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fentamed is indicated for management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/11df469f-3c64-4a17-8c35-b75d372ce524.json
11fadbf2-a03e-4444-8968-80b4feef8bd3,DUORESP ® SPIROMAX ® 160 MCG/4.5 MCG,prescription,R03AK07,FORMOTEROL AND BUDESONIDE,7779,,,WHO ATC Classification,,ILS,powder for inhalation,"FORMOTEROL FUMARATE DIHYDRATE 4.5 MCG/DOSE, BUDESONIDE MICRONIZED/DOSE",2025-07-31T02:07:07.651761,IL,טבע,,235.4749,199.555,159.644,,,DUORESP SPIROMAX 160 MCG/4.5 MCG 120DOSES,4651,,42652,PACK ,units,120.0,154 58 34443 00,valid,25.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"AsthmaDuoResp Spiromax 160/4.5 mcg/dose is indicated in adults and adolescents (12 years and older), for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long acting β2 adrenoceptor agonist) is appropriate:Patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting β2 adrenoceptor agonists.OrPatients already adequately controlled on both inhaled corticosteroids and long acting β2 adrenoceptor-agonists.Chronic Obstructive Pulmonary Disease (COPD)DuoResp Spiromax  160/4.5 mcg/dose  is indicated in adults, aged 18 years and older, for the Symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV1)< 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/11fadbf2-a03e-4444-8968-80b4feef8bd3.json
1205cf50-74c1-4977-9d13-5736dfbb2337,VANCOAVENIR 1 G,prescription,A07AA09,VANCOMYCIN,8270,,,WHO ATC Classification,,ILS,powder for solution for injection,VANCOMYCIN AS HYDROCHLORIDE/VIAL,2025-07-31T09:58:08.065486,IL,ביואבניר,,541.0123,458.485,390.2,,7290010287147,VANCOAVENIR 1G 10 VIALS,,,67040,VIAL GLASS TYPE I,units,10.0,153 18 34020 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci.It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside.Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. Vancomycin hydrochloride is not effective orally when administered for other types of infection.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1205cf50-74c1-4977-9d13-5736dfbb2337.json
1209c585-0ac4-466f-828c-a16005c6af24,ALLERGYX,off-the-counter,,,5066,,,,,ILS,tablets,LORATADINE,2025-07-31T11:12:18.115626,IL,טבע,,30.2552,25.64,nan,,729000802626,ALLERGYX  10MG 10TAB,1654,,,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,124 58 30421 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of symptoms of allergy in seasonal allergic rhinitis, perennial allergic rhinitis, chronic urticaria.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1209c585-0ac4-466f-828c-a16005c6af24.json
121993a9-c4b0-4a46-ba65-34daeb22a1da,ALCOSEPT,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5237,,,WHO ATC Classification,,ILS,solution,"CHLORHEXIDINE GLUCONATE 0.5 %W/V, ALCOHOLW/V",2025-07-31T11:10:18.299539,IL,פלוריש,,23.9776,20.32,nan,,7290008110181,ALCOSEPT 300ML,,,,BOTTLE HDPE,units,300.0,129 67 30806 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Skin antiseptic.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/121993a9-c4b0-4a46-ba65-34daeb22a1da.json
121c85bf-822e-4c21-9138-6502a5beec5d,DOPICAR,prescription,N04BA01,LEVODOPA,1529,,,WHO ATC Classification,,ILS,tablets,"LEVODOPA, CARBIDOPA",2025-07-31T02:02:34.862126,IL,טבע,,29.51960098,25.016611,18.2603,,7290000800424,DOPICAR 30TAB,4162,,719,BOTTLE HDPE,units,30.0,040 96 22970 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the relief of symptoms associated with parkinson's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/121c85bf-822e-4c21-9138-6502a5beec5d.json
12286687-52ba-4392-bd83-86840ffbea24,SANDOSTATIN ® 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,3722,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE 0.05  MG/ML,2025-07-31T08:00:02.423665,IL,נוברטיס פארמה,,2251.708823,1908.227901,1624.023745,,7298120012734,SANDOSTATIN LAR VIAL 20MG,19743,,62752,AMPOULES GLASS TYPE I,units,1.0,047 03 25697 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery.   Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery  or radiotherapy. Sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery  or in the interim period until radiotherapy becomes fully effective.   Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours:   - Carcinoid tumours with features of the carcinoid syndrome    - VIPomas    - Glucagonomas    - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors  or H2- antagonist therapy    - Insulinomas  for pre-operative control of hypoglycaemia and for maintenance therapy   - GRFomas.   Sandostatin is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12286687-52ba-4392-bd83-86840ffbea24.json
122c1992-6980-4c92-aa7f-cfa5ec13e781,MENVEO,prescription,J07AH02,OTHER MENINGOCOCCAL MONOVALENT PURIFIED POLYSACCHARIDES ANTIGEN,7246,,,WHO ATC Classification,,ILS,powder and solution for solution for injection,"MENINGOCOCCAL VACCINES GROUP Y/ 0.5  ML, MENINGOCOCCAL VACCINES GROUP W/ 0.5  ML, MENINGOCOCCAL VACCINES GROUP C/ 0.5  ML, MENINGOCOCCAL VACCINES GROUP A/ 0.5  ML",2025-07-31T05:12:18.682369,IL,ג.ס.ק,,220.8463712,187.15795,149.72636,,,MENVEO POWDER AND SOLVENT FOR SOL FOR INJ VIAL 2ML,,,,VIAL GLASS TYPE I,units,1.0,148 66 33451 00,valid,25.0,i.m,1.4,48,,,,,,,,,,0,Prescription required,"Menveo is indicated for active immunization of children (2 years of age and above), adolescents and adults up to the age of 55 years, at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y, to prevent invasive disease. The use of this vaccine should be in accordance with official recommendations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/122c1992-6980-4c92-aa7f-cfa5ec13e781.json
1238b946-7e52-4356-a338-a14bf7935943,PENTASA SLOW RELEASE GRANULES 4 G.,prescription,A07EC02,MESALAZINE,4142,,,WHO ATC Classification,,ILS,granules,MESALAZINE,2025-07-31T06:36:07.276445,IL,פרינג,,295.3039368,250.2575736,212.985169,,7640128547228,PENTASA SLOW RELEASE GRANULES 1GX100 SACHETS,16372,,20492,SACHET POLYESTER/ALUMINIUM/POLYETHYLENE,units,100.0,157 47 34816 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate ulcerative colitis or crohn's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1238b946-7e52-4356-a338-a14bf7935943.json
1238d536-f124-4f4a-9cbe-0baf964eb7be,AQUASOL A INJECTION 15MG/ML 10VIAL 2ML,29C,,,20928,,,,,,injection,AQUASOL A INJECTION 15MG/ML,2025-07-31T19:56:34.345420,IL,nan,,,,,,,AQUASOL A INJECTION 15MG/ML 10VIAL 2ML,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1238d536-f124-4f4a-9cbe-0baf964eb7be.json
124365b8-1268-41da-8129-fb2e595344d5,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,1741,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:30:30.892126,IL,דקסל פארמה,,30.3024,25.68,nan,,,DEXAMOL 500MG 50CAP,4384,,,BLISTER PVC/ALUMINIUM,units,50.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/124365b8-1268-41da-8129-fb2e595344d5.json
124568d4-fb17-4de6-a460-30ae52eea1bd,ZEFFIX TABLETS,prescription,J05AF05,LAMIVUDINE,4208,,,WHO ATC Classification,,ILS,film coated tablets,LAMIVUDINE,2025-07-31T10:44:58.611651,IL,ג.ס.ק,,274.4560112,232.58984,197.9488,,7290008086455,ZEFFIX 100MG 28TAB,26093,,20909,BLISTER ALUMINIUM,units,28.0,114 11 29544 23,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Zeffix is indicated for the treatment of chronic hepatitis B associated with the evidence of hepatitis B viral  (HBV) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/124568d4-fb17-4de6-a460-30ae52eea1bd.json
12692804-9486-493d-9023-ccbd28304985,EXFORGE 10 MG/160 MG,prescription,C08CA01,AMLODIPINE,6145,,,WHO ATC Classification,,ILS,film coated tablets,"AMLODIPINE AS BESYLATE, VALSARTAN",2025-07-31T02:49:26.804958,IL,נוברטיס פארמה,,103.3859159,87.615183,65.1414,,7290006257963,EXFORGE 5MG/80MG 28TAB,5465,,87349,BLISTER PVC/PA/ALUMINIUM,units,28.0,138 42 31568 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of essential hypertension. Exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12692804-9486-493d-9023-ccbd28304985.json
126e9a75-f8b5-48e7-8f4b-35af401c9356,LYTEERS EYE DROPS,off-the-counter,,,1810,,,,,ILS,"eye drops, solution",HYDROXYETHYLCELLULOSE 0.19 %,2025-07-31T12:23:59.604703,IL,פישר,,20.3904,17.28,nan,,7290000849584,LYTEERS EYE DRPS15CC,12114,,,BOTTLE LDPE,units,15.0,052 48 24159 00,valid,nan,ocular,1.4,48,,,,,,,,,,0,,A lubricating tear substitute for dry eyes when tear production is insufficient.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/126e9a75-f8b5-48e7-8f4b-35af401c9356.json
12774610-1fe8-46ef-847e-f7d102ba4b7e,VASODIP 10,prescription,C08CA13,LERCANIDIPINE,3651,,,WHO ATC Classification,,ILS,tablets,LERCANIDIPINE HYDROCHLORIDE 10.0   MG,2025-07-31T10:00:11.875074,IL,דקסל פארמה,,33.40364414,28.308173,20.6629,,,VASODIP 10MG 30TAB,22033,,33798,BLISTER PVC/ALUMINIUM,units,30.0,109 87 29303 05,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Mild to moderate essential hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12774610-1fe8-46ef-847e-f7d102ba4b7e.json
12999319-af0e-4a73-92ca-4b64d5b40ffd,EMTRIVIR TEVA ®,prescription,J05AF07,TENOFOVIR DISOPROXIL,7763,,,WHO ATC Classification,,ILS,film coated tablets,"EMTRICITABINE, TENOFOVIR DISOPROXIL AS FUMARATE",2025-07-31T02:18:55.900680,IL,טבע,,2203.263857,1867.17276,1589.0832,,7290106064805,EMTRIVIR TEVA 200/245MG 30 F.C.TAB,5592,,24756,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,154 32 34159 00,valid,17.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Emtrivir Teva is indicated in combination with other anti-retroviral medicinal products for the treatment of HIV-1 infected adults over 18 years of age.Emtrivir Teva® is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection in adults at high risk.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12999319-af0e-4a73-92ca-4b64d5b40ffd.json
12a1a12e-6a97-42e6-844a-07bf826bc54a,VIA-AVENIR 100 MG,prescription,G04BE03,SILDENAFIL,8262,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:11:14.766458,IL,ביואבניר,,188.0098425,159.330375,127.4643,,7290010286911,VIA AVENIR 100MG  8TABS,,,55877,BLISTER PVC/PVDC/ALUMINIUM,units,8.0,147 72 33415 01,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12a1a12e-6a97-42e6-844a-07bf826bc54a.json
12d2d40b-5147-4073-bef0-6e75f3a645fe,SEROQUEL XR 150 MG,prescription,N05AH04,QUETIAPINE,6437,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T08:07:54.937060,IL,צמל,,46.978396,39.8122,29.06,,,SEROQUEL XR 50MG 30 TAB EXTENDED RELEASE,19875,,83217,BLISTER PVC/ALUMINIUM,units,30.0,146 97 33472 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Seroquel XR is indicated for the treatment of Schizophrenia. Seroquel XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Seroquel XR.  Seroquel XR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Seroquel XR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 Pharmacodynamic properties). Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XR.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12d2d40b-5147-4073-bef0-6e75f3a645fe.json
12d4f20e-5629-4eb8-a9d9-f9f7ddd0abb4,ARMONIA,prescription,G04CB02,DUTASTERIDE,7990,,,WHO ATC Classification,,ILS,"capsule, soft",DUTASTERIDE 0.5  MG,2025-07-30T23:27:49.300190,IL,אוניפארם,,133.9406064,113.5089885,84.3933,,,ARMONIA 0.5MG 30 CAPS,9960,,58852,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,157 51 34697 02,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Armonia is indicated for: Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12d4f20e-5629-4eb8-a9d9-f9f7ddd0abb4.json
12dc3324-6422-4063-8aa5-d3ac4099382e,VERZENIO 100 MG,prescription,L01EF03,ABEMACICLIB,8334,,,WHO ATC Classification,,ILS,film coated tablets,ABEMACICLIB,2025-07-31T10:08:21.215832,IL,אלי לילי,,2286.926905,1938.073734,1761.885213,,7290016021103,VERZENIO  100MG 14 TABS,22444,,26046,BLISTER PVC/ALUMINIUM,units,14.0,161 44 35391 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"VERZENIO™ (abemaciclib) is indicated: • in combination with a non-steroidal aromatase inhibitor as initial endocrine-based therapy for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy. • as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy in the metastatic setting and prior chemotherapy in the metastatic setting including taxane in adjuvant or metastatic setting. Verzenio should not be used in adult patients after prior treatment with cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) inhibitor. • Verzenio in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) negative, node positive early breast cancer at high risk of recurrence. In pre- or perimenopausal women and in men, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12dc3324-6422-4063-8aa5-d3ac4099382e.json
12dd5f6c-709d-481a-9caf-5398886cef6d,TROSMOLYT 20 MG,prescription,G04BD09,TROSPIUM,4293,,,WHO ATC Classification,,ILS,film coated tablets,TROSPIUM CHLORIDE,2025-07-31T06:17:54.671199,IL,באייר,,60.78238174,51.510493,37.5989,,7290010038480,OSMO ADALAT 60MG 30 SR TAB,15373,,5307,BLISTER PVC/ALUMINIUM,units,30.0,159 44 35071 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of urge incontinence and /or increased urinary frequency and urgency as may occur in patients with overactive bladder (e.g. idiopathic or neurologic detrusor overactivity), ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12dd5f6c-709d-481a-9caf-5398886cef6d.json
12ee2617-eb6a-4b4d-957b-82c0b4dc0eb2,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7460,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:20:02.006481,IL,צמל,,145.0301503,122.906907,91.3806,,,METOJECT 50MG/ML SYRINGE PREFILLED 25MG/0.5ML,,,4170,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12ee2617-eb6a-4b4d-957b-82c0b4dc0eb2.json
12fd70bd-24d4-4efa-aa7f-57253f169afd,TONIGHT,off-the-counter,R06AA09,DOXYLAMINE,5153,,,WHO ATC Classification,,ILS,tablets,DOXYLAMINE SUCCINATE,2025-07-31T13:29:50.657408,IL,כ.צ.ט,,42.9048,36.36,nan,,,TONIGHT 10TAB,20582,,,BLISTER PVC/PE/PVDC,units,10.0,118 20 29793 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,An aid to the relief of temporary sleep disturbance.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/12fd70bd-24d4-4efa-aa7f-57253f169afd.json
13104843-f504-48d8-96bf-dd49b9dc60f4,VASODIP COMBO 10,prescription,C09AA02,ENALAPRIL,6357,,,WHO ATC Classification,,ILS,tablets,"LERCANIDIPINE HYDROCHLORIDE, ENALAPRIL MALEATE",2025-07-31T10:00:23.385766,IL,דקסל פארמה,,39.33209679,33.33228541,24.33013534,,,VASODIP COMBO 10 30TAB,22305,,84550,BLISTER PA/ALUMINIUM/PVC,units,30.0,141 06 31726 00,valid,37.0,per os,1.4,24 ,,,,,,,,,,0,Prescription required,Treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under Lercanidipine monotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13104843-f504-48d8-96bf-dd49b9dc60f4.json
133122ac-9157-480f-b7b7-e9d0445b506c,ABITREN TEVA ® 75 MG/3 ML,prescription,M01AB05,DICLOFENAC,8832,,,WHO ATC Classification,,ILS,solution for injection,DICLOFENAC SODIUM/,2025-07-30T23:10:46.120135,IL,טבע,,35.5652,30.14,22.0,,7290110730482,ABITREN TEVA  75MG/3ML 10 AMP,,,6945,AMPOULES GLASS TYPE I,units,10.0,159 38 34860 00,valid,37.0,i.m,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of: - Exacerbations of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondylarthritis, non-articular rheumatism.- Treatment of painful conditions due to inflammation of non rheumatic origin.- Renal colic and biliary colic - Post-traumatic and post-operative pain, inflammation and swelling",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/133122ac-9157-480f-b7b7-e9d0445b506c.json
13394035-f96e-4e6a-ad81-bfc422745a43,URALYT-U,off-the-counter,A12BA02,POTASSIUM CITRATE,2970,,,WHO ATC Classification,,ILS,granules,POTASSIUM SODIUM HYDROGEN CITRATE 2.427 G / 2.5 G,2025-07-31T12:06:23.490300,IL,פלוריש,,11.505,9.75,nan,,7290008097796,HYDROGEN  PEROXIDE 3% 100CC,8007,,,CONTAINER POLYPROPYLENE,units,100.0,063 87 22365 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,To dissolve uric acid stones in the urinary tract. Prevention of further stone formation.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13394035-f96e-4e6a-ad81-bfc422745a43.json
1346b508-fd62-4aec-b740-5fe3ecfe7c43,RENNIE ORANGE,off-the-counter,A02AC10,COMBINATIONS,5419,,,WHO ATC Classification,,ILS,chewable tablets,"CALCIUM CARBONATE, MAGNESIUM CARBONATE",2025-07-31T12:55:28.483741,IL,באייר,,25.3228,21.46,nan,,7290013092250,RENNIE ORANGE 36TAB,,,,BLISTER PVC/ALUMINIUM,units,36.0,144 16 32043 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of hyperacidity and heartburn.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1346b508-fd62-4aec-b740-5fe3ecfe7c43.json
135ab70f-5145-44a2-9c3f-22ce805b7851,ALOFISEL,prescription,L04AX08,DARVADSTROCEL,8482,,,WHO ATC Classification,,ILS,dispersion for injection,DARVADSTROCEL 5000000 CELLS/ML,2025-07-31T00:16:49.238739,IL,טקדה,,301265.8191,255310.0275,232100.025,,7920017585345,ALOFISEL 5000000 CELLS/ML 4 VIAL,,,55040,VIAL GLASS TYPE I,units,4.0,161 67 35458 00,valid,10.0,perilesional use,1.4,72,,,,,,,,,,0,Prescription required,"Alofisel is indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy. Alofisel should be used only after conditioning of the fistulas.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/135ab70f-5145-44a2-9c3f-22ce805b7851.json
137ed6a2-8109-4b78-8218-f5afe77e8a78,INVEGA 3 MG,prescription,N05AX13,PALIPERIDONE,6189,,,WHO ATC Classification,,ILS,tablets extended release,PALIPERIDONE,2025-07-31T04:10:52.901651,IL,יאנסן סילג,,203.4236381,172.3929213,137.914337,,7290008099356,INVEGA 3MG 28TAB,9258,,86203,BLISTER OPA/ALU/PVC/ALU,units,28.0,139 15 31639 01,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Invega is indicated for :-treatment of schizophrenia in adults and adolescents (12-17 years).-treatment of schizoaffective disorder in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/137ed6a2-8109-4b78-8218-f5afe77e8a78.json
1386e7b2-24dc-454c-ac42-f19e5130d5d3,MYOCHOLINE-GLENWOOD 25 MG,prescription,N07AB02,BETHANECHOL,9421,,,WHO ATC Classification,,ILS,tablets,BETHANECHOL CHLORIDE,2025-07-31T05:38:37.085133,IL,פרופארם,,152.9528506,129.6210656,103.6968525,,7290018609880,MYOCHOLINE-GLENWOOD 25 MG 50 TAB,,,73031,BLISTER PVC/ALUMINIUM,units,50.0,167 20 35286 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Myocholine Glenwood is indicated in cases of postoperative urinary retention due to atony of the bladder in adults in diseases in which a stimulation of the bladder muscle is needed.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1386e7b2-24dc-454c-ac42-f19e5130d5d3.json
13918473-dbbf-403d-b690-c0e3c5142a8d,EVRYSDI,prescription,M09AX10,RISDIPLAM,8768,,,WHO ATC Classification,,ILS,powder for solution,RISDIPLAM/BOTTLE,2025-07-31T02:47:20.745731,IL,רוש,,42545.48087,36055.49387,32777.7217,,7290014774216,EVRYSDI 0.75MG/ML BOTTLE 60MG/80ML,,,74874,BOTTLE GLASS TYPE III,units,80.0,167 71 36630 99,valid,10.0,oral,1.4,24,,,,,,,,,,0,Prescription required,"EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) types 1, 2 and 3 in pediatric and adult patients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13918473-dbbf-403d-b690-c0e3c5142a8d.json
13a578fa-d396-4251-b0a3-05410396a340,HALDOL 2 MG/ML DROPS,prescription,N05AD01,HALOPERIDOL,1379,,,WHO ATC Classification,,ILS,solution  (oral),HALOPERIDOL/ML,2025-07-31T03:41:49.891053,IL,יאנסן סילג,,21.98446672,18.630904,13.5992,,7290014577305,HALDOL 5MG 25TAB,8002,,23897,BOTTLE LDPE,units,25.0,029 70 25163 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"HALDOL is indicatedin adult patients aged 18 years and above for:•	Treatment of schizophrenia and schizoaffective disorder.•	Acute treatment of delirium when non-pharmacological treatments have failed.•	Treatment of moderate to severe manic episodes associated with bipolar I disorder when other treatments cannot be used.•	Treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar I disorder.•	Treatment of persistent aggression and psychotic symptoms in patients with moderate to severe Alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.•	Treatment of tic disorders, including Tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.•	Treatment of mild to moderate chorea in Huntington’s disease, when other medicinal products are ineffective or not tolerated.In paediatric patients for:•	Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.•	Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated.  •	Tic disorders, including Tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13a578fa-d396-4251-b0a3-05410396a340.json
13ab9544-8f5c-47d4-b9f5-f8b7ef5b2d4d,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,578,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T12:44:14.682416,IL,ג.ס.ק,,21.7946,18.47,nan,,7290006603036,OTRIVIN SPRAY 0.1% 10ML,15082,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,10.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13ab9544-8f5c-47d4-b9f5-f8b7ef5b2d4d.json
13af8ba1-5e49-4f94-badb-f7980431fd24,FOSRENOL ® 750 MG CHEWABLE TABLETS,prescription,V03AE03,LANTHANUM CARBONATE,6490,,,WHO ATC Classification,,ILS,chewable tablets,LANTHANUM AS CARBONATE HYDRATE,2025-07-31T03:18:35.466399,IL,טקדה,,702.6563862,595.4715402,506.7842895,,7290008128674,FOSRENOL 500MG 90 CHEW TAB,6449,,89496,BOTTLE HDPE,units,90.0,140 51 31998 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in CRF patients on haemodyalisis or continuous ambulatory peritoneal dialysis (CAPD).Fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/L in whom a low phosphate diet alone is insufficient to control serum phosphate levels.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13af8ba1-5e49-4f94-badb-f7980431fd24.json
13b2ec1d-77e5-4ae3-a352-4db306e45884,PENIBRIN 1 G,prescription,J01CA01,AMPICILLIN,9147,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,AMPICILLIN AS SODIUM/VIAL,2025-07-31T06:33:49.862272,IL,טבע,,244.5369585,207.2347198,165.7877758,,7290008096553,PENIBRIN 0.5 G  10 VIAL,,,83482,VIAL GLASS TYPE III,units,10.0,032 41 22422 00,valid,25.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Penibrin injection is recommended in serious infections when prompt, effective levels of the antibiotic must reach the site of infection. Such infections include meningitis, subacute bacterial endocarditis, peritonitis, septicemia, severe forms of chronic bronchitis, osteomyelitis, pneumonia and pyelonephritis due to susceptible organisms.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13b2ec1d-77e5-4ae3-a352-4db306e45884.json
13b503d9-10e4-4859-ac5e-96b630038df1,ASACOL 1600,prescription,A07EC02,MESALAZINE,4910,,,WHO ATC Classification,,ILS,modified release tablets,MESALAZINE,2025-07-30T23:28:16.425366,IL,טרדיס גת,,165.8022204,140.5103625,112.40829,,,ASACOL 800MG 60TAB,1761,,69522,BLISTER PVC/ALUMINIUM,units,60.0,174 09 36782 99,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,ASACOL 1600 is indicated for:Ulcerative colitis-For the treatment of mild to moderate acute disease-For the maintenance of remission,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13b503d9-10e4-4859-ac5e-96b630038df1.json
13bcec48-6bbc-4366-9625-9383a34dd96c,BEVACIZUMAB KAMADA,prescription,L01FG01,BEVACIZUMAB,9533,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BEVACIZUMAB/ML,2025-07-30T23:37:59.948747,IL,קמהדע,,3537.913711,2998.232092,2725.665538,,7290008072137,BEVACIZUMAB KAMADA 25MG/ML 16 ML,,,,VIAL GLASS TYPE I,units,1.0,170 95 36978 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"- Bevacizumab Kamada in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of patients with metastatic carcinoma of the colon or rectum.- Bevacizumab Kamada in addition to platinum - based chemotherapy is indicated for first - line treatment of patients with unresectable advanced metastatic or recurrent non- small cell lung cancer other than predominantly squamous cell histology. - Bevacizumab Kamada in combination with interferon alfa-2a is indicated for first line treatment of patients with advanced and /or metastatic renal cell cancer.- Bevacizumab Kamada in combination with paclitaxel is indicated for first-line treatment of patients with metastatic breast cancer.- Bevacizumab Kamada as a single agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.- Bevacizumab Kamada in combination with carboplatin and paclitaxel, is indicated for the front-line treatment of advanced (FIGO stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are at high risk for recurrence (residual disease after debulking).- Bevacizumab Kamada in combination with carboplatin and gemcitabine, is indicated for the treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor-targeted agents.- Bevacizumab Kamada in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents - Bevacizumab Kamada in combination with paclitaxel and cisplatin or paclitaxel and topotecan is indicated for treatment of patients with persistent, recurrent, or metastatic carcinoma of the cervix.- Bevacizumab Kamada in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13bcec48-6bbc-4366-9625-9383a34dd96c.json
13ea7b24-d80b-4d96-9c58-82f987b35dcf,SERETIDE DISKUS 50/100 MCG,prescription,R03AK06,SALMETEROL AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,4128,,,WHO ATC Classification,,ILS,powder for inhalation,"FLUTICASONE PROPIONATE, SALMETEROL AS XINAFOATE",2025-07-31T08:05:44.968595,IL,ג.ס.ק,,152.6295945,129.347114,103.4776912,,7290008086509,SERETIDE DISKUS 50/500MCG 60DISK,19397,,21199,BLISTER PVC,units,60.0,114 13 29551 01,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"Seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/13ea7b24-d80b-4d96-9c58-82f987b35dcf.json
1403d4c4-4c41-430d-9960-1ace16791e92,LOZAPINE 100 MG,prescription,N05AH02,CLOZAPINE,4272,,,WHO ATC Classification,,ILS,tablets,CLOZAPINE,2025-07-31T04:57:31.306239,IL,תרו יבוא,,27.2696171,23.109845,16.8685,,,LOZAPINE 25MG 50TAB,12204,,24342,BLISTER PVC/PVDC,units,50.0,116 45 29644 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics.Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state.Suicidal behavior refers to actions by a patient that put him/herself at risk for death",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1403d4c4-4c41-430d-9960-1ace16791e92.json
1423fa28-acc5-4db6-b36c-25e8fcc786ed,SOLIRIS,prescription,L04AA25,ECULIZUMAB,6725,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ECULIZUMAB/ML,2025-07-31T08:27:44.100116,IL,ניאופרם,,18912.91242,16027.8926,14570.81145,,7290012913167,SOLIRIS 10MG/ML VIAL 1X30ML (300MG/VIAL),19960,,83859,VIAL 30 ML GLASS TYPE I,units,1.0,144 09 32985 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,"Soliris is indicated for the treatment of patients with: -Paroxysmal nocturnal haemoglobinuria (PNH). Evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history. Eculizumab has not been studied in clinical trials in patients with PNH below 11 years of age. -Atypical haemolytic uremic syndrome (aHUS). - Refractory generalized myasthenia gravis (gMG) in patients aged 6 years and above who are antiacetylcholine receptor (AChR) antibody-positive Soliris is indicated in adults for the treatment of: -Neuromyelitis optica spectrum disorder (NMOSD) in patients who are anti-aquaporin-4 (AQP4) antibodypositive with a relapsing course of the disease who have received prior therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1423fa28-acc5-4db6-b36c-25e8fcc786ed.json
14264f34-532d-478a-8a8d-48f41bc11f6c,CAMZYOS 10 MG,prescription,C01EB24,MAVACAMTEN,9201,,,WHO ATC Classification,,ILS,capsules,MAVACAMTEN,2025-07-31T00:52:05.137331,IL,ב.מ.ס,,8269.567707,7008.108538,6371.007761,,,CAMZYOS 5 MG 30 CAPS,,,70908,BLISTER PVC/PCTFE(ACLAR)/ALUMINIUM,units,30.0,174 20 37421 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14264f34-532d-478a-8a8d-48f41bc11f6c.json
145e6c35-16a9-4d58-8215-46a5b2ff0da7,NOVORAPID,prescription,A10AB05,INSULIN ASPART,4881,,,WHO ATC Classification,,ILS,solution for injection,INSULIN ASPART 100 U/ML,2025-07-31T05:55:30.424019,IL,נובו נורדיסק,,140.5693695,119.1265896,95.3012717,,7290008126458,NOVORAPID FLEXPEN 5X3MLX100IU/ML,9224,,65257,VIAL GLASS TYPE I,units,15.0,118 94 29983 02,valid,25.0,"i.v, s.c",1.4,30,,,,,,,,,,0,Prescription required,"Treatment of patients with diabetes mellitus in adults, adolescents and children aged 2 years and above.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/145e6c35-16a9-4d58-8215-46a5b2ff0da7.json
1461a139-5b87-417d-b3af-e467b59ca959,KINERET 100 MG SOLUTION FOR INJECTION,prescription,L04AC03,ANAKINRA,6665,,,WHO ATC Classification,,ILS,solution for injection,ANAKINRA/ML,2025-07-31T04:26:34.857359,IL,מגאפארם,,1172.527471,993.6673923,845.6743764,,,KINERET 100MG SYR PREFIL 7X0.67ML,11290,,46286,SYRINGE PREFILLED  GLASS TYPE I,units,7.0,145 79 33059 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Kineret 100 mg solution for injection is indicated in adults for the treatment of the signs and symptoms of Rheumatoid Arthritis (RA) in combination with methotrexate, in patients with an inadequate response to methotrexate alone.Kineret 100 mg solution for injection is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including:-	Neonatal-Onset Multisystem Inflammatory Disease (NOMID) / Chronic Infantile Neurological, Cutaneous, Articular Syndrome (CINCA)-	Muckle-Wells Syndrome (MWS)-	Familial Cold Autoinflammatory Syndrome (FCAS) Kineret 100 mg solution for injection is indicated for the treatment of Familial Mediterranean Fever (FMF). Kineret 100 mg solution for injection should be given in combination with colchicine, if appropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1461a139-5b87-417d-b3af-e467b59ca959.json
147c7ffd-468d-408d-93bd-fb2a07e048dd,VEKLURY 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION,prescription,,,8891,,,,,ILS,powder for concentrate for solution for infusion,REMDESIVIR/VIAL,2025-07-31T10:02:42.915148,IL,גיליאד,,2292.399021,1942.711121,1653.371167,,,VEKLURY 100 MG PWDR FOR CONCENTRATE FOR SOL FOR INF 1 VIAL,,,21612,VIAL GLASS TYPE I,units,1.0,165 09 36554 99,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,Veklury is indicated for the treatment of coronavirus disease 2019 (COVID 19) in:•	adults and in paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment) •	adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/147c7ffd-468d-408d-93bd-fb2a07e048dd.json
14803269-bc21-461a-9e83-6a1281f9f79c,CABLIVI,prescription,B01AX07,CAPLACIZUMAB,8499,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,CAPLACIZUMAB/VIAL,2025-07-31T00:48:31.728873,IL,סאנופי אוונטיס,,18777.91535,15913.48829,14466.80754,,3664798034622,CABLIVI 10 MG VIAL,17195,,64876,VIAL GLASS TYPE I,units,1.0,165 25 36110 00,valid,10.0,"s.c, i.v",1.4,60,,,,,,,,,,0,Prescription required,"CABLIVI is indicated for the treatment of adults and adolescents of 12 years of age and older weighing at least 40 kg experiencing an episode of acquired thrombotic thrombocytopenic purpura (aTTP), in conjunction with plasma exchange and immunosuppression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14803269-bc21-461a-9e83-6a1281f9f79c.json
14924137-7a27-43f6-905d-33e2bac48b23,RYDAPT ® 25 MG,prescription,L01XE40,MIDOSTAURIN,8106,,,WHO ATC Classification,,ILS,"capsule, soft",MIDOSTAURIN,2025-07-31T07:55:27.843241,IL,נוברטיס פארמה,,59307.82687,50260.87246,45691.70224,,,RYDAPT 25 MG 112 CAPSULES,18585,,10113,BLISTER PACK PA/ALUMINIUM/PVC,units,112.0,160 65 35320 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute myeloid leukaemia (AML) :Rydapt is indicated in combination with standard induction and consolidation chemotherapy followed by single-agent maintenance therapy for adults with newly diagnosed acute myeloid leukaemia (AML) who have an FLT3 mutation.Advanced systemic mastocytosis (advanced SM) :Rydapt is indicated for the treatment of adult patients with advanced systemic mastocytosis (advanced SM).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14924137-7a27-43f6-905d-33e2bac48b23.json
14a0cc3d-b85e-49b8-8684-7ee5546b213c,RITALIN ® LA 10 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,587,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:40:44.864279,IL,נוברטיס פארמה,,30.27018836,25.652702,18.7246,,7290003257192,RITALIN 10MG 30TAB,18070,,1908,BOTTLE HDPE,units,30.0,146 50 33288 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD) .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14a0cc3d-b85e-49b8-8684-7ee5546b213c.json
14a478a3-9e2f-4b8f-b4aa-06caf34ae698,LIDOJECT 2% STERILE GEL 30G,29C,,,20861,,,,,,tablet,LIDOJECT 2% STERILE GEL 30G,2025-07-31T20:47:44.747243,IL,nan,,,,,,,LIDOJECT 2% STERILE GEL 30G,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14a478a3-9e2f-4b8f-b4aa-06caf34ae698.json
14a68c69-cddf-4db9-865a-65d3296a4ba3,PERCOCET 10,prescription,N02BE01,PARACETAMOL,4674,,,WHO ATC Classification,,ILS,tablets,"OXYCODONE HYDROCHLORIDE, PARACETAMOL",2025-07-31T06:36:50.092946,IL,תרו,,nan,nan,nan,,,PERCOCET 5MG/325MG 20TAB,16273,,58492,BLISTER PVC/ALUMINIUM,units,20.0,139 21 31414 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of moderate to moderately severe pain.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14a68c69-cddf-4db9-865a-65d3296a4ba3.json
14c2a73e-2000-4aa3-a20a-c1962ef24014,VARILRIX,prescription,,,4200,,,,,ILS,powder and solvent for solution for injection,"VARICELLA VIRUS, LIVE ATTENUATED NLT 10^3.3 PFU",2025-07-31T10:00:01.604178,IL,ג.ס.ק,,196.6907222,166.6870601,133.3496481,,,VARILRIX 2000FL/0.5ML 1VIAL,22162,,22366,VIAL GLASS TYPE I,units,1.0,115 15 29677 00,valid,25.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Varilrix is intended for the active immunization against varicella of the categories of persons listed below, where there is no history of varicella.-	Healthy subjects, from the age of 12 months.-	Patients at high risk of severe varicella, such as patients with acute leukemia or a chronic condition, those on immunosuppressive therapy or those for whom an organ transplant is being considered.Healthy persons living in close contact with patients with varicella and high-risk patients.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14c2a73e-2000-4aa3-a20a-c1962ef24014.json
14ce5643-ec15-43c8-8684-bfc5088e6ad8,DULOXETINE S.K. 30 MG,prescription,N06AX21,DULOXETINE,8863,,,WHO ATC Classification,,ILS,gastro resistant capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T02:06:08.815246,IL,SK PHARM(KS KIM),,99.1762919,84.047705,62.489,,,DULOXETINE S.K. 60 MG 28 CAPS,4733,,70646,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,166 93 35645 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Duloxetine is indicated for:- The treatment of major depressive episodes.- The management of neuropathic pain associated with diabetic peripheral neuropathy.- The treatment of generalized anxiety disorder (GAD).- The management of fibromyalgia.- The management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. This has been established in studies in patients with chronic low back pain (CLBP) and chronic pain due to osteoarthritis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14ce5643-ec15-43c8-8684-bfc5088e6ad8.json
14f3bac4-bea3-49cc-9550-5f417c3020d2,FIRAZYR 30 MG,prescription,C01EB19,ICATIBANT,6312,,,WHO ATC Classification,,ILS,solution for injection,ICATIBANT AS ACETATE/,2025-07-31T03:05:09.084808,IL,טקדה,,7496.296871,6352.793959,5775.267235,,7290008128001,FIRAZYR 30MG/3ML PREFIL. SYR.,,,43348,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,142 99 33003 01,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents and children aged 2 years and older, with C1 -esterase-inhibitor deficiency",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14f3bac4-bea3-49cc-9550-5f417c3020d2.json
14fb516c-694e-4edb-835e-253cc554364f,EYECON,off-the-counter,S01KA01,HYALURONIC ACID,3997,,,WHO ATC Classification,,ILS,"eye drops, solution",HYALURONIC ACID AS SODIUM 0.15 MG/ML,2025-07-31T11:52:51.342003,IL,רקח,,53.2534,45.13,nan,,7-290008-012843,EYECON 20*0.65ML,5182,,,CONTAINER UNIT DOSE LDPE,units,20.0,116 76 29346 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,Symptomatic treatment of dry eye syndrome.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14fb516c-694e-4edb-835e-253cc554364f.json
14fc6d65-42dd-4b8e-8d59-32e56293ef76,DAYVIGO ® 10 MG,prescription,N05CM21,LEMBOREXANT,9411,,,WHO ATC Classification,,ILS,film coated tablets,LEMBOREXANT,2025-07-31T01:43:53.231547,IL,אסיי,,nan,nan,nan,,5036519004678,DAYVIGO  5 MG 28 TAB,4790,,14309,BLISTER PVC/ALUMINIUM,units,28.0,172 65 37069 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14fc6d65-42dd-4b8e-8d59-32e56293ef76.json
14fc97d0-344c-4d76-b4e6-fff2e4471279,ORENCIA 125 MG SC,prescription,L04AA24,ABATACEPT,6520,,,WHO ATC Classification,,ILS,solution for injection,ABATACEPT/ML,2025-07-31T06:15:26.519048,IL,ב.מ.ס,,1524.870205,1292.262943,1099.798249,,7290014396074,ORENCIA 250MG 1 VIAL POWDER FOR INFUSION,15374,,17948,SYRINGE PREFILLED  GLASS,units,1.0,149 54 33788 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"ORENCIA is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. ORENCIA may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (DMARDs) other than tumor necrosis factor (TNF) antagonists.ORENCIA is indicated for the treatment of adult patients with active psoriatic arthritis (PsA).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/14fc97d0-344c-4d76-b4e6-fff2e4471279.json
150ebce1-5886-4252-a4f7-a4297bd71c40,ZOVIRAX,prescription,D06BB03,ACICLOVIR,4317,,,WHO ATC Classification,,ILS,cream,ACICLOVIRW/W,2025-07-31T10:55:20.528743,IL,ג.ס.ק,,209.8377775,177.828625,142.2629,,7290008086950,ZOVIRAX IV FOR INFUSION 250MG 5AMP,26102,,26893,PACK PUMP POLYPROPYLENE,units,5.0,126 38 30532 00,valid,25.0,topical,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of cold sores (herpes labialis).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/150ebce1-5886-4252-a4f7-a4297bd71c40.json
15185542-1f1c-44bb-a8e3-f28dd97449bc,ADENO-AVENIR,prescription,C01EB10,ADENOSINE,8280,,,WHO ATC Classification,,ILS,solution for injection,ADENOSINE/ML,2025-07-31T00:08:24.034676,IL,ביואבניר,,97.194004,82.3678,61.24,,7290010286676,ADENO AVENIR  3MG/ML  6 VIALS  2ML,,,42012,VIAL GLASS TYPE I,units,6.0,155 15 34258 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Rapid conversion to a normal sinus rhythm of paroxymal supraventicular tachycardias including those associated with accessory bypass tracts (wolf parkinson-white syndrome).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/15185542-1f1c-44bb-a8e3-f28dd97449bc.json
1535f91b-3b3b-4912-8ae7-4abd79ce87b1,KOATE DVI 1000,prescription,B02BD02,COAGULATION FACTOR VIII,7056,,,WHO ATC Classification,,ILS,powder for solution for injection,FACTOR VIII (HUMAN)/VIAL,2025-07-31T04:28:24.121039,IL,פאדאגיס,,2464.693661,2088.723534,1898.839576,,7298074020335,KOATE DVI 1000IU/VIAL,11281,,35533,VIAL GLASS TYPE I,units,1.0,117 90 29931 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of classical hemophilia (hemophilia A)  in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor VIII . Koate-DVI provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1535f91b-3b3b-4912-8ae7-4abd79ce87b1.json
1539ebef-49c2-4a4d-a977-b8650c97e49a,AMISULPRIDE MEDO 100 MG,prescription,N05AL05,AMISULPRIDE,7858,,,WHO ATC Classification,,ILS,tablets,AMISULPRIDE,2025-07-31T06:56:39.422770,IL,אוניפארם,,213.9553875,181.318125,145.0545,,,PRIDE 400 MG 30 F.C.TAB,9906,,33002,BLISTER PVC/ALUMINIUM,units,30.0,178 82 37379 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of schizophrenia .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1539ebef-49c2-4a4d-a977-b8650c97e49a.json
15587811-900f-4abb-9cf8-fa1c93002be9,synagis,prescription,J06BB16,PALIVIZUMAB,8947,,,WHO ATC Classification,,ILS,solution for injection,PALIVIZUMAB/ML,2025-07-31T08:55:26.179094,IL,אסטראזנקה,,1783.852718,1511.739658,1286.586943,,7290013075895,SYNAGIS 50MG/0.5ML 1 VIAL,17510,,73001,VIAL GLASS TYPE I,units,1.0,155 56 34505 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,Abbosynagis is indicated for the prevention of serious lower respiratory tract disease requiring hospitalisation caused by respiratory syncytial virus (RSV) in children at high risk for RSV disease: • Children born at 35 weeks of gestation or less and less than 6 months of age at the onset of the RSV season.• Children less than 2 years of age and requiring treatment for bronchopulmonary dysplasia within the last 6 months.• Children less than 2 years of age and with haemodynamically significant congenital heart disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/15587811-900f-4abb-9cf8-fa1c93002be9.json
155a7f76-89de-4295-963a-fe34ffb40bf3,FENTANYL - KALCEKS 0.05 MG/ML,prescription,N01AH01,FENTANYL,8907,,,WHO ATC Classification,,ILS,solution for injection,FENTANYL AS CITRATE 0.05 MG/ML,2025-07-31T03:01:03.872502,IL,מדי מרקט,,23.50827388,19.922266,14.5418,,,FENTANYL - KALCEKS 0.05 MG/ML 2ML 10 AMP,,,71451,AMPOULES GLASS TYPE I,units,10.0,165 89 35639 00,valid,37.0,"epidural, i.v",1.4,36,,,,,,,,,,0,Prescription required,For analgesic action of short duration during anesthtic periods (premedication induction and maintenance) and in the immediate postoperative period as need arises. As a narcotic analgesic supplement in general or regional anesthesia. For administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia and as an adjunct in the maintenance of general or regional anesthesia. For use as an anesthetic agent with oxygen in selected high-risk patients (open heart surgery or certain neurological or orthopedic procedures). By the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections and as adjunct to general anesthesia., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/155a7f76-89de-4295-963a-fe34ffb40bf3.json
155c583c-dbd8-4d6f-8531-9a00648b20c7,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,7328,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T02:58:31.884451,IL,רפא,,115.38217,97.7815,72.7,,,FENTA INJECTION 0.05MG/ML 50X2ML,,,55431,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,50.0,148 73 33262 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/155c583c-dbd8-4d6f-8531-9a00648b20c7.json
1575569c-f3be-4eb7-a784-5ad99acf3d5a,IMAPRIMINE HCL   50MG  100TABS  LEADING PHARMA USA,29C,,,20952,,,,,,tablet,IMAPRIMINE HCL 50MG S LEADING PHARMA USA,2025-07-31T20:37:23.838301,IL,nan,,,,,,,IMAPRIMINE HCL   50MG  100TABS  LEADING PHARMA USA,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1575569c-f3be-4eb7-a784-5ad99acf3d5a.json
157ed9a7-c683-4c31-ad02-7460c0a3bf27,LAMICTAL DISPERSIBLE/CHEWABLE TABLETS 5 MG,prescription,N03AX09,LAMOTRIGINE,2809,,,WHO ATC Classification,,ILS,dispersible chewable tablets,LAMOTRIGINE,2025-07-31T04:32:53.116787,IL,ג.ס.ק,,26.89521254,22.792553,16.6369,,7290008105200,LAMICTAL 25MG 30 DISP/CHEWTAB,12111,,9257,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,068 90 28230 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy• Adults and adolescents aged 13 years and above- Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- Seizures associated with Lennox-Gastaut syndrome. Lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome.• Children and adolescents aged 2 to 12 years- Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.- Monotherapy of typical absence seizures.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/157ed9a7-c683-4c31-ad02-7460c0a3bf27.json
1586f9c9-d123-49c0-a7b0-520caf8d9885,KETOZOL SHAMPOO,prescription,D01AC08,KETOCONAZOLE,6428,,,WHO ATC Classification,,ILS,shampoo,KETOCONAZOLE/G,2025-07-31T04:25:44.980017,IL,פאדאגיס,,46.7310562,39.60259,28.907,,7290012162084,KETOZOL SHAMPOO 100ML,11213,,89359,BOTTLE 120 ML HDPE,units,100.0,138 73 31583 00,valid,37.0,topical- scalp,1.4,18,,,,,,,,,,0,Prescription required,Topical treatment of seborrhoeic dermatitis including dandruff resulting from proven fungal infection including Pityriasis versicolor.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1586f9c9-d123-49c0-a7b0-520caf8d9885.json
158842f2-15f4-4b1f-8924-8751c8f90a1c,HALAVEN,prescription,L01XX41,ERIBULIN,6835,,,WHO ATC Classification,,ILS,solution for injection,ERIBULIN AS MESILATE 0.44 MG/ML,2025-07-31T03:41:24.323084,IL,אסיי,,1854.439689,1571.559129,1337.497131,,7290012849091,HALAVEN 0.44MG/ML VIAL 2.26ML,8397,,39036,VIAL GLASS TYPE I,units,1.0,148 18 33511 03,valid,17.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,Halaven is indicated for the treatment of adult patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting  unless patients were not suitable for these treatments.Halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/158842f2-15f4-4b1f-8924-8751c8f90a1c.json
158bfc2e-6ac8-46ba-8d9e-af0182b35baa,VISINE ORIGINAL EYE DROPS,off-the-counter,S01GA02,TETRYZOLINE,1185,,,WHO ATC Classification,,ILS,"eye drops, solution",TETRYZOLINE HYDROCHLORIDE 0.05 %W/V,2025-07-31T13:35:52.084931,IL,ג'ונסון אנד ג'ונסון,,25.1576,21.32,nan,,3574660725698,VISINE ORIGINAL EYE DROPS15ML,22005,,,BOTTLE LDPE,units,15.0,126 09 24800 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,"Relief  from soreness, burning, itching, irritation redness due to congestion of the eyes.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/158bfc2e-6ac8-46ba-8d9e-af0182b35baa.json
159e3430-5f18-426c-b975-843f50c84416,CELLCEPT 250 MG,29C,L04AA06,MYCOPHENOLIC ACID,20050,,,WHO ATC Classification,,ILS,capsules,MYCOPHENOLATE MOFETIL,2025-07-31T14:06:01.693618,IL,nan,,nan,nan,nan,,7290008140188,CELLCEPT ORAL SUSP 200MG/ML 110G 175ML,,,,BLISTER PVC/ALUMINIUM,units,175.0,111 34 29434 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. Cellcept should be used concomitantly with cyclosporin and corticosteroids.Allogenic hepatic transplant.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/159e3430-5f18-426c-b975-843f50c84416.json
15b77e56-76fb-4d0e-aee7-d7b039584d6f,TAFINLAR 50 MG,prescription,L01XE23,DABRAFENIB,7415,,,WHO ATC Classification,,ILS,"capsule, hard",DABRAFENIB AS MESILATE,2025-07-31T09:00:58.847032,IL,נוברטיס פארמה,,3779.876598,3203.285395,2912.077632,,7290014257689,TAFINLAR 50 MG 28 CAPSULES,20784,,53566,BOTTLE HDPE,units,28.0,151 42 33976 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Dabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.Non-small cell lung cancer (NSCLC) :Dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a BRAF V600 mutation.Adjuvant treatment of melanoma :Dabrafenib in combination with trametinib is indicated for the adjuvant treatment of adult patients with Stage III melanoma with BRAF V600 mutation, following complete resection.BRAF V600E Mutation-Positive Locally Advanced or Metastatic Anaplastic Thyroid CancerTAFINLAR is indicated, in combination with trametinib, for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment optionsBRAF V600E Mutation-Positive Unresectable or Metastatic Solid TumorsTafinlar is indicated, in combination with trametinib, for the treatment of adult and pediatric patients 6 years of age and older with unresectable or metastatic solid tumors with BRAF V600E mutation who have progressed following prior treatment and have no satisfactory alternative treatment options. Limitations of Use: Dabrafenib is not indicated for treatment of patients with colorectal cancer because of known intrinsic resistance to BRAF inhibition. Dabrafenib is indicated, in combination with trametinib, for the treatment of pediatric patients 6 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/15b77e56-76fb-4d0e-aee7-d7b039584d6f.json
15c4d9c7-255c-452f-a54a-be7126b786a7,TERIFLUNOMIDE MEDOMIE,prescription,L04AA31,TERIFLUNOMIDE,9429,,,WHO ATC Classification,,ILS,film coated tablets,TERIFLUNOMIDE,2025-07-31T09:14:41.052705,IL,מדומי פארמה,,4017.629682,3404.770917,3095.246288,,,TERIFLUNOMIDE MEDOMIE 14MG 28 TAB,,,,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,171 29 37077 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,TERIFLUNOMIDE MEDOMIE is indicated for the treatment of adult patients with relapsing remitting forms of Multiple Sclerosis (MS) to reduce the frequency of clinical relapses and to delay the progression of physical disability.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/15c4d9c7-255c-452f-a54a-be7126b786a7.json
15ca9f60-838b-4a70-8bbf-10307446a7a9,KONAKION MM PAEDIATRIC 2 MG/0.2 ML,prescription,B02BA01,PHYTOMENADIONE,3032,,,WHO ATC Classification,,ILS,solution for injection,PHYTOMENADIONE/ML,2025-07-31T04:28:55.334411,IL,צמל,,26.71064734,22.63614282,16.52273198,,7290013280480,KONAKION MM 10MG/ML 5 AMP,11012,,9202,AMPOULES GLASS TYPE I,units,5.0,105 47 28944 00,valid,37.0,"i.m, i.v, per os",1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis and treatment of haemorrhoagic disease of the newborn.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/15ca9f60-838b-4a70-8bbf-10307446a7a9.json
15cc1a09-0e07-49e5-9f76-545cd3615033,AVCAMOL 250 MG,off-the-counter,N02BE01,PARACETAMOL,5429,,,WHO ATC Classification,,ILS,granules,PARACETAMOL/STICK PACK,2025-07-31T11:15:02.466076,IL,טבע,,22.184,18.8,nan,,,AVCAMOL FOR BIG KIDS 250 MG STRAW/VANI 10 SACHETS,,,,STICK PACKS POLYESTER/ALUMINIUM/POLYETHYLENE,units,10.0,148 51 33446 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Analgesic, Antipyretic .",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/15cc1a09-0e07-49e5-9f76-545cd3615033.json
15f2c314-d28c-4e61-a163-07653854dd78,ZOLEDRONIC ACID TARO 4 MG/ 5 ML,prescription,M05BA08,ZOLEDRONIC ACID,8214,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ZOLEDRONIC ACID/,2025-07-31T10:53:40.741562,IL,תרו יבוא,,460.5006021,390.2547475,332.1317,,,ZOLEDRONIC ACID TARO 4MG/5ML 1VIAL,,,11452,VIAL GLASS,units,1.0,154 71 34213 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of hypercalcaemia of malignancy.Treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy.Prostate cancer should have progressed after treatment with at least one hormonal therapy.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/15f2c314-d28c-4e61-a163-07653854dd78.json
1605f12e-0265-4363-9897-23f7e57679d0,FANAPT TABLETS 1 MG,prescription,N05AX14,ILOPERIDONE,7155,,,WHO ATC Classification,,ILS,tablets,ILOPERIDONE,2025-07-31T02:53:25.005211,IL,מגאפארם,,nan,nan,nan,,7290014573062,FANAPT 10MG 60TAB,,,58457,BLISTER ALUMINIUM,units,60.0,148 32 33482 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,FANAPT is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1605f12e-0265-4363-9897-23f7e57679d0.json
160a1cdb-afb4-44fe-9f76-161be90c4484,LOJUXTA 10 MG,prescription,C10AX12,LOMITAPIDE,8958,,,WHO ATC Classification,,ILS,"capsule, hard",LOMITAPIDE AS MESYLATE,2025-07-31T04:53:17.049889,IL,מדיסון,,113841.3214,96475.70035,87705.18214,,7290008128629,LOJUXTA 5 MG 28 tab,,,44053,BOTTLE HDPE,units,28.0,152 86 33998 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"An adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/160a1cdb-afb4-44fe-9f76-161be90c4484.json
1627bea2-ba46-4789-bc7c-5d16acc7530f,OVITRELLE 250 MICROGRAMS,prescription,G03GA08,CHORIOGONADOTROPIN ALFA,4917,,,WHO ATC Classification,,ILS,solution for injection,CHORIOGONADOTROPIN ALFA/ 0.5  ML,2025-07-31T06:19:49.790250,IL,מרק סרונו,,152.3890604,129.1432773,103.3146218,,7290000845647,OVITRELLE 250MCG/0.5ML PREFIL PEN SOL FOR INJ,15324,,66640,PRE-FILLED PEN GLASS TYPE I,units,1.0,132 74 31099 00,valid,25.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,- For women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilization (IVF) : Ovitrelle is administered to trigger final follicular maturation AND luteinisation AFTER stimulation of follicular growth.   -  Anovulatory OR oligo-ovulatory women: Ovitrelle is administered to trigger ovulation AND luteinisation in Anovulatory OR oligo-ovulatory patients AFTER stimulation of follicular growth.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1627bea2-ba46-4789-bc7c-5d16acc7530f.json
162948b7-0cf8-4e19-bd2c-4a2051ac4169,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4550,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:23:14.885811,IL,מדיסון,,1214.079408,1028.8809,875.6433191,,8715131005863,ARANESP 40MCG 4 PREFILLED SYR 0.4ML,9484,,29744,PRE-FILLED PEN GLASS TYPE I,units,4.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/162948b7-0cf8-4e19-bd2c-4a2051ac4169.json
162bbdde-24c4-44f3-a66f-ac75499b962e,HEXAKAPRON INJECTION,prescription,B02AA02,TRANEXAMIC ACID,8756,,,WHO ATC Classification,,ILS,solution for injection,TRANEXAMIC ACID/,2025-07-31T03:46:41.109376,IL,טבע,,52.27068283,44.29718884,32.33371448,,7290110730475,HEXAKAPRON INJECTION 500MG/5ML 10 AMP,,,66993,AMPOULES GLASS TYPE I,units,10.0,102 60 20765 21,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Prevention and treatment of haemorrhages due to general or local fibrinolysis in adults and children from one year.Specific indications include:- Haemorrhage caused by general or local fibrinolysis such as:    * Menorrhagia and metrorrhagia    * Gastrointestinal bleeding    * Haemorrhagic urinary disorders, further to prostate surgery or surgical procedures affecting the urinary tract- Ear Nose Throat surgery (adenoidectomy, tonsillectomy, dental extractions)- Gynaecological surgery or disorders of obstetric origin- Thoracic and abdominal surgery and other major surgical intervention such as cardiovascular surgery- Management of haemorrhage due to the administration of a fibrinolytic agent.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/162bbdde-24c4-44f3-a66f-ac75499b962e.json
162fcf93-41a1-40d8-acb2-9f49abd27025,HEXATRIONE 40MG/2ML VIAL,29C,,,20440,,,,,,injection,HEXATRIONE 40MG/ VIAL,2025-07-31T20:34:10.103706,IL,nan,,,,,,,HEXATRIONE 40MG/2ML VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/162fcf93-41a1-40d8-acb2-9f49abd27025.json
1650f656-ee3d-4dcd-9f99-a137a56b037e,MIXTARD 30 VIAL,prescription,A10AD01,INSULIN (HUMAN),2577,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN (HUMAN)/ML,2025-07-31T05:28:26.837592,IL,נובו נורדיסק,,164.9556737,139.79295,111.83436,,7290008126113,MIXTARD 30HM 5X3ML PEN,9020,,8536,VIAL GLASS TYPE I,units,15.0,049 85 26012 00,valid,25.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,Mixtard 30 is indicated for treatment of diabetes mellitus.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1650f656-ee3d-4dcd-9f99-a137a56b037e.json
165124f4-20cb-4115-ace6-eee0b5221789,ADIZEM CD 180,prescription,,,3498,,,,,ILS,capsules controlled release,DILTIAZEM HYDROCHLORIDE,2025-07-31T00:09:16.639280,IL,רפא,,53.10646302,45.00547914,32.8507147,,7290008013475,ADIZEM CD 240MG 30CAP,1151,,53942,BLISTER PVC/ALUMINIUM,units,30.0,102 96 27681 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Calcium channel blocker that is indicated for the treatment of hypertension and angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/165124f4-20cb-4115-ace6-eee0b5221789.json
165c9ae4-d145-4874-ae3d-d9d1f052b632,ISRAPIDINE 5MG 30 caps,29C,,,20994,,,,,,capsule,ISRAPIDINE 5MG,2025-07-31T20:42:19.402881,IL,nan,,,,,,,ISRAPIDINE 5MG 30 caps,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/165c9ae4-d145-4874-ae3d-d9d1f052b632.json
16654de8-963b-4157-963e-aea658547267,FERRIPROX  ORAL SOLUTION 100 MG/ML,prescription,V03AC02,DEFERIPRONE,7014,,,WHO ATC Classification,,ILS,solution  (oral),DEFERIPRONE/,2025-07-31T03:03:34.288938,IL,לפידות,,998.8691765,846.4993398,720.42497,,,FERRIPROX ORAL SOLUTION 100MG/ML 500ML,6479,,33765,BOTTLE PET,units,500.0,147 69 33222 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Ferriprox monotherapy is indicated for the treatment of iron overload in patients over 6 years old with thalassaemia major when current chelation therapy is contraindicated or inadequate.Ferriprox in combination with another chelator is indicated in patients with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life-threatening consequences of iron overload (mainly cardiac overload) justifies rapid or intensive correction.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16654de8-963b-4157-963e-aea658547267.json
16753e7c-bf9c-4d2a-82c8-2988cbea22c0,DETRUSITOL SR 2 MG,prescription,G04BD07,TOLTERODINE,4533,,,WHO ATC Classification,,ILS,capsules slow release,TOLTERODINE L-TARTRATE,2025-07-31T01:52:02.342484,IL,דקסל פארמה,,67.18384752,56.935464,42.3312,,7298074160161,DETRUSITOL SR 2MG 28CAPS,4284,,5143,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,125 56 30466 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16753e7c-bf9c-4d2a-82c8-2988cbea22c0.json
167e72c7-d5c1-4053-a650-06acb3424054,MINJUVI 200 mg,prescription,L01FX12,TAFASITAMAB,9021,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,TAFASITAMAB/VIAL,2025-07-31T05:25:33.544737,IL,מדיסון,,3558.892054,3016.010349,2741.82759,,,MINJUVI 200 MG 1 VIAL,,,44052,VIAL GLASS TYPE I,units,1.0,169 96 37059 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,MINJUVI is indicated in combination with lenalidomide followed by MINJUVI monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplant (ASCT).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/167e72c7-d5c1-4053-a650-06acb3424054.json
16810336-b936-446e-8959-3de73522a068,CARBOPLATIN TEVA,prescription,L01XA02,CARBOPLATIN,7445,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,CARBOPLATIN/ML,2025-07-31T00:54:10.271172,IL,טבע,,411.4214137,348.662215,296.7338,,7290008002035,CARBOPLATIN 450MG/45ML VIAL,9546,,35206,VIAL GLASS TYPE I,units,1.0,042 05 25540 05,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Advanced ovarian carcinoma in initial treatment and secondary treatment.Metastatic small cell carcinoma of the lung.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16810336-b936-446e-8959-3de73522a068.json
16836bca-e3a8-4a64-8bcb-59ad2eda2ad6,BETACORTEN G OINTMENT,prescription,D07AC01,BETAMETHASONE,2166,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS VALERATE 0.1 %W/W, GENTAMICIN AS SULFATE 0.1 %W/W",2025-07-30T23:36:36.989393,IL,תרימה,,8.8913,7.535,5.5,,,BETACORTEN CREAM 15G,2066,,340,TUBE ALUMINIUM,units,15.0,050 45 23262 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,For local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16836bca-e3a8-4a64-8bcb-59ad2eda2ad6.json
1699dce8-706a-407e-aedc-ccacc5472f9c,CINACALCET TARO 30 MG,prescription,H05BX01,CINACALCET,8473,,,WHO ATC Classification,,ILS,film coated tablets,CINACALCET AS HYDROCHLORIDE,2025-07-31T01:13:39.245347,IL,תרו יבוא,,961.6726565,814.9768275,693.5973,,,CINACALCET TARO 30 MG 28 TAB,,,45478,BLISTER PVC/PE/PVDC/AL,units,28.0,160 90 35048 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet Taro may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma. Reduction of hypercalcaemia in patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1699dce8-706a-407e-aedc-ccacc5472f9c.json
16a16fff-12ee-442c-af70-6f93b9b98551,PITREX,off-the-counter,,,1659,,,,,ILS,cream,TOLNAFTATE,2025-07-31T12:48:04.167092,IL,טבע,,20.3904,17.28,nan,,7290000802183,PITREX CREAM 1% 15GR,16155,,,TUBE ALUMINIUM,units,15.0,026 52 21118 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Topical treatment of superficial dermatomycoses.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16a16fff-12ee-442c-af70-6f93b9b98551.json
16af7f62-4e5e-47e1-9d39-a7bac25b2d85,SUNITINIB TARO 12.5 MG,prescription,L01XE04,SUNITINIB,9402,,,WHO ATC Classification,,ILS,"capsule, hard",SUNITINIB 12.5  MG,2025-07-31T08:51:16.176774,IL,תרו יבוא,,2289.261918,1940.052559,1651.108561,,7290017164410,SUNITINIB TARO 12.5 MG 28 CAPS,,,15971,BLISTER OPA/ALU/PVC/ALU,units,28.0,167 94 36017 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Sunitinib taro is indicated for:• Treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • Treatment of advanced renal cell carcinoma.• Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16af7f62-4e5e-47e1-9d39-a7bac25b2d85.json
16b0b03a-4602-4ee4-abab-4c492dff27ef,IMATINIB TEVA ® 100 MG,prescription,L01XE01,IMATINIB,7757,,,WHO ATC Classification,,ILS,film coated tablets,IMATINIB AS MESYLATE,2025-07-31T03:59:47.752535,IL,טבע,,7205.710061,6106.53395,5551.3945,,7290110732134,IMATINIB TEVA 400MG 30 F.C.TAB,9859,,58509,BOTTLE HDPE,units,30.0,153 98 34034 02,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia(Ph+ -CML) in chronic phase accelerated phase or blast crisis.Imatinib Teva is also indicated for the treament of :Adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) integrated with chemotherapy.Adult patients with relapsed or refractory Ph + ALL as monotherapy.Adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.Adult patients with myelodyspiastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR ( platelet - derived growth factor receptor ) gene re- arrangements.Adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) who have the FIP1L1- PDGFRalfa fusion kinase (mutational analysis or FISH demonstration fo CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFR alfa fusion kinase negative .Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-kit mutation.Imatinib Teva is also indicated for the treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST)Imatinib Teva is also indicated for Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16b0b03a-4602-4ee4-abab-4c492dff27ef.json
16becb03-fac9-4358-a4b3-3202d681df28,VENTOLIN INJECTION,prescription,R03CC02,SALBUTAMOL,4351,,,WHO ATC Classification,,ILS,solution for injection,SALBUTAMOL AS SULFATE 0.5 MG/ML,2025-07-31T10:05:44.040623,IL,ג.ס.ק,,10.43076643,8.839632962,6.452286833,,7290008085489,VENTOLIN INJ 500MCG/ML 5X1ML,22055,,9145,AMPOULES GLASS TYPE I,units,5.0,027 64 21556 05,valid,37.0,"i.m, i.v, s.c",1.4,48,,,,,,,,,,0,Prescription required,Ventolin Injection is indicated in adults.Ventolin Injection provides short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. It is indicated for the relief of severe bronchospasm.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16becb03-fac9-4358-a4b3-3202d681df28.json
16e14412-68c7-4f85-b43d-d71cf4de8b5a,AUGMENTIN SUSPENSION 400 MG/5 ML,prescription,J01CR02,AMOXICILLIN AND ENZYME INHIBITOR,3819,,,WHO ATC Classification,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM SALT 11.4 MG/ML, AMOXICILLIN AS TRIHYDRATE/ML",2025-07-30T23:31:26.319323,IL,ג.ס.ק,,24.93055856,21.127592,15.4216,,7290010140121,AUGMENTIN 400MG SUSP 70ML,1986,,68670,BOTTLE GLASS TYPE III,units,70.0,112 75 29288 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Augmentin is indicated for the treatment of the following infections in adults and children: • Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.• Recurrent tonsillitis",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/16e14412-68c7-4f85-b43d-d71cf4de8b5a.json
1713e03e-2102-42fb-bc53-fe4a0dbac5eb,DULOXETINE SANDOZ ® 30 MG GRC,prescription,N06AX21,DULOXETINE,9066,,,WHO ATC Classification,,ILS,gastro resistant capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T02:06:31.112838,IL,סנדוז,,99.1762919,84.047705,62.489,,,DULOXETINE SANDOZ 60 MG 28 CAPS,,,,BLISTER PVC/PE/PCTFE/AL,units,28.0,167 67 35796 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Duloxetine Sandoz is indicated for - The treatment of major depressive episodes.- The management of neuropathic pain associated with diabetic peripheral neuropathy.- The treatment of generalized anxiety disorder (GAD).- The management of fibromyalgia.- The management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. This has been established in studies in patients with chronic low back pain (CLBP) and chronic pain due to osteoarthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1713e03e-2102-42fb-bc53-fe4a0dbac5eb.json
17239a41-9bd2-4425-8051-982409e6b87d,SPASMALGIN,prescription,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",2038,,,WHO ATC Classification,,ILS,tablets,"PARACETAMOL, ATROPINE SULFATE 0.4  MG, PAPAVERINE HYDROCHLORIDE, CODEINE PHOSPHATE",2025-07-31T08:32:38.124272,IL,סם און,,nan,nan,nan,,,SPASMALGIN 30TAB,19115,,7235,BLISTER PVC/ALUMINIUM,units,30.0,036 36 22208 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Analgesic and antispasmodic for the digestive system, the kidneys and the gall bladder.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17239a41-9bd2-4425-8051-982409e6b87d.json
17310c6a-87c4-45ab-86a1-59281ff1c948,COMBODEX,off-the-counter,M01AE51,"IBUPROFEN, COMBINATIONS",5506,,,WHO ATC Classification,,ILS,caplets,"IBUPROFEN, PARACETAMOL",2025-07-31T11:26:34.786636,IL,דקסל פארמה,,40.3442,34.19,nan,,,COMBODEX 24 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,24.0,156 94 34420 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Temporary relief of pain associated with: headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, sore throat, arthritis, tennis elbow, period pain, muscular pain, rheumatic pain, aches and pains associated with colds and flu. Reduces fever.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17310c6a-87c4-45ab-86a1-59281ff1c948.json
174770d3-84fa-4012-bbff-c4c716645ae1,MOUNJARO 12.5 MG KWIKPEN,prescription,A10BX16,TIRZEPATIDE,9229,,,WHO ATC Classification,,ILS,solution for injection,TIRZEPATIDE 20.8 MG/ML,2025-07-31T05:32:48.013237,IL,אלי לילי,,nan,nan,nan,,,MOUNJARO 2.5 MG/0.5 ML 4 PRE-FILLED PEN,,,,PRE-FILLED PEN GLASS TYPE I,units,4.0,177 54 38073 99,valid,nan,s.c,1.4,24,,,,,,,,,,0,Prescription required,"T2DMMounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise•	as monotherapy when metformin is considered inappropriate due to intolerance or contraindications•	in addition to other medicinal products for the treatment of diabetes.Weight managementMounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of•	&#8805; 30 kg/m2 (obesity) or•	&#8805; 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).For trial results with respect to obstructive sleep apnoea (OSA) in adults with obesity, see section 5.1.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/174770d3-84fa-4012-bbff-c4c716645ae1.json
17547ef0-250e-4dca-a743-c5e206fa2616,POSTINOR,off-the-counter,G03AC03,LEVONORGESTREL,5165,,,WHO ATC Classification,,ILS,tablets,LEVONORGESTREL 1.5  MG,2025-07-31T12:51:43.122843,IL,תרימה,,132.809,112.55,nan,,7290000843803,POSTINOR NEW 1.5MG 1 TAB,16745,,,BLISTER PVC/ALUMINIUM,units,1.0,134 46 31286 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,Emergency contraseptive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17547ef0-250e-4dca-a743-c5e206fa2616.json
175cca1f-b1a3-4ddb-9c08-e24b0995bafc,EFUDIX CREAM 5%,prescription,,,7198,,,,,ILS,cream,FLUOROURACIL/,2025-07-31T02:12:47.908544,IL,דקסל פארמה,,127.1503802,107.7545595,80.11491414,,7290004448721,EFUDIX CREAM 5% 20GR,5572,,77565,TUBE ALUMINIUM,units,20.0,062 40 21478 00,valid,34.5,dermal,1.4,60,,,,,,,,,,0,Prescription required,Antineoplastic agent to treat actinic keratosis multiple and superfacial basel cell carcinoma.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/175cca1f-b1a3-4ddb-9c08-e24b0995bafc.json
17777318-8cff-4c88-87c8-4453726417ca,XEOMIN 100,prescription,M03AX01,BOTULINUM TOXIN,8428,,,WHO ATC Classification,,ILS,powder for solution for injection,BOTULINUM TOXIN TYPE A 0.8 NG 100 LD50 UNITS / VIAL,2025-07-31T10:33:30.048747,IL,אלפאמדיקיס,,894.4015001,757.9674067,645.078644,,,XEOMIN 100 1 VIAL,,,3517,VIAL GLASS TYPE I,units,1.0,161 96 35384 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. Xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17777318-8cff-4c88-87c8-4453726417ca.json
17844df9-d888-4f0c-87d6-07790e74230a,ROSUVASTATIN INOVAMED 10 MG,prescription,C10AA07,ROSUVASTATIN,9360,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T07:50:10.958217,IL,אינובמד,,90.81529039,76.9621105,57.2209,,,ROSUVASTATIN INOVAMED 10 MG 30 TAB,23630,,4907,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,173 65 36557 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17844df9-d888-4f0c-87d6-07790e74230a.json
17850a5b-43eb-4c8e-9da7-78e219ccd53d,RYBELSUS 14 MG,prescription,A10BJ06,SEMAGLUTIDE,8786,,,WHO ATC Classification,,ILS,tablets,SEMAGLUTIDE,2025-07-31T07:54:43.439797,IL,נובו נורדיסק,,492.5240522,417.3932832,355.2283261,,,RYBELSUS 3 MG 30 TAB,18633,,69364,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,166 74 36541 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in combination with other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17850a5b-43eb-4c8e-9da7-78e219ccd53d.json
17864587-8b9b-48f1-a360-d5cefccf9153,B-SIX 300 TABLETS,off-the-counter,,,1992,,,,,ILS,tablets,PYRIDOXINE (VIT B6) HYDROCHLORIDE,2025-07-31T11:15:39.111314,IL,סם און,,44.1792,37.44,nan,,,B SIX 300 30TAB,2002,,,BLISTER PVC/ALUMINIUM,units,30.0,057 45 21250 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Vitamin B6 supplement.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17864587-8b9b-48f1-a360-d5cefccf9153.json
178c3005-ee33-4354-81a2-dd0eaba487a0,ASPAVELI,prescription,L04AA54,PEGCETACOPLAN,9466,,,WHO ATC Classification,,ILS,solution for infusion,PEGCETACOPLAN/,2025-07-31T00:25:22.965224,IL,תרומד,,130279.0822,110406.0067,100369.097,,,ASPAVELI 1080MG/20ML 8 VIALS,,,,VIAL GLASS TYPE I,units,8.0,176 68 37797 99,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,ASPAVELI is indicated as monotherapy in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/178c3005-ee33-4354-81a2-dd0eaba487a0.json
1793abdc-8681-4e0e-8207-06432ace866b,REMOTIV 250,prescription,,,7153,,,,,ILS,film coated tablets,HYPERICI HERBA EXTRACTUM SICCUM,2025-07-31T07:24:43.039954,IL,רפא,,nan,nan,nan,,7290008012522,REMOTIV 500MG 30TAB,18435,,29036,BLISTER PVC/PE/PVDC/AL,units,30.0,130 71 30720 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions. Treatment is recommended for up to 24 weeks.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1793abdc-8681-4e0e-8207-06432ace866b.json
179cd801-3e7f-47d0-a561-dfafc74f5704,TRIXEO AEROSPHERE,prescription,R03BA02,BUDESONIDE,9009,,,WHO ATC Classification,,ILS,suspension for inhalation,"FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRRONIUM 7.2  MCG, BUDESONIDE",2025-07-31T09:45:13.109448,IL,אסטראזנקה,,280.8783943,238.0325481,202.580892,,,TRIXEO AEROSPHERE 5/7.2/160 MCG 120 DOSES,17614,,76804,METERED DOSE INHALER ALUMINIUM,units,120.0,169 60 36905 99,valid,17.5,inhalation,1.4,36,,,,,,,,,,0,Prescription required,Trixeo Aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/179cd801-3e7f-47d0-a561-dfafc74f5704.json
17ae5b67-d6d4-4b27-9e78-2aea0135b9ca,GUTRON 5MG 50TAB,29C,,,20783,,,,,,tablet,GUTRON 5MG,2025-07-31T20:33:32.313637,IL,nan,,,,,,,GUTRON 5MG 50TAB,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17ae5b67-d6d4-4b27-9e78-2aea0135b9ca.json
17c3a038-60a1-44cc-83d1-178b73a7bb73,PARAMOL,off-the-counter,N02BE01,PARACETAMOL,5555,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T12:44:58.892247,IL,ליף-דקסון,,28.2374,23.93,nan,,,PARAMOL 500MG 50 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,50.0,127 96 30764 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17c3a038-60a1-44cc-83d1-178b73a7bb73.json
17cf2d42-e54c-4c7e-80ea-229e125e04c7,OCTAGAM,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7145,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T06:01:06.985853,IL,דובר מדיקל,,3163.527229,2680.955398,2437.23218,,,OCTAGAM 5% 200ML VIAL,,,,BOTTLE GLASS TYPE II,units,200.0,143 22 31778 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Replacement therapy in:   • Primary immunodeficiency syndromes such as:      - congenital agammaglobulinaemia and hypogammaglobulinaemia       - common variable immunodeficiency       - severe combined immunodeficiency       - Wiskott Aldrich syndrome.  • Children with congenital AIDS and recurrent bacterial infections.      Immunomodulatory effect:   • Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.   • Guillain barre syndrome.   • Kawasaki disease.      Allogeneic bone marrow transplantation.• Myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17cf2d42-e54c-4c7e-80ea-229e125e04c7.json
17d14145-9358-4254-878f-d51e9866ce7a,ZINFORO,prescription,J01DI02,CEFTAROLINE FOSAMIL,7994,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,CEFTAROLINE FOSAMIL,2025-07-31T10:49:08.686037,IL,פיזר,,2971.251551,2518.009901,2289.09991,,7290013075420,ZINFORO 600MG 10 VIAL,26207,,60954,VIAL 20 ML GLASS TYPE I,units,10.0,150 76 33887 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults : • Complicated skin and soft tissue infections (cSSTI) • Community-acquired pneumonia (CAP) Consideration should be given to official guidance on the appropriate use of antibacterial agents.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17d14145-9358-4254-878f-d51e9866ce7a.json
17d2b653-1865-4f19-8710-661c087a4be7,STELARA 130 MG,prescription,L04AC05,USTEKINUMAB,6418,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,USTEKINUMAB/,2025-07-31T08:42:25.104198,IL,יאנסן סילג,,8039.599337,6813.22008,6193.836436,,7290014577404,STELARA 45MG VIAL 1X0.5ML SOL. FOR INJ.,19922,,21016,VIAL GLASS TYPE I,units,1.0,158 52 35072 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Crohn’s Disease :STELARA is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNFα antagonist or have medical contraindications to such therapies.Ulcerative colitis :STELARA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17d2b653-1865-4f19-8710-661c087a4be7.json
17d781df-c17c-4249-a0b5-619496f461b7,ENTEAVENIR 0.5 MG,prescription,J05AF10,ENTECAVIR,8936,,,WHO ATC Classification,,ILS,film coated tablets,ENTECAVIR AS MONOHYDRATE 0.5  MG,2025-07-31T02:23:21.199959,IL,ביואבניר,,2281.326898,1933.32788,1757.5708,,,ENTEAVENIR 1 MG 10 TAB,,,70664,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,166 96 36713 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Enteavenir is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with: -  Compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. -  Decompensated liver disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/17d781df-c17c-4249-a0b5-619496f461b7.json
180936f9-9177-4b5b-86b4-470aaf6234d6,EUTHYROX 100 MCG,prescription,H03AA01,LEVOTHYROXINE SODIUM,9422,,,WHO ATC Classification,,ILS,tablets,LEVOTHYROXINE SODIUM,2025-07-31T02:43:47.540821,IL,מרק סרונו,,21.01579907,17.81,13.0,,,EUTHYROX 25 MCG 100 TAB,5749,,10934,BLISTER PVC,units,100.0,147 51 33605 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Euthyrox 25 - 200 microgram :- Treatment of benign euthyroid goitre.- Prophylaxis of relapse after surgery for euthyroid goitre, depending on the post - operative hormone status.- Substitution therapy in hypothyroidism.- Suppression therapy in thyroid cancer.Euthyrox 25 - 100 microgram :- Concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism.Euthyrox 100/150/200 microgram :- Diagnostic use for thyroid suppression testing.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/180936f9-9177-4b5b-86b4-470aaf6234d6.json
182356cf-254c-47ef-b53c-17a48de357dd,SEPTADINE,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",3956,,,WHO ATC Classification,,ILS,solution - external,"CHLORHEXIDINE DICLUCONATE 0.5  %W/V, ALCOHOLV/V",2025-07-31T13:16:31.349615,IL,פלוריש,,31.801,26.95,nan,,7290008103565,SEPTADINE SOL  500ML,19438,,,BOTTLE HDPE,units,500.0,108 58 29253 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"For quick disinfection of hands, also before invasive procedures.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/182356cf-254c-47ef-b53c-17a48de357dd.json
18248790-4ef8-4110-90e8-39603e16d5d0,NORVASC 10 MG TABLETS,prescription,C08CA01,AMLODIPINE,8039,,,WHO ATC Classification,,ILS,tablets,AMLODIPINE AS BESYLATE,2025-07-31T05:52:41.684393,IL,דקסל פארמה,,14.5300008,12.31356,8.988,,,NORVASC 5MG 30TAB,14614,,27186,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,129 49 30947 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Mild to moderate hypertension.  Vasospastic angina ( Prinzmetal's or variant angina). Chronic stable angina., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18248790-4ef8-4110-90e8-39603e16d5d0.json
183ae057-968d-47e4-8033-c379f3801294,ZAPPA 10,prescription,N05AH03,OLANZAPINE,6862,,,WHO ATC Classification,,ILS,film coated tablets,OLANZAPINE,2025-07-31T10:43:02.826985,IL,אוניפארם,,153.643375,130.20625,104.165,,,ZAPPA 10 30TAB,86149,,13487,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,146 72 33251 01,valid,25.0,per os,1.4,30,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of Schizophrenia. Zappa is indicated for the management of the manifestations of psychotic disorders. Zappa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar  Disorder: In patients whose manic episode has responded to Olanzapine treatment Zappa is indicated for the prevention of reccurence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zappa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/183ae057-968d-47e4-8033-c379f3801294.json
1843dec5-9ca2-49b0-aeec-42c583fa31ff,NITRODERM TTS 5,prescription,C01DA02,GLYCERYL TRINITRATE,569,,,WHO ATC Classification,,ILS,patches,GLYCERYL TRINITRATE/PATCH,2025-07-31T05:48:06.803326,IL,סנדוז,,17.55610122,14.87805254,10.85989237,,7298087000560,NITRODERM TTS 5 MG/24H 10PATCHES,14052,,1482,POUCH PAPER/POLYETHYLENE/ALUMINIUM/SURLYN,units,10.0,118 55 22967 15,valid,37.0,transdermal,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of angina pectoris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1843dec5-9ca2-49b0-aeec-42c583fa31ff.json
18484d61-2109-4ec0-967e-abb3ac7f0d2d,FAMPRIDINE TEVA 10 MG,prescription,N07XX07,FAMPRIDINE,9585,,,WHO ATC Classification,,ILS,tablets prolonged release,FAMPRIDINE,2025-07-31T02:53:04.353980,IL,טבע,,757.6815224,642.1030136,546.4706499,,,FAMPRIDINE TEVA 10 MG 56 P.R. Tab,,,30407,BLISTER ALU/PVC/PVDC,units,56.0,174 44 37498 99,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Fampridine Teva is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (EDSS 4-7),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18484d61-2109-4ec0-967e-abb3ac7f0d2d.json
186543f2-26bd-4b44-b47b-132dbfbea79b,XARELTO 1 MG/ML GRANULES FOR ORAL SUSPENSION,prescription,B01AF01,RIVAROXABAN,9376,,,WHO ATC Classification,,ILS,granules for oral suspension,RIVAROXABAN 19.7 MG/G,2025-07-31T10:29:57.023402,IL,באייר,,228.3156639,193.4878594,154.7902875,,,XARELTO 1 MG/ML GRA FOR ORAL SUSP 250 ML,,,,BOTTLE GLASS TYPE I,units,250.0,174 12 37097 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of venous thromboembolism (VTE) and prevention of VTE recurrence in term   neonates, infants and toddlers, children, and adolescents aged less than 18 years after at least 5 days of initial parenteral anticoagulation treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/186543f2-26bd-4b44-b47b-132dbfbea79b.json
18686a91-b670-4501-9388-c23cd7a3eefe,FYCOMPA 10 MG FILM COATED TABLETS,prescription,N03AX22,PERAMPANEL,7267,,,WHO ATC Classification,,ILS,film coated tablets,PERAMPANEL AS ANHYDROUS,2025-07-31T03:24:12.017234,IL,אסיי,,518.8527692,439.7057561,374.2176648,,,FYCOMPA 12MG 28 F.C TAB,6528,,51055,BLISTER PVC/ALUMINIUM,units,28.0,150 50 33794 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.Fycompa is indicated for the adjunctive treatment of primary generalised tonic clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalized epilepsy (IGE).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18686a91-b670-4501-9388-c23cd7a3eefe.json
187cd047-e17e-47d8-8233-930fe22b4012,BRONCHOLATE SYRUP,prescription,R01BA52,"PSEUDOEPHEDRINE, COMBINATIONS",3860,,,WHO ATC Classification,,ILS,syrup,"DIPHENHYDRAMINE HYDROCHLORIDE 0.2 %W/V, PSEUDOEPHEDRINE HYDROCHLORIDE 0.4 %W/V",2025-07-31T00:44:43.035302,IL,סם און,,33.38279,28.2905,20.65,,7290008066457,BRONCHOLATE FRTE NEW FORM. SYR 120ML,2278,,3668,BOTTLE HDPE,units,120.0,121 24 30198 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic relief of nasal congestion. Symptomatic relief of eustachian tube congestion in ear inflammation.Symptomatic relief of cough.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/187cd047-e17e-47d8-8233-930fe22b4012.json
18841e17-c554-47d5-9d3f-7f1cefb14076,AKNEMYCIN,29C,D10AF02,ERYTHROMYCIN,20397,,,WHO ATC Classification,,ILS,solution - external,ERYTHROMYCIN,2025-07-31T14:31:04.798943,IL,nan,,nan,nan,nan,,7290008116947,ERYTHROMYCIN ETHYLSUCCINATE  400MG/5ML SUSP,,,,BOTTLE GLASS,units,60.0,064 70 22653 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"All forms of acne, particularly inflammatory forms with papules and pustules.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18841e17-c554-47d5-9d3f-7f1cefb14076.json
188d1ab8-f6b7-458f-9c7a-25b246ef97ae,OCALIVA 10 MG,prescription,A05AA04,OBETICHOLIC ACID ,8462,,,WHO ATC Classification,,ILS,film coated tablets,OBETICHOLIC ACID,2025-07-31T05:59:51.210892,IL,ניאופרם,,13127.71527,11125.18292,10113.80266,,,OCALIVA 10MG 30 FC tablets,15504,,54990,BOTTLE POLYETHYLENE,units,30.0,160 33 35218 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,OCALIVA is indicated for the treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/188d1ab8-f6b7-458f-9c7a-25b246ef97ae.json
1899addd-7ba9-4479-b10c-e137401058af,MAVIRET,prescription,J05AP57,GLECAPREVIR AND PIBRENTASVIR,8348,,,WHO ATC Classification,,ILS,film coated tablets,"PIBRENTASVIR, GLECAPREVIR",2025-07-31T05:06:27.058110,IL,אב-וי,,58419.58796,49508.12759,45007.38872,,8054083015323,MAVIRET 84 TAB,,,54768,BLISTER PVC/PE/PCTFE/AL,units,84.0,160 05 35323 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Maviret is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults and in adolescents aged 12 to <18 years,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1899addd-7ba9-4479-b10c-e137401058af.json
18a2b16b-c7ff-421c-b1d3-563cb56f48d7,CONTROLOC 20 MG,prescription,A02BC02,PANTOPRAZOLE,7660,,,WHO ATC Classification,,ILS,tablets,PANTOPRAZOLE,2025-07-31T01:29:29.842579,IL,טקדה,,44.54347308,37.748706,27.5538,,7298074020434,CONTROLOC 40MG 28TAB,9801,,67411,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,116 36 29745 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of reflux oesophagitis and associated symptoms (e.g. heartburn, acid regurgitation, pain on swallowing).For long-term management and prevention of relapse in reflux oesophagitis.Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAIDs treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18a2b16b-c7ff-421c-b1d3-563cb56f48d7.json
18a5deb1-639e-443b-aafc-22a114faf5d2,AKYNZEO 300mg/0.50mg,prescription,A04AA55,"PALONOSETRON, COMBINATIONS",7798,,,WHO ATC Classification,,ILS,capsules,"NETUPITANT, PALONOSETRON AS HYDROCHLORIDE 0.50  MG",2025-07-30T23:18:10.387481,IL,רפא,,305.3470554,258.7687025,220.228683,,7290017179254,AKYNZEO 1 CAPS,9917,,38593,BLISTER ALUMINIUM /ALUMINIUM,units,1.0,155 79 34343 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Prevention of Acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18a5deb1-639e-443b-aafc-22a114faf5d2.json
18e25e2d-7192-4288-bf93-b9dda909d486,VFEND 200 MG POWDER FOR SOLUTION FOR INFUSION,prescription,J02AC03,VORICONAZOLE,8127,,,WHO ATC Classification,,ILS,powder for solution for infusion,VORICONAZOLE/VIAL,2025-07-31T10:10:03.680265,IL,פיזר,,501.920085,425.3560043,362.00511,,7680559450025,VFEND 200 MG 1 VIAL,22271,,12870,VIAL GLASS TYPE I,units,1.0,126 71 30598 12,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of :- invasive aspergillosis  fluconazole-resistant serious invasive Candida infections (including C. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive  possibly life-threatening infections.   - Treatment of candidemia in non neutropenic patients.- Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18e25e2d-7192-4288-bf93-b9dda909d486.json
18e9a43a-c448-40fa-8e70-acfa79fccd8a,VOSEVI,prescription,J05AP56,"SOFOSBUVIR, VELPATASVIR AND VOXILAPREVIR",8203,,,WHO ATC Classification,,ILS,film coated tablets,"VOXILAPREVIR, VELPATASVIR, SOFOSBUVIR",2025-07-31T10:21:32.406092,IL,גיליאד,,58359.52255,49457.2247,44961.11336,,5391507143044,VOSEVI 28 TABS,,,55593,BOTTLE HDPE,units,28.0,160 26 35324 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Vosevi is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18e9a43a-c448-40fa-8e70-acfa79fccd8a.json
18f41b24-b07a-484c-bd86-a000a9b361cd,CLOPIXOL 10 MG TABLETS,prescription,N05AF05,ZUCLOPENTHIXOL,630,,,WHO ATC Classification,,ILS,film coated tablets,ZUCLOPENTHIXOL AS DIHYDROCHLORIDE,2025-07-31T01:22:43.559053,IL,לנדבק,,49.64060933,42.06831486,30.70679917,,,CLOPIXOL 25MG 50TAB,3630,,8219,CONTAINER HDPE,units,50.0,047 86 25486 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute schizophrenia .Other acute psychoses.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18f41b24-b07a-484c-bd86-a000a9b361cd.json
18f59272-011f-4974-8002-a54ea82403d1,MENOPRET ®,off-the-counter,G02CX04,CIMICIFUGAE RHIZOMA,5600,,,WHO ATC Classification,,ILS,film coated tablets,"DRY EXTRACT FROM CIMICIFUGA RACEMOSA (L.) NUTT, RHIZOMA (BLACK COHOSH) (5-10:1) EXTRACTION SOLVENT: ETHANOL(V/V) 2.8  MG",2025-07-31T12:24:52.755084,IL,דר סמואלוב,,63.8734,54.13,nan,,7290014626591,MENOPRET 60 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,165 11 34785 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,Herbal medicinal product indicated in female adults for the relief of menopausal complaints such as hot flushes and profuse sweating,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18f59272-011f-4974-8002-a54ea82403d1.json
18f71e52-ac40-465e-b02a-842cf3571480,HYDROGEN PEROXIDE 3% LIFE,off-the-counter,D08AX01,HYDROGEN PEROXIDE,5452,,,WHO ATC Classification,,ILS,solution,HYDROGEN PEROXIDEW/W,2025-07-31T12:06:48.264311,IL,ויטאמד,,10.3014,8.73,nan,,,HYDROGEN PEROXIDE 3 % 100ML,,,,BOTTLE POLYETHYLENE,units,100.0,162 73 35786 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,Antiseptic, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/18f71e52-ac40-465e-b02a-842cf3571480.json
19151c54-fe4e-488c-b60e-e32d3cbaa7ca,QUETIAPINE TEVA ® 100 MG,prescription,N05AH04,QUETIAPINE,7343,,,WHO ATC Classification,,ILS,film coated tablets,QUETIAPINE AS FUMARATE,2025-07-31T07:11:33.575084,IL,טבע,,94.47514299,80.0636805,59.5269,,7290102065721,QUETIAPINE TEVA 200MG 30TAB,17030,,49802,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,150 04 33719 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Ttreatment  of schizophrenia. Treatment of manic episodes associated with bipolar disorder.Treatment of major depressive episodes in bipolar disorders.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/19151c54-fe4e-488c-b60e-e32d3cbaa7ca.json
192f5e01-041f-426d-8f80-86db35b853f2,MEPACT,prescription,L03AX15,MIFAMURTIDE,6920,,,WHO ATC Classification,,ILS,powder for concentrate for dispersion for infusion,MIFAMURTIDE/VIAL,2025-07-31T05:12:28.999179,IL,טקדה,,16182.70935,13714.16107,12467.41916,,72980008128261,MEPACT 4MG/ML VIAL 50ML,13701,,20527,VIAL GLASS TYPE I,units,1.0,147 07 33425 01,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Mepact is indicated in children, adolescents and young adults for the treatment of high grade resectable non metastatic osteosarcoma after macroscopically complete surgical resection. It is used in combination with post operative multi-agent chemotherapy. Safety and efficacy have been assessed in studies of patients 2 to 30 years of age at initial diagnosis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/192f5e01-041f-426d-8f80-86db35b853f2.json
19513631-bf56-4c5d-a714-bd8b049c6541,GLIMEPIRIDE TEVA ®  2 MG,prescription,A10BB12,GLIMEPIRIDE,7467,,,WHO ATC Classification,,ILS,tablets,GLIMEPIRIDE,2025-07-31T03:35:25.408040,IL,טבע,,15.8879448,13.46436,9.828,,7290106061255,GLIMEPIRIDE TEVA 2 MG 30 TAB,7913,,53405,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,151 16 33859 00,valid,37.0,per os,1.4,18,,,,,,,,,,0,Prescription required,"Non-insulin-dependent diabetes mellitus (adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/19513631-bf56-4c5d-a714-bd8b049c6541.json
195f6d33-47b0-46ad-87bb-3c2116b4fe4f,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7700,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:37:57.863140,IL,סנדוז,,932.7882566,790.4985225,672.7647,,,BINOCRIT 4000 IU/0.4ML 6 SYRINGE PREFILLED,2559,,56126,SYRINGE PREFILLED  GLASS TYPE I,units,6.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/195f6d33-47b0-46ad-87bb-3c2116b4fe4f.json
197a9e1e-99c2-4a89-a009-bc8f89988d7b,HUMULIN N,prescription,A10AC01,INSULIN (HUMAN),735,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN (HUMAN)/ML,2025-07-31T03:51:45.653626,IL,אלי לילי,,102.6729222,87.01095486,64.69215975,,7290008139816,HUMULIN REGULAR 100 IU/ML 10ML sol for inj,9001,,7039,VIAL GLASS TYPE I,units,10.0,054 12 22715 22,valid,34.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/197a9e1e-99c2-4a89-a009-bc8f89988d7b.json
198cef15-58ad-43f4-89d1-653f4eb09ed7,REKOVELLE,prescription,G03GA10,FOLLITROPIN DELTA,8124,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN DELTA 33.3 MCG/ML,2025-07-31T07:21:07.159543,IL,פרינג,,1864.435071,1580.029791,1344.706205,,7640128548768,REKOVELLE  72 MCG / 2.16 ML 1 PREFILLED PEN,,,65877,PEN GLASS,units,1.0,159 60 35096 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/198cef15-58ad-43f4-89d1-653f4eb09ed7.json
198d96eb-4a39-4f92-b13e-701ff33f1dec,NITROLINGUAL SPRAY,prescription,C05AE01,GLYCERYL TRINITRATE,3413,,,WHO ATC Classification,,ILS,solution,GLYCERYL TRINITRATE 0.4 MG/DOSE,2025-07-31T05:48:18.085344,IL,מגאפארם,,35.76105723,30.30598205,22.12115478,,7290004448424,NITROLINGUAL SPRAY 250DOSES,14151,,85218,BOTTLE GLASS TYPE III,units,250.0,103 04 27820 00,valid,37.0,sublingual,1.4,36,,,,,,,,,,0,Prescription required,"Relief of angina pectoris attacks, angina pectoris prophylaxis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/198d96eb-4a39-4f92-b13e-701ff33f1dec.json
1997f09f-46fb-4733-b809-ee304630bd6a,FAVOXIL 100,prescription,N06AB08,FLUVOXAMINE,2856,,,WHO ATC Classification,,ILS,tablets,FLUVOXAMINE MALEATE,2025-07-31T02:55:09.724955,IL,פאדאגיס,,60.1577275,50.981125,37.2125,,7290002925866,FAVOXIL 50MG 60TAB,6049,,9007,BLISTER PVC/PVDC,units,60.0,041 91 25728 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. Treatment of obsessive compulsive disorders (OCD).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1997f09f-46fb-4733-b809-ee304630bd6a.json
19b9afb3-d0a7-4a24-a7e3-62900c2dfb88,FENTANYL PANPHARMA 0.05 MG/ML,prescription,N01AH01,FENTANYL,7971,,,WHO ATC Classification,,ILS,solution for injection,FENTANYL AS CITRATE 0.05 MG/ML,2025-07-31T03:01:25.852577,IL,פארמלוג'יק,,47.6897,40.415,29.5,,7290006676085,FENTANYL PANPHARMA 0.05 MG/ML(500mcg/10ML) 10VIAL,6562,,27072,AMPOULES GLASS TYPE I,units,10.0,152 49 33974 00,valid,37.0,"epidural, i.v",1.4,36,,,,,,,,,,0,Prescription required,"For analgesic action of short duration during anesthtic periods (premedication, induction and maintenance) and in the immediate postoperative period  as need arises. As a narcotic analgesic supplement in general or regional anesthesia. For administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia  and as an adjunct in the maintenance of general or regional anesthesia. For use as an anesthetic agent with oxygen in selected  high-risk patients (open heart surgery or certain neurological or orthopedic procedures). By the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections  and as adjunct to general anesthesia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/19b9afb3-d0a7-4a24-a7e3-62900c2dfb88.json
19ebaccb-6358-4fb5-8c28-e0263a65da4e,DICLOREN GEL,off-the-counter,M02AA15,DICLOFENAC,3312,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T11:32:49.865626,IL,תרימה,,37.3706,31.67,nan,,7290008075329,DICLOREN GEL 50GR,4197,,,TUBE ALUMINIUM,units,50.0,062 35 27823 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to: • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :• Pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/19ebaccb-6358-4fb5-8c28-e0263a65da4e.json
19f405c7-0f3f-4709-b112-864715d5fbf9,SYMDEKO 100 MG/150 MG & 150 MG,prescription,R07AX31,IVACAFTOR AND TEZACAFTOR,8746,,,WHO ATC Classification,,ILS,film coated tablets,"IVACAFTOR, TEZACAFTOR, IVACAFTOR",2025-07-31T08:55:03.397195,IL,מדיסון,,nan,nan,nan,,,SYMDEKO 50MG/75MG 56 TAB,10491,,45985,BLISTER ACLAR/PVC/ALUMINIUM,units,56.0,162 71 35683 00,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,"SYMDEKO is a combination of tezacaftor and ivacaftor, indicated for the treatment of patients with cystic fibrosis (CF) aged 12 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence.If the patient’s genotype is unknown, a health authority cleared CF mutation test should be used to detect the presence of a CFTR mutation followed by verification with bi-directional sequencing when recommended by the mutation test instructions for use.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/19f405c7-0f3f-4709-b112-864715d5fbf9.json
19f4f5a9-d697-4e7c-a97a-addad4ed7bd9,ZOLADEX,prescription,L02AE03,GOSERELIN,4312,,,WHO ATC Classification,,ILS,implant,GOSERELIN AS ACETATE 3.6  MG/UNIT,2025-07-31T10:53:02.286898,IL,אסטראזנקה,,401.3105865,340.0937325,289.4414745,,5000455018204,ZOLADEX 3.6MG 1PREFILLED SYR,26131,,12222,SYRINGE PREFILLED  POLYETHYLENE,units,1.0,140 16 25142 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of prostate cancer suitable for hormonal manipulation.   Breast cancer in pre-menopausal women suitable for hormone manipulation.Endometriosis.   Assisted reproduction: pituitary down regulation in preparion for superovulation.   Endometrial thinning: Zoladex is indicated for the prethinning of the utetine endometrium prior ro endometrial ablation or resection.  Uterine Fibroids: For reduction of fibroid size prior to surgery.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/19f4f5a9-d697-4e7c-a97a-addad4ed7bd9.json
1a0df97e-0dea-494e-a574-d138fae90212,QINLOCK 50 MG,prescription,L01EX19,RIPRETINIB,9032,,,WHO ATC Classification,,ILS,tablets,RIPRETINIB,2025-07-31T07:08:50.244257,IL,מדיסון,,109613.998,92893.22277,84448.38434,,,QINLOCK 50MG 90 TAB,23570,,3039,BOTTLE HDPE,units,90.0,171 40 36884 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"QINLOCK is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a0df97e-0dea-494e-a574-d138fae90212.json
1a20e080-4138-47d9-9350-93b8d1e84dee,NORLEVO,off-the-counter,G03AC03,LEVONORGESTREL,5265,,,WHO ATC Classification,,ILS,tablets,LEVONORGESTREL 1.5  MG,2025-07-31T12:34:07.354337,IL,כ.צ.ט,,99.592,84.4,nan,,7290004103439,NORLEVO 1.5MG 1TAB,14508,,,BLISTER PVC/PE/PVDC/AL,units,1.0,143 50 31725 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Emergency contraceptive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a20e080-4138-47d9-9350-93b8d1e84dee.json
1a233b49-fbd5-42cf-b3c4-21ab63677c69,NOVOMIX 30 FLEXPEN,prescription,A10AD05,INSULIN ASPART,6159,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN ASPART 100 U/ML,2025-07-31T05:54:43.707579,IL,נובו נורדיסק,,182.0408004,154.2718716,123.4174973,,7290008126571,NOVOMIX 50 FLEXPEN 5X3ML,14463,,87579,PRE-FILLED PEN ,units,15.0,127 24 30599 00,valid,25.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"NovoMix® 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a233b49-fbd5-42cf-b3c4-21ab63677c69.json
1a2bdb01-77bc-453e-b5ca-adde6b84593c,BUTRANS 10,prescription,,,6618,,,,,ILS,patches matrix,BUPRENORPHINE,2025-07-31T00:47:11.197928,IL,רפא,,113.7773101,96.42145349,71.688813,,7290008012546,BUTRANS  20MG 2 PATCHES,2477,,14910,POUCH ALUMINIUM,units,2.0,135 71 31152 00,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a2bdb01-77bc-453e-b5ca-adde6b84593c.json
1a3e9bf7-4c95-44fe-9854-f47d221ddd58,LAMOGINE 100 MG,prescription,N03AX09,LAMOTRIGINE,4424,,,WHO ATC Classification,,ILS,tablets,LAMOTRIGINE,2025-07-31T04:34:28.271602,IL,תרימה,,144.1878763,122.1931155,90.8499,,,LAMOGINE 200MG 30TAB,12166,,53254,BLISTER PVC/ALUMINIUM,units,30.0,123 89 30354 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"EpilepsyAdults and adolescents aged 13 years and above- 	Adjunctive or monotherapy treatment of partial seizures and generalised seizures,                including tonic-clonic seizures.- 	Seizures associated with Lennox-Gastaut syndrome. Lamogine is given as adjunctive               therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-              Gastaut syndrome.Children and adolescents aged 2 to 12 years- 	Adjunctive treatment of partial seizures and generalised seizures, including tonic-             clonic seizures and the seizures associated with Lennox-Gastaut syndrome.-	 Monotherapy of typical absence seizures.Bipolar disorderAdults aged 18 years and above-	 Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamogine is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a3e9bf7-4c95-44fe-9854-f47d221ddd58.json
1a5aac4e-d6d8-470f-8f86-b882d76633e1,EXJADE 125 MG,prescription,V03AC03,DEFERASIROX,4925,,,WHO ATC Classification,,ILS,tablets dispersible,DEFERASIROX,2025-07-31T02:49:38.751203,IL,נוברטיס פארמה,,962.1982231,815.422223,693.97636,,7290006257826,EXJADE 125MG 28 DISPERS TAB,5423,,67378,BLISTER PVC/PE/PVDC,units,28.0,133 99 31337 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).Exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC] &#8805;5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).LIC is the preferred method of iron overload determination and should be used wherever available,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a5aac4e-d6d8-470f-8f86-b882d76633e1.json
1a79a722-d011-4c48-8a02-c044bbbd6a7f,DERMACOMBIN OINTMENT,prescription,D07CB01,TRIAMCINOLONE AND ANTIBIOTICS,2062,,,WHO ATC Classification,,ILS,ointment,"TRIAMCINOLONE ACETONIDE/G, NEOMYCIN AS SULFATE 2.5 MG/G, GRAMICIDIN 0.25 MG/G, NYSTATIN/G",2025-07-31T01:49:03.299697,IL,תרו,,nan,nan,nan,,7-290000-809120,DERMACOMBIN OINT 5G,4073,,635,TUBE ALUMINIUM,units,5.0,015 28 24536 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,"For the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a79a722-d011-4c48-8a02-c044bbbd6a7f.json
1a7aa8a1-8d02-42fe-8a7a-131a2166b0a9,LONSURF 15 MG/6.14 MG,prescription,L01BC59,"TRIFLURIDINE, COMBINATIONS",8802,,,WHO ATC Classification,,ILS,film coated tablets,"TIPIRACIL AS HYDROCHLORIDE 6.14  MG, TRIFLURIDINE",2025-07-31T04:53:39.414852,IL,מדיסון,,2631.421013,2230.017907,2027.289006,,,LONSURF 15 MG/6.14 MG 20 TAB,12530,,26483,BLISTER ALUMINIUM /ALUMINIUM,units,20.0,163 89 35314 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Colorectal cancerLonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (CRC) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR agents.LONSURF in combination with bevacizumab, is indicated for the treatment of adult patients with metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapyGastric cancerLonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a7aa8a1-8d02-42fe-8a7a-131a2166b0a9.json
1a7fe68b-e2e5-4428-ab8c-fa69cdbefefc,EZETIMIBE SANDOZ,prescription,C10AX09,EZETIMIBE,8604,,,WHO ATC Classification,,ILS,tablets,EZETIMIBE,2025-07-31T02:51:32.669551,IL,סנדוז,,219.15373,185.7235,148.5788,,7290017585338,EZETIMIBE SANDOZ 10 MG 30 TAB,5666,,14811,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,162 46 35587 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Primary hypercholesterolemia: Ezetimibe Sandoz administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Homozygous familial hypercholesterolemia (HoFH): Ezetimibe Sandoz administered with a statin are indicated for use in patients with HoFH.Patients may also receive adjunctive treatments (e.g. LDL apheresis).Homozygous sitosterolemia (Phytosterolemia): Ezetimibe Sandoz are indicated for use in patients with homozygous familial sitosterolemia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a7fe68b-e2e5-4428-ab8c-fa69cdbefefc.json
1a874b6b-c99b-4a6b-867d-646b01b18ba6,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4552,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:23:57.669958,IL,מדיסון,,1807.928448,1532.142821,1303.951337,,8715131005863,ARANESP 60MCG 4 PREFILLED SYR 0.3ML,9486,,29746,PRE-FILLED PEN GLASS TYPE I,units,4.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a874b6b-c99b-4a6b-867d-646b01b18ba6.json
1a877284-f272-46f8-b774-8b3a911c8e26,SOMATULINE AUTOGEL 120 MG,prescription,H01CB03,LANREOTIDE,6249,,,WHO ATC Classification,,ILS,solution for injection,LANREOTIDE AS ACETATE/DOSE,2025-07-31T08:29:34.808006,IL,מדיסון,,2547.441621,2158.848928,1962.589934,,7290008128667,SOMATULINE AUTOGEL 60MG 1 PREFIL SYR,19919,,57010,SYRINGE PREFILLED  POLYPROPYLENE,units,1.0,127 27 30485 00,valid,10.0,deep s.c.,1.4,36,,,,,,,,,,0,Prescription required,"Somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of Growth Hormone (GH) and/or insulin like growth factor-1 (IGF-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .The goal of treatment in acromegaly is to reduce GH and IGF-1 levels and where possible to normalize these values. Somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.Somatuline autogel is also indicated for the treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumors (GEP-NETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a877284-f272-46f8-b774-8b3a911c8e26.json
1a8e0321-629c-42ed-87da-a048b2e1d918,TRITTICO 100 MG,prescription,N06AX05,TRAZODONE,9317,,,WHO ATC Classification,,ILS,tablets,TRAZODONE HYDROCHLORIDE,2025-07-31T09:44:43.792039,IL,רז פרמהצפטי,,54.21384481,45.94393832,33.5357214,,7290015863629,TRITTICO 50 MG 30 TABS,,,77123,BLISTER PVC/ALUMINIUM,units,30.0,173 31 36296 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of depression with or without anxiety.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1a8e0321-629c-42ed-87da-a048b2e1d918.json
1ab7df0e-9ade-4536-8f0f-f5a5e3e3d17b,METADEX XR 10 MG,prescription,N06BA11,DEXMETHYLPHENIDATE,9224,,,WHO ATC Classification,,ILS,capsules extended release,DEXMETHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:15:28.888927,IL,SK PHARM(KS KIM),,nan,nan,nan,,,METADEX XR 10 MG S.K. 100 CAPSULES,,,70901,BOTTLE HDPE,units,100.0,172 56 37337 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Metadex XR extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ab7df0e-9ade-4536-8f0f-f5a5e3e3d17b.json
1abfdf9c-e2f3-4b73-be17-ad44d59ff269,XPOVIO 20 MG,prescription,L01XX66,SELINEXOR,8873,,,WHO ATC Classification,,ILS,tablets,SELINEXOR,2025-07-31T10:36:54.547634,IL,ניאופרם,,43519.28024,36880.7476,33527.95237,,7290111092886,XPOVIO 20 MG 20 TAB,24103,,57378,BLISTER PVC/PCTFE/PVC/ALU,units,20.0,167 04 36451 99,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Multiple Myeloma•	Xpovio® in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.•	XPOVIO in combination with dexamethasone is indicated for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least three prior therapies and whose disease is refractory to at least one proteasome inhibitor (PI), at least one immunomodulatory agent (IMiD), and an anti- CD38 monoclonal antibody (mAb).Diffuse Large B-Cell LymphomaXPOVIO is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1abfdf9c-e2f3-4b73-be17-ad44d59ff269.json
1ae66f25-624a-4b5a-a599-daf9c7a20702,RELERT 20 MG,prescription,N02CC06,ELETRIPTAN,8901,,,WHO ATC Classification,,ILS,film coated tablets,ELETRIPTAN HYDROBROMIDE 24.242   MG,2025-07-31T07:22:14.532147,IL,פיזר,,nan,nan,nan,,,RELERT 80 MG 4 TAB,,,72761,BLISTER ALUMINIUM,units,4.0,124 28 30370 01,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Acute treatment of the headache phase of migraine attacks, with or without aura.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ae66f25-624a-4b5a-a599-daf9c7a20702.json
1aeec496-d7c8-403e-8ed1-1d3961e22e7c,HISTADEX,prescription,R01BA52,"PSEUDOEPHEDRINE, COMBINATIONS",5633,,,WHO ATC Classification,,ILS,syrup,"DEXCHLORPHENIRAMINE MALEATE/, PSEUDOEPHEDRINE HYDROCHLORIDE/",2025-07-31T03:46:56.433050,IL,ויטאמד,,nan,nan,nan,,,HISTADEX BOTTLE 50ML,,,,BOTTLE HDPE,units,50.0,063 16 28042 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of congestion in the respiratory tract due to allergy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1aeec496-d7c8-403e-8ed1-1d3961e22e7c.json
1af2c342-1b59-4bf0-9f7e-eb1499f9286e,NUROFEN FOR CHILDREN SUPPOSITORIES 125 MG,off-the-counter,M02AA13,IBUPROFEN,5263,,,WHO ATC Classification,,ILS,suppositories,IBUPROFEN,2025-07-31T12:35:58.667263,IL,רקיט בנקיזר,,25.429,21.55,nan,,,NUROFEN FOR CHILDREN 125MG 10SUPP,14502,,,BLISTER PE/ALUMINIUM,units,10.0,142 89 32016 01,valid,nan,rectal,1.4,36,,,,,,,,,,0,,For the symptomatic treatment of muld to moderate pain.   For the symptomatic treatment of fever.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1af2c342-1b59-4bf0-9f7e-eb1499f9286e.json
1af31f77-b797-40bb-a467-a2309400a53b,TADAM 10,prescription,G04BE08,TADALAFIL,8098,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T09:00:22.563320,IL,אוניפארם,,228.0675975,193.277625,154.6221,,,TADAM 20 MG 4 	FILM COATED TABLETS,20826,,62138,BLISTER PVC/ALUMINIUM,units,4.0,157 81 34538 01,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1af31f77-b797-40bb-a467-a2309400a53b.json
1afbb0fa-dc92-4f08-af3f-0627de1e53d7,NEXIUM POWDER FOR SOLUTION FOR INJ/INF 40 MG,prescription,A02BC05,ESOMEPRAZOLE,4485,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,ESOMEPRAZOLE AS SODIUM/DOSE,2025-07-31T05:44:58.481812,IL,תרו יבוא,,43.04863539,36.4818944,26.62912,,7321839711404,NEXIUM 40MG 28TAB,14263,,2924,VIAL GLASS TYPE I,units,28.0,135 56 31128 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Nexium for iniection and infusion is indicated in adult for:• Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate. • Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.Nexium for injection and infusion is indicated in children and adolescents aged 1-18 years for:• Gastric antisecretory treatment when the oral route is not possible, such as:gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1afbb0fa-dc92-4f08-af3f-0627de1e53d7.json
1b440a62-d611-4301-aead-1bee81566266,SALVAKAL,prescription,N07AX01,PILOCARPINE,7528,,,WHO ATC Classification,,ILS,tablets,PILOCARPINE HYDROCHLORIDE,2025-07-31T07:57:37.480139,IL,סם און,,408.1982172,345.9306925,294.4091,,7290013834126,SALVAKAL 5MG 100TAB,9768,,56046,BOTTLE HDPE,units,100.0,151 93 33938 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of symptoms of xerostomia and salivary gland hypofunction caused by radiotherapy for cancer of the head and neck. Sjogren detected by biopsy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1b440a62-d611-4301-aead-1bee81566266.json
1b457689-33fa-424e-9a01-ea31c473b8c0,RONEXINE 100 MG TABLETS,prescription,,,7317,,,,,ILS,tablets,LEVOMEPROMAZINE AS MALEATE,2025-07-31T07:48:23.303782,IL,רקח,,20.94305207,17.74835,12.955,,7290008089845,RONEXINE 25MG 30TAB,18378,,25182,BLISTER PVC/ALUMINIUM,units,30.0,030 40 21109 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Therapeutic indications  Neuroleptic drug - Acute psychotic states. Chronic psychotic states (schizophrenia, chronic non-schizophrenic delirium: paranoid delirium, chronic hallucinatory psychoses). - In association with an antidepressant – short-duration treatment of certain severe forms of major depressive episodes.This association can be done only during the initial period of the treatment, namely, during the period from 4 to 6 weeks.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1b457689-33fa-424e-9a01-ea31c473b8c0.json
1b6a4034-4161-4b00-bd62-711f5668e9b1,RENNIE PEPPERMINT,off-the-counter,,,1314,,,,,ILS,chewable tablets,"CALCIUM CARBONATE, MAGNESIUM CARBONATE",2025-07-31T12:55:53.169723,IL,באייר,,52.4392,44.44,nan,,,RENNIE PEPPERMINT 96TAB,18032,,,BLISTER PVC/ALUMINIUM,units,96.0,134 20 28413 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,Relief of hyperacidity and heartburn.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1b6a4034-4161-4b00-bd62-711f5668e9b1.json
1b8732ff-b7b0-4b20-8873-548a3fc9bf2d,HEPATECT CP,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",6892,,,WHO ATC Classification,,ILS,solution for infusion,HUMAN HEPATITIS B IMMUNOGLOBULIN/ML,2025-07-31T03:45:37.019061,IL,קמהדע,,6563.696155,5562.454616,5056.776923,,,HEPATECT CP 50MG/ML 1VIAL/40ML,8359,,80939,VIAL GLASS TYPE II,units,40.0,127 04 30518 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis against hepatitis B in adults and children over 2 years of age who have not been vaccinated against hepatitis B (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis B by accidental contact with Hepatitis B virus containing material following:   - percutaneous exposure (e.g. accidental needle stick).   - direct mucous membrane contact.   When the administration of an intramuscular hepatitis B immunoglobulin is not possible.   The immunoglobulin should be administered in association with hepatitis B vaccine.   Prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis B virus.   Immunoprophylaxis of hepatitis B in the newborn of a hepatitis B virus carrier mother.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1b8732ff-b7b0-4b20-8873-548a3fc9bf2d.json
1b9fa7fa-95ff-4e74-ac3c-8c496b775773,BACLOFEN SINTETICA 0.5 MG/ML,prescription,M03BX01,BACLOFEN,7909,,,WHO ATC Classification,,ILS,solution for infusion,BACLOFEN 0.5  MG /,2025-07-31T00:27:56.446311,IL,כ.צ.ט,,2945.247591,2495.972535,2269.065941,,,BACLOFEN SINTETICA 2 MG/ ML 10 VIALS 5ML,,,,AMPOULES GLASS TYPE I,units,10.0,170 36 37175 99,valid,10.0,intrathecal,1.4,60,,,,,,,,,,0,Prescription required,"Baclofen Sintetica is indicated in patients with severe chronic spasticity resulting from trauma, multiple sclerosis or other spinal cord disorders, who are unresponsive to oral baclofen or other orally administered antispastic agents and/or those patients who experience unacceptable side effects at effective oral doses.Baclofen Sintetica is effective in adult patients with severe chronic spasticity of cerebral origin, resulting e.g. from cerebral palsy, brain trauma or cerebrovascular accident; however, clinical experience is limited.Paediatric population: Baclofen Sintetica indicated in patients aged 4 to <18 years with severe chronic spasticity of cerebral origin or of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1b9fa7fa-95ff-4e74-ac3c-8c496b775773.json
1ba16c66-64cb-48d9-af5b-8c96f8eb200f,SPECTRACEF 200 MG,prescription,J01DD16,CEFDITOREN,9062,,,WHO ATC Classification,,ILS,film coated tablets,CEFDITOREN AS PIVOXIL,2025-07-31T08:33:12.504059,IL,תרו יבוא,,158.945192,134.6993213,107.759457,,7290017164298,SPECTRACEF 200 MG 20 TABS,,,64145,BLISTER ALU/PVC/PA/ALU,units,20.0,166 36 36015 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"SPECTRACEF is indicated in adults and adolescents (12 years of age or older) for the treatment of the following infections caused by susceptible microorganisms:• Acute pharyngo-tonsillitis• Acute maxillary sinusitis• Acute exacerbations of chronic bronchitis• Community-acquired pneumonia, mild to moderate• Uncomplicated skin and skin structure infections, such as cellulitis, infected wounds, abscesses, folliculitis, impetigo and boils.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ba16c66-64cb-48d9-af5b-8c96f8eb200f.json
1baa8d0b-ef97-4855-8fc8-abe58cc8e42a,AFLUMYCIN,prescription,D07CA03,PREDNISOLONE AND ANTIBIOTICS,2363,,,WHO ATC Classification,,ILS,cream,"PREDNISOLONE 0.5 %, GENTAMICIN SULFATE 0.16 %",2025-07-31T00:11:03.778873,IL,פאדאגיס,,nan,nan,nan,,,AFLUMYCIN CREAM 20GR,1810,,7842,TUBE ALUMINIUM,units,20.0,125 91 24928 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of skin inflammation associated with bacterial infection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1baa8d0b-ef97-4855-8fc8-abe58cc8e42a.json
1bd3f701-dead-4c73-96fa-2829a5339c3d,TOPITRIM 100 MG,prescription,N03AX11,TOPIRAMATE,6029,,,WHO ATC Classification,,ILS,tablets,TOPIRAMATE,2025-07-31T09:26:38.462439,IL,תרימה,,95.65705636,81.065302,60.2716,,,TOPITRIM 50MG 60TAB,20607,,72913,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,136 65 31516 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topitim is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topitrim is indicated in adults for the prevention of migraines. The use of Topitrim in the acute treatment of migraine has not been studied.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1bd3f701-dead-4c73-96fa-2829a5339c3d.json
1bd7f4fe-dc1b-452f-81c7-12f7bb70e13c,EPHEDRINE HCL STEROP 50 MG/1 ML,prescription,R03CA02,EPHEDRINE,8665,,,WHO ATC Classification,,ILS,solution for injection,EPHEDRINE HYDROCHLORIDE/,2025-07-31T02:25:55.162668,IL,רז פרמהצפטי,,854.5828594,724.2227944,616.359825,,,EPHEDRINE HCL STEROP 50 MG/1 ML 100 AMP,5675,,77517,AMPOULES GLASS TYPE I,units,100.0,163 13 35347 00,valid,17.5,"s.c, i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,"Ephedrine Hydrochloride is used in the prevention and treatment of hypotension from spinal or epidural anesthesia and during general anesthesia, with or without a reduction in the heart rate, administered for a surgical or obstetric procedure.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1bd7f4fe-dc1b-452f-81c7-12f7bb70e13c.json
1bee6d11-e5dd-4576-8f92-8d778a1575b5,MOXYPEN ® FORTE 500 MG CAPSULES,prescription,J01CA04,AMOXICILLIN,7339,,,WHO ATC Classification,,ILS,capsules,AMOXICILLIN AS TRIHYDRATE,2025-07-31T05:34:22.934330,IL,טבע,,29.55322626,25.045107,18.2811,,7290000801605,MOXYPEN FTE 500MG 20CAPS,13703,,33901,BLISTER PVC/PVDC/ALUMINIUM/PAPER,units,20.0,130 22 30823 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Infections caused by amoxycillin - susceptible organisms. Prevention of bacteremia in patients at risk of developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1bee6d11-e5dd-4576-8f92-8d778a1575b5.json
1befe7ac-f7ce-42b8-b35b-098a831e6364,ISENTRESS 400 MG TABLETS,prescription,J05AX08,RALTEGRAVIR,8399,,,WHO ATC Classification,,ILS,film coated tablets,RALTEGRAVIR AS POTASSIUM,2025-07-31T04:13:04.392558,IL,מ.ס.ד. ישראל,,2401.648186,2035.295163,1850.26833,,7290006813435,ISENTRESS 600 MG TABLETS,,,,BOTTLE HDPE,units,60.0,140 33 31793 01,valid,10.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Isentress is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in adult patients.This indication is based on safety and efficacy data from two double-blind, placebo-controlled trials in treatment-experienced patients and one double-blind, active-controlled trial in treatment-naive patients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1befe7ac-f7ce-42b8-b35b-098a831e6364.json
1bf69923-2f59-4c1b-95b3-6ceac2cff87b,KOVALTRY 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,8168,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,RECOMBINANT HUMAN COAGULATION FACTOR VIII,2025-07-31T04:29:50.129275,IL,באייר,,2464.693661,2088.723534,1898.839576,,,KOVALTRY 1000 IU	  	VIAL 10 ML,11285,,36475,VIAL 10 ML GLASS TYPE I,units,1.0,158 45 34964 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Kovaltry can be used for all age groups.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1bf69923-2f59-4c1b-95b3-6ceac2cff87b.json
1bf82ce5-8535-42d9-85e4-03efb6b0f0ea,OTEZLA 10 MG,prescription,L04AA32,APREMILAST,7626,,,WHO ATC Classification,,ILS,film coated tablets,APREMILAST,2025-07-31T06:18:15.902122,IL,ניאופרם,,2917.826831,2472.734602,2247.940548,,,OTEZLA 30MG 56 F.C.TAB,15463,,31119,BLISTER PVC,units,56.0,153 91 34274 04,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Otezla is indicated:- For treatment of adult patients with active psoriatic arthritis (PsA).- For adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (PSOR).- For the treatment of adult patients with oral ulcers associated with Behçet’s disease (BD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1bf82ce5-8535-42d9-85e4-03efb6b0f0ea.json
1c124d9c-7a58-47c0-b5b7-ce93b8bb9ded,QUETIAPINE TEVA ® 100 MG,prescription,N05AH04,QUETIAPINE,7341,,,WHO ATC Classification,,ILS,film coated tablets,QUETIAPINE AS FUMARATE,2025-07-31T07:11:44.565666,IL,טבע,,29.99827624,25.422268,18.5564,,7290102065721,QUETIAPINE TEVA 25MG 30TAB,17028,,49799,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,150 04 33719 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Ttreatment  of schizophrenia. Treatment of manic episodes associated with bipolar disorder.Treatment of major depressive episodes in bipolar disorders.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c124d9c-7a58-47c0-b5b7-ce93b8bb9ded.json
1c2d0930-fb33-4b43-a30b-af1db739e46e,ATTENT XR 30 MG,prescription,N06BA01,AMFETAMINE,9189,,,WHO ATC Classification,,ILS,capsules extended release,"DEXTROAMPHETAMINE SULFATE 7.5  MG, DEXTROAMPHETAMINE SACCHARATE 7.5  MG, AMPHETAMINE SULFATE 7.5  MG, AMPHETAMINE ASPARTATE MONOHYDRATE 7.5  MG",2025-07-30T23:30:50.769095,IL,טבע,,nan,nan,nan,,,ATTENT XR 20 MG 30 CAPS,,,16701,BOTTLE HDPE,units,30.0,170 94 35998 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c2d0930-fb33-4b43-a30b-af1db739e46e.json
1c3ee122-ec94-4375-806d-c3e5cac7f1a5,FENTADOL 100,prescription,N02AB03,FENTANYL,7890,,,WHO ATC Classification,,ILS,patches,FENTANYL 16.8 MG/PATCH,2025-07-31T02:59:15.197184,IL,סנדוז,,144.8637325,122.765875,98.2127,,7290017585710,FENTADOL 50 5 PATCHES,166028,,59913,SACHET PAPER/PE/ALU/PE,units,5.0,154 87 34320 00,valid,25.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,"Management of chronic pain and intractable pain requiring opioid analgesia.Fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c3ee122-ec94-4375-806d-c3e5cac7f1a5.json
1c43c79b-6e5c-45c3-be50-8838d4c259cf,ZOFRAN TABLETS 4 MG,prescription,A04AA01,ONDANSETRON,312,,,WHO ATC Classification,,ILS,tablets,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE,2025-07-31T10:52:22.021798,IL,סנדוז,,217.707345,184.49775,147.5982,,,ZOFRAN INJ. 8 MG/4ML 5 AMP,26069,,8236,BLISTER PVC/ALUMINIUM,units,5.0,049 96 26549 22,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Adults:Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.  Zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). Paediatric Population:Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c43c79b-6e5c-45c3-be50-8838d4c259cf.json
1c4fd885-09a5-4453-a1c6-f68a13f1ca7e,MONTELUKAST - TRIMA 10 MG,prescription,R03DC03,MONTELUKAST,6908,,,WHO ATC Classification,,ILS,tablets,MONTELUKAST AS SODIUM SALT,2025-07-31T05:30:28.034944,IL,תרימה,,70.36868109,59.6344755,44.3379,,,MONTELUKAST-TRIMA 10MG 28TAB,13684,,19114,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,146 94 33396 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Montelukast - Trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. Montelukast - Trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast - Trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast - Trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c4fd885-09a5-4453-a1c6-f68a13f1ca7e.json
1c54dabe-1a52-467c-b8ca-544875defbe5,DROPERIDOL 5MG/2ML 10 VIAL,29C,,,20383,,,,,,injection,DROPERIDOL 5MG/,2025-07-31T20:19:10.684122,IL,nan,,,,,,,DROPERIDOL 5MG/2ML 10 VIAL,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c54dabe-1a52-467c-b8ca-544875defbe5.json
1c5905a4-45d4-4215-945b-9eba3191141e,SIRTURO,prescription,J04AK05,BEDAQUILINE,8461,,,WHO ATC Classification,,ILS,tablets,BEDAQUILINE AS FUMARATE,2025-07-31T08:18:26.975995,IL,יאנסן סילג,,115195.8484,97623.60466,88748.73151,,,SIRTURO 100MG 188 TABLETS,10392,,26050,BOTTLE HDPE,units,188.0,162 85 35758 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,SIRTURO is indicated for use as part of an appropriate combination regimen in adult patients with pulmonary multidrug resistant tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampicin and isoniazid. Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c5905a4-45d4-4215-945b-9eba3191141e.json
1c5c73ee-cd5f-458b-bae9-4a0453d150b2,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7458,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:19:07.514309,IL,צמל,,87.1206803,73.831085,54.893,,,METOJECT 50MG/ML SYRINGE PREFILLED 12.5MG/0.25ML,,,4021,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c5c73ee-cd5f-458b-bae9-4a0453d150b2.json
1c628367-4213-49f0-a29a-779e40e0dac1,PARAMOL AF & SHIUL DAY CARE,off-the-counter,R05DA09,DEXTROMETHORPHAN,5508,,,WHO ATC Classification,,ILS,caplets,"PARACETAMOL, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE",2025-07-31T12:45:35.984932,IL,ליף-דקסון,,22.243,18.85,nan,,,PARAMOL AF DAY CARE 30 TAB,,,,BLISTER PVC/ACLAR/ALUMINIUM,units,30.0,127 91 30769 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the symptomatic relief of cold, cough and nasal congestion accompanied by fever and pain, for day care.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c628367-4213-49f0-a29a-779e40e0dac1.json
1c6ee09e-c7ca-4cb8-add4-fdf95e93b6bd,ATZIRUT X,prescription,A06AB02,BISACODYL,5117,,,WHO ATC Classification,,ILS,tablets enteric coated,BISACODYL,2025-07-30T23:31:00.819232,IL,כ.צ.ט,,29.8723431,25.315545,18.4785,,,ATZIRUT X  5MG 30TAB,9725,,11537,BLISTER PVC/ALUMINIUM,units,30.0,130 99 30854 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,All types of constipation in ambulatory and bedridden patients over the age of 6 years. Preparation of patients for abdominal radiography and proctoscopy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c6ee09e-c7ca-4cb8-add4-fdf95e93b6bd.json
1c74aa3c-feba-4870-90c4-c03ad7c08c93,PARACETAMOL FRESENIUS 10 MG/ML,prescription,N02BE01,PARACETAMOL,8610,,,WHO ATC Classification,,ILS,solution for infusion,PARACETAMOL/ML,2025-07-31T06:28:12.819402,IL,ניאופרם,,63.65813524,53.94757223,40.10971913,,,PARACETAMOL FRESENIUS 10 MG/ML 10 VIAL X 50 ML,10669,,441,VIAL GLASS TYPE II,units,10.0,153 99 34200 02,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Paracetamol – Fresenius is indicated for:- the short-term treatment of moderate pain, especially following surgery- the short-term treatment of fever.when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c74aa3c-feba-4870-90c4-c03ad7c08c93.json
1c9c81bd-628c-4ea2-ad14-6f4f919b5a56,BISMU-CAL,off-the-counter,C05AX02,"BISMUTH PREPARATIONS, COMBINATIONS",5632,,,WHO ATC Classification,,ILS,tablets,BISMUTH SUBSALICYLATE 262.5  MG,2025-07-31T11:18:56.192435,IL,לייף-סופרפארם,,nan,nan,nan,,7290119916924,BISMU-CAL 262.5 MG 21TABS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,21.0,176 35 38028 99,valid,nan,per os,1.4,36,,,,,,,,,,0,,"BISMU-CAL is indicated:* for relief of diarrhea, nausea, flatulence, convulsive stomach pains, indigestion and uspet stomach. * as a preventative treatment of traveler's diarrhea.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1c9c81bd-628c-4ea2-ad14-6f4f919b5a56.json
1ca4cbec-4068-4082-b7b5-4101eeb8a961,PRYSOLINE TABLETS,prescription,N03AA03,PRIMIDONE,1406,,,WHO ATC Classification,,ILS,tablets,PRIMIDONE,2025-07-31T07:06:36.483357,IL,רקח,,26.94047734,22.830913,16.6649,,7290008089760,PRYSOLIN 250MG 30TAB,16522,,7805,BLISTER PVC/ALUMINIUM,units,30.0,024 79 21145 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Anticonvulsant.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ca4cbec-4068-4082-b7b5-4101eeb8a961.json
1cbbd5df-1dc8-4269-b0ce-5711cdbc48b6,PROCTO-GLYVENOL SUPPOSITORIES,off-the-counter,C05AX05,TRIBENOSIDE,579,,,WHO ATC Classification,,ILS,suppositories,"TRIBENOSIDE, LIDOCAINE",2025-07-31T12:52:38.833494,IL,ג.ס.ק,,53.1118,45.01,nan,,7298087020124,PROCTO-GLYVENOL CREAM  30GR,16702,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,067 40 23920 00,valid,nan,rectal,1.4,36,,,,,,,,,,0,,Local relief of haemorrhoids.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1cbbd5df-1dc8-4269-b0ce-5711cdbc48b6.json
1cbcce16-813e-4c68-bc6a-fc904790aba9,IFO-CELL 2 G,prescription,L01AA06,IFOSFAMIDE,9100,,,WHO ATC Classification,,ILS,solution for infusion,IFOSFAMIDE/,2025-07-31T03:57:57.058943,IL,אמ.בי.איי פארמה,,776.0305806,657.6530636,559.704735,,7290016369045,IFO-CELL 5 G/25ml,,,,VIAL GLASS TYPE I,units,1.0,155 73 34214 00,valid,17.5,i.v,1.4,18,,,,,,,,,,0,Prescription required,"• Testicular tumours For combination chemotherapy in patients with advanced stage II to IV tumours according to the TNM classification (seminomas and non-seminomas), which do not respond or adequately respond to initial chemotherapy.• Cervical cancerPalliative cisplatin/ifosfamide combination chemotherapy (without any other combination partners) of cervical carcinoma, FIGO stage IV B (when curative therapy of the disease is not possible with surgery or radiotherapy) – as an alternative to palliative radiotherapy.• Breast cancerFor palliative therapy in advanced, therapy-refractory or recurrent breast cancer.• Non-small-cell lung cancerFor mono- or combination chemotherapy of patients with inoperable or metastatic tumours.• Small-cell lung cancerFor combination chemotherapy.• Soft-tissue sarcoma (incl. osteosarcoma and rhabdomyosarcoma)For mono- or combination chemotherapy of rhabdomyosarcoma or osteosarcoma after failure of standard therapies. For mono- or combination chemotherapy of other soft-tissue sarcomas after failure of surgery and radiation therapy.• Ewing’s sarcomaFor combination chemotherapy after failure of primary cytostatic therapy.• Non-Hodgkin’s lymphomaFor combination chemotherapy in patients with highly malignant non-Hodgkin’s lymphoma which does not respond, or only insufficiently responds, to the initial therapy. For combination therapy of patients with recurrent tumours.• Hodgkin’s diseaseFor the treatment of patients with primary progressive forms and early relapse of Hodgkin’s disease (duration of complete remission shorter than one year) after failure of primary chemotherapeutic or radiochemotherapeutic treatment – as part of a recognised combination chemotherapy regimen, such as the MINE protocol.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1cbcce16-813e-4c68-bc6a-fc904790aba9.json
1ccab2a6-a723-4332-8c37-fbc3c2765621,DOXORUBICIN TEVA,prescription,L01DB01,DOXORUBICIN,8855,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOXORUBICIN HYDROCHLORIDE/ML,2025-07-31T02:04:21.882825,IL,טבע,,370.3935539,313.8928563,267.1428564,,7290102064281,DOXORUBICIN TEVA 2MG/ML  1 VIAL 100ML,,,58603,VIAL GLASS TYPE I,units,1.0,061 78 27503 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"To produce regression in disseminated neoplastic conditions such as: - acute lymphoblastic leukemia, - acute myeloblastic leukemia, - Wilms' tumor neuroblastoma, - soft tissue and bone sarcomas, - breast carcinoma, - lymphomas of both Hodgkin's and non-Hodgkin's types, - bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types, - gastric carcinoma.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ccab2a6-a723-4332-8c37-fbc3c2765621.json
1ccb8dd2-585e-4ead-9602-e83cad08f48b,CROMO-COMOD EYE DROPS,off-the-counter,S01GX01,CROMOGLICIC ACID,5269,,,WHO ATC Classification,,ILS,"eye drops, solution",CROMOGLICIC ACID AS SODIUM/ML,2025-07-31T11:27:53.945785,IL,קיוומא,,60.6756,51.42,nan,,7290008144117,CROMO-COMOD EYE DROPS 10ML,3854,,,BOTTLE POLYETHYLENE,units,10.0,133 90 31040 00,valid,nan,ocular,1.4,24,,,,,,,,,,0,,Preventative treatment for all types of allergic conjunctivitis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ccb8dd2-585e-4ead-9602-e83cad08f48b.json
1ccf6c80-8b7d-453f-b569-fc0fd54f366c,ACAMOLI ® FORTE 50 MG/ML SYRUP STRAWBERRY FLAVOUR,off-the-counter,N02BE01,PARACETAMOL,5256,,,WHO ATC Classification,,ILS,syrup,PARACETAMOL/,2025-07-31T11:02:37.095794,IL,טבע,,38.9282,32.99,nan,,,ACAMOLI SYR FOR BIG KIDS  TUTTI FRUTTI 100ML,,,,BOTTLE PET,units,100.0,140 18 31762 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Analgesic, antipyretic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ccf6c80-8b7d-453f-b569-fc0fd54f366c.json
1cd2dac4-0c20-41bd-a0ea-2c8f02901b61,TRAJENTA-DUO 2.5MG/850MG 60 F.C.TAB,prescription,,,7288,,,,,ILS,tablet,TRAJENTA-DUO 2.5MG/850MG 60 F.C.TAB,2025-07-31T19:36:17.102357,IL,בורינגר אינגלהיים,,212.6566494,180.2175075,144.174006,,,TRAJENTA-DUO 2.5MG/850MG 60 F.C.TAB,20778,,50206,,units,60.0,,not-registered,25.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1cd2dac4-0c20-41bd-a0ea-2c8f02901b61.json
1cd74a3f-2e5e-4679-a8fe-9e8c31b77024,ATOZET10 MG/10 MG,prescription,C10BA05,ATORVASTATIN AND EZETIMIBE ,7901,,,WHO ATC Classification,,ILS,film coated tablets,"ATORVASTATIN AS CALCIUM TRIHYDRATE, EZETIMIBE",2025-07-30T23:30:01.811340,IL,אורגנון,,143.1975503,121.3538562,90.22591541,,,ATOZET 10 MG/40 MG 30TAB,9973,,59894,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,156 65 34490 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Prevention of Cardiovascular EventsAtozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaAtozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Atozet is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1cd74a3f-2e5e-4679-a8fe-9e8c31b77024.json
1cf3d850-83e9-4597-be6d-f176773b5912,DUAC,prescription,D10AF01,CLINDAMYCIN,9119,,,WHO ATC Classification,,ILS,gel,"CLINDAMYCIN AS PHOSPHATEW/W, BENZOYL PEROXIDE AS HYDROUSW/W",2025-07-31T02:05:14.766267,IL,פאדאגיס,,105.4834273,89.392735,66.463,,7298074090093,DUAC TOPICAL GEL 30 GR,4754,,4433,TUBE ALUMINIUM,units,30.0,140 92 31439 01,valid,34.5,topical,1.4,18,,,,,,,,,,0,Prescription required,"Mild to moderate acne vulgaris, particulary inflammatory lesions.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1cf3d850-83e9-4597-be6d-f176773b5912.json
1cff6a92-5f4e-4492-b9bc-4d731a11fcc1,CICLODERM,prescription,D01AE14,CICLOPIROX,3038,,,WHO ATC Classification,,ILS,cream,CICLOPIROX OLAMINEW/W,2025-07-31T01:11:37.729558,IL,תרימה,,nan,nan,nan,,7290008075114,CICLODERM C 15GR,3081,,9200,TUBE ALUMINIUM,units,15.0,062 23 26751 00,valid,nan,topical,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of localized fungal infections of the body and fungal infections of the feet.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1cff6a92-5f4e-4492-b9bc-4d731a11fcc1.json
1d0e98b9-9367-4723-8ab5-d3654a5bc1d3,synagis,prescription,J06BB16,PALIVIZUMAB,8948,,,WHO ATC Classification,,ILS,solution for injection,PALIVIZUMAB/ML,2025-07-31T08:55:15.193454,IL,אסטראזנקה,,3104.766956,2631.158554,2391.962322,,7290013075895,SYNAGIS 100MG/ML 1 VIAL,17511,,73002,VIAL GLASS TYPE I,units,1.0,155 56 34505 00,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Abbosynagis is indicated for the prevention of serious lower respiratory tract disease requiring hospitalisation caused by respiratory syncytial virus (RSV) in children at high risk for RSV disease: • Children born at 35 weeks of gestation or less and less than 6 months of age at the onset of the RSV season.• Children less than 2 years of age and requiring treatment for bronchopulmonary dysplasia within the last 6 months.• Children less than 2 years of age and with haemodynamically significant congenital heart disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d0e98b9-9367-4723-8ab5-d3654a5bc1d3.json
1d189f9e-9c9e-48d9-a779-08a0ceff3334,ABROL TABLETS,off-the-counter,N02BE01,PARACETAMOL,3098,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T10:58:28.809405,IL,רקח,,12.154,10.3,nan,,,ABROL 500MG 20TAB,1016,,,BLISTER PVC/ALUMINIUM,units,20.0,028 47 21955 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Analgesic, antipyretic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d189f9e-9c9e-48d9-a779-08a0ceff3334.json
1d217779-97c6-4d43-a653-e5a6c543e84b,FERRIPROX TABLETS 1000 MG,prescription,V03AC02,DEFERIPRONE,8640,,,WHO ATC Classification,,ILS,film coated tablets,DEFERIPRONE,2025-07-31T03:03:13.654486,IL,לפידות,,717.6879619,608.2101642,517.6256717,,7290018216071,FERRIPROX 1000 MG 50 TAB,6631,,60709,BOTTLE HDPE,units,50.0,163 83 35170 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Ferriprox monotherapy is indicated for the treatment of iron overload in patients over 6 years old with thalassaemia major when current chelation therapy is contraindicated or inadequate.Ferriprox in combination with another chelator is indicated in patients with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life-threatening consequences of iron overload (mainly cardiac overload) justifies rapid or intensive correction.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d217779-97c6-4d43-a653-e5a6c543e84b.json
1d2cd692-3da2-4fc7-9f24-e73979d4f5d5,VENCLEXTA 10 MG TABLETS,prescription,L01XX52,VENETOCLAX,7988,,,WHO ATC Classification,,ILS,film coated tablets,VENETOCLAX,2025-07-31T10:04:03.861531,IL,אב-וי,,27392.08073,23213.62877,21103.29888,,,VENCLEXTA 100 MG 120 TABLETS,,,42783,BLISTER PVC/PCTFE/AL,units,120.0,158 19 34868 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaVENCLEXTA in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL), who have received at least one prior therapy.VENCLEXTA in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).Acute Myeloid LeukemiaVENCLEXTA in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d2cd692-3da2-4fc7-9f24-e73979d4f5d5.json
1d2e99ab-07e2-4251-846d-ca619a0f8d72,RETEVMO 120 MG TABLETS,prescription,L01EX22,SELPERCATINIB,9243,,,WHO ATC Classification,,ILS,tablets,SELPERCATINIB,2025-07-31T07:29:42.030581,IL,אלי לילי,,10782.83312,9137.994575,8307.267795,,,RETEVMO 40 MG 60 CAPS,18716,,22189,BOTTLE HDPE,units,60.0,179 73 38201 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Metastatic RET Fusion-Positive Non-Small Cell Lung CancerRETEVMO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC).RET-Mutant Medullary Thyroid CancerRETEVMO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy.RET Fusion-Positive Thyroid CancerRETEVMO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).Other RET Fusion-Positive Solid TumorsRETEVMO is indicated for the treatment of adult patients with locally advanced or metastatic solid tumors with a RET gene fusion that have progressed on or following prior systemic treatment or who have no satisfactory alternative treatment options.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d2e99ab-07e2-4251-846d-ca619a0f8d72.json
1d476484-1ac0-4b90-9138-008b3c733a37,PHENIMYXIN 10ML,prescription,,,3232,,,,,,tablet,PHENIMYXIN,2025-07-31T19:28:15.540430,IL,ויטאמד,,,,,,,PHENIMYXIN 10ML,16066,,9376,,units,10.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d476484-1ac0-4b90-9138-008b3c733a37.json
1d669245-18a5-40bb-996c-bfdef70c1605,DACARBAZINE-DACIN 200MG 12VIALS,prescription,,,7443,,,,,ILS,injection,DACARBAZINE-DACIN 200MG S,2025-07-31T19:04:19.592748,IL,פרופארם,,1716.535943,1454.691478,1238.0353,,,DACARBAZINE-DACIN 200MG 12VIALS,4514,,15926,,units,12.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d669245-18a5-40bb-996c-bfdef70c1605.json
1d743fa2-6ca4-4b9e-9bb8-04daf2a0ff19,CIBINQO 100 MG,prescription,D11AH08,ABROCITINIB,9206,,,WHO ATC Classification,,ILS,film coated tablets,ABROCITINIB,2025-07-31T01:11:06.817399,IL,פיזר,,5248.004525,4447.46166,4043.146964,,,CIBINQO 200 MG 28  F.C.T,,,46908,BLISTER PVC/ALUMINIUM,units,28.0,171 31 37239 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d743fa2-6ca4-4b9e-9bb8-04daf2a0ff19.json
1d9d7859-1117-4d24-bff6-ef86ca4825ad,AMINOPHYLLINE S.A.L.F 240 MG/10 ML,prescription,R03DA04,THEOPHYLLINE,8253,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,THEOPHYLLINE ETHYLENEDIAMINE DEHYDRATE/,2025-07-30T23:22:04.201547,IL,רז פרמהצפטי,,36.7292506,31.12648494,22.720062,,7290015863117,AMINOPHYLLINE S.A.L.F 240 MG/10 ML 5 AMP,,,52749,AMPOULES GLASS TYPE I,units,5.0,158 55 34846 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,- Bronchial asthma;- Pulmonary affections with bronchial spastic component., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d9d7859-1117-4d24-bff6-ef86ca4825ad.json
1d9e773a-64a2-4304-a494-7ca7df53f3af,LEVETIRACETAM DEXCEL 1000,prescription,N03AX14,LEVETIRACETAM,8085,,,WHO ATC Classification,,ILS,tablets,LEVETIRACETAM,2025-07-31T04:43:12.959590,IL,דקסל פארמה,,276.859565,234.62675,187.7014,,,LEVETIRACETAM DEXCEL 1000MG 60 TABLETS,12429,,64800,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,149 66 33514 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and    adolescents from 12 years of age with Idiopathic Generalised Epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1d9e773a-64a2-4304-a494-7ca7df53f3af.json
1db3d8aa-9de4-447e-934d-e3ed272ddc70,EMPLICITI 300 MG,prescription,,,7814,,,,,ILS,powder for concentrate for solution for infusion,ELOTUZUMAB/VIAL,2025-07-31T02:18:39.578840,IL,ב.מ.ס,,7417.675296,6286.165784,5714.696168,,,EMPLICITI 400 MG VIAL,5614,,62013,VIAL GLASS TYPE I,units,1.0,157 13 34688 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Empliciti is indicated in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.Empliciti is indicated in combination with pomalidomide and dexamethasone for the treatment ofadult patients with relapsed and refractory multiple myeloma who have received at least two priortherapies, including lenalidomide and a proteasome inhibitor, and have demonstrated diseaseprogression on the last therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1db3d8aa-9de4-447e-934d-e3ed272ddc70.json
1dcaab8c-5195-461d-9f1a-01b8cc040280,OZURDEX,prescription,R01AD03,DEXAMETHASONE,1929,,,WHO ATC Classification,,ILS,implant in applicator,DEXAMETHASONE 0.7  MG,2025-07-31T01:52:33.283629,IL,רקח,,176.77167,149.8065,119.8452,,7290104780011,DEXAMETHASONE 2MG 50TAB,4094,,7105,APPLICATOR STAINLESS STEEL,units,50.0,147 03 33284 00,valid,25.0,intravitreal,1.4,36,,,,,,,,,,0,Prescription required,Ozurdex is indicated for the treatment of adult patients with:• diabetic macular oedema (DME)• macular oedema following either Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO).• inflammation of the posterior segment of the eye presenting as non-infectious uveitis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1dcaab8c-5195-461d-9f1a-01b8cc040280.json
1df67e81-cdb8-42ab-98ec-79217682e769,CHILDREN'S ADVIL GRAPE FLAVOR,off-the-counter,M01AE01,IBUPROFEN,3889,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T11:05:00.015780,IL,ג.ס.ק,,99.8516,84.62,nan,,305730171304,ADVIL 200MG 80LIQUI-GELS,1610,,,BOTTLE PLASTIC,units,80.0,122 43 30111 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1df67e81-cdb8-42ab-98ec-79217682e769.json
1e167236-4e04-442f-b90c-a92ce906900c,IMFINZI,prescription,L01XC28,DURVALUMAB,8291,,,WHO ATC Classification,,ILS,solution for infusion,DURVALUMAB/ML,2025-07-31T04:01:16.743308,IL,אסטראזנקה,,2278.238535,1930.710709,1643.15805,,7290013075703,IMFINZI 120 MG/2.4 ML 1VIAL,10307,,5240,VIAL GLASS TYPE I,units,1.0,159 97 35280 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Urothelial CarcinomaIMFINZI is indicated for the treatment of patients with PD-L1 high (Tumor cell &#8805;25% or IC &#8805;25%) locally advanced or metastatic urothelial carcinoma who: - have disease progression during or following platinum-containing chemotherapy. - have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum containing chemotherapy. Non-Small Cell Lung Cancer - IMFINZI is indicated for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. - IMFINZI in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic NSCLC with no sensitising EGFR mutations or ALK positive mutations. Small Cell Lung Cancer- IMFINZI, in combination with etoposide and either carboplatin or cisplatin, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).- IMFINZI, as a single agent, is indicated for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy (cCRT).Biliary Tract Cancers IMFINZI in combination with gemcitabine and cisplatin is indicated for the first-line treatment of adults with locally advanced, unresectable, or metastatic biliary tract cancer (BTC). Hepatocellular CarcinomaIMFINZI in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (HCC).Endometrial CancerIMFINZI in combination with carboplatin and paclitaxel followed by Imfinzi as a single agent, for the treatment of adult patients with primary advanced or recurrent endometrial cancer that is mismatch repair deficient (dMMR).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e167236-4e04-442f-b90c-a92ce906900c.json
1e197979-4230-487c-bac5-4d72820d2cd8,TRIFLUCAN I.V.,prescription,J02AC01,FLUCONAZOLE,4341,,,WHO ATC Classification,,ILS,solution for infusion,FLUCONAZOLE/ML,2025-07-31T09:42:22.431697,IL,פיזר,,35.2119729,29.840655,21.7815,,7920008096652,TRIFLUCAN 2MG/ML VIAL FOR INFUS 50ML,20214,,33564,VIAL GLASS TYPE I,units,50.0,106 22 29072 00,valid,37.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections .Fluconazole is indicated in adults for the treatment of:• Cryptococcal meningitis .• Coccidioidomycosis . Invasive candidiasis.• Mucosal candidiasis (including oropharyngeal candidiasis, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis).• Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene topical treatment are insufficient.Fluconazole is indicated in adults for the prophylaxis of:• Relapse of cryptococcal meningitis in patients with high risk of recurrence.• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.• Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Haematopoetic Stem Cell Transplantation ).Fluconazole is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e197979-4230-487c-bac5-4d72820d2cd8.json
1e1b1191-7cc4-482e-8065-d4e29917aa8d,BALVERSA 3 MG,prescription,L01EX16,ERDAFITINIB,8491,,,WHO ATC Classification,,ILS,film coated tablets,ERDAFITINIB,2025-07-30T23:34:13.599519,IL,יאנסן סילג,,nan,nan,nan,,7290014577572,BALVERSA 4 MG 56 TAB,2748,,432,BOTTLE HDPE,units,56.0,165 77 36132 00,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,"BALVERSA is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has:- Susceptible FGFR3 or FGFR2 genetiic alterations, and- Progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e1b1191-7cc4-482e-8065-d4e29917aa8d.json
1e1cb5be-dd79-42c1-80e6-ad3afbe4564b,OTIDIN TEVA,off-the-counter,S02DA30,COMBINATIONS,1642,,,WHO ATC Classification,,ILS,drops,"PHENAZONE/ML, AMETHOCAINE HYDROCHLORIDE/ML",2025-07-31T12:41:52.599374,IL,טבע,,16.107,13.65,nan,,7290008084871,OTIDIN DROPS 10ML,15076,,,BOTTLE LDPE,units,10.0,165 07 36421 00,valid,nan,otic,1.4,24,,,,,,,,,,0,,"For the relief of pain in acute otitis media and the external, auditory canal.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e1cb5be-dd79-42c1-80e6-ad3afbe4564b.json
1e4bb0ba-a374-4f0f-ad73-c3498b01dd14,ALPROLIX 500 IU,29C,B02BD04,COAGULATION FACTOR IX,9002,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR IX (HUMAN- RFIXFC)/VIAL,2025-07-31T13:47:31.182100,IL,nan,,nan,nan,nan,,,ALPROLIX 500 IU,,,,VIAL GLASS TYPE I,units,1.0,171 48 36890 00,valid,nan,i.v,1.4,48,,,,,,,,,,0,,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e4bb0ba-a374-4f0f-ad73-c3498b01dd14.json
1e5a6856-60ab-4833-a3bd-6da827703cf2,MAYZENT 0.25 MG,prescription,L04AA42,SIPONIMOD,8721,,,WHO ATC Classification,,ILS,film coated tablets,SIPONIMOD AS FUMARIC ACID 0.25  MG,2025-07-31T05:07:19.694243,IL,נוברטיס פארמה,,9812.061063,8315.306355,7559.369414,,7290018375266,MAYZENT 0.25 MG 120 TAB,13977,,499,BLISTER PA/ALU/PVC/ALU,units,120.0,165 54 36195 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Mayzent is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease, and active secondary progressive disease, in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e5a6856-60ab-4833-a3bd-6da827703cf2.json
1e665947-7f10-4d7c-ab6d-7153ba325d41,FENLIPS,off-the-counter,D06BB06,PENCICLOVIR,5490,,,WHO ATC Classification,,ILS,cream,PENCICLOVIRW/W,2025-07-31T11:53:55.705834,IL,פאדאגיס,,49.9966,42.37,nan,,,FENLIPS COLOR 2GR,,,,TUBE ALUMINIUM,units,2.0,142 41 31798 01,valid,nan,topical,1.4,36,,,,,,,,,,0,,For the topical treatment for cold sores (oral herpes).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e665947-7f10-4d7c-ab6d-7153ba325d41.json
1e6c81ff-0cb5-4c3c-9640-dec64a0ded01,CIMETIDINE ORAL SOLUTION HI-TEC USA 200MG/5ML 300ML,29C,,,20823,,,,,,solution,CIMETIDINE ORAL SOLUTION HI-TEC USA 200MG/,2025-07-31T20:06:34.631749,IL,nan,,,,,,,CIMETIDINE ORAL SOLUTION HI-TEC USA 200MG/5ML 300ML,,,,,units,300.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e6c81ff-0cb5-4c3c-9640-dec64a0ded01.json
1e8c65b3-9308-4618-bd48-5b4b0e2c1432,MIGRALEVE 24TAB,prescription,,,4287,,,,,ILS,tablet,MIGRALEVE,2025-07-31T19:19:07.942617,IL,מנון,,61.5941121,52.19840241,38.80922112,,,MIGRALEVE 24TAB,13130,,1340,,units,24.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1e8c65b3-9308-4618-bd48-5b4b0e2c1432.json
1ebba237-af43-4c65-b69b-fee05fa250c2,VIGAMOX,prescription,J01MA14,MOXIFLOXACIN,4867,,,WHO ATC Classification,,ILS,"eye drops, solution",MOXIFLOXACIN AS HYDROCHLORIDE 0.5 %,2025-07-31T10:15:00.659863,IL,נוברטיס פארמה,,48.06855899,40.73606875,29.73435675,,7290016369335,VIGAMOX OPHT SOL 5ML,22263,,65019,DROPER BOTTLE POLYETHYLENE,units,5.0,133 10 31054 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of bacterial conjunctivitis caused by susceptible strains or organisms.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ebba237-af43-4c65-b69b-fee05fa250c2.json
1ee7e3c0-ef59-439f-a170-0e4d953659a1,FENTORA ® 100 MCG,prescription,N01AH01,FENTANYL,7612,,,WHO ATC Classification,,ILS,tablets,FENTANYL AS CITRATE,2025-07-31T03:02:19.815730,IL,טבע,,505.993386,428.8079733,364.942956,,,FENTORA 200MCG 28 BUCCAL TAB,6583,,76297,BLISTER PVC/ALU/POLYAMIDE/PVC,units,28.0,152 90 34050 00,valid,17.5,buccal,1.4,36,,,,,,,,,,0,Prescription required,"Fentora is indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.                                      Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ee7e3c0-ef59-439f-a170-0e4d953659a1.json
1eee3496-73f6-4f17-a180-bc7b96f9163f,ADVOCIN INJECTABLE SOLUTION 2.5 % VETERINARY,prescription,,,3344,,,,,ILS,solution for injection,DANOFLOXACIN AS MESYLATE/ML,2025-07-31T06:04:27.778216,IL,אב-וי,,12.96655439,10.98860541,8.020879864,,,OFLOX DROPS 0.3% 5ML,15030,,48875,VIAL AMBER GLASS TYPE II,units,5.0,083 84 92073 00,valid,37.0,"i.m, s.c",1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of cattle (calves, beef cattle and non-lactating dairy cattle) with respiratory infections caused by Pasteurella haemolytica and Pasteurella multocida, enteric infections caused by e.coli and salmonela spp.Only after sensitivity to danofloxacin has been confirmed by laboratory tests and after no alternative treatment was found effective (proved resistence to other treatments).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1eee3496-73f6-4f17-a180-bc7b96f9163f.json
1f1299b8-1c58-44c5-ae51-7c2b8626fa82,AZARGA,prescription,S01ED51,"TIMOLOL, COMBINATIONS",6792,,,WHO ATC Classification,,ILS,"eye drops, suspension","BRINZOLAMIDE/ML, TIMOLOL AS MALEATE/ML",2025-07-30T23:32:39.760261,IL,נוברטיס פארמה,,47.81146746,40.51819457,29.5753245,,7290016369229,AZARGA 5ML,9462,,8004,BOTTLE LDPE,units,5.0,145 12 32030 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Decrease of intra-ocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1f1299b8-1c58-44c5-ae51-7c2b8626fa82.json
1f15918a-b072-4813-8bca-4a20568c15c7,TOLTERODINE E.R. MEDOMIE 2 MG,prescription,G04BD07,TOLTERODINE,9430,,,WHO ATC Classification,,ILS,capsules extended release,TOLTERODINE TARTRATE,2025-07-31T09:24:46.788580,IL,מדומי פארמה,,67.18384752,56.935464,42.3312,,,TOLTERODINE E.R. MEDOMIE 2 MG 28 TAB,,,,BLISTER OPA/ALU/PVC/ALU,units,28.0,174 90 36958 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"TOLTERODINE E.R. MEDOMIE is indicated for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1f15918a-b072-4813-8bca-4a20568c15c7.json
1f2e6156-e330-40a9-872b-328b94d93933,BERIGLOBIN P,prescription,J06BA01,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASCULAR ADM.",8684,,,WHO ATC Classification,,ILS,solution for injection,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T00:31:34.506384,IL,סי אס אל,,108.6457204,92.07264851,68.45550075,,7290000689210,BERIGLOBIN P 16 % 2 ML  1 PFS,2071,,77199,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,125 38 29064 00,valid,34.5,"i.m, s.c",1.4,30,,,,,,,,,,0,Prescription required,"Substitution in - Primary antibody deficiency syndromes resulting from defective antibody synthesis. - Protracted transitory hypogammaglobulinaemia especially in premature infants .Prophylaxis of hepatitis A- Before exposure- Within 2 weeks after exposure בקשה לתוספת התוויה 28/4/2019Indications for subcutaneous administration (SCIg)Replacement therapy in adults, children and adolescents (0-18 years) in: •		Primary immunodeficiency syndromes with impaired antibody production (see section 4.4).•		Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (CLL), in whom prophylactic antibiotics have failed or are contra-indicated.•		Hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (MM) patients •		Hypogammaglobulinaemia in patients pre- and post- allogeneic haematopoietic stem cell transplantation (HSCT)Indications for intramuscular administration (IMIg)Hepatitis A prophylaxisIn adults and children and adolescents (0-18 years)•		Pre-exposure prophylaxis, preferably in combination with vaccination, in unvaccinated individuals travelling in less than 2 weeks to areas of hepatitis A risk.•		Post-exposure prophylaxis in unvaccinated individuals within 2 weeks of hepatitis A virus (HAV) exposure.Consideration should also be given to other official guidance on the appropriate use in hepatitis A prophylaxis. For long term hepatitis A prophylaxis, vaccination is recommended. הערה: הבקשה הינה בהתאם לנוהל EMA (25.2.15)- Guideline on core SmPC for human normal immunoglobulin for subcutaneous and intramuscular administration",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1f2e6156-e330-40a9-872b-328b94d93933.json
1f58a540-68cb-4034-ae5d-6a918542f453,DIPYRAZ ORAL DROPS,off-the-counter,N02BB02,METAMIZOLE SODIUM,5548,,,WHO ATC Classification,,ILS,drops,DIPYRONE/ML,2025-07-31T11:33:32.534764,IL,רז פרמהצפטי,,30.2552,25.64,nan,,8022086001179,DIPYRAZ ORAL DROPS 500MG/ML 20ML,,,,BOTTLE GLASS TYPE III,units,20.0,157 21 34423 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea and for high fever that does not respond to other measures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1f58a540-68cb-4034-ae5d-6a918542f453.json
1f7d73ea-863c-497e-a51d-ecd150d60cfa,GLYXAMBI 10 MG/5 MG,prescription,A10BD19,LINAGLIPTIN AND EMPAGLIFLOZIN,7820,,,WHO ATC Classification,,ILS,film coated tablets,"LINAGLIPTIN, EMPAGLIFLOZIN",2025-07-31T03:38:13.602960,IL,בורינגר אינגלהיים,,365.4970364,309.7432649,263.6112893,,,GLYXAMBI 25 MG/5 MG 30 F.C.TAB,7935,,41770,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,155 76 34531 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,GLYXAMBI tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.  Limitations of UseGLYXAMBI is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.GLYXAMBI has not been studied in patients with a history of pancreatitis.  It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using GLYXAMBI.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1f7d73ea-863c-497e-a51d-ecd150d60cfa.json
1fa866aa-1014-4f1f-b8f8-f1f1452e4345,BRONCHO D,29C,R06AA52,"DIPHENHYDRAMINE, COMBINATIONS",20373,,,WHO ATC Classification,,ILS,syrup,"DIPHENHYDRAMINE HYDROCHLORIDE/, AMMONIUM CHLORIDE/",2025-07-31T14:21:52.267872,IL,nan,,nan,nan,nan,,7290008066013,DIPHENHYDRAMINE HCL 50MG/ML 25 AMP,,,,BOTTLE HDPE,units,25.0,058 88 27178 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of coughs and congestion in the respiratory tract.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fa866aa-1014-4f1f-b8f8-f1f1452e4345.json
1fad7166-cd7f-4f23-ac7f-a2bbc294e83a,NOVOSEVEN ® RT 1 MG/VIAL,prescription,B02BD08,COAGULATION FACTOR VIIA ,7071,,,WHO ATC Classification,,ILS,powder for solution for injection,EPTACOG ALFA (ACTIVATED)/VIAL,2025-07-31T05:56:23.523430,IL,נובו נורדיסק,,5065.795192,4293.046963,3902.769967,,7290008126717,NOVOSEVEN RT 2MG/VIAL,14535,,35599,VIAL GLASS TYPE I,units,1.0,142 63 32929 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"NovoSeven ® RT is indicated for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups: •in patients with congenital haemophilia with inhibitors to coagulation factors VIII or IX > 5 Bethesda Units (BU) •in patients with congenital haemophilia who are expected to have a high anamnestic response to factor VIII or factor IX administration •in patients with acquired haemophilia •in patients with congenital FVII deficiency •in patients with Glanzmann’s thrombasthenia with past or present refractoriness to platelet transfusions, or where platelets are not readily available.Severe postpartum haemorrhageNovoSeven RT is indicated for the treatment of severe postpartum haemorrhage when uterotonics are insufficient to achieve haemostasis",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fad7166-cd7f-4f23-ac7f-a2bbc294e83a.json
1fb58fbd-0e5a-4130-b4f1-93459f291b48,HYTRIN 10 MG TABLETS,prescription,G04CA03,TERAZOSIN,3380,,,WHO ATC Classification,,ILS,tablets,TERAZOSIN AS MONOHYDRACHLORIDE DIHYDRATE,2025-07-31T03:54:54.714912,IL,ביוטיס,,65.30519725,55.3433875,41.1475,,5013158062405,HYTRIN BPH 10MG 28TAB,8099,,9563,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,103 61 28683 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For symptomatic treatment of urinary obstruction caused by benign prostatic hypertrophy (BPH). For mild to moderate hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fb58fbd-0e5a-4130-b4f1-93459f291b48.json
1fbe6c6f-555e-443a-8f0f-9891a9e64283,ARIXTRA 2.5 MG/0.5 ML,prescription,B01AX05,FONDAPARINUX,6155,,,WHO ATC Classification,,ILS,solution for injection,FONDAPARINUX SODIUM/,2025-07-31T00:25:01.909682,IL,פאדאגיס,,252.9642824,214.37652,171.501216,,,ARIXTRA 2.5MG/0.5ML 10 PREFIL SYR,9315,,78758,SYRINGE PREFILLED  GLASS TYPE I,units,10.0,138 62 31587 00,valid,25.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,Prevention of Venous Thromboembolic Events (VTE) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture  major knee surgery or hip replacement surgery.  Prevention of Venous Thromboembolic Events (VTE) in adults undergoing abdominal surgery who are judged to be at high risk of thromboembolic complications  such as patients undergoing abdominal cancer surgery. Prevention of Venous Thromboembolic Events (VTE) in adults medical patients who are judged to be at high risk for VTE and who are immobilised due to acute illness such as cardiac insufficiency and/or acute respiratory disorders  and/or acute infectious or inflammatory disease.    Treatment of unstable angina or non-ST segment elevation myocardial infarcton (UA/NSTEMI) in adults for whom urgent ( < 120 mins) invasive management (PCI) is not indicated . Treatment of ST segment elevation myocardial infarction (STEMI) in patients who are managed with thrombolytics or who initially are to receive no other form of reperfusion therapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fbe6c6f-555e-443a-8f0f-9891a9e64283.json
1fbead10-8644-45ed-a3fd-8de594ca13a3,TRUE TEST 36,off-the-counter,V01AA20,VARIOUS,5020,,,WHO ATC Classification,,ILS,plaster for provocation test,ALLERGENS (CHEMICAL) 36,2025-07-31T12:25:14.474115,IL,סם און,,45.9374,38.93,nan,,,MICAL 375MG 20TAB,13037,,,POUCH LAMINATED,units,20.0,178 06 37405 99,valid,nan,transdermal,1.4,24,,,,,,,,,,0,,This medicinal product is for diagnostic use in adults only.Diagnosis of allergic contact dermatitis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fbead10-8644-45ed-a3fd-8de594ca13a3.json
1fbf433b-ef3d-4f2c-8f22-c9709655ba56,MYOZYME,prescription,A16AB07,ALGLUCOSIDASE ALFA,6736,,,WHO ATC Classification,,ILS,powder for concentrate for infusion,ALGLUCOSIDASE ALFA/VIAL,2025-07-31T05:38:47.193405,IL,סאנופי אוונטיס,,2277.202936,1929.833082,1754.393711,,,MYOZYME 50MG/VIAL,13696,,30994,VIAL GLASS,units,1.0,135 74 31488 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Myozyme is indicated for long-term enzyme replacement therapy (ERT) in patients with a confirmed diagnosis of pompe disease (acid alpha-glucosidase deficiency). The benefits of Myozyme in patients with late-onset Pompe disease have not been established.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fbf433b-ef3d-4f2c-8f22-c9709655ba56.json
1fe1222c-3ff6-4ab3-ba0e-f4c0e37ffe8f,LEPONEX 100 MG TABLETS,prescription,,,3300,,,,,ILS,tablets,CLOZAPINE,2025-07-31T04:39:57.496099,IL,דקסל פארמה,,27.2696171,23.109845,16.8685,,8904182702795,LEPONEX 25MG 50TAB,12042,,23380,BLISTER PVC/PE/PVDC,units,50.0,047 98 23148 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for diath.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fe1222c-3ff6-4ab3-ba0e-f4c0e37ffe8f.json
1fe6e79b-2664-4fa7-b9c9-ad0344c41d90,LICAIN 1% INJECTION VIAL 5ML,29C,,,20860,,,,,,injection,LICAIN 1% INJECTION VIAL,2025-07-31T20:47:15.871690,IL,nan,,,,,,,LICAIN 1% INJECTION VIAL 5ML,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fe6e79b-2664-4fa7-b9c9-ad0344c41d90.json
1fef614f-f9ed-42d6-8617-69df87da2971,CARNITOR  SUGAR FREE  1GR/10ML 1VIAL,29C,,,20324,,,,,,injection,CARNITOR SUGAR FREE 1GR/,2025-07-31T20:03:24.974968,IL,nan,,,,,,,CARNITOR  SUGAR FREE  1GR/10ML 1VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1fef614f-f9ed-42d6-8617-69df87da2971.json
1ffef044-e24f-4e1b-aac6-5a56141a93b9,BETACORTEN G OINTMENT,prescription,D07AC01,BETAMETHASONE,2169,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS VALERATE 0.1 %W/W, GENTAMICIN AS SULFATE 0.1 %W/W",2025-07-31T00:32:45.687012,IL,תרימה,,54.87079886,46.500677,33.9421,,,BETACORTEN G CR 15GR,2067,,342,TUBE ALUMINIUM,units,15.0,050 45 23262 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,For local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/1ffef044-e24f-4e1b-aac6-5a56141a93b9.json
2009db6c-bb3f-4abe-a21d-cbe4ad877b63,PRAVALIP 40,prescription,C10AA03,PRAVASTATIN,4837,,,WHO ATC Classification,,ILS,tablets,PRAVASTATIN SODIUM,2025-07-31T06:50:29.804228,IL,אוניפארם,,47.2516014,40.04373,29.229,,,PRAVALIP 40 30TAB,16698,,13199,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,132 78 31136 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . Pravastatin should be used in addition to a diet  other nonpharmacological measures alone have been inadequate.    Primary prevention of coronary events: In hypercholesterolemic patients wihthout clinically evident coronary heart disease  pravastatin is indicated to:   1) Reduce the risk of myocardial infarcton.   2) Reduce the risk for revascularization.   3) Reduce the risk of deaths due to cardiovascular causes with no increase in death due to non-cardiovascular causes.   Secondary prevention of cardiovascular events:    a) Atherosclerosis: In hypercholesterolemic patients with clinically evident coronary artery disease  including prior MI  pravastatin  is indicated to:      1)Slow the progression of coronary atherosclerosis.      2) Reduce the risk of acute coronary events.     b) Myocardial infarction: in patients with previous myocardial infarction  and normal cholesterol levels. Pravastatin is indicated to:      1) Reduce the risk of recurrent myocardial infarction.       2)Reduce the risk of undergoing myocardial revascularization procedures.       3) Reduce the risk of stroke or transient ischemic attack (TIA).     c) Hypercholesterolemia and mixed dyslipidemia: Pravastatin is indicated as an adjunct to diet to reduce elevated Total-C  LDL-C and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Frederickson Type IIa and IIb).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2009db6c-bb3f-4abe-a21d-cbe4ad877b63.json
20180bc2-056f-482c-a8d9-2349cae3c246,MODAL FORTE TABLETS,prescription,N05AL01,SULPIRIDE,1871,,,WHO ATC Classification,,ILS,tablets,SULPIRIDE,2025-07-31T05:29:08.565753,IL,רפא,,44.84440118,38.0037315,27.73995,,7290008014748,MODAL FORTE 200MG 40TAB,13451,,8247,BLISTER PVC/ALUMINIUM,units,40.0,029 29 21895 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Anti - dopaminergic agent.   1) For use in vertigo and prepsychotic states.   2) At high doses - in psychiatric patients for treatment of depression and apathy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/20180bc2-056f-482c-a8d9-2349cae3c246.json
2023b74f-2264-4c7c-a83a-c333bbdf5013,GILEX 10 MG,prescription,N06AA12,DOXEPIN,1551,,,WHO ATC Classification,,ILS,capsules,DOXEPIN AS HYDROCHLORIDE,2025-07-31T03:32:48.608575,IL,רקח,,17.62093922,14.933,10.9,,7290008090476,GILEX 10MG 30CAP,7561,,917,BLISTER PVC/ALUMINIUM,units,30.0,033 55 22651 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of anxiety and/or depression.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2023b74f-2264-4c7c-a83a-c333bbdf5013.json
203a8479-0586-45ac-bd98-902252b3c108,DORZOLAMIDE S.K,prescription,S01EC03,DORZOLAMIDE,8725,,,WHO ATC Classification,,ILS,"eye drops, solution",DORZOLAMIDE AS HYDROCHLORIDE/ML,2025-07-31T02:02:56.306603,IL,SK PHARM(KS KIM),,34.59524,29.318,21.4,,7290016845365,DORZOLAMIDE S.K 20 MG/ML 5 ML,4713,,59392,BOTTLE LDPE,units,5.0,164 10 35562 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"Dorzolamide S.K. is indicated for the treatment of eleveated intraocular pressure in patients with ocular hypertension, openangle glaucoma and in some patients secondary glaucoma.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/203a8479-0586-45ac-bd98-902252b3c108.json
20474676-fe11-4c85-9179-8a467c5f8934,SOLU MEDROL 1000 MG,prescription,H02AB04,METHYLPREDNISOLONE,8220,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,METHYLPREDNISOLONE AS SODIUM SUCCINATE 62.5  MG/ML,2025-07-31T08:28:20.217314,IL,פיזר,,135.5396414,114.8641029,85.40082,,7298074000658,SOLU MEDROL 1000 MG/16ML 1 VIAL,17920,,75593,VIAL GLASS TYPE I,units,1.0,114 10 22489 00,valid,34.5,"i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,"Solu Medrol is indicated to treat any condition in which IM or IV corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/20474676-fe11-4c85-9179-8a467c5f8934.json
204c7692-24a9-4a0e-9b06-4de56729161b,HYQVIA,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",8151,,,WHO ATC Classification,,ILS,solution for infusion,HUMAN NORMAL IMMUNOGLOBULIN/,2025-07-31T03:54:04.356423,IL,טקדה,,10213.46492,8655.479128,7868.617389,,7290018375235,HYQVIA 1vial normal 30g/300ml + 1vial recombinant 15ml,8473,,59755,VIAL GLASS TYPE I,units,300.0,160 21 35267 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, children and adolescents (0-18 years) in:• Primary immunodeficiency syndromes with impaired antibody production • Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (CLL), in whom prophylactic antibiotics have failed or are contra-indicated.• Hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (MM) patients.• Hypogammaglobulinaemia in patients pre- and post-allogeneic hematopoietic stem cell transplantation (HSCT).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/204c7692-24a9-4a0e-9b06-4de56729161b.json
206103e1-8984-49e4-b2e1-78b43d8f6a58,JANUVIA 100 MG,prescription,A10BH01,SITAGLIPTIN,6107,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS MONOHYDRATE PHOSPHATE,2025-07-31T04:17:43.333233,IL,מ.ס.ד. ישראל,,118.7477665,100.6337004,74.82059508,,,JANUVIA 50MG 28TAB,10041,,86457,BLISTER PVC/PE/PVDC/AL,units,28.0,138 15 31556 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.Important limitations of use:Januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.Januvia has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januvia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/206103e1-8984-49e4-b2e1-78b43d8f6a58.json
2085154f-2380-4792-9573-9fafc33c89ae,VALSARTAN -MEDO 160 MG,prescription,C09CA03,VALSARTAN,8906,,,WHO ATC Classification,,ILS,film coated tablets,VALSARTAN,2025-07-31T09:57:03.938390,IL,מדי מרקט,,43.39293886,36.773677,26.8421,,,VALSARTAN -MEDO 160 MG 30TAB,,,71510,BLISTER PVC/PCTFE/AL,units,30.0,167 40 35704 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For treatment of hypertension. Valsartan-Medo is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan-Medo signicantly reduced hospitalisations for heart failure. There is no evidence that Valsartan-Medo provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan-Medo is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2085154f-2380-4792-9573-9fafc33c89ae.json
208b4c4e-816b-4b7b-98f8-d5dbf77756e1,LOTAN 100,prescription,C09CA01,LOSARTAN,6099,,,WHO ATC Classification,,ILS,tablets,LOSARTAN POTASSIUM,2025-07-31T04:56:43.202767,IL,אוניפארם,,25.59546614,21.691073,15.8329,,,LOTAN 50MG 30TAB,12395,,15982,BLISTER PVC/ALUMINIUM,units,30.0,139 36 31707 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Hypertension: Lotan 100 is indicated for the treatment of hypertension. Heart failure:Lotan 100 is indicated for the treatment of heart failure, when treatment with an ACE inhibitor is not appropriate. Switching patients with heart failure who are stable on an ACE inhibitor to Lotan 100 is not recommended. Renal protection in Type-2 diabetic patients with proteinuria: Lotan 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria. Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Lotan 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy. The benefit of Lotan 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/208b4c4e-816b-4b7b-98f8-d5dbf77756e1.json
209fd90c-b4ca-4d99-b883-8e83de530de2,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5202,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:01:51.565577,IL,טבע,,47.3062,40.09,nan,,7290000800028,ACAMOL TSINUN& SHAAPAT 35D+14N CAPLETS,9245,,,BLISTER PVC/ALUMINIUM,units,49.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/209fd90c-b4ca-4d99-b883-8e83de530de2.json
20c91684-83cb-49fe-8228-d333ef21cb5e,GENTATRIM OINTMENT,prescription,D06AX07,GENTAMICIN,2186,,,WHO ATC Classification,,ILS,ointment,GENTAMICIN AS SULFATE 0.10 %W/W,2025-07-31T03:31:35.925941,IL,תרימה,,17.80878892,15.092194,11.0162,,,GENTATRIM  DERMAL CREAM 15GR,7020,,908,TUBE ALUMINIUM,units,15.0,047 61 23635 01,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of wounds, burns, acne spots and dermatoses infected with bacteria sensitive to gentamycin.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/20c91684-83cb-49fe-8228-d333ef21cb5e.json
20d19c07-853d-427d-a5a1-e832da3b0bca,REBIF 22 MCG,prescription,L03AB07,INTERFERON BETA-1A,6118,,,WHO ATC Classification,,ILS,solution for injection,INTERFERON BETA 1A/ML,2025-07-31T07:18:49.118701,IL,מרק סרונו,,3522.877167,2985.489258,2714.081143,,7290000845265,REBIF 44MCG/0.5ML 12 SYRINGES,18323,,22664,CARTRIDGE GLASS TYPE I,units,12.0,110 94 29437 06,valid,10.0,s.c,1.4,18,,,,,,,,,,0,Prescription required,Rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. Efficacy of Rebif in chronic progressive multiple sclerosis has not been established.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/20d19c07-853d-427d-a5a1-e832da3b0bca.json
20f479bd-171b-4783-b418-ebdb3c30b61b,PERGOVERIS ®,prescription,G03GA05,FOLLITROPIN ALFA,8403,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,"FOLLITROPIN ALFA, LUTROPIN ALFA",2025-07-31T06:37:17.058233,IL,מרק סרונו,,706.0001792,598.3052632,509.1959687,,7290000845470,PERGOVERIS PRE-FILLED PEN 0.48ML,,,4984,VIAL GLASS TYPE I,units,1.0,145 07 33159 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Pergoveris is indicated for the stimulation of follicular development in adult women with sever LH and FSH deficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/20f479bd-171b-4783-b418-ebdb3c30b61b.json
210ac869-9a21-4dc0-a92f-ad808572a19d,ONUREG 200 MG,prescription,L01BC07,AZACITIDINE,9048,,,WHO ATC Classification,,ILS,film coated tablets,AZACITIDINE,2025-07-31T06:13:13.359802,IL,ב.מ.ס,,35390.90331,29992.29227,27265.72025,,7290014396203,ONUREG 300 MG 7 TAB,,,33376,BLISTER PVC/OPA/AL,units,7.0,169 93 36929 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,ONUREG is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/210ac869-9a21-4dc0-a92f-ad808572a19d.json
210ce777-4e02-4d82-ab25-92a5381550d5,SITAR PLUS 50/1000,prescription,A10BD07,METFORMIN AND SITAGLIPTIN,9130,,,WHO ATC Classification,,ILS,film coated tablets,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN AS HYDROCHLORIDE",2025-07-31T08:20:56.366686,IL,אוניפארם,,87.00082796,73.72951522,54.81748343,,,SITAR PLUS 50/1000 56 TAB,,,5823,BLISTER OPAQUE PVC/PVDC/ALUMINIUM,units,56.0,168 98 36685 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Sitar plus is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use: Sitar plus should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. Sitar plus has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitar plus.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/210ce777-4e02-4d82-ab25-92a5381550d5.json
2118a1b6-63bc-4da4-9413-dd052e7d6ffc,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,575,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T12:42:28.105754,IL,ג.ס.ק,,19.8476,16.82,nan,,7290006603036,OTRIVIN DROPS 0.1% 10ML,15081,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,10.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2118a1b6-63bc-4da4-9413-dd052e7d6ffc.json
212217d7-f936-4e09-8a11-65b09f589835,FERRIPROX TABLETS 1000 MG,prescription,V03AC02,DEFERIPRONE,6248,,,WHO ATC Classification,,ILS,film coated tablets,DEFERIPRONE,2025-07-31T03:03:23.846923,IL,לפידות,,693.9866434,588.1243002,500.5313193,,7290018216071,FERRIPROX 500MG 100TAB,6421,,70243,BOTTLE HDPE,units,100.0,163 83 35170 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Ferriprox monotherapy is indicated for the treatment of iron overload in patients over 6 years old with thalassaemia major when current chelation therapy is contraindicated or inadequate.Ferriprox in combination with another chelator is indicated in patients with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life-threatening consequences of iron overload (mainly cardiac overload) justifies rapid or intensive correction.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/212217d7-f936-4e09-8a11-65b09f589835.json
212c3cc9-c7d0-443f-9f14-216297b278dd,PARSABIV,prescription,H05BX04,ETELCALCETIDE,8104,,,WHO ATC Classification,,ILS,solution for injection,ETELCALCETIDE AS HYDROCHLORIDE/,2025-07-31T06:29:22.752522,IL,מדיסון,,1799.671894,1525.145741,1297.996375,,8715131020538,PARSABIV 10 MG/2ML 6 VIALS,10311,,5363,VIAL GLASS TYPE I,units,6.0,161 94 35289 00,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,Parsabiv is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/212c3cc9-c7d0-443f-9f14-216297b278dd.json
2133d97b-af61-4a1b-a9c8-277e38700796,QLAIR,prescription,G03CA03,ESTRADIOL,6915,,,WHO ATC Classification,,ILS,film coated tablets,"ESTRADIOL VALERATE, ESTRADIOL VALERATE, DIENOGEST, DIENOGEST, ESTRADIOL VALERATE",2025-07-31T07:09:06.556770,IL,באייר,,63.43119625,53.75525345,39.96673119,,7290013092052,QLAIR 1X28TAB,17023,,33632,BLISTER PVC/ALUMINIUM,units,28.0,146 16 33128 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Oral contraception.Treatment of heavy menstrual bleeding in women without organic pathology who desire oral contraception.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2133d97b-af61-4a1b-a9c8-277e38700796.json
21412637-6387-43f1-bc88-602ec97c579f,NYOLOL GEL 0.1% 5GR,prescription,,,4140,,,,,ILS,tablet,NYOLOL GEL 0.1% 5GR,2025-07-31T19:24:16.816538,IL,כ.צ.ט,,25.62407996,21.715322,15.8506,,,NYOLOL GEL 0.1% 5GR,14230,,26037,,units,5.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21412637-6387-43f1-bc88-602ec97c579f.json
2155fd56-d549-4ba2-8f33-f008545bd51b,ZOVIRAX,prescription,D06BB03,ACICLOVIR,1192,,,WHO ATC Classification,,ILS,cream,ACICLOVIRW/W,2025-07-31T10:54:50.743051,IL,ג.ס.ק,,37.52920734,31.804413,23.2149,,7290008086950,ZOVIRAX 200MG 25TAB,26020,,2458,PACK PUMP POLYPROPYLENE,units,25.0,126 38 30532 00,valid,37.0,topical,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of cold sores (herpes labialis).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2155fd56-d549-4ba2-8f33-f008545bd51b.json
21621e07-6a93-4a6e-a57d-81bca53c2020,ETORICOXIB TARO 120 MG,prescription,M01AH05,ETORICOXIB,8211,,,WHO ATC Classification,,ILS,film coated tablets,ETORICOXIB,2025-07-31T02:42:10.416484,IL,תרו יבוא,,45.16670944,38.27687241,27.93932293,,,ETORICOXIB TARO 90MG  14TAB,,,45477,BLISTER OPA/ALU/PVC/ALU,units,14.0,160 52 34825 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21621e07-6a93-4a6e-a57d-81bca53c2020.json
216319b9-caa6-4c57-80d2-1c9015376c09,TRANDATE INJECTION,prescription,C07AG01,LABETALOL,285,,,WHO ATC Classification,,ILS,solution for injection,LABETALOL HYDROCHLORIDE/ML,2025-07-31T09:33:43.905866,IL,פאדאגיס,,38.32760396,32.48102175,23.708775,,7290008086899,TRANDATE 100MG 50TAB,20167,,2222,AMPOULES GLASS TYPE I,units,50.0,041 03 23598 21,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment of hypertension when rapid control of blood pressure is essential.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/216319b9-caa6-4c57-80d2-1c9015376c09.json
21744a00-26cc-48e0-8313-0d6d2dc07e4a,DILATAM 120 SR,prescription,C08DB01,DILTIAZEM,2443,,,WHO ATC Classification,,ILS,tablets sustained release,DILTIAZEM HYDROCHLORIDE,2025-07-31T01:56:25.295917,IL,טבע,,30.9150501,26.199195,19.1235,,,DILATAM 120MG 30 SRTAB,4067,,9083,BLISTER PVC/ALUMINIUM,units,30.0,057 29 26825 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Hypertension: either as monotherapy or with other antihypertensive medications such as diuretics. Angina pectoris: chronic stable angina, angina due to coronary artery spasm.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21744a00-26cc-48e0-8313-0d6d2dc07e4a.json
21813f12-0fd0-4aec-8555-307d7ebe2225,REPLENINE - VF 1000,prescription,B02BD04,COAGULATION FACTOR IX,6894,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR IX (HUMAN)/VIAL,2025-07-31T07:26:48.013649,IL,קמהדע,,3580.605529,3034.4116,2758.556,,7290011225391,REPLENINE - VF 1000IU/1VIAL,18568,,28171,VIAL GLASS TYPE I,units,1.0,122 96 29998 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B ( congenital factor IX deficiency).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21813f12-0fd0-4aec-8555-307d7ebe2225.json
2185aa34-9f90-4a1b-80e7-b6004ce933d9,VIA-AVENIR 100 MG,prescription,G04BE03,SILDENAFIL,8259,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:11:25.983486,IL,ביואבניר,,101.1492159,85.7196745,63.7321,,7290010286911,VIA AVENIR 100MG 4TABS,,,55876,BLISTER PVC/PVDC/ALUMINIUM,units,4.0,147 72 33415 01,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2185aa34-9f90-4a1b-80e7-b6004ce933d9.json
21ae114b-efd6-44ad-b14b-c092d0f73b90,FLUCONAZOLE MBI 2 MG/ ML,prescription,J02AC01,FLUCONAZOLE,9278,,,WHO ATC Classification,,ILS,solution for infusion,FLUCONAZOLE/,2025-07-31T03:11:32.933670,IL,אמ.בי.איי פארמה,,2827.044,2395.8,2178.0,,,FLUCONAZOLE MBI 2 MG/ ML 100 ML 50 BAG,,,84872,BAG PVC,units,5000.0,161 92 35274 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections (see section 5.1). Fluconazole is indicated in adults for the treatment of:•	Cryptococcal meningitis (see section 4.4).•	Coccidioidomycosis (see section 4.4).•	Invasive candidiasis.•	Mucosal candidiasis (including oropharyngeal candidiasis, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis).•	Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.Fluconazole is indicated in adults for the prophylaxis of:•	Relapse of cryptococcal meningitis in patients with high risk of recurrence.•	Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•	Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Haematopoetic Stem Cell Transplantation (see section 5.1)).Fluconazole is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence (see section 4.4).Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21ae114b-efd6-44ad-b14b-c092d0f73b90.json
21b06bff-4f95-4ee6-93c3-d40fa0a71412,GLIADEL,prescription,L01AD01,CARMUSTINE,6922,,,WHO ATC Classification,,ILS,wafer,CARMUSTINE 7.7   MG,2025-07-31T03:34:53.531834,IL,מגאפארם,,44364.08484,37596.68374,34178.8034,,3161379010015,GLIADEL 7.7MG 8 WAFERS IMPLANT,7872,,69961,POUCH LAMINATED,units,8.0,110 34 29392 00,valid,10.0,implant,1.4,48,,,,,,,,,,0,Prescription required,For use as an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated.   Gliadel implant is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation.   Gliadel implant is indicated for use as an adjunct to surgery in patients with Recurrent histogically proved glioblastoma multiforme for whom surgical resection is indicated.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21b06bff-4f95-4ee6-93c3-d40fa0a71412.json
21cc33e8-2c51-4cc5-b339-d491eccde1db,FML LIQUIFILM,prescription,S01BA07,FLUOROMETHOLONE,1299,,,WHO ATC Classification,,ILS,"eye drops, suspension",FLUOROMETHOLONE 0.1 %W/V,2025-07-31T03:15:25.659753,IL,אב-וי,,10.56677529,8.954894715,6.5364195,,72991244,FML LIQUIFILM 5ML,822,,6320,DROPER BOTTLE POLYETHYLENE,units,5.0,042 55 24101 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,To treat eye inflammation.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21cc33e8-2c51-4cc5-b339-d491eccde1db.json
21cda70d-d276-4a48-85ce-525f1c4f7dbd,HULIO,prescription,L04AB04,ADALIMUMAB,9095,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/ML,2025-07-31T03:47:38.461986,IL,דקסל פארמה,,2331.675847,1975.996569,1796.360517,,,HULIO 40MG/0.8ML 2 VIAL,8490,,72624,PRE-FILLED PEN GLASS TYPE I,units,2.0,167 87 36610 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis: Hulio in combination with methotrexate is indicated for:-The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.-The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.Hulio can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.Axial spondyloarthritis: Ankylosing spondylitis (AS): Hulio is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Axial spondyloarthritis without radiographic evidence of AS: Hulio is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels , who have had an inadequate response to, or are intolerant to, non-steroidal anti-inflammatory drugs.  Psoriatic arthritis: Hulio is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti rheumatic drug therapy has been inadequate. Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.Psoriasis: Hulio is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.Hidradenitis suppurativa (HS): Hulio is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult patients with an inadequate response to conventional systemic HS therapy.Crohn’s disease:Hulio is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. Hulio is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab. Ulcerative colitis: Hulio is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies. Uveitis: Hulio is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.Intestinal Behcet's disease: Hulio is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21cda70d-d276-4a48-85ce-525f1c4f7dbd.json
21e098e8-1ea4-4855-86bc-0ccb269c72e1,RAMIPRIL INOVAMED 10,prescription,C09AA05,RAMIPRIL,8920,,,WHO ATC Classification,,ILS,tablets,RAMIPRIL,2025-07-31T07:16:08.139172,IL,אינובמד,,25.024968,21.2076,15.48,,,RAMIPRIL INOVAMED 5 MG 30TAB,18642,,72750,BLISTER PVC/ALUMINIUM,units,30.0,166 49 35582 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hypertension congestive heart failure reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction, stroke, cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction, stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) high total cholesterol (>5.2 mmol/L) low HDL ( <0.9 mmol/L) current smoker known microalbuminuria clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21e098e8-1ea4-4855-86bc-0ccb269c72e1.json
21e79d9d-e658-4b3f-83b6-d1d5445238c9,IMBRUVICA 140 MG TABLETS,prescription,L01XE27,IBRUTINIB,9157,,,WHO ATC Classification,,ILS,film coated tablets,IBRUTINIB,2025-07-31T03:59:59.863886,IL,יאנסן סילג,,8325.319084,7055.35547,6413.959518,,7290014577688,IMBRUVICA 140 MG 30 TABLETS,17537,,74055,BLISTER PVC/PCTFE/AL,units,30.0,167 61 36458 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"•	Mantle Cell Lymphoma:Imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.•	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma :Imbruvica is indicated for the treatment of adult patients, with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)•	Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) with 17p deletion:Imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)  /Small Lymphocytic Lymphoma (SLL) with 17p deletion.•	Waldenström’s MacroglobulinemiaImbruvica is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).•	Marginal Zone LymphomaIMBRUVICA is indicated for the treatment of adult patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.•	Chronic Graft versus Host DiseaseIMBRUVICA is indicated for the treatment of adult patients with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21e79d9d-e658-4b3f-83b6-d1d5445238c9.json
21eccc31-32ae-4202-b9a1-194cd7995d21,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,1742,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:30:20.012230,IL,דקסל פארמה,,15.8474,13.43,nan,,,DEXAMOL 500MG 20CAP,4383,,,BLISTER PVC/ALUMINIUM,units,20.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21eccc31-32ae-4202-b9a1-194cd7995d21.json
21f26016-1edb-4fa3-b9d4-c2e852986851,SECTOR 100,prescription,C09DX04,VALSARTAN AND SACUBITRIL,9293,,,WHO ATC Classification,,ILS,sodium salt complex,SACUBITRIL/VALSARTAN AS SODIUM SALT COMPLEX AS SODIUM SALT COMPLEX 49/51  MG,2025-07-31T08:02:05.395934,IL,אוניפארם,,573.9739676,486.4186166,413.9732907,,,SECTOR 100 MG 56 TAB,,,47044,BLISTER PVC/ALUMINIUM,units,56.0,171 72 37119 99,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Sector is indicated for the treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction. Sector has been shown to reduce the rate of cardiovascular death and heart failure hospitalisation compared to angiotensin converting enzyme (ACE) inhibitor therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/21f26016-1edb-4fa3-b9d4-c2e852986851.json
2215a659-9bee-4829-9736-6b67e7b11481,EMPLICITI 300 MG,prescription,,,7815,,,,,ILS,powder for concentrate for solution for infusion,ELOTUZUMAB/VIAL,2025-07-31T02:18:28.812662,IL,ב.מ.ס,,5564.593411,4715.757338,4287.052125,,,EMPLICITI 300 MG VIAL,5616,,73727,VIAL GLASS TYPE I,units,1.0,157 13 34688 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Empliciti is indicated in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.Empliciti is indicated in combination with pomalidomide and dexamethasone for the treatment ofadult patients with relapsed and refractory multiple myeloma who have received at least two priortherapies, including lenalidomide and a proteasome inhibitor, and have demonstrated diseaseprogression on the last therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2215a659-9bee-4829-9736-6b67e7b11481.json
2244697b-f4eb-4709-87a5-28239b94aa23,ATOMIC 100,prescription,N06BA09,ATOMOXETINE,8893,,,WHO ATC Classification,,ILS,coated tablets,ATOMOXETINE AS HYDROCHLORIDE,2025-07-30T23:29:11.799495,IL,אוניפארם,,nan,nan,nan,,,ATOMIC 18 MG 28 TAB,,,66453,BLISTER PVC/ALUMINIUM,units,28.0,167 84 36235 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Atomic is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD. In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Atomic should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD.Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2244697b-f4eb-4709-87a5-28239b94aa23.json
2253010c-3484-422b-8113-b88fca12c7f5,EDECRIN 25MG 100TAB,29C,,,20386,,,,,,tablet,EDECRIN 25MG,2025-07-31T20:20:26.596090,IL,nan,,,,,,,EDECRIN 25MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2253010c-3484-422b-8113-b88fca12c7f5.json
225f1843-1f6f-4f8a-802e-e11ed1936069,QUETIAPINE SANDOZ ® 150 MG PRT,prescription,N05AH04,QUETIAPINE,8837,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:10:42.988379,IL,סנדוז,,103.6111807,87.80608535,65.28333483,,,QUETIAPINE SANDOZ  200 MG  30 PRT,17356,,70536,BLISTER PVC/PCTFE/AL,units,30.0,166 02 35776 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Sandoz PRT is indicated for the treatment of Schizophrenia. Quetiapine Sandoz PRT is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Sandoz PRT. Quetiapine Sandoz PRT  is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for the treatment of major depressive episodes in bipolar disorder. Quetiapine Sandoz PRT is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy . Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Sandoz PRT.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/225f1843-1f6f-4f8a-802e-e11ed1936069.json
226285f3-c13f-4f4b-8fd9-9ac0a7c4faa9,DESMOPRESSIN TEVA 0.1 MG,prescription,H01BA02,DESMOPRESSIN,6771,,,WHO ATC Classification,,ILS,tablets,DESMOPRESSIN ACETATE 0.1  MG,2025-07-31T01:51:14.895246,IL,טבע,,99.64321672,84.443404,62.7832,,7290102065516,DESMOPRESSIN TEVA 0.1MG 30TAB,4551,,30583,BLISTER OPA/AL/PVC,units,30.0,144 40 33065 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. The treatment must be started befor the age of 65.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/226285f3-c13f-4f4b-8fd9-9ac0a7c4faa9.json
2279b486-01c1-47d6-a733-9ffe943a7141,OPTALGIN ® DROPS NEW,off-the-counter,N02BB02,METAMIZOLE SODIUM,5581,,,WHO ATC Classification,,ILS,tablet,DIPYRONE/,2025-07-31T12:40:15.196976,IL,טבע,,34.2908,29.06,nan,,7290110731670,OPTALGIN  DROPS NEW 20 ML,,,,BOTTLE GLASS TYPE III,units,20.0,164 35 35644 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea and for high fever that does not respond to other measures.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2279b486-01c1-47d6-a733-9ffe943a7141.json
2283afce-b848-425f-a969-340dcc50a005,PROSTIN E2 10 MG/ML,prescription,G02AD02,DINOPROSTONE,8926,,,WHO ATC Classification,,ILS,solution for injection,DINOPROSTONE/ML,2025-07-31T07:03:37.375639,IL,פיזר,,276.9590033,234.7110302,187.7688242,,7298074000481,PROSTIN E2 3 MG 4 VAG STRIPS,,,35606,AMPOULES GLASS TYPE I,units,4.0,128 11 22245 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Therapeutic termination of pregnancy, missed abortion.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2283afce-b848-425f-a969-340dcc50a005.json
22882d53-cc53-47c9-bc35-6f18d43f8b38,DILTIAZEM TEVA 30 MG,prescription,C08DB01,DILTIAZEM,6528,,,WHO ATC Classification,,ILS,tablets,DILTIAZEM HYDROCHLORIDE,2025-07-31T01:56:36.603004,IL,טבע,,nan,nan,nan,,,DILTIAZEM TEVA 30MG 30TAB,4533,,27833,BLISTER PVC/ALUMINIUM,units,30.0,140 85 27958 00,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,Calcium channel blocker for the treatment of angina pectoris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22882d53-cc53-47c9-bc35-6f18d43f8b38.json
228d26b5-a5b9-48b3-bec3-65da19311ed8,BUDESONIDE STERINEBS TEVA ® 0.5 MG/2 ML,prescription,R01AD05,BUDESONIDE,6641,,,WHO ATC Classification,,ILS,suspension for inhalation,BUDESONIDE 0.25  MG /,2025-07-30T23:45:35.916608,IL,טבע,,135.0303093,114.4324655,85.0799,,,BUDESONIDE STERINEBS TEVA 1MG/2ML 20UNITS,2508,,24007,AMPOULES POLYETHYLENE,units,20.0,142 43 33002 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Bronchial asthma especially in cases where other therapy is insufficient or insuitable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/228d26b5-a5b9-48b3-bec3-65da19311ed8.json
2298e04a-14d5-44a5-932e-4ca22d6eeb59,NICOTINELL GUM 2 MG (MINT),off-the-counter,N07BA01,NICOTINE,3905,,,WHO ATC Classification,,ILS,chewing gum,NICOTINE,2025-07-31T12:30:58.088782,IL,ג.ס.ק,,61.0296,51.72,nan,,,NICOTINELL GUM 2MG FRUIT 48 tab,14411,,,BLISTER PVC/PVDC/ALUMINIUM,units,48.0,115 78 29638 23,valid,nan,per os,1.4,30,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2298e04a-14d5-44a5-932e-4ca22d6eeb59.json
229af1a7-65da-4807-a51d-3f90ef9be36c,OCTANINE F 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,7719,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR IX (HUMAN)/ML,2025-07-31T06:01:53.633601,IL,דובר מדיקל,,1944.535791,1647.911761,1402.478094,,,OCTANINE F 1000 IU VIAL,,,5096,VIAL GLASS TYPE I,units,1.0,150 35 33831 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/229af1a7-65da-4807-a51d-3f90ef9be36c.json
22ae9c2f-7155-463b-ba78-cff9b04c93b9,HUMALOG,prescription,A10AB04,INSULIN LISPRO,7998,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO 100 U/ML,2025-07-31T03:48:20.776397,IL,אלי לילי,,307.0251471,260.1908142,221.4389908,,7290008067676,HUMALOG KWIKPEN 200 U/ML 5*3 ML,8430,,55367,CARTRIDGE GLASS TYPE I,units,15.0,102 83 28580 00,valid,17.5,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilization of diabetes mellitus.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22ae9c2f-7155-463b-ba78-cff9b04c93b9.json
22b108dd-8640-4c60-8995-0366ed5eeda9,TEGRETOL 200 MG,prescription,N03AF01,CARBAMAZEPINE,603,,,WHO ATC Classification,,ILS,tablets,CARBAMAZEPINE,2025-07-31T09:09:52.344349,IL,נוברטיס פארמה,,23.35712178,19.794171,14.4483,,7298087000836,TEGRETOL CR 200 50T,20479,,7897,BLISTER PVC/PE/PVDC,units,50.0,015 41 24602 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic depressive illness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22b108dd-8640-4c60-8995-0366ed5eeda9.json
22b38cee-576d-4022-81d7-261eecbf7b2a,IXIARO,prescription,J07BA02,"ENCEPHALITIS, JAPANESE, INACTIVATED, WHOLE VIRUS",6921,,,WHO ATC Classification,,ILS,suspension for injection,JAPANESE ENCEPHALITIS PURIFIED INACTIVATED VACCINE 6 AU / 0.5  ML,2025-07-31T04:14:56.053316,IL,קמהדע,,440.9274068,373.6673105,318.0147323,,5060453140000,IXIARO VACCINE 6MCG/0.5ML PREFILLED SYR,35999,,19583,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,146 12 33231 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Ixiaro is indicated for active immunization against Japanese encephalitis in adults, adolescents, children and infants aged 2 months and older. Ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22b38cee-576d-4022-81d7-261eecbf7b2a.json
22c20388-35ff-41d3-bafc-54802fd47e28,STIMOFIL 300 MCG/0.5 ML,prescription,L03AA02,FILGRASTIM,8745,,,WHO ATC Classification,,ILS,solution for injection / infusion,FILGRASTIM/ 0.5  ML,2025-07-31T08:44:02.616126,IL,צמל,,255.2158137,216.2845975,173.027678,,7290015245999,STIMOFIL 480 MCG/0.5 ML 1 SYR PREFILLED,,,51641,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,164 19 36445 00,valid,25.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Stimofil is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia.The safety and efficacy of Stimofil  are similar in adults and children receiving cytotoxic chemotherapy.Stimofil  is indicated for the mobilisation of peripheral blood progenitor cells (PBPCs).In patients, children or adults with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of less or equal to 0.5 x 109 /L, and a history of severe or recurrent infections, long term administration of Stimofil  is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.Stimofil  is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 x 109 /L) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22c20388-35ff-41d3-bafc-54802fd47e28.json
22c3ac86-8152-442f-89e3-0751d9f83623,ADATAR,prescription,D10AD03,ADAPALENE,8945,,,WHO ATC Classification,,ILS,gel,"BENZOYL PEROXIDE AS HYDROUS 2.5 %W/W, ADAPALENE 0.1 %W/W",2025-07-30T23:14:19.904019,IL,תרו יבוא,,145.18425,123.0375,98.43,,7290017164199,ADATAR GEL 45G,,,,CONTAINER PP,units,45.0,163 95 35656 00,valid,25.0,topical,1.4,24,,,,,,,,,,0,Prescription required,"Cutaneous treatment of acne vulgaris when comedones, papules and pustules are present",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22c3ac86-8152-442f-89e3-0751d9f83623.json
22d599f0-af8a-4f81-840b-d4b239d62c48,INDERAL LA 60MG  E.R. 30CAPS,29C,,,20955,,,,,,capsule,INDERAL LA 60MG E.R.,2025-07-31T20:38:04.858964,IL,nan,,,,,,,INDERAL LA 60MG  E.R. 30CAPS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22d599f0-af8a-4f81-840b-d4b239d62c48.json
22f8191f-c766-41df-8ae5-20c4901f8522,TERIL 200,prescription,N03AF01,CARBAMAZEPINE,2112,,,WHO ATC Classification,,ILS,tablets,CARBAMAZEPINE,2025-07-31T09:15:06.131546,IL,תרו,,19.74693066,16.734687,12.2151,,,TERIL 200MG 50TAB,20044,,2134,BLISTER PVC/PVDC,units,50.0,129 63 30784 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neurolgia, diabetes insipidus, mania, prophylactic in manic depressive illness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22f8191f-c766-41df-8ae5-20c4901f8522.json
22f9ecc8-7825-47ef-87d9-42d6d83ebf48,BRAFTOVI 75 MG,29C,L01XE46,ENCORAFENIB,20966,,,WHO ATC Classification,,ILS,hard gelatin capsules,ENCORAFENIB,2025-07-31T14:00:41.703579,IL,nan,,nan,nan,nan,,,BRAFTOVI 50MG  HARD 120 CAPS,,,,BOTTLE HDPE,units,120.0,167 76 35722 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,"BRAF V600E or V600K Mutation-Positive Unresectable or Metastatic MelanomaEncorafenib is a kinase inhibitor indicated, in combination with binimetinib, for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation.BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (CRC)Encorafenib is indicated in combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAF V600E mutation, as detected by an approved test after prior therapy.BRAF V600E Mutation-Positive metastatic non-small cell lung cancer (NSCLC)Encorafenib is a kinase inhibitor indicated, in combination with binimetinib, for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) adenocarcinoma with a BRAF V600E mutation, as detected by an approved test.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/22f9ecc8-7825-47ef-87d9-42d6d83ebf48.json
2301df24-9564-4eb5-b512-fb7f8c6ed2d5,RINVOQ 15 MG,prescription,L04AA44,UPADACITINIB,8740,,,WHO ATC Classification,,ILS,tablets prolonged release,UPADACITINIB AS HEMIHYDRATE,2025-07-31T07:35:33.780240,IL,אב-וי,,3332.268858,2823.956785,2567.233441,,8054083020266,RINVOQ 15 MG 28  SR TAB,,,54200,BLISTER PVC/PE/PCTFE/AL,units,28.0,164 29 36194 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate. Psoriatic arthritis RINVOQ is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. RINVOQ may be used as monotherapy or in combination with methotrexate. Axial spondyloarthritis Non-radiographic axial spondyloarthritis (nr-axSpA) RINVOQ is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs). Ankylosing spondylitis (AS, radiographic axial spondyloarthritis)RINVOQ is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. Atopic dermatitis RINVOQ is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. Ulcerative colitis RINVOQ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. Crohn’s disease RINVOQ is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.Polyarticular juvenile idiopathic arthritisRINVOQ 15mg tablets is indicated for the treatment of patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.Limitations of Use RINVOQ 15 MG is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine.Juvenile psoriatic arthritis RINVOQ 15 MG is indicated for the treatment of pediatric patients 2 years of age and older with active juvenile psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.Limitations of Use RINVOQ 15 MG is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2301df24-9564-4eb5-b512-fb7f8c6ed2d5.json
23040cce-5bf1-4441-b0fd-5ff8a30463af,DELSTRIGO FILM-COATED TABLETS,prescription,J05AR24,"LAMIVUDINE,TENOFOVIR DISOPROXIL AND DORAVIRINE",8504,,,WHO ATC Classification,,ILS,film coated tablets,"DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL AS FUMARATE",2025-07-31T01:46:15.701507,IL,מ.ס.ד. ישראל,,2411.689197,2043.804495,1858.004087,,7290017512167,DELSTRIGO 300 MG/245 MG/100 MG 30 TAB,,,60677,BOTTLE HDPE,units,30.0,165 35 36061 00,valid,10.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) is indicated as a complete regimen for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults without past or present evidence of viral resistance to doravirine, lamivudine, or tenofovir.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/23040cce-5bf1-4441-b0fd-5ff8a30463af.json
232693f2-71eb-4b19-b4a4-4b8767b5cf44,CLONEX 0.5 MG,prescription,N03AE01,CLONAZEPAM,1500,,,WHO ATC Classification,,ILS,tablets,CLONAZEPAM 0.5   MG,2025-07-31T01:21:31.288519,IL,טבע,,15.972008,13.5356,9.88,,7290000800592,CLONEX 0.5MG 30TAB,3181,,502,BLISTER PVC/ALUMINIUM,units,30.0,027 85 22043 12,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Typical or atypical petit mal, Lennox - Gastaut syndrome (petit mal variant), generalized primary or secondary tonic-clonic seizures including grand mal and focal seizures. Panic disorder.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/232693f2-71eb-4b19-b4a4-4b8767b5cf44.json
2333681c-0eff-4dcf-a848-8ee8f13982c1,VOCABRIA INJECTION,prescription,,,9045,,,,,ILS,prolonged release suspension for injection,CABOTEGRAVIR/,2025-07-31T10:19:24.814423,IL,ג.ס.ק,,2632.426494,2230.87001,2028.063645,,,VOCABRIA 30 MG 30 TABLETS,,,89153,VIAL GLASS TYPE I,units,30.0,169 81 36948 99,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Vocabria injection is indicated, in combination with rilpivirine injection, for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with agents of the NNRTI and INI class",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2333681c-0eff-4dcf-a848-8ee8f13982c1.json
2349a3b0-e3e9-476e-a289-f24d40bd7789,OZEMPIC,prescription,A10BJ06,SEMAGLUTIDE,8390,,,WHO ATC Classification,,ILS,solution for injection,SEMAGLUTIDE 1.34  MG /,2025-07-31T06:23:17.793117,IL,נובו נורדיסק,,398.8387806,337.9989816,287.6587078,,,OZEMPIC 1 prefilled pen 0.5MG/0.37ML,15498,,35419,PRE-FILLED PEN GLASS TYPE I,units,1.0,162 09 35750 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2349a3b0-e3e9-476e-a289-f24d40bd7789.json
234b972a-1c0b-4019-87b1-07c6896e52d1,RISPERIDEX 1 MG,prescription,N05AX08,RISPERIDONE,8046,,,WHO ATC Classification,,ILS,tablets,RISPERIDONE,2025-07-31T07:39:03.371623,IL,דקסל פארמה,,31.1971468,26.43826,19.298,,7290010577439,RISPERIDEX 1MG 30TAB,10086,,13505,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,134 54 31353 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/234b972a-1c0b-4019-87b1-07c6896e52d1.json
23507e7e-560c-4778-a9dc-812b9c7a3880,NUROFEN GEL 5 %,off-the-counter,M02AA13,IBUPROFEN,5464,,,WHO ATC Classification,,ILS,gel,IBUPROFENW/W,2025-07-31T12:38:02.687325,IL,רקיט בנקיזר,,50.3034,42.63,nan,,5000158100800,NUROFEN FORTE LIQUID GEL 20 CAPS,14588,,,TUBE ALUMINIUM,units,20.0,134 23 31074 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/23507e7e-560c-4778-a9dc-812b9c7a3880.json
2355103c-e0fc-420c-9200-f1254e8656b6,BRIVIACT ORAL SOLUTION,prescription,N03AX23,BRIVARACETAM,8465,,,WHO ATC Classification,,ILS,solution  (oral),BRIVARACETAM/,2025-07-30T23:44:24.839002,IL,ניאופרם,,533.3256381,451.9708999,384.656085,,72901110927425,BRIVIACT ORAL SOLUTION 10MG/ML 300ML,2633,,74100,BOTTLE GLASS TYPE III,units,300.0,159 93 35246 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2355103c-e0fc-420c-9200-f1254e8656b6.json
235db032-82cd-418d-a7ec-8b96656eafe8,KIOVIG 100 MG/ML,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7133,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/",2025-07-31T04:26:56.378881,IL,טקדה,,1630.995365,1382.199524,1176.34002,,7290018375280,KIOVIG 5G/50ML VIAL,11296,,37083,VIAL GLASS TYPE I,units,50.0,146 45 33157 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"IVIg can be used in all age ranges, unless otherwise specified below.Replacement therapy in:Primary immunodeficiency syndromes with impaired antibody production.Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.Children and adolescents (age 0-18) with congenital AIDS and recurrent bacterial infections.Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).ImmunomodulationPrimary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.Guillain Barré syndrome.Kawasaki disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/235db032-82cd-418d-a7ec-8b96656eafe8.json
2367412d-7507-49c2-9a6f-237a109d8e19,DEPIXOL 100MG/ML 10 ampoule,29C,,,20976,,,,,,injection,DEPIXOL 100MG/ML oule,2025-07-31T20:12:19.499098,IL,nan,,,,,,,DEPIXOL 100MG/ML 10 ampoule,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2367412d-7507-49c2-9a6f-237a109d8e19.json
2375a550-7c32-4312-942f-17112b721a07,N-KE'EV,off-the-counter,M02AA15,DICLOFENAC,5433,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T12:33:26.682271,IL,ליף-טרי אוף ליף,,35.5062,30.09,nan,,7290102747436,N-KE'EV 50GR,,,,TUBE ALUMINIUM,units,50.0,140 07 31948 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to:• Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries).• Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :Pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2375a550-7c32-4312-942f-17112b721a07.json
23813908-d3b8-421f-96c1-1eb1af8fc7b0,OCREVUS,prescription,L04AA36,OCRELIZUMAB,8347,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,OCRELIZUMAB/ML,2025-07-31T06:00:13.830285,IL,רוש,,24474.65371,20741.23288,18855.66625,,7290014774056,OCREVUS 300MG/10ML 1VIAL 15ML,,,55497,VIAL GLASS TYPE I,units,1.0,159 11 34981 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,OCREVUS is indicated for the treatment of adult patients with relapsing or primary progressive forms of multiple sclerosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/23813908-d3b8-421f-96c1-1eb1af8fc7b0.json
238c30f3-8018-41c1-85e6-c0088c89d449,PREGABALIN INOVAMED 150 MG,prescription,N03AX16,PREGABALIN,8327,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:53:22.161948,IL,אינובמד,,200.1721025,169.637375,135.7099,,7290104530364,PREGABALIN INOVAMED 300 MG 56 CAPS,10304,,4218,BLISTER PVC/ALUMINIUM,units,56.0,156 17 34774 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Pregabalin Inovamed is indicated for the:* treatment of peripheral and central neuropathic pain in adults. * Management of Fibromyalgia.* Treatment of Generalised Anxiety Disorder (GAD) in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/238c30f3-8018-41c1-85e6-c0088c89d449.json
238d8629-8884-4c21-9652-10a376b5064f,EVENITY ®,prescription,M05BX06,ROMOSOZUMAB,8507,,,WHO ATC Classification,,ILS,solution for injection,ROMOSOZUMAB/,2025-07-31T02:44:08.444366,IL,מדיסון,,2422.773194,2053.197714,1747.40231,,,EVENITY 105 MG/1.17ML 2 PREFILLED SYR,5663,,3652,SYRINGE PREFILLED  ,units,2.0,164 77 36165 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"EVENITY is indicated for the treatment of severe osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/238d8629-8884-4c21-9652-10a376b5064f.json
23a9312c-7757-47d4-bccd-8b1776ed7ed7,RISPERDAL 1 MG,prescription,N05AX08,RISPERIDONE,4612,,,WHO ATC Classification,,ILS,film coated tablets,RISPERIDONE,2025-07-31T07:38:21.018949,IL,יאנסן סילג,,287.8735494,243.960646,207.6260817,,7290008124744,RISPERDAL CONSTA/DELTOID 25MG VIAL,18425,,11174,BLISTER PVC/PE/PVDC/AL,units,1.0,144 78 28260 01,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/23a9312c-7757-47d4-bccd-8b1776ed7ed7.json
23c34bdc-1f11-46d3-8607-4cbeaf21cedf,EFEXOR XR 150,prescription,N06AX16,VENLAFAXINE,4524,,,WHO ATC Classification,,ILS,capsules extended release,VENLAFAXINE AS HYDROCHLORIDE,2025-07-31T02:11:33.746070,IL,פיזר,,57.10623334,48.395113,35.3249,,,EFEXOR  XR 150MG 28 SR CAPS,5186,,30643,BLISTER PVC/FOIL,units,28.0,111 18 29395 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of depression.   Maintenance of recurrent depression.   Generalized anxiety disorder (GAD) - short term and long-term.   Social anxiety Disorder (SAD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/23c34bdc-1f11-46d3-8607-4cbeaf21cedf.json
23c8eb81-3a9a-4151-998a-789bbed23bd8,FEXY 180,off-the-counter,R06AX26,FEXOFENADINE,5623,,,WHO ATC Classification,,ILS,film coated tablets,FEXOFENADINE HYDROCHLORIDE,2025-07-31T11:55:47.045481,IL,תרימה,,37.5122,31.79,nan,,,FEXY 180 30 TAB,,,,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,170 13 37246 99,valid,nan,per os,1.4,24,,,,,,,,,,0,,Relief of symptoms associated with chronic idiopathic urticaria, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/23c8eb81-3a9a-4151-998a-789bbed23bd8.json
23cdbeb1-324a-43c6-a8c7-8ee45baee69a,LOCERYL,prescription,D01AE16,AMOROLFINE,6003,,,WHO ATC Classification,,ILS,lacquer,AMOROLFINE AS HYDROCHLORIDEW/V,2025-07-31T04:52:45.697331,IL,אמי טכנולוגיות,,52.87187296,44.806672,32.7056,,,LOCERYL LACQUE 2.5ML,12383,,71194,BOTTLE GLASS,units,2.5,133 12 30949 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,"Topical treatment of onycomycosis caused by dermatophytes, yeast and moulds.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/23cdbeb1-324a-43c6-a8c7-8ee45baee69a.json
23df6efe-6dcb-4fc3-8f9c-20aea6e65de4,TIPTIPOT AFALPI,off-the-counter,R01BA02,PSEUDOEPHEDRINE,5058,,,WHO ATC Classification,,ILS,drops,PSEUDOEPHEDRINE AS HYDROCHLORIDE/ML,2025-07-31T13:29:38.942233,IL,כ.צ.ט,,31.8954,27.03,nan,, 7290008104579,TIPTIPOT SIMICOL DROPS 30ML,20332,,,BOTTLE GLASS,units,30.0,121 43 30172 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relief eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/23df6efe-6dcb-4fc3-8f9c-20aea6e65de4.json
24010c15-0e62-4eec-914c-4b1a2e598fba,AGISERC 16,prescription,N07CA01,BETAHISTINE,7306,,,WHO ATC Classification,,ILS,tablets,BETAHISTINE DIHYDROCHLORIDE,2025-07-30T23:37:10.206743,IL,טבע,,15.737601,13.33695,9.735,,7-290002-925422,BETAHISTINE TEVA 16MG 30TAB,2556,,49797,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,056 87 27365 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Meniere's syndrom. Symptomatic treatment of peripheral vertigo.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24010c15-0e62-4eec-914c-4b1a2e598fba.json
24188070-9d6b-4ecd-8f2c-a411f67c0ef8,ENTYVIO I.V.,prescription,L04AG05,VEDOLIZUMAB,9454,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,VEDOLIZUMAB/VIAL,2025-07-31T02:24:57.539472,IL,טקדה,,3712.048094,3145.803609,2859.821463,,50335382011547,ENTYVIO 108MG/0.68ML 2 PREFILLED PEN,,,57232,VIAL GLASS TYPE I,units,2.0,153 58 34277 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Ulcerative Colitis:Entyvio is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFα) antagonist.Crohn’s Disease:Entyvio is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFα) antagonist.Pouchitis Entyvio is indicated for the treatment of adult patients with moderately to severely active chronic pouchitis, who have undergone proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis, and have had an inadequate response with or lost response to antibiotic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24188070-9d6b-4ecd-8f2c-a411f67c0ef8.json
241ff2e9-25c3-4f22-9fff-0afe5eb80b29,STATOR 10,prescription,C10AA07,ROSUVASTATIN,6517,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T08:40:46.064734,IL,אוניפארם,,124.0558302,105.1320595,78.1651,,,STATOR 20MG 28FC TAB,19893,,85913,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,143 13 31932 02,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as  an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise  weight reduction ) is inadequate.  Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/241ff2e9-25c3-4f22-9fff-0afe5eb80b29.json
242562be-7644-48b0-8684-bf113c5841f5,NUROFEN FORTE LIQUID CAPSULES 400 MG,off-the-counter,M02AA13,IBUPROFEN,5080,,,WHO ATC Classification,,ILS,capsules liquid filled,IBUPROFEN,2025-07-31T12:38:41.864204,IL,רקיט בנקיזר,,33.4294,28.33,nan,,,NUROFEN LIQUID 200MG 20 CAPS,14381,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,148 44 31886 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Relief of mild to moderate pain such as headache, toothache, menstrual pain, backache, muscular pain, anti-inflammatory for rheumatic disease, reduction of fever.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/242562be-7644-48b0-8684-bf113c5841f5.json
24495f2a-ad75-4e26-a1f8-150ba2c40d01,ULTRAVIST 300,prescription,V08AB05,IOPROMIDE,7005,,,WHO ATC Classification,,ILS,solution for injection,IOPROMIDE 623.4   MG /,2025-07-31T09:51:29.474652,IL,באייר,,321.4087934,272.3803455,231.81306,,7290013092267,ULTRAVIST 300 623.4MG/ML 200ML,21135,,64785,BOTTLE GLASS TYPE II,units,200.0,064 18 27492 00,valid,17.5,"i.v, intra-arterial",1.4,36,,,,,,,,,,0,Prescription required,"Contrast enhancement in computerized tomography (CT) , digital subtraction angiography (DSA), intravenous urography, arteriography ,phlebography of the extremities, venography, visualization of body cavities (e.g. arthrography, hysterosalpingography,fistulography) with the exception of myelography, ventriculography, cisternography.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24495f2a-ad75-4e26-a1f8-150ba2c40d01.json
24611344-f510-4665-bc21-0747735df492,AETHOXYSKLEROL 3% 5AMPX2ML,29C,,,20031,,,,,,injection,AETHOXYSKLEROL 3% X,2025-07-31T19:51:11.322619,IL,nan,,,,,,,AETHOXYSKLEROL 3% 5AMPX2ML,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24611344-f510-4665-bc21-0747735df492.json
24791336-b156-48b6-a861-6d07b5938eed,TALZENNA 0.25 MG,prescription,L01XX60,TALAZOPARIB,8544,,,WHO ATC Classification,,ILS,"capsule, hard",TALAZOPARIB AS TOSYLATE 0.25  MG,2025-07-31T09:02:24.389798,IL,פיזר,,7912.790637,6705.755075,6096.140978,,7290013592620,TALZENNA 0.25 MG  30 CAPS,,,548,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,164 07 36019 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,TALZENNA is indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA) mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24791336-b156-48b6-a861-6d07b5938eed.json
249e066a-244d-4369-97cc-b52b6985a542,SILDENAFIL TEVA ® 100 MG,prescription,G04BE03,SILDENAFIL,7527,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T08:12:39.021604,IL,טבע,,188.0098425,159.330375,127.4643,,,SILDENAFIL TEVA  100 MG 8 TAB,9772,,55922,BLISTER PVC/PE/PVDC/AL,units,8.0,147 86 33474 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Sildenafil Teva ® 100 mg FC Tablets is indicated for the treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/249e066a-244d-4369-97cc-b52b6985a542.json
24a4aad2-56dc-423c-a338-5ed13ee5bbea,INIPARIB 100MG/10ML 10 VIALX10ML,29C,,,20463,,,,,,injection,INIPARIB 100MG/ X,2025-07-31T20:38:39.422236,IL,nan,,,,,,,INIPARIB 100MG/10ML 10 VIALX10ML,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24a4aad2-56dc-423c-a338-5ed13ee5bbea.json
24ac9cf0-49f5-439b-aad3-ba77d0c55dbd,STILNOX 10 MG TABLETS,prescription,N05CF02,ZOLPIDEM,9349,,,WHO ATC Classification,,ILS,film coated tablets,ZOLPIDEM TARTRATE,2025-07-31T08:43:23.907954,IL,סאנופי אוונטיס,,14.015922,11.8779,8.67,,,STILNOX 10 MG 14 TABLETS,23385,,89040,BLISTER PVC/ALUMINIUM,units,14.0,104 51 27587 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Zolpidem is indicated for the short-term treatment of occasional or transient insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24ac9cf0-49f5-439b-aad3-ba77d0c55dbd.json
24af2c0f-b152-4c01-b839-bd093a693aee,PENIBRIN 1 G,prescription,J01CA01,AMPICILLIN,9152,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,AMPICILLIN AS SODIUM/VIAL,2025-07-31T06:34:00.898726,IL,טבע,,101.9930121,86.43475989,64.263762,,7290008096553,PENIBRIN 1 G 10 VIAL,,,83477,VIAL GLASS TYPE III,units,10.0,032 41 22422 00,valid,34.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Penibrin injection is recommended in serious infections when prompt, effective levels of the antibiotic must reach the site of infection. Such infections include meningitis, subacute bacterial endocarditis, peritonitis, septicemia, severe forms of chronic bronchitis, osteomyelitis, pneumonia and pyelonephritis due to susceptible organisms.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24af2c0f-b152-4c01-b839-bd093a693aee.json
24cd85dc-0dee-429d-8087-5747aec6b382,ESMOLOL AMOMED 100 MG/10 ML,prescription,C07AB09,ESMOLOL,8135,,,WHO ATC Classification,,ILS,solution for injection,ESMOLOL HYDROCHLORIDE/ML,2025-07-31T02:35:52.560648,IL,אי.או.פי אורפן,,276.0307625,233.924375,187.1395,,7290103847739,ESMOLOL 10MG/ML (100MG/10ML) 5 VIALX10ML,5625,,65876,VIAL GLASS TYPE I,units,5.0,159 69 34872 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Esmolol Amomed 100 mg/10 ml  is indicated for supraventricular tachycardia (except for pre-excitation syndromes) and for the rapid control of the ventricular rate in adult patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.Esmolol Amomed 100 mg/10 ml is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia in adult patients where, in the physician’s judgement the rapid heart rate requires specific intervention.Esmolol Amomed 100 mg/10 ml is not intended for use in chronic settings.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24cd85dc-0dee-429d-8087-5747aec6b382.json
24ea8cd9-b398-4e9d-804e-e1b2d57c232f,HUMALOG,prescription,A10AB04,INSULIN LISPRO,6629,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO 100 U/ML,2025-07-31T03:48:47.184090,IL,אלי לילי,,189.4390139,160.5415444,128.4332355,,7290008067676,HUMALOG MIX 25 KWIKPEN 5X3ML,9387,,18782,CARTRIDGE GLASS TYPE I,units,15.0,102 83 28580 00,valid,25.0,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilization of diabetes mellitus.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24ea8cd9-b398-4e9d-804e-e1b2d57c232f.json
24eb18e2-850f-42e5-895b-a5f0673bd058,EVICEL HUMAN SURGICAL SEALANT,prescription,B05BA10,COMBINATIONS,6854,,,WHO ATC Classification,,ILS,solution,"THROMBIN 800 -/, CALCIUM CHLORIDE 5.6 - 6.20  MG /, PROTEIN CLOTTABLE 50 -/",2025-07-31T02:45:48.582741,IL,אומריקס,,nan,nan,nan,,7290004961862,EVICEL HUMAN SURGICAL SEALANT 2X2ML (ללא אפליקטור),,,35932,VIAL 10 ML GLASS TYPE I,units,2.0,118 61 29895 02,valid,nan,topical in surgery,1.4,24,,,,,,,,,,0,Prescription required,"General haemostasis : Evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. Efficacy has been demonstrated in liver surgery and orthopaedic surgery.Evicel ® is also indicated as suture support for haemostasis for suture line sealing in dura mater closure.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24eb18e2-850f-42e5-895b-a5f0673bd058.json
24f60ca1-8885-4eb3-978f-8373044a0866,TASIGNA 150 MG,prescription,L01XE08,NILOTINIB,6700,,,WHO ATC Classification,,ILS,capsules,NILOTINIB AS HYDROCHLORIDE MONOHYDRATE,2025-07-31T09:07:26.891925,IL,נוברטיס פארמה,,9873.472437,8367.349895,7606.681722,,,TASIGNA 150MG 112CAPS,20707,,3416,BLISTER PVC/PVDC/ALUMINIUM,units,112.0,145 84 33271 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24f60ca1-8885-4eb3-978f-8373044a0866.json
24f8fafd-9921-443c-a5e1-7dc3e4a38c74,TOPAMAX 100,prescription,N03AX11,TOPIRAMATE,3551,,,WHO ATC Classification,,ILS,film coated tablets,TOPIRAMATE,2025-07-31T09:25:10.128759,IL,יאנסן סילג,,149.81929,126.9655,101.5724,,,TOPAMAX 100MG 60TAB,20165,,52947,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,107 57 29033 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topamax is indicated in adults for the prevention of migraines. The use of Topamax in the acute treatment of migraine has not been studied.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24f8fafd-9921-443c-a5e1-7dc3e4a38c74.json
24fdcda7-caeb-4785-a834-86dcbe988a64,THREOLONE,prescription,D07XA02,PREDNISOLONE,1426,,,WHO ATC Classification,,ILS,ointment,"PREDNISOLONE 0.5 %, CHLORAMPHENICOL",2025-07-31T09:19:26.427027,IL,טבע,,nan,nan,nan,,7290008001458,THREOLONE OINT 10GR,20113,,2183,TUBE ALUMINIUM,units,10.0,027 40 21618 00,valid,nan,topical,1.4,36,,,,,,,,,,0,Prescription required,"Infected eczema, pruritic lesions, angular stomatitis, impetigo, external otitis and pyoderma and other skin infections caused by chloramphenicol susceptible organisms.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/24fdcda7-caeb-4785-a834-86dcbe988a64.json
2502a96b-5cf8-4063-95b8-427da4062bb0,FENTAMED 100 MCG,prescription,N01AH01,FENTANYL,9364,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE MICRONIZED,2025-07-31T02:59:46.670140,IL,אינובמד,,1057.051101,895.8060175,762.3881,,7290104531170,FENTAMED 200 MCG 30 TAB SUBLINGUAL,23635,,5026,BLISTER PA/AL/PVC//ALU/PET,units,30.0,173 43 36706 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fentamed is indicated for management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2502a96b-5cf8-4063-95b8-427da4062bb0.json
251a722d-859e-4883-b1d4-c8c50e602122,HEMANGIOL,prescription,C07AA05,PROPRANOLOL,8105,,,WHO ATC Classification,,ILS,solution,PROPRANOLOL AS HYDROCHLORIDE 3.75  MG /,2025-07-31T03:43:48.771892,IL,פאדאגיס,,934.8289572,792.2279651,674.236566,,7290012162411,HEMANGIOL SOLUTION 3.75 MG/ML 120 ML BOTTLE,8448,,26396,BOTTLE GLASS TYPE III,units,120.0,159 68 35287 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of proliferating infantile haemangioma requiring systemic therapy:• Life- or function-threatening haemangioma,• Ulcerated haemangioma with pain and/or lack of response to simple wound care measures,• Haemangioma with a risk of permanent scars or disfigurement.It is to be initiated in infants aged 5 weeks to 5 months",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/251a722d-859e-4883-b1d4-c8c50e602122.json
254679e1-eb67-46f3-9df1-fceacfa507bc,TIMOLAN-AVENIR,prescription,S01ED01,TIMOLOL,8282,,,WHO ATC Classification,,ILS,"eye drops, solution","TIMOLOL AS MALEATE/, LATANOPROST 0.05  MG /",2025-07-31T09:21:07.572807,IL,ביואבניר,,40.2331325,34.095875,24.8875,,7290010287048,TIMOLAN AVENIR  2.5ML OPHTALMIC SOLUTION,,,4205,VIAL LDPE,units,2.5,159 54 34958 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/254679e1-eb67-46f3-9df1-fceacfa507bc.json
25491b72-4d83-4764-8dac-2285e1078151,CLEXANE,prescription,B01AB05,ENOXAPARIN,6484,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/ML  ML,2025-07-31T01:19:33.831467,IL,סאנופי אוונטיס,,70.1460872,59.44583925,44.19765,,7290012711121,CLEXANE 100MG SAFETY LOCK 2X1ML SYR PREFIL,3993,,84290,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,046 77 26037 11,valid,34.5,"i.v, s.c, extracorporeal",1.4,36,,,,,,,,,,0,Prescription required,"Clexane is indicated in adults for: • Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery. • Prevention of thrombus formation in extra corporeal circulation during haemodialysis. • Acute coronary syndrome: - Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid. - Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25491b72-4d83-4764-8dac-2285e1078151.json
255ec67d-9daa-4aa9-981c-b5a3346f95fb,STAQUIS,prescription,,,8540,,,,,ILS,ointment,CRISABOROLEW/W,2025-07-31T08:40:20.173550,IL,פיזר,,nan,nan,nan,,,STAQUIS 2% 60 G,,,29658,TUBE HDPE,units,60.0,161 76 35303 00,valid,nan,topical,1.4,36,,,,,,,,,,0,Prescription required,Staquis is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/255ec67d-9daa-4aa9-981c-b5a3346f95fb.json
257216c2-7df6-4f05-9853-dba7f2228d5a,SPASMEX 15,prescription,G04BD09,TROSPIUM,4960,,,WHO ATC Classification,,ILS,film coated tablets,TROSPIUM CHLORIDE,2025-07-31T08:32:49.284627,IL,ליברה,,53.52386714,45.35920944,33.108912,,4028305000521,SPASMEX 15MG 30TAB,19755,,64797,BLISTER PVC,units,30.0,132 49 30583 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/257216c2-7df6-4f05-9853-dba7f2228d5a.json
2585232f-e535-4ec0-92ab-6305f20438df,NOXAFIL 100 MG GASTRO-RESISTANT TABLETS,prescription,J02AC04,POSACONAZOLE,9519,,,WHO ATC Classification,,ILS,gastro resistant tablets,POSACONAZOLE,2025-07-31T06:47:29.899522,IL,אופק פארמה,,1809.553485,1533.519971,1305.123379,,7290006813893,POSACONAZOLE 100 MG OFEK PHARMA 24 TAB,,,666,BLISTER PVC/ACLAR/ALUMINIUM,units,24.0,156 42 34550 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Noxafil gastro-resistant tablets are indicated for use in the treatment of the following fungal infections in adults:- Invasive aspergillosis in patients with disease that is refractory to amphotericin B or itraconazole or in patients who are intolerant of these medicinal products;- Fusariosis in patients with disease that is refractory to amphotericin B or in patients who are intolerant of amphotericin B;- Chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole;- Coccidioidomycosis in patients with disease that is refractory to amphotericin B, itraconazole or fluconazole or in patients who are intolerant of these medicinal products.- Zygomycosis in patients intolerant of or with disease that is refractory to alternative therapy.Refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.Noxafil gastro-resistant tablets are also indicated for prophylaxis of invasive fungal infections in the following patients:- Patients receiving remission-induction chemotherapy for acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS) expected to result in prolonged neutropenia and who are at high risk of developing invasive fungal infections;- Hematopoietic stem cell transplant (HSCT) recipients who are undergoing high-dose immunosuppressive therapy for graft versus host disease and who are at high risk of developing invasive fungal infections.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2585232f-e535-4ec0-92ab-6305f20438df.json
258c33b7-7318-4beb-88ae-110149624a9d,SIMVASTATIN TEVA ® 40 MG,prescription,C10AA01,SIMVASTATIN,4686,,,WHO ATC Classification,,ILS,tablets,SIMVASTATIN,2025-07-31T08:15:46.235604,IL,טבע,,29.3534145,24.875775,18.1575,,,SIMVASTATIN-TEVA 40MG 30TAB,19714,,59805,BLISTER PVC/PE/PVDC/AL,units,30.0,129 18 30737 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia  Simvastatin-teva is indicated to:     Reduce the risk of total mortality by reducing coronary death ;Reduce the risk of non-fatal myocardial infarction ;Reduce the risk for undergoing myocardial revascularization procedures.      Reduce the risk of stroke and transient ischemic attacks (TIA).   Hyperlipidemia: Simvastatin-teva is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvastatin-teva therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios.   Homozygous familial hypercholesterolemia: Simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Simvastatin-teva is indicated for the treatment of patients with hypertriglyceridemia ( Fredrickson type IV  hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia): Simvastatin-teva is also indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/258c33b7-7318-4beb-88ae-110149624a9d.json
25a1d6fb-06d8-4fd5-9f91-c990f804df2a,BENEMIDE 500MG 30TAB,29C,,,20306,,,,,,tablet,BENEMIDE 500MG,2025-07-31T20:00:01.151960,IL,nan,,,,,,,BENEMIDE 500MG 30TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25a1d6fb-06d8-4fd5-9f91-c990f804df2a.json
25c0f320-9680-4b10-ae56-02c0a7471a72,ASASANTINE 200MG/25MG 10CAPS SR,29C,,,20810,,,,,,capsule,ASASANTINE 200MG/25MG SR,2025-07-31T19:57:25.777241,IL,nan,,,,,,,ASASANTINE 200MG/25MG 10CAPS SR,,,,,units,10.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25c0f320-9680-4b10-ae56-02c0a7471a72.json
25da1c13-6fd3-4eda-8b7c-52c941ec81ce,YUFLYMA,prescription,L04AB04,ADALIMUMAB,9515,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/ML,2025-07-31T10:42:41.094396,IL,פאדאגיס,,2374.023693,2011.884575,1828.985978,,,YUFLYMA 80MG/0.8ML 1 PEN,,,,PRE-FILLED PEN GLASS TYPE I,units,1.0,171 96 37092 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis   Yuflyma in combination with methotrexate, is indicated for:• the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.• the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.Yuflyma can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.Juvenile idiopathic arthritisPolyarticular juvenile idiopathic arthritisYuflyma in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years  who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs). Yuflyma can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. Adalimumab has not been studied in patients aged less than 2 years.Enthesitis-related arthritisYuflyma is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy.Axial spondyloarthritis• Ankylosing spondylitis (AS)Yuflyma is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.• Axial spondyloarthritis without radiographic evidence of ASYuflyma is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels, who have had an inadequate response to, or are intolerant to non-steroidal anti-inflammatory drugs (NSAIDs).Psoriatic arthritisYuflyma is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate.Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.PsoriasisYuflyma is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.Paediatric plaque psoriasisYuflyma is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age  who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.Hidradenitis suppurativa (HS)Yuflyma is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy.Crohn’s diseaseYuflyma is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease, who have had an inadequate response to conventional therapy. Yuflyma is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.Paediatric Crohn's diseaseYuflyma is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and corticosteroid and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies.Ulcerative colitisYuflyma is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.Paediatric ulcerative colitis Yuflyma is indicated for the treatment of moderately to severely active ulcerative colitis in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including corticosteroids and/or 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.  UveitisYuflyma is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.Paediatric uveitisYuflyma is indicated for the treatment of chronic non-infectious uveitis in paediatric patients from 2 years of age, who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.Intestinal Behcet's diseaseYuflyma is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25da1c13-6fd3-4eda-8b7c-52c941ec81ce.json
25dfa70b-a90b-433e-b72f-c47f46a18cb6,MESNA-CELL 100 MG/ML,prescription,V03AF01,MESNA,7760,,,WHO ATC Classification,,ILS,solution for injection,MESNA/,2025-07-31T05:14:56.969944,IL,אמ.בי.איי פארמה,,134.3494434,113.8554605,84.6509,,7290014257535,MESNA-CELL 400MG/4ML 10AMPOULES,,,62575,AMPOULES GLASS,units,10.0,154 04 34131 00,valid,34.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Prevention of urinary tract toxicity of oxazaphosphorines (the active components of Ifosfamide, Cyclophosphamide , Trofosfamide) in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous ifosfamide, Cyclophosphamide or Trofosfamide, urinary passage diseases in anamnesis.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25dfa70b-a90b-433e-b72f-c47f46a18cb6.json
25f660ad-9bbb-4041-9ff0-13806fd4409f,ETORICOXIB DEXCEL 120 MG,prescription,M01AH05,ETORICOXIB,8179,,,WHO ATC Classification,,ILS,tablets,ETORICOXIB,2025-07-31T02:41:07.174167,IL,דקסל פארמה,,50.63365793,42.9098796,31.32108,,,ETORICOXIB DEXCEL 30 MG 28 tabs,5627,,74261,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,160 18 34751 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25f660ad-9bbb-4041-9ff0-13806fd4409f.json
25fa0435-9c3a-4294-b2c7-a2ecfd1265da,ELOCTA 250 IU,29C,B02BD05,COAGULATION FACTOR VII,9067,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR VIII,2025-07-31T14:26:59.770135,IL,nan,,nan,nan,nan,,,ELOCTA 250 IU,,,,VIAL GLASS TYPE I,units,1.0,170 48 36894 00,valid,nan,i.v,1.4,60,,,,,,,,,,0,,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25fa0435-9c3a-4294-b2c7-a2ecfd1265da.json
25fb692a-890c-44ac-832f-a8d9caf169b9,CORDAMIL 40 MG,prescription,C08DA01,VERAPAMIL,9124,,,WHO ATC Classification,,ILS,film coated tablets,VERAPAMIL HYDROCHLORIDE,2025-07-31T01:30:22.038977,IL,טרוסטפארם,,36.308836,30.7702,22.46,,5944708138700,CORDAMIL 80 MG 60 TAB,23212,,30332,BLISTER PVC/ALUMINIUM,units,60.0,169 31 36504 99,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Cordamil is indicated for treatment of coronary heart disease, including:- chronic stable angina pectoris (effort angina), - unstable angina pectoris: - aggravated angina, resting angina, vasospastic angina (Prinzmetal angina)   - post heart-attack angina in patients without heart failure, when adrenergic beta-blockers are contraindicated. Prevention of ventricular fast heart rate disorders not controlled by tonic-cardiac glycosides or beta-blockers (for example supraventricular paroxysmal tachycardia, atrial fibrillation/ flutter with rapid ventricular response, except for Wolff-Parkinson-White syndrome.) Moderate to mild essential hypertension",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25fb692a-890c-44ac-832f-a8d9caf169b9.json
25fc51ea-4b8e-42cc-b6e5-ea7e8910db9a,ALDOMET (METHYLDOPA) 250MG 30TAB,29C,,,20032,,,,,,tablet,ALDOMET (METHYLDOPA) 250MG,2025-07-31T19:52:06.252818,IL,nan,,,,,,,ALDOMET (METHYLDOPA) 250MG 30TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25fc51ea-4b8e-42cc-b6e5-ea7e8910db9a.json
25fe29bc-b28a-458e-9dfc-0fcc946c2acb,MARGENZA,prescription,L01FD06,MARGETUXIMAB,9020,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,MARGETUXIMAB/ML,2025-07-31T05:05:38.816072,IL,ניאופרם,,nan,nan,nan,,,MARGENZA 25 MG IV 1 VIAL,17871,,88148,VIAL GLASS TYPE I,units,1.0,172 18 37089 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,Prescription required,"MARGENZA is indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/25fe29bc-b28a-458e-9dfc-0fcc946c2acb.json
2621e24e-744a-4e48-b0d6-da55ea54894d,VILDAGLIPTIN S.K.,prescription,A10BH02,VILDAGLIPTIN,9559,,,WHO ATC Classification,,ILS,tablets,VILDAGLIPTIN,2025-07-31T10:15:12.244001,IL,SK PHARM(KS KIM),,68.72294743,58.23978855,43.30095803,,,VILDAGLIPTIN S.K. 50 MG 56 TAB,,,,BLISTER OPA/AL/PVC,units,56.0,174 65 36635 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Vildagliptin S.K. is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose. As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Vildagliptin S.K. is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control. Vildagliptin S.K. is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• In combination with a thiazolidinedione, in patients with insufficient glycaemic control and for whom the use of a thiazolidinedione is appropriate.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2621e24e-744a-4e48-b0d6-da55ea54894d.json
2629e469-3773-4278-9575-7a7ece9d7660,TAVANIC TABLETS 500 MG,prescription,J01MA12,LEVOFLOXACIN,8452,,,WHO ATC Classification,,ILS,film coated tablets,LEVOFLOXACIN AS HEMIHYDRATE,2025-07-31T04:45:36.125603,IL,ליברה,,110.017772,93.2354,69.32,,,LEVOFLOX 5 MG/ML 1 vial (100ML),,,26822,BLISTER PVC/ALUMINIUM,units,1.0,119 44 29963 21,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tavanic Tablets 500 mg is indicated in adults for the treatment of the following infections:-	Acute pyelonephritis and complicated urinary tract infections -	Chronic bacterial prostatitisIn the below-mentioned infections, Tavanic should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections.-	Acute bacterial sinusitis -	Acute exacerbations of chronic obstructive pulmonary disease including bronchitis -	Community-acquired pneumonia-	Complicated skin and soft tissue infections.Tavanic may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.Consideration should be given to official guidance on the appropriate use of antibacterial agents.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2629e469-3773-4278-9575-7a7ece9d7660.json
262bf9cc-5a16-48ea-a42c-6bc1b1d1ad59,ERIVEDGE,prescription,,,7166,,,,,ILS,capsules,VISMODEGIB,2025-07-31T02:33:59.767952,IL,רוש,,21860.5559,18525.89565,16841.72332,,7290008140942,ERIVEDGE 150MG 28 CAPSULES,5619,,77201,BOTTLE HDPE,units,28.0,149 22 33688 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"ERIVEDGE® is indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/262bf9cc-5a16-48ea-a42c-6bc1b1d1ad59.json
262d07db-5741-4940-84a7-343a941e519b,ZOVIRAX SUSPENSION,prescription,J05AB01,ACICLOVIR,1191,,,WHO ATC Classification,,ILS,suspension,ACICLOVIR/,2025-07-31T10:55:32.008587,IL,ג.ס.ק,,108.9053298,92.29265644,68.61907542,,,ZOVIRAX SUSP 125ML,26057,,20743,BOTTLE GLASS TYPE III,units,125.0,018 21 24481 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Zovirax suspenion is indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and severe HSV infections in immunocompromised children). Zovirax suspenion is indicated  for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients.Zovirax suspenion is indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.Zovirax suspenion is indicated  for the treatment of varicella (chickenpox ) and herpes zoster (shingles) infections.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/262d07db-5741-4940-84a7-343a941e519b.json
263b182f-f68a-403a-9e01-6cf77d245d9c,KESIMPTA,prescription,L01XC10,OFATUMUMAB,8900,,,WHO ATC Classification,,ILS,solution for injection,OFATUMUMAB/ML,2025-07-31T04:25:11.923500,IL,נוברטיס פארמה,,6528.827899,5532.905245,5029.913859,,7290018609446,KESIMPTA 20MG/0.4ML 1PF PEN,11302,,70898,PRE-FILLED PEN GLASS TYPE I,units,1.0,167 85 36656 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/263b182f-f68a-403a-9e01-6cf77d245d9c.json
264d1e77-8b1d-4c3e-80f6-10a860a20707,MAALOX PLUS CHEWABLE TABLETS,off-the-counter,A02AB10,COMBINATIONS,5243,,,WHO ATC Classification,,ILS,chewable tablets,"MAGNESIUM HYDROXIDE, DIMETHICONE, ALUMINIUM OXIDE HYDRATED",2025-07-31T12:24:10.332211,IL,פרמה שלום,,29.0988,24.66,nan,,3582910034995,MAALOX PLUS 40 CHEW TAB,,,,BLISTER PVC/ALUMINIUM,units,40.0,107 66 20355 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Antacid, antiflatulent, relief of sensation of heartburn.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/264d1e77-8b1d-4c3e-80f6-10a860a20707.json
264f141d-ec92-4cd2-bacf-32abc7b1161a,CLONEX 0.5 MG,prescription,N03AE01,CLONAZEPAM,1501,,,WHO ATC Classification,,ILS,tablets,CLONAZEPAM 0.5   MG,2025-07-31T01:21:41.563183,IL,טבע,,17.29762,14.659,10.7,,7290000800592,CLONEX 2MG 30TAB,3182,,503,BLISTER PVC/ALUMINIUM,units,30.0,027 85 22043 12,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Typical or atypical petit mal, Lennox - Gastaut syndrome (petit mal variant), generalized primary or secondary tonic-clonic seizures including grand mal and focal seizures. Panic disorder.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/264f141d-ec92-4cd2-bacf-32abc7b1161a.json
266213c4-fe83-4312-8037-4d5454053a3a,ARESTIN,prescription,J01AA08,MINOCYCLINE,2860,,,WHO ATC Classification,,ILS,powder soluble,MINOCYCLINE AS HYDROCHLORIDE,2025-07-31T05:26:21.894836,IL,רפא,,21.92481418,18.580351,13.5623,,,MINOCYCLIN 100MG 10CAP,13046,,8962,CARTRIDGE POLYPROPYLENE,units,10.0,144 92 31853 00,valid,37.0,subgingival,1.4,36,,,,,,,,,,0,Prescription required,"Arestin is indicated as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis. Arestin may be used as part of a periodontal maintenance program which includes good oral hygiene, and scaling and root planing.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/266213c4-fe83-4312-8037-4d5454053a3a.json
26937cb8-24f5-4d67-b6de-00c0bc42a327,FRAGMIN 2500 I.U /0.2 ML,prescription,B01AB04,DALTEPARIN,6196,,,WHO ATC Classification,,ILS,solution for injection,DALTEPARIN SODIUM/ 0.2  ML,2025-07-31T03:19:40.739094,IL,פיזר,,175.6785987,148.880175,119.10414,,7290013592880,FRAGMIN 10000 IU/0.4ML,6419,,23366,SYRINGE GLASS TYPE I,units,5.0,123 11 26544 00,valid,25.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,Prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. Treatment of acute deep venous thrombosis and/or pulmonary embolism. Unstable coronary artery disease. Thromboprophylaxis in conjunction with surgery.   Prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency  respiratory insufficiency and severe infections.Cancer patients : Treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26937cb8-24f5-4d67-b6de-00c0bc42a327.json
26945dcd-e8c8-4cde-9c5b-d9c35812457e,FYCOMPA 10 MG FILM COATED TABLETS,prescription,N03AX22,PERAMPANEL,9340,,,WHO ATC Classification,,ILS,film coated tablets,PERAMPANEL AS ANHYDROUS,2025-07-31T03:25:10.786557,IL,אסיי,,350.3060282,296.8695287,252.654918,,,FYCOMPA ORAL SUSPENSION BOTTLE 340 ML,6688,,14308,BLISTER PVC/ALUMINIUM,units,340.0,150 50 33794 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.Fycompa is indicated for the adjunctive treatment of primary generalised tonic clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalized epilepsy (IGE).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26945dcd-e8c8-4cde-9c5b-d9c35812457e.json
26b09c03-c831-4768-b16e-3c7038648047,STILNOX 10 MG TABLETS,prescription,N05CF02,ZOLPIDEM,3374,,,WHO ATC Classification,,ILS,film coated tablets,ZOLPIDEM TARTRATE,2025-07-31T08:43:35.166890,IL,סאנופי אוונטיס,,20.01900444,16.965258,12.3834,,,STILNOX 10MG 20TAB,19869,,81981,BLISTER PVC/ALUMINIUM,units,20.0,104 51 27587 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Zolpidem is indicated for the short-term treatment of occasional or transient insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26b09c03-c831-4768-b16e-3c7038648047.json
26c24662-c963-4d73-8cdf-52f2014fcb2c,LEUCOVORIN TEVA 10 MG/ML,prescription,V03AF03,CALCIUM FOLINATE,8845,,,WHO ATC Classification,,ILS,solution for injection,CALCIUM FOLINATE 10.8 MG/ML,2025-07-31T04:41:47.758138,IL,טבע,,239.9545935,203.3513594,162.6810876,,,LEUCOVORIN TEVA 10 MG/ML 1 VIAL 10ML,,,35248,VIAL GLASS,units,1.0,053 49 26932 05,valid,25.0,"i.v, i.m",1.4,24,,,,,,,,,,0,Prescription required,To diminish the toxicity and counteract the action of folic acid antagonists in cytotoxic therapy. As Leucovorin-Fluorouracil chemotherapy combination for cancer treatment.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26c24662-c963-4d73-8cdf-52f2014fcb2c.json
26cf80fe-9fb0-444f-8063-1ff43899f69b,KALGARON ORANGE,off-the-counter,R02AD02,LIDOCAINE,5593,,,WHO ATC Classification,,ILS,lozenges,"CETYLPYRIDINIUM CHLORIDE 1.25  MG, LIDOCAINE HYDROCHLORIDE ( AS MONOHYDRATE)",2025-07-31T12:15:15.708431,IL,רפא,,30.621,25.95,nan,,7290017179315,KALGARON ORANGE 24 LOZENGES,,,,BLISTER PVDC/ALUMINIUM,units,24.0,163 63 36018 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the relief of severe sore throat.  Relief of mouth and throat infections.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26cf80fe-9fb0-444f-8063-1ff43899f69b.json
26d26901-0b69-4036-bd7e-6617e8ef75da,GEMCITABINE TEVA ® CONCENTRATE,prescription,L01BC05,GEMCITABINE,7473,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,GEMCITABINE AS HYDROCHLORIDE/ML,2025-07-31T03:29:54.384480,IL,טבע,,502.9835167,426.2572175,362.7721,,7290106061309,GEMCITABINE TEVA CONCENTRATE 40MG/ML (2000MG/50ML),7918,,43115,VIAL 10 ML GLASS TYPE I,units,1.0,150 90 33868 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"GEMCITABINE TEVA®  CONCENTRATE is indicated for the palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer.GEMCITABINE TEVA®  CONCENTRATE is indicated for the treatment of patients with bladder cancer at the invasive stage.Breast cancer:GEMCITABINE TEVA®  CONCENTRATE in combination with paclitaxel,is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant /neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.Ovarian cancer:GEMCITABINE TEVA®  CONCENTRATE in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma who have relapsed at least 6 months after platinum-based therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26d26901-0b69-4036-bd7e-6617e8ef75da.json
26d55c43-ea92-427e-b408-9c27ec669f44,ROSUVASTATIN SANDOZ 10 MG,prescription,C10AA07,ROSUVASTATIN,8433,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T07:51:21.308989,IL,סנדוז,,177.3783375,150.320625,120.2565,,,ROSUVASTATIN SANDOZ 40 MG 30 TAB,18615,,14866,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,162 39 35574 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26d55c43-ea92-427e-b408-9c27ec669f44.json
26d5a6e7-a967-43fd-8bce-6cfa07eacc96,OMEPRADEX - Z,prescription,A02BC01,OMEPRAZOLE,4358,,,WHO ATC Classification,,ILS,caplets,OMEPRAZOLE,2025-07-31T06:07:42.247788,IL,דקסל פארמה,,29.0988,24.66,18.0,,7290010578511,OMEPRADEX 20MG 14CAPLETS,15307,,59979,BLISTER ALUMINIUM /ALUMINIUM,units,14.0,131 25 30841 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26d5a6e7-a967-43fd-8bce-6cfa07eacc96.json
26f46606-b10e-46b1-a4ce-d2f45a38ca41,LAMODEX 100 MG DISPERSIBLE/CHEWABLE TABLETS,prescription,N03AX09,LAMOTRIGINE,4720,,,WHO ATC Classification,,ILS,dispersible/chewable tablets,LAMOTRIGINE,2025-07-31T04:33:56.891161,IL,דקסל פארמה,,40.56178728,34.374396,25.0908,,,LAMODEX 50MG 30DISP/CHEW TAB,12310,,60142,BLISTER ACLAR/PVC/ALUMINIUM,units,30.0,129 88 30814 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy • Adults and adolescents aged 13 years and above:   - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.   - Seizures associated with Lennox-Gastaut syndrome. Lamodex is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome. • Children and adolescents aged 2 to 12 years:   - Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.   - Monotherapy of typical absence seizures.Bipolar disorder • Adults aged 18 years and above   - Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamodex is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/26f46606-b10e-46b1-a4ce-d2f45a38ca41.json
27026dcd-d147-4ac4-af6f-f37eabd07a0f,TARIOL,prescription,D07AC01,BETAMETHASONE,9452,,,WHO ATC Classification,,ILS,gel,"CALCIPOTRIOL AS MONOHYDRATE/, BETAMETHASONE AS DIPROPIONATE 0.5  MG /",2025-07-31T09:07:00.995696,IL,תרו יבוא,,69.37684922,58.79394263,43.7129685,,7290017164496,TARIOL GEL 30 GR,,,73686,BOTTLE HDPE,units,30.0,168 51 36732 99,valid,34.5,topical,1.4,24,,,,,,,,,,0,Prescription required,Topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27026dcd-d147-4ac4-af6f-f37eabd07a0f.json
2714af92-82ed-4715-82a6-1013cce11880,TEVAGRASTIM,prescription,L03AA02,FILGRASTIM,6563,,,WHO ATC Classification,,ILS,solution for injection / infusion,FILGRASTIM 0.6 MG/ML,2025-07-31T09:17:42.897317,IL,טבע,,167.9440789,142.3254969,113.8603976,,7290102062447,TEVAGRASTIM  0.6MG/ML SYR PREFIL 0.5ML(30MU/0.5ML),20675,,18959,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,143 29 31990 00,valid,25.0,"i.v, s.c",1.4,30,,,,,,,,,,0,Prescription required,Tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy  (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. The safety and efficacy of Tevagrastim are similar in adults and children receiving cytotoxic chemotherapy.   Tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic PBPC).  In patients  children or adults with severe congenital neutropenia  cyclic or idiopathic neutropenia  with an absolute nuetrophil count (ANC) less than or equal to  0.5 x 1000000000 /l   and a history of severe or recurrent infections  long term administration of Tevagrastim is indicated to increase neutophil count and to reduce the incidence and duration of infection-related events.   Tevagrastim in indicated for the treatment of persistent neutopenia (ANC less than or equal to 1.0 x 1000000000/l ) in patients with advanced HIV infection  in order to reduce the risk of bacterial infections when other options to manage neutopenia are inappropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2714af92-82ed-4715-82a6-1013cce11880.json
271d76f7-08c9-46ba-8d0a-a37af43e3a43,XPOVIO 20 MG,off-the-counter,L01XX66,SELINEXOR,5526,,,WHO ATC Classification,,ILS,tablets,SELINEXOR,2025-07-31T12:20:31.629328,IL,טבע,,29.9012,25.34,nan,,7290111092886,LINEX NASAL SPRAY 0.1% 10ML,,,,BLISTER PVC/PCTFE/PVC/ALU,units,10.0,167 04 36451 99,valid,nan,per os,1.4,60,,,,,,,,,,0,,"Multiple Myeloma•	Xpovio® in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.•	XPOVIO in combination with dexamethasone is indicated for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least three prior therapies and whose disease is refractory to at least one proteasome inhibitor (PI), at least one immunomodulatory agent (IMiD), and an anti- CD38 monoclonal antibody (mAb).Diffuse Large B-Cell LymphomaXPOVIO is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/271d76f7-08c9-46ba-8d0a-a37af43e3a43.json
2729dcb8-7d60-4074-9095-30bdcd2b8e73,KYLEENA,prescription,G03AC03,LEVONORGESTREL,8396,,,WHO ATC Classification,,ILS,intrauterine delivery system,LEVONORGESTREL 19.5  MG,2025-07-31T04:30:45.138056,IL,באייר,,510.6708326,432.7719113,368.3165202,,TU041DJ,KYLEENA 19.5MG 1 IDS,11286,,37277,BLISTER PETG/PE,units,1.0,161 26 35400 00,valid,17.5,intrauterine,1.4,36,,,,,,,,,,0,Prescription required,Contraception for up to 5 years, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2729dcb8-7d60-4074-9095-30bdcd2b8e73.json
2736e7f6-83e1-4214-bbf7-0866bbdc2a7c,ALKINDI 0.5 MG,prescription,H02AB09,HYDROCORTISONE,9082,,,WHO ATC Classification,,ILS,granules in capsules for opening,HYDROCORTISONE 0.5  MG,2025-07-30T23:19:53.030869,IL,מדומי פארמה,,1942.063746,1645.816807,1400.695155,,,ALKINDI 5 MG 50 CAPSULES,,,83373,BOTTLE HDPE,units,50.0,164 46 35964 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Alkindi is indicated for replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old)", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2736e7f6-83e1-4214-bbf7-0866bbdc2a7c.json
273ebf41-d4cd-4ade-93a7-2dbb8b599f86,LYRICA 100 MG,prescription,N03AX16,PREGABALIN,6774,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T05:01:53.851999,IL,דקסל פארמה,,75.57087747,64.0431165,47.6157,,,LYRICA 50MG 56 CAPSULES,12455,,32216,BLISTER PVC,units,56.0,133 01 31188 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,LLyrica is indicated for the:- Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia.- Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/273ebf41-d4cd-4ade-93a7-2dbb8b599f86.json
27428aae-961d-4483-a97a-8291eb1b6e2d,ONGENTYS 50 MG,29C,N04BX04,OPICAPONE,20808,,,WHO ATC Classification,,ILS,"capsule, hard",OPICAPONE,2025-07-31T13:51:51.183958,IL,nan,,nan,nan,nan,,,APO PRAZOCIN 5MG TAB,,,,BLISTER OPA/ALU/PVC/ALU,units,30.0,170 17 37081 99,valid,nan,per os,1.4,60,,,,,,,,,,0,,ONGENTYS is indicated as adjunctive therapy to preparations of levodopa/ DOPA decarboxylase inhibitors (DDCI) in adult patients with Parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27428aae-961d-4483-a97a-8291eb1b6e2d.json
2751056f-edaf-4b9e-96e9-ff205df2cb45,BUTRANS 10,prescription,,,6616,,,,,ILS,patches matrix,BUPRENORPHINE,2025-07-31T00:47:33.201333,IL,רפא,,41.24748843,34.95550022,25.51496367,,7290008012546,BUTRANS 5MG 2 PATCHES,14908,,14908,POUCH ALUMINIUM,units,2.0,135 71 31152 00,valid,37.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2751056f-edaf-4b9e-96e9-ff205df2cb45.json
276ccfda-75a2-40d8-8aee-a249bed101fc,BRUKINSA,prescription,,,8764,,,,,ILS,capsules,ZANUBRUTINIB,2025-07-30T23:44:46.265411,IL,מדיסון,,25712.16233,21789.96904,19809.06277,,7290018081099,BRUKINSA  80mg 120 CAPS,,,64272,BOTTLE HDPE,units,120.0,166 56 36452 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"• BRUKINSA is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. • BRUKINSA is indicated for the treatment of adult patients with Waldenström’s macroglobulinaemia (WM). • BRUKINSA is indicated for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen. • BRUKINSA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).• BRUKINSA is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL), in combination with obinutuzumab, after two or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/276ccfda-75a2-40d8-8aee-a249bed101fc.json
277b4c2f-7788-4ec0-bd09-252bc74abb95,OPDIVO,prescription,L01XC17,NIVOLUMAB,7623,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,NIVOLUMAB/ML,2025-07-31T06:13:34.054204,IL,ב.מ.ס,,2362.367639,2002.006563,1703.835372,,7290014396111,OPDIVO 10MG/ML VIAL 4ML,15445,,82231,VIAL GLASS TYPE I,units,4.0,153 55 34333 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Unresectable or Metastatic Melanoma:Opdivo as monotherapy or in combination with ipilimumab is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults and pediatric patients 12 years and older.Adjuvant Treatment of Melanoma:OPDIVO is indicated for the adjuvant treatment of adult and pediatric patients 12 years and older with completely resected Stage IIB, IIC, III, or IV melanoma.Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer:OPDIVO, in combination with platinum-doublet chemotherapy, is indicated as neoadjuvant treatment of adult patients with resectable (tumors &#8805;4 cm or node positive) non-small cell lung cancer (NSCLC).Neoadjuvant and Adjuvant Treatment of Resectable Non-Small Cell Lung Cancer:OPDIVO, in combination with platinum-doublet chemotherapy, is indicated for the neoadjuvant treatment of adult patients with resectable (tumors &#8805;4 cm or node positive) NSCLC with tumour cell PD-L1 expression &#8805; 1% and no known epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) rearrangements, followed by single-agent OPDIVO as adjuvant treatment after surgery.Metastatic Non-Small Cell Lung Cancer:- Opdivo, in combination with ipilimumab and 2 cycles of platinum-doublet chemotherapy, is indicated for the first-line treatment of adult patients with metastatic or recurrent non-small cell lung cancer (NSCLC), with no EGFR or ALK genomic tumor aberrations.- Opdivo is indicated for the treatment of adult patients with metastatic non small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.Renal Cell Carcinoma:- Opdivo as a single agent is indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC) in patients who have received prior anti-angiogenic therapy.- Opdivo in combination with ipilimumab is indicated for the first line treatment of adult patients with intermediate or poor risk, advanced renal cell carcinoma (RCC).- OPDIVO, in combination with cabozantinib, is indicated for the first-line treatment of adult patients with advanced RCC.Classical Hodgkin Lymphoma:Opdivo is indicated for the treatment of adult patients with classical Hodgkin lymphoma (cHL) that has relapsed or progressed after:- autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin, or- 3 or more lines of systemic therapy that includes autologous HSCT.Squamous Cell Carcinoma of the Head and Neck:Opdivo is indicated for the treatment of adult patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) with disease progression on or after platinum-based therapy.Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Metastatic Colorectal Cancer- OPDIVO, in combination with ipilimumab, is indicated for the first-line treatment of adult and pediatric patients 12 years and older with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer (CRC).- OPDIVO, as a single agent or in combination with ipilimumab, is indicated for the treatment of adult and pediatric patients 12 years and older with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.Urothelial carcinoma:- OPDIVO is indicated for the adjuvant treatment of adult patients with urothelial carcinoma (UC) who are at high risk of recurrence after undergoing radical resection of UC.- OPDIVO, in combination with cisplatin and gemcitabine, is indicated for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma.- Opdivo is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma who:     * have disease progression during or following platinum-containing chemotherapy     * have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.Hepatocellular Carcinoma:Opdivo, in combination with ipilimumab, is indicated for the treatment of adult patients with hepatocellular carcinoma (HCC) Child-Pugh A who have been previously treated with sorafenib.Esophageal cancer:- OPDIVO is indicated for the adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in adult patients who have received neoadjuvant chemoradiotherapy (CRT). - OPDIVO is indicated for the treatment of adult patients with unresectable, advanced, recurrent or metastatic esophageal squamous cell carcinoma after prior fluoropyrimidine- and platinum-based chemotherapy.- OPDIVO in combination with ipilimumab is indicated for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma with tumour cell PD-L1 expression &#8805; 1%.- OPDIVO in combination with fluoropyrimidine- and platinum-based combination chemotherapy is indicated for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma with tumour cell PD-L1 expression &#8805; 1%.Malignant Pleural Mesothelioma:OPDIVO, in combination with ipilimumab, is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma.Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma:OPDIVO, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the treatment of adult patients with unresectable advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/277b4c2f-7788-4ec0-bd09-252bc74abb95.json
277bd15a-519c-4083-aec9-29c8d23744c1,TAVALISSE 100 MG,prescription,B02BX09,FOSTAMATINIB,8792,,,WHO ATC Classification,,ILS,film coated tablets,FOSTAMATINIB AS DISODIUM HEXAHYDRATE,2025-07-31T09:07:49.879856,IL,מדיסון,,14209.22716,12041.71847,10947.01679,,,TAVALISSE 100 MG 60 TAB,,,60247,BOTTLE HDPE,units,60.0,168 04 36449 99,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,TAVALISSE is indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/277bd15a-519c-4083-aec9-29c8d23744c1.json
27811a0f-32fb-4f5e-a012-44b37f0e5921,PROSTIN E2 VAGINAL GEL 1 MG,prescription,G02AD02,DINOPROSTONE,8927,,,WHO ATC Classification,,ILS,gel,DINOPROSTONE 0.033 %W/W,2025-07-31T07:03:48.468071,IL,פיזר,,195.1296219,165.3640937,132.291275,,7298074000498,PROSTIN E2 VAGINAL GEL 1 MG/3 GR,,,35540,SYRINGE LDPE,units,3.0,056 32 26453 00,valid,25.0,vaginal,1.4,24,,,,,,,,,,0,Prescription required,For labour induction in term and near term pregnant women who have favorable induction features and who have a singleton pregnancy with vertex presentation,תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27811a0f-32fb-4f5e-a012-44b37f0e5921.json
27825dc3-1b58-413f-8da9-816c3d268a37,KOSELUGO 10 MG,prescription,L01EE04,SELUMETINIB,8775,,,WHO ATC Classification,,ILS,"capsule, hard",SELUMETINIB AS HYD-SULFATE,2025-07-31T04:29:43.226243,IL,אסטראזנקה,,61468.03929,52091.56104,47355.96458,,7290013075826,KOSELUGO 25 MG 60 CAPS,11304,,73205,BOTTLE HDPE,units,60.0,167 72 36526 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Koselugo is indicated for the treatment of pediatric patients 2 years of age and older withneurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27825dc3-1b58-413f-8da9-816c3d268a37.json
278c5df6-01fd-4bf9-9504-4d952812e51d,PROCOR,prescription,C01BD01,AMIODARONE,2262,,,WHO ATC Classification,,ILS,tablets,AMIODARONE HYDROCHLORIDE,2025-07-31T06:58:36.474359,IL,אוניפארם,,28.0738756,23.79142,17.366,,,PROCOR 200MG 30TAB,16237,,1781,BLISTER PVC/ALUMINIUM,units,30.0,038 81 22620 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Coronary insufficiency, arrhythmias resistant to other treatments.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/278c5df6-01fd-4bf9-9504-4d952812e51d.json
2790d63e-cac8-44d7-b73a-d0119c8e74ba,IPRATRIM,prescription,R03BB01,IPRATROPIUM BROMIDE,9139,,,WHO ATC Classification,,ILS,inhaler,IPRATROPIUM BROMIDE AS MONOHYDRATE,2025-07-31T04:11:40.191842,IL,תרימה,,23.79869917,20.16838913,14.72145192,,,IPRATRIM 20 MCG,23318,,47813,INHALER ALUMINIUM,units,200.0,169 62 35731 00,valid,37.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"IPRATRIM is indicated for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2790d63e-cac8-44d7-b73a-d0119c8e74ba.json
2799953f-f3e5-42f9-9e46-f3afc563ec44,MERCAPTIZOL,29C,H03BB02,THIAMAZOLE,21008,,,WHO ATC Classification,,ILS,tablets,METHIMAZOLE,2025-07-31T15:11:15.266388,IL,nan,,nan,nan,nan,,7290012066498,METHIMAZOLE 10MG 100 tab,,,,BLISTER PVC/ALUMINIUM,units,100.0,014 89 24453 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the treatment of hyperthyroidism.בקשה לתוספת משטר מינון: 8/8/2023Adult - The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8-hour intervals. The maintenance dosage is 5 to 15 mg daily. To achieve a required dosage of 5 mg, an intake of 10 mg every other day is suggested.Pediatric - Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8-hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2799953f-f3e5-42f9-9e46-f3afc563ec44.json
27aa77de-56f5-403d-b736-5192514d3393,ZEMPLAR 1 MICROGRAM,prescription,H05BX02,PARICALCITOL,6014,,,WHO ATC Classification,,ILS,"capsule, soft",PARICALCITOL,2025-07-31T10:45:55.924817,IL,אב-וי,,302.4876789,256.3454906,218.166375,,,ZEMPLAR 5MCG/ML 5AMPX1ML,26147,,71202,BLISTER PVC/PVDC/ALUMINIUM,units,5.0,141 12 31816 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27aa77de-56f5-403d-b736-5192514d3393.json
27af96b1-7831-45fd-9048-3a309c218fd8,IRINOTECAN  TEVA,prescription,L01XX19,IRINOTECAN,6820,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,IRINOTECAN HYDROCHLORIDE TRIHYDRATE/ML,2025-07-31T04:12:22.354854,IL,טבע,,485.4347248,411.38536,350.1152,,,IRINOTECAN TEVA 100MG/5ML VIAL,9439,,61637,VIAL GLASS TYPE I,units,1.0,154 73 33833 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"* For the treatment of patients with metastatic colorectal cancer:      - In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic       disease.      - As a single agent in patients who have failed an established 5-fluorouracil containing treatment      regimen.   * For the treatment of patients with small cell lung cancer.* For the treatment of patients with gastric cancer.* Irinotecan in combination with leucovorin, Oxaliplatin and 5-fluorouracil, for the first-line treatment of patients with metastatic pancreatic adenocarcinoma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27af96b1-7831-45fd-9048-3a309c218fd8.json
27bfcd06-7629-40c9-899a-45dc3b3b08a0,DUODOPA,prescription,N04BA01,LEVODOPA,6662,,,WHO ATC Classification,,ILS,gel,"LEVODOPA/ML, CARBIDOPA AS MONOHYDRATE/ML",2025-07-31T02:06:57.049456,IL,אב-וי,,2926.802568,2480.341269,2254.855699,,7298074060102,DUODOPA  GEL 7x100ML BAG,4599,,43446,BAG PVC,units,7.0,143 32 32029 01,valid,10.0,intestinal,1.4,15,,,,,,,,,,0,Prescription required,Treatment of advanced levodopa-responsive Parkinson's disease with severe motor fluctuations and hyper-/dyskinesia when available combinations of Parkinson medicinal products have not given satisfactory results.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27bfcd06-7629-40c9-899a-45dc3b3b08a0.json
27ce0239-1f81-4062-8f35-a32cd94efff0,LIXIANA15 MG,prescription,B01AF03,EDOXABAN,8519,,,WHO ATC Classification,,ILS,film coated tablets,EDOXABAN AS TOSYLATE,2025-07-31T04:51:47.528847,IL,מדיסון,,299.9887669,254.2277799,216.364068,,,LIXIANA 30 MG 30 TAB,12607,,73226,BLISTER PVC/ALUMINIUM,units,30.0,166 82 36013 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"• Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with  one or more risk factors, such as congestive heart failure, hypertension, age &#8805; 75 years,diabetes mellitus, prior stroke or transient ischaemic attack (TIA).• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27ce0239-1f81-4062-8f35-a32cd94efff0.json
27d90753-1d44-4cd0-8b53-e1532816627e,COMPETACT 15 MG / 850 MG,prescription,A10BA02,METFORMIN,7141,,,WHO ATC Classification,,ILS,film coated tablets,"METFORMIN HYDROCHLORIDE, PIOGLITAZONE AS HYDROCHLORIDE",2025-07-31T01:27:25.027467,IL,צמל,,183.7678595,155.7354811,124.5883849,,,COMPETACT 15MG/850MG 56 F.C.TAB,9736,,51285,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,150 65 33826 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Competact is indicated as second line treatment of type 2 diabetes mellitus adult patients,particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.After initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in HbA1c). In patients who fail to show an adequate response, pioglitazone should be discontinued. In light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27d90753-1d44-4cd0-8b53-e1532816627e.json
27fff963-0478-4012-b62b-fdc9b069db97,ALPHA D3 0.25 MCG,prescription,A11CC03,ALFACALCIDOL,6476,,,WHO ATC Classification,,ILS,capsules soft gelatin,ALFACALCIDOL 0.25  MCG,2025-07-31T00:17:14.318953,IL,תרומד,,54.23692759,45.9635,33.55,,,ALPHA D3 1MCG 30CAP,9434,,84634,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,125 64 30474 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,-  Renal bone disease (renal osteodystrophy). -  Hypoparathyroidism. -  Hyperparathyroidism (with bone disease) - primary and tertiary. -  Rickets and osteomalacia.  -  Osteoporosis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/27fff963-0478-4012-b62b-fdc9b069db97.json
281358ae-6f50-4d35-9154-24f5fc6c70b3,RUBRACA 200 MG,prescription,L01XX55,RUCAPARIB,8470,,,WHO ATC Classification,,ILS,film coated tablets,RUCAPARIB AS CAMSYLATE,2025-07-31T07:52:56.937012,IL,ניאופרם,,13175.44599,11165.63269,10150.57517,,7290111090660,RUBRACA 250 MG 60 TAB,18609,,54994,BOTTLE HDPE,units,60.0,162 81 35664 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube,or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/281358ae-6f50-4d35-9154-24f5fc6c70b3.json
285fed99-7b25-42e1-8b19-7f920dd60d2b,FENTADOL 100,prescription,N02AB03,FENTANYL,7891,,,WHO ATC Classification,,ILS,patches,FENTANYL 16.8 MG/PATCH,2025-07-31T02:59:25.438525,IL,סנדוז,,211.794365,179.48675,143.5894,,7290017585710,FENTADOL 75 5 PATCHES,166029,,59914,SACHET PAPER/PE/ALU/PE,units,5.0,154 87 34320 00,valid,25.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,"Management of chronic pain and intractable pain requiring opioid analgesia.Fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/285fed99-7b25-42e1-8b19-7f920dd60d2b.json
286078ca-0c63-4ff8-925a-f12f26796b46,DES-LORATADIM,off-the-counter,R06AX27,DESLORATADINE,5064,,,WHO ATC Classification,,ILS,tablets,DESLORATADINE,2025-07-31T12:22:41.839048,IL,כ.צ.ט,,30.385,25.75,nan,,,LORATADIM 10MG 10TAB,12024,,,BLISTER ALU/PVC/TE/PVDC,units,10.0,152 01 32034 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Des-Loratadim is indicated for the relief of symptoms associated with allergic rhinitis, urticaria.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/286078ca-0c63-4ff8-925a-f12f26796b46.json
286b57ac-c4fb-47de-b241-f0b8343b35d9,PRAVALIP 10,prescription,C10AA03,PRAVASTATIN,4835,,,WHO ATC Classification,,ILS,tablets,PRAVASTATIN SODIUM,2025-07-31T06:50:09.014376,IL,אוניפארם,,24.00861158,20.346281,14.8513,,,PRAVALIP 10 30TAB,16696,,13197,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,132 80 31134 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . Pravastatin should be used in addition to a diet  and other nonpharmacological measures alone has been inadequate.    Primary prevention of coronary events: In hypercholesterolemic patients wihthout clinically evident coronary heart disease  pravastatin is indicated to:   1) Reduce the risk of myocardial infarcton.   2) Reduce the risk for revascularization.   3) Reduce the risk of deaths due to cardiovascular causes with no increase in death non-cardiovascular causes.   Secondary prevention of cardiovascular events:    a) Atherosclerosis: In hypercholesterolemic patients with clinically evident coronary artery disease  including prior MI  pravastatin  is indicated to:      1)Slow the progression of coronary atherosclerosis.      2) Reduce the risk of acute coronary events.     b) Myocardial infarction: in patients with previous myocardial infarction  and normal cholesterol levels. Pravastatin is indicated to:      1) Reduce the risk of recurrent myocardial infarction.       2)Reduce the risk of undergoing myocardial revascularization procedures.       3) Reduce the risk of stroke or transient ischemic attack (TIA).     c) Hypercholesterolemia and mixed dyslipidemia: Pravastatin is indicated as an adjunct to diet to reduce elevated Total-C  LDL-C and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Frederickson Type IIa and IIb).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/286b57ac-c4fb-47de-b241-f0b8343b35d9.json
287496bb-02a0-43a1-a695-f0736e99e7bd,RISPOND SOLUTION,prescription,N05AX08,RISPERIDONE,6304,,,WHO ATC Classification,,ILS,solution,RISPERIDONE/ML,2025-07-31T07:40:32.675907,IL,אוניפארם,,36.56215722,30.984879,22.6167,,7290008546478,RISPOND SOLUTION 1MG/ML 30ML,18404,,80979,BOTTLE AMBER GLASS TYPE III,units,30.0,141 17 31711 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Rispond is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Rispond was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients.Rispond is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Rispond is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Rispond is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/287496bb-02a0-43a1-a695-f0736e99e7bd.json
2898f748-7b3c-4922-83e4-47a8a1b8d6cc,CARDILOC 2.5,prescription,C07AB07,BISOPROLOL,6972,,,WHO ATC Classification,,ILS,tablets,BISOPROLOL HEMIFUMARATE 2.5   MG,2025-07-31T00:54:42.172509,IL,אוניפארם,,17.80878892,15.092194,11.0162,,,CARDILOC 2.5MG 30TAB,3275,,56392,BLISTER PVC/ALUMINIUM,units,30.0,128 07 30654 02,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2898f748-7b3c-4922-83e4-47a8a1b8d6cc.json
28992c90-337f-4540-8e34-642c514318ff,DYSPORT 300,prescription,M03AX01,BOTULINUM TOXIN,7955,,,WHO ATC Classification,,ILS,powder for solution for injection,BOTULINUM TOXIN TYPE A 300 U/VIAL,2025-07-31T02:09:28.263927,IL,מדיסון,,911.0492624,772.0756805,657.0856855,,,DYSPORT 300 U/VIAL,4642,,32240,VIAL GLASS TYPE I,units,1.0,153 44 34183 00,valid,17.5,"s.c, i.m",1.4,24,,,,,,,,,,0,Prescription required,"Dysport is indicated for symptomatic treatment of focal spasticity of:- Upper limbs in adults due to stroke or traumatic brain injury- Lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (TBI) - Dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older.- Upper limbs in pediatric cerebral palsy patients, two years of age or older.Dysport is indicated in adults for symptomatic treatment of:- Spasmodic torticollis- Blepharospasm- Hemifacial spasm.Dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment.Dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows) seen at frown,and/or - Lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/28992c90-337f-4540-8e34-642c514318ff.json
28adcd8f-1f23-4514-8410-5a93ac12f759,RIAVENIR LA 30 MG MODIFIED RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,8940,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:33:56.799326,IL,ביואבניר,,131.5100387,111.4491853,82.86184784,,,RIAVENIR LA 30 MG 30 CAPSULES,,,76592,BOTTLE HDPE,units,30.0,167 45 36190 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/28adcd8f-1f23-4514-8410-5a93ac12f759.json
28bfb0a4-95ed-45d5-acef-9a8355e1ecd4,VEOZA 45 MG,prescription,G02CX06,FEZOLINETANT,9496,,,WHO ATC Classification,,ILS,film coated tablets,FEZOLINETANT,2025-07-31T10:06:21.480604,IL,אסטלס,,317.4011805,268.9840632,228.922607,,8718692517400,VEOZA 45 MG 30 TAB,,,28853,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,176 65 37787 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Veoza is indicated for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/28bfb0a4-95ed-45d5-acef-9a8355e1ecd4.json
28ea5109-9240-446e-ba46-55240fe20276,CIPRAMIL 20 MG TABLETS,prescription,N06AB04,CITALOPRAM,3340,,,WHO ATC Classification,,ILS,film coated tablets,CITALOPRAM AS HYDROBROMIDE,2025-07-31T01:16:02.219729,IL,לנדבק,,31.02627218,26.293451,19.1923,,,CIPRAMIL 20MG 28TAB,3144,,9506,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,102 51 28198 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of states of depression and panic disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/28ea5109-9240-446e-ba46-55240fe20276.json
28ee63a8-aaf8-476b-9dd0-21393c0298a2,MENACTRA,prescription,J07AH02,OTHER MENINGOCOCCAL MONOVALENT PURIFIED POLYSACCHARIDES ANTIGEN,7485,,,WHO ATC Classification,,ILS,solution for injection,"MENINGOCOCCAL VACCINES GROUP C/ 0.5  ML, MENINGOCOCCAL VACCINES GROUP Y/ 0.5  ML, MENINGOCOCCAL VACCINES GROUP W/ 0.5  ML, MENINGOCOCCAL VACCINES GROUP A/ 0.5  ML",2025-07-31T05:11:04.183139,IL,סאנופי אוונטיס,,nan,nan,nan,,7290101535713,MENACTRA VIAL 4MCG/0.5ML,13776,,69341,VIAL GLASS,units,1.0,149 59 33384 00,valid,nan,i.m,1.4,24,,,,,,,,,,0,Prescription required,"Active immunization of individuals 9 months through 55 years of age for the prevention of invasive meningococcal disease caused by N meningitidis serogroups A, C, Y, and W-135 Menactra vaccine does not prevent N meningitidis serogroup B disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/28ee63a8-aaf8-476b-9dd0-21393c0298a2.json
28f0f0de-c481-4f75-9688-dee657e0eede,SEEBRI BREEZHALER 50 MCG,prescription,A03AB02,GLYCOPYRRONIUM,7119,,,WHO ATC Classification,,ILS,inhalation powder hard capsules,GLYCOPYRRONIUM AS BROMIDE,2025-07-31T08:02:51.374802,IL,נוברטיס פארמה,,137.4157256,116.4540099,86.582907,,7290016369014,SEEBRI BREEZHALER 50 MCG 30CAPS FOR INH,9646,,40695,BLISTER PVC/OPA/AL,units,30.0,149 18 33751 01,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/28f0f0de-c481-4f75-9688-dee657e0eede.json
2911c8a0-c6d1-4580-b760-51c6a12a8f79,TREPROSTINIL S.K. 10 MG/ML,prescription,B01AC21,TREPROSTINIL,8599,,,WHO ATC Classification,,ILS,solution for injection / infusion,TREPROSTINIL/,2025-07-31T09:39:56.679256,IL,SK PHARM(KS KIM),,26226.61793,22225.94838,20205.40762,,7290016845150,TREPROSTINIL S.K. 5 MG/ML 20ML 1 VIAL,20935,,55044,VIAL GLASS TYPE I,units,1.0,162 27 35642 00,valid,10.0,"s.c, i.v",1.4,24,,,,,,,,,,0,Prescription required,Treprostinil s.k. is indicated for the treatment of:* Primary pulmonary arterial hypertension.* Pulmonary arterial hypertension associated with connective tissue disorders. * Pulmonary hypertension associated with congenital systemic to pulmonary shunts.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2911c8a0-c6d1-4580-b760-51c6a12a8f79.json
291ee4c0-04b9-4d92-a5e2-8e50fdc7e025,MAALOX PLUS SUSPENSION,off-the-counter,,,1305,,,,,ILS,suspension,"ALUMINIUM HYDROXIDE/, MAGNESIUM HYDROXIDE/, SIMETHICONE/",2025-07-31T12:24:21.315099,IL,פרמה שלום,,40.7454,34.53,nan,,7290008880299,MAALOX PLUS SUSP 355ML,13005,,,BOTTLE PET,units,355.0,107 65 20354 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Antacid, antiflatulent, relief of sensation of heatburn.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/291ee4c0-04b9-4d92-a5e2-8e50fdc7e025.json
29338fb1-79c8-4ffb-b313-35509cccf77f,AVODART,prescription,G04CB02,DUTASTERIDE,8238,,,WHO ATC Classification,,ILS,"capsule, soft",DUTASTERIDE 0.5   MG,2025-07-31T02:09:18.012003,IL,טבע,,133.9406064,113.5089885,84.3933,,,DUTASTERIDE TEVA 0.5MG 30 CAPS,,,20083,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,128 27 30679 01,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Avodart is indicated for : Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/29338fb1-79c8-4ffb-b313-35509cccf77f.json
293f859d-d03b-4389-afae-c4034005da71,EPCLUSA,prescription,J05AX15,SOFOSBUVIR,7976,,,WHO ATC Classification,,ILS,film coated tablets,"VELPATASVIR, SOFOSBUVIR",2025-07-31T02:25:28.291674,IL,גיליאד,,41469.72014,35143.83219,31948.93835,,5391507143006,EPCLUSA 28 TAB,5615,,62097,BOTTLE HDPE,units,28.0,158 31 34976 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Epclusa is indicated for the treatment of chronic hepatitis C virus (HCV) infection in patients aged 12 years and older or weighing at least 30 kg,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/293f859d-d03b-4389-afae-c4034005da71.json
294336be-4a35-4fb6-9f22-614e72772f46,ADATAR,prescription,D10AD03,ADAPALENE,8944,,,WHO ATC Classification,,ILS,gel,"BENZOYL PEROXIDE AS HYDROUS 2.5 %W/W, ADAPALENE 0.1 %W/W",2025-07-30T23:14:14.944197,IL,תרו יבוא,,104.145502,88.2589,65.62,,7290017164199,ADATAR GEL 30G,,,68994,CONTAINER PP,units,30.0,163 95 35656 00,valid,34.5,topical,1.4,24,,,,,,,,,,0,Prescription required,"Cutaneous treatment of acne vulgaris when comedones, papules and pustules are present",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/294336be-4a35-4fb6-9f22-614e72772f46.json
29485801-f2b6-43c6-aebc-2e0ce6495739,TRITACE COMP 2.5 MG/12.5 MG,prescription,C09BA05,RAMIPRIL AND DIURETICS,4607,,,WHO ATC Classification,,ILS,tablets,"RAMIPRIL 2.5  MG, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T09:44:19.427728,IL,סאנופי אוונטיס,,29.4512188,24.95866,18.218,,7290008880947,TRITACE COMP 5MG/25MG 28TAB,20298,,27929,BLISTER PVC/ALUMINIUM,units,28.0,122 27 30187 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Essential hypertension.Tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone or hydrochlorothiazide alone.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/29485801-f2b6-43c6-aebc-2e0ce6495739.json
295636dc-69d1-439c-9994-624559cf7e78,GLUBEN,prescription,A10BB01,GLIBENCLAMIDE,1757,,,WHO ATC Classification,,ILS,tablets,GLIBENCLAMIDE,2025-07-31T03:36:33.227388,IL,דקסל פארמה,,13.8025308,11.69706,8.538,,,GLUBEN 5MG 30TAB,7204,,7940,BLISTER PVC,units,30.0,040 08 20814 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Control of hyperglycemia in stable, mild, nonketosis prone Glibenclamide responsive type II diabetes mellitus, which cannot be controlled by proper dietary management or when insulin therapy is inappropriate.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/295636dc-69d1-439c-9994-624559cf7e78.json
29786a44-f92b-4bbd-954d-f1f519cf2a61,IMATINIB TEVA ® 100 MG,prescription,L01XE01,IMATINIB,7756,,,WHO ATC Classification,,ILS,film coated tablets,IMATINIB AS MESYLATE,2025-07-31T03:59:36.903880,IL,טבע,,3673.604922,3113.22451,2830.2041,,7290110732134,IMATINIB TEVA 100MG 60 F.C.TAB,9858,,58508,BOTTLE HDPE,units,60.0,153 98 34034 02,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia(Ph+ -CML) in chronic phase accelerated phase or blast crisis.Imatinib Teva is also indicated for the treament of :Adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) integrated with chemotherapy.Adult patients with relapsed or refractory Ph + ALL as monotherapy.Adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.Adult patients with myelodyspiastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR ( platelet - derived growth factor receptor ) gene re- arrangements.Adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) who have the FIP1L1- PDGFRalfa fusion kinase (mutational analysis or FISH demonstration fo CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFR alfa fusion kinase negative .Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-kit mutation.Imatinib Teva is also indicated for the treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST)Imatinib Teva is also indicated for Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/29786a44-f92b-4bbd-954d-f1f519cf2a61.json
2986e064-45f7-4cc6-aaa8-2fee93e3fbe8,DUREZOL 0.05% ophthalmic emulsion 5ML,29C,,,21004,,,,,,tablet,DUREZOL 0.05% ophthalmic emulsion,2025-07-31T20:20:09.761899,IL,nan,,,,,,,DUREZOL 0.05% ophthalmic emulsion 5ML,,,,,units,5.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2986e064-45f7-4cc6-aaa8-2fee93e3fbe8.json
298e035a-0fea-424b-8c81-dda3ee1919a3,RECTOGESIC ®,prescription,C01DA02,GLYCERYL TRINITRATE,6338,,,WHO ATC Classification,,ILS,ointment,GLYCERYL TRINITRATE 0.4 %,2025-07-31T07:19:52.798837,IL,פאדאגיס,,236.5999627,200.5084519,160.4067615,,7298074050202,RECTOGESIC 0.4% 30GR,18414,,83584,TUBE ALUMINIUM,units,30.0,140 66 31709 00,valid,25.0,rectal,1.4,36,,,,,,,,,,0,Prescription required,For relief of pain associated with chronic anal fissure.   In the clinical development of the drug  a modest effect has shown on improvement in average daily pain intensity.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/298e035a-0fea-424b-8c81-dda3ee1919a3.json
29b74acd-36f3-424b-b0f8-0eb3ca658ac6,URSOFALK 500,prescription,A05AA02,URSODEOXYCHOLIC ACID,7766,,,WHO ATC Classification,,ILS,film coated tablets,URSODEOXYCHOLIC ACID,2025-07-31T09:55:08.771964,IL,רפא,,159.2011716,134.9162531,107.9330025,,729000812294,URSOFALK 500MG 50 F.C.TAB,21120,,55418,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,150 68 33832 01,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"For the symptomatic treatment of primary biliary cholangitis (PBC), in patients without decompensated hepatic cirrhosis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/29b74acd-36f3-424b-b0f8-0eb3ca658ac6.json
29dd8682-b3b7-43b7-9b61-78146f9b71db,HYALASE,prescription,B06AA03,HYALURONIDASE,8615,,,WHO ATC Classification,,ILS,powder for solution for injection,HYALURONIDASE/AMPOULE,2025-07-31T03:51:58.221443,IL,פרופארם,,nan,nan,nan,,5012727911793,HYALASE 1500 IU 10 AMP,,,33604,AMPOULES GLASS TYPE I,units,10.0,128 29 29170 00,valid,nan,"i.m, s.c",1.4,36,,,,,,,,,,0,Prescription required,"To enhance permeation of subcutaneous or intramuscular injections, local anesthetics and subcutaneous infusions to promote resorption of excess fluids and blood in the tissues .",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/29dd8682-b3b7-43b7-9b61-78146f9b71db.json
2a081478-5b66-4758-a2bd-ba5ed7a33275,CYSTADANE,prescription,A16AA06,BETAINE,4020,,,WHO ATC Classification,,ILS,powder for solution,BETAINE ANHYDROUS/G,2025-07-31T01:37:45.109144,IL,מדיסון,,2189.289524,1855.330188,1579.004415,,7290008128575,CYSTADANE 180GR PWDR/ORAL SOL,9538,,21918,BOTTLE HDPE,units,180.0,111 87 29443 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of homocystinuria.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a081478-5b66-4758-a2bd-ba5ed7a33275.json
2a16cee5-ecb3-4e94-9f74-8d43b6ac8cf8,VERORAB,prescription,J07BG01,"RABIES, INACTIVATED, WHOLE VIRUS",7529,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,"RABIES, INACTIVATED, WHOLE VIRUS 3.25 IU/VIAL",2025-07-31T10:07:24.167755,IL,סאנופי אוונטיס,,278.9392178,236.3891781,201.1822793,,7290101535409,VERORAB 2.5IU 1VIAL,,,61755,VIAL GLASS TYPE I,units,1.0,140 97 31875 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of rabies in children and adults. It can be used before and after exposure, as a primary vaccination or as a booster dose.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a16cee5-ecb3-4e94-9f74-8d43b6ac8cf8.json
2a184fbb-97aa-492b-9657-5adbe289125e,EZATOR S.K. 10/10 MG,prescription,C10BA05,ATORVASTATIN AND EZETIMIBE ,9334,,,WHO ATC Classification,,ILS,film coated tablets,"EZETIMIBE, ATORVASTATIN AS CALCIUM TRIHYDRATE",2025-07-31T02:50:49.031157,IL,SK PHARM(KS KIM),,129.9606955,110.1361826,81.88563764,,,EZATOR S.K. 10/20 MG 30 TAB,5743,,13716,BLISTER OPA/ALU/PVC/ALU,units,30.0,170 85 36878 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Prevention of Cardiovascular EventsEzator S.K. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaEzator S.K. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Ezator S.K. is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a184fbb-97aa-492b-9657-5adbe289125e.json
2a18de3e-d736-47f7-a8c4-52953dbc2c4c,ABROLET SUPPOSITORIES,off-the-counter,N02BE05,PROPACETAMOL,3100,,,WHO ATC Classification,,ILS,suppositories,PARACETAMOL,2025-07-31T10:58:41.235710,IL,רקח,,12.8148,10.86,nan,,7290008089500,ABROLET 150MG 12SUPP,1090,,,FOIL PVC/ALUMINIUM,units,12.0,027 21 24032 00,valid,nan,rectal,1.4,24,,,,,,,,,,0,,"Analgesic, antipyretic pediatric suppositories.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a18de3e-d736-47f7-a8c4-52953dbc2c4c.json
2a591e58-0249-4ac0-bbe0-4da671a69ede,PREGABALIN TEVA ® 100 MG,prescription,N03AX16,PREGABALIN,8018,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:55:14.022108,IL,טבע,,123.5665273,104.717396,77.8568,,,PREGABALIN TEVA  75 MG 56 TAB,16984,,56106,BLISTER PVC/ALUMINIUM,units,56.0,157 26 34479 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,PREGABALIN TEVA ® is indicated for the: - Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia. - Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a591e58-0249-4ac0-bbe0-4da671a69ede.json
2a645218-eeee-4b6d-afb2-01b9b223001e,SPASMALGIN,prescription,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",8576,,,WHO ATC Classification,,ILS,tablets,"PARACETAMOL, ATROPINE SULFATE 0.4  MG, PAPAVERINE HYDROCHLORIDE, CODEINE PHOSPHATE",2025-07-31T06:26:51.721684,IL,טבע,,38.59631421,32.70874085,23.87499332,,,PAPAVERINE 40 MG/ 2 ML INJECTION 10 AMP,,,6946,BLISTER PVC/ALUMINIUM,units,10.0,036 36 22208 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Analgesic and antispasmodic for the digestive system, the kidneys and the gall bladder.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a645218-eeee-4b6d-afb2-01b9b223001e.json
2a6bab87-c38a-4a02-993c-edafe6a3b7e3,SILDENAFIL TEVA ® 100 MG,prescription,G04BE03,SILDENAFIL,7526,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T08:12:27.726026,IL,טבע,,101.1492159,85.7196745,63.7321,,,SILDENAFIL TEVA  100 MG 4 TAB,9771,,55921,BLISTER PVC/PE/PVDC/AL,units,4.0,147 86 33474 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Sildenafil Teva ® 100 mg FC Tablets is indicated for the treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a6bab87-c38a-4a02-993c-edafe6a3b7e3.json
2a722f80-8c3b-4151-b5a5-c2bf14d86cb7,VESICARE 5MG 30TAB,prescription,,,6000,,,,,ILS,tablet,VESICARE 5MG,2025-07-31T19:38:29.504284,IL,כ.צ.ט,,164.87196,139.722,111.7776,,,VESICARE 5MG 30TAB,22294,,75668,,units,30.0,,not-registered,25.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a722f80-8c3b-4151-b5a5-c2bf14d86cb7.json
2a7409a3-a956-4505-8024-e39faa05af8d,ISTURISA 1 MG,prescription,H02CA02,OSILODROSTAT ,9209,,,WHO ATC Classification,,ILS,film coated tablets,OSILODROSTAT  AS PHOSPHATE,2025-07-31T04:14:08.114075,IL,מדיסון,,7144.762342,6054.88361,5504.439645,,,ISTURISA 1 MG 60 F.C.T,23565,,3003,BLISTER PVC/ALUMINIUM,units,60.0,171 12 37207 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Isturisa is indicated for the treatment of endogenous Cushing’s syndrome in adult patients for whom surgery is not an option or has not been curative,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a7409a3-a956-4505-8024-e39faa05af8d.json
2a8048b2-aeb7-49d9-8148-f31474098e88,AGISPOR SHAMPOO,prescription,D01AC10,BIFONAZOLE,2891,,,WHO ATC Classification,,ILS,shampoo,BIFONAZOLE,2025-07-30T23:17:02.123075,IL,פאדאגיס,,nan,nan,nan,,,AGISPOR SHAMPO 100ML,1045,,8432,BOTTLE HDPE,units,100.0,126 23 26745 00,valid,nan,topical- scalp,1.4,24,,,,,,,,,,0,Prescription required,Pityriorisis versicolor and sebarrrhoeic dermatitis of the scalp caused by pityrosporum.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a8048b2-aeb7-49d9-8148-f31474098e88.json
2a85be86-42ef-4e37-b2cb-d7c4e16d03b3,APROKAM 50MG INTRACAMERAL INJECTION,29C,,,20809,,,,,,injection,APROKAM 50MG INTRACAMERAL INJECTION,2025-07-31T19:56:11.758463,IL,nan,,,,,,,APROKAM 50MG INTRACAMERAL INJECTION,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a85be86-42ef-4e37-b2cb-d7c4e16d03b3.json
2a8c4152-3274-4dc9-ba93-218d22d96659,LIPIODOL ULTRA FLUID,prescription,,,8917,,,,,ILS,solution for injection,IODINE AS ETHYL ESTERS OF IODIZED FATTY ACIDS OF POPPY SEED OIL/ML,2025-07-31T04:47:48.550128,IL,ניאופרם,,1449.632665,1228.502313,1045.533884,,7-298120-003749,LIPIODOL ULTRA FLUID 480MG/ML AMP 10ML,,,,AMPOULES GLASS,units,1.0,056 03 21367 00,valid,17.5,"intra-lymphatic, intra-arterial",1.4,36,,,,,,,,,,0,Prescription required,"- Lymphography.- Visualisation, localisation and vectorisation during Trans-Arterial Chemo-Embolisation (TACE) of hepatocellular carcinoma, in adults.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a8c4152-3274-4dc9-ba93-218d22d96659.json
2a923a53-411f-4b23-8a21-451074b94d70,MESTINON DRAGEES 60 MG,prescription,N07AA02,PYRIDOSTIGMINE,6825,,,WHO ATC Classification,,ILS,dragee,PYRIDOSTIGMINE BROMIDE 60.0   MG,2025-07-31T07:08:16.300691,IL,רפא,,34.42614364,29.174698,21.2954,,,PYRIDOSTIGMINE 60MG 30TAB,16834,,26166,BOTTLE AMBER GLASS,units,30.0,130 84 21200 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of myasthenia gravis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2a923a53-411f-4b23-8a21-451074b94d70.json
2aa66b3f-17c1-4fc3-b9a6-15eef0cf312c,KALYDECO 150 MG FILM COATED TABLETS,prescription,R07AX02,IVACAFTOR,8367,,,WHO ATC Classification,,ILS,film coated tablets,IVACAFTOR,2025-07-31T04:22:17.710230,IL,מדיסון,,52580.81505,44560.01473,40509.1043,,,KALYDECO 75 MG GRANULES 56 SACHETS,11280,,18720,BLISTER PVC/ALUMINIUM,units,56.0,153 89 34269 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Kalydeco tablets are indicated for the treatment of patients with cystic fibrosis (CF) aged 6 years and older and weighing 25 kg or more who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data. Limitations of use : Kalydeco is not effective in patients with CF who are homozygous for the F508del mutation in the CFTR gene.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2aa66b3f-17c1-4fc3-b9a6-15eef0cf312c.json
2ab6c700-5eed-45de-a322-4bdcc22e080d,OCTREOTIDE BENDALIS 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,8995,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE AS ACETATE 0.05 MG/ML,2025-07-31T06:02:36.216252,IL,מרגלית,,3560.36855,3017.261618,2742.965107,,,OCTREOTIDE BENDALIS 0.2 MG/ML 10 VIAL,,,74014,AMPOULES GLASS TYPE I,units,10.0,164 14 34086 00,valid,10.0,"s.c, i.v",1.4,60,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery. Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy.Octreotide Bendalis treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - Carcinoid tumours with features of the carcinoid syndrome. - VIPomas . - Glucagonomas . - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors or H2- antagonist therapy . - Insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy . - GRFomas. - Octreotide Bendalis is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ab6c700-5eed-45de-a322-4bdcc22e080d.json
2abad057-f8ec-4f56-9247-4e221af4da8b,PROTHIAZINE EXPECTORANT SYRUP,prescription,R05CA10,COMBINATIONS,2341,,,WHO ATC Classification,,ILS,syrup,"PROMETHAZINE HYDROCHLORIDE/, GUAIFENESIN/, IPECACUANHA/",2025-07-31T07:04:59.190056,IL,כ.צ.ט,,22.2387579,18.846405,13.7565,,7290008005265,PROTHIAZINE SYR110ML,16279,,1822,BOTTLE GLASS TYPE III,units,110.0,117 30 23206 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For temporary relief of cough due to colds, allergies.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2abad057-f8ec-4f56-9247-4e221af4da8b.json
2ac4db25-3a0e-4ec5-9b28-a0421694eeb4,AZITHROVENIR,prescription,J01FA10,AZITHROMYCIN,8841,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,AZITHROMYCIN AS DIHYDRATE/VIAL,2025-07-30T23:33:09.510220,IL,טבע,,36.0129982,30.51949,22.277,,7290010286287,AZITHRO TEVA 200 MG / 5 ML 22.5ML,,,15245,VIAL GLASS TYPE II,units,22.5,159 58 34834 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment of infections caused by susceptible strains of the designated microorganism in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ac4db25-3a0e-4ec5-9b28-a0421694eeb4.json
2acc5d71-6625-4fcb-8fca-38aae4f3e25a,FLUCONAZOLE TEVA ® 150 MG,prescription,J02AC01,FLUCONAZOLE,6203,,,WHO ATC Classification,,ILS,capsules,FLUCONAZOLE,2025-07-31T03:12:04.622186,IL,טבע,,21.66502656,18.360192,13.4016,,,FLUCONAZOLE TEVA 150MG 1CAPS,6424,,78352,BLISTER PVC/PVDC/ALUMINIUM,units,1.0,138 70 31385 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in adults for the treatment of:•	Cryptococcal meningitis.•	Coccidioidomycosis.•	Invasive candidiasis.•	Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.•	Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.•	Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.•	Candidal balanitis when local therapy is not appropriate.•	Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.•	Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:•	Relapse of cryptococcal meningitis in patients with high risk of recurrence.•	Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•	To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).•	Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2acc5d71-6625-4fcb-8fca-38aae4f3e25a.json
2ae12cae-ef35-4026-929f-80b8ecc69914,ADCORTYL 10 MG/ML VIAL 5ML,29C,,,20026,,,,,,injection,ADCORTYL 10 MG/ML VIAL,2025-07-31T19:49:19.670415,IL,nan,,,,,,,ADCORTYL 10 MG/ML VIAL 5ML,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ae12cae-ef35-4026-929f-80b8ecc69914.json
2b019ff2-6092-4159-b591-d1a0ff6d9c8b,MERONEM 500 MG,prescription,J01DH02,MEROPENEM,6435,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,MEROPENEM AS TRIHYDRATE/VIAL,2025-07-31T05:14:03.101858,IL,פיזר,,960.8428362,814.27359,692.9988,,,MERONEM 1G 10VIAL POWDER FOR SOL. FOR INJ.,13632,,29018,VIAL GLASS TYPE I,units,10.0,104 08 28622 02,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,Meronem is indicated for treatment  in adults and children  of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem:  - Pneumonias and nosocomial pneumonias.   - Pulmonary infections in patients with cystic fibrosis.   - Urinary tract infections.   - Intra-abdominal infections.  - Gynecological infections  such as endometritis and pelvic inflammatory disease.   - Skin and skin structure infections.   - Meningitis.   - Septicemia.   Meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections.   There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b019ff2-6092-4159-b591-d1a0ff6d9c8b.json
2b084fd3-72b4-4324-a584-23b46b815243,NICOTINELL LOZENGES 1 MG,off-the-counter,,,5422,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:32:38.378757,IL,ג.ס.ק,,71.1068,60.26,nan,,,NICOTINELL LOZENGES 2 MG 36 loz,,,,BLISTER PVC/PE/PVDC/AL,units,36.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b084fd3-72b4-4324-a584-23b46b815243.json
2b13b805-dbc4-43aa-b1e9-6630c18c3515,OXYTOCIN - GRINDEKS,prescription,H01BB02,OXYTOCIN,6969,,,WHO ATC Classification,,ILS,solution for injection / infusion,OXYTOCIN/,2025-07-31T06:22:44.723707,IL,פארמלוג'יק,,92.3946136,78.30052,58.216,,,OXYTOCIN INJECTION BP 10AMP (10IU/ML),15474,,18816,AMPOULES GLASS TYPE I,units,10.0,165 47 35690 00,valid,34.5,"i.v, i.m",1.4,48,,,,,,,,,,0,Prescription required,"- Induction of labour for medical reasons;- Stimulation of labour in hypnotic uterine inertia;- During Caesarean section following the delivery of the child;- Prevention and treatment of postpartum uterine atony and hemorrhage.- In early stages of pregnancy as an adjunctive therapy for the management of incomplete, inevitable of missed abortion.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b13b805-dbc4-43aa-b1e9-6630c18c3515.json
2b3a7896-8186-48c8-a2cd-42c8b037c7cf,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4553,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:24:19.120425,IL,מדיסון,,2286.668651,1937.854875,1761.68625,,8715131005863,ARANESP 80MCG 4 PREFILLED SYR 0.4ML,9487,,29747,PRE-FILLED PEN GLASS TYPE I,units,4.0,124 46 30400 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b3a7896-8186-48c8-a2cd-42c8b037c7cf.json
2b46a214-5a8d-45a6-88dd-3904d0c1cccf,BUDESONIDE STERINEBS TEVA ® 0.5 MG/2 ML,prescription,R01AD05,BUDESONIDE,3346,,,WHO ATC Classification,,ILS,suspension for inhalation,BUDESONIDE 0.25  MG /,2025-07-30T23:45:13.681670,IL,רפא,,327.9891937,277.9569562,236.5591117,,,BUDESON 3MG 100CAPS,2104,,9252,AMPOULES POLYETHYLENE,units,100.0,142 43 33002 00,valid,17.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Bronchial asthma especially in cases where other therapy is insufficient or insuitable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b46a214-5a8d-45a6-88dd-3904d0c1cccf.json
2b47ba1a-32f5-4b9f-a5ce-efb2dc166651,MOXYVIT 250 CAPSULES,prescription,J01CA04,AMOXICILLIN,2293,,,WHO ATC Classification,,ILS,capsules,AMOXICILLIN AS TRIHYDRATE,2025-07-31T05:34:33.382836,IL,ויטאמד,,8.2252608,6.97056,5.088,,7-290008-068581,MOXYVIT 250MG 10CAP,13428,,7923,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,023 75 25058 02,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,•	For the treatment of infections caused by bacteria susceptible to amoxicillin.•	Intended for the prevention of bacterial infections in patients who are at risk for developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b47ba1a-32f5-4b9f-a5ce-efb2dc166651.json
2b4925f1-6643-4bb6-93bb-70ca04630ece,NEOMYCINE 500MG 20TAB,prescription,,,3416,,,,,ILS,tablet,NEOMYCINE 500MG,2025-07-31T19:22:23.075263,IL,רקח,,53.8877444,45.66758,33.334,,,NEOMYCINE 500MG 20TAB,14080,,1454,,units,20.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b4925f1-6643-4bb6-93bb-70ca04630ece.json
2b5e21ff-740b-439f-87ff-d6a2af6dd7ec,IPADINE 0.5 %,off-the-counter,D08AC02,CHLORHEXIDINE,5605,,,WHO ATC Classification,,ILS,solution,"ISOPROPANOLV/V, CHLORHEXIDINE DIGLUCONATE 0.5 %W/V",2025-07-31T12:13:11.431878,IL,פלוריש,,42.716,36.2,nan,,7290017399362,IPADINE 0.5 % 500ml,,,,BOTTLE HDPE,units,500.0,166 25 36467 99,valid,nan,dermal,1.4,24,,,,,,,,,,0,,1) Skin disinfectant especially for pre-invasive procedures.   2) Disinfection of the newly born umbilical cord.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b5e21ff-740b-439f-87ff-d6a2af6dd7ec.json
2b696633-c4f9-4b61-b077-17931359d5f3,CERNEVIT,prescription,B05CB10,COMBINATIONS,6982,,,WHO ATC Classification,,ILS,powder for solution for injection,"RETINOL PALMITATE/VIAL, COLECALCIFEROL/VIAL, TOCOPHEROL 10.2  MG/VIAL, ASCORBIC ACID/VIAL, RIBOFLAVINE 5.67  MG/VIAL, PYRIDOXINE (VIT B6) HYDROCHLORIDE 5.5  MG/VIAL, CYANOCOBALAMIN (VIT B12) 0.006  MG/VIAL, FOLIC ACID 0.414  MG/VIAL, DEXPANTHENOL 16.15  MG/VIAL, BIOTIN 0.069  MG/VIAL, NICOTINAMIDE/VIAL, COCARBOXYLASE TETRAHYDRATE 5.8 MG/VIAL",2025-07-31T01:07:11.992768,IL,סופר-פארם,,60.85964761,51.57597485,38.3464497,,,CERNEVIT 1VIAL POWDER FOR INJ,,,28557,VIAL GLASS TYPE I,units,1.0,139 72 30602 12,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Vitamin supplementation in patients receiving parenteral nutrition. Only for adults and children over 11 years of age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b696633-c4f9-4b61-b077-17931359d5f3.json
2b6e1a6c-2ad6-47ca-8409-68b2e00639a9,CARDILOC 1.25,prescription,C07AB07,BISOPROLOL,3841,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL HEMIFUMARATE 1.25  MG,2025-07-31T00:54:52.446300,IL,אוניפארם,,15.19604,12.878,9.4,,,CARDILOC 5MG 30TAB,3687,,24788,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,148 63 33513 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function (ejection fraction < 35%, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b6e1a6c-2ad6-47ca-8409-68b2e00639a9.json
2b6ed671-ba6f-44f0-9063-005bf97eaf67,GYNERA ®,prescription,G03CA01,ETHINYLESTRADIOL,2708,,,WHO ATC Classification,,ILS,coated tablets,"ETHINYLESTRADIOL 0.03   MG, GESTODENE 0.075   MG",2025-07-31T03:39:42.642747,IL,באייר,,66.48917385,56.3467575,41.8935,,7-298074-040128,GYNERA 3X21TAB,7012,,8724,BLISTER PVC/ALUMINIUM,units,63.0,050 51 25622 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Hormonal contraception.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b6ed671-ba6f-44f0-9063-005bf97eaf67.json
2b7a958d-029e-418f-8382-f233733d13e1,TICOVAC 0.5 ML,prescription,J07BA01,"ENCEPHALITIS, TICK BORNE, INACTIVATED, WHOLE VIRUS",8417,,,WHO ATC Classification,,ILS,suspension for injection,"ENCEPHALITIS, TICK BORNE, INACTIVATED, WHOLE VIRUS 2.4  MCG / 0.5  ML",2025-07-31T09:20:05.690980,IL,פיזר,,214.5124707,181.7902375,145.43219,,7290013592392,TICOVAC 0.25 ML  1 PREFILLED SYRINGE,10483,,45683,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,162 33 35413 00,valid,25.0,i.m,1.4,30,,,,,,,,,,0,Prescription required,Ticovac 0.5 ml is indicated for the active (prophylactic) immunization of adolescents from 16 years of age and adults against tick-borne encephalitis (TBE).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b7a958d-029e-418f-8382-f233733d13e1.json
2b91a558-4f55-400f-a394-a755069b9411,XYLOVIT 0.05%,off-the-counter,R01AA07,XYLOMETAZOLINE,3443,,,WHO ATC Classification,,ILS,drops+spray,XYLOMETAZOLINE HYDROCHLORIDE 0.05 %,2025-07-31T13:39:25.909701,IL,ויטאמד,,19.9656,16.92,nan,,7290008068970,XYLOVIT 0.1% DRP10ML,24003,,,BOTTLE LDPE,units,10.0,062 58 27663 01,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to 10 hours.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b91a558-4f55-400f-a394-a755069b9411.json
2b9f11dc-7960-4050-bed8-7f305db608b4,RUFINAMIDE – TRIMA 40MG/ML,prescription,N03AF03,RUFINAMIDE,9620,,,WHO ATC Classification,,ILS,suspension,RUFINAMIDE/,2025-07-31T07:53:34.931207,IL,תרימה,,566.9556376,480.4709007,408.9114049,,,RUFINAMIDE - TRIMA 40MG/ML 460ML,,,,BOTTLE PET,units,460.0,178 38 37248 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Adjunctive therapy in the treatment of seizures associated with Lennox Gastaut syndrome in patients 1 year of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2b9f11dc-7960-4050-bed8-7f305db608b4.json
2ba2b6e7-121d-4ce4-b9be-bab3d813efd2,KADCYLA,prescription,L01FD03,TRASTUZUMAB EMTANSINE,7399,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,TRASTUZUMAB EMTANSINE/ML,2025-07-31T04:20:34.905998,IL,רוש,,12003.20631,10172.20919,9247.462901,,7290008140959,KADCYLA 20MG/ML VIAL 20ML 160MG,,,77598,VIAL 15 ML GLASS TYPE I,units,160.0,151 63 33939 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"""Early Breast Cancer (EBC):KADCYLA, as a single agent, is indicated for the adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and trastuzumab -based treatment.""Metastatic Breast Cancer (MBC)Kadcyla, as a single agent, is indicated for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either:•	Received prior therapy for metastatic disease, or•	Developed disease recurrence during or within six months of completing adjuvant therapy.""",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ba2b6e7-121d-4ce4-b9be-bab3d813efd2.json
2ba6277f-af84-480a-a261-6d7e6bfa012d,RIBOMUSTIN 100 MG,prescription,L01AA09,BENDAMUSTINE ,7675,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BENDAMUSTINE  HYDROCHLORIDE/VIAL,2025-07-31T07:34:40.034711,IL,דור שירותים פרמצבטיים,,2486.028313,2106.803655,1915.27605,,8718692510647,RIBOMUSTIN 100MG 5 VIAL,18517,,65550,VIAL BROWN GLASS,units,5.0,152 40 33966 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"First-line of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotheraphy is not appropiate. Indolent non-Hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen.Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ba6277f-af84-480a-a261-6d7e6bfa012d.json
2baa277e-7c56-41db-8868-89f21923fea9,VOLIBRIS 10 MG,prescription,C02KX02,AMBRISENTAN,6243,,,WHO ATC Classification,,ILS,film coated tablets,AMBRISENTAN,2025-07-31T10:19:48.876474,IL,ג.ס.ק,,4039.989548,3423.719956,3112.472687,,7290010140589,VOLIBRIS 10 MG FC 30 TABLETS,22300,,78756,BLISTER PVC/PVDC,units,30.0,140 09 31884 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Volibris is indicated for treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment with tadalafil.Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2baa277e-7c56-41db-8868-89f21923fea9.json
2badaf8b-bd53-4e36-bdfb-7a0b24be9213,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,3482,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:31:14.614629,IL,דקסל פארמה,,13.9122,11.79,nan,,,DEXAMOL COLD NIGHT 20 CAPLIOTS,4237,,,BLISTER PVC/ALUMINIUM,units,20.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2badaf8b-bd53-4e36-bdfb-7a0b24be9213.json
2bb6b472-2735-459d-85af-74c0a0e3f303,EFEXOR XR 150,prescription,N06AX16,VENLAFAXINE,4713,,,WHO ATC Classification,,ILS,capsules extended release,VENLAFAXINE AS HYDROCHLORIDE,2025-07-31T10:04:39.100806,IL,אוניפארם,,46.49002114,39.398323,28.7579,,,VENLA 75MG 28TAB,22242,,59682,BLISTER PVC/FOIL,units,28.0,111 18 29395 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of depression.   Maintenance of recurrent depression.   Generalized anxiety disorder (GAD) - short term and long-term.   Social anxiety Disorder (SAD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2bb6b472-2735-459d-85af-74c0a0e3f303.json
2bb9b99d-f4d1-4729-b041-d138e4932a5d,BEPANTHEN PLUS,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",2684,,,WHO ATC Classification,,ILS,cream,"DEXPANTHENOL, CHLORHEXIDINE DIHYDROCHLORIDE 0.5 %",2025-07-31T11:18:05.769371,IL,באייר,,41.0758,34.81,nan,,7290008905398,BEPANTHEN PLUS CR 5% 30G,2019,,,TUBE ALUMINIUM,units,30.0,127 48 26501 01,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Antiseptic healing treatment of wounds of any kind with an infection risk : such as slight skin irritations, wounds, cuts, burns and skin inflammation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2bb9b99d-f4d1-4729-b041-d138e4932a5d.json
2bbf4ec6-b9fb-4062-a868-15d7fe2a8393,EVETOR 10,prescription,L04AA18,EVEROLIMUS,9057,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS,2025-07-31T02:44:51.861900,IL,אוניפארם,,5159.461319,4372.424847,3974.931679,,,EVETOR 10MG 30 TABS,,,75169,BLISTER ALU-PA/AI/PVC,units,30.0,168 89 36326 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Evetor is indicated for:- Treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of Evetor is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. - Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. The safety and effectiveness of EVETOR in the treatment of patients with carcinoid tumors have not been established. - Treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non – steroidal aromatase inhibitor. - Treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Evetor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes. - Treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.- Treatment of unresectable, locally advanced or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2bbf4ec6-b9fb-4062-a868-15d7fe2a8393.json
2bd97a52-8c24-479e-a5df-74c6f44cb8c3,TRIUMEQ,prescription,J05AR13,LAMIVUDINE AND ABACAVIR AND DOLUTEGRAVIR,7555,,,WHO ATC Classification,,ILS,film coated tablets,"DOLUTEGRAVIR AS SODIUM, ABACAVIR AS SULFATE, LAMIVUDINE",2025-07-31T09:44:55.177390,IL,ג.ס.ק,,3756.270753,3183.280441,2893.89131,,7290014547155,TRIUMEQ 30TAB,20797,,75758,BOTTLE HDPE,units,30.0,153 49 34304 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Triumeq is indicated for the treatment of Human Immunodeficiency Virus (HIV) infected adults and adolescents above 12 years of age weighing at least 40 kg.Before initiating treatment with abacavir-containing products, screening for carriage of the HLA-B*5701 allele should be performed in any HIV-infected patient, irrespective of racial origin. Abacavir should not be used in patients known to carry the HLA-B*5701 allele.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2bd97a52-8c24-479e-a5df-74c6f44cb8c3.json
2bfa6765-9b70-401f-b343-5ca2560623d6,VIEPAX XR 225,prescription,N06AX16,VENLAFAXINE,8418,,,WHO ATC Classification,,ILS,tablets prolonged release,VENLAFAXINE AS HYDROCHLORIDE,2025-07-31T10:14:43.225378,IL,דקסל פארמה,,103.7952617,87.96209011,65.3993235,,,VIEPAX XR 225 30 TAB,22464,,19278,BLISTER PVC/PE/PVDC/AL,units,30.0,161 42 35039 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of depression. Maintenance of recurrent depression. Generalized anxiety disorder (GAD) - short term and long-term. Social anxiety Disorder (SAD)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2bfa6765-9b70-401f-b343-5ca2560623d6.json
2bfc2d64-b531-4dee-8c70-5e90cfcf9c23,ZINPLAVA 25 MG/ML 40 ML VIAL,prescription,,,8557,,,,,ILS,injection,ZINPLAVA 25 MG/ML VIAL,2025-07-31T19:39:49.333465,IL,מ.ס.ד. ישראל,,16285.27549,13801.08154,12546.43776,,,ZINPLAVA 25 MG/ML 40 ML VIAL,,,,,units,1.0,,not-registered,10.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2bfc2d64-b531-4dee-8c70-5e90cfcf9c23.json
2c1e1f0e-a243-4672-b255-9eeecff98050,KUVAN,prescription,A16AX07,SAPROPTERIN,6300,,,WHO ATC Classification,,ILS,tablets soluble,SAPROPTERIN DIHYDROCHLORIDE,2025-07-31T04:30:28.480814,IL,מדיסון,,1915.430816,1623.246526,1381.486406,,7290000845449,KUVAN 100MG 30TAB SOLUBLE,11230,,25164,BOTTLE HDPE,units,30.0,144 23 33052 01,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Kuvan is indicated for the treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with phenylketonuria (PKU) who have been shown to be responsive to such treatment.Kuvan is also indicated for the treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with tetrahydrobiopterin (BH4) deficiency who have been shown to be responsive to such treatment.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c1e1f0e-a243-4672-b255-9eeecff98050.json
2c3c13d6-87a8-4ddc-8789-9d96bd806ca1,GILEX 10 MG,prescription,N06AA12,DOXEPIN,1552,,,WHO ATC Classification,,ILS,capsules,DOXEPIN AS HYDROCHLORIDE,2025-07-31T03:32:59.114859,IL,רקח,,22.470739,19.043,13.9,,7290008090476,GILEX 25 MG 30 TAB,7034,,918,BLISTER PVC/ALUMINIUM,units,30.0,033 55 22651 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of anxiety and/or depression.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c3c13d6-87a8-4ddc-8789-9d96bd806ca1.json
2c4b2446-5dd9-4df7-b947-dc17a5630932,LANTON 30,prescription,A02BC03,LANSOPRAZOLE,4834,,,WHO ATC Classification,,ILS,capsules,LANSOPRAZOLE,2025-07-31T04:35:47.038582,IL,רפא,,41.74125864,35.373948,25.8204,,7290008013871,LANTON 30 28CAPS,12304,,59268,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,129 25 30761 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,• Treatment of duodenal and gastric ulcer• Treatment of reflux oesophagitis• Prophylaxis of reflux oesophagitis• Eradication of Helicobacter pylori (H. pylori) concurrently given with appropriate antibiotic therapy for treatment of H.pylori-associated ulcers• Treatment of NSAID-associated benign gastric and duodenal ulcers in patients requiring continued NSAID treatment• Prophylaxis of NSAID-associated gastric ulcers and duodenal ulcers in patients at risk requiring continued therapy• Symptomatic gastroesophageal reflux disease• Zollinger-Ellison syndrome.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c4b2446-5dd9-4df7-b947-dc17a5630932.json
2c5ca58d-9d48-4386-9336-ff53a3396a08,LEVETRIM SOLUTION,prescription,N03AX14,LEVETIRACETAM,7348,,,WHO ATC Classification,,ILS,solution  (oral),LEVETIRACETAM/ML,2025-07-31T04:44:16.544252,IL,תרימה,,251.7825,213.375,170.7,,7290000843513,LEVETRIM SOLUTION 100MG/ML 300ML,12499,,51488,BOTTLE GLASS TYPE III,units,300.0,150 58 33779 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Levetrim Solution is indicated as:- monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. - adjunctive therapy:in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c5ca58d-9d48-4386-9336-ff53a3396a08.json
2c5d18d7-eb9b-46fd-93e5-b0b9807ff29d,LORAMIDE 12 CAPLETS,off-the-counter,,,5435,,,,,ILS,tablet,LORAMIDE 12 CAPLETS,2025-07-31T19:45:27.457521,IL,ליף-פריגו,,26.432,22.4,,,,LORAMIDE 12 CAPLETS,,,,,units,12.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c5d18d7-eb9b-46fd-93e5-b0b9807ff29d.json
2c734ca3-c50b-438a-9b58-0580f01a1dee,MOVEX TABLETS,off-the-counter,R05CB02,BROMHEXINE,2938,,,WHO ATC Classification,,ILS,tablets,BROMHEXINE HYDROCHLORIDE,2025-07-31T12:26:52.861104,IL,ויטאמד,,19.6116,16.62,nan,,7290008068345,MOVEX SOL INHALATION 50ML,13050,,,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,124 50 27560 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Mucolitic expectorant in conditions associated with the retention of viscid mucoid secretion in the respiratory tract e.g.: bronchitis asthma and sinusitis,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c734ca3-c50b-438a-9b58-0580f01a1dee.json
2c820137-c646-4937-8aac-1abc71dcb09c,IMITREX INJECTION,prescription,N02CC01,SUMATRIPTAN,3408,,,WHO ATC Classification,,ILS,solution for injection,SUMATRIPTAN AS SUCCINATE/ 0.5  ML,2025-07-31T04:01:49.114088,IL,ג.ס.ק,,55.43450728,46.978396,34.2908,,7290008085953,IMITREX 50MG 6TAB,9042,,9594,SYRINGE PREFILLED  GLASS TYPE I,units,6.0,055 92 26920 00,valid,37.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache.Imitrex should only be used where there is a clear diagnosis of migraine or cluster headache.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c820137-c646-4937-8aac-1abc71dcb09c.json
2c907e15-0e22-4e08-9690-e874a5283ef3,KAMRHO-D IM VIAL 2ML,prescription,,,3823,,,,,ILS,injection,KAMRHO-D IM VIAL,2025-07-31T19:14:58.923308,IL,קמהדע,,355.6246958,301.3768742,256.4909568,,,KAMRHO-D IM VIAL 2ML,11120,,19728,,units,1.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c907e15-0e22-4e08-9690-e874a5283ef3.json
2c93a6c0-aec3-425e-bd31-1c47f274ed02,LIDOCAINE HYDROCHLORIDE S.A.L.F. 10 MG/ML,prescription,N01BB02,LIDOCAINE,9426,,,WHO ATC Classification,,ILS,solution for injection,LIDOCAINE HYDROCHLORIDE/,2025-07-31T04:46:55.244080,IL,רז פרמהצפטי,,25.6699914,21.75423,15.879,,,LIDOCAINE HYDROCHLORIDE S.A.L.F.20 MG/ML 5 AMP 10ML,12596,,60964,AMPOULES GLASS TYPE I,units,5.0,165 32 35867 00,valid,37.0,"intradermal, submucosal, perineural, spinal, i.m, s.c, i.v regional anaesthesia, epidural",1.4,36,,,,,,,,,,0,Prescription required,Local and regional anaesthesia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c93a6c0-aec3-425e-bd31-1c47f274ed02.json
2c9f2096-6c4b-4371-aeb2-49e731d0f4a7,DEXMEDETOMIDINE EVER PHARMA 100 MCG/ML,29C,N05CM18,DEXMEDETOMIDINE,20929,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DEXMEDETOMIDINE AS HYDROCHLORIDE/,2025-07-31T14:18:00.716605,IL,nan,,nan,nan,nan,,,DEXMEDETOMIDINE HCL SUN USA  200MCG/2ML  5 VIALS 2ML,,,,AMPOULES GLASS TYPE I,units,5.0,168 31 36278 00,valid,nan,i.v,1.4,24,,,,,,,,,,0,,"Dexmedetomidine Ever Pharma is indicated:For sedation of adult ICU (Intensive Care Unit) patients requiring sedation level not deeper than arousal in response to verbal stimulation (corresponding to Richmond Agitation-Sedation Scale (RASS) 0 to -3).For sedation of non-intubated adult patients prior to and/or during diagnostic or surgicalprocedures requiring sedation, i.e. procedural/awake sedation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2c9f2096-6c4b-4371-aeb2-49e731d0f4a7.json
2ca02e4c-8c2d-4691-9a6c-e21841e382db,ENTYVIO I.V.,prescription,L04AG05,VEDOLIZUMAB,7558,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,VEDOLIZUMAB/VIAL,2025-07-31T02:25:07.721432,IL,טקדה,,10189.37178,8635.061214,7850.055649,,50335382011547,ENTYVIO 300 MG/VIAL,5585,,66601,VIAL GLASS TYPE I,units,1.0,153 58 34277 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Ulcerative Colitis:Entyvio is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFα) antagonist.Crohn’s Disease:Entyvio is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFα) antagonist.Pouchitis Entyvio is indicated for the treatment of adult patients with moderately to severely active chronic pouchitis, who have undergone proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis, and have had an inadequate response with or lost response to antibiotic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ca02e4c-8c2d-4691-9a6c-e21841e382db.json
2cb449d9-7346-450d-8335-f976288a3816,ESCITALOPRAM TEVA ® 10 MG,prescription,N06AB10,ESCITALOPRAM,6283,,,WHO ATC Classification,,ILS,tablets,ESCITALOPRAM AS OXALATE,2025-07-31T02:35:21.077168,IL,טבע,,40.43084268,34.263426,25.0098,,7290102062966,ESCITALOPRAM TEVA 10MG 30TAB,5480,,80701,BLISTER PVDC/ALUMINIUM,units,30.0,137 84 31381 12,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of depression.Treatment of panic disorder. Treatment of generalized anxiety disorder (GAD).Treatment of social anxiety disorder ( social phobia).Treatment of obsessive - compulsive disorder.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2cb449d9-7346-450d-8335-f976288a3816.json
2cb5ccfa-ad2e-4cff-a8eb-025c1868c985,AMBUTYRATE POWDER 100MG,29C,,,20282,,,,,,tablet,AMBUTYRATE POWDER 100MG,2025-07-31T19:52:44.043806,IL,nan,,,,,,,AMBUTYRATE POWDER 100MG,,,,,units,1.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2cb5ccfa-ad2e-4cff-a8eb-025c1868c985.json
2cb6706a-4278-4bc6-8456-c9e80b9f8e82,ZINCOL ENTERIC COATING TABLETS,prescription,A12CB01,ZINC SULFATE,2046,,,WHO ATC Classification,,ILS,tablets,ZINC AS SULFATE,2025-07-31T10:48:37.080819,IL,סם און,,27.80552,23.564,17.2,,,ZINCOL 220MG 30TAB,26014,,2447,BLISTER PVC/ALUMINIUM,units,30.0,010 61 24158 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Zinc supplement.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2cb6706a-4278-4bc6-8456-c9e80b9f8e82.json
2cd27941-9129-4bef-a1c4-08200af06e33,NUWIQ 2000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,9076,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,SIMOCTOCOG ALFA/VIAL,2025-07-31T05:58:58.569422,IL,דובר מדיקל,,5803.33784,4918.083134,4470.984667,,,NUWIQ 2000 IU,,,75586,VIAL GLASS TYPE I,units,1.0,168 23 36552 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients 2 years of age and older with haemophilia A (congenital factor VIII deficiency). Nuwiq does not contain von Willebrand Factor and is thus not indicated to treat von Willebrand’s Disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2cd27941-9129-4bef-a1c4-08200af06e33.json
2cdb165d-e9dc-4358-b58b-7f2350ff2c75,CHAMPIX 0.5 MG,prescription,N07BA03,VARENICLINE,7326,,,WHO ATC Classification,,ILS,film coated tablets,VARENICLINE AS TARTRATE 0.5  MG,2025-07-31T01:08:51.335421,IL,פיזר,,1311.055722,1111.06422,945.5865705,,7290010355747,CHAMPIX COMBO (1STARTER PACK+2PACKS 1MGX56),9687,,48808,BLISTER ACLAR/PVC/ALUMINIUM,units,165.0,137 66 31510 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Champix is indicated as an aid to smoking cessation treatment adults over 18 years of age.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2cdb165d-e9dc-4358-b58b-7f2350ff2c75.json
2cef6cd4-80a6-4d8c-8143-5ed7f0ca3e98,NULIBRY,prescription,A16AX19,FOSDENOPTERIN,9023,,,WHO ATC Classification,,ILS,powder for reconstitution for solution for injection,FOSDENOPTERIN HYDROBROMIDE 9.5 MG/VIAL,2025-07-31T05:58:05.731578,IL,מדיסון,,nan,nan,nan,,,NULIBRY 9.5 MG / VIAL 10 ML,,,,VIAL GLASS TYPE I,units,1.0,170 28 36983 99,valid,nan,i.v,1.4,24,,,,,,,,,,0,Prescription required,Nulibry is indicated to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2cef6cd4-80a6-4d8c-8143-5ed7f0ca3e98.json
2cf0199d-c9b7-4369-bfce-74dd3c4736e5,CILARIL 1,prescription,C09AA08,CILAZAPRIL,9378,,,WHO ATC Classification,,ILS,tablets,CILAZAPRIL,2025-07-31T01:12:25.509756,IL,אוניפארם,,20.44999,17.3305,12.65,,,CILARIL 1 MG 30 TAB,,,14029,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,136 01 31495 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Cilaril is indicated for the treatment of hypertension. Cilaril is indicated for the treatment of chronic heart failure.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2cf0199d-c9b7-4369-bfce-74dd3c4736e5.json
2cfce1f6-2131-4bc9-8e84-7f475144c5dd,GAVISCON LIQUID PEPPERMINT,off-the-counter,A02BX13,ALGINIC ACID,5582,,,WHO ATC Classification,,ILS,suspension,"ALGINIC ACID AS SODIUM/ML, SODIUM BICARBONATE 26.7 MG/ML, CALCIUM CARBONATE/ML",2025-07-31T11:59:18.711296,IL,רקיט בנקיזר,,74.989,63.55,nan,,,GAVISCON LIQUID PEPPERMINT 600 ML,7982,,,BOTTLE AMBER GLASS,units,600.0,141 67 31756 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Gastro reflux, heartburn, flatulence associated with gastric reflux, heartburn of pregnancy, all cases of epigastric and retrosternal distress where the underlying cause is gastric reflux.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2cfce1f6-2131-4bc9-8e84-7f475144c5dd.json
2d066ba4-e650-4564-9e3c-13fd8b3d0ac6,ESTREPTOMICINA 1G REIG JOFRE SPAIN,29C,,,20837,,,,,,tablet,ESTREPTOMICINA 1G REIG JOFRE SPAIN,2025-07-31T20:23:47.813033,IL,nan,,,,,,,ESTREPTOMICINA 1G REIG JOFRE SPAIN,,,,,units,1.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d066ba4-e650-4564-9e3c-13fd8b3d0ac6.json
2d0b3a31-9621-4455-a64e-6eff01ec9034,GELOFUSINE 40MG/ML SOLUTION FOR INFUSION,29C,,,20844,,,,,,solution,GELOFUSINE 40MG/ML SOLUTION FOR INFUSION,2025-07-31T20:31:32.418565,IL,nan,,,,,,,GELOFUSINE 40MG/ML SOLUTION FOR INFUSION,,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d0b3a31-9621-4455-a64e-6eff01ec9034.json
2d145e92-989a-49a1-a042-cba991462f4d,TIVICAY 10 MG,prescription,J05AX12,DOLUTEGRAVIR,7419,,,WHO ATC Classification,,ILS,film coated tablets,DOLUTEGRAVIR AS SODIUM,2025-07-31T09:23:17.295253,IL,ג.ס.ק,,2532.170773,2145.90753,1950.825027,,7290014547513,TIVICAY 50MG 30 F.C.TAB,20783,,52458,BOTTLE HDPE,units,30.0,160 06 35311 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d145e92-989a-49a1-a042-cba991462f4d.json
2d15cfcd-306f-41b0-a1c0-92f39172a5a3,ATOSIBAN PHARMIDEA,prescription,G02CX01,ATOSIBAN,8903,,,WHO ATC Classification,,ILS,solution for injection/ concentrate for solution for infusion,ATOSIBAN AS ACETATE 7.5 MG/ML,2025-07-30T23:29:46.780682,IL,מדי מרקט,,347.7030584,294.6636088,250.7775394,,7290015841634,ATOSIBAN PHARMIDEA 37.5 MG/5 ML,,,71506,VIAL GLASS TYPE I,units,1.0,166 78 35706 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Atosiban is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes- a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d15cfcd-306f-41b0-a1c0-92f39172a5a3.json
2d1dc7f4-4e51-4360-9009-dbe3b0d60621,AMOXICLAV TEVA ® 875 MG,prescription,J01CA51,"AMPICILLIN, COMBINATIONS",6962,,,WHO ATC Classification,,ILS,film coated tablets,"AMOXICILLIN AS TRIHYDRATE, CLAVULANIC ACID AS POTASSIUM SALT",2025-07-30T23:22:55.417179,IL,טבע,,39.29243296,33.298672,24.3056,,7290102065776,AMOXICLAV TEVA 875MG 14TAB,9505,,20585,BLISTER ALUMINIUM /ALUMINIUM,units,14.0,146 13 33189 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Amoxiclav teva is indicated for the treatment of the following infections in adults and children :• Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d1dc7f4-4e51-4360-9009-dbe3b0d60621.json
2d369b31-9754-4d97-a9a0-02feebfa77f5,EBETAXEL 6 MG/ML,prescription,L01CD01,PACLITAXEL,7929,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PACLITAXEL/ML,2025-07-31T02:10:15.543066,IL,סנדוז,,744.3712256,630.8230725,536.8707,,,EBETAXEL 6 MG/ML VIAL 100MG/16.7ML,5420,,10324,VIAL GLASS TYPE I,units,1.0,130 95 30965 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Paclitaxel is indicated alone or in combination, for the treatment of advanced carcinoma of the ovary. For the treatment of metastatic breast cancer after failure of combination chemotherapy. Prior therapy should have included an anthracycline unless clinically containdicated. Paclitaxel is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. Advanced non small cell lung cancer: Paclitaxel associated with cisplatinum is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. Kaposis's sarcoma: Paclitaxel is indicated in the second-line treatment of AIDS related Kaposi's sarcoma",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d369b31-9754-4d97-a9a0-02feebfa77f5.json
2d38b2da-a04f-405b-9ddf-554835881b45,EVETOR 10,prescription,L04AA18,EVEROLIMUS,9056,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS,2025-07-31T02:45:12.546103,IL,אוניפארם,,3931.799305,3332.033309,3029.12119,,,EVETOR 5MG 30 TABS,,,75165,BLISTER ALU-PA/AI/PVC,units,30.0,168 89 36326 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Evetor is indicated for:- Treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of Evetor is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. - Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. The safety and effectiveness of EVETOR in the treatment of patients with carcinoid tumors have not been established. - Treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non – steroidal aromatase inhibitor. - Treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Evetor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes. - Treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.- Treatment of unresectable, locally advanced or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d38b2da-a04f-405b-9ddf-554835881b45.json
2d4ab889-3e8b-4933-8e2f-88febe5fe540,LARGACTIL 50MG/2ML 5VIAL,29C,,,20491,,,,,,injection,LARGACTIL 50MG/,2025-07-31T20:45:49.880688,IL,nan,,,,,,,LARGACTIL 50MG/2ML 5VIAL,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d4ab889-3e8b-4933-8e2f-88febe5fe540.json
2d57bfb8-3983-476a-836b-a4e6d4ba2f0b,FOMINIC,prescription,G03AC09,DESOGESTREL,7993,,,WHO ATC Classification,,ILS,tablets,DESOGESTREL 0.075  MG,2025-07-31T03:16:29.620983,IL,דקסל פארמה,,64.44657615,54.6157425,40.6065,,7290010578825,FOMINIC 0.075MG 84 TAB,6579,,58860,BLISTER PVC/PVDC/ALUMINIUM,units,84.0,155 65 34262 00,valid,34.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Contraseptive.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d57bfb8-3983-476a-836b-a4e6d4ba2f0b.json
2d5f3711-d38f-4da6-8160-d3bd1ba4a941,NAPROCEN,off-the-counter,M01AE02,NAPROXEN,5432,,,WHO ATC Classification,,ILS,tablets,NAPROXEN SODIUM,2025-07-31T12:28:39.569790,IL,ליף-טרי אוף ליף,,35.9074,30.43,nan,,,NAPROXEN SODIUM SP 275MG 20TAB,,,,BLISTER PVC/PE/PVDC/AL,units,20.0,140 34 31895 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Mild and moderate analgesic such as relief of toothache, backache and menstrual pain (primary dysmenorrhea).Fever reduction.Non-steroidal anti-inflammatory for the treatment of rheumatic inflammations, tendinitis and musculoskeletal inflammations.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d5f3711-d38f-4da6-8160-d3bd1ba4a941.json
2d622747-60e3-49ab-8eb8-a549a3e117fa,DIPYRONE KALCEKS 500 MG/ML,prescription,N02BB02,METAMIZOLE SODIUM,8713,,,WHO ATC Classification,,ILS,solution for injection,METAMIZOLE SODIUM MONOHYDRATE/,2025-07-31T01:59:49.385062,IL,מדי מרקט,,34.07881069,28.88034804,21.08054601,,,DIPYRONE KALCEKS1000 MG/2ML 10 AMP,,,11433,AMPOULES GLASS TYPE I,units,10.0,163 58 35578 00,valid,37.0,"i.m, i.v",1.4,48,,,,,,,,,,0,Prescription required,"As an analgesic: Dypirone Kalceks, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. As an antipyretic: Dypirone Kalceks by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. Hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d622747-60e3-49ab-8eb8-a549a3e117fa.json
2d7661e0-5fc8-422b-bad1-e7cc8bb444cb,COROSAN 75 MG,prescription,B01AC07,DIPYRIDAMOLE,9299,,,WHO ATC Classification,,ILS,tablets,DIPYRIDAMOLE,2025-07-31T01:30:32.552526,IL,רז פרמהצפטי,,19.75808432,16.74414,12.222,,7290015863698,COROSAN 75 MG 10 TABLETS,23367,,77068,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,167 53 35927 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Corosan is indicated for:• As an adjunct to oral anticoagulation for prophylaxis of thromboembolism associated with prosthetic heart valves.• As an alternative to exercise stress in thallium myocardial imaging particularly in patients unable to exercise or in those for whom exercise may be contraindicated.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d7661e0-5fc8-422b-bad1-e7cc8bb444cb.json
2d820816-c315-4826-b8e8-b88a43fde6ac,RISPERDAL 1 MG,prescription,N05AX08,RISPERIDONE,4614,,,WHO ATC Classification,,ILS,film coated tablets,RISPERIDONE,2025-07-31T07:38:53.118310,IL,יאנסן סילג,,413.820578,350.6954207,298.4641878,,7290008124744,RISPERDAL CONSTA/DELTOID 50MG VIAL,18427,,11177,BLISTER PVC/PE/PVDC/AL,units,1.0,144 78 28260 01,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d820816-c315-4826-b8e8-b88a43fde6ac.json
2d8c63d4-1914-4b0d-ad4e-eba2d682a863,LYCLEAR DERMAL CREAM,prescription,P03AC04,PERMETHRIN,2987,,,WHO ATC Classification,,ILS,cream,PERMETHRINW/W,2025-07-31T05:00:40.980335,IL,ג.ס.ק,,57.47815144,48.7103,35.5549635,,7290008086936,LYCLEAR CRM 5% 30GR,12352,,68083,TUBE ALUMINIUM,units,30.0,060 18 27015 06,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,Is indicated for the treatment of scabies.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d8c63d4-1914-4b0d-ad4e-eba2d682a863.json
2d9830cf-3039-47e2-935a-edd41b45f265,ACROSE 100,prescription,A10BF01,ACARBOSE,6619,,,WHO ATC Classification,,ILS,tablets,ACARBOSE,2025-07-30T23:12:21.883094,IL,רפא,,19.90810568,16.871276,12.3148,,7290008016360,ACROSE 50MG 30TAB,9385,,18667,BLISTER PVC/PE/PVDC/AL,units,30.0,142 79 31979 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Treatment of non-insulin dependent diabetes mellitus (NIDDM) in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d9830cf-3039-47e2-935a-edd41b45f265.json
2d9cf115-36a1-4df8-bdff-96358027f880,ALBUNORM 20 %,prescription,B05AA01,ALBUMIN,7722,,,WHO ATC Classification,,ILS,solution for infusion,"ALBUMIN HUMAN/, PLASMA PROTEIN FRACTION",2025-07-31T00:14:09.820121,IL,דובר מדיקל,,175.9130352,149.07885,119.26308,,,ALBUNORM 20%  BOTTLE 50ML,,,,BOTTLE GLASS TYPE II,units,50.0,150 28 33713 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on the official recommendations",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2d9cf115-36a1-4df8-bdff-96358027f880.json
2da022c4-64c2-4591-88e0-8bcfc09f2575,PREGABALIN TEVA ® 100 MG,prescription,N03AX16,PREGABALIN,8017,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:55:01.358441,IL,טבע,,75.57087747,64.0431165,47.6157,,,PREGABALIN TEVA  50 MG 56 TAB,16983,,56058,BLISTER PVC/ALUMINIUM,units,56.0,157 26 34479 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,PREGABALIN TEVA ® is indicated for the: - Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia. - Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2da022c4-64c2-4591-88e0-8bcfc09f2575.json
2dc009dc-1c93-4c1d-bed0-9b42b6aef95e,BRILINTA 60 MG,prescription,B01AC24,TICAGRELOR,6678,,,WHO ATC Classification,,ILS,film coated tablets,TICAGRELOR,2025-07-30T23:43:10.018783,IL,אסטראזנקה,,259.4570368,219.8788545,175.9030836,,,BRILINTA 90MG 56TAB,2523,,15216,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,156 54 34752 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Brilinta, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event (see sections 4.2 and 5.1).Limitations of use:  90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2dc009dc-1c93-4c1d-bed0-9b42b6aef95e.json
2dc345fb-f658-447a-abbc-a678c982669b,LEVITRA 10MG 4TAB,prescription,,,4682,,,,,ILS,tablet,LEVITRA 10MG,2025-07-31T19:16:06.696653,IL,באייר,,70.93703925,60.11613763,44.69601311,,,LEVITRA 10MG 4TAB,12315,,60181,,units,4.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2dc345fb-f658-447a-abbc-a678c982669b.json
2dd34bc6-c5d5-4078-98ba-c9757cf9d884,ENALADEX 10 MG,prescription,C09AA02,ENALAPRIL,4329,,,WHO ATC Classification,,ILS,tablets,ENALAPRIL MALEATE,2025-07-31T02:19:48.290306,IL,כ.צ.ט,,18.93588244,16.047358,11.7134,,,ENALAPRIL 20MG 30TAB,5172,,27973,BLISTER ALUMINIUM,units,30.0,115 85 29810 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. To retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2dd34bc6-c5d5-4078-98ba-c9757cf9d884.json
2dff22ff-09e9-40f5-9c48-0f9367c69bf2,IODO-VIT VETERINARY OINTMENT,off-the-counter,D08AG02,POVIDONE-IODINE,2478,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:12:46.205874,IL,ויטאמד,,11.092,9.4,nan,,7290008082495,IODO-VIT SOL.20ML,9052,,,JAR PLASTIC,units,20.0,083 26 92362 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Disinfection of wounds, scratches, minor burns and skin infections in farm animals and pets.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2dff22ff-09e9-40f5-9c48-0f9367c69bf2.json
2e043956-9ace-4765-8896-ece04b9de9af,TUMS SMOOTHIES EX PEPPERMINT,off-the-counter,A02AC01,CALCIUM CARBONATE,5499,,,WHO ATC Classification,,ILS,chewable tablets,CALCIUM CARBONATE,2025-07-31T13:31:04.256768,IL,ג.ס.ק,,35.6596,30.22,nan,,7290010140497,TUMS SMOOTHIES EX BERRY FUSION 60 TABS 750MG,,,,BOTTLE POLYPROPYLENE,units,60.0,134 94 31175 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For relief from heartburn and acidity,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e043956-9ace-4765-8896-ece04b9de9af.json
2e08ae0d-40b3-459c-87b1-92951821af78,BEKUNIS 45 DRAGEES,prescription,,,364,,,,,ILS,tablet,BEKUNIS 45 DRAGEES,2025-07-31T19:00:18.818196,IL,דקסל פארמה,,57.14777996,48.430322,35.3506,,,BEKUNIS 45 DRAGEES,2047,,79115,,units,45.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e08ae0d-40b3-459c-87b1-92951821af78.json
2e08b9e0-031c-4748-a1e4-a78f8e0c6923,GASTRO 10,off-the-counter,A02BA03,FAMOTIDINE,3491,,,WHO ATC Classification,,ILS,tablets,FAMOTIDINE,2025-07-31T11:58:40.876004,IL,אוניפארם,,29.4528,24.96,nan,,,GASTRO 10MG 20TAB,7023,,,BLISTER PVC/ALUMINIUM,units,20.0,107 36 28578 01,valid,nan,per os,1.4,48,,,,,,,,,,0,,For the treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e08b9e0-031c-4748-a1e4-a78f8e0c6923.json
2e118be1-1c67-47c9-855f-776a19adb65f,STELARA 130 MG,prescription,L04AC05,USTEKINUMAB,8002,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,USTEKINUMAB/,2025-07-31T08:42:12.344481,IL,יאנסן סילג,,10177.22256,8624.765267,7840.695697,,7290014577404,STELARA 130MG 1 VIAL,9989,,60533,VIAL GLASS TYPE I,units,1.0,158 52 35072 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Crohn’s Disease :STELARA is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNFα antagonist or have medical contraindications to such therapies.Ulcerative colitis :STELARA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e118be1-1c67-47c9-855f-776a19adb65f.json
2e2fbd00-778d-4e12-a63b-c3fdb5ae6153,PRIVIGEN,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7138,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/L",2025-07-31T06:57:16.136422,IL,סי אס אל,,3053.778557,2587.948044,2352.68004,,,PRIVIGEN 10G/100ML VIAL,16920,,40653,BOTTLE GLASS TYPE I,units,100.0,146 46 33254 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Replacement therapy in• Primary immunodeficiency syndromes (PID) such as:  – congenital agammaglobulinaemia and hypogammaglobulinaemia  – common variable immunodeficiency  – severe combined immunodeficiency  – Wiskott-Aldrich syndrome• Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections• Children with congenital AIDS and recurrent infectionsImmunomodulation• Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count• Guillain-Barré syndrome• Kawasaki disease• Chronic inflammatory demyelinating polyneuropathy (CIDP)Allogeneic bone marrow transplantation,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e2fbd00-778d-4e12-a63b-c3fdb5ae6153.json
2e3d581e-6ae4-4544-bd78-60a7fa2f56b9,RINGER LACTATED SOLUTION/VIOSER,prescription,B05BB01,ELECTROLYTES,9443,,,WHO ATC Classification,,ILS,solution for infusion,"SODIUM LACTATE 3.14 G/L, CALCIUM CHLORIDE DIHYDRATE 0.26 G/L, POTASSIUM CHLORIDE 0.41 G/L, SODIUM CHLORIDE 6.02 G/L",2025-07-31T08:25:31.807857,IL,רז פרמהצפטי,,nan,nan,nan,,7290111096761,SODIUM CHLORIDE MONICO 0.45 %  BAG 1000 ML,,,,BOTTLE LDPE,units,1000.0,169 66 36052 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,Prescription required,Source of water and electrolytes. Regulation or maintenance of metabolic acidosis (except lactic acidosis),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e3d581e-6ae4-4544-bd78-60a7fa2f56b9.json
2e70eba5-f106-4c29-af3a-fec35e2ec4e7,KENALOG 40MG/ML 5 VIALS,29C,,,20097,,,,,,injection,KENALOG 40MG/ML S,2025-07-31T20:44:27.185549,IL,nan,,,,,,,KENALOG 40MG/ML 5 VIALS,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e70eba5-f106-4c29-af3a-fec35e2ec4e7.json
2e83a3d3-b77b-4268-998f-2d6c9ab90f5d,TOVIAZ 4 MG,prescription,G04BD11,FESOTERODINE,6261,,,WHO ATC Classification,,ILS,tablets sustained release,FESOTERODINE FUMARATE,2025-07-31T09:28:24.891891,IL,פיזר,,82.98155631,70.32335594,52.285023,,,TOVIAZ 8MG 28 S.R.TAB,20648,,80262,BLISTER ALU/PVC/PA/ALU,units,28.0,139 55 31658 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e83a3d3-b77b-4268-998f-2d6c9ab90f5d.json
2e83d114-1243-43a3-8d54-8c7c2beeaa2d,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,7244,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T00:04:22.829530,IL,ניאופרם,,1032.394278,874.910405,744.6046,,,ABSTRAL 400MCG 30TAB SUBLINGUAL,9669,,46853,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,30.0,148 73 33262 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e83d114-1243-43a3-8d54-8c7c2beeaa2d.json
2e8fd29b-b009-4cf3-9b6a-df79b07cad46,ISOVENIR 10 MG,prescription,D10BA01,ISOTRETINOIN,9398,,,WHO ATC Classification,,ILS,"capsule, soft",ISOTRETINOIN,2025-07-31T04:13:25.493722,IL,ביואבניר,,107.1851159,90.834844,67.5352,,,ISOVENIR 20 MG  30 CAPS,,,15533,BLISTER ALU/PVC/TE/PVDC,units,30.0,174 46 36774 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Isovenir is indicated for the treatment of severe cystic acne that does not respond to other treatment,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e8fd29b-b009-4cf3-9b6a-df79b07cad46.json
2e8fe481-aefb-4145-97d9-5d1136637e3e,FERROCAL TABLETS,off-the-counter,,,1545,,,,,ILS,tablets,"CALCIUM CITRATE, FERROUS CITRATE",2025-07-31T11:55:09.675089,IL,רקח,,24.5558,20.81,nan,,7290008090438,FERROCAL 500MG 50TAB,6019,,,BLISTER PVC/ALUMINIUM,units,50.0,137 54 25091 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Prevention and treatment of iron-deficiency anemia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e8fe481-aefb-4145-97d9-5d1136637e3e.json
2e919397-a066-414f-8278-d5daa3f49564,TEVAPIRIN,off-the-counter,B01AC06,ACETYLSALICYLIC ACID,3851,,,WHO ATC Classification,,ILS,tablets enteric coated,ACETYLSALICYLIC ACID,2025-07-31T13:26:52.341318,IL,טבע,,19.1632,16.24,nan,,7290008097307,TEVAPIRIN 100MG 30TAB,20305,,,BLISTER PVDC/ALUMINIUM,units,30.0,119 71 29957 13,valid,nan,per os,1.4,24,,,,,,,,,,0,,The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e919397-a066-414f-8278-d5daa3f49564.json
2e9316e2-6e82-46be-929c-69f38d96f2df,AKEEGA 100/500,prescription,L01XX54,NIRAPARIB,9463,,,WHO ATC Classification,,ILS,film coated tablets,"ABIRATERONE ACETATE, NIRAPARIB AS TOSYLATE MONOHYDRATE",2025-07-30T23:17:41.751406,IL,יאנסן סילג,,26541.13163,22492.48544,20447.71403,,,AKEEGA 100/500 56 TAB,,,,BLISTER PVDC/PE/PVC/AL,units,56.0,175 83 37789 99,valid,10.0,per os,1.4,30,,,,,,,,,,0,Prescription required,Akeega is indicated with prednisone or prednisolone for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC) and BRCA 1/2 mutations (germline and/or somatic) in whom chemotherapy is not clinically indicated.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e9316e2-6e82-46be-929c-69f38d96f2df.json
2e97f655-0419-444b-a950-dc1e05a57b4c,VYVANSE 30 MG,prescription,N06BA12,LISDEXAMFETAMINE,7379,,,WHO ATC Classification,,ILS,capsules,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T10:24:17.695284,IL,מדיסון,,370.28703,313.8025817,267.066027,,7290008128957,VYVANSE 50MG 30CAPS,22406,,32834,BOTTLE HDPE,units,30.0,153 19 33994 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Vyvanse is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Vyvanse is indicated for the treatment of  Moderate to Severe Binge Eating Disorder (BED) for patient over 18 years.Limitation of Use:Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2e97f655-0419-444b-a950-dc1e05a57b4c.json
2eb739da-90a2-439c-bc8e-3e893b2f2b06,ADVIL FORTE 400,off-the-counter,M02AA13,IBUPROFEN,5459,,,WHO ATC Classification,,ILS,capsules liquid filled,IBUPROFEN,2025-07-31T11:05:36.972560,IL,ג.ס.ק,,50.327,42.65,nan,,,ADVIL FORTE 400MG 20CAPS,,,,BLISTER PVC/PE/PVDC/AL,units,20.0,145 20 32014 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the relief of mild to moderate pain associated with headache, toothache, backache, muscularand menstrual pains.Antipyretic.Anti-inflammatory for rheumatic diseases.For the treatment of pain associated with migraine.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2eb739da-90a2-439c-bc8e-3e893b2f2b06.json
2ecf4058-2062-4991-852e-335bc68f73cb,PENICILLIN G SODIUM 10 M.U.,prescription,J01CE01,BENZYLPENICILLIN,8879,,,WHO ATC Classification,,ILS,powder for solution for injection,BENZYLPENICILLIN SODIUM 10 MU/VIAL,2025-07-31T06:34:23.235938,IL,טבע,,nan,nan,nan,,7290008096522,PENICILLIN G SODIUM 10 M.U.1 VIAL,,,35254,VIAL GLASS TYPE III,units,1.0,137 28 21065 00,valid,nan,"i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,Infections due to penicillin - sensitive microorganisms.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ecf4058-2062-4991-852e-335bc68f73cb.json
2ed8f80f-d591-40c8-9152-2bdf0bff7b4f,ADRENALINE AGUETTANT  0.1 MG/ML PRE-FILLED SYRINGE,prescription,C01CA24,EPINEPHRINE,8851,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE AS TARTRATE 0.1  MG /,2025-07-30T23:15:35.047559,IL,טבע,,49.500292,41.9494,30.62,,,ADRENALINE TEVA 1MG/ML 10 AMP,,,48820,SYRINGE PREFILLED  POLYPROPYLENE,units,10.0,174 89 36923 99,valid,37.0,"i.v, intracardiac",1.4,24,,,,,,,,,,0,Prescription required,ADRENALINE AGUETTANT  0.1 MG/ML PRE-FILLED SYRINGE is indicated for cardiac arrest and cardiopulmonary resuscitation (physical measures should be used first).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ed8f80f-d591-40c8-9152-2bdf0bff7b4f.json
2edbcbb9-fee4-4015-a7d8-0e089c5c6e08,RISPOND 1,prescription,N05AX08,RISPERIDONE,7944,,,WHO ATC Classification,,ILS,coated tablets,RISPERIDONE,2025-07-31T07:39:57.042089,IL,אוניפארם,,60.12248562,50.951259,37.1907,,,RISPOND 2 MG 30 TAB,18559,,55823,BLISTER PVC/ALUMINIUM,units,30.0,134 58 31403 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2edbcbb9-fee4-4015-a7d8-0e089c5c6e08.json
2edf8179-7e81-44f6-9de7-1b62f46269e5,FRAGMIN 2500 I.U /0.2 ML,prescription,B01AB04,DALTEPARIN,4370,,,WHO ATC Classification,,ILS,solution for injection,DALTEPARIN SODIUM/ 0.2  ML,2025-07-31T03:20:14.539872,IL,פיזר,,195.7945851,165.9276219,132.7420975,,7290013592880,FRAGMIN 5000UI/0.2ML 10INJ,6324,,23324,SYRINGE GLASS TYPE I,units,10.0,123 11 26544 00,valid,25.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,Prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. Treatment of acute deep venous thrombosis and/or pulmonary embolism. Unstable coronary artery disease. Thromboprophylaxis in conjunction with surgery.   Prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency  respiratory insufficiency and severe infections.Cancer patients : Treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2edf8179-7e81-44f6-9de7-1b62f46269e5.json
2ef8df68-f1a2-44d9-ada5-e9cdb1f7c748,MAGNESIUM SULFATE 50 % W/V INOVAMED,29C,A12CC02,MAGNESIUM SULFATE,20797,,,WHO ATC Classification,,ILS,solution for injection / concentrate for solution for inj/inf,MAGNESIUM SULFATE AS HEPTAHYDRATE/,2025-07-31T15:05:09.657592,IL,nan,,nan,nan,nan,,7290104530517,MAGNESIUM SULFATE 5G/10ML 10VIAL,,,,AMPOULES POLYPROPYLENE,units,10.0,164 55 35842 00,valid,nan,"i.v, i.m",1.4,36,,,,,,,,,,0,,Magnesium Sulfate 50%w/v Inovamed  is indicated for:1.  the treatment of Magnesium deficiency in hypomagnesaemia. 2. the prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutrition. 3. the control and prevention of seizures in severe pre-eclampsia.  4. the control and prevention of recurrent seizures in eclampsia, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ef8df68-f1a2-44d9-ada5-e9cdb1f7c748.json
2ef91c3c-9234-4d6d-a602-7e48df476f0e,CO-DIOVAN 80/12.5 MG FILM COATED TABLETS,prescription,C09DA03,VALSARTAN AND DIURETICS,4433,,,WHO ATC Classification,,ILS,film coated tablets,"VALSARTAN, HYDROCHLOROTHIAZIDE 12.5   MG",2025-07-31T01:25:44.694030,IL,נוברטיס פארמה,,26.99689668,22.878726,16.6998,,,CO-DIOVAN 80/12.5MG 28TAB,3014,,28195,BLISTER PA/ALUMINIUM/PVC,units,28.0,114 50 29616 21,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2ef91c3c-9234-4d6d-a602-7e48df476f0e.json
2efcb6fb-db24-42dd-8ae2-a9c5696ead76,AUGMENTIN SUSPENSION 400 MG/5 ML,prescription,J01CR02,AMOXICILLIN AND ENZYME INHIBITOR,2637,,,WHO ATC Classification,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM SALT 11.4 MG/ML, AMOXICILLIN AS TRIHYDRATE/ML",2025-07-30T23:31:16.067736,IL,ג.ס.ק,,27.336706,23.1667,16.91,,7290010140121,AUGMENTIN 250MG 20TAB,1008,,8642,BOTTLE GLASS TYPE III,units,20.0,112 75 29288 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Augmentin is indicated for the treatment of the following infections in adults and children: • Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.• Recurrent tonsillitis",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2efcb6fb-db24-42dd-8ae2-a9c5696ead76.json
2f2d44fa-a423-4e2b-aff7-db0eab06f838,GIROFLOX,prescription,J01MA02,CIPROFLOXACIN,7095,,,WHO ATC Classification,,ILS,solution for infusion,CIPROFLOXACIN/,2025-07-31T03:33:50.418179,IL,ביואבניר,,51.91969556,43.999742,32.1166,,7290010286041,GIROFLOX 200MG/100ML (100ML),7890,,83421,BOTTLE PLASTIC,units,100.0,133 31 30984 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,* Adults :Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens.* Children and adolescents:• Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa• Complicated urinary tract infections and pyelonephritis• Inhalation anthrax (post-exposure prophylaxis and curative treatment)Ciprofloxacin may also be used to treat severe infections in children and adolescents when there is no otheralternative .Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2f2d44fa-a423-4e2b-aff7-db0eab06f838.json
2f3cffb6-5ba1-487f-aba7-118848466656,BENZAC 5 %,off-the-counter,,,3359,,,,,ILS,gel,BENZOYL PEROXIDEW/W,2025-07-31T11:17:04.311412,IL,אמי טכנולוגיות,,66.4104,56.28,nan,,7290008067935,BENZAC AC 2.5% 60GR,2099,,,TUBE LDPE,units,60.0,103 30 27997 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,For the topical treatment of acne vulgaris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2f3cffb6-5ba1-487f-aba7-118848466656.json
2f43f5eb-3dca-45ee-b4a6-efaa32bd99e9,KALBETEN FORTE SUSPENSION,off-the-counter,,,5149,,,,,ILS,suspension,BISMUTH SUBSALICYLATE/ML,2025-07-31T12:14:53.625777,IL,סם און,,44.0258,37.31,nan,,7290008080309,KALBETEN SUSP 200ML,11202,,,BOTTLE HDPE,units,200.0,131 72 30868 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Kalbeten Forte Suspension is indicated for relief of diarrhea, nausea, flatulence, convulsive stomach pains, upset stomach, indigestion. Kalbeten Forte Suspension is indicated as a preventative treatment of traveler's diarrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2f43f5eb-3dca-45ee-b4a6-efaa32bd99e9.json
2f444326-031e-406b-83f3-6e3b0147e3b5,TEARS NATURAL FREE,off-the-counter,,,5123,,,,,ILS,"eye drops, solution","DEXTRAN 70 0.1 %, HYPROMELLOSE 0.3 %",2025-07-31T13:25:57.191414,IL,לפידות,,77.6558,65.81,nan,,300650416085,TEARS NATURAL FREE 32 AMP*0.9ML,20558,,,AMPOULES LDPE,units,32.0,127 88 30655 00,valid,nan,ocular,1.4,24,,,,,,,,,,0,,Dry eye syndromes. Deficient tears secretion.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2f444326-031e-406b-83f3-6e3b0147e3b5.json
2f4ac89c-5310-4f2c-ab9e-b480cecc9d07,CURATANE 10 MG,prescription,,,4426,,,,,ILS,capsules soft gelatin,ISOTRETINOIN,2025-07-31T01:35:40.618248,IL,תרו יבוא,,63.74333214,54.019773,40.1634,,,CURATANE 10MG 30CAPS,3084,,29295,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,136 12 30295 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of severe cystic acne that does not respond to other treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2f4ac89c-5310-4f2c-ab9e-b480cecc9d07.json
2f741ed5-e776-4e31-a03f-dd487e6ef8ea,ARSENIC TRIOXIDE S.K.1 MG/ML,prescription,L01XX27,ARSENIC TRIOXIDE,9064,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ARSENIC TRIOXIDE/,2025-07-30T23:28:06.405504,IL,SK PHARM(KS KIM),,19523.56142,16545.39177,15041.26525,,,ARSENIC TRIOXIDE S.K.1 MG/ML 10 VIAL 10ML,17390,,70644,VIAL GLASS TYPE I,units,10.0,167 36 36741 99,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Arsenic Trioxide S.K. is indicated for induction of remission, and consolidation in adult patients with: •Newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (APL) (white blood cell count, ≤ 10x1000µl incombination with all-trans-retinoic acid (ATRA) •Relapsed/refractory acute promyelocytic leukaemia (APL)(Previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the Pro-Myelocytic Leukaemia/Retinoic-Acid-Receptor-alpha (PML/RAR-alpha) gene.The response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2f741ed5-e776-4e31-a03f-dd487e6ef8ea.json
2fa34b72-5193-463f-ac7a-a337bf6a9e39,ACAMOL FOCUS,29C,N02BE01,PARACETAMOL,20319,,,WHO ATC Classification,,ILS,caplets,"ACETYLSALICYLIC ACID, PARACETAMOL, CAFFEINE",2025-07-31T14:02:09.347567,IL,nan,,nan,nan,nan,,7290000803913,CAFFEINE CITRATE 20MG/ML VIAL,,,,BOTTLE HDPE,units,1.0,131 35 30995 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For temporary relief of the pain of headache, mild to moderate pain associated with migraine headache,  pain of menstrual descomfort and pain accompanied by fever.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2fa34b72-5193-463f-ac7a-a337bf6a9e39.json
2fa4816f-4dda-4df7-96bb-8b739eb1b296,PROGYNOVA 2MG 28TAB,prescription,,,4365,,,,,ILS,tablet,PROGYNOVA 2MG,2025-07-31T19:29:07.861465,IL,באייר,,18.81673902,15.946389,11.6397,,,PROGYNOVA 2MG 28TAB,16400,,2981,,units,28.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2fa4816f-4dda-4df7-96bb-8b739eb1b296.json
2fbdbd7d-e662-455a-9183-dad5ae3817ea,SODIUM CHLORIDE 0.9% IMUNA,prescription,B05CB01,SODIUM CHLORIDE,8890,,,WHO ATC Classification,,ILS,solution for infusion,SODIUM CHLORIDE/ML,2025-07-31T08:24:47.940692,IL,מדי מרקט,,88.05214538,74.6204655,55.4799,,,SODIUM CHLORIDE 0.9% IMUNA 1000ML,,,70782,BAG PLASTIC,units,1000.0,167 57 36009 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Short- term intravascular volume substitution. Hypotonic dehydration or isotonic dehydration. Vehicle solution for supplementary medication.Fluid and electrolyte replacement, hypochloremic alkalosis and chloride losses.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2fbdbd7d-e662-455a-9183-dad5ae3817ea.json
2fca5172-fcdf-43c9-96dd-f44d2317f508,TRANDATE INJECTION,prescription,C07AG01,LABETALOL,286,,,WHO ATC Classification,,ILS,solution for injection,LABETALOL HYDROCHLORIDE/ML,2025-07-31T09:33:54.549160,IL,פאדאגיס,,51.81406057,43.91022278,32.0512575,,7290008086899,TRANDATE 200MG 50TAB,20169,,2224,AMPOULES GLASS TYPE I,units,50.0,041 03 23598 21,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment of hypertension when rapid control of blood pressure is essential.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2fca5172-fcdf-43c9-96dd-f44d2317f508.json
2fdb0f1f-977b-4f31-be90-c0679e12f8a7,V-DALGIN CONCENTRATED SYRUP FOR ADULTS,off-the-counter,,,2995,,,,,ILS,syrup,DIPYRONE 1.25 G /,2025-07-31T13:34:43.551005,IL,ויטאמד,,28.8392,24.44,nan,,7290008084369,V-DALGIN SYRUP 50ML,22100,,,BOTTLE GLASS TYPE III,units,50.0,115 41 28046 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2fdb0f1f-977b-4f31-be90-c0679e12f8a7.json
2fe48677-e88c-4f05-965f-5f20bd671072,MINOCLIN 50MG 30CAP,prescription,,,2936,,,,,ILS,tablet,MINOCLIN 50MG 30CAP,2025-07-31T19:19:47.729704,IL,ויטאמד,,45.69497726,38.724557,28.2661,,,MINOCLIN 50MG 30CAP,13030,,9304,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/2fe48677-e88c-4f05-965f-5f20bd671072.json
3009b8c9-7159-495f-bfb8-927bc5982bc2,TRAJENTA-DUO 2.5MG/500MG 60 F.C.TAB,prescription,,,7287,,,,,,tablet,TRAJENTA-DUO 2.5MG/500MG 60 F.C.TAB,2025-07-31T19:35:49.165353,IL,בורינגר אינגלהיים,,,,,,,TRAJENTA-DUO 2.5MG/500MG 60 F.C.TAB,20777,,50205,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3009b8c9-7159-495f-bfb8-927bc5982bc2.json
30222fd9-6682-4de2-8e70-113f38abbdf1,MIDRO TEA,prescription,A06AB06,SENNA GLYCOSIDES,1120,,,WHO ATC Classification,,ILS,tea,SENNAE FOLIUM,2025-07-31T05:22:34.348724,IL,ניאופרם,,nan,nan,nan,,7298120000649,MIDRO TEA 80GR,13129,,1339,BOX PVDC,units,80.0,130 27 20919 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Laxative.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/30222fd9-6682-4de2-8e70-113f38abbdf1.json
30285022-ff31-41f0-9eb9-75dcc1067caf,IBRANCE TABLETS 100 MG,prescription,L01XE33,PALBOCICLIB,7906,,,WHO ATC Classification,,ILS,film coated tablets,PALBOCICLIB,2025-07-31T03:55:44.073722,IL,פיזר,,8802.615101,7459.843638,6781.676034,,5415062107560,IBRANCE 75 MG 21 CAPS,9981,,60266,BLISTER PVC/OPA/AL,units,21.0,173 62 36956 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"IIBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:* an aromatase inhibitor as initial endocrine-based therapy; or* fulvestrant in patients with disease progression following endocrine therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/30285022-ff31-41f0-9eb9-75dcc1067caf.json
30369d27-3ab8-44c6-a6de-ae0b3fd06aed,IMCIVREE,prescription,,,9018,,,,,ILS,solution for injection,SETMELANOTIDE/ML,2025-07-31T04:01:05.953532,IL,מדיסון,,13384.00672,11342.37908,10311.25371,,,IMCIVREE 10MG/ML 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,171 28 37060 99,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"IMCIVREE is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed Bardet-Biedl syndrome (BBS), loss-of-function biallelic pro-opiomelanocortin (POMC), including PCSK1, deficiency or biallelic leptin receptor (LEPR) deficiency in adults and children 6 years of age and above.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/30369d27-3ab8-44c6-a6de-ae0b3fd06aed.json
304fc981-3afa-4f2b-8a58-bf837fe9a75a,MORPHINE INJECTIONS 1 MG/ML,prescription,N02AA01,MORPHINE,6613,,,WHO ATC Classification,,ILS,solution for injection,MORPHINE SULFATE/ML,2025-07-31T05:31:43.001745,IL,רפא,,293.1628453,248.4431002,211.4409364,,7290008014618,MORPHINE INJECTION 20MG/ML 5ML 5 VIAL,,,35315,AMPOULES GLASS TYPE I,units,5.0,101 29 28476 00,valid,17.5,"intrathecal, epidural, i.v",1.4,12,,,,,,,,,,0,Prescription required,"For the relief of pain that does not respond to treatment with non-opioid analgesics. Morphine injection is a systemic opioid analgesic administered by the IV , epidural and intrathecal routes. Morphine sulphate administered epidurally or intrathecally provides pain relief for extended periods without attendant loss of motor, sensory or sympathetic function", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/304fc981-3afa-4f2b-8a58-bf837fe9a75a.json
3050cc13-0589-4e10-a467-f1e9cf227bbd,CHILDREN'S ADVIL GRAPE FLAVOR,off-the-counter,M01AE01,IBUPROFEN,5046,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T11:05:53.596947,IL,ג.ס.ק,,29.9012,25.34,nan,,305730171304,ADVIL GRAP SYR CHILD 120ML,1341,,,BOTTLE PLASTIC,units,120.0,122 43 30111 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3050cc13-0589-4e10-a467-f1e9cf227bbd.json
3069d470-4826-4e59-b6dc-9d2d0baaa71a,STATOR 10,prescription,C10AA07,ROSUVASTATIN,6518,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T08:40:32.229998,IL,אוניפארם,,84.76098002,71.831339,53.4062,,,STATOR 10MG 28FC TAB,19892,,85912,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,143 13 31932 02,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as  an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise  weight reduction ) is inadequate.  Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3069d470-4826-4e59-b6dc-9d2d0baaa71a.json
307c7c90-4220-4aa1-b244-0deae6470dd2,CURATANE 10 MG,prescription,,,6225,,,,,ILS,capsules soft gelatin,ISOTRETINOIN,2025-07-31T01:36:11.835677,IL,תרו יבוא,,202.56588,171.666,137.3328,,,CURATANE 40 MG 30 CAPS,3952,,78791,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,136 12 30295 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of severe cystic acne that does not respond to other treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/307c7c90-4220-4aa1-b244-0deae6470dd2.json
3087ebcb-20b4-479e-b313-e457849c9908,SEROQUEL XR 150 MG,prescription,N05AH04,QUETIAPINE,6440,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T08:07:41.432194,IL,צמל,,150.91315,127.8925,102.314,,,SEROQUEL XR 400MG 30 TAB EXTENDED RELEASE,19878,,83220,BLISTER PVC/ALUMINIUM,units,30.0,146 97 33472 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Seroquel XR is indicated for the treatment of Schizophrenia. Seroquel XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Seroquel XR.  Seroquel XR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Seroquel XR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 Pharmacodynamic properties). Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XR.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3087ebcb-20b4-479e-b313-e457849c9908.json
308927ea-6ab1-41cb-a37f-8c4be95a6128,ATROPINE AGUETTANT 0.1 MG/ML,prescription,A03BA01,ATROPINE,9508,,,WHO ATC Classification,,ILS,solution for injection,ATROPINE SULFATE MONOHYDRATE 0.1  MG /,2025-07-31T00:25:33.865403,IL,אמ.בי.איי פארמה,,342.5152185,290.2671473,247.03587,,,ATROPINE AGUETTANT 0.1 MG/ML  5ML 10 PFS,,,31633,SYRINGE PREFILLED  POLYPROPYLENE,units,10.0,175 53 36801 99,valid,17.5,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. Treatment of sinus bradycardia, particularly if complicated by hypotension. Antidote in poisoning by organophosphorus.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/308927ea-6ab1-41cb-a37f-8c4be95a6128.json
30a94ce8-4e1d-487d-b30c-20ac3d78edf5,RELERT 20 MG,prescription,N02CC06,ELETRIPTAN,4454,,,WHO ATC Classification,,ILS,film coated tablets,ELETRIPTAN HYDROBROMIDE 24.242   MG,2025-07-31T07:22:26.541504,IL,דקסל פארמה,,nan,nan,nan,,,RELERT 80MG 3TAB,18043,,72761,BLISTER ALUMINIUM,units,3.0,124 28 30370 01,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Acute treatment of the headache phase of migraine attacks, with or without aura.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/30a94ce8-4e1d-487d-b30c-20ac3d78edf5.json
30aaa264-a233-4f07-b121-df9e95f614a3,SANDOSTATIN ® 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,2607,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE 0.05  MG/ML,2025-07-31T07:59:29.919851,IL,נוברטיס פארמה,,542.9254399,460.106305,391.5798341,,7298120012734,SANDOSTATIN 0.5MG/ML,19012,,8651,AMPOULES GLASS TYPE I,units,5.0,047 03 25697 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery.   Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery  or radiotherapy. Sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery  or in the interim period until radiotherapy becomes fully effective.   Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours:   - Carcinoid tumours with features of the carcinoid syndrome    - VIPomas    - Glucagonomas    - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors  or H2- antagonist therapy    - Insulinomas  for pre-operative control of hypoglycaemia and for maintenance therapy   - GRFomas.   Sandostatin is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/30aaa264-a233-4f07-b121-df9e95f614a3.json
30e8025b-ec88-4c62-9821-24ace5f81c2c,FINOLIM 0.5 MG,prescription,L04AA27,FINGOLIMOD,8365,,,WHO ATC Classification,,ILS,capsules,FINGOLIMOD AS HYDROCHLORIDE 0.5  MG,2025-07-31T03:04:58.650938,IL,רפא,,8981.583169,7611.51116,6919.5556,,,FINOLIM 0.5 MG 28 CAPS,,,39358,BLISTER PVC/PE/PVDC/AL,units,28.0,158 49 34966 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/30e8025b-ec88-4c62-9821-24ace5f81c2c.json
310da3eb-1df8-46b2-bd85-ae4efd122743,NEXIUM POWDER FOR SOLUTION FOR INJ/INF 40 MG,prescription,A02BC05,ESOMEPRAZOLE,4484,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,ESOMEPRAZOLE AS SODIUM/DOSE,2025-07-31T05:44:48.210445,IL,תרו יבוא,,28.15108442,23.8568512,17.41376,,7321839711404,NEXIUM 20MG 28TAB,14262,,2923,VIAL GLASS TYPE I,units,28.0,135 56 31128 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Nexium for iniection and infusion is indicated in adult for:• Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate. • Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.Nexium for injection and infusion is indicated in children and adolescents aged 1-18 years for:• Gastric antisecretory treatment when the oral route is not possible, such as:gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/310da3eb-1df8-46b2-bd85-ae4efd122743.json
31133e94-7b60-44f3-a880-3e95240d471c,LETROZOLE DEXCEL,prescription,L02BG04,LETROZOLE,6586,,,WHO ATC Classification,,ILS,film coated tablets,LETROZOLE 2.5  MG,2025-07-31T04:41:25.747683,IL,טבע,,229.99616,194.912,155.9296,,,LETROZOLE TEVA 2.5MG 30TAB,12443,,21769,BLISTER PVC/ALUMINIUM,units,30.0,145 49 33275 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/31133e94-7b60-44f3-a880-3e95240d471c.json
312654bd-9e68-42d4-a498-8a6e8feb5930,ALFU-KAL XL,prescription,G04CA01,ALFUZOSIN,6401,,,WHO ATC Classification,,ILS,tablets prolonged release,ALFUZOSIN HYDROCHLORIDE,2025-07-30T23:19:16.549423,IL,פאדאגיס,,76.98752293,65.2436635,48.5083,,7298074050028,ALFU-KAL XL 10MG 30TAB,9326,,81501,BLISTER PVC/ALUMINIUM,units,30.0,141 23 31829 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of certain functional symptoms of benign prostatic hypertrophy  particularly if surgery has to be delayed for some reason. Adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/312654bd-9e68-42d4-a498-8a6e8feb5930.json
313d3f0f-0f83-4d9d-930b-c7eda2d1e120,PHENIDIN 18 MG,prescription,N06BA04,METHYLPHENIDATE,8340,,,WHO ATC Classification,,ILS,tablets prolonged release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T06:40:07.423178,IL,תרימה,,170.9435144,144.8673851,115.8939081,,,PHENIDIN 36 MG 30SR TAB,10595,,51723,BOTTLE HDPE,units,30.0,161 08 35114 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/313d3f0f-0f83-4d9d-930b-c7eda2d1e120.json
313d51c1-8538-455e-8e81-c529159a5b65,CELLCEPT 250 MG,29C,L04AA06,MYCOPHENOLIC ACID,20328,,,WHO ATC Classification,,ILS,capsules,MYCOPHENOLATE MOFETIL,2025-07-31T14:05:44.392342,IL,nan,,nan,nan,nan,,7290008140188,CELLCEPT 500MG VIAL,,,,BLISTER PVC/ALUMINIUM,units,4.0,111 34 29434 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. Cellcept should be used concomitantly with cyclosporin and corticosteroids.Allogenic hepatic transplant.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/313d51c1-8538-455e-8e81-c529159a5b65.json
3163ee1e-949c-4fe8-a901-6436507b39b5,QLAIR,prescription,G03CA03,ESTRADIOL,7106,,,WHO ATC Classification,,ILS,film coated tablets,"ESTRADIOL VALERATE, ESTRADIOL VALERATE, DIENOGEST, DIENOGEST, ESTRADIOL VALERATE",2025-07-31T07:09:24.138386,IL,באייר,,176.8527776,149.875242,119.9001936,,7290013092052,QLAIR 3X28TAB,17024,,33634,BLISTER PVC/ALUMINIUM,units,84.0,146 16 33128 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Oral contraception.Treatment of heavy menstrual bleeding in women without organic pathology who desire oral contraception.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3163ee1e-949c-4fe8-a901-6436507b39b5.json
31754b72-6ffc-4fa9-8e38-5321244dbb2a,DULCIFAK EYE DROPS  10ml,29C,,,20832,,,,,,drops,DULCIFAK EYE DROPS,2025-07-31T20:19:35.063625,IL,nan,,,,,,,DULCIFAK EYE DROPS  10ml,,,,,units,10.0,,not-registered,,ophthalmic,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/31754b72-6ffc-4fa9-8e38-5321244dbb2a.json
3179bbce-94de-4231-8418-9083859c1629,CARBOPLATIN TEVA,prescription,L01XA02,CARBOPLATIN,7444,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,CARBOPLATIN/ML,2025-07-31T00:53:59.970847,IL,טבע,,159.3413,135.035,108.028,,7290008002035,CARBOPLATIN 150MG/15ML VIAL,9551,,35247,VIAL GLASS TYPE I,units,1.0,042 05 25540 05,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Advanced ovarian carcinoma in initial treatment and secondary treatment.Metastatic small cell carcinoma of the lung.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3179bbce-94de-4231-8418-9083859c1629.json
318e0cf7-e8ff-415f-b301-a6dd29b250b2,ATOSIBAN ALTAN,prescription,G02CX01,ATOSIBAN,9415,,,WHO ATC Classification,,ILS,solution for injection/ concentrate for solution for infusion,ATOSIBAN 7.5  MG /,2025-07-30T23:29:36.788505,IL,פרופארם,,347.7030584,294.6636088,250.7775394,,8470007045946,ATOSIBAN ALTAN 37.5MG/5ML 1 AMP,,,17129,AMPOULES GLASS TYPE I,units,1.0,162 49 35198 00,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,Atosiban Altan is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes- a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/318e0cf7-e8ff-415f-b301-a6dd29b250b2.json
3195ef5d-aca2-4526-8f4d-ccfc39de69f5,SPECTRACEF 200 MG,prescription,J01DD16,CEFDITOREN,9063,,,WHO ATC Classification,,ILS,film coated tablets,CEFDITOREN AS PIVOXIL,2025-07-31T08:33:26.117017,IL,תרו יבוא,,158.6428539,134.4431025,107.554482,,7290017164298,SPECTRACEF 400 MG 10 TABS,,,64146,BLISTER ALU/PVC/PA/ALU,units,10.0,166 36 36015 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"SPECTRACEF is indicated in adults and adolescents (12 years of age or older) for the treatment of the following infections caused by susceptible microorganisms:• Acute pharyngo-tonsillitis• Acute maxillary sinusitis• Acute exacerbations of chronic bronchitis• Community-acquired pneumonia, mild to moderate• Uncomplicated skin and skin structure infections, such as cellulitis, infected wounds, abscesses, folliculitis, impetigo and boils.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3195ef5d-aca2-4526-8f4d-ccfc39de69f5.json
3196685b-d24e-4c4f-b361-cf4c437200b2,IMUNOVIR 500MG 100TAB,29C,,,20458,,,,,,tablet,IMUNOVIR 500MG,2025-07-31T20:37:35.714534,IL,nan,,,,,,,IMUNOVIR 500MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3196685b-d24e-4c4f-b361-cf4c437200b2.json
3196d937-3c79-4129-9e70-803f4382a0e3,PRADAXA 110,prescription,B01AE07,DABIGATRAN ETEXILATE,6321,,,WHO ATC Classification,,ILS,capsules,DABIGATRAN ETEXILATE AS MESILATE,2025-07-31T06:48:43.213058,IL,בורינגר אינגלהיים,,95.07029174,80.56804743,59.901894,,9006968012391,PRADAXA 75MG 30CAPS,16812,,84205,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,142 96 32974 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with nonvalvular  atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3196d937-3c79-4129-9e70-803f4382a0e3.json
319d33b5-7d78-45b2-a3d7-0fc6e7a6432d,ACERIL 12.5,prescription,,,4539,,,,,ILS,tablets,CAPTOPRIL 12.5  MG,2025-07-30T23:12:00.072269,IL,דקסל פארמה,,50.0070961,42.378895,30.9335,,,ACERIL 50MG 90TAB,1438,,33616,BLISTER ,units,90.0,106 49 29061 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,-HypertensionCongestive Heart Failure-insulin dependent diabetic nephropathy in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl.-improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less or equals to 40% and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/319d33b5-7d78-45b2-a3d7-0fc6e7a6432d.json
31a25b0c-9c76-473e-a6f7-73f3e1baa865,STRENSIQ ® 100 MG/ML,prescription,A16AB13,ASFOTASE ALFA,8373,,,WHO ATC Classification,,ILS,solution for injection,ASFOTASE ALFA/,2025-07-31T08:46:39.942325,IL,ניאופרם,,55715.01967,47216.12047,42923.74588,,,STRENSIQ ® 40 MG/ML 12 vials 18mg,9985,,62118,VIAL GLASS TYPE I,units,12.0,155 44 34545 00,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,Strensiq is indicated for long-term enzyme replacement therapy in patients with paediatric-onset hypophosphatasia to treat the bone manifestations of the disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/31a25b0c-9c76-473e-a6f7-73f3e1baa865.json
31b7ae20-9cb7-45f5-8ed2-f28b9604ea8a,SOMAVERT 10 MG,prescription,H01AX01,PEGVISOMANT,8165,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,PEGVISOMANT,2025-07-31T08:30:13.178398,IL,פיזר,,13589.67566,11516.6748,10469.70437,,7290010355631,SOMAVERT 15 MG  30 PreFilledSyringe x 1 ml solvent,10268,,76487,VIAL GLASS TYPE I,units,30.0,135 41 31357 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize IGF-I concentrations or was not tolerated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/31b7ae20-9cb7-45f5-8ed2-f28b9604ea8a.json
31dc7ff7-1b41-4f6a-9130-239f95e861dd,ATTENT XR 30 MG,prescription,N06BA01,AMFETAMINE,9188,,,WHO ATC Classification,,ILS,capsules extended release,"DEXTROAMPHETAMINE SULFATE 7.5  MG, DEXTROAMPHETAMINE SACCHARATE 7.5  MG, AMPHETAMINE SULFATE 7.5  MG, AMPHETAMINE ASPARTATE MONOHYDRATE 7.5  MG",2025-07-30T23:30:45.233958,IL,טבע,,nan,nan,nan,,,ATTENT XR 10 MG  30 CAPS,,,16700,BOTTLE HDPE,units,30.0,170 94 35998 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/31dc7ff7-1b41-4f6a-9130-239f95e861dd.json
31e7cca1-8c5a-4834-9001-48c467ad754b,RISPERIDEX 1 MG,prescription,N05AX08,RISPERIDONE,8047,,,WHO ATC Classification,,ILS,tablets,RISPERIDONE,2025-07-31T07:39:13.969897,IL,דקסל פארמה,,60.12248562,50.951259,37.1907,,7290010577439,RISPERIDEX 2MG 30TAB,10087,,15415,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,134 54 31353 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/31e7cca1-8c5a-4834-9001-48c467ad754b.json
320b335b-066c-4c20-9ce7-d2cde674697c,EXIDOL,off-the-counter,N02BA01,ACETYLSALICYLIC ACID,5176,,,WHO ATC Classification,,ILS,caplets,"ACETYLSALICYLIC ACID, PARACETAMOL, CAFFEINE",2025-07-31T11:51:53.536345,IL,פאדאגיס,,60.003,50.85,nan,,7298074010176,EXIDOL 50 CAPLETS,5445,,,BOTTLE HDPE,units,50.0,136 77 31055 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"For temporary relief of the pain of headache, mild to moderate pain associated with migraine headache,  pain of menstrual descomfort and pain accompanied by fever.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/320b335b-066c-4c20-9ce7-d2cde674697c.json
3211e723-8806-4c8e-9b12-adaf359588d8,EVEROLIMUS TEVA 2.5 MG,prescription,L04AA18,EVEROLIMUS,8980,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS 2.5  MG,2025-07-31T02:44:31.033543,IL,טבע,,3115.894118,2640.588235,2400.534759,,,EVEROLIMUS TEVA 2.5 MG 30TAB,5696,,74040,BLISTER OPA/ALU/PVC/ALU,units,30.0,163 28 35376 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"• For the treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of Everolimus is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. • Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. The safety and effectiveness of Everolimus in the treatment of patients with carcinoid tumors have not been established.• For the treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.• Everolimus Teva is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Everolimus in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes.• Everolimus Teva is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.• Treatment of unresectable, locally advanced or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3211e723-8806-4c8e-9b12-adaf359588d8.json
323acb44-abc4-4a8c-a71a-b1fb14341cb3,QDENGA,prescription,J07BX04,DENGUE VIRUS VACCINES ,9614,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,"DENGUE VIRUS SEROTYPE 4 (LIVE, ATTENUATED), DENGUE VIRUS SEROTYPE 3 (LIVE, ATTENUATED), DENGUE VIRUS, SEROTYPE 2, LIVE, ATTENUATED), DENGUE VIRUS SEROTYPE 1 (LIVE, ATTENUATED)",2025-07-31T07:08:38.877965,IL,טקדה,,443.4613339,375.8147064,319.8423033,,,QDENGA 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,176 51 37674 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,Qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/323acb44-abc4-4a8c-a71a-b1fb14341cb3.json
3250e670-2f7b-40cf-ba6e-8668bb4cd094,FUNGINAIL,off-the-counter,D01AE14,CICLOPIROX,5449,,,WHO ATC Classification,,ILS,lacque,CICLOPIROX/G,2025-07-31T11:58:10.618175,IL,ליף-פריגו,,100.005,84.75,nan,,7290103447366,FUNGINAIL NAIL LACQER 6.6ML,,,,BOTTLE GLASS TYPE III,units,6.6,146 90 33500 00,valid,nan,nail,1.4,24,,,,,,,,,,0,,For the treatment of fungal infections of the nails.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3250e670-2f7b-40cf-ba6e-8668bb4cd094.json
325480db-bef3-466e-b1a9-969abd2a8d09,STRATTERA 4 MG/ML ORAL SOLUTION,prescription,N06BA09,ATOMOXETINE,7949,,,WHO ATC Classification,,ILS,solution  (oral),ATOMOXETINE/,2025-07-31T08:45:53.115037,IL,אלי לילי,,380.8193123,322.7282308,274.6623241,,7290016021059,STRATTERA 60MG 28CAPS,9809,,71832,BOTTLE GLASS TYPE III,units,28.0,158 61 35026 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD. Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/325480db-bef3-466e-b1a9-969abd2a8d09.json
32558537-f5e8-404b-9f04-48f62b5c3a5d,FEBURIC 80 MG,prescription,M04AA03,FEBUXOSTAT,7537,,,WHO ATC Classification,,ILS,film coated tablets,FEBUXOSTAT,2025-07-31T02:55:20.187203,IL,ניאופרם,,121.25444,102.758,76.4,,7290012850615,FEBURIC 80 MG 28 F.C.TAB,6526,,50856,BLISTER PVC/ACLAR/ALUMINIUM,units,28.0,151 81 34037 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).Feburic is indicated in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/32558537-f5e8-404b-9f04-48f62b5c3a5d.json
325a633b-8e05-44f7-a3b9-4fcce226f7b9,CEENU 40MG 20CAPS,29C,,,20048,,,,,,capsule,CEENU 40MG,2025-07-31T20:04:02.635955,IL,nan,,,,,,,CEENU 40MG 20CAPS,,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/325a633b-8e05-44f7-a3b9-4fcce226f7b9.json
325e0c92-0aa6-4a00-bd9c-2b5d22ab462c,MAVENCLAD 10 MG TABLETS,prescription,L01BB04,CLADRIBINE,8149,,,WHO ATC Classification,,ILS,tablets,CLADRIBINE,2025-07-31T05:05:59.889394,IL,מרק סרונו,,31787.86518,26938.86999,24489.88181,,,MAVENCLAD 10 MG  4 TABLETS,13831,,64836,BLISTER ALUMINIUM /ALUMINIUM,units,4.0,159 78 35306 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clinical or imaging features,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/325e0c92-0aa6-4a00-bd9c-2b5d22ab462c.json
327290b9-3ad6-4886-a6e9-3f45d813f213,NEOBLOC,prescription,C07AB02,METOPROLOL,2251,,,WHO ATC Classification,,ILS,tablets,METOPROLOL TARTRATE,2025-07-31T05:41:23.203100,IL,אוניפארם,,16.166,13.7,10.0,,,NEOBLOC 100MG 30TAB,14072,,1445,BLISTER PVC/ALUMINIUM,units,30.0,010 52 24172 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Cardio-selective beta receptor blocker for the treatment of hypertension and angina pectoris, antiarrhithmic, prophlaxis of myocardial reinfarction and migraine.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/327290b9-3ad6-4886-a6e9-3f45d813f213.json
3291ae70-5c8c-4f8a-9fe1-382fd66b1543,VIEPAX 37.5,prescription,N06AX16,VENLAFAXINE,4737,,,WHO ATC Classification,,ILS,tablets,VENLAFAXINE AS HYDROCHLORIDE 37.5   MG,2025-07-31T10:14:15.468582,IL,דקסל פארמה,,46.49002114,39.398323,28.7579,,,VIEPAX 75MG 28TAB,22246,,60617,BLISTER ACLAR COATED PVC/ALUMINIUM,units,28.0,130 68 31015 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of depression.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3291ae70-5c8c-4f8a-9fe1-382fd66b1543.json
32939338-425c-40cb-aa4e-7dc13d53ffbb,EVICEL HUMAN SURGICAL SEALANT,prescription,B05BA10,COMBINATIONS,6853,,,WHO ATC Classification,,ILS,solution,"THROMBIN 800 -/, CALCIUM CHLORIDE 5.6 - 6.20  MG /, PROTEIN CLOTTABLE 50 -/",2025-07-31T02:45:35.211711,IL,אומריקס,,nan,nan,nan,,7290004961862,EVICEL HUMAN SURGICAL SEALANT 2X1ML (ללא אפליקטור),,,,VIAL 10 ML GLASS TYPE I,units,2.0,118 61 29895 02,valid,nan,topical in surgery,1.4,24,,,,,,,,,,0,Prescription required,"General haemostasis : Evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. Efficacy has been demonstrated in liver surgery and orthopaedic surgery.Evicel ® is also indicated as suture support for haemostasis for suture line sealing in dura mater closure.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/32939338-425c-40cb-aa4e-7dc13d53ffbb.json
32a7fd81-0299-4b04-9670-7e84b62827b1,VECTOR PLUS 160/25,prescription,C09CA03,VALSARTAN,9169,,,WHO ATC Classification,,ILS,film coated tablets,"VALSARTAN, HYDROCHLOROTHIAZIDE",2025-07-31T10:02:17.529701,IL,אוניפארם,,38.5066037,32.632715,23.8195,,,VECTOR PLUS 160/25 30 TAB,,,35662,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,145 47 33146 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. This fixed combination should be used as second-line therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/32a7fd81-0299-4b04-9670-7e84b62827b1.json
32c0f215-fef3-4165-9723-cb39ca03e8fc,YONDELIS 1 MG,prescription,L01CX01,TRABECTEDIN,6626,,,WHO ATC Classification,,ILS,powder for concentrate for solution for injection,TRABECTEDIN/VIAL,2025-07-31T10:41:51.199707,IL,מגאפארם,,6617.258006,5607.846017,5098.041834,,,YONDELIS 1MG  VIAL,25014,,22931,VIAL GLASS TYPE I,units,1.0,142 85 31830 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Yondelis is indicated for the treatment of patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. Efficacy data are based mainly on liposarcoma and leiomyosarcoma patients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/32c0f215-fef3-4165-9723-cb39ca03e8fc.json
32d63c67-b8b2-4abd-9c18-1dd36d1074e5,PEMETREXED S.K. 500 MG,prescription,L01BA04,PEMETREXED,8070,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,PEMETREXED AS DISODIUM HEMIPENTAHYDRATE,2025-07-31T06:32:11.888252,IL,SK PHARM(KS KIM),,4932.985268,4180.49599,3800.4509,,7290016845020,PEMETREXED S.K. 1 VIAL 50 ML,16975,,56906,VIAL 50 ML GLASS TYPE I,units,1.0,157 35 34702 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Pemetrexed S.K. in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Pemetrexed S.K. in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed S.K. is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed S.K. is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/32d63c67-b8b2-4abd-9c18-1dd36d1074e5.json
3311a0ea-2bd2-4619-af7d-cba535e828dd,UBRELVY 100 MG,prescription,,,9114,,,,,ILS,tablets,UBROGEPANT AS TRIHYDRATE,2025-07-31T09:50:40.837754,IL,אב-וי,,nan,nan,nan,,,UBRELVY 50 MG 10 TAB,21185,,76367,POUCH ALUMINIUM,units,10.0,169 78 37038 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Ubrelvy is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults.Limitations of UseUbrelvy is not indicated for the preventive treatment of migraine.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3311a0ea-2bd2-4619-af7d-cba535e828dd.json
33297579-8d12-48bf-8f84-1efc9ff46e66,VALSARTAN DEXCEL 160,prescription,C09CA03,VALSARTAN,7018,,,WHO ATC Classification,,ILS,film coated tablets,VALSARTAN,2025-07-31T09:56:41.718945,IL,דקסל פארמה,,40.50003316,34.322062,25.0526,,,VALSARTAN DEXCEL 160MG 28TAB,22349,,34573,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,147 21 33427 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Valsartan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan significantly reduced hospitalisations for heart failure. There is no evidence that Valsartan provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.For treatment of hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/33297579-8d12-48bf-8f84-1efc9ff46e66.json
3336f968-722c-41fb-b4f1-dd924050a93e,HYTRIN 10 MG TABLETS,prescription,G04CA03,TERAZOSIN,3364,,,WHO ATC Classification,,ILS,tablets,TERAZOSIN AS MONOHYDRACHLORIDE DIHYDRATE,2025-07-31T03:55:11.264843,IL,ביוטיס,,48.73741846,41.302897,30.1481,,5013158062405,HYTRIN BPH 5MG 28TAB,8004,,9536,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,103 61 28683 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For symptomatic treatment of urinary obstruction caused by benign prostatic hypertrophy (BPH). For mild to moderate hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3336f968-722c-41fb-b4f1-dd924050a93e.json
334aaa37-aa67-4fa2-b65e-8f1479c5e04f,ETORICOXIB DEXCEL 120 MG,prescription,M01AH05,ETORICOXIB,8180,,,WHO ATC Classification,,ILS,tablets,ETORICOXIB,2025-07-31T02:41:17.881165,IL,דקסל פארמה,,32.72225948,27.73072838,20.24140757,,,ETORICOXIB DEXCEL 60 MG 14 tabs,5628,,74262,BLISTER ALUMINIUM /ALUMINIUM,units,14.0,160 18 34751 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/334aaa37-aa67-4fa2-b65e-8f1479c5e04f.json
334e930b-5272-4770-be5a-7872ced10668,DALACIN 2 % VAGINAL CREAM,29C,G01AA10,CLINDAMYCIN,20353,,,WHO ATC Classification,,ILS,cream,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T14:13:04.262532,IL,nan,,nan,nan,nan,,7298074000054,DALACIN C FLAVOURED GRANULES 75MG/5ML,,,,TUBE PLASTIC,units,1.0,064 17 27818 00,valid,nan,vaginal,1.4,24,,,,,,,,,,0,,Treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/334e930b-5272-4770-be5a-7872ced10668.json
338290d0-5d46-459b-9734-46a8c660e7f1,FUROSEMIDE S.A.L.F 250 MG/25 ML,prescription,C03CA01,FUROSEMIDE,8228,,,WHO ATC Classification,,ILS,solution for infusion,FUROSEMIDE/ML,2025-07-31T03:23:12.816775,IL,רז פרמהצפטי,,15.51936,13.152,9.6,,7290018490181,FUROSEMIDE S.A.L.F 20 MG/ 2 ML 5 vials,,,52755,VIAL GLASS TYPE I,units,5.0,166 77 35843 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Furosemide is a potent diuretic indicated for use when a prompt and effective diuresis is required.Furosemide is appropriate for use in emergencies or where oral therapy is not feasible. The indications include cardiac, pulmonary, hepatic and renal oedema",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/338290d0-5d46-459b-9734-46a8c660e7f1.json
33abd56e-b085-4db6-b9f9-3b677d9fa2e3,TRITACE COMP 2.5 MG/12.5 MG,prescription,C09BA05,RAMIPRIL AND DIURETICS,2660,,,WHO ATC Classification,,ILS,tablets,"RAMIPRIL 2.5  MG, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T09:43:56.324787,IL,סאנופי אוונטיס,,23.35776842,19.794719,14.4487,,7290008880947,TRITACE 5MG 28TAB,20030,,4870,BLISTER PVC/ALUMINIUM,units,28.0,122 27 30187 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Essential hypertension.Tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone or hydrochlorothiazide alone.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/33abd56e-b085-4db6-b9f9-3b677d9fa2e3.json
33bc9a21-3006-4190-b187-2cfdf70654f5,REBLOZYL 25 MG,prescription,B03XA06,LUSPATERCEPT,8784,,,WHO ATC Classification,,ILS,powder for solution for injection,LUSPATERCEPT,2025-07-31T07:18:59.864007,IL,ב.מ.ס,,6236.017456,5284.760791,4804.327992,,7290014396180,REBLOZYL 25 MG 1 VIAL,,,16519,VIAL GLASS TYPE I,units,1.0,169 03 36646 00,valid,10.0,s.c,1.4,60,,,,,,,,,,0,Prescription required,"Reblozyl is indicated in: •	Adults for the treatment of transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (MDS).•	Adults for the treatment of anaemia associated with transfusion dependent and non-transfusion-dependent beta-thalassaemia",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/33bc9a21-3006-4190-b187-2cfdf70654f5.json
33d1d009-e73e-4ce2-873e-a1e4adf5afbd,ZOSTRIX,off-the-counter,N01BX04,CAPSAICIN,3189,,,WHO ATC Classification,,ILS,cream,CAPSAICIN 0.025 %,2025-07-31T13:40:17.005528,IL,רפא,,76.6646,64.97,nan,,7290008014182,ZOSTRIX H.P. 30GR,26034,,,TUBE ALUMINIUM,units,30.0,101 20 28410 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,For the symptomatic relief of pain associated with arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/33d1d009-e73e-4ce2-873e-a1e4adf5afbd.json
33de5d58-61eb-43ea-aa57-63e06d4ec6f8,AVODART,prescription,G04CB02,DUTASTERIDE,4646,,,WHO ATC Classification,,ILS,"capsule, soft",DUTASTERIDE 0.5   MG,2025-07-30T23:32:21.419581,IL,ג.ס.ק,,133.9406064,113.5089885,84.3933,,,AVODART 0.5MG 30CAPS,1891,,58281,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,128 27 30679 01,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Avodart is indicated for : Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/33de5d58-61eb-43ea-aa57-63e06d4ec6f8.json
33e33e63-36cd-43b9-8019-530bdf26063a,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7699,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:37:30.951269,IL,סנדוז,,709.5201616,601.2882725,511.7347,,,BINOCRIT 3000 IU/0.3ML 6 SYRINGE PREFILLED,2558,,56121,SYRINGE PREFILLED  GLASS TYPE I,units,6.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/33e33e63-36cd-43b9-8019-530bdf26063a.json
33e5547c-9bc3-4ea5-bb61-ff0b789c927f,MYLOTARG,prescription,L01XC05,GEMTUZUMAB,8463,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,GEMTUZUMAB OZOGAMICIN/VIAL,2025-07-31T05:38:26.651237,IL,פיזר,,35395.24557,29995.97216,27269.0656,,7290013592583,MYLOTARG 5MG/VIAL,,,69619,VIAL GLASS TYPE I,units,1.0,162 34 35804 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older.MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/33e5547c-9bc3-4ea5-bb61-ff0b789c927f.json
33f7cab9-e3d0-4d14-be83-6d9dd11fbb33,RIVAROXABAN S.K. 10 MG,prescription,B01AF01,RIVAROXABAN,9332,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:43:50.609784,IL,SK PHARM(KS KIM),,259.285825,219.73375,175.787,,,RIVAROXABAN S.K. 20 MG 28 TAB,18700,,8729,BLISTER ALU-PVC/PE/PVDC ,units,28.0,170 37 36327 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/33f7cab9-e3d0-4d14-be83-6d9dd11fbb33.json
340fb1d9-3f9c-4c4e-9861-4e409f0ee783,KLARIDEX 250MG 14TAB,prescription,,,3758,,,,,ILS,tablet,KLARIDEX 250MG,2025-07-31T19:15:10.188557,IL,דקסל פארמה,,31.04744964,26.311398,19.2054,,,KLARIDEX 250MG 14TAB,11102,,22667,,units,14.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/340fb1d9-3f9c-4c4e-9861-4e409f0ee783.json
3413607e-9661-4fc4-84f2-98e56e61bb21,LUSTRAL TABLETS 100 MG,prescription,N06AB06,SERTRALINE,2979,,,WHO ATC Classification,,ILS,film coated tablets,SERTRALINE AS HYDROCHLORIDE,2025-07-31T04:59:52.909431,IL,דקסל פארמה,,25.24789714,21.396523,15.6179,,,LUSTRAL 50MG 28TAB,12375,,69971,BLISTER PVC/ALUMINIUM,units,28.0,120 52 27481 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"For the treatment of symptoms of depression in patients with or without a history of mania. Following satisfactory response, continuation with sertraline therapy is effective in prevention relapse of the initial episode of depression or recurrence of further depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3413607e-9661-4fc4-84f2-98e56e61bb21.json
341882f0-5ebf-4d43-8a33-2c2bb757bc62,RAZAMOL 500 MG SUPPOSITORIES,off-the-counter,N02BE01,PARACETAMOL,5547,,,WHO ATC Classification,,ILS,suppositories,PARACETAMOL,2025-07-31T12:53:47.527360,IL,רז פרמהצפטי,,20.1662,17.09,nan,,7290015863049,RAZAMOL 500 MG  10 SUPP,,,,BLISTER PVC,units,10.0,156 32 34427 00,valid,nan,rectal,1.4,60,,,,,,,,,,0,,Analgesic and antipyretic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/341882f0-5ebf-4d43-8a33-2c2bb757bc62.json
34216011-3a22-4c56-a521-820dce593ece,CAPD 2 PERITONEAL DIALYSIS SOLUTION,prescription,B05XA30,COMBINATIONS OF ELECTROLYTES,8848,,,WHO ATC Classification,,ILS,solution for peritoneal dialysis,"MAGNESIUM CHLORIDE 0.1017 G/L, SODIUM CHLORIDE 5.786 G/L, CALCIUM CHLORIDE 0.2573 G/L, GLUCOSE AS MONOHYDRATE 16.5 G/L, LACTIC ACID AS SODIUM 3.925 G/L",2025-07-31T03:37:42.148983,IL,טבע,,9.475644059,8.030207187,5.8614651,,,GLUCOSE 5 % INTRAVENOUS INFUSION BP  VIAFLO 500ml,,,42634,BAG POLYPROPYLENE,units,1.0,107 95 26735 00,valid,37.0,intra-peritoneal,1.4,24,,,,,,,,,,0,Prescription required,For use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34216011-3a22-4c56-a521-820dce593ece.json
3426b0ef-3859-48b7-b2b4-3c1c595f5d7b,TRAJENTA,prescription,A10BH05,LINAGLIPTIN,7286,,,WHO ATC Classification,,ILS,film coated tablets,LINAGLIPTIN,2025-07-31T09:29:04.191787,IL,בורינגר אינגלהיים,,191.0036651,161.86752,129.494016,,,TRAJENTA 5MG 30 F.C.TAB,20775,,50168,BLISTER PVC/ALUMINIUM,units,30.0,149 96 33738 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. TRAJENTA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.  TRAJENTA has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using TRAJENTA.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3426b0ef-3859-48b7-b2b4-3c1c595f5d7b.json
34272c23-b155-4f37-919c-f6582868088b,STALEVO 200/50/200 MG,prescription,N04BA02,LEVODOPA AND DECARBOXYLASE INHIBITOR,6454,,,WHO ATC Classification,,ILS,film coated tablets,"LEVODOPA, ENTACAPONE, CARBIDOPA AS MONOHYDRATE",2025-07-31T08:39:05.681339,IL,אינובמד,,83.25940863,70.55882401,52.4600922,,,STALEVO 200/50/200MG 30TAB,19890,,84824,BOTTLE HDPE,units,30.0,141 94 31768 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34272c23-b155-4f37-919c-f6582868088b.json
34477e87-9424-431c-bc88-1bb31958c7ad,PERGOVERIS ®,prescription,G03GA05,FOLLITROPIN ALFA,8404,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,"FOLLITROPIN ALFA, LUTROPIN ALFA",2025-07-31T06:37:33.097917,IL,מרק סרונו,,1058.412832,896.9600668,763.3702697,,7290000845470,PERGOVERIS PRE-FILLED PEN 0.72ML,,,4985,VIAL GLASS TYPE I,units,1.0,145 07 33159 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Pergoveris is indicated for the stimulation of follicular development in adult women with sever LH and FSH deficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34477e87-9424-431c-bc88-1bb31958c7ad.json
3448670c-2866-4e7c-8561-ccc191929faa,VELTASSA 8.4 G,prescription,V03AE09,PATIROMER CALCIUM ,8313,,,WHO ATC Classification,,ILS,powder for oral suspension,PATIROMER AS SORBITEX CALCIUM 8.4 G,2025-07-31T10:03:30.340054,IL,כ.צ.ט,,1126.41259,954.5869829,812.4144535,,,VELTASSA 8.4 G 30 SACHETS,22452,,30764,SACHET ALUMINIUM,units,30.0,161 52 35491 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Veltassa is indicated for the treatment of hyperkalaemia in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3448670c-2866-4e7c-8561-ccc191929faa.json
344c1ad6-63f5-40df-b030-0f15c12846ab,ABIVENIR 250 MG,prescription,L02BX03,ABIRATERONE,9521,,,WHO ATC Classification,,ILS,tablets,ABIRATERONE ACETATE,2025-07-30T23:10:26.260393,IL,סנדוז,,17160.87617,14543.1154,13221.014,,,ABIRATERONE SANDOZ 250MG 120 TAB,,,,BOTTLE HDPE,units,120.0,172 52 37297 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,AbiVenir is a CYP17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/344c1ad6-63f5-40df-b030-0f15c12846ab.json
346bafd1-01d3-46b3-9062-96bb79d3e3dd,V.CRIMA 15ML,off-the-counter,,,3224,,,,,ILS,tablet,V.CRIMA,2025-07-31T19:47:27.013272,IL,ויטאמד,,16.343,13.85,,,,V.CRIMA 15ML,22039,,,,units,15.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/346bafd1-01d3-46b3-9062-96bb79d3e3dd.json
34946b3a-9255-43aa-a7b1-84ab1fc13ce9,RITALIN ® LA 10 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,4755,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:41:30.237220,IL,נוברטיס פארמה,,159.9873946,135.5825378,108.4660303,,7290003257192,RITALIN LA 40MG 30CAPS,18326,,61783,BOTTLE HDPE,units,30.0,146 50 33288 01,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD) .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34946b3a-9255-43aa-a7b1-84ab1fc13ce9.json
34968e7b-05e7-4961-a6a2-2c73e6b06ce0,MITOCIN 20 MG,prescription,L01DC03,MITOMYCIN,9495,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,MITOMYCIN/VIAL,2025-07-31T05:28:00.010939,IL,דקסל פארמה,,288.1842844,244.2239807,207.8501963,,,MITOCIN 20 MG 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,175 89 37070 99,valid,17.5,"i.v, intravesical, , intra-arterial, intraserosal",1.4,24,,,,,,,,,,0,Prescription required,"Intravenous, intra-arterial (hepatic artery), and local (intraserosal) administration for treatment ofadenocarcinomas of the stomach, pancreas, colon, rectum, breast and their Metastases.Intravesical administration for the prevention of recurrence in superficial cancer of bladder after transurethral resection.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34968e7b-05e7-4961-a6a2-2c73e6b06ce0.json
349ac014-de36-4682-ae40-e37934006f49,GENTATRIM OINTMENT,prescription,D06AX07,GENTAMICIN,2187,,,WHO ATC Classification,,ILS,ointment,GENTAMICIN AS SULFATE 0.10 %W/W,2025-07-31T03:31:46.267378,IL,תרימה,,19.67143544,16.670708,12.1684,,,GENTATRIM OINT 15GR,7021,,909,TUBE ALUMINIUM,units,15.0,047 61 23635 01,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of wounds, burns, acne spots and dermatoses infected with bacteria sensitive to gentamycin.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/349ac014-de36-4682-ae40-e37934006f49.json
34acabe4-34ac-490d-94d0-9a76aeba2884,MIFLONIDE PWDR INH 200MCG 60CAPS,prescription,,,4525,,,,,ILS,capsule,MIFLONIDE PWDR INH 200MCG,2025-07-31T19:18:34.303085,IL,נוברטיס פארמה,,54.35671603,46.06501563,33.624099,,,MIFLONIDE PWDR INH 200MCG 60CAPS,13195,,30241,,units,60.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34acabe4-34ac-490d-94d0-9a76aeba2884.json
34b498a8-9a51-41f6-99c1-16fbb83eed67,URALYT-U,prescription,A12BA02,POTASSIUM CITRATE,995,,,WHO ATC Classification,,ILS,granules,POTASSIUM SODIUM HYDROGEN CITRATE 2.427 G / 2.5 G,2025-07-31T09:54:08.828265,IL,מגאפארם,,121.8763143,103.2850167,76.791834,,7290008097796,URALYT-U GRANUL.280G,21025,,2047,CONTAINER POLYPROPYLENE,units,280.0,063 87 22365 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,To dissolve uric acid stones in the urinary tract. Prevention of further stone formation.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34b498a8-9a51-41f6-99c1-16fbb83eed67.json
34d62b07-7de8-463e-bbc5-3654c31739fc,DEPALEPT SYRUP,prescription,N03AG01,VALPROIC ACID,2313,,,WHO ATC Classification,,ILS,syrup,VALPROIC ACID AS SODIUM/ML  ML,2025-07-31T01:46:36.423830,IL,כ.צ.ט,,38.10019046,32.288297,23.5681,,7290008005104,DEPALEPT 500MG 40 E.C.TAB,4042,,598,BOTTLE GLASS TYPE III,units,40.0,033 72 22644 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34d62b07-7de8-463e-bbc5-3654c31739fc.json
34d6bf51-4972-45cc-89b3-22bc6f62af87,LENALIDOMIDE S.K. 10 MG,prescription,L04AX04,LENALIDOMIDE,8730,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE,2025-07-31T04:37:59.879219,IL,SK PHARM(KS KIM),,21607.7809,18311.67873,16646.98066,,7290016845327,LENALIDOMIDE S.K. 10 MG 21 CAPS,12586,,59395,BLISTER PVC/ACLAR/ALUMINIUM,units,21.0,164 86 36219 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM)Lenalidomide S.K. is indicated for the treatment of multiple myeloma. Myelodysplastic Syndromes Lenalidomide S.K. is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Lenalidomide S.K. 7.5 mg is not indicated for treatment in MDS. Mantle Cell Lymphoma Lenalidomide S.K. is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL). Follicular lymphomaLenalidomide S.K. in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34d6bf51-4972-45cc-89b3-22bc6f62af87.json
34de8e04-310f-4c4b-b224-2f5f7b596b9f,GIROFLOX,prescription,J01MA02,CIPROFLOXACIN,8616,,,WHO ATC Classification,,ILS,solution for infusion,CIPROFLOXACIN/,2025-07-31T01:17:04.737764,IL,פרופארם,,2226.483295,1886.85025,1605.83,,7290010286041,CIPROFLOXACIN I.V G.E.S. 2 MG/ML 100 ML 50 BAGS,,,50069,BOTTLE PLASTIC,units,5000.0,133 31 30984 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,* Adults :Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens.* Children and adolescents:• Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa• Complicated urinary tract infections and pyelonephritis• Inhalation anthrax (post-exposure prophylaxis and curative treatment)Ciprofloxacin may also be used to treat severe infections in children and adolescents when there is no otheralternative .Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34de8e04-310f-4c4b-b224-2f5f7b596b9f.json
34e797c0-dd9d-4f2c-a5a9-4d78df55adcb,SEREVENT INHALER CFC FREE,prescription,R03AC12,SALMETEROL,6049,,,WHO ATC Classification,,ILS,suspension for inhalation,SALMETEROL AS XINAFOATE/ACTUATION,2025-07-31T08:06:09.531940,IL,ג.ס.ק,,98.52984265,83.49987036,62.081688,,7290010140275,SEREVENT INHALER CFC FREE 25MCG 120 ACT,19812,,75228,CAN ALUMINIUM,units,120.0,056 26 26922 05,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"Asthma:Serevent is indicated for the regular symptomatic add-on treatment of reversible airways obstruction in patients with asthma, including those with nocturnal asthma, who are inadequately controlled on inhaled corticosteroids in accordance with current treatment guidelines. Serevent is also indicated in the prevention of exercise-induced asthma.Chronic Obstructive Pulmonary Disease (COPD):Serevent is indicated in the treatment of patients with COPD.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/34e797c0-dd9d-4f2c-a5a9-4d78df55adcb.json
3510f35c-efbf-431b-9626-0e6d62907964,MONTELUKAST-TRIMA 5MG 28 CHEWTAB,prescription,,,6907,,,,,ILS,tablet,MONTELUKAST-TRIMA 5MG 28 CHEWTAB,2025-07-31T19:20:33.152445,IL,תרימה,,82.03307254,69.519553,51.6874,,,MONTELUKAST-TRIMA 5MG 28 CHEWTAB,13681,,19113,,units,28.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3510f35c-efbf-431b-9626-0e6d62907964.json
351becff-1338-415a-a3da-6e8875ddcfb0,CLOPIXOL DEPOT 200,prescription,N05AF05,ZUCLOPENTHIXOL,2426,,,WHO ATC Classification,,ILS,prolonged release solution for injection,ZUCLOPENTHIXOL DECANOATE/ML,2025-07-31T01:23:25.456798,IL,לנדבק,,24.75797733,20.98133765,15.314845,,5702157109203,CLOPIXOL DEPOT 200MG 1AMP,3634,,8223,AMPOULES GLASS TYPE I,units,1.0,069 70 25491 00,valid,37.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Clopixol Depot injection is a depot neuroleptic preparation designed for the maintenance treatment of acute and chronic schizophrenia and other paranoid psychoses, especially where compliance with oral medication is a problem.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/351becff-1338-415a-a3da-6e8875ddcfb0.json
3529ad8a-33f8-4b8d-8902-c2de6141aec1,MACROBID,prescription,J01XE01,NITROFURANTOIN,9371,,,WHO ATC Classification,,ILS,capsules,"NITROFURANTOIN ANHYDROUS, NITROFURANTOIN MACROCRYSTALS",2025-07-31T05:04:32.974150,IL,SK PHARM(KS KIM),,369.6547756,313.2667729,266.6100195,,,MACROBID 100MG 100 CAPS,,,8557,BOTTLE HDPE,units,100.0,170 53 36483 99,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus Saprophyticus in adult andadolescence 12 years and older.Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3529ad8a-33f8-4b8d-8902-c2de6141aec1.json
35352958-8093-41cf-9949-c703d0da895c,CLEXANE,prescription,B01AB05,ENOXAPARIN,6634,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/ML  ML,2025-07-31T01:19:44.715289,IL,סאנופי אוונטיס,,342.6139343,290.3508047,247.1070678,,7290012711121,CLEXANE 120MG/0.8ML SAFETY LOCK 10 SYR PREFIL,12436,,22699,SYRINGE PREFILLED  GLASS TYPE I,units,10.0,046 77 26037 11,valid,17.5,"i.v, s.c, extracorporeal",1.4,36,,,,,,,,,,0,Prescription required,"Clexane is indicated in adults for: • Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery. • Prevention of thrombus formation in extra corporeal circulation during haemodialysis. • Acute coronary syndrome: - Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid. - Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35352958-8093-41cf-9949-c703d0da895c.json
3535a2cf-eccd-4e84-92c6-49ea38efbeba,KALSINUS,off-the-counter,R01BA02,PSEUDOEPHEDRINE,5454,,,WHO ATC Classification,,ILS,tablets,PSEUDOEPHEDRINE HYDROCHLORIDE,2025-07-31T12:16:01.468904,IL,סם און,,13.1688,11.16,nan,,7290013834010,KALSINUS 60MG 10 TAB,,,,BLISTER PVC/ALUMINIUM,units,10.0,148 21 33484 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relieve eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3535a2cf-eccd-4e84-92c6-49ea38efbeba.json
35368df3-081b-470d-8ee2-618edd1decaa,ALKINDI 0.5 MG,prescription,H02AB09,HYDROCORTISONE,9084,,,WHO ATC Classification,,ILS,granules in capsules for opening,HYDROCORTISONE 0.5  MG,2025-07-30T23:19:43.032554,IL,מדומי פארמה,,390.2050902,330.6822945,281.43174,,,ALKINDI 1 MG 50 CAPSULES,,,83371,BOTTLE HDPE,units,50.0,164 46 35964 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Alkindi is indicated for replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old)", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35368df3-081b-470d-8ee2-618edd1decaa.json
35535446-a928-4927-afcd-6fad3a180ff9,MYOCHOLINE-GLENWOOD 25 MG,29C,N07AB02,BETHANECHOL,20111,,,WHO ATC Classification,,ILS,tablets,BETHANECHOL CHLORIDE,2025-07-31T15:17:22.250878,IL,nan,,nan,nan,nan,,7290018609880,MYOCHOLINE 25MG 100TAB,,,,BLISTER PVC/ALUMINIUM,units,100.0,167 20 35286 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Myocholine Glenwood is indicated in cases of postoperative urinary retention due to atony of the bladder in adults in diseases in which a stimulation of the bladder muscle is needed.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35535446-a928-4927-afcd-6fad3a180ff9.json
3567b3df-aa6a-42ab-b606-0d9a0be57a57,CREON 10000,off-the-counter,A09AA02,"MULTIENZYMES (LIPASE, PROTEASE ETC.)",3569,,,WHO ATC Classification,,ILS,capsules,PANCREATIN,2025-07-31T11:27:39.712971,IL,אבוט,,150.6388,127.66,nan,,,CREON 10000 U(150MG) 100CAPS,9776,,,BLISTER ALUMINIUM /ALUMINIUM,units,100.0,103 48 28837 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Pancreatic exocrine insufficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3567b3df-aa6a-42ab-b606-0d9a0be57a57.json
35711430-f7a0-4734-8770-3d5d0a9538dd,CINACALCET TARO 30 MG,prescription,H05BX01,CINACALCET,7777,,,WHO ATC Classification,,ILS,film coated tablets,CINACALCET AS HYDROCHLORIDE,2025-07-31T01:14:33.674188,IL,טבע,,1932.936288,1638.0816,1394.112,,,CINACALCET TEVA 60MG 30TAB,9886,,32510,BLISTER PVC/PE/PVDC/AL,units,30.0,160 90 35048 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet Taro may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma. Reduction of hypercalcaemia in patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35711430-f7a0-4734-8770-3d5d0a9538dd.json
357b3206-b90f-4d03-b551-a290b3bc6eab,SMOFKABIVEN,prescription,,,7113,,,,,ILS,emulsion for infusion,"FISH OIL/, OLIVE OIL/, TRIGLYCERIDES, MEDIUM-CHAIN/, SOYBEAN OIL/, ZINC SULFATE HEPTAHYDRATE 0.023 G /, SODIUM ACETATE TRIHYDRATE 5.62 G /, POTASSIUM CHLORIDE 4.48 G /, MAGNESIUM SULFATE HEPTAHYDRATE 2.47 G /, SODIUM GLYCEROPHOSPHATE HYDRATE 4.18 G /, CALCIUM CHLORIDE DIHYDRATE 0.74 G /, L- VALINE 6.2 G /, L- TYROSINE 0.40 G /, L- TRYPTOPHAN 2.0 G /, L- THREONINE 4.4 G /, TAURINE 1.0 G /, L- SERINE 6.5 G /, L- PROLINE 11.2 G /, L- PHENYLALANINE 5.1 G /, L- METHIONINE 4.3 G /, L- LEUCINE 7.4 G /, L- ISOLEUCINE 5.0 G /, L-HISTIDINE 3.0 G /, L-ARGININE 12.0 G /, L- ALANINE 14.0 G /, GLUCOSE MONOHYDRATE/, L- LYSINE ACETATE 9.3 G /, AMINOACETIC ACID 11.0 G /",2025-07-31T08:22:50.511012,IL,ניאופרם,,543.5135163,460.6046953,392.003996,,,SMOFKABIVEN 1970ML/BAG,,,,BAG POLYPROPYLENE,units,1970.0,147 81 33335 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/357b3206-b90f-4d03-b551-a290b3bc6eab.json
35ae22f7-e802-45fe-8b30-13dccbb26584,ILARIS 150 MG/ML SOLUTION FOR INJECTION,prescription,L04AC08,CANAKINUMAB,8415,,,WHO ATC Classification,,ILS,solution for injection,CANAKINUMAB/,2025-07-31T03:58:29.658997,IL,נוברטיס פארמה,,57084.3976,48376.61029,43978.73663,,7290016369526,ILARIS 150 MG/ML SOLUTION FOR INJECTION 1 VIAL,10461,,38474,VIAL GLASS TYPE I,units,1.0,161 35 35349 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"►Periodic Fever SyndromesIlaris is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents and children aged 2 years and older:Cryopyrin-Associated Periodic Syndromes (CAPS)Ilaris is indicated for the treatment of cryopyrin-associated periodic syndromes (CAPS) in adults, adolescents and children aged 2 years and older with body weight of 7.5 kg or above, including:•	Muckle-Wells syndrome (MWS),•	Neonatal-onset multisystem inflammatory disease (NOMID) / chronic infantile neurological, cutaneous, articular syndrome (CINCA),•	Severe forms of familial cold autoinflammatory syndrome (FCAS) / familial cold urticaria (FCU) presenting with signs and symptoms beyond cold-induced urticarial skin rash.►Tumour necrosis factor receptor associated periodic syndrome (TRAPS)Ilaris is indicated for the treatment of tumour necrosis factor (TNF) receptor associated periodic syndrome (TRAPS).►Hyperimmunoglobulin D syndrome (HIDS)/ mevalonate kinase deficiency (MKD)Ilaris is indicated for the treatment of hyperimmunoglobulin D syndrome (HIDS)/ mevalonate kinase deficiency (MKD).►Familial Mediterranean Fever (FMF)Ilaris is indicated for the treatment of Familial Mediterranean Fever (FMF) in patients in whom colchicine is contraindicated, is not tolerated, or does not provide an adequate response despite the highest tolerable dose of colchicine.Ilaris can be given as monotherapy or in combination with colchicine.Ilaris is also indicated for the treatment of:►Still’s diseaseIlaris is indicated for the treatment of active Still’s disease including adult-onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (SJIA) in patients aged 2 years and older who have responded inadequately to previous therapy with non-steroidal anti-inflammatory drugs (NSAIDs) and systemic corticosteroids. Ilaris can be given as monotherapy or in combination with methotrexate.►Gouty arthritisIlaris is indicated for the symptomatic treatment of adult patients with frequent gouty arthritis attacks (at least 3 attacks in the previous 12 months) in whom non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine are contraindicated, are not tolerated, or do not provide an adequate response, and in whom repeated courses of corticosteroids are not appropriate",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35ae22f7-e802-45fe-8b30-13dccbb26584.json
35b7534f-aa6d-430b-9d6b-4b9eb761c853,KWELLS 0.3MG 12TAB,29C,,,20485,,,,,,tablet,KWELLS 0.3MG,2025-07-31T20:44:45.096395,IL,nan,,,,,,,KWELLS 0.3MG 12TAB,,,,,units,12.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35b7534f-aa6d-430b-9d6b-4b9eb761c853.json
35b7f735-3be4-496e-9490-f6bf6c61498f,TRAZODIL 100,prescription,N06AX05,TRAZODONE,2268,,,WHO ATC Classification,,ILS,coated tablets,TRAZODONE HYDROCHLORIDE,2025-07-31T09:37:21.807628,IL,אוניפארם,,48.32591725,40.95416898,29.893554,,,TRAZODIL 100MG 30TAB,20435,,7379,BLISTER PVC/ALUMINIUM,units,30.0,039 36 20141 02,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of depression and anxiety.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35b7f735-3be4-496e-9490-f6bf6c61498f.json
35b9a3c7-c34b-49d3-897e-a2ff8cd73c24,FOLINATO CALCICO 50MG NORMON SPAIN powder/solution for injection,29C,,,20842,,,,,,injection,FOLINATO CALCICO 50MG NORMON SPAIN powder/solution for injection,2025-07-31T20:29:46.498927,IL,nan,,,,,,,FOLINATO CALCICO 50MG NORMON SPAIN powder/solution for injection,,,,,units,25.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35b9a3c7-c34b-49d3-897e-a2ff8cd73c24.json
35c5c689-abf9-449f-8df6-62016b6c3714,L-THYROXINE SERB,prescription,H03AA01,LEVOTHYROXINE SODIUM,8666,,,WHO ATC Classification,,ILS,solution for injection/ concentrate for solution for infusion,LEVOTHYROXINE SODIUM 0.2  MG /,2025-07-31T04:57:42.067290,IL,רז פרמהצפטי,,nan,nan,nan,,7290015863155,L-THYROXINE SERB 6 AMP,,,68101,AMPOULES GLASS TYPE I,units,6.0,165 27 35356 00,valid,nan,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,•Myxedema coma•Replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35c5c689-abf9-449f-8df6-62016b6c3714.json
35ce1f26-e415-40b2-8af3-087f34e717c2,PROTOPIC 0.03 %,prescription,L04AA05,TACROLIMUS,4615,,,WHO ATC Classification,,ILS,ointment,TACROLIMUS 0.03 %W/W,2025-07-31T07:05:32.270757,IL,דקסל פארמה,,92.44824633,78.34597495,58.2497955,,7290015912518,PROTOPIC 0.1% OINT 30GR,16432,,55939,TUBE LAMINATED,units,30.0,127 71 30667 00,valid,34.5,dermal,1.4,36,,,,,,,,,,0,Prescription required,"-Treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.-Treatment of moderate to severe atopic dermatitis in children (2 years of age and above) who are not adequately responsive to or are intolerant of conventional therapies.-Maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35ce1f26-e415-40b2-8af3-087f34e717c2.json
35d56ae4-6898-407d-9cf8-af95480ebde5,DERMASIL,prescription,D01BA02,TERBINAFINE,3798,,,WHO ATC Classification,,ILS,cream,TERBINAFINE HYDROCHLORIDE,2025-07-31T09:14:07.120391,IL,טבע,,53.5611912,45.39084,33.132,,7290103439651,TERBINAFINE 250MG 14TAB,20303,,25803,TUBE ALUMINIUM,units,14.0,134 74 31484 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidemophyton floccosum. Yeast infections of the skin, principally those caused by the genus Candida (e.g. candida albicans). Pityriasis (tinea versicolor due to pityrosporum orbiculare (also known as malassezia furfur).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35d56ae4-6898-407d-9cf8-af95480ebde5.json
35efee35-5309-4323-85eb-d5a8f0fea850,VINCRISTINE TEVA,prescription,L01CA02,VINCRISTINE,8853,,,WHO ATC Classification,,ILS,solution for injection,VINCRISTINE SULFATE/ML,2025-07-31T10:16:49.855712,IL,טבע,,nan,nan,nan,,,VINCRISTINE TEVA 5MG/5ML 1 VIAL,,,57486,VIAL GLASS TYPE I,units,1.0,115 51 22790 05,valid,nan,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Vincristine may be used either as sole agent or in combination therapy in the treatment of acute leukemias. Malignant lymphomas including Hodgkin's disease lymphosarcoma and reticulum cell sarcoma, neuroblastoma, Wilm's tumor, rhabdomyosarcoma.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35efee35-5309-4323-85eb-d5a8f0fea850.json
35f54f54-c50d-4781-bb86-2f16c30dc88f,IBUFEN 400,off-the-counter,M01AE01,IBUPROFEN,5478,,,WHO ATC Classification,,ILS,caplets,IBUPROFEN,2025-07-31T12:08:22.548047,IL,דקסל פארמה,,33.7834,28.63,nan,,,IBUFEN 400 50 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,50.0,039 70 26008 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the relief of mild to moderate pain such as headache, toothache, primary dysmenorrhea, backache, muscular pain. Anti - inflammatory and relieves pain in reumatoid arthritis and osteo arthritis.For the treatment of pain associated with migraine.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/35f54f54-c50d-4781-bb86-2f16c30dc88f.json
36070817-d4ee-4bf3-8a1c-200d3124c40f,BATRAFEN NAIL LACQUER,off-the-counter,D01AE14,CICLOPIROX,2959,,,WHO ATC Classification,,ILS,lacque,CICLOPIROX/G,2025-07-31T11:16:20.343903,IL,פרמה שלום,,121.1742,102.69,nan,,7290008880602,BATRAFEN NAIL LAQUER 3ML,2025,,,BOTTLE GLASS,units,3.0,121 29 27875 00,valid,nan,topical-nail,1.4,36,,,,,,,,,,0,,For the treatment of fungal infections of the nails.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36070817-d4ee-4bf3-8a1c-200d3124c40f.json
364f9e13-ed69-4192-84d4-9bd39800b0a5,VALERIANE TINCTURA FLORIS,off-the-counter,N05CM09,VALERIAN,5049,,,WHO ATC Classification,,ILS,drops,VALERIAN DRY EXTRACT/ML,2025-07-31T13:34:09.739191,IL,פלוריש,,24.0956,20.42,nan,,7290008103725,VALERIANE TINCTURA DROPS 20ML,22037,,,BOTTLE LDPE,units,20.0,122 72 30249 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of mild symptoms of mental stress and to aid sleep for ages 12 and older,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/364f9e13-ed69-4192-84d4-9bd39800b0a5.json
36546c11-9e2d-4be0-8e2c-351ea30d6629,MELODIL 25,prescription,N06AA21,MAPROTILINE,2249,,,WHO ATC Classification,,ILS,tablets,MAPROTILINE HYDROCHLORIDE,2025-07-31T05:09:55.627295,IL,אוניפארם,,23.35890004,19.795678,14.4494,,7290000812199,MELODIL 50MG 30TAB,13071,,2564,BLISTER PVC/ALUMINIUM,units,30.0,032 57 22655 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of depressive states and anxiety states associated with depression.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36546c11-9e2d-4be0-8e2c-351ea30d6629.json
365e2430-0688-4bb5-b89e-9c5dce09b4c4,TRACLEER 62.5 MG,prescription,C02KX01,BOSENTAN,4660,,,WHO ATC Classification,,ILS,film coated tablets,BOSENTAN AS MONOHYDRATE 62.5  MG,2025-07-31T09:28:52.074007,IL,יאנסן סילג,,5015.789205,4250.668818,3864.24438,,7640111932413,TRACLEER 62.5MG 60TAB,20612,,57712,BOTTLE HDPE,units,60.0,125 57 30487 01,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Treatment of pulmonary arterial hypertension (PAH) in patients of WHO functional class II-IV.Reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/365e2430-0688-4bb5-b89e-9c5dce09b4c4.json
3669117b-022e-471f-a6a3-863326dad8fa,STUNARONE TABLETS,prescription,N07CA02,CINNARIZINE,1420,,,WHO ATC Classification,,ILS,tablets,CINNARIZINE,2025-07-31T08:47:31.720321,IL,יאנסן סילג,,8.891299605,7.535,5.5,,7290008124591,STUNARONE 25MG 25TAB,1420,,22301,BLISTER PVC/ALUMINIUM,units,25.0,031 26 21879 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of nausea and vertigo due to meniere's disease and other labyrinthine disturbances and for travel sickness.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3669117b-022e-471f-a6a3-863326dad8fa.json
36873b9e-821e-47bb-8294-1b0f90220b8a,EXCEDRIN,off-the-counter,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",5485,,,WHO ATC Classification,,ILS,caplets,"PARACETAMOL, ACETYLSALICYLIC ACID, CAFFEINE",2025-07-31T11:51:20.665090,IL,ג.ס.ק,,38.999,33.05,nan,,7290105040077,EXCEDRIN 32 CAPLETS,,,,BLISTER PVC/PCTFE/PVC,units,32.0,141 82 31782 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For temporary relief of the pain of headache, mild to moderate pain associated with migraine headache,  pain of menstrual descomfort and pain accompanied by fever.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36873b9e-821e-47bb-8294-1b0f90220b8a.json
36b4533a-716d-41c0-b6fb-3deb98c17b2e,SINUCLEAR SYRUP,off-the-counter,,,5615,,,,,ILS,syrup,"EXTRACT (1:38.5) FROM 0.011 G OF A MIXTURE OF GENTIAN ROOT, VERBENA HERB, COMMON SORREL HERB, ELDER FLOWER, PRIMULA FLOWER WITH CALYX (1:3:3:3:3);1. EXTRACTING AGENT: ETHANOL(V/V), 2. - 4. EXTRACTING AGENT: PURIFIED WATER/ML",2025-07-31T13:18:01.043895,IL,דר סמואלוב,,45.3828,38.46,nan,,7290012024719,SINUCLEAR SYRUP 100 ML,,,,BOTTLE GLASS,units,100.0,171 01 34683 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Provides relief of symptoms in the nose and its sinuses in connection with common cold, in adults and children older than 12 years.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36b4533a-716d-41c0-b6fb-3deb98c17b2e.json
36d7e8e1-0bfe-4fcd-bf82-712286a4e9d8,BUCCOLAM 10 MG,prescription,N05CD08,MIDAZOLAM,7130,,,WHO ATC Classification,,ILS,oromucosal solution,MIDAZOLAM AS HYDROCHLORIDE,2025-07-31T00:44:53.786848,IL,ניאופרם,,389.9489723,330.4652454,281.2470174,,5060147020083,BUCCOLAM 10 MG SYRINGE PREFILLED 4X2ML,2547,,40571,SYRINGE PREFILLED  HDPE,units,4.0,149 81 33746 07,valid,17.5,buccal,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36d7e8e1-0bfe-4fcd-bf82-712286a4e9d8.json
36d97d14-5d01-4275-99b2-a2fd60cdb7d7,KALETRA  200 MG/50 MG TABLETS,prescription,J05AE06,LOPINAVIR,4789,,,WHO ATC Classification,,ILS,film coated tablets,"RITONAVIR, LOPINAVIR",2025-07-31T04:21:13.591289,IL,אב-וי,,1817.842425,1540.544496,1311.101699,,8054083003238,KALETRA ORAL SOL 5X60ML,11180,,56828,BLISTER PVC/ALUMINIUM,units,300.0,137 96 31542 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Kaletra is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36d97d14-5d01-4275-99b2-a2fd60cdb7d7.json
36f3228b-75cc-4e4d-949e-e021485411ba,RETAVIT CREAM 0.05% 20GR,prescription,,,2343,,,,,ILS,cream,RETAVIT CREAM 0.05% 20GR,2025-07-31T19:30:22.017196,IL,כ.צ.ט,,24.26726758,20.565481,15.0113,,,RETAVIT CREAM 0.05% 20GR,18195,,19792,,units,20.0,,not-registered,37.0,topical,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36f3228b-75cc-4e4d-949e-e021485411ba.json
36f5dcd3-2d28-4190-9f79-de7b97b48ec6,VITRAKVI  100 MG,prescription,L01XE53,LAROTRECTINIB,9494,,,WHO ATC Classification,,ILS,capsules,LAROTRECTINIB AS SULFATE,2025-07-31T10:18:52.380213,IL,באייר,,10450.66915,8856.499674,8051.36334,,,VITRAKVI 20 MG/ML ORAL SOLUTION 2*50ML,,,,BOTTLE HDPE,units,100.0,164 41 36178 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Vitrakvi as monotherapy is indicated for the treatment of adult and paediatric patients with solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion:• Who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and• Who have no satisfactory treatment options",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36f5dcd3-2d28-4190-9f79-de7b97b48ec6.json
36f7aa3a-2d9e-477d-a7a4-50a35ca8f064,RITALIN ® LA 10 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,4754,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:41:19.326837,IL,נוברטיס פארמה,,131.5100387,111.4491853,82.86184784,,7290003257192,RITALIN LA 30MG 30CAPS,18325,,61782,BOTTLE HDPE,units,30.0,146 50 33288 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD) .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/36f7aa3a-2d9e-477d-a7a4-50a35ca8f064.json
3711f917-78d5-4d0d-9a91-f50a4b57de06,TISSEEL FROZEN,prescription,B02BC30,COMBINATIONS,8974,,,WHO ATC Classification,,ILS,solutions for sealant,"CALCIUM CHLORIDE DIHYDRATE 40 MCMOL/ML, HUMAN THROMBIN/, APROTININ ACETATE 3000 KIU /, HUMAN FIBRINOGEN/",2025-07-31T09:22:28.402901,IL,בקסטר,,1405.30146,1190.933494,1013.56042,,,TISSEEL FROZEN PREF SYR 4ML,,,,SYRINGE POLYPROPYLENE,units,1.0,162 87 35322 00,valid,17.5,epilesional,1.4,24,,,,,,,,,,0,Prescription required,"Supportive treatment in adults and children from 1 month of age where standard surgical techniques appear insufficient: * For improvement of Hemostasis.* As a tissue glue to improve wound healing or to support sutures in vascular surgery and in gastrointestinal anastomoses.* For tissue sealing, to improve adhesion of the separated tissue (e.g. tissue flaps, grafts, split skin grafts [mesh grafts]).Efficacy in fully heparinized patients has been proven.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3711f917-78d5-4d0d-9a91-f50a4b57de06.json
3723d491-7047-4baf-b0a2-44ee854fa4a6,OLANZAPINE ODT TEVA ® 10 MG,prescription,N05AH03,OLANZAPINE,8053,,,WHO ATC Classification,,ILS,tablets orodispersible,OLANZAPINE,2025-07-31T06:05:38.476977,IL,טבע,,89.93540215,76.2164425,56.6665,,7290106063143,OLANZAPINE ODT TEVA ® 5 MG NEW FORMULATION 28 TAB,15472,,12692,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,157 16 34591 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia. Olanza ODT Teva is indicated for the management  of the manifestations of psychotic disorders.Olanza ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanza ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanza ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3723d491-7047-4baf-b0a2-44ee854fa4a6.json
372f2d34-4989-4e5c-a2be-71782b9feef7,RADIAN B MUSCLE RUB,off-the-counter,,,3474,,,,,ILS,cream,"MENTHOL 2.54 %W/W, CAMPHOR 1.43 %W/W, CAPSICUM OLEORESIN 0.005 %W/W, METHYL SALICYLATE 0.42 %W/W",2025-07-31T12:53:01.501884,IL,דפריס,,43.1644,36.58,nan,,5011309145915,RADIAN B MUSCLE CREAM 100GR,18004,,,TUBE ALUMINIUM,units,100.0,137 01 22841 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Relief of rheumatic pains and mild muscle pains.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/372f2d34-4989-4e5c-a2be-71782b9feef7.json
3743647d-22f9-47f7-a568-6430a8c8398c,ETOPAN XL 500,prescription,M01AB08,ETODOLAC,3600,,,WHO ATC Classification,,ILS,tablets extended release,ETODOLAC,2025-07-31T02:39:22.098966,IL,תרו,,31.62037268,26.796926,19.5598,,,ETOPAN 300MG 30CAPS,5103,,76313,BOTTLE HDPE,units,30.0,128 08 30651 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the management of signs and symptoms of osteoarthrities and rheumatoid arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3743647d-22f9-47f7-a568-6430a8c8398c.json
3747f728-5d45-4f27-92e8-11f612910f4e,RINGER LACTATED SOLUTION/VIOSER,prescription,B05BB01,ELECTROLYTES,8667,,,WHO ATC Classification,,ILS,solution for infusion,"SODIUM LACTATE 3.14 G/L, CALCIUM CHLORIDE DIHYDRATE 0.26 G/L, POTASSIUM CHLORIDE 0.41 G/L, SODIUM CHLORIDE 6.02 G/L",2025-07-31T08:26:07.804166,IL,רז פרמהצפטי,,8.968880235,7.6007463,5.54799,,7290111096761,SODIUM CHLORIDE S.A.L.F. 0.9%  1 BOTTLE 100 ML,,,,BOTTLE LDPE,units,100.0,169 66 36052 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Source of water and electrolytes. Regulation or maintenance of metabolic acidosis (except lactic acidosis),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3747f728-5d45-4f27-92e8-11f612910f4e.json
3757edf2-430f-49df-bc9e-84d6a5bb1bc5,SIMPONI,prescription,L04AB06,GOLIMUMAB,8581,,,WHO ATC Classification,,ILS,solution for injection,GOLIMUMAB/ML,2025-07-31T08:14:01.512145,IL,יאנסן סילג,,3929.702142,3330.256201,3027.505637,,7290014577299,SIMPONI 50MG/0.5ML 1 PREFILLED SYR,8581,,31568,AUTO - INJECTOR PEN GLASS TYPE I,units,1.0,147 32 33213 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid Arthritis:Simponi, in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis when the response to disease-modifying anti-rheumatic drug (DMARD) therapy including MTX has been inadequate.Juvenile idiopathic arthritis: Polyarticular juvenile idiopathic arthritis (pJIA)Simponi in combination with MTX is indicated for the treatment of polyarticular juvenile idiopathic arthritis in children with a body weight of at least 40 kg, who have responded inadequately to previous therapy with MTX.Simponi 100 mg is not recommended in children aged less than 18.Psoriatic Arthritis:Simponi, alone or in combination with methotrexate, is indicated for the treatment of adult patients with active and progressive  psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.Axial spondyloarthritis:* Ankylosing SpondylitisSimponi is indicated for the treatment of adult patients with severe active ankylosing spondylitis who have responded inadequately to conventional therapy.* Non-radiographic axial spondyloarthritis (nr-Axial SpA)Simponi is indicated for the treatment of adults with severe, active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to, or are intolerant to nonsteroidal anti-inflammatory drugs (NSAIDS).Ulcerative colitis (UC):Simponi is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3757edf2-430f-49df-bc9e-84d6a5bb1bc5.json
377f6bdc-d6ad-4d67-8504-eed466abf8d7,FEMINET,prescription,G03CA01,ETHINYLESTRADIOL,4657,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.02  MG, DESOGESTREL 0.15  MG",2025-07-31T02:56:23.455680,IL,דקסל פארמה,,56.59619604,47.962878,35.0094,,7290005680557,FEMINET 3X21TAB,6339,,58268,BLISTER PVC/PVDC/ALUMINIUM,units,63.0,128 57 30568 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/377f6bdc-d6ad-4d67-8504-eed466abf8d7.json
37a42f90-7ddf-4963-b3a3-23e58e1ce3bb,LONITEN 2.5MG 60 tab,29C,,,20995,,,,,,tablet,LONITEN 2.5MG,2025-07-31T20:49:17.829005,IL,nan,,,,,,,LONITEN 2.5MG 60 tab,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37a42f90-7ddf-4963-b3a3-23e58e1ce3bb.json
37a60469-7006-4e30-8042-9b40403a2571,DYSPORT 300,prescription,M03AX01,BOTULINUM TOXIN,6720,,,WHO ATC Classification,,ILS,powder for solution for injection,BOTULINUM TOXIN TYPE A 300 U/VIAL,2025-07-31T02:09:44.382257,IL,מדיסון,,1027.564743,870.8176176,741.1213767,,,DYSPORT 500 U/VIAL IM/SC 1 VIAL,4546,,2995,VIAL GLASS TYPE I,units,1.0,153 44 34183 00,valid,17.5,"s.c, i.m",1.4,24,,,,,,,,,,0,Prescription required,"Dysport is indicated for symptomatic treatment of focal spasticity of:- Upper limbs in adults due to stroke or traumatic brain injury- Lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (TBI) - Dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older.- Upper limbs in pediatric cerebral palsy patients, two years of age or older.Dysport is indicated in adults for symptomatic treatment of:- Spasmodic torticollis- Blepharospasm- Hemifacial spasm.Dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment.Dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows) seen at frown,and/or - Lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37a60469-7006-4e30-8042-9b40403a2571.json
37a9fe57-7883-455e-98d7-f458c19e5558,RAFASSAL 4 GRAM ENEMA,prescription,A07EC02,MESALAZINE,3263,,,WHO ATC Classification,,ILS,enema,MESALAZINE/,2025-07-31T07:14:04.649922,IL,רפא,,137.8699486,116.8389395,86.8691,,7290008013765,RAFASSAL 1GR 15SUPP,18103,,9254,BOTTLE POLYETHYLENE,units,15.0,029 58 25321 00,valid,34.5,rectal,1.4,18,,,,,,,,,,0,Prescription required,Treatment and prevention of ulcerative colitis and Crohn's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37a9fe57-7883-455e-98d7-f458c19e5558.json
37ab34d7-3294-48c1-aca3-578ef48c4f85,OMNIC OCAS 0.4 30 FILM COATED TAB,prescription,,,6004,,,,,ILS,tablet,OMNIC OCAS 0.4 30 FILM COATED TAB,2025-07-31T19:25:09.599238,IL,כ.צ.ט,,58.18806206,49.311917,35.9941,,,OMNIC OCAS 0.4 30 FILM COATED TAB,15336,,75666,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37ab34d7-3294-48c1-aca3-578ef48c4f85.json
37b05692-6857-41a7-83b9-9be94f135a1d,FLUPIDOL 20MG 12TAB,29C,,,20082,,,,,,tablet,FLUPIDOL 20MG,2025-07-31T20:28:31.517721,IL,nan,,,,,,,FLUPIDOL 20MG 12TAB,,,,,units,12.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37b05692-6857-41a7-83b9-9be94f135a1d.json
37c0a432-ada4-49c4-8210-67621b2220fb,DISTILBENE 1MG 26TAB,29C,,,20374,,,,,,tablet,DISTILBENE 1MG,2025-07-31T20:16:39.964624,IL,nan,,,,,,,DISTILBENE 1MG 26TAB,,,,,units,26.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37c0a432-ada4-49c4-8210-67621b2220fb.json
37c0fb70-4f51-4248-a0af-0f6b225042b3,VELTASSA 16.8 G,off-the-counter,V03AE09,PATIROMER CALCIUM ,5154,,,WHO ATC Classification,,ILS,powder for oral suspension,PATIROMER AS SORBITEX CALCIUM 16.8 G,2025-07-31T12:46:32.318827,IL,רפא,,45.7604,38.78,nan,,,PATIR CREAM 15GR,16707,,,SACHET ALUMINIUM,units,15.0,161 53 35492 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Veltassa is indicated for the treatment of hyperkalaemia in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37c0fb70-4f51-4248-a0af-0f6b225042b3.json
37cfd40e-5b9f-4307-9c1e-6a0ef64f766d,OCTANINE F 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,7718,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR IX (HUMAN)/ML,2025-07-31T06:02:04.117464,IL,דובר מדיקל,,981.3053865,831.6147713,707.7572522,,,OCTANINE F 500 IU VIAL,,,5091,VIAL GLASS TYPE I,units,1.0,150 35 33831 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37cfd40e-5b9f-4307-9c1e-6a0ef64f766d.json
37d13649-8ad4-4838-90b5-9c17bcda4c39,BIAFINE,off-the-counter,,,3004,,,,,ILS,cream,TROLAMINE 0.67  %W/W,2025-07-31T11:18:17.107459,IL,ג'ונסון אנד ג'ונסון,,72.0036,61.02,nan,,7290008099110,BIAFINE 186GR,2458,,,TUBE ALUMINIUM,units,186.0,067 13 28323 01,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Soothes burns, sunburns, sores and wounds.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37d13649-8ad4-4838-90b5-9c17bcda4c39.json
37d370b9-0c76-4032-8ceb-3daacff1c2e8,NEXVIAZYME,prescription,A16AB22,AVALGLUCOSIDASE ALPHA,9022,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,AVALGLUCOSIDASE ALPHA/VIAL,2025-07-31T05:45:41.690816,IL,סאנופי אוונטיס,,5035.344771,4267.241521,3879.310474,,,NEXVIAZYME 100MG 1 VIAL,14709,,78964,VIAL GLASS TYPE I,units,1.0,170 81 37090 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Nexviazyme is indicated long-term enzyme replacement therapy (ERT) for the treatment of patients with Pompe disease (acid α-glucosidase deficiency),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37d370b9-0c76-4032-8ceb-3daacff1c2e8.json
37dea9de-9508-47f6-b824-b8ecad9dfdf0,BETAREN 100 S.R.,prescription,M01AB05,DICLOFENAC,1730,,,WHO ATC Classification,,ILS,tablets slow release,DICLOFENAC SODIUM,2025-07-31T00:33:49.445445,IL,דקסל פארמה,,11.6007216,9.83112,7.176,,,BETAREN 100MG 10 S.R.TAB,2363,,8267,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,015 73 24619 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis, osteoarthritis, low back pain and other acute musculoskeletal disorders such as periarthritis, tendinitis, tenosynovitis, bursitis, sprains, strains and dislocation, ankylosing spondylitis and acute gout.Control of pain and inflammation in orthopedic, dental, and other minor surgery.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/37dea9de-9508-47f6-b824-b8ecad9dfdf0.json
38051790-e4c7-4324-9f16-6002e8ea682e,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,6024,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T02:57:33.059054,IL,רפא,,250.0259225,211.886375,169.5091,,,FENTA 100 5 PATCH,6400,,71216,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,5.0,148 73 33262 01,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/38051790-e4c7-4324-9f16-6002e8ea682e.json
380b2081-f6e8-462b-88a5-305913f5d4b6,ZERBAXA 1 G/0.5 G,prescription,J01DI54,CEFTOLOZANE AND ENZYME INHIBITOR,8697,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,"TAZOBACTAM AS SODIUM 0.5 G, CEFTOLOZANE AS SULFATE",2025-07-31T10:47:36.495579,IL,מ.ס.ד. ישראל,,4471.930955,3789.772164,3445.247422,,7290017512006,ZERBAXA 1 G/0.5 G 10 VIALS,,,13735,VIAL GLASS TYPE I,units,10.0,160 01 34967 01,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Zerbaxa is indicated for the treatment of the following infections in adults:-Complicated intra abdominal infections;-Acute pyelonephritis caused by pathogens resistant to other treatments as confirmed by urine culture-Complicated urinary tract infections.-Hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP).Consideration should be given to official guidance on the appropriate use of antibacterial agents",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/380b2081-f6e8-462b-88a5-305913f5d4b6.json
381a5047-e6a6-40d4-a869-ff293835407d,TINDEN DROPS,prescription,R06AB03,DIMETINDENE,8186,,,WHO ATC Classification,,ILS,"oral drops, solution",DIMETINDENE MALEATE/,2025-07-31T09:21:44.041806,IL,תרימה,,19.6983029,16.69347703,12.18501973,,,TINDEN DROPS 20 ml,20857,,6695,BOTTLE GLASS,units,20.0,160 63 35127 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Antipruritic, antihistaminic and antiallergic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/381a5047-e6a6-40d4-a869-ff293835407d.json
381a7601-e5dc-4f7f-9ddb-04d44834825f,TERROSA,prescription,H05AA02,TERIPARATIDE,8546,,,WHO ATC Classification,,ILS,solution for injection,TERIPARATIDE/ML,2025-07-31T09:16:20.635518,IL,דקסל פארמה,,1058.734037,897.232275,763.6019362,,7290015912679,TERROSA 250 MCG/  ML,20992,,58884,CARTRIDGE GLASS TYPE I,units,1.0,163 82 35787 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Terrosa is indicated* For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis Terrosa reduces the risk of vertebral and nonvertebral fractures . * To increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, or who have failed or are intolerant to other available osteoporosis therapy. * For the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/381a7601-e5dc-4f7f-9ddb-04d44834825f.json
381e5610-d959-44f8-ae22-9bf3d166bf23,TIPTIPOT AFALPI,off-the-counter,R01BA02,PSEUDOEPHEDRINE,5580,,,WHO ATC Classification,,ILS,drops,PSEUDOEPHEDRINE AS HYDROCHLORIDE/ML,2025-07-31T13:29:22.115925,IL,כ.צ.ט,,60.416,51.2,nan,, 7290008104579,TIPTIPOT NOVIMOL SUSP 50 ML,,,,BOTTLE GLASS,units,50.0,121 43 30172 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relief eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/381e5610-d959-44f8-ae22-9bf3d166bf23.json
383cb738-243c-4de5-93f1-6f1e4d6294fa,AIMOVIG 140 MG,prescription,N02CX07,ERENUMAB,8285,,,WHO ATC Classification,,ILS,solution for injection,ERENUMAB/,2025-07-31T00:12:11.257560,IL,נוברטיס פארמה,,1954.548941,1656.397482,1409.699984,,7290017585802,AIMOVIG 140 MG PREFILLLED PEN,10608,,54457,PRE-FILLED PEN GLASS TYPE I,units,1.0,164 09 36005 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Aimovig is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month when initiating treatment with Aimovig,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/383cb738-243c-4de5-93f1-6f1e4d6294fa.json
3848d8a4-95aa-4d94-b0c0-a1aaba6ebf69,CROMOPTIC,off-the-counter,S01GX01,CROMOGLICIC ACID,4235,,,WHO ATC Classification,,ILS,"eye drops, solution",CROMOGLICIC ACID SODIUMW/V,2025-07-31T11:28:24.293033,IL,ויטאמד,,29.4174,24.93,nan,,7290008106030,CROMOPTIC 2% EYE DROPS 13.5ML,3133,,,BOTTLE LDPE,units,13.5,100 35 28587 00,valid,nan,ocular,1.4,12,,,,,,,,,,0,,Preventative treatment of all forms of allergic conjunctivitis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3848d8a4-95aa-4d94-b0c0-a1aaba6ebf69.json
384df902-5923-48f2-8b95-3506886c03ef,EPANUTIN 100 MG,29C,N03AB02,PHENYTOIN,20391,,,WHO ATC Classification,,ILS,capsules,PHENYTOIN SODIUM,2025-07-31T14:28:56.787766,IL,nan,,nan,nan,nan,,,EPANUTIN 50MG 28CAPS,,,,BOTTLE HDPE,units,28.0,104 27 24678 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/384df902-5923-48f2-8b95-3506886c03ef.json
386e074d-2086-4bc6-aef6-1ec2c9dfe794,METADEX XR 10 MG,prescription,N06BA11,DEXMETHYLPHENIDATE,9225,,,WHO ATC Classification,,ILS,capsules extended release,DEXMETHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:15:40.165642,IL,SK PHARM(KS KIM),,nan,nan,nan,,,METADEX XR 15 MG S.K. 100 CAPSULES,,,70902,BOTTLE HDPE,units,100.0,172 56 37337 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Metadex XR extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/386e074d-2086-4bc6-aef6-1ec2c9dfe794.json
38763c19-f740-45bc-951d-6b8803b44664,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8030,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:53:20.491912,IL,יאנסן סילג,,12949.86177,10974.45961,9976.781465,,7640111932642,UPTRAVI ® 200 MCG 60 TAB,21125,,22481,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/38763c19-f740-45bc-951d-6b8803b44664.json
387ea6f5-7ea1-41b3-b489-9f36a785ae8d,IODO-VIT VETERINARY OINTMENT,off-the-counter,D08AG02,POVIDONE-IODINE,2990,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:12:04.967701,IL,ויטאמד,,11.092,9.4,nan,,7290008082495,IODO-VIT OINT 15GR,9097,,,JAR PLASTIC,units,15.0,083 26 92362 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Disinfection of wounds, scratches, minor burns and skin infections in farm animals and pets.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/387ea6f5-7ea1-41b3-b489-9f36a785ae8d.json
388a7900-ff7a-47b6-8bb7-9166e34c3d3a,PALOXI INJECTION,prescription,A04AA05,PALONOSETRON,4974,,,WHO ATC Classification,,ILS,solution for injection,PALONOSETRON AS HYDROCHLORIDE 0.25  MG/VIAL,2025-07-31T06:25:31.925878,IL,רפא,,210.2160921,178.1492385,142.5193908,,7290008012379,PALOXI INJECTION 0.25MG/VIAL 5ML,16728,,69317,VIAL GLASS TYPE I,units,1.0,134 84 31150 00,valid,25.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Paloxi is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/388a7900-ff7a-47b6-8bb7-9166e34c3d3a.json
38a09cae-4ec2-4c34-9559-ec127b8d8e3f,REMSIMA 100 MG I.V.,prescription,L04AB02,INFLIXIMAB,8807,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,INFLIXIMAB/VIAL,2025-07-31T07:25:04.871495,IL,פאדאגיס,,2611.976125,2213.539188,2012.308352,,7290012162299,REMSIMA 120 MG/ML 2 PFS,18660,,81856,VIAL 20 ML GLASS TYPE I,units,2.0,154 60 34158 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"* Rheumatoid arthritis:Remsima, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in:• adult patients with active disease when the response to disease modifying antirheumatic drugs (DMARDs),including methotrexate, has been inadequate.• adult patients with severe, active and progressive disease not previously treated with methotrexate or other DMARDs.In these patient populations, a reduction in the rate of the progression of joint damage, as measured by X ray,has been demonstrated.* Ankylosing spondylitis:Remsima is indicated for treatment of severe, active ankylosing spondylitis, in adult patients who have responded inadequately to conventional therapy.* Psoriatic arthritis:Remsima is indicated for treatment of active and progressive psoriatic arthritis in adult patients when the response to previous DMARD therapy has been inadequate.* Remsima should be administered:• in combination with methotrexate• or alone in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated.Infliximab has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.* Psoriasis:Remsima is indicated for treatment of moderate to severe plaque psoriasis in adult patients who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or psoralen ultra-violet A (PUVA)* Adult Crohn’s disease Remsima is indicated for treatment :•	of moderately to severely active Crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.•	treatment of fistulising, active Crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with conventional treatment (including antibiotics, drainage and immunosuppressive therapy).* Ulcerative colitis•	Remsima is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6 mercaptopurine (6 MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.Paediatric Crohn’s diseaseRemsima is indicated for treatment of severe, active Crohn’s disease in children and adolescents aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition therapy; or who are intolerant to or have contraindications for such therapies. Infliximab has been studied only in combination with conventional immunosuppressive therapy.Paediatric ulcerative colitisRemsima is indicated for treatment of severely active ulcerative colitis in children and adolescents aged 6 to 17 years, who have had an inadequate response to conventional therapy including corticosteroids and 6 MP or AZA, or who are intolerant to or have medical contraindications for such therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/38a09cae-4ec2-4c34-9559-ec127b8d8e3f.json
38aa54f3-935d-4773-ac21-26faf0aab648,LATUDA 40MG 30 tab,29C,,,21006,,,,,,tablet,LATUDA 40MG,2025-07-31T20:46:12.569543,IL,nan,,,,,,,LATUDA 40MG 30 tab,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/38aa54f3-935d-4773-ac21-26faf0aab648.json
38b9926a-807c-4e5d-a896-6420e13a385b,ESOPRIM S.K 20 MG,prescription,A02BC05,ESOMEPRAZOLE,8436,,,WHO ATC Classification,,ILS,"capsule, hard",ESOMEPRAZOLE AS SODIUM,2025-07-31T02:36:45.869099,IL,SK PHARM(KS KIM),,28.15108442,23.8568512,17.41376,,7290016845174,ESOPRIM S.K 20 MG 28 tab,5659,,55166,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,162 75 35708 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Esoprim S.K. 20 mg indicated in adults for:Gastroesophageal Reflux Disease (GERD)- treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease. In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and- healing of Helicobacter pylori associated duodenal ulcer and prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers -Patients requiring continued NSAID therapy Healing of gastric ulcers associated with NSAID therapy. - Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk. - Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers. Esoprim S.K 20 mg is indicated in adolescents from the age of 12 years for: Gastro-esophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis -long-term management of patients with healed esophagitis to prevent relapse-symptomatic treatment of gastro-esophageal reflux diseaseIn combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/38b9926a-807c-4e5d-a896-6420e13a385b.json
38c3acf1-122d-4f78-9cf7-cdd29012b99e,ATARAX 20MG/ML  ORAL SOLUTION,29C,,,20922,,,,,,solution,ATARAX 20MG/ML ORAL SOLUTION,2025-07-31T19:58:22.441863,IL,nan,,,,,,,ATARAX 20MG/ML  ORAL SOLUTION,,,,,units,1.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/38c3acf1-122d-4f78-9cf7-cdd29012b99e.json
38f00d0f-fa1e-416f-84a5-b66bdfcc9cb3,FOLIC ACID 10 MG,off-the-counter,B03BB01,FOLIC ACID,3391,,,WHO ATC Classification,,ILS,tablets,FOLIC ACID,2025-07-31T11:57:02.400531,IL,רקח,,21.004,17.8,nan,,,FOLIC ACID 5MG 30TAB,6092,,,BLISTER POLYVINYL CHLORIDE,units,30.0,128 86 21946 00,valid,nan,per os,1.4,18,,,,,,,,,,0,,Treatment of folic acid deficiency megaloblastic anemia in malabsorption states.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/38f00d0f-fa1e-416f-84a5-b66bdfcc9cb3.json
3904ea34-d949-48b5-876f-2caf5665d10a,GENOTROPIN 5.3 MG,prescription,H01AC01,SOMATROPIN,8385,,,WHO ATC Classification,,ILS,powder for solution for injection,SOMATROPIN 5.3  MG,2025-07-31T03:30:47.636197,IL,פיזר,,534.9155587,453.3182902,385.8028002,,7-317961-665876,GENOTROPIN 5.3 MG 1 prefilled pen,7428,,30741,CARTRIDGE GLASS TYPE I,units,1.0,111 08 26780 22,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Children:   Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome. Short stature in children with renal insufficiency.   Growth disturbance (height SDS<2.5 and parenteral adjusted height SDS < -1) in short children born SGA (SGA - small for gestational age  i.e. born small in relation to the length of the fetus development)  with a birth weight and/or length < 2 SD  who failed to show catch up growth (HV SDS < 0 during the last year) by 4 years of age or later.   Prader willi syndrome  for improvement of growth and body composition.  Adults:    For adults who have suffered from growth-hormone deficiency since childhood.   For adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3904ea34-d949-48b5-876f-2caf5665d10a.json
3910c5b6-04c4-4158-a6a4-0f51604901a0,HYDERGIN 1.5MG 30TAB,29C,,,925,,,,,,tablet,HYDERGIN 1.5MG,2025-07-31T20:35:04.144028,IL,nan,,,,,,,HYDERGIN 1.5MG 30TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3910c5b6-04c4-4158-a6a4-0f51604901a0.json
3927b88d-ecd6-49bf-b7bb-8c65b33e0499,TRANSLARNA 1000 MG,prescription,M09AX03,ATALUREN,7638,,,WHO ATC Classification,,ILS,granules for oral suspension,ATALUREN,2025-07-31T09:34:31.298518,IL,מדיסון,,127443.1509,108002.6751,98184.25005,,,TRANSLARNA 1000MG 30 SACHETS,9835,,80552,SACHET ALUMINIUM,units,30.0,154 28 34267 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Translarna is indicated for the treatment of Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older.  The presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3927b88d-ecd6-49bf-b7bb-8c65b33e0499.json
3938134e-6abe-4119-bd9f-4b69495bc797,GIOTRIF 20 MG,prescription,L01XE13,AFATINIB,7392,,,WHO ATC Classification,,ILS,film coated tablets,AFATINIB AS DIMALEATE,2025-07-31T03:33:29.844477,IL,בורינגר אינגלהיים,,8756.765492,7420.988035,6746.352759,,,GIOTRIF 40MG 28F.C.TAB,7910,,50943,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,151 47 33984 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,GIOTRIF as monotherapy is indicated for the treatment of: • EGFR TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s);• locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3938134e-6abe-4119-bd9f-4b69495bc797.json
393babc0-e115-4955-8efd-93d63cac15c1,DIAZIGAL VETERINARY SOLUTION,29C,,,20027,,,,,ILS,solution,"TRIMETHOPRIM 1.75 %, SULFADIAZINE SODIUM 8.75 %",2025-07-31T13:44:06.843187,IL,nan,,nan,nan,nan,,7290016183238,ADIAZINE 500MG 20TAB,,,,BOTTLE HDPE,units,20.0,082 17 92271 00,valid,nan,per os in drinking water,1.4,36,,,,,,,,,,0,,Treatment of bacterial infections in turkeys caused by sensitive bacteria to sulphonamides and trimethoprim .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/393babc0-e115-4955-8efd-93d63cac15c1.json
393fb472-0295-46d2-88ea-87472b44ddaa,RIVASTIGMINE PATCH DEXCEL 4.6 MG/24 H,prescription,N06DA03,RIVASTIGMINE,8183,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 6.9  MG,2025-07-31T07:45:19.447637,IL,דקסל פארמה,,210.1366125,178.081875,142.4655,,,RIVASTIGMINE PATCH DEXCEL 4.6 MG/24 H30PATCHES,18578,,66786,SACHET PAPER /POLYETHYLENE TEREPHTHALATE/ALUMINUM/POLYACRYLNITRILE,units,30.0,158 87 34462 00,valid,25.0,transdermal,1.4,36,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/393fb472-0295-46d2-88ea-87472b44ddaa.json
3943bdbe-edc4-44ea-a197-dad7791b4997,FINASTERIDE TEVA,prescription,G04CB01,FINASTERIDE,7564,,,WHO ATC Classification,,ILS,film coated tablets,FINASTERIDE,2025-07-31T03:04:31.920179,IL,טבע,,148.55079,125.8905,100.7124,,,FINASTERIDE TEVA 1MG 30TAB,6546,,58971,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,140 59 31427 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Finasteride Teva 1 mg is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3943bdbe-edc4-44ea-a197-dad7791b4997.json
394bc317-9c42-4184-8d50-ef844b878918,ALLORIL 100,prescription,M04AA01,ALLOPURINOL,8050,,,WHO ATC Classification,,ILS,tablets,ALLOPURINOL,2025-07-30T23:20:02.964600,IL,דקסל פארמה,,18.1350188,15.36866,11.218,,7290000806181,ALLORIL 300MG 30TAB,10089,,17648,BLISTER PVC,units,30.0,039 76 26038 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis and/or nephropathy). Management of patients with leukemia, lymphoma, and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/394bc317-9c42-4184-8d50-ef844b878918.json
3954fcbc-21b7-4a4c-9b5f-77d36a265ad0,ALBIOMIN 20 %,prescription,B01AD12,PROTEIN C,6891,,,WHO ATC Classification,,ILS,solution for infusion,ALBUMIN HUMAN/ML,2025-07-30T23:18:20.340345,IL,קמהדע,,175.9130352,149.07885,119.26308,,7290011225049,ALBIOMIN  20%  1VIAL/50ML,,,,VIAL GLASS TYPE II,units,50.0,128 48 28642 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3954fcbc-21b7-4a4c-9b5f-77d36a265ad0.json
39643276-4702-427f-b60b-4c201f2784c3,ALKINDI 0.5 MG,prescription,H02AB09,HYDROCORTISONE,9083,,,WHO ATC Classification,,ILS,granules in capsules for opening,HYDROCORTISONE 0.5  MG,2025-07-30T23:19:47.999634,IL,מדומי פארמה,,778.2123838,659.5020495,561.27834,,,ALKINDI 2 MG 50 CAPSULES,,,83372,BOTTLE HDPE,units,50.0,164 46 35964 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Alkindi is indicated for replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old)", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/39643276-4702-427f-b60b-4c201f2784c3.json
39ac81c3-d0de-4367-b070-2ca20c9b1096,PROTOCIDE,prescription,P01AB02,TINIDAZOLE,2263,,,WHO ATC Classification,,ILS,tablets,TINIDAZOLE,2025-07-31T07:05:10.083428,IL,אוניפארם,,21.82911146,18.499247,13.5031,,,PROTOCIDE 500MG 4TAB,16280,,1824,BLISTER PVC/ALUMINIUM,units,4.0,107 87 21159 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the oral treatment of Trichomonas Vaginals infections of the genito urinary tract in both female and male. For the prevention of anerobic infections after gynocological operations and stomach operations.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/39ac81c3-d0de-4367-b070-2ca20c9b1096.json
39bb8811-b909-4328-a652-3d17c5f34011,SIMDAX 2.5 MG/ML,prescription,C01CX08,LEVOSIMENDAN,7913,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,LEVOSIMENDAN 2.5  MG/ML,2025-07-31T08:13:24.690541,IL,ביומד,,2390.553498,2025.892885,1724.164157,,4800221097416,SIMDAX 2.5 MG/ML VIAL 5ML,,,1798,VIAL GLASS TYPE I,units,1.0,129 66 30801 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Short-term treatment of acutely decompensated severe chronic heart failure.Simdax should only be used as add-on therapy in situations where conventional therapy with e.g. diuretics, ACE-inhibitors and digitalis is not sufficient and where there is a need for inotropic support.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/39bb8811-b909-4328-a652-3d17c5f34011.json
39ea11aa-afec-4e45-bb30-00de06325728,DIATRIM,prescription,M01AX21,DIACEREIN,4802,,,WHO ATC Classification,,ILS,capsules,DIACEREIN,2025-07-31T01:54:37.735380,IL,תרימה,,44.19897562,37.456759,27.3407,,7-290008-075978,DIATRIM 50MG 30CAPS,4467,,12510,BLISTER PVC/ALUMINIUM,units,30.0,132 16 30996 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of functional symptoms of osteoarthritis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/39ea11aa-afec-4e45-bb30-00de06325728.json
39f8f2c7-9b34-4657-bd7e-aba5848e7c70,HISTAFED COMPOUND LINCTUS,prescription,R06AX07,TRIPROLIDINE,2191,,,WHO ATC Classification,,ILS,syrup,"CODEINE PHOSPHATE/, PSEUDOEPHEDRINE HYDROCHLORIDE/, TRIPROLIDINE HYDROCHLRIDE 1.25  MG /",2025-07-31T03:47:06.855022,IL,תרימה,,nan,nan,nan,,729000843322,HISTAFED COMP LINCTUS 115ML,8048,,978,BOTTLE GLASS,units,115.0,027 93 21823 00,valid,nan,per os,1.4,18,,,,,,,,,,0,Prescription required,Antitussive syrup for the symptomatic relief of cough accompanied by nasal congestion and congestion of the upper respiratory tract.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/39f8f2c7-9b34-4657-bd7e-aba5848e7c70.json
3a06fc1c-5098-4f77-bf97-e0e52fd536d6,ARIPLY 10,prescription,N05AX12,ARIPIPRAZOLE,7200,,,WHO ATC Classification,,ILS,tablets,ARIPIPRAZOLE,2025-07-30T23:27:32.241697,IL,אוניפארם,,245.7773325,208.285875,166.6287,,,ARIPLY 5MG 28TAB,9641,,40537,BLISTER PVC/ALUMINIUM,units,28.0,149 03 33529 01,valid,25.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Ariply is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.Ariply  is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD). Efficacy was established in two 6-week trials in adults with MDD who had an inadequate response to antidepressant therapy during the current episode.Ariply  is indicated for the treatment of irritability associated with autistic disorder. Efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a06fc1c-5098-4f77-bf97-e0e52fd536d6.json
3a0b7e15-4f16-461a-984f-0512736be2ec,LIPITOR 10 MG,prescription,C10AA05,ATORVASTATIN,4562,,,WHO ATC Classification,,ILS,film coated tablets,ATORVASTATIN AS CALCIUM,2025-07-31T04:48:19.932609,IL,דקסל פארמה,,54.31921494,46.033233,33.6009,,,LIPITOR 40MG 30TAB,12485,,68181,BLISTER PVC/OPA/AL,units,30.0,126 04 30587 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol  LDL- cholesterol  apolipoprotein B  and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Lipitor is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable.   Pediatric patients (10-17 years of age) :   Atorvastatin is indicated as an adjunct to diet to reduce total -C  LDL-C  and apo B levels in boys and postmenarchal girls  10 to 17 years of age  with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:   1. LDL-C remains >or = 190 mg/dl or   2. LDL-C remains > or = 160 mg/dl and:    there is a positive family history of premature cardiovascular disease or    two or more other CVD risk factors are present in the pediatric patient.   Prevention of cardiovascular and/or cerebrovascular event sush as MI or stroke  as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor.   In patients with clinically evident coronary heart disease  Lipitor is indicated to :    Reduce the risk of non-fatal myocardial infarction.    Reduce the risk of fatal and non fatal stroke.    Reduce the risk for revascularization procedures.    Reduce the risk of hospitalization for CHF.    Reduce the risk of angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a0b7e15-4f16-461a-984f-0512736be2ec.json
3a162db5-f077-45ff-83a1-7e8128d563ef,TORID 20MG 30TAB,prescription,,,4796,,,,,ILS,tablet,TORID 20MG,2025-07-31T19:34:30.106907,IL,אוניפארם,,32.64788364,27.667698,20.1954,,,TORID 20MG 30TAB,20548,,17779,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a162db5-f077-45ff-83a1-7e8128d563ef.json
3a193967-ac7d-4856-928a-0489404c7962,AKNE-MYCIN PLUS SOL 25ML,prescription,,,4522,,,,,ILS,solution,AKNE-MYCIN PLUS SOL,2025-07-31T18:57:11.078174,IL,ניאופרם,,62.90426925,53.30870513,39.634725,,,AKNE-MYCIN PLUS SOL 25ML,1680,,30027,,units,25.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a193967-ac7d-4856-928a-0489404c7962.json
3a19f5ee-d369-45a2-a94c-af67b6708c5c,"FLUDARABIN ""EBEWE"" 50 MG/2 ML",prescription,L01BB05,FLUDARABINE,7931,,,WHO ATC Classification,,ILS,concentrate for solution for injection / infusion,FLUDARABINE PHOSPHATE/DOSE,2025-07-31T03:12:18.079641,IL,סנדוז,,603.1295798,511.1267625,435.0015,,7290016369717,FLUDARABIN EBEWE 50 MG/2 ML 1 VIAL,6415,,88439,VIAL GLASS TYPE I,units,1.0,138 60 31781 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludarabine is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a19f5ee-d369-45a2-a94c-af67b6708c5c.json
3a1ef84f-a338-4757-931e-7088d79c3aec,DULOX TEVA 30 MG,prescription,N06AX21,DULOXETINE,8916,,,WHO ATC Classification,,ILS,gastro resistant capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T02:05:46.654000,IL,טבע,,106.2603128,90.0511125,66.9525,,,DULOX TEVA 60 MG 30 CAPS,,,70648,BLISTER AL/OPA/AL/PVC,units,30.0,166 98 35976 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Dulox Teva is indicated for:- The treatment of major depressive episodes. - The management of neuropathic pain associated with diabetic peripheral neuropathy. - The treatment of generalized anxiety disorder (GAD).- The management of fibromyalgia. - The management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. This has been established in studies in patients with chronic low ‎back pain (CLBP) and chronic pain due to osteoarthritis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a1ef84f-a338-4757-931e-7088d79c3aec.json
3a211bd1-dbe4-4187-861f-96451a20abe2,FOSTER 100/6,prescription,R03AK08,FORMOTEROL AND BECLOMETASONE,7389,,,WHO ATC Classification,,ILS,pressurised solution,"FORMOTEROL FUMARATE DIHYDRATE/DOSE, BECLOMETASONE DIPROPIONATE ANHYDROUS/DOSE",2025-07-31T03:19:08.138986,IL,קמהדע,,145.7581867,123.5238925,98.819114,,7290011225544,FOSTER INHALER 120 ACTUATIONS,6515,,49869,INHALER ALUMINIUM,units,120.0,150 73 33783 00,valid,25.0,inhalation,1.4,21,,,,,,,,,,0,Prescription required,"Foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.COPD :Symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a211bd1-dbe4-4187-861f-96451a20abe2.json
3a2364bb-a013-4d13-bf23-65fd849fd497,LYRICA 100 MG,prescription,N03AX16,PREGABALIN,4879,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T05:01:12.302286,IL,דקסל פארמה,,168.9678875,143.193125,114.5545,,,LYRICA 150MG 56CAPS,12339,,65303,BLISTER PVC,units,56.0,133 01 31188 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,LLyrica is indicated for the:- Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia.- Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a2364bb-a013-4d13-bf23-65fd849fd497.json
3a2a7e32-d16a-4f90-958a-c3d6c121e237,ELIDEL CREAM 1 %,prescription,D11AX15,PIMECROLIMUS,4619,,,WHO ATC Classification,,ILS,cream,PIMECROLIMUS,2025-07-31T02:14:40.579719,IL,דקסל פארמה,,130.5459336,110.632152,82.2543881,,7290001173510,ELIDEL CREAM 1% 30G,5209,,56194,TUBE ALUMINIUM,units,30.0,126 12 30517 01,valid,34.5,dermal,1.4,24,,,,,,,,,,0,Prescription required,Elidel 1 % cream is indicated for the short-term treatment of the signs and symptoms of atopic dermatitis (eczema) and intermittent long-term treatment to prevent progression to flares in patients 3 months of age and above. Treatment with Elidel is indicated in patients in whom the use of conventional topical corticosteroids therapy is deemed inadvisable because of potential risks or in patients who are not adequately responsive to or intolerant of conventional topical corticosteroids therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3a2a7e32-d16a-4f90-958a-c3d6c121e237.json
3ab2ff86-a62a-4c13-8159-a2511e3f18cb,ENALADEX 10 MG,prescription,C09AA02,ENALAPRIL,4330,,,WHO ATC Classification,,ILS,tablets,ENALAPRIL MALEATE,2025-07-31T02:19:59.479359,IL,כ.צ.ט,,14.614064,12.3848,9.04,,,ENALAPRIL 5MG 30TAB,5173,,27971,BLISTER ALUMINIUM,units,30.0,115 85 29810 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. To retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3ab2ff86-a62a-4c13-8159-a2511e3f18cb.json
3abdf8fe-d287-4790-a699-3cba34177309,TROSPAS 15 MG,prescription,G04BD09,TROSPIUM,8371,,,WHO ATC Classification,,ILS,film coated tablets,TROSPIUM CHLORIDE,2025-07-31T09:46:16.988626,IL,כ.צ.ט,,74.92422627,63.49510701,47.208258,,,TROSPAS 30 MG 30 TAB,20855,,4232,BLISTER PVC/ALUMINIUM,units,30.0,159 75 34856 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3abdf8fe-d287-4790-a699-3cba34177309.json
3b3103f4-f5da-4cf1-a6e0-475ac18b0263,CANESTEN V,off-the-counter,G01AF02,CLOTRIMAZOLE,5540,,,WHO ATC Classification,,ILS,vaginal tablets,CLOTRIMAZOLE,2025-07-31T11:23:11.775918,IL,באייר,,24.1074,20.43,nan,,7290013092489,CANESTEN CREAM 1% 20GR,,,,BLISTER PE/ALUMINIUM,units,20.0,149 92 33642 02,valid,nan,intravaginal,1.4,48,,,,,,,,,,0,,Infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (e.g. Candida albicans) in adults and children 12 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3b3103f4-f5da-4cf1-a6e0-475ac18b0263.json
3b3d926f-1333-49dc-884d-0d195357603d,PREGABALIN DEXCEL 100 MG,prescription,N03AX16,PREGABALIN,8078,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:52:14.374915,IL,דקסל פארמה,,43.82877422,37.143029,27.1117,,,PREGABALIN DEXCEL 25 MG 56 CAPSULES,16990,,58328,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,158 75 34730 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of peripheral and central neuropathic pain in adults.Management of FibromyalgiaTreatment of Generalised Anxiety Disorder (GAD) in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3b3d926f-1333-49dc-884d-0d195357603d.json
3b516019-051c-4669-832e-9455eb56f461,HAKF SINEMET CR 25/100   60TABS,29C,,,20918,,,,,,tablet,HAKF SINEMET CR 25/100 S,2025-07-31T20:33:54.172717,IL,nan,,,,,,,HAKF SINEMET CR 25/100   60TABS,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3b516019-051c-4669-832e-9455eb56f461.json
3b568901-a3ba-471e-97d3-9dc6c240d642,ORFIRIL INJECTION,prescription,N03AG01,VALPROIC ACID,4093,,,WHO ATC Classification,,ILS,solution for injection / infusion,VALPROIC ACID AS SODIUM/ML,2025-07-31T06:16:07.630733,IL,מגאפארם,,202.6713453,171.755385,137.404308,,,ORFIRIL 300MG/3ML INJ 5AMP,15120,,25439,AMPOULES GLASS TYPE I,units,5.0,117 73 29852 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of:•	Generalized seizures in the form of absences, myoclonic and tonic-clonic seizures•	Partial and secondary generalized seizures.Combination treatment of other forms of seizures.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3b568901-a3ba-471e-97d3-9dc6c240d642.json
3b87a98d-016a-4727-9b1c-413fa354ad2c,RINVOQ 15 MG,prescription,L04AA44,UPADACITINIB,9307,,,WHO ATC Classification,,ILS,tablets prolonged release,UPADACITINIB AS HEMIHYDRATE,2025-07-31T07:35:57.351680,IL,אב-וי,,7893.250307,6689.195473,6081.086794,,8054083020266,RINVOQ 45 MG  28 PR TABLETS,,,4178,BLISTER PVC/PE/PCTFE/AL,units,28.0,164 29 36194 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate. Psoriatic arthritis RINVOQ is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. RINVOQ may be used as monotherapy or in combination with methotrexate. Axial spondyloarthritis Non-radiographic axial spondyloarthritis (nr-axSpA) RINVOQ is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs). Ankylosing spondylitis (AS, radiographic axial spondyloarthritis)RINVOQ is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. Atopic dermatitis RINVOQ is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. Ulcerative colitis RINVOQ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. Crohn’s disease RINVOQ is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.Polyarticular juvenile idiopathic arthritisRINVOQ 15mg tablets is indicated for the treatment of patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.Limitations of Use RINVOQ 15 MG is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine.Juvenile psoriatic arthritis RINVOQ 15 MG is indicated for the treatment of pediatric patients 2 years of age and older with active juvenile psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.Limitations of Use RINVOQ 15 MG is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3b87a98d-016a-4727-9b1c-413fa354ad2c.json
3b88cfcb-837c-4151-8383-2d00e6519758,NICOTINELL LOZENGES 1 MG,off-the-counter,,,5414,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:33:14.741236,IL,ג.ס.ק,,293.82,249.0,nan,,,NICOTINELL TTS 30 28 PATCHES,,,,BLISTER PVC/PE/PVDC/AL,units,28.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3b88cfcb-837c-4151-8383-2d00e6519758.json
3b8d5473-06c7-4c60-983d-8bb7e5691cba,QARZIBA,prescription,L01XC16,DINUTUXIMAB,8955,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DINUTUXIMAB BETA 4.5  MG /,2025-07-31T07:08:27.646714,IL,מדיסון,,45761.89657,38781.27,35255.7,,7290015666732,QARZIBA 20MG/4.5ML 1 VIAL,4677,,64848,VIAL GLASS TYPE I,units,1.0,162 50 35299 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Qarziba is indicated for the treatment of high-risk neuroblastoma in patients aged 12 months and above, who have previously received induction chemotherapy and achieved at least a partial response, followed by myeloablative therapy and stem cell transplantation, as well as patients with history of relapsed or refractory neuroblastoma, with or without residual disease. Prior to the treatment of relapsed neuroblastoma, any actively progressing disease should be stabilised by other suitable measures.In patients with a history of relapsed/refractory disease and in patients who have not achieved a complete response after first line therapy, Qarziba should be combined with interleukin-2 (IL-2).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3b8d5473-06c7-4c60-983d-8bb7e5691cba.json
3bb87fde-9323-46ce-aca3-138f91ecf66e,GRAMSE PIRIN 325 MG 100TAB,off-the-counter,,,5451,,,,,ILS,tablet,GRAMSE PIRIN 325 MG,2025-07-31T19:43:35.364698,IL,גרמזה,,49.9022,42.29,,,,GRAMSE PIRIN 325 MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3bb87fde-9323-46ce-aca3-138f91ecf66e.json
3bbf6467-1e5d-4f86-8afc-d2842fd72f02,OCTANATE 1000,prescription,B02BD02,COAGULATION FACTOR VIII,8321,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,FACTOR VIII/VIAL,2025-07-31T06:01:43.211577,IL,דובר מדיקל,,787.7048571,667.5465188,568.1246968,,,OCTANATE 500 VIAL,,,5089,VIAL GLASS TYPE I,units,1.0,138 12 31683 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).This preparation does not contain von Willebrand factor in pharmacologically effective quantities and is therefore not indicated in von Willebrand’s disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3bbf6467-1e5d-4f86-8afc-d2842fd72f02.json
3bd9affa-cf5a-4a17-8352-29020d1234ad,DESCOVY 200 MG/10 MG,prescription,J05AR03,TENOFOVIR DISOPROXIL AND EMTRICITABINE,7980,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR ALAFENAMIDE FUMARATE, EMTRICITABINE",2025-07-31T01:50:00.862196,IL,גיליאד,,2426.294506,2056.181876,1749.942022,,5391507143198,DESCOVY 200MG/25MG 30 TAB,4666,,62098,BOTTLE HDPE,units,30.0,158 05 34949 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (HIV 1)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3bd9affa-cf5a-4a17-8352-29020d1234ad.json
3bf78e6d-f46e-4e8e-9971-47bda9404931,BRINZOTOL S.K,prescription,S01ED51,"TIMOLOL, COMBINATIONS",9438,,,WHO ATC Classification,,ILS,"eye drops, suspension","TIMOLOL AS MALEATE/, BRINZOLAMIDE/",2025-07-31T00:43:57.568662,IL,SK PHARM(KS KIM),,47.81146746,40.51819457,29.5753245,,,BRINZOTOL S.K BOTTLE 5 ML,,,17325,BOTTLE LDPE,units,5.0,172 03 36386 00,valid,37.0,ocular,1.4,30,,,,,,,,,,0,Prescription required,Brinzotol S.K is indicated for decrease of intra-ocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3bf78e6d-f46e-4e8e-9971-47bda9404931.json
3bfc8730-5660-462f-911f-33bf000c5c46,MORPHINE MARTINDALE 10 MG/ML,prescription,N02AA01,MORPHINE,8954,,,WHO ATC Classification,,ILS,solution for injection,MORPHINE SULFATE/,2025-07-31T05:32:14.944564,IL,אמ.בי.איי פארמה,,38.6160873,32.72549916,23.88722567,,,MORPHINE MARTINDALE 20 MG/ML 10 AMP,,,,AMPOULES GLASS TYPE I,units,10.0,163 86 35125 00,valid,37.0,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Symptomatic relief of moderate to severe pain especially that associated with neoplastic disease myocardial infarction and surgery.Pre-operatively as an adjunct to anesthesia for pain relief and to allay anxiety.Alleviation of the anxiety associated with severe pain. It is useful as a hypnotic wheresleeplessness is due to pain., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3bfc8730-5660-462f-911f-33bf000c5c46.json
3c2a1a11-074d-464d-a688-dea3a697e07f,OXYCONTIN 10,prescription,N02AA05,OXYCODONE,3199,,,WHO ATC Classification,,ILS,tablets controlled release,OXYCODONE HYDROCHLORIDE,2025-07-31T06:21:57.102805,IL,רפא,,39.38229693,33.37482939,24.36118933,,7290008014373,OXYCONTIN 20MG 20TAB,15029,,9405,BLISTER PVC/ALUMINIUM,units,20.0,100 71 28431 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the relief of moderate to severe chronic pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c2a1a11-074d-464d-a688-dea3a697e07f.json
3c447446-9664-44f2-aaec-1120a4bb24af,PERCOCET 10,prescription,N02BE01,PARACETAMOL,2085,,,WHO ATC Classification,,ILS,tablets,"OXYCODONE HYDROCHLORIDE, PARACETAMOL",2025-07-31T06:36:39.900315,IL,תרו,,nan,nan,nan,,,PERCOCET 5MG/325MG 10TAB,16116,,2514,BLISTER PVC/ALUMINIUM,units,10.0,139 21 31414 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of moderate to moderately severe pain.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c447446-9664-44f2-aaec-1120a4bb24af.json
3c540834-e244-4199-af96-4c38ce2b7de2,ATROSPAN EYE DROPS,prescription,S01FA01,ATROPINE,1790,,,WHO ATC Classification,,ILS,"eye drops, solution",ATROPINE SULFATE,2025-07-31T00:25:44.372915,IL,פישר,,46.71973792,39.593,28.9,,7290000849508,ATROSPAN DROPS 1% 10CC,1363,,282,BOTTLE POLYETHYLENE,units,10.0,106 40 23520 00,valid,37.0,ocular,1.4,48,,,,,,,,,,0,Prescription required,Mydriatic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c540834-e244-4199-af96-4c38ce2b7de2.json
3c63155d-45c8-4efa-87ab-e6954f5d3b4d,DOTAREM,prescription,V08CA02,GADOTERIC ACID,6989,,,WHO ATC Classification,,ILS,solution for injection,GADOTERIC ACID 279.3 MG/ML  ML,2025-07-31T02:04:00.540809,IL,ניאופרם,,179.2865711,151.9377788,121.5502231,,,DOTAREM 27.93/100ML 1VIAL/20ML,,,,VIAL GLASS TYPE II,units,20.0,107 18 28627 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Enhancement of contrast in magnetic resonance imaging. Encephalic and spinal pathologies: brain tumors, tumors of the spine and the surrounding tissue.  intervertebral disk prolapse infectious diseases.Abdominal pathologies: primary and secondary liver tumors. Osteo-articular pathology: bone and soft tissue tumors, synovial diseases.Magnetic resonance imaging for angiography.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c63155d-45c8-4efa-87ab-e6954f5d3b4d.json
3c690aa0-a2a7-4640-880d-965fec72f087,STOPIT,off-the-counter,A07DA03,LOPERAMIDE,3020,,,WHO ATC Classification,,ILS,capsules,LOPERAMIDE HYDROCHLORIDE,2025-07-31T13:21:40.796038,IL,רפא,,28.9926,24.57,nan,,7290008015509,STOPIT 2MG 10CAPS,19088,,,BLISTER PVC/ALUMINIUM,units,10.0,067 64 28224 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Control and symptomatic relief of acute diarrhea in adults, adolescents and children aged 6 years and older.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c690aa0-a2a7-4640-880d-965fec72f087.json
3c6bf3c9-5641-4364-91b6-2f2e07e6a546,BRENZYS 50 MG/ML,prescription,L04AB01,ETANERCEPT,8700,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ML,2025-07-31T00:42:02.514626,IL,אורגנון,,2418.646751,2049.700727,1863.364298,,8809593171331,BRENZYS 50 MG/ML 4 PREFILLED SYR,,,57397,PRE-FILLED PEN GLASS TYPE I,units,4.0,161 75 35387 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritisBrenzys is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs) including methotrexate (unless contraindicated) has been inadequate. Brenzys can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis. Brenzys, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.Juvenile idiopathic arthritisTreatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents wighing at least 62.5 Kg who have had an inadequate response to, or who have proved intolerant of, methotrexate. Treatment of psoriatic arthritis in adolescents from the age of 12 years  weighing at least 62.5 Kg who have had an inadequate response to, or who have proved intolerant of, methotrexate.Treatment of enthesitis-related arthritis in adolescents from the age of 12 years  weighing at least 62.5 Kg who have had an inadequate response to, or who have proved intolerant of conventional therapy.Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Brenzys has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.Axial spondyloarthritisAnkylosing spondylitis (AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to nonsteroidal anti-inflammatory drugs (NSAIDs).Plaque psoriasisTreatment of adults patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.Paediatric plaque psoriasisTreatment of chronic severe plaque psoriasis in children and adolescents weighing at least 62.5 Kg who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c6bf3c9-5641-4364-91b6-2f2e07e6a546.json
3c7f9128-8698-4f3e-8310-1317d25d2cc5,BLINCYTO,prescription,L01XC19,BLINATUMOMAB,7802,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BLINATUMOMAB/ 1 VIAL,2025-07-30T23:40:47.430933,IL,מדיסון,,12169.50263,10313.13828,9375.580256,,8715131011208,BLINCYTO 35 MCG/1VIAL,2594,,32804,VIAL GLASS TYPE I,units,1.0,156 76 34580 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,•	BLINCYTO is indicated as monotherapy for the treatment of adults with CD19 positive relapsed or refractory B- precursor acute lymphoblastic leukaemia (ALL). Patients with Philadelphia chromosome positive B-precursor ALL should have failed treatment with at least 2 tyrosine kinase inhibitors (TKIs) and have no alternative treatment options.•	BLINCYTO is indicated as monotherapy for the treatment of adults with Philadelphia chromosome negative CD19 positive B-precursor ALL in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%.•	BLINCYTO is indicated as monotherapy for the treatment of pediatric patients aged 1 year or older with Philadelphia chromosome negative CD19 positive B-cell precursor ALL which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic hematopoietic stem cell transplantation.•	BLINCYTO is indicated as monotherapy for the treatment of pediatric patients aged 1 year or older with high-risk first relapsed Philadelphia chromosome negative CD19 positive B precursor ALL as part of the consolidation therapy.Limitations of use: After failure of two previous treatments and with no CNS involvement.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c7f9128-8698-4f3e-8310-1317d25d2cc5.json
3c81da02-9562-4ead-80cf-ea78604633e0,TEZSPIRE,prescription,R03DX11,TEZEPELUMAB,9255,,,WHO ATC Classification,,ILS,solution for injection,TEZEPELUMAB/ML,2025-07-31T09:18:25.935452,IL,אסטראזנקה,,5320.742809,4509.104276,4099.185705,,7107929,TEZSPIRE 110MG 1PEN,23822,,14663,PRE-FILLED PEN GLASS TYPE I,units,1.0,171 59 37290 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Tezspire is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c81da02-9562-4ead-80cf-ea78604633e0.json
3c84d57b-babb-4746-8b10-3102e9db16cb,PHESGO 1200 MG / 600 MG,prescription,L01FY01,PERTUZUMAB AND TRASTUZUMAB,9031,,,WHO ATC Classification,,ILS,solution for injection,"TRASTUZUMAB/ML, PERTUZUMAB/ML",2025-07-31T06:41:40.827195,IL,רוש,,34228.25572,29006.99767,26369.99788,,,PHESGO 1200 MG / 600 MG (VIAL 15 ML),,,88137,VIAL GLASS TYPE I,units,1.0,168 67 36651 00,valid,10.0,s.c,1.4,18,,,,,,,,,,0,Prescription required,"Early Breast Cancer (EBC)Phesgo is indicated for use in combination with chemotherapy for:•The neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer .•The adjuvant treatment of patients with HER2-positive early breast cancer (node positive) at high risk of recurrence.Metastatic Breast Cancer (MBC)Phesgo is indicated for use in combination with docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c84d57b-babb-4746-8b10-3102e9db16cb.json
3c8b61b0-d838-4f30-81e0-9461ad1eec58,EXJADE 125 MG,prescription,V03AC03,DEFERASIROX,4927,,,WHO ATC Classification,,ILS,tablets dispersible,DEFERASIROX,2025-07-31T02:49:59.897223,IL,נוברטיס פארמה,,3477.253269,2946.824804,2678.93164,,7290006257826,EXJADE 500MG 28 DISPERS TAB,5425,,67381,BLISTER PVC/PE/PVDC,units,28.0,133 99 31337 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).Exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC] &#8805;5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).LIC is the preferred method of iron overload determination and should be used wherever available,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c8b61b0-d838-4f30-81e0-9461ad1eec58.json
3c8f3527-a6b9-4f73-b23c-9ba3632fa4b3,TAMBOCOR INJECTION,prescription,C01BC04,FLECAINIDE,7300,,,WHO ATC Classification,,ILS,solution for injection,FLECAINIDE ACETATE/ML,2025-07-31T09:03:09.091505,IL,דקסל פארמה,,223.5588776,189.4566844,151.5653475,,5000485088604,TAMBOCOR INJECTION 10MG/ML 5AMP/15ML,20779,,3642,AMPOULES GLASS TYPE I,units,5.0,106 41 23294 00,valid,25.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,Serious sustained life threatening ventricular arrhthymias that have not respoded to other drugs.,תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c8f3527-a6b9-4f73-b23c-9ba3632fa4b3.json
3c96205e-e29d-41f6-9e32-a016405d9328,ALPRALID 0.25,prescription,N05BA12,ALPRAZOLAM,3287,,,WHO ATC Classification,,ILS,tablets,ALPRAZOLAM 0.25   MG,2025-07-30T23:20:39.903643,IL,כ.צ.ט,,23.77194134,20.145713,14.7049,,,ALPRALID 1MG 30TAB,1145,,9496,BLISTER PVC/ALUMINIUM,units,30.0,137 10 28371 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of symptoms of tension and anxiety, anxiety accompanied by depression and in panic states with or without phobia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3c96205e-e29d-41f6-9e32-a016405d9328.json
3ca6e55d-e491-462a-8b14-321d118c33e5,PAXXET 20,prescription,N06AB05,PAROXETINE,3791,,,WHO ATC Classification,,ILS,tablets,PAROXETINE AS HYDROCHLORIDE,2025-07-31T06:30:55.428617,IL,אוניפארם,,52.76760226,44.718307,32.6411,,,PAXXET 30MG 30TAB,16379,,23536,BLISTER PVC/ALUMINIUM,units,30.0,117 10 29855 02,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. Treatment of symptoms and prevention of relapse of obsessive compulsive disorder (OCD). Treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.Treatment of symptoms of social phobia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3ca6e55d-e491-462a-8b14-321d118c33e5.json
3caa53ed-bbf8-4f3d-b52a-fd975643ffd4,IDEFIRIX 11 MG,prescription,L04AA41,IMLIFIDASE,9440,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,IMLIFIDASE/VIAL,2025-07-31T03:56:58.455876,IL,מדיסון,,751492.5123,636858.0896,578961.8996,,,IDEFIRIX 11 MG/VIAL 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,169 35 37017 00,valid,10.0,i.v,1.4,18,,,,,,,,,,0,Prescription required,Idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. The use of Idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3caa53ed-bbf8-4f3d-b52a-fd975643ffd4.json
3cb2afca-a05f-47cc-b41f-c13c8c8e1bc0,GALZIN 25MG 250CAPS,29C,,,20083,,,,,,capsule,GALZIN 25MG,2025-07-31T20:30:50.923897,IL,nan,,,,,,,GALZIN 25MG 250CAPS,,,,,units,250.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3cb2afca-a05f-47cc-b41f-c13c8c8e1bc0.json
3cb90dc1-049c-4d57-9fa7-5b8aed2e9d88,IMODIUM CAPSULES,off-the-counter,,,5621,,,,,ILS,capsules,LOPERAMIDE HYDROCHLORIDE,2025-07-31T12:10:02.772668,IL,ג'ונסון אנד ג'ונסון,,36.4266,30.87,nan,,,IMODIUM 12 CAPSULES,23269,,,BLISTER PVC/ALUMINIUM,units,12.0,025 10 20676 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,Control and symptomatic relief of acute diarrhea in adults and adolescents aged 12 years and older,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3cb90dc1-049c-4d57-9fa7-5b8aed2e9d88.json
3cc96954-0a3d-4571-9fae-a5b7d975c2f2,LATARO-TIM,prescription,S01ED01,TIMOLOL,8177,,,WHO ATC Classification,,ILS,"eye drops, solution","TIMOLOL AS MALEATE 5.0 MG/ML, LATANOPROST 0.05 MG/ML",2025-07-31T04:37:06.400742,IL,תרו יבוא,,40.2331325,34.095875,24.8875,,,LATARO-TIM  	EYE DROPS   2.5 ML,,,57673,BOTTLE LPDE,units,2.5,156 64 34246 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta- blockers.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3cc96954-0a3d-4571-9fae-a5b7d975c2f2.json
3cf2b841-afe7-46ae-9f53-37007f4c1cb2,VOTRIENT 200 MG,prescription,L01XE11,PAZOPANIB,6705,,,WHO ATC Classification,,ILS,film coated tablets,PAZOPANIB AS HYDROCHLORIDE,2025-07-31T10:21:56.032232,IL,נוברטיס פארמה,,5924.677392,5020.913268,4564.466607,,7290014257719,VOTRIENT 400MG 30TAB,22323,,26142,BOTTLE HDPE,units,30.0,145 09 33192 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Renal cell carcinoma (RCC)Votrient is indicated in adults for the first line treatment of advanced Renal Cell Carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease.Soft tissue sarcoma (STS)Votrient is indicated for the treatment of adult patients with selective subtypes of advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3cf2b841-afe7-46ae-9f53-37007f4c1cb2.json
3d0a2388-c7ef-4ce9-8e2a-4c3d6e859f7b,LUCRIN DEPOT KIT 3.75MG,prescription,,,3483,,,,,ILS,tablet,LUCRIN DEPOT KIT 3.75MG,2025-07-31T19:17:41.301223,IL,אב-וי,,354.2697478,300.2286132,255.5137134,,,LUCRIN DEPOT KIT 3.75MG,12378,,70088,,units,1.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d0a2388-c7ef-4ce9-8e2a-4c3d6e859f7b.json
3d0ed9e8-e71f-4e7a-be1e-aa232448e3dc,OPTALGIN TABLETS,off-the-counter,N02BB02,METAMIZOLE SODIUM,5492,,,WHO ATC Classification,,ILS,tablets,DIPYRONE,2025-07-31T12:41:02.072652,IL,טבע,,55.9792,47.44,nan,,7290000801834,OPTALGIN 500MG 50 CAP,,,,BLISTER PVC/ALUMINIUM,units,50.0,016 87 20611 12,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d0ed9e8-e71f-4e7a-be1e-aa232448e3dc.json
3d2ec1a8-0ed2-4396-a3a0-14c81ded1278,APO-NITROFURANTOIN 100MG 100TAB,29C,,,20039,,,,,,tablet,APO-NITROFURANTOIN 100MG,2025-07-31T19:55:49.624988,IL,nan,,,,,,,APO-NITROFURANTOIN 100MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d2ec1a8-0ed2-4396-a3a0-14c81ded1278.json
3d359ee5-2c23-4ac1-b5f3-fc07e406cfb3,RUXIENCE,prescription,L01XC02,RITUXIMAB,9094,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T07:54:20.451704,IL,פיזר,,3920.040699,3322.068537,3020.062306,,7290013592811,RUXIENCE 500 MG/50 ML 1 VIAL,,,87036,VIAL GLASS TYPE I,units,1.0,167 66 36478 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Ruxience is indicated for:Non-Hodgkin’s lymphoma (NHL):Ruxience is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma.Ruxience is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapyRuxience is indicated for the treatment of patients with CD20 positive diffuse large B-cell nonHodgkin's lymphoma in combination with CHOP chemotherapy.Ruxience maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.Chronic lymphocytic leukaemia (CLL):Ruxience in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. Rheumatoid arthritis:Ruxience is indicated, in combination with methotrexate, to reduce signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more TNF antagonist therapies.Granulomatosis with polyangiitis and microscopic polyangiitis:Ruxience, in combination with glucocorticoids, is indicated for the treatment of adult patients with granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis (WG)) and microscopic polyangiitis (MPA).Pemphigus vulgaris:Ruxience is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d359ee5-2c23-4ac1-b5f3-fc07e406cfb3.json
3d402805-7f5a-438e-ac6b-e700b20c879a,ALPHA D3 0.25 MCG,prescription,A11CC03,ALFACALCIDOL,6477,,,WHO ATC Classification,,ILS,capsules soft gelatin,ALFACALCIDOL 0.25  MCG,2025-07-31T00:17:02.030865,IL,תרומד,,22.4400236,19.01697,13.881,,,ALPHA D3 0.25MCG 30CAP,9344,,84635,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,125 64 30474 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,-  Renal bone disease (renal osteodystrophy). -  Hypoparathyroidism. -  Hyperparathyroidism (with bone disease) - primary and tertiary. -  Rickets and osteomalacia.  -  Osteoporosis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d402805-7f5a-438e-ac6b-e700b20c879a.json
3d55a165-ffe9-49eb-bb76-7d60a9509271,EXIPAN,off-the-counter,M02AA07,PIROXICAM,3151,,,WHO ATC Classification,,ILS,gel,PIROXICAM 0.5 %W/W,2025-07-31T11:52:05.761244,IL,פאדאגיס,,76.2516,64.62,nan,,7290002925965,EXIPAN GEL ROLL ON  90GR,5077,,,ROLL-ON HDPE,units,90.0,065 11 27132 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,For local treatment of inflammatory conditions accompanied by pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d55a165-ffe9-49eb-bb76-7d60a9509271.json
3d6961b1-d519-4c34-b6a7-07c458133f8f,DIAMILLA,prescription,G03AC09,DESOGESTREL,7915,,,WHO ATC Classification,,ILS,film coated tablets,DESOGESTREL 0.075  MG,2025-07-31T01:54:15.436487,IL,טבע,,64.44657615,54.6157425,40.6065,,,DIAMILLA 0.075 MG 84 TAB,4664,,61642,BLISTER PVC/PVDC/ALUMINIUM,units,84.0,155 98 34400 00,valid,34.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Oral contraception .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d6961b1-d519-4c34-b6a7-07c458133f8f.json
3d875024-6ef1-4ad8-8e0a-c22d15059488,HUMALOG,prescription,A10AB04,INSULIN LISPRO,6630,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO 100 U/ML,2025-07-31T03:48:04.772432,IL,אלי לילי,,184.235775,156.1320197,124.9056158,,7290008067676,HUMALOG KWIKPEN 100U/ML 5X3ML,9389,,18784,CARTRIDGE GLASS TYPE I,units,15.0,102 83 28580 00,valid,25.0,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilization of diabetes mellitus.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d875024-6ef1-4ad8-8e0a-c22d15059488.json
3d88d70a-28b5-4086-b8da-a84614fc3443,ACTILYSE 20 MG,prescription,,,7364,,,,,ILS,powder and solvent for solution for injection/infusion,ALTEPLASE/VIAL,2025-07-30T23:12:45.517333,IL,בורינגר אינגלהיים,,1040.898319,882.1172589,750.7380927,,,ACTILYSE 20 MG 1VIAL/20ML,9710,,47792,VIAL GLASS TYPE I,units,1.0,136 78 31438 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Acute myocardial infarction :Actilyse is indicated for use in the management of acute myocardial infraction (AMI) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infract size, improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with AMI. Treatment should be initiated as soon as possible after the onset of AMI symptoms.Acute massive pulmonary embolism with hemodynamic deprivation:Actylise is indicated in the management of acute massive pulmonary embolism (PE) in adults:- for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and- for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. The diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. For fibrinolytic treatment of acute ischaemic stroke.Treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging techniques (e.g. cranial computerised tomography or other diagnostic imaging method sensitive for the presence of haemorrhage). The treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome. This treatment is restricted to a prescription by a specialist in neurology.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d88d70a-28b5-4086-b8da-a84614fc3443.json
3d8c5306-6f29-4192-9fa4-8bcf98837c50,MOXYVIT FORTE 250 SUSPENSION,prescription,J01CA04,AMOXICILLIN,6971,,,WHO ATC Classification,,ILS,powder for oral suspension,AMOXICILLIN AS TRIHYDRATE/ML,2025-07-31T05:34:54.190865,IL,ויטאמד,,29.55322626,25.045107,18.2811,,,MOXYVIT FORTE 20 CAPS,13031,,9630,BOTTLE HDPE,units,20.0,045 22 26064 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,•	For the treatment of infections caused by bacteria susceptible to amoxicillin.•	Intended for the prevention of bacterial infections in patients who are at risk for developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3d8c5306-6f29-4192-9fa4-8bcf98837c50.json
3db92af1-9259-493a-92ae-4e18c115a32a,ISOKET RETARD 60MG 50TAB,29C,,,20777,,,,,,tablet,ISOKET RETARD 60MG,2025-07-31T20:39:54.394456,IL,nan,,,,,,,ISOKET RETARD 60MG 50TAB,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3db92af1-9259-493a-92ae-4e18c115a32a.json
3dcda37f-b4b9-4d06-8777-8a1557d07eb0,PARAMOL,off-the-counter,N02BE01,PARACETAMOL,5440,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T12:46:21.638257,IL,ליף-פריגו,,49.0762,41.59,nan,,,PARAMOL TARGET 50 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,50.0,127 96 30764 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3dcda37f-b4b9-4d06-8777-8a1557d07eb0.json
3dcf6119-95a3-4336-aa14-f0274952768e,CHLORPROMAZINE 100MG CHELONIA UK TABLETS,29C,,,20822,,,,,,tablet,CHLORPROMAZINE 100MG CHELONIA UK TABLETS,2025-07-31T20:05:44.032997,IL,nan,,,,,,,CHLORPROMAZINE 100MG CHELONIA UK TABLETS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3dcf6119-95a3-4336-aa14-f0274952768e.json
3df47691-04eb-489e-ac6e-2a0cd9405ca9,AGISTEN ALOEVERA CREAM,off-the-counter,D01AC01,CLOTRIMAZOLE,2373,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T11:08:08.299302,IL,פאדאגיס,,23.8006,20.17,nan,,7290004850432,AGISTEN SOL 1% 20ML,1160,,,TUBE ALUMINIUM,units,20.0,043 17 22461 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as Malassezia furfur, as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3df47691-04eb-489e-ac6e-2a0cd9405ca9.json
3df600e2-e371-4232-a1a9-67fb9f9d097b,DOCETAXEL HOSPIRA 10 MG/ML,prescription,L01CD02,DOCETAXEL,7051,,,WHO ATC Classification,,ILS,solution for infusion,DOCETAXEL/,2025-07-31T02:00:36.825835,IL,פיזר,,2349.430351,1991.04267,1694.5044,,7290013592651,DOCETAXEL HOSPIRA 10MG/ML VIAL 160MG/16ML,4596,,41883,VIAL GLASS TYPE I,units,1.0,148 24 33345 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Breast cancer:  Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer.  Docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.  Docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. Previous chemotherapy should have included an anthracycline or an alkylating agent.  Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2 and who previously have not received chemotherapy for metastatic disease. Docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Doxorubicin and cyclophosphamide followed by Docetaxel in combination with trastuzumab (AC-TH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high risk node-negative, breast cancer. Docetaxel in combination with trastuzumab, and carboplatin (TCH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high risk node-negative, breast cancer. Non-small cell lung cancer:   Docetaxel is indicated for the treatment of patients with advanced non-small cell lung carcinoma. Ovarian Cancer:   Docetaxel is indicated for treatment of metastatic carcinoma of the ovary after failure of first line or subsequent chemotherapy. Prostate cancer:   Docetaxel in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.Esophageal cancer:   Docetaxel for the treatment of esophageal cancer. Gastric cancer:   Docetaxel for the treatment of advanced gastric cancer. Head and neck (SCCHN):   Docetaxel as monotherapy in the treatment of patients with recurrent and/or metastasis squamos cell carcinoma of the head and neck after failure of a previous chemotherapy regimen.   Docetaxel in combination with cisplatin and 5 fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3df600e2-e371-4232-a1a9-67fb9f9d097b.json
3e17cb99-2bb0-4000-aab6-6fcda49a7000,EXELON PATCH 10,prescription,N06DA03,RIVASTIGMINE,4564,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 9.5 MG/DAY,2025-07-31T02:48:01.705473,IL,נוברטיס פארמה,,118.2583126,100.218909,74.5122,,,EXELON 4.5MG 28CAPS,5201,,30604,POUCH PAPER/PET/PE/AL/POLYAMIDE,units,28.0,139 70 31675 01,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e17cb99-2bb0-4000-aab6-6fcda49a7000.json
3e217442-af45-46f1-824f-a2315f920cc0,ZYLLERGY,off-the-counter,R06AE07,CETIRIZINE,3922,,,WHO ATC Classification,,ILS,caplets,CETIRIZINE DIHYDROCHLORIDE,2025-07-31T13:41:00.244439,IL,דקסל פארמה,,44.2972,37.54,nan,,7290010577170,ZYLLERGY10MG 20TAB,26104,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,116 43 29833 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antihistaminic drug for the treatment of allergies. For the treatment of seasonal and perennial allergic rhinitis and of chronic idiopatic urticaria in children aged 6 years and over and adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e217442-af45-46f1-824f-a2315f920cc0.json
3e336d3a-2933-4805-bb9b-398a39f68a54,ELIGARD 22.5 MG,prescription,,,7883,,,,,ILS,powder and solvent for solution for injection,LEUPRORELIN ACETATE 22.5  MG,2025-07-31T02:15:01.849255,IL,קמהדע,,2337.309859,1980.771155,1685.762685,,8718692510845,ELIGARD 45 MG 1 PREFILLED SYR,5608,,51303,SYRINGE PREFILLED  CYCLIC OLEFIN COPOLYMER,units,1.0,156 79 33678 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,ELIGARD is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e336d3a-2933-4805-bb9b-398a39f68a54.json
3e3d593f-76ac-4fe3-8ff4-c95e6050c116,MEDOSIL,prescription,D01AE15,TERBINAFINE,9574,,,WHO ATC Classification,,ILS,tablets,TERBINAFINE AS HYDROCHLORIDE,2025-07-31T05:08:01.349686,IL,מדומי פארמה,,53.56118882,45.39084,33.132,,,MEDOSIL 250 MG 14 TABS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,14.0,177 23 37306 99,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidermophyton floccosum. Oral Terbinafine should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). Oral Terbinafine is not effective against vaginal candidiasis or pityriasis (tinea) versicolor.Onychomycoses ( tinea unguium, ringworm of the nails) due to infection with dermatophyte organisms ( hyphomycetes).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e3d593f-76ac-4fe3-8ff4-c95e6050c116.json
3e42e5fb-fe68-48d1-88c4-03aee950308f,MAXITROL OPHTHALMIC SUSPENSION,prescription,S01AA18,POLYMYXIN B,3246,,,WHO ATC Classification,,ILS,"eye drops, suspension","DEXAMETHASONE 1.0  MG/ML, NEOMYCIN AS SULFATE 3,500  IU/ML, POLYMYXIN B SULFATE/ML",2025-07-31T05:06:47.535065,IL,נוברטיס פארמה,,25.82418964,21.88490745,15.974385,,7290008067195,MAXITROL OINT 3.5GR,13095,,9407,DROPER BOTTLE POLYETHYLENE,units,3.5,116 23 22787 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Maxitrol is indicated in ocular inflammation when concurrent use of antimicrobial in judged necessary.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e42e5fb-fe68-48d1-88c4-03aee950308f.json
3e54253f-a2a9-4863-85d5-ad86160651aa,QUETIAPINE INOVAMED SR 300 MG,prescription,N05AH04,QUETIAPINE,8827,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:10:21.268814,IL,אינובמד,,46.978396,39.8122,29.06,,7290104530685,QUETIAPINE INOVAMED SR 50 MG 30 TAB,17325,,69622,BLISTER PVC/PCTFE/AL,units,30.0,165 71 35461 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Inovamed SR is indicated for the treatment of Schizophrenia. Quetiapine Inovamed SR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Inovamed SR. Quetiapine Inovamed SR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. Quetiapine Inovamed SR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Inovamed SR.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e54253f-a2a9-4863-85d5-ad86160651aa.json
3e8f006e-eef1-455e-9532-b984644ebe4e,ZOVIRAX,prescription,D06BB03,ACICLOVIR,3047,,,WHO ATC Classification,,ILS,cream,ACICLOVIRW/W,2025-07-31T10:55:02.797895,IL,ג.ס.ק,,143.6940934,121.7746609,97.4197287,,7290008086950,ZOVIRAX 800MG 35 DISPERS TAB,26028,,9112,PACK PUMP POLYPROPYLENE,units,35.0,126 38 30532 00,valid,25.0,topical,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of cold sores (herpes labialis).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e8f006e-eef1-455e-9532-b984644ebe4e.json
3e9154a1-a9c8-4202-929d-0dee0e008c8c,YAZ,prescription,G03AA12,DROSPIRENONE AND ESTROGEN,7732,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ETHINYLESTRADIOL 0.02   MG",2025-07-31T10:40:28.801629,IL,באייר,,nan,nan,nan,,,YAZ PLUS 1X28TAB,25017,,83043,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,141 04 32023 01,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,- Oral contraception.   - Treatment of moderate acne vulgaris in women who seek oral contraception.   - Treatment of symptoms of premenstrual dysphoric disorder (PMDD ) in women who have chosen oral contraceptives as their method of birth control. The efficacy of Yaz for PMDD was not assessed beyond 3 cycles. Yaz has not been evaluated for treatment of PMS ( premenstrual syndrome ).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e9154a1-a9c8-4202-929d-0dee0e008c8c.json
3e9207a8-558d-4347-a3af-3ad140029aeb,FAMCICLOVIR 125MG 30TAB,29C,,,20407,,,,,,tablet,FAMCICLOVIR 125MG,2025-07-31T20:25:15.100629,IL,nan,,,,,,,FAMCICLOVIR 125MG 30TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e9207a8-558d-4347-a3af-3ad140029aeb.json
3e95579d-0a3f-4fda-aa21-de6368965f6b,NUWIQ 500 IU,prescription,B02BD02,COAGULATION FACTOR VIII,9074,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,SIMOCTOCOG ALFA/VIAL,2025-07-31T05:59:09.027876,IL,דובר מדיקל,,787.7048571,667.5465188,568.1246968,,,NUWIQ 500 IU,,,75584,VIAL GLASS TYPE I,units,1.0,168 21 36550 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients 2 years of age and older with haemophilia A (congenital factor VIII deficiency). Nuwiq does not contain von Willebrand Factor and is thus not indicated to treat von Willebrand’s Disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e95579d-0a3f-4fda-aa21-de6368965f6b.json
3e9df974-7dd9-4272-bfe4-716ff55a01c9,CARVEDEXXON 6.25,prescription,C07AG02,CARVEDILOL,4602,,,WHO ATC Classification,,ILS,tablets,CARVEDILOL 6.25  MG,2025-07-31T00:56:17.879952,IL,דקסל פארמה,,16.8191064,14.25348,10.404,,,CARVEDEXXON 6.25MG 30TAB,3729,,53250,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,127 19 30614 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of symptomatic congestive heart failure. Carvedexxon may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ACE inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3e9df974-7dd9-4272-bfe4-716ff55a01c9.json
3ea0d2d2-dae9-4928-9b26-142c41cd9ebf,ENTRESTO 100 MG,prescription,C09DX04,VALSARTAN AND SACUBITRIL,7792,,,WHO ATC Classification,,ILS,film coated tablets,SACUBITRIL/VALSARTAN AS SODIUM SALT COMPLEX 49/51  MG,2025-07-31T02:24:24.990522,IL,נוברטיס פארמה,,573.9639449,486.4101228,413.966062,,290014257498,ENTRESTO 200 MG 56F.C.TAB,5599,,32621,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,154 98 34485 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Entresto is indicated for the treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction. Entresto has been shown to reduce the rate of cardiovascular death and heart failure hospitalisation compared to angiotensin converting enzyme (ACE) inhibitor therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3ea0d2d2-dae9-4928-9b26-142c41cd9ebf.json
3ea2082a-52c3-451a-921e-73b4c89da6a6,MYFORTIC 180 MG,prescription,L04AA06,MYCOPHENOLIC ACID,4698,,,WHO ATC Classification,,ILS,gastro resistant tablets,MYCOPHENOLIC ACID,2025-07-31T05:37:54.302593,IL,נוברטיס פארמה,,423.581428,358.9673118,305.5040952,,7290100419984,MYFORTIC 180MG 120TAB,13507,,59275,BLISTER PA/ALUMINIUM/PVC,units,120.0,128 30 30715 01,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Myfortic is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3ea2082a-52c3-451a-921e-73b4c89da6a6.json
3ea9bc5a-470b-4daf-83ec-9b6d341b5d21,PROGRAF 0.5 MG,prescription,L04AA05,TACROLIMUS,6134,,,WHO ATC Classification,,ILS,capsules,TACROLIMUS 0.5   MG,2025-07-31T06:59:49.159670,IL,אסטלס,,1752.945433,1485.546978,1264.2953,,8718692511460,PROGRAF 5 MG 50CAPSULES,16774,,29079,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,122 07 30215 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in liver  kidney or heart allograft recipients.   Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3ea9bc5a-470b-4daf-83ec-9b6d341b5d21.json
3ede9ff7-5430-466a-bef8-605c3b409dc4,SMOFLIPID 200 MG/ML,prescription,B05BA10,COMBINATIONS,6976,,,WHO ATC Classification,,ILS,emulsion for infusion,"TRIGLYCERIDES, MEDIUM-CHAIN/L, SOYA OIL/L, REFINED OLIVE OIL/L, PURIFIED FISH OIL/L",2025-07-31T08:24:10.226286,IL,ניאופרם,,658.5147996,558.0634143,474.9475867,,,SMOFLIPID 200 MG/ML (10 bottles 100ML),,,,BOTTLE GLASS TYPE II,units,1000.0,137 75 31387 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Supply of energy and essential fatty acids and omega-3 fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3ede9ff7-5430-466a-bef8-605c3b409dc4.json
3f08d74d-c0a7-4c9c-a4e0-614edc97d6f1,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,6022,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T02:58:04.945259,IL,רפא,,144.8637325,122.765875,98.2127,,,FENTA 50 5 PATCH,6398,,71214,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,5.0,148 73 33262 01,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f08d74d-c0a7-4c9c-a4e0-614edc97d6f1.json
3f0927ef-a815-40e2-8038-e925d4c4f985,ISTODAX,prescription,L01XX39,ROMIDEPSIN,7089,,,WHO ATC Classification,,ILS,powder and diluent for solution for injection,ROMIDEPSIN/VIAL,2025-07-31T04:13:57.594899,IL,ניאופרם,,nan,nan,nan,,359572984011,ISTODAX 10MG/ML KIT(VIAL POWDER+VIAL DILUENT),,,,KIT GLASS TYPE I,units,1.0,150 75 33742 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,Prescription required,Cutaneous T-Cell LymphomaISTODAX is indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy.Peripheral T-Cell LymphomaISTODAX is indicated for the treatment of peripheral T-cell lymphoma (PTCL) in adult patients who have received at least one prior therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f0927ef-a815-40e2-8038-e925d4c4f985.json
3f11361a-b549-4c29-9cf7-a03bd78d6916,MILHARDT,29C,C01CE02,MILRINONE,20534,,,WHO ATC Classification,,ILS,solution for injection / infusion,MILRINONE/,2025-07-31T15:14:17.838451,IL,nan,,nan,nan,nan,,5012727913728,MILRINONE 1MG/ML 10AMPX10ML,,,,AMPOULES GLASS TYPE I,units,10.0,165 39 35427 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,,"For the treatment of refractory heart failure immediately (up to 72 hours) following cardiac surgery. For the short term ( up to 48 hours) intravenous therapy of severe refractory congestive heart failure.In pediatric population Milhardt is indicated for the short-term treatment (up to 35 hours) of severe congestive heart failure unresponsive to conventional maintenance therapy (glycosides, diuretics, vasodilators and/or angiotensin converting enzyme (ACE) inhibitors), and for the short-term treatment (up to 35 hours) of pediatric patients with acute heart failure, including low output states following cardiac surgery",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f11361a-b549-4c29-9cf7-a03bd78d6916.json
3f190f7c-44c7-4fb3-90e2-238f40882075,DASATINIB TEVA 100 MG,prescription,L01XE06,DASATINIB,9176,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB AS MONOHYDRATE,2025-07-31T01:43:20.620108,IL,טבע,,6399.316607,5423.149667,4930.136061,,,DASATINIB TEVA 50 MG 60 TAB,,,37189,BLISTER OPA/ALU/PVC/ALU,units,60.0,169 90 36435 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with : * Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase. * Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate. * Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f190f7c-44c7-4fb3-90e2-238f40882075.json
3f215979-3bc9-40be-b79c-549220f00daf,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,5274,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:23:04.044587,IL,רקיט בנקיזר,,41.5832,35.24,nan,,7290000852973,STREPSILS HONEY AND LEMON 36 LOZ,19746,,,BLISTER PVC/PVDC/ALUMINIUM,units,36.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f215979-3bc9-40be-b79c-549220f00daf.json
3f2db15f-5500-4410-ab5c-8624a1286834,KOVALTRY 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,9305,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,RECOMBINANT HUMAN COAGULATION FACTOR VIII,2025-07-31T04:30:00.794085,IL,באייר,,5803.33784,4918.083134,4470.984667,,,KOVALTRY 2000 IU VIAL 10 ML,,,89155,VIAL 10 ML GLASS TYPE I,units,1.0,158 45 34964 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Kovaltry can be used for all age groups.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f2db15f-5500-4410-ab5c-8624a1286834.json
3f33327f-89a9-4fc3-b5d4-873201c1eaeb,AETHOXYSKLEROL 2% 5AMPX2ML,29C,,,20030,,,,,,injection,AETHOXYSKLEROL 2% X,2025-07-31T19:50:44.328230,IL,nan,,,,,,,AETHOXYSKLEROL 2% 5AMPX2ML,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f33327f-89a9-4fc3-b5d4-873201c1eaeb.json
3f3bb264-0e2b-4a8e-8d0b-2462335bec21,NUROFEN GEL 5 %,off-the-counter,M02AA13,IBUPROFEN,5087,,,WHO ATC Classification,,ILS,gel,IBUPROFENW/W,2025-07-31T12:35:29.834780,IL,רקיט בנקיזר,,38.763,32.85,nan,,5000158100800,NUROFEN COLD&FLU 24 TAB,14393,,,TUBE ALUMINIUM,units,24.0,134 23 31074 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f3bb264-0e2b-4a8e-8d0b-2462335bec21.json
3f5cfa62-bff2-4125-b069-3d71e2769c95,IPADINE 2% FORTE,off-the-counter,D08AC02,CHLORHEXIDINE,5606,,,WHO ATC Classification,,ILS,solution,"ISOPROPANOLV/V, CHLORHEXIDINE DIGLUCONATEW/V",2025-07-31T12:13:25.427137,IL,פלוריש,,51.2592,43.44,nan,,7290017399379,IPADINE 2% FORTE 500 ML,,,,BOTTLE HDPE,units,500.0,167 19 36501 99,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Ipadine 2% forte is indicated for use in subjects aged 2 months and above for disinfection of the skin prior to invasive medical procedures to help reduce bacteria that can potentially cause skin infection.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f5cfa62-bff2-4125-b069-3d71e2769c95.json
3f7dc390-0ebc-4a4b-bd3b-ba975095dbcc,FASENRA,prescription,R03DX10,BENRALIZUMAB,8969,,,WHO ATC Classification,,ILS,solution for injection,BENRALIZUMAB/ML,2025-07-31T02:54:48.871298,IL,אסטראזנקה,,10505.71671,8903.150151,8093.772864,,7290013075796,FASENRA 30MG/ML PREFILLED PEN,6627,,57235,PREFILLED PEN GLASS TYPE I,units,1.0,160 82 35371 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,AsthmaFasenra is indicated as an add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists.Eosinophilic Granulomatosis with PolyangiitisFasenra is indicated as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f7dc390-0ebc-4a4b-bd3b-ba975095dbcc.json
3f8d4547-ccc8-43db-9b29-16f223be5c84,PROGYLUTON,prescription,G03FB01,NORGESTREL AND ESTROGEN,121,,,WHO ATC Classification,,ILS,tablets,"ESTRADIOL VALERATE, NORGESTREL 0.5   MG, ESTRADIOL VALERATE",2025-07-31T07:00:10.875100,IL,באייר,,13.47187666,11.41684513,8.3334636,,7298074040333,PROGYLUTON 21TAB(11+10),16252,,1796,BLISTER PVC/ALUMINIUM,units,21.0,032 90 22502 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Two phase preparation for climacteric and cycle disturbances.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3f8d4547-ccc8-43db-9b29-16f223be5c84.json
3fa5ee0b-16ac-473f-99cf-b021d8f1d3ae,VAXIGRIP,prescription,J07BB02,"INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN ",1173,,,WHO ATC Classification,,ILS,suspension for injection,"B/AUSTRIA/1359417/2021-LIKE STRAIN (B/MICHIGAN/01/2021, WILD TYPE)HA, A/CROATIA/10136RV/2023 (H3N2)-LIKE STRAIN (A/CROATIA/10136RV/2023, X-425A)HA, A/VICTORIA/4897/2022 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/4897/2022, IVR-238)HA",2025-07-31T10:01:07.399136,IL,סאנופי אוונטיס,,69.68264608,59.05309253,43.905645,,,VAXIGRIP VIAL 0.5ML,22036,,67069,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,179 71 38363 00,valid,34.5,"i.m, s.c",1.4,12,,,,,,,,,,0,Prescription required,"Prevention of influenza disease caused by the two influenza A virus subtypes and the influenza B virus type contained in the vaccine for:- active immunisation of adults, including pregnant women, and children from 6 months of age and older, - passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women The use of Vaxigrip should be based on official recommendations on vaccination against influenza",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fa5ee0b-16ac-473f-99cf-b021d8f1d3ae.json
3fa8cea5-85f0-4d7e-9fbd-4973a75b2fed,UPSTAZA,prescription,,,9257,,,,,ILS,solution for infusion,ELADOCAGENE EXUPARVOVEC 5.6x10^11 VG /,2025-07-31T09:52:06.558856,IL,מדיסון,,17888592.14,15159824.52,13781658.65,,,UPSTAZA 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,175 66 37437 00,valid,10.0,intraputaminal,1.4,45,,,,,,,,,,0,Prescription required,"Upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic L-amino acid decarboxylase (AADC) deficiency with a severe phenotype.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fa8cea5-85f0-4d7e-9fbd-4973a75b2fed.json
3fa9628c-1b21-4d8d-a1ec-7d76b56f580f,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8036,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:52:29.092308,IL,יאנסן סילג,,13039.06554,11050.05603,10045.50548,,7640111932642,UPTRAVI ® 1200 MCG 60 TAB,21130,,22780,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fa9628c-1b21-4d8d-a1ec-7d76b56f580f.json
3fab0a1b-9215-428c-9e13-d678a5b9d5c1,DALACIN 2 % VAGINAL CREAM,29C,G01AA10,CLINDAMYCIN,20058,,,WHO ATC Classification,,ILS,cream,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T14:13:22.526713,IL,nan,,nan,nan,nan,,7298074000054,DALACIN C PALMITATE 75MG/5ML 80ML,,,,TUBE PLASTIC,units,80.0,064 17 27818 00,valid,nan,vaginal,1.4,24,,,,,,,,,,0,,Treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fab0a1b-9215-428c-9e13-d678a5b9d5c1.json
3fdccd43-1d5f-4cc0-94c4-0a911ac11917,FLOLAN INFUSION OF EPOPROSTENOL 1500 MCG,prescription,B01AC09,EPOPROSTENOL,8255,,,WHO ATC Classification,,ILS,powder for solution for infusion,EPOPROSTENOL AS SODIUM 1.5 MG/VIAL,2025-07-31T03:09:27.342580,IL,ג.ס.ק,,226.0765479,191.5903033,153.2722427,,7290014547483,FLOLAN INFUSION OF EPOPROSTENOL 500 MCG VIAL DIL PH12,6607,,20048,VIAL GLASS TYPE I,units,1.0,112 41 29467 05,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Flolan is indicated for the treatment of pulmonary arterial hypertension (PAH) (idiopathic or heritable PAH and PAH associated with connective tissue diseases) in patients with WHO Functional Class III-IV symptoms to improve exercise capacity,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fdccd43-1d5f-4cc0-94c4-0a911ac11917.json
3fe00a21-6162-4a4b-8b59-6b4b0d2e370a,CARDIOLITE,prescription,C01CA30,COMBINATIONS,6580,,,WHO ATC Classification,,ILS,lyophilized powder for injection,TETRAKIS COPPER - TETRAFLUOROBORATE/VIAL,2025-07-31T00:55:02.806165,IL,שורק נוקלאר,,3038.884683,2575.326117,2341.205561,,,CARDIOLITE 1MG/VIAL 5VIAL,,,,VIAL GLASS TYPE I,units,5.0,117 11 27948 11,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Myocardial imaging. Prognostication.  Pharmacologic stress. Breast imaging.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fe00a21-6162-4a4b-8b59-6b4b0d2e370a.json
3fe318ca-363f-4be2-b565-868da5c5c209,DAKTARIN ORAL GEL,off-the-counter,A01AB09,MICONAZOLE,5301,,,WHO ATC Classification,,ILS,gel,MICONAZOLEW/W,2025-07-31T11:28:52.069193,IL,ג'ונסון אנד ג'ונסון,,27.5,23.31,nan,,7290008124386,DAKTARIN CREAM 15GR,,,,TUBE ALUMINIUM,units,15.0,038 08 20857 00,valid,nan,local oral,1.4,36,,,,,,,,,,0,,"Oral mycosis (thrush) and fungal infections of the upper gastrointestinal tract. Daktarin oral gel can be used for the prevention of oral thrush in patient receiving long-term treatment with antibiotics, steroids, cytotoxic and radiation therapy.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fe318ca-363f-4be2-b565-868da5c5c209.json
3fe447f7-71c3-4f87-b68b-80661d9672ec,TACHOSIL,prescription,B02BB01,HUMAN FIBRINOGEN,6689,,,WHO ATC Classification,,ILS,sealant matrix,"THROMBIN/CM^2, HUMAN FIBRINOGEN 5.5 MG/CM^2",2025-07-31T08:57:24.952478,IL,כ.צ.ט,,1451.142725,1229.782025,1046.623,,5728300100927,TACHOSIL 2IU/5.5MG SPONGE (9.5x4.8CM),20706,,3291,BLISTER HDPE,units,1.0,139 51 31704 00,valid,17.5,"topical in surgery, epilesional, epilesional",1.4,36,,,,,,,,,,0,Prescription required,"Tachosil is indicated for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for sutute support in vascular surgery where standard techniques are insufficient.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fe447f7-71c3-4f87-b68b-80661d9672ec.json
3fe7c798-9834-45ec-b9eb-e9a13e994871,TAMIFLU 30 MG,prescription,J05AH02,OSELTAMIVIR,6194,,,WHO ATC Classification,,ILS,capsules,OSELTAMIVIR AS PHOSPHATE,2025-07-31T09:03:31.462824,IL,רוש,,96.16967957,81.49973207,60.59459633,,7290008140911,TAMIFLU 45MG 10 CAPSULES,20634,,88116,BLISTER PVC/PE/PVDC,units,10.0,138 02 31733 00,valid,34.5,per os,1.4,120,,,,,,,,,,0,Prescription required,Treatment of influenza : Treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days.  Prophylaxis of influenza : Post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community.   The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains  and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3fe7c798-9834-45ec-b9eb-e9a13e994871.json
3ff2037a-3262-480b-955f-555bbab1e0a2,SERENADA 50,prescription,N06AB06,SERTRALINE,6043,,,WHO ATC Classification,,ILS,coated tablets,SERTRALINE AS HYDROCHLORIDE,2025-07-31T08:05:05.461986,IL,אוניפארם,,25.24789714,21.396523,15.6179,,,SERENADA 50 28TAB,19810,,74581,BLISTER PVC/ALUMINIUM,units,28.0,136 98 31205 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of symptoms of depression in patients with or without a history of mania. Following satisfactory respose, continuation with sertaline therapy is effective in preventon relapse of the initial episode of depression or recurrence of further depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/3ff2037a-3262-480b-955f-555bbab1e0a2.json
40012eaa-f24b-41ef-9a3f-8d69262d0cfa,EMFOVIR S.K. 200/245 MG,prescription,J05AR03,TENOFOVIR DISOPROXIL AND EMTRICITABINE,9439,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR DISOPROXIL AS FUMARATE, EMTRICITABINE",2025-07-31T02:18:07.525298,IL,SK PHARM(KS KIM),,2203.263857,1867.17276,1589.0832,,,EMFOVIR S.K. 200/245 MG 30 TAB,,,17327,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,172 62 36385 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Emfovir S.K. 200/245 mg is indicated in combination with other anti-retroviral medicinal products for the treatment of HIV-1 infected adults over 18 years of age. Emfovir S.K. 200/245 mg is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection in adults at high risk,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40012eaa-f24b-41ef-9a3f-8d69262d0cfa.json
407d25cc-f12e-45de-b580-736760b8f7eb,REZUROCK,29C,L04AA48,BELUMOSUDIL,21021,,,WHO ATC Classification,,ILS,film coated tablets,BELUMOSUDIL AS MESYLATE,2025-07-31T15:46:29.680658,IL,nan,,nan,nan,nan,,,REZUROCK 200 MG 30 TAB,,,,BOTTLE HDPE,units,30.0,174 01 37521 99,valid,nan,per os,1.4,24,,,,,,,,,,0,,Rezurock is indicated for the treatment of patients aged 12 years and older with chronic graft-versus host disease (chronic GVHD) who have received at least two prior lines of systemic therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/407d25cc-f12e-45de-b580-736760b8f7eb.json
408fd1aa-08b5-452f-a493-ff8e48642345,ASPIRIN CARDIO,off-the-counter,B01AC06,ACETYLSALICYLIC ACID,5426,,,WHO ATC Classification,,ILS,tablets enteric coated,ACETYLSALICYLIC ACID,2025-07-31T11:14:31.354731,IL,באייר,,39.6716,33.62,nan,,7290013092502,ASPIRIN CARDIO 90 TAB,,,,BLISTER POLYPROPYLENE/ALUMINIUM,units,90.0,143 06 31982 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/408fd1aa-08b5-452f-a493-ff8e48642345.json
4092c312-8802-47e1-914b-d9c045b1d327,MERCAPTIZOL,prescription,H03BB02,THIAMAZOLE,6903,,,WHO ATC Classification,,ILS,tablets,METHIMAZOLE,2025-07-31T05:12:39.211347,IL,תרו,,19.90163597,16.86579395,12.3107985,,7290012066498,MERCAPTIZOL 20MG 30TAB,13687,,19705,BLISTER PVC/ALUMINIUM,units,30.0,014 89 24453 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of hyperthyroidism.בקשה לתוספת משטר מינון: 8/8/2023Adult - The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8-hour intervals. The maintenance dosage is 5 to 15 mg daily. To achieve a required dosage of 5 mg, an intake of 10 mg every other day is suggested.Pediatric - Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8-hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4092c312-8802-47e1-914b-d9c045b1d327.json
4095de42-8827-4f22-ba1e-d8dd6cb69562,TZAREVET X MELON FLAVOUR,off-the-counter,A02AC01,CALCIUM CARBONATE,5120,,,WHO ATC Classification,,ILS,chewable tablets,CALCIUM AS CARBONATE,2025-07-31T13:32:23.704186,IL,כ.צ.ט,,20.2016,17.12,nan,,,TZAREVET X MENTHOL 36 TAB,,,,BLISTER PVC/ALUMINIUM,units,36.0,131 17 30850 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antacid,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4095de42-8827-4f22-ba1e-d8dd6cb69562.json
409a09c2-666f-4dc7-975d-e2a85cae2a4b,LEVETIRACETAM DEXCEL 1000,prescription,N03AX14,LEVETIRACETAM,8083,,,WHO ATC Classification,,ILS,tablets,LEVETIRACETAM,2025-07-31T04:43:23.650179,IL,דקסל פארמה,,91.57201967,77.6034065,57.6977,,,LEVETIRACETAM DEXCEL 250MG 60 TABLETS,12427,,64802,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,149 66 33514 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and    adolescents from 12 years of age with Idiopathic Generalised Epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/409a09c2-666f-4dc7-975d-e2a85cae2a4b.json
409d5ea5-4d7c-4a1d-85af-15ce384649f6,LEVITRA 5MG 4TAB,prescription,,,4681,,,,,ILS,tablet,LEVITRA 5MG,2025-07-31T19:16:41.097224,IL,באייר,,57.59379993,48.80830719,35.6265016,,,LEVITRA 5MG 4TAB,12314,,60176,,units,4.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/409d5ea5-4d7c-4a1d-85af-15ce384649f6.json
40ba6051-5f3e-4464-bf83-8711d5385c9f,PRED-FORTE,prescription,S01BA04,PREDNISOLONE,4507,,,WHO ATC Classification,,ILS,"eye drops, suspension",PREDNISOLONE ACETATEW/V,2025-07-31T06:51:18.782021,IL,אב-וי,,15.48794945,13.12538147,9.580570417,,7290008127349,PRED-FORTE 1% OPH 5ML,16424,,29889,BOTTLE LDPE,units,5.0,118 24 29914 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40ba6051-5f3e-4464-bf83-8711d5385c9f.json
40bb852d-1291-4f2a-9910-9b5bc554eae1,SALBUTEC RESPIRATORY SOLUTION,prescription,R03AC02,SALBUTAMOL,9386,,,WHO ATC Classification,,ILS,solution for inhalation,SALBUTAMOL AS SULFATE/,2025-07-31T07:57:07.915568,IL,סם און,,22.97005337,19.46614779,14.208867,,,SALBUTEC RESPIRATORY SOL BOTTLE 20 ML,,,45089,BOTTLE GLASS,units,20.0,172 07 36477 99,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Salbutec Respiratory Solution is indicated for the treatment of severe acute asthma (status asthmaticus) and other forms of bronchospasm,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40bb852d-1291-4f2a-9910-9b5bc554eae1.json
40c3a677-6d6a-4533-9e3d-94fb5a82c1a5,SPRYCEL 50 MG 60 FILM COATED TAB,prescription,,,6378,,,,,ILS,tablet,SPRYCEL 50 MG 60 FILM COATED TAB,2025-07-31T19:33:18.115331,IL,ב.מ.ס,,6399.316607,5423.149667,4930.136061,,,SPRYCEL 50 MG 60 FILM COATED TAB,19871,,81978,,units,60.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40c3a677-6d6a-4533-9e3d-94fb5a82c1a5.json
40c6e363-d7dd-4f37-a13a-5091e6b33556,FANAPT TABLETS 1 MG,prescription,N05AX14,ILOPERIDONE,6942,,,WHO ATC Classification,,ILS,tablets,ILOPERIDONE,2025-07-31T02:53:45.597296,IL,מגאפארם,,nan,nan,nan,,7290014573062,FANAPT 1MG 60TAB,6505,,43871,BLISTER ALUMINIUM,units,60.0,148 32 33482 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,FANAPT is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40c6e363-d7dd-4f37-a13a-5091e6b33556.json
40d05979-a9fc-4371-931c-933418e52fba,AFINITOR 10 MG,prescription,L04AA18,EVEROLIMUS,6512,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS,2025-07-30T23:16:35.231752,IL,נוברטיס פארמה,,3931.799305,3332.033309,3029.12119,,7290006257383,AFINITOR 5MG 30TABLETS,9450,,2559,BLISTER PA/AL/PVC,units,30.0,142 87 32046 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"- For the treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection.The effectiveness of Afinitor is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated.- Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease.The safety and effectiveness of AFINITOR® in the treatment of patients with carcinoid tumors have not been established.- For the treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.- Afinitor ® is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Afinitor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes.- Afinitor ® is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.-  Treatment of unresectable, locally advanced  or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40d05979-a9fc-4371-931c-933418e52fba.json
40e6781a-2697-4034-90b2-9c31e57e97d7,RIVAROXABAN S.K. 2.5 MG,prescription,B01AF01,RIVAROXABAN,9329,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN 2.5  MG,2025-07-31T07:43:39.958245,IL,SK PHARM(KS KIM),,301.1194655,255.1859877,217.179564,,,RIVAROXABAN S.K. 2.5 MG 56 TAB,18707,,8864,BLISTER ALU/PVC/PE/PVDC,units,56.0,173 04 37601 99,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Rivaroxaban S.K, co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel , is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers.Rivaroxaban S.K,, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40e6781a-2697-4034-90b2-9c31e57e97d7.json
40e7351f-1591-4265-a4e1-15b91a52bb09,BRONCHOLATE SYRUP,off-the-counter,R01BA52,"PSEUDOEPHEDRINE, COMBINATIONS",3861,,,WHO ATC Classification,,ILS,syrup,"DIPHENHYDRAMINE HYDROCHLORIDE 0.2 %W/V, PSEUDOEPHEDRINE HYDROCHLORIDE 0.4 %W/V",2025-07-31T11:20:54.568516,IL,סם און,,32.981,27.95,nan,,7290008066457,BRONCHOLATE SYRUP 120ML,2277,,,BOTTLE HDPE,units,120.0,121 24 30198 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Symptomatic relief of nasal congestion. Symptomatic relief of eustachian tube congestion in ear inflammation.Symptomatic relief of cough.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40e7351f-1591-4265-a4e1-15b91a52bb09.json
40edfaf4-5768-46b2-86f0-a38df4544529,GLYCERINE 1.33GR 5 SUP PEDIA,off-the-counter,,,2020,,,,,ILS,tablet,GLYCERINE 1.33GR 5 SUP PEDIA,2025-07-31T19:42:29.780707,IL,סם און,,11.092,9.4,,,,GLYCERINE 1.33GR 5 SUP PEDIA,7192,,,,units,5.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/40edfaf4-5768-46b2-86f0-a38df4544529.json
41080528-a755-4638-ad0d-8a5d5bb8541e,BYLVAY 1200 MICROGRAMS,prescription,A05AX05,ODEVIXIBAT,9196,,,WHO ATC Classification,,ILS,"capsule, hard",ODEVIXIBAT AS SESQUIHYDRATE,2025-07-31T00:47:55.882958,IL,מדיסון,,16976.52697,14386.88791,13078.98901,,,BYLVAY 200 MCG 30 HARD CAPS,,,25873,BOTTLE HDPE,units,30.0,171 44 37200 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older.Bylvay is indicated for the treatment of cholestatic pruritus in patients 12 months of age and older with Alagille syndrome (ALGS).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41080528-a755-4638-ad0d-8a5d5bb8541e.json
4108702c-20fd-4eb1-942d-b4f97ea33b9a,CAYSTON,prescription,J01DF01,AZTREONAM,7382,,,WHO ATC Classification,,ILS,lyophilized powder for nebuliser solution,AZTREONAM/VIAL,2025-07-31T00:58:01.912992,IL,גיליאד,,11329.02583,9600.869775,8728.063432,,5391507141040,CAYSTON  75MG/VIAL 84 VIALS,9724,,50858,VIAL 2 ML GLASS,units,84.0,151 57 34026 02,valid,10.0,inhalation,1.4,48,,,,,,,,,,0,Prescription required,Cayston is indicated for the suppressive therapy of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis (CF) aged 6 years and older. Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4108702c-20fd-4eb1-942d-b4f97ea33b9a.json
410c2d8b-3ab7-4bae-b1cf-5a6afc4bce55,CLOOD,prescription,B01AC04,CLOPIDOGREL,6269,,,WHO ATC Classification,,ILS,tablets,CLOPIDOGREL AS HYDROGEN SULFATE,2025-07-31T01:22:01.988905,IL,אוניפארם,,53.4981438,45.33741,33.093,,,CLOOD 75MG 30TAB,3956,,80150,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,140 84 31971 03,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of atherotrobmotic eventsClopidogrel is indicated in :• Adult Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• Adult Patients suffering from Acute Coronary Syndrome- Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapyPrevention of atherotrobmotic and thromboembolic events in atrial fibrillation: In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with Vitamin K antagonists (VKA) Anti-Thrombin or Anti Factor Xa, and who have a low bleeding risk, clopidogrel is indicated in combination  with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/410c2d8b-3ab7-4bae-b1cf-5a6afc4bce55.json
41122e09-7514-4382-a5f2-1a7bdcdd6077,FLUTIFORM 125/5,prescription,R01AD08,FLUTICASONE,7387,,,WHO ATC Classification,,ILS,pressurised suspention for inhalation,"FLUTICASONE PROPIONATE 0.125 MG/DOSE, FORMOTEROL FUMARATE DIHYDRATE 0.005 MG/DOSE",2025-07-31T03:14:43.675018,IL,רפא,,159.0540337,134.79156,107.833248,,7290008015967,FLUTIFORM 125/5  INHALER 120 DOSES,6534,,51485,CANISTER ALUMINIUM,units,120.0,150 63 33813 00,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,The regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting β2 agonist) is appropriate:• For patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting β2 agonist.• For patients already adequately controlled on both an inhaled corticosteroid and a long-acting β2 agonist.Flutiform 125mcg/5mcg inhaler is indicated in adults and adolescents aged 12 years and above.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41122e09-7514-4382-a5f2-1a7bdcdd6077.json
413b516f-5d65-49f6-8ce4-97acb4c8f459,LEUKERAN TABLETS 2 MG,prescription,L01AA02,CHLORAMBUCIL,1112,,,WHO ATC Classification,,ILS,tablets,CHLORAMBUCIL,2025-07-31T04:42:08.707839,IL,פאדאגיס,,82.74812222,70.12553042,52.13794083,,7290008105422,LEUKERAN 2MG 25TAB,12043,,1194,BOTTLE GLASS TYPE III,units,25.0,019 60 20450 05,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Leukeran is indicated in the treatment of Hodgkin's disease, indolent non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, and Waldenstrom's macroglobulinaemia",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/413b516f-5d65-49f6-8ce4-97acb4c8f459.json
4161be6b-d480-452e-8def-66ae5e330c60,TRAMADEX OD 100,prescription,N02AX02,TRAMADOL,3219,,,WHO ATC Classification,,ILS,tablets prolonged release,TRAMADOL HYDROCHLORIDE,2025-07-31T09:31:02.275004,IL,דקסל פארמה,,nan,nan,nan,,,TRAMADEX 100MG 30TAB,20138,,47623,BLISTER PVC/PE/PCTFE/AL,units,30.0,139 25 31580 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4161be6b-d480-452e-8def-66ae5e330c60.json
41691b88-d1f5-44ea-a5dd-c92f071bd17e,BEPANTHEN PLUS,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5173,,,WHO ATC Classification,,ILS,cream,"DEXPANTHENOL, CHLORHEXIDINE DIHYDROCHLORIDE 0.5 %",2025-07-31T11:17:47.686850,IL,באייר,,6.6434,5.63,nan,,7290008905398,BEPANTHEN PLUS CR 5% 3.5G,2459,,,TUBE ALUMINIUM,units,3.5,127 48 26501 01,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Antiseptic healing treatment of wounds of any kind with an infection risk : such as slight skin irritations, wounds, cuts, burns and skin inflammation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41691b88-d1f5-44ea-a5dd-c92f071bd17e.json
416c4c23-e1ef-4aa2-8c9b-0b72b098a392,TADALIS TEVA ® 20 MG,prescription,G04BE08,TADALAFIL,8063,,,WHO ATC Classification,,ILS,tablets,TADALAFIL,2025-07-31T08:59:50.892781,IL,טבע,,237.1314725,200.958875,160.7671,,,TADALIS TEVA 20 MG 4 TAB,,,55633,BLISTER ALUMINIUM /ALUMINIUM,units,4.0,154 90 34233 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/416c4c23-e1ef-4aa2-8c9b-0b72b098a392.json
416f8025-4e81-4e5d-8612-12106e231aab,DALACIN 2 % VAGINAL CREAM,prescription,G01AA10,CLINDAMYCIN,7728,,,WHO ATC Classification,,ILS,cream,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T01:40:03.033964,IL,פיזר,,21.30740361,18.05712171,13.18038081,,7298074000054,DALACIN C 150MG/ML AMPOULES 4ML,4635,,85242,TUBE PLASTIC,units,1.0,064 17 27818 00,valid,37.0,vaginal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/416f8025-4e81-4e5d-8612-12106e231aab.json
4182c6a4-6d70-45e0-8219-00b2901b8b9e,XARELTO 1 MG/ML GRANULES FOR ORAL SUSPENSION,prescription,B01AF01,RIVAROXABAN,6408,,,WHO ATC Classification,,ILS,granules for oral suspension,RIVAROXABAN 19.7 MG/G,2025-07-31T10:30:07.476422,IL,באייר,,270.578248,229.3036,195.152,,,XARELTO 10MG  30  TABLETS,24055,,83857,BOTTLE GLASS TYPE I,units,30.0,174 12 37097 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of venous thromboembolism (VTE) and prevention of VTE recurrence in term   neonates, infants and toddlers, children, and adolescents aged less than 18 years after at least 5 days of initial parenteral anticoagulation treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4182c6a4-6d70-45e0-8219-00b2901b8b9e.json
41846258-ac39-43b0-a275-1e375c31f5b8,AGGRASTAT,prescription,B01AC17,TIROFIBAN,7349,,,WHO ATC Classification,,ILS,solution for infusion,TIROFIBAN AS HYDROCHLORIDE MONOHYDRATE 0.05 MG/ML,2025-07-31T00:11:21.962263,IL,צמל,,833.1259236,706.0389497,600.8842125,,7290012240133,AGGRASTAT 0.05MG/ML BAG 250ML,1265,,8402,BAG NON PVC,units,250.0,116 15 29580 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Aggrastat in combination with heparin, is indicated for patients with unstable angina or non-Q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy. In this setting, AGGRASTAT has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41846258-ac39-43b0-a275-1e375c31f5b8.json
41b6d059-2dd3-44de-b8cc-e52d14f1930f,ATOMIC 100,prescription,N06BA09,ATOMOXETINE,8146,,,WHO ATC Classification,,ILS,coated tablets,ATOMOXETINE AS HYDROCHLORIDE,2025-07-30T23:29:26.808885,IL,אוניפארם,,380.8193123,322.7282308,274.6623241,,,ATOMIC 60MG 28 TAB,,,11115,BLISTER PVC/ALUMINIUM,units,28.0,167 84 36235 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Atomic is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD. In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Atomic should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD.Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41b6d059-2dd3-44de-b8cc-e52d14f1930f.json
41d299ac-4153-42ac-85e1-1418eb0a46fc,ALIQOPA  15MG/ML,29C,,,20932,,,,,,tablet,ALIQOPA 15MG/ML,2025-07-31T19:52:28.178509,IL,nan,,,,,,,ALIQOPA  15MG/ML,,,,,units,1.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41d299ac-4153-42ac-85e1-1418eb0a46fc.json
41d38b28-ab97-46f8-ae24-2fcc418c52d1,DAUNOBLASTINA 20MG/10ML INJECTION PFIEZER ITALY,29C,,,20829,,,,,,injection,DAUNOBLASTINA 20MG/ INJECTION PFIEZER ITALY,2025-07-31T20:11:34.656685,IL,nan,,,,,,,DAUNOBLASTINA 20MG/10ML INJECTION PFIEZER ITALY,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41d38b28-ab97-46f8-ae24-2fcc418c52d1.json
41f34bc6-44f8-4fa1-9627-4659a1893eba,AZITHROVENIR,prescription,J01FA10,AZITHROMYCIN,8284,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,AZITHROMYCIN AS DIHYDRATE/VIAL,2025-07-30T23:33:24.478308,IL,ביואבניר,,57.75413429,48.9441816,35.72568,,7290010286287,AZITHROVENIR  500MG/VIAL  5ML,,,65679,VIAL GLASS TYPE II,units,1.0,159 58 34834 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment of infections caused by susceptible strains of the designated microorganism in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41f34bc6-44f8-4fa1-9627-4659a1893eba.json
41f58557-3c4b-4be7-ace4-4edb5efed3ed,CAPECITABINE  TARO 500 MG,prescription,L01BC06,CAPECITABINE,8208,,,WHO ATC Classification,,ILS,film coated tablets,CAPECITABINE,2025-07-31T00:52:57.526328,IL,תרו יבוא,,845.2917876,716.3489725,609.6587,,,CAPECITABINE TARO 500MG 120TABS,,,5165,BLISTER ALUMINIUM /ALUMINIUM,units,120.0,157 76 34725 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Adjuvant Colon Cancer: Capecitabine Taro 500mg is indicated for the adjuvant treatment of patients following surgery of stage III (Dukes stage C) colon cancer. Colorectal Cancer: Capecitabine Taro 500mg is indicated for the treatment of patients with advanced or metastatic colorectal cancer. Advanced gastric cancer: Capecitabine Taro 500mg is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. Breast Cancer Combination Therapy: Capecitabine Taro 500mg in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Breast Cancer Monotherapy: Capecitabine Taro 500mg is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/41f58557-3c4b-4be7-ace4-4edb5efed3ed.json
420114b2-5b06-44b8-9c0d-2235ed8c61e7,CHOLESTYRAMINE 4GR 30SACHETS,29C,,,20053,,,,,,tablet,CHOLESTYRAMINE 4GR 30SACHETS,2025-07-31T20:06:05.411935,IL,nan,,,,,,,CHOLESTYRAMINE 4GR 30SACHETS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/420114b2-5b06-44b8-9c0d-2235ed8c61e7.json
420aca5d-15ce-47eb-ad59-c547eedc20ae,DOXYCYCLIN-RATIOPHARM SF 100MG/5ML 5AMP,29C,,,20382,,,,,,injection,DOXYCYCLIN-RATIOPHARM SF 100MG/,2025-07-31T20:18:38.065199,IL,nan,,,,,,,DOXYCYCLIN-RATIOPHARM SF 100MG/5ML 5AMP,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/420aca5d-15ce-47eb-ad59-c547eedc20ae.json
4212960a-e552-4b54-89ce-ff392898db1b,PEMETREXED SANDOZ ® 25 MG/ML,prescription,L01BA04,PEMETREXED,8235,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PEMETREXED AS DISODIUM HEMIPENTAHYDRATE/ML,2025-07-31T06:32:19.563691,IL,סנדוז,,4932.985268,4180.49599,3800.4509,,,PEMETREXED SANDOZ  500	mg VIAL,10380,,25959,VIAL GLASS TYPE I,units,1.0,179 06 37262 99,valid,10.0,i.v,1.4,18,,,,,,,,,,0,Prescription required,Pemetrexed Sandoz in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Pemetrexed Sandoz in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Sandoz is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Sandoz is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4212960a-e552-4b54-89ce-ff392898db1b.json
42232c1b-9451-4680-be56-0bbc9eceb464,KEVZARA 150 MG,prescription,L04AC14,SARILUMAB,8118,,,WHO ATC Classification,,ILS,solution for injection,SARILUMAB 131.6  MG /,2025-07-31T04:25:55.606083,IL,סאנופי אוונטיס,,4571.240986,3873.933212,3521.757465,,,KEVZARA 150 MG PREFIL SYR 1.14ML,112277,,67498,PRE-FILLED PEN GLASS TYPE I,units,2.0,160 37 35260 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Kevzara in combination with methotrexate (MTX) is indicated for the treatment of moderately to severely active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (DMARDs). Kevzara can be given as monotherapy in case of intolerance to MTX or when treatment with MTX is inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/42232c1b-9451-4680-be56-0bbc9eceb464.json
423b7217-fd4d-402b-ab16-4f76314a7289,NEVANAC,prescription,S01BC10,NEPAFENAC,7007,,,WHO ATC Classification,,ILS,"eye drops, suspension",NEPAFENAC 0.1 %,2025-07-31T05:44:27.596994,IL,נוברטיס פארמה,,108.8485212,92.24451362,68.5832815,,,NEVANAC 0.1% OPHTALMIC SUSP. 5ML,14548,,31048,BOTTLE LDPE,units,5.0,143 57 31467 00,valid,34.5,ocular,1.4,24,,,,,,,,,,0,Prescription required,Prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/423b7217-fd4d-402b-ab16-4f76314a7289.json
42403918-33fc-4d62-ac83-8368888c9d72,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8037,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:52:40.585321,IL,יאנסן סילג,,13039.06554,11050.05603,10045.50548,,7640111932642,UPTRAVI ® 1400 MCG 60 TABS,21131,,22882,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/42403918-33fc-4d62-ac83-8368888c9d72.json
4242190e-e4bd-40a1-8a95-e9c54e99eb26,VIAGRA 100 MG,prescription,G04BE03,SILDENAFIL,3679,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:12:45.548770,IL,דקסל פארמה,,187.2596575,158.694625,126.9557,,7290008108812,VIAGRA 25MG 8TAB,22117,,33851,BLISTER PVC/ALUMINIUM,units,8.0,111 38 29461 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4242190e-e4bd-40a1-8a95-e9c54e99eb26.json
425977d5-ef27-4d15-9839-4b058b1ea508,LAMISIL ONCE,off-the-counter,,,5247,,,,,ILS,solution,TERBINAFINE AS HYDROCHLORIDE/G,2025-07-31T12:17:14.630937,IL,ג.ס.ק,,86.4586,73.27,nan,,7290011363437,LAMISIL CREAM 1% 30GR,12426,,,TUBE ALUMINIUM,units,30.0,137 26 31486 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,For the treatment of athlete's foot.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/425977d5-ef27-4d15-9839-4b058b1ea508.json
426c8760-86df-49f8-b8b3-8c6132da48f0,"METHOTREXAT ""EBEWE"" 100 MG/ML",prescription,L01BA01,METHOTREXATE,7241,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,METHOTREXATE/ML,2025-07-31T05:17:10.866914,IL,סנדוז,,1032.75144,875.213085,744.8622,,729000667694-8,METHOTREXAT EBEWE 100MG/ML VIAL 5000MG/50ML,13555,,58780,VIAL GLASS TYPE I,units,50.0,129 09 30803 00,valid,17.5,"i.m, intra-arterial, i.v, intra ventricular, intrathecal",1.4,24,,,,,,,,,,0,Prescription required,"Antineoplastic Chemotherapy: Treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Palliation of acute lymphocytic leukemia. In the treatment and prophylaxis of meningeal leukemia. Greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. In combination with other anticancer agents, methotrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. Methotrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. Methotrexate is effective in the treatment of the advanced stages (III and IV, Peters’ Staging System) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/426c8760-86df-49f8-b8b3-8c6132da48f0.json
427a232f-4406-4d17-9a52-c58f1f446019,FENLIPS,off-the-counter,D06BB06,PENCICLOVIR,5261,,,WHO ATC Classification,,ILS,cream,PENCICLOVIRW/W,2025-07-31T11:54:08.454515,IL,פאדאגיס,,44.7338,37.91,nan,,,FENLIPS CREAM 2GR,6446,,,TUBE ALUMINIUM,units,2.0,142 41 31798 01,valid,nan,topical,1.4,36,,,,,,,,,,0,,For the topical treatment for cold sores (oral herpes).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/427a232f-4406-4d17-9a52-c58f1f446019.json
428aaa5e-729f-4391-88c5-36f27d503250,BELARA,prescription,G03AA01,ETYNODIOL AND ESTROGEN,4962,,,WHO ATC Classification,,ILS,film coated tablets,"ETHINYLESTRADIOL 0.03  MG, CHLORMADINONE ACETATE",2025-07-31T00:29:45.423629,IL,ליברה,,39.80791102,33.73551931,24.62446665,,7290008872218,BELARA 1X21TAB,2411,,61868,BLISTER PVC/PVDC/ALUMINIUM,units,21.0,127 34 30410 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral hormonal contraceptive.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/428aaa5e-729f-4391-88c5-36f27d503250.json
429d8021-781e-4067-906f-02526c2fe4f5,JANUET XR 50/1000 MG TABLETS,prescription,A10BA02,METFORMIN,6246,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T04:16:15.655064,IL,מ.ס.ד. ישראל,,87.00082796,73.72951522,54.81748343,,,JANUET 50/1000 MG 56TAB,10045,,78969,BOTTLE HDPE,units,56.0,151 32 33933 02,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/429d8021-781e-4067-906f-02526c2fe4f5.json
42cfcb81-0f3d-4b2b-9959-429de00b86af,ESMERON,prescription,M03AC09,ROCURONIUM BROMIDE,6270,,,WHO ATC Classification,,ILS,solution for injection,ROCURONIUM BROMIDE/ML,2025-07-31T02:35:42.011500,IL,מ.ס.ד. ישראל,,183.1164563,155.1834375,124.14675,,7290008121743,ESMERON 10MG/ML 5ML 10 VIAL,5508,,2851,VIAL GLASS TYPE I,units,10.0,103 96 28560 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Esmeron is indicated in adult and paediatric patients (from term neonates to adolescents [0 to <18 years]) as an adjunct to general anaesthesia to facilitate tracheal intubation during routine sequence induction and to provide skeletal muscle relaxation during surgery. In adults Esmeron is also indicated to facilitate tracheal intubation during rapid sequence induction and as an adjunct in the intensive care unit (ICU) to facilitate intubation and mechanical ventilation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/42cfcb81-0f3d-4b2b-9959-429de00b86af.json
42de6896-363f-4c84-b407-179c3f0d5742,LAMODEX 100 MG DISPERSIBLE/CHEWABLE TABLETS,prescription,N03AX09,LAMOTRIGINE,4719,,,WHO ATC Classification,,ILS,dispersible/chewable tablets,LAMOTRIGINE,2025-07-31T04:33:46.012666,IL,דקסל פארמה,,26.89521254,22.792553,16.6369,,,LAMODEX 25MG 30DISP/CHEW TAB,12309,,60141,BLISTER ACLAR/PVC/ALUMINIUM,units,30.0,129 88 30814 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy • Adults and adolescents aged 13 years and above:   - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.   - Seizures associated with Lennox-Gastaut syndrome. Lamodex is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome. • Children and adolescents aged 2 to 12 years:   - Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.   - Monotherapy of typical absence seizures.Bipolar disorder • Adults aged 18 years and above   - Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamodex is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/42de6896-363f-4c84-b407-179c3f0d5742.json
42fd93b2-aae9-4342-9253-f008e5ef6c0a,MONOLONG 40 MG,29C,C01DA14,ISOSORBIDE MONONITRATE,20470,,,WHO ATC Classification,,ILS,capsules slow release,ISOSORBIDE-5-MONONITRATE,2025-07-31T14:54:36.272508,IL,nan,,nan,nan,nan,,,ISOSORBIDE DINITRATE SUBLINGUAL 2.5MG 100TAB,,,,BLISTER PVC/ALUMINIUM,units,100.0,052 97 26218 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,Prevention and treatment of angina pectoris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/42fd93b2-aae9-4342-9253-f008e5ef6c0a.json
4300e704-0df1-4466-844f-0a8403140818,CELSENTRI 150 MG,prescription,J05AX09,MARAVIROC,6279,,,WHO ATC Classification,,ILS,film coated tablets,MARAVIROC,2025-07-31T01:05:14.452496,IL,ג.ס.ק,,2692.830644,2282.059969,2074.599972,,,CELSENTRI 150MG 60TAB,3965,,80883,BLISTER PVC/ALU/PET,units,60.0,139 61 31670 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Celsentri is a CCR5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only CCR5-tropic HIV-1.• In treatment-naïve subjects, more subjects treated with Celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• Tropism testing with a highly sensitive tropism assay is required for the appropriate use of Celsentri.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4300e704-0df1-4466-844f-0a8403140818.json
431f24ec-1ed2-456b-8403-6586502cf392,RODENAL 2 MG TBLETS,prescription,,,3400,,,,,ILS,tablets,TRIHEXYPHENIDYL HYDROCHLORIDE,2025-07-31T07:47:47.525005,IL,רקח,,17.249122,14.6179,10.67,,7290008089791,RODENAL 5MG 30TAB,18106,,85592,BLISTER PVC/ALUMINIUM,units,30.0,111 02 21626 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Rodenal tablet is an adjunct medicine in the therapy of all forms of Parkinsonism (postencephalitic, arteriosclerotic and idiopathic), It is also indicated to control extrapyramidal disorders  due to  central nervous system drugs such as phenothiazines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/431f24ec-1ed2-456b-8403-6586502cf392.json
431f2ea9-3855-4bde-82f2-8ac4d122cd60,ENTACAPONE MEDOCHEMIE,prescription,N04BX02,ENTACAPONE,8345,,,WHO ATC Classification,,ILS,film coated tablets,ENTACAPONE,2025-07-31T02:22:59.680020,IL,דפריס,,79.00191673,66.95077987,49.7775315,,5290931020764,ENTACAPONE MEDOCHEMIE 200mg 30tab,5650,,28166,BLISTER OPAQUE PVC/PVDC/ALUMINIUM,units,30.0,160 98 35150 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with Parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/431f2ea9-3855-4bde-82f2-8ac4d122cd60.json
4336aa93-797b-494f-9b08-ced9b7cf5b3a,EPREX/PROTECS 4000IU/0.4ML 6 SYRINGES,prescription,,,4573,,,,,ILS,tablet,EPREX/PROTECS 4000IU/0. 6 SYRINGES,2025-07-31T19:08:37.959187,IL,יאנסן סילג,,932.7882566,790.4985225,672.7647,,,EPREX/PROTECS 4000IU/0.4ML 6 SYRINGES,5458,,86980,,units,6.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4336aa93-797b-494f-9b08-ced9b7cf5b3a.json
436c03c4-d4b4-4dd2-b35e-7d16d59b745c,VIMPAT 10 MG/ML,prescription,N03AX18,LACOSAMIDE,7190,,,WHO ATC Classification,,ILS,solution for infusion,LACOSAMIDE/,2025-07-31T10:16:13.035707,IL,ניאופרם,,595.2727296,504.4684149,429.3348212,,7290100412688,VIMPAT 200MG 56 F.C.TAB,22415,,46140,VIAL 20 ML GLASS TYPE I,units,56.0,149 13 33552 01,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.בקשה לשינוי משטר מינון: 17/5/20204.2	Posology and method of administrationPosologyLacosamide must be taken twice a day (usually once in the morning and once in the evening).Lacosamide may be taken with or without food.If a dose is missed, the patient should be instructed to take the missed dose immediately, and then to take the next dose of lacosamide at the regularly scheduled time. If the patient notices the missed dose within 6 hours of the next one, he/she should be instructed to wait to take the next dose of lacosamide at the regularly scheduled time. Patients should not take a double dose.Adolescents and children weighing 50 kg or more, and adultsThe following table summarises the recommended posology for adolescents and children weighing 50 kg or more, and for adults. More details are provided in the table below.	Monotherapy	Adjunctive therapyStarting dose	100 mg/day or 200 mg/day	100 mg/daySingle loading dose (if applicable)	200 mg	200 mgTitration (incremental steps)	50 mg twice a day (100 mg/day) at weekly intervals	50 mg twice a day (100 mg/day) at weekly intervalsMaximum recommended dose	up to 600 mg/day	up to 400 mg/dayMonotherapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week.Lacosamide can also be initiated at the dose of 100 mg twice a day based on the physician's assessment of required seizure reduction versus potential side effects.Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 300 mg twice a day (600 mg/day). In patients having reached a dose greater than 400 mg/day and who need an additional antiepileptic medicinal product, the posology that is recommended for adjunctive therapy below should be followed.Adjunctive therapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week. Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 400 mg (200 mg twice a day). Initiation of lacosamide treatment with a loading dose Lacosamide treatment may also be initiated with a single loading dose of 200 mg, followed approximately 12 hours later by a 100 mg twice a day (200 mg/day) maintenance dose regimen. Subsequent dose adjustments should be performed according to individual response and tolerability as described above. A loading dose may be initiated in patients in situations when the physician determines that rapid attainment of lacosamide steady state plasma concentration and therapeutic effect is warranted. It should be administered under medical supervision with consideration of the potential for increased incidence of serious cardiac arrhythmia and central nervous system adverse reactions (see section 4.8). Administration of a loading dose has not been studied in acute conditions such as status epilepticus.DiscontinuationIn accordance with current clinical practice, if lacosamide has to be discontinued, it is recommended this be done gradually (e.g. taper the daily dose by 200 mg/week).In patients who develop serious cardiac arrhythmia, clinical benefit/risk assessment should be performed and if needed lacosamide should be discontinued.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/436c03c4-d4b4-4dd2-b35e-7d16d59b745c.json
436d1dcf-ea1c-45a5-b433-fd4d6540187d,CIPRALEX 10 MG,prescription,N06AB10,ESCITALOPRAM,6152,,,WHO ATC Classification,,ILS,film coated tablets,ESCITALOPRAM AS OXALATE,2025-07-31T01:15:49.949324,IL,לנדבק,,55.96378212,47.426934,34.6182,,,CIPRALEX 20MG 28TAB,3930,,87703,BLISTER PVC/PE/PVDC/AL,units,28.0,127 01 30558 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of depression and panic disorder.   Treatment of generalized anxiety disorder (GAD)  treatment of social anxiety disorder (social phobia).   Treatment of obsessive - compulsive disorder.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/436d1dcf-ea1c-45a5-b433-fd4d6540187d.json
43725fca-e01d-465c-ab1f-b3b22120d665,MERCILON,prescription,G03AC09,DESOGESTREL,3030,,,WHO ATC Classification,,ILS,tablets,"DESOGESTREL, ETHINYLESTRADIOL",2025-07-31T05:13:10.070784,IL,אורגנון,,56.59619604,47.962878,35.0094,,7290006537010,MERCILON 3X21 TAB,13080,,60838,BLISTER PVC/ALUMINIUM,units,63.0,103 11 26498 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraception,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43725fca-e01d-465c-ab1f-b3b22120d665.json
437e7c9a-4ce9-4e44-9cfa-13f4a92930ac,DIOVAN ® 40 MG FILM-COATED TABLETS,prescription,C09CA03,VALSARTAN,3631,,,WHO ATC Classification,,ILS,film coated tablets,VALSARTAN,2025-07-31T01:57:51.838997,IL,נוברטיס פארמה,,28.10184278,23.815121,17.3833,,,DIOVAN 80MG 28 FC TABS,4456,,58661,BLISTER PVC/PA/ALUMINIUM,units,28.0,137 42 31281 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Diovan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial  Diovan significantly reduced hospitalisations for heart failure. There is no evidence that Diovan provides added benefits when it is used with an adequate dose of an ACE inhibitor.   Diovan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/437e7c9a-4ce9-4e44-9cfa-13f4a92930ac.json
4382993e-a7e8-4a9b-b5fb-f2691eb26180,XANAX X.R. 0.5 MG,prescription,N05BA12,ALPRAZOLAM,4308,,,WHO ATC Classification,,ILS,tablets sustained release,ALPRAZOLAM 0.5   MG,2025-07-31T10:29:12.692458,IL,דקסל פארמה,,31.5236986,26.715,19.5,,7298074000702,XANAX XR 1MG 30 SR TAB,24020,,2496,BLISTER ALUMINIUM,units,30.0,110 49 28804 21,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of anxiety and anxiety associated with depression.Treatment of panic disorder with or without phobic avoidance,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4382993e-a7e8-4a9b-b5fb-f2691eb26180.json
438c2ecb-5532-46d1-acbb-7ff2be9dce13,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7459,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:19:29.528213,IL,צמל,,121.9546685,103.351414,76.8412,,,METOJECT 50MG/ML SYRINGE PREFILLED 17.5MG/0.35ML,,,4027,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/438c2ecb-5532-46d1-acbb-7ff2be9dce13.json
439245be-070a-44d1-8427-d1d2795790e8,MACLIVAN 250 MG/5 ML,prescription,,,7544,,,,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM 62.5  MG /, AMOXICILLIN AS TRIHYDRATE/",2025-07-31T05:04:22.642311,IL,סנדוז,,33.16341738,28.104591,20.5143,,,MACLIVAN 500 MG+125MG 20 TABLETS,13774,,74196,BOTTLE AMBER GLASS TYPE III,units,20.0,120 17 30001 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Maclivan is indicated for the treatment of the following infections in adults and children :• Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/439245be-070a-44d1-8427-d1d2795790e8.json
43a2525c-92d6-4874-9b34-182dc46cd87a,ACARIZAX,prescription,V01AA03,HOUSE DUST,8808,,,WHO ATC Classification,,ILS,tablets,"DERMATOPHAGOIDES PTERONYSSINUS 6 SQ-HDM, DERMATOPHAGOIDES FARINA 6 SQ-HDM",2025-07-31T00:05:07.082662,IL,תרופארם,,392.2043662,332.3765963,282.873699,,,ACARIZAX 12 SQ- HDM 30 TAB,,,70274,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,165 50 35659 00,valid,17.5,sublingual,1.4,48,,,,,,,,,,0,Prescription required,ACARIZAX is indicated in adult patients (18-65 years) diagnosed by clinical history and a positive test of house dust mite sensitisation (skin prick test and/or specific IgE) with at least one of the following conditions: • persistent moderate to severe house dust mite allergic rhinitis despite use of symptom-relieving medication • house dust mite allergic asthma not well controlled by inhaled corticosteroids and associated with mild to severe house dust mite allergic rhinitis. Patients' asthma status should be carefully evaluated before the initiation of treatment.ACARIZAX is indicated in adolescents (12-17 years) diagnosed by clinical   history and a positive test of house dust mite sensitisation (skin prick test and/or specific IgE) with persistent moderate to severe house dust mite allergic rhinitis despite use of symptom-relieving medication.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43a2525c-92d6-4874-9b34-182dc46cd87a.json
43a50a46-b038-4a71-9780-566323556ac6,ZYTIGA 250 MG,prescription,L02BX03,ABIRATERONE,6934,,,WHO ATC Classification,,ILS,tablets,ABIRATERONE ACETATE,2025-07-31T10:57:53.269962,IL,יאנסן סילג,,17160.87617,14543.1154,13221.014,,7290008099943,ZYTIGA 250MG 120TAB,26181,,34314,BOTTLE HDPE,units,120.0,148 03 33481 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Zytiga is a CYP17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43a50a46-b038-4a71-9780-566323556ac6.json
43af374b-e704-46bb-863e-8bd5ea67d1e3,NITROGEN MEDICAL LIQUID,29C,V03AN04,NITROGEN,20912,,,WHO ATC Classification,,ILS,liquefied gas,NITROGEN 99.5 %,2025-07-31T15:23:15.236816,IL,nan,,nan,nan,nan,,,NITRO POHL   1MG/ML,,,,CRIOGENIC TANKER STAINLESS STEEL,units,1.0,147 59 33517 00,valid,nan,topical,1.4,12,,,,,,,,,,0,,Liquefied Nitrogen for treatment of skin lesions by freezing (cryotherapy).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43af374b-e704-46bb-863e-8bd5ea67d1e3.json
43b76854-9032-4ac2-ae85-2bc267dcf301,BETISTINE 16 MG,prescription,N07CA01,BETAHISTINE,4229,,,WHO ATC Classification,,ILS,tablets,BETAHISTINE DIHYDROCHLORIDE,2025-07-30T23:37:28.278778,IL,רפא,,15.737601,13.33695,9.735,,7290008014953,BETISTINE 16MG 30TAB,2271,,27298,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,120 76 30126 11,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Meniere`s syndrome. Symptomatic treatment of peripheral vertigo.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43b76854-9032-4ac2-ae85-2bc267dcf301.json
43bf055f-0259-4026-bb1d-d6890058b903,ETOPAN XL 500,prescription,M01AB08,ETODOLAC,3493,,,WHO ATC Classification,,ILS,tablets extended release,ETODOLAC,2025-07-31T02:39:11.881794,IL,תרו,,nan,nan,nan,,,ETOPAN 200MG 20CAPS,5115,,76314,BOTTLE HDPE,units,20.0,128 08 30651 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the management of signs and symptoms of osteoarthrities and rheumatoid arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43bf055f-0259-4026-bb1d-d6890058b903.json
43f9fd6d-3c08-4934-ab01-cf98a86693a5,JEMPERLI,prescription,L01XC40,DOSTARLIMAB,9019,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOSTARLIMAB/ML,2025-07-31T04:19:10.621185,IL,ג.ס.ק,,26625.01631,22563.57414,20512.34013,,7290014547681,JEMPERLI 500MG/10ML 1 VIAL,,,71371,VIAL GLASS TYPE I,units,1.0,169 79 36883 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Jemperli is indicated in combination with carboplatin and paclitaxel for the treatment of adult patients with mismatch repair deficient (dMMR)/ microsatellite instability high (MSI H) primary advanced or recurrent endometrial cancer (EC) and who are candidates for systemic therapy.Jemperli is indicated as monotherapy for the treatment of adult patients with dMMR/MSI-H recurrent or advanced EC that has progressed on or following prior treatment with a platinum containing regimen.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43f9fd6d-3c08-4934-ab01-cf98a86693a5.json
43faf494-793b-4a27-bb54-a091ee25555b,METOPIRONE 250,prescription,V04CD01,METYRAPONE,563,,,WHO ATC Classification,,ILS,capsules,METYRAPONE,2025-07-31T05:20:44.151955,IL,כ.צ.ט,,1347.419781,1141.881221,971.813805,,7298087000478,METOPIRONE 250MG 50CAPS,13113,,1324,BOTTLE HDPE,units,50.0,068 34 23659 01,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Diagnostic test for ACTH insufficiency and in the differential diagnosis of ACTH dependant Cushing’s Syndrome. For the Management of patient with endogenous Cushing’s syndrome.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43faf494-793b-4a27-bb54-a091ee25555b.json
43fd3a1d-895a-4238-8ead-de3c1cc2fe1c,ISONIAZID 300MG 30TAB,29C,,,20468,,,,,,tablet,ISONIAZID 300MG,2025-07-31T20:40:30.589847,IL,nan,,,,,,,ISONIAZID 300MG 30TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43fd3a1d-895a-4238-8ead-de3c1cc2fe1c.json
43fdea09-6a46-44ac-b6de-391ee843ff76,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,574,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T12:43:18.310473,IL,ג.ס.ק,,32.686,27.7,nan,,7290006603036,OTRIVIN MD SPY 10ML 0.1%,15319,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,10.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/43fdea09-6a46-44ac-b6de-391ee843ff76.json
44043035-8f4c-4a96-b08d-9d520bb4bbac,AEROVENT,prescription,R03BB01,IPRATROPIUM BROMIDE,1442,,,WHO ATC Classification,,ILS,inhalation solution,IPRATROPIUM BROMIDE 0.25  MG/ML,2025-07-31T00:10:52.031507,IL,בורינגר אינגלהיים,,35.95007862,30.46616832,22.23807907,,9006968011943,AEROVENT SOL 20ML,1772,,49689,BOTTLE GLASS TYPE III,units,20.0,055 80 27113 01,valid,37.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"For the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema. Aerovent respirator solution is of particular benefit in relieving acute bronchospasm when used concomitantly with inhaled beta agonists.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44043035-8f4c-4a96-b08d-9d520bb4bbac.json
440c9fdd-2c56-4416-9b5d-775169c82dba,NOTENSYL TABLETS,prescription,A03AA07,DICYCLOVERINE,2334,,,WHO ATC Classification,,ILS,tablets,DICYCLOMINE HYDROCHLORIDE,2025-07-31T05:53:02.757976,IL,כ.צ.ט,,nan,nan,nan,,,NOTENSYL 10MG 20TAB,14159,,1513,BLISTER PVC/ALUMINIUM,units,20.0,117 85 23254 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Adjunctive therapy in irritable bowel syndrome, neurogenic bowel disturbance.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/440c9fdd-2c56-4416-9b5d-775169c82dba.json
4417e94a-f682-409b-bb4a-65d83feaf851,FIRDAPSE,prescription,N07XX05,AMIFAMPRIDINE,6711,,,WHO ATC Classification,,ILS,tablets,AMIFAMPRIDINE,2025-07-31T03:05:19.495348,IL,מדיסון,,8148.774805,6905.741667,6277.94697,,,FIRDAPSE 10MG 100TAB,6457,,15378,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,146 29 33301 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4417e94a-f682-409b-bb4a-65d83feaf851.json
442c6feb-734b-4c2d-ad1d-1f5ea5115241,"FLUOROURACIL ""EBEWE"" 50 MG/ML",prescription,L01BC02,FLUOROURACIL,7932,,,WHO ATC Classification,,ILS,concentrate for solution for injection / infusion,FLUOROURACIL/ML,2025-07-31T03:13:38.244246,IL,סנדוז,,83.88013952,71.084864,52.8512,,7290016369649,FLUOROURACIL EBEWE 50 MG/ML VIAL 5000MG/100ML,6377,,61079,VIAL GLASS TYPE I,units,100.0,130 30 30866 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas, in selected patients considered incurable by surgery or other means.As leucovorin-fluorouracil chemotherapy combination for cancer treatment.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/442c6feb-734b-4c2d-ad1d-1f5ea5115241.json
44466eeb-f513-4fa7-ac2c-f50102fb56f2,ETOPAN XL 500,prescription,M01AB08,ETODOLAC,6858,,,WHO ATC Classification,,ILS,tablets extended release,ETODOLAC,2025-07-31T02:39:53.780241,IL,תרו,,nan,nan,nan,,,ETOPAN 500MG 20TAB,5522,,16271,BOTTLE HDPE,units,20.0,128 08 30651 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the management of signs and symptoms of osteoarthrities and rheumatoid arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44466eeb-f513-4fa7-ac2c-f50102fb56f2.json
444f10c1-9a6e-4454-98ee-f780385a3228,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,5275,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:23:14.847434,IL,רקיט בנקיזר,,41.5832,35.24,nan,,7290000852973,STREPSILS ORANGE  WITH VITAMIN C 36 LOZ,19789,,,BLISTER PVC/PVDC/ALUMINIUM,units,36.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/444f10c1-9a6e-4454-98ee-f780385a3228.json
44594210-97b0-4d13-a7e6-da5b23d033fe,FLIXOTIDE INHALER CFC FREE 125 MCG,prescription,R03BA05,FLUTICASONE,4784,,,WHO ATC Classification,,ILS,suspension for inhalation,FLUTICASONE PROPIONATE/DOSE,2025-07-31T03:09:05.005160,IL,ג.ס.ק,,51.4098477,43.56766948,31.8012186,,,FLIXOTIDE INH CFC FREE 50MCG 120DOSES,6354,,12323,CAN ALUMINIUM,units,120.0,129 81 30973 11,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Prophylactic management of all grades of asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44594210-97b0-4d13-a7e6-da5b23d033fe.json
44616f15-64b7-46d5-8fab-2e4129ddf449,ROSUVASTATIN INOVAMED 10 MG,prescription,C10AA07,ROSUVASTATIN,9361,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T07:50:22.297306,IL,אינובמד,,132.9169269,112.6414635,83.7483,,,ROSUVASTATIN INOVAMED 20 MG 30 TAB,23631,,4908,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,173 65 36557 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44616f15-64b7-46d5-8fab-2e4129ddf449.json
446c5b30-8f68-4d74-9b2e-f79d976392f6,EFEXOR XR 150,prescription,N06AX16,VENLAFAXINE,4523,,,WHO ATC Classification,,ILS,capsules extended release,VENLAFAXINE AS HYDROCHLORIDE,2025-07-31T02:11:44.356686,IL,פיזר,,31.71268054,26.875153,19.6169,,,EFEXOR XR 75MG 28 SR CAPS,5203,,31230,BLISTER PVC/FOIL,units,28.0,111 18 29395 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of depression.   Maintenance of recurrent depression.   Generalized anxiety disorder (GAD) - short term and long-term.   Social anxiety Disorder (SAD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/446c5b30-8f68-4d74-9b2e-f79d976392f6.json
4479a73e-e56f-4528-a74f-c47ba6f6defa,SECTOR 100,prescription,C09DX04,VALSARTAN AND SACUBITRIL,9294,,,WHO ATC Classification,,ILS,sodium salt complex,SACUBITRIL/VALSARTAN AS SODIUM SALT COMPLEX AS SODIUM SALT COMPLEX 49/51  MG,2025-07-31T08:02:16.483993,IL,אוניפארם,,573.9639449,486.4101228,413.966062,,,SECTOR 200 MG 56 TAB,,,47030,BLISTER PVC/ALUMINIUM,units,56.0,171 72 37119 99,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Sector is indicated for the treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction. Sector has been shown to reduce the rate of cardiovascular death and heart failure hospitalisation compared to angiotensin converting enzyme (ACE) inhibitor therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4479a73e-e56f-4528-a74f-c47ba6f6defa.json
447a46c4-223b-492a-afab-e23e01997ddb,SIMPONI,prescription,L04AB06,GOLIMUMAB,7677,,,WHO ATC Classification,,ILS,solution for injection,GOLIMUMAB/ML,2025-07-31T08:13:37.048472,IL,יאנסן סילג,,4766.269144,4039.211318,3672.010289,,7290014577299,SIMPONI 100MG/1ML SYR/PEN PREFILLED,7677,,85391,AUTO - INJECTOR PEN GLASS TYPE I,units,1.0,147 32 33213 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid Arthritis:Simponi, in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis when the response to disease-modifying anti-rheumatic drug (DMARD) therapy including MTX has been inadequate.Juvenile idiopathic arthritis: Polyarticular juvenile idiopathic arthritis (pJIA)Simponi in combination with MTX is indicated for the treatment of polyarticular juvenile idiopathic arthritis in children with a body weight of at least 40 kg, who have responded inadequately to previous therapy with MTX.Simponi 100 mg is not recommended in children aged less than 18.Psoriatic Arthritis:Simponi, alone or in combination with methotrexate, is indicated for the treatment of adult patients with active and progressive  psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.Axial spondyloarthritis:* Ankylosing SpondylitisSimponi is indicated for the treatment of adult patients with severe active ankylosing spondylitis who have responded inadequately to conventional therapy.* Non-radiographic axial spondyloarthritis (nr-Axial SpA)Simponi is indicated for the treatment of adults with severe, active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to, or are intolerant to nonsteroidal anti-inflammatory drugs (NSAIDS).Ulcerative colitis (UC):Simponi is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/447a46c4-223b-492a-afab-e23e01997ddb.json
447a59ad-cecb-4808-9629-d58591a9b84b,EZATOR S.K. 10/10 MG,prescription,C10BA05,ATORVASTATIN AND EZETIMIBE ,9336,,,WHO ATC Classification,,ILS,film coated tablets,"EZETIMIBE, ATORVASTATIN AS CALCIUM TRIHYDRATE",2025-07-31T02:51:11.508707,IL,SK PHARM(KS KIM),,145.8326912,123.5870265,98.86962118,,,EZATOR S.K. 10/80 MG 30 TAB,5745,,13724,BLISTER OPA/ALU/PVC/ALU,units,30.0,170 85 36878 99,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Prevention of Cardiovascular EventsEzator S.K. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaEzator S.K. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Ezator S.K. is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/447a59ad-cecb-4808-9629-d58591a9b84b.json
447aef6c-8065-4968-b086-9feb0bb4fe16,XEPLION 100 MG,prescription,N05AX13,PALIPERIDONE,6717,,,WHO ATC Classification,,ILS,suspension for injection extended release,PALIPERIDONE AS PALMITATE/,2025-07-31T10:34:08.144861,IL,יאנסן סילג,,683.0575031,578.8623165,492.64878,,7290008099844,XEPLION 100MG/1ML 1 SYRINGE 0.75ML,24060,,1629,SYRINGE PREFILLED  ,units,1.0,169 09 37280 99,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,Xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.Xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/447aef6c-8065-4968-b086-9feb0bb4fe16.json
447c39f7-6543-4ae2-a82a-bc721472243c,LAMICTAL DISPERSIBLE/CHEWABLE TABLETS 5 MG,prescription,N03AX09,LAMOTRIGINE,2810,,,WHO ATC Classification,,ILS,dispersible chewable tablets,LAMOTRIGINE,2025-07-31T04:33:03.683172,IL,ג.ס.ק,,40.56178728,34.374396,25.0908,,7290008105200,LAMICTAL 50MG 30 DISP/CHEWTAB,12197,,20920,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,068 90 28230 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy• Adults and adolescents aged 13 years and above- Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- Seizures associated with Lennox-Gastaut syndrome. Lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome.• Children and adolescents aged 2 to 12 years- Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.- Monotherapy of typical absence seizures.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/447c39f7-6543-4ae2-a82a-bc721472243c.json
448c6e93-d10f-49fd-b840-c7ed64662430,PARSABIV,prescription,H05BX04,ETELCALCETIDE,8121,,,WHO ATC Classification,,ILS,solution for injection,ETELCALCETIDE AS HYDROCHLORIDE/,2025-07-31T06:29:39.550524,IL,מדיסון,,405.3709415,343.5347115,292.3699672,,8715131020538,PARSABIV 2.5 MG/ 0.5ML 6VIALS,10309,,5361,VIAL GLASS TYPE I,units,6.0,161 94 35289 00,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,Parsabiv is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/448c6e93-d10f-49fd-b840-c7ed64662430.json
4493d6ef-5947-4995-acbc-03c06c1e3eb7,GALVUS 50 MG,prescription,A10BH02,VILDAGLIPTIN,6291,,,WHO ATC Classification,,ILS,tablets,VILDAGLIPTIN,2025-07-31T03:26:23.208330,IL,נוברטיס פארמה,,68.72294743,58.23978855,43.30095803,,7290006257673,GALVUS 50MG 56TAB,7834,,78970,BLISTER PA/ALUMINIUM/PVC,units,56.0,139 87 31692 02,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Galvus is indicated as an adjunct to diet and exercise in patients with  type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.Galvus is indicated as an adjunct to diet and exercise in patients with  type 2 diabetes mellitus• In combination with a thiazolidinedione, in patients with insufficient glycaemic control and for whom the use of a thiazolidinedione is appropriate.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4493d6ef-5947-4995-acbc-03c06c1e3eb7.json
449d4677-f1d1-4a4c-9801-bdd7354aaceb,PRENATAL,off-the-counter,,,3907,,,,,ILS,tablets,"BETACAROTENE, VITAMIN A, ASCORBIC ACID, FOLIC ACID, RIBOFLAVINE 3.4  MG, NICOTINAMIDE, CYANOCOBALAMIN (VIT B12), COLECALCIFEROL, BIOTIN, COPPER, SODIUM MOLYBDATE, MANGANESE AS SULFATE, ZINC AS OXIDE, FERROUS FUMARATE, POTASSIUM IODIDE 0.15  MG, MAGNESIUM OXIDE, CHROMIUM AS CHLORIDE, CALCIUM PANTOTHENATE, PYRIDOXINE (VIT B6) HYDROCHLORIDE, THIAMINE (VIT B1) MONONITRATE, TOCOPHEROL (VIT E) (AS TOCOPHERYL ACETATE), CALCIUM CARBONATE, SODIUM SELENATE",2025-07-31T12:52:05.625242,IL,מנון,,42.2558,35.81,nan,,066000010388,PRENATAL 30TAB,,,,BOTTLE POLYETHYLENE,units,30.0,129 27 29977 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Vitamin and mineral supplement for use during pregnancy and lactation.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/449d4677-f1d1-4a4c-9801-bdd7354aaceb.json
44a509e5-c9d5-4baf-90b2-065770ea0b70,BAVENCIO,prescription,,,8147,,,,,ILS,concentrate for solution for infusion,AVELUMAB/,2025-07-31T00:29:13.691466,IL,מרק סרונו,,4477.219242,3794.253764,3449.321603,,7290000845609,BAVENCIO 20MG/ML SOL FOR INJ 1 VIAL 10 ML,2629,,64838,VIAL GLASS TYPE I,units,1.0,159 77 35284 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Metastatic Merkel Cell CarcinomaBavencio is indicated for the treatment of adult patients with metastatic Merkel cell carcinoma (MCC).Locally Advanced or Metastatic Urothelial CarcinomaFirst-Line Maintenance Treatment of Urothelial CarcinomaBAVENCIO is indicated for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) that has not progressed with first-line platinum-containing chemotherapy.Previously-Treated Urothelial CarcinomaBAVENCIO is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) who:• Have disease progression during or following platinum-containing chemotherapy• Have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy Advanced Renal Cell CarcinomaBAVENCIO in combination with axitinib is indicated for the first-line treatment of patients with advanced renal cell carcinoma (RCC).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44a509e5-c9d5-4baf-90b2-065770ea0b70.json
44a538a6-0227-4c81-8094-3a78b70e8f5a,SILVEROL CREAM,prescription,D06BA01,SILVER SULFADIAZINE,2913,,,WHO ATC Classification,,ILS,cream,SULPHADIAZINE SILVER,2025-07-31T08:12:54.609595,IL,טבע,,22.87860818,19.388651,14.1523,,7290008001083,SILVEROL CREAM 50GR,19069,,9056,TUBE ALUMINIUM LAMINATE,units,50.0,020 56 20515 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of infected burn wounds, leg ulcers and pressure sores.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44a538a6-0227-4c81-8094-3a78b70e8f5a.json
44ba87e8-7997-4896-b056-d262736f2dd6,ELOCOM OINTMENT,prescription,D07AC13,MOMETASONE,3070,,,WHO ATC Classification,,ILS,ointment,MOMETASONE FUROATE 0.1 %,2025-07-31T02:15:49.130459,IL,אורגנון,,11.67831788,9.89688,7.224,,72989807,ELOCOM CREAM TUBE 15GR,5054,,9194,TUBE ALUMINIUM,units,15.0,060 06 26513 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,For the relief of the inflammatory and pruritic manifestations of corticosteroid - responsive dermatoses such as psoriasis and atopic dermatitis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44ba87e8-7997-4896-b056-d262736f2dd6.json
44bed66f-a22f-48f3-bd52-430b7f1be98f,TAGRISSO 40 MG,prescription,L01XE35,OSIMERTINIB,8353,,,WHO ATC Classification,,ILS,tablets,OSIMERTINIB AS MESYLATE,2025-07-31T09:01:25.872737,IL,אסטראזנקה,,25401.12848,21526.38102,19569.4373,,,TAGRISSO 40 MG 30 TAB,20819,,58674,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,155 86 34627 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Adjuvant Treatment of EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)•	TAGRISSO is indicated as adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations.First-line Treatment of EGFR Mutation-Positive Locally Advanced or Metastatic NSCLC•	TAGRISSO in combination with pemetrexed and platinum-based chemotherapy is indicated for the first line treatment of adult patients with locally advanced or metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations. Locally Advanced, Unresectable (Stage III) EGFR Mutation-Positive NSCLC •	TAGRISSO is indicated for the treatment of adult patients with locally advanced, unresectable (stage III) NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based chemoradiation therapy and whose tumors have EGFR exon 19 deletions or exon 21 L858R mutationsTAGRISSO as monotherapy is indicated for:•	The first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.•	The treatment of adult patients with locally advanced or metastatic EGFR T790M mutation-positive NSCLC.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44bed66f-a22f-48f3-bd52-430b7f1be98f.json
44c24443-9d8d-4ca2-a2e4-086e75609a4c,FLINDIX 5MG 20 TABLETS,29C,,,20839,,,,,,tablet,FLINDIX 5MG LETS,2025-07-31T20:27:32.069339,IL,nan,,,,,,,FLINDIX 5MG 20 TABLETS,,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44c24443-9d8d-4ca2-a2e4-086e75609a4c.json
44cc1a9b-7c86-4686-97c5-93c234d60c64,DIANE ® 35,prescription,G03HB01,CYPROTERONE AND ESTROGEN,46,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL, CYPROTERONE ACETATE",2025-07-31T01:54:25.837552,IL,באייר,,22.1377204,18.76078,13.694,,7298074040036,DIANE 21TAB,4105,,674,BLISTER PVC/ALUMINIUM,units,21.0,034 03 25085 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age.  For the treatment of acne, Diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44cc1a9b-7c86-4686-97c5-93c234d60c64.json
44d40802-0b24-4181-b732-3a5bced0091e,EREMFAT 300MG 1000TAB,29C,,,20074,,,,,,tablet,EREMFAT 300MG,2025-07-31T20:22:42.233809,IL,nan,,,,,,,EREMFAT 300MG 1000TAB,,,,,units,1000.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44d40802-0b24-4181-b732-3a5bced0091e.json
44dc6884-3880-4c87-9613-1e035dd8a50a,BLEPHAMIDE EYES DROPS 5ML,29C,,,20930,,,,,,drops,BLEPHAMIDE EYES DROPS,2025-07-31T20:00:59.974522,IL,nan,,,,,,,BLEPHAMIDE EYES DROPS 5ML,,,,,units,5.0,,not-registered,,ophthalmic,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44dc6884-3880-4c87-9613-1e035dd8a50a.json
44e7ce15-5c0c-4ef4-b910-5f6aa2dfd580,EURAX,off-the-counter,,,533,,,,,ILS,cream,CROTAMITONW/W,2025-07-31T11:51:09.427801,IL,דפריס,,28.7094,24.33,nan,,5011309023510,EURAX CREAM 10% 20GR,5094,,,TUBE ALUMINIUM,units,20.0,127 17 22132 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Relief of pruritus and treatment of scabies.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/44e7ce15-5c0c-4ef4-b910-5f6aa2dfd580.json
451ea001-6732-4eb1-86c9-de2990111f87,SPRAVATO,prescription,N06AX27,ESKETAMINE,8539,,,WHO ATC Classification,,ILS,solution for spray,ESKETAMINE AS HYDROCHLORIDE/VIAL,2025-07-31T08:35:38.903659,IL,יאנסן סילג,,2070.835174,1754.945141,1493.570333,,7290014577619,SPRAVATO NASAL SPRAY 28MG 2 VIALS,10682,,418,VIAL GLASS TYPE I,units,2.0,164 65 36113 00,valid,17.5,nasal,1.4,48,,,,,,,,,,0,Prescription required,"Spravato, in combination with a SSRI or SNRI, is indicated for adults with treatment-resistant Major Depressive Disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.Spravato, co-administered with oral antidepressant therapy, is indicated in adults with a moderate to severe episode of Major Depressive Disorder, as acute short-term treatment, for the rapid reduction of depressive symptoms, which according to clinical judgement constitute a psychiatric emergency.Limitations of Use: The effectiveness of SPRAVATO in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. Use of SPRAVATO does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of SPRAVATO.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/451ea001-6732-4eb1-86c9-de2990111f87.json
453c09d9-9147-4b47-aea2-e0be7bce9e46,SULIQUA 100/33,prescription,A10AE04,INSULIN GLARGINE,8095,,,WHO ATC Classification,,ILS,solution for injection,"LIXISENATIDE/ML / 1, INSULIN GLARGINE 100 UNITS /",2025-07-31T08:50:22.534508,IL,סאנופי אוונטיס,,780.6711275,661.5857306,563.0516857,,,SULIQUA 100/50 SOL FOR INJ 3ML 5 PRE FILLED PEN,10154,,64778,PRE-FILLED PEN GLASS TYPE I,units,15.0,159 27 35118 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sodium-glucose co-transporter-2 (SGLT-2) inhibitors,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/453c09d9-9147-4b47-aea2-e0be7bce9e46.json
4549b10c-731f-444c-942c-ff46a5cb5a90,PREGABALIN INOVAMED 150 MG,prescription,N03AX16,PREGABALIN,8325,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:53:44.372682,IL,אינובמד,,123.5665273,104.717396,77.8568,,7290104530364,PREGABALIN INOVAMED 75 MG 56 CAPS,10302,,4215,BLISTER PVC/ALUMINIUM,units,56.0,156 17 34774 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Pregabalin Inovamed is indicated for the:* treatment of peripheral and central neuropathic pain in adults. * Management of Fibromyalgia.* Treatment of Generalised Anxiety Disorder (GAD) in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4549b10c-731f-444c-942c-ff46a5cb5a90.json
454e5912-7c54-4aff-b100-86f94a0659fa,ALDACTONE 25 MG,prescription,C03DA01,SPIRONOLACTONE,3060,,,WHO ATC Classification,,ILS,coated tablets,SPIRONOLACTONE,2025-07-30T23:18:50.103499,IL,פיזר,,11.55869,9.7955,7.15,,,ALDACTONE 25MG 20T,1100,,9234,BLISTER PVC/ALUMINIUM,units,20.0,125 97 24826 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Congestive heart failure, cirrhotic ascites.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/454e5912-7c54-4aff-b100-86f94a0659fa.json
455c5214-23e4-4f8d-8941-5ab2ba0b9f47,LOCALIN DROPS,prescription,S01HA02,OXYBUPROCAINE,1809,,,WHO ATC Classification,,ILS,"eye drops, solution",OXYBUPROCAINE HYDROCHLORIDE 0.4 %W/V,2025-07-31T04:52:28.994755,IL,פישר,,28.4190197,24.083915,17.5795,,7290000843577,LOCALIN DROPS 15CC,12083,,1223,BOTTLE POLYETHYLENE,units,15.0,051 87 23942 00,valid,37.0,ocular,1.4,18,,,,,,,,,,0,Prescription required,As a topical ocular anaestetic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/455c5214-23e4-4f8d-8941-5ab2ba0b9f47.json
45641fac-f300-442f-bd89-35ef172fd7d5,GENOTROPIN 12 MG,prescription,H01AC01,SOMATROPIN,4041,,,WHO ATC Classification,,ILS,powder for solution for injection,SOMATROPIN,2025-07-31T03:30:25.677264,IL,פיזר,,534.9155587,453.3182902,385.8028002,,7317961351113,GENOTROPIN 16IU CARTRIDGE,7428,,19926,CARTRIDGE GLASS TYPE I,units,1.0,121 35 27540 22,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Children:   Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome. Short stature in children with renal insufficiency.   Growth disturbance (height SDS<2.5 and parenteral adjusted height SDS < -1) in short children born SGA (SGA - small for gestational age  i.e. born small in relation to the length of the fetus development)  with a birth witght and/or length < 2 SD  who failed to show catch up growth (HV SDS < 0 during the last year) by 4 years of age or later.   Prader willi syndrome  for improvement of growth and body composition.  Adults:    For adults who have suffered from growth-hormone deficiency since childhood.   For adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/45641fac-f300-442f-bd89-35ef172fd7d5.json
4572e5f2-10bd-4f79-9479-de33ef00d9fc,SIFROL ER 0.75 MG,prescription,N04BC05,PRAMIPEXOLE,6829,,,WHO ATC Classification,,ILS,tablets extended release,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 0.75  MG,2025-07-31T08:10:24.919735,IL,בורינגר אינגלהיים,,70.21616401,59.50522638,44.241804,,,SIFROL ER 0.75MG 30P.R TAB,9788,,3051,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,144 96 33089 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of signs and symptoms of idiopathic Parkinson's disease, as monotherapy or in combination with levodopa.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4572e5f2-10bd-4f79-9479-de33ef00d9fc.json
45731266-3b46-415f-bae0-b8c6d199f150,ORACORT E,off-the-counter,A01AC01,TRIAMCINOLONE,2080,,,WHO ATC Classification,,ILS,paste,"LIDOCAINE HYDROCHLORIDE MONOHYDRATE/, TRIAMCINOLONE ACETONIDE 0.1 G /",2025-07-31T12:41:19.497899,IL,תרו,,45.2648,38.36,nan,,7290000808222,ORACORT E PASTE 5G,15048,,,TUBE ALUMINIUM,units,5.0,037 10 22812 00,valid,nan,local oral,1.4,36,,,,,,,,,,0,,Adjunctive treatment and temporary relief of pain and symptoms associated with oral inflammatory and ulcerative lesions.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/45731266-3b46-415f-bae0-b8c6d199f150.json
4573bd6f-6fd3-4453-807d-7bb88f915d0c,LENALIDOMIDE TEVA ® 10 MG,prescription,L04AX04,LENALIDOMIDE,8424,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE AS HYDROCHLORIDE HYDRATE,2025-07-31T04:38:55.236595,IL,טבע,,22606.81805,19158.32038,17416.65489,,,LENALIDOMIDE TEVA  15 MG 21 CAPS,,,45710,BLISTER OPA/ALU/PVC/ALU,units,21.0,161 82 35502 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM): Lenalidomide Teva is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes: Lenalidomide Teva is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Lenalidomide Teva 7.5 mg is not indicated for treatment in MDS.Mantle Cell Lymphoma:Lenalidomide Teva is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphoma:Lenalidomide Teva in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4573bd6f-6fd3-4453-807d-7bb88f915d0c.json
458292dc-11b4-4c74-aba2-3b0add56cd86,NOCTURNO 3.75,prescription,N05CF01,ZOPICLONE,3875,,,WHO ATC Classification,,ILS,tablets,ZOPICLONE 3.75  MG,2025-07-31T05:50:22.443233,IL,אוניפארם,,19.72672316,16.717562,12.2026,,,NOCTURNO LS 3.75MG 20TAB,14231,,26756,BLISTER PVC/ALUMINIUM,units,20.0,121 81 30138 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Short-term treatment of insomnia in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/458292dc-11b4-4c74-aba2-3b0add56cd86.json
4583003b-cbb5-4b13-aa1e-6f88000b2e06,DASATINIB SANDOZ ® 100 MG,prescription,L01XE06,DASATINIB,9352,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB,2025-07-31T01:42:38.126414,IL,סנדוז,,6621.389314,5611.346876,5101.224433,,,DASATINIB SANDOZ  70 MG 60 TAB,,,14595,BLISTER OPA/ALU/PVC/ALU,units,60.0,173 10 36531 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with :  Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase.  Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate.  Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4583003b-cbb5-4b13-aa1e-6f88000b2e06.json
458ad7b4-cff2-4d99-b277-1fbfbdda3d53,NUBEQA 300 MG,prescription,L02BB06,DAROLUTAMIDE,8779,,,WHO ATC Classification,,ILS,film coated tablets,DAROLUTAMIDE,2025-07-31T05:57:16.988529,IL,באייר,,16154.21342,13690.01198,12445.46544,,7290015876155,NUBEQA 300 MG 112 TAB,,,75012,BLISTER PVC/ALUMINIUM,units,112.0,167 12 36564 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"NUBEQA ,in combination with ADT is indicated for the treatment of adult men with non metastatic castration resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease NUBEQA is indicated for the treatment of adult patients with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with docetaxel",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/458ad7b4-cff2-4d99-b277-1fbfbdda3d53.json
458bd77a-a68c-46cc-9dc3-d29ccad40e33,ODOMZO  200 MG,prescription,L01XX48,SONIDEGIB,7835,,,WHO ATC Classification,,ILS,"capsule, hard",SONIDEGIB AS DIPHOSPHATE,2025-07-31T06:03:31.205915,IL,תרו יבוא,,23077.916,19557.5568,17779.59709,,,ODOMZO  200 MG 30 CAPS,15481,,64576,BLISTER PCTFE (ACLAR)/PVC/ALU,units,30.0,156 37 34574 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Odomzo 200 mg is indicated for the treatment of adult patients with locally advanced basal cell carcinoma which cannot be treated with curative surgery or radiation therapy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/458bd77a-a68c-46cc-9dc3-d29ccad40e33.json
458f26fb-a2a2-4b51-8a05-4f25d1cadee5,BASAGLAR,prescription,A10AE04,INSULIN GLARGINE,7859,,,WHO ATC Classification,,ILS,solution for injection,INSULIN GLARGINE 100 U/ML,2025-07-31T00:29:02.075572,IL,אלי לילי,,266.70419,226.0205,180.8164,,,BASAGLAR 100 U/ML 5X3ML KWIK PEN,2815,,59388,CARTRIDGE GLASS TYPE I,units,15.0,155 01 34409 00,valid,25.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of adult and pediatric patients, 6 years and over, with type 1 diabetes mellitus or adults patients with type 2 diabetes mellitus who require basal (long acting) insulin for the control of hyperglycemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/458f26fb-a2a2-4b51-8a05-4f25d1cadee5.json
45b0a1ac-64a3-4c94-91f9-f53618fed8b0,BERIRAB,prescription,J06BB05,RABIES IMMUNOGLOBULIN,9327,,,WHO ATC Classification,,ILS,solution for injection,HUMAN-RABIES IMMUNOGLOBULIN/ML,2025-07-30T23:36:05.024368,IL,סי אס אל,,1508.397007,1278.302605,1087.917111,,,BERIRAB 150IU/ML 2ML,,,,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,114 08 29142 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of rabies.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/45b0a1ac-64a3-4c94-91f9-f53618fed8b0.json
45c38ccf-d305-464a-8d18-df6778f48d64,MAYZENT 0.25 MG,prescription,L04AA42,SIPONIMOD,9553,,,WHO ATC Classification,,ILS,film coated tablets,SIPONIMOD AS FUMARIC ACID 0.25  MG,2025-07-31T05:07:40.800662,IL,נוברטיס פארמה,,5957.235472,5048.504862,4589.549874,,7290018375266,MAYZENT1 MG 28 F.C. TABS,,,,BLISTER PA/ALU/PVC/ALU,units,28.0,165 54 36195 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Mayzent is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease, and active secondary progressive disease, in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/45c38ccf-d305-464a-8d18-df6778f48d64.json
45d3051b-b0a7-432a-b822-ca2e6912c013,DIOVAN ® 40 MG FILM-COATED TABLETS,prescription,C09CA03,VALSARTAN,6097,,,WHO ATC Classification,,ILS,film coated tablets,VALSARTAN,2025-07-31T01:57:41.020950,IL,נוברטיס פארמה,,24.03948864,20.372448,14.8704,,,DIOVAN 40MG 28 FC TABS,4476,,86388,BLISTER PVC/PA/ALUMINIUM,units,28.0,137 42 31281 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Diovan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial  Diovan significantly reduced hospitalisations for heart failure. There is no evidence that Diovan provides added benefits when it is used with an adequate dose of an ACE inhibitor.   Diovan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/45d3051b-b0a7-432a-b822-ca2e6912c013.json
45ddd58f-1840-4654-a234-bc0155ce8a03,GLYCERINE  CHILD 5SUP,off-the-counter,,,5039,,,,,ILS,tablet,GLYCERINE CHILD 5SUP,2025-07-31T19:42:07.414662,IL,רקח,,11.1038,9.41,,,,GLYCERINE  CHILD 5SUP,7056,,,,units,5.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/45ddd58f-1840-4654-a234-bc0155ce8a03.json
45f1a2ca-196b-4b1b-b1ec-3e6341632011,CEFOVIT FORTE 500,prescription,J01DB01,CEFALEXIN,2277,,,WHO ATC Classification,,ILS,capsules,CEFALEXIN AS MONOHYDRATE,2025-07-31T01:00:29.477474,IL,ויטאמד,,15.042463,12.74785,9.305,,,CEFOVIT FORTE 500MG 10CAPS,3586,,7691,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,026 85 25146 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of infections caused by cephalexin susceptible microorganisms.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/45f1a2ca-196b-4b1b-b1ec-3e6341632011.json
45f295c7-42a8-4c49-85d1-390deb44059e,BONEFOS 400MG 60CAP,29C,,,20313,,,,,,tablet,BONEFOS 400MG 60CAP,2025-07-31T20:01:22.194692,IL,nan,,,,,,,BONEFOS 400MG 60CAP,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/45f295c7-42a8-4c49-85d1-390deb44059e.json
460ce658-3c82-4a84-abe3-1c5279a3ce8f,CEFURAX 500MG 10TAB,prescription,,,4741,,,,,ILS,tablet,CEFURAX 500MG,2025-07-31T19:01:57.151022,IL,ביואבניר,,42.92784304,36.379528,26.5544,,,CEFURAX 500MG 10TAB,3763,,60869,,units,10.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/460ce658-3c82-4a84-abe3-1c5279a3ce8f.json
463dda11-52c6-4d3c-afb1-f3a11f716659,CHOLBAM 250 MG,prescription,A05AA03,CHOLIC ACID,7609,,,WHO ATC Classification,,ILS,"capsule, hard",CHOLIC ACID,2025-07-31T01:09:43.897356,IL,מגאפארם,,130813.574,110858.9659,100780.8781,,345043002025,CHOLBAM 250MG 90CAPS,9997,,62152,BOTTLE HDPE,units,90.0,155 89 34270 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"• Cholbam is indicated for the treatment of inborn errors in primary bile acid synthesis due to Sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, CTX) deficiency, • 2- (or alfa - ) methylacyl-CoA racemase (AMACR) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• Cholesterol 7 alfa - hydroxylase (CYP7A1) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• 3β-hydroxy-5-C27-steroid oxidoreductase deficiency (also known as 3β-hydroxy-5-C27-steroid dehydrogenase/isomerase or 3β-HSD or HSD3β7.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/463dda11-52c6-4d3c-afb1-f3a11f716659.json
467774cc-a6ff-4c52-b1a8-df6d4d2a4d74,GODAMED 100 MG,off-the-counter,B01AC06,ACETYLSALICYLIC ACID,3901,,,WHO ATC Classification,,ILS,tablets,ACETYLSALICYLIC ACID,2025-07-31T12:02:03.540494,IL,גרמזה,,18.054,15.3,nan,,,GODAMED 100MG 30TAB,7450,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,133 80 29716 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/467774cc-a6ff-4c52-b1a8-df6d4d2a4d74.json
46864aaa-9ad7-4960-b96c-0a7ff2669d2e,SPASMALGIN,prescription,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",1953,,,WHO ATC Classification,,ILS,tablets,"PARACETAMOL, ATROPINE SULFATE 0.4  MG, PAPAVERINE HYDROCHLORIDE, CODEINE PHOSPHATE",2025-07-31T06:27:02.115188,IL,רקח,,nan,nan,nan,,,PAPAVERINE 40MG 10 SUPP,16553,,8002,BLISTER PVC/ALUMINIUM,units,10.0,036 36 22208 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Analgesic and antispasmodic for the digestive system, the kidneys and the gall bladder.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/46864aaa-9ad7-4960-b96c-0a7ff2669d2e.json
469e4cf7-8f67-4bcb-a440-cbf81bd52109,MALARONE PAEDIATRIC TABLETS,prescription,P01BB51,"PROGUANIL, COMBINATIONS",4647,,,WHO ATC Classification,,ILS,film coated tablets,"ATOVAQUONE 62.5   MG, PROGUANIL HYDROCHLORIDE",2025-07-31T05:05:17.327237,IL,ג.ס.ק,,59.83165811,50.70479726,37.01080092,,7290008102605,MALARONE PAEDIATRIC 12TAB,13501,,59163,BLISTER PVC/ALUMINIUM,units,12.0,128 45 30732 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"""- Prevention of malaria:For the prophylaxis of P.falciparum malaria, including in areas where chloroquine resistance has been reported.- Treatment of malaria: For the treatment of acute, uncomplicated P.flaciparum malaria.Malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/469e4cf7-8f67-4bcb-a440-cbf81bd52109.json
46bf7d96-a806-4978-ba2e-a6271f76cb39,NICOTINELL GUM 2 MG (MINT),off-the-counter,N07BA01,NICOTINE,5618,,,WHO ATC Classification,,ILS,chewing gum,NICOTINE,2025-07-31T12:30:10.333576,IL,ג.ס.ק,,122.0592,103.44,nan,,,NICOTINELL GUM 2 MG (FRUIT) 96 GUMS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,96.0,115 78 29638 23,valid,nan,per os,1.4,30,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/46bf7d96-a806-4978-ba2e-a6271f76cb39.json
46d1ae91-6bfd-4c29-9f65-bc9a69cd749d,THYMOGLOBULINE,prescription,L04AA04,ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT),6996,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,IMMUNOGLOBULIN RABBIT ANTI-HUMAN THYMOCYTE/VIAL,2025-07-31T09:19:37.774494,IL,סאנופי אוונטיס,,858.4498877,727.4999371,619.1488827,,7290013773043,THYMOGLOBULINE 25MG/VIAL,20721,,29009,VIAL GLASS TYPE I,units,1.0,123 24 25723 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Immunosuppression in transplantation: prevention and treatment of graft rejection. Treatment of acute graft versus host disease (GvHD). Hematology  treatment of aplastic anemia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/46d1ae91-6bfd-4c29-9f65-bc9a69cd749d.json
46eef27a-f13e-48ac-8174-a89faa832dea,TARGIN 10,prescription,V03AB15,NALOXONE,6524,,,WHO ATC Classification,,ILS,tablets prolonged release,"OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (AS DIHYDRATE)",2025-07-31T09:05:57.535481,IL,רפא,,140.0785253,118.7106199,94.96849593,,7290008012973,TARGIN 40/20 MG 20 P.R.TAB,20682,,20609,BLISTER PVC/ALUMINIUM,units,20.0,139 95 31636 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Targin is indicated for the relief of moderate to severe pain.The oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. The opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/46eef27a-f13e-48ac-8174-a89faa832dea.json
46f2770b-1649-4dd7-b888-d8d0b251f4cb,ERELZI 25,prescription,L04AB01,ETANERCEPT,8655,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ 0.5  ML,2025-07-31T02:33:49.357813,IL,סנדוז,,2418.646751,2049.700727,1863.364298,,,ERELZI 50 MG/1ML 4 PRE FILLED PEN,,,41370,PRE-FILLED SYRINGE  GLASS TYPE I,units,4.0,163 20 36011 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritisErelzi is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs) including methotrexate (unless contraindicated) has been inadequate. Erelzi can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis .Etanercept, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.Juvenile idiopathic arthritisTreatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. Treatment of psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. Treatment of enthesitis-related arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, conventional therapy. Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Etanercept has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease.Axial spondyloarthritisAnkylosing spondylitis (AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs).Plaque psoriasisTreatment of adults patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Paediatric plaque psoriasisTreatment of chronic severe plaque psoriasis in children and adolescents from the age of 6 years who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/46f2770b-1649-4dd7-b888-d8d0b251f4cb.json
47206084-7e2b-48d7-a1b4-7e9ca3b71ed2,PHENOBARBITONE REKAH 100 MG,prescription,N03AA02,PHENOBARBITAL,7322,,,WHO ATC Classification,,ILS,tablets,PHENOBARBITAL,2025-07-31T06:40:54.910684,IL,רקח,,86.71057366,73.483537,54.6346,,7290008089319,PHENOBARBITONE 15MG 30TAB,16072,,19232,BLISTER PVC/ALUMINIUM,units,30.0,028 67 21938 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sedative, hypnotic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47206084-7e2b-48d7-a1b4-7e9ca3b71ed2.json
472ea47d-6478-4f26-9d3d-3b5025b3ce4b,CALMANERVIN S ELIXIR,off-the-counter,N05CM09,VALERIAN,2002,,,WHO ATC Classification,,ILS,elixir,"PASSIFLORA LIQ. EXTR./ML, VALERIAN LIQUID EXTRACT/ML",2025-07-31T11:22:24.794900,IL,סם און,,42.539,36.05,nan,,7290008066044,CALMANERVIN 20TAB,3043,,,BOTTLE HDPE,units,20.0,035 48 25445 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,relief of mild symptoms of mental stress and to aid sleep           .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/472ea47d-6478-4f26-9d3d-3b5025b3ce4b.json
472f0076-368c-4473-b062-1d20a33e0945,PRASUGREL - TRIMA 10 MG,prescription,B01AC22,PRASUGREL,9388,,,WHO ATC Classification,,ILS,film coated tablets,PRASUGREL,2025-07-31T06:49:47.225302,IL,תרימה,,117.2212294,99.34002494,73.8587546,,,PRASUGREL - TRIMA 10 MG 30 TAB,23876,,15855,BLISTER ALU/PVC/PA/ALU,units,30.0,173 37 36447 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prasugrel - Trima 10 mg, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI] undergoing primary or delayed percutaneous coronary intervention (PCI). The increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had TIA/CVA in the past and in those above the age of 75 or weight below 60 kg.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/472f0076-368c-4473-b062-1d20a33e0945.json
4753c50c-bc8e-4fc0-964e-ac56becf16bb,RIBOMUSTIN 100 MG,prescription,L01AA09,BENDAMUSTINE ,7666,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BENDAMUSTINE  HYDROCHLORIDE/VIAL,2025-07-31T07:34:18.127576,IL,דור שירותים פרמצבטיים,,649.2488679,550.210905,468.2646,,8718692510647,RIBOMUSTIN  25 MG 5 VIALS,18516,,65545,VIAL BROWN GLASS,units,5.0,152 40 33966 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"First-line of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotheraphy is not appropiate. Indolent non-Hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen.Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4753c50c-bc8e-4fc0-964e-ac56becf16bb.json
475920b6-b213-4d88-9620-a2884fd596c4,FUCIDIN,prescription,J01XC01,FUSIDIC ACID,4931,,,WHO ATC Classification,,ILS,tablets,SODIUM FUSIDATE,2025-07-31T03:21:07.110505,IL,דקסל פארמה,,28.36788263,24.04057957,17.5478683,,7290005680687,FUCIDIN OINT 2% 30GR,6386,,69963,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,100 49 24510 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of infections caused by Staphylococcus.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/475920b6-b213-4d88-9620-a2884fd596c4.json
4764e44c-6783-4f12-a9a5-c8db344a131b,XOFLUZA 40 MG,prescription,J05AX25,BALOXAVIR MARBOXIL,9453,,,WHO ATC Classification,,ILS,film coated tablets,BALOXAVIR MARBOXIL,2025-07-31T10:35:57.150300,IL,רוש,,nan,nan,nan,,7290014774186,XOFLUZA 40 MG 1 TAB,,,75512,BLISTER OPA/AL/PVC,units,1.0,163 38 35956 00,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,"Xofluza is indicated for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours and who are: •	otherwise healthy, or •	at high risk of developing influenza-related complications. Xofluza is indicated for post-exposure prophylaxis of influenza in persons 12 years of age and older following contact with an individual who has influenza.Limitations of Use: Influenza viruses change over time, and factors such as the virus type or subtype, emergence of resistance, or changes in viral virulence could diminish the clinical benefit of antiviral drugs. Consider available information on drug susceptibility patterns for circulating influenza virus strains when deciding whether to use Xofluza",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4764e44c-6783-4f12-a9a5-c8db344a131b.json
47943483-e352-4870-876f-1d47496b8bf3,CONCERTA 18 MG,prescription,N06BA04,METHYLPHENIDATE,4832,,,WHO ATC Classification,,ILS,tablets extended release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T01:28:07.351985,IL,יאנסן סילג,,233.7339737,198.0796388,158.463711,,7290008124966,CONCERTA 54MG XR 30TAB,3794,,63277,BOTTLE HDPE,units,30.0,126 85 30589 24,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Concerta is indicated for the treatment of Attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47943483-e352-4870-876f-1d47496b8bf3.json
47a0365f-ef6c-40ab-bc3c-51828834550e,NEMDATINE 10 MG,prescription,N06DX01,MEMANTINE,8514,,,WHO ATC Classification,,ILS,film coated tablets,MEMANTINE HYDROCHLORIDE,2025-07-31T05:41:12.578240,IL,טבע,,118.8329063,100.7058528,74.87424,,7290110732110,NEMDATINE 10 MG  56 TAB,,,25982,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,157 02 34401 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of patients with moderate to severe Alzheimer’s disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47a0365f-ef6c-40ab-bc3c-51828834550e.json
47a60a19-0c85-4c84-8451-a370cc36fe30,VELCADE 3.5 MG,prescription,L01XX32,BORTEZOMIB,4829,,,WHO ATC Classification,,ILS,powder for solution for injection,BORTEZOMIB 3.5   MG,2025-07-31T10:02:53.992614,IL,יאנסן סילג,,5218.217134,4422.21791,4020.1981,,7290008099981,VELCADE 3.5MG POWDER FOR INJ 1 VIAL,22260,,12925,VIAL GLASS TYPE I,units,1.0,131 60 31039 01,valid,10.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Velcade (bortezomib) for injection is indicated for the treatment of patients with multiple myeloma.Velcade (bortezomib) for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.Velcade in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47a60a19-0c85-4c84-8451-a370cc36fe30.json
47b4b9ad-87c1-42ec-b99c-e9d0f1ad96ed,PRADAXA 110,prescription,B01AE07,DABIGATRAN ETEXILATE,6317,,,WHO ATC Classification,,ILS,capsules,DABIGATRAN ETEXILATE AS MESILATE,2025-07-31T06:47:50.818083,IL,בורינגר אינגלהיים,,25.46931379,21.58416519,15.7548651,,9006968012391,PRADAXA 110MG 10CAPS,16814,,84207,BLISTER ALUMINIUM /ALUMINIUM,units,10.0,142 96 32974 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with nonvalvular  atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47b4b9ad-87c1-42ec-b99c-e9d0f1ad96ed.json
47b9e965-5795-40c5-83fe-6ecf7a415164,AKYNZEO 300mg/0.50mg,prescription,A04AA55,"PALONOSETRON, COMBINATIONS",8966,,,WHO ATC Classification,,ILS,capsules,"NETUPITANT, PALONOSETRON AS HYDROCHLORIDE 0.50  MG",2025-07-30T23:18:15.303378,IL,רפא,,1221.388222,1035.07481,880.914732,,7290017179254,AKYNZEO 4 CAPS,10856,,21585,BLISTER ALUMINIUM /ALUMINIUM,units,4.0,155 79 34343 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Prevention of Acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47b9e965-5795-40c5-83fe-6ecf7a415164.json
47c637d5-8f3b-48b7-b2eb-dd9c348eeb43,CO-DIOVAN 160/12.5 MG FILM-COATED TABLETS,prescription,C09DA03,VALSARTAN AND DIURETICS,4697,,,WHO ATC Classification,,ILS,film coated tablets,"VALSARTAN, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T01:25:34.305493,IL,נוברטיס פארמה,,35.9394429,30.457155,22.2315,,,CO-DIOVAN 160/25MG FCT 28TAB,3750,,59274,BLISTER OPA/AL/PVC,units,28.0,127 62 30611 21,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. This fixed combination should be used as second-line therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47c637d5-8f3b-48b7-b2eb-dd9c348eeb43.json
47cedcfa-819e-4446-9dcd-dc8cc149e1e6,DORZATOL-AVENIR,prescription,S01ED01,TIMOLOL,8281,,,WHO ATC Classification,,ILS,"eye drops, solution","TIMOLOL AS MALEATE/ML, DORZOLAMIDE AS HYDROCHLORIDE/ML",2025-07-31T02:02:45.608680,IL,ביואבניר,,43.85463982,37.164949,27.1277,,7290010287000,DORZATOL AVENIR  5ML  EYE DROP,,,51372,BOTTLE LDPE,units,5.0,155 93 34413 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension, open-angle glaucoma, or other secondary open-angle glaucoma when concomitant therapy is appropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47cedcfa-819e-4446-9dcd-dc8cc149e1e6.json
47f25da1-98cb-4894-a4fe-5166542ed083,EUCREAS 50/1000 MG,prescription,A10BA02,METFORMIN,7199,,,WHO ATC Classification,,ILS,film coated tablets,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",2025-07-31T02:42:57.425432,IL,נוברטיס פארמה,,91.51765362,77.55733702,57.6634476,,,EUCREAS 50/1000MG 60 FC TAB,5536,,34570,BLISTER ,units,60.0,147 90 33627 01,valid,34.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Eucreas is indicated in the treatment of type 2 diabetes mellitus:- Eucreas is indicated in the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.- Eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea.- Eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in adult patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47f25da1-98cb-4894-a4fe-5166542ed083.json
47fb3fa5-c491-45d5-9784-eab3509d9252,ZEPOSIA 0.23 MG,prescription,L04AA38,OZANIMOD,8798,,,WHO ATC Classification,,ILS,capsules,OZANIMOD AS HYDROCHLORIDE 0.23  MG,2025-07-31T10:46:53.068489,IL,ב.מ.ס,,1559.537953,1321.642392,1124.802035,,7290014396159,ZEPOSIA 0.23 MG 4 CAPS +3 CAPS 0.46 MG,,,72975,BLISTER PVC/PCTFE/AL,units,7.0,167 33 36599 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Zeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease as defined by clinical or imaging features.ZEPOSIA is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/47fb3fa5-c491-45d5-9784-eab3509d9252.json
4825982c-3b51-472c-b37b-6102d813e8e5,OVALEAP,prescription,G03GA05,FOLLITROPIN ALFA,8025,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN ALFA/,2025-07-31T06:19:11.272624,IL,תרומד,,626.8085455,531.1937063,452.07975,,,OVALEAP 450IU/0.75 ML 1 CARTRIDGE,15476,,23876,CARTRIDGE GLASS TYPE I,units,1.0,157 82 34716 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"In adult women:• Anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate.• Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra fallopian transfer (ZIFT).• Ovaleap in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/L.In adult men:• Ovaleap is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotropic hypogonadism with concomitant human chorionic gonadotropin (hCG) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4825982c-3b51-472c-b37b-6102d813e8e5.json
4825d22c-c929-4066-b803-884f27bc0e9a,CROMO-COMOD NASAL SPRAY,off-the-counter,R01AC01,CROMOGLICIC ACID,5270,,,WHO ATC Classification,,ILS,"nasal spray, solution",CROMOGLICIC ACID AS SODIUM/ML,2025-07-31T11:28:07.008517,IL,קיוומא,,48.7222,41.29,nan,,7290008144124,CROMO-COMOD NASAL SPRAY 15ML,3855,,,BOTTLE POLYETHYLENE,units,15.0,133 89 31023 00,valid,nan,nasal,1.4,24,,,,,,,,,,0,,"Prophylactic treatment for allergic rhinitis, seasonal and perrenial.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4825d22c-c929-4066-b803-884f27bc0e9a.json
4866be60-dcc5-433b-9021-f4f1ab6799ea,CRESTOR ® 5 MG,prescription,C10AA07,ROSUVASTATIN,7062,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T02:38:19.970644,IL,אוניפארם,,34.35970138,29.118391,21.2543,,,ESTO 15MG  28 F.C.TAB,5553,,38163,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,139 22 31615 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4866be60-dcc5-433b-9021-f4f1ab6799ea.json
4870f034-2f67-4cd7-919e-422cdf887bc2,NOVONORM 0.5 MG,prescription,A10BX02,REPAGLINIDE,3810,,,WHO ATC Classification,,ILS,tablets,REPAGLINIDE 0.5  MG,2025-07-31T05:55:14.818122,IL,נובו נורדיסק,,58.10739372,49.243554,35.9442,,,NOVONORM 2MG 90TAB,14216,,20254,BLISTER ALUMINIUM,units,90.0,114 47 29661 12,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Repaglinide is also indicated in combination with metformin in adults with type 2diabetes mellitus who are not satisfactorily controlled on metformin alone.Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4870f034-2f67-4cd7-919e-422cdf887bc2.json
48946466-0a75-41bf-9803-5473d7e36fe6,DIULO 5MG 50TAB,29C,,,20831,,,,,,tablet,DIULO 5MG,2025-07-31T20:17:01.953694,IL,nan,,,,,,,DIULO 5MG 50TAB,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/48946466-0a75-41bf-9803-5473d7e36fe6.json
48a0fa88-f3c9-4c5c-9a2b-f26bb0927744,ABITREXATE TEVA,prescription,L01BA01,METHOTREXATE,8843,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-30T23:10:53.068959,IL,טבע,,44.24807809,37.49837293,27.37107513,,7290000850627,ABITREXATE TEVA 50MG/2 ML 1VIAL,1935,,28807,VIAL GLASS TYPE I,units,1.0,048 96 23819 05,valid,37.0,"i.m, i.v, intrathecal, intra-arterial, intra ventricular",1.4,36,,,,,,,,,,0,Prescription required,"Antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. Palliation of acute lymphocytic leukemia. Abitrexate is also indicated in the treatment and prophylaxis of meningeal leukemia. Greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. In combination with other anticancer agents, Abitrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. Abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. Abitrexate is effective in the treatment of the advanced stages (III and IV Peter's Staging System) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. Psoriasis: because of the high risk attending its use, Abitrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Abitrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/48a0fa88-f3c9-4c5c-9a2b-f26bb0927744.json
48a55afd-1abc-403b-870b-2eca1d36e1d8,ZINNAT TABLETS 125 MG,prescription,J01DC02,CEFUROXIME,306,,,WHO ATC Classification,,ILS,tablets,CEFUROXIME AS AXETIL,2025-07-31T10:49:19.053644,IL,סנדוז,,20.0894882,17.02499,12.427,,,ZINNAT 125MG 10TAB,26062,,7881,BLISTER ALUMINIUM,units,10.0,041 40 25801 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Zinnat is indicated for the treatment of the infections listed below in adults and children from the age of 3 months .• Acute streptococcal tonsillitis and pharyngitis.• Acute bacterial sinusitis.• Acute otitis media.• Acute exacerbations of chronic bronchitis.• Cystitis.• Pyelonephritis.• Uncomplicated skin and soft tissue infections. •Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/48a55afd-1abc-403b-870b-2eca1d36e1d8.json
48cffb98-59a2-4533-ad9a-f167ecd324d4,XELJANZ 1 MG/ML,prescription,L04AA29,TOFACITINIB,9493,,,WHO ATC Classification,,ILS,oral solution,TOFACITINIB AS CITRATE/,2025-07-31T10:32:10.008432,IL,פיזר,,3690.792477,3127.790374,2843.445794,,,XELJANZ 1 MG/ML BOTTLE 240ML,,,28867,BOTTLE HDPE,units,240.0,176 47 37836 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"XELJANZ 1 MG/ML is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [RF+] or negative [RF-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (PsA) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (DMARDs). XELJANZ 1 MG/ML can be given in combination with methotrexate (MTX) or as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/48cffb98-59a2-4533-ad9a-f167ecd324d4.json
48f69528-bda3-417e-bbe0-b312b04612fd,CAMZYOS 10 MG,prescription,C01EB24,MAVACAMTEN,9202,,,WHO ATC Classification,,ILS,capsules,MAVACAMTEN,2025-07-31T00:50:58.220038,IL,ב.מ.ס,,8269.567707,7008.108538,6371.007761,,,CAMZYOS 10 MG 30 CAPS,,,70947,BLISTER PVC/PCTFE(ACLAR)/ALUMINIUM,units,30.0,174 20 37421 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/48f69528-bda3-417e-bbe0-b312b04612fd.json
48f90f8e-c7cf-40ac-9076-5e92b573e4f4,CARMUSTINE NAVINTA 100 MG,prescription,L01AD01,CARMUSTINE,8951,,,WHO ATC Classification,,ILS,powder and solvent for concentrate for solution for infusion,CARMUSTINE/VIAL,2025-07-31T00:55:46.599635,IL,אמ.בי.איי פארמה,,6445.181814,5462.01873,4965.471572,,7290018609804,CARMUSTINE NAVINTA 100 MG/VIAL 1VIAL,,,84828,VIAL GLASS TYPE I,units,1.0,166 26 36490 99,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved agents in the following:• Brain tumors - glioblastoma, medulloblastoma, astrocytoma and metastatic brain tumors.• Multiple myeloma - in combination with glucocorticoid such as prednisone. • Hodgkin’s disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy.• Non-Hodgkin’s lymphomas - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/48f90f8e-c7cf-40ac-9076-5e92b573e4f4.json
48ff61c5-11e6-46aa-9745-f70b7486de29,BONSERIN,prescription,N06AX03,MIANSERIN,1845,,,WHO ATC Classification,,ILS,tablets,MIANSERIN HYDROCHLORIDE,2025-07-30T23:41:07.842940,IL,רפא,,20.01560958,16.962381,12.3813,,7290008014960,BONSERIN 30MG 20TAB,2364,,8273,BLISTER PVC/ALUMINIUM,units,20.0,043 28 26084 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of depression.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/48ff61c5-11e6-46aa-9745-f70b7486de29.json
48ffe66d-d166-4d19-9a65-7cada6c9c941,EFMODY 10 MG,prescription,H02AB09,HYDROCORTISONE,9291,,,WHO ATC Classification,,ILS,modified release capsules hard,HYDROCORTISONE,2025-07-31T02:12:05.159320,IL,מדומי פארמה,,1737.221709,1472.221853,1252.954768,,,EFMODY 10 MG 50 M.R CAPS,,,47540,BOTTLE HDPE,units,50.0,173 55 37411 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/48ffe66d-d166-4d19-9a65-7cada6c9c941.json
49024606-0fc8-4393-9e14-e53c72c47f1d,BETNOVATE OINTMENT,prescription,D07AC01,BETAMETHASONE,254,,,WHO ATC Classification,,ILS,ointment,BETAMETHASONE AS VALERATE 0.1 %W/W,2025-07-30T23:37:49.038693,IL,ג.ס.ק,,8.454818,7.1651,5.23,,7290008102629,BETNOVATE OINT 15G,2083,,354,TUBE ALUMINIUM,units,15.0,017 04 24760 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.These include the following:Atopic dermatitis (including infantile atopic dermatitis)Nummular dermatitis (discoid eczema)Prurigo nodularisPsoriasis (excluding widespread plaque psoriasis)Lichen simplex chronicus (neurodermatitis) and lichen planusSeborrhoeic dermatitisIrritant or allergic contact dermatitisDiscoid lupus erythematosusAdjunct to systemic steroid therapy in generalised erythroderma",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49024606-0fc8-4393-9e14-e53c72c47f1d.json
4907465d-117a-45ae-864d-f35a6c2031b1,OXALIPLATIN TEVA ®,prescription,L01XA03,OXALIPLATIN,6466,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,OXALIPLATIN/ML,2025-07-31T06:20:36.922050,IL,טבע,,990.7102646,839.58497,714.5404,,,OXALIPLATIN TEVA 100MG/20ML  VIAL,15363,,64987,VIAL GLASS TYPE I,units,1.0,142 23 31784 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Oxaliplatin in combination with 5- fluorouracil (5-FU) and folinic acid (FA)  is indicated for :   - Adjuvant treatment of stage III (Duke's C) colon cancer after complete resection of the primary tumour.   - Treatment of metastatic colorectal cancer.Oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on NCCNguidelines, version 2.2014).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4907465d-117a-45ae-864d-f35a6c2031b1.json
49163cef-c774-43dd-9d88-f7cd1ad983c8,DAUNOXOME 50MG 1 VIAL,29C,,,20359,,,,,,injection,DAUNOXOME 50MG,2025-07-31T20:11:45.583525,IL,nan,,,,,,,DAUNOXOME 50MG 1 VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49163cef-c774-43dd-9d88-f7cd1ad983c8.json
4923c87c-1f95-46ef-ad2e-915b39199c0b,CALQUENCE,prescription,,,8293,,,,,ILS,capsules,ACALABRUTINIB,2025-07-31T00:50:03.958444,IL,אסטראזנקה,,26152.84939,22163.43267,20148.57516,,,CALQUENCE100 mg 60 capsule,10773,,12763,BLISTER ALUMINIUM FOIL,units,60.0,163 15 35692 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Mantle Cell Lymphoma CALQUENCE is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma CALQUENCE is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).Previously Untreated Mantle Cell Lymphoma CALQUENCE in combination with bendamustine and rituximab is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4923c87c-1f95-46ef-ad2e-915b39199c0b.json
492a5172-aa65-49cb-b73e-3ade5c16bc36,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7704,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:37:04.024386,IL,סנדוז,,2365.062168,2004.289973,1705.7787,,,BINOCRIT 10000 I.U/0.1 ML 6 SYRINGE PREFILLED,2563,,56146,SYRINGE PREFILLED  GLASS TYPE I,units,6.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/492a5172-aa65-49cb-b73e-3ade5c16bc36.json
49454cad-5c5a-43ba-9b2a-577aa647e028,LENALIDOMIDE TEVA ® 10 MG,prescription,L04AX04,LENALIDOMIDE,8423,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE AS HYDROCHLORIDE HYDRATE,2025-07-31T04:38:44.674358,IL,טבע,,21607.7809,18311.67873,16646.98066,,,LENALIDOMIDE TEVA  10 MG 21 CAPS,,,45709,BLISTER OPA/ALU/PVC/ALU,units,21.0,161 82 35502 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM): Lenalidomide Teva is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes: Lenalidomide Teva is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Lenalidomide Teva 7.5 mg is not indicated for treatment in MDS.Mantle Cell Lymphoma:Lenalidomide Teva is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphoma:Lenalidomide Teva in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49454cad-5c5a-43ba-9b2a-577aa647e028.json
4945fc1f-a3a2-4453-984c-2e3001423b9b,VALERIANE TINCTURA FLORIS,off-the-counter,N05CM09,VALERIAN,5048,,,WHO ATC Classification,,ILS,drops,VALERIAN DRY EXTRACT/ML,2025-07-31T13:33:52.393144,IL,פלוריש,,17.4758,14.81,nan,,7290008103725,VALERIANE TINCTURA DROPS 10ML,22022,,,BOTTLE LDPE,units,10.0,122 72 30249 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of mild symptoms of mental stress and to aid sleep for ages 12 and older,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4945fc1f-a3a2-4453-984c-2e3001423b9b.json
496906e7-0e7d-4819-8e79-3734f3dc3920,RIVAR TEVA 10 MG,prescription,B01AF01,RIVAROXABAN,9174,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:42:15.786493,IL,טבע,,259.285825,219.73375,175.787,,,RIVAR TEVA 20 MG 28 TAB,,,38145,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,168 08 36158 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/496906e7-0e7d-4819-8e79-3734f3dc3920.json
49777ec1-8862-4dc3-9228-3fd6f78e1e66,ISTURISA 1 MG,prescription,H02CA02,OSILODROSTAT ,9210,,,WHO ATC Classification,,ILS,film coated tablets,OSILODROSTAT  AS PHOSPHATE,2025-07-31T04:14:18.570108,IL,מדיסון,,29966.27337,25395.14805,23086.49823,,,ISTURISA 10 MG 60 F.C.T,,,25859,BLISTER PVC/ALUMINIUM,units,60.0,171 12 37207 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Isturisa is indicated for the treatment of endogenous Cushing’s syndrome in adult patients for whom surgery is not an option or has not been curative,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49777ec1-8862-4dc3-9228-3fd6f78e1e66.json
497aa5dd-c547-4f09-9f73-8636ed3f1e2f,AGIOCUR,off-the-counter,,,3067,,,,,ILS,granules,"ISPAGHULA HUSKS 2.2 G /, ISPAGHULA SEED/",2025-07-31T11:06:03.991609,IL,מגאפארם,,49.7134,42.13,nan,,7290008095105,AGIOCUR GRANULES 200GR,1085,,,CONTAINER PVC/PVDC,units,200.0,062 97 25777 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Managemant of bowel function.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/497aa5dd-c547-4f09-9f73-8636ed3f1e2f.json
49951ea2-ca7c-4e8f-a637-ea1247e36dc2,ADRENALINE AGUETTANT  0.1 MG/ML PRE-FILLED SYRINGE,prescription,C01CA24,EPINEPHRINE,9507,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE AS TARTRATE 0.1  MG /,2025-07-31T00:09:29.425062,IL,אמ.בי.איי פארמה,,nan,nan,nan,,,ADRENALINE AGUETTANT  0.1 MG/ML 10ML 10 PFS,,,17378,SYRINGE PREFILLED  POLYPROPYLENE,units,10.0,174 89 36923 99,valid,nan,"i.v, intracardiac",1.4,24,,,,,,,,,,0,Prescription required,ADRENALINE AGUETTANT  0.1 MG/ML PRE-FILLED SYRINGE is indicated for cardiac arrest and cardiopulmonary resuscitation (physical measures should be used first).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49951ea2-ca7c-4e8f-a637-ea1247e36dc2.json
49bcdf78-919d-4f81-95a8-1024ef715118,ERBITUX 5 MG/ML,prescription,L01XC06,CETUXIMAB,6541,,,WHO ATC Classification,,ILS,solution for infusion,CETUXIMAB/ML,2025-07-31T02:32:54.535682,IL,מרק סרונו,,4038.883894,3422.783113,3111.621012,,7290000845432,ERBITUX 5MG/ML 100ML,5531,,85543,VIAL GLASS TYPE I,units,100.0,141 40 31828 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (EGFR) - expressing, RAS wild-type metastatic colorectal cancer• In combination with irinotecan-based chemotherapy• In first-line in combination with FOLFOX• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanErbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (SCCHN)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49bcdf78-919d-4f81-95a8-1024ef715118.json
49c54b21-3ebd-4d45-a3e4-7286cee8c363,FLIXOTIDE DISKUS 100 MCG,prescription,R03BA05,FLUTICASONE,3539,,,WHO ATC Classification,,ILS,powder for inhalation,FLUTICASONE PROPIONATE,2025-07-31T03:08:22.404114,IL,ג.ס.ק,,135.7501087,115.0424701,85.533435,,,FLIXOTIDE DISK 500MCG 60DOSES,6110,,47597,BLISTER PVC/OPA/AL,units,60.0,069 97 28478 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Prophylactic management of all grades of asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49c54b21-3ebd-4d45-a3e4-7286cee8c363.json
49d0eddf-6c87-4bba-ad4e-68beb9690e7b,OFLODEX,prescription,J01MA01,OFLOXACIN,4398,,,WHO ATC Classification,,ILS,caplets,OFLOXACIN,2025-07-31T06:04:12.041777,IL,דקסל פארמה,,67.72123958,57.390881,42.6698,,,OFLODEX 200MG 20TAB,15123,,3658,BLISTER PVC/ALUMINIUM,units,20.0,121 99 30179 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Ofloxacin is indicated in adults for the treatment of the following bacterial infections: - acute pyelonephritis and complicated infections of the urinary tract - bacterial prostatitis, epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae- gonococcal urethritis and cervicitis due to susceptible Neisseria gonorrhoeae - pelvic inflammatory disease, in combination with other antibacterial agents.- Chronic bacterial sinusitis- Chronic suppurative otitis mediaIn the infections below, Ofloxacin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. -Uncomplicated acute cystitis - Urethritis - Bone and joint infections - Complicated skin and soft-tissue infections - Acute bacterial sinusitis - Acute exacerbation of chronic obstructive pulmonary disease including bronchitis - Community-acquired pneumonia - Prophylaxis of bacterial infections in neutropenic patientsOfloxacin is not effective against Treponema pallidum.Consideration should be given to official guidance on the appropriate use of antibacterial agents.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49d0eddf-6c87-4bba-ad4e-68beb9690e7b.json
49d38b96-fc45-4eef-ac4b-f4ee8919e033,CRESTOR ® 5 MG,prescription,C10AA07,ROSUVASTATIN,6365,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T02:38:30.420312,IL,אוניפארם,,55.96378212,47.426934,34.6182,,,ESTO 20 MG 28TAB,5481,,81268,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,139 22 31615 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49d38b96-fc45-4eef-ac4b-f4ee8919e033.json
49d437d4-469f-40eb-9061-c40f386e9f4e,GALLIFEN VETERINARY,off-the-counter,,,5626,,,,,ILS,suspension,FENBENDAZOLE/,2025-07-31T12:19:10.074297,IL,ליף-פלוריש,,59.5074,50.43,nan,,,LIFE ALCOHOL 70% BOTTLE 1 LITER,,,,BOTTLE HDPE,units,1000.0,173 23 35803 00,valid,nan,per os in drinking water,1.4,30,,,,,,,,,,0,,Treatment of chicken infected with Heterakis gallinarum (adult  stages) or Ascardia galli (adult stages),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49d437d4-469f-40eb-9061-c40f386e9f4e.json
49dc9bfc-b37d-4b46-853f-8d5101c9a915,MAGNESIUM SULFATE 50 % W/V INOVAMED,29C,A12CC02,MAGNESIUM SULFATE,20867,,,WHO ATC Classification,,ILS,solution for injection / concentrate for solution for inj/inf,MAGNESIUM SULFATE AS HEPTAHYDRATE/,2025-07-31T15:04:46.916726,IL,nan,,nan,nan,nan,,7290104530517,MAGNESIUM SULFATE 40MG/ML 1000ML HOSPIRAL USA SOLUTION FOR INJECTION,,,,AMPOULES POLYPROPYLENE,units,1.0,164 55 35842 00,valid,nan,"i.v, i.m",1.4,36,,,,,,,,,,0,,Magnesium Sulfate 50%w/v Inovamed  is indicated for:1.  the treatment of Magnesium deficiency in hypomagnesaemia. 2. the prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutrition. 3. the control and prevention of seizures in severe pre-eclampsia.  4. the control and prevention of recurrent seizures in eclampsia, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49dc9bfc-b37d-4b46-853f-8d5101c9a915.json
49e0ca04-b0cb-483b-bdd8-5027aca5ddc5,EPINEPHRINE INJECTION MYLAN JR 0.15 MG,prescription,R01AA14,EPINEPHRINE,8627,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE 0.5 MG/ML,2025-07-31T02:26:38.617344,IL,תרופארם,,269.6624528,228.5275125,194.4915,,,EPINEPHRINE  INJECTION MYLAN JR 0.15 MG 1 syr,5640,,6501,AUTO-INJECTOR GLASS TYPE I,units,1.0,161 58 35820 00,valid,17.5,i.m,1.4,19,,,,,,,,,,0,Prescription required,"Epinephrine is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera which includes bees,wasps,hornets,yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs,diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise induced anaphylaxis.Epinephrine is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.Epinephrine is intended for immediate administration as emergency supportive therapy only, and is not a substitute for immediate medical care", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49e0ca04-b0cb-483b-bdd8-5027aca5ddc5.json
49f88b10-2840-4761-baf2-0ada3b4b7fa6,GLYCERINE ADULT 20SUP,off-the-counter,,,1943,,,,,ILS,tablet,GLYCERINE ADULT 20SUP,2025-07-31T19:43:17.663381,IL,רקח,,20.1662,17.09,,,,GLYCERINE ADULT 20SUP,7059,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/49f88b10-2840-4761-baf2-0ada3b4b7fa6.json
4a055607-b201-415e-9f2f-e9005272bd14,BRAINAL 30MG 30 tab,29C,,,21009,,,,,,tablet,BRAINAL 30MG,2025-07-31T20:01:33.152896,IL,nan,,,,,,,BRAINAL 30MG 30 tab,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a055607-b201-415e-9f2f-e9005272bd14.json
4a1c5480-0ba8-4199-b793-24f13be83af9,ENTECAVIR TEVA ® 0.5 MG,prescription,J05AF10,ENTECAVIR,7810,,,WHO ATC Classification,,ILS,film coated tablets,ENTECAVIR AS MONOHYDRATE 0.5  MG,2025-07-31T02:23:53.349337,IL,טבע,,2274.594984,1927.622868,1640.5301,,,ENTECAVIR TEVA 0.5 MG 30 F.C.TAB,5594,,75751,BLISTER AL/OPA/AL/PVC,units,30.0,154 78 34441 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Entecavir teva is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with: - Compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. - Decompensated liver disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a1c5480-0ba8-4199-b793-24f13be83af9.json
4a3fc548-5e8b-49b1-8f97-9a21c66fb5e1,ZIAGEN TABLETS,prescription,J05AF06,ABACAVIR,4210,,,WHO ATC Classification,,ILS,film coated tablets,ABACAVIR AS SULFATE,2025-07-31T10:47:58.781118,IL,ג.ס.ק,,819.3082254,694.3290354,590.918328,,7290008086400,ZIAGEN 300MG 60TAB,26088,,17666,BLISTER PVC/ALUMINIUM,units,60.0,112 97 29542 22,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Ziagen is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected .,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a3fc548-5e8b-49b1-8f97-9a21c66fb5e1.json
4a5776a0-8b41-498c-bdaa-47104f7f1554,SPASMALGIN,prescription,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",1962,,,WHO ATC Classification,,ILS,tablets,"PARACETAMOL, ATROPINE SULFATE 0.4  MG, PAPAVERINE HYDROCHLORIDE, CODEINE PHOSPHATE",2025-07-31T06:27:28.307252,IL,רקח,,nan,nan,nan,,,PAPAVERINE 80MG 30TAB,16551,,8000,BLISTER PVC/ALUMINIUM,units,30.0,036 36 22208 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Analgesic and antispasmodic for the digestive system, the kidneys and the gall bladder.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a5776a0-8b41-498c-bdaa-47104f7f1554.json
4a66623b-c180-4fc7-9f82-f5be2184ad9f,TRIMBOW 100/6/12.5,prescription,R03AL09,"FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BECLOMETASONE ",8805,,,WHO ATC Classification,,ILS,pressurised inhalation solution,"GLYCOPYRRONIUM BROMIDE 12.5 MCG/ACTUATION, FORMOTEROL FUMARATE DIHYDRATE/ACTUATION, BECLOMETASONE DIPROPIONATE/ACTUATION",2025-07-31T09:43:21.640879,IL,קמהדע,,268.4884783,227.5326189,193.644782,,,TRIMBOW 120 ACTUATIONS,,,64719,CONTAINER ALUMINIUM,units,120.0,164 94 36103 00,valid,17.5,inhalation,1.4,22,,,,,,,,,,0,Prescription required,"COPD Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist. Asthma Maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.…",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a66623b-c180-4fc7-9f82-f5be2184ad9f.json
4a6cf7d8-ec26-49a8-b8a3-2c5afcaf3f8f,UBRELVY 100 MG,prescription,,,9115,,,,,ILS,tablets,UBROGEPANT AS TRIHYDRATE,2025-07-31T09:50:29.930797,IL,אב-וי,,nan,nan,nan,,,UBRELVY 100 MG 10 TAB,21186,,76390,POUCH ALUMINIUM,units,10.0,169 78 37038 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Ubrelvy is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults.Limitations of UseUbrelvy is not indicated for the preventive treatment of migraine.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a6cf7d8-ec26-49a8-b8a3-2c5afcaf3f8f.json
4a6f3f66-63be-4255-858a-2e2fc16b12ed,NIFEDILONG 30,prescription,C08CA05,NIFEDIPINE,6237,,,WHO ATC Classification,,ILS,tablets prolonged release,NIFEDIPINE,2025-07-31T05:46:14.959681,IL,כ.צ.ט,,35.90727256,30.429892,22.2116,,,NIFEDILONG 30MG 30 SRTAB,14469,,87931,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,137 89 31415 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Chronic stable angina, hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a6f3f66-63be-4255-858a-2e2fc16b12ed.json
4a858eaf-0d2a-440b-a439-1869dc59fbe5,RAFASSAL 4 GRAM ENEMA,prescription,A07EC02,MESALAZINE,8692,,,WHO ATC Classification,,ILS,enema,MESALAZINE/,2025-07-31T07:13:48.247517,IL,רפא,,157.0765621,133.1157306,106.4925845,,7290008013765,RAFASSAL 1 G 50 GRANULES,,,76624,BOTTLE POLYETHYLENE,units,50.0,029 58 25321 00,valid,25.0,rectal,1.4,18,,,,,,,,,,0,Prescription required,Treatment and prevention of ulcerative colitis and Crohn's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a858eaf-0d2a-440b-a439-1869dc59fbe5.json
4a8a0054-7dda-4547-96a8-3743d0888a36,FENTANYL - KALCEKS 0.05 MG/ML,prescription,N01AH01,FENTANYL,8908,,,WHO ATC Classification,,ILS,solution for injection,FENTANYL AS CITRATE 0.05 MG/ML,2025-07-31T03:00:52.562650,IL,מדי מרקט,,47.6897,40.415,29.5,,,FENTANYL - KALCEKS 0.05 MG/ML 10ML 10 AMP,,,71454,AMPOULES GLASS TYPE I,units,10.0,165 89 35639 00,valid,37.0,"epidural, i.v",1.4,36,,,,,,,,,,0,Prescription required,For analgesic action of short duration during anesthtic periods (premedication induction and maintenance) and in the immediate postoperative period as need arises. As a narcotic analgesic supplement in general or regional anesthesia. For administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia and as an adjunct in the maintenance of general or regional anesthesia. For use as an anesthetic agent with oxygen in selected high-risk patients (open heart surgery or certain neurological or orthopedic procedures). By the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections and as adjunct to general anesthesia., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4a8a0054-7dda-4547-96a8-3743d0888a36.json
4ab4517b-e3b1-44e5-bb92-2b0bbe552962,VENTOLIN SYRUP,prescription,R03AC02,SALBUTAMOL,292,,,WHO ATC Classification,,ILS,syrup,SALBUTAMOL AS SULFATE/,2025-07-31T10:06:07.978516,IL,ג.ס.ק,,11.63566995,9.860737688,7.19761875,,,VENTOLIN SYRUP 150ML,22059,,2369,BOTTLE GLASS TYPE III,units,150.0,050 54 24044 20,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Relief of bronchospasm in bronchial asthma of all types,chronic bronchitis ,emphysema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4ab4517b-e3b1-44e5-bb92-2b0bbe552962.json
4ad1810b-1b41-428d-81be-001a997daccf,TIVICAY 10 MG,prescription,J05AX12,DOLUTEGRAVIR,9408,,,WHO ATC Classification,,ILS,film coated tablets,DOLUTEGRAVIR AS SODIUM,2025-07-31T09:23:05.179865,IL,ג.ס.ק,,593.1964744,502.7088989,427.8373608,,7290014547513,TIVICAY 5  MG 60 DISPERSIBLE TABLETS,,,17313,BOTTLE HDPE,units,60.0,160 06 35311 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4ad1810b-1b41-428d-81be-001a997daccf.json
4af162ef-ee2f-459b-aa54-6e2369c8453d,XPOVIO 20 MG,off-the-counter,L01XX66,SELINEXOR,5527,,,WHO ATC Classification,,ILS,tablets,SELINEXOR,2025-07-31T12:20:15.153878,IL,טבע,,30.5502,25.89,nan,,7290111092886,LINEX FOR KIDS 0.05% 10ML,,,,BLISTER PVC/PCTFE/PVC/ALU,units,10.0,167 04 36451 99,valid,nan,per os,1.4,60,,,,,,,,,,0,,"Multiple Myeloma•	Xpovio® in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.•	XPOVIO in combination with dexamethasone is indicated for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least three prior therapies and whose disease is refractory to at least one proteasome inhibitor (PI), at least one immunomodulatory agent (IMiD), and an anti- CD38 monoclonal antibody (mAb).Diffuse Large B-Cell LymphomaXPOVIO is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4af162ef-ee2f-459b-aa54-6e2369c8453d.json
4afd3c0e-96ed-48e1-94d6-3662293cff6f,VENCLEXTA 10 MG TABLETS,prescription,L01XX52,VENETOCLAX,7986,,,WHO ATC Classification,,ILS,film coated tablets,VENETOCLAX,2025-07-31T10:03:52.114842,IL,אב-וי,,336.6408875,285.2889004,242.7990642,,,VENCLEXTA 10 MG 14 TABLETS,,,60674,BLISTER PVC/PCTFE/AL,units,14.0,158 19 34868 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaVENCLEXTA in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL), who have received at least one prior therapy.VENCLEXTA in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).Acute Myeloid LeukemiaVENCLEXTA in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4afd3c0e-96ed-48e1-94d6-3662293cff6f.json
4b12423c-c528-41d6-bc03-57a16240d32b,TASIGNA 150 MG,prescription,L01XE08,NILOTINIB,7040,,,WHO ATC Classification,,ILS,capsules,NILOTINIB AS HYDROCHLORIDE MONOHYDRATE,2025-07-31T09:07:38.286935,IL,נוברטיס פארמה,,14021.80814,11882.88878,10802.62616,,,TASIGNA 200MG 120CAPS,20742,,37070,BLISTER PVC/PVDC/ALUMINIUM,units,120.0,145 84 33271 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b12423c-c528-41d6-bc03-57a16240d32b.json
4b192be2-21c2-4827-a5f5-77370cc1ea7d,STEGLUJAN 15/100 MG TABLETS,prescription,A10BD24,SITAGLIPTIN AND ERTUGLIFLOZIN ,8541,,,WHO ATC Classification,,ILS,film coated tablets,"SITAGLIPTIN AS MONOHYDRATE PHOSPHATE, ERTUGLIFLOZIN (L-PGA)",2025-07-31T08:42:00.434960,IL,מ.ס.ד. ישראל,,320.7510477,271.8229338,231.3386671,,,STEGLUJAN 5/100 MG 28 TAB,,,,BLISTER PVC/ALUMINIUM,units,28.0,167 02 36036 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,STEGLUJAN is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:• when metformin and/or a sulphonylurea (SU) and one of the monocomponents of Steglujan do not provide adequate glycaemic control• in patients already being treated with the combination of ertugliflozin and sitagliptin as separate tablets.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b192be2-21c2-4827-a5f5-77370cc1ea7d.json
4b2989cf-0f1b-4ffb-9ceb-98907c89c6d1,DISOTHIAZIDE 25,prescription,C03AA03,HYDROCHLOROTHIAZIDE,4620,,,WHO ATC Classification,,ILS,tablets,HYDROCHLOROTHIAZIDE,2025-07-31T02:00:25.645662,IL,דקסל פארמה,,12.197247,10.33665,7.545,,,DISOTHIAZIDE 25MG 30TAB,4344,,56306,BLISTER PVC/ALUMINIUM,units,30.0,032 85 21827 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Diuretic to treat hypertension, edema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b2989cf-0f1b-4ffb-9ceb-98907c89c6d1.json
4b2aacc7-f93e-4407-becd-81bfc09fdaa2,DUPHASTON,prescription,G03DB01,DYDROGESTERONE,8190,,,WHO ATC Classification,,ILS,film coated tablets,DYDROGESTERONE,2025-07-31T02:07:44.240667,IL,אבוט,,65.0280275,55.10850033,40.9728627,,7290014257306,DUPHASTON 10MG 42 TABS,,,12658,BLISTER PVC/ALUMINIUM,units,42.0,129 45 30880 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Cases where progesterone supplement is needed.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b2aacc7-f93e-4407-becd-81bfc09fdaa2.json
4b550244-833c-464d-a383-a54f1b8293f3,LABETAKERN 5 MG/ML,prescription,C07AG01,LABETALOL,9626,,,WHO ATC Classification,,ILS,solution for injection,LABETALOL HYDROCHLORIDE/,2025-07-31T04:31:16.355880,IL,אמ.בי.איי פארמה,,182.8748384,154.9786835,123.9829468,,,LABETAKERN 5 MG/ML,,,,AMPOULES GLASS TYPE I,units,5.0,176 78 37176 99,valid,25.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Treatment of hypertension when rapid control of blood pressure is essential,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b550244-833c-464d-a383-a54f1b8293f3.json
4b5deeb5-d215-464b-bd6a-fbddf8bede12,FENISTIL GEL,off-the-counter,D04AA13,DIMETINDENE,5220,,,WHO ATC Classification,,ILS,gel,DIMETINDENE MALEATE 0.1 %W/W,2025-07-31T11:53:33.032311,IL,ג.ס.ק,,89.9632,76.24,nan,,7290011363543,FENISTIL GEL 100GR,6423,,,TUBE ALUMINIUM,units,100.0,133 24 24020 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b5deeb5-d215-464b-bd6a-fbddf8bede12.json
4b6a9294-eb1e-4035-a5d7-d58808cae745,PABAL,prescription,H01BB03,CARBETOCIN,8158,,,WHO ATC Classification,,ILS,solution for injection,CARBETOCIN/ML,2025-07-31T06:24:00.051127,IL,פרינג,,667.8752175,565.9959722,481.6986998,,7640128548751,PABAL  100 MCG/ML  5VIAL,,,11763,VIAL GLASS TYPE I,units,5.0,160 34 35090 00,valid,17.5,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,PABAL is indicated for the prevention of postpartum haemorrhage due to uterine atony,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b6a9294-eb1e-4035-a5d7-d58808cae745.json
4b6fcda2-bd0a-4d5d-89e5-dd363da78a9d,REVOLADE 25 MG,prescription,B02BX05,ELTROMBOPAG,6328,,,WHO ATC Classification,,ILS,film coated tablets,ELTROMBOPAG AS OLAMINE,2025-07-31T07:31:37.571737,IL,נוברטיס פארמה,,7728.289482,6549.398157,5953.998324,,7290014547254,REVOLADE 50MG 28TAB,18441,,24718,BLISTER POLYAMIDE/ALUMINIUM/PVC,units,28.0,143 55 32036 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (ITP) who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).Revolade is indicated for the treatment of paediatric patients aged 6 year and above with primary immune thrombocytopenia (ITP) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).Revolade is indicated for the treatment of adult patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.Revolade is indicated for the treatment of thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.Revolade is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 6 years and older with severe aplastic anemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b6fcda2-bd0a-4d5d-89e5-dd363da78a9d.json
4b87f935-d0ea-4179-8554-ee99991b2821,LAMISIL ONCE,off-the-counter,,,2801,,,,,ILS,solution,TERBINAFINE AS HYDROCHLORIDE/G,2025-07-31T12:17:03.362901,IL,ג.ס.ק,,51.0822,43.29,nan,,7290011363437,LAMISIL CREAM 1% 15GR(GSL),12382,,,TUBE ALUMINIUM,units,15.0,137 26 31486 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,For the treatment of athlete's foot.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4b87f935-d0ea-4179-8554-ee99991b2821.json
4bb2f4c7-c548-4253-a92e-f1c89733c8e4,ALLERGY-CARE,off-the-counter,R06AE07,CETIRIZINE,5552,,,WHO ATC Classification,,ILS,tablets,CETIRIZINE DIHYDROCHLORIDE,2025-07-31T11:12:06.089896,IL,מכבי קאר,,37.6538,31.91,nan,,,ALLERGY-CARE 20 tab,,,,BLISTER PVC/ALUMINIUM,units,20.0,134 83 31477 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antihistaminic drug for the treatment of allergies. For the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in children aged 6 years and over and adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4bb2f4c7-c548-4253-a92e-f1c89733c8e4.json
4bbd8c19-9fd7-443f-b68e-83c91a9e7cb5,INTRATECT 100 G/L,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",6898,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T04:10:16.262752,IL,קמהדע,,3163.527229,2680.955398,2437.23218,,,INTRATECT 50MG/ML 1VIAL (10G/200ML),9457,,4134,VIAL GLASS TYPE II,units,200.0,159 72 35202 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, and children and adolescents (0-18 years) in:     -	Primary immunodeficiency syndromes (PID) with impaired antibody production     -	Secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent      infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)*      or serum IgG level of <4 g/l     * PSAF= failure to mount at least a 2-fold rise in IgG antibody titre to pneumococcal         polysaccharide and polypeptide antigen vaccinesImmunomodulation in adults, and children and adolescents (0-18 years) in:     -	Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery      to correct the platelet count     -	Guillain Barré syndrome     -	Kawasaki disease (in conjunction with acetylsalicylic acid)     -	Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)     -	Multifocal motor neuropathy (MMN)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4bbd8c19-9fd7-443f-b68e-83c91a9e7cb5.json
4bc0f6b2-3816-40a6-ba04-557ce8ecd9d8,ATTENT XR 30 MG,prescription,N06BA01,AMFETAMINE,8484,,,WHO ATC Classification,,ILS,capsules extended release,"DEXTROAMPHETAMINE SULFATE 7.5  MG, DEXTROAMPHETAMINE SACCHARATE 7.5  MG, AMPHETAMINE SULFATE 7.5  MG, AMPHETAMINE ASPARTATE MONOHYDRATE 7.5  MG",2025-07-30T23:30:34.371747,IL,טבע,,nan,nan,nan,,,ATTENT 20 MG 30 TAB,,,16795,BOTTLE HDPE,units,30.0,170 94 35998 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4bc0f6b2-3816-40a6-ba04-557ce8ecd9d8.json
4bd20363-7735-4b40-880c-00a8ee386651,TARGIN 10,prescription,V03AB15,NALOXONE,6523,,,WHO ATC Classification,,ILS,tablets prolonged release,"OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (AS DIHYDRATE)",2025-07-31T09:06:14.533707,IL,רפא,,52.16972306,44.21163168,32.271264,,7290008012973,TARGIN 5/2.5 MG 20 P.R.TAB,20681,,20606,BLISTER PVC/ALUMINIUM,units,20.0,139 95 31636 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Targin is indicated for the relief of moderate to severe pain.The oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. The opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4bd20363-7735-4b40-880c-00a8ee386651.json
4bd2fd33-5b45-4c8d-8c7d-a9296a7117fe,KLISYRI/ONAKTA OINTMENT 10 MG 5 SACHETS,prescription,,,9215,,,,,ILS,ointment,KLISYRI/ONAKTA OINTMENT 10 MG 5 SACHETS,2025-07-31T19:15:39.099728,IL,מגאפארם,,298.9334821,253.3334707,215.6029538,,,KLISYRI/ONAKTA OINTMENT 10 MG 5 SACHETS,,,,,units,5.0,,not-registered,17.5,topical,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4bd2fd33-5b45-4c8d-8c7d-a9296a7117fe.json
4bd372f7-c076-466f-9d7c-29b8c0ff6915,PARAMOL,off-the-counter,N02BE01,PARACETAMOL,5443,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T12:46:11.117613,IL,ליף-דקסון,,21.3462,18.09,nan,,,PARAMOL PLUS 20 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,20.0,127 96 30764 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4bd372f7-c076-466f-9d7c-29b8c0ff6915.json
4bd82045-e6de-4431-9ab5-639d7eaff693,CEFOTAXIMA 1G NORMON SPAIN powder for solution for injection,29C,,,20820,,,,,,injection,CEFOTAXIMA 1G NORMON SPAIN powder for solution for injection,2025-07-31T20:04:25.792890,IL,nan,,,,,,,CEFOTAXIMA 1G NORMON SPAIN powder for solution for injection,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4bd82045-e6de-4431-9ab5-639d7eaff693.json
4bed0c12-e217-4c9a-9a38-91eadf3e0d60,NUEDEXTA,prescription,C01BA01,QUINIDINE,8001,,,WHO ATC Classification,,ILS,capsules,"QUINIDINE SULFATE, DEXTROMETHORPHAN HYDROBROMIDE",2025-07-31T07:12:31.743075,IL,רקח,,nan,nan,nan,,7290008128308,QUINIDINE SULFATE 200MG 30 TAB,17004,,7077,BOTTLE HDPE,units,30.0,149 88 33554 00,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of Pseudobulbar Affect (PBA) .,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4bed0c12-e217-4c9a-9a38-91eadf3e0d60.json
4c254246-6e89-4370-accb-2fade1742609,CINACALCET TARO 30 MG,prescription,H05BX01,CINACALCET,8474,,,WHO ATC Classification,,ILS,film coated tablets,CINACALCET AS HYDROCHLORIDE,2025-07-31T01:13:49.957736,IL,תרו יבוא,,1804.073869,1528.87616,1301.1712,,,CINACALCET TARO 60 MG 28 TAB,,,45479,BLISTER PVC/PE/PVDC/AL,units,28.0,160 90 35048 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet Taro may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma. Reduction of hypercalcaemia in patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4c254246-6e89-4370-accb-2fade1742609.json
4c45d7da-4eec-4084-b9d2-b34b2784c3e8,RECITAL 20,prescription,N06AB04,CITALOPRAM,4359,,,WHO ATC Classification,,ILS,tablets,CITALOPRAM AS HYDROBROMIDE,2025-07-31T07:19:20.646434,IL,אוניפארם,,31.02627218,26.293451,19.1923,,,RECITAL 20MG 28TAB,18305,,28048,BLISTER PVC/ALUMINIUM,units,28.0,123 22 30309 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of states of depression or panic disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4c45d7da-4eec-4084-b9d2-b34b2784c3e8.json
4c70f5be-e882-4ffa-8599-3937f331438d,HUMALOG,prescription,A10AB04,INSULIN LISPRO,9164,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO 100 U/ML,2025-07-31T03:48:31.212892,IL,אלי לילי,,184.235775,156.1320197,124.9056158,,7290008067676,HUMALOG KWIKPEN JUNIOR 100 U/ML,8498,,85372,CARTRIDGE GLASS TYPE I,units,15.0,102 83 28580 00,valid,25.0,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilization of diabetes mellitus.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4c70f5be-e882-4ffa-8599-3937f331438d.json
4c76abc3-d222-4aad-a0fb-d81a63fca42f,BIKTARVY 30/120/15 MG,prescription,J05AR20,"EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND BICTEGRAVIR ",8287,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR ALAFENAMIDE AS FUMARATE, EMTRICITABINE, BICTEGRAVIR AS SODIUM",2025-07-30T23:38:47.385254,IL,גיליאד,,3298.413009,2795.265386,2541.150351,,,BIKTARVY 30 TAB,,,25132,BOTTLE HDPE,units,30.0,178 43 38033 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Biktarvy 30/120/15 mg is indicated for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4c76abc3-d222-4aad-a0fb-d81a63fca42f.json
4c79b9fe-24ab-403d-bb3b-1a938f0a66f5,ADVIL FORTE 400,off-the-counter,M02AA13,IBUPROFEN,5611,,,WHO ATC Classification,,ILS,capsules liquid filled,IBUPROFEN,2025-07-31T11:05:24.462226,IL,ג.ס.ק,,124.0534,105.13,nan,,,ADVIL FORTE 400 mg 50 caps,,,,BLISTER PVC/PE/PVDC/AL,units,50.0,145 20 32014 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the relief of mild to moderate pain associated with headache, toothache, backache, muscularand menstrual pains.Antipyretic.Anti-inflammatory for rheumatic diseases.For the treatment of pain associated with migraine.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4c79b9fe-24ab-403d-bb3b-1a938f0a66f5.json
4c8c3d3b-443a-4619-a15d-f06821c44ee5,CREON 10000,prescription,A09AA02,"MULTIENZYMES (LIPASE, PROTEASE ETC.)",8189,,,WHO ATC Classification,,ILS,capsules,PANCREATIN,2025-07-31T01:32:59.169682,IL,אבוט,,81.23920362,68.84678579,51.18720133,,,CREON 25000U 50 CAPS,,,12657,BLISTER ALUMINIUM /ALUMINIUM,units,50.0,103 48 28837 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Pancreatic exocrine insufficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4c8c3d3b-443a-4619-a15d-f06821c44ee5.json
4c8e0801-9e8b-4f13-aa78-b6f5d6c79429,SEPTOL,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",3958,,,WHO ATC Classification,,ILS,solution - external,"ALCOHOL70 %W/V, CHLORHEXIDINE GLUCONATE 0.5 %W/V",2025-07-31T13:17:24.690493,IL,טבע,,31.801,26.95,nan,,7291064690419,SEPTOL 500ML,19637,,,BOTTLE HDPE,units,500.0,029 79 25425 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Antiseptic hand rub .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4c8e0801-9e8b-4f13-aa78-b6f5d6c79429.json
4cc7ddd2-77c6-419d-b209-958a9df0bdb4,FUCIDIN,prescription,J01XC01,FUSIDIC ACID,4930,,,WHO ATC Classification,,ILS,tablets,SODIUM FUSIDATE,2025-07-31T03:20:56.788240,IL,דקסל פארמה,,39.43841194,33.422383,24.3959,,7290005680687,FUCIDIN CREAM 30GR,6385,,69964,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,100 49 24510 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of infections caused by Staphylococcus.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4cc7ddd2-77c6-419d-b209-958a9df0bdb4.json
4cced7f7-0394-4903-9fde-ad282373ffef,ETORICOXIB TARO 120 MG,prescription,M01AH05,ETORICOXIB,8210,,,WHO ATC Classification,,ILS,film coated tablets,ETORICOXIB,2025-07-31T02:42:00.047629,IL,תרו יבוא,,32.72225948,27.73072838,20.24140757,,,ETORICOXIB TARO 60MG 14TAB,,,74262,BLISTER OPA/ALU/PVC/ALU,units,14.0,160 52 34825 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4cced7f7-0394-4903-9fde-ad282373ffef.json
4cd2e48f-2da7-42c5-bde8-f8e40afd48e6,SYNAREL,prescription,H01CA02,NAFARELIN,4996,,,WHO ATC Classification,,ILS,nasal solution,NAFARELIN ACETATE/ML,2025-07-31T08:55:42.842203,IL,פיזר,,478.8739784,405.8254235,345.3833391,,7290010355662,SYNAREL NASAL SOL 8ML,19805,,70951,BOTTLE GLASS PVC,units,8.0,135 64 26707 06,valid,17.5,nasal,1.4,24,,,,,,,,,,0,Prescription required,"- Controlled ovarian stimulation programmes prior to in-vitro fertilisation.- Hormonal management of endometriosis, including pain relief and reduction of endometrial lesions. - Uterine fibroids.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4cd2e48f-2da7-42c5-bde8-f8e40afd48e6.json
4cd6288f-67cc-4e66-bf70-7c39f0220ef2,FRESCO TABLETS,off-the-counter,A02AC01,CALCIUM CARBONATE,1940,,,WHO ATC Classification,,ILS,chewable tablets,"CALCIUM CARBONATE, MAGNESIUM CARBONATE",2025-07-31T11:57:54.488501,IL,רקח,,21.2754,18.03,nan,,7290008089821,FRESCO 40TAB,6078,,,BLISTER PVC/ALUMINIUM,units,40.0,028 58 21952 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antacid.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4cd6288f-67cc-4e66-bf70-7c39f0220ef2.json
4ceb3d7c-5e10-4d5b-b166-ec06d2410775,HAEMATE-P 500 I.U. 1 VIAL 30ml,prescription,,,8317,,,,,ILS,injection,HAEMATE-P 500 I.U.,2025-07-31T19:12:05.009520,IL,סי אס אל,,2037.199315,1726.440174,1469.310787,,,HAEMATE-P 500 I.U. 1 VIAL 30ml,8339,,30795,,units,1.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4ceb3d7c-5e10-4d5b-b166-ec06d2410775.json
4d0a8220-550a-477c-9f97-21bad54aba88,NOVOEIGHT 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,8015,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,TUROCTOCOG ALFA/,2025-07-31T05:53:39.309064,IL,נובו נורדיסק,,2464.693661,2088.723534,1898.839576,,7290015659055,NOVOEIGHT 1000 IU/4ML 1VIAL,14618,,58048,VIAL GLASS TYPE I,units,1.0,154 52 34374 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).NovoEight can be used for all age groups., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d0a8220-550a-477c-9f97-21bad54aba88.json
4d1ff2ee-0d51-4a59-b94b-a9249260a13c,CERDELGA,prescription,A16AX10,ELIGLUSTAT,8004,,,WHO ATC Classification,,ILS,"capsule, hard",ELIGLUSTAT AS TARTRATE 84.4  MG,2025-07-31T01:06:29.721248,IL,סאנופי אוונטיס,,95843.35859,81223.18885,73839.26259,,,CERDELGA 84.4 MG 56 CAPS,10077,,73597,BLISTER ALUMINIUM,units,56.0,157 56 34703 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Cerdelga is indicated for the long-term treatment of adult patients with Gaucher disease type 1 (GD1), who are CYP2D6 poor metabolisers (PMs), intermediate metabolisers (IMs) or extensive metabolisers (EMs).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d1ff2ee-0d51-4a59-b94b-a9249260a13c.json
4d210337-7fa6-487b-a74b-720502b5c271,EXIDOL,off-the-counter,N02BA01,ACETYLSALICYLIC ACID,5175,,,WHO ATC Classification,,ILS,caplets,"ACETYLSALICYLIC ACID, PARACETAMOL, CAFFEINE",2025-07-31T11:51:42.912578,IL,פאדאגיס,,30.798,26.1,nan,,7298074010176,EXIDOL 24 CAPLETS,5444,,,BOTTLE HDPE,units,24.0,136 77 31055 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"For temporary relief of the pain of headache, mild to moderate pain associated with migraine headache,  pain of menstrual descomfort and pain accompanied by fever.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d210337-7fa6-487b-a74b-720502b5c271.json
4d474d62-64ae-4faf-97db-8a35502feea2,SUBOXONE FILM 4 MG/1 MG,prescription,N02AE01,BUPRENORPHINE,9078,,,WHO ATC Classification,,ILS,sublingual film,"BUPRENORPHINE AS HYDROCHLORIDE, NALOXONE AS HYDROCHLORIDE DIHYDRATE",2025-07-31T08:48:09.226104,IL,נעמי שאקו עזרה,,188.6589816,159.8805,127.9044,,,SUBOXONE 2 MG/0.5 MG 30 FILMS,10330,,10232,FOIL ALUMINIUM,units,30.0,164 26 35833 00,valid,25.0,"buccal, sublingual",1.4,24,,,,,,,,,,0,Prescription required,Suboxone sublingual film is indicated for treatment of opioid dependence in adults and adolescents over 15 years of age. Suboxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d474d62-64ae-4faf-97db-8a35502feea2.json
4d47ae84-dd52-4aca-bb2a-3036a58cc190,ERYTHROMYCIN FISIOPHARMA 1 G/ 20  ML,prescription,J01FA01,ERYTHROMYCIN,4922,,,WHO ATC Classification,,ILS,powder and solvent for solution for infusion,ERYTHROMYCIN AS LACTOBIONATE/VIAL,2025-07-31T09:23:30.641866,IL,דקסל פארמה,,6656.929672,5641.466074,5128.605522,,,TOBI 300MG/5ML 56AMPX5ML INH WITH NEBULISER,20595,,67228,VIAL GLASS TYPE III,units,56.0,171 56 35595 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of bacterial infections susceptible to erythromycin and require I.V. treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d47ae84-dd52-4aca-bb2a-3036a58cc190.json
4d490459-2a60-4346-8fe9-e94ba1fd5199,XALATAN EYE DROPS,prescription,S01EE01,LATANOPROST,3815,,,WHO ATC Classification,,ILS,"eye drops, solution",LATANOPROST/ML,2025-07-31T10:27:16.017622,IL,דקסל פארמה,,36.8932369,31.265455,22.8215,,7298120014165,XALATAN 50MCG/ML DROPS 2.5ML,24006,,76255,BOTTLE PLASTIC,units,2.5,109 36 29264 05,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d490459-2a60-4346-8fe9-e94ba1fd5199.json
4d4c033f-b20e-4cb8-b9c3-b05e1795fdc4,PREGABALIN TEVA ® 100 MG,prescription,N03AX16,PREGABALIN,8020,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:54:50.743224,IL,טבע,,200.1721025,169.637375,135.7099,,,PREGABALIN TEVA  300 MG 56 TAB,16986,,56134,BLISTER PVC/ALUMINIUM,units,56.0,157 26 34479 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,PREGABALIN TEVA ® is indicated for the: - Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia. - Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d4c033f-b20e-4cb8-b9c3-b05e1795fdc4.json
4d52903d-2666-495e-81ed-63028af6111f,ELONVA 100 MCG / 0.5 ML,prescription,G03GA09,CORIFOLLITROPIN ALFA,6675,,,WHO ATC Classification,,ILS,solution for injection,CORIFOLLITROPIN ALFA/ 0.5  ML,2025-07-31T02:16:35.712380,IL,אורגנון,,2410.332304,2042.654585,1856.958714,,7290008121804,ELONVA 100MCG/0.5ML 1SYRINGE PREFILLED,5528,,19924,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,147 30 33282 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d52903d-2666-495e-81ed-63028af6111f.json
4d5a4d71-0679-4c90-a3d9-d576503689ce,GASTRO 10,off-the-counter,A02BA03,FAMOTIDINE,2243,,,WHO ATC Classification,,ILS,tablets,FAMOTIDINE,2025-07-31T11:58:53.614157,IL,אוניפארם,,33.7126,28.57,nan,,,GASTRO 20MG 20TAB (OTC),7209,,,BLISTER PVC/ALUMINIUM,units,20.0,107 36 28578 01,valid,nan,per os,1.4,48,,,,,,,,,,0,,For the treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d5a4d71-0679-4c90-a3d9-d576503689ce.json
4d62882e-f32d-431f-93f5-65d8944d9159,ISRADIPINE 2.5MG 30 caps,29C,,,20993,,,,,,capsule,ISRADIPINE 2.5MG,2025-07-31T20:42:02.800587,IL,nan,,,,,,,ISRADIPINE 2.5MG 30 caps,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d62882e-f32d-431f-93f5-65d8944d9159.json
4d662f7b-1eb1-4a3c-b57a-656b2a17d427,VIMPAT 10 MG/ML,prescription,N03AX18,LACOSAMIDE,7191,,,WHO ATC Classification,,ILS,solution for infusion,LACOSAMIDE/,2025-07-31T10:15:38.277415,IL,ניאופרם,,124.2501077,105.2967061,78.28751385,,7290100412688,VIMPAT 10 MG/ML (200MG/20ML) VIAL 1X20ML,22416,,46141,VIAL 20 ML GLASS TYPE I,units,1.0,149 13 33552 01,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.בקשה לשינוי משטר מינון: 17/5/20204.2	Posology and method of administrationPosologyLacosamide must be taken twice a day (usually once in the morning and once in the evening).Lacosamide may be taken with or without food.If a dose is missed, the patient should be instructed to take the missed dose immediately, and then to take the next dose of lacosamide at the regularly scheduled time. If the patient notices the missed dose within 6 hours of the next one, he/she should be instructed to wait to take the next dose of lacosamide at the regularly scheduled time. Patients should not take a double dose.Adolescents and children weighing 50 kg or more, and adultsThe following table summarises the recommended posology for adolescents and children weighing 50 kg or more, and for adults. More details are provided in the table below.	Monotherapy	Adjunctive therapyStarting dose	100 mg/day or 200 mg/day	100 mg/daySingle loading dose (if applicable)	200 mg	200 mgTitration (incremental steps)	50 mg twice a day (100 mg/day) at weekly intervals	50 mg twice a day (100 mg/day) at weekly intervalsMaximum recommended dose	up to 600 mg/day	up to 400 mg/dayMonotherapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week.Lacosamide can also be initiated at the dose of 100 mg twice a day based on the physician's assessment of required seizure reduction versus potential side effects.Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 300 mg twice a day (600 mg/day). In patients having reached a dose greater than 400 mg/day and who need an additional antiepileptic medicinal product, the posology that is recommended for adjunctive therapy below should be followed.Adjunctive therapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week. Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 400 mg (200 mg twice a day). Initiation of lacosamide treatment with a loading dose Lacosamide treatment may also be initiated with a single loading dose of 200 mg, followed approximately 12 hours later by a 100 mg twice a day (200 mg/day) maintenance dose regimen. Subsequent dose adjustments should be performed according to individual response and tolerability as described above. A loading dose may be initiated in patients in situations when the physician determines that rapid attainment of lacosamide steady state plasma concentration and therapeutic effect is warranted. It should be administered under medical supervision with consideration of the potential for increased incidence of serious cardiac arrhythmia and central nervous system adverse reactions (see section 4.8). Administration of a loading dose has not been studied in acute conditions such as status epilepticus.DiscontinuationIn accordance with current clinical practice, if lacosamide has to be discontinued, it is recommended this be done gradually (e.g. taper the daily dose by 200 mg/week).In patients who develop serious cardiac arrhythmia, clinical benefit/risk assessment should be performed and if needed lacosamide should be discontinued.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4d662f7b-1eb1-4a3c-b57a-656b2a17d427.json
4da9c860-a4fa-48de-9be7-6ac2c8bb75ca,PERGOVERIS ®,prescription,G03GA05,FOLLITROPIN ALFA,8405,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,"FOLLITROPIN ALFA, LUTROPIN ALFA",2025-07-31T06:37:49.323367,IL,מרק סרונו,,2114.790428,1792.195358,1525.272645,,7290000845470,PERGOVERIS PRE-FILLED PEN 1.44ML,,,5017,VIAL GLASS TYPE I,units,1.0,145 07 33159 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Pergoveris is indicated for the stimulation of follicular development in adult women with sever LH and FSH deficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4da9c860-a4fa-48de-9be7-6ac2c8bb75ca.json
4dd786ee-fe56-4a78-969d-24a2b9750c2e,ANTABUSE 250MG 100 tab,29C,,,21005,,,,,,tablet,ANTABUSE 250MG,2025-07-31T19:54:10.523295,IL,nan,,,,,,,ANTABUSE 250MG 100 tab,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4dd786ee-fe56-4a78-969d-24a2b9750c2e.json
4de21ea7-d4de-40c6-b1d8-765a04921e69,MYCOPHENOLATE TEVA ® 500 MG,prescription,L04AA06,MYCOPHENOLIC ACID,6545,,,WHO ATC Classification,,ILS,tablets,MYCOPHENOLATE MOFETIL,2025-07-31T05:37:11.340366,IL,טבע,,321.1983925,272.2020275,231.6613,,,MYCOPHENOLATE TEVA 500 MG 50 TAB,13639,,16401,BLISTER PVDC/ALUMINIUM,units,50.0,142 37 32978 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Prophylaxis of rejection in renal allograft recepients, in patients receiving allogenic cardiac transplants and in allogenic hepatic transplants.Mycophenolate Teva should be used concomitantly with ciclosporin and corticosteroids.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4de21ea7-d4de-40c6-b1d8-765a04921e69.json
4df314be-efc7-4da2-bf74-5c964066f03c,HEMOSOL B0,prescription,B05XA30,COMBINATIONS OF ELECTROLYTES,8975,,,WHO ATC Classification,,ILS,solution for haemofiltration,"CALCIUM CHLORIDE DIHYDRATE 5.145 G /, MAGNESIUM CHLORIDE HEXAHYDRATE 2.033 G /, LACTIC ACID 5.400 G /, SODIUM CHLORIDE 6.45 G /, SODIUM CARBONATE HYDROGEN 3.090 G /",2025-07-31T03:44:41.035643,IL,בקסטר,,189.7320804,160.7899058,128.6319246,,7290018454046,HEMOSOL B0 5000ML(4750+250),,,,BAG POLYOLEFINE,units,2.0,129 26 30751 00,valid,25.0,for use with hemodialysis machines,1.4,18,,,,,,,,,,0,Prescription required,As substitution solution in continuous haemofiltration and haemodiafiltration and as dialysis solution in continuous haemodialysis for acute renal failure.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4df314be-efc7-4da2-bf74-5c964066f03c.json
4df98e96-630c-4a55-a02e-d90dcdf219ca,PRALUENT 150 MG/ML,prescription,C10AX14,ALIROCUMAB,7837,,,WHO ATC Classification,,ILS,solution for injection,ALIROCUMAB/,2025-07-31T06:48:54.650113,IL,סאנופי אוונטיס,,2178.405193,1846.106178,1571.154194,,7290012711602,PRALUENT 150 MG INJECTION 2 PREFILLED PEN,16946,,27284,PRE-FILLED PEN GLASS TYPE I,units,2.0,156 09 34568 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Primary hypercholesterolaemia and mixed dyslipidaemia Praluent is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, and in paediatric patients 8 years of age and older with heterozygous familial hypercholesterolaemia (HeFH) as an adjunct to diet:-	in combination with a statin or statin with other lipid lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin or,-	alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.Established atherosclerotic cardiovascular disease Praluent is indicated in adults with established atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL-C levels, as an adjunct to correction of other risk factors: -	in combination with the maximum tolerated dose of a statin with or without other lipid-lowering therapies or,-	alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4df98e96-630c-4a55-a02e-d90dcdf219ca.json
4dfe2319-385f-4964-b9e9-62451aaa5d49,OXYCOD 2 MG/ML SYRUP,prescription,N02AA05,OXYCODONE,3689,,,WHO ATC Classification,,ILS,syrup,OXYCODONE HYDROCHLORIDE/,2025-07-31T06:21:36.287066,IL,רפא,,nan,nan,nan,,7290008014564,OXYCOD SYRUP 50ML,15104,,35564,BOTTLE HDPE,units,50.0,107 54 29027 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For use in the relief of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4dfe2319-385f-4964-b9e9-62451aaa5d49.json
4e3e8002-191e-4678-9910-360d58e1e601,ACTIQ 1200 MCG,prescription,N02AB03,FENTANYL,6123,,,WHO ATC Classification,,ILS,compressed tablet on a handle,FENTANYL AS CITRATE/DOSE,2025-07-31T00:07:35.227313,IL,טבע,,847.0288812,717.8211177,610.9115895,,7290106061019,ACTIQ 400MCG 30 COMPRESSED TAB,9270,,86430,BLISTER PVC/ACLAR,units,30.0,138 25 31575 00,valid,17.5,oral transmucosal,1.4,36,,,,,,,,,,0,Prescription required,Actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4e3e8002-191e-4678-9910-360d58e1e601.json
4e5294eb-cd21-4b29-98bc-6de08497e27f,ENDARI,prescription,B05BA01,AMINO ACIDS,8506,,,WHO ATC Classification,,ILS,powder,GLUTAMINE/SACHET,2025-07-31T02:20:53.599897,IL,מגאפארם,,nan,nan,nan,,7290014573277,ENDARI 5 G 60 PACKETS,,,,PACKETS PAPER/FOIL/PLASTIC LAMINATE ,units,60.0,164 80 35650 00,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,ENDARI is an amino acid indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4e5294eb-cd21-4b29-98bc-6de08497e27f.json
4e5e2adb-1a6c-49ca-bf21-4705224b8e7d,DORZOLAMIDE TIMOLOL TARO,prescription,S01EC03,DORZOLAMIDE,8178,,,WHO ATC Classification,,ILS,"eye drops, solution","TIMOLOL AS MALEATE/ML, DORZOLAMIDE AS HYDROCHLORIDE/ML",2025-07-31T02:03:03.272617,IL,תרו יבוא,,43.85463982,37.164949,27.1277,,7290012066603,DORZOLAMIDE TIMOLOL TARO   	5 ML EYES DROPS,,,26783,VIAL LDPE,units,5.0,152 22 33539 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of elevated intraocular pressure (IOP ) in patients with ocular hypertension, open-angle glaucoma, or other secondary open-angle glaucoma when concomitant therapy is appropriate",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4e5e2adb-1a6c-49ca-bf21-4705224b8e7d.json
4e6d8ca9-f089-41ad-8f71-0ffc3ebaf6d6,DASATINIB SANDOZ ® 100 MG,prescription,L01XE06,DASATINIB,9353,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB,2025-07-31T01:42:06.106867,IL,סנדוז,,6252.333003,5298.587291,4816.897537,,,DASATINIB SANDOZ  100 MG 30 TAB,,,14582,BLISTER OPA/ALU/PVC/ALU,units,30.0,173 10 36531 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with :  Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase.  Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate.  Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4e6d8ca9-f089-41ad-8f71-0ffc3ebaf6d6.json
4e765e74-9add-46e4-9899-a397cb5d206f,ROSUVASTATIN INOVAMED 10 MG,prescription,C10AA07,ROSUVASTATIN,9359,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T07:50:44.735083,IL,אינובמד,,77.45048,65.636,48.8,,,ROSUVASTATIN INOVAMED 5 MG 30 TAB,23633,,4960,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,173 65 36557 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4e765e74-9add-46e4-9899-a397cb5d206f.json
4e7f4942-e8eb-42c9-8daa-f7467f31d0f0,EPIPEN,prescription,C01CA24,EPINEPHRINE,1322,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE/ML,2025-07-31T02:27:21.378863,IL,דקסל פארמה,,269.6624528,228.5275125,194.4915,,7290103846848,EPIPEN 0.3MG/0.3ML AUTO-INJECTOR 2ML,5045,,7084,AUTO-INJECTOR GLASS,units,1.0,019 37 24854 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"EpiPen is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.EpiPen is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. EpiPen is intended for immediate administration as emergency supportive therapy only and  is not a substitute for immediate medical care.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4e7f4942-e8eb-42c9-8daa-f7467f31d0f0.json
4e83305b-2f87-492b-be23-27cc2342d8b9,AERIUS TABLETS,prescription,R06AX27,DESLORATADINE,7152,,,WHO ATC Classification,,ILS,film coated tablets,DESLORATADINE,2025-07-30T23:16:14.303053,IL,אורגנון,,29.94783832,25.379524,18.5252,,7290006813626,AERIUS 5MG 30TAB,9624,,40124,BLISTER PVC/ALUMINIUM,units,30.0,125 49 30441 21,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Aerius tablet is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with:- allergic rhinitis - urticaria,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4e83305b-2f87-492b-be23-27cc2342d8b9.json
4eadab6d-dcf6-439d-984b-f49802e5e5ab,TIGER BALM RED,off-the-counter,,,5141,,,,,ILS,ointment,"CAMPHORW/W, MENTHOLW/W, CAJUPUT OILW/W, DEMENTHOLISED MINT OILW/W, CLOVE OILW/W",2025-07-31T13:27:20.722959,IL,רפא,,37.4768,31.76,nan,,7290008015448,TIGER BALM RED OINT 19G,20192,,,JAR GLASS TYPE III,units,19.0,127 22 30565 00,valid,nan,topical,1.4,48,,,,,,,,,,0,,For the temporary relief of muscular aches and pains.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4eadab6d-dcf6-439d-984b-f49802e5e5ab.json
4eb00d31-752b-4459-82ed-4b544126cfda,MACLIVAN 250 MG/5 ML,prescription,,,7541,,,,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM 62.5  MG /, AMOXICILLIN AS TRIHYDRATE/",2025-07-31T05:03:49.321613,IL,סנדוז,,20.97279844,17.773558,12.9734,,,MACLIVAN 250 MG/5 ML POWDER FOR SUSP 100 ML,13771,,74191,BOTTLE AMBER GLASS TYPE III,units,100.0,120 17 30001 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Maclivan is indicated for the treatment of the following infections in adults and children :• Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4eb00d31-752b-4459-82ed-4b544126cfda.json
4ebffc92-92ff-4316-941c-3330549ad834,ALRIN AF TEVA,off-the-counter,S01GA04,OXYMETAZOLINE,5587,,,WHO ATC Classification,,ILS,solution,OXYMETAZOLINE HYDROCHLORIDE 0.05 %W/V,2025-07-31T11:12:48.543092,IL,טבע,,38.1258,32.31,nan,,7290000802886,ALRIN AF TEVA 0.05% 30 ml,,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,30.0,162 61 35825 00,valid,nan,nasal,1.4,24,,,,,,,,,,0,,"Relief of nasal congestion, which is a result of common colds, sinusitis, hay fever or allergies of the upper respiratory system.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4ebffc92-92ff-4316-941c-3330549ad834.json
4ed871ca-7cc8-4855-a037-96de861ad2c0,PHYSICARE GEL,off-the-counter,,,5388,,,,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T12:47:52.995486,IL,מכבי קאר,,25.9954,22.03,nan,,7290008082617,PHYSICARE GEL 50 GR,,,,TUBE ALUMINIUM,units,50.0,136 05 31442 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications:Local treatment of pain, inflammation and swelling due to: • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order:• Pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4ed871ca-7cc8-4855-a037-96de861ad2c0.json
4ee4c38b-2e4e-445b-b20c-b3b2e8afc9f9,CAMPTO,prescription,L01XX19,IRINOTECAN,6137,,,WHO ATC Classification,,ILS,solution for infusion,IRINOTECAN HYDROCHLORIDE/ML,2025-07-31T00:50:37.044667,IL,פיזר,,83.55216024,70.80691861,52.64454915,,7290010355754,CAMPTO 40MG/2ML IV SOL FOR INF,3717,,10486,VIAL POLYPROPYLENE,units,1.0,106 12 29047 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Campto is indicated for the treatment of patients with metastatic colorectal cancer:   In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease.   As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.   For the treatment of patients with small cell lung cancer.  For the treatment of patients with gastric cancer.Irinotecan in combination with leucovorin, Oxaliplatin and 5-fluorouracil for the first-line treatment of patients with metastatic pancreatic adenocarcinoma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4ee4c38b-2e4e-445b-b20c-b3b2e8afc9f9.json
4eec101a-8ba7-4433-ad49-21e4092b06e9,ZAPPA 7.5,prescription,N05AH03,OLANZAPINE,6861,,,WHO ATC Classification,,ILS,film coated tablets,OLANZAPINE 7.5  MG,2025-07-31T10:43:26.417937,IL,אוניפארם,,253.4830275,214.816125,171.8529,,,ZAPPA 7.5MG 60TAB,86150,,13488,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,146 71 33250 01,valid,25.0,per os,1.4,30,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of Schizophrenia. Zappa is indicated for the management of the manifestations of psychotic disorders. Zappa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar  Disorder: In patients whose manic episode has responded to Olanzapine treatment Zappa is indicated for the prevention of reccurence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zappa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4eec101a-8ba7-4433-ad49-21e4092b06e9.json
4f18f5ff-089f-4d50-b1a4-9908428240b9,YTRACIS VIAL 1850 MBQ,prescription,,,6748,,,,,ILS,injection,YTRACIS VIAL 1850 MBQ,2025-07-31T19:39:32.074699,IL,איזוטופיה,,12185.59488,10326.77578,9387.977985,,,YTRACIS VIAL 1850 MBQ,,,,,units,1.0,,not-registered,10.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4f18f5ff-089f-4d50-b1a4-9908428240b9.json
4f25adb7-3357-4844-96a6-b5c5ac6560d4,ERELZI 25,prescription,L04AB01,ETANERCEPT,8656,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ 0.5  ML,2025-07-31T02:33:36.346633,IL,סנדוז,,2418.646751,2049.700727,1863.364298,,,ERELZI 50 MG/1 ML 4 PREFILLED SYR,5671,,41371,PRE-FILLED SYRINGE  GLASS TYPE I,units,4.0,163 20 36011 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritisErelzi is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs) including methotrexate (unless contraindicated) has been inadequate. Erelzi can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis .Etanercept, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.Juvenile idiopathic arthritisTreatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. Treatment of psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. Treatment of enthesitis-related arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, conventional therapy. Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Etanercept has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease.Axial spondyloarthritisAnkylosing spondylitis (AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs).Plaque psoriasisTreatment of adults patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Paediatric plaque psoriasisTreatment of chronic severe plaque psoriasis in children and adolescents from the age of 6 years who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4f25adb7-3357-4844-96a6-b5c5ac6560d4.json
4f279424-70de-4b3b-b391-c8cdc443c122,ADATAR,off-the-counter,D10AD03,ADAPALENE,3053,,,WHO ATC Classification,,ILS,gel,"BENZOYL PEROXIDE AS HYDROUS 2.5 %W/W, ADAPALENE 0.1 %W/W",2025-07-31T11:16:31.249147,IL,ג'ונסון אנד ג'ונסון,,53.9614,45.73,nan,,7290017164199,BEN GAY ULTRA STR 2 OZ (57gr),2519,,,CONTAINER PP,units,2.0,163 95 35656 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Cutaneous treatment of acne vulgaris when comedones, papules and pustules are present",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4f279424-70de-4b3b-b391-c8cdc443c122.json
4f845d00-c81f-4e34-b151-7842e459619f,NUWIQ 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,9075,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,SIMOCTOCOG ALFA/VIAL,2025-07-31T05:58:53.458176,IL,דובר מדיקל,,2464.693661,2088.723534,1898.839576,,,NUWIQ 1000 IU,,,75585,VIAL GLASS TYPE I,units,1.0,168 22 36551 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients 2 years of age and older with haemophilia A (congenital factor VIII deficiency). Nuwiq does not contain von Willebrand Factor and is thus not indicated to treat von Willebrand’s Disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4f845d00-c81f-4e34-b151-7842e459619f.json
4f8617db-5c9a-46ae-8622-ba32bb47ada5,ATOZET10 MG/10 MG,prescription,C10BA05,ATORVASTATIN AND EZETIMIBE ,7899,,,WHO ATC Classification,,ILS,film coated tablets,"ATORVASTATIN AS CALCIUM TRIHYDRATE, EZETIMIBE",2025-07-30T23:29:51.876088,IL,אורגנון,,118.5487397,100.4650337,74.69519232,,,ATOZET 10 MG/10 MG 30 TAB,9971,,59892,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,156 65 34490 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Prevention of Cardiovascular EventsAtozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaAtozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Atozet is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4f8617db-5c9a-46ae-8622-ba32bb47ada5.json
4f91f633-494f-46b3-83bc-ecfd3085efaf,CASODEX 50 MG,prescription,L02BB03,BICALUTAMIDE,3703,,,WHO ATC Classification,,ILS,tablets,BICALUTAMIDE,2025-07-31T00:56:49.129753,IL,תרו יבוא,,207.8294175,176.126625,140.9013,,,CASODEX 50MG 28TAB,3019,,9568,BLISTER PVC/ALUMINIUM,units,28.0,103 82 28597 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of advanced prostate cancer in combination with LHRH analog therapy or surgical castration.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4f91f633-494f-46b3-83bc-ecfd3085efaf.json
4f96b964-d1bc-42b7-9b70-d2e32d52e6f2,LENALIDOMIDE TEVA ® 10 MG,prescription,L04AX04,LENALIDOMIDE,8422,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE AS HYDROCHLORIDE HYDRATE,2025-07-31T04:39:16.337284,IL,טבע,,23276.24185,19725.62869,17932.38972,,,LENALIDOMIDE TEVA  5 MG 21 CAPS,,,45712,BLISTER OPA/ALU/PVC/ALU,units,21.0,161 82 35502 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM): Lenalidomide Teva is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes: Lenalidomide Teva is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Lenalidomide Teva 7.5 mg is not indicated for treatment in MDS.Mantle Cell Lymphoma:Lenalidomide Teva is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphoma:Lenalidomide Teva in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4f96b964-d1bc-42b7-9b70-d2e32d52e6f2.json
4f971a1b-2025-4476-944f-ad0dcfb56bf7,FIRMAGON 120 MG,prescription,L02BX02,DEGARELIX,6672,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,DEGARELIX AS ACETATE,2025-07-31T03:05:41.853310,IL,פרינג,,582.0003495,493.2206571,419.7622613,,5015919788876,FIRMAGON 80MG 1VIAL POWDER + 1VIAL SOLV.,6463,,7161,VIAL GLASS TYPE I,units,1.0,145 04 32955 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of adult male patients with advanced hormone-dependent prostate cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4f971a1b-2025-4476-944f-ad0dcfb56bf7.json
4fa0d37a-b807-45a8-ae31-724e982aa03d,SUPRAMOL 'M' PEDIATRIC SUPPOSITORIES,off-the-counter,N02BE01,PARACETAMOL,2039,,,WHO ATC Classification,,ILS,suppositories,PARACETAMOL,2025-07-31T13:24:33.548793,IL,סם און,,16.1188,13.66,nan,,,SUPRAMOL M 150MG 12 SUPP,19672,,,POUCH PVC/PE,units,12.0,042 50 23368 00,valid,nan,rectal,1.4,48,,,,,,,,,,0,,"Analgesic, antipyretic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4fa0d37a-b807-45a8-ae31-724e982aa03d.json
4fc8edd7-5eb5-4561-a26a-83b2f0f5600c,MESNA-CELL 100 MG/ML,prescription,V03AF01,MESNA,9098,,,WHO ATC Classification,,ILS,solution for injection,MESNA/,2025-07-31T05:14:46.489704,IL,אמ.בי.איי פארמה,,181.3423993,153.6800063,122.944005,,7290014257535,MESNA-CELL 100 MG/ML 50 ML 1VIAL,,,31633,AMPOULES GLASS,units,1.0,154 04 34131 00,valid,25.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Prevention of urinary tract toxicity of oxazaphosphorines (the active components of Ifosfamide, Cyclophosphamide , Trofosfamide) in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous ifosfamide, Cyclophosphamide or Trofosfamide, urinary passage diseases in anamnesis.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4fc8edd7-5eb5-4561-a26a-83b2f0f5600c.json
4fe24743-6438-49b4-b1dd-fcf8ad7fd669,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1827,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:51:13.721254,IL,פישר,,10.9976,9.32,nan,,7290000849188,POLYDINE SOL 20CC,16183,,,BOTTLE HDPE,units,20.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4fe24743-6438-49b4-b1dd-fcf8ad7fd669.json
4ffc9ad9-8a49-4b3e-a5e6-6cb644470118,ZEBINIX 200 MG,prescription,N03AF04,ESLICARBAZEPINE,9310,,,WHO ATC Classification,,ILS,tablets,ESLICARBAZEPINE ACETATE,2025-07-31T10:44:45.839443,IL,תרומד,,435.4933789,369.0622019,314.095491,,,ZEBINIX 800 MG 30 TAB,,,2588,BLISTER PVC/ALUMINIUM,units,30.0,170 76 37082 99,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Zebinix is indicated as:• monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;• adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/4ffc9ad9-8a49-4b3e-a5e6-6cb644470118.json
50006625-ffcd-4967-99a4-4c5554df2d1e,AMPISULVENIR 1.5 G,prescription,J01CG01,SULBACTAM,8266,,,WHO ATC Classification,,ILS,powder for solution for injection,"AMPICILLIN AS SODIUM SALT, SULBACTAM AS SODIUM SALT",2025-07-30T23:23:05.328855,IL,ביואבניר,,364.8706024,309.2123749,263.159468,,7290010286294,AMPISULVENIR 3G 10VIAL 20ML,,,18457,VIAL GLASS TYPE I,units,10.0,152 55 33564 00,valid,17.5,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Antibiotic for the treatment of bacterial infections caused by susceptible beta-lactamase producing strains of microorganisms, in the following conditions: 1. Skin and Skin Structure Infections ;2. Intra- Abdominal Infections ;3. Gynecological Infections .",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50006625-ffcd-4967-99a4-4c5554df2d1e.json
500801c1-3f06-4dc7-8440-5efabf723adf,SUNITINIB TEVA  ® 12.5 MG,prescription,L01XE04,SUNITINIB,8979,,,WHO ATC Classification,,ILS,capsules,SUNITINIB AS BASE 12.5  MG,2025-07-31T08:52:13.841402,IL,טבע,,8639.835353,7321.894367,6656.267606,,7290106065529,SUNITINIB TEVA 50 MG 30CAPS,17532,,70265,BLISTER PVC/ACLAR/PVC/ALUMINIUM,units,30.0,163 78 35252 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sunitinib Teva is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to Imatinib Mesylate. Sunitinib Teva is indicated for the treatment of advanced renal cell carcinoma. Treatment of unresectable or metastatic,  well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/500801c1-3f06-4dc7-8440-5efabf723adf.json
5013366f-d3f0-47ea-8fca-6c62ab7c97de,ITRANOL,prescription,J02AC02,ITRACONAZOLE,4885,,,WHO ATC Classification,,ILS,capsules,ITRACONAZOLE,2025-07-31T04:14:40.085902,IL,רפא,,68.42321391,57.9857745,43.1121,,7290008013918,ITRANOL 100MG 14CAP,9225,,65403,BLISTER ALUMINIUM /ALUMINIUM,units,14.0,132 86 31044 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Blastomycosis (pulmonary and extrapulmonary). Histoplasmosis. Onchomycosis caused by dermatophytes and/or yeast. Dermatomycoses. Vulvovaginal candidosis. Oral candidosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5013366f-d3f0-47ea-8fca-6c62ab7c97de.json
5014f0e7-4a3a-4d0c-8642-ee527f20f1c3,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7702,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:38:36.202923,IL,סנדוז,,1393.624669,1181.037855,1005.1386,,,BINOCRIT 6000 IU/0.6ML 6 SYRINGE PREFILLED,2561,,56138,SYRINGE PREFILLED  GLASS TYPE I,units,6.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5014f0e7-4a3a-4d0c-8642-ee527f20f1c3.json
5028f2aa-24ed-444b-9920-ad2ccdb419fc,NUROFEN GEL 5 %,off-the-counter,M02AA13,IBUPROFEN,5250,,,WHO ATC Classification,,ILS,gel,IBUPROFENW/W,2025-07-31T12:36:51.814066,IL,רקיט בנקיזר,,26.137,22.15,nan,,5000158100800,NUROFEN FOR CHILDREN ORANGE SYR 100ML,14061,,,TUBE ALUMINIUM,units,100.0,134 23 31074 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5028f2aa-24ed-444b-9920-ad2ccdb419fc.json
502d75e9-f21c-447d-8604-00ef73a8aa8b,SITAMET - AVENIR 50 MG/1000 MG,prescription,A10BD07,METFORMIN AND SITAGLIPTIN,9132,,,WHO ATC Classification,,ILS,film coated tablets,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE",2025-07-31T08:19:53.280741,IL,ביואבניר,,87.00082796,73.72951522,54.81748343,,,SITAMET - AVENIR 50 MG/1000 MG  56 TAB,,,8983,BLISTER PVC/ALU/OPA/ALU,units,56.0,169 30 36666 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Sitamet-Avenir is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use: Sitamet-Avenir should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. Sitamet-Avenir has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitamet-Avenir.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/502d75e9-f21c-447d-8604-00ef73a8aa8b.json
50300297-3346-481b-b6c6-4fdcda1c7b89,ACTIQ 1200 MCG,prescription,N02AB03,FENTANYL,6127,,,WHO ATC Classification,,ILS,compressed tablet on a handle,FENTANYL AS CITRATE/DOSE,2025-07-31T00:07:09.552439,IL,טבע,,1110.249384,940.8893507,800.7568942,,7290106061019,ACTIQ 1600MCG 30 COMPRESSED TAB,9268,,86434,BLISTER PVC/ACLAR,units,30.0,138 25 31575 00,valid,17.5,oral transmucosal,1.4,36,,,,,,,,,,0,Prescription required,Actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50300297-3346-481b-b6c6-4fdcda1c7b89.json
50357a26-297e-4f4a-9cd9-0b685a42c303,DALACIN 2 % VAGINAL CREAM,prescription,G01AA10,CLINDAMYCIN,8130,,,WHO ATC Classification,,ILS,cream,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T01:39:41.945039,IL,פיזר,,91.37732658,77.4384158,57.57503033,,7298074000054,DALACIN C 150MG 100CAPS,4006,,35574,TUBE PLASTIC,units,100.0,064 17 27818 00,valid,34.5,vaginal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50357a26-297e-4f4a-9cd9-0b685a42c303.json
503c7f67-d435-4e55-ae1f-4e8202e00565,CYRAMZA 10 MG/ML,prescription,L01XC21,RAMUCIRUMAB ,7806,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RAMUCIRUMAB/ML,2025-07-31T01:37:34.729247,IL,אלי לילי,,10890.55982,9229.28839,8390.262173,,7290008139793,CYRAMZA 10 MG/ML VIAL 50ML,9933,,47396,VIAL GLASS TYPE I,units,50.0,156 19 34510 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Gastric cancerCyramza in combination with paclitaxel is indicated for the treatment of adult patients with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum and fluoropyrimidine chemotherapy. Cyramza monotherapy is indicated for the treatment of adult patients with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum or fluoropyrimidine chemotherapy, for whom treatment in combination with paclitaxel is not appropriate.Colorectal cancerCyramza, in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil), is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin and a fluoropyrimidine.Non-small cell lung cancerCyramza in combination with erlotinib is indicated for the first-line treatment of adult patients with metastatic non-small cell lung adenocarcinoma with activating epidermal growth factor receptor (EGFR) mutations.Cyramza in combination with docetaxel is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with disease progression after platinum-based chemotherapy.Hepatocellular carcinomaCyramza monotherapy is indicated for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have a serum alpha fetoprotein (AFP) of &#8805; 400 ng/ml and who have been previously treated with sorafenib.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/503c7f67-d435-4e55-ae1f-4e8202e00565.json
506b767d-3581-4a3c-96f0-df6006c5de1c,CEFURAX 250MG 10TAB,prescription,,,4740,,,,,ILS,tablet,CEFURAX 250MG,2025-07-31T19:01:40.050750,IL,ביואבניר,,22.92888444,19.431258,14.1834,,,CEFURAX 250MG 10TAB,3764,,60868,,units,10.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/506b767d-3581-4a3c-96f0-df6006c5de1c.json
506f87bd-910a-447a-90f4-afa615d11740,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1817,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:49:46.683714,IL,פישר,,40.3324,34.18,nan,,7290000849188,POLYDINE CLEANSER 1L,16178,,,BOTTLE HDPE,units,1000.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/506f87bd-910a-447a-90f4-afa615d11740.json
5087b58e-54f9-431d-b670-b21e2523808f,FORIC PREGNANCY TABLETS,off-the-counter,,,5109,,,,,ILS,tablets,"FOLIC ACID, FERROUS AS FUMARATE",2025-07-31T11:57:32.548201,IL,סם און,,41.3826,35.07,nan,,,FORIC PREGNANCY 30TAB,6128,,,BLISTER PVC/ALUMINIUM,units,30.0,125 34 30478 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the prevention and treatment of iron deficiency anemia and for maintaining the level of folic acid particular in pregnancy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5087b58e-54f9-431d-b670-b21e2523808f.json
50ae3397-2c28-4a58-b5d5-5bab93f4fae8,JAKAVI 10 MG,prescription,L01XE18,RUXOLITINIB,8088,,,WHO ATC Classification,,ILS,tablets,RUXOLITINIB AS PHOSPHATE,2025-07-31T04:15:16.987234,IL,נוברטיס פארמה,,15068.36617,12769.80241,11608.91128,,7290016369212,JAKAVI 10 MG 56 TAB,10137,,64606,BLISTER PVC/PCTFE,units,56.0,158 58 34859 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"* Myelofibrosis (MF) Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. * Polycythaemia vera (PV) Jakavi is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.*Graft versus host disease (GvHD)Jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50ae3397-2c28-4a58-b5d5-5bab93f4fae8.json
50b78d99-4193-4ba7-a83f-3b4b44c979a5,FERROCAL TABLETS,off-the-counter,,,5430,,,,,ILS,tablets,"CALCIUM CITRATE, FERROUS CITRATE",2025-07-31T11:54:57.758330,IL,רקח,,18.6558,15.81,nan,,7290008090438,FERROCAL 500MG 30 TAB,,,,BLISTER PVC/ALUMINIUM,units,30.0,137 54 25091 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Prevention and treatment of iron-deficiency anemia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50b78d99-4193-4ba7-a83f-3b4b44c979a5.json
50b87f58-fcbe-4036-b849-f5d3fb9aa5da,BACTROBAN NASAL,prescription,R01AX06,MUPIROCIN,3718,,,WHO ATC Classification,,ILS,ointment,MUPIROCIN AS CALCIUMW/W,2025-07-31T05:35:47.275770,IL,טבע,,29.73800364,25.201698,18.3954,,7290008102582,MUPIROCIN 2% OINT 15GR,13009,,22715,TUBE ALUMINIUM,units,15.0,050 85 26431 21,valid,37.0,nasal,1.4,36,,,,,,,,,,0,Prescription required,"The elimination of nasal carriage of staphylococci, including methycillin-resistant staphylococus aureus (MRSA).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50b87f58-fcbe-4036-b849-f5d3fb9aa5da.json
50bb334c-92c6-4f39-90ad-a92341eafa7a,RIZATRIPTAN INOVAMED 10 MG,prescription,N02CC04,RIZATRIPTAN,8042,,,WHO ATC Classification,,ILS,tablets,RIZATRIPTAN AS BENZOATE,2025-07-31T07:47:03.954623,IL,אינובמד,,155.34759,131.6505,105.3204,,,RIZATRIPTAN INOVAMED 10 MG 12 TAB,18555,,54753,BLISTER ALUMINIUM,units,12.0,155 08 34133 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the acute treatment of migraine attacks with or without aura in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50bb334c-92c6-4f39-90ad-a92341eafa7a.json
50bc2d35-82e3-4e28-8f8b-71d6269445e7,HEXAKAPRON  TABLETS,prescription,B02AA02,TRANEXAMIC ACID,1562,,,WHO ATC Classification,,ILS,tablets,TRANEXAMIC ACID,2025-07-31T03:46:29.027521,IL,טבע,,31.41716606,26.624717,19.4341,,,HEXAKAPRON 500MG 20T,8038,,975,BLISTER PVC/ALUMINIUM,units,20.0,016 35 24864 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment  of hemorrhage occuring in some forms of surgery, including prostatectomy. Hematuria. Menorrhagia. Hereditary angioneurotic edema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50bc2d35-82e3-4e28-8f8b-71d6269445e7.json
50e12b5b-58c4-45c8-a65d-20932e78c50b,IMNOVID 1 MG,prescription,L04AX06,POMALIDOMIDE,7408,,,WHO ATC Classification,,ILS,"capsule, hard",POMALIDOMIDE,2025-07-31T04:03:04.107540,IL,ניאופרם,,23009.70114,19499.7476,17727.04327,,7640133683157,IMNOVID 4MG 3X7 CAPSULES (POMALYST),9780,,77992,BLISTER PVC/PCTFE,units,21.0,152 02 33954 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.Imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50e12b5b-58c4-45c8-a65d-20932e78c50b.json
50e27df4-d150-4624-988e-b4ceb400624d,RIPALID 0.5 MG,prescription,A10BX02,REPAGLINIDE,8074,,,WHO ATC Classification,,ILS,tablets,REPAGLINIDE 0.5  MG,2025-07-31T07:36:16.090892,IL,פאדאגיס,,33.54962312,28.431884,20.7532,,,RIPALID 1 MG 90 TABLETS,18572,,63287,BLISTER ALUMINIUM /ALUMINIUM,units,90.0,159 05 34990 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Ripalid is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Ripalid is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50e27df4-d150-4624-988e-b4ceb400624d.json
50f2f54c-1166-4250-8f72-2b9deefa4696,ASSIVAL 5 MG,prescription,N05BA01,DIAZEPAM,8585,,,WHO ATC Classification,,ILS,tablets,DIAZEPAM,2025-07-30T23:28:41.635779,IL,טבע,,30.92938231,26.21134211,19.1323665,,,ASSIVAL TEVA 10 MG/2 ML 10 AMP,,,61650,BLISTER PVC/ALUMINIUM,units,10.0,014 61 24381 03,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tension, anxiety, agitation due to acute alcohol withdrawal, adjunct for the relief of skeletal muscle spasm, convulsive disorders.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/50f2f54c-1166-4250-8f72-2b9deefa4696.json
510718ad-8bca-4ca0-8dfe-5efa072bc89c,SITAGLIPTIN S.K. 100 MG,prescription,A10BH01,SITAGLIPTIN,9445,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE,2025-07-31T08:19:40.224976,IL,SK PHARM(KS KIM),,127.221936,107.8152,80.16,,,SITAGLIPTIN S.K. 50 MG 30 TAB,,,22233,BLISTER PVC/PE/PVDC/AL,units,30.0,171 99 36508 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Sitagliptin S.K. is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: Sitagliptin S.K. should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. Sitagliptin S.K. has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitagliptin S.K..,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/510718ad-8bca-4ca0-8dfe-5efa072bc89c.json
510bbde9-3810-4f28-8f0f-58e4890d89c9,AIMOVIG 140 MG,prescription,N02CX07,ERENUMAB,8449,,,WHO ATC Classification,,ILS,solution for injection,ERENUMAB/,2025-07-31T00:11:59.011276,IL,נוברטיס פארמה,,1994.054713,1689.87695,1438.193149,,7290017585802,AIMOVIG  70MG   1 PREFILLED PEN,10373,,24690,PRE-FILLED PEN GLASS TYPE I,units,1.0,164 09 36005 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Aimovig is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month when initiating treatment with Aimovig,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/510bbde9-3810-4f28-8f0f-58e4890d89c9.json
51201ca3-37c2-4410-a977-b4301f1f6a37,CIPRALEX 10 MG,prescription,N06AB10,ESCITALOPRAM,4592,,,WHO ATC Classification,,ILS,film coated tablets,ESCITALOPRAM AS OXALATE,2025-07-31T01:15:27.755851,IL,לנדבק,,37.7354855,31.979225,23.3425,,,CIPRALEX 10MG 28TAB,3734,,56414,BLISTER PVC/PE/PVDC/AL,units,28.0,127 01 30558 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of depression and panic disorder.   Treatment of generalized anxiety disorder (GAD)  treatment of social anxiety disorder (social phobia).   Treatment of obsessive - compulsive disorder.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51201ca3-37c2-4410-a977-b4301f1f6a37.json
51395c4b-18e3-4420-a898-a5b0aa182e17,GONAL-F,prescription,G03GA05,FOLLITROPIN ALFA,6544,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN ALFA/ML,2025-07-31T03:38:51.291481,IL,מרק סרונו,,1312.957597,1112.675979,946.95828,,7290000845364,GONAL-F 600UI/ML PREFILLED PEN 1.5ML (900 IU),7658,,10866,PRE-FILLED PEN GLASS TYPE I,units,1.0,131 55 31061 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"In adult women: • Anovulation (including polycystic ovarian disease, PCOD) in women who have been unresponsive to treatment with clomiphene citrate. • Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). • Follitropin alfa in association with a luteinising hormone (LH) preparation is indicated for the stimulation of follicular development in women with severe LH and FSH deficiency. In adult men: • Follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human Chorionic Gonadotrophin (hCG) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51395c4b-18e3-4420-a898-a5b0aa182e17.json
513a8e94-98ea-43dc-8327-6654092a2fce,FENTADOL 100,prescription,N02AB03,FENTANYL,7892,,,WHO ATC Classification,,ILS,patches,FENTANYL 16.8 MG/PATCH,2025-07-31T02:58:42.368803,IL,סנדוז,,250.0259225,211.886375,169.5091,,7290017585710,FENTADOL 100 5 PATCHES,166030,,59915,SACHET PAPER/PE/ALU/PE,units,5.0,154 87 34320 00,valid,25.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,"Management of chronic pain and intractable pain requiring opioid analgesia.Fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/513a8e94-98ea-43dc-8327-6654092a2fce.json
513c1c6c-cb4e-4d1a-8f1b-7d0d4d8d1e7a,LUVERIS 75 IU,prescription,,,6539,,,,,ILS,powder for solution for injection,LUTEINIZING HORMONE/ML,2025-07-31T05:00:14.409593,IL,מרק סרונו,,149.6875859,126.853892,101.4831136,,,LUVERIS 75 IU 1VIAL,12221,,56841,VIAL GLASS TYPE I,units,1.0,124 27 30373 00,valid,25.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Luveris in association with a follicle stimulating hormone (FSH) preparation is indicated for the stimulation of follicular development in women with severe LH and FSH deficiency.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/513c1c6c-cb4e-4d1a-8f1b-7d0d4d8d1e7a.json
5156df8f-c25f-4dc8-9e2b-9c122dcebd3c,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,576,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T12:42:45.319258,IL,ג.ס.ק,,26.8922,22.79,nan,,7290006603036,OTRIVIN GEL 0.1% 10G,15083,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,10.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5156df8f-c25f-4dc8-9e2b-9c122dcebd3c.json
51584112-2d40-429d-b978-740c9269f5f6,CRESTOR ® 5 MG,prescription,C10AA07,ROSUVASTATIN,4707,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T01:33:30.095088,IL,אסטראזנקה,,124.0558302,105.1320595,78.1651,,,CRESTOR 20MG 28TAB,3755,,60450,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,139 22 31615 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51584112-2d40-429d-b978-740c9269f5f6.json
51623174-dd6f-4fc1-a5f0-45ce41fd0701,CASPOVIDAE 50 MG,prescription,J02AX04,CASPOFUNGIN,8597,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,CASPOFUNGIN AS ACETATE/VIAL,2025-07-31T00:56:59.482740,IL,SK PHARM(KS KIM),,952.4488434,807.1600727,686.9447427,,,CASPOVIDAE 50 MG 1 VIAL,10703,,3783,VIAL GLASS TYPE I,units,1.0,163 22 35317 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Indicated in adults and pediatric patients (3 months and older) for: - Empirical therapy for presumed fungal infections in febrile, neutropenic patients.- Treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. Has not been studied in endocarditis, ostemyelitis, and meningitis due to Candida.- Treatment of esophageal candidiasis.- Treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin B, lipid formulations of amphotericin B, and/or itraconazole). Has not been studied as initial therapy for invasive aspergillosis.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51623174-dd6f-4fc1-a5f0-45ce41fd0701.json
5162a4bb-976e-44b1-9dec-12fe0e1857f4,FOSRENOL ® 750 MG CHEWABLE TABLETS,prescription,V03AE03,LANTHANUM CARBONATE,6491,,,WHO ATC Classification,,ILS,chewable tablets,LANTHANUM AS CARBONATE HYDRATE,2025-07-31T03:18:24.669649,IL,טקדה,,956.349562,810.4657666,689.7580992,,7290008128674,FOSRENOL 1000MG 90 CHEWTAB,6448,,81785,BOTTLE HDPE,units,90.0,140 51 31998 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in CRF patients on haemodyalisis or continuous ambulatory peritoneal dialysis (CAPD).Fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/L in whom a low phosphate diet alone is insufficient to control serum phosphate levels.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5162a4bb-976e-44b1-9dec-12fe0e1857f4.json
516c00cf-c19b-4e86-86de-957369e19348,CADEX 1 MG,prescription,C02CA04,DOXAZOSIN,3755,,,WHO ATC Classification,,ILS,tablets,DOXAZOSIN AS MESYLATE,2025-07-31T00:49:19.352257,IL,דקסל פארמה,,18.06437338,15.308791,11.1743,,,CADEX 2MG 30CAPL,3573,,51388,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,113 78 29600 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antihypertensive agent. For the treatment of benign prostatic hyperthropy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/516c00cf-c19b-4e86-86de-957369e19348.json
518bcb2e-5187-428b-8fb1-395d03198c84,METABOLASE VETERINARY,29C,,,20322,,,,,ILS,solution for injection,"THIOCTIC ACID 0.2 MG/ML, CYANOCOBALAMIN (VIT B12) 0.03 MG/ML, GLYCINE 1.5 MG/ML, ASPARTIC ACID 1.5 MG/ML, GLUTAMIC ACID 1.5 MG/ML, FRUCTOSE/ML, SORBITOL/ML, PYRIDOXINE (VIT B6) HYDROCHLORIDE 0.15 MG/ML, L- ORNITHINE AS HYDROCHLORIDE 1.20 MG/ML, L- LYSINE AS HYDROCHLORIDE 0.50 MG/ML, L- CITRULLINE 1.20 MG/ML, L-CARNITINE AS HYDROCHLORIDE 5.00 MG/ML, L-ARGININE 2.40 MG/ML, D, L-ACETYLMETHIONINE 20.00 MG/ML",2025-07-31T14:03:52.438326,IL,nan,,nan,nan,nan,,,CARNITINE INJ 1G/5ML 5AMP,,,,BOTTLE GLASS TYPE II,units,5.0,082 87 92329 00,valid,nan,"s.c, i.v, intra-peritoneal",1.4,24,,,,,,,,,,0,,"Supplement  of vitamins, amino acid and sugars",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/518bcb2e-5187-428b-8fb1-395d03198c84.json
518d181f-53eb-44fa-bd02-680746bf9eb4,ULCERON,prescription,A02BC02,PANTOPRAZOLE,8071,,,WHO ATC Classification,,ILS,powder for solution for injection,PANTOPRAZOLE AS SODIUM/VIAL,2025-07-31T09:50:51.418471,IL,SK PHARM(KS KIM),,23.92131518,20.272301,14.7973,,2802743401018,ULCERON 40MG/VIAL,21134,,51232,VIAL GLASS TYPE I,units,1.0,150 02 33651 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of duodenal ulcer, gastric ulcer, moderate and severe forms of reflux oesophagitis. Zollinger Ellison Syndrome.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/518d181f-53eb-44fa-bd02-680746bf9eb4.json
518eb093-6e2c-4cd3-b2f3-83c657413225,MESTINON DRAGEES 60 MG,prescription,N07AA02,PYRIDOSTIGMINE,2468,,,WHO ATC Classification,,ILS,dragee,PYRIDOSTIGMINE BROMIDE 60.0   MG,2025-07-31T07:08:05.537012,IL,רפא,,nan,nan,nan,,,PYRIDOSTIGMINE 30MG 21TAB,16620,,8299,BOTTLE AMBER GLASS,units,21.0,130 84 21200 01,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of myasthenia gravis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/518eb093-6e2c-4cd3-b2f3-83c657413225.json
51bc3ff1-12c0-461e-a5e3-9e15838fc425,NUROFEN FORTE FOR CHILDREN ORANGE 40MG/1ML SUSPENSION,off-the-counter,M01AE01,IBUPROFEN,5574,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T12:36:21.815810,IL,רקיט בנקיזר,,121.0208,102.56,nan,,,NUROFEN FOR CHILDREN FORTE ORANGE 200MG/5ML 100 ML SUSPENSION,14700,,,BOTTLE PET,units,100.0,165 23 35418 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years (i.e. weighing about 40 kg)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51bc3ff1-12c0-461e-a5e3-9e15838fc425.json
51c7d9fd-9df2-443e-84db-9d62bc892618,DEXIMUNE 100,prescription,L04AA01,CYCLOSPORIN,4436,,,WHO ATC Classification,,ILS,capsules,CICLOSPORIN,2025-07-31T01:53:47.690076,IL,דקסל פארמה,,169.1189275,143.321125,114.6569,,,DEXIMUNE 25MG 50 CAPSULES,4536,,10442,BLISTER ALUMINIUM /ALUMINIUM,units,50.0,124 48 30358 11,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of organ rejection in kidney  liver heart allogenic transplants in conjunction with corticosteroids. May also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents.  Bone marrow transplantation.   Endogenous uveitis.   Severe psoriasis above age 16 that did not respond to other treatment.   Atopic dermatitis in adults only up to 8 weeks  for severe cases in which conventional therapy is ineffective or inappropriate.   Rheumatoid arthritis: Severe cases in which standard treatments are ineffective or inappropriate. Nephrotic syndrom type MCD (minimal change disease) in cases where conventional therapy has failed.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51c7d9fd-9df2-443e-84db-9d62bc892618.json
51ce8605-6fe2-45c0-a566-c268080aefe8,LOJUXTA 10 MG,prescription,C10AX12,LOMITAPIDE,8959,,,WHO ATC Classification,,ILS,"capsule, hard",LOMITAPIDE AS MESYLATE,2025-07-31T04:52:56.117542,IL,מדיסון,,113841.3214,96475.70035,87705.18214,,7290008128629,LOJUXTA 10 MG  28 tab,,,44056,BOTTLE HDPE,units,28.0,152 86 33998 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"An adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51ce8605-6fe2-45c0-a566-c268080aefe8.json
51e11d4c-216c-45de-b91e-64013256537b,LENALIDOMIDE S.K. 10 MG,prescription,L04AX04,LENALIDOMIDE,8732,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE,2025-07-31T04:38:23.361170,IL,SK PHARM(KS KIM),,24330.36379,20618.95236,18744.50215,,7290016845327,LENALIDOMIDE S.K. 25 MG 21 CAPS,12588,,59404,BLISTER PVC/ACLAR/ALUMINIUM,units,21.0,164 86 36219 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM)Lenalidomide S.K. is indicated for the treatment of multiple myeloma. Myelodysplastic Syndromes Lenalidomide S.K. is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Lenalidomide S.K. 7.5 mg is not indicated for treatment in MDS. Mantle Cell Lymphoma Lenalidomide S.K. is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL). Follicular lymphomaLenalidomide S.K. in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51e11d4c-216c-45de-b91e-64013256537b.json
51e45f7f-6fb1-46be-b2ae-892281d069c9,STALEVO ® 150/37.5/200 MG,prescription,N04BA02,LEVODOPA AND DECARBOXYLASE INHIBITOR,4846,,,WHO ATC Classification,,ILS,film coated tablets,"LEVODOPA, CARBIDOPA 37.5   MG, ENTACAPONE",2025-07-31T08:38:53.559666,IL,אינובמד,,76.97580925,65.23373955,48.5009216,,7290100418222,STALEVO 150/37.5/200MG 30TAB,19739,,13354,BOTTLE HDPE,units,30.0,132 36 31107 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51e45f7f-6fb1-46be-b2ae-892281d069c9.json
51f06189-6fd4-436a-a3ca-70a3dbd08321,VIA-AVENIR 100 MG,prescription,G04BE03,SILDENAFIL,8263,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:11:02.299774,IL,ביואבניר,,149.907495,127.04025,101.6322,,7290010286911,VIA AVENIR  50MG  8TABS,,,55874,BLISTER PVC/PVDC/ALUMINIUM,units,8.0,147 72 33415 01,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51f06189-6fd4-436a-a3ca-70a3dbd08321.json
51f51a02-21eb-447d-9e62-438b3f821768,EDRONAX,prescription,N06AX18,REBOXETINE,4070,,,WHO ATC Classification,,ILS,tablets,REBOXETINE METHAN SULFONATE,2025-07-31T02:11:12.727407,IL,פיזר,,131.9659841,111.8355847,83.1491336,,7298074000863,EDRONAX 4MG 60TAB,5149,,21196,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,113 94 29592 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Reboxetine is indicated for the acute treatment of depressive illness/major depression and for maintaining the clinical improvement  in patients initially responding to treatment.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/51f51a02-21eb-447d-9e62-438b3f821768.json
5207b259-6ca5-43e0-b965-0ddebf37c85f,NINLARO 2.3 MG,prescription,L01XX50,IXAZOMIB,7816,,,WHO ATC Classification,,ILS,capsules,IXAZOMIB AS CITRATE 2.3  MG,2025-07-31T05:46:51.833793,IL,טקדה,,21144.0101,17918.65342,16289.68493,,7290014257856,NINLARO 2.3 MG 3CAPS,14601,,56187,BLISTER PVC/ALUMINIUM,units,3.0,156 81 34609 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"NINLARO is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5207b259-6ca5-43e0-b965-0ddebf37c85f.json
522fbf25-e5c6-40f0-9ec9-5fe86e4ed9b2,EBETAXEL 6 MG/ML,prescription,L01CD01,PACLITAXEL,7928,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PACLITAXEL/ML,2025-07-31T02:10:26.183306,IL,סנדוז,,2188.562797,1854.714235,1578.4802,,,EBETAXEL 6 MG/ML VIAL 300MG/50ML,5422,,10326,VIAL GLASS TYPE I,units,1.0,130 95 30965 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Paclitaxel is indicated alone or in combination, for the treatment of advanced carcinoma of the ovary. For the treatment of metastatic breast cancer after failure of combination chemotherapy. Prior therapy should have included an anthracycline unless clinically containdicated. Paclitaxel is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. Advanced non small cell lung cancer: Paclitaxel associated with cisplatinum is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. Kaposis's sarcoma: Paclitaxel is indicated in the second-line treatment of AIDS related Kaposi's sarcoma",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/522fbf25-e5c6-40f0-9ec9-5fe86e4ed9b2.json
5232183a-5695-4574-b543-67c8410f2b57,INS.MIXTARD 30HM10ML,prescription,,,674,,,,,ILS,tablet,INS.MIXTARD 30HM,2025-07-31T19:14:15.090343,IL,נובו נורדיסק,,95.64935388,81.05877808,60.2667495,,,INS.MIXTARD 30HM10ML,9173,,8208,,units,10.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5232183a-5695-4574-b543-67c8410f2b57.json
5232d210-d4da-4b49-b3aa-57fcc391a246,OGIVRI 420 MG,prescription,L01FD01,TRASTUZUMAB,8479,,,WHO ATC Classification,,ILS,powder and solvent for concentrate for solution for infusion,TRASTUZUMAB/VIAL,2025-07-31T06:05:03.930312,IL,דקסל פארמה,,4395.045268,3724.614799,3386.013454,,7290015912587,OGIVRI 420 MG VIAL,15508,,12850,VIAL GLASS TYPE I,units,1.0,162 70 35705 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Ogivri is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress HER2: 1. As a single agent for the treatment of those patients who have received one or more chemotherapy regiments for their metastatic disease. 2. In combination with Paclitaxel or Docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease. 3. In combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer. Early breast cancer (EBC) :Ogivri is indicated to treat patients with HER2-positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding Anthracyclines. Ogivri should only be used in patients whose tumors have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay.HER2 metastatic gastric cancer (mGC).Ogivri in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.Ogivri should only be used in patients with metastatic gastric cancer whose tumours have HER2 overexpression as defined by IHC2+ and a confirmatory FISH+ result, or IHC 3+, as determined by an accurate and validated assay.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5232d210-d4da-4b49-b3aa-57fcc391a246.json
5232e2ae-8ccf-461e-8385-5e741022ffeb,REPHENIDATE LA 30 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,9144,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:26:18.752033,IL,דקסל פארמה,,131.5100387,111.4491853,82.86184784,,,REPHENIDATE LA 30 MG 30 CAPS,18682,,41267,BLISTER ACLAR/ALUMINIUM,units,30.0,170 57 37009 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention deficit hyperactivity disorder (ADHD),תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5232e2ae-8ccf-461e-8385-5e741022ffeb.json
52542f28-a12c-4aac-b31a-ca0bbb97dabc,BISOPROLOL FUMARATE INOVAMED 10 MG,prescription,C07AB07,BISOPROLOL,1785,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE,2025-07-31T07:00:55.628413,IL,דקסל פארמה,,15.29756248,12.964036,9.4628,,,PROLOL 40MG 50TAB,16539,,7944,BLISTER PVC/ALUMINIUM,units,50.0,152 68 34097 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.- Hypertension. - Coronary heart disease (angina pectoris).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/52542f28-a12c-4aac-b31a-ca0bbb97dabc.json
5257bdf5-8853-4581-80a2-f9fde32dce1f,LAMICTAL DISPERSIBLE/CHEWABLE TABLETS 5 MG,prescription,N03AX09,LAMOTRIGINE,2811,,,WHO ATC Classification,,ILS,dispersible chewable tablets,LAMOTRIGINE,2025-07-31T04:32:31.713777,IL,ג.ס.ק,,66.07271881,55.9938295,41.6311,,7290008105200,LAMICTAL 100MG 30 DISP/CHEWTAB,12116,,9258,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,068 90 28230 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy• Adults and adolescents aged 13 years and above- Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- Seizures associated with Lennox-Gastaut syndrome. Lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome.• Children and adolescents aged 2 to 12 years- Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.- Monotherapy of typical absence seizures.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5257bdf5-8853-4581-80a2-f9fde32dce1f.json
525b800c-bd4b-4280-b3d6-c71506413fec,MESTINON DRAGEES 60 MG,prescription,N07AA02,PYRIDOSTIGMINE,334,,,WHO ATC Classification,,ILS,dragee,PYRIDOSTIGMINE BROMIDE 60.0   MG,2025-07-31T05:15:07.689420,IL,דקסל פארמה,,22.9508702,19.44989,14.197,,,MESTINON 60MG 20DRAG,13097,,1312,BOTTLE AMBER GLASS,units,20.0,130 84 21200 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of myasthenia gravis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/525b800c-bd4b-4280-b3d6-c71506413fec.json
5266a617-a81d-4657-8f12-97eb07961f71,CIPRODEX 250,prescription,J01MA02,CIPROFLOXACIN,4576,,,WHO ATC Classification,,ILS,tablets,CIPROFLOXACIN AS HYDROCHLORIDE,2025-07-31T01:16:48.059973,IL,דקסל פארמה,,38.23452992,32.402144,23.6512,,,CIPRODEX 750MG 10TAB,3721,,5079,BLISTER PVC/ALUMINIUM,units,10.0,123 59 30427 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,CIPRODEX caplets are indicated for the treatment of the following infections:Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Adults • Lower respiratory tract infections due to Gram-negative bacteria - exacerbations of chronic obstructive pulmonary disease o In exacerbation of chronic obstructive pulmonary disease CIPRODEX should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis - pneumonia • Chronic suppurative otitis media • Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria • Uncomplicated acute cystitis - In uncomplicated acute cystitis CIPRODEX should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. • Acute pyelonephritis • Complicated urinary tract infections • Bacterial prostatitis • Genital tract infections - gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae - epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae - pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae • Infections of the gastro-intestinal tract (e.g. travellers’ diarrhoea) • Intra-abdominal infections • Infections of the skin and soft tissue caused by Gram-negative bacteria • Malignant external otitis • Infections of the bones and joints • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Children and adolescents • Broncho-pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis • Complicated urinary tract infections and acute pyelonephritis • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary. Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5266a617-a81d-4657-8f12-97eb07961f71.json
5273fc2c-de7b-40aa-9ee3-0f31bf055eaf,CAPRELSA 100 MG,prescription,L01XE12,VANDETANIB,7139,,,WHO ATC Classification,,ILS,film coated tablets,VANDETANIB,2025-07-31T00:53:28.986500,IL,סאנופי אוונטיס,,8420.130435,7135.704076,6487.003706,,7290012711695,CAPRELSA 100 MG 30TAB,9652,,41306,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,149 23 33769 01,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Caprelsa is indicated for the treatment of aggressive and symptomatic Rearranged during Transfection (RET) mutant medullary thyroid cancer (MTC) in patients with unresectable locally advanced or metastatic disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5273fc2c-de7b-40aa-9ee3-0f31bf055eaf.json
528f965e-e1f6-4ea6-9323-975383824792,AGISTEN ALOEVERA CREAM,off-the-counter,D01AC01,CLOTRIMAZOLE,5073,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T11:07:28.324019,IL,פאדאגיס,,31.211,26.45,nan,,7290004850432,AGISTEN CREAM 1%+ALOE VERA 20G,1695,,,TUBE ALUMINIUM,units,20.0,043 17 22461 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as Malassezia furfur, as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/528f965e-e1f6-4ea6-9323-975383824792.json
52967607-c267-4641-8f7c-0b24b7c345d6,CONCERTA 18 MG,prescription,N06BA04,METHYLPHENIDATE,4626,,,WHO ATC Classification,,ILS,tablets extended release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T01:27:36.371739,IL,יאנסן סילג,,121.5693206,103.024848,76.5984,,7290008124966,CONCERTA 18MG XR 30TAB,3735,,56948,BOTTLE HDPE,units,30.0,126 85 30589 24,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Concerta is indicated for the treatment of Attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/52967607-c267-4641-8f7c-0b24b7c345d6.json
52a9337a-ebf6-445c-b33a-ac7ac19a29af,MEMOX 10,prescription,N06DX01,MEMANTINE,4862,,,WHO ATC Classification,,ILS,tablets,MEMANTINE HYDROCHLORIDE,2025-07-31T05:10:38.368484,IL,אוניפארם,,155.9268225,132.141375,105.7131,,,MEMOX 10MG 56TAB,13538,,63643,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,133 16 31117 02,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of patient with moderate  to severe Alzheimer's disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/52a9337a-ebf6-445c-b33a-ac7ac19a29af.json
52bb34e1-0189-40ee-b9f1-f5b7cc5838d0,NINLARO 2.3 MG,prescription,L01XX50,IXAZOMIB,7818,,,WHO ATC Classification,,ILS,capsules,IXAZOMIB AS CITRATE 2.3  MG,2025-07-31T05:47:13.095887,IL,טקדה,,21141.84226,17916.81627,16288.01479,,7290014257856,NINLARO 4 MG 3CAPS,14603,,56222,BLISTER PVC/ALUMINIUM,units,3.0,156 81 34609 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"NINLARO is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/52bb34e1-0189-40ee-b9f1-f5b7cc5838d0.json
52c513fa-f2fe-4411-bfe7-ce1eed3267e7,GIROFLOX,prescription,J01MA02,CIPROFLOXACIN,7096,,,WHO ATC Classification,,ILS,solution for infusion,CIPROFLOXACIN/,2025-07-31T03:34:00.624140,IL,ביואבניר,,101.9445117,86.393654,64.2332,,7290010286041,GIROFLOX 200MG/100ML (200ML),7889,,83422,BOTTLE PLASTIC,units,200.0,133 31 30984 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,* Adults :Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens.* Children and adolescents:• Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa• Complicated urinary tract infections and pyelonephritis• Inhalation anthrax (post-exposure prophylaxis and curative treatment)Ciprofloxacin may also be used to treat severe infections in children and adolescents when there is no otheralternative .Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/52c513fa-f2fe-4411-bfe7-ce1eed3267e7.json
52db66a9-0e6f-46b3-99b2-534d3f34668c,URAMOX,29C,S01EC01,ACETAZOLAMIDE,20264,,,WHO ATC Classification,,ILS,tablets,ACETAZOLAMIDE,2025-07-31T13:41:35.685784,IL,nan,,nan,nan,nan,,7290012066573,ACETAZOLAMIDE SODIUM 500 MG/VIAL,,,,BOTTLE HDPE,units,1.0,016 94 21225 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For adjunctive treatment of drug induced edema and edema due to congestive heart failure. Chronic simple (open angle) glaucoma, secondary glaucoma and pre operatively in acute angle closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acute mountain sickness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/52db66a9-0e6f-46b3-99b2-534d3f34668c.json
52de0654-38be-4055-bd4f-8c4c803f84f7,UNDECYL POWDER,off-the-counter,D01AE04,UNDECYLENIC ACID,3398,,,WHO ATC Classification,,ILS,powder,"UNDECENOIC ACID, ZINC UNDECENOATE",2025-07-31T13:32:56.462729,IL,רקח,,38.43,32.57,nan,,7290008090780,UNDECYL POWDER 80GR,21021,,,SECURITAINER HDPE,units,80.0,029 47 25330 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,Prophylaxis and treatment of mycotic skin infections particulary athlete's  foot.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/52de0654-38be-4055-bd4f-8c4c803f84f7.json
52fc314e-51f2-477d-9dcf-eb0adbcd69c8,FANAPT TABLETS 1 MG,prescription,N05AX14,ILOPERIDONE,6945,,,WHO ATC Classification,,ILS,tablets,ILOPERIDONE,2025-07-31T02:54:27.881554,IL,מגאפארם,,nan,nan,nan,,7290014573062,FANAPT 6MG 60TAB,6507,,43875,BLISTER ALUMINIUM,units,60.0,148 32 33482 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,FANAPT is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/52fc314e-51f2-477d-9dcf-eb0adbcd69c8.json
5310eefe-e603-4dae-a081-b533631acde9,SULFACID,prescription,S01AB04,SULFACETAMIDE,1834,,,WHO ATC Classification,,ILS,"eye drops, solution",SULFACETAMIDE SODIUM,2025-07-31T08:49:41.209380,IL,פישר,,13.75726539,11.6587,8.51,,7290000849645,SULFACID DROPS 5CC,19171,,2061,BOTTLE POLYETHYLENE,units,5.0,106 39 24176 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Eye infections caused by micro-organisms sensitive to sulfacetamide.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5310eefe-e603-4dae-a081-b533631acde9.json
532dab4a-caa9-4e9f-9712-4067c6045f9b,ACYCLOVENIR,prescription,J05AB01,ACICLOVIR,7103,,,WHO ATC Classification,,ILS,powder for solution for infusion,ACICLOVIR,2025-07-30T23:13:59.540884,IL,ביואבניר,,209.8377775,177.828625,142.2629,,7290010286348,ACYCLOVENIR 250MG 5VIAL/10ML,9596,,40523,VIAL GLASS TYPE II,units,5.0,143 05 31907 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,•	indicated for the treatment of Herpes simplex infections in immunocompromised patients and severe initial genital herpes in the non-immunocompromised. •	indicated for the prophylaxis of Herpes simplex infections in immunocompromised patients. •	indicated for the treatment of Varicella zoster infections. •	indicated for the treatment of herpes encephalitis. •	indicated for the treatment of Herpes simplex infections in the neonate and infant up to 3 months of age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/532dab4a-caa9-4e9f-9712-4067c6045f9b.json
532eee38-37dd-44b3-b617-0c1b677077f5,NEXAVAR ®,prescription,L01XE05,SORAFENIB,6135,,,WHO ATC Classification,,ILS,film coated tablets,SORAFENIB AS TOSYLATE,2025-07-31T05:44:37.950571,IL,באייר,,6384.726022,5410.784764,4918.89524,,7298074020595,NEXAVAR 200MG 112 TAB,14447,,89330,BLISTER POLYPROPYLENE/ALUMINIUM,units,112.0,138 01 31543 00,valid,10.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Nexavar is indicated for the treatment of patients with advanced renal cell carcinoma.   Treatment of patients with hepatocellular carcinoma.Nexavar is indicated for the treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma, refractory to radioactive iodine.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/532eee38-37dd-44b3-b617-0c1b677077f5.json
5331675f-39e3-4e8c-9222-f770c8a7633b,TAMIFLU 30 MG,prescription,J05AH02,OSELTAMIVIR,6193,,,WHO ATC Classification,,ILS,capsules,OSELTAMIVIR AS PHOSPHATE,2025-07-31T09:03:20.513721,IL,רוש,,51.8083467,43.90538051,32.047723,,7290008140911,TAMIFLU 30MG 10 CAPSULES,20633,,88115,BLISTER PVC/PE/PVDC,units,10.0,138 02 31733 00,valid,37.0,per os,1.4,120,,,,,,,,,,0,Prescription required,Treatment of influenza : Treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days.  Prophylaxis of influenza : Post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community.   The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains  and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5331675f-39e3-4e8c-9222-f770c8a7633b.json
5358c1bd-e175-4288-bd04-7231399ec2a7,TRANSLARNA 1000 MG,prescription,M09AX03,ATALUREN,7636,,,WHO ATC Classification,,ILS,granules for oral suspension,ATALUREN,2025-07-31T09:34:43.753983,IL,מדיסון,,15930.95458,13500.80956,12273.46324,,,TRANSLARNA 125MG 30 SACHETS,9848,,16013,SACHET ALUMINIUM,units,30.0,154 28 34267 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Translarna is indicated for the treatment of Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older.  The presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5358c1bd-e175-4288-bd04-7231399ec2a7.json
5364b260-c09a-456d-974c-69f383ecf86b,SORBON 10,prescription,N05BE01,BUSPIRONE,3144,,,WHO ATC Classification,,ILS,tablets,BUSPIRONE HYDROCHLORIDE,2025-07-31T08:32:13.436337,IL,אוניפארם,,31.53469288,26.724316,19.5068,,,SORBON 10MG 30TAB,19105,,9286,BLISTER PVC/ALUMINIUM,units,30.0,100 07 27954 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the short-term management of anxiety disorders.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5364b260-c09a-456d-974c-69f383ecf86b.json
5366fc9a-8fd4-45c2-897c-c4d732775c59,EMGALITY 120 MG,prescription,N02CX08,GALCANEZUMAB,8741,,,WHO ATC Classification,,ILS,solution for injection,GALCANEZUMAB/ML,2025-07-31T02:18:17.974148,IL,אלי לילי,,2325.69747,1970.930147,1677.387359,,7290016021158,EMGALITY 120 MG 1 PEN,5655,,42703,PRE-FILLED PEN ,units,1.0,162 90 35852 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,Emgality is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5366fc9a-8fd4-45c2-897c-c4d732775c59.json
5369f492-06f6-406c-a0ef-04632c4244cc,ABITREN TEVA ® 75 MG/3 ML,off-the-counter,M01AB05,DICLOFENAC,5588,,,WHO ATC Classification,,ILS,solution for injection,DICLOFENAC SODIUM/,2025-07-31T13:26:41.561329,IL,טבע,,21.6648,18.36,nan,,7290110730482,TEVA - COLD CAPLETS 20 CAPLETS,,,,AMPOULES GLASS TYPE I,units,20.0,159 38 34860 00,valid,nan,i.m,1.4,24,,,,,,,,,,0,,"Treatment of: - Exacerbations of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondylarthritis, non-articular rheumatism.- Treatment of painful conditions due to inflammation of non rheumatic origin.- Renal colic and biliary colic - Post-traumatic and post-operative pain, inflammation and swelling",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5369f492-06f6-406c-a0ef-04632c4244cc.json
537c4229-c4ca-4f4f-bb61-7260519bc7f2,EYE RELIEF,off-the-counter,S01GA02,TETRYZOLINE,5387,,,WHO ATC Classification,,ILS,"eye drops, solution",TETRYZOLINE HYDROCHLORIDE 0.05 %W/V,2025-07-31T11:52:31.920917,IL,מכבי קאר,,16.2014,13.73,nan,,7290008082631,EYE RELIEF 10ML,,,,DROPER BOTTLE LDPE,units,10.0,135 01 31443 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,"Relief from soreness, burning, itching, irritation redness due to congestion of the eyes.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/537c4229-c4ca-4f4f-bb61-7260519bc7f2.json
537ee810-d51a-412d-bd87-82ac56010a77,DISEPTYL,prescription,J01EE01,SULFAMETHOXAZOLE AND TRIMETHOPRIM,3849,,,WHO ATC Classification,,ILS,suspension,"SULPHAMETHOXAZOLE, TRIMETHOPRIM 0.8 %",2025-07-31T01:59:59.670632,IL,רקח,,17.8957612,15.1659,11.07,,,DISEPTYL FORTE 10CAPLETS,4172,,25257,BOTTLE GLASS TYPE III,units,10.0,115 02 22578 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Antibacterial for treatment of infections due to susceptible micro-organisms in the upper and lower respiratory tract infections, urinary tract infections, gastro-intestinal tract infections.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/537ee810-d51a-412d-bd87-82ac56010a77.json
538714e2-603b-411c-8782-97587fdb96d4,CEFOVIT 250,prescription,J01DB01,CEFALEXIN,8876,,,WHO ATC Classification,,ILS,capsules,CEFALEXIN AS MONOHYDRATE,2025-07-31T00:59:41.254622,IL,ויטאמד,,16.40849,13.9055,10.15,,,CEFOVIT 250 20 CAPS,,,25786,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,026 84 25145 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic for the treatment of infections caused by micro-organisms sensitive to Cephalexin.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/538714e2-603b-411c-8782-97587fdb96d4.json
53afff0c-ad06-43a7-b506-9e84fcf2a713,ZELBORAF,prescription,L01XE15,VEMURAFENIB,6933,,,WHO ATC Classification,,ILS,film coated tablets,VEMURAFENIB,2025-07-31T10:45:32.354088,IL,רוש,,6758.4847,5727.529661,5206.845147,,7290008140362,ZELBORAF 240MG 56TAB,26169,,35612,BLISTER ALUMINIUM,units,56.0,147 24 33558 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,ZELBORAF is indicated for the treatment of BRAFV600 mutation-positive unresectable or metastatic melanoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/53afff0c-ad06-43a7-b506-9e84fcf2a713.json
53b41672-8c30-460e-8a3e-aabfe038441d,UTROGESTAN 100,prescription,G03DA04,PROGESTERONE,4728,,,WHO ATC Classification,,ILS,capsules,PROGESTERONE,2025-07-31T09:55:55.146689,IL,כ.צ.ט,,46.02294738,39.00249952,28.46897775,,,UTROGESTAN 200MG 15 VAG CAPS,21087,,5747,BLISTER PVC/ALUMINIUM,units,15.0,132 44 26341 11,valid,37.0,"per os, vaginal",1.4,36,,,,,,,,,,0,Prescription required,"Vaginal or oral addministration: Disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).Vaginal administration: Progesterone substitution for ovary deprived women in situation of total progesterone deficiency. Supplementation of the luteal phase during in vitro fertilization cycles. Supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. In cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. For all other progesterone indications, in the case of : Adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/53b41672-8c30-460e-8a3e-aabfe038441d.json
53bc46aa-dcc1-4499-b82d-b7c7c48cbb2f,GEFITINIB TEVA ®,prescription,L01XX31,GEFITINIB,8673,,,WHO ATC Classification,,ILS,film coated tablets,GEFITINIB,2025-07-31T03:29:02.312990,IL,טבע,,3161.251219,2679.026576,2435.478706,,7290106065406 ,GEFITINIB TEVA  250 MG 30 TAB,,,56603,BLISTER OPA/ALU/PVC/ALU,units,30.0,165 17 35616 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Gefitinib Teva is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/53bc46aa-dcc1-4499-b82d-b7c7c48cbb2f.json
53c0dbff-57bf-49d2-a9b3-4e681fa145d3,VOCABRIA INJECTION,prescription,,,9046,,,,,ILS,prolonged release suspension for injection,CABOTEGRAVIR/,2025-07-31T10:19:37.037577,IL,ג.ס.ק,,5268.473145,4464.807948,4058.916317,,,VOCABRIA INJECTION 600MG/3ML,,,89152,VIAL GLASS TYPE I,units,1.0,169 81 36948 99,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Vocabria injection is indicated, in combination with rilpivirine injection, for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with agents of the NNRTI and INI class",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/53c0dbff-57bf-49d2-a9b3-4e681fa145d3.json
53c616e6-5722-4803-8571-607406e73487,WILATE  1000,prescription,B02BD02,COAGULATION FACTOR VIII,7717,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,"VON WILLEBRAND FACTOR/VIAL, FACTOR VIII (HUMAN)/VIAL",2025-07-31T10:26:14.136462,IL,דובר מדיקל,,2374.443466,2012.240315,1829.309377,,7290012225536,WILATE 1000 1VIAL,,,,VIAL GLASS TYPE I,units,1.0,151 14 33872 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Von Willebrand disease (VWD) :Prevention and treatment of haemorrhage or surgical bleeding in von Willebrand disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or contra-indicated.Haemophilia A :Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital FVIII deficiency).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/53c616e6-5722-4803-8571-607406e73487.json
53dbfb9d-0ca8-4243-98c0-8db8344444c3,ESOMED GEL,prescription,D11AX11,HYDROQUINONE,5132,,,WHO ATC Classification,,ILS,gel,HYDROQUINONEW/W,2025-07-31T02:36:13.414709,IL,פאדאגיס,,nan,nan,nan,,7290010137169,ESOMED GEL 4% 60GR,5416,,63780,TUBE ALUMINIUM,units,60.0,132 93 30978 00,valid,nan,topical,1.4,36,,,,,,,,,,0,Prescription required,Lightening skin spots.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/53dbfb9d-0ca8-4243-98c0-8db8344444c3.json
53e83d45-15d7-4ad1-8b37-3a682ea3d479,TESTOMAX 25 MG,prescription,G03BA03,TESTOSTERONE,6035,,,WHO ATC Classification,,ILS,gel,TESTOSTERONE/DOSE,2025-07-31T09:16:42.869734,IL,פאדאגיס,,255.6754675,216.674125,173.3393,,7290004850463,TESTOMAX 50MG 30SACHX5G,20622,,75521,SACHET ALUMINIUM,units,30.0,136 20 31297 00,valid,25.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/53e83d45-15d7-4ad1-8b37-3a682ea3d479.json
54073234-b6de-45a5-b333-b79fc72010ab,NERVEN,off-the-counter,,,3969,,,,,ILS,film coated tablets,"VALERIAN NATIVE EXTRACT 67.5  MG, HOP NATIVE EXTRACT 29.4  MG, PASSION FLOWER HOWTHORN BERRIES (2.8:1) NATIVE EXTRACT, HAWTHORN LEAF AND FLOWER NATIVE EXTRACT",2025-07-31T12:29:12.744055,IL,ניאופרם,,46.3976,39.32,nan,,7290004560669,NERVEN 20 DRAGEES,14055,,,BLISTER PVC/PE/PVDC,units,20.0,067 74 28081 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,relief of mild symptoms of mental stress and to aid sleep,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54073234-b6de-45a5-b333-b79fc72010ab.json
54177012-b316-4640-996a-51b8cb5439eb,LORIVAN,prescription,N05BA06,LORAZEPAM,4662,,,WHO ATC Classification,,ILS,tablets,LORAZEPAM,2025-07-31T04:54:10.357171,IL,דקסל פארמה,,5.8747244,4.97858,3.634,,7290008004664,LORIVAN 1MG 20TAB,12489,,40516,BLISTER PVC/ALUMINIUM,units,20.0,043 71 23353 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Anxiety and tension.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54177012-b316-4640-996a-51b8cb5439eb.json
541db55a-d5ec-4bb1-a811-b68f0903c90a,KOATE DVI 1000,prescription,B02BD02,COAGULATION FACTOR VIII,7054,,,WHO ATC Classification,,ILS,powder for solution for injection,FACTOR VIII (HUMAN)/VIAL,2025-07-31T04:28:34.448890,IL,פאדאגיס,,678.5387762,575.0328867,489.3896908,,7298074020335,KOATE DVI 250IU/VIAL,,,,VIAL GLASS TYPE I,units,1.0,117 90 29931 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of classical hemophilia (hemophilia A)  in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor VIII . Koate-DVI provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/541db55a-d5ec-4bb1-a811-b68f0903c90a.json
5424fad9-a121-4617-a433-c4130904beeb,TIPTIPOT MUCOLIT,off-the-counter,R05CB03,CARBOCISTEINE,2329,,,WHO ATC Classification,,ILS,drops,CARBOCISTEINE/ML,2025-07-31T12:27:31.806944,IL,כ.צ.ט,,26.0662,22.09,nan,,7290008104586,MUCOLIT 250MG/4ML SYR 110ML,13401,,,BOTTLE GLASS,units,110.0,122 54 30239 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Treatment of disorders of the respiratory tract characterized by excessive or viscous mucus.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5424fad9-a121-4617-a433-c4130904beeb.json
5425408d-c298-4bbd-89cb-bc945e40c189,SIGNIFOR LAR 10 MG,prescription,H01CB05,PASIREOTIDE,9344,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,PASIREOTIDE AS PAMOATE/VIAL,2025-07-31T08:11:37.496214,IL,מדיסון,,14360.6709,12170.06063,11063.69148,,,SIGNIFOR LAR 30 MG 1 VIAL,,,78948,VIAL GLASS TYPE I,units,1.0,172 50 36981 99,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5425408d-c298-4bbd-89cb-bc945e40c189.json
54260ed2-3dfd-409b-a0d5-a7871d5242e3,DEPALEPT SYRUP,prescription,N03AG01,VALPROIC ACID,2312,,,WHO ATC Classification,,ILS,syrup,VALPROIC ACID AS SODIUM/ML  ML,2025-07-31T01:46:26.069027,IL,כ.צ.ט,,17.80878892,15.092194,11.0162,,7290008005104,DEPALEPT 200MG 40TAB,4041,,596,BOTTLE GLASS TYPE III,units,40.0,033 72 22644 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54260ed2-3dfd-409b-a0d5-a7871d5242e3.json
544984a1-5273-4f46-8f54-db7e3ed4cc8e,BITNI TABLETS,off-the-counter,,,5457,,,,,ILS,tablets,BISMUTH SUBSALICYLATE,2025-07-31T11:19:12.703056,IL,כ.צ.ט,,36.8042,31.19,nan,,,BITNI X 20 TAB,,,,BLISTER PVC/ALUMINIUM,units,20.0,140 65 31601 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of diarrhea, nausea, flatulence, convulsive stomach pains, uspet stomach. As a preventative treatment of traveler's diarrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/544984a1-5273-4f46-8f54-db7e3ed4cc8e.json
5465dc00-6ca2-48bc-965a-3c60164bd3e4,OCTANATE 1000,prescription,B02BD02,COAGULATION FACTOR VIII,8322,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,FACTOR VIII/VIAL,2025-07-31T06:01:32.890518,IL,דובר מדיקל,,2464.693661,2088.723534,1898.839576,,,OCTANATE 1000 1 VIAL,,,5090,VIAL GLASS TYPE I,units,1.0,138 12 31683 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).This preparation does not contain von Willebrand factor in pharmacologically effective quantities and is therefore not indicated in von Willebrand’s disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5465dc00-6ca2-48bc-965a-3c60164bd3e4.json
546bdb28-c291-4c5f-828e-ec0555a43df2,AIRWAYS RESPIRATORY SOLUTION,prescription,R03BB01,IPRATROPIUM BROMIDE,9387,,,WHO ATC Classification,,ILS,solution,IPRATROPIUM BROMIDE 0.25 MG/ML,2025-07-31T00:12:31.723179,IL,סם און,,35.95007862,30.46616832,22.23807907,,,AIRWAYS RESPIRATORY SOL 0.25MG/ML 20 ML BOTTLE,,,,BOTTLE GLASS TYPE I,units,20.0,173 12 36642 99,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"AIRWAYS RESPIRATORY SOLUTION is indicated for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema. AIRWAYS RESPIRATORY SOLUTION is of particular benefit in relieving acute bronchospasm when used concomitantly with inhaled beta agonists.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/546bdb28-c291-4c5f-828e-ec0555a43df2.json
548576d1-56f6-4134-b7de-20a88c2562bf,MOUNJARO 7.5 MG KWIKPEN,prescription,A10BX16,TIRZEPATIDE,9231,,,WHO ATC Classification,,ILS,solution for injection,TIRZEPATIDE 12.5 MG/ML,2025-07-31T05:33:10.153527,IL,אלי לילי,,nan,nan,nan,,,MOUNJARO 7.5 MG/0.5 ML SOL FOR INJ 4 PF PEN,,,,PRE-FILLED PEN GLASS TYPE I,units,4.0,177 52 38071 99,valid,nan,s.c,1.4,24,,,,,,,,,,0,Prescription required,"T2DMMounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise•	as monotherapy when metformin is considered inappropriate due to intolerance or contraindications•	in addition to other medicinal products for the treatment of diabetes.Weight managementMounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of•	&#8805; 30 kg/m2 (obesity) or•	&#8805; 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).For trial results with respect to obstructive sleep apnoea (OSA) in adults with obesity, see section 5.1.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/548576d1-56f6-4134-b7de-20a88c2562bf.json
5488795e-ad9f-47f1-906c-ebe047b6e358,MYOCHOLINE-GLENWOOD 25 MG,29C,N07AB02,BETHANECHOL,20309,,,WHO ATC Classification,,ILS,tablets,BETHANECHOL CHLORIDE,2025-07-31T13:59:05.319574,IL,nan,,nan,nan,nan,,7290018609880,BETHANECHOL 10MG 100TAB,,,,BLISTER PVC/ALUMINIUM,units,100.0,167 20 35286 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Myocholine Glenwood is indicated in cases of postoperative urinary retention due to atony of the bladder in adults in diseases in which a stimulation of the bladder muscle is needed.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5488795e-ad9f-47f1-906c-ebe047b6e358.json
549097b3-1433-4001-90f6-143b2a13b7e0,EPREX/PROTECS 8000 IU/0.8ML 6SYRINGES,prescription,,,4429,,,,,ILS,tablet,EPREX/PROTECS 8000 IU/0. 6SYRINGES,2025-07-31T19:09:44.348058,IL,יאנסן סילג,,1854.476471,1571.59023,1337.5236,,,EPREX/PROTECS 8000 IU/0.8ML 6SYRINGES,5461,,86984,,units,6.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/549097b3-1433-4001-90f6-143b2a13b7e0.json
54995c80-5923-47ff-95eb-318f18e91bc7,GLUCOSE 10 % BAXTER,29C,B05BA03,CARBOHYDRATES,20846,,,WHO ATC Classification,,ILS,solution for infusion,GLUCOSE AS MONOHYDRATEW/V,2025-07-31T14:42:09.107830,IL,nan,,nan,nan,nan,,,GLUCOSE 10% 500ml  BRAUN GERMANY SOLUTION FOR INFUSION,,,,CONTAINER PLASTIC,units,10.0,170 80 36044 00,valid,nan,i.v,1.4,18,,,,,,,,,,0,,Carbohydrate infusion therapy:*   Hypoglycemic situations*   Hypertonic dehydration*   Hypertonic electrolyte disturbance.Vehicle solution for supplementary medication.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54995c80-5923-47ff-95eb-318f18e91bc7.json
549ad7ce-5c1b-4dda-a618-d90193567743,FLIXOTIDE DISKUS 100 MCG,prescription,R03BA05,FLUTICASONE,3538,,,WHO ATC Classification,,ILS,powder for inhalation,FLUTICASONE PROPIONATE,2025-07-31T03:08:11.710262,IL,ג.ס.ק,,67.8740089,57.52034909,42.7660588,,,FLIXOTIDE DISK 250MCG 60DOSES,6109,,47596,BLISTER PVC/OPA/AL,units,60.0,069 97 28478 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Prophylactic management of all grades of asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/549ad7ce-5c1b-4dda-a618-d90193567743.json
54a0bd19-44a4-48e4-aa04-76ed46cbc2fe,TOPAMAX 100,prescription,N03AX11,TOPIRAMATE,3550,,,WHO ATC Classification,,ILS,film coated tablets,TOPIRAMATE,2025-07-31T09:25:44.947544,IL,יאנסן סילג,,95.65705636,81.065302,60.2716,,,TOPAMAX 50MG 60TAB,20164,,52946,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,107 57 29033 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topamax is indicated in adults for the prevention of migraines. The use of Topamax in the acute treatment of migraine has not been studied.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54a0bd19-44a4-48e4-aa04-76ed46cbc2fe.json
54aa8477-073a-4f38-8a30-e8a957ccc923,CEQUA,prescription,S01XA18,CICLOSPORIN,8500,,,WHO ATC Classification,,ILS,"eye drops, solution",CICLOSPORIN 0.09 %W/V,2025-07-31T01:05:41.311705,IL,תרו,,nan,nan,nan,,,CEQUA 0.09 % 60 AMP*0.25 ML,,,72978,VIAL LDPE,units,60.0,165 76 36091 00,valid,nan,ocular,1.4,18,,,,,,,,,,0,Prescription required,Indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54aa8477-073a-4f38-8a30-e8a957ccc923.json
54af4e21-446c-4e24-9962-e7ef891221a5,NUROFEN FORTE LIQUID CAPSULES 400 MG,off-the-counter,M02AA13,IBUPROFEN,5081,,,WHO ATC Classification,,ILS,capsules liquid filled,IBUPROFEN,2025-07-31T12:38:52.712361,IL,רקיט בנקיזר,,59.8024,50.68,nan,,,NUROFEN LIQUID 200MG 40 CAPS,14382,,,BLISTER PVC/PVDC/ALUMINIUM,units,40.0,148 44 31886 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Relief of mild to moderate pain such as headache, toothache, menstrual pain, backache, muscular pain, anti-inflammatory for rheumatic disease, reduction of fever.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54af4e21-446c-4e24-9962-e7ef891221a5.json
54c6ae33-ade4-4512-8cec-6a269b44b470,SULIQUA 100/33,prescription,A10AE04,INSULIN GLARGINE,8094,,,WHO ATC Classification,,ILS,solution for injection,"LIXISENATIDE/ML / 1, INSULIN GLARGINE 100 UNITS /",2025-07-31T08:50:03.067092,IL,סאנופי אוונטיס,,510.5517964,432.6710331,368.2306665,,,SULIQUA 100/33 SOL FOR INJ 3ML 5 PRE FILLED PEN,10153,,64777,PRE-FILLED PEN GLASS TYPE I,units,15.0,159 27 35118 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sodium-glucose co-transporter-2 (SGLT-2) inhibitors,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54c6ae33-ade4-4512-8cec-6a269b44b470.json
54da1cc6-46a8-421f-ad54-7376dc711225,TORID 80MG 30TAB,prescription,,,6909,,,,,ILS,tablet,TORID 80MG,2025-07-31T19:34:52.316063,IL,אוניפארם,,65.84528738,55.801091,41.4878,,,TORID 80MG 30TAB,20689,,17781,,units,30.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54da1cc6-46a8-421f-ad54-7376dc711225.json
54dd1103-083c-49a2-b466-9738c7858a1c,IMNOVID 1 MG,prescription,L04AX06,POMALIDOMIDE,7406,,,WHO ATC Classification,,ILS,"capsule, hard",POMALIDOMIDE,2025-07-31T04:02:42.752417,IL,ניאופרם,,25387.77912,21515.06801,19559.15274,,7640133683157,IMNOVID 2MG 3X7 CAPSULES (POMALYST),9793,,77869,BLISTER PVC/PCTFE,units,21.0,152 02 33954 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.Imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/54dd1103-083c-49a2-b466-9738c7858a1c.json
5522223f-4281-4984-896a-26007d752e1a,FEXOFENADINE - TRIMA 120 MG,off-the-counter,R06AX26,FEXOFENADINE,8393,,,WHO ATC Classification,,ILS,film coated tablets,FEXOFENADINE HYDROCHLORIDE,2025-07-31T11:55:34.365305,IL,תרימה,,18.762,15.9,nan,,,FEXOFENADINE - TRIMA 180 MG 15 TAB,6612,,,BLISTER ALUMINIUM /ALUMINIUM,units,15.0,162 12 35365 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Relief of symptoms associated with seasonal allergic rhinitis., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5522223f-4281-4984-896a-26007d752e1a.json
553d6b77-46f3-4c37-a979-5ab3a8167c4d,DOPAMINE HYDROCHLORIDE S.A.L.F. 40 MG/1 ML,prescription,C01CA04,DOPAMINE,8573,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOPAMINE HYDROCHLORIDE/,2025-07-31T02:02:24.668060,IL,רז פרמהצפטי,,149.1927525,126.4345417,101.1476333,,7290015863551,DOPAMINE HYDROCHLORIDE S.A.L.F. 200 MG/5 ML 5 AMP,,,45708,AMPOULES GLASS TYPE I,units,5.0,164 32 35059 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"DOPAMINE HYDROCHLORIDE S.A.L.F. is used for the treatment of states of shock of different nature:- post myocardial infarction cardiogenic shock, a shock caused by a heart attack,- surgical shock, caused by a surgical operation,- hypovolemic or haemorrhagic shock, caused by a decrease in blood volume due to a hemorrhage,A shock is characterized by a sharp decrease in blood pressure in response to a reduced blood flow in the organism.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/553d6b77-46f3-4c37-a979-5ab3a8167c4d.json
554362ab-24ec-409a-9952-16f76495505e,HISTAFED EXPECTORANT SYRUP,off-the-counter,R06AX07,TRIPROLIDINE,2190,,,WHO ATC Classification,,ILS,syrup,"GUAIFENESIN/, PSEUDOEPHEDRINE HYDROCHLORIDE/, TRIPROLIDINE HYDROCHLRIDE 1.25  MG /",2025-07-31T12:04:57.566324,IL,תרימה,,23.2814,19.73,nan,,7290000843698,HISTAFED SYRUP 115ML,8050,,,BOTTLE GLASS,units,115.0,050 31 26252 00,valid,nan,per os,1.4,18,,,,,,,,,,0,,"Histafed expectorant is a proven combination for providing an effective antiallergic action, decongestion with an added expectorant effect.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/554362ab-24ec-409a-9952-16f76495505e.json
5549cebf-7d4f-427e-b0e4-7615797c7a0a,POLIVY,prescription,,,8528,,,,,ILS,powder for concentrate for solution for infusion,POLATUZUMAB VEDOTIN/VIAL,2025-07-31T06:46:57.440981,IL,רוש,,48267.11758,40904.33875,37185.7625,,7290014774148,POLIVY 140 MG 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,165 19 36153 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,"Polivy in combination with bendamustine and rituximab is indicated for the treatment of previously treated adult patients with diffuse large B-cell lymphoma who are not candidates for hematopoietic stem cell transplant.Polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP) is indicated for the treatment of adult patients with previously untreated diffuse large B-cell lymphoma (DLBCL).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5549cebf-7d4f-427e-b0e4-7615797c7a0a.json
55586f69-b1a1-47ee-b052-71d78138c2fb,NAFLOXIN,prescription,S03AA07,CIPROFLOXACIN,7869,,,WHO ATC Classification,,ILS,solution,CIPROFLOXACIN AS HYDROCHLORIDE/,2025-07-31T05:38:57.453588,IL,תרימה,,21.15741416,17.930012,13.0876,,7290000843247,NAFLOXIN 3MG 5ML,14595,,51365,BOTTLE LDPE,units,5.0,155 32 34358 00,valid,37.0,"ocular, otic",1.4,24,,,,,,,,,,0,Prescription required,"Corneal ulcers and conjunctivitis caused by susceptible gram positive and gram negative microorganisms for adults and pediatric patients above the age of 1 year. For localized or diffuse otitis externa accompanied by a strong inflammatory reaction and of which the strains are susceptible to ciprofloxacin, and for the acute flare-up of a chronic otitis media. In this case, a mucopurulent secretion comes through the perforated eardrum.Pseudomonas aeruginosa is one of the organisms most likely to be found in this case. Also in other infections of the ear in which Pseudomonas aeruginosa and/or other susceptible strains may be demonstrated or suspected (for example with suppurating tympanic tubes), Nafloxin can be used under the strict supervision of an ear specialist. It must be understood that this is not a routine treatment and that improper use must be avoided.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/55586f69-b1a1-47ee-b052-71d78138c2fb.json
5588da19-29a9-4e60-a30d-e4faa5b7d68d,CURATANE 10 MG,prescription,,,8962,,,,,ILS,capsules soft gelatin,ISOTRETINOIN,2025-07-31T01:36:01.416861,IL,תרו יבוא,,nan,nan,nan,,,CURATANE 30 MG 30 CAPS,,,68327,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,136 12 30295 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of severe cystic acne that does not respond to other treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5588da19-29a9-4e60-a30d-e4faa5b7d68d.json
5588ec5c-0084-4538-abd4-ba50950d9c2a,RESOLOR 1 MG,prescription,A03AE04,PRUCALOPRIDE,7060,,,WHO ATC Classification,,ILS,film coated tablets,PRUCALOPRIDE AS SUCCINATE,2025-07-31T07:27:52.393595,IL,ביוטיס,,342.3333319,290.1130061,246.904686,,7290014577107,RESOLOR 2MG 28 FC TAB,18505,,48927,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,149 82 33682 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Resolor is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5588ec5c-0084-4538-abd4-ba50950d9c2a.json
5596c71c-86c8-4f9e-926d-ebbf1978efc6,LAMOGINE 100 MG,prescription,N03AX09,LAMOTRIGINE,4423,,,WHO ATC Classification,,ILS,tablets,LAMOTRIGINE,2025-07-31T04:34:17.902374,IL,תרימה,,56.14791286,47.582977,34.7321,,,LAMOGINE 100MG 30TAB,12089,,30857,BLISTER PVC/ALUMINIUM,units,30.0,123 89 30354 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"EpilepsyAdults and adolescents aged 13 years and above- 	Adjunctive or monotherapy treatment of partial seizures and generalised seizures,                including tonic-clonic seizures.- 	Seizures associated with Lennox-Gastaut syndrome. Lamogine is given as adjunctive               therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-              Gastaut syndrome.Children and adolescents aged 2 to 12 years- 	Adjunctive treatment of partial seizures and generalised seizures, including tonic-             clonic seizures and the seizures associated with Lennox-Gastaut syndrome.-	 Monotherapy of typical absence seizures.Bipolar disorderAdults aged 18 years and above-	 Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamogine is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5596c71c-86c8-4f9e-926d-ebbf1978efc6.json
559ad0d9-06b3-4011-a956-11ea140b3309,CITRAFLEET POWDER FOR SOL 2 SACHET,prescription,,,7484,,,,,ILS,solution,CITRAFLEET POWDER FOR SOL 2 SACHET,2025-07-31T19:02:19.816296,IL,טרדיס גת,,63.08532048,53.462136,39.7488,,,CITRAFLEET POWDER FOR SOL 2 SACHET,9830,,76151,,units,2.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/559ad0d9-06b3-4011-a956-11ea140b3309.json
55a37a70-cf4a-4c26-8397-878974b8bc0a,COLOTAL TABLETS 135 MG,off-the-counter,A03AA04,MEBEVERINE,2386,,,WHO ATC Classification,,ILS,tablets,MEBEVERINE HYDROCHLORIDE,2025-07-31T11:26:12.621602,IL,פאדאגיס,,44.3798,37.61,nan,,,COLOTAL 135MG 50TAB,3594,,,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,035 72 25831 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Irritable bowel syndrome and conditions included in this group such as: Chronic irritable colon, Gastro- intestinal spasm secondary to organic diseases",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/55a37a70-cf4a-4c26-8397-878974b8bc0a.json
55c20484-5d81-4ca8-9c68-acfb1d672498,SUBUTEX 2 MG,prescription,N07BC01,BUPRENORPHINE,4384,,,WHO ATC Classification,,ILS,tablets sublingual,BUPRENORPHINE AS HYDROCHLORIDE,2025-07-31T08:49:07.375859,IL,נעמי שאקו עזרה,,83.50379663,70.76593249,52.6140762,,7290008121378,SUBUTEX 8MG 7 SUBLING TAB,19448,,3881,BLISTER ALUMINIUM /ALUMINIUM,units,7.0,133 88 29872 00,valid,34.5,sublingual,1.4,24,,,,,,,,,,0,Prescription required,"Substitution treatment for opioid dependence within a Framework of medical, social and psychological treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/55c20484-5d81-4ca8-9c68-acfb1d672498.json
55ca5eca-4ff3-41aa-8908-71f8a784a0c9,SIMULECT ® 20 MG,prescription,L04AA09,BASILIXIMAB,7006,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection/infusion,BASILIXIMAB/VIAL,2025-07-31T08:14:13.629932,IL,נוברטיס פארמה,,4640.826926,3932.904349,3575.36759,,7290001180310,SIMULECT 20MG 1VIAL,19759,,57812,VIAL 6 ML GLASS TYPE I,units,1.0,113 38 29524 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of acute organ rejection in de novo renal transplantation in combination with cyclosporin and corticosteroid based immunosuppression,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/55ca5eca-4ff3-41aa-8908-71f8a784a0c9.json
55cf9833-1c80-471c-b784-0e2d91a2c301,XGEVA,prescription,M05BX04,DENOSUMAB,6929,,,WHO ATC Classification,,ILS,solution for injection,DENOSUMAB/ 1.7  ML,2025-07-31T10:35:01.168604,IL,מדיסון,,1394.071279,1181.416391,1005.460758,,8715131010911,XGEVA 120MG/1.7ML 1VIAL,24068,,20069,VIAL GLASS TYPE I,units,1.0,147 01 33411 00,valid,17.5,s.c,1.4,48,,,,,,,,,,0,Prescription required,"Prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with multiple myeloma and in adults with bone metastases from solid tumours.Treatment of adult and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/55cf9833-1c80-471c-b784-0e2d91a2c301.json
55eb8872-d6a7-462f-9816-df0437ebd2db,RIPOL 10 MG/ML,prescription,N01AX10,PROPOFOL,8233,,,WHO ATC Classification,,ILS,emulsion for injection or infusion,PROPOFOL/ML,2025-07-31T07:36:40.149457,IL,רז פרמהצפטי,,49.46565635,41.92004775,30.598575,,7290015863360,RIPOL 10 MG/ML 20 ML  5 AMPOULES,,,69588,AMPOULES GLASS TYPE I,units,5.0,159 41 34438 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Ripol 10 mg/ml is a short-acting intravenous general anaesthetic for: - Induction and maintenance of general anaesthesia in adults and paediatric patients > 1 month of age- Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and paediatric patients > 1 month of age- Sedation of ventilated patients > 16 years of age in the intensive care unit",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/55eb8872-d6a7-462f-9816-df0437ebd2db.json
55ed77f4-d7c6-4b71-a041-e1c5be3fd3a9,MEROPENEM / ANFARM 1 G,prescription,J01DH02,MEROPENEM,8068,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,MEROPENEM AS TRIHYDRATE/VIAL,2025-07-31T05:14:35.926873,IL,SK PHARM(KS KIM),,467.3339673,396.045735,337.0602,,2802860602015,MEROPENEM / ANFARM 500 MG 10 VIALS,13768,,49077,VIAL GLASS TYPE III,units,10.0,150 54 33679 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary  infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological  infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis -Septicemia. Meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/55ed77f4-d7c6-4b71-a041-e1c5be3fd3a9.json
5615d5a2-aca3-4786-9c16-f4af85028791,EXONDYS 51,prescription,M09AX06,ETEPLIRSEN,8401,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ETEPLIRSEN/,2025-07-31T02:50:10.327547,IL,תרומד,,nan,nan,nan,,,EXONDYS 51 500MG/10ML 1 VIAL,,,,VIAL GLASS TYPE I,units,10.0,160 85 35258 00,valid,nan,i.v,1.4,30,,,,,,,,,,0,Prescription required,EXONDYS 51 is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5615d5a2-aca3-4786-9c16-f4af85028791.json
56190d1d-f902-4269-9383-bc981cc3b416,MEMORIT 10,prescription,,,3763,,,,,ILS,tablets,DONEPEZIL HYDROCHLORIDE,2025-07-31T05:10:27.395118,IL,אוניפארם,,136.6986688,115.8463295,86.1311,,,MEMORIT 10MG 28TAB,13362,,20959,BLISTER PVC/ALUMINIUM,units,28.0,132 20 29786 03,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Treatment of mild to moderately severe Alzheimer`s dementia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56190d1d-f902-4269-9383-bc981cc3b416.json
562aa0b9-edf9-4130-8095-ca53bec8bc3c,MEKTOVI 15 MG,prescription,L01XE41,BINIMETINIB,8865,,,WHO ATC Classification,,ILS,film coated tablets,BINIMETINIB,2025-07-31T05:09:09.075002,IL,מדיסון,,22113.91504,18740.6068,17036.91527,,,MEKTOVI  15MG  180 TABS,13852,,25965,BOTTLE HDPE,units,180.0,167 73 35723 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"BRAF V600E or V600K Mutation-Positive Unresectable or Metastatic MelanomaBinimetinib is a kinase inhibitor indicated, in combination with encorafenib, for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation.BRAF V600E Mutation-Positive metastatic non-small cell lung cancer (NSCLC)Binimetinib is a kinase inhibitor indicated, in combination with encorafenib, for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) adenocarcinoma with a BRAF V600E mutation, as detected by an approved test.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/562aa0b9-edf9-4130-8095-ca53bec8bc3c.json
56392e52-8607-4b59-ad6d-b112ca2999cc,OXYCONTIN 10,prescription,N02AA05,OXYCODONE,3687,,,WHO ATC Classification,,ILS,tablets controlled release,OXYCODONE HYDROCHLORIDE,2025-07-31T06:22:07.647269,IL,רפא,,67.06216116,56.83234249,42.25452973,,7290008014373,OXYCONTIN 40MG 20 CR TAB,15102,,35562,BLISTER PVC/ALUMINIUM,units,20.0,100 71 28431 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,For the relief of moderate to severe chronic pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56392e52-8607-4b59-ad6d-b112ca2999cc.json
56421549-2a0e-4a24-8284-fba5b8323fdc,VEMLIDY,prescription,J05AF13,TENOFOVIR ALAFENAMIDE,8202,,,WHO ATC Classification,,ILS,film coated tablets,TENOFOVIR ALAFENAMIDE,2025-07-31T10:03:41.257492,IL,גיליאד,,1567.248693,1328.176917,1130.363334,,5391507143631,VEMLIDY 25MG 30 TABS,,,12458,BOTTLE HDPE,units,30.0,159 67 35160 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Vemlidy is indicated for the treatment of chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg), ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56421549-2a0e-4a24-8284-fba5b8323fdc.json
5664df1b-4d8e-44e8-a2eb-2bfc813792e1,AGISTEN COMBI,off-the-counter,D01AC01,CLOTRIMAZOLE,5502,,,WHO ATC Classification,,ILS,vaginal tablets + cream,CLOTRIMAZOLE,2025-07-31T11:07:10.141601,IL,פאדאגיס,,71.71,60.77,nan,,,AGISTEN COMBI,,,,BLISTER ALUMINIUM,units,1.0,152 26 34103 00,valid,nan,"dermal, vaginal",1.4,48,,,,,,,,,,0,,"Cream:For the treatment of fungal infections of the skin and mucosa caused be dermatophytes, yeasts, molds and other fungi such as Malassezia furfur as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.Vag Tablets: Infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (as Candida albicans) in adults and children 12 years of age and older.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5664df1b-4d8e-44e8-a2eb-2bfc813792e1.json
56712a44-890e-4a75-9cd4-76803bf6f5fa,STEGLATRO 15 MG,prescription,A10BK04,ERTUGLIFLOZIN,8311,,,WHO ATC Classification,,ILS,film coated tablets,ERTUGLIFLOZIN (L-PGA),2025-07-31T08:41:35.416766,IL,מ.ס.ד. ישראל,,167.2984811,141.7783801,113.4227041,,,STEGLATRO 5 MG 28 TAB,,,29321,BLISTER ALU/PVC/PA/ALU,units,28.0,161 73 35637 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Steglatro is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:• as monotherapy in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindications.• in addition to other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56712a44-890e-4a75-9cd4-76803bf6f5fa.json
56722028-88fd-4de8-80ba-2b7c0befb409,AMGEVITA ®,prescription,L04AB04,ADALIMUMAB,8972,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/,2025-07-31T00:18:34.290793,IL,מדיסון,,2331.675847,1975.996569,1796.360517,,,AMGEVITA 40MG/0.8ML 2 SYR,,,66055,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,165 56 36181 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid arthritisAMGEVITA in combination with methotrexate is indicated for:• The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.• The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.AMGEVITA can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.Axial spondyloarthritisAnkylosing spondylitis (AS):AMGEVITA is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Axial spondyloarthritis without radiographic evidence of AS:AMGEVITA is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels, who have had an inadequate response to, or are intolerant to, non - steroidal anti-inflammatory drugs.Psoriatic arthritisAMGEVITA is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate.Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease to improve physical function.PsoriasisAMGEVITA is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.Hidradenitis suppurativa (HS)AMGEVITA is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult patients with an inadequate response to conventional systemic HS therapy.Crohn’s diseaseAMGEVITA is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. AMGEVITA is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.Ulcerative colitisAMGEVITA is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6- mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.UveitisAMGEVITA is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroidsparing, or in whom corticosteroid treatment is inappropriate.Intestinal Behcet's diseaseAmgevita is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56722028-88fd-4de8-80ba-2b7c0befb409.json
568c1efb-c34d-4747-9971-7403c62ee4cc,SIMBRINZA,prescription,S01EC54,"BRINZOLAMIDE, COMBINATIONS",7977,,,WHO ATC Classification,,ILS,"eye drops, suspension","BRIMONIDINE TARTRATE/ML, BRINZOLAMIDE/ML",2025-07-31T08:13:12.414988,IL,נוברטיס פארמה,,57.31160689,48.56916054,35.451942,,7290016369397,SIMBRINZA EYE DROPS 5 ML,10126,,61675,BOTTLE LDPE,units,5.0,158 81 34867 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/568c1efb-c34d-4747-9971-7403c62ee4cc.json
568d0f58-fda7-4b26-9afd-55db478ba712,SOLEZOL,prescription,A02BC05,ESOMEPRAZOLE,8160,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,ESOMEPRAZOLE AS SODIUM/VIAL,2025-07-31T08:26:32.590052,IL,SK PHARM(KS KIM),,29.56551242,25.055519,18.2887,,7290016845082,SOLEZOL  40 MG/VIAL 1 VIAL,10178,,89816,VIAL 5 ML GLASS TYPE I,units,1.0,159 99 34845 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Solezol is indicated in adult for:                                                    :• Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate.  • Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.                                                                                                                          Solezol is indicated in children and adolescents aged 1-18 years for: • Gastric antisecretory treatment when the oral route is not possible, such as:                    gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/568d0f58-fda7-4b26-9afd-55db478ba712.json
56a2ac9a-91d6-4d7b-b972-08dad7da8aef,PRALUENT 150 MG/ML,prescription,C10AX14,ALIROCUMAB,7836,,,WHO ATC Classification,,ILS,solution for injection,ALIROCUMAB/,2025-07-31T06:49:05.414773,IL,סאנופי אוונטיס,,2145.811113,1818.484075,1547.646021,,7290012711602,PRALUENT 75 MG INJECTION 2 PREFILLED SYR,16948,,27286,PRE-FILLED PEN GLASS TYPE I,units,2.0,156 09 34568 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Primary hypercholesterolaemia and mixed dyslipidaemia Praluent is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, and in paediatric patients 8 years of age and older with heterozygous familial hypercholesterolaemia (HeFH) as an adjunct to diet:-	in combination with a statin or statin with other lipid lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin or,-	alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.Established atherosclerotic cardiovascular disease Praluent is indicated in adults with established atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL-C levels, as an adjunct to correction of other risk factors: -	in combination with the maximum tolerated dose of a statin with or without other lipid-lowering therapies or,-	alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56a2ac9a-91d6-4d7b-b972-08dad7da8aef.json
56b1a5e1-7ab7-4626-abb3-53ba64de9834,PADCEV 20 MG,prescription,L01XC36,ENFORTUMAB VEDOTIN ,3336,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,ENFORTUMAB VEDOTIN/VIAL,2025-07-31T03:17:05.938581,IL,סנדוז,,37.1688672,31.49904,22.992,,8718692511422,FORTUM 1G INJ 1 VIAL,6075,,9502,VIAL GLASS TYPE I,units,1.0,167 37 36604 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"PADCEV, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer (mUC). PADCEV, as a single agent , is indicated for the treatment of adult patients with locally advanced or mUC who: •	have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic settingor:•	are ineligible for cisplatin-containing chemotherapy and have previously received a PD-1/PD-L1 inhibitor.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56b1a5e1-7ab7-4626-abb3-53ba64de9834.json
56b32d09-52b2-474c-bd57-c6bbe1d57f37,HAIRGAIN 5%,off-the-counter,D11AX01,MINOXIDIL,5556,,,WHO ATC Classification,,ILS,solution - external,MINOXIDILW/V,2025-07-31T12:34:53.344504,IL,ליף-פריגו,,119.8998,101.61,nan,,7290008856119,NOXIDIL 5 % SOLUTION 60 ML,,,,BOTTLE HDPE,units,60.0,138 28 31485 00,valid,nan,topical- scalp,1.4,24,,,,,,,,,,0,,Hair regrowth treatment for men.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56b32d09-52b2-474c-bd57-c6bbe1d57f37.json
56cdbd31-ceb4-46b4-97e5-dd2a9ef90780,ORAMORPH 20 MG/ML,prescription,N02AA01,MORPHINE,6612,,,WHO ATC Classification,,ILS,solution  (oral),MORPHINE AS SULFATE/ML,2025-07-31T05:31:32.365693,IL,רפא,,238.7310404,202.31445,161.85156,,7290010286867,MORPHINE 1MG/ML 5ML 5 AMP,,,10066,BOTTLE AMBER GLASS TYPE III,units,5.0,153 96 34100 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of moderate to severe pain, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56cdbd31-ceb4-46b4-97e5-dd2a9ef90780.json
56dc848e-309b-430b-a76f-c59cd8a22e81,NUCALA POWDER FOR SOLUTION FOR INJECTION,prescription,L04AC06,MEPOLIZUMAB,7972,,,WHO ATC Classification,,ILS,powder for solution for injection,MEPOLIZUMAB,2025-07-31T05:57:27.311614,IL,ג.ס.ק,,4533.902377,3842.290321,3492.991201,,,NUCALA 100mg/ml vial,14605,,59906,VIAL 10 ML GLASS TYPE I,units,1.0,157 57 34861 00,valid,10.0,s.c,1.4,48,,,,,,,,,,0,Prescription required,Severe eosinophilic asthmaNucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adult patientsChronic rhinosinusitis with nasal polyps (CRSwNP)Nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe CRSwNP for whom therapy with corticosteroids and surgery in the last 10 years do not provide adequate disease control.Eosinophilic Granulomatosis with Polyangiitis (EGPA)Nucala is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).Hypereosinophilic syndrome (HES)Nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56dc848e-309b-430b-a76f-c59cd8a22e81.json
56ea0be9-4b65-4da4-b3cf-e5331f4eff30,SINUFED TABLETS,prescription,R01BA02,PSEUDOEPHEDRINE,6393,,,WHO ATC Classification,,ILS,tablets,PSEUDOEPHEDRINE HYDROCHLORIDE,2025-07-31T08:18:15.357668,IL,תרימה,,23.18915704,19.651828,14.3444,,,SINUFED 60MG 20TAB,19611,,7670,BLISTER PVC/ALUMINIUM,units,20.0,030 06 25464 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Symptomatic treatment of nasal congestion, to relieve eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56ea0be9-4b65-4da4-b3cf-e5331f4eff30.json
56f1d711-f512-4c0f-8041-6b48352b52d6,DUPIXENT 200 MG,prescription,D11AH05,DUPILUMAB,8878,,,WHO ATC Classification,,ILS,solution for injection,DUPILUMAB/ML,2025-07-31T02:07:54.627302,IL,סאנופי אוונטיס,,5819.964305,4932.173359,4483.793963,,3664798045000,DUPIXENT 200 MG/1.14ML 2 PFS,4701,,51408,PRE-FILLED PEN GLASS TYPE I,units,2.0,164 42 36128 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Atopic Dermatitis DUPIXENT is indicated for the treatment of treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids. Asthma DUPIXENT is indicated as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Limitation of Use: DUPIXENT is not indicated for the relief of acute bronchospasm or status asthmaticus.Eosinophilic EsophagitisDUPIXENT is indicated for the treatment of adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with eosinophilic esophagitis (EoE).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56f1d711-f512-4c0f-8041-6b48352b52d6.json
56f9b6fa-a211-4283-a7e8-7fd228c880f6,TILOPTIC 0.5 %,prescription,S01ED01,TIMOLOL,1709,,,WHO ATC Classification,,ILS,"eye drops, solution",TIMOLOL AS MALEATE 0.5 %W/V,2025-07-31T09:20:49.376793,IL,רפא,,18.77891058,15.914331,11.6163,,7290000802640,TILOPTIC COL 0.5% 5ML,20122,,2190,DROPER BOTTLE HDPE,units,5.0,113 20 22175 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"For the reduction of elevated intraocular pressure may be used in patients with chronic open-angle glaucoma, aphakic glaucoma, some patients with secondary glaucoma and patients with ocular hypertension",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56f9b6fa-a211-4283-a7e8-7fd228c880f6.json
56fbffba-89e5-4dc9-a7ec-7173e979d566,VISABELLE,prescription,G03FA15,DIENOGEST AND ESTROGEN,6917,,,WHO ATC Classification,,ILS,tablets,DIENOGEST,2025-07-31T10:18:01.338391,IL,באייר,,70.65936628,59.88082154,44.52105691,,7290013092120,VISABELLE 2MG 28 TAB,22347,,34506,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,146 40 33320 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of endometriosis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56fbffba-89e5-4dc9-a7ec-7173e979d566.json
56fcf8a7-8d64-4f33-aa49-340cfc142f64,LITORVA 10,prescription,C10AA05,ATORVASTATIN,6758,,,WHO ATC Classification,,ILS,tablets,ATORVASTATIN AS CALCIUM,2025-07-31T04:50:28.653313,IL,דקסל פארמה,,32.64788364,27.667698,20.1954,,7290010578429,LITORVA 20MG 30 TAB,12450,,26468,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,145 31 33305 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Litorva is indicated as an adjunct to diet for reduction of elevated total cholesterol LDL- cholesterol apolipoprotein B and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Litorva is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable. Pediatric patients (10-17 years of age) : Atorvastatin is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:  1. LDL-C remains >or = 190 mg/dl or   2. LDL-C remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the pediatric patient. Prevention of cardiovascular and/or cerebrovascular event sush as MI or stroke as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor. In patients with clinically evident coronary heart disease, Litorva is indicated to : Reduce the risk of non-fatal myocardial infarction. Reduce the risk of fatal and non fatal stroke. Reduce the risk for revascularization procedures. Reduce the risk of hospitalization for CHF. Reduce the risk of angina.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/56fcf8a7-8d64-4f33-aa49-340cfc142f64.json
5716e373-930d-4e71-9b8b-ea65af6c822c,INS.INSULATARD H10ML,prescription,,,664,,,,,ILS,tablet,INS.INSULATARD H,2025-07-31T19:13:53.317998,IL,נובו נורדיסק,,61.35309068,51.99414696,38.65735833,,,INS.INSULATARD H10ML,9063,,1068,,units,10.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5716e373-930d-4e71-9b8b-ea65af6c822c.json
571e7318-b656-4287-82ba-7e5d14ef3d2c,SITAMET - AVENIR 50 MG/1000 MG,prescription,A10BD07,METFORMIN AND SITAGLIPTIN,9131,,,WHO ATC Classification,,ILS,film coated tablets,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE",2025-07-31T08:20:08.980601,IL,ביואבניר,,145.5086668,123.3124295,91.68210368,,,SITAMET - AVENIR 50 MG/850 MG 56 tab,,,8982,BLISTER PVC/ALU/OPA/ALU,units,56.0,169 30 36666 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Sitamet-Avenir is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use: Sitamet-Avenir should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. Sitamet-Avenir has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitamet-Avenir.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/571e7318-b656-4287-82ba-7e5d14ef3d2c.json
5728da44-d0bd-4cfe-aa87-e9989caedd1e,IODO-VIT VETERINARY OINTMENT,off-the-counter,D08AG02,POVIDONE-IODINE,5282,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:12:17.068813,IL,ויטאמד,,40.1672,34.04,nan,,7290008082495,IODO-VIT OINT 250GR,9070,,,JAR PLASTIC,units,250.0,083 26 92362 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Disinfection of wounds, scratches, minor burns and skin infections in farm animals and pets.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5728da44-d0bd-4cfe-aa87-e9989caedd1e.json
572f4a4c-d201-4975-b36e-0e8a9d7c02ce,LUCENTIS,prescription,S01LA04,RANIBIZUMAB,6036,,,WHO ATC Classification,,ILS,solution for injection,RANIBIZUMAB/ML,2025-07-31T04:57:57.971057,IL,נוברטיס פארמה,,2151.406901,1823.226269,1551.681931,,7290014257351,LUCENTIS 1 PFS 1.65mg/0.165ml,12420,,32622,SYRINGE PREFILLED  GLASS,units,1.0,136 75 31520 00,valid,17.5,intravitreal,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of patients with neovascular (wet) age-related macular degeneration (AMD). Treatment of adult patients with visual impairment due to diabetic macular oedema (DME) . The treatment of visual impairement due to macular oedema secondary to retinal vein occlusion (RVO). The treatment of visual impaiment due to choroidal neovascularization (CNV) . Lucentis is indicated in preterm infants for: the treatment of retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 3+) or AP-ROP (aggressive posterior ROP) disease.The treatment of proliferative diabetic retinopathy (PDR)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/572f4a4c-d201-4975-b36e-0e8a9d7c02ce.json
573b4120-788d-4b67-ae43-c141d77c75b9,REXULTI ® 0.5 MG,prescription,N05AX16,BREXPIPRAZOLE,8636,,,WHO ATC Classification,,ILS,film coated tablets,BREXPIPRAZOLE 0.5  MG,2025-07-31T07:32:23.315476,IL,לנדבק,,455.7147997,386.199,328.68,,5702150153210,REXULTI ® 2 MG 28 TAB,18626,,59879,BLISTER PVC/ALUMINIUM,units,28.0,163 39 35733 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rexulti is indicated for:• Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults• Treatment of schizophrenia in adults and pediatric patients ages 13 years and older• Treatment of agitation associated with dementia due to Alzheimer’s diseaseLimitations of Use:Rexulti is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/573b4120-788d-4b67-ae43-c141d77c75b9.json
574b9b20-e10f-4550-9bc0-e4fbbd200fd1,AKNE-MYCIN SOL 25ML,prescription,,,845,,,,,ILS,solution,AKNE-MYCIN SOL,2025-07-31T18:58:00.318648,IL,ניאופרם,,18.43716134,15.624713,11.4049,,,AKNE-MYCIN SOL 25ML,1169,,210,,units,25.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/574b9b20-e10f-4550-9bc0-e4fbbd200fd1.json
574ed9a3-d3b7-4698-a07d-4c70a08d42aa,ANTEPSIN SUSPENSION 1GR/5ML 250ML,29C,,,20807,,,,,,suspension,ANTEPSIN SUSPENSION 1GR/,2025-07-31T19:54:32.000714,IL,nan,,,,,,,ANTEPSIN SUSPENSION 1GR/5ML 250ML,,,,,units,250.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/574ed9a3-d3b7-4698-a07d-4c70a08d42aa.json
574fd619-cdfd-422e-ac41-f9da40a359f6,SUBOXONE FILM 4 MG/1 MG,prescription,N02AE01,BUPRENORPHINE,7181,,,WHO ATC Classification,,ILS,sublingual film,"BUPRENORPHINE AS HYDROCHLORIDE, NALOXONE AS HYDROCHLORIDE DIHYDRATE",2025-07-31T08:48:45.648765,IL,נעמי שאקו עזרה,,216.1928276,183.2142607,146.5714086,,,SUBOXONE 8MG/2MG 28 TAB SUBLINGUAL,19888,,84716,FOIL ALUMINIUM,units,28.0,164 26 35833 00,valid,25.0,"buccal, sublingual",1.4,24,,,,,,,,,,0,Prescription required,Suboxone sublingual film is indicated for treatment of opioid dependence in adults and adolescents over 15 years of age. Suboxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/574fd619-cdfd-422e-ac41-f9da40a359f6.json
5770c614-e065-4df7-a29c-be7cec9440b1,BRONCHICLEAR   ® TABLETS,off-the-counter,R05CA10,COMBINATIONS,5515,,,WHO ATC Classification,,ILS,film coated tablets,"PRIMULA ROOT DRY EXTRACT (6-7:1);                      EXTRACTING AGENT : ETHANOL 47.4 % (V/V), THYME HERB DRY EXTRACT (6-10:1);                  EXTRACTING AGENT: ETHANOL 70.0 % (V/V)",2025-07-31T11:19:40.008514,IL,דר סמואלוב,,46.5982,39.49,nan,,7290014626713,BRONCHICLEAR 20 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,159 49 34894 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the relief of symptoms in acute bronchitis with coughs and colds associated with viscous mucus in children from 12 years of age, adolescents and adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5770c614-e065-4df7-a29c-be7cec9440b1.json
577bd452-e7d6-493c-ad96-7b2ad5cff43e,CAPECITABINE TEVA ® 150 MG,prescription,L01BC06,CAPECITABINE,7546,,,WHO ATC Classification,,ILS,film coated tablets,CAPECITABINE,2025-07-31T00:53:07.932142,IL,טבע,,140.9853675,119.479125,95.5833,,7290106061460,CAPECITABINE TEVA 150MG 60TAB,9774,,57488,BLISTER PVC/PE/PVDC/AL,units,60.0,152 61 34182 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Adjuvant Colon Cancer: Capecitabine Teva® is indicated for the adjuvant treatment of patients following surgery of stage III (Dukesע stage C) colon cancer. Colorectal Cancer: Capecitabine Teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. Advanced gastric cancer: Capecitabine Teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. Breast Cancer Combination Therapy: Capecitabine Teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Breast Cancer Monotherapy: Capecitabine Teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/577bd452-e7d6-493c-ad96-7b2ad5cff43e.json
577d154a-9c65-42fa-9b39-78a3d0317a2b,INOVELON 100 MG TABLETS,prescription,N03AF03,RUFINAMIDE,6669,,,WHO ATC Classification,,ILS,film coated tablets,RUFINAMIDE,2025-07-31T04:06:22.296646,IL,אסיי,,36.81552746,31.19960093,22.77343133,,5036519000519,INOVELON 100 MG 10TAB,9419,,25165,BLISTER PA/ALUMINIUM/PVC,units,10.0,145 35 33202 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Inovelon is indicated as adjunctive therapy in the treatment of seizures associated with Lennox Gastaut syndrome in patients 1 year of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/577d154a-9c65-42fa-9b39-78a3d0317a2b.json
57815b1c-22c7-4d13-bca9-080b5bf463bc,SYMBICORT TURBUHALER 320/9 MCG/DOSE,prescription,R03AK07,FORMOTEROL AND BUDESONIDE,4774,,,WHO ATC Classification,,ILS,powder for inhalation,"BUDESONIDE MICRONIZED/DOSE, FORMOTEROL FUMARATE/DOSE",2025-07-31T08:54:29.817460,IL,אסטראזנקה,,144.0646427,122.0886857,90.772257,,7290013075093,SYMBICORT TURBUHAL 320/9MCG/DOSE 60DOSES,19915,,18412,METERED DOSE INHALER ,units,60.0,130 94 30921 00,valid,34.5,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"Symbicort Turbuhaler 320/9 mcg/dose  is indicated in adults and adolescents, age 12 -17 for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting β2 adrenoceptor-agonist) is appropriate:-Patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting β2 adrenoceptor-agonists.Or- Patients already adequately controlled on both inhaled corticosteroids and long acting β2 adrenoceptoragonists.Chronic Obstructive Pulmonary Disease (COPD)Symbicort Turbuhaler  320/9 mcg/dose  is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with COPD with forced expiratory volume in I second (FEV1) < 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/57815b1c-22c7-4d13-bca9-080b5bf463bc.json
5793e810-ab66-482b-9050-8af21e0bd9e8,RIZALT  RPD 10 MG WAFERS,prescription,N02CC04,RIZATRIPTAN,7570,,,WHO ATC Classification,,ILS,tablets soluble in mouth,RIZATRIPTAN AS BENZOATE,2025-07-31T07:46:41.310286,IL,אורגנון,,208.210056,176.4492,141.15936,,,RIZALT RPD 10MG 12 WAFER,18515,,61225,BLISTER PVC/PVDC/ALUMINIUM,units,12.0,112 38 29510 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5793e810-ab66-482b-9050-8af21e0bd9e8.json
57a2d96e-1667-4535-89bb-ad2b1494126d,ALDARA 5 %,prescription,D06BB10,IMIQUIMOD,4005,,,WHO ATC Classification,,ILS,cream,IMIQUIMOD,2025-07-31T00:15:32.453509,IL,מגאפארם,,268.385985,227.44575,181.9566,,72900081072402,ALDARA 5% CREAM 12SACH,1446,,20226,SACHET POLYESTER/ALUMINIUM/POLYETHYLENE,units,12.0,114 44 29675 00,valid,25.0,"dermal, perianal, genital",1.4,24,,,,,,,,,,0,Prescription required,Indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients. For the treatment of actinic keratoses in adults with normal immune systems.   For the treatment of superficial basal cell carcinoma in adults with normal immune systems when surgical methods are less appropriate.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/57a2d96e-1667-4535-89bb-ad2b1494126d.json
57a41fe0-9d79-4542-9333-33b859e62189,CELONTIN 300MG 100CAPS,29C,,,20051,,,,,,capsule,CELONTIN 300MG,2025-07-31T20:04:41.964510,IL,nan,,,,,,,CELONTIN 300MG 100CAPS,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/57a41fe0-9d79-4542-9333-33b859e62189.json
57beae09-2a64-48dd-8577-b2662091114b,REVATIO,prescription,G04BE03,SILDENAFIL,4988,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T07:30:31.690396,IL,דקסל פארמה,,2322.673119,1968.36705,1675.206,,7290010355495,REVATIO 20MG 90TAB,18367,,70246,BLISTER PVC/ALUMINIUM,units,90.0,135 61 31377 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,For adults > 18 years:  Treatment of primary pulmonary hypertension (PPH)  pulmonary hypertension (PH) associated with connective tissue disease (CTD)  or PH following surgical repair at least 5 years previously of atrial septal defect (ASD)  ventricular septal defect (VSD)  patent ductus arteriosus (PDA)  or aorto-pulmonary window.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/57beae09-2a64-48dd-8577-b2662091114b.json
57f4a64e-b5d5-46ee-a1db-67157a5fd53d,FUSID TABLETS,29C,C03CA01,FUROSEMIDE,20423,,,WHO ATC Classification,,ILS,tablets,FUROSEMIDE,2025-07-31T14:39:56.031426,IL,nan,,nan,nan,nan,,7290102064144,FUROSEMIDE ORAL SOL 10MG/ML 120ML,,,,BLISTER PVC/ALUMINIUM,units,120.0,020 20 20472 12,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Adjunctive therapy in acute pulmonary edema. Treatment of hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/57f4a64e-b5d5-46ee-a1db-67157a5fd53d.json
582979fc-21ae-4057-9dc5-2e8f4cde9e61,SANDIMMUM CONC I.V. INF 250MG/5ML 10X5ML,prescription,,,4914,,,,,ILS,tablet,SANDIMMUM CONC I.V. INF 250MG/ 10X,2025-07-31T19:31:36.239240,IL,נוברטיס פארמה,,456.6339078,386.9779052,329.342898,,,SANDIMMUM CONC I.V. INF 250MG/5ML 10X5ML,19113,,76235,,units,10.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/582979fc-21ae-4057-9dc5-2e8f4cde9e61.json
58453aba-469c-43dc-b5ed-5d26354726ca,XEPLION 100 MG,prescription,N05AX13,PALIPERIDONE,6718,,,WHO ATC Classification,,ILS,suspension for injection extended release,PALIPERIDONE AS PALMITATE/,2025-07-31T10:34:21.465531,IL,יאנסן סילג,,1112.064321,942.4274325,802.0659,,7290008099844,XEPLION 100MG/1ML 1 SYRINGE 1.5ML,24062,,1633,SYRINGE PREFILLED  ,units,1.0,169 09 37280 99,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,Xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.Xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58453aba-469c-43dc-b5ed-5d26354726ca.json
585c0548-b99a-4275-9291-e32e0b4c175c,COLIRCUSI 1% 10ML EYE DROPS,29C,,,20054,,,,,,drops,COLIRCUSI 1% EYE DROPS,2025-07-31T20:07:25.559331,IL,nan,,,,,,,COLIRCUSI 1% 10ML EYE DROPS,,,,,units,10.0,,not-registered,,ophthalmic,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/585c0548-b99a-4275-9291-e32e0b4c175c.json
586ebf2b-e7bf-4889-ba08-33f6aa15f7db,BRIVIACT 10 MG FILM COATED TABLETS,prescription,N03AX23,BRIVARACETAM,8359,,,WHO ATC Classification,,ILS,film coated tablets,BRIVARACETAM,2025-07-31T00:44:09.630930,IL,ניאופרם,,1184.308132,1003.651004,854.171067,,,BRIVIACT 10MG/ML SO FOR INJ  10VIALS 5ML,2628,,64879,BLISTER PVC/PCTFE/AL,units,10.0,159 88 35241 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/586ebf2b-e7bf-4889-ba08-33f6aa15f7db.json
5875b34e-834f-4477-82d1-b92e39e7c4c8,NITISINONE DIPHARMA 10 MG,prescription,A16AX04,NITISINONE,9127,,,WHO ATC Classification,,ILS,"capsule, hard",NITISINONE,2025-07-31T05:47:34.987354,IL,אמ.בי.איי פארמה,,9674.326236,8198.581556,7453.25596,,,NITISINONE DIPHARMA 10 MG 60 CAPS,,,84876,BOTTLE HDPE,units,60.0,167 25 35824 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5875b34e-834f-4477-82d1-b92e39e7c4c8.json
587907e5-e225-4053-b951-82732706c85d,BOSENTAN TEVA ® 125 MG,prescription,C02KX01,BOSENTAN,8408,,,WHO ATC Classification,,ILS,film coated tablets,BOSENTAN AS MONOHYDRATE,2025-07-30T23:41:48.615820,IL,טבע,,5015.789205,4250.668818,3864.24438,,,BOSENTAN TEVA ® 62.5 MG 60 tab,,,38565,BLISTER PVC/ACLAR/PVC/ALUMINIUM,units,60.0,162 02 34906 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of pulmonary arterial hypertension (PAH) in patients of WHO functional class II-IV.Reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/587907e5-e225-4053-b951-82732706c85d.json
587d0340-34de-4608-8be9-bf87d79b34f9,DANALONE,prescription,H02AB06,PREDNISOLONE,4913,,,WHO ATC Classification,,ILS,syrup,PREDNISOLONE/,2025-07-31T01:40:54.988295,IL,מגאפארם,,nan,nan,nan,,7290000843292,DANALONE SYRUP 60ML,4481,,66605,BOTTLE GLASS,units,60.0,133 81 31155 00,valid,nan,per os,1.4,20,,,,,,,,,,0,Prescription required,"For glucocorticoid respousive inflamination as: Endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states and gastrointestinal diseases.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/587d0340-34de-4608-8be9-bf87d79b34f9.json
5880bb7d-40f7-45b7-aa35-c956700eec90,CIPRODEX 250,prescription,J01MA02,CIPROFLOXACIN,4575,,,WHO ATC Classification,,ILS,tablets,CIPROFLOXACIN AS HYDROCHLORIDE,2025-07-31T01:16:37.201707,IL,דקסל פארמה,,27.44081504,23.254928,16.9744,,,CIPRODEX 500MG 10TAB,3720,,4881,BLISTER PVC/ALUMINIUM,units,10.0,123 59 30427 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,CIPRODEX caplets are indicated for the treatment of the following infections:Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Adults • Lower respiratory tract infections due to Gram-negative bacteria - exacerbations of chronic obstructive pulmonary disease o In exacerbation of chronic obstructive pulmonary disease CIPRODEX should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis - pneumonia • Chronic suppurative otitis media • Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria • Uncomplicated acute cystitis - In uncomplicated acute cystitis CIPRODEX should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. • Acute pyelonephritis • Complicated urinary tract infections • Bacterial prostatitis • Genital tract infections - gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae - epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae - pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae • Infections of the gastro-intestinal tract (e.g. travellers’ diarrhoea) • Intra-abdominal infections • Infections of the skin and soft tissue caused by Gram-negative bacteria • Malignant external otitis • Infections of the bones and joints • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Children and adolescents • Broncho-pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis • Complicated urinary tract infections and acute pyelonephritis • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary. Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5880bb7d-40f7-45b7-aa35-c956700eec90.json
588aa710-749a-41e3-81f0-87c57392af85,MYLERAN TABLETS 2 MG,prescription,L01AB01,BUSULFAN,4404,,,WHO ATC Classification,,ILS,tablets,BUSULFAN,2025-07-31T05:38:15.836377,IL,פאדאגיס,,345.4955986,292.7928932,249.185441,,,MYLERAN 2MG 100TAB,13067,,26244,BOTTLE GLASS TYPE III,units,100.0,129 38 30943 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the palliative treatment of the chronic granulocytic leukemia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/588aa710-749a-41e3-81f0-87c57392af85.json
58a6bf65-51a0-419f-8c3c-da25cba2c7b6,CETRIN CONCENTRATED SOLUTION,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",3927,,,WHO ATC Classification,,ILS,solution,"CETRIMIDE, CHLORHEXIDINE GLUCONATE 1.5 %",2025-07-31T11:24:28.514673,IL,ויטאמד,,58.73,49.77,nan,,7-290008-068703,CETRIN CONCENTRATED SOL 1L,3056,,,BOTTLE HDPE,units,1000.0,062 88 27733 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"As an antiseptic for external use, for cleansing and sterilizing of instruments, hands and skin.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58a6bf65-51a0-419f-8c3c-da25cba2c7b6.json
58aa38d3-77f8-4147-ba49-3a5693a5cbcd,DASATINIB SANDOZ ® 100 MG,prescription,L01XE06,DASATINIB,9350,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB,2025-07-31T01:42:16.801561,IL,סנדוז,,4389.218971,3719.677094,3381.524631,,,DASATINIB SANDOZ  20 MG 60 TAB,,,14587,BLISTER OPA/ALU/PVC/ALU,units,60.0,173 10 36531 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with :  Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase.  Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate.  Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58aa38d3-77f8-4147-ba49-3a5693a5cbcd.json
58ac8551-969d-422b-8f1e-be500467c409,ULTIVA 5 MG,prescription,N01AH06,REMIFENTANIL,8268,,,WHO ATC Classification,,ILS,powder for concentrate for solution for injection / infusion,REMIFENTANIL AS HYDROCHLORIDE/VIAL,2025-07-31T07:23:37.287997,IL,ביואבניר,,164.526515,139.42925,111.5434,,7290008086189,REMIFENTANIL  2MG  5VIAL 5ML,,,20081,VIAL GLASS TYPE I,units,5.0,108 35 29195 22,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Ultiva is indicated as an analgesic agent  for use during induction and/or maintenance of general anaesthesia under close supervision . Ultiva is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58ac8551-969d-422b-8f1e-be500467c409.json
58c91b9b-1d04-48ca-a42c-654b015c8446,LEMOCIN CHERRY,off-the-counter,R02AD02,LIDOCAINE,3898,,,WHO ATC Classification,,ILS,lozenges,"LIDOCAINE, TYROTHRICIN, CETRIMONIUM BROMIDE",2025-07-31T12:18:33.875612,IL,דפריס,,30.6446,25.97,nan,,7290011363185,LEMOCIN LEMON 24LOZ,12373,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,117 79 29907 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of pain associated with severe sore throat and mouth infections.This medicine is intended for adults and children over 12 years old.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58c91b9b-1d04-48ca-a42c-654b015c8446.json
58d50f80-dc21-48c0-a587-cf256fd6618c,S.C.P 47 VETERINARY,prescription,,,2336,,,,,ILS,powder for solution,SULFACHLORPYRAZINE SODIUM MONOHYDRATEW/W,2025-07-31T07:17:43.437388,IL,כ.צ.ט,,nan,nan,nan,,,RAZIN 15MG 30CAPSULES,18316,,57843,BAG ALUMINIUM,units,30.0,072 14 91672 01,valid,nan,per os in drinking water,1.4,40,,,,,,,,,,0,Prescription required,"Prevention and treatment of coccidiosis, salmonellosis, fowl cholera in chicken.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58d50f80-dc21-48c0-a587-cf256fd6618c.json
58e3a6c6-e199-4c47-83af-163d06dc0e6a,BUSULFEX,prescription,L01AB01,BUSULFAN,6995,,,WHO ATC Classification,,ILS,solution for injection,BUSULFAN/,2025-07-30T23:46:14.008138,IL,צמל,,1334.085787,1130.581226,962.196788,,7290012240096,BUSULFEX 60MG/10ML 1VIAL/10ML,2484,,78664,VIAL GLASS TYPE I,units,1.0,117 29 29837 02,valid,17.5,i.v,1.4,30,,,,,,,,,,0,Prescription required,For use in combination with other chemotherapeutic agents and/or radiotherapy as a conditioning regimen prior to hematopoietic progenitor cell transplantation.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58e3a6c6-e199-4c47-83af-163d06dc0e6a.json
58eccdf9-45a5-4d71-9eb3-3bfcdc8fca3e,VOLTAREN EMULGEL 1%,off-the-counter,M02AA15,DICLOFENAC,614,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T13:36:59.126003,IL,ג.ס.ק,,76.6528,64.96,nan,,,VOLTAREN EMULGEL 100G,22215,,,TUBE ALUMINIUM,units,100.0,037 66 25000 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to:  • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :• Pain caused by osteoarthrosis of the peripheral joints,  as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58eccdf9-45a5-4d71-9eb3-3bfcdc8fca3e.json
58feb779-84e8-43cd-8978-644fc9d60230,KIMMTRAK,prescription,L01XX75,TEBENTAFUSP,9214,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,TEBENTAFUSP 0.2 MG/ML,2025-07-31T04:26:23.377000,IL,מדיסון,,58661.24646,49712.92294,45193.56631,,,KIMMTRAK 100 MCG/ 0.5 ML 1 VIAL,,,44049,VIAL GLASS TYPE I,units,1.0,173 92 37400 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,KIMMTRAK is indicated as monotherapy for the treatment of human leukocyte antigen (HLA)-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/58feb779-84e8-43cd-8978-644fc9d60230.json
590cdcda-b466-4285-b6e5-2141285e7277,OFEV 100 MG,prescription,,,7619,,,,,ILS,"capsule, soft",NINTEDANIB AS ESILATE,2025-07-31T06:03:51.619454,IL,בורינגר אינגלהיים,,7704.306718,6529.07378,5935.521618,,,OFEV 100MG 60CAPS,15460,,30846,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,154 74 34335 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Idiopathic Pulmonary Fibrosis OFEV is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adults. Systemic Sclerosis-Associated Interstitial Lung DiseaseOFEV is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD).Chronic Fibrosing Interstitial Lung Diseases with a Progressive PhenotypeOFEV is indicated in adults for the treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/590cdcda-b466-4285-b6e5-2141285e7277.json
5920f164-06cd-4ae9-90fe-71be7912d245,REXULTI ® 0.5 MG,prescription,N05AX16,BREXPIPRAZOLE,8637,,,WHO ATC Classification,,ILS,film coated tablets,BREXPIPRAZOLE 0.5  MG,2025-07-31T07:32:34.564516,IL,לנדבק,,683.6276596,579.3455,493.06,,5702150153210,REXULTI ® 3 MG 28 TAB,18627,,59881,BLISTER PVC/ALUMINIUM,units,28.0,163 39 35733 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rexulti is indicated for:• Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults• Treatment of schizophrenia in adults and pediatric patients ages 13 years and older• Treatment of agitation associated with dementia due to Alzheimer’s diseaseLimitations of Use:Rexulti is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5920f164-06cd-4ae9-90fe-71be7912d245.json
593b7b31-45c7-45e0-ba25-fe5600002562,DIPROFOL 1 %,prescription,N01AX10,PROPOFOL,8204,,,WHO ATC Classification,,ILS,emulsion for injection or infusion,PROPOFOL/ML,2025-07-31T01:58:09.101133,IL,תרו יבוא,,49.46565635,41.92004775,30.598575,,,DIPROFOL 1% 20ML X 5AMP,,,,AMPOULES GLASS TYPE I,units,5.0,113 40 29567 01,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Diprofol 1% is a short-acting intravenous general anaesthetic for:• Induction and maintenance of general anaesthesia in adults and children > 1 month.• Sedation of ventilated patients > 16 years of age in the intensive care unit.• Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 1 month..",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/593b7b31-45c7-45e0-ba25-fe5600002562.json
5941c753-d307-44a6-b22e-74dbf268dce4,CORSODYL DENTAL GEL,off-the-counter,S02AA09,CHLORHEXIDINE,3980,,,WHO ATC Classification,,ILS,gel,CHLORHEXIDINE DIGLUCONATEW/W,2025-07-31T11:27:05.054768,IL,ג.ס.ק,,34.41,29.16,nan,,7290008102933,CORSODYL MINT 0.2% SOL 300ML,3571,,,TUBE ALUMINIUM,units,300.0,114 62 29571 21,valid,nan,local oral,1.4,36,,,,,,,,,,0,,1. As an aid to maintaining oral hygiene.2. As an aid in the treatment and  prevention of gingivitis.3. Inhibition of formation of dental plaque.4. For use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush).5. For use in a post- periodontal  surgery or treatment regimen to promote gingival healing.6. As an adjunct to fluoride in the prevention of dental caries in high risk patients.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5941c753-d307-44a6-b22e-74dbf268dce4.json
599aba6b-9f53-47ef-aa95-1ca8628cff64,MYCONAIL,off-the-counter,D01AE14,CICLOPIROX,5400,,,WHO ATC Classification,,ILS,lacque,CICLOPIROX/G,2025-07-31T12:28:10.195856,IL,פאדאגיס,,121.2096,102.72,nan,,7298074010299,MYCONAIL NAIL LACQUER 6.6ML,,,,BOTTLE GLASS TYPE III,units,6.6,141 71 31856 00,valid,nan,nail,1.4,24,,,,,,,,,,0,,For the treatment of fungal infections of the nails.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/599aba6b-9f53-47ef-aa95-1ca8628cff64.json
599bdaae-59b9-400d-a3bf-d4a9a25495c0,MERCILON,prescription,G03AC09,DESOGESTREL,3029,,,WHO ATC Classification,,ILS,tablets,"DESOGESTREL, ETHINYLESTRADIOL",2025-07-31T05:12:54.655088,IL,אורגנון,,18.86539868,15.987626,11.6698,,7290006537010,MERCILON 1X21TAB,13081,,9330,BLISTER PVC/ALUMINIUM,units,21.0,103 11 26498 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraception,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/599bdaae-59b9-400d-a3bf-d4a9a25495c0.json
59d17863-9349-49e0-b04e-b4256cc5acc0,COUMADIN 1 MG,prescription,B01AA03,WARFARIN,3707,,,WHO ATC Classification,,ILS,tablets,WARFARIN SODIUM,2025-07-31T01:32:12.817820,IL,תרו,,8.144556129,6.902166518,5.03807775,,7290000808048,COUMADIN 1MG 30TAB,3548,,9907,BOTTLE HDPE,units,30.0,111 43 29373 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. Coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. Coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/59d17863-9349-49e0-b04e-b4256cc5acc0.json
59d4642d-117a-477c-87fc-898463d0ec99,KLACID SR TABLETS,prescription,J01FA09,CLARITHROMYCIN,2761,,,WHO ATC Classification,,ILS,tablets slow release,CLARITHROMYCIN,2025-07-31T04:27:34.089843,IL,אבוט,,22.58567279,19.14040152,13.971096,,,KLACID PED SUSP 60ML,11006,,8846,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,130 74 29326 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For treatment of infections caused by susceptible organisms. For lower respiratory tract infections, upper respiratory tract infections, skin and soft tissue infections",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/59d4642d-117a-477c-87fc-898463d0ec99.json
59f1bd5f-9b58-4be7-8606-a055e4aec78c,DIPROSALIC OINTMENT,prescription,D07XC01,BETAMETHASONE,1245,,,WHO ATC Classification,,ILS,ointment,"SALICYLIC ACID/G, BETAMETHASONE AS DIPROPIONATE 0.5 MG/G",2025-07-31T01:59:06.513259,IL,אורגנון,,12.08570106,10.24212,7.476,,72989586,DIPROSALIC OINT 15GR,4433,,8461,TUBE ALUMINIUM,units,15.0,135 51 24242 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Provides anti inflammatory, antipruritic, anti allergic and chronic hyperkeratotic and dry keratolytic activity in the topical management of subacute dermatoses responsive to corticosteroid therapy.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/59f1bd5f-9b58-4be7-8606-a055e4aec78c.json
59f25c0f-43fd-488d-93fd-50b1118adcd6,EVEROLIMUS TEVA ® 10 MG,prescription,L04AA18,EVEROLIMUS,8982,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS,2025-07-31T02:44:20.423779,IL,טבע,,5159.461319,4372.424847,3974.931679,,,EVEROLIMUS TEVA 10 MG  30TAB,5698,,74042,BLISTER OPA/ALU/PVC/ALU,units,30.0,163 31 35379 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"• For the treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of Everolimus is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. • Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. The safety and effectiveness of Everolimus in the treatment of patients with carcinoid tumors have not been established.• For the treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.• Everolimus Teva is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Everolimus in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes.• Everolimus Teva is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.•Treatment of unresectable, locally advanced or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/59f25c0f-43fd-488d-93fd-50b1118adcd6.json
5a066f31-4e03-422e-8c77-5888d79d8b56,ARIPLY 10,prescription,N05AX12,ARIPIPRAZOLE,7202,,,WHO ATC Classification,,ILS,tablets,ARIPIPRAZOLE,2025-07-30T23:27:22.157572,IL,אוניפארם,,270.6154475,229.335125,183.4681,,,ARIPLY 15MG 28TAB,9643,,40540,BLISTER PVC/ALUMINIUM,units,28.0,149 03 33529 01,valid,25.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Ariply is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.Ariply  is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD). Efficacy was established in two 6-week trials in adults with MDD who had an inadequate response to antidepressant therapy during the current episode.Ariply  is indicated for the treatment of irritability associated with autistic disorder. Efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a066f31-4e03-422e-8c77-5888d79d8b56.json
5a0c6b44-e5ab-40ca-bc17-6cade387f050,COUMADIN 1 MG,prescription,B01AA03,WARFARIN,2052,,,WHO ATC Classification,,ILS,tablets,WARFARIN SODIUM,2025-07-31T01:32:43.587017,IL,תרו,,22.5927923,19.146435,13.9755,,7290000808048,COUMADIN 5MG 30TAB,3397,,35351,BOTTLE HDPE,units,30.0,111 43 29373 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. Coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. Coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a0c6b44-e5ab-40ca-bc17-6cade387f050.json
5a202373-9d48-4d22-bcff-826623e2cfba,MONOCORD 20,prescription,C01DA14,ISOSORBIDE MONONITRATE,3644,,,WHO ATC Classification,,ILS,tablets,ISOSORBIDE MONONITRATE,2025-07-31T05:29:18.981346,IL,דקסל פארמה,,9.6996,8.22,6.0,,7290008113427,MONOCORD 20MG 30TAB,13253,,33331,BLISTER PVC/ALUMINIUM,units,30.0,052 51 23128 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of angina pectoris and prevention of anginal attacks. Treatment of congestive heart failure.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a202373-9d48-4d22-bcff-826623e2cfba.json
5a248afe-d33b-48f7-a915-743aeefe6906,YASMIN,prescription,G03AA12,DROSPIRENONE AND ESTROGEN,7734,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ETHINYLESTRADIOL 0.03   MG",2025-07-31T10:39:20.749002,IL,באייר,,nan,nan,nan,,7-298074-040876,YASMIN PLUS 1X28 F.C.TAB,25018,,85445,BLISTER PVC/ALUMINIUM,units,28.0,122 02 30220 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraception.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a248afe-d33b-48f7-a915-743aeefe6906.json
5a260b93-cc00-40d5-bbb7-949c0c43111b,KALBETEN TABLETS,off-the-counter,,,5249,,,,,ILS,tablets,BISMUTH SUBSALICYLATE,2025-07-31T12:14:18.276560,IL,סם און,,34.7392,29.44,nan,,7290008080903,KALBETEN FORTE 10 CAPLETS,11217,,,BLISTER PVC/ALUMINIUM,units,10.0,114 90 29652 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Kalbeten Tablets is indicated for relief of diarrhea, nausea, flatulence, convulsive stomach pains, upset stomach, indigestion. Kalbeten Tablets is indicated as a preventative treatment of traveler's diarrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a260b93-cc00-40d5-bbb7-949c0c43111b.json
5a2716f4-a448-4314-b618-0aad3bbc7b9c,ELOCOM OINTMENT,prescription,D07AC13,MOMETASONE,3055,,,WHO ATC Classification,,ILS,ointment,MOMETASONE FUROATE 0.1 %,2025-07-31T02:16:09.882738,IL,אורגנון,,12.88349313,10.918215,7.9695,,72989807,ELOCOM OINT TUBE 15GR,5052,,9183,TUBE ALUMINIUM,units,15.0,060 06 26513 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,For the relief of the inflammatory and pruritic manifestations of corticosteroid - responsive dermatoses such as psoriasis and atopic dermatitis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a2716f4-a448-4314-b618-0aad3bbc7b9c.json
5a46f898-8bc2-4807-a2cf-8c78c6a04b3f,ROPIVACAINE B.BRAUN 10 MG/ML,prescription,N01BB09,ROPIVACAINE,9107,,,WHO ATC Classification,,ILS,solution for injection,ROPIVACAINE HYDROCHLORIDE/ML,2025-07-31T07:48:47.228967,IL,לפידות,,389.2607879,329.8820383,280.7506709,,,ROPIVACAINE B.BRAUN 10 MG/ML 20 AMP 10ml,,,45662,AMPOULES LDPE,units,20.0,156 93 34315 00,valid,17.5,"perineural, epidural",1.4,30,,,,,,,,,,0,Prescription required,Ropivacaine B. Braun 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:Surgical anaesthesiaLumbar epidural administration for surgery,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a46f898-8bc2-4807-a2cf-8c78c6a04b3f.json
5a5950ae-daf8-4eb3-b9da-c00575ff11d6,EMBESIN,prescription,H01BA06,ARGIPRESSIN,8643,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ARGIPRESSIN/,2025-07-31T02:17:40.772990,IL,אי.או.פי אורפן,,4711.213768,3992.554218,3629.594744,,,EMBESIN 40 iu/2 ml 10 AMP,5676,,58472,AMPOULES GLASS TYPE I,units,10.0,163 92 35430 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Embesin is indicated for the treatment of catecholamine-refractory hypotension following septic shock in patients older than 18 years. A catecholamine-refractory hypotension is present if the mean arterial blood pressure cannot be stabilized to 65 – 75 mmHg despite adequate volume substitution and application of catecholamines.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a5950ae-daf8-4eb3-b9da-c00575ff11d6.json
5a5e5158-4798-4d3c-8c8e-7ebe8c2b5fa0,NGENLA 24 MG,prescription,H01AC08,SOMATROGON,9235,,,WHO ATC Classification,,ILS,solution for injection,SOMATROGON/ML,2025-07-31T05:45:53.068139,IL,פיזר,,941.2774059,797.6927523,678.8874488,,5415062383872,NGENLA 24 MG /1.2 ML SOL FOR INJ 1 PEN,,,17852,PRE-FILLED PEN GLASS TYPE I,units,1.0,175 08 37406 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Ngenla is indicated for the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a5e5158-4798-4d3c-8c8e-7ebe8c2b5fa0.json
5a792663-fcf2-48e8-aefa-127c4567356c,MEGALOTECT CP,prescription,J06BB09,CYTOMEGALOVIRUS IMMUNOGLOBULIN,6893,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN, HUMAN PLASMA PROTEIN/ML, CYTOMEGALOVIRUS ANTIBODY 100 U/ML",2025-07-31T05:08:27.395820,IL,קמהדע,,1055.794919,894.7414969,761.482125,,4036124019808,MEGALOTECT SOL FOR INJ 1AMP/10ML,,,25663,VIAL GLASS TYPE II,units,1.0,155 14 34329 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.The concomitant use of adequate virostatic agents should be considered for CMV-prophylaxis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a792663-fcf2-48e8-aefa-127c4567356c.json
5a7bfc4d-a974-4bba-a28b-86a3c3a03d41,SATIVEX,prescription,N02BG10,NABIXIMOLS,7230,,,WHO ATC Classification,,ILS,oromucosal spray,"CANNABIDIOL DRUG SUBSTANCE ( CBD BDS )/, DELTA-9-TETRAHYDROCANNABINOL DRUG SUBSTANCE  ( THC BDS )/",2025-07-31T08:01:11.338518,IL,ניאופרם,,1823.594801,1545.419391,1315.250546,,,SATIVEX 3X10ML OROMUCOSAL SPRAY,19970,,31035,VIAL AMBER GLASS TYPE I,units,3.0,147 48 33290 00,valid,17.5,oral transmucosal,1.4,24,,,,,,,,,,0,Prescription required,"Sativex is indicated, as add-on treatment, for symptom relief in patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other medication and who demonstrate at least 20 % improvement in spasticity related symptoms during a four week trial of therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a7bfc4d-a974-4bba-a28b-86a3c3a03d41.json
5a827a3c-e1e4-4842-933d-9e556e4d2397,JARDIANCE 10 MG,prescription,A10BD19,LINAGLIPTIN AND EMPAGLIFLOZIN,7596,,,WHO ATC Classification,,ILS,film coated tablets,EMPAGLIFLOZIN,2025-07-31T04:17:54.361699,IL,בורינגר אינגלהיים,,203.8007728,172.712527,138.1700216,,,JARDIANCE 10MG 30 F.C.TAB,10068,,18588,BLISTER PVC/ALUMINIUM,units,30.0,154 22 34202 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"JARDIANCE 10mg is indicated: •to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. •as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus •to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease•to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a827a3c-e1e4-4842-933d-9e556e4d2397.json
5a932705-f49d-49e5-8bad-3144aabf064e,NOVOMIX 30 FLEXPEN,prescription,A10AD05,INSULIN ASPART,4621,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN ASPART 100 U/ML,2025-07-31T05:54:27.308927,IL,נובו נורדיסק,,186.2039961,157.8000038,126.240003,,7290008126571,NOVOMIX 30 FLEXPEN 5X3ML,9218,,58181,PRE-FILLED PEN ,units,15.0,127 24 30599 00,valid,25.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"NovoMix® 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5a932705-f49d-49e5-8bad-3144aabf064e.json
5aa0dd08-4cb5-4b5e-a5d5-83472f4c1234,TAVANIC TABLETS 500 MG,prescription,J01MA12,LEVOFLOXACIN,4191,,,WHO ATC Classification,,ILS,film coated tablets,LEVOFLOXACIN AS HEMIHYDRATE,2025-07-31T09:08:12.559862,IL,סאנופי אוונטיס,,44.81603184,37.979688,27.7224,,,TAVANIC 500MG 5TAB,20105,,24902,BLISTER PVC/ALUMINIUM,units,5.0,119 44 29963 21,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tavanic Tablets 500 mg is indicated in adults for the treatment of the following infections:-	Acute pyelonephritis and complicated urinary tract infections -	Chronic bacterial prostatitisIn the below-mentioned infections, Tavanic should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections.-	Acute bacterial sinusitis -	Acute exacerbations of chronic obstructive pulmonary disease including bronchitis -	Community-acquired pneumonia-	Complicated skin and soft tissue infections.Tavanic may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.Consideration should be given to official guidance on the appropriate use of antibacterial agents.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5aa0dd08-4cb5-4b5e-a5d5-83472f4c1234.json
5aa1cc4e-745b-4e61-9ce3-1c41a62b2aa3,PEMETREXED TARO 100 MG,prescription,L01BA04,PEMETREXED,8478,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,PEMETREXED/VIAL,2025-07-31T06:32:49.444231,IL,תרו,,7688.653293,6515.807876,5923.461705,,7290017164151,PEMETREXED TARO 1000 MG VIAL,,,68643,VIAL GLASS TYPE I,units,1.0,163 33 35358 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,1.Pemetrexed Taro in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. 2.Pemetrexed Taro in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. 3.Pemetrexed Taro is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.4.Pemetrexed Taro is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5aa1cc4e-745b-4e61-9ce3-1c41a62b2aa3.json
5aa87c4b-a264-45d4-a6ce-37a4fd7e7aed,PRIZMA,prescription,N06AB03,FLUOXETINE,3114,,,WHO ATC Classification,,ILS,coated tablets,FLUOXETINE AS HYDROCHLORIDE,2025-07-31T06:57:37.304864,IL,אוניפארם,,37.46211844,31.747558,23.1734,,,PRIZMA 20MG 30TAB,16160,,9274,BLISTER PVC/ALUMINIUM,units,30.0,100 63 28423 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Adults:Major depressive episodes.Obsessive-compulsive disorder (OCD).Bulimia nervosa: Fluoxetine is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.Children and adolescents aged 8 years and above:Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. Antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5aa87c4b-a264-45d4-a6ce-37a4fd7e7aed.json
5abdd132-5ddf-422a-a9db-44adbf0b26cf,CARTIA,off-the-counter,B01AC06,ACETYLSALICYLIC ACID,978,,,WHO ATC Classification,,ILS,tablets enteric coated,ACETYLSALICYLIC ACID,2025-07-31T11:24:04.685650,IL,פאדאגיס,,17.8888,15.16,nan,,7290008102131,CARTIA 100MG 28TAB,3639,,,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,050 89 26384 00,valid,nan,per os,1.4,18,,,,,,,,,,0,,The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5abdd132-5ddf-422a-a9db-44adbf0b26cf.json
5ac0b17a-cacf-4c1f-9910-22ab74c32d7d,NOVOSEVEN ® RT 1 MG/VIAL,prescription,B02BD08,COAGULATION FACTOR VIIA ,7070,,,WHO ATC Classification,,ILS,powder for solution for injection,EPTACOG ALFA (ACTIVATED)/VIAL,2025-07-31T05:56:11.706522,IL,נובו נורדיסק,,2532.91765,2146.540477,1951.400434,,7290008126717,NOVOSEVEN RT 1MG/VIAL,14534,,35598,VIAL GLASS TYPE I,units,1.0,142 63 32929 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"NovoSeven ® RT is indicated for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups: •in patients with congenital haemophilia with inhibitors to coagulation factors VIII or IX > 5 Bethesda Units (BU) •in patients with congenital haemophilia who are expected to have a high anamnestic response to factor VIII or factor IX administration •in patients with acquired haemophilia •in patients with congenital FVII deficiency •in patients with Glanzmann’s thrombasthenia with past or present refractoriness to platelet transfusions, or where platelets are not readily available.Severe postpartum haemorrhageNovoSeven RT is indicated for the treatment of severe postpartum haemorrhage when uterotonics are insufficient to achieve haemostasis",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ac0b17a-cacf-4c1f-9910-22ab74c32d7d.json
5ac3643b-391b-4875-b936-3912f38184e4,KUVAN,prescription,A16AX07,SAPROPTERIN,6299,,,WHO ATC Classification,,ILS,tablets soluble,SAPROPTERIN DIHYDROCHLORIDE,2025-07-31T04:30:18.080649,IL,מדיסון,,7172.677099,6078.540184,5525.945622,,7290000845449,KUVAN 100MG 120TAB SOLUBLE,11231,,26687,BOTTLE HDPE,units,120.0,144 23 33052 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Kuvan is indicated for the treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with phenylketonuria (PKU) who have been shown to be responsive to such treatment.Kuvan is also indicated for the treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with tetrahydrobiopterin (BH4) deficiency who have been shown to be responsive to such treatment.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ac3643b-391b-4875-b936-3912f38184e4.json
5ae054bc-43f9-4b4d-a3b4-2cdf9054b82d,RAZALAX CHILDREN,off-the-counter,A06AG04,GLYCEROL,5550,,,WHO ATC Classification,,ILS,enema,GLYCEROL 2.25 G,2025-07-31T12:53:36.493918,IL,רז פרמהצפטי,,24.2018,20.51,nan,,7290015863216,RAZALAX CHILDREN 2.25 GR 6ENEMA,,,,BOTTLE POLYETHYLENE,units,6.0,158 38 34408 00,valid,nan,rectal,1.4,48,,,,,,,,,,0,,Constipation.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ae054bc-43f9-4b4d-a3b4-2cdf9054b82d.json
5aee0b77-bd20-4f3c-b09c-9555ff6d321b,CAPECITABINE TEVA ® 150 MG,prescription,L01BC06,CAPECITABINE,7545,,,WHO ATC Classification,,ILS,film coated tablets,CAPECITABINE,2025-07-31T00:53:18.631538,IL,טבע,,845.2917876,716.3489725,609.6587,,7290106061460,CAPECITABINE TEVA 500MG 12X10TAB,9774,,57489,BLISTER PVC/PE/PVDC/AL,units,120.0,152 61 34182 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Adjuvant Colon Cancer: Capecitabine Teva® is indicated for the adjuvant treatment of patients following surgery of stage III (Dukesע stage C) colon cancer. Colorectal Cancer: Capecitabine Teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. Advanced gastric cancer: Capecitabine Teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. Breast Cancer Combination Therapy: Capecitabine Teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Breast Cancer Monotherapy: Capecitabine Teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5aee0b77-bd20-4f3c-b09c-9555ff6d321b.json
5af68a4a-d2a2-4b69-940d-c6ee95608d9b,ANTURAN 200MG 84TAB,29C,,,20036,,,,,,tablet,ANTURAN 200MG,2025-07-31T19:55:00.458946,IL,nan,,,,,,,ANTURAN 200MG 84TAB,,,,,units,84.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5af68a4a-d2a2-4b69-940d-c6ee95608d9b.json
5afc7d21-9742-472d-a628-dd001ebfe8ea,INS.ACTRAPID HM 5  PENFILL*3ML,prescription,,,2862,,,,,ILS,tablet,INS.ACTRAPID HM 5 PENFILL*,2025-07-31T19:13:37.008319,IL,נובו נורדיסק,,128.5834136,108.9689994,81.01784345,,,INS.ACTRAPID HM 5  PENFILL*3ML,9016,,8613,,units,15.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5afc7d21-9742-472d-a628-dd001ebfe8ea.json
5b174aa7-66e9-4566-99d5-22c380b8e8e9,YAZ,prescription,G03AA12,DROSPIRENONE AND ESTROGEN,7733,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ETHINYLESTRADIOL 0.02   MG",2025-07-31T10:40:41.151814,IL,באייר,,nan,nan,nan,,,YAZ PLUS 3X28 F.C.TAB,25021,,6993,BLISTER PVC/PVDC/ALUMINIUM,units,84.0,141 04 32023 01,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,- Oral contraception.   - Treatment of moderate acne vulgaris in women who seek oral contraception.   - Treatment of symptoms of premenstrual dysphoric disorder (PMDD ) in women who have chosen oral contraceptives as their method of birth control. The efficacy of Yaz for PMDD was not assessed beyond 3 cycles. Yaz has not been evaluated for treatment of PMS ( premenstrual syndrome ).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5b174aa7-66e9-4566-99d5-22c380b8e8e9.json
5b27bfe8-bf81-409d-a397-d99891fe4002,EPHEDRINE AGUETTANT 3 MG/ML PRE-FILLED SYRINGE,prescription,R01AA03,EPHEDRINE,9622,,,WHO ATC Classification,,ILS,solution for injection,EPHEDRINE HYDROCHLORIDE/,2025-07-31T02:25:44.280332,IL,אמ.בי.איי פארמה,,57.53865107,48.76157088,35.5923875,,,EPHEDRINE AGUETTANT 3 MG/ML PRE-FILLED SYRINGE,,,,SYRINGE PREFILLED  POLYPROPYLENE,units,1.0,177 79 37046 99,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of hypotension from spinal, epidural and general anaesthesia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5b27bfe8-bf81-409d-a397-d99891fe4002.json
5b3059ba-3eb1-4dc0-9468-2d7f188c0d47,LIDOCAINE HYDROCHLORIDE S.A.L.F. 10 MG/ML,prescription,N01BB02,LIDOCAINE,9425,,,WHO ATC Classification,,ILS,solution for injection,LIDOCAINE HYDROCHLORIDE/,2025-07-31T04:46:43.899145,IL,רז פרמהצפטי,,25.906015,21.95425,16.025,,,LIDOCAINE HYDROCHLORIDE S.A.L.F. 10MG/ML 5 AMP 10ML,12595,,60963,AMPOULES GLASS TYPE I,units,5.0,165 32 35867 00,valid,37.0,"intradermal, submucosal, perineural, spinal, i.m, s.c, i.v regional anaesthesia, epidural",1.4,36,,,,,,,,,,0,Prescription required,Local and regional anaesthesia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5b3059ba-3eb1-4dc0-9468-2d7f188c0d47.json
5b50ab22-0389-4dec-85ce-3a3923029e06,LANTUS 100 UNITS/ML,prescription,N/A,,4978,,,WHO ATC Classification,,ILS,solution for injection,INSULIN GLARGINE 100 U/ML,2025-07-31T04:36:04.306472,IL,סאנופי אוונטיס,,266.70419,226.0205,180.8164,,7290008880756,LANTUS  100UI/ML OPTISET/SOLOSTAR PRE FILLED PEN 5X3ML,12376,,15344,PRE-FILLED PEN GLASS TYPE I,units,15.0,124 36 30365 00,valid,25.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult and pediatric patients, 6 years and over, with type 1 diabetes mellitus or adults patients with type 2 diabetes mellitus who require basal (long acting) insulin for the control of hyperglycemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5b50ab22-0389-4dec-85ce-3a3923029e06.json
5b557251-fa1f-4d63-8520-c34e452ddb71,XYLOVIT 0.05%,off-the-counter,R01AA07,XYLOMETAZOLINE,2994,,,WHO ATC Classification,,ILS,drops+spray,XYLOMETAZOLINE HYDROCHLORIDE 0.05 %,2025-07-31T13:39:44.660196,IL,ויטאמד,,30.1608,25.56,nan,,7290008068970,XYLOVIT 0.1% SPY10ML,24004,,,BOTTLE LDPE,units,10.0,062 58 27663 01,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to 10 hours.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5b557251-fa1f-4d63-8520-c34e452ddb71.json
5b8f15ec-e23e-42d2-83e3-b5ba295c303d,SITAR 100,prescription,A10BH01,SITAGLIPTIN,9381,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS HYDROCHLORIDE,2025-07-31T08:20:32.466191,IL,אוניפארם,,98.225619,83.24205,61.89,,,SITAR 25MG 28 TAB,,,14547,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,172 98 36638 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,SITAR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: SITAR should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. SITAR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using SITAR.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5b8f15ec-e23e-42d2-83e3-b5ba295c303d.json
5bb06601-ac6b-4227-8095-d03e609d0f3e,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1825,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:50:51.433223,IL,פישר,,20.1662,17.09,nan,,7290000849188,POLYDINE SOL 100CC,16528,,,BOTTLE HDPE,units,100.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5bb06601-ac6b-4227-8095-d03e609d0f3e.json
5bb61be5-ff2f-4261-9133-8ca2bae8a2fe,TIMONIL 300 RETARD,prescription,N03AF01,CARBAMAZEPINE,3193,,,WHO ATC Classification,,ILS,tablets prolonged release,CARBAMAZEPINE,2025-07-31T09:21:33.092492,IL,מגאפארם,,65.2298071,55.2795,41.1,,7290004448332,TIMONIL RET 600MG 50TAB,20135,,9116,BLISTER PVC/ALUMINIUM,units,50.0,068 94 27055 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neuralgia, diabetes insipidus mania, prophylactic in manic depressive illness.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5bb61be5-ff2f-4261-9133-8ca2bae8a2fe.json
5bc825db-c535-409d-806b-b69e1350ee76,ORGALUTRAN 0.25 MG/0.5 ML,prescription,H01CC01,GANIRELIX,4581,,,WHO ATC Classification,,ILS,solution for injection,GANIRELIX 0.25  MG / 0.5  ML,2025-07-31T06:16:18.147245,IL,אורגנון,,124.4968607,105.5058188,78.44298798,,7290006537171,ORGALUTRAN 0.25MG/0.5ML 1PREFILLED SYR,15134,,53116,SYRINGE GLASS TYPE I,units,1.0,124 95 30448 00,valid,34.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,The prevention of premature luteinsing hormone (LT) surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5bc825db-c535-409d-806b-b69e1350ee76.json
5be50039-fd3c-4998-8f17-85697cdab69f,TRELEGY ELLIPTA 184 / 55 / 22 MCG,prescription,R03AL08,"VILANTEROL, UMECLIDINIUM BROMIDE AND FLUTICASONE FUROATE",8998,,,WHO ATC Classification,,ILS,powder for inhalation pre-dispensed,"VILANTEROL AS TRIFENATATE/INH, UMECLIDINIUM AS BROMIDE/INH, FLUTICASONE FUROATE/INH",2025-07-31T09:38:18.988844,IL,ג.ס.ק,,nan,nan,nan,,,TRELEGY ELLIPTA 184 / 55 / 22 MCG 30 DOSES,17772,,86554,PLASTIC INHALER WITH TWO BLISTER STRIP ALUMINIUM,units,30.0,168 61 36629 99,valid,nan,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"AsthmaTrelegy Ellipta 184/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older. Trelegy Ellipta 184/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ICS/LABA.Important Limitations of UseTrelegy Ellipta 184/55/22 mcg is NOT indicated for the relief of acute asthma.Trelegy Ellipta 184/55/22 mcg is not indicated for patients with COPD.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5be50039-fd3c-4998-8f17-85697cdab69f.json
5be8b6e4-78ae-4fc6-bf4d-5ba21919498c,UNDECYL POWDER,off-the-counter,D01AE04,UNDECYLENIC ACID,3397,,,WHO ATC Classification,,ILS,powder,"UNDECENOIC ACID, ZINC UNDECENOATE",2025-07-31T13:32:34.076443,IL,רקח,,22.25,18.86,nan,,7290008090780,UNDECYL OINT 25GR,21020,,,SECURITAINER HDPE,units,25.0,029 47 25330 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,Prophylaxis and treatment of mycotic skin infections particulary athlete's  foot.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5be8b6e4-78ae-4fc6-bf4d-5ba21919498c.json
5bef3279-6f85-407d-99e8-e907179ca02e,TARODENT MOUTHWASH,off-the-counter,A01AB03,CHLORHEXIDINE,5372,,,WHO ATC Classification,,ILS,solution,CHLORHEXIDINE GLUCONATE 0.2 %W/V,2025-07-31T13:25:28.890079,IL,תרו,,34.4324,29.18,nan,,7290000810515,TARODENT MINT 0.2% SOL 300ML,,,,BOTTLE POLYETHYLENE,units,300.0,060 32 27698 00,valid,nan,local oral,1.4,18,,,,,,,,,,0,,1. As an aid to maintaining oral hygiene.2. As an aid in the treatment and  prevention of gingivitis.3. Inhibition of formation of dental plaque.4. For use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush).5. For use in a post- periodontal  surgery or treatment regimen to promote gingival healing.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5bef3279-6f85-407d-99e8-e907179ca02e.json
5bf2caa4-4fa8-4737-876b-47b9af511957,TRUXIMA,prescription,L01XC02,RITUXIMAB,8342,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T09:48:02.383021,IL,פאדאגיס,,1789.170808,1516.246515,1290.422566,,7290012162404,TRUXIMA100MG/10ML 2 VIALS,20866,,30925,VIAL 10 ML GLASS TYPE I,units,2.0,161 74 35585 00,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Truxima is indicated in adults for the following indications: * Non-Hodgkin’s lymphoma (NHL) Truxima is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma. Truxima is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy. Truxima is indicated for the treatment of patients with CD20 positive diffuse large B-cell non-Hodgkin's lymphoma in combination with CHOP chemotherapy. Truxima maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.* Chronic lymphocytic leukaemia (CLL)Truxima in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory CLL. Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including rituximab or patients refractory to previous rituximab plus chemotherapy.* Granulomatosis with polyangiitis and microscopic polyangiitisTruxima, in combination with glucocorticoids, is indicated for the treatment of adult patients with granulomatosis with polyangiitis (GPA)  (Wegener’s Granulomatosis (WG)) and microscopic polyangiitis (MPA).*pemphigus vulgaris (PV):Truxima is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5bf2caa4-4fa8-4737-876b-47b9af511957.json
5bf8f8cb-ab7a-4365-9d9d-8c236141368e,EPANUTIN 100 MG,29C,N03AB02,PHENYTOIN,20392,,,WHO ATC Classification,,ILS,capsules,PHENYTOIN SODIUM,2025-07-31T14:28:45.666664,IL,nan,,nan,nan,nan,,,EPANUTIN 30MG/5ML SUSP 500ML,,,,BOTTLE HDPE,units,500.0,104 27 24678 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5bf8f8cb-ab7a-4365-9d9d-8c236141368e.json
5c2001f5-6a79-427a-b14d-4fa95a7be778,FLUANXOL 3MG 50 tab,29C,,,20987,,,,,,tablet,FLUANXOL 3MG,2025-07-31T20:27:59.215515,IL,nan,,,,,,,FLUANXOL 3MG 50 tab,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c2001f5-6a79-427a-b14d-4fa95a7be778.json
5c3e0d58-3951-42ba-bb02-7eea59dbfe44,OMEPRADEX - Z,prescription,A02BC01,OMEPRAZOLE,6567,,,WHO ATC Classification,,ILS,caplets,OMEPRAZOLE,2025-07-31T06:07:08.596863,IL,רפא,,40.73832,34.524,25.2,,7290010578511,OMEPRA 20MG 28 CAPSULES,15340,,13851,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,131 25 30841 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c3e0d58-3951-42ba-bb02-7eea59dbfe44.json
5c416a26-2646-46c9-b7a3-94aca10b09e9,SERTRALINE TEVA ® 100 MG,prescription,N06AB06,SERTRALINE,4838,,,WHO ATC Classification,,ILS,film coated tablets,SERTRALINE AS HYDROCHLORIDE,2025-07-31T08:08:31.860311,IL,טבע,,27.0513761,22.924895,16.7335,,7290106060715,SERTRALINE TEVA 50MG 30TAB,19740,,61845,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,132 13 30900 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of symptoms of depression in patients with or without a history of mania. Following satisfactory response, continuation with sertaline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c416a26-2646-46c9-b7a3-94aca10b09e9.json
5c4ea832-7ae7-4966-a6cb-d06c8e25bc45,PREVENAR 13,prescription,J07AL02,"PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED",9324,,,WHO ATC Classification,,ILS,suspension for injection,"PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19 F 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B 4.4  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A 2.2  MCG / 0.5  ML",2025-07-31T06:55:53.898267,IL,פיזר,,377.6615846,320.0522046,272.384855,,7290012914447,PREVENAR 20 1 PFS,,,,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,143 54 33058 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to 17 years of age.Active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in adults &#8805;18 years of age and the elderly",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c4ea832-7ae7-4966-a6cb-d06c8e25bc45.json
5c4f17b6-67b1-40b1-94f4-644633697235,SLIDER,prescription,G04BE03,SILDENAFIL,7297,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T08:22:28.094473,IL,אוניפארם,,2322.673119,1968.36705,1675.206,,,SLIDER 20MG 90 F.C.TAB,9644,,40627,BLISTER PVC/ALUMINIUM,units,90.0,149 17 33602 01,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,For adults > 18 years: Indicated for treatment of primary pulmonary hypertension (PPH) pulmonary hypertension (PH) associated with connective tissue disease (CTD) or PH following surgical repair at least 5 years previously of atrial septal defect (ASD) ventricular septal defect (VSD) patent ductus arteriosus (PDA) or aorto-pulmonary window.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c4f17b6-67b1-40b1-94f4-644633697235.json
5c5fd1eb-b8c2-4a02-bfd1-ad8267e2cfee,SEPTADINE,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",3955,,,WHO ATC Classification,,ILS,solution - external,"CHLORHEXIDINE DICLUCONATE 0.5  %W/V, ALCOHOLV/V",2025-07-31T13:16:13.666147,IL,פלוריש,,51.743,43.85,nan,,7290008103565,SEPTADINE SCRUB 500ML,,,,BOTTLE HDPE,units,500.0,108 58 29253 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"For quick disinfection of hands, also before invasive procedures.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c5fd1eb-b8c2-4a02-bfd1-ad8267e2cfee.json
5c6044e6-75f9-466b-8eb0-cfae08d744fc,OMACOR ®,prescription,C10AX06,OMEGA-3-TRIGLYCERIDES,4924,,,WHO ATC Classification,,ILS,capsules,OMEGA-3   ACID ETHYL ESTERS,2025-07-31T06:06:42.214318,IL,אבוט,,80.11988673,67.89821212,50.48194209,,,OMACOR 28 CAPSULES,15440,,71200,BOTTLE HDPE,units,28.0,134 24 31088 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hypertriglyceridaemia: Endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response: - type IV hypertriglyceridaemia. - type IIb/III hypertriglyceridaemia in combination with statin, when control of triglycerides by statins is insufficient.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c6044e6-75f9-466b-8eb0-cfae08d744fc.json
5c7e50b5-e62f-428b-ae12-94533634a3ec,BORTEZOMIB INOVAMED 3.5 MG,prescription,L01XX32,BORTEZOMIB,9158,,,WHO ATC Classification,,ILS,powder for solution for injection,BORTEZOMIB 3.5  MG,2025-07-31T00:40:24.420565,IL,אינובמד,,5218.217134,4422.21791,4020.1981,,7290104530326,BORTEZOMIB INOVAMED 3.5 MG PWDR FOR INJ 1VIAL 10ML,,,58672,VIAL 10 ML GLASS TYPE I,units,1.0,156 86 34777 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Bortezomib Inovamed is indicated for the treatment of patients with multiple myeloma.Bortezomib Inovamed is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Inovamed in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c7e50b5-e62f-428b-ae12-94533634a3ec.json
5c7ee823-4a63-43c7-91fc-cffe75ceb00c,V-TABUR,off-the-counter,D08AC02,CHLORHEXIDINE,3130,,,WHO ATC Classification,,ILS,solution - external,"ALCOHOL70 %V/V, CHLORHEXIDINE GLUCONATE 0.5 %W/V",2025-07-31T13:37:58.192264,IL,ויטאמד,,13.8414,11.73,nan,,7290008083164,V-TABUR 60ML,22150,,,BOTTLE HDPE,units,60.0,107 90 29156 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Disinfection of the skin, and for the cleaning of babies umbillical cords until detached.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c7ee823-4a63-43c7-91fc-cffe75ceb00c.json
5c8a69be-b432-40f3-a97e-f5b3cbfa2ff5,FENISTIL GEL,off-the-counter,D04AA13,DIMETINDENE,1095,,,WHO ATC Classification,,ILS,gel,DIMETINDENE MALEATE 0.1 %W/W,2025-07-31T11:53:44.687939,IL,ג.ס.ק,,43.0346,36.47,nan,,7290011363543,FENISTIL GEL 30G,6357,,,TUBE ALUMINIUM,units,30.0,133 24 24020 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c8a69be-b432-40f3-a97e-f5b3cbfa2ff5.json
5c91f60d-4b89-4c34-826b-252b9abe45b7,TROSPAS 15 MG,prescription,G04BD09,TROSPIUM,8370,,,WHO ATC Classification,,ILS,film coated tablets,TROSPIUM CHLORIDE,2025-07-31T09:46:03.882594,IL,כ.צ.ט,,53.52386714,45.35920944,33.108912,,,TROSPAS 15 MG 30 TAB,20853,,4222,BLISTER PVC/ALUMINIUM,units,30.0,159 75 34856 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5c91f60d-4b89-4c34-826b-252b9abe45b7.json
5ca55ce4-e7aa-42b9-b9de-2d75b80005d5,PEMETREXED TEVA ® 100 MG,prescription,L01BA04,PEMETREXED,7905,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,PEMETREXED,2025-07-31T06:33:22.534602,IL,טבע,,7688.653293,6515.807876,5923.461705,,7290106064980,PEMETREXED TEVA ® 1000 MG 1 VIAL,16961,,52426,VIAL GLASS TYPE I,units,1.0,156 39 34393 01,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Malignant pleural mesothelioma :Pemetrexed Teva in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Non-small cell lung cancer: Pemetrexed Teva in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. Pemetrexed Teva is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ca55ce4-e7aa-42b9-b9de-2d75b80005d5.json
5ccf7158-6ec5-49c3-b954-e48ab34d524c,CEFTAZIDIME-VIT 2 G.,prescription,J01DD02,CEFTAZIDIME,8249,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFTAZIDIME AS PENTAHYDRATE/VIAL,2025-07-31T01:00:50.623439,IL,ויטאמד,,318.78408,270.156,229.92,,7290104344343,CEFTAZIDIME-VIT 1GR/VIAL   10VIALS,129283,,17058,VIAL GLASS TYPE III,units,10.0,173 81 37596 99,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Ceftazidime-VIT  2 G is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).•Nosocomial pneumonia•Broncho-pulmonary infections in cystic fibrosis•Bacterial meningitis•Chronic suppurative otitis media•Malignant otitis externa•Complicated urinary tract infections•Complicated skin and soft tissue infections•Complicated intra-abdominal infections•Bone and joint infections•Peritonitis associated with dialysis in patient on CAPD.Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Ceftazidime VIT 2 G may be used in the management of neutropenic patients with fever that is suspected to be due to abacterial infection. Ceftazidime VIT 2 G may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (TURP). The selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic Gram negative bacteria. Ceftazidime VIT 2 G should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity. Consideration should be given to official guidelines on the appropriate use of antibacterial agents.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ccf7158-6ec5-49c3-b954-e48ab34d524c.json
5ced8243-aeb2-4f0b-8a33-9162083d3e3c,HUMATIN 125MG/5ML 60ML,29C,,,20445,,,,,,tablet,HUMATIN 125MG/,2025-07-31T20:34:31.501667,IL,nan,,,,,,,HUMATIN 125MG/5ML 60ML,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ced8243-aeb2-4f0b-8a33-9162083d3e3c.json
5cf05898-5779-44cd-8155-7843351e536b,PENIBRIN 1 G,prescription,J01CA01,AMPICILLIN,9137,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,AMPICILLIN AS SODIUM/VIAL,2025-07-31T06:34:11.915794,IL,טבע,,267.3273582,226.5486188,181.238895,,7290008096553,PENIBRIN 2 G 10 VIALS,,,83478,VIAL GLASS TYPE III,units,10.0,032 41 22422 00,valid,25.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Penibrin injection is recommended in serious infections when prompt, effective levels of the antibiotic must reach the site of infection. Such infections include meningitis, subacute bacterial endocarditis, peritonitis, septicemia, severe forms of chronic bronchitis, osteomyelitis, pneumonia and pyelonephritis due to susceptible organisms.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5cf05898-5779-44cd-8155-7843351e536b.json
5d0e7a3d-009c-4a1e-bf6e-915e23ff6e18,SPIRIVA ®,prescription,R03BB04,TIOTROPIUM BROMIDE,4874,,,WHO ATC Classification,,ILS,inhalation powder hard capsules,TIOTROPIUM BROMIDE,2025-07-31T08:34:28.043091,IL,בורינגר אינגלהיים,,125.370587,106.2462649,78.9935055,,9006968012605,SPIRIVA 18MCG 30 HARD CAPS+HANDIHALER,19758,,65853,BLISTER PVC/ALUMINIUM,units,30.0,133 47 31120 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Tiotropium is a bronchodilator for the maintenance treatment of chronic obstructive pulmonary disease (COPD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d0e7a3d-009c-4a1e-bf6e-915e23ff6e18.json
5d15cd81-3f5c-4cb8-a6c7-02442d3e2ece,ALPHAGAN P,prescription,S01EA05,BRIMONIDINE,4785,,,WHO ATC Classification,,ILS,"eye drops, solution",BRIMONIDINE TARTRATE 0.15 %W/V,2025-07-31T00:17:33.572024,IL,אב-וי,,nan,nan,nan,,,ALPHAGAN P 0.15% 5ML,1940,,12494,BOTTLE LDPE,units,5.0,131 06 30961 00,valid,nan,ocular,1.4,24,,,,,,,,,,0,Prescription required,Alphagan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d15cd81-3f5c-4cb8-a6c7-02442d3e2ece.json
5d1924a8-d20f-40ec-abeb-6f36778e7299,MENOPUR 75 IU,prescription,G03GA02,HUMAN MENOPAUSAL GONADOTROPHIN,4419,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,MENOTROPHIN/DOSE,2025-07-31T05:11:19.912615,IL,פרינג,,925.9949533,784.7415207,667.865124,,4031925151283,MENOPUR INJ 75IU /1ML 10AMP,13153,,28448,VIAL GLASS TYPE I,units,10.0,123 86 30045 00,valid,17.5,"s.c, i.m",1.4,24,,,,,,,,,,0,Prescription required,Sterility in females with hypo or normogonadotropic ovarian insufficiency : stimulation of follicle growth. Sterility in males with hypo or normogonadotropic hypogonadism: In combination with HCG to spermatogenesis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d1924a8-d20f-40ec-abeb-6f36778e7299.json
5d251c66-7f08-4b97-a1fa-1d420f5c3960,TRAVATAN,prescription,S01EE04,TRAVOPROST,4598,,,WHO ATC Classification,,ILS,"eye drops, solution",TRAVOPROST 0.004 %W/V,2025-07-31T09:36:29.161468,IL,נוברטיס פארמה,,39.38113863,33.3738463,24.36047175,,729001636928,TRAVATAN 0.004% OPHT SOL 2.5ML,20713,,19765,DROPER BOTTLE POLYPROPYLENE,units,2.5,126 37 30541 20,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,For the reduction of elevated intra ocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other IOP lowering medications or insufficiently responsive to another IOP lowering medication.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d251c66-7f08-4b97-a1fa-1d420f5c3960.json
5d2a79cc-f77c-4bca-bbab-42fe39be616d,STUD 100,off-the-counter,D04AB01,LIDOCAINE,2499,,,WHO ATC Classification,,ILS,spray,LIDOCAINE 9.6 %W/W,2025-07-31T13:24:09.810886,IL,תרופארם,,59.5074,50.43,nan,,348132100206,STUD 100 SPRAY FOR MEN 12GR,19157,,,CAN ALUMINIUM,units,12.0,133 05 24173 00,valid,nan,topical,1.4,60,,,,,,,,,,0,,To reduce tacticle sensitivity of the penis in advance of intercourse.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d2a79cc-f77c-4bca-bbab-42fe39be616d.json
5d2ad57b-3cb2-40d0-a02f-cf2954f26eb2,CLARISCAN,prescription,V08CA02,GADOTERIC ACID,9059,,,WHO ATC Classification,,ILS,solution for injection,GADOTERIC ACID 279.3  MG /,2025-07-31T01:18:46.697969,IL,אלדן,,421.323442,357.0537803,303.8755577,,,CLARISCAN 279.3MG/ML 50ML,,,,BOTTLE GLASS TYPE I,units,50.0,163 65 35367 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Enhancement of contrast in magnetic resonance imaging.Encephalic and spinal pathologies: brain tumours, tumours of the spine and the surrounding tissue, intervertebral disk prolapse infectious diseases.Abdominal pathologies: primary and secondary liver tumours.Osteo-articular pathology: bone and soft tissue tumours synovial diseases.Magnetic resonance imaging for angiography.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d2ad57b-3cb2-40d0-a02f-cf2954f26eb2.json
5d2b5bf6-8aa3-4797-84ce-064e46e8c8cd,ISENTRESS 400 MG TABLETS,prescription,J05AX08,RALTEGRAVIR,6339,,,WHO ATC Classification,,ILS,film coated tablets,RALTEGRAVIR AS POTASSIUM,2025-07-31T04:12:54.096824,IL,מ.ס.ד. ישראל,,2401.648186,2035.295163,1850.26833,,7290006813435,ISENTRESS 400MG 60TAB,9327,,81706,BOTTLE HDPE,units,60.0,140 33 31793 01,valid,10.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Isentress is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in adult patients.This indication is based on safety and efficacy data from two double-blind, placebo-controlled trials in treatment-experienced patients and one double-blind, active-controlled trial in treatment-naive patients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d2b5bf6-8aa3-4797-84ce-064e46e8c8cd.json
5d2bb0f6-9c92-4afc-b935-0d4a6b75e190,ABECMA,prescription,L01XL07,IDECABTAGENE VICLEUCEL,9546,,,WHO ATC Classification,,ILS,dispersion for infusion,IDECABTAGENE VICLEUCEL,2025-07-30T23:09:37.700383,IL,ב.מ.ס,,1569759.536,1330304.751,1209367.955,,,ABECMA 1 BAG,,,,BAG ETHYLENE VINYL ACETATE (EVA),units,1.0,171 53 37039 00,valid,10.0,i.v,1.4,12,,,,,,,,,,0,Prescription required,"Abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody and have demonstrated disease progression on the last therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d2bb0f6-9c92-4afc-b935-0d4a6b75e190.json
5d2e21ba-26f8-4d39-a6b8-76207cf3b3af,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4901,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:22:53.174943,IL,מדיסון,,2337.605169,1981.021418,1685.975675,,8715131005863,ARANESP 300MCG PREFILLED PEN 1X0.6ML,9490,,65753,PRE-FILLED PEN GLASS TYPE I,units,1.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d2e21ba-26f8-4d39-a6b8-76207cf3b3af.json
5d434528-bb81-42a1-93b9-b191d8f161d1,SINTREDIUS,prescription,H02AB06,PREDNISOLONE,9531,,,WHO ATC Classification,,ILS,solution,PREDNISOLONE AS SODIUM PHOSPHATE/ML,2025-07-31T08:18:03.677270,IL,קמהדע,,nan,nan,nan,,5060347610015,SINTREDIUS 1MG/ML 5 ML,,,17427,CONTAINER LDPE,units,5.0,168 82 35801 00,valid,nan,oral,1.4,24,,,,,,,,,,0,Prescription required,"Sintredius oral solution is indicated for the treatment of:- Rheumatological disorders and connective tissue diseases such as:   • rheumatoid arthritis (for primary chronic disease and maintenance therapy),   • systemic lupus erythematosus (non-organ threatening disease),   • mild-moderate juvenile dermatomyositis.- Severe or debilitating allergic conditions, not treatable in a conventional manner such as:   • bronchial asthma in children,   • bronchial asthma in adults (for maintenance therapy).- Sarcoidosis in children and for maintenance therapy in adults.- Acquired haemolytic anaemia (autoimmune, for maintenance therapy).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d434528-bb81-42a1-93b9-b191d8f161d1.json
5d507a8d-c99f-46c4-924c-3adbe112f0cb,ZOKINVY 50 MG,prescription,A16AX20,LONAFARNIB,9043,,,WHO ATC Classification,,ILS,hard gelatin capsules,LONAFARNIB,2025-07-31T10:52:33.776236,IL,ניאופרם,,99976.59543,84725.9321,77023.57464,,7290111098451,ZOKINVY 50 MG 30 CAPS,26230,,43137,BOTTLE HDPE,units,30.0,169 67 36861 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"ZOKINVY is indicated in patients 12 months of age and older with a body surface area (BSA) of0.39 m2 and above:To reduce the risk of mortality in Hutchinson-Gilford Progeria Syndrome (HGPS)• For the treatment of processing-deficient Progeroid Laminopathies with either:o Heterozygous LMNA mutation with progerin-like protein accumulationo Homozygous or compound heterozygous ZMPSTE24 mutationsLimitations of UseZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies. Based upon its mechanism of action, ZOKINVY would not be expected to be effective in these populations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d507a8d-c99f-46c4-924c-3adbe112f0cb.json
5d86689e-6f35-448c-ad0c-1848c46ffd63,HUMALOG,prescription,A10AB04,INSULIN LISPRO,6628,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO 100 U/ML,2025-07-31T03:49:03.112909,IL,אלי לילי,,189.4390139,160.5415444,128.4332355,,7290008067676,HUMALOG MIX 50 KWIKPEN 5X3ML,9388,,18783,CARTRIDGE GLASS TYPE I,units,15.0,102 83 28580 00,valid,25.0,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilization of diabetes mellitus.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d86689e-6f35-448c-ad0c-1848c46ffd63.json
5d9b208e-7bcf-4bc7-8b29-f90d75a4a7ca,THIO GEL,off-the-counter,D04AA22,ISOTHIPENDYL,3797,,,WHO ATC Classification,,ILS,gel,ISOTHIPENDYL HYDROCHLORIDE 0.75 %,2025-07-31T13:27:04.553238,IL,רקח,,36.8042,31.19,nan,,7290008091343,THIO GEL 40G,20107,,,TUBE ALUMINIUM,units,40.0,140 23 24394 00,valid,nan,dermal,1.4,18,,,,,,,,,,0,,"For the temporary relief of itching due to minor skin disorders, insect bites (non poisonous) and stings, sunburn, hives, ivy and oak poisoning.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5d9b208e-7bcf-4bc7-8b29-f90d75a4a7ca.json
5da43209-cfc3-49d1-b1f5-fa3fd6ccc16c,CONJUPRI 2.5 MG,prescription,C08CA17,LEVAMLODIPINE,9520,,,WHO ATC Classification,,ILS,tablets,LEVAMLODIPINE AS MALEATE 2.5  MG,2025-07-31T01:28:59.008000,IL,אופק פארמה,,nan,nan,nan,,,CONJUPRI 5MG 30 TAB,,,,BOTTLE HDPE,units,30.0,176 44 37508 99,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,"CONJUPRI is calcium channel blocker and may be used alone or in combination with other antihypertensive agents for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5da43209-cfc3-49d1-b1f5-fa3fd6ccc16c.json
5db10602-2fb0-4a82-90fe-58fa9265d553,GABAPENTIN INOVAMED 300 MG,prescription,N03AX12,GABAPENTIN,7681,,,WHO ATC Classification,,ILS,capsules,GABAPENTIN,2025-07-31T03:25:21.305557,IL,אינובמד,,106.9560974,90.6407605,67.3909,,,GABAPENTIN INOVAMED 300 MG 100CAPS,7866,,8550,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,146 48 33100 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Epilepsy :- Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- Treatment of neuropathic pain- Gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5db10602-2fb0-4a82-90fe-58fa9265d553.json
5db73a0d-ebfe-460b-8061-587a61480d89,SPEVIGO IV,prescription,L04AC22,SPESOLIMAB,9250,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,SPESOLIMAB/ML,2025-07-31T08:33:38.828001,IL,בורינגר אינגלהיים,,95199.21419,80677.30375,73343.00341,,9006968015491,SPEVIGO 450MG 2 VIALS,,,25409,VIAL GLASS TYPE I,units,2.0,175 59 37506 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Spevigo is indicated for the treatment of generalized pustular psoriasis (GPP) flares in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5db73a0d-ebfe-460b-8061-587a61480d89.json
5df1d82b-cf7c-471f-acc7-a762c1bd1f44,STELARA 130 MG,prescription,L04AC05,USTEKINUMAB,7302,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,USTEKINUMAB/,2025-07-31T08:42:36.919245,IL,יאנסן סילג,,8039.599337,6813.22008,6193.836436,,7290014577404,STELARA 45MG/0.5ML PREFILLED SYRINGE,19964,,24037,VIAL GLASS TYPE I,units,1.0,158 52 35072 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Crohn’s Disease :STELARA is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNFα antagonist or have medical contraindications to such therapies.Ulcerative colitis :STELARA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5df1d82b-cf7c-471f-acc7-a762c1bd1f44.json
5e1c323d-1b08-478c-85f2-e0c9800012c6,EPREX/PROTECS 30000 IU/0.75ML 1SYRINGE,prescription,,,6158,,,,,ILS,tablet,EPREX/PROTECS 30000 IU/0. 1SYRINGE,2025-07-31T19:07:28.303558,IL,יאנסן סילג,,976.5919511,827.6202975,704.3577,,,EPREX/PROTECS 30000 IU/0.75ML 1SYRINGE,31601,,86953,,units,1.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5e1c323d-1b08-478c-85f2-e0c9800012c6.json
5e4fd57b-6f0d-41e7-9485-10f2d0e842f1,IMNOVID 1 MG,prescription,L04AX06,POMALIDOMIDE,7405,,,WHO ATC Classification,,ILS,"capsule, hard",POMALIDOMIDE,2025-07-31T04:02:31.948673,IL,ניאופרם,,23732.32085,20112.13721,18283.7611,,7640133683157,IMNOVID 1MG 3X7 CAPSULES (POMALYST),9798,,65781,BLISTER PVC/PCTFE,units,21.0,152 02 33954 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.Imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5e4fd57b-6f0d-41e7-9485-10f2d0e842f1.json
5e5e8541-5c16-4a15-b0f5-11f122452779,PIRFENIDONE SANDOZ ® 267 MG,prescription,L04AX05,PIRFENIDONE,9523,,,WHO ATC Classification,,ILS,film coated tablets,PIRFENIDONE,2025-07-31T06:45:02.615463,IL,סנדוז,,1551.135245,1314.521452,1118.741661,,,PIRFENIDONE SANDOZ 267MG 63 TAB,,,,BLISTER PVC/PE/PVDC,units,63.0,175 20 37557 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Pirfenidone Sandoz is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5e5e8541-5c16-4a15-b0f5-11f122452779.json
5e7b1bb2-7932-4817-9fef-8fa8517f4f64,PROTOPIC 0.03 %,prescription,L04AA05,TACROLIMUS,4616,,,WHO ATC Classification,,ILS,ointment,TACROLIMUS 0.03 %W/W,2025-07-31T07:05:21.765953,IL,דקסל פארמה,,108.7291366,92.14334016,68.5080596,,7290015912518,PROTOPIC 0.03% OINT 30GR,16433,,55925,TUBE LAMINATED,units,30.0,127 71 30667 00,valid,34.5,dermal,1.4,36,,,,,,,,,,0,Prescription required,"-Treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.-Treatment of moderate to severe atopic dermatitis in children (2 years of age and above) who are not adequately responsive to or are intolerant of conventional therapies.-Maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5e7b1bb2-7932-4817-9fef-8fa8517f4f64.json
5e9c2587-b27c-4a11-b737-d9e4022d6df1,ASPIRIN C,off-the-counter,N02BA01,ACETYLSALICYLIC ACID,5500,,,WHO ATC Classification,,ILS,tablets effervescent,"ACETYLSALICYLIC ACID, ASCORBIC ACID",2025-07-31T11:14:08.230982,IL,באייר,,40.5802,34.39,nan,,7290013092441,ASPIRIN C 20 TAB EFF.,,,,BLISTER PAPER/PE/ALU/PE,units,20.0,057 86 24955 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Pain relief, fever reduction, antirheumatic treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5e9c2587-b27c-4a11-b737-d9e4022d6df1.json
5eb1174d-e042-4e13-b6e3-42a6a457e712,MIDAZOLAM KALCEKS 1 MG/ML,prescription,N05CD08,MIDAZOLAM,8912,,,WHO ATC Classification,,ILS,solution for injection / infusion,MIDAZOLAM/,2025-07-31T05:21:42.223474,IL,מדי מרקט,,46.5111986,39.41627,28.771,,,MIDAZOLAM KALCEKS 5 MG/ML 3ML X 10AMP,,,71513,AMPOULES GLASS TYPE I,units,10.0,171 77 37234 99,valid,37.0,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,Midazolam is a short-acting sleep-inducing drug that is indicated: In adults * CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia * ANAESTHESIA* Premedication before induction of anaesthesia* Induction of anaesthesia* As a sedative component in combined anaesthesia * SEDATION IN INTENSIVE CARE UNITSIn children * CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia * ANAESTHESIA* Premedication before induction of anaesthesia * SEDATION IN INTENSIVE CARE UNITS,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5eb1174d-e042-4e13-b6e3-42a6a457e712.json
5eb40094-54cc-4312-94ed-2f9145da3102,ARIMIDEX,prescription,L02BG03,ANASTROZOLE,4747,,,WHO ATC Classification,,ILS,film coated tablets,ANASTROZOLE 1.0   MG,2025-07-30T23:26:51.298955,IL,תרו,,167.2819625,141.764375,113.4115,,7290008001984,ARIMIDEX 1MG 28TAB,9605,,28825,BLISTER PVC/ALUMINIUM,units,28.0,105 16 28931 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen.  Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5eb40094-54cc-4312-94ed-2f9145da3102.json
5ec00ea5-5b09-4054-98ca-23f41ec1d6a9,LABURIDE 200MG 100TAB,29C,,,20489,,,,,,tablet,LABURIDE 200MG,2025-07-31T20:44:57.263348,IL,nan,,,,,,,LABURIDE 200MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ec00ea5-5b09-4054-98ca-23f41ec1d6a9.json
5edf8483-4c6e-45c7-9bf1-5735019d02c1,TELFAST 120 MG,off-the-counter,R06AX26,FEXOFENADINE,4192,,,WHO ATC Classification,,ILS,film coated tablets,FEXOFENADINE HYDROCHLORIDE,2025-07-31T13:26:30.406932,IL,פרמה שלום,,18.762,15.9,nan,,,TELFAST 180MG 15TAB,20301,,,BLISTER PVC/PE/PVDC/AL,units,15.0,108 90 29135 21,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of symptoms associated with seasonal allergic rhinitis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5edf8483-4c6e-45c7-9bf1-5735019d02c1.json
5ee18d80-a60b-4d7f-944a-b8ef0c777e65,FUROLIN 100MG  30TAB,29C,,,20843,,,,,,tablet,FUROLIN 100MG,2025-07-31T20:30:34.983955,IL,nan,,,,,,,FUROLIN 100MG  30TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ee18d80-a60b-4d7f-944a-b8ef0c777e65.json
5ee4ffb5-54c4-4a1f-955e-d3069fe9d003,REVLIMID ® 10 MG,prescription,L04AX04,LENALIDOMIDE,6276,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE,2025-07-31T07:30:53.427682,IL,ניאופרם,,22606.81805,19158.32038,17416.65489,,7640133681382,REVLIMID 15MG 21 CAPS,18463,,83866,BLISTER PVC/PCTFE,units,21.0,140 46 31661 11,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM) Revlimid is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes REVLIMID is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Revlimid 7.5 mg is not indicated for treatment in MDS.Mantle Cell LymphomaREVLIMID is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphomaRevlimid in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ee4ffb5-54c4-4a1f-955e-d3069fe9d003.json
5eeb5ca8-e7ba-448a-9905-37f4cf4fc7a5,STRENSIQ ® 100 MG/ML,prescription,A16AB13,ASFOTASE ALFA,8372,,,WHO ATC Classification,,ILS,solution for injection,ASFOTASE ALFA/,2025-07-31T08:46:27.389543,IL,ניאופרם,,nan,nan,nan,,,STRENSIQ ® 40 MG/ML 12 vials 12 mg,9984,,62117,VIAL GLASS TYPE I,units,12.0,155 44 34545 00,valid,nan,s.c,1.4,30,,,,,,,,,,0,Prescription required,Strensiq is indicated for long-term enzyme replacement therapy in patients with paediatric-onset hypophosphatasia to treat the bone manifestations of the disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5eeb5ca8-e7ba-448a-9905-37f4cf4fc7a5.json
5eed529b-416a-4458-9cef-bc2bf112b19e,TRAMAL INJECTION 100,prescription,N02AX02,TRAMADOL,4818,,,WHO ATC Classification,,ILS,solution for injection,TRAMADOL HYDROCHLORIDE/,2025-07-31T09:33:27.511447,IL,ליברה,,37.2941537,31.605215,23.0695,,7290008872140,TRAMAL SR 100MG 30TAB,20002,,57212,AMPOULES GLASS TYPE I,units,30.0,125 54 30477 00,valid,37.0,"i.v, s.c, i.m",1.4,60,,,,,,,,,,0,Prescription required,Moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5eed529b-416a-4458-9cef-bc2bf112b19e.json
5ef87aa9-3c65-4e85-a497-778d17784742,HEMLIBRA 150 MG/ML,prescription,B02BX06,EMICIZUMAB,8446,,,WHO ATC Classification,,ILS,solution for injection,EMICIZUMAB/,2025-07-31T03:44:09.757179,IL,רוש,,18029.34952,15279.11044,13890.1004,,7290014774094,HEMLIBRA 150 MG/ML (60MG/0.4ML),,,26630,VIAL GLASS TYPE I,units,1.0,161 19 35415 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ef87aa9-3c65-4e85-a497-778d17784742.json
5f0305ba-60f2-4425-9439-33300faaf8a8,LACRISERT  INSERT OPHT 5MG 60 UNITS,29C,,,20490,,,,,,tablet,LACRISERT INSERT OPHT 5MG 60 UNITS,2025-07-31T20:45:32.108149,IL,nan,,,,,,,LACRISERT  INSERT OPHT 5MG 60 UNITS,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f0305ba-60f2-4425-9439-33300faaf8a8.json
5f05f810-0541-4fda-8af9-54b30d97f21d,ORLADEYO 110 MG,prescription,B06AC06,BEROTRALSTAT,9025,,,WHO ATC Classification,,ILS,capsules,BEROTRALSTAT AS DIHYDROCHLORIDE,2025-07-31T06:17:00.974913,IL,ניאופרם,,63744.54891,54020.80656,49109.82415,,,ORLADEYO 150 MG 28 CAPS,15537,,76934,BLISTER PVC/ALUMINIUM,units,28.0,170 35 37012 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,ORLADEYO is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years of age and older,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f05f810-0541-4fda-8af9-54b30d97f21d.json
5f12ce55-bf63-4934-9fd0-0958b2819b01,IODIFLOR SOLUTION,off-the-counter,D08AG02,POVIDONE-IODINE,3379,,,WHO ATC Classification,,ILS,solution,POVIDONE-IODINEW/V,2025-07-31T12:11:35.067247,IL,פלוריש,,10.9976,9.32,nan,,7290008103299,IODIFLOR SOL 20ML,9043,,,BOTTLE HDPE,units,20.0,061 40 27622 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Antiseptic, disinfection of infected skin, superficial wounds and burns.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f12ce55-bf63-4934-9fd0-0958b2819b01.json
5f17f0e2-5c7f-48bd-bbdb-200ebdc189fc,FLUCANOL 100,prescription,J02AC01,FLUCONAZOLE,6608,,,WHO ATC Classification,,ILS,capsules,FLUCONAZOLE,2025-07-31T03:10:19.218393,IL,רפא,,106.8675372,90.5657095,67.3351,,7290008012423,FLUCANOL 100MG 7CAPSULES,6335,,57809,BLISTER PVC/PVDC/ALUMINIUM,units,7.0,128 37 30644 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:• Cryptococcal meningitis.• Coccidioidomycosis.• Invasive candidiasis.• Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.• Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.• Candidal balanitis when local therapy is not appropriate.• Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.• Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:• Relapse of cryptococcal meningitis in patients with high risk of recurrence.• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.• To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).• Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis and cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f17f0e2-5c7f-48bd-bbdb-200ebdc189fc.json
5f31d656-1502-49fd-8b94-5d13eb4175ee,XYLOVIT 0.05%,off-the-counter,R01AA07,XYLOMETAZOLINE,3444,,,WHO ATC Classification,,ILS,drops+spray,XYLOMETAZOLINE HYDROCHLORIDE 0.05 %,2025-07-31T13:38:59.062555,IL,ויטאמד,,18.762,15.9,nan,,7290008068970,XYLOVIT 0.05% DRP10ML,24005,,,BOTTLE LDPE,units,10.0,062 58 27663 01,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to 10 hours.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f31d656-1502-49fd-8b94-5d13eb4175ee.json
5f3213d9-0f78-426e-a25e-28e4fc86ca98,RUXIENCE,prescription,L01XC02,RITUXIMAB,9093,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T07:54:08.346664,IL,פיזר,,894.5854042,758.1232576,645.2112831,,7290013592811,RUXIENCE 100MG/10ML 1 VIAL,,,87035,VIAL GLASS TYPE I,units,1.0,167 66 36478 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Ruxience is indicated for:Non-Hodgkin’s lymphoma (NHL):Ruxience is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma.Ruxience is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapyRuxience is indicated for the treatment of patients with CD20 positive diffuse large B-cell nonHodgkin's lymphoma in combination with CHOP chemotherapy.Ruxience maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.Chronic lymphocytic leukaemia (CLL):Ruxience in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. Rheumatoid arthritis:Ruxience is indicated, in combination with methotrexate, to reduce signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more TNF antagonist therapies.Granulomatosis with polyangiitis and microscopic polyangiitis:Ruxience, in combination with glucocorticoids, is indicated for the treatment of adult patients with granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis (WG)) and microscopic polyangiitis (MPA).Pemphigus vulgaris:Ruxience is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f3213d9-0f78-426e-a25e-28e4fc86ca98.json
5f427422-69fb-421a-8ce8-6780f3be1d76,DIPROFOL 1 %,prescription,N01AX10,PROPOFOL,8205,,,WHO ATC Classification,,ILS,emulsion for injection or infusion,PROPOFOL/ML,2025-07-31T01:58:24.649046,IL,תרו יבוא,,85.46214493,72.42554655,53.84799,,,DIPROFOL 2% 50ML  1VIAL,,,,AMPOULES GLASS TYPE I,units,1.0,113 40 29567 01,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Diprofol 1% is a short-acting intravenous general anaesthetic for:• Induction and maintenance of general anaesthesia in adults and children > 1 month.• Sedation of ventilated patients > 16 years of age in the intensive care unit.• Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 1 month..",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f427422-69fb-421a-8ce8-6780f3be1d76.json
5f4ce99d-1c83-417b-8c7d-a6af3a8fa483,OCTOCAINE 100,prescription,N01BB02,LIDOCAINE,9280,,,WHO ATC Classification,,ILS,solution for injection,"EPINEPHRINE AS BITARTRATE 0.01 MG/ML, LIDOCAINE HYDROCHLORIDE ( AS MONOHYDRATE)/ML",2025-07-31T04:47:05.959869,IL,רז פרמהצפטי,,nan,nan,nan,,,LIDOCAINE RAZ SPRAY 10 % 1 bottle,,,43216,CARTRIDGE GLASS TYPE I,units,80.0,136 86 31595 00,valid,nan,"dental nerve block, dental infiltration inj.",1.4,24,,,,,,,,,,0,Prescription required,Production of local anesthesia for dental procedures by nerve block or infiltration technique.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f4ce99d-1c83-417b-8c7d-a6af3a8fa483.json
5f50e4fe-8a76-4dbd-96e2-5165f428b5f2,PARAMOL,off-the-counter,N02BE01,PARACETAMOL,5509,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T12:45:47.287557,IL,ליף-דקסון,,11.8118,10.01,nan,,,PARAMOL AF NIGHT CARE 20 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,20.0,127 96 30764 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f50e4fe-8a76-4dbd-96e2-5165f428b5f2.json
5f6632b7-6ddf-4155-a1da-8cca3c2fc384,PARTANE 5 MG,prescription,N04AA01,TRIHEXYPHENIDYL,2084,,,WHO ATC Classification,,ILS,tablets,TRIHEXYPHENIDYL HYDROCHLORIDE,2025-07-31T06:30:02.033291,IL,תרו,,26.05215564,22.078098,16.1154,,,PARTANE 5MG 50TAB,16049,,7177,BLISTER PVC/ALUMINIUM,units,50.0,021 57 21465 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Partane tablet is an adjunct medicine in the therapy of all forms of Parkinsonism (postencephalitic, arteriosclerotic and idiopathic). It is also indicated to control extrapyramidal disorders  due to  central nervous system drugs such as phenothiazines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f6632b7-6ddf-4155-a1da-8cca3c2fc384.json
5f6d0eec-dcd4-400e-b4b5-af9a8685e344,CHLORAMPHENICOL VUAB 1 G.,29C,S01AA01,CHLORAMPHENICOL,20333,,,WHO ATC Classification,,ILS,powder for concentrate for solution for injection,CHLORAMPHENICOL AS SODIUM SUCCINATE,2025-07-31T14:07:14.687997,IL,nan,,nan,nan,nan,,8594159933460,CHLORAMPHENICOL 1G 400 VIALS,,,,VIAL 20 ML GLASS TYPE I,units,400.0,159 56 34926 00,valid,nan,"i.m, i.v",1.4,36,,,,,,,,,,0,,"Typhus and parathyphus, salmonellosis with septic development, meningitis, epiglottis, pertussis and parapertussis, serious infections with aerobe and anaerobe flora (pulmonary, abdominal, gynecologic) and other infections caused by bacteria susceptible to chloramphenicol.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f6d0eec-dcd4-400e-b4b5-af9a8685e344.json
5f6e9624-0fa3-4179-95cb-83b4a554c6fb,ALCOXIDINE,off-the-counter,D08AC02,CHLORHEXIDINE,3972,,,WHO ATC Classification,,ILS,solution - external,"ALCOHOLV/V, CHLORHEXIDINE GLUCONATE 0.5 %W/V",2025-07-31T11:10:57.297161,IL,ויטאמד,,11.32,9.59,nan,,7290008083089,ALCOXIDINE 100ML,1329,,,BOTTLE HDPE,units,100.0,116 50 28130 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Disinfection of hands and skin,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f6e9624-0fa3-4179-95cb-83b4a554c6fb.json
5f702bf4-3d75-4bd9-96f7-23ac68941d98,ENTECAVIR S.K. 0.5 MG,prescription,J05AF10,ENTECAVIR,8734,,,WHO ATC Classification,,ILS,film coated tablets,ENTECAVIR AS MONOHYDRATE 0.5  MG,2025-07-31T02:23:42.564739,IL,SK PHARM(KS KIM),,2281.326898,1933.32788,1757.5708,,7290016845525,ENTECAVIR S.K. 1 MG 30 TAB,5678,,59407,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,165 57 36439 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Entecavir S.K. is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with: - Compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels.- Decompensated liver disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f702bf4-3d75-4bd9-96f7-23ac68941d98.json
5f78d375-e841-4003-8f27-70b13ab7c548,CELCOX 100 MG,prescription,M01AH01,CELECOXIB,3883,,,WHO ATC Classification,,ILS,capsules,CELECOXIB,2025-07-31T01:04:07.050965,IL,תרימה,,18.26935826,15.482507,11.3011,,7-290008-075749,CELCOX 100MG 20CAPS,3706,,27393,BLISTER PVC/ALUMINIUM,units,20.0,134 40 30074 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of inflammation and pain in osteoarthritis (OA) and rheumatoid arthritis (RA).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f78d375-e841-4003-8f27-70b13ab7c548.json
5f946eca-076b-497e-a105-c6ce51bf6f14,KALBETEN FORTE SUSPENSION,off-the-counter,,,5131,,,,,ILS,suspension,BISMUTH SUBSALICYLATE/ML,2025-07-31T12:14:29.171811,IL,סם און,,38.5624,32.68,nan,,7290008080309,KALBETEN FORTE SUSP 100ML,11194,,,BOTTLE HDPE,units,100.0,131 72 30868 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Kalbeten Forte Suspension is indicated for relief of diarrhea, nausea, flatulence, convulsive stomach pains, upset stomach, indigestion. Kalbeten Forte Suspension is indicated as a preventative treatment of traveler's diarrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5f946eca-076b-497e-a105-c6ce51bf6f14.json
5fad0bbf-4519-4dd0-875d-991bb500211f,ALCOSEPT,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5239,,,WHO ATC Classification,,ILS,solution,"CHLORHEXIDINE GLUCONATE 0.5 %W/V, ALCOHOLW/V",2025-07-31T11:09:55.996322,IL,פלוריש,,52.4746,44.47,nan,,7290008110181,ALCOSEPT 1 LITER,,,,BOTTLE HDPE,units,1000.0,129 67 30806 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Skin antiseptic.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5fad0bbf-4519-4dd0-875d-991bb500211f.json
5fc0c62e-f9ca-46dc-98ee-effccf4a9443,FEMINET,prescription,G03CA01,ETHINYLESTRADIOL,4656,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.02  MG, DESOGESTREL 0.15  MG",2025-07-31T02:56:07.466961,IL,דקסל פארמה,,18.86539868,15.987626,11.6698,,7290005680557,FEMINET 1X21TAB,6338,,58267,BLISTER PVC/PVDC/ALUMINIUM,units,21.0,128 57 30568 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5fc0c62e-f9ca-46dc-98ee-effccf4a9443.json
5fcde6ec-2638-4ff4-9514-33530aa1c8de,CONCOR 2.5 MG,prescription,C07AB07,BISOPROLOL,9118,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE 2.5  MG,2025-07-31T01:28:38.483709,IL,מרק סרונו,,17.80878892,15.092194,11.0162,,,CONCOR 2.5 MG 30 TAB,,,69386,BLISTER PVC/ALUMINIUM,units,30.0,167 23 35984 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function (ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5fcde6ec-2638-4ff4-9514-33530aa1c8de.json
5fd68352-1a91-47f8-8307-b27148a599bd,ELIGARD 22.5 MG,prescription,,,7882,,,,,ILS,powder and solvent for solution for injection,LEUPRORELIN ACETATE 22.5  MG,2025-07-31T02:14:51.244222,IL,קמהדע,,1146.578029,971.6763387,826.9585862,,8718692510845,ELIGARD 22.5 MG 1 PREFILLED SYR,5607,,51301,SYRINGE PREFILLED  CYCLIC OLEFIN COPOLYMER,units,1.0,156 79 33678 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,ELIGARD is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5fd68352-1a91-47f8-8307-b27148a599bd.json
5fe69c3a-b523-4bdf-bd94-7107f3306d0c,RAFASSAL 4 GRAM ENEMA,prescription,A07EC02,MESALAZINE,1888,,,WHO ATC Classification,,ILS,enema,MESALAZINE/,2025-07-31T07:14:54.526729,IL,רפא,,100.3187499,85.01589357,63.2088428,,7290008013765,RAFASSAL 500MG 60  E.C. TAB,18229,,8275,BOTTLE POLYETHYLENE,units,60.0,029 58 25321 00,valid,34.5,rectal,1.4,18,,,,,,,,,,0,Prescription required,Treatment and prevention of ulcerative colitis and Crohn's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5fe69c3a-b523-4bdf-bd94-7107f3306d0c.json
5fef9cb7-125d-43fb-bc7f-6ba9251c3b6e,BRONCHO D,off-the-counter,R06AA52,"DIPHENHYDRAMINE, COMBINATIONS",3859,,,WHO ATC Classification,,ILS,syrup,"DIPHENHYDRAMINE HYDROCHLORIDE/, AMMONIUM CHLORIDE/",2025-07-31T11:20:31.458772,IL,סם און,,32.981,27.95,nan,,7290008066013,BRONCHO KID SYROP 120ML,2266,,,BOTTLE HDPE,units,120.0,058 88 27178 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of coughs and congestion in the respiratory tract.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5fef9cb7-125d-43fb-bc7f-6ba9251c3b6e.json
5ff5d4e2-7a7f-46e3-be30-420227dbefd2,VOXZOGO 0.4 MG,prescription,M05BX07,VOSORITIDE,9490,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,VOSORITIDE 0.4 MG/VIAL,2025-07-31T10:22:26.582172,IL,מדיסון,,34813.91266,29503.31713,26821.19739,,,VOXZOGO 0.4 MG 10 VIAL,,,26033,VIAL GLASS TYPE I,units,10.0,175 72 37698 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Voxzogo is indicated for the treatment of achondroplasia in paediatric patients whose epiphyses are not closed. The diagnosis of achondroplasia should be confirmed by appropriate genetic testing.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ff5d4e2-7a7f-46e3-be30-420227dbefd2.json
5ff7eb4b-f5be-480b-b305-c347ac081880,CUBICIN 500 MG,prescription,J01XX09,DAPTOMYCIN,7073,,,WHO ATC Classification,,ILS,lyophilized powder for solution for injection,DAPTOMYCIN/VIAL,2025-07-31T01:35:30.256126,IL,מ.ס.ד. ישראל,,472.8307388,400.7040159,341.0246944,,7290017512129,CUBICIN 500MG VIAL 10ML,9537,,72079,VIAL 10 ML GLASS TYPE I,units,1.0,131 21 30994 01,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Cubicin is indicated for the treatment of the infections listed below. *  Complicated Skin and Skin Structure InfectionsComplicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive bacteria:  Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only).*  Staphylococcus aureus Bloodstream Infections (Bacteremia), Including Those with Right-Sided Infective Endocarditis, Caused by Methicillin-Susceptible and Methicillin-Resistant IsolatesStaphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.* Combination therapy may be clinically indicated if the documented or presumed pathogens include Gram negative or anaerobic organisms",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/5ff7eb4b-f5be-480b-b305-c347ac081880.json
60010c41-a9bf-478d-98ef-3c131f7194de,AZARGA,prescription,S01ED51,"TIMOLOL, COMBINATIONS",8595,,,WHO ATC Classification,,ILS,"eye drops, suspension","BRINZOLAMIDE/ML, TIMOLOL AS MALEATE/ML",2025-07-31T00:43:41.464874,IL,SK PHARM(KS KIM),,36.05018,30.551,22.3,,7290016369229,BRINZOLAMIDE SK  DROPS 5 ML,2757,,3781,BOTTLE LDPE,units,5.0,145 12 32030 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Decrease of intra-ocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/60010c41-a9bf-478d-98ef-3c131f7194de.json
600b26a2-2c53-4885-b54c-2b831a8fe049,HYDRALAZINE 50MG 100TAB,29C,,,20089,,,,,,tablet,HYDRALAZINE 50MG,2025-07-31T20:35:31.214945,IL,nan,,,,,,,HYDRALAZINE 50MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/600b26a2-2c53-4885-b54c-2b831a8fe049.json
60167c15-0c68-4b7f-8873-847e20d1094a,FLUSALMER S.K. 50/250 MCG,prescription,R03AK06,SALMETEROL AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,8727,,,WHO ATC Classification,,ILS,powder for inhalation,"SALMETEROL AS XINAFOATE, FLUTICASONE PROPIONATE",2025-07-31T03:14:21.822477,IL,SK PHARM(KS KIM),,152.6295945,129.347114,103.4776912,,7290016845266,FLUSALMER S.K. 50/500 MCG 60 DOSES,6630,,29642,BLISTER ALUMINIUM,units,60.0,164 50 35043 00,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"FLUSALMER SK is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate . FLUSALMER SK is indicated for the symptomatic treatment of patients with COPD, with a FEV1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who havesignificant symptoms despite regular bronchodilator therapy.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/60167c15-0c68-4b7f-8873-847e20d1094a.json
60347409-34b6-4c4d-9a70-565be549c8d1,CHAMPIX 0.5 MG,prescription,N07BA03,VARENICLINE,6144,,,WHO ATC Classification,,ILS,film coated tablets,VARENICLINE AS TARTRATE 0.5  MG,2025-07-31T01:08:14.910689,IL,פיזר,,305.3960125,258.8101916,220.2639929,,7290010355747,CHAMPIX 0.5MG 55TAB,3923,,86738,BLISTER ACLAR/PVC/ALUMINIUM,units,55.0,137 66 31510 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Champix is indicated as an aid to smoking cessation treatment adults over 18 years of age.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/60347409-34b6-4c4d-9a70-565be549c8d1.json
6035bab3-ef8d-4e6e-b713-d5a3468d196a,HYDROCORTISONE PANPHARMA 100 MG,prescription,,,7959,,,,,ILS,powder for solution for injection,HYDROCORTISONE AS SODIUM SUCCINATE/DOSE,2025-07-31T03:53:04.076839,IL,פארמלוג'יק,,308.7373624,261.6418325,222.6739,,7290006676535,HYDROCORTISONE PANPHARMA 100 MG 25 VIAL,8371,,84936,VIAL GLASS TYPE I,units,25.0,141 33 31513 01,valid,17.5,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,"Hydrocortisone panpharma is indicated to treat any condition in which IM or IV corticosteroid treatment is required such as: - allergic states, - dermatologic diseases, - endocrine disorders, - gastrointestinal diseases,- hematologic disorders, - neoplastic diseases, - nervous system disorders, - ophthalmic diseases, - renal diseases, - respiratory diseases, - rheumatic disorders,- certain medical emergencies.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6035bab3-ef8d-4e6e-b713-d5a3468d196a.json
604513f8-d636-47a5-9632-448f448c5c58,METADEX XR 10 MG,prescription,N06BA11,DEXMETHYLPHENIDATE,9226,,,WHO ATC Classification,,ILS,capsules extended release,DEXMETHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:15:50.778075,IL,SK PHARM(KS KIM),,nan,nan,nan,,,METADEX XR 20 MG S.K. 100 CAPSULES,,,70903,BOTTLE HDPE,units,100.0,172 56 37337 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Metadex XR extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/604513f8-d636-47a5-9632-448f448c5c58.json
604f3087-75cb-4edd-8313-93709f5dda2c,RINVOQ 15 MG,prescription,L04AA44,UPADACITINIB,9072,,,WHO ATC Classification,,ILS,tablets prolonged release,UPADACITINIB AS HEMIHYDRATE,2025-07-31T07:35:46.152580,IL,אב-וי,,5299.745805,4491.310204,4083.009276,,8054083020266,RINVOQ 30 MG 28 PR TAB,,,81261,BLISTER PVC/PE/PCTFE/AL,units,28.0,164 29 36194 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate. Psoriatic arthritis RINVOQ is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. RINVOQ may be used as monotherapy or in combination with methotrexate. Axial spondyloarthritis Non-radiographic axial spondyloarthritis (nr-axSpA) RINVOQ is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs). Ankylosing spondylitis (AS, radiographic axial spondyloarthritis)RINVOQ is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. Atopic dermatitis RINVOQ is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. Ulcerative colitis RINVOQ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. Crohn’s disease RINVOQ is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.Polyarticular juvenile idiopathic arthritisRINVOQ 15mg tablets is indicated for the treatment of patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.Limitations of Use RINVOQ 15 MG is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine.Juvenile psoriatic arthritis RINVOQ 15 MG is indicated for the treatment of pediatric patients 2 years of age and older with active juvenile psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.Limitations of Use RINVOQ 15 MG is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/604f3087-75cb-4edd-8313-93709f5dda2c.json
6079191c-cf30-4f32-88ff-767a1e05731b,BRINTELLIX 10 MG,prescription,N06AX26,VORTIOXETINE,7725,,,WHO ATC Classification,,ILS,film coated tablets,VORTIOXETINE AS HYDROBROMIDE,2025-07-31T00:42:50.426140,IL,לנדבק,,134.6931411,114.1467348,84.86746081,,,BRINTELLIX 10MG 28 F.C.TAB,2587,,85110,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,153 73 34155 00,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Brintellix is indicated for the treatment of major depressive episodes in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6079191c-cf30-4f32-88ff-767a1e05731b.json
60a59dc8-ef44-4023-9636-a8a49a7a642d,LAMOGINE 100 MG,prescription,N03AX09,LAMOTRIGINE,4421,,,WHO ATC Classification,,ILS,tablets,LAMOTRIGINE,2025-07-31T04:34:38.709777,IL,תרימה,,24.06907242,20.397519,14.8887,,,LAMOGINE 25MG 30TAB,12078,,30855,BLISTER PVC/ALUMINIUM,units,30.0,123 89 30354 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"EpilepsyAdults and adolescents aged 13 years and above- 	Adjunctive or monotherapy treatment of partial seizures and generalised seizures,                including tonic-clonic seizures.- 	Seizures associated with Lennox-Gastaut syndrome. Lamogine is given as adjunctive               therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-              Gastaut syndrome.Children and adolescents aged 2 to 12 years- 	Adjunctive treatment of partial seizures and generalised seizures, including tonic-             clonic seizures and the seizures associated with Lennox-Gastaut syndrome.-	 Monotherapy of typical absence seizures.Bipolar disorderAdults aged 18 years and above-	 Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamogine is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/60a59dc8-ef44-4023-9636-a8a49a7a642d.json
60c0a17c-2fef-4eae-a4f7-ad34c1a3212b,ABILIFY  MAINTENA 300 MG,prescription,N05AX12,ARIPIPRAZOLE,7940,,,WHO ATC Classification,,ILS,powder and solvent for prolonged-release suspension for injection,ARIPIPRAZOLE AS MONOHYDRATE/VIAL,2025-07-30T23:10:01.289898,IL,לנדבק,,1113.614261,943.7409412,803.1837798,,,ABILIFY MAINTENA 400 MG/PREFILLED SYR,9950,,85126,VIAL GLASS TYPE I,units,1.0,153 68 34089 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,Abilify Maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/60c0a17c-2fef-4eae-a4f7-ad34c1a3212b.json
60c4e9bf-bf8e-4704-8f85-32f47ec9d98f,"GEMCITABINE ""EBEWE"" 40MG/ML",prescription,L01BC05,GEMCITABINE,7739,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,GEMCITABINE AS HYDROCHLORIDE/,2025-07-31T03:29:33.320750,IL,סנדוז,,63.43051473,53.7546735,39.9663,,7290016369724,GEMCITABINE  EBEWE  200MG/5ML,7861,,3559,VIAL GLASS TYPE I,units,1.0,145 95 33400 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/60c4e9bf-bf8e-4704-8f85-32f47ec9d98f.json
610c1c68-feba-4011-899d-4f7a98b34098,ZINNAT TABLETS 125 MG,prescription,J01DC02,CEFUROXIME,3730,,,WHO ATC Classification,,ILS,tablets,CEFUROXIME AS AXETIL,2025-07-31T10:49:41.507527,IL,סנדוז,,19.88175422,16.848945,12.2985,,,ZINNAT 250MG/5ML  SUSP 50ML,26086,,36714,BLISTER ALUMINIUM,units,50.0,041 40 25801 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Zinnat is indicated for the treatment of the infections listed below in adults and children from the age of 3 months .• Acute streptococcal tonsillitis and pharyngitis.• Acute bacterial sinusitis.• Acute otitis media.• Acute exacerbations of chronic bronchitis.• Cystitis.• Pyelonephritis.• Uncomplicated skin and soft tissue infections. •Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/610c1c68-feba-4011-899d-4f7a98b34098.json
611cdaa1-cb14-4dc7-957d-cea40c5b01b9,TACROCEL 0.5 MG,prescription,L04AD02,TACROLIMUS,7078,,,WHO ATC Classification,,ILS,capsules,TACROLIMUS AS MONOHYDRATE 0.5  MG,2025-07-31T08:57:37.044884,IL,פאדאגיס,,214.0166,181.37,145.096,,,TACROCEL 0.5 MG 50 CAPSULES,20745,,38112,BLISTER PVC/PE/PVDC/AL,units,50.0,148 54 33452 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in liver kidney or heart allograft recipients.Treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/611cdaa1-cb14-4dc7-957d-cea40c5b01b9.json
612dc223-0116-4549-9b38-c8003b10f2f8,CEFUAVENIR 250 MG,prescription,J01DC02,CEFUROXIME,9401,,,WHO ATC Classification,,ILS,tablets,CEFUROXIME AS AXETIL,2025-07-31T01:03:12.038320,IL,ביואבניר,,42.92784304,36.379528,26.5544,,,CEFUAVENIR 500 MG 10 TAB,,,15561,BLISTER PVC/ALUMINIUM,units,10.0,174 07 36745 99,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CefuAvenir is indicated for the treatment of the infections listed below in adults and children from the  age of 3 :months .• Acute streptococcal tonsillitis and pharyngitis.• Acute bacterial sinusitis.• Acute otitis media.• Acute exacerbations of chronic bronchitis.• Cystitis.• Pyelonephritis.• Uncomplicated skin and soft tissue infections. •Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/612dc223-0116-4549-9b38-c8003b10f2f8.json
615f6878-966e-400c-8ae8-f16f5b72874c,SHINGRIX,prescription,J07BK03,"ZOSTER, PURIFIED ANTIGEN",9249,,,WHO ATC Classification,,ILS,powder and suspension for suspension for injection,VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN,2025-07-31T08:09:37.925234,IL,ג.ס.ק,,897.6151467,760.6908361,647.3964563,,,SHINGRIX 1 vial,,,1987,VIAL GLASS TYPE I,units,1.0,171 33 37389 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Shingrix is indicated for prevention of herpes zoster (HZ) and post-herpetic neuralgia (PHN), in: • adults 50 years of age or older; • adults 18 years of age or older at increased risk of HZ.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/615f6878-966e-400c-8ae8-f16f5b72874c.json
61659f6e-57c1-4523-84d6-6bd7b2605c84,PROLUTEX,prescription,G03DA04,PROGESTERONE,9460,,,WHO ATC Classification,,ILS,solution for injection,PROGESTERONE 22.48 MG/ML,2025-07-31T07:01:06.354625,IL,כ.צ.ט,,229.8093997,194.7537372,155.8029898,,,PROLUTEX 25 MG 7 VIALS,24425,,28868,VIAL GLASS TYPE I,units,7.0,175 15 37196 99,valid,25.0,"i.m, s.c",1.4,24,,,,,,,,,,0,Prescription required,Prolutex is indicated in adults for luteal support as part of an Assisted Reproductive Technology (ART) treatment program in infertile women who are unable to use or tolerate vaginal preparations.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/61659f6e-57c1-4523-84d6-6bd7b2605c84.json
617dc72f-5b07-4210-99e1-b18ac1f1e682,MYCOBUTIN,prescription,J04AB04,RIFABUTIN,3115,,,WHO ATC Classification,,ILS,capsules,RIFABUTIN,2025-07-31T05:37:00.625077,IL,פיזר,,414.4911597,351.2637102,298.9478385,,7298074160017,MYCOBUTIN 150MG 30CAP,13012,,9265,BLISTER PVC/ALUMINIUM,units,30.0,068 76 28228 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of chronic tuberculosis where there is evidence of acid fast bacteria resistant to rifampicin or to two other alternative drugs. For the treatment of infections  caused by MAC or other atypical mycobacteria where there is evidence of resistant bacteria as above. For the treatment of infections caused by MAC or other atypical mycobacteria in AIDS patients in all cases not subject to the above restrictions. For prevention of MAC infections in AIDS patients whose CD4 counts lower or eqval to 200/mm3,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/617dc72f-5b07-4210-99e1-b18ac1f1e682.json
618ef423-5be3-48cc-8d46-b8bc267b2804,SANDIMMUN ® NEORAL ® 100 MG CAPSULES,prescription,L04AA01,CYCLOSPORIN,3005,,,WHO ATC Classification,,ILS,capsules,CICLOSPORIN,2025-07-31T07:58:19.018921,IL,נוברטיס פארמה,,594.259446,503.6097,428.604,,7298120012772,SANDIMMUN NEO 100MG 50CAPS,19079,,9077,BLISTER PVC/PA/ALUMINIUM,units,50.0,066 78 28140 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of organ rejection in kidney  liver heart allogenic transplants in conjunction with corticosteroids. May also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents.  Bone marrow transplantation.   Endogenous uveitis.   Severe psoriasis above age 16 that did not respond to other treatment. Atopic dermatitis in adults only up to 8 weeks  for severe cases in which conventional therapy is ineffective or inappropriate.   Rheumatoid arthritis: Severe cases in which standard treatments are ineffective or inappropriate.  Nephrotic syndrom type MCD (minimal change disease) in cases where conventional therapy has failed.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/618ef423-5be3-48cc-8d46-b8bc267b2804.json
61ff34cd-4482-4d4c-90c7-7b41946a63c2,IMURAN TABLETS 25 MG,prescription,L04AX01,AZATHIOPRINE,2457,,,WHO ATC Classification,,ILS,film coated tablets,AZATHIOPRINE,2025-07-31T04:04:34.361865,IL,פאדאגיס,,74.70692092,63.31095275,47.07134033,,7290008105446,IMURAN 50MG 100TAB,9021,,1020,BLISTER PVC/ALUMINIUM,units,100.0,034 79 25384 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Immunosuppressive agent used in transplantation surgery for suppression of graft rejection. For special cases of rheumatoid arthritis- not responsive to other agents- and only by rheumatology experts in hospitals or rheumatic clinics.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/61ff34cd-4482-4d4c-90c7-7b41946a63c2.json
620d2878-070e-432e-b652-6c4b31346146,VIEPAX XR 75,prescription,N06AX16,VENLAFAXINE,6750,,,WHO ATC Classification,,ILS,caplets,VENLAFAXINE AS HYDROCHLORIDE,2025-07-31T10:13:50.180419,IL,דקסל פארמה,,35.54450752,30.122464,21.9872,,,VIEPAX  XR 75MG 30CAPLETS,22326,,26451,BLISTER ACLAR COATED PVC/ALUMINIUM,units,30.0,130 53 30839 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of depression.Maintenance of recurrent depression, generalized anxiety disorder (GAD) - short term and long-term, social anxiety disorder (SAD).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/620d2878-070e-432e-b652-6c4b31346146.json
620d6116-fb4d-48aa-b346-e574249f7216,NORMITEN 100,prescription,C07AB03,ATENOLOL,1399,,,WHO ATC Classification,,ILS,tablets,ATENOLOL,2025-07-31T05:51:58.218642,IL,טבע,,14.339242,12.1519,8.87,,,NORMITEN 50MG 30TAB,14326,,7803,BLISTER PVC/ALUMINIUM,units,30.0,045 35 24916 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of angina pectoris, acute myocardial infarction, hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/620d6116-fb4d-48aa-b346-e574249f7216.json
621b021c-c77a-480d-8e13-b407d06aea98,BILAXTEN,prescription,R06AX29,BILASTINE,8134,,,WHO ATC Classification,,ILS,tablets,BILASTINE,2025-07-30T23:38:52.307123,IL,רפא,,25.99208001,22.02718743,16.078239,,,BILAXTEN 20MG 30TAB,2631,,66789,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,159 06 34829 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Bilaxten is indicated for the symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticariai in adults and adolescents (12 years of age and over).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/621b021c-c77a-480d-8e13-b407d06aea98.json
621cc572-f991-4406-a583-aa8aa7eaf154,GAVRETO,prescription,L01EX23,PRALSETINIB,9016,,,WHO ATC Classification,,ILS,"capsule, hard",PRALSETINIB,2025-07-31T03:28:41.229555,IL,רוש,,23303.87955,19749.05134,17953.68304,,,GAVRETO 90 CAPS 100 MG,,,,BOTTLE HDPE,units,90.0,169 37 36872 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,- GAVRETO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC).- GAVRETO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy.- GAVRETO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/621cc572-f991-4406-a583-aa8aa7eaf154.json
622858f1-87be-468d-bbc8-96bb520a8a3d,GAVISCON PEPPERMINT TABLETS,off-the-counter,,,5287,,,,,ILS,tablets,"CALCIUM CARBONATE, SODIUM BICARBONATE 133.5  MG, ALGINIC ACID AS SODIUM",2025-07-31T13:19:03.559696,IL,רקח,,93.5858,79.31,nan,,,SODIUM BICARBONATE 500MG 100TAB,19086,,,BLISTER PVC/PE/PVDC/AL,units,100.0,141 58 31757 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Treatment of symptoms of gastro-oesophageal reflux such as acid regurgatation, heartburn and indigestion (related to reflux), for example, following meals or during pregnancy or in patients with symptoms related to reflux oesophagitis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/622858f1-87be-468d-bbc8-96bb520a8a3d.json
622e77dc-02a1-4d58-b6ba-218fd2edb59e,BIOCORYL 100MG/ML (1000MG/10ML) 1VIAL,29C,,,20312,,,,,,injection,BIOCORYL 100MG/ML (1000MG/),2025-07-31T20:00:37.146512,IL,nan,,,,,,,BIOCORYL 100MG/ML (1000MG/10ML) 1VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/622e77dc-02a1-4d58-b6ba-218fd2edb59e.json
62481773-7d56-4e7e-b8a0-605f5ed92486,CIALIS 2.5 MG,prescription,G04BE08,TADALAFIL,6218,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL 2.5  MG,2025-07-31T01:10:15.017633,IL,אלי לילי,,501.2767352,424.8107925,361.5411,,,CIALIS 2.5MG 28TAB,3945,,89210,BLISTER PVC/PE/PCTFE/AL,units,28.0,139 19 31765 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62481773-7d56-4e7e-b8a0-605f5ed92486.json
624a6f97-4b6b-4769-9932-ef73bfa96a0e,HYDROAGISTEN CREAM,prescription,D07AA02,HYDROCORTISONE,1924,,,WHO ATC Classification,,ILS,cream,"CLOTRIMAZOLE, HYDROCORTISONE ACETATE",2025-07-31T01:30:53.274484,IL,רקח,,nan,nan,nan,,,CORTISONE ACETATE 50TAB,3251,,6894,TUBE ALUMINIUM,units,50.0,042 82 24888 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,Prescription required,Skin inflammation involving fungal infection,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/624a6f97-4b6b-4769-9932-ef73bfa96a0e.json
6255c30f-449d-4f5c-a458-a3fb3ce817b5,ESBRIET 267 MG TABLETS,prescription,L04AX05,PIRFENIDONE,8450,,,WHO ATC Classification,,ILS,film coated tablets,PIRFENIDONE,2025-07-31T02:35:10.681033,IL,רוש,,7849.480695,6652.10258,6047.365982,,7290014774131,ESBRIET 801 MG 90  COATED TAB,,,26637,BOTTLE HDPE,units,90.0,162 66 35826 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6255c30f-449d-4f5c-a458-a3fb3ce817b5.json
6267585c-70fb-49d4-9041-ed226a64da01,RAPAMUNE 1 MG TABLETS,prescription,L04AA10,SIROLIMUS,4405,,,WHO ATC Classification,,ILS,coated tablets,SIROLIMUS,2025-07-31T07:16:51.062495,IL,פיזר,,1043.824384,884.596975,752.8484894,,72900064011731,RAPAMUNE 1MG/ML 60ML,18307,,30364,BLISTER PVC/PE/ALUMINIUM,units,60.0,131 73 30909 22,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. It is recommended that Rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. Rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6267585c-70fb-49d4-9041-ed226a64da01.json
626d1e88-d8b5-4ded-87f2-e0dca25df1af,MESULID 100,prescription,M01AX17,NIMESULIDE,3118,,,WHO ATC Classification,,ILS,caplets,NIMESULIDE,2025-07-31T05:15:17.961833,IL,רפא,,17.68019294,14.98321502,10.9366533,,,MESULID 100MG 30CAPLETS,13013,,9259,BLISTER PVC/ALUMINIUM,units,30.0,068 27 27431 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute pain.Primary dysmenorrhea.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/626d1e88-d8b5-4ded-87f2-e0dca25df1af.json
626d253f-3f55-4184-931b-1c269e95c9f9,EBIXA TABLETS 10 MG,prescription,N06DX01,MEMANTINE,6150,,,WHO ATC Classification,,ILS,film coated tablets,MEMANTINE HYDROCHLORIDE,2025-07-31T02:11:02.376812,IL,לנדבק,,281.8194317,238.8300375,191.06403,,,EBIXA DROPS 10MG/G 50ML,5468,,87670,BLISTER PP/ALUMINIUM,units,50.0,129 83 30891 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Treatment of patient with moderate to severe Alzheimer's disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/626d253f-3f55-4184-931b-1c269e95c9f9.json
6279184f-0685-4a1c-b34e-506f1045681c,POINT,off-the-counter,M01AE02,NAPROXEN,5150,,,WHO ATC Classification,,ILS,tablets,NAPROXEN SODIUM,2025-07-31T12:49:25.798924,IL,תרימה,,43.601,36.95,nan,,,POINT 275MG 24TAB,16644,,,BLISTER PVC/PE/PVDC/AL,units,24.0,103 81 28780 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Mild and moderate analgesic such as relief of toothache, backache and menstrual pain (primary dysmenorrhea).Fever reduction.Non-steroidal anti-inflammatory for the treatment of rheumatic inflammations, tendinitis and musculoskeletal inflammations.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6279184f-0685-4a1c-b34e-506f1045681c.json
6283d858-ac4b-46d9-8717-19c60bd85d88,TROSMOLYT 20 MG,prescription,G04BD09,TROSPIUM,8369,,,WHO ATC Classification,,ILS,film coated tablets,TROSPIUM CHLORIDE,2025-07-31T09:45:50.253179,IL,כ.צ.ט,,30.57362418,25.909851,18.9123,,7290010038480,TROSMOLYT 20 MG 30 tab,20854,,4223,BLISTER PVC/ALUMINIUM,units,30.0,159 44 35071 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of urge incontinence and /or increased urinary frequency and urgency as may occur in patients with overactive bladder (e.g. idiopathic or neurologic detrusor overactivity), ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6283d858-ac4b-46d9-8717-19c60bd85d88.json
628b1e49-9038-4bf4-a536-a1992fd8610f,DUOTRAV,prescription,S01ED51,"TIMOLOL, COMBINATIONS",6407,,,WHO ATC Classification,,ILS,"eye drops, solution","TRAVOPROST/ML, TIMOLOL AS MALEATE/ML",2025-07-31T02:07:33.791397,IL,נוברטיס פארמה,,39.28965996,33.29632348,24.30388575,,729001639250,DUOTRAV 2.5ML OPHTHALMIC SOLUTION,4543,,48349,BOTTLE POLYPROPYLENE,units,2.5,144 33 31764 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Decrease of intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/628b1e49-9038-4bf4-a536-a1992fd8610f.json
6296e5ba-a7cf-449c-8f3e-49d36117dbbc,FENTAMED 100 MCG,prescription,N01AH01,FENTANYL,9366,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE MICRONIZED,2025-07-31T18:52:23.852798,IL,אינובמד,,1050.17725,889.98072,757.4304,,7290104531170,FENTAMED 600 MCG 30 TAB SUBLINGUAL,23637,,5056,BLISTER PA/AL/PVC//ALU/PET,units,30.0,173 43 36706 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fentamed is indicated for management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6296e5ba-a7cf-449c-8f3e-49d36117dbbc.json
62977684-fbc6-492a-ae8b-1a5e9c968e1a,TRILEPTIN 300 MG,prescription,N03AF02,OXCARBAZEPINE,3582,,,WHO ATC Classification,,ILS,film coated tablets,OXCARBAZEPINE,2025-07-31T09:43:09.236217,IL,נוברטיס פארמה,,105.5216043,89.42509234,66.4870575,,7290001173992,TRILEPTIN 600MG 50TAB,20211,,75886,BLISTER PVC/PE/PVDC/AL,units,50.0,106 80 28707 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of primary generalised tonic-clonic seizures and partial seizures with or without secondary generalization.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62977684-fbc6-492a-ae8b-1a5e9c968e1a.json
62a01f0c-0506-4923-9139-7d2b5faf9a1a,LEUCOVORIN TEVA 10 MG/ML,prescription,V03AF03,CALCIUM FOLINATE,8856,,,WHO ATC Classification,,ILS,solution for injection,CALCIUM FOLINATE 10.8 MG/ML,2025-07-31T04:41:58.381961,IL,טבע,,784.9521187,665.2136895,566.1393102,,,LEUCOVORIN TEVA 10 MG/ML 1 VIAL 50ML,,,58639,VIAL GLASS,units,1.0,053 49 26932 05,valid,17.5,"i.v, i.m",1.4,24,,,,,,,,,,0,Prescription required,To diminish the toxicity and counteract the action of folic acid antagonists in cytotoxic therapy. As Leucovorin-Fluorouracil chemotherapy combination for cancer treatment.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62a01f0c-0506-4923-9139-7d2b5faf9a1a.json
62a3db05-5c06-4474-b2bc-80746a3c7b44,DETRUSITOL SR 2 MG,prescription,G04BD07,TOLTERODINE,4534,,,WHO ATC Classification,,ILS,capsules slow release,TOLTERODINE L-TARTRATE,2025-07-31T01:52:12.810230,IL,דקסל פארמה,,99.35166645,84.1963275,62.5995,,7298074160161,DETRUSITOL SR 4MG 28CAPS,4126,,5144,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,125 56 30466 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62a3db05-5c06-4474-b2bc-80746a3c7b44.json
62bbcd9e-0b51-4af0-97ae-8cca199d95be,EZECOR,prescription,C10AX09,EZETIMIBE,7885,,,WHO ATC Classification,,ILS,tablets,EZETIMIBE,2025-07-31T02:51:21.896842,IL,אוניפארם,,219.15373,185.7235,148.5788,,,EZECOR 10MG 30TAB,5610,,50193,BLISTER PVC/ALUMINIUM,units,30.0,156 11 34500 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Primary hypercholesterolemia: Ezecor administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Homozygous familial hypercholesterolemia (HoFH): Ezecor administered with a statin are indicated for use in patients with HoFH.Patients may also receive adjunctive treatments (e.g. LDL apheresis).Homozygous sitosterolemia (Phytosterolemia): Ezecor are indicated for use in patients with homozygous familial sitosterolemia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62bbcd9e-0b51-4af0-97ae-8cca199d95be.json
62c2bbfd-3f66-4f05-a673-a94237e513f0,ELIDEL CREAM 1 %,prescription,D11AX15,PIMECROLIMUS,4583,,,WHO ATC Classification,,ILS,cream,PIMECROLIMUS,2025-07-31T02:14:24.925791,IL,דקסל פארמה,,65.27296678,55.316076,41.12719405,,7290001173510,ELIDEL CREAM 1% 15G,5525,,4924,TUBE ALUMINIUM,units,15.0,126 12 30517 01,valid,34.5,dermal,1.4,24,,,,,,,,,,0,Prescription required,Elidel 1 % cream is indicated for the short-term treatment of the signs and symptoms of atopic dermatitis (eczema) and intermittent long-term treatment to prevent progression to flares in patients 3 months of age and above. Treatment with Elidel is indicated in patients in whom the use of conventional topical corticosteroids therapy is deemed inadvisable because of potential risks or in patients who are not adequately responsive to or intolerant of conventional topical corticosteroids therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62c2bbfd-3f66-4f05-a673-a94237e513f0.json
62d13e77-6e83-49d6-8167-d69a636ef523,PIOGLITAZONE TEVA 15 MG,prescription,A10BG03,PIOGLITAZONE,8922,,,WHO ATC Classification,,ILS,tablets,PIOGLITAZONE AS HYDROCHLORIDE,2025-07-31T06:43:42.274716,IL,אינובמד,,88.18744374,74.73512514,55.5651488,,,PIOGLITAZONE TEVA 15 MG 30TAB,17475,,72746,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,165 40 36343 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Pioglitazone Teva is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.Pioglitazone Teva is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62d13e77-6e83-49d6-8167-d69a636ef523.json
62e60c04-5218-4b5d-b31a-73ba433ed87c,NEOTIGASON 10 MG,prescription,D05BB02,ACITRETIN,4541,,,WHO ATC Classification,,ILS,capsules,ACITRETIN,2025-07-31T05:42:37.184187,IL,טבע,,147.8727063,125.3158584,100.2526867,,5690528199024,NEOTIGASON 25MG 30CAPS,14485,,61639,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,100 62 28448 11,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Severe disorders of keratinization  such as erythrodermic psoriasis  local or generalized pustular psoriasis  congenital ichthyosis  pityriasis rubra pilaris  darier's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62e60c04-5218-4b5d-b31a-73ba433ed87c.json
62eb4646-1419-4615-94be-2904c90756e8,EBETAXEL 6 MG/ML,29C,L01CD01,PACLITAXEL,20815,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PACLITAXEL/ML,2025-07-31T13:58:42.677808,IL,nan,,nan,nan,nan,,,BETA PROGRANE 160MG  SR CAPS,,,,VIAL GLASS TYPE I,units,30.0,130 95 30965 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,,"Paclitaxel is indicated alone or in combination, for the treatment of advanced carcinoma of the ovary. For the treatment of metastatic breast cancer after failure of combination chemotherapy. Prior therapy should have included an anthracycline unless clinically containdicated. Paclitaxel is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. Advanced non small cell lung cancer: Paclitaxel associated with cisplatinum is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. Kaposis's sarcoma: Paclitaxel is indicated in the second-line treatment of AIDS related Kaposi's sarcoma",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62eb4646-1419-4615-94be-2904c90756e8.json
62fa202e-a74a-419a-b0cb-ee9743cf9f8e,ORFADIN 10 MG HARD CAPSULES,prescription,A16AX04,NITISINONE,6925,,,WHO ATC Classification,,ILS,"capsule, hard",NITISINONE,2025-07-31T06:15:57.251587,IL,מגאפארם,,5322.304479,4510.427525,4100.388659,,7350031443066,ORFADIN 5MG 60CAPS,15418,,38095,CONTAINER HDPE,units,60.0,147 27 33457 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT-1) in  combination with dietary restriction of tyrosine and phenylalanine05/06/2018 בקשה לשינוי משטר מינון Once Daily,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/62fa202e-a74a-419a-b0cb-ee9743cf9f8e.json
631d2110-18b6-4f0d-bc0a-e3cb1af47995,JARDIANCE 10 MG,prescription,A10BD19,LINAGLIPTIN AND EMPAGLIFLOZIN,7597,,,WHO ATC Classification,,ILS,film coated tablets,EMPAGLIFLOZIN,2025-07-31T04:18:04.791285,IL,בורינגר אינגלהיים,,215.7431282,182.8331676,146.2665341,,,JARDIANCE 25MG 30 F.C.TAB,10069,,18589,BLISTER PVC/ALUMINIUM,units,30.0,154 22 34202 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"JARDIANCE 10mg is indicated: •to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. •as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus •to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease•to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/631d2110-18b6-4f0d-bc0a-e3cb1af47995.json
63216bf5-d731-459c-8553-e20f27e1045b,CORTIMENT,prescription,A07EA06,BUDESONIDE,7870,,,WHO ATC Classification,,ILS,tablets prolonged release,BUDESONIDE,2025-07-31T01:30:43.027452,IL,פרינג,,476.2458108,403.5981627,343.487798,,,CORTIMENT 9MG 30 P.R.TAB,9916,,38490,BLISTER PVC/PA/ALUMINIUM,units,30.0,155 34 34254 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For induction of remission in patients with mild to moderate active ulcerative colitis (UC).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63216bf5-d731-459c-8553-e20f27e1045b.json
634447ed-e44e-46b9-a6fa-61eedc2338ec,PALOXI INJECTION,prescription,A04AA05,PALONOSETRON,8884,,,WHO ATC Classification,,ILS,solution for injection,PALONOSETRON AS HYDROCHLORIDE 0.25  MG/VIAL,2025-07-31T06:25:16.246342,IL,רפא,,301.718567,255.6937123,217.61167,,7290008012379,PALOXI 0.5MG 1 CAPSULES,,,901,VIAL GLASS TYPE I,units,1.0,134 84 31150 00,valid,17.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Paloxi is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/634447ed-e44e-46b9-a6fa-61eedc2338ec.json
6348733c-21f2-4997-9daa-926741445cf2,SUTENT 12.5 MG,prescription,L01XE04,SUNITINIB,6045,,,WHO ATC Classification,,ILS,capsules,SUNITINIB AS MALATE 12.5  MG,2025-07-31T08:53:18.684029,IL,פיזר,,2289.261918,1940.052559,1651.108561,,,SUTENT 12.5MG 28CAPS,19813,,75524,BLISTER PVC/ACLAR/ALUMINIUM,units,28.0,136 89 31430 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate.   Sutent is indicated for the treatment of advanced renal cell carcinoma.Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6348733c-21f2-4997-9daa-926741445cf2.json
635031c0-50b4-45db-819b-74050890bc26,CEFTAZIDINE PANPHARMA 2G 10VIALS,prescription,,,8216,,,,,ILS,injection,CEFTAZIDINE PANPHARMA 2G S,2025-07-31T19:01:21.863192,IL,פארמלוג'יק,,636.81945,539.6775,459.3,,,CEFTAZIDINE PANPHARMA 2G 10VIALS,,,66930,,units,10.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/635031c0-50b4-45db-819b-74050890bc26.json
6361e6d2-4a10-47b5-b0ac-dfd251e9940d,XOSPATA 40 MG,prescription,L01XE54,GILTERITINIB,8556,,,WHO ATC Classification,,ILS,film coated tablets,GILTERITINIB AS FUMARATE,2025-07-31T10:36:20.232091,IL,אסטלס,,83270.72448,70568.41371,64153.10338,,8718692511347,XOSPATA 40 MG 84 TAB,24108,,61811,BLISTER ALUMINIUM /ALUMINIUM,units,84.0,165 30 36203 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Xospata is indicated as monotherapy for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6361e6d2-4a10-47b5-b0ac-dfd251e9940d.json
63882c0d-da2d-4c9a-8c9a-e19a16974761,ZINC LOTION VITAMED,off-the-counter,D11AX12,PYRITHIONE ZINC,2926,,,WHO ATC Classification,,ILS,lotion,ZINC AS OXIDE/,2025-07-31T13:39:55.578364,IL,ויטאמד,,16.343,13.85,nan,,7290008083409,ZINC LOTION 100ML,26019,,,BOTTLE PET,units,100.0,064 83 28120 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,Relief of minor skin irritations.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63882c0d-da2d-4c9a-8c9a-e19a16974761.json
63900822-84fd-4b78-9bf0-edab4534e73b,SIFROL ER 1.5 MG,prescription,N04BC05,PRAMIPEXOLE,6830,,,WHO ATC Classification,,ILS,tablets extended release,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 1.5  MG,2025-07-31T08:10:37.110291,IL,בורינגר אינגלהיים,,145.598343,123.3884318,91.738611,,900698012513,SIFROL ER 1.5MG 30P.R TAB,9789,,3062,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,144 97 33090 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of signs and symptoms of idiopathic Parkinson's disease, as monotherapy or in combination with levodopa.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63900822-84fd-4b78-9bf0-edab4534e73b.json
63a184ea-541e-451c-a59c-339e4d70da56,VFEND 200 MG POWDER FOR SOLUTION FOR INFUSION,prescription,J02AC03,VORICONAZOLE,4608,,,WHO ATC Classification,,ILS,powder for solution for infusion,VORICONAZOLE/VIAL,2025-07-31T10:10:51.195578,IL,פיזר,,544.2867971,461.2599975,392.5617,,7680559450025,VFEND 50MG 14TAB,22083,,55086,VIAL GLASS TYPE I,units,14.0,126 71 30598 12,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of :- invasive aspergillosis  fluconazole-resistant serious invasive Candida infections (including C. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive  possibly life-threatening infections.   - Treatment of candidemia in non neutropenic patients.- Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63a184ea-541e-451c-a59c-339e4d70da56.json
63a2f527-7f89-42ff-a6ed-387c9eecec50,DESOREN EAR DROPS,prescription,S02CA06,DEXAMETHASONE AND ANTIINFECTIVES,2725,,,WHO ATC Classification,,ILS,drops,"POLYMYXIN B SULFATE/ML, DEXAMETHASONE AS SODIUM PHOSPHATE/ML, NEOMYCIN AS SULFATE/ML",2025-07-31T01:51:41.239418,IL,ויטאמד,,nan,nan,nan,,7-290008-068376,DESOREN EAR DRPS 5ML,4032,,8829,BOTTLE LDPE,units,5.0,060 83 27506 00,valid,nan,otic,1.4,20,,,,,,,,,,0,Prescription required,"For the treatment of superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63a2f527-7f89-42ff-a6ed-387c9eecec50.json
63ad23eb-a4e2-4abb-95d7-d38cbae50adf,ELAPRASE,prescription,A16AB09,IDURSULFASE,6834,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,IDURSULFASE/ML,2025-07-31T02:13:26.528737,IL,טקדה,,12027.76263,10193.01964,9266.381486,,7290008128100,ELAPRASE 2MG/ML VIAL 3ML,5527,,86190,VIAL GLASS TYPE I,units,1.0,138 94 31772 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Long term treatment of patients with Hunter syndrome (MPS II).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63ad23eb-a4e2-4abb-95d7-d38cbae50adf.json
63b31eca-018f-4a20-918f-8c182e3ffa47,L-THYROXINE SERB,prescription,H03AA01,LEVOTHYROXINE SODIUM,4685,,,WHO ATC Classification,,ILS,solution for injection/ concentrate for solution for infusion,LEVOTHYROXINE SODIUM 0.2  MG /,2025-07-31T04:45:25.479409,IL,אוניפארם,,44.81603184,37.979688,27.7224,,7290015863155,LEVO 500MG 5TAB,12305,,59321,AMPOULES GLASS TYPE I,units,5.0,165 27 35356 00,valid,37.0,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,•Myxedema coma•Replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63b31eca-018f-4a20-918f-8c182e3ffa47.json
63c3a937-cf43-4aa1-8fd2-82eb4f26f86d,VALGANCICLOVIR TEVA ®,prescription,J05AB14,VALGANCICLOVIR,8021,,,WHO ATC Classification,,ILS,film coated tablets,VALGANCICLOVIR AS HYDROCHLORIDE,2025-07-31T09:56:30.882047,IL,טבע,,4740.296779,4017.20066,3652.0006,,,VALGANCICLOVIR TEVA 450mg 60tab,,,73725,BLISTER PVC/ACLAR/PVC/ALUMINIUM,units,60.0,157 38 34391 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Valganciclovir Teva is indicated for the induction and maintenance treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). Valganciclovir Teva is indicated for the prevention of  CMV disease in CMV-negative patients who have received a solid organ transplant from a CMV-positive donor.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63c3a937-cf43-4aa1-8fd2-82eb4f26f86d.json
63d9eb40-dc96-44c4-a78c-a80d233ccad7,FANAPT TABLETS 1 MG,prescription,N05AX14,ILOPERIDONE,7156,,,WHO ATC Classification,,ILS,tablets,ILOPERIDONE,2025-07-31T02:53:35.138773,IL,מגאפארם,,nan,nan,nan,,7290014573062,FANAPT 12MG 60TAB,,,58459,BLISTER ALUMINIUM,units,60.0,148 32 33482 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,FANAPT is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63d9eb40-dc96-44c4-a78c-a80d233ccad7.json
63dcd535-c7a1-4a58-8652-c30028a28135,MILN-AVENIR 25 MG,prescription,N06AX17,MILNACIPRAN,9102,,,WHO ATC Classification,,ILS,capsules,MILNACIPRAN AS HYDROCHLORIDE,2025-07-31T05:24:10.208318,IL,ביואבניר,,61.42136603,52.05200742,37.994166,,,MILN-AVENIR 25 MG 56 CAPS,,,73068,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,169 70 36192 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63dcd535-c7a1-4a58-8652-c30028a28135.json
63de3219-3f2b-429a-ac1b-0e7aa17ac32d,DUPIXENT 200 MG,prescription,D11AH05,DUPILUMAB,8245,,,WHO ATC Classification,,ILS,solution for injection,DUPILUMAB/ML,2025-07-31T02:08:05.115706,IL,סאנופי אוונטיס,,5778.960936,4897.42474,4452.204309,,3664798045000,DUPIXENT 300MG/2ML 2 PREFILLED SYR 2ML,4678,,64842,PRE-FILLED PEN GLASS TYPE I,units,2.0,164 42 36128 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Atopic Dermatitis DUPIXENT is indicated for the treatment of treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids. Asthma DUPIXENT is indicated as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Limitation of Use: DUPIXENT is not indicated for the relief of acute bronchospasm or status asthmaticus.Eosinophilic EsophagitisDUPIXENT is indicated for the treatment of adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with eosinophilic esophagitis (EoE).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63de3219-3f2b-429a-ac1b-0e7aa17ac32d.json
63de5e93-271b-43e3-9f93-55e3e9ed7306,OMEGAVEN,prescription,B05BA02,FAT EMULSIONS,7996,,,WHO ATC Classification,,ILS,emulsion for infusion,"GLYCEROL 2.5 G /, PURIFIED EGG PHOSPHATIDE 1.2 G /, HIGHLY REFINED FISH OIL/",2025-07-31T06:06:57.705203,IL,ניאופרם,,3263.674609,2765.826063,2514.38733,,,OMEGAVEN 10*100ml,15399,,18402,VIAL GLASS TYPE II,units,10.0,123 18 30247 00,valid,10.0,i.v,1.4,18,,,,,,,,,,0,Prescription required,"Parenteral nutrition supplementation with long chain Omega-3-fatty acids, especially eicosapentaenoic and docosahexaenoic acids when oral or enternal nutrition is impossible, insufficient or contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63de5e93-271b-43e3-9f93-55e3e9ed7306.json
63fe6537-cbd9-482b-bb0b-b8394089231e,CUROSURF,prescription,,,6994,,,,,ILS,suspension,PHOSPHOLIPIDS FRACTION FROM PORCINE LUNG/ML,2025-07-31T01:36:42.983908,IL,טבע,,2097.887406,1777.870763,1513.0815,,7290000801940,CUROSURF 80MG/ML 1VIAL(1.5ML),,,61745,VIAL GLASS TYPE I,units,1.0,068 79 28250 00,valid,17.5,endotracheopulmonary instillation,1.4,18,,,,,,,,,,0,Prescription required,Treatment of preterm babies with respiratory distress syndrome (RDS). Prophylactic use in premature infants at high risk of RDS.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/63fe6537-cbd9-482b-bb0b-b8394089231e.json
6403add5-70ed-42be-83b9-59c8fa48a3de,EVISTA,prescription,G03XC01,RALOXIFENE,3618,,,WHO ATC Classification,,ILS,film coated tablets,RALOXIFENE HYDROCHLORIDE,2025-07-31T02:46:22.371695,IL,אלי לילי,,81.74691841,69.2770495,51.5071,,,EVISTA 60MG 28TAB,5116,,76523,BLISTER PVC/PE/PCTFE/AL,units,28.0,109 37 29234 05,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Evista is indicated for the treatment of osteoporosis in post menopausal women.   Evista is indicated for the prevention of osteoporosis in post menopausal women .  Evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis.  Evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6403add5-70ed-42be-83b9-59c8fa48a3de.json
64048065-ef27-489c-852a-67c3322abd73,LERCAPRESS 10,prescription,C08CA13,LERCANIDIPINE,6363,,,WHO ATC Classification,,ILS,film coated tablets,LERCANIDIPINE HYDROCHLORIDE,2025-07-31T04:40:43.116082,IL,אוניפארם,,33.40364414,28.308173,20.6629,,,LERCAPRESS 10MG 30 FC TAB,12419,,81286,BLISTER PVC/ALUMINIUM,units,30.0,141 51 31848 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Mild to moderate essential hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64048065-ef27-489c-852a-67c3322abd73.json
64049e9f-dfae-42f5-afa0-508d96d44caf,DICLECTIN  ®,prescription,R06AA09,DOXYLAMINE,7581,,,WHO ATC Classification,,ILS,tablets delayed release,"PYRIDOXINE (VIT B6) HYDROCHLORIDE, DOXYLAMINE SUCCINATE",2025-07-31T01:54:54.334359,IL,צמל,,534.6708412,453.1109025,385.6263,,7290013280657,DICLECTIN 100 DELAYED RELEASE TAB,4632,,80806,BOTTLE HDPE,units,100.0,153 11 34066 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Diclectin® is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64049e9f-dfae-42f5-afa0-508d96d44caf.json
640e9860-69f7-4413-8ea8-d8b49b59ccfc,NOVOEIGHT 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,8014,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,TUROCTOCOG ALFA/,2025-07-31T05:54:00.406809,IL,נובו נורדיסק,,787.7048571,667.5465188,568.1246968,,7290015659055,NOVOEIGHT 500 IU/4ML 1 VIAL,14617,,58047,VIAL GLASS TYPE I,units,1.0,154 52 34374 00,valid,17.5,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).NovoEight can be used for all age groups., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/640e9860-69f7-4413-8ea8-d8b49b59ccfc.json
6413a3cc-03bb-4362-b696-e91743abdda7,SUNITINIB TEVA  ® 12.5 MG,prescription,L01XE04,SUNITINIB,8977,,,WHO ATC Classification,,ILS,capsules,SUNITINIB AS BASE 12.5  MG,2025-07-31T08:51:52.255308,IL,טבע,,2296.220161,1945.949375,1769.044887,,7290106065529,SUNITINIB TEVA 12.5 MG 30CAPS,17530,,74038,BLISTER PVC/ACLAR/PVC/ALUMINIUM,units,30.0,163 78 35252 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sunitinib Teva is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to Imatinib Mesylate. Sunitinib Teva is indicated for the treatment of advanced renal cell carcinoma. Treatment of unresectable or metastatic,  well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6413a3cc-03bb-4362-b696-e91743abdda7.json
641d0143-f2b9-4eaa-ac62-7bd209b79508,FULVESTRANT TEVA,prescription,L02BA03,FULVESTRANT,8859,,,WHO ATC Classification,,ILS,solution for injection,FULVESTRANT/ML,2025-07-31T03:22:23.178217,IL,טבע,,973.4604421,824.9664764,702.0991288,,,FULVESTRANT TEVA 250MG/5ML 2 VIAL,,,67132,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,161 90 35053 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"MonotherapyFulvestrant Teva is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:* not previously treated with endocrine therapy,or* with disease relapse on or after adjuvant endocrine therapy, or* with disease progression on endocrine therapy.Combination TherapyFulvestrant Teva is indicated for the treatment of:- HR-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in men and postmenopausal women in combination with ribociclib as initial endocrine based therapy or following disease progression on endocrine therapy.- HR- positive, human epidermal  growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with palbociclib or abemaciclib in women with disease progression after endocrine therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/641d0143-f2b9-4eaa-ac62-7bd209b79508.json
642ab25f-d408-4f35-98c2-9c860da8b313,FRAGMIN 2500 I.U /0.2 ML,prescription,B01AB04,DALTEPARIN,6195,,,WHO ATC Classification,,ILS,solution for injection,DALTEPARIN SODIUM/ 0.2  ML,2025-07-31T03:20:24.996892,IL,פיזר,,268.9922334,227.95953,182.367624,,7290013592880,FRAGMIN 7500 IU/0.3ML 10 INJ,6418,,89274,SYRINGE GLASS TYPE I,units,10.0,123 11 26544 00,valid,25.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,Prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. Treatment of acute deep venous thrombosis and/or pulmonary embolism. Unstable coronary artery disease. Thromboprophylaxis in conjunction with surgery.   Prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency  respiratory insufficiency and severe infections.Cancer patients : Treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/642ab25f-d408-4f35-98c2-9c860da8b313.json
642c266c-48bd-41c9-b4cb-72dcdc8f9c99,BONJESTA,prescription,R06AA09,DOXYLAMINE,3532,,,WHO ATC Classification,,ILS,tablets extended release,"DOXYLAMINE SUCCINATE, PYRIDOXINE (VIT B6) HYDROCHLORIDE",2025-07-31T02:04:42.826209,IL,ויטאמד,,12.0145712,10.18184,7.432,,7290100819074,DOXY 100 MG 10 TAB,4060,,52769,BLISTER OPA/AL/PVC,units,10.0,167 52 36428 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,BONJESTA is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.Limitations of UseBONJESTA has not been studied in women with hyperemesis gravidarum.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/642c266c-48bd-41c9-b4cb-72dcdc8f9c99.json
642fb837-aee2-406b-b380-00412e6d2cff,TERAZOSIN TEVA ® 5 MG,prescription,G04CA03,TERAZOSIN,6173,,,WHO ATC Classification,,ILS,tablets,TERAZOSIN AS HYDROCHLORIDE DIHYDRATE,2025-07-31T09:13:56.799600,IL,טבע,,52.2186049,44.253055,32.3015,,7290102061365,TERAZOSIN TEVA 5MG 30TAB,20635,,89473,BLISTER PVDC/ALUMINIUM,units,30.0,138 82 31457 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia  (BPH). For mild to moderate hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/642fb837-aee2-406b-b380-00412e6d2cff.json
643a971c-f6a1-4a35-bff2-96899d97f11f,RECTOZORIN OINTMENT,off-the-counter,C05AX02,"BISMUTH PREPARATIONS, COMBINATIONS",1670,,,WHO ATC Classification,,ILS,ointment,"ZINC OXIDEW/W, BENZOCAINEW/W, MENTHOL 0.25 %W/W, BISMUTH OXYCHLORIDEW/W, THYMOL BIIODIDEW/W",2025-07-31T12:54:13.431162,IL,טבע,,32.0134,27.13,nan,,7290000802282,RECTOZORIN 12 SUPP,18174,,,TUBE ALUMINIUM,units,12.0,135 34 20466 00,valid,nan,topical annal,1.4,36,,,,,,,,,,0,,"Symptomatic relief of pain and discomfort in irritated anorectal tissues in: hemorrhoids, proctitis, papillitis, cryptitis, fissures and following anorectal surgery.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/643a971c-f6a1-4a35-bff2-96899d97f11f.json
644aec17-a99d-404a-86af-f966a4f6e82a,TADALAMED 10 MG,prescription,G04BE08,TADALAFIL,9319,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T19:34:01.927797,IL,אינובמד,,289.4992589,245.338355,208.7986,,,TADALAMED 10 MG 4 tabs,23571,,2921,BLISTER PVDC/PVC/PE // PAPER/PET/ALU,units,4.0,169 52 37026 99,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of Erectile dysfunction in adult men.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/644aec17-a99d-404a-86af-f966a4f6e82a.json
64525356-0d16-4f15-93a2-531a19e7d08b,CEFTRIAXONE-VIT,prescription,J01DD04,CEFTRIAXONE,8126,,,WHO ATC Classification,,ILS,powder for solution for injection,CEFTRIAXONE AS DISODIUM HEMIHEPTAHYDRATE 1.0 G/VIAL,2025-07-31T01:02:31.027398,IL,SK PHARM(KS KIM),,28.78129976,24.390932,17.8036,,7290015793087,CEFTRIAXONE S.K. 1GR 1 VIAL,10160,,77104,VIAL GLASS TYPE III,units,1.0,159 42 34699 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Ceftriaxone VIT  is indicated for the treatment of the following infections in adults andchildren including term neonates (from birth):-Bacterial Meningitis- Community acquired pneumonia-Hospital acquired pneumonia-Acute otitis media-Intra-abdominal infections-Complicated urinary tract infections (including pyelonephritis)-Infections of bones and joints-Complicated skin and soft tissue infections-Gonorrhoea-Syphilis-Bacterial endocarditisCeftriaxone VIT may be used:-  For treatment of acute exacerbations of chronic obstructive pulmonary diseasein adults- For treatment of disseminated Lyme borreliosis (early (stage II) and late (stageIII) in adults and children including neonates from 15 days of age.- For pre-operative prophylaxis of surgical site infections-In the management of neutropenic patients with fever that is suspected to be dueto a ceftriaxone – susceptible  bacterial infection- In the treatment of patients with bacteraemia that occurs in association with, oris suspected to be associated with, any of the infections listed aboveCeftriaxone VIT should be co-administered with other antibacterial agents whenever thepossible range of causative bacteria would not fall within its spectrum.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64525356-0d16-4f15-93a2-531a19e7d08b.json
6455b677-4af4-4ae4-ab45-389419bc2c66,INS.ACTRAPID HM 10ML,prescription,,,646,,,,,ILS,tablet,INS.ACTRAPID HM,2025-07-31T19:13:09.935972,IL,נובו נורדיסק,,78.11266305,66.19717502,49.2172305,,,INS.ACTRAPID HM 10ML,9039,,1073,,units,10.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6455b677-4af4-4ae4-ab45-389419bc2c66.json
6462f08c-a203-4ea5-b272-3de4ac235288,DEPIXOL 3MG TABS,29C,,,20944,,,,,,tablet,DEPIXOL 3MG TABS,2025-07-31T20:13:00.213053,IL,nan,,,,,,,DEPIXOL 3MG TABS,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6462f08c-a203-4ea5-b272-3de4ac235288.json
646691d7-8a15-4b03-9b6b-6801c8aab64e,NICOTINELL LOZENGES 1 MG,off-the-counter,,,3994,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:32:13.895489,IL,ג.ס.ק,,76.287,64.65,nan,,,NICOTINELL GUM MINT 4GR 48tab,14410,,,BLISTER PVC/PE/PVDC/AL,units,48.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/646691d7-8a15-4b03-9b6b-6801c8aab64e.json
6496b79d-4f6d-496e-87e2-11f28027a17d,SPIKEVAX,prescription,J07BX03,COVID-19 VACCINES,9321,,,WHO ATC Classification,,ILS,dispersion for injection,CX-024414 MRNA 1.26 MG/VIAL,2025-07-31T08:33:49.639153,IL,מדיסון,,8572.427091,7264.769045,6604.335495,,,SPIKEVAX 10 VIALS,,,,VIAL GLASS TYPE I,units,10.0,168 86 36765 00,valid,10.0,i.m,1.4,9,,,,,,,,,,0,Prescription required,Spikevax is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6496b79d-4f6d-496e-87e2-11f28027a17d.json
649c824f-f56d-4e36-97bd-908b00ae3713,ICHTHAMOL OINT 14GR,off-the-counter,,,3133,,,,,ILS,tablet,ICHTHAMOL OINT 14GR,2025-07-31T19:44:20.465202,IL,ויטאמד,,26.9748,22.86,,,,ICHTHAMOL OINT 14GR,9100,,,,units,14.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/649c824f-f56d-4e36-97bd-908b00ae3713.json
649f309b-6192-41af-a5ca-ad69149c0362,ROSETEMIB S.K. 10/10 MG,prescription,C10BA06,ROSUVASTATIN AND EZETIMIBE,9536,,,WHO ATC Classification,,ILS,film coated tablets,"EZETIMIBE, ROSUVASTATIN AS CALCIUM",2025-07-31T07:49:22.798512,IL,SK PHARM(KS KIM),,85.85511961,72.75857918,54.0955979,,,ROSETEMIB S.K. 10/10 MG 30 TAB,,,58761,BLISTER AL/OPA/AL/PVC,units,30.0,175 17 36803 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary Hypercholesterolaemia/Homozygous Familial Hypercholesterolaemia (HoFH):ROSETEMIB S.K is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/649f309b-6192-41af-a5ca-ad69149c0362.json
64a1502a-0837-42aa-8862-606fd91482c0,XADAGO 100 MG,prescription,N04BD03,SAFINAMIDE,8886,,,WHO ATC Classification,,ILS,film coated tablets,SAFINAMIDE AS METHANESULFONATE,2025-07-31T10:26:38.031109,IL,מדיסון,,411.5411514,348.7637032,296.8201729,,,XADAGO 100 MG 30 TAB,24096,,7118,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,164 64 35607 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Xadago is indicated for the treatment of adult patients with idiopathic Parkinson’s disease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64a1502a-0837-42aa-8862-606fd91482c0.json
64aebadf-4ccd-4452-88c1-e23fc8b6112f,REZOLSTA,prescription,J05AE10,DARUNAVIR,8674,,,WHO ATC Classification,,ILS,film coated tablets,"COBICISTATE, DARUNAVIR AS ETHANOLATE",2025-07-31T01:41:34.704039,IL,טבע,,1716.015502,1454.250425,1237.659936,,7290014577329,DARUNAVIR TEVA 600 MG 60 TAB,,,56604,BOTTLE HDPE,units,60.0,154 69 34386 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"REZOLSTA is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV 1) infection in treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions (V11i, V32i, L33F, i47V, i50V, i54L, i54M, T74P, L76V, i84V, L89V).שינוי משטר מינון 2/4/2019Pregnancy and postpartumTreatment with REZOLSTA during pregnancy results in low darunavir exposure (see sections 4.4 and 5.2). Therefore, therapy with REZOLSTA should not be initiated during pregnancy, and women who become pregnant during therapy with REZOLSTA should be switched to an alternative regimen, see section 4.4 and 4.6. Darunavir/ritonavir may be considered as an alternative.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64aebadf-4ccd-4452-88c1-e23fc8b6112f.json
64b18131-4ce1-4234-9c8f-845f955c19f2,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4549,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:23:03.917788,IL,מדיסון,,921.9430527,781.3077065,664.9427289,,8715131005863,ARANESP 30MCG 4 PREFILLED SYR 0.3ML,9483,,29743,PRE-FILLED PEN GLASS TYPE I,units,4.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64b18131-4ce1-4234-9c8f-845f955c19f2.json
64db8b2b-e340-4489-9351-c9a9e490f7c1,OSPOLOT,prescription,N03AX03,SULTIAME,2977,,,WHO ATC Classification,,ILS,film coated tablets,SULTHIAME,2025-07-31T06:18:04.969720,IL,מגאפארם,,269.8406423,228.6785206,182.9428165,,,OSPOLOT 200MG 50TAB,15071,,1589,BOTTLE GLASS TYPE III,units,50.0,066 04 28222 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of epilepsy in adults and in treatment of the so called focal benign epilepsy of children, when other medication was not adequate.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64db8b2b-e340-4489-9351-c9a9e490f7c1.json
64e2e371-7b97-4109-a34a-2090ffcb761f,LYRICA 100 MG,prescription,N03AX16,PREGABALIN,4880,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T05:01:43.542553,IL,דקסל פארמה,,200.1721025,169.637375,135.7099,,,LYRICA 300MG 56CAPS,12341,,65305,BLISTER PVC,units,56.0,133 01 31188 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,LLyrica is indicated for the:- Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia.- Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64e2e371-7b97-4109-a34a-2090ffcb761f.json
64ef153b-17e1-4205-8179-f56818c03552,ELIQUIS 2.5 MG,prescription,B01AF02,APIXABAN,7157,,,WHO ATC Classification,,ILS,film coated tablets,APIXABAN 2.5  MG,2025-07-31T02:15:38.629073,IL,פיזר,,270.2136389,228.9946194,194.8890378,,,ELIQUIS 5 MG 60 F.C.TAB,5563,,77583,BLISTER PVC/PVDC,units,60.0,148 31 33496 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age&#8805; 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class &#8805; II).Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/64ef153b-17e1-4205-8179-f56818c03552.json
6501556f-edbb-4d82-a47b-f5cdba0aec2f,DIPROGENTA OINTMENT,prescription,N/A,,1236,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS DIPROPIONATE 0.5  MG /, GENTAMICIN AS SULFATE/",2025-07-31T01:58:35.064640,IL,אורגנון,,26.532201,22.4849171,16.41234825,,72989722,DIPROGENTA CRM 15GR,4435,,8458,TUBE ALUMINIUM,units,15.0,134 12 23893 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of dermatosis complicated by secondary infection caused by organisms sensitive to Gentamicin,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6501556f-edbb-4d82-a47b-f5cdba0aec2f.json
650b555c-1334-403d-962c-486c7bf9db45,DITRIPENTAT 1G/5ML 5AMP,29C,,,20376,,,,,,injection,DITRIPENTAT 1G/,2025-07-31T20:16:50.688674,IL,nan,,,,,,,DITRIPENTAT 1G/5ML 5AMP,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/650b555c-1334-403d-962c-486c7bf9db45.json
65142b9d-dcf0-49a8-b951-d88208f48b43,HALOPER 0.5,prescription,N05AD01,HALOPERIDOL,7312,,,WHO ATC Classification,,ILS,tablets,HALOPERIDOL 0.5   MG,2025-07-31T03:42:26.341587,IL,כ.צ.ט,,72.197179,61.18405,45.49,,7290010038329,HALOPER 0.5MG 60TAB,8379,,29204,BLISTER PVC/ALUMINIUM,units,60.0,115 93 25918 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Management of psychotic disorders.  Control of tics and vocal utterances of Tourette's disorder in children.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65142b9d-dcf0-49a8-b951-d88208f48b43.json
65310a91-116b-414c-8463-c4a683beafa0,ENBREL 25 MG SOLUTION FOR INJECTION,prescription,L04AB01,ETANERCEPT,7549,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ML,2025-07-31T02:20:43.194455,IL,פיזר,,2418.646751,2049.700727,1863.364298,,,ENBREL 50MG SOL FOR INJ 4X1ML PREFILLED PEN MYCLIC,5570,,50125,SYRINGE PREFILLED  GLASS TYPE I,units,4.0,142 52 31949 00,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"* Rheumatoid arthritis:- Enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs)  including methotrexate (unless contraindicated)  has been inadequate..   Enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.  - Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.Enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.* Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Enbrel has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.   * Plaque psoriasis Treatment of adults patients (18 years or older) with moderate to severe plaque psoriasis  who  are candidates for systemic therapy or phototherapy.* Paediatric plaque psoriasis Treatment of chronic severe plaque psoriasis in children and adolescents from the age of  6 years  who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.* Juvenile idiopathic arthritis- Treatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. - Treatment of psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.Treatment of enthesitis-related arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, conventional therapy. Enbrel has not been studied in children aged less than 2 years.* Axial spondyloarthritis- Ankylosing spondylitis(AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.- Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to nonsteroidal anti-inflammatory drugs (NSAIDs)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65310a91-116b-414c-8463-c4a683beafa0.json
65469b06-5be9-4f33-a44d-4d50028e66e6,ZYPREXA 10 MG,prescription,N05AH03,OLANZAPINE,3355,,,WHO ATC Classification,,ILS,tablets,OLANZAPINE,2025-07-31T10:56:46.250586,IL,אלי לילי,,87.88597992,74.479644,55.3752,,,ZYPREXA 5MG 28TAB,26037,,9514,BLISTER ALUMINIUM,units,28.0,104 86 28859 21,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia.   Zyprexa is indicated for the management of the manifestations of psychotic disorders.   Zyprexa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment  Zyprexa is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65469b06-5be9-4f33-a44d-4d50028e66e6.json
6554b72c-cea3-43da-a50e-82f2886c195e,VENTOLIN DISKUS,prescription,R03AC02,SALBUTAMOL,290,,,WHO ATC Classification,,ILS,powder for inhalation,SALBUTAMOL AS SULFATE/DOSE,2025-07-31T10:05:56.690076,IL,ג.ס.ק,,22.97005337,19.46614779,14.208867,,7290008085410,VENTOLIN RESP. SOLUTION FOR INHALATION 20CC,22056,,2372,BLISTER LAMINATED,units,20.0,126 97 30674 00,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"Relief of bronchospasm in broncial asthma of all types, chronic, bronchitis and emphysema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6554b72c-cea3-43da-a50e-82f2886c195e.json
65582192-8c82-405b-999d-6306227b7999,NITYR ( NITISINONE) 2 MG 60TAB,prescription,,,8704,,,,,ILS,tablet,NITYR ( NITISINONE) 2 MG,2025-07-31T19:22:57.070941,IL,תרומד,,2647.102794,2243.307453,2039.370412,,,NITYR ( NITISINONE) 2 MG 60TAB,14686,,58130,,units,60.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65582192-8c82-405b-999d-6306227b7999.json
658f1bb6-a71a-40ba-b20b-6ddbdb9e66a9,ESOMEPRAZOLE INOVAMED 20 MG,prescription,A02BC05,ESOMEPRAZOLE,8394,,,WHO ATC Classification,,ILS,gastro resistant tablets,ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE,2025-07-31T02:36:24.065999,IL,אינובמד,,30.16187616,25.560912,18.6576,,,ESOMEPRAZOLE INOVAMED 20 MG 30 tab,5653,,36177,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,161 48 35207 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Esomeprazole Inovamed tablets are indicated  in adults for:Gastroesophageal Reflux Disease (GERD)-  treatment of erosive reflux esophagitis-  long-term management of patients with healed esophagitis to prevent relapse-  symptomatic treatment of gastroesophageal reflux disease (GERD)In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:- healing of Helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers.Patients requiring NSAID therapy- healing of gastric ulcers associated with NSAID therapy. - prevention of gastric and duodenal ulcers associated with NSAID therapy in    patients at risk.Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.Esomeprazole Inovamed 20 mg tablets are indicated in adolescents from the age of 12 years forGastroesophageal Reflux Disease (GERD)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophgeal reflux disease (GERD)In combination with antibiotics in treatment of duodenal ulcer caused by Helicobactor  pylori,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/658f1bb6-a71a-40ba-b20b-6ddbdb9e66a9.json
65985d19-7d8d-4b90-94e3-5498535ac62e,RODENAL 2 MG TBLETS,prescription,,,3399,,,,,ILS,tablets,TRIHEXYPHENIDYL HYDROCHLORIDE,2025-07-31T07:47:36.928102,IL,רקח,,16.00433929,13.563,9.9,,7290008089791,RODENAL 2MG 30TAB,18105,,9353,BLISTER PVC/ALUMINIUM,units,30.0,111 02 21626 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Rodenal tablet is an adjunct medicine in the therapy of all forms of Parkinsonism (postencephalitic, arteriosclerotic and idiopathic), It is also indicated to control extrapyramidal disorders  due to  central nervous system drugs such as phenothiazines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65985d19-7d8d-4b90-94e3-5498535ac62e.json
65ae883e-7244-444e-983e-86eee37eae1b,STRATTERA 4 MG/ML ORAL SOLUTION,prescription,N06BA09,ATOMOXETINE,7947,,,WHO ATC Classification,,ILS,solution  (oral),ATOMOXETINE/,2025-07-31T08:44:38.250803,IL,אלי לילי,,307.9986985,261.0158462,222.1411457,,7290016021059,STRATTERA 100MG 28 CAPS,9811,,71825,BOTTLE GLASS TYPE III,units,28.0,158 61 35026 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD. Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65ae883e-7244-444e-983e-86eee37eae1b.json
65b2f89f-c8bd-4ad9-82cf-8ad792819e0a,TOBREX OPHTHALMIC OINTMENT,prescription,S01AA12,TOBRAMYCIN,6848,,,WHO ATC Classification,,ILS,eye ointment,TOBRAMYCIN 0.3 %,2025-07-31T09:24:01.884403,IL,נוברטיס פארמה,,11.9467252,10.12434384,7.390032,,7290008067188,TOBREX 2X EYE DROPS 5ML,20433,,9874,TUBE ALUMINIUM,units,5.0,047 16 22795 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic for the treatment of eye infections caused by bacteria sensitive to Tobramycin.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65b2f89f-c8bd-4ad9-82cf-8ad792819e0a.json
65b7b14a-3222-427d-ab9a-ba5775bf213c,AZACITIDINE TEVA,prescription,L01BC07,AZACITIDINE,8426,,,WHO ATC Classification,,ILS,lyophilized powder for suspension for sc injection / solution for infusion,AZACITIDINE/VIAL,2025-07-31T00:27:45.374819,IL,טבע,,1789.972551,1516.925891,1291.000758,,7290110731618,AZACITIDINE TEVA 100 MG\VIAL,,,45713,VIAL GLASS TYPE I,units,1.0,162 19 35720 00,valid,17.5,"s.c, i.v",1.4,24,,,,,,,,,,0,Prescription required,"Azacitidine Teva is indicated for treatment of patients with the following French-American- British (FAB) myelodysplastic syndrome subtypes: refractory anemia (RA) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65b7b14a-3222-427d-ab9a-ba5775bf213c.json
65be41ac-6bd8-4957-acc6-0413d90c9af4,ADEMPAS 0.5 MG,prescription,C02KX05,RIOCIGUAT,7575,,,WHO ATC Classification,,ILS,film coated tablets,RIOCIGUAT 0.5  MG,2025-07-30T23:14:45.455404,IL,באייר,,4588.795159,3888.80963,3535.281482,,,ADEMPAS 2MG 42TAB,9872,,28791,BLISTER PP/ALUMINIUM,units,42.0,153 76 34132 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Chronic thromboembolic pulmonary hypertension (CTEPH) Adempas is indicated for the treatment of adult patients with WHO Functional Class (FC) II to III with	• inoperable CTEPH, • persistent or recurrent CTEPH after surgical treatment, to improve exercise capacity. Pulmonary arterial hypertension (PAH)Adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH) with WHO Functional Class (FC) II to III to improve exercise capacity.Efficacy has been shown in a PAH population including aetiologies of idiopathic or heritable PAH or PAH associated with connective tissue disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65be41ac-6bd8-4957-acc6-0413d90c9af4.json
65ca7065-2a44-4c74-b171-f9887c48a747,DALACIN 2 % VAGINAL CREAM,prescription,G01AA10,CLINDAMYCIN,4402,,,WHO ATC Classification,,ILS,cream,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T01:40:39.523564,IL,פיזר,,82.55213945,69.95944332,52.014456,,7298074000054,DALACIN VAGINAL 100MG 3 OVULES,4341,,4561,TUBE PLASTIC,units,3.0,064 17 27818 00,valid,34.5,vaginal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65ca7065-2a44-4c74-b171-f9887c48a747.json
65d34543-0319-4113-9b9d-03f512e40e61,TEMODAL 100 MG,prescription,L01AX03,TEMOZOLOMIDE,4194,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T09:11:51.373583,IL,מ.ס.ד. ישראל,,300.518329,254.67655,216.746,,7290008121972,TEMODAL 20MG 5CAP,20750,,38955,SACHET POLYETHYLENE,units,5.0,120 30 30116 23,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65d34543-0319-4113-9b9d-03f512e40e61.json
65dca4df-b9b7-4ef3-845b-8faeb0da608f,BORTEZOMIB TARO 3.5 MG,prescription,L01XX32,BORTEZOMIB,8472,,,WHO ATC Classification,,ILS,powder for solution for injection,BORTEZOMIB 3.5 MG/VIAL,2025-07-31T00:40:35.680322,IL,תרו יבוא,,5218.217134,4422.21791,4020.1981,,7290017164090,BORTEZOMIB TARO 3.5 MG  PWDR FOR INJ 1VIAL,,,89743,VIAL GLASS TYPE I,units,1.0,162 44 35830 00,valid,10.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Bortezomib is indicated for the treatment of patients with multiple myeloma.Bortezomib is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65dca4df-b9b7-4ef3-845b-8faeb0da608f.json
65e2f5e3-7dc9-441d-b172-2335f13df1ac,DAFLON 500MG film-coated tablets,29C,,,20828,,,,,,tablet,DAFLON 500MG film-coated tablets,2025-07-31T20:09:46.414017,IL,nan,,,,,,,DAFLON 500MG film-coated tablets,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65e2f5e3-7dc9-441d-b172-2335f13df1ac.json
65e3d142-d2c2-421e-aaec-5018e2c346ce,ESTROFEM 1 MG,prescription,G03CA03,ESTRADIOL,2694,,,WHO ATC Classification,,ILS,film coated tablets,ESTRADIOL AS HEMIHYDRATE,2025-07-31T02:38:51.121922,IL,נובו נורדיסק,,18.81673902,15.946389,11.6397,,7290008126410,ESTROFEM 2MG 28TAB,5075,,8782,DISPENSER PACK POLYPROPYLENE,units,28.0,117 54 29845 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women. Prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. Estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.The experience treating women older than 65 years is limited.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65e3d142-d2c2-421e-aaec-5018e2c346ce.json
65eedbbe-d52d-42e5-b140-e4ccd00f6a50,DERMOVATE OINTMENT,prescription,D07AD01,CLOBETASOL,8198,,,WHO ATC Classification,,ILS,ointment,CLOBETASOL 17- PROPIONATE 0.05 %W/W,2025-07-31T01:49:13.672686,IL,ג.ס.ק,,19.90810568,16.871276,12.3148,,7290008086127,DERMOVATE CREAM 30GR,4691,,25765,TUBE ALUMINIUM,units,30.0,027 57 22063 00,valid,37.0,topical,1.4,24,,,,,,,,,,0,Prescription required,"Clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. These include the following:• Psoriasis (excluding widespread plaque psoriasis)• Recalcitrant dermatoses  •Lichen planus• Discoid lupus erythematosus • Other skin conditions which do not respond satisfactorily to less potent steroids.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65eedbbe-d52d-42e5-b140-e4ccd00f6a50.json
65fde652-8fdd-4d14-90dd-94e139195605,SOLIFENACIN TRIMA 10,prescription,G04BD08,SOLIFENACIN,7515,,,WHO ATC Classification,,ILS,tablets,SOLIFENACIN SUCCINATE,2025-07-31T08:27:31.920040,IL,תרימה,,164.87196,139.722,111.7776,,7290000843889,SOLIFENACIN TRIMA 5MG 30TAB,9813,,71844,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,152 33 33869 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/65fde652-8fdd-4d14-90dd-94e139195605.json
66001094-00c2-47a9-b911-954c3816e2f8,MINULET,prescription,G03CA01,ETHINYLESTRADIOL,370,,,WHO ATC Classification,,ILS,tablets,"GESTODENE 0.075  MG, ETHINYLESTRADIOL 0.030  MG",2025-07-31T05:26:47.566375,IL,פיזר,,22.5750107,19.131365,13.9645,,,MINULET 1X21TAB,13450,,29927,BLISTER PVC/ALUMINIUM,units,21.0,050 50 25757 06,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraception.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/66001094-00c2-47a9-b911-954c3816e2f8.json
660ba3fe-41fe-4c0b-8299-5441fe765cee,MOVEX TABLETS,off-the-counter,R05CB02,BROMHEXINE,2962,,,WHO ATC Classification,,ILS,tablets,BROMHEXINE HYDROCHLORIDE,2025-07-31T12:26:35.992008,IL,ויטאמד,,24.0838,20.41,nan,,7290008068345,MOVEX 8MG 20TAB,13079,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,124 50 27560 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Mucolitic expectorant in conditions associated with the retention of viscid mucoid secretion in the respiratory tract e.g.: bronchitis asthma and sinusitis,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/660ba3fe-41fe-4c0b-8299-5441fe765cee.json
6619c0d9-9d2d-42f2-b077-b773e2bcca87,ZINACEF 750 MG,prescription,J01DC02,CEFUROXIME,3410,,,WHO ATC Classification,,ILS,powder for solution or suspension for injection or infusion,CEFUROXIME AS SODIUM/VIAL,2025-07-31T10:48:26.287956,IL,סנדוז,,72.57205202,61.501739,45.7262,,7290008086257,ZINACEF INJ 750MGX5,26012,,9575,VIAL GLASS TYPE I,units,5.0,042 53 23790 00,valid,34.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Therapeutic indications Zinacef is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth)• Community acquired pneumonia• Acute exacerbations of chronic bronchitis• Complicated urinary tract infections, including pyelonephritis• Soft-tissue infections: cellulitis, erysipelas and wound infections• Intra-abdominal infections • Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section) • nose infections for example, sinusitis • septic arthritis",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6619c0d9-9d2d-42f2-b077-b773e2bcca87.json
661d8acc-32ed-4629-b61a-9d74c735fdaa,FULPHILA,prescription,L03AA13,PEGFILGRASTIM,8639,,,WHO ATC Classification,,ILS,solution for injection,PEGFILGRASTIM/ML,2025-07-31T03:21:28.551807,IL,דקסל פארמה,,2716.455979,2302.08144,2092.801309,,7290015912693,FULPHILA 6MG/0.6ML PRE-FILED SYR,6633,,28673,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,164 12 35791 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy, given at intervals of 14 days or more, for malignancy. ( with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/661d8acc-32ed-4629-b61a-9d74c735fdaa.json
6627b528-6a56-4dbf-8a22-40abb140f7e8,SAPHRIS 10 MG,prescription,N05AH05,ASENAPINE,6837,,,WHO ATC Classification,,ILS,tablets sublingual,ASENAPINE AS MALEATE,2025-07-31T08:00:54.864601,IL,מ.ס.ד. ישראל,,213.8363455,181.21725,144.9738,,,SAPHRIS 5MG 20 SUBLINGUAL TAB,,,,BLISTER ALUMINIUM,units,20.0,146 05 33229 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Schizophrenia SAPHRIS is indicated for the treatment of schizophrenia in adults. The efficacy of SAPHRIS was established in two 6-week trials and one maintenance trial in adults Bipolar Disorder Monotherapy: SAPHRIS is indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder. Efficacy was established in two 3-week monotherapy trials in adults Adjunctive Therapy: SAPHRIS is indicated as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder. Efficacy was established in one 3-week adjunctive trial in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6627b528-6a56-4dbf-8a22-40abb140f7e8.json
662bc5b1-7822-4769-b183-12fdeeb7f7a9,PARAMOL,off-the-counter,N02BE01,PARACETAMOL,5444,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T12:44:45.206028,IL,ליף-דקסון,,14.2308,12.06,nan,,,PARAMOL 500MG 20 TAB,,,,BLISTER PVC/ALUMINIUM,units,20.0,127 96 30764 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/662bc5b1-7822-4769-b183-12fdeeb7f7a9.json
66347896-0767-409e-8016-2d233f4c7d1f,VOLTAREN EMULGEL 1%,off-the-counter,M02AA15,DICLOFENAC,5528,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T13:37:47.501725,IL,ג.ס.ק,,133.1276,112.82,nan,,,VOLTAREN EMULGEL FORTE 2% 150GR,,,,TUBE ALUMINIUM,units,150.0,037 66 25000 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to:  • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :• Pain caused by osteoarthrosis of the peripheral joints,  as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/66347896-0767-409e-8016-2d233f4c7d1f.json
6635f7ba-0c87-4ce4-a7c3-9cb6b4fe176a,OXYCONTIN 10,prescription,N02AA05,OXYCODONE,3688,,,WHO ATC Classification,,ILS,tablets controlled release,OXYCODONE HYDROCHLORIDE,2025-07-31T06:22:17.863614,IL,רפא,,105.6050596,89.49581723,66.53964107,,7290008014373,OXYCONTIN 80MG 20TAB,15103,,35563,BLISTER PVC/ALUMINIUM,units,20.0,100 71 28431 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,For the relief of moderate to severe chronic pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6635f7ba-0c87-4ce4-a7c3-9cb6b4fe176a.json
6638c0b6-b6ac-432e-a5c2-505c5d6ee566,CABOMETYX 20 MG,prescription,L01XE26,CABOZANTINIB,8114,,,WHO ATC Classification,,ILS,film coated tablets,CABOZANTINIB AS (S) MALATE,2025-07-31T00:49:08.920067,IL,מדיסון,,21894.46497,18554.63215,16867.84741,,7290015666565,CABOMETYX 60 MG 30 FC TABLETS,10145,,64851,BOTTLE HDPE,units,30.0,160 99 35263 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Renal Cell Carcinoma (RCC)Cabometyx is indicated as monotherapy for advanced renal cell carcinoma- as first-line treatment of adult patients with intermediate or poor risk, per IMDC criteria.- in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy.Cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults.Hepatocellular Carcinoma (HCC)Cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (HCC), in adults with Child-Pugh Class A hepatic impairment who have previously been treated with sorafenib.Differentiated thyroid carcinoma (DTC)Cabometyx is indicated as monotherapy for the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma (DTC), refractory or not eligible to radioactive iodine (RAI) who have progressed during or after prior systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6638c0b6-b6ac-432e-a5c2-505c5d6ee566.json
664989bf-b477-439c-9722-45ca7c04f02b,YENTREVE 20 MG,prescription,N06AX21,DULOXETINE,4892,,,WHO ATC Classification,,ILS,capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T10:41:04.701611,IL,אלי לילי,,219.5267305,186.0396104,148.8316883,,7290008139618,YENTREVE 40MG 56CAPS,25011,,66603,BLISTER PVC/PE/PCTFE/AL,units,56.0,132 68 31140 12,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Yentreve is indicated for women for the treatment of moderate to severe Stress Urinary Incontinence (SUI).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/664989bf-b477-439c-9722-45ca7c04f02b.json
66547693-d695-4de4-ba65-2760e1a478bb,ISUPREL 0.2MG/ML 25AMPX1ML,29C,,,20472,,,,,,injection,ISUPREL 0.2MG/ML X,2025-07-31T20:42:43.359854,IL,nan,,,,,,,ISUPREL 0.2MG/ML 25AMPX1ML,,,,,units,25.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/66547693-d695-4de4-ba65-2760e1a478bb.json
6667ab0f-9a97-4840-8ed8-e38e5c840750,ROSETEMIB S.K. 40/10 MG,prescription,C10BA06,ROSUVASTATIN AND EZETIMIBE,9538,,,WHO ATC Classification,,ILS,film coated tablets,"EZETIMIBE, ROSUVASTATIN AS CALCIUM",2025-07-31T07:49:46.895792,IL,SK PHARM(KS KIM),,103.139369,87.40624882,64.9860586,,,ROSETEMIB S.K. 40/10 MG 30 TAB,,,,BLISTER AL/OPA/AL/PVC,units,30.0,175 19 36805 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary Hypercholesterolaemia/Homozygous Familial Hypercholesterolaemia (HoFH):ROSETEMIB S.K is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6667ab0f-9a97-4840-8ed8-e38e5c840750.json
6673cb0a-e1e7-4f7f-8f64-f47c7c4cae07,ACTOS 15 MG,prescription,A10BG03,PIOGLITAZONE,7091,,,WHO ATC Classification,,ILS,tablets,PIOGLITAZONE AS HYDROCHLORIDE,2025-07-30T23:13:34.287368,IL,צמל,,82.30828082,69.75278346,51.86080555,,,ACTOS 15MG 28TAB,9526,,33609,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,149 69 33828 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6673cb0a-e1e7-4f7f-8f64-f47c7c4cae07.json
669b0c0a-5162-4a36-8c7b-0366ebe48564,AZITHROMYCIN MBI 500 MG/VIAL,prescription,J01FA10,AZITHROMYCIN,8949,,,WHO ATC Classification,,ILS,powder for solution for infusion,AZITHROMYCIN AS DIHYDRATE,2025-07-30T23:33:19.571739,IL,אמ.בי.איי פארמה,,57.75413429,48.9441816,35.72568,,7290017585246,AZITHROMYCIN MBI 500 MG/VIAL 1 VIAL,,,84874,VIAL GLASS TYPE I,units,1.0,160 66 35164 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/669b0c0a-5162-4a36-8c7b-0366ebe48564.json
66be9e8e-bf42-4607-af7f-5a6066907fc5,LUSTRAL TABLETS 100 MG,prescription,N06AB06,SERTRALINE,4273,,,WHO ATC Classification,,ILS,film coated tablets,SERTRALINE AS HYDROCHLORIDE,2025-07-31T04:59:42.611752,IL,דקסל פארמה,,43.28349504,36.680928,26.7744,,,LUSTRAL 100MG 28TAB,12372,,69744,BLISTER PVC/ALUMINIUM,units,28.0,120 52 27481 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"For the treatment of symptoms of depression in patients with or without a history of mania. Following satisfactory response, continuation with sertraline therapy is effective in prevention relapse of the initial episode of depression or recurrence of further depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/66be9e8e-bf42-4607-af7f-5a6066907fc5.json
66bfe409-481f-46ea-8a81-5a7d481ff105,ANAFRANIL SR 75 MG TABLETS,prescription,N06AA04,CLOMIPRAMINE,3534,,,WHO ATC Classification,,ILS,tablets slow release,CLOMIPRAMINE HYDROCHLORIDE,2025-07-30T23:23:25.478528,IL,צמל,,27.0311686,22.90777,16.721,,7298087000065,ANAFRANIL SR 75MG 20TAB,1868,,8402,BLISTER PVC/ALUMINIUM,units,20.0,053 91 26407 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Adults:Depression of varying originObsessive-compulsive syndromesChildren and adolescents (5-18 years old):Obsessive-compulsive syndromes,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/66bfe409-481f-46ea-8a81-5a7d481ff105.json
66d35245-5a82-4fed-b2a4-9f076f03d3fb,ERLOTINIB TARO 100 MG,prescription,L01XE03,ERLOTINIB,9406,,,WHO ATC Classification,,ILS,film coated tablets,ERLOTINIB AS HYDROCHLORIDE,2025-07-31T02:34:31.428302,IL,תרו,,3850.25639,3262.929289,2966.299354,,7290017164458,ERLOTINIB TARO 150 MG 30 TABS,,,15996,BLISTER OPA/ALU/PVC/ALU,units,30.0,168 92 35954 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Non-Small Cell Lung Cancer (NSCLC): Erlotinib Taro is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations. Erlotinib Taro is indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations and stable disease after first-line chemotherapy. Erlotinib Taro is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.Pancreatic cancer: Erlotinib Taro is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/66d35245-5a82-4fed-b2a4-9f076f03d3fb.json
66f1a2af-749d-4123-90e2-853441606d2d,MUCOLESS SOLUTION,off-the-counter,R05CB02,BROMHEXINE,5424,,,WHO ATC Classification,,ILS,solution,BROMHEXINE HYDROCHLORIDE/ML,2025-07-31T12:27:03.634823,IL,מכבי קאר,,17.5938,14.91,nan,,7290008082648,MUCOLESS 8MG 20TAB,,,,BOTTLE GLASS TYPE III,units,20.0,135 11 31423 00,valid,nan,"per os, inhalation",1.4,36,,,,,,,,,,0,,Bronchial mucolytic. It can also be given by inhalation as an aerosol solution.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/66f1a2af-749d-4123-90e2-853441606d2d.json
66f7a6d4-abef-4a7a-8d56-eeb0e2919dbc,LENVIMA 10 MG,prescription,L01XE29,LENVATINIB,7825,,,WHO ATC Classification,,ILS,"capsule, hard",LENVATINIB AS MESILATE,2025-07-31T04:39:26.617441,IL,אסיי,,7285.41632,6174.081901,5612.801729,,5036519001691,LENVIMA 10 MG 30CAPS,12519,,32837,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,155 37 34530 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"LENVIMA is indicated for the treatment of adult patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma (DTC), refractory to radioactive iodine (RAI).LENVIMA is indicated in combination with everolimus for the treatment of adult patients with advanced clear cell renal cell carcinoma (RCC) following one prior vascular endothelial growth factor (VEGF)-targeted therapy.LENVIMA is indicated as monotherapy for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have received no prior systemic therapy.Lenvima, in combination with pembrolizumab, is indicated for the treatment of adult patients with advanced or recurrent endometrial carcinoma who have disease progression on or following prior treatment with a platinum containing therapy and who are not candidates for curative surgery or radiation.LENVIMA is indicated in combination with pembrolizumab for the first-line treatment of adult patients with advanced RCC.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/66f7a6d4-abef-4a7a-8d56-eeb0e2919dbc.json
6709b6e9-b1ed-4ba1-975f-aa61cb42ee0c,XIGDUO XR 10 MG/1000 MG,prescription,A10BD15,METFORMIN AND DAPAGLIFLOZIN,7935,,,WHO ATC Classification,,ILS,tablets extended release,"METFORMIN HYDROCHLORIDE 1005.04  MG, DAPAGLIFLOZIN PROPANEDIOL 12.30  MG",2025-07-31T10:35:13.417257,IL,אסטראזנקה,,nan,nan,nan,,,XIGDUO XR 10 MG/1000 MG 28 E.R TAB,24091,,43969,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,155 69 34428 01,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6709b6e9-b1ed-4ba1-975f-aa61cb42ee0c.json
671b59bf-e17d-4d4b-853d-c4ac9912f391,LORATRIM,off-the-counter,R06AX13,LORATADINE,5054,,,WHO ATC Classification,,ILS,syrup,LORATADINE 0.1 G /,2025-07-31T12:23:09.612953,IL,תרימה,,31.801,26.95,nan,,7290008075787,LORATRIM SYR 120ML,12219,,,BOTTLE GLASS TYPE III,units,120.0,125 79 30442 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antihistamine preparation for treatment of allergic rhinitis and urticaria.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/671b59bf-e17d-4d4b-853d-c4ac9912f391.json
674df04b-3cd3-4f64-ae6f-f668bc797d46,DECITABINE S.K,prescription,L01BC08,DECITABINE,8735,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,DECITABINE/VIAL,2025-07-31T01:44:51.052757,IL,SK PHARM(KS KIM),,5009.994634,4245.758164,3859.780149,,7290016845419,DECITABINE S.K 50 MG/VIAL 1 VIAL 20 ML,4712,,59391,VIAL GLASS TYPE I,units,1.0,165 59 36259 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Decitabine s.k.  is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and Intermediate-1, Intermediate-2 and High-Risk International Prognostic Scoring System groups. Decitabine s.k.  is indicated for the treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/674df04b-3cd3-4f64-ae6f-f668bc797d46.json
678cc2b9-c5cb-4fa8-bca0-182fc52f6a9f,INVEGA 3 MG,prescription,N05AX13,PALIPERIDONE,6190,,,WHO ATC Classification,,ILS,tablets extended release,PALIPERIDONE,2025-07-31T04:11:03.143531,IL,יאנסן סילג,,204.9872544,173.7180199,138.9744159,,7290008099356,INVEGA 6MG 28TAB,9259,,86204,BLISTER OPA/ALU/PVC/ALU,units,28.0,139 15 31639 01,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Invega is indicated for :-treatment of schizophrenia in adults and adolescents (12-17 years).-treatment of schizoaffective disorder in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/678cc2b9-c5cb-4fa8-bca0-182fc52f6a9f.json
6791a519-9085-4e01-a972-d3c9844587b0,VIEPAX 37.5,prescription,N06AX16,VENLAFAXINE,4736,,,WHO ATC Classification,,ILS,tablets,VENLAFAXINE AS HYDROCHLORIDE 37.5   MG,2025-07-31T10:14:04.438307,IL,דקסל פארמה,,25.28556392,21.428444,15.6412,,,VIEPAX 37.5MG 28TAB,22245,,60616,BLISTER ACLAR COATED PVC/ALUMINIUM,units,28.0,130 68 31015 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of depression.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6791a519-9085-4e01-a972-d3c9844587b0.json
6796bfa8-87cd-41f7-ac0d-e9a49b08a722,DEFITELIO,prescription,B01AX01,DEFIBROTIDE,7580,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DEFIBROTIDE/,2025-07-31T01:45:54.699983,IL,מדיסון,,22288.09937,18888.22064,17171.10967,,7290015666046,DEFITELIO 200MG/2.5ML 10VIALX2.5ML,4571,,35014,VIAL GLASS TYPE I,units,10.0,153 84 34276 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Defitelio is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstructive syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy.It is indicated in adults and in adolescents, children and infants over 1 month of age .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6796bfa8-87cd-41f7-ac0d-e9a49b08a722.json
679e03aa-ee3f-4d7e-874f-a9d4e212e997,INOVELON 100 MG TABLETS,prescription,N03AF03,RUFINAMIDE,6670,,,WHO ATC Classification,,ILS,film coated tablets,RUFINAMIDE,2025-07-31T04:06:32.645324,IL,אסיי,,339.582297,287.7816204,244.920528,,5036519000519,INOVELON 200 MG 60TAB,9420,,25918,BLISTER PA/ALUMINIUM/PVC,units,60.0,145 35 33202 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Inovelon is indicated as adjunctive therapy in the treatment of seizures associated with Lennox Gastaut syndrome in patients 1 year of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/679e03aa-ee3f-4d7e-874f-a9d4e212e997.json
67e3f8db-405b-440b-a75e-9cd039525e56,COSMEGEN 0.5MG 1VIAL,29C,,,20340,,,,,,injection,COSMEGEN 0.5MG,2025-07-31T20:08:08.677212,IL,nan,,,,,,,COSMEGEN 0.5MG 1VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/67e3f8db-405b-440b-a75e-9cd039525e56.json
67f41025-80df-4bf4-a529-9ae94c52ac94,BALVERSA 3 MG,prescription,L01EX16,ERDAFITINIB,8490,,,WHO ATC Classification,,ILS,film coated tablets,ERDAFITINIB,2025-07-30T23:34:08.672645,IL,יאנסן סילג,,nan,nan,nan,,7290014577572,BALVERSA 4 MG 28 TAB,2747,,431,BOTTLE HDPE,units,28.0,165 77 36132 00,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,"BALVERSA is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has:- Susceptible FGFR3 or FGFR2 genetiic alterations, and- Progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/67f41025-80df-4bf4-a529-9ae94c52ac94.json
67f8c772-3a36-46f6-ba82-83053cdab0c2,ERLOTINIB TARO 100 MG,prescription,L01XE03,ERLOTINIB,9405,,,WHO ATC Classification,,ILS,film coated tablets,ERLOTINIB AS HYDROCHLORIDE,2025-07-31T02:34:20.756211,IL,תרו,,3176.992665,2692.366785,2447.606169,,7290017164458,ERLOTINIB TARO 100 MG 30 TAB,,,16003,BLISTER OPA/ALU/PVC/ALU,units,30.0,168 92 35954 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Non-Small Cell Lung Cancer (NSCLC): Erlotinib Taro is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations. Erlotinib Taro is indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations and stable disease after first-line chemotherapy. Erlotinib Taro is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.Pancreatic cancer: Erlotinib Taro is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/67f8c772-3a36-46f6-ba82-83053cdab0c2.json
67faf448-433a-4f6e-a40d-e7ea4e4e7522,ICLUSIG 15 MG,prescription,L01XE24,PONATINIB,8451,,,WHO ATC Classification,,ILS,coated tablets,PONATINIB AS HYDROCHLORIDE,2025-07-31T03:56:26.949306,IL,מדיסון,,23878.73323,20236.2155,18396.55954,,,ICLUSIG 30 MG 30 TAB,17205,,66849,BOTTLE HDPE,units,30.0,153 53 34243 02,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Iclusig is indicated in adult patients with:  • chronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (CML) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the T315I mutation  • Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the T315I mutation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/67faf448-433a-4f6e-a40d-e7ea4e4e7522.json
67fc1b07-4698-4d1b-971a-b14440cadd0c,TECVAYLI 10 MG/ML,prescription,,,9488,,,,,ILS,solution for injection,TECLISTAMAB/,2025-07-31T09:09:16.516936,IL,יאנסן סילג,,3803.24515,3223.089253,2930.081139,,,TECVAYLI 10 MG/ML 1 VIAL 3 ML,,,41024,VIAL GLASS TYPE I,units,1.0,173 74 37566 00,valid,10.0,s.c,1.4,18,,,,,,,,,,0,Prescription required,"TECVAYLI is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and have demonstrated disease progression on the last therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/67fc1b07-4698-4d1b-971a-b14440cadd0c.json
67feacfb-57ee-4bed-bee0-36a14eb4bcf8,IMITREX INJECTION,prescription,N02CC01,SUMATRIPTAN,270,,,WHO ATC Classification,,ILS,solution for injection,SUMATRIPTAN AS SUCCINATE/ 0.5  ML,2025-07-31T04:01:38.641043,IL,ג.ס.ק,,75.50294959,63.9855505,47.5729,,7290008085953,IMITREX 100MG 6TAB,9185,,8417,SYRINGE PREFILLED  GLASS TYPE I,units,6.0,055 92 26920 00,valid,34.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache.Imitrex should only be used where there is a clear diagnosis of migraine or cluster headache.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/67feacfb-57ee-4bed-bee0-36a14eb4bcf8.json
680ae938-10ba-430a-911d-4e505fe712a1,SCEMBLIX 20 MG,prescription,L01EA06,ASCIMINIB,9248,,,WHO ATC Classification,,ILS,film coated tablets,ASCIMINIB AS HYDROCHLORIDE,2025-07-31T08:01:54.922610,IL,נוברטיס פארמה,,21912.92454,18570.27586,16882.06896,,,SCEMBLIX 40 MG 60 TABS,23307,,46712,BLISTER PVC/PCTFE/AL,units,60.0,172 84 37483 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"SCEMBLIX is indicated for the treatment of adult patients with:• Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs).• Ph+ CML in CP with the T315I mutation",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/680ae938-10ba-430a-911d-4e505fe712a1.json
682740e8-1992-4774-b2be-57d81ea5c7c1,FUROSEMIDE INOVAMED,prescription,C03CA01,FUROSEMIDE,9372,,,WHO ATC Classification,,ILS,tablets,FUROSEMIDE,2025-07-31T03:23:01.956927,IL,אינובמד,,15.03438,12.741,9.3,,7290104531156,FUROSEMIDE INOVAMED 40 MG 30 TAB,6675,,10734,BLISTER PVC/ALUMINIUM,units,30.0,174 14 36620 99,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Adjunctive therapy in acute pulmonary edema. Treatment of hypertension.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/682740e8-1992-4774-b2be-57d81ea5c7c1.json
6829762e-43e5-4ecc-8b90-670d5496e766,RIZALT 10 MG TABLETS,prescription,N02CC04,RIZATRIPTAN,3830,,,WHO ATC Classification,,ILS,tablets,RIZATRIPTAN AS BENZOATE,2025-07-31T07:46:29.834891,IL,אורגנון,,83.57700342,70.827969,52.6602,,,RIZALT 10MG 6TAB,18273,,9760,BLISTER PVC/ALUMINIUM,units,6.0,112 36 29508 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6829762e-43e5-4ecc-8b90-670d5496e766.json
68408222-70a0-461d-b1d7-abfa17e5f1aa,IMFINZI,prescription,L01XC28,DURVALUMAB,8292,,,WHO ATC Classification,,ILS,solution for infusion,DURVALUMAB/ML,2025-07-31T04:01:27.562189,IL,אסטראזנקה,,11705.40534,9919.835473,9018.032248,,7290013075703,IMFINZI 500 MG/10 ML 1 VIAL,10308,,5277,VIAL GLASS TYPE I,units,1.0,159 97 35280 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Urothelial CarcinomaIMFINZI is indicated for the treatment of patients with PD-L1 high (Tumor cell &#8805;25% or IC &#8805;25%) locally advanced or metastatic urothelial carcinoma who: - have disease progression during or following platinum-containing chemotherapy. - have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum containing chemotherapy. Non-Small Cell Lung Cancer - IMFINZI is indicated for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. - IMFINZI in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic NSCLC with no sensitising EGFR mutations or ALK positive mutations. Small Cell Lung Cancer- IMFINZI, in combination with etoposide and either carboplatin or cisplatin, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).- IMFINZI, as a single agent, is indicated for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy (cCRT).Biliary Tract Cancers IMFINZI in combination with gemcitabine and cisplatin is indicated for the first-line treatment of adults with locally advanced, unresectable, or metastatic biliary tract cancer (BTC). Hepatocellular CarcinomaIMFINZI in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (HCC).Endometrial CancerIMFINZI in combination with carboplatin and paclitaxel followed by Imfinzi as a single agent, for the treatment of adult patients with primary advanced or recurrent endometrial cancer that is mismatch repair deficient (dMMR).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68408222-70a0-461d-b1d7-abfa17e5f1aa.json
6841288f-3d27-4117-be89-ddcbbd364569,BRILINTA 60 MG,prescription,B01AC24,TICAGRELOR,7933,,,WHO ATC Classification,,ILS,film coated tablets,TICAGRELOR,2025-07-30T23:43:05.017487,IL,אסטראזנקה,,297.15573,251.826901,214.3207668,,,BRILINTA 60 MG 56 TAB,2603,,53183,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,156 54 34752 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Brilinta, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event (see sections 4.2 and 5.1).Limitations of use:  90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6841288f-3d27-4117-be89-ddcbbd364569.json
6847a9c1-d253-4b82-b5b3-e28e3d0e3495,"VINORELBIN ""EBEWE"" 10 MG/ML",prescription,N/A,,7969,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,VINORELBINE AS TARTRATE/ML,2025-07-31T10:17:02.188678,IL,סנדוז,,96.01018611,81.3645645,60.4941,,,VINORELBIN EBEWE 10 MG/ML 1 vial,22276,,71241,VIAL GLASS,units,1.0,136 44 31351 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of non small cell lung cancer. For the treatment of advanced breast cancer. Hormone- refractory prostate cancer, especially in combination with low dose oral corticoid therapy or Estramustin.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6847a9c1-d253-4b82-b5b3-e28e3d0e3495.json
6880d679-1b33-418c-b179-e77d74b01b1f,PACLITAXEL ALBUMIN TEVA,prescription,L01CD01,PACLITAXEL,8349,,,WHO ATC Classification,,ILS,powder for suspension for infusion,PACLITAXEL/VIAL,2025-07-31T06:24:27.780660,IL,טבע,,1486.188463,1259.481748,1071.89936,,,PACLITAXEL TEVA  300MG/50ML 1VIAL,,,15927,VIAL GLASS TYPE I,units,1.0,166 86 36321 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Paclitaxel Albumin Teva monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6880d679-1b33-418c-b179-e77d74b01b1f.json
68875157-7f49-4032-a2b4-03ec2533a0c1,SMOFKABIVEN PERIPHERAL,prescription,,,7111,,,,,ILS,emulsion for infusion,"GLUCOSE MONOHYDRATE/, SOYA OIL/, TRIGLYCERIDES, MEDIUM-CHAIN/, OLIVE OIL/, FISH OIL/, L- ALANINE 14.0 G /, L-ARGININE 12.0 G /, L-HISTIDINE 3.0 G /, L- ISOLEUCINE 5.0 G /, L- LEUCINE 7.4 G /, L- METHIONINE 4.3 G /, L- PHENYLALANINE 5.1 G /, L- PROLINE 11.2 G /, L- SERINE 6.5 G /, TAURINE 1.0 G /, L- THREONINE 4.4 G /, L- TRYPTOPHAN 2.0 G /, L- TYROSINE 0.4 G /, L- VALINE 6.2 G /, CALCIUM CHLORIDE DIHYDRATE 0.74 G /, SODIUM GLYCEROPHOSPHATE HYDRATE 4.18 G /, MAGNESIUM SULFATE HEPTAHYDRATE 2.47 G /, POTASSIUM CHLORIDE 4.48 G /, SODIUM ACETATE TRIHYDRATE 5.62 G /, ZINC SULFATE HEPTAHYDRATE 0.023 G /, L- LYSINE ACETATE 9.3 G /, AMINOACETIC ACID 11.0 G /, L- LYSINE ACETATE 9.3 G /, AMINOACETIC ACID 11.0 G /",2025-07-31T08:23:46.561717,IL,ניאופרם,,nan,nan,nan,,7290012848247,SMOFKABIVEN PERIPHERAL 1904ML/BAG,,,,BAG PROPYLENE ,units,1904.0,147 83 33337 00,valid,nan,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68875157-7f49-4032-a2b4-03ec2533a0c1.json
68911275-8329-4f2e-9656-e61c18f7073b,FERRLECIT,prescription,B03AE10,VARIOUS COMBINATIONS,6979,,,WHO ATC Classification,,ILS,solution for injection/ concentrate for solution for infusion,IRON AS IRON III SODIUM FERRIC GLUGONATE COMPL. 62.5  MG /,2025-07-31T03:03:49.975149,IL,סאנופי אוונטיס,,84.10294062,71.27368166,52.99158488,,7290008880190,FERRLECIT 62.5MG/5ML  5 amp,6429,,28921,AMPOULES GLASS TYPE I,units,5.0,125 67 28020 01,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Ferrlecit is indicated in adults and children 6 years and above.Severe iron deficiency states only when oral administration has been found impossible;  in cases of gastrointestinal malabsorption which rules out oral iron therapy;  patients treated by dialysis getting Erythropoietin.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68911275-8329-4f2e-9656-e61c18f7073b.json
689dba0f-0791-439d-ba46-2b138f102e00,NEXTELA,prescription,G03AA18,DROSPIRENONE AND ESTETROL ,9281,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ESTETROL AS MONOHYDRATE 14.2  MG",2025-07-31T05:45:30.977612,IL,דקסל פארמה,,54.04656066,45.80217209,33.4322424,,,NEXTELA 24 FILM COATED TABLETS,,,,BLISTER PVC/ALUMINIUM,units,24.0,173 99 37210 99,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Nextela is indicated for oral contraception,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/689dba0f-0791-439d-ba46-2b138f102e00.json
68af4b06-41e3-4b2a-aa90-ecc5de63876b,XELJANZ XR 11 MG,prescription,L04AA29,TOFACITINIB,9289,,,WHO ATC Classification,,ILS,tablets extended release,TOFACITINIB AS CITRATE,2025-07-31T10:32:42.721996,IL,פיזר,,3712.056997,3145.811155,2859.828322,,,XELJANZ XR 11 MG 30 TABS,,,46905,BOTTLE HDPE,units,30.0,170 19 34983 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis Tofacitinib in combination with methotrexate (MTX) is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (DMARDs). Tofacitinib can be given as monotherapy in case of intolerance to MTX or when treatment with MTX is inappropriate.Ankylosing spondylitis Tofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapyPsoriatic arthritis Tofacitinib in combination with MTX is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (DMARD) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68af4b06-41e3-4b2a-aa90-ecc5de63876b.json
68b7752c-ec97-4376-9d70-28c3e41b553a,SPRYCEL 70 MG 60 FILM COATED TAB,prescription,,,6379,,,,,ILS,tablet,SPRYCEL 70 MG 60 FILM COATED TAB,2025-07-31T19:33:40.914879,IL,ב.מ.ס,,6621.389314,5611.346876,5101.224433,,,SPRYCEL 70 MG 60 FILM COATED TAB,19872,,81979,,units,60.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68b7752c-ec97-4376-9d70-28c3e41b553a.json
68d222c3-ddc1-4089-a969-9350fe65766e,GIROFLOX,prescription,J01MA02,CIPROFLOXACIN,7232,,,WHO ATC Classification,,ILS,solution for infusion,CIPROFLOXACIN/,2025-07-31T01:17:36.891909,IL,טבע,,445.296659,377.37005,321.166,,7290010286041,CIPROFLOXACIN TEVA INFUSION 2MG/ML 10BAGX100ML,9512,,18817,BOTTLE PLASTIC,units,1000.0,133 31 30984 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,* Adults :Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens.* Children and adolescents:• Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa• Complicated urinary tract infections and pyelonephritis• Inhalation anthrax (post-exposure prophylaxis and curative treatment)Ciprofloxacin may also be used to treat severe infections in children and adolescents when there is no otheralternative .Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68d222c3-ddc1-4089-a969-9350fe65766e.json
68d697e1-f030-4017-b957-43ca86bb507d,DONEPEZIL TEVA 10 MG,prescription,N06DA02,DONEPEZIL,6368,,,WHO ATC Classification,,ILS,film coated tablets,DONEPEZIL HYDROCHLORIDE ( AS MONOHYDRATE),2025-07-31T02:02:03.225040,IL,טבע,,146.4628254,124.1210385,92.2833,,7291064976285,DONEPEZIL TEVA 10MG 30TAB,4530,,76343,BLISTER OPA/ALU/PVC/ALU,units,30.0,159 51 34714 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of mild to moderately severe Alzheimer's dementia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68d697e1-f030-4017-b957-43ca86bb507d.json
68e48bd7-9dcc-4382-abc2-0e8c583ce849,SIFROL ER 1.5 MG,prescription,N04BC05,PRAMIPEXOLE,6143,,,WHO ATC Classification,,ILS,tablets extended release,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 1.5  MG,2025-07-31T08:10:01.351076,IL,בורינגר אינגלהיים,,309.4372399,262.2349608,223.17869,,900698012513,SIFROL 1.0 MG 100 TAB,9791,,17218,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,144 97 33090 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of signs and symptoms of idiopathic Parkinson's disease, as monotherapy or in combination with levodopa.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68e48bd7-9dcc-4382-abc2-0e8c583ce849.json
68fb6138-fd6e-4fb2-97ce-98b0b45e2dfc,EPIDUO,prescription,D10AE01,BENZOYL PEROXIDE,8943,,,WHO ATC Classification,,ILS,gel,"BENZOYL PEROXIDE/G, ADAPALENE/G",2025-07-31T02:26:27.688124,IL,אמי טכנולוגיות,,53.040646,44.9497,32.81,,3499320011709,EPIDUO GEL PUMP 15 GR,5681,,67347,PUMP PP/HDPE/LDPE/EURICAMIDE,units,15.0,156 10 34289 00,valid,37.0,dermal,1.4,24,,,,,,,,,,0,Prescription required,"Cutaneous treatment of Acne vulgaris when comedones, papules and pustules are present.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/68fb6138-fd6e-4fb2-97ce-98b0b45e2dfc.json
690c9f50-a4a8-4eef-af17-0d443c19239c,ESKAZOLE,prescription,P02CA03,ALBENDAZOLE,2754,,,WHO ATC Classification,,ILS,tablets,ALBENDAZOLE,2025-07-31T02:35:31.363433,IL,ג.ס.ק,,727.4782242,616.5069971,524.686806,,,ESKAZOLE 400MG 60TAB,5010,,8904,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,114 55 27464 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Albendazole is indicated for the treatment of the following systemic helminth diseases: * Echinococcosis (hydatid disease)Albendazole is indicated for the treatment of liver, lung and peritoneal cysts. Experience with bone cysts and those in the central nervous system and heart is limited.  * Cystic echinococcosis (caused by Echinococcus granulosus)Albendazole is used in patients with cystic echinococcosis:1. When surgical intervention is not feasible .2. As a co-adjunct to surgical treatment. 3. Prior to surgical intervention. 4. If preoperative treatment was too short, if spillage has occurred or if viable cysts were found at surgery. 5. Following percutaneous drainage of cysts for diagnostic or therapeutic reasons.  * Alveolar echinococcosis (caused by Echinococcus multilocularis)Although its efficacy has not been completely demonstrated in clinical trials, albendazole is used in patients with alveolar echinococcosis in the following situations:1. In inoperable disease, particularly in cases of local or distant metastasis.2. Following palliative surgery.3. Following radical surgery or liver transplantation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/690c9f50-a4a8-4eef-af17-0d443c19239c.json
69204ca2-7c7e-4d62-9784-a6581e76f866,METHYLPHENIDATE SANDOZ ® 54 MG PRT,prescription,N06BA04,METHYLPHENIDATE,9356,,,WHO ATC Classification,,ILS,tablets prolonged release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:17:42.925263,IL,סנדוז,,160.12128,135.696,108.5568,,,METHYLPHENIDATE SANDOZ  27 MG 30 SR TAB,,,14605,BOTTLE HDPE,units,30.0,169 45 36080 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Methylphenidate Sandoz® PRT is indicated for the treatment of Attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/69204ca2-7c7e-4d62-9784-a6581e76f866.json
69213494-25aa-4b3e-b8c0-aaea8ef5a258,LEVOTHROID 500MCG 1VIAL,29C,,,20492,,,,,,injection,LEVOTHROID 500MCG,2025-07-31T20:46:46.144490,IL,nan,,,,,,,LEVOTHROID 500MCG 1VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/69213494-25aa-4b3e-b8c0-aaea8ef5a258.json
6929d406-8949-4194-80b2-b4e4188bbe58,SUNLENCA FILM-COATED TABLETS,prescription,J05AX31,LENACAPAVIR ,9251,,,WHO ATC Classification,,ILS,film coated tablets,LENACAPAVIR  AS SODIUM,2025-07-31T08:52:25.722529,IL,גיליאד,,16533.47791,14011.42258,12737.65689,,5391507148285,SUNLENCA 300MG 5  TABLETS,,,17501,BLISTER PVC/ALUMINIUM,units,5.0,173 21 37470 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sunlenca film-coated tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen, for oral loading prior to administration of long-acting lenacapavir injection.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6929d406-8949-4194-80b2-b4e4188bbe58.json
692b7e6e-b3b1-45d0-bb42-73a599349bc1,ULTIVA 5 MG,prescription,N01AH06,REMIFENTANIL,8267,,,WHO ATC Classification,,ILS,powder for concentrate for solution for injection / infusion,REMIFENTANIL AS HYDROCHLORIDE/VIAL,2025-07-31T07:23:26.923926,IL,ביואבניר,,88.61795044,75.099958,55.8364,,7290008086189,REMIFENTANIL  1MG  5VIAL 3ML,,,20080,VIAL GLASS TYPE I,units,5.0,108 35 29195 22,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Ultiva is indicated as an analgesic agent  for use during induction and/or maintenance of general anaesthesia under close supervision . Ultiva is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/692b7e6e-b3b1-45d0-bb42-73a599349bc1.json
693fb5f4-d310-45f9-947a-91405b141e51,OPTILAST,prescription,S01GX07,AZELASTINE,4556,,,WHO ATC Classification,,ILS,"eye drops, solution",AZELASTINE HYDROCHLORIDE 0.05 %,2025-07-31T06:14:43.239983,IL,מגאפארם,,30.01394431,25.43554603,18.56609199,,4019338199016,OPTILAST EYE DROPS 0.05% 6ML,15133,,51961,BOTTLE HDPE,units,6.0,117 67 29826 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment and prevention of seasonal allergic conjunctivitis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/693fb5f4-d310-45f9-947a-91405b141e51.json
694020aa-970e-4df9-b6a4-e5a122bec7e8,JANUET XR 50/1000 MG TABLETS,prescription,A10BA02,METFORMIN,6244,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T04:16:26.072568,IL,מ.ס.ד. ישראל,,nan,nan,nan,,,JANUET 50/500 MG 56TAB,10043,,78967,BOTTLE HDPE,units,56.0,151 32 33933 02,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/694020aa-970e-4df9-b6a4-e5a122bec7e8.json
69768551-ed84-4548-bd84-d6db6b9e1f0a,NAVELBINE 20 MG,prescription,L01CA04,VINORELBINE,6504,,,WHO ATC Classification,,ILS,capsules,VINORELBINE AS TARTRATE,2025-07-31T05:40:30.013458,IL,פאדאגיס,,221.9904662,188.1275221,150.5020177,,7290010137039,NAVELBINE 20MG 1CAPSULE,14416,,63502,BLISTER PVC/PVDC/ALUMINIUM,units,1.0,130 90 30910 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of non small cell lung cancer. For the treatment of advanced breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/69768551-ed84-4548-bd84-d6db6b9e1f0a.json
6979c568-499a-458f-8895-42742c2c20b1,STRATTERA 4 MG/ML ORAL SOLUTION,prescription,N06BA09,ATOMOXETINE,7951,,,WHO ATC Classification,,ILS,solution  (oral),ATOMOXETINE/,2025-07-31T08:45:13.335839,IL,אלי לילי,,372.6599572,315.8135231,268.7774664,,7290016021059,STRATTERA 25MG 28CAPS,9807,,71828,BOTTLE GLASS TYPE III,units,28.0,158 61 35026 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD. Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6979c568-499a-458f-8895-42742c2c20b1.json
69a4641d-437b-44b8-bb90-68a0a0b234d9,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,7242,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T00:03:57.938204,IL,ניאופרם,,1037.509631,879.24545,748.294,,,ABSTRAL 100MCG 30TAB SUBLINGUAL,9667,,46851,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,30.0,148 73 33262 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/69a4641d-437b-44b8-bb90-68a0a0b234d9.json
69af7484-997e-4d35-acc3-976a9b9659ca,SELINCRO 18 MG,prescription,N07BB05,NALMEFENE,7413,,,WHO ATC Classification,,ILS,film coated tablets,NALMEFENE AS HYDROCHLORIDE DIHYDRATE 18.06  MG,2025-07-31T08:03:56.391034,IL,לנדבק,,260.6178709,220.8626123,176.6900898,,,SELINCRO 18.06 MG 14 F.C.TAB,9666,,44662,BLISTER PVC/PVDC/ALUMINIUM,units,14.0,151 35 33944 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (DRL), without physical withdrawal symptoms and who do not require immediate detoxification.Selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.Selincro should be initiated only in patients who continue to have a high DRL two weeks after initial assessment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/69af7484-997e-4d35-acc3-976a9b9659ca.json
69c63c9e-079f-4914-8765-0c4c3106a296,RETROVIR IV FOR INFUSION,prescription,J05AF01,ZIDOVUDINE,4298,,,WHO ATC Classification,,ILS,solution for infusion,ZIDOVUDINE/,2025-07-31T07:30:21.329889,IL,ג.ס.ק,,309.490185,262.2798295,223.2168762,,7290004557805,RETROVIR IV 5X200MG/20ML,18040,,26832,VIAL GLASS TYPE I,units,5.0,100 74 28753 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Retrovir IV for infusion is indicated for the short term management of serious manifestations of Human immunodeficiency Virus (HIV) infection in patients with Acquired Immuno Deficiency Syndrome (AIDS) or AIDS who are unable to take Retrovir oral formulations.Retrovir chemoprophylaxis, is indicated for use in HIV-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal HIV transmission and for primary prophylaxis of HIV infection in newborn infants. Retrovir I.V. should only be used when oral treatment is not possible (except during labour and delivery).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/69c63c9e-079f-4914-8765-0c4c3106a296.json
69cea3d3-b593-4569-8628-cb3f19b47568,DEPO MEDROL 40 MG/ML,prescription,H02AB04,METHYLPREDNISOLONE,37,,,WHO ATC Classification,,ILS,suspension for injection,METHYLPREDNISOLONE ACETATE/ML,2025-07-31T01:47:41.057560,IL,פיזר,,27.00946099,22.88937474,16.7075728,,72982006,DEPO MEDROL 40MG/ML 5ML,4053,,623,VIAL GLASS TYPE I,units,1.0,024 49 21841 00,valid,37.0,"periarticular, i.m, intra-articular, intra-lesional, intrabursal, intrarectal instillation, soft tissues",1.4,60,,,,,,,,,,0,Prescription required,For the treatment of conditions responsive to steroid injection therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/69cea3d3-b593-4569-8628-cb3f19b47568.json
69e1e00c-bbcb-4bde-844d-234453d1ea67,"METHOTREXAT ""EBEWE"" 2.5 MG TABLETS",prescription,L04AX03,METHOTREXATE,4679,,,WHO ATC Classification,,ILS,tablets,METHOTREXATE 2.5  MG,2025-07-31T05:17:21.322112,IL,סנדוז,,40.18237126,34.052857,24.8561,,,METHOTREXAT EBEWE 2.5MG 50TAB,13510,,58781,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,129 29 30819 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"The treatment of acute lymphoblastic leukaemia and Burkitt's lymphoma. The treatment of severe cases of uncontrolled psoriasis, unresponsive to conventional therapy. The treatment of adults with severe, active, classical or definite rheumatoid arthritis who are unresponsive or intolerant to conventional therapy.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/69e1e00c-bbcb-4bde-844d-234453d1ea67.json
6a196a73-1536-4a51-8e7d-43460227acbb,TARIM 100,prescription,G04BE03,SILDENAFIL,7211,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T09:06:38.768373,IL,אוניפארם,,149.907495,127.04025,101.6322,,,TARIM 50MG 8 F.C.TAB,20767,,40999,BLISTER PVC/ALUMINIUM,units,8.0,149 16 33583 01,valid,25.0,per os,1.4,30,,,,,,,,,,0,Prescription required,TARIM is indicated for the treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a196a73-1536-4a51-8e7d-43460227acbb.json
6a203333-e510-478d-b4dc-cf05b5a2efde,EASOTIC VETERINARY,prescription,,,8355,,,,,ILS,ear drops suspension,"MICONAZOLE AS NITRATE 15.1 MG/ML, GENTAMICIN AS SULFATE/ML, HYDROCORTISONE ACEPONATE 1.11 MG/ML",2025-07-31T03:52:53.317246,IL,רקח,,54.35027331,46.0595557,33.62011365,,,HYDROCORTISONE 10 MG 30 tab,8135,,9665,CONTAINER POLYPROPYLENE,units,30.0,159 84 34886 00,valid,37.0,otic,1.4,18,,,,,,,,,,0,Prescription required,"In dogs: treatment of acute otitis externa, and acute exacerbation of recurrent otitis externa associated with bacteria susceptible to gentamicin and fungi susceptible to miconazole in particular Malassezia pachydermatis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a203333-e510-478d-b4dc-cf05b5a2efde.json
6a3826f6-c3ff-4059-ac4b-f212e5b098d3,ANAGRID 0.5,prescription,L01XX35,ANAGRELIDE,7693,,,WHO ATC Classification,,ILS,capsules,ANAGRELIDE AS HYDROCHLORIDE 0.5  MG,2025-07-30T23:23:30.388898,IL,רפא,,1377.185216,1167.106115,993.2818,,7290008013956,ANAGRID 0.5MG 60CAPS,9623,,40018,BLISTER PVDC/ALUMINIUM,units,60.0,148 64 33344 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of patients with Essential Thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a3826f6-c3ff-4059-ac4b-f212e5b098d3.json
6a3bf27f-c4ec-457d-a1a2-56408e92c271,N-KE'EV,off-the-counter,M02AA15,DICLOFENAC,5560,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T12:33:38.851506,IL,ליף-טרי אוף ליף,,58.7994,49.83,nan,,7290102747436,N-KE'EV GEL 2*50GR,,,,TUBE ALUMINIUM,units,100.0,140 07 31948 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to:• Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries).• Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :Pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a3bf27f-c4ec-457d-a1a2-56408e92c271.json
6a4584ff-f10a-4ecd-ac3c-7d78cfa4b5c0,SUNACTIC,prescription,D11AX18,DICLOFENAC,7457,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUM,2025-07-31T08:51:05.152175,IL,פאדאגיס,,229.5438091,194.5286604,155.6229283,,7290008856027,SUNACTIC GEL 3% 50G,9745,,53734,TUBE ALUMINIUM,units,50.0,150 56 33561 00,valid,25.0,topical,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of Actinic Keratoses,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a4584ff-f10a-4ecd-ac3c-7d78cfa4b5c0.json
6a488aef-a2c8-43b3-a863-e9da1d4a756a,PROAVENIR,prescription,G04CB01,FINASTERIDE,7742,,,WHO ATC Classification,,ILS,film coated tablets,FINASTERIDE,2025-07-31T06:58:13.720462,IL,ביואבניר,,148.55079,125.8905,100.7124,,7290010286973,PROAVENIR 1MG 30 F.C.TAB,16936,,55451,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,150 83 33638 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,ProAvenir is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a488aef-a2c8-43b3-a863-e9da1d4a756a.json
6a4d2b4b-4174-491f-a68c-283a65212573,QUETIAPINE TEVA ® 100 MG,prescription,N05AH04,QUETIAPINE,7356,,,WHO ATC Classification,,ILS,film coated tablets,QUETIAPINE AS FUMARATE,2025-07-31T07:11:55.102294,IL,טבע,,140.2610735,118.8653165,88.3757,,7290102065721,QUETIAPINE TEVA 300 MG 30TAB,17031,,49803,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,150 04 33719 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Ttreatment  of schizophrenia. Treatment of manic episodes associated with bipolar disorder.Treatment of major depressive episodes in bipolar disorders.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a4d2b4b-4174-491f-a68c-283a65212573.json
6a4f2a58-ac5b-4868-a0ab-eec201fbe00c,VITRAKVI  100 MG,prescription,L01XE53,LAROTRECTINIB,8549,,,WHO ATC Classification,,ILS,capsules,LAROTRECTINIB AS SULFATE,2025-07-31T10:18:27.902990,IL,באייר,,29110.11015,24669.58597,22426.89633,,,VITRAKVI  100 MG 56 CAPS,,,1789,BOTTLE HDPE,units,56.0,164 41 36178 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Vitrakvi as monotherapy is indicated for the treatment of adult and paediatric patients with solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion:• Who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and• Who have no satisfactory treatment options",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a4f2a58-ac5b-4868-a0ab-eec201fbe00c.json
6a859198-9c31-4058-9fd4-7bed7b600791,OCSAAR PLUS,prescription,C09DA01,LOSARTAN AND DIURETICS,3828,,,WHO ATC Classification,,ILS,tablets,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE 12.50   MG",2025-07-31T06:00:35.186548,IL,אורגנון,,24.79444084,21.012238,15.3374,,,OCSAAR PLUS 30TAB,15020,,33990,BLISTER PVC/PE/PVDC/AL,units,30.0,111 23 29411 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Ocsaar plus is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. To reduce the risk of stroke in patients with hyperfension adn left ventricular hypertrophy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a859198-9c31-4058-9fd4-7bed7b600791.json
6a8c9f2e-11c4-4719-acc9-425afb0dbffb,VIMIZIM,prescription,A16AB12,ELOSULFASE ALFA,7643,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ELOSULFASE ALFA/ML,2025-07-31T10:15:22.948641,IL,מדיסון,,3967.885457,3362.614943,3056.922676,,,VIMIZIM 1MG/ML 1X5MLVIAL,22383,,53748,VIAL GLASS TYPE I,units,1.0,154 16 34261 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Vimizim is indicated for the treatment of mucopolysaccharidosis, type IVA (Morquio A Syndrome ,MPS IVA) in patients of all ages.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6a8c9f2e-11c4-4719-acc9-425afb0dbffb.json
6aa68918-999f-465f-9a9f-8f4b7a0b761f,IMJUDO,prescription,L01FX20,TREMELIMUMAB,9475,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,TREMELIMUMAB/,2025-07-31T04:02:21.400135,IL,אסטראזנקה,,10068.20257,8532.37544,7756.704945,,7290013075628,IMJUDO 20MG/ML 1.25 ML 1 VIAL,,,22336,VIAL GLASS TYPE I,units,1.0,174 80 37652 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Hepatocellular CarcinomaIMJUDO in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (HCC).Non-Small Cell Lung Cancer (NSCLC)IMJUDO in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic NSCLC with no sensitising EGFR mutations or ALK positive mutations.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6aa68918-999f-465f-9a9f-8f4b7a0b761f.json
6aafe3ac-579a-4fe0-9303-cb663e08e15f,VYNDAMAX,prescription,N07XX08,TAFAMIDIS,8550,,,WHO ATC Classification,,ILS,capsules soft gelatin,TAFAMIDIS,2025-07-31T10:23:43.358429,IL,פיזר,,52575.27892,44555.3231,40504.83918,,7290013592767,VYNDAMAX 61 MG 30 CAPS,,,70767,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,166 51 36151 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,VYNDAMAX is indicated for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6aafe3ac-579a-4fe0-9303-cb663e08e15f.json
6ab82431-96dc-46a2-a4e3-26bee9547e55,LOPRESOR DIVITABS 200 MG,29C,C07AB02,METOPROLOL,20530,,,WHO ATC Classification,,ILS,tablets slow release,METOPROLOL TARTRATE,2025-07-31T15:12:44.875363,IL,nan,,nan,nan,nan,,7298087000386,METOPROLOL 5MG/5ML 10VIAL,,,,BLISTER PVC/PE/PVDC,units,10.0,045 04 22324 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,"Hypertension, angina pectoris, arrhythmia, prophylaxis of migrain, prophylaxis of reinfarction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ab82431-96dc-46a2-a4e3-26bee9547e55.json
6adc3e15-b225-4284-aba0-56d551113915,CAPECITABINE INOVAMED 500 MG,prescription,L01BC06,CAPECITABINE,7785,,,WHO ATC Classification,,ILS,film coated tablets,CAPECITABINE,2025-07-31T00:52:47.077036,IL,אינובמד,,845.2917876,716.3489725,609.6587,,,CAPECITABINE INOVAMED 500 MG 120 F.C.TAB,9875,,30845,BLISTER ALUMINIUM /ALUMINIUM,units,120.0,153 90 34426 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Adjuvant Colon Cancer: Capecitabine is indicated for the adjuvant treatment of patients following surgery of stage III (Dukesע stage C) colon cancer.Colorectal Cancer: Capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.Advanced gastric cancer: Capecitabine is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy.Breast Cancer Combination Therapy: Capecitabine in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy.Breast Cancer Monotherapy: Capecitabine is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6adc3e15-b225-4284-aba0-56d551113915.json
6af6b9a8-60d1-4b2b-952d-5ea61709392c,SIGNIFOR LAR 10 MG,prescription,H01CB05,PASIREOTIDE,7794,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,PASIREOTIDE AS PAMOATE/VIAL,2025-07-31T08:11:24.557877,IL,מדיסון,,13142.40856,11137.63487,10125.12261,,,SIGNIFOR LAR 20 MG 1VIAL,9921,,41058,VIAL GLASS TYPE I,units,1.0,172 50 36981 99,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6af6b9a8-60d1-4b2b-952d-5ea61709392c.json
6b0b81c5-9fc9-4df0-9e12-7f88d376381e,STRENSIQ ® 100 MG/ML,prescription,A16AB13,ASFOTASE ALFA,8374,,,WHO ATC Classification,,ILS,solution for injection,ASFOTASE ALFA/,2025-07-31T08:46:52.104430,IL,ניאופרם,,86635.15402,73419.62531,66745.11392,,,STRENSIQ ® 40 MG/ML 12 vials 28mg,9986,,62119,VIAL GLASS TYPE I,units,12.0,155 44 34545 00,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,Strensiq is indicated for long-term enzyme replacement therapy in patients with paediatric-onset hypophosphatasia to treat the bone manifestations of the disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b0b81c5-9fc9-4df0-9e12-7f88d376381e.json
6b242119-d2f2-4f73-8f03-5b402cbed9a2,CABOMETYX 20 MG,prescription,L01XE26,CABOZANTINIB,8112,,,WHO ATC Classification,,ILS,film coated tablets,CABOZANTINIB AS (S) MALATE,2025-07-31T00:48:44.692749,IL,מדיסון,,21894.46497,18554.63215,16867.84741,,7290015666565,CABOMETYX 20 MG 30 FC TABLETS,10143,,64849,BOTTLE HDPE,units,30.0,160 99 35263 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Renal Cell Carcinoma (RCC)Cabometyx is indicated as monotherapy for advanced renal cell carcinoma- as first-line treatment of adult patients with intermediate or poor risk, per IMDC criteria.- in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy.Cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults.Hepatocellular Carcinoma (HCC)Cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (HCC), in adults with Child-Pugh Class A hepatic impairment who have previously been treated with sorafenib.Differentiated thyroid carcinoma (DTC)Cabometyx is indicated as monotherapy for the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma (DTC), refractory or not eligible to radioactive iodine (RAI) who have progressed during or after prior systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b242119-d2f2-4f73-8f03-5b402cbed9a2.json
6b2c5ae9-6c4f-4a11-bf46-6e7c4d38f0e3,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5484,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:01:15.819091,IL,טבע,,12.2956,10.42,nan,,7290000800028,ACAMOL TSINUN & SHAPA'AT NIGHT 14 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,14.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b2c5ae9-6c4f-4a11-bf46-6e7c4d38f0e3.json
6b301740-91f6-4d78-af0a-70652ed0b712,RALOXIFENE TEVA ®,prescription,G03XC01,RALOXIFENE,7280,,,WHO ATC Classification,,ILS,tablets,RALOXIFENE HYDROCHLORIDE,2025-07-31T07:15:43.485126,IL,טבע,,87.58585931,74.2253045,55.1861,,,RALOXIFENE TEVA 60MG 30TAB,18502,,46799,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,145 48 31964 03,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,- Treatment of osteoporosis in post menopausal women.- Prevention of osteoporosis in post menopausal women.- Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. - Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b301740-91f6-4d78-af0a-70652ed0b712.json
6b3a9b37-de97-4d26-9dac-dd8b56f0e16c,SEROQUEL 100 MG,prescription,N05AH04,QUETIAPINE,6025,,,WHO ATC Classification,,ILS,film coated tablets,QUETIAPINE AS FUMARATE,2025-07-31T08:06:54.984814,IL,צמל,,140.2610735,118.8653165,88.3757,,,SEROQUEL 300MG 30TAB,19809,,72566,BLISTER PVC/ALUMINIUM,units,30.0,109 40 29314 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of schizophrenia.   Treatment of manic episodes associated with bipolar disorder. Treatment of major depressive episodes in bipolar disorders.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b3a9b37-de97-4d26-9dac-dd8b56f0e16c.json
6b5a9c7e-61ec-4256-b7f1-d700ec74a57e,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8038,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:52:51.928108,IL,יאנסן סילג,,13039.06554,11050.05603,10045.50548,,7640111932642,UPTRAVI ® 1600 MCG 60 TAB,21132,,22883,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b5a9c7e-61ec-4256-b7f1-d700ec74a57e.json
6b6ccda8-bf31-48b2-88c0-782ab509a929,EVOREL 50,prescription,G03CA03,ESTRADIOL,4459,,,WHO ATC Classification,,ILS,patches,ESTRADIOL AS HEMIHYDRATE 3.2  MG,2025-07-31T02:46:44.804786,IL,תרומד,,112.8233535,95.61301568,71.087744,,7290103848538,EVOREL CONTI  8 PATCH,5180,,3046,POUCH ALUMINIUM,units,8.0,103 09 28671 00,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,"Deficiency symptoms by absence of Estrogen after the menopause or after surgical removal of the ovarians. They comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis. In women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b6ccda8-bf31-48b2-88c0-782ab509a929.json
6b6f40fb-f6fb-4853-b848-02cc01b1dad7,PHENYLEPHRINE AGUETTANT 50 MCG/ML,prescription,C01CA06,PHENYLEPHRINE,9509,,,WHO ATC Classification,,ILS,solution for injection,PHENYLEPHRINE AS HYDROCHLORIDE/,2025-07-31T06:41:05.566918,IL,אמ.בי.איי פארמה,,nan,nan,nan,,,PHENYLEPHRINE AGUETTANT 50 MCG/ML 10PFS,,,17377,AMPOULES POLYPROPYLENE,units,10.0,173 76 36718 99,valid,nan,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of hypotension during general anaesthesia and locoregional anaesthesia, whether spinal or epidural, and whether for surgical or obstetric procedures. Preventive treatment of hypotension during spinal anaesthesia for surgical or obstetric procedures.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b6f40fb-f6fb-4853-b848-02cc01b1dad7.json
6b93abe2-7026-4189-b9b4-97ed1cfc3c73,NICOTINELL LOZENGES 1 MG,off-the-counter,,,5193,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:32:26.396176,IL,ג.ס.ק,,57.2064,48.48,nan,,,NICOTINELL LOZENGES 1MG 36 LOZ,14452,,,BLISTER PVC/PE/PVDC/AL,units,36.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6b93abe2-7026-4189-b9b4-97ed1cfc3c73.json
6bbd182a-3867-432b-b093-59ed058d17e3,V.TEARS 15ML,off-the-counter,,,3222,,,,,ILS,tablet,V.TEARS,2025-07-31T19:47:38.433418,IL,ויטאמד,,21.87,18.53,,,,V.TEARS 15ML,22040,,,,units,15.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6bbd182a-3867-432b-b093-59ed058d17e3.json
6bcc6705-426d-4c01-a26b-691bf6f959b2,AKINETON 5MG/ML 5VIAL,29C,,,20280,,,,,,injection,AKINETON 5MG/ML,2025-07-31T19:51:44.670216,IL,nan,,,,,,,AKINETON 5MG/ML 5VIAL,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6bcc6705-426d-4c01-a26b-691bf6f959b2.json
6bcfba5b-a60b-4e86-95fa-7ed57a95bbdd,INSPRA 25 MG,prescription,C03DA04,EPLERENONE,4959,,,WHO ATC Classification,,ILS,film coated tablets,EPLERENONE,2025-07-31T04:08:40.409954,IL,דקסל פארמה,,85.81270503,72.72263462,54.06887332,,,INSPRA 50MG 28TAB,9238,,65825,BLISTER PVC/ALUMINIUM,units,28.0,134 67 31192 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (LVEF < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.Inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with NYHA class II (chronic) heart failure and left ventricular systolic dysfunction (LVEF < or = 30%).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6bcfba5b-a60b-4e86-95fa-7ed57a95bbdd.json
6bd06960-9304-43c2-a663-1410bb967efa,HYDROXYUREA MEDAC 500 MG,29C,L01XX05,HYDROXYCARBAMIDE,20450,,,WHO ATC Classification,,ILS,capsules,HYDROXYCARBAMIDE,2025-07-31T14:48:37.573688,IL,nan,,nan,nan,nan,,7290100819135,HYDROXYUREA 500MG 20CAPS,,,,BLISTER PVDC/ALUMINIUM,units,20.0,168 84 35373 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,Treatment of patient with chronic myeloid leukaemia (CML) in the chronic or accelerated phase of the disease.Treatment of patients with essential thrombocytaemia or polycythaemia vera with a high risk for thrmboembolic complications.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6bd06960-9304-43c2-a663-1410bb967efa.json
6be14bf4-bdbe-4ffc-9dde-521d377eda21,XOFIGO,prescription,V10XX03,RADIUM (223 RA) DICHLORIDE,7423,,,WHO ATC Classification,,ILS,solution for injection,RADIUM-223 DICHLORIDE 1100 KBQ/ML AT REFERENCE DATE,2025-07-31T10:35:45.539304,IL,באייר,,20710.12254,17550.95209,15955.41099,,7290013092656,XOFIGO 1000KBQ/ML VIAL 1X6ML,24079,,51046,VIAL GLASS TYPE I,units,1.0,151 53 33970 00,valid,10.0,i.v,1.4,28,,,,,,,,,,0,Prescription required,"Xofigo monotherapy or in combination with luteinising hormone releasing hormone (LHRH) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced PC (other than LHRH analogues), or ineligible for any available systemic mCRPC treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6be14bf4-bdbe-4ffc-9dde-521d377eda21.json
6be433a8-2cda-4740-8446-a903ac699fe9,CARBOSYLANE,off-the-counter,A07BA51,"MEDICINAL CHARCOAL, COMBINATIONS",5373,,,WHO ATC Classification,,ILS,capsules,"SIMETHICONE, CHARCOAL ACTIVATED",2025-07-31T11:23:35.827248,IL,תרימה,,50.327,42.65,nan,,7290008075107,CARBOSYLANE 48CAPS(24 blue+24pink),,,,BLISTER PVC/ALUMINIUM,units,48.0,134 82 21600 07,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Anti-flatulent, for symptomatic treatment of stomach ache resulting from accumulation of gas, relief of sensation of fullness, meteorism, bloating and flatulence.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6be433a8-2cda-4740-8446-a903ac699fe9.json
6bee0836-7c4d-49ec-a855-de9414d3fe47,ABIVENIR 250 MG,prescription,L02BX03,ABIRATERONE,8065,,,WHO ATC Classification,,ILS,tablets,ABIRATERONE ACETATE,2025-07-30T23:10:36.103973,IL,טבע,,17160.87617,14543.1154,13221.014,,,ABIRATERONE TEVA 250MG 120TAB,,,55637,BOTTLE HDPE,units,120.0,172 52 37297 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,AbiVenir is a CYP17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6bee0836-7c4d-49ec-a855-de9414d3fe47.json
6bf3d169-14c4-4e22-88ac-d0e88b1f84e7,ROSUVASTATIN SANDOZ 10 MG,prescription,C10AA07,ROSUVASTATIN,8431,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T07:50:57.937616,IL,סנדוז,,90.81529039,76.9621105,57.2209,,,ROSUVASTATIN SANDOZ 10 MG 30 TAB,18613,,14819,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,162 39 35574 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6bf3d169-14c4-4e22-88ac-d0e88b1f84e7.json
6c0cfe65-d8c7-4f44-aae2-600e3ed4da75,FLUMAZENIL KABI 0.1 MG/ML,prescription,V03AB25,FLUMAZENIL,7938,,,WHO ATC Classification,,ILS,solution for injection / infusion,FLUMAZENIL 0.1  MG /,2025-07-31T03:12:44.588997,IL,ניאופרם,,304.4754,258.03,219.6,,,FLUMAZENIL MYLAN 0.1 MG/ML 5 VIAL 10ML,,,,AMPOULES GLASS TYPE I,units,5.0,177 37 37182 99,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Benzodiazepine antagonist for reversal of benzodiazepine anesthesia, as well as for patients with Benzodiazepine intoxication. In a hospital setting:In anaesthesiology to neutralise the sedative effects of benzodiazepines on the central nervous system in adults and children older than 1 year:•	reversal of sedative effect during general anaesthesia induced and maintained by benzodiazepines,•	reversal of conscious sedation induced by benzodiazepines in short operations with a diagnostic or therapeutic objective.In intensive care to neutralise the sedative effects of benzodiazepines on the central nervous system and treat a coma of unknown aetiology, in adults and children (including newborns) if the semiology is compatible with the hypothesis of a benzodiazepine or related substance-induced coma:•	diagnosis and/or treatment of intentional or accidental benzodiazepine overdose,•	aetiological diagnosis of an unexplained coma in order to differentiate what is caused by a benzodiazepine from another cause (pharmacological or neurological).•	specific cancellation of the effects on the central nervous system by excessive benzodiazepine doses (re-establishment of spontaneous ventilation to avoid intubation or interrupt ventilatory assistance).In an emergency situation or medical transport, in adults and children older than 6 years:•	reversal of benzodiazepine-induced conscious sedation in case of respiratory depression or apnoea.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c0cfe65-d8c7-4f44-aae2-600e3ed4da75.json
6c0f8598-5c96-464d-bec3-02d09a6b488d,VINCRISTINE TEVA,prescription,L01CA02,VINCRISTINE,8846,,,WHO ATC Classification,,ILS,solution for injection,VINCRISTINE SULFATE/ML,2025-07-31T10:16:37.674445,IL,טבע,,45.915365,38.911328,28.4024292,,,VINCRISTINE TEVA 1 MG/1ML 1 VIAL,22350,,35255,VIAL GLASS TYPE I,units,1.0,115 51 22790 05,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Vincristine may be used either as sole agent or in combination therapy in the treatment of acute leukemias. Malignant lymphomas including Hodgkin's disease lymphosarcoma and reticulum cell sarcoma, neuroblastoma, Wilm's tumor, rhabdomyosarcoma.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c0f8598-5c96-464d-bec3-02d09a6b488d.json
6c3caffd-f3d1-46e3-b4b1-7a578ecd33eb,HYRIMOZ,prescription,L04AB04,ADALIMUMAB,8809,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/ML,2025-07-31T03:54:38.624522,IL,סנדוז,,2331.675847,1975.996569,1796.360517,,,HYRIMOZ 40MG/0.8ML 2 PFS,8484,,66319,PREFILLED PEN GLASS TYPE I,units,2.0,164 72 36144 00,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis Hyrimoz in combination with methotrexate is indicated for:  The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. Hyrimoz can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate. Juvenile idiopathic arthritisPolyarticular juvenile idiopathic arthritis:Hyrimoz in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs). Hyrimoz can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate . Adalimumab has not been studied in patients aged less than 2 years. Enthesitis-related arthritis:Hyrimoz is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapyAxial spondyloarthritisAnkylosing spondylitis (AS): Hyrimoz is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy. Axial spondyloarthritis without radiographic evidence of AS: Hyrimoz is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels , who have had an inadequate response to, or are intolerant to, non - steroidal anti-inflammatory drugs. Psoriatic arthritis Hyrimoz is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function. Psoriasis Hyrimoz is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy. Paediatric plaque psoriasis Hyrimoz is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.Hidradenitis suppurativa (HS)Hyrimoz is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults  and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy. Crohn’s disease Hyrimoz is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. Hyrimoz is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.Paediatric Crohn's disease Hyrimoz is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6- years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and corticosteroid, and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies Ulcerative colitis Hyrimoz is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6- mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.Paediatric ulcerative colitis Hyrimoz is indicated for the treatment of moderately to severely active ulcerative colitis in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including corticosteroids and/or 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.Uveitis Hyrimoz is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroidsparing, or in whom corticosteroid treatment is inappropriate.Paediatric Uveitis Hyrimoz is indicated for the treatment of chronic non-infectious uveitis in paediatric patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.Intestinal Behcet’s diseaseHyrimoz is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c3caffd-f3d1-46e3-b4b1-7a578ecd33eb.json
6c4b5668-58af-4900-82f7-202391278019,MOXYPEN ® FORTE 500 MG CAPSULES,prescription,J01CA04,AMOXICILLIN,6742,,,WHO ATC Classification,,ILS,capsules,AMOXICILLIN AS TRIHYDRATE,2025-07-31T05:33:36.095004,IL,טבע,,24.63326582,20.875649,15.2377,,7290000801605,MOXYPEN FTE 250MG 100ML,13695,,24156,BLISTER PVC/PVDC/ALUMINIUM/PAPER,units,100.0,130 22 30823 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Infections caused by amoxycillin - susceptible organisms. Prevention of bacteremia in patients at risk of developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c4b5668-58af-4900-82f7-202391278019.json
6c5a0ac5-8b7c-4cb9-a893-3c7bc67e33f0,TEMO 100 MG,prescription,L01AX03,TEMOZOLOMIDE,6793,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T09:11:27.217833,IL,פאדאגיס,,91.10303162,77.205959,57.4022,,7298074050721,TEMO 5 MG 5CAPS,20701,,32067,BOTTLE GLASS TYPE III,units,5.0,145 26 33258 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c5a0ac5-8b7c-4cb9-a893-3c7bc67e33f0.json
6c5b2b4f-2813-4d65-ad77-0d52d513faff,CAMZYOS 2.5 MG,prescription,C01EB24,MAVACAMTEN,9501,,,WHO ATC Classification,,ILS,capsules,MAVACAMTEN 2.5  MG,2025-07-31T00:51:33.032375,IL,ב.מ.ס,,7718.263193,6540.901302,5946.273911,,,CAMZYOS 2.5 MG 28 CAPS,,,31529,BLISTER PVC/PCTFE(ACLAR)/ALUMINIUM,units,28.0,174 18 37419 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c5b2b4f-2813-4d65-ad77-0d52d513faff.json
6c831f1d-d090-4bef-8ce6-7318d832f504,CICLODERM,prescription,D01AE14,CICLOPIROX,3039,,,WHO ATC Classification,,ILS,cream,CICLOPIROX OLAMINEW/W,2025-07-31T01:11:47.959723,IL,תרימה,,nan,nan,nan,,7290008075114,CICLODERM C 30GR,3087,,9201,TUBE ALUMINIUM,units,30.0,062 23 26751 00,valid,nan,topical,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of localized fungal infections of the body and fungal infections of the feet.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c831f1d-d090-4bef-8ce6-7318d832f504.json
6c8a1eb9-36a9-4f8f-912b-b818ec505f6c,SINUFED SYRUP,off-the-counter,R01BA02,PSEUDOEPHEDRINE,2209,,,WHO ATC Classification,,ILS,syrup,PSEUDOEPHEDRINE HYDROCHLORIDE/,2025-07-31T13:18:24.564993,IL,תרימה,,25.2756,21.42,nan,,729008045688,SINUFED SYRUP 115ML,19612,,,BOTTLE GLASS,units,115.0,118 91 29978 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relief eustachian tube congestion.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c8a1eb9-36a9-4f8f-912b-b818ec505f6c.json
6c904672-c77a-4d02-b245-ba119c9a5cbd,SKYRIZI 150 MG,prescription,L04AC18,RISANKIZUMAB,9314,,,WHO ATC Classification,,ILS,solution for injection,RISANKIZUMAB/,2025-07-31T08:21:52.147911,IL,אב-וי,,11601.63406,9831.893709,8938.08519,,,SKYRIZI 600 MG/10 ML,23145,,31575,PRE-FILLED PEN GLASS TYPE I,units,1.0,169 73 36871 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Plaque PsoriasisSkyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who arecandidates for systemic therapy.Psoriatic ArthritisSkyrizi, alone or in combination with methotrexate (MTX), is indicated for the treatment of activepsoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (DMARDs).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6c904672-c77a-4d02-b245-ba119c9a5cbd.json
6ca3d5c9-bff4-414e-9da5-700ac83ffdd8,EXIPAN,off-the-counter,M02AA07,PIROXICAM,3169,,,WHO ATC Classification,,ILS,gel,PIROXICAM 0.5 %W/W,2025-07-31T11:52:19.030359,IL,פאדאגיס,,47.6602,40.39,nan,,7290002925965,EXIPAN GEL TUBE  50GR,5055,,,ROLL-ON HDPE,units,50.0,065 11 27132 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,For local treatment of inflammatory conditions accompanied by pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ca3d5c9-bff4-414e-9da5-700ac83ffdd8.json
6ca5a091-5fe6-49dd-ba00-1fe3ff05b784,LEVETRIM 1000,prescription,N03AX14,LEVETIRACETAM,6624,,,WHO ATC Classification,,ILS,film coated tablets,LEVETIRACETAM,2025-07-31T04:44:06.226863,IL,תרימה,,147.6547375,125.1311335,93.0343,,,LEVETRIM 500MG 60 FC TAB,12441,,21385,BLISTER PVC/ALUMINIUM,units,60.0,143 77 31941 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,- Levetrim is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetrim is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Levetrim is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Levetrim is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ca5a091-5fe6-49dd-ba00-1fe3ff05b784.json
6cb44c79-2db3-4996-8d6c-e0e19c3fc870,ELOCTA 500 IU,29C,B02BD05,COAGULATION FACTOR VII,9068,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR VIII,2025-07-31T14:27:05.284623,IL,nan,,nan,nan,nan,,,ELOCTA 500 IU,,,,VIAL GLASS TYPE I,units,1.0,170 49 36895 00,valid,nan,i.v,1.4,60,,,,,,,,,,0,,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6cb44c79-2db3-4996-8d6c-e0e19c3fc870.json
6cb6096f-eff0-4b4c-983d-4f9d61086ec3,BORTEZOMIB S.K. 3.5 MG,prescription,L01XX32,BORTEZOMIB,8066,,,WHO ATC Classification,,ILS,powder for solution for injection,BORTEZOMIB AS MANNITOL BORONIC ESTER 3.5  MG,2025-07-30T23:41:26.753462,IL,SK PHARM(KS KIM),,5218.217134,4422.21791,4020.1981,,7290016845044,BORTEZOMIB S.K. 3.5 MG  1 VIAL,2605,,56911,VIAL GLASS TYPE I,units,1.0,157 36 34619 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Multiple MyelomaBORTEZOMIB S.K is indicated for the treatment of patients with multiple myeloma.Mantle Cell LymphomaBORTEZOMIB S.K is indicated for the treatment of patients with mantle cell Lymphoma who have received at least one prior therapy.BORTEZOMIB S.K in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6cb6096f-eff0-4b4c-983d-4f9d61086ec3.json
6ccc7478-436e-4933-91a2-93e5fe573439,NATPARA 100 MCG 2CARTRIDGES,prescription,,,7832,,,,,ILS,tablet,NATPARA 100 MCG 2CARTRIDGES,2025-07-31T19:20:55.313764,IL,ניאופרם,,30398.00655,25761.02364,23419.1124,,,NATPARA 100 MCG 2CARTRIDGES,14669,,54980,,units,2.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ccc7478-436e-4933-91a2-93e5fe573439.json
6d0b78b4-cb14-4447-a778-c2158ce49784,LOPAMIDE,off-the-counter,A07DA03,LOPERAMIDE,5608,,,WHO ATC Classification,,ILS,capsules,LOPERAMIDE HYDROCHLORIDE,2025-07-31T12:21:21.073848,IL,ליף-רפא,,22.9982,19.49,nan,,,LOPAMIDE 2 mg 10 caps,,,,BLISTER PVC/ALUMINIUM,units,10.0,168 48 37078 99,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Control and symptomatic relief of acute diarrhea in adults, adolescents and children aged 6 years and older.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d0b78b4-cb14-4447-a778-c2158ce49784.json
6d301f1e-9626-4fb5-b6c6-e37a400e31ac,ESTO 10,prescription,N06AB10,ESCITALOPRAM,6082,,,WHO ATC Classification,,ILS,tablets,ESCITALOPRAM AS OXALATE,2025-07-31T01:17:57.753584,IL,טבע,,33.24230746,28.171447,20.5631,,,CITALOPRAM  20 MG 30 TABLETS,3909,,13767,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,141 60 31712 02,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Treatment of depression and panic disorder. Treatment of generalized anxiety disorder (GAD), treatment of social anxiety disorder (social phobia).Treatment of obsessive compulsive disorder.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d301f1e-9626-4fb5-b6c6-e37a400e31ac.json
6d4c8693-ec24-45d3-ab9b-27374ae14b81,ESOMEPRAZOLE INOVAMED 20 MG,prescription,A02BC05,ESOMEPRAZOLE,8395,,,WHO ATC Classification,,ILS,gastro resistant tablets,ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE,2025-07-31T02:36:34.812621,IL,אינובמד,,46.12353792,39.087744,28.5312,,,ESOMEPRAZOLE INOVAMED 40 MG 30 tab,5654,,36215,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,161 48 35207 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Esomeprazole Inovamed tablets are indicated  in adults for:Gastroesophageal Reflux Disease (GERD)-  treatment of erosive reflux esophagitis-  long-term management of patients with healed esophagitis to prevent relapse-  symptomatic treatment of gastroesophageal reflux disease (GERD)In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:- healing of Helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers.Patients requiring NSAID therapy- healing of gastric ulcers associated with NSAID therapy. - prevention of gastric and duodenal ulcers associated with NSAID therapy in    patients at risk.Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.Esomeprazole Inovamed 20 mg tablets are indicated in adolescents from the age of 12 years forGastroesophageal Reflux Disease (GERD)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophgeal reflux disease (GERD)In combination with antibiotics in treatment of duodenal ulcer caused by Helicobactor  pylori,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d4c8693-ec24-45d3-ab9b-27374ae14b81.json
6d5e400c-e665-437c-84d3-49570dd208cd,TELFAST 120 MG,off-the-counter,R06AX26,FEXOFENADINE,4302,,,WHO ATC Classification,,ILS,film coated tablets,FEXOFENADINE HYDROCHLORIDE,2025-07-31T13:26:20.009155,IL,פרמה שלום,,13.2632,11.24,nan,,,TELFAST 120MG 15TAB,20300,,,BLISTER PVC/PE/PVDC/AL,units,15.0,108 90 29135 21,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of symptoms associated with seasonal allergic rhinitis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d5e400c-e665-437c-84d3-49570dd208cd.json
6d641f92-6132-49f3-996b-1c5b696af3d5,DERMOSTAMIN GEL,off-the-counter,D04AA13,DIMETINDENE,5609,,,WHO ATC Classification,,ILS,gel,DIMETINDENE MALEATE 0.1 %W/W,2025-07-31T11:29:54.172897,IL,ליף- תרימה,,58.1976,49.32,nan,,,DERMOSTAMIN GEL 100g,,,,TUBE ALUMINIUM,units,100.0,162 15 35946 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d641f92-6132-49f3-996b-1c5b696af3d5.json
6d64c496-4c62-4b05-b4ef-637a38cffdd2,AUGMENTIN SUSPENSION 400 MG/5 ML,prescription,J01CR02,AMOXICILLIN AND ENZYME INHIBITOR,3105,,,WHO ATC Classification,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM SALT 11.4 MG/ML, AMOXICILLIN AS TRIHYDRATE/ML",2025-07-30T23:31:10.812156,IL,ג.ס.ק,,20.97279844,17.773558,12.9734,,7290010140121,AUGMENTIN 250MG 100ML,1328,,70378,BOTTLE GLASS TYPE III,units,100.0,112 75 29288 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Augmentin is indicated for the treatment of the following infections in adults and children: • Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.• Recurrent tonsillitis",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d64c496-4c62-4b05-b4ef-637a38cffdd2.json
6d659a43-a6f3-41fb-b0db-3a7355521976,SAFLUTAN,prescription,S01EE05,TAFLUPROST,7010,,,WHO ATC Classification,,ILS,"eye drops, solution",TAFLUPROST/ML,2025-07-31T07:56:11.297872,IL,רפא,,85.21163693,72.21325484,53.6901523,,7290006813510,SAFLUTAN 15MCG/ML OPHT SOL SINGLE DOSE 30X0.3ML,19990,,36461,CONTAINERS SINGLE DOSE LDPE,units,30.0,146 96 33302 01,valid,34.5,ocular,1.4,36,,,,,,,,,,0,Prescription required,Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.As monotherapy in patients  • who would benefit from preservative free eye drops • insufficiently responsive to first line therapy • intolerant or contra-indicated to first line therapyAs adjunctive therapy to beta-blockers.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d659a43-a6f3-41fb-b0db-3a7355521976.json
6d6a4b10-14a0-4007-b190-37794e84f09f,FLIXOTIDE INHALER CFC FREE 125 MCG,prescription,R03BA05,FLUTICASONE,4030,,,WHO ATC Classification,,ILS,suspension for inhalation,FLUTICASONE PROPIONATE/DOSE,2025-07-31T03:08:43.610026,IL,ג.ס.ק,,115.0162323,97.47138765,72.4694332,,,FLIXOTIDE INH CFC FREE 125MCG 120DOSES,6169,,2761,CAN ALUMINIUM,units,120.0,129 81 30973 11,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Prophylactic management of all grades of asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d6a4b10-14a0-4007-b190-37794e84f09f.json
6d7c7866-3045-4ada-bb4c-74469c01305d,KARIN 250,prescription,J01FA09,CLARITHROMYCIN,3358,,,WHO ATC Classification,,ILS,coated tablets,CLARITHROMYCIN,2025-07-31T04:23:27.562278,IL,אוניפארם,,31.04744964,26.311398,19.2054,,,KARIN 250MG 14TAB,11028,,9561,BLISTER PVC/ALUMINIUM,units,14.0,104 96 28719 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Karin is indicated in the treatment of infections caused by one or more susceptible organisms. Indications include:* Lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia.* Upper respiratory tract infections, for example, sinusitis and pharyngitis.Karin is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section.Karin is also indicated in:* skin and soft tissue infections of mild to moderate severity.* combination with proton pump inhibitor for the eradication of H. Pylori in patients with proven duodenal ulcer.* treatment of Mycobacterium Avium Complex infection in AIDS patients.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d7c7866-3045-4ada-bb4c-74469c01305d.json
6d8a6195-04a2-457b-ac93-73bc714f81a5,LIVOSTINE,off-the-counter,S01GX02,LEVOCABASTINE,2813,,,WHO ATC Classification,,ILS,"eye drops, suspension",LEVOCABASTINE AS HYDROCHLORIDE 0.05 %W/V,2025-07-31T12:20:51.567213,IL,ג'ונסון אנד ג'ונסון,,44.8754,38.03,nan,,,LIVOSTIN DROPS 4ML,12060,,,BOTTLE POLYETHYLENE,units,4.0,141 53 27673 02,valid,nan,ocular,1.4,24,,,,,,,,,,0,,"Allergic conjunctivitis ( classic and vernal). Livostine eye drops is  indicated for the rapid and long-lasting relief of eye complaints such as itching, redness, and watering eyes associated with allergies, for example to grass, pollen, moulds and dust.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d8a6195-04a2-457b-ac93-73bc714f81a5.json
6d943cd2-2fb0-499f-a1df-da11fcf71819,AUVELITY ®,prescription,N07XX59,"DEXTROMETHORPHAN, COMBINATIONS",9517,,,WHO ATC Classification,,ILS,tablets extended release,"BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE",2025-07-31T00:46:31.219478,IL,אופק פארמה,,74.89420533,63.46966835,47.1893445,,,BUPROPION HCL 150 MG 30 XR TAB,,,4231,BOTTLE HDPE,units,30.0,177 80 37881 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,AUVELITY is indicated for the treatment of major depressive disorder (MDD) in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d943cd2-2fb0-499f-a1df-da11fcf71819.json
6d949cf3-2688-42b2-b952-8b17803feee8,GLIOLAN ®,prescription,L01XD04,AMINOLEVULINIC ACID,9456,,,WHO ATC Classification,,ILS,powder for solution,5-AMINOLEVULINIC ACID HYDROCHLORIDE 1.5 G,2025-07-31T03:35:51.525787,IL,צמל,,4884.798664,4139.660069,3763.327335,,7290100819159,GLIOLAN 1.5 G 1 VIAL,,,19097,VIAL GLASS TYPE I,units,1.0,150 85 33857 01,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Gliolan® is indicated in adult patients for visualisation of malignant tissue during surgery for malignant  glioma (WHO grade III and IV).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6d949cf3-2688-42b2-b952-8b17803feee8.json
6daae4a1-28cc-416b-ab01-3ac31fea9bfb,PENICILLIN G SODIUM 5 MU,prescription,J01CE01,BENZYLPENICILLIN,8880,,,WHO ATC Classification,,ILS,powder for solution for injection,BENZYLPENICILLIN SODIUM 5 MIU/VIAL,2025-07-31T06:34:35.312498,IL,טבע,,31.51854496,26.71063251,19.49681205,,,PENICILLIN G SODIUM 5 MU 1 VIAL,,,35253,VIAL GLASS TYPE III,units,1.0,024 73 21066 00,valid,37.0,"i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,Infections due to penicillin sensitive organisms.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6daae4a1-28cc-416b-ab01-3ac31fea9bfb.json
6db5dbd0-1d19-43ee-aa65-913a2ceb179f,DROPERIDOL 2.5MG/ML 25 VIALX1ML,29C,,,20384,,,,,,injection,DROPERIDOL 2.5MG/ML X,2025-07-31T20:18:59.966903,IL,nan,,,,,,,DROPERIDOL 2.5MG/ML 25 VIALX1ML,,,,,units,25.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6db5dbd0-1d19-43ee-aa65-913a2ceb179f.json
6db8addc-5493-40de-a391-3e2ba247e34c,MYDRAMIDE,prescription,S01FA06,TROPICAMIDE,1814,,,WHO ATC Classification,,ILS,"eye drops, solution",TROPICAMIDE 0.5 %,2025-07-31T05:37:42.961761,IL,פישר,,16.9516676,14.36582,10.486,,7290000849591,MYDRAMIDE DROPS 10CC,13208,,1416,BOTTLE LDPE,units,10.0,108 37 20498 00,valid,37.0,ocular,1.4,60,,,,,,,,,,0,Prescription required,Mydriatic for diagnostic use.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6db8addc-5493-40de-a391-3e2ba247e34c.json
6dc2773b-5cb8-424e-af1d-87947e0f9ab3,FLUDECATE,29C,N05AB02,FLUPHENAZINE,20080,,,WHO ATC Classification,,ILS,solution for injection,FLUPHENAZINE DECANOATE/ML,2025-07-31T14:36:28.303847,IL,nan,,nan,nan,nan,,,FLUPHENAZINE 1MG 100TAB,,,,AMPOULES GLASS TYPE I,units,100.0,025 22 21358 00,valid,nan,i.m,1.4,30,,,,,,,,,,0,,Fludecate is a long acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g. chronic schizophrenics).Fluphenazine Decanoate Injection has not been shown effective in the management of behavioral complications in patients with mental retardation.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6dc2773b-5cb8-424e-af1d-87947e0f9ab3.json
6ddf7a10-c282-45e5-b217-3cf015b7777d,REPLAGAL,prescription,A16AB03,AGALSIDASE ALFA,6738,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,AGALSIDASE ALFA/ML,2025-07-31T07:26:36.034915,IL,טקדה,,6424.62498,5444.597683,4949.634257,,7290008128230,REPLAGAL 1MG/ML VIAL 3.5ML,18487,,86580,VIAL GLASS TYPE I,units,1.0,124 32 30382 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (alfa-galactosidase A deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ddf7a10-c282-45e5-b217-3cf015b7777d.json
6df8fccf-67d6-4a72-be90-76dfc170aed6,ARICEPT 23MG 50TAB,29C,,,20299,,,,,,tablet,ARICEPT 23MG,2025-07-31T19:57:02.751194,IL,nan,,,,,,,ARICEPT 23MG 50TAB,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6df8fccf-67d6-4a72-be90-76dfc170aed6.json
6df9be93-e156-4977-b250-aa85543285e5,ASSIVAL 5 MG,prescription,N05BA01,DIAZEPAM,1467,,,WHO ATC Classification,,ILS,tablets,DIAZEPAM,2025-07-30T23:28:26.818386,IL,טבע,,17.13596,14.522,10.6,,,ASSIVAL 10MG 30TAB,1826,,20757,BLISTER PVC/ALUMINIUM,units,30.0,014 61 24381 03,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tension, anxiety, agitation due to acute alcohol withdrawal, adjunct for the relief of skeletal muscle spasm, convulsive disorders.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6df9be93-e156-4977-b250-aa85543285e5.json
6e0947f7-27f0-42d4-b95a-c64728ec9da2,IMURAN TABLETS 25 MG,prescription,L04AX01,AZATHIOPRINE,1107,,,WHO ATC Classification,,ILS,film coated tablets,AZATHIOPRINE,2025-07-31T04:04:24.133254,IL,פאדאגיס,,62.62788638,53.07448234,39.46058167,,7290008105446,IMURAN 25MG 100TAB,9157,,7860,BLISTER PVC/ALUMINIUM,units,100.0,034 79 25384 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Immunosuppressive agent used in transplantation surgery for suppression of graft rejection. For special cases of rheumatoid arthritis- not responsive to other agents- and only by rheumatology experts in hospitals or rheumatic clinics.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e0947f7-27f0-42d4-b95a-c64728ec9da2.json
6e0d2d71-4409-4d04-9278-00ddf2fa942b,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,3995,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T12:43:36.391985,IL,ג.ס.ק,,34.7274,29.43,nan,,7290006603036,OTRIVIN MENTHOL MDS 0.1% 10ML,15321,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,10.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e0d2d71-4409-4d04-9278-00ddf2fa942b.json
6e1d3047-5eb2-4640-9d51-b49c806ef8b2,PROGRAF 0.5 MG,prescription,L04AA05,TACROLIMUS,6133,,,WHO ATC Classification,,ILS,capsules,TACROLIMUS 0.5   MG,2025-07-31T06:59:38.338954,IL,אסטלס,,725.8682444,615.14258,523.5256,,8718692511460,PROGRAF 1 MG 100 CAPSULES,16773,,29078,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,122 07 30215 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in liver  kidney or heart allograft recipients.   Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e1d3047-5eb2-4640-9d51-b49c806ef8b2.json
6e203760-3a68-4d42-ae62-bb4387d5bd97,ENTOCORT 0.02MG/ML  7enema,29C,,,20836,,,,,,tablet,ENTOCORT 0.02MG/ML 7enema,2025-07-31T20:21:57.178229,IL,nan,,,,,,,ENTOCORT 0.02MG/ML  7enema,,,,,units,7.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e203760-3a68-4d42-ae62-bb4387d5bd97.json
6e24494d-eda5-42bf-b9a3-8dff12d7fcf6,OTEZLA 10 MG,prescription,L04AA32,APREMILAST,7625,,,WHO ATC Classification,,ILS,film coated tablets,APREMILAST,2025-07-31T06:18:33.538442,IL,ניאופרם,,1544.751025,1309.111096,1114.137103,,,OTEZLA STARTER PACK 27 F.C.TAB (4X10MG 4X20MG 19X30MG),15462,,31118,BLISTER PVC,units,27.0,153 91 34274 04,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Otezla is indicated:- For treatment of adult patients with active psoriatic arthritis (PsA).- For adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (PSOR).- For the treatment of adult patients with oral ulcers associated with Behçet’s disease (BD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e24494d-eda5-42bf-b9a3-8dff12d7fcf6.json
6e244e90-e653-432b-804d-a20c46fba8a2,ACTEMRA 162 MG S.C.,prescription,L04AC07,TOCILIZUMAB,7772,,,WHO ATC Classification,,ILS,solution for injection,TOCILIZUMAB/ 0.9  ML,2025-07-31T00:06:17.669308,IL,רוש,,3401.763052,2882.850172,2620.772884,,,ACTEMRA 162 MG S.C. 4 SYRINGE PREFILLED,9812,,71842,SYRINGE PREFILLED  GLASS TYPE I,units,4.0,153 15 34111 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"- Actemra in combination with methotrexate (MTX) is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease modifying anti rheumatic drugs (DMARDs) or tumor necrosis factor (TNF) antagonists. In these patients, Actemra can be given as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate. - Actemra has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function when given in combination with methotrexate. - Actemra in combination with methotrexate (MTX) in indicated for the treatment of severe, active and progressive rheumatoid arthritis (RA) in adults not previously treated with MTX - Actemra (tocilizumab) is indicated for the treatment of giant cell arteritis (GCA) in adult patients.  - Actemra in combination with methotrexate (MTX) is indicated for the treatment of juvenile idiopathic polyarthritis (pJIA; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with MTX. Actemra can be given as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate. - Actemra is indicated for the treatment of active systemic juvenile idiopathic arthritis (sJIA) in patients 1 year of age and older, who have responded inadequately to previous therapy with NSAIDs and systemic corticosteroids. Actemra can be given as monotherapy (in case of intolerance to MTX or where treatment with MTX is inappropriate) or in combination with MTX.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e244e90-e653-432b-804d-a20c46fba8a2.json
6e2ca0c0-01bd-42b7-b766-dd1d7268d9d1,FORXIGA 10 MG,prescription,A10BX09,DAPAGLIFLOZIN,7585,,,WHO ATC Classification,,ILS,film coated tablets,DAPAGLIFLOZIN PROPANEDIOL 12.30 MG/DOSE,2025-07-31T03:17:26.416399,IL,אסטראזנקה,,196.5410065,166.5601824,133.2481459,,,FORXIGA 10MG 30TAB,6545,,58567,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,152 58 34013 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Type 2 diabetes mellitusForxiga is indicated in adults aged 18 years and older for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise•	as monotherapy when metformin is considered inappropriate due to intolerance.•	in addition to other medicinal products for the treatment of type 2 diabetes.Heart FailureForxiga is indicated in adults for the treatment of symptomatic chronic heart failureChronic kidney diseaseForxiga is indicated in adults for the treatment of chronic kidney disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e2ca0c0-01bd-42b7-b766-dd1d7268d9d1.json
6e2e9ffa-1510-4c8d-9da8-7a285491e897,SABRILAN,prescription,N03AG04,VIGABATRIN,4300,,,WHO ATC Classification,,ILS,film coated tablets,VIGABATRIN,2025-07-31T07:56:00.417642,IL,פאדאגיס,,242.714173,205.6899863,164.551989,,,SABRILAN 500MG 100TAB,19015,,9235,BLISTER PVC/PVDC,units,100.0,058 94 27254 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment in combination with other anti epileptic drugs for patients with resistant partial epilepsy with or without secondary generalisation, that is where all other appropriate drug combinations have proven inadeqate or have not been tolerated.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e2e9ffa-1510-4c8d-9da8-7a285491e897.json
6e316340-11f2-4cb2-93d3-b8f1606ae7f3,JANUVIA 100 MG,prescription,A10BH01,SITAGLIPTIN,6106,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS MONOHYDRATE PHOSPHATE,2025-07-31T04:17:32.734244,IL,מ.ס.ד. ישראל,,98.22674377,83.24300319,61.89070869,,,JANUVIA 25MG 28TAB,10040,,86456,BLISTER PVC/PE/PVDC/AL,units,28.0,138 15 31556 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.Important limitations of use:Januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.Januvia has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januvia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e316340-11f2-4cb2-93d3-b8f1606ae7f3.json
6e3a86ad-3c00-42b0-85bc-2ba4f1ec0631,SEROQUEL 100 MG,prescription,N05AH04,QUETIAPINE,4131,,,WHO ATC Classification,,ILS,film coated tablets,QUETIAPINE AS FUMARATE,2025-07-31T08:06:44.151107,IL,צמל,,29.99827624,25.422268,18.5564,,,SEROQUEL 25MG 30TAB,19418,,25350,BLISTER PVC/ALUMINIUM,units,30.0,109 40 29314 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of schizophrenia.   Treatment of manic episodes associated with bipolar disorder. Treatment of major depressive episodes in bipolar disorders.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e3a86ad-3c00-42b0-85bc-2ba4f1ec0631.json
6e4228a7-dd1f-4ddd-ab76-84add2ddc36d,ZALDIAR,prescription,N02BE01,PARACETAMOL,4998,,,WHO ATC Classification,,ILS,film coated tablets,"PARACETAMOL, TRAMADOL HYDROCHLORIDE 37.5  MG",2025-07-31T10:42:52.361121,IL,ליברה,,18.0097315,15.262485,11.1405,,7290008872300,ZALDIAR 20 TAB,26149,,6007,BLISTER PAPER/PET/ALUMINIUM-PVC,units,20.0,135 90 31296 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of moderate to severe pain.The use of Zaldiar should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e4228a7-dd1f-4ddd-ab76-84add2ddc36d.json
6e58854f-04ea-48fd-a13c-698c760ce1cc,GLYXAMBI 10 MG/5 MG,prescription,A10BD19,LINAGLIPTIN AND EMPAGLIFLOZIN,7821,,,WHO ATC Classification,,ILS,film coated tablets,"LINAGLIPTIN, EMPAGLIFLOZIN",2025-07-31T03:38:02.997166,IL,בורינגר אינגלהיים,,365.0139001,309.3338274,263.2628318,,,GLYXAMBI 10 MG/5 MG 30 F.C.TAB,7934,,41768,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,155 76 34531 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,GLYXAMBI tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.  Limitations of UseGLYXAMBI is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.GLYXAMBI has not been studied in patients with a history of pancreatitis.  It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using GLYXAMBI.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e58854f-04ea-48fd-a13c-698c760ce1cc.json
6e67ae07-e692-4866-98d0-7f6194cdeab7,MINESSE,prescription,G03AA10,GESTODENE AND ESTROGEN,4508,,,WHO ATC Classification,,ILS,film coated tablets,"ETHINYLESTRADIOL 0.015  MG, GESTODENE 0.06  MG",2025-07-31T05:24:31.181790,IL,פיזר,,47.87526415,40.57225956,29.614788,,7290008142946,MINESSE 28TAB,13042,,30847,BLISTER PVC/ALUMINIUM,units,28.0,122 57 30271 11,valid,37.0,per os,1.4,34,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e67ae07-e692-4866-98d0-7f6194cdeab7.json
6e7f77a5-f680-4790-a6c6-b6e160b4c2e4,POTELIGEO 4 MG/ML,prescription,L01FX09,MOGAMULIZUMAB,9342,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,MOGAMULIZUMAB/,2025-07-31T06:47:40.488192,IL,מדיסון,,6426.659211,5446.321607,4951.201461,,7290018081402,POTELIGEO  20MG/5ML  1 VIAL,23280,,43900,VIAL GLASS TYPE I,units,1.0,172 20 37345 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,POTELIGEO is indicated for the treatment of adult patients with mycosis fungoides (MF) or Sézary syndrome (SS) who have received at least one prior systemic therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e7f77a5-f680-4790-a6c6-b6e160b4c2e4.json
6e882b3e-1f5a-46ab-936b-9c8901eab3fe,SIRAN 200 MG EFFERVESCENT TABLETS,29C,R05CB01,ACETYLCYSTEINE,20266,,,WHO ATC Classification,,ILS,tablets effervescent,ACETYLCYSTEINE,2025-07-31T13:42:24.068424,IL,nan,,nan,nan,nan,,7290004448134,ACETYLCYSTEINE FOR INHALATION 20% 10VIALX20ML,,,,TUBE POLYPROPYLENE,units,10.0,112 05 27057 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Mucolytic in respiratory tract disorders where reduction of sputum viscosity is required.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e882b3e-1f5a-46ab-936b-9c8901eab3fe.json
6e927c91-9157-4707-a32e-844f57dcfa50,RINGER LACTATE S.A.L.F,prescription,B05BB01,ELECTROLYTES,8683,,,WHO ATC Classification,,ILS,solution for infusion,"CALCIUM CHLORIDE DIHYDRATE 0.27 MG/ML, POTASSIUM CHLORIDE 0.4 MG/ML, SODIUM CHLORIDE/ML, SODIUM LACTATE 3.2 MG/ML",2025-07-31T07:35:23.243365,IL,רז פרמהצפטי,,22.19830015,18.81211961,13.73147417,,7290015863452,RINGER LACTATE S.A.L.F 500 ML BOTTLE,,,59050,BOTTLE POLYPROPYLENE,units,1.0,163 77 35516 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Source of water and electrolytes. Regulation or maintenance of metabolic acidosis ( except lactic acidosis).,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6e927c91-9157-4707-a32e-844f57dcfa50.json
6ea632b8-8ae8-4675-a9f8-60ad20288b39,BYLVAY 1200 MICROGRAMS,prescription,A05AX05,ODEVIXIBAT,9197,,,WHO ATC Classification,,ILS,"capsule, hard",ODEVIXIBAT AS SESQUIHYDRATE,2025-07-31T00:47:44.317946,IL,מדיסון,,101517.5566,86031.83149,78210.7559,,,BYLVAY 1200 MCG 30 HARD CAPS,,,25917,BOTTLE HDPE,units,30.0,171 44 37200 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older.Bylvay is indicated for the treatment of cholestatic pruritus in patients 12 months of age and older with Alagille syndrome (ALGS).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ea632b8-8ae8-4675-a9f8-60ad20288b39.json
6eb7a6d7-9dfe-45fb-843d-3d33ed728ea9,"HEPARIN SODIUM ROVI 5,000 IU/ML",prescription,B01AB01,HEPARIN,8833,,,WHO ATC Classification,,ILS,solution for injection,HEPARIN SODIUM/,2025-07-31T03:45:15.394615,IL,קמהדע,,2598.61945,2202.219971,2002.018155,,7290011225995,HEPARIN SODIUM ROVI 5000 IU/ML 5 ML 100 VIALS,,,60994,VIAL GLASS TYPE I,units,100.0,162 77 35345 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"• Prevention of thromboembolic disorders• As part of the treatment of venous or arterial thromboembolic disorders (including the early treatment of heart attacks as well as unstable angina pectoris)• For anticoagulation during treatment or operation with an extracorporeal circulation (e.g. heart/lung machine, haemodialysis)", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6eb7a6d7-9dfe-45fb-843d-3d33ed728ea9.json
6ebc4f2b-ae64-433b-bee6-c7a39d40673d,FLUSALMER S.K. 50/250 MCG,prescription,R03AK06,SALMETEROL AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,8726,,,WHO ATC Classification,,ILS,powder for inhalation,"SALMETEROL AS XINAFOATE, FLUTICASONE PROPIONATE",2025-07-31T03:14:11.132870,IL,SK PHARM(KS KIM),,133.3809242,113.0346815,84.0406554,,7290016845266,FLUSALMER S.K 50/250 MCG 60 DOSES,6629,,29556,BLISTER ALUMINIUM,units,60.0,164 50 35043 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"FLUSALMER SK is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate . FLUSALMER SK is indicated for the symptomatic treatment of patients with COPD, with a FEV1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who havesignificant symptoms despite regular bronchodilator therapy.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ebc4f2b-ae64-433b-bee6-c7a39d40673d.json
6ec3cc21-8466-42b8-bdb5-cfb9030919b8,CHOLBAM 250 MG,prescription,A05AA03,CHOLIC ACID,7608,,,WHO ATC Classification,,ILS,"capsule, hard",CHOLIC ACID,2025-07-31T01:09:54.167726,IL,מגאפארם,,36730.58188,31127.61314,28297.83013,,345043002025,CHOLBAM 50MG 90CAPS,9996,,62151,BOTTLE HDPE,units,90.0,155 89 34270 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"• Cholbam is indicated for the treatment of inborn errors in primary bile acid synthesis due to Sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, CTX) deficiency, • 2- (or alfa - ) methylacyl-CoA racemase (AMACR) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• Cholesterol 7 alfa - hydroxylase (CYP7A1) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• 3β-hydroxy-5-C27-steroid oxidoreductase deficiency (also known as 3β-hydroxy-5-C27-steroid dehydrogenase/isomerase or 3β-HSD or HSD3β7.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ec3cc21-8466-42b8-bdb5-cfb9030919b8.json
6ed22dd3-e1d6-40be-a3a1-b982d614da7a,COMBIGAN,prescription,S01EA05,BRIMONIDINE,6069,,,WHO ATC Classification,,ILS,"eye drops, solution","TIMOLOL AS MALEATE 0.5 %W/V, BRIMONIDINE TARTRATE 0.2 %W/V",2025-07-31T01:27:03.394007,IL,אב-וי,,60.94862209,51.65137695,37.701735,,,COMBIGAN EYE DROPS 5 ML,3916,,86189,BOTTLE LDPE,units,5.0,137 56 31401 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Combigan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ed22dd3-e1d6-40be-a3a1-b982d614da7a.json
6ed344b2-ebb0-4563-a8cc-e0d4b28b331f,TEGRETOL 200 MG,prescription,N03AF01,CARBAMAZEPINE,605,,,WHO ATC Classification,,ILS,tablets,CARBAMAZEPINE,2025-07-31T09:10:21.132083,IL,נוברטיס פארמה,,32.15584306,27.25071567,19.89103333,,7298087000836,TEGRETOL SYR2% 250ML,20037,,7165,BLISTER PVC/PE/PVDC,units,250.0,015 41 24602 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic depressive illness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ed344b2-ebb0-4563-a8cc-e0d4b28b331f.json
6eddec77-0e99-423c-a72a-236538ca08fb,SUNLENCA FILM-COATED TABLETS,prescription,J05AX31,LENACAPAVIR ,9252,,,WHO ATC Classification,,ILS,film coated tablets,LENACAPAVIR  AS SODIUM,2025-07-31T08:52:42.726799,IL,גיליאד,,105865.2522,89716.31945,81560.29041,,5391507148285,SUNLENCA 463.5 MG 2 VIALS,,,17502,BLISTER PVC/ALUMINIUM,units,2.0,173 21 37470 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sunlenca film-coated tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen, for oral loading prior to administration of long-acting lenacapavir injection.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6eddec77-0e99-423c-a72a-236538ca08fb.json
6ef9d817-19b6-4e60-8964-d639df0921f8,UTROGESTAN 100,29C,G03DA04,PROGESTERONE,20206,,,WHO ATC Classification,,ILS,capsules,PROGESTERONE,2025-07-31T15:40:57.907648,IL,nan,,nan,nan,nan,,,PROGESTERONE RETARD PHARLON 500MG/2ML 3AMP,,,,BLISTER PVC/ALUMINIUM,units,3.0,132 44 26341 11,valid,nan,"per os, vaginal",1.4,36,,,,,,,,,,0,,"Vaginal or oral addministration: Disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).Vaginal administration: Progesterone substitution for ovary deprived women in situation of total progesterone deficiency. Supplementation of the luteal phase during in vitro fertilization cycles. Supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. In cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. For all other progesterone indications, in the case of : Adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ef9d817-19b6-4e60-8964-d639df0921f8.json
6f00e0ea-bed6-47bb-9eb5-f351bd00ab24,NORVIR 100 MG TABLETS,prescription,J05AE03,RITONAVIR,7219,,,WHO ATC Classification,,ILS,film coated tablets,RITONAVIR,2025-07-31T05:52:52.193728,IL,אב-וי,,90.28164305,76.50987039,56.884662,,8054083026978,NORVIR 100MG 30 F.C.TAB,14527,,17398,BOTTLE HDPE,units,30.0,148 06 33504 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Is indicated alone or in combination with other antiretroviral agents for the treatment of patients with HIV infection when therapy is warranted based on clinical and/or immunological evidence of disease progression,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f00e0ea-bed6-47bb-9eb5-f351bd00ab24.json
6f0b44bc-080f-43eb-9f4f-4e07afed3cb7,EPREX/PROTECS 20000 IU/0.5ML 1SYRINGE,prescription,,,6157,,,,,ILS,tablet,EPREX/PROTECS 20000 IU/0. 1SYRINGE,2025-07-31T19:07:06.537874,IL,יאנסן סילג,,709.2040396,601.0203725,511.5067,,,EPREX/PROTECS 20000 IU/0.5ML 1SYRINGE,5470,,86952,,units,1.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f0b44bc-080f-43eb-9f4f-4e07afed3cb7.json
6f25d90f-5ece-42b9-9598-f999e1c5e460,PIFELTRO 100 MG FILM - COATED TABLETS,prescription,G05AG06,DORAVIRINE,8524,,,WHO ATC Classification,,ILS,film coated tablets,DORAVIRINE,2025-07-31T06:42:52.695053,IL,מ.ס.ד. ישראל,,1804.002533,1528.815774,1301.119808,,7290017512150,PIFELTRO 100 MG 30 TAB,,,60678,BOTTLE HDPE,units,30.0,164 62 36060 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,"Pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults infected with HIV-1 without past or present evidence of viral resistance to doravirine.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f25d90f-5ece-42b9-9598-f999e1c5e460.json
6f273581-ae33-467a-bf7c-3824b6a9c7a3,GLYCOPYRROLATE 1MG 100 TAB,29C,,,20085,,,,,,tablet,GLYCOPYRROLATE 1MG,2025-07-31T20:32:31.676973,IL,nan,,,,,,,GLYCOPYRROLATE 1MG 100 TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f273581-ae33-467a-bf7c-3824b6a9c7a3.json
6f2b9cfe-afdf-4539-a5e3-4599bdd7f3c2,EXCEDRIN,off-the-counter,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",5406,,,WHO ATC Classification,,ILS,caplets,"PARACETAMOL, ACETYLSALICYLIC ACID, CAFFEINE",2025-07-31T11:51:31.412765,IL,ג.ס.ק,,57.8318,49.01,nan,,7290105040077,EXCEDRIN 50 CAPLETS,,,,BLISTER PVC/PCTFE/PVC,units,50.0,141 82 31782 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For temporary relief of the pain of headache, mild to moderate pain associated with migraine headache,  pain of menstrual descomfort and pain accompanied by fever.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f2b9cfe-afdf-4539-a5e3-4599bdd7f3c2.json
6f45d40e-e3f3-4bcb-a0b3-1af559dcd609,FEIBA 1000U,prescription,B02BD03,FACTOR VIII INHIBITOR BYPASSING ACTIVITY,6807,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection/infusion,FACTOR VIII INHIBITOR BYPASSING FRACTION 1000  U/VIAL,2025-07-31T02:55:36.183584,IL,טקדה,,3617.633702,3065.791409,2787.083099,,5413760377667,FEIBA NF 1000 IU/VIAL,6474,,25660,VIAL GLASS TYPE II,units,1.0,026 15 25390 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Control of bleeding episodes in haemophilia A patients with Factor VIII Inhibitors and also in patients with acquired Factor VIII Inhibitors .Control of bleeding in hemophilia B patients with inhibitors, if no other specific treatment is available.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f45d40e-e3f3-4bcb-a0b3-1af559dcd609.json
6f5cbf5e-40f5-41ac-9785-719c0ba48b6b,CARDIOXANE,prescription,V03AF02,DEXRAZOXANE,4051,,,WHO ATC Classification,,ILS,powder for solution for infusion,DEXRAZOXANE AS HYDROCHLORIDE/VIAL,2025-07-31T00:55:13.525813,IL,מגאפארם,,950.4580924,805.4729955,685.5089323,,,CARDIOXANE 500MG VIAL PWDR FOR INFUS,3698,,26704,VIAL GLASS TYPE I,units,1.0,109 84 29292 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Prevention of cardiotoxicity in adult women with advanced and/or metastatic  breast cancer at high risk of heart failure who have received a prior cumulative dose of 300 mg/m2 of doxorubicin or a prior cumulative dose of 540 mg/m2 of epirubicin when further anthracycline treatment is required.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f5cbf5e-40f5-41ac-9785-719c0ba48b6b.json
6f5f0995-b78d-4864-82cf-eddb7c0ddfff,PERPHENAN 4 MG,prescription,N05AB03,PERPHENAZINE,2087,,,WHO ATC Classification,,ILS,film coated tablets,PERPHENAZINE,2025-07-31T06:38:30.435223,IL,תרו,,nan,nan,nan,,7-290000-809823,PERPHENAN 4MG 30TAB,16119,,1681,BLISTER PVC/ALUMINIUM,units,30.0,015 38 24729 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tranquilizer,antiemetic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f5f0995-b78d-4864-82cf-eddb7c0ddfff.json
6f60a210-ed4f-4c62-92f4-386d9800e4ca,OFLOXACINA,prescription,J01MA01,OFLOXACIN,7094,,,WHO ATC Classification,,ILS,solution for infusion,OFLOXACIN AS HYDROCHLORIDE/ML,2025-07-31T06:04:38.248980,IL,ביואבניר,,123.2264118,104.4291625,77.6425,,132483098500,OFLOXACINA 2MG/ML (100ML),15422,,30085,BOTTLE GLASS TYPE I,units,1.0,132 48 30985 00,valid,34.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. Prevention of infections in patients with a signifcant reduction of resistance to infections.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f60a210-ed4f-4c62-92f4-386d9800e4ca.json
6f813c2d-b29f-427b-a615-bc1c658b72b3,AMINOPLASMAL B. BRAUN 10% E,prescription,B05CB10,COMBINATIONS,9101,,,WHO ATC Classification,,ILS,solution for infusion,"ISOLEUCINE 5.00 G/L, LEUCINE 8.9 G/L, METHIONINE 4.40 G/L, PHENYLALANINE 4.70 G/L, THREONINE 4.20 G/L, TRYPTOPHAN 1.60 G/L, VALINE 6.20 G/L, ARGININE 11.50 G/L, HISTIDINE 3.00 G/L, GLYCINE 12.00 G/L, L- ALANINE 10.50 G/L, PROLINE 5.50 G/L, ASPARTIC ACID 5.60 G/L, GLUTAMINE 7.20 G/L, SERINE 2.30 G/L, TYROSINE 0.40 G/L, POTASSIUM ACETATE 2.453 G/L, SODIUM ACETATE TRIHYDRATE 2.858 G/L, MAGNESIUM CHLORIDE HEXAHYDRATE 0.508 G/L, LYSINE AS ACETATE 8.56 G/L, DISODIUM PHOSPHATE DODECAHYDRATE 3.581 G/L",2025-07-31T00:18:45.612354,IL,לפידות,,1588.665841,1346.327044,1145.81025,,,AMINOPLASMAL B. BRAUN 10% E 500ml 10 BOTTLE,,,18704,BOTTLE GLASS TYPE II,units,5000.0,150 94 33650 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Supply of amino acids and a limited amount of electrolytes for parenteral nutrition, when oral or enteral nutrition is impossible, insufficient or contraindicated. For adults, adolescents and children over 2 years of age.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f813c2d-b29f-427b-a615-bc1c658b72b3.json
6f947191-5fdc-4d4d-ac77-f912e6798237,NUVIGIL 150 MG,prescription,N06BA07,MODAFINIL,7833,,,WHO ATC Classification,,ILS,tablets,ARMODAFINIL,2025-07-31T05:58:36.853033,IL,טבע,,nan,nan,nan,,,NUVIGIL 150 MG 30TAB,14599,,51369,BLISTER PVC/ALUMINIUM,units,30.0,155 84 34389 06,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,"Nuvigil is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f947191-5fdc-4d4d-ac77-f912e6798237.json
6f950647-4f01-4e8e-b6ba-5d136fed8bea,CEFTRIAXONE - FRESENIUS,prescription,J01DD04,CEFTRIAXONE,8607,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFTRIAXONE AS SODIUM/VIAL,2025-07-31T01:02:03.294971,IL,ניאופרם,,262.6035425,222.545375,178.0363,,,CEFTRIAXONE - FRESENIUS 1000MG 10 VIAL,10671,,437,VIAL GLASS TYPE II,units,10.0,149 94 33587 00,valid,25.0,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,"* Ceftriaxone-Fresenius is indicated for the treatment of the following infections in adults and children including term neonates (from birth) :- Bacterial Meningitis- Community acquired pneumonia- Hospital acquired pneumonia- Acute otitis media- Intra-abdominal infections- Complicated urinary tract infections (including pyelonephritis)- Infections of bones and joints- Complicated skin and soft tissue infections- Gonorrhoea- Syphilis- Bacterial endocarditis* Ceftriaxone-Fresenius may be used:- For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults- For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III)) in adults and children including neonates from 15 days of age.- For Pre-operative prophylaxis of surgical site infectionsIn the management of neutropenic patients with fever that is suspected to be due to a bacterial infectionIn the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above* Ceftriaxone-Fresenius should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum.* Consideration should be given to official guidelines on the appropriate use of antibacterial agents.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f950647-4f01-4e8e-b6ba-5d136fed8bea.json
6f9ab7f5-fc47-4918-bb3c-2e72d6d1111b,PICO-SALAX ORANGE POWDER FOR SOL SACHET 2X16.1G,prescription,,,6590,,,,,ILS,solution,PICO-SALAX ORANGE POWDER FOR SOL SACHET 2X16.1G,2025-07-31T19:28:44.239256,IL,פרינג,,63.08532048,53.462136,39.7488,,,PICO-SALAX ORANGE POWDER FOR SOL SACHET 2X16.1G,16837,,4168,,units,2.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6f9ab7f5-fc47-4918-bb3c-2e72d6d1111b.json
6fdf3569-9274-409e-abba-f376270e1e02,DEPO MEDROL 40 MG/ML,prescription,H02AB04,METHYLPREDNISOLONE,35,,,WHO ATC Classification,,ILS,suspension for injection,METHYLPREDNISOLONE ACETATE/ML,2025-07-31T01:47:19.151637,IL,פיזר,,13.07391021,11.07958542,8.087288625,,72982006,DEPO MEDROL 40MG/ML 1ML,4051,,620,VIAL GLASS TYPE I,units,1.0,024 49 21841 00,valid,37.0,"periarticular, i.m, intra-articular, intra-lesional, intrabursal, intrarectal instillation, soft tissues",1.4,60,,,,,,,,,,0,Prescription required,For the treatment of conditions responsive to steroid injection therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6fdf3569-9274-409e-abba-f376270e1e02.json
6ff1176d-dd0f-4dd1-b4ad-462c3f1272b2,STRENSIQ ® 100 MG/ML,prescription,A16AB13,ASFOTASE ALFA,8375,,,WHO ATC Classification,,ILS,solution for injection,ASFOTASE ALFA/,2025-07-31T08:47:05.799707,IL,ניאופרם,,123739.334,104863.847,95330.77,,,STRENSIQ ® 40 MG/ML 12 VIALS 40 MG,9987,,62120,VIAL GLASS TYPE I,units,12.0,155 44 34545 00,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,Strensiq is indicated for long-term enzyme replacement therapy in patients with paediatric-onset hypophosphatasia to treat the bone manifestations of the disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/6ff1176d-dd0f-4dd1-b4ad-462c3f1272b2.json
700c991e-7536-4c95-b0a1-bedc7414b64d,FRISIUM,prescription,N05BA09,CLOBAZAM,6267,,,WHO ATC Classification,,ILS,tablets,CLOBAZAM,2025-07-31T03:20:35.856030,IL,סאנופי אוונטיס,,15.89159761,13.4674562,9.83026,,7290012711039,FRISIUM 10MG 30TAB,6428,,80292,BLISTER PVC/ALUMINIUM,units,30.0,125 90 24542 21,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Frisium is a 1,5-benzodiazepine indicated for the short-term relief (2 – 4 weeks) only of anxiety in adult patients that is severe, disabling or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short term psychosomatic, organic or psychotic illness.The use of Frisium to treat short-term “mild” anxiety is inappropriate and unsuitable.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/700c991e-7536-4c95-b0a1-bedc7414b64d.json
70128164-ae95-4050-88e0-70879fd8f789,MEGAXIN IV,prescription,J01MA14,MOXIFLOXACIN,4279,,,WHO ATC Classification,,ILS,solution for infusion,MOXIFLOXACIN AS HYDROCHLORIDE 1.6 MG/ML,2025-07-31T05:08:37.599031,IL,באייר,,40.32825468,34.17648854,24.946342,,7298074020410,MEGAXIN 400MG 5TAB,13628,,81895,BOTTLE GLASS TYPE II,units,5.0,126 36 30540 00,valid,37.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Megaxin IV is indicated for the treatment of adults (> 18 years of age) with Community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and Complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. Therapy with Megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70128164-ae95-4050-88e0-70879fd8f789.json
702cc559-4646-473f-a5e5-ba7729f3e06b,VESOMNI,prescription,G04CA53,TAMSULOSIN AND SOLIFENACIN,7340,,,WHO ATC Classification,,ILS,tablets modified release,"TAMSULOSIN HYDROCHLORIDE 0.4  MG, SOLIFENACIN SUCCINATE",2025-07-31T08:26:49.347469,IL,טבע,,217.034745,183.92775,147.1422,,,SOLIFENACIN TEVA 10MG 30TAB,9727,,49804,BLISTER PA/ALUMINIUM/PVC,units,30.0,162 69 35421 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic hyperplasia (BPH) in men who are not adequately responding to treatment with monotherapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/702cc559-4646-473f-a5e5-ba7729f3e06b.json
7030ac9b-0bc8-4a21-9724-331d73900994,SMOFKABIVEN,prescription,,,7112,,,,,ILS,emulsion for infusion,"FISH OIL/, OLIVE OIL/, TRIGLYCERIDES, MEDIUM-CHAIN/, SOYBEAN OIL/, ZINC SULFATE HEPTAHYDRATE 0.023 G /, SODIUM ACETATE TRIHYDRATE 5.62 G /, POTASSIUM CHLORIDE 4.48 G /, MAGNESIUM SULFATE HEPTAHYDRATE 2.47 G /, SODIUM GLYCEROPHOSPHATE HYDRATE 4.18 G /, CALCIUM CHLORIDE DIHYDRATE 0.74 G /, L- VALINE 6.2 G /, L- TYROSINE 0.40 G /, L- TRYPTOPHAN 2.0 G /, L- THREONINE 4.4 G /, TAURINE 1.0 G /, L- SERINE 6.5 G /, L- PROLINE 11.2 G /, L- PHENYLALANINE 5.1 G /, L- METHIONINE 4.3 G /, L- LEUCINE 7.4 G /, L- ISOLEUCINE 5.0 G /, L-HISTIDINE 3.0 G /, L-ARGININE 12.0 G /, L- ALANINE 14.0 G /, GLUCOSE MONOHYDRATE/, L- LYSINE ACETATE 9.3 G /, AMINOACETIC ACID 11.0 G /",2025-07-31T08:22:39.563961,IL,ניאופרם,,407.4971896,345.3366167,293.9035036,,,SMOFKABIVEN 1477ML/BAG,,,,BAG POLYPROPYLENE,units,1477.0,147 81 33335 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7030ac9b-0bc8-4a21-9724-331d73900994.json
7040eb4d-7f49-418e-81ae-87e5c2047662,XANAGIS 0.25 MG,prescription,N05BA12,ALPRAZOLAM,2791,,,WHO ATC Classification,,ILS,tablets,ALPRAZOLAM 0.25   MG,2025-07-31T10:28:11.373789,IL,פאדאגיס,,17.86343,15.1385,11.05,,,XANAGIS 0.25MG 50TAB,24009,,8888,BLISTER PVC/PVDC,units,50.0,063 48 26906 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of anxiety accompanied by depression. Treatment of panic states with or without accompanying phobia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7040eb4d-7f49-418e-81ae-87e5c2047662.json
70489df0-1911-4c53-9000-9762a05563fb,PROZAC,prescription,N06AB03,FLUOXETINE,746,,,WHO ATC Classification,,ILS,capsules,FLUOXETINE AS HYDROCHLORIDE,2025-07-31T07:06:25.384522,IL,אלי לילי,,69.2562827,58.691765,43.637,,,PROZAC 20MG 56CAP,16600,,78216,BLISTER PVC/ALUMINIUM,units,56.0,046 82 26225 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Adults:Major depressive episodes.Obsessive-compulsive disorder (OCD).Bulimia nervosa: Fluoxetine is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.Children and adolescents aged 8 years and above:Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. Antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70489df0-1911-4c53-9000-9762a05563fb.json
7053868d-eb9e-4911-a45f-2f9793b2096a,FOSRENOL ® 750 MG CHEWABLE TABLETS,prescription,V03AE03,LANTHANUM CARBONATE,6489,,,WHO ATC Classification,,ILS,chewable tablets,LANTHANUM AS CARBONATE HYDRATE,2025-07-31T03:18:45.952930,IL,טקדה,,915.3102506,775.6866875,660.158883,,7290008128674,FOSRENOL 750 MG 90 CHEWTAB,6450,,81786,BOTTLE HDPE,units,90.0,140 51 31998 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in CRF patients on haemodyalisis or continuous ambulatory peritoneal dialysis (CAPD).Fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/L in whom a low phosphate diet alone is insufficient to control serum phosphate levels.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7053868d-eb9e-4911-a45f-2f9793b2096a.json
70548cae-889b-4aa9-b28d-bff8f702a0d9,OCTREOTIDE BENDALIS 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,8987,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE AS ACETATE 0.05 MG/ML,2025-07-31T06:02:14.840072,IL,מרגלית,,90.41345712,76.62157724,56.96771542,,,OCTREOTIDE BENDALIS 0.05 MG/ML 5 AMPS,,,74011,AMPOULES GLASS TYPE I,units,5.0,164 14 34086 00,valid,34.5,"s.c, i.v",1.4,60,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery. Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy.Octreotide Bendalis treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - Carcinoid tumours with features of the carcinoid syndrome. - VIPomas . - Glucagonomas . - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors or H2- antagonist therapy . - Insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy . - GRFomas. - Octreotide Bendalis is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70548cae-889b-4aa9-b28d-bff8f702a0d9.json
70641549-ebfd-476b-873e-c4dd7a04d887,CARVEDILOL TEVA ® 6.25 MG,prescription,C07AG02,CARVEDILOL,6109,,,WHO ATC Classification,,ILS,tablets,CARVEDILOL 6.25   MG,2025-07-31T00:56:38.907839,IL,טבע,,16.8191064,14.25348,10.404,,,CARVEDILOL TEVA 6.25MG 30TAB,9659,,42315,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,135 45 31252 11,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of symptomatic congestive heart failure. Carvedilol Teva  may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ACE inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70641549-ebfd-476b-873e-c4dd7a04d887.json
7069d7b7-b5d9-480b-a2c9-eb3173ddb4e7,CELLCEPT 250 MG,prescription,L04AA06,MYCOPHENOLIC ACID,3668,,,WHO ATC Classification,,ILS,capsules,MYCOPHENOLATE MOFETIL,2025-07-31T01:04:48.516627,IL,רוש,,321.1983925,272.2020275,231.6613,,7290008140188,CELLCEPT 500MG 50TAB,3391,,33841,BLISTER PVC/ALUMINIUM,units,50.0,111 34 29434 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prophylaxis of rejection in renal allograft recepients, and in patients reciving allogenic cardiac transplants. Cellcept should be used concomitantly with cyclosporin and corticosteroids.Allogenic hepatic transplant.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7069d7b7-b5d9-480b-a2c9-eb3173ddb4e7.json
70b0f4f6-6cec-4e3f-9358-dea437f44ea5,GLUCO-RITE,prescription,A10BB07,GLIPIZIDE,2858,,,WHO ATC Classification,,ILS,tablets,GLIPIZIDE,2025-07-31T03:37:04.082956,IL,פאדאגיס,,16.68573616,14.140455,10.3215,,,GLUCO-RITE 5MG 30TAB,7028,,8907,BLISTER PVC/PVDC,units,30.0,132 27 27134 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Is indicated as an adjunct to diet for the control of hyperglycemia and its associated symptomatology in patients with  diabetes mellitus type II,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70b0f4f6-6cec-4e3f-9358-dea437f44ea5.json
70c0131a-fe25-4a9f-98fc-7e9a1b1ad430,OLOPATADINE S.K.,prescription,S01GX09,OLOPATADINE,8736,,,WHO ATC Classification,,ILS,"eye drops, solution",OLOPATADINE AS HYDROCHLORIDE/,2025-07-31T06:06:10.607027,IL,SK PHARM(KS KIM),,34.8325946,29.51914797,21.54682333,,7290016845372,OLOPATADINE S.K. 1 MG/ 1 ML 1 VIAL 5 ML,15549,,59408,VIAL LDPE,units,5.0,165 05 35368 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,For the temporary prevention of itching of the eye due to allergic conjunctivitis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70c0131a-fe25-4a9f-98fc-7e9a1b1ad430.json
70e0649c-db2b-4d77-ab31-5de76d3f043f,LAMISIL ONCE,off-the-counter,,,5194,,,,,ILS,solution,TERBINAFINE AS HYDROCHLORIDE/G,2025-07-31T12:17:42.285043,IL,ג.ס.ק,,76.6174,64.93,nan,,7290011363437,LAMISIL ONCE SOL 10MG/G 4 GR,12397,,,TUBE ALUMINIUM,units,4.0,137 26 31486 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,For the treatment of athlete's foot.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70e0649c-db2b-4d77-ab31-5de76d3f043f.json
70e560e5-09bf-4479-ba20-293c9f48c9a5,XARELTO 1 MG/ML GRANULES FOR ORAL SUSPENSION,prescription,B01AF01,RIVAROXABAN,9375,,,WHO ATC Classification,,ILS,granules for oral suspension,RIVAROXABAN 19.7 MG/G,2025-07-31T10:29:43.016142,IL,באייר,,98.26706175,83.27717468,61.916115,,,XARELTO 1 MG/ML GRA FOR ORAL SUSP 100ML,,,,BOTTLE GLASS TYPE I,units,100.0,174 12 37097 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of venous thromboembolism (VTE) and prevention of VTE recurrence in term   neonates, infants and toddlers, children, and adolescents aged less than 18 years after at least 5 days of initial parenteral anticoagulation treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70e560e5-09bf-4479-ba20-293c9f48c9a5.json
70eb0085-4c68-4535-87c2-5908ed2878d3,SOLU MEDROL 1000 MG,prescription,H02AB04,METHYLPREDNISOLONE,138,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,METHYLPREDNISOLONE AS SODIUM SUCCINATE 62.5  MG/ML,2025-07-31T08:28:43.028906,IL,פיזר,,13.73210673,11.6373791,8.4944373,,7298074000658,SOLU MEDROL 40MG/ML,19108,,2019,VIAL GLASS TYPE I,units,1.0,114 10 22489 00,valid,37.0,"i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,"Solu Medrol is indicated to treat any condition in which IM or IV corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70eb0085-4c68-4535-87c2-5908ed2878d3.json
70f88754-277d-46b4-bc53-c46537fa50dd,REKAMIDE,off-the-counter,A07DA03,LOPERAMIDE,3881,,,WHO ATC Classification,,ILS,tablets,LOPERAMIDE HYDROCHLORIDE,2025-07-31T12:54:46.184576,IL,רקח,,23.4,19.83,nan,,7290015840569,REKAMID 2MG 10TAB,18041,,,BLISTER PVC/ALUMINIUM,units,10.0,119 92 29984 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Control and symptomatic relief of acute diarrhea in adults, adolescents and children aged 6 years and older.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70f88754-277d-46b4-bc53-c46537fa50dd.json
70fc9f22-cd0f-42d6-9d21-310d9f3299cb,ANDROCUR 10MG 15TAB,prescription,,,8,,,,,ILS,tablet,ANDROCUR 10MG,2025-07-31T18:59:05.306644,IL,באייר,,40.32516799,34.1738727,24.94443263,,,ANDROCUR 10MG 15TAB,1269,,238,,units,15.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/70fc9f22-cd0f-42d6-9d21-310d9f3299cb.json
71066bea-d94b-49df-a1b9-78b45cc4b6ae,BOVACLOX DC VETERINARY,29C,,,20921,,,,,ILS,suspension,"CLOXACILLIN AS BENZATHINE SALT/DOSE, AMPICILLIN AS TRIHYDRATE/DOSE",2025-07-31T14:09:28.735521,IL,nan,,nan,nan,nan,,5023534025481,CLOXACILLIN 10G INJECTION STERIMAX CANADA,,,,SYRINGE LDPE,units,1.0,083 60 92376 00,valid,nan,intramammary,1.4,24,,,,,,,,,,0,,"For routine use in cows at drying off, to treat existing intramammary infections and to assist in preventing new infections occurring during the dry period. It also aids in reducing the incidence of summer mastitis in dry cows and heifers at risk. Amongst the organisms found to be sensitive to Ampicillin and Cloxacillin are  Streptococcus agalactiae, Streptococcus spp.,Staphylococcus spp, Corynebacterium spp and Escherichia coli.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/71066bea-d94b-49df-a1b9-78b45cc4b6ae.json
7133fc77-badc-4f23-9994-2720b3c4d958,EPREX/PROTECS 3000IU/0.3ML 6 SYRINGES,prescription,,,4572,,,,,ILS,tablet,EPREX/PROTECS 3000IU/0. 6 SYRINGES,2025-07-31T19:07:52.609061,IL,יאנסן סילג,,709.5201616,601.2882725,511.7347,,,EPREX/PROTECS 3000IU/0.3ML 6 SYRINGES,5457,,86979,,units,6.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7133fc77-badc-4f23-9994-2720b3c4d958.json
7135354b-5228-4cd5-bd0a-d06ce30c8801,CONCOR 1.25 MG,prescription,C07AB07,BISOPROLOL,2757,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE 1.25  MG,2025-07-31T01:28:48.659375,IL,מרק סרונו,,15.19604,12.878,9.4,,,CONCOR 5MG 30TAB,9357,,8939,BLISTER PVC/ALUMINIUM,units,30.0,167 22 35983 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function (ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7135354b-5228-4cd5-bd0a-d06ce30c8801.json
714a6f60-af89-4bb1-8f87-d011dc393112,CRESEMBA 100 MG CAPSULES,prescription,J05AC05,ISAVUCONAZOLE,8294,,,WHO ATC Classification,,ILS,"capsule, hard",ISAVUCONAZOLE AS SULFATE,2025-07-31T01:33:09.545708,IL,פיזר,,1789.650254,1516.652825,1290.768362,,7290013592545,CRESEMBA 200MG/10ML 1 VIAL,10457,,40385,BLISTER PVC/ALUMINIUM,units,1.0,162 03 35594 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Cresemba is indicated in adults for the treatment of: Invasive aspergillosis Mucormycosis in patients for whom amphotericin B is inappropriateConsideration should be given to official guidance on the appropriate use of antifungal agents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/714a6f60-af89-4bb1-8f87-d011dc393112.json
714b25e0-c329-47ec-8d62-d6569c78c6cd,EMLA 5%,off-the-counter,N01BB54,"PRILOCAINE, COMBINATIONS",2535,,,WHO ATC Classification,,ILS,cream,"LIDOCAINE 2.5 %, PRILOCAINE 2.5 %",2025-07-31T11:34:47.735330,IL,פאדאגיס,,112.159,95.05,nan,,,EMLA CREAM 5% 30GR,5396,,,TUBE ALUMINIUM,units,30.0,043 25 25706 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"EMLA 5% Cream is indicated for: • Topical anaesthesia of the skin in connection with: o needle insertion, e.g. intravenous catheters or blood sampling; o superficial surgical procedures; in adults and in the paediatric population. • Topical anaesthesia of the genital mucosa, e.g. prior to superficial surgical procedures or infiltration anaesthesia; • Topical anaesthesia of leg ulcers to facilitate mechanical cleansing/debridement in adults only",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/714b25e0-c329-47ec-8d62-d6569c78c6cd.json
7157775e-a439-4053-aacb-bf385963a18d,RUPAFIN ORAL SOLUTION 1 MG/ML,prescription,R06AX28,RUPATADINE,9165,,,WHO ATC Classification,,ILS,solution,RUPATADINE AS FUMARATE/,2025-07-31T07:53:57.244116,IL,קמהדע,,47.45112006,40.2128154,29.35242,,7290011225872,RUPAFIN ORAL SOLUTION 1 MG/ML  120 ML,,,76816,BOTTLE PET,units,120.0,166 17 35846 00,valid,37.0,per os,1.4,30,,,,,,,,,,0,Prescription required,Symptomatic treatment of:- Allergic rhinitis (including persistent allergic rhinitis) in children aged 2 to 11 years - Urticaria in children aged 2 to 11 years,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7157775e-a439-4053-aacb-bf385963a18d.json
715bf59f-649d-4aa0-b48e-c6f2bfce05db,VIA-AVENIR 100 MG,prescription,G04BE03,SILDENAFIL,8260,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:12:00.374361,IL,ביואבניר,,80.65023231,68.3476545,50.8161,,7290010286911,VIA AVENIR 50MG 4TABS,,,55873,BLISTER PVC/PVDC/ALUMINIUM,units,4.0,147 72 33415 01,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/715bf59f-649d-4aa0-b48e-c6f2bfce05db.json
7177dd9c-86a7-43fe-9dbf-9c10d2fcaee9,HUMATIN 250MG 16CAPS,29C,,,20444,,,,,,capsule,HUMATIN 250MG,2025-07-31T20:34:47.990336,IL,nan,,,,,,,HUMATIN 250MG 16CAPS,,,,,units,16.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7177dd9c-86a7-43fe-9dbf-9c10d2fcaee9.json
7177df5f-52ab-4bc8-ab40-fc146cb8f1c9,STABILANOL,prescription,J02AC01,FLUCONAZOLE,9370,,,WHO ATC Classification,,ILS,solution for infusion,FLUCONAZOLE/ML,2025-07-31T08:37:57.839572,IL,תרימה,,138.277992,117.184739,87.1262,,7290000843407,STABILANOL 2 MG/ML IV  SOL. FOR INFUSION 200ML,23650,,9882,VIAL GLASS TYPE I,units,200.0,134 81 31179 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Stabilanol is indicated in the following fungal infections .Stabilanol is indicated in adults for the treatment of: • Cryptococcal meningitis .• Coccidioidomycosis. Invasive candidiasis.• Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.Stabilanol is indicated in adults for the prophylaxis of: • Relapse of crytopcoccal meningitis in patients with high risk of recurrence.• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.• Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation ).Stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: Stabilanol is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. stabilanol can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7177df5f-52ab-4bc8-ab40-fc146cb8f1c9.json
718a6bf9-9295-4de4-8aba-d44b4f6058e6,ESMYA 5 MG 28TAB,prescription,,,7819,,,,,ILS,tablet,ESMYA 5 MG,2025-07-31T19:09:54.993756,IL,כ.צ.ט,,653.4277948,553.7523931,471.2786324,,,ESMYA 5 MG 28TAB,5611,,44502,,units,28.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/718a6bf9-9295-4de4-8aba-d44b4f6058e6.json
718ddc2e-e07d-4be1-ac81-2177d12f2715,ALBUNORM 20 %,prescription,B05AA01,ALBUMIN,7723,,,WHO ATC Classification,,ILS,solution for infusion,"ALBUMIN HUMAN/, PLASMA PROTEIN FRACTION",2025-07-31T00:14:28.743256,IL,דובר מדיקל,,330.7165061,280.268238,238.52616,,,ALBUNORM 20% BOTTLE 100ML,,,,BOTTLE GLASS TYPE II,units,100.0,150 28 33713 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on the official recommendations",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/718ddc2e-e07d-4be1-ac81-2177d12f2715.json
7196d9c2-a8ca-4b9d-a2d0-f01323f05d75,LOTEMAX® GEL,prescription,S01BA14,LOTEPREDNOL,6453,,,WHO ATC Classification,,ILS,eye gel,LOTEPREDNOL ETABONATE/,2025-07-31T04:57:10.098734,IL,טבע,,45.8621337,38.866215,28.3695,,,LOTEMAX 0.5% EYE DROPS 5 ML,12432,,84777,BOTTLE LDPE,units,5.0,159 22 34925 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,LOTEMAX® is a corticosteroid indicated for the treatment of post-operative   inflammation and pain following ocular surgery.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7196d9c2-a8ca-4b9d-a2d0-f01323f05d75.json
71d271a6-933a-4614-937e-816a2252ad3b,NEUPOGEN 30 MU PRE-FILLED SYRINGE,prescription,L03AA02,FILGRASTIM,4135,,,WHO ATC Classification,,ILS,solution for injection,FILGRASTIM 30 MU / 0.5  ML,2025-07-31T05:43:40.231534,IL,מדיסון,,255.2158137,216.2845975,173.027678,,8715131009762,NEUPOGEN 1 PREFIL.SYR. 48MU/0.5ML,14609,,3758,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,117 22 29875 00,valid,25.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Neupogen is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia.The safety and efficacy of Neupogen are similar in adults and children receiving cytotoxic chemotherapy.Neupogen is indicated for the mobilisation of peripheral blood progenitor cells (PBPCs).In patients, children or adults, with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of ≤ 0.5 × 109/l, and a history of severe or recurrent infections, long term administration of Neupogen is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.Neupogen is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 × 109/l) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/71d271a6-933a-4614-937e-816a2252ad3b.json
721454db-32f5-43b4-93e0-a2670e8409bf,LISSIN 20 MG,prescription,N06BA12,LISDEXAMFETAMINE,9527,,,WHO ATC Classification,,ILS,tablets,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T04:49:14.455352,IL,אוניפארם,,387.3392185,328.2535896,279.3647571,,,LISSIN 40 MG 30 TAB,,,,BLISTER PVDC/ALUMINIUM,units,30.0,176 71 37820 99,valid,17.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Lissin is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Lissin is indicated for the treatment of Moderate to Severe Binge Eating Disorder (BED) for patients over 18 years.Limitation of Use:Lissin is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Lissin for the treatment of obesity have not been established.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/721454db-32f5-43b4-93e0-a2670e8409bf.json
7227172f-a648-453b-9334-d990511017e8,ALECENSA,prescription,,,7799,,,,,ILS,capsules,ALECTINIB AS HYDROCHLORIDE,2025-07-30T23:19:05.737249,IL,רוש,,24630.57312,20873.36798,18975.78907,,,ALECENSA 150MG 240 CAPS,,,77754,BLISTER ALUMINIUM,units,240.0,155 82 34552 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Adjuvant Treatment of Resected ALK-Positive Non-Small Cell Lung Cancer (NSCLC)Alecensa is indicated as adjuvant treatment in adult patients following tumor resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumors &#8805; 4 cm or node positive), as detected by a validated test.Treatment of Advanced Non-Small Cell Lung Cancer-    Alecensa is indicated for the treatment of patients with ALK positive, locally advanced or metastatic non-small cell lung cancer (NSCLC) who progressed on or are intolerant to crizotinib.-    Alecensa as monotherapy is indicated for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7227172f-a648-453b-9334-d990511017e8.json
722a2932-0885-4de5-8ea1-7600192c59f4,STAPHIDERM - B,prescription,D07CC01,BETAMETHASONE AND ANTIBIOTICS,7231,,,WHO ATC Classification,,ILS,cream,"BETAMETHASONE AS VALERATE 0.1 %W/W, FUSIDIC ACIDW/W",2025-07-31T08:40:00.747157,IL,תרימה,,39.43841194,33.422383,24.3959,,,STAPHIDERM CREAM 2% 30GR,9660,,42403,TUBE ALUMINIUM,units,30.0,177 40 37155 99,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,STAPHIDERM - B is indicated for the treatment of eczematous dermatoses when secondary bacterial infection is confirmed,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/722a2932-0885-4de5-8ea1-7600192c59f4.json
722ee950-7795-42bb-b2c4-f75a3499cd7d,YASMIN,prescription,G03AA12,DROSPIRENONE AND ESTROGEN,4401,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ETHINYLESTRADIOL 0.03   MG",2025-07-31T10:39:09.470438,IL,באייר,,101.6387957,86.13457647,64.0405773,,7-298074-040876,YASMIN  3X21TAB,25006,,3914,BLISTER PVC/ALUMINIUM,units,63.0,122 02 30220 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraception.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/722ee950-7795-42bb-b2c4-f75a3499cd7d.json
7230ed2a-e891-441f-bf9a-d7e8da3c7882,SODIUM BICARBONATE 8.4%,prescription,,,6984,,,,,ILS,solution for infusion,SODIUM BICARBONATE 8.4 %W/V,2025-07-31T08:24:21.334159,IL,לפידות,,1085.664884,920.0550271,783.025555,,4030539049382,SODIUM BICARBONATE 8.4% 100ML 20 BOTTLES,19724,,87775,BOTTLE GLASS TYPE I,units,20.0,055 42 26716 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Metabolic acidosis, urine alkalization.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7230ed2a-e891-441f-bf9a-d7e8da3c7882.json
723fab7e-5ebc-4364-857f-612dad725b39,NPLATE 250 MCG,prescription,B02BX04,ROMIPLOSTIM,6683,,,WHO ATC Classification,,ILS,powder for solution for injection,ROMIPLOSTIM/VIAL,2025-07-31T05:57:06.382207,IL,מדיסון,,2547.594192,2158.978225,1962.707477,,8715131005948,NPLATE 250MCG 1VIAL/5ML POWDER FOR SOL FOR INJ,14517,,25186,VIAL GLASS TYPE I,units,1.0,145 85 33243 00,valid,10.0,s.c,1.4,60,,,,,,,,,,0,Prescription required,"Adults:Nplate is indicated for the treatment of primary immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).Paediatrics:Nplate is indicated for the treatment of chronic primary immune thrombocytopenia (ITP) in paediatric patients one year of age and older who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/723fab7e-5ebc-4364-857f-612dad725b39.json
72421c23-e6b2-4f8f-b40c-64f73fdfb939,BETAFERON ®,prescription,L03AB08,INTERFERON BETA-1B,6119,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,INTERFERON BETA 1B 0.3  MG/VIAL,2025-07-31T00:33:38.788442,IL,באייר,,3029.091678,2567.02696,2333.660873,,72980740740821,BETAFERON 0.3MG/VIAL 15VIAL+SYR,2529,,10345,VIAL GLASS TYPE I,units,15.0,069 34 28359 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Use in ambulatory patients with relapsing-remitting multiple sclerosis (RRMS) and relapsing progressive M.S. to reduce the frequency of clinical exacerbations. Treatment of secondary progressive (SP) form of multiple sclerosis. Treatment of patients who have experienced a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, including the prescence of MRI abnormalities characteristic of M.S. and if they are determined to be at high risk of developing clinically definite multiple sclerosis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/72421c23-e6b2-4f8f-b40c-64f73fdfb939.json
7262bc4f-f027-4043-8e60-f84a2d36f014,BRIDION,prescription,V03AB35,SUGAMMADEX,6583,,,WHO ATC Classification,,ILS,solution for injection,SUGAMMADEX/ML,2025-07-31T00:42:29.243998,IL,מ.ס.ד. ישראל,,2552.159726,2162.847225,1966.22475,,7290008121620,BRIDION  10 VIALS 2ML,2541,,77549,VIAL GLASS TYPE I,units,10.0,142 27 31898 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Reversal of neuromuscular blockade induced by rocuronium or vecuronium.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7262bc4f-f027-4043-8e60-f84a2d36f014.json
7267fd8c-5d84-4961-bdde-17b7be9cfab2,RELERT 20 MG,prescription,N02CC06,ELETRIPTAN,4452,,,WHO ATC Classification,,ILS,film coated tablets,ELETRIPTAN HYDROBROMIDE 24.242   MG,2025-07-31T07:21:40.805461,IL,דקסל פארמה,,57.18108192,48.458544,35.3712,,,RELERT 20MG 3TAB,18025,,28687,BLISTER ALUMINIUM,units,3.0,124 28 30370 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Acute treatment of the headache phase of migraine attacks, with or without aura.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7267fd8c-5d84-4961-bdde-17b7be9cfab2.json
72879d3c-cd1b-4502-a6a5-c6cc190b06a1,DIFLUCAN 50 MG/5 ML,prescription,J02AC01,FLUCONAZOLE,3624,,,WHO ATC Classification,,ILS,powder for oral suspension,FLUCONAZOLE/,2025-07-31T01:55:37.189748,IL,פיזר,,50.20204376,42.54410677,31.05409253,,7290008094153,DIFLUCAN SUSP 50MG/5ML 35ML,4182,,76478,BOTTLE HDPE,units,35.0,106 79 29073 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:•	Cryptococcal meningitis.•	Coccidioidomycosis.•	Invasive candidiasis.•	Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.•	Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.•	Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.•	Candidal balanitis when local therapy is not appropriate.•	Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.•	Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:•	Relapse of cryptococcal meningitis in patients with high risk of recurrence.•	Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•	To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).•	Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.  Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/72879d3c-cd1b-4502-a6a5-c6cc190b06a1.json
728a3be4-e0a7-4a9e-81d4-a266f22db0a7,ESTELLE-35,prescription,N/A,,4807,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.035  MG, CYPROTERONE ACETATE",2025-07-31T02:37:43.564199,IL,תרו יבוא,,22.1377204,18.76078,13.694,,7290000808987,ESTELLE 35 21TAB,5407,,11996,BLISTER PVC/PVDC,units,21.0,131 46 30957 11,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of signs of androgenization in women such as pronounced forms of acne, androgenic alopecia and mild forms of hirsutism.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/728a3be4-e0a7-4a9e-81d4-a266f22db0a7.json
729a0ce1-4b86-4624-b2a6-564ad5c477f3,MAYZENT 0.25 MG,prescription,L04AA42,SIPONIMOD,8521,,,WHO ATC Classification,,ILS,film coated tablets,SIPONIMOD AS FUMARIC ACID 0.25  MG,2025-07-31T05:07:09.055914,IL,נוברטיס פארמה,,1048.106523,888.2259061,755.9369414,,7290018375266,MAYZENT 0.25 MG 12 TAB,13978,,512,BLISTER PA/ALU/PVC/ALU,units,12.0,165 54 36195 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Mayzent is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease, and active secondary progressive disease, in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/729a0ce1-4b86-4624-b2a6-564ad5c477f3.json
729c209c-a232-44b0-bf58-80a8cc55a2e0,PRADAXA 110,prescription,B01AE07,DABIGATRAN ETEXILATE,6320,,,WHO ATC Classification,,ILS,capsules,DABIGATRAN ETEXILATE AS MESILATE,2025-07-31T06:48:32.980582,IL,בורינגר אינגלהיים,,32.27913251,27.35519826,19.967298,,9006968012391,PRADAXA 75MG 10CAPS,16811,,84204,BLISTER ALUMINIUM /ALUMINIUM,units,10.0,142 96 32974 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with nonvalvular  atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/729c209c-a232-44b0-bf58-80a8cc55a2e0.json
72aa9a6b-a623-4ef0-a75f-778e6416f7ba,ARCO-TEVA 90MG 14TABS,prescription,,,8241,,,,,ILS,tablet,ARCO- 90MG S,2025-07-31T18:59:45.614791,IL,טבע,,45.16670944,38.27687241,27.93932293,,,ARCO-TEVA 90MG 14TABS,,,20087,,units,14.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/72aa9a6b-a623-4ef0-a75f-778e6416f7ba.json
72adef5b-181e-4da5-9df9-ed9754fb4c62,BENLYSTA I.V. 120 MG,prescription,L04AA26,BELIMUMAB,6840,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BELIMUMAB,2025-07-31T00:31:07.296047,IL,ג.ס.ק,,2341.182176,1984.05278,1803.684345,,7290010140893,BENLYSTA 1X400MG PWD FOR CONCENTRATE FOR INF VIAL 20ML,84607,,20589,VIAL GLASS TYPE I,units,1.0,147 37 33499 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Benlysta is indicated as add-on therapy in patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) with a high degree of disease activity (e.g., positive anti-dsDNA and low complement) despite standard therapy.Benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/72adef5b-181e-4da5-9df9-ed9754fb4c62.json
72ba6e6b-9310-4e25-ad70-2c63488b5b8d,ENTRESTO 100 MG,prescription,C09DX04,VALSARTAN AND SACUBITRIL,7791,,,WHO ATC Classification,,ILS,film coated tablets,SACUBITRIL/VALSARTAN AS SODIUM SALT COMPLEX 49/51  MG,2025-07-31T02:24:14.462678,IL,נוברטיס פארמה,,573.9739676,486.4186166,413.9732907,,290014257498,ENTRESTO 100 MG 56 F.C.TAB,5598,,32620,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,154 98 34485 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Entresto is indicated for the treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction. Entresto has been shown to reduce the rate of cardiovascular death and heart failure hospitalisation compared to angiotensin converting enzyme (ACE) inhibitor therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/72ba6e6b-9310-4e25-ad70-2c63488b5b8d.json
72c66cf2-4ce0-4451-9c59-ab670f08b9f4,CONCERTA 18 MG,prescription,N06BA04,METHYLPHENIDATE,4627,,,WHO ATC Classification,,ILS,tablets extended release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T01:27:57.063614,IL,יאנסן סילג,,170.9435144,144.8673851,115.8939081,,7290008124966,CONCERTA 36MG XR 30TAB,3736,,56949,BOTTLE HDPE,units,30.0,126 85 30589 24,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Concerta is indicated for the treatment of Attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/72c66cf2-4ce0-4451-9c59-ab670f08b9f4.json
72d1ba41-2938-43bf-9411-e12e8f69d9d7,ENTECAVIR S.K. 0.5 MG,prescription,J05AF10,ENTECAVIR,8733,,,WHO ATC Classification,,ILS,film coated tablets,ENTECAVIR AS MONOHYDRATE 0.5  MG,2025-07-31T02:23:31.945033,IL,SK PHARM(KS KIM),,2274.594984,1927.622868,1640.5301,,7290016845525,ENTECAVIR S.K. 0.5 MG 30 TAB,5677,,59406,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,165 57 36439 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Entecavir S.K. is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with: - Compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels.- Decompensated liver disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/72d1ba41-2938-43bf-9411-e12e8f69d9d7.json
72fe1268-af63-44b8-acdb-e8b35a70b4c0,ELMIRON 100MG 100CAPS,29C,,,20069,,,,,,capsule,ELMIRON 100MG,2025-07-31T20:20:43.537168,IL,nan,,,,,,,ELMIRON 100MG 100CAPS,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/72fe1268-af63-44b8-acdb-e8b35a70b4c0.json
73289baf-2e9b-4977-9091-8edd0e28941d,EUCREAS 50/1000 MG,prescription,A10BA02,METFORMIN,6290,,,WHO ATC Classification,,ILS,film coated tablets,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",2025-07-31T02:43:07.918263,IL,נוברטיס פארמה,,109.2458868,92.58126409,68.8336536,,,EUCREAS 50/850MG 60 FC TAB,5511,,20830,BLISTER ,units,60.0,147 90 33627 01,valid,34.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Eucreas is indicated in the treatment of type 2 diabetes mellitus:- Eucreas is indicated in the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.- Eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea.- Eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in adult patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73289baf-2e9b-4977-9091-8edd0e28941d.json
7335393d-4ea2-43e0-be0c-04c13add2334,RIVAROXABAN TARO 10 MG,prescription,B01AX06,RIVAROXABAN,9296,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:44:02.311454,IL,תרו יבוא,,270.578248,229.3036,195.152,,,RIVAROXABAN TARO 10 MG 30 TAB,,,24886,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,162 53 35228 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"*  Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.*  Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7335393d-4ea2-43e0-be0c-04c13add2334.json
7364782f-ffc6-4ccc-aecb-3d465443fc1d,LITORVA 10,prescription,C10AA05,ATORVASTATIN,6757,,,WHO ATC Classification,,ILS,tablets,ATORVASTATIN AS CALCIUM,2025-07-31T04:50:17.953413,IL,דקסל פארמה,,24.426826,20.7007,15.11,,7290010578429,LITORVA 10MG 30 TAB,12449,,26467,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,145 31 33305 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Litorva is indicated as an adjunct to diet for reduction of elevated total cholesterol LDL- cholesterol apolipoprotein B and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Litorva is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable. Pediatric patients (10-17 years of age) : Atorvastatin is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:  1. LDL-C remains >or = 190 mg/dl or   2. LDL-C remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the pediatric patient. Prevention of cardiovascular and/or cerebrovascular event sush as MI or stroke as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor. In patients with clinically evident coronary heart disease, Litorva is indicated to : Reduce the risk of non-fatal myocardial infarction. Reduce the risk of fatal and non fatal stroke. Reduce the risk for revascularization procedures. Reduce the risk of hospitalization for CHF. Reduce the risk of angina.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7364782f-ffc6-4ccc-aecb-3d465443fc1d.json
736bea8a-1a16-458f-bc97-fa04eef5a87e,ACETOSAL 300,off-the-counter,A01AD05,ACETYLSALICYLIC ACID,3795,,,WHO ATC Classification,,ILS,tablets,ACETYLSALICYLIC ACID,2025-07-31T11:03:04.715782,IL,רקח,,19.94,16.9,nan,,7290008090162,ACETOSAL 300MG 30TAB,1617,,,BLISTER PVC/ALUMINIUM,units,30.0,020 68 20911 00,valid,nan,per os,1.4,30,,,,,,,,,,0,,"Analgesic, antipyretic, treatment of non-infective inflammatory conditions.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/736bea8a-1a16-458f-bc97-fa04eef5a87e.json
7370173d-c2af-4a33-9575-15affad70a32,PREGABALIN INOVAMED 150 MG,prescription,N03AX16,PREGABALIN,8323,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:53:11.178546,IL,אינובמד,,43.82877422,37.143029,27.1117,,7290104530364,PREGABALIN INOVAMED 25 MG 56 CAPS,10300,,4213,BLISTER PVC/ALUMINIUM,units,56.0,156 17 34774 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Pregabalin Inovamed is indicated for the:* treatment of peripheral and central neuropathic pain in adults. * Management of Fibromyalgia.* Treatment of Generalised Anxiety Disorder (GAD) in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7370173d-c2af-4a33-9575-15affad70a32.json
73763dbe-3f08-4281-ae2f-a2a14f5b26ad,ETOPOSIDE TEVA,prescription,L01CB01,ETOPOSIDE,8578,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ETOPOSIDE/ML,2025-07-31T02:40:45.894184,IL,טבע,,85.7034,72.63,54.0,,7290106061774,ETOPOSIDE VIAL 200MG/10 ML,,,35133,VIAL GLASS TYPE I,units,10.0,106 48 28897 05,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Hodgkin's disease. Malignant (non-Hodgkin's) Lymphomas, especially of the Histiocytic variety.Acute Non-Lymphocytic leukemia.  Management of refractory testicular tumors and of small cell lung cancer.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73763dbe-3f08-4281-ae2f-a2a14f5b26ad.json
73a12361-de33-4b00-b996-92c2bcb4bd83,XARELTO 1 MG/ML GRANULES FOR ORAL SUSPENSION,prescription,B01AF01,RIVAROXABAN,6948,,,WHO ATC Classification,,ILS,granules for oral suspension,RIVAROXABAN 19.7 MG/G,2025-07-31T10:30:18.728199,IL,באייר,,259.28671,219.7345,175.7876,,,XARELTO 15MG 28 TAB,24070,,34117,BOTTLE GLASS TYPE I,units,28.0,174 12 37097 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of venous thromboembolism (VTE) and prevention of VTE recurrence in term   neonates, infants and toddlers, children, and adolescents aged less than 18 years after at least 5 days of initial parenteral anticoagulation treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73a12361-de33-4b00-b996-92c2bcb4bd83.json
73b688be-1304-4e4f-b05c-cd11cf611d51,ENDOMETRIN,prescription,G03DA04,PROGESTERONE,6396,,,WHO ATC Classification,,ILS,vaginal tablets,PROGESTERONE,2025-07-31T02:21:24.869584,IL,פרינג,,331.9920887,281.3492402,239.4461619,,,ENDOMETRIN 100MG 45 VAG.TAB,5429,,69711,BLISTER ALUMINIUM /ALUMINIUM,units,45.0,126 08 29832 00,valid,17.5,vaginal,1.4,36,,,,,,,,,,0,Prescription required,Progesterone supplementation or replacement in cases such as treatment of infertile women and IVF.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73b688be-1304-4e4f-b05c-cd11cf611d51.json
73c9c310-ec1d-45a0-871f-7830ca7bd9ef,SINGULAIR 10 MG TABLETS,prescription,R03DC03,MONTELUKAST,3640,,,WHO ATC Classification,,ILS,tablets,MONTELUKAST AS SODIUM,2025-07-31T08:17:52.874977,IL,אורגנון,,82.03307254,69.519553,51.6874,,7290004997410,SINGULAIR 5MG 28 CHEWTAB,19247,,85214,BLISTER PVC/OPA/AL,units,28.0,109 91 29317 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.   Singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.Because the benefits of SINGULAIR may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see Warnings and Precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73c9c310-ec1d-45a0-871f-7830ca7bd9ef.json
73de829d-852f-4966-908a-061ca8d06c36,DEXILANT 30 MG,prescription,A02BC06,DEXLANSOPRAZOLE,7911,,,WHO ATC Classification,,ILS,modified release capsules,DEXLANSOPRAZOLE,2025-07-31T01:53:15.562034,IL,טקדה,,332.4500684,281.7373586,239.7764754,,,DEXILANT 30 MG 28  MR CAPS,4657,,48635,BLISTER PVC/PE/PCTFE/AL,units,28.0,155 45 34383 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Dexilant 30 is indicated in adults and in adolescents aged 12 to 17 years for the following:• Maintenance of healed erosive reflux oesophagitis and maintenance of relief of heartburn• Short-term treatment of heartburn and acid regurgitation associated with symptomatic non-erosive gastro-oesophageal reflux disease (GORD).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73de829d-852f-4966-908a-061ca8d06c36.json
73e2c1ff-ef3b-4a89-ad96-c8b440e21858,TRUMENBA 60 MCG 0.5 ML 1 PFS,prescription,,,8657,,,,,ILS,tablet,TRUMENBA 60 MCG 0. 1 PFS,2025-07-31T19:37:57.003096,IL,פיזר,,402.3161248,340.9458837,290.1667095,,,TRUMENBA 60 MCG 0.5 ML 1 PFS,20975,,35344,,units,1.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73e2c1ff-ef3b-4a89-ad96-c8b440e21858.json
73e6456b-a717-475a-a2ef-5408bfa3c191,TRANEX INJECTION,prescription,B02AA02,TRANEXAMIC ACID,8755,,,WHO ATC Classification,,ILS,solution for injection,TRANEXAMIC ACID/ML,2025-07-31T09:34:07.732510,IL,ליברה,,26.13534142,22.14859442,16.16685724,,7290008872447,TRANEX INJECTION 500MG/5ML 5 AMP,,,77316,AMPOULES GLASS TYPE I,units,5.0,155 07 34063 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Prevention and treatment of haemorrhages due to general or local fibrinolysis in adults and children from one year.Specific indications include:- Haemorrhage caused by general or local fibrinolysis such as:   * Menorrhagia and metrorrhagia   * Gastrointestinal bleeding   * Haemorrhagic urinary disorders, further to prostate surgery or surgical procedures affecting the urinary tract-	Ear Nose Throat surgery (adenoidectomy, tonsillectomy, dental extractions)-	Gynaecological surgery or disorders of obstetric origin-	Thoracic and abdominal surgery and other major surgical intervention such as cardiovascular surgery-	Management of haemorrhage due to the administration of a fibrinolytic agent",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73e6456b-a717-475a-a2ef-5408bfa3c191.json
73e67776-8af4-48bc-8816-df023b1fd819,OPTALGIN TABLETS,off-the-counter,N02BB02,METAMIZOLE SODIUM,3794,,,WHO ATC Classification,,ILS,tablets,DIPYRONE,2025-07-31T12:40:51.000837,IL,טבע,,41.9136,35.52,nan,,7290000801834,OPTALGIN 500MG 42CAPL,15118,,,BLISTER PVC/ALUMINIUM,units,42.0,016 87 20611 12,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73e67776-8af4-48bc-8816-df023b1fd819.json
73e81cac-f962-4f3c-a5fd-c7cbbfbb8738,TIPTIPOT AFALPI,off-the-counter,R01BA02,PSEUDOEPHEDRINE,5036,,,WHO ATC Classification,,ILS,drops,PSEUDOEPHEDRINE AS HYDROCHLORIDE/ML,2025-07-31T13:28:14.146904,IL,כ.צ.ט,,25.9836,22.02,nan,, 7290008104579,TIPTIPOT AFALPI ORAL DROPS 15MG/ML 15ML,20329,,,BOTTLE GLASS,units,15.0,121 43 30172 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relief eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73e81cac-f962-4f3c-a5fd-c7cbbfbb8738.json
73ecea09-0032-4050-9f50-c43a8142d45d,FAMCICLOVIR 250MG  APOTEX USA  21 TABS,29C,,,20924,,,,,,tablet,FAMCICLOVIR 250MG APOTEX USA S,2025-07-31T20:25:38.255842,IL,nan,,,,,,,FAMCICLOVIR 250MG  APOTEX USA  21 TABS,,,,,units,21.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/73ecea09-0032-4050-9f50-c43a8142d45d.json
740452ba-9daf-45fd-889a-1d0a170fc0d7,NOVOEIGHT 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,8029,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,TUROCTOCOG ALFA/,2025-07-31T05:53:49.866265,IL,נובו נורדיסק,,678.5387762,575.0328867,489.3896908,,7290015659055,NOVOEIGHT 250 IU/4 ML 1 VIAL,14616,,58046,VIAL GLASS TYPE I,units,1.0,154 52 34374 00,valid,17.5,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).NovoEight can be used for all age groups., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/740452ba-9daf-45fd-889a-1d0a170fc0d7.json
740b997b-c495-468a-9d56-8175bb95f078,BETADINE TOPICAL SPRAY,off-the-counter,D08AG02,POVIDONE-IODINE,2973,,,WHO ATC Classification,,ILS,"cutaneous spray, powder",POVIDONE-IODINE 2.5 %W/W,2025-07-31T12:11:53.847196,IL,פלוריש,,14.5848,12.36,nan,,7290008016971,IODINE TINCTURE 10ML,9071,,,CAN ALUMINIUM,units,10.0,160 94 35157 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"As antiseptic for prevention and treatment of infections associated with burns, cuts and scrapes, and for preventive treatment of wounds at risk of infection, e.g. after placement of a suture for wound treatment or after surgery.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/740b997b-c495-468a-9d56-8175bb95f078.json
740f79e1-00a5-44f9-b0b4-bf139ee2c509,MINIRIN MELT 120 MCG,prescription,H01BA02,DESMOPRESSIN,6063,,,WHO ATC Classification,,ILS,sublingual tablets,DESMOPRESSIN AS ACETATE,2025-07-31T05:25:12.647880,IL,פרינג,,140.0632227,118.6976516,94.9581213,,7640128540427,MINIRIN MELT 120MCG 30TAB,13597,,460,BLISTER PVC/ALUMINIUM,units,30.0,137 23 31463 00,valid,25.0,sublingual,1.4,36,,,,,,,,,,0,Prescription required,Nocturnal enuresis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/740f79e1-00a5-44f9-b0b4-bf139ee2c509.json
7414091d-1c6b-4848-8b9b-04c8606d1f86,TECVAYLI 10 MG/ML,prescription,,,9489,,,,,ILS,solution for injection,TECLISTAMAB/,2025-07-31T09:09:28.455552,IL,יאנסן סילג,,21652.99962,18350.0005,16681.81863,,,TECVAYLI 90 MG/ML 1 VIAL 1.7 ML,,,41035,VIAL GLASS TYPE I,units,1.0,173 74 37566 00,valid,10.0,s.c,1.4,18,,,,,,,,,,0,Prescription required,"TECVAYLI is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and have demonstrated disease progression on the last therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7414091d-1c6b-4848-8b9b-04c8606d1f86.json
741fde07-4f49-4868-abde-518c8d996a80,OLUMIANT 2 MG,prescription,L04AA37,BARICITINIB,8307,,,WHO ATC Classification,,ILS,film coated tablets,BARICITINIB,2025-07-31T06:06:21.140921,IL,אלי לילי,,3443.229664,2917.991371,2652.719428,,,OLUMIANT 2 MG 28 TAB,15493,,26042,BLISTER PVC/PE/PCTFE/AL,units,28.0,161 15 35738 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid Arthritis Olumiant is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs. Olumiant may be used as monotherapy or in combination with methotrexate. Atopic Dermatitis Olumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and pediatric patients 2 years of age and older who are candidates for systemic therapy.Alopecia areata Olumiant is indicated for the treatment of severe alopecia areata in adult patients.Juvenile idiopathic arthritis Baricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic disease-modifying antirheumatic drugs (DMARDs): - Polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [RF+] or negative [RF-], extended oligoarticular), - Enthesitis-related arthritis, and - Juvenile psoriatic arthritis. Baricitinib may be used as monotherapy or in combination with Methotrexate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/741fde07-4f49-4868-abde-518c8d996a80.json
743c8bd6-4430-47d6-8164-18380d8a859e,SUTENT 12.5 MG,prescription,L01XE04,SUNITINIB,6046,,,WHO ATC Classification,,ILS,capsules,SUNITINIB AS MALATE 12.5  MG,2025-07-31T08:53:29.058536,IL,פיזר,,4062.601892,3442.88296,3129.8936,,,SUTENT 25MG 28CAPS,19814,,75525,BLISTER PVC/ACLAR/ALUMINIUM,units,28.0,136 89 31430 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate.   Sutent is indicated for the treatment of advanced renal cell carcinoma.Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/743c8bd6-4430-47d6-8164-18380d8a859e.json
7454aca0-6cb0-4624-a609-5dea7679777c,XYLOCAINE PUMP SPRAY 10 %,prescription,D04AB01,LIDOCAINE,8421,,,WHO ATC Classification,,ILS,solution,LIDOCAINE/ 0.1  ML,2025-07-31T10:37:44.316921,IL,פאדאגיס,,nan,nan,nan,,6091403218424,XYLOCAINE PUMP SPRAY 10 % 50GR,24010,,8163,BOTTLE GLASS TYPE I,units,50.0,116 41 25500 00,valid,nan,topical,1.4,36,,,,,,,,,,0,Prescription required,"Surface anaesthesia in dental practice otorhinolaryngology, obstetric and anaesthesiology.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7454aca0-6cb0-4624-a609-5dea7679777c.json
745598fd-c977-4b89-9ffd-4f0df18e1b80,ENALADEX 10 MG,prescription,C09AA02,ENALAPRIL,3770,,,WHO ATC Classification,,ILS,tablets,ENALAPRIL MALEATE,2025-07-31T02:19:06.178379,IL,דקסל פארמה,,15.29756248,12.964036,9.4628,,,ENALADEX 10MG 30TAB,5029,,22583,BLISTER ALUMINIUM,units,30.0,115 85 29810 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. To retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/745598fd-c977-4b89-9ffd-4f0df18e1b80.json
74582eb9-db07-4c60-a0f5-3006a992881f,MEKINIST 0.5 MG,prescription,L01EE01,TRAMETINIB,7826,,,WHO ATC Classification,,ILS,film coated tablets,TRAMETINIB AS DIMETHYL SULFOXIDE 0.5  MG,2025-07-31T05:08:58.705406,IL,נוברטיס פארמה,,20356.85248,17251.57066,15683.24606,,7290014257627,MEKINIST 2 MG 30 F.C.TAB,14604,,56398,BOTTLE HDPE,units,30.0,154 95 34309 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Trametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. Trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior BRAF inhibitor therapy. Non-small cell lung cancer (NSCLC) :Trametinib in combination with dabrafenib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a BRAF V600 mutation.Adjuvant treatment of melanoma :Trametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with Stage III melanoma with a BRAF V600 mutation, following complete resection.BRAF V600E Mutation-Positive Locally Advanced or Metastatic Anaplastic Thyroid CancerTAFINLAR is indicated, in combination with trametinib, for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment optionsBRAF V600E Mutation-Positive Unresectable or Metastatic Solid TumorsMekinist is indicated, in combination with dabrafenib, for the treatment of adult and pediatric patients 6 years of age and older with unresectable or metastatic solid tumors with BRAF V600E mutation who have progressed following prior treatment and have no satisfactory alternative treatment options. Limitations of Use: Trametinib is not indicated for treatment of patients with colorectal cancer because of known intrinsic resistance to BRAF inhibitionTrametinib is indicated, in combination with dabrafenib, for the treatment of pediatric patients 6 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/74582eb9-db07-4c60-a0f5-3006a992881f.json
7482cbc8-5ed0-434e-8070-8ac8dfdc6290,SIFROL TABLETS 0.25 MG,prescription,N04BC05,PRAMIPEXOLE,6142,,,WHO ATC Classification,,ILS,tablets,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 0.25   MG,2025-07-31T08:09:49.676906,IL,בורינגר אינגלהיים,,137.0414824,116.1368495,86.3471,,9006968012483,SIFROL 0.25 MG 100 TAB,9790,,17216,BLISTER POLYAMIDE/ALUMINIUM/PVC,units,100.0,126 17 30500 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa. For symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7482cbc8-5ed0-434e-8070-8ac8dfdc6290.json
7495c614-5d4a-46dd-9c29-3381ef363e95,PENTASA SLOW RELEASE GRANULES 4 G.,prescription,A07EC02,MESALAZINE,7956,,,WHO ATC Classification,,ILS,granules,MESALAZINE,2025-07-31T06:35:54.768846,IL,פרינג,,362.3332613,307.0620995,261.3294464,,7640128547228,PENTASA S.R GRANULES 4GR 30 SACHETS,16980,,11976,SACHET POLYESTER/ALUMINIUM/POLYETHYLENE,units,30.0,157 47 34816 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate ulcerative colitis or crohn's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7495c614-5d4a-46dd-9c29-3381ef363e95.json
749b3eac-15d5-4971-931a-deba7cba6bba,JANUET XR 100/1000 MG TABLETS,prescription,A10BA02,METFORMIN,7568,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T04:16:48.809897,IL,מ.ס.ד. ישראל,,nan,nan,nan,,7290006813640,JANUET XR 100/1000 MG 30TAB,10061,,53753,BOTTLE HDPE,units,30.0,151 33 33934 00,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/749b3eac-15d5-4971-931a-deba7cba6bba.json
74c90218-e75f-410e-be8f-71070aa477c7,ADAFERIN CREAM,prescription,D10AD03,ADAPALENE,6010,,,WHO ATC Classification,,ILS,cream,ADAPALENE 0.1 %W/W,2025-07-31T00:08:11.246482,IL,אמי טכנולוגיות,,43.69346852,37.0283648,27.0280035,,3499320002691,ADAFERIN CREAM 0.1% 30GR,1379,,71193,TUBE ALUMINIUM,units,30.0,136 13 30260 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,"For the cutaneous treatment of acne vulgaris, where comedones, papules and postules predominate. Acne of the face, chest or back is appropriate for treatment. The treatment is limited up to six months in adolescents over 12 years.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/74c90218-e75f-410e-be8f-71070aa477c7.json
74d8a239-0f51-49b0-956a-176c9a99b6ce,ETOPOSIDE TEVA,prescription,L01CB01,ETOPOSIDE,8577,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ETOPOSIDE/ML,2025-07-31T02:40:30.323408,IL,טבע,,43.6482,36.99,27.0,,7290106061774,ETOPOSIDE VIAL 100MG/5 ML,,,35132,VIAL GLASS TYPE I,units,5.0,106 48 28897 05,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Hodgkin's disease. Malignant (non-Hodgkin's) Lymphomas, especially of the Histiocytic variety.Acute Non-Lymphocytic leukemia.  Management of refractory testicular tumors and of small cell lung cancer.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/74d8a239-0f51-49b0-956a-176c9a99b6ce.json
750cfbea-1143-49f7-9996-4b754a1e9cb9,TRAMADEX OD 100,prescription,N02AX02,TRAMADOL,4820,,,WHO ATC Classification,,ILS,tablets prolonged release,TRAMADOL HYDROCHLORIDE,2025-07-31T09:31:27.431655,IL,דקסל פארמה,,27.20236654,23.052853,16.8269,,,TRAMADEX 50MG 30 FLASH TAB,20560,,63535,BLISTER PVC/PE/PCTFE/AL,units,30.0,139 25 31580 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/750cfbea-1143-49f7-9996-4b754a1e9cb9.json
75162ac3-f9e3-46bd-a10d-58ddda7b8276,OPTI GENTA,29C,S01AA11,GENTAMICIN,20429,,,WHO ATC Classification,,ILS,drops,GENTAMICIN AS SULFATE 0.3 %W/V,2025-07-31T14:41:45.295945,IL,nan,,nan,nan,nan,,7-290008-083850,GENTAMICIN SULPHATE 80MG/2ML 10 AMP,,,,DROPER BOTTLE LDPE,units,10.0,069 76 28591 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,Infection of external eye and its adnexa caused by susceptible bacteria.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75162ac3-f9e3-46bd-a10d-58ddda7b8276.json
75254b47-417c-42c1-a1f1-8c1dc58480f5,CRUSIA,prescription,B01AB05,ENOXAPARIN,8442,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/,2025-07-31T01:34:38.074385,IL,צמל,,50.02725563,42.39598123,30.9459717,,,CRUSIA 60MG/0.6ML 2 SYR,10626,,55130,SYRINGE 0.5 ML GLASS TYPE I,units,2.0,162 88 35673 00,valid,37.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Crusia is indicated in adults for:•Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery.•Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism.•Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE ikely to require thrombolytic therapy or surgery. Prevention of thrombus formation in extra corporeal circulation during haemodialysis.•Acute coronary syndrome:-Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid.-Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75254b47-417c-42c1-a1f1-8c1dc58480f5.json
7533cf5a-2a52-48a2-9f38-27bcad7c8e2f,XPOVIO 20 MG,prescription,L01XX66,SELINEXOR,8797,,,WHO ATC Classification,,ILS,tablets,SELINEXOR,2025-07-31T10:36:30.996848,IL,ניאופרם,,26111.56814,22128.44856,20116.77142,,7290111092886,XPOVIO 20 MG 12 TAB,24101,,57376,BLISTER PVC/PCTFE/PVC/ALU,units,12.0,167 04 36451 99,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Multiple Myeloma•	Xpovio® in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.•	XPOVIO in combination with dexamethasone is indicated for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least three prior therapies and whose disease is refractory to at least one proteasome inhibitor (PI), at least one immunomodulatory agent (IMiD), and an anti- CD38 monoclonal antibody (mAb).Diffuse Large B-Cell LymphomaXPOVIO is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7533cf5a-2a52-48a2-9f38-27bcad7c8e2f.json
7538bd38-2792-4af9-bd40-5f1a5661d493,OTOMYCIN,prescription,S02AA30,"ANTIINFECTIVES, COMBINATIONS",2081,,,WHO ATC Classification,,ILS,drops,"BENZOCAINE, NEOMYCIN AS SULFATE 0.35 %, PHENYLEPHRINE HYDROCHLORIDE 0.25 %, SODIUM PROPIONATE",2025-07-31T06:18:49.332454,IL,תרו,,nan,nan,nan,,7290000808253,OTOMYCIN EAR DROPS10ML,15078,,1597,BOTTLE GLASS TYPE III,units,10.0,015 86 24749 00,valid,nan,otic,1.4,18,,,,,,,,,,0,Prescription required,"Antibacterial, antifungal ear drops.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7538bd38-2792-4af9-bd40-5f1a5661d493.json
75407531-114f-42eb-9e85-86cebfe0ddc5,AGNUCASTON ®,off-the-counter,G02CX03,AGNI CASTI FRUCTUS ,8171,,,WHO ATC Classification,,ILS,film coated tablets,AGNI CASTI  FRUCTUS DRY EXTRACT:(7-11:1) EXTRACTION SOLVENT ETHANOLV/V),2025-07-31T11:08:36.633634,IL,דר סמואלוב,,46.5982,39.49,nan,,7290014626720,AGNUCASTON  2*15 TABS   4 MG,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,159 79 34979 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Premenstrual syndrome, mastodynia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75407531-114f-42eb-9e85-86cebfe0ddc5.json
754c81ac-0ce8-46e3-b5ab-fe969545f5c6,CEFTRIAXONE - TRIMA 1G,prescription,J01DD04,CEFTRIAXONE,9138,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFTRIAXONE AS SODIUM/VIAL,2025-07-31T01:02:14.092859,IL,תרימה,,28.78129976,24.390932,17.8036,,,CEFTRIAXONE - TRIMA 1G 1 VIAL,23361,,88449,VIAL GLASS TYPE I,units,1.0,169 65 36258 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Ceftriaxone is indicated for the treatment of the following infections in adults and children including term neonates (from birth): - Bacterial Meningitis - Community acquired pneumonia - Hospital acquired pneumonia - Acute otitis media - Intra-abdominal infections - Complicated urinary tract infections (including pyelonephritis) - Infections of bones and joints - Complicated skin and soft tissue infections - Gonorrhoea - Syphilis - Bacterial endocarditis Ceftriaxone may be used: - For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults - For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III) in adults and children including neonates from 15 days of age. - For pre-operative prophylaxis of surgical site infections - In the management of neutropenic patients with fever that is suspected to be due to a ceftriaxone - susceptible bacterial infection - In the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above Ceftriaxone should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum. Consideration should be given to official guidelines on the appropriate use of antibacterial agents.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/754c81ac-0ce8-46e3-b5ab-fe969545f5c6.json
75597547-61a3-4c45-8167-ab1487671782,ZIDOVAL 7.5 MG/G VAGINAL GEL,prescription,G01AF01,METRONIDAZOLE,9105,,,WHO ATC Classification,,ILS,gel,METRONIDAZOLE 7.5 MG/G,2025-07-31T05:20:54.633656,IL,לפידות,,282.6631566,239.5450586,203.868135,,7290008107310,METRONIDAZOLE 500MG/100ML 20 BOTTLES,,,30099,TUBE ALUMINIUM,units,20.0,118 72 29887 01,valid,17.5,vaginal,1.4,36,,,,,,,,,,0,Prescription required,Zidoval vaginal gel is indicated for the treatment of bacterial vaginosis (formally called non-specific vaginitis gardnella vaginalis vaginitis or haemophilus vaginitis).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75597547-61a3-4c45-8167-ab1487671782.json
75661e25-26a2-45d7-9913-96cbd199f61a,JAKAVI 10 MG,prescription,L01XE18,RUXOLITINIB,7171,,,WHO ATC Classification,,ILS,tablets,RUXOLITINIB AS PHOSPHATE,2025-07-31T04:15:27.499299,IL,נוברטיס פארמה,,15076.44155,12776.64595,11615.13268,,7290016369212,JAKAVI 15MG 56TAB,10063,,76461,BLISTER PVC/PCTFE,units,56.0,158 58 34859 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"* Myelofibrosis (MF) Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. * Polycythaemia vera (PV) Jakavi is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.*Graft versus host disease (GvHD)Jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75661e25-26a2-45d7-9913-96cbd199f61a.json
756af34d-bfcb-489d-822c-54e49f20ac7c,ADEX 200,off-the-counter,M01AE01,IBUPROFEN,5278,,,WHO ATC Classification,,ILS,caplets,IBUPROFEN,2025-07-31T11:03:32.433726,IL,דקסל פארמה,,39.7778,33.71,nan,,,ADEX 200MG 40CAPLETS,9264,,,BLISTER PVC/ALUMINIUM,units,40.0,039 71 26007 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the relief of mild to moderate pain such as headache, toothache, primary dysmenorrhea, backache, muscular pain. Anti - inflammatory and relieves pain in reumatoid arthritis and osteo arthritis. For the reduction of fever.For the treatment of pain associated with migraine.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/756af34d-bfcb-489d-822c-54e49f20ac7c.json
75ca1b62-e3f8-4db3-8ffa-2e2715d25881,DEXIMUNE 100,prescription,L04AA01,CYCLOSPORIN,4601,,,WHO ATC Classification,,ILS,capsules,CICLOSPORIN,2025-07-31T01:53:58.785638,IL,דקסל פארמה,,309.0002428,261.8646125,222.8635,,,DEXIMUNE 50MG 50 CAPSULES,4537,,10443,BLISTER ALUMINIUM /ALUMINIUM,units,50.0,124 48 30358 11,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of organ rejection in kidney  liver heart allogenic transplants in conjunction with corticosteroids. May also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents.  Bone marrow transplantation.   Endogenous uveitis.   Severe psoriasis above age 16 that did not respond to other treatment.   Atopic dermatitis in adults only up to 8 weeks  for severe cases in which conventional therapy is ineffective or inappropriate.   Rheumatoid arthritis: Severe cases in which standard treatments are ineffective or inappropriate. Nephrotic syndrom type MCD (minimal change disease) in cases where conventional therapy has failed.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75ca1b62-e3f8-4db3-8ffa-2e2715d25881.json
75d8fb5f-2391-49c0-bd76-76350ed95d29,PROSTIN E2 10 MG/ML,prescription,G02AD02,DINOPROSTONE,8924,,,WHO ATC Classification,,ILS,solution for injection,DINOPROSTONE/ML,2025-07-31T07:03:26.651908,IL,פיזר,,170.5546348,144.5378325,115.630266,,7298074000481,PROSTIN E2 10 MG/ML 0.5 ML 1 AMP,,,35607,AMPOULES GLASS TYPE I,units,1.0,128 11 22245 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Therapeutic termination of pregnancy, missed abortion.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75d8fb5f-2391-49c0-bd76-76350ed95d29.json
75de3bfa-41ff-4a03-ba82-c7b20a5feddb,GLIVEC ® 400 MG,prescription,L01XX28,IMATINIB,4855,,,WHO ATC Classification,,ILS,film coated tablets,IMATINIB AS MESYLATE,2025-07-31T03:36:12.729974,IL,נוברטיס פארמה,,7205.710061,6106.53395,5551.3945,,,GLIVEC 400MG 30 FCTAB,7709,,62802,BLISTER PVC,units,30.0,129 92 30790 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Glivec is indicated for the treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia (Ph+ -CML) in chronic phase  accelerated phase or blast crisis. Glivec is also indicated for the treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST).   Glivec is also indicated for the treament of :   * Adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) integrated with chemotherapy. * Adult patients with relapsed or refractory Ph + ALL as monotherapy.   * Adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.   * Adult patients with myelodyspiastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet - derived growth factor receptor ) gene re- arrangements.   * Adult patients with hypereosinophilic syndrome (HES) and/or  chronic eosinophilic leukaemia (CEL) who have the FIP1L1- PDGFRalfa fusion kinase (mutational analysis or FISH demonstration for CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFR alfa fusion kinase negative.  * Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-kit mutation. * Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75de3bfa-41ff-4a03-ba82-c7b20a5feddb.json
75fa927a-1c29-4431-bd02-765d6683b97d,HARMONET,prescription,G03AA10,GESTODENE AND ESTROGEN,4087,,,WHO ATC Classification,,ILS,coated tablets,"ETHINYLESTRADIOL 0.020   MG, GESTODENE 0.075   MG",2025-07-31T03:43:12.375943,IL,פיזר,,67.81852881,57.4733295,42.7311,,7290008142908,HARMONET 3X21TAB,8045,,29926,BLISTER PVC/ALUMINIUM,units,63.0,121 88 30272 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/75fa927a-1c29-4431-bd02-765d6683b97d.json
760a8b75-0a37-43a4-8cc3-e4187575c09a,DIOVAN ® 40 MG FILM-COATED TABLETS,prescription,C09CA03,VALSARTAN,3632,,,WHO ATC Classification,,ILS,film coated tablets,VALSARTAN,2025-07-31T01:57:30.461298,IL,נוברטיס פארמה,,40.50003316,34.322062,25.0526,,,DIOVAN 160MG 28 FC TABS,4457,,58662,BLISTER PVC/PA/ALUMINIUM,units,28.0,137 42 31281 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Diovan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial  Diovan significantly reduced hospitalisations for heart failure. There is no evidence that Diovan provides added benefits when it is used with an adequate dose of an ACE inhibitor.   Diovan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/760a8b75-0a37-43a4-8cc3-e4187575c09a.json
763b61d1-298d-416c-8067-885da4002e06,BRENZYS 50 MG/ML,prescription,L04AB01,ETANERCEPT,8699,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ML,2025-07-31T00:41:51.738652,IL,אורגנון,,2418.646751,2049.700727,1863.364298,,8809593171331,BRENZYS 50 MG/ML 4 PREFILLED PEN,,,57396,PRE-FILLED PEN GLASS TYPE I,units,4.0,161 75 35387 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritisBrenzys is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs) including methotrexate (unless contraindicated) has been inadequate. Brenzys can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis. Brenzys, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.Juvenile idiopathic arthritisTreatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents wighing at least 62.5 Kg who have had an inadequate response to, or who have proved intolerant of, methotrexate. Treatment of psoriatic arthritis in adolescents from the age of 12 years  weighing at least 62.5 Kg who have had an inadequate response to, or who have proved intolerant of, methotrexate.Treatment of enthesitis-related arthritis in adolescents from the age of 12 years  weighing at least 62.5 Kg who have had an inadequate response to, or who have proved intolerant of conventional therapy.Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Brenzys has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.Axial spondyloarthritisAnkylosing spondylitis (AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to nonsteroidal anti-inflammatory drugs (NSAIDs).Plaque psoriasisTreatment of adults patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.Paediatric plaque psoriasisTreatment of chronic severe plaque psoriasis in children and adolescents weighing at least 62.5 Kg who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/763b61d1-298d-416c-8067-885da4002e06.json
764ba582-b008-44be-a205-6356e828981a,CEFAZOLIN - TRIMA 1 G,prescription,J01DB04,CEFAZOLIN,8868,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFAZOLIN AS SODIUM/VIAL,2025-07-31T00:58:35.605884,IL,תרימה,,10.4982004,8.89678,6.494,,,CEFAZOLIN - TRIMA 1 G 1 VIAL,17872,,88160,VIAL GLASS TYPE III,units,1.0,167 50 36109 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. Treatment Respiratory tract: Respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species, haemophilus influenzae, staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group A B - hemolytic streptococci. Cefazolin is effective in the eradication of streptococci from the nasopharynx. However data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.Urinary tract: Infections due to escherichia coli klebsiella species proteus mirabilis and some strains of Enterobacter and enterococci.Skin and skin structure: hemolytic beta Infections due to Staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group A streptococci and other strains of streptococci. Biliary tract: Infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella species and staphylococcus aureus.Bone and joint :Infections due to staphylococcus aureus.Genital infections (i.e. prostatitis epididymitis) due to escherichia coli proteus mirabilis klebsiella species and some strains of enterococci.Septicemia due to streptococcus pneumoniae (formerly diplococcus pneumoniae) staphylococcus aureus (penicillin-sensitive and penicillin-resistant) proteus mirabilis escherichia coli and klebsiella species.Endocarditis caused by staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group A beta-hemolytic streptococci. Appropriate culture and susceptibility studies should be performed to determine the susceptibility of the causative organism to cefazolin.Perioperative prophylaxis: The prophylactic administraton of cefazolin perioperatively (preoperatively intraoperatively and postoperatively) may reduce the incidence of certain postoperative infectons in patients undergoing surgical procedures (e.g. hysterectomy gastrointestinal surgery and transurethral prostatectomy) that are classified as contaminated or potentially contaminated. The perioperative use of cefazolin may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g. open-heart surgery and prosthetic arthroplasty).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/764ba582-b008-44be-a205-6356e828981a.json
767e092c-95dc-4e1a-b2e1-da7d0a608163,ROKACET,off-the-counter,N02BE01,PARACETAMOL,5003,,,WHO ATC Classification,,ILS,caplets,"PARACETAMOL, CAFFEINE, CODEINE PHOSPHATE",2025-07-31T13:14:45.178247,IL,תרו,,25.5234,21.63,nan,,,ROKACET 20 CAPLIOT,18232,,,BLISTER PVC/PVDC,units,20.0,027 84 21960 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of pain and coughs and for the reduction of fever accompanied by pain.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/767e092c-95dc-4e1a-b2e1-da7d0a608163.json
767e8f74-e681-4781-b2d3-040a5baa0aa2,HAVRIX 1440,prescription,J07BC02,"HEPATITIS A, INACTIVATED, WHOLE VIRUS",3217,,,WHO ATC Classification,,ILS,suspension for injection,"HEPATITIS A VIRUS ANTIGEN, INACTIVATED 1440 E.L.U/ML",2025-07-31T03:43:32.925780,IL,ג.ס.ק,,140.0964461,118.7258071,94.98064567,,7290008102049,HAVRIX 1440 MONODOSE,8126,,9393,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,101 61 28393 00,valid,25.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Active immunisation against infections caused by Hepatitis A virus.The vaccine is particularly indicated for those at increased risk of infection or transmission.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/767e8f74-e681-4781-b2d3-040a5baa0aa2.json
768fff0f-f57d-45ff-aa97-2d45fd0ec407,LONQUEX,prescription,L03AA14,LIPEGFILGRASTIM,7617,,,WHO ATC Classification,,ILS,solution for injection,LIPEGFILGRASTIM/ 0.6  ML,2025-07-31T04:53:27.701973,IL,טבע,,3269.259689,2770.559182,2518.690165,,7290106061859,LONQUEX 6MG/0.6ML SYRINGE PREFILLED,12509,,71824,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,153 25 34055 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/768fff0f-f57d-45ff-aa97-2d45fd0ec407.json
7694515e-a68b-4c56-81a2-e14350efd35d,GAMUNEX ® - C,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",6420,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN 0.1 G/ML",2025-07-31T03:26:39.143335,IL,פאדאגיס,,326.1990731,276.4399047,235.268004,,7298074020687,GAMUNEX  0.1G/ML 1GR 10ML SOLUTION FOR INJECTION,7924,,35515,VIAL GLASS,units,10.0,132 95 31058 00,valid,17.5,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Gamunex is indicated as replacement therapy of primary immunodeficiency (PI) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, X-limked immunodeficiency with hyper IgM, Wiskott- Aldrich syndrom, and severed combined immunodeficiencies. Gamunex is also indicated in Idiopathic Thrombocytopenia Purpura (ITP) to raise platelet counts to prevent bleeding or to allow a patient with ITP to undergo surgery.Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7694515e-a68b-4c56-81a2-e14350efd35d.json
769ccc5a-9896-4c72-8b41-03a7b0e9d03d,GLYPRESSIN,prescription,H01BA04,TERLIPRESSIN,6871,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,TERLIPRESSIN ACETATE/VIAL,2025-07-31T03:37:52.369690,IL,פרינג,,489.6618186,414.9676613,353.1639671,,7645821048300,GLYPRESSIN 1MG/5ML 5VIAL,7868,,29200,VIAL GLASS TYPE I,units,5.0,133 74 31265 01,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Bleeding oesophageal varices.   Treatment of type I hepatorenal syndrome.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/769ccc5a-9896-4c72-8b41-03a7b0e9d03d.json
76b80a66-b625-40fd-8801-e501876b38f0,CILARIL PLUS,prescription,C09AA08,CILAZAPRIL,9380,,,WHO ATC Classification,,ILS,tablets,"CILAZAPRIL, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T01:12:56.903825,IL,אוניפארם,,91.5359925,77.572875,57.675,,,CILARIL PLUS 30 TAB,,,14028,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,135 95 31365 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/76b80a66-b625-40fd-8801-e501876b38f0.json
76d37bce-aef5-483c-9ab1-eddb1238e9ca,TRAVAMIN TABLETS,off-the-counter,R06AA52,"DIPHENHYDRAMINE, COMBINATIONS",3418,,,WHO ATC Classification,,ILS,tablets,DIMENHYDRINATE,2025-07-31T13:30:12.236364,IL,רקח,,24.74,20.97,nan,,7290008089852,TRAVAMIN 10 TAB,20172,,,BLISTER PVC/ALUMINIUM,units,10.0,020 17 20777 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"For  prevention and treatment of motion sickness (air, sea, car sickness) and radiation sickness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/76d37bce-aef5-483c-9ab1-eddb1238e9ca.json
76dd126e-d79f-46f1-8449-46e8c7769173,ZOVIRAX TABLETS 200 MG,prescription,D06BB03,ACICLOVIR,8163,,,WHO ATC Classification,,ILS,tablets,ACICLOVIR,2025-07-31T10:55:42.920921,IL,ג.ס.ק,,31.99219068,27.112026,19.7898,,7290008105026,ZOVIRAX TABLETS 400 MG 25TAB,26209,,54676,BLISTER PVC/PVDC/ALUMINIUM,units,25.0,126 41 30640 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,•Zovirax Tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and severe HSV infections in immunocompromised children).•Zovirax Tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immunocompetent patients.•Zovirax Tablets are indicated for the prophylaxis of herpes simplex infections in  immunocompromised patients.•Zovirax Tablets are indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/76dd126e-d79f-46f1-8449-46e8c7769173.json
76f5ecbf-730e-456e-ba51-cc2479d8f401,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1828,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:49:36.401379,IL,פישר,,36.1316,30.62,nan,,7290000849188,POLYDINE 12 VAG SUPP,16181,,,BOTTLE HDPE,units,12.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/76f5ecbf-730e-456e-ba51-cc2479d8f401.json
7704dd45-4701-4d51-9484-38c5fd5ebc20,STATOR 10,prescription,C10AA07,ROSUVASTATIN,6516,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T08:40:58.333946,IL,אוניפארם,,165.553115,140.29925,112.2394,,,STATOR 40MG 28FC TAB,19894,,85914,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,143 13 31932 02,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as  an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise  weight reduction ) is inadequate.  Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7704dd45-4701-4d51-9484-38c5fd5ebc20.json
77189d4a-48db-4ea3-a97c-ec5afe3608d2,BMD GRANULATED 10 % VETERINARY,29C,,,20529,,,,,ILS,premix,BACITRACIN METHYLENE DISALICYLATEW/W,2025-07-31T15:11:59.230553,IL,nan,,nan,nan,nan,,7290016226041,METHYLENE BLUE 10MG/ML(100MG/10ML) 5AMPX10ML,,,,BAG PAPER/PE,units,5.0,083 70 92374 00,valid,nan,per os in food,1.4,24,,,,,,,,,,0,,Prevention and treatment of necrotic enteritis in broilers caused by Clostridium perfringens susceptible to bacitracin methylene disalicylate. Secondary infection caused by micro-organisms susceptible to bacitracin methylene disalicylate in transmissible enteritis in turkeys.The presence of the disease in the flock should be established before preventative treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/77189d4a-48db-4ea3-a97c-ec5afe3608d2.json
773193b8-5aed-4df6-8b73-d3a98ef961b1,IMBRUVICA 140 MG TABLETS,prescription,L01XE27,IBRUTINIB,9154,,,WHO ATC Classification,,ILS,film coated tablets,IBRUTINIB,2025-07-31T04:00:43.569941,IL,יאנסן סילג,,24317.86357,20608.35987,18734.87261,,7290014577688,IMBRUVICA 420 MG 30 FILM COATED TABLET,9154,,74057,BLISTER PVC/PCTFE/AL,units,30.0,167 61 36458 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"•	Mantle Cell Lymphoma:Imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.•	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma :Imbruvica is indicated for the treatment of adult patients, with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)•	Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) with 17p deletion:Imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)  /Small Lymphocytic Lymphoma (SLL) with 17p deletion.•	Waldenström’s MacroglobulinemiaImbruvica is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).•	Marginal Zone LymphomaIMBRUVICA is indicated for the treatment of adult patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.•	Chronic Graft versus Host DiseaseIMBRUVICA is indicated for the treatment of adult patients with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/773193b8-5aed-4df6-8b73-d3a98ef961b1.json
77333439-75d5-4aee-a273-fb1d9cdb01a0,VORICONAZOLE-TRIMA 200MG,prescription,J02AC03,VORICONAZOLE,7482,,,WHO ATC Classification,,ILS,tablets,VORICONAZOLE,2025-07-31T10:21:08.397607,IL,תרימה,,3257.891866,2760.92531,2509.9321,,7290000843971,VORICONAZOLE-TRIMA 200MG 28TAB,22385,,53868,BLISTER PVC/ALUMINIUM,units,28.0,151 41 33937 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of: invasive aspergillosis, Candidemia in non-neutropenic patients, Fluconazole-resistant serious invasive Candida infections (including C. krusei), serious fungal infections caused by Scedosporium spp. and Fusarium spp. Voriconazole should be administered primarily to immunocompromised patients with progressive, possibly life-threatening infections. Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/77333439-75d5-4aee-a273-fb1d9cdb01a0.json
773a54f9-d259-4c26-8c93-52e2b4126df6,GAVISCON LIQUID PEPPERMINT,off-the-counter,A02BX13,ALGINIC ACID,5272,,,WHO ATC Classification,,ILS,suspension,"ALGINIC ACID AS SODIUM/ML, SODIUM BICARBONATE 26.7 MG/ML, CALCIUM CARBONATE/ML",2025-07-31T11:59:06.886881,IL,רקיט בנקיזר,,37.5004,31.78,nan,,,GAVISCON LIQUID PEPPERMINT 300ML,7849,,,BOTTLE AMBER GLASS,units,300.0,141 67 31756 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Gastro reflux, heartburn, flatulence associated with gastric reflux, heartburn of pregnancy, all cases of epigastric and retrosternal distress where the underlying cause is gastric reflux.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/773a54f9-d259-4c26-8c93-52e2b4126df6.json
775f5aa7-82bf-43bd-9a8f-719d032b4c6b,REVLIMID ® 10 MG,prescription,L04AX04,LENALIDOMIDE,6275,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE,2025-07-31T07:30:42.662197,IL,ניאופרם,,21607.7809,18311.67873,16646.98066,,7640133681382,REVLIMID 10MG 21CAPS,18462,,23430,BLISTER PVC/PCTFE,units,21.0,140 46 31661 11,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM) Revlimid is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes REVLIMID is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Revlimid 7.5 mg is not indicated for treatment in MDS.Mantle Cell LymphomaREVLIMID is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphomaRevlimid in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/775f5aa7-82bf-43bd-9a8f-719d032b4c6b.json
77a5167c-d5d1-4478-bcf6-d9c935b09e06,NURTEC ODT,prescription,,,8957,,,,,ILS,orally disintegrating tablets,RIMEGEPANT AS SULFATE,2025-07-31T05:58:16.098844,IL,פיזר,,903.9168912,766.0312978,651.94153,,,NURTEC ODT 75MG 8TAB,14691,,66320,BLISTER PVC/ALUMINIUM,units,8.0,166 81 36535 99,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,NURTEC ODT is a calcitonin gene-related peptide receptor antagonist indicated for the: • acute treatment of migraine with or without aura in adults • preventive treatment of episodic migraine in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/77a5167c-d5d1-4478-bcf6-d9c935b09e06.json
77aa0fbe-1885-4ce9-9ff1-33bae19eb167,BEDRANOL 160MG SR CAPS,29C,,,20813,,,,,,capsule,BEDRANOL 160MG SR CAPS,2025-07-31T19:59:48.701701,IL,nan,,,,,,,BEDRANOL 160MG SR CAPS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/77aa0fbe-1885-4ce9-9ff1-33bae19eb167.json
77ab4422-b0ba-4c8f-b1cf-0a81372c6ee7,TRAZODIL 100,prescription,N06AX05,TRAZODONE,3886,,,WHO ATC Classification,,ILS,coated tablets,TRAZODONE HYDROCHLORIDE,2025-07-31T09:37:34.942180,IL,אוניפארם,,54.21384481,45.94393832,33.5357214,,,TRAZODIL 50MG 30TAB,20176,,2234,BLISTER PVC/ALUMINIUM,units,30.0,039 36 20141 02,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of depression and anxiety.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/77ab4422-b0ba-4c8f-b1cf-0a81372c6ee7.json
77c06fb7-562c-44f6-945a-d23a102c1af6,LEMTRADA,prescription,L01XC04,ALEMTUZUMAB,7616,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ALEMTUZUMAB/ 1.2  ML,2025-07-31T04:37:48.985047,IL,סאנופי אוונטיס,,32637.13086,27658.5867,25144.16973,,7290013773173,LEMTRADA 12MG/1.2ML VIAL,12508,,66550,VIAL GLASS,units,1.0,152 76 34028 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"LEMTRADA is indicated as a single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (RRMS) for the following patient groups: • Patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (DMT) or • Patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more Gadolinium enhancing lesions on brain MRI or a significant increase in T2 lesion load as compared to a previous recent MRI.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/77c06fb7-562c-44f6-945a-d23a102c1af6.json
7805b16b-81a4-4c8e-a548-3296d67a208c,IODIFLOR OINTMENT,off-the-counter,D08AG03,IODINE,5533,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:11:12.711553,IL,פלוריש,,20.2134,17.13,nan,,7290006411907,IODIFLOR OINTMENT 50 GR,,,,BOTTLE HDPE,units,50.0,141 02 31802 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"For the disinfection of skin infections and inflammations, wounds and superficial burns.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7805b16b-81a4-4c8e-a548-3296d67a208c.json
780858fd-e477-442e-9414-fea39a458528,AVASTIN,prescription,L01FG01,BEVACIZUMAB,4933,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BEVACIZUMAB/ML,2025-07-31T00:27:27.384926,IL,רוש,,3537.913711,2998.232092,2725.665538,,7290008140737,AVASTIN 400MG 25MG/ML VIAL 16ML,9567,,35508,VIAL GLASS TYPE I,units,1.0,131 59 31060 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"- Avastin in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of patients with metastatic carcinoma of the colon or rectum.- Avastin  in addition to platinum - based chemotherapy  is indicated for first - line treatment of patients with unresectable advanced  metastatic or recurrent non- small cell lung cancer other than predominantly squamous cell histology.  - Avastin in combination with interferon alfa-2a is indicated for first line treatment of patients with advanced and /or metastatic renal cell cancer.  - Avastin in combination with paclitaxel is indicated for first-line treatment of patients with metastatic breast cancer.- Avastin as asingle agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.- Avastin, in combination with carboplatin and paclitaxel, is indicated for the front-line treatment of advanced (FIGO stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are at high risk for recurrence (residual disease after debulking).- Avastin, in combination with carboplatin and gemcitabine, is indicated for the treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor-targeted agents.- Avastin ( Bevacizumab) in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents - Avastin ( Bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan is indicated for treatment of patients with persistent, recurrent, or metastatic carcinoma of the cervix.- Bevacizumab, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations. - Bevacizumab, in combination with atezolizumab, is indicated for the treatment of patients with  unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/780858fd-e477-442e-9414-fea39a458528.json
7818982b-5fbe-42d0-b9f2-793282a5f1e7,VENOFER,prescription,B03AC03,IRON-SORBITOL-CITRIC ACID COMPLEX,7259,,,WHO ATC Classification,,ILS,solution for injection,FERROUS AS IRON III HYDROXIDE SUCROSE COMPLEX/ML,2025-07-31T10:04:51.054418,IL,כ.צ.ט,,341.7328734,289.60413,246.4716,,7290008098656,VENOFER 100MG/5ML 5AMP,22076,,9602,AMPOULES GLASS TYPE I,units,5.0,100 36 28277 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Venofer is indicated for the treatment of iron deficiency in the following indications:• Where there is a clinical need for a rapid iron supply,• In patients who cannot tolerate oral iron therapy or who are non-compliant,• In active inflammatory bowel disease where oral iron preparations are ineffective,• In chronic kidney disease when oral iron preparations are less effective.The diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. Hb, serum ferritin, TSAT, serum iron, etc.)(Hb haemoglobin, TSAT transferrin saturation)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7818982b-5fbe-42d0-b9f2-793282a5f1e7.json
7820a860-fb5d-4d8f-9b68-9b59397abd39,REZOLSTA,prescription,J05AE10,DARUNAVIR,7856,,,WHO ATC Classification,,ILS,film coated tablets,"COBICISTATE, DARUNAVIR AS ETHANOLATE",2025-07-31T07:32:58.527195,IL,יאנסן סילג,,2031.590737,1721.687142,1465.265653,,7290014577329,REZOLSTA 30 F.C.TAB,18549,,33160,BOTTLE HDPE,units,30.0,154 69 34386 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"REZOLSTA is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV 1) infection in treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions (V11i, V32i, L33F, i47V, i50V, i54L, i54M, T74P, L76V, i84V, L89V).שינוי משטר מינון 2/4/2019Pregnancy and postpartumTreatment with REZOLSTA during pregnancy results in low darunavir exposure (see sections 4.4 and 5.2). Therefore, therapy with REZOLSTA should not be initiated during pregnancy, and women who become pregnant during therapy with REZOLSTA should be switched to an alternative regimen, see section 4.4 and 4.6. Darunavir/ritonavir may be considered as an alternative.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7820a860-fb5d-4d8f-9b68-9b59397abd39.json
783874a5-43b3-4db6-b0e3-727cdb4543c0,HYDROXOCOBALAMIN 1000MCG/ML 1VIAL,29C,,,20453,,,,,,injection,HYDROXOCOBALAMIN 1000MCG/ML,2025-07-31T20:36:32.398766,IL,nan,,,,,,,HYDROXOCOBALAMIN 1000MCG/ML 1VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/783874a5-43b3-4db6-b0e3-727cdb4543c0.json
78507d79-b4e7-4232-8d1e-edd45cb1ddd9,LEQVIO 284 MG,prescription,C10AX16,INCLISIRAN,8899,,,WHO ATC Classification,,ILS,solution for injection,INCLISIRAN AS SODIUM/ML,2025-07-31T04:40:08.826440,IL,נוברטיס פארמה,,10649.9624,9025.392267,8204.902061,,7290018609644,LEQVIO 284 MG/1.5ML 1PFS,12605,,70789,PREFILLED SYRINGE WITH AUTOMATIC NEEDLE GUARD (BLISTERED) GLASS TYPE I,units,1.0,167 93 36715 99,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or mixed dyslipidaemia, as an adjunct to diet:• in combination with a statin or statin with other lipid lowering therapies in patients unable to reach LDL C goals with the maximum tolerated dose of a statin, or• alone or in combination with other lipid lowering therapies in patients who are statin intolerant, or for whom a statin is contraindicated.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78507d79-b4e7-4232-8d1e-edd45cb1ddd9.json
786319ad-40a2-4587-a403-54d699db46da,POINT,off-the-counter,M01AE02,NAPROXEN,3339,,,WHO ATC Classification,,ILS,tablets,NAPROXEN SODIUM,2025-07-31T12:49:13.891539,IL,תרימה,,43.601,36.95,nan,,,POINT 275MG 20TAB,16197,,,BLISTER PVC/PE/PVDC/AL,units,20.0,103 81 28780 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Mild and moderate analgesic such as relief of toothache, backache and menstrual pain (primary dysmenorrhea).Fever reduction.Non-steroidal anti-inflammatory for the treatment of rheumatic inflammations, tendinitis and musculoskeletal inflammations.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/786319ad-40a2-4587-a403-54d699db46da.json
78641f5a-3d5d-49e4-855f-aecd60cf9472,JULUCA,prescription,J05AR21,DOLUTEGRAVIR AND RILPIVIRINE ,8302,,,WHO ATC Classification,,ILS,film coated tablets,"RILPIVIRINE AS HYDROCHLORIDE, DOLUTEGRAVIR AS SODIUM",2025-07-31T04:20:13.858560,IL,ג.ס.ק,,3288.059274,2786.491034,2533.173667,,,JULUCA 30 tab,10395,,26818,BOTTLE HDPE,units,30.0,161 69 35445 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Juluca is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically-suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78641f5a-3d5d-49e4-855f-aecd60cf9472.json
78690c25-e767-435e-90b4-64ff1ebd91bb,TRELEGY ELLIPTA 184 / 55 / 22 MCG,prescription,R03AL08,"VILANTEROL, UMECLIDINIUM BROMIDE AND FLUTICASONE FUROATE",8997,,,WHO ATC Classification,,ILS,powder for inhalation pre-dispensed,"VILANTEROL AS TRIFENATATE/INH, UMECLIDINIUM AS BROMIDE/INH, FLUTICASONE FUROATE/INH",2025-07-31T09:38:05.056941,IL,ג.ס.ק,,nan,nan,nan,,,TRELEGY ELLIPTA 184 / 55 / 22 MCG 14 DOSES,,,,PLASTIC INHALER WITH TWO BLISTER STRIP ALUMINIUM,units,14.0,168 61 36629 99,valid,nan,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"AsthmaTrelegy Ellipta 184/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older. Trelegy Ellipta 184/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ICS/LABA.Important Limitations of UseTrelegy Ellipta 184/55/22 mcg is NOT indicated for the relief of acute asthma.Trelegy Ellipta 184/55/22 mcg is not indicated for patients with COPD.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78690c25-e767-435e-90b4-64ff1ebd91bb.json
787accca-676d-4ebc-96e8-75009da86a2d,CELSENTRI 150 MG,prescription,J05AX09,MARAVIROC,6280,,,WHO ATC Classification,,ILS,film coated tablets,MARAVIROC,2025-07-31T01:05:24.905433,IL,ג.ס.ק,,2692.830644,2282.059969,2074.599972,,,CELSENTRI 300MG 60TAB,3966,,80884,BLISTER PVC/ALU/PET,units,60.0,139 61 31670 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Celsentri is a CCR5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only CCR5-tropic HIV-1.• In treatment-naïve subjects, more subjects treated with Celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• Tropism testing with a highly sensitive tropism assay is required for the appropriate use of Celsentri.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/787accca-676d-4ebc-96e8-75009da86a2d.json
78814886-f702-44cb-bf60-1663fe86d5d2,ONCOTICE,29C,L03AX03,BCG VACCINE,20305,,,WHO ATC Classification,,ILS,powder for solution for instillation,BCG STRAIN 200 - 800 MIU,2025-07-31T13:57:27.008593,IL,nan,,nan,nan,nan,,7290006537195,BCG VACCINE SSI 0.75MG 10VIAL,,,,VIAL GLASS TYPE I,units,10.0,103 18 28561 00,valid,nan,intra-vesically,1.4,12,,,,,,,,,,0,,OncoTICE is used as a treatment of flat  urothelial cell carcinoma in situ (CIS) of the bladder and as an adjuvant therapy after transurethral resection (TUR) of a primary or relapsing superficial papillary urothelial cell carcinoma of the bladder stage Ta (grade 2 or 3) or T1 (grade 1 2 or 3).   OncoTICE is only recommended for stage Ta grade 1 papillary tumors  when there is judged to be a high risk of tumor recurrence.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78814886-f702-44cb-bf60-1663fe86d5d2.json
7882c38e-fd3f-41e6-9fdb-60daa179347f,ANIDULAFUNGIN S.K.,prescription,J02AX06,ANIDULAFUNGIN,8679,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,ANIDULAFUNGIN/VIAL,2025-07-30T23:24:07.102789,IL,טבע,,1114.095732,944.148925,803.531,,,ANIDULAFUNGIN TEVA 100 MG 1 VIAL,,,56610,VIAL GLASS TYPE I,units,1.0,172 69 36555 99,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment of invasive candidiasis in adult patients,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7882c38e-fd3f-41e6-9fdb-60daa179347f.json
78862dfe-a330-48c8-9b2c-c5dcade79cb0,SCEMBLIX 20 MG,prescription,L01EA06,ASCIMINIB,9247,,,WHO ATC Classification,,ILS,film coated tablets,ASCIMINIB AS HYDROCHLORIDE,2025-07-31T08:01:44.515451,IL,נוברטיס פארמה,,21935.69906,18589.5763,16899.61482,,,SCEMBLIX 20 MG 60 TABS,23306,,46711,BLISTER PVC/PCTFE/AL,units,60.0,172 84 37483 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"SCEMBLIX is indicated for the treatment of adult patients with:• Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs).• Ph+ CML in CP with the T315I mutation",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78862dfe-a330-48c8-9b2c-c5dcade79cb0.json
78aaa64e-abae-414e-89dc-ee9c8414127e,OXYCOD FORTE 10 MG/ML SYRUP,prescription,N02AA05,OXYCODONE,7694,,,WHO ATC Classification,,ILS,syrup,OXYCODONE HYDROCHLORIDE/ML,2025-07-31T06:21:25.649099,IL,רפא,,73.34652801,62.15807735,46.2141839,,7290008013321,OXYCOD FORTE 10MG/ML SYRUP 30ML,15415,,57242,BOTTLE AMBER GLASS,units,30.0,147 46 33521 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of moderate to severe pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78aaa64e-abae-414e-89dc-ee9c8414127e.json
78ad4219-54ec-4034-9c25-205ab8aa7a95,ALCOXIDINE,off-the-counter,D08AC02,CHLORHEXIDINE,5591,,,WHO ATC Classification,,ILS,solution - external,"ALCOHOLV/V, CHLORHEXIDINE GLUCONATE 0.5 %W/V",2025-07-31T11:11:08.315482,IL,ויטאמד,,23.9776,20.32,nan,,7290008083089,ALCOXIDINE 300ML,,,,BOTTLE HDPE,units,300.0,116 50 28130 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Disinfection of hands and skin,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78ad4219-54ec-4034-9c25-205ab8aa7a95.json
78b45d8f-8fd6-4bf7-999f-633dc2bde367,GLYCOPHOS 1MMOL/ML VIAL 20ML,29C,,,20848,,,,,,injection,GLYCOPHOS 1MMOL/ML VIAL,2025-07-31T20:32:15.418473,IL,nan,,,,,,,GLYCOPHOS 1MMOL/ML VIAL 20ML,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78b45d8f-8fd6-4bf7-999f-633dc2bde367.json
78c8cd54-680f-4d1b-b02d-e044b562a1f9,INTELENCE 100 MG,prescription,J05AG04,ETRAVIRINE,7256,,,WHO ATC Classification,,ILS,tablets,ETRAVIRINE,2025-07-31T04:09:28.258197,IL,יאנסן סילג,,1570.10451,1330.597101,1132.423065,,7290008099332,INTELENCE 200MG 60TAB,9696,,46177,BOTTLE HDPE,units,60.0,141 29 31789 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Intelence is indicated in combination with other antiretroviral medicinal products  for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients  including those with non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance.  Treatment history and when available  resistance testing  should guide the use of Intelence. In patients who have experienced virological failure on an NNRTI- and nucleoside or nucleotide reverse transcriptase inhibitor (N[t]RTI) - containing regimen  Intelence is not recommended for use in combination with N(t)RTIs only.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78c8cd54-680f-4d1b-b02d-e044b562a1f9.json
78d43c00-fc34-4056-ac9b-90eb64d94d67,EXFORGE 10 MG/160 MG,prescription,C08CA01,AMLODIPINE,6148,,,WHO ATC Classification,,ILS,film coated tablets,"AMLODIPINE AS BESYLATE, VALSARTAN",2025-07-31T02:49:04.551674,IL,נוברטיס פארמה,,119.4676828,101.243799,75.2742,,7290006257963,EXFORGE 10MG/160MG 28TAB,5467,,87351,BLISTER PVC/PA/ALUMINIUM,units,28.0,138 42 31568 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of essential hypertension. Exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/78d43c00-fc34-4056-ac9b-90eb64d94d67.json
79108d2c-419c-494b-8c9c-3d2eae2a9d7a,AGISTEN ALOEVERA CREAM,prescription,D01AC01,CLOTRIMAZOLE,2368,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T00:11:46.370630,IL,פאדאגיס,,35.27567615,29.89464213,21.82090667,,7290004850432,AGISTEN 3 VCR  2% 20GR,1158,,233,TUBE ALUMINIUM,units,20.0,043 17 22461 00,valid,37.0,dermal,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as Malassezia furfur, as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79108d2c-419c-494b-8c9c-3d2eae2a9d7a.json
7916794e-dd5c-44a1-adfd-95d90189e721,REQUIP MODUTAB 2 MG,prescription,N04BC04,ROPINIROLE,6356,,,WHO ATC Classification,,ILS,film coated tablets - prolonged release,ROPINIROLE AS HYDROCHLORIDE,2025-07-31T07:27:00.388832,IL,ג.ס.ק,,43.41470846,36.79212745,26.85556748,,7290010140510,REQUIP MODUTAB 2MG 28 FILM COATED TABLETS,18407,,81951,BLISTER PVC/PE/PVDC,units,28.0,141 62 31838 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of Parkinson’s disease under the following conditions:•         Initial treatment as monotherapy, in order to delay the introduction of levodopa•         In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).""",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7916794e-dd5c-44a1-adfd-95d90189e721.json
792112ca-cd79-48c5-996b-70231ce7c234,RELAXINE,off-the-counter,,,5590,,,,,ILS,film coated tablets,VALERIAN DRY EXTRACT,2025-07-31T12:55:14.341678,IL,תרימה,,67.5668,57.26,nan,,,RELAXINE 500MG 30TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,115 58 29788 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of mild symptoms of mental stress and to aid sleep.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/792112ca-cd79-48c5-996b-70231ce7c234.json
7923cfd3-f1a4-43a3-b239-9d6be2cf65b8,XTANDI 40 MG TABLETS,prescription,L02BB04,ENZALUTAMIDE,9339,,,WHO ATC Classification,,ILS,film coated tablets,ENZALUTAMIDE,2025-07-31T10:37:16.128582,IL,אסטלס,,13933.31853,11807.89758,10734.45235,,,XTANDI 40 MG  112 TABLETS,24110,,42898,BLISTER PVC/PCTFE/AL,units,112.0,169 82 36204 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Xtandi is indicated:- as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.- in combination with androgen deprivation therapy for the treatment of adult men with metastatic hormone-sensitive prostate cancer (mHSPC).- for the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (CRPC).- for the treatment of adult men with metastatic CRPC who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated.-for the treatment of adult men with metastatic CRPC whose disease has progressed on or after docetaxel therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7923cfd3-f1a4-43a3-b239-9d6be2cf65b8.json
7924c8ef-6306-4eda-a1cc-61a5e848a974,PURI-NETHOL TABLETS 50 MG,prescription,L01BB02,MERCAPTOPURINE,1143,,,WHO ATC Classification,,ILS,tablets,MERCAPTOPURINE,2025-07-31T07:07:54.770800,IL,פאדאגיס,,96.77849956,82.01568124,60.97820167,,7290008105095,PURI-NETHOL 50MG 25TAB,16292,,1907,BOTTLE GLASS TYPE III,units,25.0,033 44 22532 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of acute Leukemia and also in cases of chronic myelogenous Leukemia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7924c8ef-6306-4eda-a1cc-61a5e848a974.json
7935965a-f24d-44eb-bf79-4fe53b123249,TEVACUTAN,prescription,D10AA03,DEXAMETHASONE,3766,,,WHO ATC Classification,,ILS,cream,"CLOTRIMAZOLE, DEXAMETHASONE ACETATE 0.044 %, NEOMYCIN SULFATE 0.645 %",2025-07-31T09:17:12.469250,IL,טבע,,nan,nan,nan,,,TEVACUTAN CREAM 15GR,20115,,21364,TUBE ALUMINIUM,units,15.0,115 99 29683 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,Tevacutan is indicated for the treatment of mycotic infections of the skin complicated by inflammation and/or secondary infection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7935965a-f24d-44eb-bf79-4fe53b123249.json
79410302-c302-4619-a60f-7e98547a198a,AGISTEN ALOEVERA CREAM,off-the-counter,D01AC01,CLOTRIMAZOLE,2375,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T11:06:52.066152,IL,פאדאגיס,,36.3912,30.84,nan,,7290004850432,AGISTEN 1 VAGINAL TAB  0.5GR,1163,,,TUBE ALUMINIUM,units,1.0,043 17 22461 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as Malassezia furfur, as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79410302-c302-4619-a60f-7e98547a198a.json
794dd471-a0ab-4ac8-8c05-390665f1d629,DECITABINE - TRIMA 50 MG/VIAL,prescription,L01BC08,DECITABINE,9390,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,DECITABINE,2025-07-31T01:44:40.172329,IL,תרימה,,5009.99444,4245.758,3859.78,,,DECITABINE - TRIMA 50 MG/VIAL,4803,,15856,VIAL GLASS TYPE I,units,1.0,171 25 36984 99,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Decitabine Trima is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and Intermediate-1, Intermediate-2 and High-Risk International Prognostic Scoring System groups. Decitabine Trima is indicated for the treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/794dd471-a0ab-4ac8-8c05-390665f1d629.json
7962e7de-c094-404d-8748-4173bc4dbf23,BONJESTA,prescription,R06AA09,DOXYLAMINE,8864,,,WHO ATC Classification,,ILS,tablets extended release,"DOXYLAMINE SUCCINATE, PYRIDOXINE (VIT B6) HYDROCHLORIDE",2025-07-30T23:41:02.324325,IL,צמל,,518.5662978,439.4629838,374.01105,,7290100819074,BONJESTA 50 TAB,2871,,70698,BLISTER OPA/AL/PVC,units,50.0,167 52 36428 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,BONJESTA is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.Limitations of UseBONJESTA has not been studied in women with hyperemesis gravidarum.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7962e7de-c094-404d-8748-4173bc4dbf23.json
7965c03e-5688-4f66-ba2d-c0e5f7cf483c,"GEMCITABINE ""EBEWE"" 40MG/ML",prescription,L01BC05,GEMCITABINE,7740,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,GEMCITABINE AS HYDROCHLORIDE/,2025-07-31T03:29:12.638568,IL,סנדוז,,260.6854525,220.919875,176.7359,,7290016369724,GEMCITABINE  EBEWE  1000MG/25ML,7862,,3560,VIAL GLASS TYPE I,units,1.0,145 95 33400 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7965c03e-5688-4f66-ba2d-c0e5f7cf483c.json
797346ef-0f14-4b08-8770-e77090415e07,TIGER BALM RED,off-the-counter,,,5140,,,,,ILS,ointment,"CAMPHORW/W, MENTHOLW/W, CAJUPUT OILW/W, DEMENTHOLISED MINT OILW/W, CLOVE OILW/W",2025-07-31T13:27:36.611464,IL,רפא,,37.4768,31.76,nan,,7290008015448,TIGER BALM WHITE OINT 19G,20201,,,JAR GLASS TYPE III,units,19.0,127 22 30565 00,valid,nan,topical,1.4,48,,,,,,,,,,0,,For the temporary relief of muscular aches and pains.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/797346ef-0f14-4b08-8770-e77090415e07.json
797492f4-74fe-4453-87af-fb5b8d879511,FAMPYRA 10 MG,prescription,N07XX07,FAMPRIDINE,6918,,,WHO ATC Classification,,ILS,tablets prolonged release,FAMPRIDINE,2025-07-31T02:53:14.806839,IL,מדיסון,,757.681556,642.1030136,546.4706499,,7290008128865,FAMPYRA 10MG 56 P.R.TAB,6472,,20557,BLISTER POLYAMIDE/ALUMINIUM,units,56.0,147 80 33543 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,FAMPYRA is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (EDSS 4-7).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/797492f4-74fe-4453-87af-fb5b8d879511.json
79797e19-f58e-4374-bba5-97341fa07b67,SINEMET CR,prescription,N04BA02,LEVODOPA AND DECARBOXYLASE INHIBITOR,8247,,,WHO ATC Classification,,ILS,tablets controlled release,"LEVODOPA, CARBIDOPA AS MONOHYDRATE",2025-07-31T08:17:01.729803,IL,אורגנון,,122.1268883,103.4973676,76.94971567,,,SINEMET CR  50/200   100 TABS,,,27587,BLISTER PVC/ALUMINIUM,units,100.0,127 63 26900 01,valid,34.5,per os,1.4,30,,,,,,,,,,0,Prescription required,"Idiopathic parkinson's disease. Postencephalitic parkinsonism. Symptomatic parkinsonism. To reduce ""off"" time in patients previously treated with levodopa/decarboxylase inhibitor preparations, or with levodopa alone, who have had motor fluctuations characterized by end-of-dose deterioration (""wearing-off"" phenomenon), peak dose dyskinesias, akinesia, or similar evidence of short-duration motor disturbances.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79797e19-f58e-4374-bba5-97341fa07b67.json
79a38356-b629-4acc-95ec-ee00a3f79e5b,PEMAZYRE 13.5 MG,prescription,L01EX20,PEMIGATINIB,9028,,,WHO ATC Classification,,ILS,tablets,PEMIGATINIB 13.5  MG,2025-07-31T06:31:59.157722,IL,מדיסון,,34163.00999,28951.70467,26319.73152,,,PEMAZYRE 9 MG 14 TABS,,,3035,BLISTER PVC/ALUMINIUM,units,14.0,169 76 36997 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"PEMAZYRE is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as determined by a validated test.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79a38356-b629-4acc-95ec-ee00a3f79e5b.json
79ac8482-6081-4133-97a6-620f34b84336,MORPHINE KALCEKS 10 MG/ML,prescription,N02AA01,MORPHINE,8818,,,WHO ATC Classification,,ILS,solution for injection,MORPHINE HYDROCHLORIDE/ML,2025-07-31T05:31:53.580297,IL,מדי מרקט,,36.20688351,30.68380095,22.396935,,7290015841269,MORPHINE KALCEKS 10 MG/ML 10 AMP,,,11434,AMPOULES GLASS TYPE I,units,10.0,163 85 35523 00,valid,37.0,"s.c, i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Symptomatic relief of moderate to severe pain, especially that associated with neoplastic disease, myocardial infarction, and surgery.Pre-operatively as an adjunct to anesthesia for pain relief and to allay anxiety.Alleviation of the anxiety associated with severe pain. It is useful as a hypnotic where sleeplessness is due to pain.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79ac8482-6081-4133-97a6-620f34b84336.json
79b27be5-fa18-4961-9993-5974b2b04aaa,EREMFAT I.V 600MG VIAL,29C,,,20395,,,,,,injection,EREMFAT I.V 600MG VIAL,2025-07-31T20:23:03.653164,IL,nan,,,,,,,EREMFAT I.V 600MG VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79b27be5-fa18-4961-9993-5974b2b04aaa.json
79bcce65-d44f-4757-b2d7-db8f3ba761e0,BOSULIF 100 MG,prescription,L01XE14,BOSUTINIB,8714,,,WHO ATC Classification,,ILS,film coated tablets,BOSUTINIB AS MONOHYDRATE,2025-07-30T23:41:59.374169,IL,פיזר,,9305.458178,7885.981858,7169.074416,,7290013592224,BOSULIF 400 MG 28 TAB,,,59454,BLISTER PVC/ALUMINIUM,units,28.0,152 88 34014 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Bosulif is indicated for the treatment of adult patients with:• newly diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukaemia (Ph+ CML).• chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukaemia (Ph+ CML) previously treated with one or more tyrosine kinase inhibitor(s) [TKI(s)] and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79bcce65-d44f-4757-b2d7-db8f3ba761e0.json
79c26e12-06f0-477a-8b4d-927bf39ba584,RIPALID 0.5 MG,prescription,A10BX02,REPAGLINIDE,8073,,,WHO ATC Classification,,ILS,tablets,REPAGLINIDE 0.5  MG,2025-07-31T07:36:04.350750,IL,פאדאגיס,,29.80169768,25.255676,18.4348,,,RIPALID 0.5 MG 90 	TABLETS,18571,,63286,BLISTER ALUMINIUM /ALUMINIUM,units,90.0,159 05 34990 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Ripalid is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Ripalid is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79c26e12-06f0-477a-8b4d-927bf39ba584.json
79e0dc0f-ca9c-4f82-baaf-a7aa709e245b,ELOCTA 1000 IU,prescription,B02BD05,COAGULATION FACTOR VII,9069,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR VIII,2025-07-31T02:16:14.907775,IL,מגאפארם,,2464.693661,2088.723534,1898.839576,,,ELOCTA 1000 IU,,,,VIAL GLASS TYPE I,units,1.0,170 50 36896 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/79e0dc0f-ca9c-4f82-baaf-a7aa709e245b.json
7a053192-25d0-4eaf-bce3-35095e8d432d,ILUMYA,prescription,L04AC17,TILDRAKIZUMAB,8772,,,WHO ATC Classification,,ILS,solution for injection,TILDRAKIZUMAB/ML,2025-07-31T03:59:04.166473,IL,תרו יבוא,,13411.64141,11365.79831,10332.54392,,7290017164380,ILUMYA 1 PFS,,,72977,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,167 49 36455 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a053192-25d0-4eaf-bce3-35095e8d432d.json
7a0ee4ef-6b91-4089-90b6-f3e59380c8e8,MIFLONIDE PWDR INH 400MCG 60CAPS,prescription,,,4526,,,,,ILS,capsule,MIFLONIDE PWDR INH 400MCG,2025-07-31T19:18:56.989846,IL,נוברטיס פארמה,,64.27191897,54.46773036,40.4964538,,,MIFLONIDE PWDR INH 400MCG 60CAPS,13407,,30243,,units,60.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a0ee4ef-6b91-4089-90b6-f3e59380c8e8.json
7a18d212-ac94-48c5-9e24-d92e13766fc9,LENALIDOMIDE S.K. 10 MG,prescription,L04AX04,LENALIDOMIDE,8729,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE,2025-07-31T04:38:34.008937,IL,SK PHARM(KS KIM),,23276.24185,19725.62869,17932.38972,,7290016845327,LENALIDOMIDE S.K. 5 MG 21 CAPS,12585,,59394,BLISTER PVC/ACLAR/ALUMINIUM,units,21.0,164 86 36219 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM)Lenalidomide S.K. is indicated for the treatment of multiple myeloma. Myelodysplastic Syndromes Lenalidomide S.K. is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Lenalidomide S.K. 7.5 mg is not indicated for treatment in MDS. Mantle Cell Lymphoma Lenalidomide S.K. is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL). Follicular lymphomaLenalidomide S.K. in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a18d212-ac94-48c5-9e24-d92e13766fc9.json
7a20123e-1599-4fb1-a989-62dd5040e9b9,FLEET ENEMA 133,prescription,A06AG20,COMBINATIONS,5079,,,WHO ATC Classification,,ILS,enema,"SODIUM PHOSPHATE/ML, SODIUM PHOSPHATE/ML",2025-07-31T03:07:50.175048,IL,דקסל פארמה,,nan,nan,nan,,7290008004626,FLEET ENEMA 250 ML,6337,,58105,BOTTLE POLYETHYLENE,units,250.0,034 95 22406 11,valid,nan,rectal,1.4,36,,,,,,,,,,0,Prescription required,"Cleaning the colon before surgery, child birth or medical examinations.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a20123e-1599-4fb1-a989-62dd5040e9b9.json
7a22985b-f4f6-4173-bd28-3a479d3a7513,RETROVIR IV FOR INFUSION,prescription,J05AF01,ZIDOVUDINE,3108,,,WHO ATC Classification,,ILS,solution for infusion,ZIDOVUDINE/,2025-07-31T07:30:04.340455,IL,ג.ס.ק,,443.6593297,375.9824996,319.985106,,7290004557805,RETROVIR 250MG 40CAPS,18097,,9228,VIAL GLASS TYPE I,units,40.0,100 74 28753 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Retrovir IV for infusion is indicated for the short term management of serious manifestations of Human immunodeficiency Virus (HIV) infection in patients with Acquired Immuno Deficiency Syndrome (AIDS) or AIDS who are unable to take Retrovir oral formulations.Retrovir chemoprophylaxis, is indicated for use in HIV-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal HIV transmission and for primary prophylaxis of HIV infection in newborn infants. Retrovir I.V. should only be used when oral treatment is not possible (except during labour and delivery).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a22985b-f4f6-4173-bd28-3a479d3a7513.json
7a2777ce-7da2-4cdf-929d-f1615060bf0c,BEZAFIBRATE MEDOMIE,prescription,C10AB02,BEZAFIBRATE,9541,,,WHO ATC Classification,,ILS,tablets sustained release,BEZAFIBRATE,2025-07-31T00:35:14.380086,IL,מדומי פארמה,,36.79882746,31.185447,22.7631,,,BEZAFIBRATE MEDOMIE 400 MG 30 SR TAB,,,7322,BLISTER PVC/ALUMINIUM,units,30.0,176 67 37746 99,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Bezafibrate Medomie is indicated as an adjunct to diet and other non- pharmacological treatment (e.g. exercise, weight reduction) for the following: - Treatment of severe hypertriglyceridaemia",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a2777ce-7da2-4cdf-929d-f1615060bf0c.json
7a35ae0e-47f4-43c8-b20e-02855420e2ee,FYCOMPA 10 MG FILM COATED TABLETS,prescription,N03AX22,PERAMPANEL,7262,,,WHO ATC Classification,,ILS,film coated tablets,PERAMPANEL AS ANHYDROUS,2025-07-31T03:24:22.787017,IL,אסיי,,62.77725123,53.20106273,39.55469348,,,FYCOMPA 2MG 7 F.C TAB,6529,,51056,BLISTER PVC/ALUMINIUM,units,7.0,150 50 33794 01,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.Fycompa is indicated for the adjunctive treatment of primary generalised tonic clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalized epilepsy (IGE).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a35ae0e-47f4-43c8-b20e-02855420e2ee.json
7a37349f-422e-48f5-9a34-5e648c1c15e1,ASPIRIN 500,off-the-counter,B01AC06,ACETYLSALICYLIC ACID,10,,,WHO ATC Classification,,ILS,tablets,ACETYLSALICYLIC ACID,2025-07-31T11:13:57.571252,IL,באייר,,17.8062,15.09,nan,,7298074020014,ASPIRIN 0.5GR 20TAB,1345,,,BLISTER PP/ALUMINIUM,units,20.0,025 43 21130 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Pain relief, fever reduction .",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a37349f-422e-48f5-9a34-5e648c1c15e1.json
7a39204e-fbbe-4b35-9a84-88071f24460c,TOLTERODINE E.R. MEDOMIE 2 MG,prescription,G04BD07,TOLTERODINE,9431,,,WHO ATC Classification,,ILS,capsules extended release,TOLTERODINE TARTRATE,2025-07-31T09:24:57.581665,IL,מדומי פארמה,,99.35166645,84.1963275,62.5995,,,TOLTERODINE E.R. MEDOMIE 4 MG 28 TAB,,,,BLISTER OPA/ALU/PVC/ALU,units,28.0,174 90 36958 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"TOLTERODINE E.R. MEDOMIE is indicated for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a39204e-fbbe-4b35-9a84-88071f24460c.json
7a3a09fa-c305-48bb-809f-b3243e3397ba,MYCAMINE 100 MG,prescription,J02AX05,MICAFUNGIN,7827,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,MICAFUNGIN AS SODIUM,2025-07-31T05:36:50.331893,IL,אסטלס,,739.6370203,626.811062,533.456223,,8718692510883,MYCAMINE 50 MG VIAL,13789,,33078,VIAL GLASS TYPE I,units,1.0,155 91 34429 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Adults, adolescents &#8805; 16 years of age and elderly:- Treatment of invasive candidiasis.- Treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate.- Prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.Children (including neonates) and adolescents < 16 years of age:- Treatment of invasive candidiasis.- Prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.The decision to use Mycamine should take into account a potential risk for the development of liver tumours. Mycamine should therefore only be used if other antifungals are not appropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a3a09fa-c305-48bb-809f-b3243e3397ba.json
7a417eb7-c9b6-47e3-bf5f-b66d191cae91,MEMANTINE GRINDEKS 10 MG,prescription,N06DX01,MEMANTINE,9627,,,WHO ATC Classification,,ILS,film coated tablets,MEMANTINE HYDROCHLORIDE,2025-07-31T05:10:16.742976,IL,מדי מרקט,,155.9268156,132.141375,105.7131,,,MEMANTINE GRINDEKS 10 MG TABS,,,65930,BLISTER PVC/ALUMINIUM,units,30.0,173 38 36376 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of patient with moderate to severe Alzheimer's disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a417eb7-c9b6-47e3-bf5f-b66d191cae91.json
7a4e5173-91fa-430e-b6e9-4af7f9438a07,JARDIANCE DUO 12.5 MG/850 MG,prescription,A10BD20,METFORMIN AND EMPAGLIFLOZIN,7855,,,WHO ATC Classification,,ILS,film coated tablets,"EMPAGLIFLOZIN 12.5  MG, METFORMIN HYDROCHLORIDE",2025-07-31T04:18:16.154114,IL,בורינגר אינגלהיים,,206.0035955,174.579326,139.6634608,,,JARDIANCE DUO 12.5 MG/1000 MG 60  F.C. TAB,10071,,32902,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,155 29 34534 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a4e5173-91fa-430e-b6e9-4af7f9438a07.json
7a5054d0-9c90-411b-9e4a-edf565b02d6f,LECIGON,prescription,N04BA01,LEVODOPA,9218,,,WHO ATC Classification,,ILS,gel,"ENTACAPONE/, CARBIDOPA MONOHYDRATE/, LEVODOPA/",2025-07-31T04:37:27.776019,IL,תרומד,,2926.802568,2480.341269,2254.855699,,,LECIGON GEL 7 CART,,,,CARTRIDGE POLYPROPYLENE,units,7.0,173 28 37033 99,valid,10.0,intestinal,1.4,26,,,,,,,,,,0,Prescription required,Treatment of advanced Parkinson's disease with severe motor fluctuations and hyperkinesia or dyskinesia when available oral combinations of Parkinson medicinal products have not given satisfactory results.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a5054d0-9c90-411b-9e4a-edf565b02d6f.json
7a5284ae-3cfa-436c-b388-628711f52a01,LIDOCAINE B.BRAUN 2%,prescription,D04AB01,LIDOCAINE,9109,,,WHO ATC Classification,,ILS,solution for injection,LIDOCAINE HYDROCHLORIDE MONOHYDRATE/ML,2025-07-31T04:46:32.669301,IL,לפידות,,100.8062436,85.42902,63.516,,,LIDOCAINE B.BRAUN 2 % 10 ML 20 AMP,,,55470,AMPOULES LDPE,units,20.0,157 39 34112 00,valid,34.5,"i.v, i.m, epidural, s.c, intradermal, submucosal, spinal, perineural, i.v regional anaesthesia",1.4,24,,,,,,,,,,0,Prescription required,"Local and regional anaesthesia.Severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be life-threatening.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a5284ae-3cfa-436c-b388-628711f52a01.json
7a57c9bd-993f-4b57-9e7b-d370e115d749,CLARITONE RINSE15 ML,off-the-counter,,,1795,,,,,ILS,tablet,CLARITONE RINSE,2025-07-31T19:41:02.371239,IL,פישר,,16.1306,13.67,,,,CLARITONE RINSE15 ML,3392,,,,units,15.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a57c9bd-993f-4b57-9e7b-d370e115d749.json
7a815dac-8598-4976-8748-4cf184f1ee05,FENTORA ® 100 MCG,prescription,N01AH01,FENTANYL,7611,,,WHO ATC Classification,,ILS,tablets,FENTANYL AS CITRATE,2025-07-31T03:02:09.180870,IL,טבע,,433.7707612,367.6023563,312.8530692,,,FENTORA 100MCG 28 BUCCAL TAB,6582,,76296,BLISTER PVC/ALU/POLYAMIDE/PVC,units,28.0,152 90 34050 00,valid,17.5,buccal,1.4,36,,,,,,,,,,0,Prescription required,"Fentora is indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.                                      Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a815dac-8598-4976-8748-4cf184f1ee05.json
7a958e8d-e250-47cb-bafd-c2e52a21f535,CETRAXAL,prescription,S03AA07,CIPROFLOXACIN,8668,,,WHO ATC Classification,,ILS,ear drops,"CIPROFLOXACIN AS HYDROCHLORIDE/, FLUOCINOLONE ACETONIDE 0.25  MG /",2025-07-31T01:07:54.278325,IL,כ.צ.ט,,33.88922829,28.71968627,20.96327465,,7290018386149,CETRAXAL 3 MG/ML+0.25 MG/ ML 10 ML,,,67355,BOTTLE LDPE,units,10.0,148 13 33374 00,valid,37.0,otic,1.4,24,,,,,,,,,,0,Prescription required,Cetraxal is indicated in adults and in children aged 6 months and older for the following infections:- Acute otitis externa (AOE)- Acute otitis media in patients with tympanostomy tubes (AOMT)caused by ciprofloxacin susceptible microorganisms.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a958e8d-e250-47cb-bafd-c2e52a21f535.json
7a9fecdf-1cf6-4357-80d9-d40cacf41222,LEVETIRACETAM ALTAN 100 MG/ML,prescription,N03AX14,LEVETIRACETAM,9414,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,LEVETIRACETAM/,2025-07-31T04:43:01.581906,IL,פרופארם,,454.6116916,385.2641454,327.8843791,,8470006926536,LEVETIRACETAM ALTAN 100 MG/ML 5ML 10AMP,,,17128,VIAL GLASS TYPE I,units,10.0,162 07 35480 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Levetiracetam Altan 100 mg/ml is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.Levetiracetam Altan 100 mg/ml is indicated as adjunctive therapy•in the treatment of partial onset seizures with or without secondary generalization in adults, adolescents patients and children from 4 years of age with epilepsy.•in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy•in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalized Epilepsy.Levetiracetam Altan 100 mg/ml is an alternative for patients when oral administration is temporarily not feasible.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7a9fecdf-1cf6-4357-80d9-d40cacf41222.json
7ac08505-491e-4e80-b05e-75616d68d118,STELARA 130 MG,prescription,L04AC05,USTEKINUMAB,7301,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,USTEKINUMAB/,2025-07-31T08:42:48.113767,IL,יאנסן סילג,,9130.261773,7737.510321,7034.100292,,7290014577404,STELARA 90MG/1ML PREFILLED SYRINGE,49196,,66817,VIAL GLASS TYPE I,units,1.0,158 52 35072 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Crohn’s Disease :STELARA is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNFα antagonist or have medical contraindications to such therapies.Ulcerative colitis :STELARA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ac08505-491e-4e80-b05e-75616d68d118.json
7ad5f7dd-e9cc-4180-83fc-05cf711bf2d0,KOVALTRY 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,8169,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,RECOMBINANT HUMAN COAGULATION FACTOR VIII,2025-07-31T04:30:07.718589,IL,באייר,,787.7048571,667.5465188,568.1246968,,,KOVALTRY 500 IU  	VIAL 10 ML,11284,,36472,VIAL 10 ML GLASS TYPE I,units,1.0,158 45 34964 00,valid,17.5,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Kovaltry can be used for all age groups.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ad5f7dd-e9cc-4180-83fc-05cf711bf2d0.json
7adcc5bc-2c50-45ec-82cf-b6601f5c2461,ESOPRIM S.K 20 MG,prescription,A02BC05,ESOMEPRAZOLE,8437,,,WHO ATC Classification,,ILS,"capsule, hard",ESOMEPRAZOLE AS SODIUM,2025-07-31T02:36:56.737352,IL,SK PHARM(KS KIM),,43.04863539,36.4818944,26.62912,,7290016845174,ESOPRIM S.K 40 MG 28 tab,5660,,55250,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,162 75 35708 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Esoprim S.K. 20 mg indicated in adults for:Gastroesophageal Reflux Disease (GERD)- treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease. In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and- healing of Helicobacter pylori associated duodenal ulcer and prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers -Patients requiring continued NSAID therapy Healing of gastric ulcers associated with NSAID therapy. - Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk. - Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers. Esoprim S.K 20 mg is indicated in adolescents from the age of 12 years for: Gastro-esophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis -long-term management of patients with healed esophagitis to prevent relapse-symptomatic treatment of gastro-esophageal reflux diseaseIn combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7adcc5bc-2c50-45ec-82cf-b6601f5c2461.json
7ae12ee2-deb4-45f0-9c51-b49d3670c41a,ISOVENIR 10 MG,prescription,D10BA01,ISOTRETINOIN,9396,,,WHO ATC Classification,,ILS,"capsule, soft",ISOTRETINOIN,2025-07-31T04:13:46.492873,IL,ביואבניר,,38.68782456,32.786292,23.9316,,,ISOVENIR 5 MG 30 CAPS,,,15527,BLISTER ALU/PVC/TE/PVDC,units,30.0,174 46 36774 99,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Isovenir is indicated for the treatment of severe cystic acne that does not respond to other treatment,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ae12ee2-deb4-45f0-9c51-b49d3670c41a.json
7b0d6df2-2127-478c-9bd0-efadc77eeade,OVALEAP,prescription,G03GA05,FOLLITROPIN ALFA,8024,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN ALFA/,2025-07-31T06:19:21.853679,IL,תרומד,,1312.957597,1112.675979,946.95828,,,OVALEAP 900IU/1.5 ML 1 CARTRIDGE,15477,,24170,CARTRIDGE GLASS TYPE I,units,1.0,157 82 34716 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"In adult women:• Anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate.• Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra fallopian transfer (ZIFT).• Ovaleap in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/L.In adult men:• Ovaleap is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotropic hypogonadism with concomitant human chorionic gonadotropin (hCG) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b0d6df2-2127-478c-9bd0-efadc77eeade.json
7b2f32d7-6436-4198-94c4-7a22e0047f97,INUTEST 25% SOL FOR PERF 25AMPX20ML,29C,,,20466,,,,,,injection,INUTEST 25% SOL FOR PERF X,2025-07-31T20:39:02.819201,IL,nan,,,,,,,INUTEST 25% SOL FOR PERF 25AMPX20ML,,,,,units,25.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b2f32d7-6436-4198-94c4-7a22e0047f97.json
7b2fe5c6-21c8-49b1-ac58-10ded144fcb3,HYRIMOZ,prescription,L04AB04,ADALIMUMAB,8810,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/ML,2025-07-31T03:54:26.072184,IL,סנדוז,,2331.675847,1975.996569,1796.360517,,,HYRIMOZ 40MG/0.8ML 2 PEN,8483,,66318,PREFILLED PEN GLASS TYPE I,units,2.0,164 72 36144 00,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis Hyrimoz in combination with methotrexate is indicated for:  The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. Hyrimoz can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate. Juvenile idiopathic arthritisPolyarticular juvenile idiopathic arthritis:Hyrimoz in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs). Hyrimoz can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate . Adalimumab has not been studied in patients aged less than 2 years. Enthesitis-related arthritis:Hyrimoz is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapyAxial spondyloarthritisAnkylosing spondylitis (AS): Hyrimoz is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy. Axial spondyloarthritis without radiographic evidence of AS: Hyrimoz is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels , who have had an inadequate response to, or are intolerant to, non - steroidal anti-inflammatory drugs. Psoriatic arthritis Hyrimoz is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function. Psoriasis Hyrimoz is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy. Paediatric plaque psoriasis Hyrimoz is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.Hidradenitis suppurativa (HS)Hyrimoz is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults  and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy. Crohn’s disease Hyrimoz is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. Hyrimoz is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.Paediatric Crohn's disease Hyrimoz is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6- years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and corticosteroid, and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies Ulcerative colitis Hyrimoz is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6- mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.Paediatric ulcerative colitis Hyrimoz is indicated for the treatment of moderately to severely active ulcerative colitis in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including corticosteroids and/or 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.Uveitis Hyrimoz is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroidsparing, or in whom corticosteroid treatment is inappropriate.Paediatric Uveitis Hyrimoz is indicated for the treatment of chronic non-infectious uveitis in paediatric patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.Intestinal Behcet’s diseaseHyrimoz is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b2fe5c6-21c8-49b1-ac58-10ded144fcb3.json
7b3ce1b4-017e-4043-8fc6-a708ef8cc97b,FLUTIFORM 125/5,prescription,R01AD08,FLUTICASONE,7386,,,WHO ATC Classification,,ILS,pressurised suspention for inhalation,"FLUTICASONE PROPIONATE 0.125 MG/DOSE, FORMOTEROL FUMARATE DIHYDRATE 0.005 MG/DOSE",2025-07-31T03:15:04.878931,IL,רפא,,128.8034437,109.1554656,81.15648,,7290008015967,FLUTIFORM 50/5  INHALER 120 DOSES,6533,,51480,CANISTER ALUMINIUM,units,120.0,150 63 33813 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,The regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting β2 agonist) is appropriate:• For patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting β2 agonist.• For patients already adequately controlled on both an inhaled corticosteroid and a long-acting β2 agonist.Flutiform 125mcg/5mcg inhaler is indicated in adults and adolescents aged 12 years and above.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b3ce1b4-017e-4043-8fc6-a708ef8cc97b.json
7b40bc98-82bc-4c02-9722-c11ccbdca64a,TREVICTA,prescription,N05AX13,PALIPERIDONE,7922,,,WHO ATC Classification,,ILS,extended release suspension for injection,PALIPERIDONE AS PALMITATE/,2025-07-31T09:41:00.408164,IL,יאנסן סילג,,2036.618453,1725.947918,1468.891845,,,TREVICTA PREFILLED SYR 263MG/1.315ML,20828,,73578,SYRINGE PREFILLED  CYCLIC OLEFIN COPOLYMER,units,1.0,157 43 34606 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"TREVICTA, a 3 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly paliperidone palmitate injectable product",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b40bc98-82bc-4c02-9722-c11ccbdca64a.json
7b40dffa-a3dd-4e8e-95db-d9263c62dc3d,HUMIRA,prescription,L04AB04,ADALIMUMAB,8968,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/,2025-07-31T03:50:12.332339,IL,אב-וי,,2303.621878,1952.222018,1661.465547,,,HUMIRA 40MG/0.4ML 2 PFS,,,73626,PRE-FILLED PEN GLASS TYPE I,units,2.0,157 78 34788 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"• Rheumatoid arthritis:Humira in combination with methotrexate is indicated for:- The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.- The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Humira has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.• Polyarticular juvenile idiopathic arthritis:Humira in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs).  Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. Humira has not been studied in patients aged less than 2 years.• Enthesitis-related arthritis:Humira is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy.• Axial spondyloarthritis :Humira is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.• Axial spondyloarthritis without radiographic evidence of AS:Humira is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels , who have had an inadequate response to, or are intolerant to, non - steroidal anti-inflammatory drugs. • Psoriatic arthritis:Humira is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti rheumatic drug therapy has been inadequate. Humira has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.• Psoriasis:Humira is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.• Paediatric plaque psoriasis:Humira is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.• Hidradenitis suppurativa (HS):Humira is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy.• Crohn’s disease:Humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy.  Humira is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab. • Paediatric Crohn's disease:Humira is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6- years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and corticosteroid, and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies• Ulcerative colitis:Humira is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.  • Uveitis:Humira is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.• Intestinal Behcet's disease:Humira is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.• Paediatric UveitisHumira is indicated for the treatment of chronic non-infectious uveitis in paediatric patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.•	Paediatric ulcerative colitis Humira is indicated for the treatment of moderately to severely active ulcerative colitis in pediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including corticosteroids and/or 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b40dffa-a3dd-4e8e-95db-d9263c62dc3d.json
7b4f8bc7-395a-4b07-9eae-353ca42cfacd,CYMBALTA 30 MG,prescription,N06AX21,DULOXETINE,4824,,,WHO ATC Classification,,ILS,gastro resistant capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T01:37:03.422420,IL,אלי לילי,,99.1762919,84.047705,62.489,,,CYMBALTA 60MG 28CAPS,3788,,13276,BLISTER PVC/PE/PCTFE/AL,units,28.0,132 70 31142 12,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Cymbalta is indicated for the treatment of major depressive episodes.- Cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy.- Cymbalta is indicated for the treatment of generalized anxiety disorder (GAD).- Cymbalta is indicated for the management of fibromyalgia.- Cymbalta is indicated for the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. This has been established in studies in patients with chronic low back pain (CLBP) and chronic pain due to osteoarthritis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b4f8bc7-395a-4b07-9eae-353ca42cfacd.json
7b4fd387-453b-495e-80b6-2e44631297f1,MOUNJARO 12.5 MG KWIKPEN,prescription,A10BX16,TIRZEPATIDE,9233,,,WHO ATC Classification,,ILS,solution for injection,TIRZEPATIDE 20.8 MG/ML,2025-07-31T05:32:26.106522,IL,אלי לילי,,nan,nan,nan,,,MOUNJARO 12.5 MG/0.5 ML  SOL FOR INJ 4 PF PEN,,,,PRE-FILLED PEN GLASS TYPE I,units,4.0,177 54 38073 99,valid,nan,s.c,1.4,24,,,,,,,,,,0,Prescription required,"T2DMMounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise•	as monotherapy when metformin is considered inappropriate due to intolerance or contraindications•	in addition to other medicinal products for the treatment of diabetes.Weight managementMounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of•	&#8805; 30 kg/m2 (obesity) or•	&#8805; 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).For trial results with respect to obstructive sleep apnoea (OSA) in adults with obesity, see section 5.1.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b4fd387-453b-495e-80b6-2e44631297f1.json
7b710be6-8ad2-4af2-a47d-8e37c4fe5937,TRAMARAZ 100 MG/ML,prescription,N02AX02,TRAMADOL,8232,,,WHO ATC Classification,,ILS,drops,TRAMADOL,2025-07-31T09:33:33.034670,IL,רז פרמהצפטי,,17.14533628,14.529946,10.6058,,8022086001025,TRAMARAZ 100 MG/ML 10 ML,,,52434,BOTTLE GLASS TYPE III,units,10.0,154 88 34205 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b710be6-8ad2-4af2-a47d-8e37c4fe5937.json
7b830809-5b1f-496d-912b-193dcfd8b8f1,RISPOND 1,prescription,N05AX08,RISPERIDONE,7946,,,WHO ATC Classification,,ILS,coated tablets,RISPERIDONE,2025-07-31T07:40:21.684417,IL,אוניפארם,,104.4948227,88.5549345,65.8401,,,RISPOND 4 MG 30 TAB,18561,,55825,BLISTER PVC/ALUMINIUM,units,30.0,134 58 31403 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b830809-5b1f-496d-912b-193dcfd8b8f1.json
7b87c972-bb35-4202-85f5-566e6e812907,ALDACTONE 25 MG,prescription,C03DA01,SPIRONOLACTONE,1447,,,WHO ATC Classification,,ILS,coated tablets,SPIRONOLACTONE,2025-07-31T08:35:21.232479,IL,טבע,,11.55869,9.7955,7.15,,,SPIRONOLACTONE TEVA (ALDOSPIRONE) 25MG 20TAB,1191,,33902,BLISTER PVC/ALUMINIUM,units,20.0,125 97 24826 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Congestive heart failure, cirrhotic ascites.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b87c972-bb35-4202-85f5-566e6e812907.json
7b8f4a94-228c-4407-adde-d4217739cea1,PROPYL-THIOCIL,prescription,,,1667,,,,,ILS,tablets,PROPYLTHIOURACIL,2025-07-31T07:03:02.169775,IL,טבע,,26.6181273,22.557735,16.4655,,7290000804088,PROPYL-THIOCIL 30TAB,16555,,20764,BLISTER PVC/ALUMINIUM,units,30.0,026 63 21054 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Hyperthyroidism.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b8f4a94-228c-4407-adde-d4217739cea1.json
7b90c8f2-7639-4544-9d86-8b4d80e443c4,OMR-IGG-AM 5 %,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",6424,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML MG/ML",2025-07-31T06:09:29.148786,IL,אומריקס,,1689.611134,1431.873906,1218.61609,,,OMR-IGG-AM 5% SOL FOR INJ 100ML,15026,,9693,BOTTLE GLASS TYPE I,units,100.0,127 54 30698 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Replacement therapy     * PRIMARY immunodeficiency (patients with PRIMARY defective antibody synthesis such as agammaglobulinemia OR hypogammaglobulinemia)     * Myeloma OR chronic Lymphocytic Leukemia (CLL) with severe secondary hypogammaglobulinemia AND recurrent infections.     * Children with congenital AIDS AND recurrent infections    - Immunomodulation     * Idiopathic Thrombocytopenic Purpura (ITP)     * Guillain Barre Syndrome     * Kawasaki Disease    - Allogenic Bone Marrow Transplantation,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b90c8f2-7639-4544-9d86-8b4d80e443c4.json
7b975fbe-dcb8-4ca9-a9f9-f8879cefe88f,DEFIROX 125 MG,prescription,V03AC03,DEFERASIROX,9122,,,WHO ATC Classification,,ILS,dispersible tablets,DEFERASIROX,2025-07-31T01:45:44.513633,IL,דקסל פארמה,,3477.253269,2946.824804,2678.93164,,,DEFIROX 500 MG  28 TAB,4759,,30302,BLISTER PVC/PCTFE/AL,units,28.0,167 88 35880 00,valid,10.0,per os,1.4,30,,,,,,,,,,0,Prescription required,Defirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over). Defirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC] &#8805;5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 µg/l). LIC is the preferred method of iron overload determination and should be used wherever available,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7b975fbe-dcb8-4ca9-a9f9-f8879cefe88f.json
7ba2e370-fa1f-4c8c-ba8a-73992b20c623,SUBUTEX 2 MG,prescription,N07BC01,BUPRENORPHINE,4383,,,WHO ATC Classification,,ILS,tablets sublingual,BUPRENORPHINE AS HYDROCHLORIDE,2025-07-31T08:48:56.475369,IL,נעמי שאקו עזרה,,30.82667323,26.12430051,19.06883249,,7290008121378,SUBUTEX 2MG 7SUBLING TAB,19447,,3880,BLISTER ALUMINIUM /ALUMINIUM,units,7.0,133 88 29872 00,valid,37.0,sublingual,1.4,24,,,,,,,,,,0,Prescription required,"Substitution treatment for opioid dependence within a Framework of medical, social and psychological treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ba2e370-fa1f-4c8c-ba8a-73992b20c623.json
7bab1501-6ed7-454e-9ef2-c9174645e5ad,TRUXIMA,prescription,L01XC02,RITUXIMAB,8343,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T09:47:50.110500,IL,פאדאגיס,,3920.040699,3322.068537,3020.062306,,7290012162404,TRUXIMA 500MG/50 ML 1 VIAL,20865,,30893,VIAL 10 ML GLASS TYPE I,units,1.0,161 74 35585 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Truxima is indicated in adults for the following indications: * Non-Hodgkin’s lymphoma (NHL) Truxima is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma. Truxima is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy. Truxima is indicated for the treatment of patients with CD20 positive diffuse large B-cell non-Hodgkin's lymphoma in combination with CHOP chemotherapy. Truxima maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.* Chronic lymphocytic leukaemia (CLL)Truxima in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory CLL. Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including rituximab or patients refractory to previous rituximab plus chemotherapy.* Granulomatosis with polyangiitis and microscopic polyangiitisTruxima, in combination with glucocorticoids, is indicated for the treatment of adult patients with granulomatosis with polyangiitis (GPA)  (Wegener’s Granulomatosis (WG)) and microscopic polyangiitis (MPA).*pemphigus vulgaris (PV):Truxima is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7bab1501-6ed7-454e-9ef2-c9174645e5ad.json
7baff4e5-0ece-4857-950d-baa59f7836ad,EPINEPHRINE INJECTION MYLAN JR 0.15 MG,prescription,R01AA14,EPINEPHRINE,8516,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE 0.5 MG/ML,2025-07-31T02:27:05.727426,IL,דקסל פארמה,,539.3249055,457.055025,388.983,,,EPINEPHRINE INJECTION MYLAN JR 0.15 MG,5651,,28514,AUTO-INJECTOR GLASS TYPE I,units,2.0,161 58 35820 00,valid,17.5,i.m,1.4,19,,,,,,,,,,0,Prescription required,"Epinephrine is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera which includes bees,wasps,hornets,yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs,diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise induced anaphylaxis.Epinephrine is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.Epinephrine is intended for immediate administration as emergency supportive therapy only, and is not a substitute for immediate medical care", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7baff4e5-0ece-4857-950d-baa59f7836ad.json
7bb10e77-e96c-4bc1-b04f-159b56c1c8bb,FANAPT TABLETS 1 MG,prescription,N05AX14,ILOPERIDONE,6946,,,WHO ATC Classification,,ILS,tablets,ILOPERIDONE,2025-07-31T02:54:38.105296,IL,מגאפארם,,nan,nan,nan,,7290014573062,FANAPT 8MG 60TAB,6509,,43876,BLISTER ALUMINIUM,units,60.0,148 32 33482 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,FANAPT is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7bb10e77-e96c-4bc1-b04f-159b56c1c8bb.json
7bb2bf97-55e9-42f0-8329-e5a4a8026aa4,ZOELY,29C,G03CA03,ESTRADIOL,20105,,,WHO ATC Classification,,ILS,film coated tablets,"NOMEGESTROL ACETATE 2.5  MG, ESTRADIOL AS HEMIHYDRATE 1.5  MG",2025-07-31T15:07:42.973745,IL,nan,,nan,nan,nan,,7290008121897,MEGESTROL 40MG/ML 240ML,,,,BLISTER PVC/ALUMINIUM,units,240.0,150 67 33784 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Oral contraception,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7bb2bf97-55e9-42f0-8329-e5a4a8026aa4.json
7bb644bb-a8eb-4c4f-9815-7358a4e37120,SERENADA 100,prescription,N06AB06,SERTRALINE,6044,,,WHO ATC Classification,,ILS,coated tablets,SERTRALINE AS HYDROCHLORIDE,2025-07-31T08:04:53.735542,IL,אוניפארם,,43.28349504,36.680928,26.7744,,,SERENADA 100 28TAB,19811,,74582,BLISTER PVC/ALUMINIUM,units,28.0,136 99 31204 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of symptoms of depression in patients with or without a history of mania. Following satisfactory respose, continuation with sertaline therapy is effective in preventon relapse of the initial episode of depression or recurrence of further depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7bb644bb-a8eb-4c4f-9815-7358a4e37120.json
7bc127ff-9c6f-460d-9800-e94182442896,RITALIN ® LA 10 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,4753,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:41:08.399850,IL,נוברטיס פארמה,,77.92893605,66.04147123,49.1014656,,7290003257192,RITALIN LA 20MG 30CAPS,18324,,61781,BOTTLE HDPE,units,30.0,146 50 33288 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD) .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7bc127ff-9c6f-460d-9800-e94182442896.json
7bce0f0c-55f2-44aa-852f-314916957f62,BENDAMUSTINE MEDAC 100 MG,prescription,L01AA09,BENDAMUSTINE ,8662,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BENDAMUSTINE  HYDROCHLORIDE,2025-07-30T23:35:02.480541,IL,צמל,,531.1060487,450.0898718,383.05521,,7290100819029,BENDAMUSTINE MEDAC 100 MG 1 VIAL,2780,,28456,VIAL GLASS TYPE I,units,1.0,163 73 35386 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate.Indolent non-Hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7bce0f0c-55f2-44aa-852f-314916957f62.json
7bdbf193-4f46-49c3-944e-cb8961b72b99,STRATTERA 4 MG/ML ORAL SOLUTION,prescription,N06BA09,ATOMOXETINE,7952,,,WHO ATC Classification,,ILS,solution  (oral),ATOMOXETINE/,2025-07-31T08:45:02.366410,IL,אלי לילי,,212.557188,180.1332101,144.1065681,,7290016021059,STRATTERA 18MG 28CAPS,9806,,71827,BOTTLE GLASS TYPE III,units,28.0,158 61 35026 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD. Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7bdbf193-4f46-49c3-944e-cb8961b72b99.json
7be536fb-8346-4b25-9aa4-87439120b967,PARACETAMOL S.A.L.F 10 MG/ML,prescription,N02BE01,PARACETAMOL,9179,,,WHO ATC Classification,,ILS,solution for infusion,PARACETAMOL/,2025-07-31T06:28:23.682216,IL,רז פרמהצפטי,,277.68822,235.329,200.28,,7290018490075,PARACETAMOL S.A.L.F 10 MG/ML 100ML 30 VIALS,,,70516,BOTTLE PP,units,30.0,165 92 35757 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Paracetamol is indicated for the short-term treatment of moderate pain, especially following surgery and for the short-term treatment of fever, when intravenous administration  is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7be536fb-8346-4b25-9aa4-87439120b967.json
7be5ac76-8622-4771-b878-c46aafd547a0,SONGHA NIGHT,off-the-counter,,,5015,,,,,ILS,coated tablets,"VALERIAN DRY EXTRACT, MELISSA OFFICINALIS",2025-07-31T13:19:44.959194,IL,פרמה שלום,,63.13,53.5,nan,,,SONGHA NIGHT 30 TAB,19449,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,134 16 29935 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Sedative in states of tension, nervousness and insomnia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7be5ac76-8622-4771-b878-c46aafd547a0.json
7bf3a82c-7249-4c42-b50b-b19bfbffddaf,BUDESONIDE STERINEBS TEVA ® 0.5 MG/2 ML,prescription,R01AD05,BUDESONIDE,9542,,,WHO ATC Classification,,ILS,suspension for inhalation,BUDESONIDE 0.25  MG /,2025-07-31T00:45:48.331098,IL,רפא,,366.8245473,310.8682743,264.568744,,,BUDESON RECTAL FOAM 1 CANISTER,,,62789,AMPOULES POLYETHYLENE,units,1.0,142 43 33002 00,valid,17.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Bronchial asthma especially in cases where other therapy is insufficient or insuitable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7bf3a82c-7249-4c42-b50b-b19bfbffddaf.json
7c0ee3c2-fc91-4055-a61a-f26027f54aea,ZOFRAN TABLETS 4 MG,prescription,A04AA01,ONDANSETRON,311,,,WHO ATC Classification,,ILS,tablets,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE,2025-07-31T10:52:03.730293,IL,סנדוז,,130.226475,110.3614195,82.0531,,,ZOFRAN INJ 5X4MG/2ML,26068,,8235,BLISTER PVC/ALUMINIUM,units,5.0,049 96 26549 22,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Adults:Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.  Zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). Paediatric Population:Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c0ee3c2-fc91-4055-a61a-f26027f54aea.json
7c1373cd-41a3-42dd-b965-d8dec35b2413,ARAVA 10 MG,prescription,L04AA13,LEFLUNOMIDE,4010,,,WHO ATC Classification,,ILS,film coated tablets,LEFLUNOMIDE,2025-07-30T23:26:20.467702,IL,סאנופי אוונטיס,,147.4865776,124.9886306,99.9909045,,,ARAVA 20MG 30TAB,1650,,27277,BOTTLE HDPE,units,30.0,121 78 30132 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Arava is indicated in adults for the treatment of active rheumatoid arthritis (RA) :   1. to reduce signs and symptoms    2. to inhibit structural damage as evidenced by X-ray erosions and joint space narrowing    3. to imptove physical function.   Arava is indicated for the treatment of adult patients with active psoriatic arthritis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c1373cd-41a3-42dd-b965-d8dec35b2413.json
7c167907-fbf0-4470-a694-6c8347936911,VIA-AVENIR 100 MG,prescription,G04BE03,SILDENAFIL,8261,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:11:49.873989,IL,ביואבניר,,100.7457751,85.3777755,63.4779,,7290010286911,VIA AVENIR 25MG 4 TABS,,,55869,BLISTER PVC/PVDC/ALUMINIUM,units,4.0,147 72 33415 01,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c167907-fbf0-4470-a694-6c8347936911.json
7c1c58d5-41e3-4ea4-97f3-9fd6d2733e34,CEFOVIT 250,prescription,J01DB01,CEFALEXIN,2274,,,WHO ATC Classification,,ILS,capsules,CEFALEXIN AS MONOHYDRATE,2025-07-31T01:00:07.297804,IL,ויטאמד,,8.1977786,6.94727,5.071,,,CEFOVIT 250MG 10CAPS,3587,,7690,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,026 84 25145 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic for the treatment of infections caused by micro-organisms sensitive to Cephalexin.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c1c58d5-41e3-4ea4-97f3-9fd6d2733e34.json
7c2b615b-2b2b-4b79-8960-8ac7b9cec5b2,BONDORMIN,prescription,N05CD09,BROTIZOLAM,1844,,,WHO ATC Classification,,ILS,tablets,BROTIZOLAM 0.25  MG,2025-07-30T23:40:52.372086,IL,רפא,,15.51936,13.152,9.6,,7290008013932,BONDORMIN 0.25MG 10TAB,2337,,7872,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,120 37 26021 12,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Insomnia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c2b615b-2b2b-4b79-8960-8ac7b9cec5b2.json
7c4bd89e-1d8c-4b20-9aa1-fb9fc7c879ba,LEMOCIN CHERRY,off-the-counter,R02AD02,LIDOCAINE,5417,,,WHO ATC Classification,,ILS,lozenges,"LIDOCAINE, TYROTHRICIN, CETRIMONIUM BROMIDE",2025-07-31T12:18:47.107697,IL,ג.ס.ק,,50.7636,43.02,nan,,7290011363185,LEMOCIN LEMON 50 LOZ,,,,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,117 79 29907 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of pain associated with severe sore throat and mouth infections.This medicine is intended for adults and children over 12 years old.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c4bd89e-1d8c-4b20-9aa1-fb9fc7c879ba.json
7c5024b6-ac0e-4c2b-8ce4-bd4901a21002,SEROXAT,prescription,N06AB05,PAROXETINE,2892,,,WHO ATC Classification,,ILS,coated tablets,PAROXETINE AS HYDROCHLORIDE,2025-07-31T08:08:06.181828,IL,ג.ס.ק,,37.18163834,31.509863,22.9999,,,SEROXAT 20MG 30TAB,19839,,14008,BLISTER PVC/ALUMINIUM/PAPER,units,30.0,131 27 27592 07,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of (in adults):­	Major Depressive Disorder ­	Obsessive Compulsive Disorder (OCD)­	Panic Disorder with and without agoraphobia­	Social Anxiety Disorders/Social phobia­	Generalised Anxiety Disorder­	Post-Traumatic Stress Disorder,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c5024b6-ac0e-4c2b-8ce4-bd4901a21002.json
7c54cd12-37b2-457d-a31c-d09c5e4418b0,NORTYLIN 25 MG,prescription,N06AA10,NORTRIPTYLINE,3393,,,WHO ATC Classification,,ILS,tablets,NORTRIPTYLINE HYDROCHLORIDE,2025-07-31T05:52:18.703417,IL,רקח,,23.27903897,19.728,14.4,,,NORTYLIN 25MG 30TAB,14064,,9428,BLISTER PVC/ALUMINIUM,units,30.0,030 15 20692 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Depressive states, endogenous depressions are more likely to be alleviated than other depressive states.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c54cd12-37b2-457d-a31c-d09c5e4418b0.json
7c5755cc-7cb8-419f-97af-671846becb11,VIEPAX XR 150,prescription,N06AX16,VENLAFAXINE,8999,,,WHO ATC Classification,,ILS,tablets prolonged release,VENLAFAXINE AS HYDROCHLORIDE,2025-07-31T10:14:29.834957,IL,דקסל פארמה,,66.13699636,56.048302,41.6716,,,VIEPAX XR 150 30TAB NEW FORMULATION,22473,,56721,BLISTER PVC/PE/PVDC/AL,units,30.0,161 41 35038 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of depression. Maintenance of recurrent depression. Generalized anxiety disorder (GAD) - short term and long-term. Social anxiety Disorder (SAD)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c5755cc-7cb8-419f-97af-671846becb11.json
7c686a2d-8c82-4000-acbc-0b044e0c6705,FOLIC ACID 10 MG,off-the-counter,B03BB01,FOLIC ACID,2721,,,WHO ATC Classification,,ILS,tablets,FOLIC ACID,2025-07-31T11:57:01.837167,IL,סם און,,21.004,17.8,nan,,,FOLIC ACID 5MG 30TAB,6038,,,BLISTER POLYVINYL CHLORIDE,units,30.0,128 86 21946 00,valid,nan,per os,1.4,18,,,,,,,,,,0,,Treatment of folic acid deficiency megaloblastic anemia in malabsorption states.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c686a2d-8c82-4000-acbc-0b044e0c6705.json
7c728644-9527-4751-b872-3310265be5e5,IODO-VIT VETERINARY SOLUTION,off-the-counter,,,5541,,,,,ILS,solution,POVIDONE-IODINE,2025-07-31T12:12:58.932151,IL,ויטאמד,,24.0484,20.38,nan,,,IODO-VIT SOLUTION 300ML,,,,BOTTLE HDPE,units,300.0,083 35 92361 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Disinfection of wounds, scratches, minor burns, skin infections in farm animals and pets. Prevention of mastitis in cattle.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c728644-9527-4751-b872-3310265be5e5.json
7c732fbc-0f60-4574-97b8-fb03060ecf48,AVASTIN,prescription,L01FG01,BEVACIZUMAB,4932,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BEVACIZUMAB/ML,2025-07-31T00:27:16.653640,IL,רוש,,944.0973032,800.0824959,680.9212731,,7290008140737,AVASTIN 100MG 25MG/ML VIAL 4ML,9566,,35507,VIAL GLASS TYPE I,units,1.0,131 59 31060 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"- Avastin in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of patients with metastatic carcinoma of the colon or rectum.- Avastin  in addition to platinum - based chemotherapy  is indicated for first - line treatment of patients with unresectable advanced  metastatic or recurrent non- small cell lung cancer other than predominantly squamous cell histology.  - Avastin in combination with interferon alfa-2a is indicated for first line treatment of patients with advanced and /or metastatic renal cell cancer.  - Avastin in combination with paclitaxel is indicated for first-line treatment of patients with metastatic breast cancer.- Avastin as asingle agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.- Avastin, in combination with carboplatin and paclitaxel, is indicated for the front-line treatment of advanced (FIGO stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are at high risk for recurrence (residual disease after debulking).- Avastin, in combination with carboplatin and gemcitabine, is indicated for the treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor-targeted agents.- Avastin ( Bevacizumab) in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents - Avastin ( Bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan is indicated for treatment of patients with persistent, recurrent, or metastatic carcinoma of the cervix.- Bevacizumab, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations. - Bevacizumab, in combination with atezolizumab, is indicated for the treatment of patients with  unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c732fbc-0f60-4574-97b8-fb03060ecf48.json
7c98231d-3355-44a8-9408-4e8f1ec3ad50,FENTANYL PANPHARMA 0.05 MG/ML,prescription,N01AH01,FENTANYL,7958,,,WHO ATC Classification,,ILS,solution for injection,FENTANYL AS CITRATE 0.05 MG/ML,2025-07-31T03:01:15.123883,IL,פארמלוג'יק,,23.50827388,19.922266,14.5418,,7290006676085,FENTANYL PANPHARMA 0.05 MG/ML 10 VIAL 2ML,6561,,27071,AMPOULES GLASS TYPE I,units,10.0,152 49 33974 00,valid,37.0,"epidural, i.v",1.4,36,,,,,,,,,,0,Prescription required,"For analgesic action of short duration during anesthtic periods (premedication, induction and maintenance) and in the immediate postoperative period  as need arises. As a narcotic analgesic supplement in general or regional anesthesia. For administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia  and as an adjunct in the maintenance of general or regional anesthesia. For use as an anesthetic agent with oxygen in selected  high-risk patients (open heart surgery or certain neurological or orthopedic procedures). By the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections  and as adjunct to general anesthesia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7c98231d-3355-44a8-9408-4e8f1ec3ad50.json
7ca93093-3699-4a5b-975c-0cb4b2ab0984,EBIXA TABLETS 10 MG,prescription,N06DX01,MEMANTINE,6499,,,WHO ATC Classification,,ILS,film coated tablets,MEMANTINE HYDROCHLORIDE,2025-07-31T02:10:46.823171,IL,לנדבק,,147.1755,124.725,99.78,,,EBIXA 20MG 28TABS,5512,,21040,BLISTER PP/ALUMINIUM,units,28.0,129 83 30891 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Treatment of patient with moderate to severe Alzheimer's disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ca93093-3699-4a5b-975c-0cb4b2ab0984.json
7cb033e7-3eab-421b-ab94-9b3779016dfb,RISPERDAL 1 MG,prescription,N05AX08,RISPERIDONE,4122,,,WHO ATC Classification,,ILS,film coated tablets,RISPERIDONE,2025-07-31T07:37:33.957932,IL,יאנסן סילג,,36.56215722,30.984879,22.6167,,7290008124744,RISPERDAL 1MG/ML SOL 30ML,18295,,23466,BLISTER PVC/PE/PVDC/AL,units,30.0,144 78 28260 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7cb033e7-3eab-421b-ab94-9b3779016dfb.json
7cc6e36c-1a99-4bba-85f0-7156921b5793,EXONDYS 51,prescription,M09AX06,ETEPLIRSEN,8237,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ETEPLIRSEN/,2025-07-31T02:50:17.284657,IL,תרומד,,nan,nan,nan,,,EXONDYS 51	 1VIAL  100 MG/2ML,,,,VIAL GLASS TYPE I,units,2.0,160 85 35258 00,valid,nan,i.v,1.4,30,,,,,,,,,,0,Prescription required,EXONDYS 51 is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7cc6e36c-1a99-4bba-85f0-7156921b5793.json
7ccd87c0-2621-4240-afd6-d4175ac477cc,REBIF 22 MCG,prescription,L03AB07,INTERFERON BETA-1A,6117,,,WHO ATC Classification,,ILS,solution for injection,INTERFERON BETA 1A/ML,2025-07-31T07:18:37.635559,IL,מרק סרונו,,2786.863317,2361.748679,2147.044253,,7290000845265,REBIF 22MCG/0.5ML 12 SYRINGES,18322,,22663,CARTRIDGE GLASS TYPE I,units,12.0,110 94 29437 06,valid,10.0,s.c,1.4,18,,,,,,,,,,0,Prescription required,Rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. Efficacy of Rebif in chronic progressive multiple sclerosis has not been established.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ccd87c0-2621-4240-afd6-d4175ac477cc.json
7cd2a008-a717-482d-940d-b30a05dadffa,VIAGRA 100 MG,prescription,G04BE03,SILDENAFIL,3674,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:12:34.993176,IL,דקסל פארמה,,100.7457751,85.3777755,63.4779,,7290008108812,VIAGRA 25MG 4TAB,22115,,33544,BLISTER PVC/ALUMINIUM,units,4.0,111 38 29461 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7cd2a008-a717-482d-940d-b30a05dadffa.json
7cd86b0d-5228-4409-adf9-209fbd3831ed,HEPARIN SODIUM TEVA 25000 IU/ 5 ML,prescription,C05BA03,HEPARIN,8842,,,WHO ATC Classification,,ILS,solution for injection / infusion,HEPARIN SODIUM/,2025-07-31T03:45:26.524630,IL,טבע,,147.6488324,125.1261347,100.1009078,,,HEPARIN SODIUM TEVA 25000 IU/ 5 ML 5 VIAL,,,27195,VIAL GLASS TYPE I,units,5.0,158 04 34799 00,valid,25.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"- Prevention of thromboembolic disorders.- As part of the treatment of venous and arterial thromboembolic disorders (including early treatment of  heart attacks as well as unstable angina pectoris)- For the anticoagulation in case of treatment or operation with extracorporeal circulation (e.g. heart-lung machine, hemodialysis)", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7cd86b0d-5228-4409-adf9-209fbd3831ed.json
7cdc1265-14ab-412b-9803-2bf83f20384f,AMLOW 10,prescription,C08CA01,AMLODIPINE,7942,,,WHO ATC Classification,,ILS,tablets,AMLODIPINE AS MALEATE,2025-07-30T23:22:50.490629,IL,אוניפארם,,14.5300008,12.31356,8.988,,,AMLOW 5 MG 30 TAB,9951,,55819,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,131 66 31035 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate hypertension. Vasospastic angina (Prinzmetal's or variant angina). Chronic stable angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7cdc1265-14ab-412b-9803-2bf83f20384f.json
7ce51a64-c458-4d1f-b523-3e7c439774b6,EPIDIOLEX,prescription,N03AX24,CANNABIDIOL,8767,,,WHO ATC Classification,,ILS,solution,CANNABIDIOL/,2025-07-31T02:26:05.428478,IL,ניאופרם,,5447.811889,4616.789942,4197.081765,,7290111096938,EPIDIOLEX 100MG/ML 100ML,5685,,70073,BOTTLE GLASS TYPE III,units,100.0,167 13 36105 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Epidiolex is indicated for use as adjunctive therapy of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ce51a64-c458-4d1f-b523-3e7c439774b6.json
7d0dbc05-aa39-4ae3-84dd-b08f0efb8c6f,NOVOSEVEN ® RT 1 MG/VIAL,prescription,B02BD08,COAGULATION FACTOR VIIA ,7072,,,WHO ATC Classification,,ILS,powder for solution for injection,EPTACOG ALFA (ACTIVATED)/VIAL,2025-07-31T05:56:33.910641,IL,נובו נורדיסק,,12664.50826,10732.63459,9756.940538,,7290008126717,NOVOSEVEN RT 5MG/VIAL,14536,,35602,VIAL GLASS TYPE I,units,1.0,142 63 32929 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"NovoSeven ® RT is indicated for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups: •in patients with congenital haemophilia with inhibitors to coagulation factors VIII or IX > 5 Bethesda Units (BU) •in patients with congenital haemophilia who are expected to have a high anamnestic response to factor VIII or factor IX administration •in patients with acquired haemophilia •in patients with congenital FVII deficiency •in patients with Glanzmann’s thrombasthenia with past or present refractoriness to platelet transfusions, or where platelets are not readily available.Severe postpartum haemorrhageNovoSeven RT is indicated for the treatment of severe postpartum haemorrhage when uterotonics are insufficient to achieve haemostasis",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d0dbc05-aa39-4ae3-84dd-b08f0efb8c6f.json
7d0ef6c6-b997-4121-9106-a011a92a4785,VENTAVIS,prescription,B01AC11,ILOPROST,4973,,,WHO ATC Classification,,ILS,solution for inhalation,ILOPROST 0.01  MG/ML,2025-07-31T10:05:09.642887,IL,באייר,,3723.411757,3155.433833,2868.576212,,,VENTAVIS SOL FOR INH 0.01MG/ML 30AMP 2ML,22353,,69523,AMPOULES GLASS TYPE I,units,30.0,133 14 31070 00,valid,10.0,inhalation with nebuliser,1.4,48,,,,,,,,,,0,Prescription required,"Treatment of patients with primary pulmonary hypertension (PPH) or secondary pulmonary hypertension (SPH) . Due to connective tissue disease or drug - induced, in moderate or severe stages of the disease. In addition, treatment of moderate or severe secondary pulmonary hypertension due to chronic pulmonary thromboembolism, where surgery is not possible.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d0ef6c6-b997-4121-9106-a011a92a4785.json
7d1027f7-1d57-4786-a728-6f072937877a,IMNOVID 1 MG,prescription,L04AX06,POMALIDOMIDE,7407,,,WHO ATC Classification,,ILS,"capsule, hard",POMALIDOMIDE,2025-07-31T04:02:53.307337,IL,ניאופרם,,21116.10068,17895.00137,16268.18306,,7640133683157,IMNOVID 3MG 3X7 CAPSULES (POMALYST),9799,,65785,BLISTER PVC/PCTFE,units,21.0,152 02 33954 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.Imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d1027f7-1d57-4786-a728-6f072937877a.json
7d1ce296-9fdd-444d-b296-24b9f3a75c9e,LISSIN 20 MG,prescription,N06BA12,LISDEXAMFETAMINE,9530,,,WHO ATC Classification,,ILS,tablets,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T04:49:45.890105,IL,אוניפארם,,385.3381468,326.557766,277.921503,,,LISSIN 70 MG 30 TAB,,,37695,BLISTER PVDC/ALUMINIUM,units,30.0,176 71 37820 99,valid,17.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Lissin is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Lissin is indicated for the treatment of Moderate to Severe Binge Eating Disorder (BED) for patients over 18 years.Limitation of Use:Lissin is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Lissin for the treatment of obesity have not been established.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d1ce296-9fdd-444d-b296-24b9f3a75c9e.json
7d26b3be-c5c9-4a38-81c3-12bf0c8faeb6,NORIT 125MG 50TAB,off-the-counter,,,509,,,,,ILS,tablet,NORIT 125MG,2025-07-31T19:45:39.068534,IL,הרשברג,,26.963,22.85,,,,NORIT 125MG 50TAB,14357,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d26b3be-c5c9-4a38-81c3-12bf0c8faeb6.json
7d2dfb32-24cc-4c20-b5e8-bd10ba415f58,FORTEO,prescription,H05AA02,TERIPARATIDE,4730,,,WHO ATC Classification,,ILS,solution for injection,TERIPARATIDE/ML,2025-07-31T03:16:55.517768,IL,אלי לילי,,1100.798471,932.8800598,793.9404764,,7290008139632,FORTEO PEN INJECTOR 2.4ML,6349,,19256,PEN INJECTOR GLASS TYPE I,units,1.0,129 28 30777 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"FORTEO is indicated:•	For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, FORTEO reduces the risk of vertebral and nonvertebral fractures.•	 To increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture  or who have failed or are intolerant to other available osteoporosis therapy.•	 For the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture  or who have failed or are intolerant to other available osteoporosis therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d2dfb32-24cc-4c20-b5e8-bd10ba415f58.json
7d2e23b7-6e7b-4bd2-96a1-a2fd6af40ff5,ADIZEM CD 180,prescription,,,3497,,,,,ILS,capsules controlled release,DILTIAZEM HYDROCHLORIDE,2025-07-31T00:09:04.352119,IL,רפא,,41.2413855,34.95032825,25.5111885,,7290008013475,ADIZEM CD 180MG 30CAP,1080,,53941,BLISTER PVC/ALUMINIUM,units,30.0,102 96 27681 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Calcium channel blocker that is indicated for the treatment of hypertension and angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d2e23b7-6e7b-4bd2-96a1-a2fd6af40ff5.json
7d466465-4984-4ff0-b96a-b68b140ab347,REMODULIN 10 MG/ML,prescription,B01AC21,TREPROSTINIL,6723,,,WHO ATC Classification,,ILS,solution for injection,TREPROSTINIL AS SODIUM/ML,2025-07-31T07:24:21.227639,IL,רפא,,26226.61793,22225.94838,20205.40762,,7290008016629,REMODULIN 5MG/ML VIAL 1X20ML,18320,,60209,VIAL GLASS,units,1.0,135 55 31251 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Remodulin is indicated as a continuous subcutaneous infusion or  intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders.   Pulmonary hypertension associated with congenital systemic to pulmonary shunts.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d466465-4984-4ff0-b96a-b68b140ab347.json
7d50aabe-3889-4585-b4a2-1641bb8ac52a,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7452,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:20:33.822967,IL,צמל,,71.33982758,60.457481,44.9498,,,METOJECT 50MG/ML SYRINGE PREFILLED 7.5MG/0.15ML,13742,,3994,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d50aabe-3889-4585-b4a2-1641bb8ac52a.json
7d6c128e-27d9-4589-9b77-4f3ee46a8989,AGGRENOX 10CAPS SR,29C,,,20806,,,,,,capsule,AGGRENOX SR,2025-07-31T19:51:33.623809,IL,nan,,,,,,,AGGRENOX 10CAPS SR,,,,,units,10.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d6c128e-27d9-4589-9b77-4f3ee46a8989.json
7d7d00f7-73a5-4b40-88b5-b78391a84f6a,GILURYTMAL 50MG 5AMP,29C,,,20431,,,,,,injection,GILURYTMAL 50MG,2025-07-31T20:31:43.056077,IL,nan,,,,,,,GILURYTMAL 50MG 5AMP,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d7d00f7-73a5-4b40-88b5-b78391a84f6a.json
7d7fd7c4-3206-4a64-8257-56a4ab4f531b,SINGULAIR 10 MG TABLETS,prescription,R03DC03,MONTELUKAST,3641,,,WHO ATC Classification,,ILS,tablets,MONTELUKAST AS SODIUM,2025-07-31T08:17:12.659641,IL,אורגנון,,70.36868109,59.6344755,44.3379,,7290004997410,SINGULAIR 10MG 28TAB,19248,,85215,BLISTER PVC/OPA/AL,units,28.0,109 91 29317 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.   Singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.Because the benefits of SINGULAIR may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see Warnings and Precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d7fd7c4-3206-4a64-8257-56a4ab4f531b.json
7d8d23a7-b229-4977-a378-76d5d560322a,CRESTOR ® 5 MG,off-the-counter,C10AA07,ROSUVASTATIN,917,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T11:22:03.134806,IL,ג.ס.ק,,39.8722,33.79,nan,,,CALCIUM SANDOZ 500MG 20T EFF,3083,,,BLISTER ALUMINIUM /ALUMINIUM,units,20.0,139 22 31615 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d8d23a7-b229-4977-a378-76d5d560322a.json
7d9f0af4-51a0-477e-b902-6d5ce4a1ef46,MINIRIN TABLETS 0.1 MG,prescription,H01BA02,DESMOPRESSIN,4411,,,WHO ATC Classification,,ILS,tablets,DESMOPRESSIN ACETATE 0.1  MG,2025-07-31T05:25:02.296826,IL,פרינג,,147.4123874,124.925752,92.8816,,7315372504647,MINIRIN 0.2MG 30TAB,13389,,4069,BOTTLE HDPE,units,30.0,141 99 25705 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Central diabetes insipidus.Nocturnal Enuresis. Treatment of nocturia in adults associated with nocturnal polyuria.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7d9f0af4-51a0-477e-b902-6d5ce4a1ef46.json
7da5fa69-1b0f-4017-a83c-7c639bc37e00,BETACORTEN G OINTMENT,prescription,D07AC01,BETAMETHASONE,2170,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS VALERATE 0.1 %W/W, GENTAMICIN AS SULFATE 0.1 %W/W",2025-07-31T00:32:56.296634,IL,תרימה,,54.87079886,46.500677,33.9421,,,BETACORTEN G OINT15G,2068,,343,TUBE ALUMINIUM,units,15.0,050 45 23262 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,For local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7da5fa69-1b0f-4017-a83c-7c639bc37e00.json
7db248d1-1df5-43c2-abe4-9a5e3e601862,PENTASA SLOW RELEASE GRANULES 4 G.,prescription,A07EC02,MESALAZINE,2824,,,WHO ATC Classification,,ILS,granules,MESALAZINE,2025-07-31T06:35:20.438564,IL,פרינג,,239.17951,202.6945,162.1556,,7640128547228,PENTASA 1G 28SUPP,16063,,8879,SACHET POLYESTER/ALUMINIUM/POLYETHYLENE,units,28.0,157 47 34816 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate ulcerative colitis or crohn's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7db248d1-1df5-43c2-abe4-9a5e3e601862.json
7dba8a92-c4dc-47a2-86da-7011a3521f6c,BISOPROLOL FUMARATE INOVAMED 10 MG,prescription,C07AB07,BISOPROLOL,1786,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE,2025-07-31T07:00:44.672093,IL,דקסל פארמה,,13.466278,11.4121,8.33,,,PROLOL 10MG 50TAB,16556,,7967,BLISTER PVC/ALUMINIUM,units,50.0,152 68 34097 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.- Hypertension. - Coronary heart disease (angina pectoris).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7dba8a92-c4dc-47a2-86da-7011a3521f6c.json
7dc461c7-f186-465c-a1b6-242bde20926c,ATOSIBAN ALTAN,prescription,G02CX01,ATOSIBAN,9416,,,WHO ATC Classification,,ILS,solution for injection/ concentrate for solution for infusion,ATOSIBAN 7.5  MG /,2025-07-30T23:29:41.735525,IL,פרופארם,,99.162008,84.0356,62.48,,8470007045946,ATOSIBAN ALTAN 6.75MG/5ML 1 AMP,,,17131,AMPOULES GLASS TYPE I,units,1.0,162 49 35198 00,valid,34.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,Atosiban Altan is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes- a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7dc461c7-f186-465c-a1b6-242bde20926c.json
7dc62f42-7b04-4deb-9bb6-bb4bc80e44c0,V-DALGIN DROPS,off-the-counter,,,2996,,,,,ILS,drops,DIPYRONE/ML,2025-07-31T13:34:31.986726,IL,ויטאמד,,19.3992,16.44,nan,,7290008068765,V-DALGIN DROPS 10ML,22103,,,BOTTLE GLASS TYPE III,units,10.0,065 91 28293 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7dc62f42-7b04-4deb-9bb6-bb4bc80e44c0.json
7dcad2f7-2a2e-4ae7-bbd8-2ef426b01459,PROPESS,prescription,G02AD02,DINOPROSTONE,6873,,,WHO ATC Classification,,ILS,vaginal delivery system,DINOPROSTONE,2025-07-31T07:02:26.333389,IL,פרינג,,1405.776572,1191.336131,1013.90309,,73153725026243,PROPESS 10MG 5VAGINAL PESSARY,16854,,29633,SACHET ALUMINIUM,units,5.0,131 89 29517 00,valid,17.5,vaginal,1.4,36,,,,,,,,,,0,Prescription required,"Initiation and/or continuation of cervical ripening in patients at term, from 38th week of gestation, with bishop score of 6 or less.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7dcad2f7-2a2e-4ae7-bbd8-2ef426b01459.json
7dcc12c4-e932-4412-9ea9-99c5bd8e7a2d,AMINOPLASMAL B. BRAUN 10% E,29C,B05CB10,COMBINATIONS,20297,,,WHO ATC Classification,,ILS,solution for infusion,"ISOLEUCINE 5.00 G/L, LEUCINE 8.9 G/L, METHIONINE 4.40 G/L, PHENYLALANINE 4.70 G/L, THREONINE 4.20 G/L, TRYPTOPHAN 1.60 G/L, VALINE 6.20 G/L, ARGININE 11.50 G/L, HISTIDINE 3.00 G/L, GLYCINE 12.00 G/L, L- ALANINE 10.50 G/L, PROLINE 5.50 G/L, ASPARTIC ACID 5.60 G/L, GLUTAMINE 7.20 G/L, SERINE 2.30 G/L, TYROSINE 0.40 G/L, POTASSIUM ACETATE 2.453 G/L, SODIUM ACETATE TRIHYDRATE 2.858 G/L, MAGNESIUM CHLORIDE HEXAHYDRATE 0.508 G/L, LYSINE AS ACETATE 8.56 G/L, DISODIUM PHOSPHATE DODECAHYDRATE 3.581 G/L",2025-07-31T13:53:53.084888,IL,nan,,nan,nan,nan,,,ARGININE 1G/5ML ORAL SOLUTION 20 AMP,,,,BOTTLE GLASS TYPE II,units,20.0,150 94 33650 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,,"Supply of amino acids and a limited amount of electrolytes for parenteral nutrition, when oral or enteral nutrition is impossible, insufficient or contraindicated. For adults, adolescents and children over 2 years of age.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7dcc12c4-e932-4412-9ea9-99c5bd8e7a2d.json
7dcc38b7-adf0-46f5-ab4d-bd2f3b690d03,SODIUM CHLORIDE 0.9% IMUNA,prescription,B05CB01,SODIUM CHLORIDE,8887,,,WHO ATC Classification,,ILS,solution for infusion,SODIUM CHLORIDE/ML,2025-07-31T08:24:33.466846,IL,מדי מרקט,,8.968880235,7.6007463,5.54799,,,SODIUM CHLORIDE 0.9% IMUNA 100 ML,,,70777,BAG PLASTIC,units,100.0,167 57 36009 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Short- term intravascular volume substitution. Hypotonic dehydration or isotonic dehydration. Vehicle solution for supplementary medication.Fluid and electrolyte replacement, hypochloremic alkalosis and chloride losses.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7dcc38b7-adf0-46f5-ab4d-bd2f3b690d03.json
7de314dd-c05a-4a25-a5fb-38548a0a5a06,MVASI,prescription,L01FG01,BEVACIZUMAB,8970,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BEVACIZUMAB/,2025-07-31T05:36:18.951306,IL,מדיסון,,944.0973032,800.0824959,680.9212731,,8715131022426,MVASI 100MG 25MG/ML VIAL 4ML,,,69460,VIAL GLASS TYPE I,units,1.0,164 30 35864 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"MVASI in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum.MVASI in addition to platinum - based chemotherapy is indicated for first - line treatment of adult patients with unresectable advanced metastatic or recurrent non- small cell lung cancer other than predominantly squamous cell histology.MVASI in combination with interferon alfa-2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer.MVASI in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer. MVASI as a single agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.MVASI in combination with carboplatin and paclitaxel, is indicated for the front-line treatment of advanced (FIGO stages IIIB, IIIC and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients who are at high risk for recurrence (residual disease after debulking).MVASI  in combination with carboplatin and gemcitabine, is indicated for the treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor-targeted agents.MVASI in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin isindicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents.MVASI in combination with paclitaxel and cisplatin or paclitaxel and topotecan is indicated, in patients who cannot receive platinum therapy, for treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.MVASI, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7de314dd-c05a-4a25-a5fb-38548a0a5a06.json
7deecefb-4fce-439f-a640-46759fd6b523,CUPRIPEN 250MG 30CAPS,29C,,,20345,,,,,,capsule,CUPRIPEN 250MG,2025-07-31T20:08:24.612154,IL,nan,,,,,,,CUPRIPEN 250MG 30CAPS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7deecefb-4fce-439f-a640-46759fd6b523.json
7df24912-4e78-4b5f-b6ed-820597110a46,KISQALI 200 MG,prescription,L01EF02,RIBOCICLIB,8116,,,WHO ATC Classification,,ILS,film coated tablets,RIBOCICLIB AS SUCCINATE,2025-07-31T04:27:17.663516,IL,נוברטיס פארמה,,11093.78152,9401.510177,8546.827434,,,KISQALI 200 MG 63 FC TABLETS,11279,,10109,BLISTER PA/ALUMINIUM/PVC,units,63.0,160 68 35298 00,valid,10.0,per os,1.4,12,,,,,,,,,,0,Prescription required,"Kisqali is indicated in combination with:* a non-steroid aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer, as initial endocrine-based therapy.or* fulvestrant for the treatment of men and postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer, as initial endocrine based therapy or following disease progression on endocrine therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7df24912-4e78-4b5f-b6ed-820597110a46.json
7dfd038e-bd4d-466b-b4d3-9d995da3e8b8,AGISPOR GEL,off-the-counter,D01AC10,BIFONAZOLE,2477,,,WHO ATC Classification,,ILS,gel,BIFONAZOLEW/W,2025-07-31T11:06:15.421773,IL,פאדאגיס,,13.0626,11.07,nan,,7290000857305,AGISPOR GEL 15GR,1812,,,TUBE ALUMINIUM,units,15.0,036 81 25610 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,Broad spectrum antimycotic agent.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7dfd038e-bd4d-466b-b4d3-9d995da3e8b8.json
7e022ac0-e49d-409b-9678-f15b1874d682,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4554,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:21:59.517362,IL,מדיסון,,2831.231648,2399.348961,2181.226328,,8715131005863,ARANESP 100MCG 4 PREFILLED SYR 0.5ML,9480,,29748,PRE-FILLED PEN GLASS TYPE I,units,4.0,124 46 30400 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7e022ac0-e49d-409b-9678-f15b1874d682.json
7e03e7a4-2e7f-458e-88b0-439b538abfc7,REVLIMID ® 10 MG,prescription,L04AX04,LENALIDOMIDE,6278,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE,2025-07-31T07:31:15.453440,IL,ניאופרם,,23276.24185,19725.62869,17932.38972,,7640133681382,REVLIMID 5MG 21CAPS,18461,,23426,BLISTER PVC/PCTFE,units,21.0,140 46 31661 11,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM) Revlimid is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes REVLIMID is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Revlimid 7.5 mg is not indicated for treatment in MDS.Mantle Cell LymphomaREVLIMID is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphomaRevlimid in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7e03e7a4-2e7f-458e-88b0-439b538abfc7.json
7e146edd-1659-4ee0-9a6d-cea8ddaff48e,ETOPAN XL 500,prescription,M01AB08,ETODOLAC,3419,,,WHO ATC Classification,,ILS,tablets extended release,ETODOLAC,2025-07-31T02:39:43.480175,IL,תרו,,nan,nan,nan,,,ETOPAN 400MG 30TAB,5036,,75951,BOTTLE HDPE,units,30.0,128 08 30651 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the management of signs and symptoms of osteoarthrities and rheumatoid arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7e146edd-1659-4ee0-9a6d-cea8ddaff48e.json
7e3d7ce8-7a1e-412e-a889-1209a05ec751,RISPERDAL 1 MG,prescription,N05AX08,RISPERIDONE,3051,,,WHO ATC Classification,,ILS,film coated tablets,RISPERIDONE,2025-07-31T07:37:54.805018,IL,יאנסן סילג,,52.68547898,44.648711,32.5903,,7290008124744,RISPERDAL 3MG 20TAB,18074,,9157,BLISTER PVC/PE/PVDC/AL,units,20.0,144 78 28260 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7e3d7ce8-7a1e-412e-a889-1209a05ec751.json
7e6b5eb2-770a-4514-ab12-1e7e9ad5d49d,XALKORI 200 MG,prescription,L01XE16,CRIZOTINIB,6928,,,WHO ATC Classification,,ILS,capsules,CRIZOTINIB,2025-07-31T10:27:36.527810,IL,פיזר,,20588.32052,17447.73003,15861.57276,,7290013592064,XALKORI 250MG 60CAPS,34073,,20582,BLISTER PVC/ALUMINIUM,units,60.0,147 40 33588 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,XALKORI is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive.  Xalkori is indicated for the treatment of patients with metastatic NSCLC whose tumors are ROS1-positive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7e6b5eb2-770a-4514-ab12-1e7e9ad5d49d.json
7e8e80ac-0ac4-4e1a-9e9b-292ba5ed0e3f,ERBITUX 5 MG/ML,prescription,L01XC06,CETUXIMAB,6540,,,WHO ATC Classification,,ILS,solution for infusion,CETUXIMAB/ML,2025-07-31T02:33:04.764807,IL,מרק סרונו,,862.8524683,731.2309378,622.3242024,,7290000845432,ERBITUX 5MG/ML 20ML,5530,,85542,VIAL GLASS TYPE I,units,20.0,141 40 31828 00,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (EGFR) - expressing, RAS wild-type metastatic colorectal cancer• In combination with irinotecan-based chemotherapy• In first-line in combination with FOLFOX• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanErbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (SCCHN)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7e8e80ac-0ac4-4e1a-9e9b-292ba5ed0e3f.json
7ec10307-c0fc-42cb-aa9e-ddef45f60d79,SITAGLIPTIN S.K. 100 MG,prescription,A10BH01,SITAGLIPTIN,9446,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE,2025-07-31T08:19:15.971653,IL,SK PHARM(KS KIM),,167.225175,141.71625,113.373,,,SITAGLIPTIN S.K. 100 MG 30 TAB,,,22251,BLISTER PVC/PE/PVDC/AL,units,30.0,171 99 36508 99,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Sitagliptin S.K. is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: Sitagliptin S.K. should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. Sitagliptin S.K. has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitagliptin S.K..,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ec10307-c0fc-42cb-aa9e-ddef45f60d79.json
7ec4d096-b3cf-43f2-b283-4617d222302a,CHEMET 100MG 100CAPSULES,29C,,,20330,,,,,,capsule,CHEMET 100MG ULES,2025-07-31T20:04:58.543942,IL,nan,,,,,,,CHEMET 100MG 100CAPSULES,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ec4d096-b3cf-43f2-b283-4617d222302a.json
7ec518ac-392d-407c-af34-4926ba22d6b1,EFUDIX CREAM 5%,prescription,,,8384,,,,,ILS,cream,FLUOROURACIL/,2025-07-31T03:13:48.801770,IL,טבע,,26.075758,22.0981,16.13,,7290004448721,FLUOROURACIL 50 MG/ML (1000mg/20ml) 1 vial,,,28933,TUBE ALUMINIUM,units,20.0,062 40 21478 00,valid,37.0,dermal,1.4,60,,,,,,,,,,0,Prescription required,Antineoplastic agent to treat actinic keratosis multiple and superfacial basel cell carcinoma.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ec518ac-392d-407c-af34-4926ba22d6b1.json
7ed1d34c-0d63-4e04-9107-8ea6752a854a,CETROTIDE 0.25,prescription,H01CC02,CETRORELIX,4054,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,CETRORELIX AS ACETATE 0.25  MG/VIAL,2025-07-31T01:08:04.558563,IL,מרק סרונו,,1090.110953,923.8228826,786.2322405,,7290000845173,CETROTIDE 0.25MG 7AMP,3111,,22906,VIAL GLASS TYPE I,units,7.0,117 19 29780 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ed1d34c-0d63-4e04-9107-8ea6752a854a.json
7ee987e5-a2c2-4a33-9cf9-58015cfd6580,AUGMENTIN SUSPENSION 400 MG/5 ML,prescription,J01CR02,AMOXICILLIN AND ENZYME INHIBITOR,3666,,,WHO ATC Classification,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM SALT 11.4 MG/ML, AMOXICILLIN AS TRIHYDRATE/ML",2025-07-31T00:26:18.147624,IL,ג.ס.ק,,39.29243296,33.298672,24.3056,,7290010140121,AUGMENTIN B.I.D 875MG 14TAB,1004,,76015,BOTTLE GLASS TYPE III,units,14.0,112 75 29288 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Augmentin is indicated for the treatment of the following infections in adults and children: • Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.• Recurrent tonsillitis",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ee987e5-a2c2-4a33-9cf9-58015cfd6580.json
7f27de69-6dcd-411b-bba6-4bf61c558a5c,OESTROGEL,prescription,G03CA03,ESTRADIOL,2901,,,WHO ATC Classification,,ILS,gel,ESTRADIOL 0.06 %W/W,2025-07-31T06:03:41.333101,IL,כ.צ.ט,,46.26705114,39.20936712,28.619976,,7290008098205,OESTROGEL 80G,15006,,9008,TUBE ALUMINIUM,units,80.0,060 93 26342 00,valid,37.0,transdermal,1.4,36,,,,,,,,,,0,Prescription required,Hormonal replacement therapy for the treatment of symptoms associated with estrogen deficiency in menopausal women. Prevention of postmenopausal osteoporosis in women with an increased risk for osteoporotic fractures and presenting intolerace or a contraindication to others treatments indicated in the prevention of osteoporosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f27de69-6dcd-411b-bba6-4bf61c558a5c.json
7f332142-77eb-40d8-8fda-1c3500f4d5da,ALEXAN,prescription,L01BC01,CYTARABINE,7698,,,WHO ATC Classification,,ILS,solution for injection / infusion,CYTARABINE/,2025-07-31T00:15:45.114842,IL,סנדוז,,157.5961594,133.5560732,106.8448586,,7290016369595,ALEXAN 2000MG/40ML VIAL,9296,,88441,VIAL GLASS TYPE I,units,1.0,133 79 27970 00,valid,25.0,"intrathecal, s.c, i.v",1.4,24,,,,,,,,,,0,Prescription required,"For induction and maintenance of clinical remission in patients with acute myeloid leukemia, acute non-lymphoblastic leukemias, acute lymphoblastic leukemias, blast crises of chronic myeloid leukemia, diffuse histiocytic lymphomas ( non-Hodgkin's lymphomas of high malignancy).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f332142-77eb-40d8-8fda-1c3500f4d5da.json
7f3c5d7d-2687-4847-bdfe-45b84ac32a94,PREGABALIN INOVAMED 150 MG,prescription,N03AX16,PREGABALIN,8326,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:53:00.238274,IL,אינובמד,,168.9678875,143.193125,114.5545,,7290104530364,PREGABALIN INOVAMED 150 MG 56 CAPS,10303,,4217,BLISTER PVC/ALUMINIUM,units,56.0,156 17 34774 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Pregabalin Inovamed is indicated for the:* treatment of peripheral and central neuropathic pain in adults. * Management of Fibromyalgia.* Treatment of Generalised Anxiety Disorder (GAD) in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f3c5d7d-2687-4847-bdfe-45b84ac32a94.json
7f423bb3-8aba-47f0-9ec3-5e791c4b9004,FENTORA ® 100 MCG,prescription,N01AH01,FENTANYL,7614,,,WHO ATC Classification,,ILS,tablets,FENTANYL AS CITRATE,2025-07-31T03:02:41.610342,IL,טבע,,663.3597057,562.1692671,478.4419295,,,FENTORA 600MCG 28 BUCCAL TAB,6585,,76299,BLISTER PVC/ALU/POLYAMIDE/PVC,units,28.0,152 90 34050 00,valid,17.5,buccal,1.4,36,,,,,,,,,,0,Prescription required,"Fentora is indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.                                      Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f423bb3-8aba-47f0-9ec3-5e791c4b9004.json
7f489141-f40d-44dd-98d9-5a503baed25b,MIDAZOLAM KALCEKS 1 MG/ML,prescription,N05CD08,MIDAZOLAM,8911,,,WHO ATC Classification,,ILS,solution for injection / infusion,MIDAZOLAM/,2025-07-31T05:21:20.828995,IL,מדי מרקט,,148.4735,125.825,100.66,,,MIDAZOLAM KALCEKS 5 MG/ML 10ML X 10 AMP,,,71512,AMPOULES GLASS TYPE I,units,10.0,171 77 37234 99,valid,25.0,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,Midazolam is a short-acting sleep-inducing drug that is indicated: In adults * CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia * ANAESTHESIA* Premedication before induction of anaesthesia* Induction of anaesthesia* As a sedative component in combined anaesthesia * SEDATION IN INTENSIVE CARE UNITSIn children * CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia * ANAESTHESIA* Premedication before induction of anaesthesia * SEDATION IN INTENSIVE CARE UNITS,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f489141-f40d-44dd-98d9-5a503baed25b.json
7f5038a7-3dfa-4d33-92f5-49b114ab4349,TRAMADEX OD 100,prescription,N02AX02,TRAMADOL,4819,,,WHO ATC Classification,,ILS,tablets prolonged release,TRAMADOL HYDROCHLORIDE,2025-07-31T09:31:14.878362,IL,דקסל פארמה,,8.72964,7.398,5.4,,,TRAMADEX 50MG 10 FLASH TAB,20559,,63534,BLISTER PVC/PE/PCTFE/AL,units,10.0,139 25 31580 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f5038a7-3dfa-4d33-92f5-49b114ab4349.json
7f5bb0de-4e4d-45dd-bfb4-9fa83e075bbf,SPASMALGIN,prescription,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",1961,,,WHO ATC Classification,,ILS,tablets,"PARACETAMOL, ATROPINE SULFATE 0.4  MG, PAPAVERINE HYDROCHLORIDE, CODEINE PHOSPHATE",2025-07-31T06:27:17.591559,IL,רקח,,nan,nan,nan,,,PAPAVERINE 4OMG 30TAB,16552,,8001,BLISTER PVC/ALUMINIUM,units,30.0,036 36 22208 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Analgesic and antispasmodic for the digestive system, the kidneys and the gall bladder.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f5bb0de-4e4d-45dd-bfb4-9fa83e075bbf.json
7f625bd2-cba1-4ae1-a2f2-64fc0090b76e,RIVAR TEVA 10 MG,prescription,B01AF01,RIVAROXABAN,9173,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:41:53.972727,IL,טבע,,259.28671,219.7345,175.7876,,,RIVAR TEVA 15 MG 28 TAB,,,38131,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,168 08 36158 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f625bd2-cba1-4ae1-a2f2-64fc0090b76e.json
7f66fda6-0c6d-4914-ad61-4426027db59f,RIVASTIGMINE DEXCEL 4.5 MG,prescription,N06DA03,RIVASTIGMINE,7553,,,WHO ATC Classification,,ILS,"capsule, hard",RIVASTIGMINE AS HYDROGEN TARTRATE 4.5  MG,2025-07-31T07:44:57.696154,IL,דקסל פארמה,,118.2583126,100.218909,74.5122,,,RIVASTIGMINE DEXCEL 4.5 MG 28 CAPSULES,18512,,58801,BLISTER PVC/ALUMINIUM,units,28.0,152 79 33951 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of patients with mild to moderately severe dementia of the Alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.Symptomatic treatment of mild to moderately severe alzheimer's dementia.Symptomatic treatment of mild to moderately severe dementiaassociated with Parkinson's disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f66fda6-0c6d-4914-ad61-4426027db59f.json
7f68e6e3-e8c2-42d4-89cc-0875a9a9b823,OXYTOCIN - GRINDEKS,prescription,H01BB02,OXYTOCIN,8834,,,WHO ATC Classification,,ILS,solution for injection / infusion,OXYTOCIN/,2025-07-31T06:22:28.872604,IL,מדי מרקט,,92.3946136,78.30052,58.216,,,OXYTOCIN - GRINDEKS 10IU/1 ML 10 AMP,,,70222,AMPOULES GLASS TYPE I,units,10.0,165 47 35690 00,valid,34.5,"i.v, i.m",1.4,48,,,,,,,,,,0,Prescription required,"- Induction of labour for medical reasons;- Stimulation of labour in hypnotic uterine inertia;- During Caesarean section following the delivery of the child;- Prevention and treatment of postpartum uterine atony and hemorrhage.- In early stages of pregnancy as an adjunctive therapy for the management of incomplete, inevitable of missed abortion.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f68e6e3-e8c2-42d4-89cc-0875a9a9b823.json
7f6dec05-2c1c-434c-b40d-2b137de46ef9,TAROCLINDIN GEL,prescription,D10AF51,"CLINDAMYCIN, COMBINATIONS",8207,,,WHO ATC Classification,,ILS,gel,"BENZOYL PEROXIDE AS HYDROUSW/W, CLINDAMYCIN AS PHOSPHATEW/W",2025-07-31T09:07:12.206009,IL,תרו יבוא,,147.0495021,124.6182221,99.6945777,,,TAROCLINDIN GEL 45GR,,,23378,TUBE LAMINATED,units,45.0,160 25 34826 00,valid,25.0,topical,1.4,20,,,,,,,,,,0,Prescription required,"Mild to moderate acne vulgaris, particulary inflammatory lesions.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f6dec05-2c1c-434c-b40d-2b137de46ef9.json
7f75ddad-b1c6-471c-b158-3248207e3bcf,TIMONIL 300 RETARD,prescription,N03AF01,CARBAMAZEPINE,3192,,,WHO ATC Classification,,ILS,tablets prolonged release,CARBAMAZEPINE,2025-07-31T09:21:20.262746,IL,מגאפארם,,39.59053224,33.5513,24.49,,7290004448332,TIMONIL RET 300MG 50TAB,20134,,9115,BLISTER PVC/ALUMINIUM,units,50.0,068 94 27055 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neuralgia, diabetes insipidus mania, prophylactic in manic depressive illness.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f75ddad-b1c6-471c-b158-3248207e3bcf.json
7f8cabe0-bd6c-40bf-bfa3-6f791efb7d1b,UTROGESTAN 100,29C,G03DA04,PROGESTERONE,20615,,,WHO ATC Classification,,ILS,capsules,PROGESTERONE,2025-07-31T15:40:41.077765,IL,nan,,nan,nan,nan,,,PROGESTERONE 50MG 10AMP,,,,BLISTER PVC/ALUMINIUM,units,10.0,132 44 26341 11,valid,nan,"per os, vaginal",1.4,36,,,,,,,,,,0,,"Vaginal or oral addministration: Disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).Vaginal administration: Progesterone substitution for ovary deprived women in situation of total progesterone deficiency. Supplementation of the luteal phase during in vitro fertilization cycles. Supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. In cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. For all other progesterone indications, in the case of : Adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7f8cabe0-bd6c-40bf-bfa3-6f791efb7d1b.json
7faa8f8b-cdbf-4678-8fd2-5c87bd1eb544,PRODUODOPA,prescription,N04BA07,FOSLEVODOPA AND DECARBOXYLASE INHIBITOR,9238,,,WHO ATC Classification,,ILS,solution for infusion,"FOSLEVODOPA/, FOSCARBIDOPA/",2025-07-31T06:58:54.796749,IL,אב-וי,,3859.233033,3270.536614,2973.215103,,,PRODUODOPA SOLUTION FOR INFUSION 7 VIALS 10 ML,,,,VIAL GLASS TYPE I,units,7.0,173 60 37468 99,valid,10.0,s.c,1.4,20,,,,,,,,,,0,Prescription required,Treatment of advanced levodopa-responsive Parkinson’s disease with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of Parkinson medicinal products have not given satisfactory results.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7faa8f8b-cdbf-4678-8fd2-5c87bd1eb544.json
7fc64e38-3354-4acf-aff1-ab8136c92910,VIDAZA,prescription,L01BC07,AZACITIDINE,7338,,,WHO ATC Classification,,ILS,lyophilized powder for suspension for sc injection / solution for infusion,AZACITIDINE/VIAL,2025-07-31T10:13:38.736518,IL,ניאופרם,,1789.972551,1516.925891,1291.000758,,359572102019,VIDAZA 100MG 1VIAL,22302,,83101,VIAL GLASS TYPE I,units,1.0,134 76 31390 01,valid,17.5,"i.v, s.c",1.4,48,,,,,,,,,,0,Prescription required,"For the treatment of patients with the following FAB myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7fc64e38-3354-4acf-aff1-ab8136c92910.json
7fd69e3f-265f-45c4-915c-d6ef63479a86,HYDROGEN PEROXIDE 3% LIFE,off-the-counter,D08AX01,HYDROGEN PEROXIDE,2922,,,WHO ATC Classification,,ILS,solution,HYDROGEN PEROXIDEW/W,2025-07-31T12:06:34.931626,IL,ויטאמד,,7.3514,6.23,nan,,,HYDROGEN  PEROXIDE 3% 50ML,8036,,,BOTTLE POLYETHYLENE,units,50.0,162 73 35786 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,Antiseptic, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7fd69e3f-265f-45c4-915c-d6ef63479a86.json
7fd9a0e1-f732-4141-b80e-d91d25cbd5f8,TARIM 100,prescription,G04BE03,SILDENAFIL,7213,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T09:06:26.445333,IL,אוניפארם,,188.0098425,159.330375,127.4643,,,TARIM 100MG 8 F.C.TAB,20769,,41005,BLISTER PVC/ALUMINIUM,units,8.0,149 16 33583 01,valid,25.0,per os,1.4,30,,,,,,,,,,0,Prescription required,TARIM is indicated for the treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7fd9a0e1-f732-4141-b80e-d91d25cbd5f8.json
7fe88e3e-4bb8-4fcb-b4cd-df006436a3e9,DUODART,prescription,G04CA02,TAMSULOSIN,6833,,,WHO ATC Classification,,ILS,capsules,"DUTASTERIDE 0.5  MG, TAMSULOSIN HYDROCHLORIDE 0.4  MG",2025-07-31T02:06:41.399290,IL,ג.ס.ק,,69.4047233,58.81756473,43.7305314,,,DUODART 30 CAPSULES,4557,,4527,BOTTLE HDPE,units,30.0,146 34 33278 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7fe88e3e-4bb8-4fcb-b4cd-df006436a3e9.json
7ff715de-216d-40a9-b98c-0da7dd9952ff,CALMANERVIN S ELIXIR,off-the-counter,N05CM09,VALERIAN,3646,,,WHO ATC Classification,,ILS,elixir,"PASSIFLORA LIQ. EXTR./ML, VALERIAN LIQUID EXTRACT/ML",2025-07-31T11:22:14.356975,IL,סם און,,21.2754,18.03,nan,,7290008066044,CALMANERVIN 10TAB,3092,,,BOTTLE HDPE,units,10.0,035 48 25445 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,relief of mild symptoms of mental stress and to aid sleep           .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ff715de-216d-40a9-b98c-0da7dd9952ff.json
7ffc3720-63f7-4e65-8bd9-f4322779ef36,CAMPTO,prescription,L01XX19,IRINOTECAN,6471,,,WHO ATC Classification,,ILS,solution for infusion,IRINOTECAN HYDROCHLORIDE/ML,2025-07-31T00:50:25.224124,IL,פיזר,,583.8056137,494.750542,421.0642911,,7290010355754,CAMPTO 300MG IV SOL FOR INF,9365,,16338,VIAL POLYPROPYLENE,units,1.0,106 12 29047 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Campto is indicated for the treatment of patients with metastatic colorectal cancer:   In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease.   As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.   For the treatment of patients with small cell lung cancer.  For the treatment of patients with gastric cancer.Irinotecan in combination with leucovorin, Oxaliplatin and 5-fluorouracil for the first-line treatment of patients with metastatic pancreatic adenocarcinoma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/7ffc3720-63f7-4e65-8bd9-f4322779ef36.json
80009562-f66c-42a7-b58b-8ce98018ddf0,ALLEGRO NASAL SPRAY,off-the-counter,R01AD08,FLUTICASONE,3800,,,WHO ATC Classification,,ILS,suspension,FLUTICASONE PROPIONATE 0.05 %W/W,2025-07-31T11:11:53.202634,IL,תרימה,,47.4006,40.17,nan,,7290008075664,ALLEGRO NASAL SPRAY 15ML (120DOSES),1641,,,BOTTLE AMBER GLASS,units,120.0,118 30 29900 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Self medication:Prophylaxis and treatment of seasonal allergic rhinitis including hay fever in adults.By Physicians order:Prophylaxis and treatment of seasonal allergic rhinitis including hay fever in children of the age of4 years and above and perennial rhinitis in adults and children of the age of 4 years and above.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/80009562-f66c-42a7-b58b-8ce98018ddf0.json
8001969c-0d0d-4e37-b8a7-5b6c851e8b81,INLYTA 1 MG,prescription,L01XE17,AXITINIB,7321,,,WHO ATC Classification,,ILS,film coated tablets,AXITINIB,2025-07-31T04:06:00.863595,IL,פיזר,,3067.302861,2599.40932,2363.099382,,,INLYTA 1MG 60 F.C.TAB,9684,,48746,BLISTER ALUMINIUM,units,60.0,149 67 33736 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8001969c-0d0d-4e37-b8a7-5b6c851e8b81.json
80023860-3693-423e-a463-03602fb573f3,AZACTAM 1GR VIAL,29C,,,20042,,,,,,injection,AZACTAM 1GR VIAL,2025-07-31T19:58:56.227638,IL,nan,,,,,,,AZACTAM 1GR VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/80023860-3693-423e-a463-03602fb573f3.json
80186741-e8c6-4f0a-8680-9f120faea4d5,BERINERT,prescription,B06AC01,"C1- INHIBITOR,PLASMA DERIVED",6677,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,C - 1 ESTERASE INHIBITOR HUMAN/VIAL,2025-07-31T00:31:45.447241,IL,סי אס אל,,2824.162785,2393.358398,2175.780362,,7290012854323,BERINERT 500U/VIAL POWDER FOR SOL FOR INJ/INF,2514,,1608,VIAL GLASS TYPE II,units,1.0,145 06 33056 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Hereditary angioedema type I and II (HAE).Treatment and pre-procedure (prior to oral, dental, and upper respiratory tract procedures) prevention of acute episodes",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/80186741-e8c6-4f0a-8680-9f120faea4d5.json
802953fe-5790-4218-8ca3-3c16858035c2,OPDIVO,prescription,L01XC17,NIVOLUMAB,7622,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,NIVOLUMAB/ML,2025-07-31T06:13:23.726868,IL,ב.מ.ס,,5528.945538,4685.547274,4259.588431,,7290014396111,OPDIVO 10MG/ML VIAL 10ML,15444,,82248,VIAL GLASS TYPE I,units,10.0,153 55 34333 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Unresectable or Metastatic Melanoma:Opdivo as monotherapy or in combination with ipilimumab is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults and pediatric patients 12 years and older.Adjuvant Treatment of Melanoma:OPDIVO is indicated for the adjuvant treatment of adult and pediatric patients 12 years and older with completely resected Stage IIB, IIC, III, or IV melanoma.Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer:OPDIVO, in combination with platinum-doublet chemotherapy, is indicated as neoadjuvant treatment of adult patients with resectable (tumors &#8805;4 cm or node positive) non-small cell lung cancer (NSCLC).Neoadjuvant and Adjuvant Treatment of Resectable Non-Small Cell Lung Cancer:OPDIVO, in combination with platinum-doublet chemotherapy, is indicated for the neoadjuvant treatment of adult patients with resectable (tumors &#8805;4 cm or node positive) NSCLC with tumour cell PD-L1 expression &#8805; 1% and no known epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) rearrangements, followed by single-agent OPDIVO as adjuvant treatment after surgery.Metastatic Non-Small Cell Lung Cancer:- Opdivo, in combination with ipilimumab and 2 cycles of platinum-doublet chemotherapy, is indicated for the first-line treatment of adult patients with metastatic or recurrent non-small cell lung cancer (NSCLC), with no EGFR or ALK genomic tumor aberrations.- Opdivo is indicated for the treatment of adult patients with metastatic non small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.Renal Cell Carcinoma:- Opdivo as a single agent is indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC) in patients who have received prior anti-angiogenic therapy.- Opdivo in combination with ipilimumab is indicated for the first line treatment of adult patients with intermediate or poor risk, advanced renal cell carcinoma (RCC).- OPDIVO, in combination with cabozantinib, is indicated for the first-line treatment of adult patients with advanced RCC.Classical Hodgkin Lymphoma:Opdivo is indicated for the treatment of adult patients with classical Hodgkin lymphoma (cHL) that has relapsed or progressed after:- autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin, or- 3 or more lines of systemic therapy that includes autologous HSCT.Squamous Cell Carcinoma of the Head and Neck:Opdivo is indicated for the treatment of adult patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) with disease progression on or after platinum-based therapy.Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Metastatic Colorectal Cancer- OPDIVO, in combination with ipilimumab, is indicated for the first-line treatment of adult and pediatric patients 12 years and older with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer (CRC).- OPDIVO, as a single agent or in combination with ipilimumab, is indicated for the treatment of adult and pediatric patients 12 years and older with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.Urothelial carcinoma:- OPDIVO is indicated for the adjuvant treatment of adult patients with urothelial carcinoma (UC) who are at high risk of recurrence after undergoing radical resection of UC.- OPDIVO, in combination with cisplatin and gemcitabine, is indicated for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma.- Opdivo is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma who:     * have disease progression during or following platinum-containing chemotherapy     * have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.Hepatocellular Carcinoma:Opdivo, in combination with ipilimumab, is indicated for the treatment of adult patients with hepatocellular carcinoma (HCC) Child-Pugh A who have been previously treated with sorafenib.Esophageal cancer:- OPDIVO is indicated for the adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in adult patients who have received neoadjuvant chemoradiotherapy (CRT). - OPDIVO is indicated for the treatment of adult patients with unresectable, advanced, recurrent or metastatic esophageal squamous cell carcinoma after prior fluoropyrimidine- and platinum-based chemotherapy.- OPDIVO in combination with ipilimumab is indicated for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma with tumour cell PD-L1 expression &#8805; 1%.- OPDIVO in combination with fluoropyrimidine- and platinum-based combination chemotherapy is indicated for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma with tumour cell PD-L1 expression &#8805; 1%.Malignant Pleural Mesothelioma:OPDIVO, in combination with ipilimumab, is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma.Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma:OPDIVO, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the treatment of adult patients with unresectable advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/802953fe-5790-4218-8ca3-3c16858035c2.json
802cabbc-70fb-4ec9-be14-4c5b7291839b,TRIENTINE RAZ 250 MG,prescription,A16AX12,TRIENTINE ,9308,,,WHO ATC Classification,,ILS,capsules,TRIENTINE  DIHYDROCHLORIDE,2025-07-31T09:42:10.332965,IL,רז פרמהצפטי,,19510.44526,16534.27638,15031.16035,,,TRIENTINE RAZ 250 MG 100 caps,,,77449,BLISTER OPA/AL/PVC,units,100.0,170 23 36784 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of Wilson’s disease in patient's intolerant of D-Penicillaminetherapy, in adults, adolescents and children aged 5 years or older.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/802cabbc-70fb-4ec9-be14-4c5b7291839b.json
802e8cca-44da-4ebc-bb65-9e189be88b0e,ENALADEX 10 MG,prescription,C09AA02,ENALAPRIL,4328,,,WHO ATC Classification,,ILS,tablets,ENALAPRIL MALEATE,2025-07-31T02:19:37.884536,IL,כ.צ.ט,,15.29756248,12.964036,9.4628,,,ENALAPRIL 10MG 30TAB,5174,,27972,BLISTER ALUMINIUM,units,30.0,115 85 29810 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. To retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/802e8cca-44da-4ebc-bb65-9e189be88b0e.json
804bdc86-51b6-4cf1-aac7-b2e416094e48,PREVENAR 13,prescription,J07AL02,"PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED",7465,,,WHO ATC Classification,,ILS,suspension for injection,"PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19 F 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B 4.4  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C 2.2  MCG / 0.5  ML, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A 2.2  MCG / 0.5  ML",2025-07-31T06:55:42.046164,IL,פיזר,,290.0045548,245.7665828,209.1630492,,7290012914447,PREVENAR 13  SYRINGE PREFILLED 1X0.5ML,16762,,21669,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,143 54 33058 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to 17 years of age.Active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in adults &#8805;18 years of age and the elderly",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/804bdc86-51b6-4cf1-aac7-b2e416094e48.json
805f4d48-edf8-47d2-820e-495cbefba618,PRADAXA 110,prescription,B01AE07,DABIGATRAN ETEXILATE,6318,,,WHO ATC Classification,,ILS,capsules,DABIGATRAN ETEXILATE AS MESILATE,2025-07-31T06:48:01.373720,IL,בורינגר אינגלהיים,,75.01363587,63.57088068,47.2645953,,9006968012391,PRADAXA 110MG 30CAPS,16815,,84208,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,142 96 32974 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with nonvalvular  atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/805f4d48-edf8-47d2-820e-495cbefba618.json
806f3d66-65ce-4455-af96-a64476caac27,MILHARDT,prescription,C01CE02,MILRINONE,9417,,,WHO ATC Classification,,ILS,solution for injection / infusion,MILRINONE/,2025-07-31T05:23:59.739411,IL,פרופארם,,625.1783751,529.8122059,450.904005,,5012727913728,MILHARDT 1MG/1ML 10 ML 10 AMP,,,17133,AMPOULES GLASS TYPE I,units,10.0,165 39 35427 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of refractory heart failure immediately (up to 72 hours) following cardiac surgery. For the short term ( up to 48 hours) intravenous therapy of severe refractory congestive heart failure.In pediatric population Milhardt is indicated for the short-term treatment (up to 35 hours) of severe congestive heart failure unresponsive to conventional maintenance therapy (glycosides, diuretics, vasodilators and/or angiotensin converting enzyme (ACE) inhibitors), and for the short-term treatment (up to 35 hours) of pediatric patients with acute heart failure, including low output states following cardiac surgery",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/806f3d66-65ce-4455-af96-a64476caac27.json
806fbc99-d491-4c7a-b198-d0a197c09600,LOZAPINE 100 MG,prescription,N05AH02,CLOZAPINE,4271,,,WHO ATC Classification,,ILS,tablets,CLOZAPINE,2025-07-31T04:57:20.970392,IL,תרו יבוא,,101.4582243,85.981546,63.9268,,,LOZAPINE 100MG 50TAB,12205,,24343,BLISTER PVC/PVDC,units,50.0,116 45 29644 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics.Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state.Suicidal behavior refers to actions by a patient that put him/herself at risk for death",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/806fbc99-d491-4c7a-b198-d0a197c09600.json
8074810f-dcf2-4c83-be6f-206bdfd1f782,ZOVIRAX,off-the-counter,D06BB03,ACICLOVIR,5083,,,WHO ATC Classification,,ILS,cream,ACICLOVIRW/W,2025-07-31T13:40:50.058998,IL,ג.ס.ק,,39.8958,33.81,nan,,7290008086950,ZOVIRAX CREAM 5% 2G PUMP,26121,,,PACK PUMP POLYPROPYLENE,units,2.0,126 38 30532 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,For the treatment of cold sores (herpes labialis).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8074810f-dcf2-4c83-be6f-206bdfd1f782.json
8080a8d1-aaf7-4c73-9ec2-0ce59cc9c15e,COMAGIS CREAM,prescription,D01AC10,BIFONAZOLE,3116,,,WHO ATC Classification,,ILS,cream,"FLUOCINONIDE 0.05  W/W, BIFONAZOLE 1.00  W/W",2025-07-31T01:26:47.745759,IL,פאדאגיס,,nan,nan,nan,,7290002925033,COMAGIS CREAM 15GR,3053,,9297,TUBE ALUMINIUM,units,15.0,063 04 26742 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Broad-spectrum drug for relief of inflammatory conditions accompanied by fungal infection, which respond to corticoid therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8080a8d1-aaf7-4c73-9ec2-0ce59cc9c15e.json
80913f58-3ea6-44ba-abb8-3dcd2372626d,BRONCHOLATE PLUS,off-the-counter,R01BA52,"PSEUDOEPHEDRINE, COMBINATIONS",5053,,,WHO ATC Classification,,ILS,tablets,"PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE",2025-07-31T11:20:42.001401,IL,סם און,,22.1722,18.79,nan,,7290008080927,BRONCHOLATE PLUS  20TAB,2012,,,CONTAINER HDPE,units,20.0,126 07 30479 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Symptomatic relief of cold, cough, nasal congestion and auditory canal congestion accompanied by fever and pain.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/80913f58-3ea6-44ba-abb8-3dcd2372626d.json
80c6f2ee-ec71-4dad-a307-91320d2572b3,GAZYVA,prescription,L01FA03,OBINUTUZUMAB,7586,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,OBINUTUZUMAB/ML,2025-07-31T03:28:51.618901,IL,רוש,,13585.84922,11513.43205,10466.75641,,7290008140980,GAZYVA 1000MG/40ML 1 VIAL,7943,,77650,VIAL GLASS TYPE I,units,1.0,153 41 34195 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Chronic Lymphocytic Leukaemia (CLL)Gazyva, in combination with chlorambucil, is indicated for the treatment of patients with previously untreated chronic lymphocytic Leukaemia (CLL).Follicular Lymphoma (FL )Gazyva, in combination with bendamustine followed by Gazyva monotherapy, is indicated for the treatment of patients with follicular lymphoma (FL) who did not respond or who progressed during or up to 6 months after treatment with a rituximab-containing regimen.Gazyva in combination with chemotherapy, followed by Gazyva maintenance therapy in patients achieving a response, is indicated for the treatment of patients with previously untreated advanced follicular lymphoma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/80c6f2ee-ec71-4dad-a307-91320d2572b3.json
80eb5c86-8aa3-4539-9fa8-7b39f345079f,COMBODEX IV,prescription,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",9287,,,WHO ATC Classification,,ILS,solution for infusion,"IBUPROFEN AS SODIUM DIHYDRATE/ML, PARACETAMOL/ML",2025-07-31T01:27:14.759453,IL,דקסל פארמה,,277.5812886,235.2383906,188.1907125,,7290015912778,COMBODEX IV 100 ML 10 VIAL,23339,,61173,VIAL GLASS TYPE II,units,10.0,168 56 36312 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Combodex IV is indicated in adults for the relief of mild to moderate pain and the reduction of fever, where an intravenous route of administration is considered clinically necessary.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/80eb5c86-8aa3-4539-9fa8-7b39f345079f.json
80fdef27-a1d8-428d-8ff9-50b63e09c312,FLUMAZENIL KABI 0.1 MG/ML,prescription,V03AB25,FLUMAZENIL,7937,,,WHO ATC Classification,,ILS,solution for injection / infusion,FLUMAZENIL 0.1  MG /,2025-07-31T03:13:00.653366,IL,ניאופרם,,263.21375,223.0625,178.45,,,FLUMAZENIL MYLAN 0.1 MG/ML 5 VIAL 5ML,,,,AMPOULES GLASS TYPE I,units,5.0,177 37 37182 99,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Benzodiazepine antagonist for reversal of benzodiazepine anesthesia, as well as for patients with Benzodiazepine intoxication. In a hospital setting:In anaesthesiology to neutralise the sedative effects of benzodiazepines on the central nervous system in adults and children older than 1 year:•	reversal of sedative effect during general anaesthesia induced and maintained by benzodiazepines,•	reversal of conscious sedation induced by benzodiazepines in short operations with a diagnostic or therapeutic objective.In intensive care to neutralise the sedative effects of benzodiazepines on the central nervous system and treat a coma of unknown aetiology, in adults and children (including newborns) if the semiology is compatible with the hypothesis of a benzodiazepine or related substance-induced coma:•	diagnosis and/or treatment of intentional or accidental benzodiazepine overdose,•	aetiological diagnosis of an unexplained coma in order to differentiate what is caused by a benzodiazepine from another cause (pharmacological or neurological).•	specific cancellation of the effects on the central nervous system by excessive benzodiazepine doses (re-establishment of spontaneous ventilation to avoid intubation or interrupt ventilatory assistance).In an emergency situation or medical transport, in adults and children older than 6 years:•	reversal of benzodiazepine-induced conscious sedation in case of respiratory depression or apnoea.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/80fdef27-a1d8-428d-8ff9-50b63e09c312.json
81091b9b-b24b-4e18-9b24-43b1f2a1848c,RIVAR TEVA 10 MG,prescription,B01AF01,RIVAROXABAN,9172,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:41:41.826591,IL,טבע,,270.578248,229.3036,195.152,,,RIVAR TEVA 10 MG 30 TAB,,,38132,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,168 08 36158 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81091b9b-b24b-4e18-9b24-43b1f2a1848c.json
810c73d7-d2a9-44cb-81c8-503e25d0f935,AGISTEN LOZENGES,prescription,A01AB18,CLOTRIMAZOLE,8101,,,WHO ATC Classification,,ILS,lozenges,CLOTRIMAZOLE,2025-07-30T23:17:12.869080,IL,פאדאגיס,,nan,nan,nan,,7298074010367,AGISTEN LOZENGES 10 MG 70 TABLETS,10134,,64520,BOTTLE HDPE,units,70.0,159 13 34540 00,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,"For local treatment of oropharyngeal candidiasis.Prophylactic treatment to reduce incidence of oropharyngeal candidiasis in patientsimmunocompromised by:- chemotherapy,- radiotherapy,- steroid therapy in Leukemia,- solid tumors,- renal transplantation.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/810c73d7-d2a9-44cb-81c8-503e25d0f935.json
81113536-eda2-4d40-9ef2-1114384e5913,SEROQUEL XR 150 MG,prescription,N05AH04,QUETIAPINE,6438,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T08:07:17.731967,IL,צמל,,103.6111807,87.80608535,65.28333483,,,SEROQUEL XR 200MG 30 TAB EXTENDED RELEASE,19876,,83218,BLISTER PVC/ALUMINIUM,units,30.0,146 97 33472 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Seroquel XR is indicated for the treatment of Schizophrenia. Seroquel XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Seroquel XR.  Seroquel XR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Seroquel XR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 Pharmacodynamic properties). Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XR.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81113536-eda2-4d40-9ef2-1114384e5913.json
81418d40-c61b-4e35-85a8-899cfbb4f6f5,VAQTA 50 U/ML,prescription,J07BC02,"HEPATITIS A, INACTIVATED, WHOLE VIRUS",4826,,,WHO ATC Classification,,ILS,suspension for injection,"HEPATITIS A VIRUS ANTIGEN, INACTIVATED 50 U/ML",2025-07-31T09:59:21.988134,IL,מ.ס.ד. ישראל,,150.7990083,127.7957754,102.2366203,,,VAQTA 50U/ML,22179,,66549,VIAL 3 ML GLASS TYPE I,units,1.0,134 52 29740 00,valid,25.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Vaqta is indicated for active pre-exposure prophylaxis against disease caused by hepatitis A virus in persons 2 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81418d40-c61b-4e35-85a8-899cfbb4f6f5.json
81514662-b2e1-4d44-b8a3-fafb20eabdde,VORICONAZOLE-TEVA 200MG 2X7TAB,prescription,,,7520,,,,,ILS,tablet,VORICONAZOLE- 200MG 2X,2025-07-31T19:38:52.918273,IL,טבע,,1740.010498,1474.585168,1254.9661,,,VORICONAZOLE-TEVA 200MG 2X7TAB,22391,,69266,,units,14.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81514662-b2e1-4d44-b8a3-fafb20eabdde.json
81558861-c93a-4dcd-9253-722b42666cc0,SEGLUROMET 7.5/1000 MG 56 TAB,prescription,,,8310,,,,,ILS,tablet,SEGLUROMET 7.5/1000 MG,2025-07-31T19:32:10.470117,IL,מ.ס.ד. ישראל,,197.7871739,167.6162565,134.0930052,,,SEGLUROMET 7.5/1000 MG 56 TAB,,,29479,,units,56.0,,not-registered,25.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81558861-c93a-4dcd-9253-722b42666cc0.json
8165ea76-9a2f-421d-89c4-2ed666574ac6,LISINOPRIL 10MG 1A PHARMA TABLETS,29C,,,20863,,,,,,tablet,LISINOPRIL 10MG 1A PHARMA TABLETS,2025-07-31T20:48:08.453029,IL,nan,,,,,,,LISINOPRIL 10MG 1A PHARMA TABLETS,,,,,units,28.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8165ea76-9a2f-421d-89c4-2ed666574ac6.json
8165f423-97df-4b52-9b0a-5fbc2d091a24,YUFLYMA,prescription,L04AB04,ADALIMUMAB,9338,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/ML,2025-07-31T10:42:28.339696,IL,פאדאגיס,,2303.621878,1952.222018,1661.465547,,,YUFLYMA 40 MG/0.4ML 2 PENS,,,18498,PRE-FILLED PEN GLASS TYPE I,units,2.0,171 96 37092 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis   Yuflyma in combination with methotrexate, is indicated for:• the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.• the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.Yuflyma can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.Juvenile idiopathic arthritisPolyarticular juvenile idiopathic arthritisYuflyma in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years  who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs). Yuflyma can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. Adalimumab has not been studied in patients aged less than 2 years.Enthesitis-related arthritisYuflyma is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy.Axial spondyloarthritis• Ankylosing spondylitis (AS)Yuflyma is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.• Axial spondyloarthritis without radiographic evidence of ASYuflyma is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels, who have had an inadequate response to, or are intolerant to non-steroidal anti-inflammatory drugs (NSAIDs).Psoriatic arthritisYuflyma is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate.Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.PsoriasisYuflyma is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.Paediatric plaque psoriasisYuflyma is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age  who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.Hidradenitis suppurativa (HS)Yuflyma is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy.Crohn’s diseaseYuflyma is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease, who have had an inadequate response to conventional therapy. Yuflyma is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.Paediatric Crohn's diseaseYuflyma is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and corticosteroid and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies.Ulcerative colitisYuflyma is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.Paediatric ulcerative colitis Yuflyma is indicated for the treatment of moderately to severely active ulcerative colitis in paediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including corticosteroids and/or 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.  UveitisYuflyma is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.Paediatric uveitisYuflyma is indicated for the treatment of chronic non-infectious uveitis in paediatric patients from 2 years of age, who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.Intestinal Behcet's diseaseYuflyma is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8165f423-97df-4b52-9b0a-5fbc2d091a24.json
8176b91d-a5d9-4f47-a03b-1bd3ce748d0c,COSENTYX  SOLUTION FOR INJECTION,prescription,L04AC10,SECUKINUMAB,9322,,,WHO ATC Classification,,ILS,solution for injection,SECUKINUMAB/ML,2025-07-31T01:31:36.437442,IL,נוברטיס פארמה,,1732.318241,1468.066371,1249.418188,,7290014257429,COSENTYX 75 MG/0.5 ML SOLUTION FOR INJECTION,23470,,1544,PRE-FILLED PEN GLASS TYPE I,units,1.0,154 20 34342 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"- Plaque psoriasis: Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. - Paediatric plaque psoriasis: Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy. - Psoriatic arthritis: Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous disease modifying anti rheumatic drug (DMARD) therapy has been inadequate. - Axial spondyloarthritis (axSpA) : •Ankylosing spondylitis (AS, radiographic axial spondyloarthritis) Cosentyx is indicated for the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy. •Non-radiographic axial spondyloarthritis (nr-axSpA) Cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to non-steroidal anti-inflammatory drugs (NSAIDs). - Juvenile idiopathic arthritis (JIA) •Enthesitis-related arthritis (ERA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active enthesitisrelated arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. •Juvenile psoriatic arthritis (JPsA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.Hidradenitis suppurativa (HS)Cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic HS therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8176b91d-a5d9-4f47-a03b-1bd3ce748d0c.json
817d6a6e-fc60-486a-8358-9e870e049da5,CARDIOPIRIN 100MG 30 TAB,off-the-counter,,,5553,,,,,ILS,tablet,CARDIOPIRIN 100MG,2025-07-31T19:40:34.536741,IL,ליף-דקסון,,10.9976,9.32,,,,CARDIOPIRIN 100MG 30 TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/817d6a6e-fc60-486a-8358-9e870e049da5.json
8181555d-4f77-43b4-a03c-7a314a3cc344,PRESSOLAT 10MG 30TAB,prescription,,,6902,,,,,ILS,tablet,PRESSOLAT 10MG,2025-07-31T19:28:55.635353,IL,באייר,,21.09695332,17.878774,13.0502,,,PRESSOLAT 10MG 30TAB,16817,,9149,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8181555d-4f77-43b4-a03c-7a314a3cc344.json
8185cb73-0e7d-4d6f-84ed-87578f6af486,LERCAPRESS 10,prescription,C08CA13,LERCANIDIPINE,6561,,,WHO ATC Classification,,ILS,film coated tablets,LERCANIDIPINE HYDROCHLORIDE,2025-07-31T04:40:53.733358,IL,אוניפארם,,45.70015038,38.728941,28.2693,,,LERCAPRESS 20 MG 30 FC TAB,12434,,19189,BLISTER PVC/ALUMINIUM,units,30.0,141 51 31848 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Mild to moderate essential hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8185cb73-0e7d-4d6f-84ed-87578f6af486.json
818cb484-24ca-4a4a-b0ca-1464cba15735,MONTAIR 4 MG,prescription,R03DC03,MONTELUKAST,7865,,,WHO ATC Classification,,ILS,chewable tablets,MONTELUKAST AS SODIUM,2025-07-31T05:30:12.690739,IL,כ.צ.ט,,87.89248703,74.4851585,55.3793,,,MONTAIR 5 MG 30 CHEWTAB,13791,,33176,BLISTER PA/ALUMINIUM/PVC,units,30.0,145 58 31866 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Montair is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction.Montair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma.Montair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.Montair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/818cb484-24ca-4a4a-b0ca-1464cba15735.json
81a14500-c92c-4934-94a9-b7e0c3b6398f,HUMIRA,prescription,L04AB04,ADALIMUMAB,8515,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/,2025-07-31T03:49:50.964749,IL,אב-וי,,1452.291523,1230.755583,1047.45156,,,HUMIRA 20 MG/0.2 ML SOL FOR INJ 2 PEN,,,4211,PRE-FILLED PEN GLASS TYPE I,units,2.0,157 78 34788 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"• Rheumatoid arthritis:Humira in combination with methotrexate is indicated for:- The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.- The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Humira has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.• Polyarticular juvenile idiopathic arthritis:Humira in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs).  Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. Humira has not been studied in patients aged less than 2 years.• Enthesitis-related arthritis:Humira is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy.• Axial spondyloarthritis :Humira is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.• Axial spondyloarthritis without radiographic evidence of AS:Humira is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels , who have had an inadequate response to, or are intolerant to, non - steroidal anti-inflammatory drugs. • Psoriatic arthritis:Humira is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti rheumatic drug therapy has been inadequate. Humira has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.• Psoriasis:Humira is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.• Paediatric plaque psoriasis:Humira is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.• Hidradenitis suppurativa (HS):Humira is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy.• Crohn’s disease:Humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy.  Humira is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab. • Paediatric Crohn's disease:Humira is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6- years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and corticosteroid, and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies• Ulcerative colitis:Humira is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.  • Uveitis:Humira is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.• Intestinal Behcet's disease:Humira is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.• Paediatric UveitisHumira is indicated for the treatment of chronic non-infectious uveitis in paediatric patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.•	Paediatric ulcerative colitis Humira is indicated for the treatment of moderately to severely active ulcerative colitis in pediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including corticosteroids and/or 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81a14500-c92c-4934-94a9-b7e0c3b6398f.json
81a1a19b-212f-4fe9-af45-989ba062f0fb,OXACATIN,prescription,R06AD08,OXOMEMAZINE,3351,,,WHO ATC Classification,,ILS,syrup,"OXOMEMAZINE 1.65  MG /, BENZOIC ACID AS SODIUM 33.3  MG /, GUAIACOLSULFONATE AS POTASSIUM 33.3  MG /",2025-07-31T06:20:05.311852,IL,תרו,,nan,nan,nan,,,OXACATIN SYR 120ML,15017,,9649,BOTTLE POLYETHYLENE,units,120.0,030 54 21959 00,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,Antitussive expectorant.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81a1a19b-212f-4fe9-af45-989ba062f0fb.json
81d95b6a-79e6-4ede-80e0-3c34c17e4c5a,ONDANSETRON INOVAMED 4 MG,prescription,A04AA01,ONDANSETRON,7783,,,WHO ATC Classification,,ILS,film coated tablets,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE,2025-07-31T06:12:07.507172,IL,אינובמד,,136.8453169,115.9706075,86.2235,,,ONDANSETRON INOVAMED 4 MG 10 F.C.TAB,15451,,79250,BLISTER PVC/ALUMINIUM,units,10.0,152 95 34231 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Adults : Ondansetron Inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. For prevention and treatment of post operative nausea and vomiting (PONV).Pediatric population : Ondansetron Inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81d95b6a-79e6-4ede-80e0-3c34c17e4c5a.json
81d9700f-c8d8-4656-b9e5-ddf5571fbdca,MONOLONG 40 MG,29C,C01DA14,ISOSORBIDE MONONITRATE,20471,,,WHO ATC Classification,,ILS,capsules slow release,ISOSORBIDE-5-MONONITRATE,2025-07-31T14:54:52.065926,IL,nan,,nan,nan,nan,,,ISOSORBIDE DINITRATE SUBLINGUAL 5MG 100TAB,,,,BLISTER PVC/ALUMINIUM,units,100.0,052 97 26218 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,Prevention and treatment of angina pectoris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81d9700f-c8d8-4656-b9e5-ddf5571fbdca.json
81e26614-addd-4dfb-9518-365d0696b487,BETNESOL TABLETS,29C,H02AB01,BETAMETHASONE,20047,,,WHO ATC Classification,,ILS,tablets,BETAMETHASONE 0.5  MG,2025-07-31T13:59:21.005567,IL,nan,,nan,nan,nan,,,BETNESOL ENEMA 5MG/100ML 7x100ML,,,,BLISTER ALUMINIUM/LDPE,units,700.0,135 65 22066 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Diseases responsive to oral glucocorticosteroid therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81e26614-addd-4dfb-9518-365d0696b487.json
81f30489-968f-4eba-bdbe-8d31158b4185,TADALIS TEVA ® 20 MG,prescription,G04BE08,TADALAFIL,8062,,,WHO ATC Classification,,ILS,tablets,TADALAFIL,2025-07-31T09:00:02.506976,IL,טבע,,445.8071683,377.802685,321.5342,,,TADALIS TEVA 20 MG 8 TAB,,,55632,BLISTER ALUMINIUM /ALUMINIUM,units,8.0,154 90 34233 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81f30489-968f-4eba-bdbe-8d31158b4185.json
81f4ef5b-6e19-43b1-8d62-4992f3337324,PROFEX 150 MG,prescription,C01BC03,PROPAFENONE,4149,,,WHO ATC Classification,,ILS,tablets,PROPAFENONE HYDROCHLORIDE,2025-07-31T06:59:16.191877,IL,תרו,,40.97499024,34.724568,25.3464,,7290000810485,PROFEX 300MG 30TAB,16375,,66472,BLISTER PVC,units,30.0,133 93 29804 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis and treatment of ventricular arrhythmias. Prophylaxis and treatment of atrial fibrillation and flutter. Prophylaxis and treatment of Paroxysmal supraventricular tachycardia (PSVT) associated with disabling symptoms.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/81f4ef5b-6e19-43b1-8d62-4992f3337324.json
821e38e5-ab18-473b-9ddb-340848c3ac9f,NAXYN 500 MG,prescription,M01AE02,NAPROXEN,1611,,,WHO ATC Classification,,ILS,tablets,NAPROXEN,2025-07-31T05:40:50.484063,IL,טבע,,28.17458978,23.876771,17.4283,,7290000801681,NAXYN 500MG 30TAB,14063,,1437,BLISTER PVC/ALUMINIUM,units,30.0,055 98 20619 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,- Relief of the signs and symptoms of rheumatic diseases including osteoarthritis  ankylosing spondylitis of Rheumatoid arthritis  both in the treatment of acute flares and in the long-term management of the disease.   - Juvenile Rheumatoid Arthritis.   - Periarticular and musculoskeletal disorders - Relief of pain in bursitis  tendinitis  synovitis  tenosynovitis and lumbago.   - Relief of pain  swelling  tenderness and fever in acute gouty Arthritis.   - Relief of symptoms of primary dysmenorrhea.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/821e38e5-ab18-473b-9ddb-340848c3ac9f.json
823719c4-4e57-4b73-b093-1698b58a3bbb,LEVETRIM 1000,prescription,N03AX14,LEVETIRACETAM,6625,,,WHO ATC Classification,,ILS,film coated tablets,LEVETIRACETAM,2025-07-31T04:43:44.934256,IL,תרימה,,276.859565,234.62675,187.7014,,,LEVETRIM 1000MG 60TAB,12442,,21386,BLISTER PVC/ALUMINIUM,units,60.0,143 77 31941 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,- Levetrim is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetrim is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Levetrim is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Levetrim is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/823719c4-4e57-4b73-b093-1698b58a3bbb.json
8244aba7-531e-40c7-89be-d67065a4f419,FLUTIFORM 125/5,prescription,R01AD08,FLUTICASONE,7388,,,WHO ATC Classification,,ILS,pressurised suspention for inhalation,"FLUTICASONE PROPIONATE 0.125 MG/DOSE, FORMOTEROL FUMARATE DIHYDRATE 0.005 MG/DOSE",2025-07-31T03:14:54.254499,IL,רפא,,259.6479702,220.0406625,176.03253,,7290008015967,FLUTIFORM 250/10 INHALER 120 DOSES,6535,,51486,CANISTER ALUMINIUM,units,120.0,150 63 33813 00,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,The regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting β2 agonist) is appropriate:• For patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting β2 agonist.• For patients already adequately controlled on both an inhaled corticosteroid and a long-acting β2 agonist.Flutiform 125mcg/5mcg inhaler is indicated in adults and adolescents aged 12 years and above.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8244aba7-531e-40c7-89be-d67065a4f419.json
82479f7d-b41f-43d8-9326-64210a0b398b,DALACIN 2 % VAGINAL CREAM,prescription,G01AA10,CLINDAMYCIN,2871,,,WHO ATC Classification,,ILS,cream,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T01:40:29.028555,IL,פיזר,,83.5801009,70.83059713,52.662154,,7298074000054,DALACIN VAG CR2% 40G,4066,,8990,TUBE PLASTIC,units,40.0,064 17 27818 00,valid,34.5,vaginal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/82479f7d-b41f-43d8-9326-64210a0b398b.json
826848e3-b419-4963-885f-e18c16d98168,MOXYPEN ® FORTE 500 MG CAPSULES,prescription,J01CA04,AMOXICILLIN,1603,,,WHO ATC Classification,,ILS,capsules,AMOXICILLIN AS TRIHYDRATE,2025-07-31T05:33:51.786340,IL,טבע,,15.03438,12.741,9.3,,7290000801605,MOXYPEN FTE 250MG 60ML,13183,,1395,BLISTER PVC/PVDC/ALUMINIUM/PAPER,units,60.0,130 22 30823 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Infections caused by amoxycillin - susceptible organisms. Prevention of bacteremia in patients at risk of developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/826848e3-b419-4963-885f-e18c16d98168.json
826ae501-09fd-444f-ac4f-778c1e6c52d0,HARMONET,prescription,G03AA10,GESTODENE AND ESTROGEN,4086,,,WHO ATC Classification,,ILS,coated tablets,"ETHINYLESTRADIOL 0.020   MG, GESTODENE 0.075   MG",2025-07-31T03:42:57.063143,IL,פיזר,,23.02636542,19.513869,14.2437,,7290008142908,HARMONET 21TAB,8032,,29925,BLISTER PVC/ALUMINIUM,units,21.0,121 88 30272 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/826ae501-09fd-444f-ac4f-778c1e6c52d0.json
829975d1-e01f-4540-8ba0-5f42c1fbaab0,TRAMAL INJECTION 100,prescription,N02AX02,TRAMADOL,4815,,,WHO ATC Classification,,ILS,solution for injection,TRAMADOL HYDROCHLORIDE/,2025-07-31T09:32:59.763510,IL,ליברה,,10.27378369,8.706596737,6.3551801,,7290008872140,TRAMAL 50MG 30 CAPS,20053,,57214,AMPOULES GLASS TYPE I,units,30.0,125 54 30477 00,valid,37.0,"i.v, s.c, i.m",1.4,60,,,,,,,,,,0,Prescription required,Moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/829975d1-e01f-4540-8ba0-5f42c1fbaab0.json
82ab5fb4-e178-40ed-974a-9f89b35ef7a3,ATACAND ® 16 MG,prescription,C09CA06,CANDESARTAN,6431,,,WHO ATC Classification,,ILS,tablets,CANDESARTAN CILEXETIL,2025-07-30T23:28:46.575945,IL,צמל,,33.5274757,28.413115,20.7395,,,ATACAND 16MG 28TAB,9321,,80923,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,109 10 29185 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Hypertension. Treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ACE inhibitors or when ACE inhibitors are not tolerated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/82ab5fb4-e178-40ed-974a-9f89b35ef7a3.json
82af4bd1-636f-40bf-8afc-1373831a1c70,NORMOPRESAN,prescription,C02AC01,CLONIDINE,1875,,,WHO ATC Classification,,ILS,tablets,CLONIDINE HYDROCHLORIDE,2025-07-31T05:52:08.358946,IL,רפא,,18.15441719,15.3851,11.23,,7290008013253,NORMOPRESAN 30TAB,14155,,1507,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,043 98 22680 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antihypertensive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/82af4bd1-636f-40bf-8afc-1373831a1c70.json
82b263d4-0c2c-4788-a89a-c28fef4ff8bc,RELERT 20 MG,prescription,N02CC06,ELETRIPTAN,7325,,,WHO ATC Classification,,ILS,film coated tablets,ELETRIPTAN HYDROBROMIDE 24.242   MG,2025-07-31T07:21:52.618723,IL,דקסל פארמה,,250.5675425,212.345375,169.8763,,,RELERT 40MG 10 F.C.TAB,18503,,48804,BLISTER ALUMINIUM,units,10.0,124 28 30370 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Acute treatment of the headache phase of migraine attacks, with or without aura.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/82b263d4-0c2c-4788-a89a-c28fef4ff8bc.json
82b3dcf1-f4a0-4b3c-a23c-36dadec4a5bc,MABTHERA 10 MG/ML I.V,prescription,L01XC02,RITUXIMAB,4944,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T05:03:17.602086,IL,רוש,,1789.170808,1516.246515,1290.422566,,7290008140119,MABTHERA 100MG/10ML 2 VIALS,13543,,9769,VIAL GLASS TYPE I,units,2.0,112 51 29472 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"MabThera is indicated for the following indications: * Non-Hodgkin’s lymphoma (NHL)MabThera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma.MabThera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy MabThera is indicated for the treatment of patients with CD20 positive diffuse large B-cell non-Hodgkin's lymphoma in combination with CHOP chemotherapy. MabThera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * Chronic lymphocytic leukaemia (CLL)MabThera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including MabThera or patients refractory to previous MabThera plus chemotherapy.* Rheumatoid arthritisMabThera is indicated, in combination with methotrexate, to reduce signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more TNF antagonist therapies.* Granulomatosis with polyangiitis and Microscopic polyangiitisMabThera, in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis (WG) and Microscopic polyangiitis (MPA). *Pemphigus vulgarisMabThera is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/82b3dcf1-f4a0-4b3c-a23c-36dadec4a5bc.json
82b670a2-5026-4c08-a33a-21f9db2e4a33,TRAMADEX DROPS,prescription,N02AX02,TRAMADOL,3650,,,WHO ATC Classification,,ILS,drops,TRAMADOL HYDROCHLORIDE/ML,2025-07-31T09:31:38.541434,IL,דקסל פארמה,,17.14533628,14.529946,10.6058,,7290008113335,TRAMADEX DROPS 10ML,20217,,33480,BOTTLE GLASS,units,10.0,109 75 27636 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Short to medium term treatment of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/82b670a2-5026-4c08-a33a-21f9db2e4a33.json
8313f03f-2fdd-446d-9b3a-370ca5316e00,ENGERIX B 10 MCG,prescription,J07BC01,"HEPATITIS B, PURIFIED ANTIGEN",984,,,WHO ATC Classification,,ILS,suspension for injection,PURIFIED HEPATITIS B ANTIGEN/ 0.5  ML,2025-07-31T02:22:06.879421,IL,ג.ס.ק,,90.06509083,76.32635155,56.74821677,,,ENGERIX B 20MCG/ML ADULT VIAL,5442,,75231,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,055 06 26267 00,valid,34.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Engerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects . The  20 µg dose vaccine in 1.0 ml suspension is intended for use in subjects 16 years of age and above.  The 10 µg dose vaccine in 0.5 ml suspension is intended for use in subjects up to and including 15 years of age, including neonates. The categories within the population to be immunised are determined on the basis of official recommendations.It can be expected that hepatitis D will also be prevented by immunisation with Engerix B as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8313f03f-2fdd-446d-9b3a-370ca5316e00.json
8321fb82-6596-4b70-a706-8a19c15132dd,ORAMORPH 20 MG/ML,prescription,N02AA01,MORPHINE,8276,,,WHO ATC Classification,,ILS,solution  (oral),MORPHINE AS SULFATE/ML,2025-07-31T06:15:04.978955,IL,ביואבניר,,39.80424852,33.732414,24.6222,,7290010286867,ORAMORPH  20MG/ML 20ml,,,85582,BOTTLE AMBER GLASS TYPE III,units,20.0,153 96 34100 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of moderate to severe pain, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8321fb82-6596-4b70-a706-8a19c15132dd.json
832a7ec8-fa26-4c87-8ac2-98e1fd57c2f9,KERENDIA 10 MG,prescription,C03DA05,FINERENON,9213,,,WHO ATC Classification,,ILS,film coated tablets,FINERENON,2025-07-31T04:25:01.141411,IL,באייר,,276.1309301,234.0092732,187.2074185,,,KERENDIA 20 MG 28 F.C.T,,,89208,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,171 38 37226 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Kerendia is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/832a7ec8-fa26-4c87-8ac2-98e1fd57c2f9.json
83399397-bc5b-42e9-9987-d07aad5c57df,SEPTAL SCRUB,off-the-counter,D08AC02,CHLORHEXIDINE,3957,,,WHO ATC Classification,,ILS,solution - external,CHLORHEXIDINE GLUCONATEW/V,2025-07-31T13:17:12.327279,IL,טבע,,51.743,43.85,nan,,7291064690402,SEPTAL SCRUB 500ML,19043,,,BOTTLE PLASTIC,units,500.0,043 08 23618 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,•	Antiseptic hand wash•	Pre-operative Surgical Scrub  •	Pre-operative Skin Preparation,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/83399397-bc5b-42e9-9987-d07aad5c57df.json
836bb2c2-02d0-4484-898f-ec929a2e40cb,FOMINIC,prescription,G03AC09,DESOGESTREL,7992,,,WHO ATC Classification,,ILS,tablets,DESOGESTREL 0.075  MG,2025-07-31T03:16:14.161182,IL,דקסל פארמה,,21.8814893,18.543635,13.5355,,7290010578825,FOMINIC 0.075MG 28 TAB,6578,,58859,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,155 65 34262 00,valid,37.0,per os,1.4,30,,,,,,,,,,0,Prescription required,Contraseptive.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/836bb2c2-02d0-4484-898f-ec929a2e40cb.json
837a564d-2051-417a-98f0-d91627083ac2,PROMNIX 0.4,prescription,G04CA02,TAMSULOSIN,6085,,,WHO ATC Classification,,ILS,modified release capsules hard,TAMSULOSIN HYDROCHLORIDE 0.4   MG,2025-07-31T07:01:55.056582,IL,תרו יבוא,,41.95222494,35.552733,25.9509,,7290000810676,PROMNIX 0.4 MG 30  MR CAPSULES,16771,,86496,BLISTER PVC/PE/PVDC,units,30.0,137 08 31452 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of functional symptoms of benign prostatic hyperplasia (BPH).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/837a564d-2051-417a-98f0-d91627083ac2.json
837ad1ca-3e48-41fb-8b3d-9a58a49a0ab7,FIBROGAMMIN 1250 IU FXIII,prescription,B02BD07,COAGULATION FACTOR XIII,6343,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection/solution for infusion,FACTOR XIII,2025-07-31T03:04:10.750470,IL,סי אס אל,,678.5387762,575.0328867,489.3896908,,,FIBROGAMMIN P 250,6605,,57487,VIAL GLASS TYPE II,units,1.0,110 54 29118 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Fibrogammin is indicated for adult and paediatric patients • for prophylactic treatment of congenital FXIII deficiency and • for peri-operative management of surgical bleeding with congentital FXIII deficiency. Fibrogammin is furthermore indicated • for haemorrhagic diatheses caused completely or in part by acquired FXIII deficiency • for supportive therapy in case of disturbance in wound healing, especially in ulcus cruris, after large surgery or injuries.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/837ad1ca-3e48-41fb-8b3d-9a58a49a0ab7.json
839031d1-899d-4a7a-a558-8aaf8fec528b,EPIPEN,prescription,C01CA24,EPINEPHRINE,7653,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE/ML,2025-07-31T02:28:01.542308,IL,דקסל פארמה,,539.3249055,457.055025,388.983,,7290103846848,EPIPEN JR. 0.15MG/0.3ML AUTO-INJECTOR 2X2ML כולל מזרק תרגול,5582,,65552,AUTO-INJECTOR GLASS,units,2.0,019 37 24854 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"EpiPen is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.EpiPen is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. EpiPen is intended for immediate administration as emergency supportive therapy only and  is not a substitute for immediate medical care.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/839031d1-899d-4a7a-a558-8aaf8fec528b.json
839b2328-e2ae-4df5-8cff-41e50cfa6d71,MIZOLLEN TABLETS 10 MG,prescription,R06AX25,MIZOLASTINE,4116,,,WHO ATC Classification,,ILS,film coated tablets,MIZOLASTINE,2025-07-31T05:28:37.327193,IL,פרמה שלום,,27.55471363,23.35145327,17.0448564,,7290008880176,MIZOLLEN 10MG 15 F.C TAB,13638,,16277,BLISTER OPA/AL/PVC,units,15.0,114 94 29697 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Symptomatic treatment of seasonal allergic rhinoconjuctivitis (hay fever), perennial allergic rhino-conjuctivitis and urticaria.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/839b2328-e2ae-4df5-8cff-41e50cfa6d71.json
839e6e01-7dfd-4092-b1fc-e3b49b36164f,NOVORAPID,prescription,A10AB05,INSULIN ASPART,6585,,,WHO ATC Classification,,ILS,solution for injection,INSULIN ASPART 100 U/ML,2025-07-31T05:55:46.019541,IL,נובו נורדיסק,,139.1616362,117.9335953,87.68297045,,7290008126458,NOVORAPID PENFILL 5X3MLX100IU/ML,9401,,20874,VIAL GLASS TYPE I,units,15.0,118 94 29983 02,valid,34.5,"i.v, s.c",1.4,30,,,,,,,,,,0,Prescription required,"Treatment of patients with diabetes mellitus in adults, adolescents and children aged 2 years and above.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/839e6e01-7dfd-4092-b1fc-e3b49b36164f.json
83bd0bde-f098-4b06-b32e-f739cd92706a,ENDARI,prescription,B05BA01,AMINO ACIDS,8651,,,WHO ATC Classification,,ILS,powder,GLUTAMINE/SACHET,2025-07-31T02:21:04.080841,IL,מגאפארם,,nan,nan,nan,,7290014573277,ENDARI 5 G/SACHET 60 PACKETS,,,,PACKETS PAPER/FOIL/PLASTIC LAMINATE ,units,60.0,164 80 35650 00,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,ENDARI is an amino acid indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/83bd0bde-f098-4b06-b32e-f739cd92706a.json
83c1ecda-7ea0-44a6-8fc3-501edcf96c38,CLOTRIVIT,off-the-counter,D01AC01,CLOTRIMAZOLE,3787,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLE,2025-07-31T11:26:00.977930,IL,ויטאמד,,26.2196,22.22,nan,,7290008084017,CLOTRIVIT CREAM 1% 20GR,3718,,,TUBE ALUMINIUM,units,20.0,114 95 29730 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,Antifungal agent for the local treatment of skin infections caused by candida species or dermatophytes.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/83c1ecda-7ea0-44a6-8fc3-501edcf96c38.json
83c21041-2141-465d-b70b-92f002ec4ab0,DULERGIN,off-the-counter,N02BB02,METAMIZOLE SODIUM,5551,,,WHO ATC Classification,,ILS,drops,DIPYRONE/ML,2025-07-31T11:34:01.810465,IL,ליף-רז,,27.9,23.64,nan,,7290111604942,DULERGIN ORAL DROPS 500MG/ML 20ML,,,,BOTTLE GLASS TYPE III,units,20.0,162 62 36039 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea and for high fever that does not respond to other measures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/83c21041-2141-465d-b70b-92f002ec4ab0.json
83c9b628-4fae-4e31-a173-8dae0c3535ef,FLUMIL-ANTIDOTO  20% 10VIALSX10ML,29C,,,20415,,,,,,injection,FLUMIL-ANTIDOTO 20% SX,2025-07-31T20:28:20.831563,IL,nan,,,,,,,FLUMIL-ANTIDOTO  20% 10VIALSX10ML,,,,,units,100.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/83c9b628-4fae-4e31-a173-8dae0c3535ef.json
83d620ab-303e-4a19-9600-d0d800235810,TUMS SMOOTHIES EX PEPPERMINT,off-the-counter,A02AC01,CALCIUM CARBONATE,5201,,,WHO ATC Classification,,ILS,chewable tablets,CALCIUM CARBONATE,2025-07-31T13:31:21.019930,IL,ג.ס.ק,,35.6596,30.22,nan,,7290010140497,TUMS SMOOTHIES EX PEPERMINT 60 TABS 750MG,20628,,,BOTTLE POLYPROPYLENE,units,60.0,134 94 31175 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For relief from heartburn and acidity,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/83d620ab-303e-4a19-9600-d0d800235810.json
83deb215-97dd-4ca1-883a-109fa001155a,DOCETAXEL HOSPIRA 10 MG/ML,prescription,L01CD02,DOCETAXEL,7049,,,WHO ATC Classification,,ILS,solution for infusion,DOCETAXEL/,2025-07-31T02:00:48.090098,IL,פיזר,,336.4060791,285.0898975,242.6297,,7290013592651,DOCETAXEL HOSPIRA 10MG/ML VIAL 20MG/2ML,4595,,41882,VIAL GLASS TYPE I,units,1.0,148 24 33345 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Breast cancer:  Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer.  Docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.  Docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. Previous chemotherapy should have included an anthracycline or an alkylating agent.  Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2 and who previously have not received chemotherapy for metastatic disease. Docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Doxorubicin and cyclophosphamide followed by Docetaxel in combination with trastuzumab (AC-TH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high risk node-negative, breast cancer. Docetaxel in combination with trastuzumab, and carboplatin (TCH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high risk node-negative, breast cancer. Non-small cell lung cancer:   Docetaxel is indicated for the treatment of patients with advanced non-small cell lung carcinoma. Ovarian Cancer:   Docetaxel is indicated for treatment of metastatic carcinoma of the ovary after failure of first line or subsequent chemotherapy. Prostate cancer:   Docetaxel in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.Esophageal cancer:   Docetaxel for the treatment of esophageal cancer. Gastric cancer:   Docetaxel for the treatment of advanced gastric cancer. Head and neck (SCCHN):   Docetaxel as monotherapy in the treatment of patients with recurrent and/or metastasis squamos cell carcinoma of the head and neck after failure of a previous chemotherapy regimen.   Docetaxel in combination with cisplatin and 5 fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/83deb215-97dd-4ca1-883a-109fa001155a.json
83f37528-7d11-4429-b839-d632d04ba191,ATOMIC 100,prescription,N06BA09,ATOMOXETINE,8895,,,WHO ATC Classification,,ILS,coated tablets,ATOMOXETINE AS HYDROCHLORIDE,2025-07-30T23:29:06.823050,IL,אוניפארם,,nan,nan,nan,,,ATOMIC 100 MG 28 TAB,,,66455,BLISTER PVC/ALUMINIUM,units,28.0,167 84 36235 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Atomic is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD. In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Atomic should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD.Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/83f37528-7d11-4429-b839-d632d04ba191.json
840347ae-22f6-4b77-b273-36b12e5e5da5,ADEX 200,off-the-counter,M01AE01,IBUPROFEN,5421,,,WHO ATC Classification,,ILS,caplets,IBUPROFEN,2025-07-31T11:04:02.841001,IL,דקסל פארמה,,40.8516,34.62,nan,,,ADEX LIQUIGEL 200MG 30CAPS,,,,BLISTER PVC/ALUMINIUM,units,30.0,039 71 26007 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the relief of mild to moderate pain such as headache, toothache, primary dysmenorrhea, backache, muscular pain. Anti - inflammatory and relieves pain in reumatoid arthritis and osteo arthritis. For the reduction of fever.For the treatment of pain associated with migraine.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/840347ae-22f6-4b77-b273-36b12e5e5da5.json
841334cb-3ed7-47ef-8d89-27b157b2577d,ENDOXAN 1 G INJECTION,prescription,L01AA01,CYCLOPHOSPHAMIDE,4080,,,WHO ATC Classification,,ILS,powder for solution for injection,CYCLOPHOSPHAMIDE/VIAL,2025-07-31T02:21:35.115703,IL,מגאפארם,,120.9652132,102.5128971,76.21776735,,7290004448271,ENDOXAN 1G/50ML 1INJ,5166,,26706,VIAL GLASS TYPE I,units,1.0,144 19 29660 02,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Malignant Diseases: Cycophosphamide although effective alone in susceptible melignancies  is more frequently used concurrently or sequentially with other antineoplastic drugs. The following malignancies are often susceptible.  Cycophosphamide treatment:   1) Malignant lymphomas (Stages III and IV of the Ann Arbor staging system)  Hodgkin`s disease  lymphocytic lymphoma (nodular or diffuse)  mixed-cell type lymphoma  histiocytic lymphoma  Burkitt`s lymphoma.   2) Multiple myeloma.   3) Leukemias: Chronic lymphocytic leukemia  chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis)  acute myelogenous and monocytic leukemia  acute lymphoblastic (stemcell) leukemia in children.   4) Mycosis fungoides (advenced disease).   5) Neuroblastoma (disseminated disease).   6) Adenocarcinoma of the ovary.  7) Retinoblastoma.   8) Carcinoma of the breast.   Nonmallgnant Disease Biopsy proven ""Minimal Change"" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. Severe cases of systemic lupus Erythematos as which did not respond to other treatment  especially with nephritis",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/841334cb-3ed7-47ef-8d89-27b157b2577d.json
84181b1f-bf94-436e-8358-090097c6e5ad,EFLUELDA TETRA,prescription,J07BB02,"INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN ",9135,,,WHO ATC Classification,,ILS,suspension for injection,"B/PHUKET/3073/2013 LIKE STRAIN/ 0.7  ML, B/AUSTRIA/1359417/2021 (B/VICTORIA LINEAGE)-LIKE VIRUS/ 0.7  ML, A/DARWIN/9/2021 (H3N2)-LIKE VIRUS/ 0.7  ML, A/VICTORIA/4897/2022 (H1N1)PDM09-LIKE VIRUS/ 0.7  ML",2025-07-31T02:11:54.634468,IL,סאנופי אוונטיס,,189.9288017,160.9566188,128.765295,,,EFLUELDA  1 PFS,,,,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,169 15 36617 00,valid,25.0,"s.c, i.m",1.4,12,,,,,,,,,,0,Prescription required,Active immunisation in adults 60 years of age and older for the prevention of influenza disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84181b1f-bf94-436e-8358-090097c6e5ad.json
842e13f3-48a0-4acd-bc89-e9f1da51b5ae,MOZOBIL,prescription,L03AX16,PLERIXAFOR,6406,,,WHO ATC Classification,,ILS,solution for injection,PLERIXAFOR/ 1.2  ML,2025-07-31T05:35:26.327174,IL,סאנופי אוונטיס,,14965.02191,12682.22252,11529.2932,,5030045000258,MOZOBIL 20MG/ML SOL FOR INJ 24MG/1.2ML,13691,,83844,VIAL 2 ML GLASS TYPE I,units,1.0,142 58 32938 01,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Mozobil is indicated in combination with G-CSF to enhance mobilisation of haematopietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma .בקשה לשינוי משטר מינון 12/2018,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/842e13f3-48a0-4acd-bc89-e9f1da51b5ae.json
84a2c6b2-f5d2-41e8-bfeb-7235d9fd4cdc,ERELZI 25,prescription,L04AB01,ETANERCEPT,8654,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ 0.5  ML,2025-07-31T02:33:25.697297,IL,סנדוז,,1395.715685,1182.809955,1006.64677,,,ERELZI 25 MG/0.5 ML 4 PREFILLED SYR,5670,,41368,PRE-FILLED SYRINGE  GLASS TYPE I,units,4.0,163 20 36011 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritisErelzi is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs) including methotrexate (unless contraindicated) has been inadequate. Erelzi can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis .Etanercept, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.Juvenile idiopathic arthritisTreatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. Treatment of psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. Treatment of enthesitis-related arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, conventional therapy. Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Etanercept has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease.Axial spondyloarthritisAnkylosing spondylitis (AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to non-steroidal anti-inflammatory drugs (NSAIDs).Plaque psoriasisTreatment of adults patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Paediatric plaque psoriasisTreatment of chronic severe plaque psoriasis in children and adolescents from the age of 6 years who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84a2c6b2-f5d2-41e8-bfeb-7235d9fd4cdc.json
84a5d43d-88d5-4278-9c30-23689fccdd91,NEOSTIGMINE -  HAMELN 2.5 MG/ML INJECTION,29C,N07AA01,NEOSTIGMINE,20546,,,WHO ATC Classification,,ILS,solution for injection,NEOSTIGMINE METHYLSULFATE 2.5 MG/ML,2025-07-31T15:21:54.176502,IL,nan,,nan,nan,nan,,4260016651313,NEOSTIGMINE 2.5MG/ML 50AMP,,,,AMPOULES GLASS TYPE I,units,50.0,151 23 33874 00,valid,nan,"i.v, i.m, s.c",1.4,36,,,,,,,,,,0,,"Myasthenia Gravis, antagonist to non-depolarizing neuromuscular blockade, Paralytic Ileus.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84a5d43d-88d5-4278-9c30-23689fccdd91.json
84d81367-59c0-48ba-9ccd-ee3428e06491,RIXATHON,prescription,L01XC02,RITUXIMAB,8397,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T07:45:57.909861,IL,סנדוז,,1789.170808,1516.246515,1290.422566,,7290017585413,RIXATHON 100MG/10ML 2 VIALS,18599,,45465,VIAL GLASS TYPE I,units,2.0,162 10 35741 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Rixathon is indicated for the following indications: * Non-Hodgkin’s lymphoma (NHL): Rixathon is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma. Rixathon is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy.Rixathon is indicated for the treatment of patients with CD20 positive diffuse large B-cell non-Hodgkin's lymphoma in combination with CHOP chemotherapy. Rixathon maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.* Chronic lymphocytic leukaemia (CLL):  Rixathon in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including Rixathon or patients refractory to previous Rixathon plus chemotherapy.* Granulomatosis with polyangiitis and Microscopic polyangiitis: Rixathon, in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis (WG) and Microscopic polyangiitis (MPA).*pemphigus vulgaris (PV):Rixathon is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).*Rheumatoid arthritis:Rixathon is indicated, in combination with methotrexate, to reduce signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more TNF antagonist therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84d81367-59c0-48ba-9ccd-ee3428e06491.json
84da68b2-69c3-4dca-9b3f-30d89c552736,LYNPARZA 100 MG,prescription,L01XX46,,8454,,,WHO ATC Classification,,ILS,film coated tablets,OLAPARIB,2025-07-31T05:01:02.050536,IL,אסטראזנקה,,10508.18347,8905.240621,8095.673292,,7290013075734,LYNPARZA 150 MG 56 TAB,12553,,28049,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,161 63 35469 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Ovarian cancer:Lynparza is indicated as monotherapy for the: •           maintenance treatment of adult patients with advanced (FIGO stages III and IV) BRCA1/2- mutated (germline and/or somatic) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. •           Maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete response or partial response) to platinum-based chemotherapy.First-line Maintenance Treatment of Advanced Ovarian Cancer in Combination with BevacizumabLynparza is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD) positive status defined by either:• a deleterious or suspected deleterious BRCA mutation, and/or• genomic instability Breast cancer:Germline BRCA-mutated HER2-negative Metastatic Breast CancerLynparza is indicated in patients with deleterious or suspected deleterious gBRCAm, HER2-negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. Patients with hormone receptor (HR)- positive breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy.Adjuvant Treatment of Germline BRCA-mutated HER2-negative High Risk Early Breast Cancer Lynparza is indicated for the adjuvant treatment of adult patients with deleterious or suspected deleterious gBRCAm human epidermal growth factor receptor 2 (HER2)-negative high risk early breast cancer who have been treated with neoadjuvant or adjuvant chemotherapy. Adenocarcinoma of the pancreas:First-line Maintenance Treatment of Germline BRCA-mutated Metastatic Pancreatic AdenocarcinomaLynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen.Prostate cancer:•	germline or somatic BRCA1/2 or ATM- mutated metastatic castration-resistant prostate cancer Lynparza is indicated for the treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA1/2 or ATM- mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with enzalutamide or abiraterone.•	Lynparza is indicated in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with deleterious or suspected deleterious HRR-mutated (HRRm) metastatic castration-resistant prostate cancer (mCRPC). Select patients for therapy based on an approved companion diagnostic for Lynparza",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84da68b2-69c3-4dca-9b3f-30d89c552736.json
84e16cc9-68ce-441e-b0e6-102037c3b875,CRUSIA,prescription,B01AB05,ENOXAPARIN,8440,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/,2025-07-31T01:34:17.211588,IL,צמל,,20.1654675,17.08938,12.474,,,CRUSIA 20MG/0.2ML 2 SYR,10624,,55057,SYRINGE 0.5 ML GLASS TYPE I,units,2.0,162 88 35673 00,valid,37.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Crusia is indicated in adults for:•Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery.•Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism.•Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE ikely to require thrombolytic therapy or surgery. Prevention of thrombus formation in extra corporeal circulation during haemodialysis.•Acute coronary syndrome:-Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid.-Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84e16cc9-68ce-441e-b0e6-102037c3b875.json
84e50f70-4cc1-4e14-a1a7-5f8912d9df29,GLIMEPIRIDE TEVA ®  2 MG,prescription,A10BB12,GLIMEPIRIDE,7466,,,WHO ATC Classification,,ILS,tablets,GLIMEPIRIDE,2025-07-31T03:35:14.644296,IL,טבע,,12.8374206,10.87917,7.941,,7290106061255,GLIMEPIRIDE TEVA 1 MG 30 TAB,7912,,53400,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,151 16 33859 00,valid,37.0,per os,1.4,18,,,,,,,,,,0,Prescription required,"Non-insulin-dependent diabetes mellitus (adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84e50f70-4cc1-4e14-a1a7-5f8912d9df29.json
84e7e971-d0d2-4b36-b8f3-0c6fdfb96a6b,IBOO 2 % FOR CHILDREN,off-the-counter,M02AA13,IBUPROFEN,5518,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/ML,2025-07-31T12:07:31.519826,IL,טבע,,26.137,22.15,nan,,7290110730642,IBOO 2 % FOR CHILDREN SYR 100 ML,,,,BOTTLE PET,units,100.0,153 81 34080 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years (i.e. weighing about 40 kg).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84e7e971-d0d2-4b36-b8f3-0c6fdfb96a6b.json
84f8434c-0d8d-4fcd-9617-c5e88f616ee6,NOVOFEM,prescription,G03CA53,"ESTRADIOL, COMBINATIONS",4622,,,WHO ATC Classification,,ILS,film coated tablets,"ESTRADIOL AS HEMIHYDRATE, NORETHISTERONE ACETATE",2025-07-31T05:54:10.906107,IL,נובו נורדיסק,,48.63607261,41.21701252,30.0854106,,7290008126595,NOVOFEM 28TAB,14394,,59190,DISPENSER PACK POLYPROPYLENE,units,28.0,127 11 30604 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women with an intact uterus. Prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis.The experience treating women older than 65 years is limited.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84f8434c-0d8d-4fcd-9617-c5e88f616ee6.json
84f8b380-1b1b-46a8-81ec-d6df1e890a9e,SEPTADINE,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5525,,,WHO ATC Classification,,ILS,solution - external,"CHLORHEXIDINE DICLUCONATE 0.5  %W/V, ALCOHOLV/V",2025-07-31T13:16:59.766471,IL,פלוריש,,17.1336,14.52,nan,,7290008103565,SEPTADINE TARHITZ 4% 100ML,,,,BOTTLE HDPE,units,100.0,108 58 29253 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"For quick disinfection of hands, also before invasive procedures.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84f8b380-1b1b-46a8-81ec-d6df1e890a9e.json
84fbebdf-87a9-4d98-ac78-4a7713e0ce78,ARCOXIA 120 MG TABLETS,prescription,M01AH05,ETORICOXIB,6658,,,WHO ATC Classification,,ILS,film coated tablets,ETORICOXIB,2025-07-30T23:26:35.811876,IL,אורגנון,,50.63365793,42.9098796,31.32108,,7290006813046,ARCOXIA 30MG 28TAB,9408,,23573,BLISTER PVC/ALUMINIUM,units,28.0,129 44 30788 11,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Arcoxia 120 mg tablets are indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/84fbebdf-87a9-4d98-ac78-4a7713e0ce78.json
850cf5de-1fdd-4cdd-b38b-dfaae661bb63,GEODON IM 20 MG,prescription,N05AE04,ZIPRASIDONE,4502,,,WHO ATC Classification,,ILS,powder for solution for injection,ZIPRASIDONE MESYLATE TRIHYDRATE 40.93   MG,2025-07-31T03:32:07.081625,IL,דקסל פארמה,,335.4663638,284.2935413,241.95195,,7290008095341,GEODON 40MG 60CAPS,7598,,29816,VIAL GLASS TYPE I,units,60.0,125 75 30516 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Rapid control of agitation in patients with schizophrenia, when oral therapy is not appropriate, for a maximum of 3 consecutive days.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/850cf5de-1fdd-4cdd-b38b-dfaae661bb63.json
85165470-b2f2-47c0-803a-52abd102e6ea,NICOTINELL LOZENGES 1 MG,off-the-counter,,,5413,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:33:01.928033,IL,ג.ס.ק,,293.82,249.0,nan,,,NICOTINELL TTS 20 28 PATCHES,,,,BLISTER PVC/PE/PVDC/AL,units,28.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85165470-b2f2-47c0-803a-52abd102e6ea.json
8521e5aa-10b7-42fc-9ad1-b34f169a47fc,OMR-IGG-AM 5 %,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",6426,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML MG/ML",2025-07-31T06:09:11.585525,IL,אומריקס,,844.8055668,715.9369529,609.308045,,,OMR-IGG-AM 5% (5 G/100ML) SOL FOR INJ 50ML,15025,,9692,BOTTLE GLASS TYPE I,units,50.0,127 54 30698 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Replacement therapy     * PRIMARY immunodeficiency (patients with PRIMARY defective antibody synthesis such as agammaglobulinemia OR hypogammaglobulinemia)     * Myeloma OR chronic Lymphocytic Leukemia (CLL) with severe secondary hypogammaglobulinemia AND recurrent infections.     * Children with congenital AIDS AND recurrent infections    - Immunomodulation     * Idiopathic Thrombocytopenic Purpura (ITP)     * Guillain Barre Syndrome     * Kawasaki Disease    - Allogenic Bone Marrow Transplantation,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8521e5aa-10b7-42fc-9ad1-b34f169a47fc.json
85317596-4387-4463-8b22-3b736c905077,PREVYMIS 240 MG FILM-COATED TABLETS,prescription,J05AX18,LETERMOVIR,8530,,,WHO ATC Classification,,ILS,film coated tablets,LETERMOVIR,2025-07-31T06:56:15.722646,IL,מ.ס.ד. ישראל,,44151.30697,37416.3635,34014.87591,,7290017512037,PREVYMIS 480 MG 28 TAB,,,74622,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,166 13 35974 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,PREVYMIS is indicated for prophylaxis of cytomegalovirus (CMV) reactivation and disease in adult CMV-seropositive recipients [R+] of an allogeneic haematopoietic stem cell transplant (HSCT).Consideration should be given to official guidance on the appropriate use of antiviral agents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85317596-4387-4463-8b22-3b736c905077.json
853285bc-efbf-4018-994f-d6f52a9b3570,ELZONRIS,prescription,L01XX67,TAGRAXOFUSP,9011,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,TAGRAXOFUSP/,2025-07-31T02:17:27.849558,IL,סטמליין ישראל,,47890.35687,40585.05,36895.5,,7290019908005,ELZONRIS 1MG/ML I.V 1 VIAL,,,60941,VIAL GLASS TYPE I,units,1.0,172 66 36969 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,ELZONRIS is a CD123-directed cytotoxin for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/853285bc-efbf-4018-994f-d6f52a9b3570.json
853c018d-7c87-4c12-8d21-8130e3173380,AZENIL 200 MG/5 ML SUSPENSION,prescription,J01FA10,AZITHROMYCIN,3091,,,WHO ATC Classification,,ILS,powder for oral suspension,AZITHROMYCIN AS DIHYDRATE/,2025-07-30T23:32:44.744402,IL,פיזר,,24.00861158,20.346281,14.8513,,,AZENIL 200MG 15ML,1073,,9137,BOTTLE POLYETHYLENE,units,15.0,118 26 29828 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Infections caused by susceptible organisms in lower respiratory tract including bronchitis and pneumonia, skin and soft tissue infections, otitis media, upper respiratory tract infections including sinusitis and pharyngitis, tonsilitis, also in the treatment of uncomplicated genital infections due to chlamydia trachomatis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/853c018d-7c87-4c12-8d21-8130e3173380.json
85467f25-8a8c-436b-81c6-22d4c8fa4613,CODIVIS SYRUP,prescription,R05DA04,CODEINE,2310,,,WHO ATC Classification,,ILS,syrup,"PHENYLTOLOXAMINE AS RESINATE 3.3  MG / 4.5  ML, CODEINE AS RESINATE/ 4.5  ML",2025-07-31T01:25:55.062004,IL,כ.צ.ט,,nan,nan,nan,,,CODIVIS 10 SR CAP,3020,,8806,BOTTLE GLASS TYPE II,units,10.0,132 47 22196 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of cough.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85467f25-8a8c-436b-81c6-22d4c8fa4613.json
85536da2-83cd-4dc3-8858-c017add28079,AUSTEDO 12 MG,prescription,,,8758,,,,,ILS,tablets extended release,DEUTETRABENAZINE,2025-07-31T00:26:39.761415,IL,טבע,,nan,nan,nan,,,AUSTEDO 6 MG 60 SR TAB,,,72481,BOTTLE HDPE,units,60.0,166 59 36156 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,AUSTEDO is indicated in adults for the treatment of: • Chorea associated with Huntington’s disease  • Tardive dyskinesia,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85536da2-83cd-4dc3-8858-c017add28079.json
8553c012-4e3e-4ff6-b77f-c1830e3dfc5c,TAVALISSE 100 MG,prescription,B02BX09,FOSTAMATINIB,8793,,,WHO ATC Classification,,ILS,film coated tablets,FOSTAMATINIB AS DISODIUM HEXAHYDRATE,2025-07-31T09:08:00.738930,IL,מדיסון,,21278.44976,18032.58535,16393.25941,,,TAVALISSE 150 MG 60 TAB,,,60249,BOTTLE HDPE,units,60.0,168 04 36449 99,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,TAVALISSE is indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8553c012-4e3e-4ff6-b77f-c1830e3dfc5c.json
856e2b8f-6519-4ee8-ba25-f7241100c53c,CEFOTAXIME MEDO 1 GR,prescription,J01DD01,CEFOTAXIME,9058,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFOTAXIME AS SODIUM/VIAL,2025-07-31T00:59:15.045298,IL,מדי מרקט,,151.1727272,128.1124863,102.4899891,,,CEFOTAXIME MEDO 1 GR/VIAL 10 VIAL,,,,VIAL GLASS TYPE I,units,10.0,167 79 36007 00,valid,25.0,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,"Imetoxim 1 gr is indicated in the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity. SepticaemiasRespiratory Tract Infections such as acute and chronic bronchitis, bacterial pneumonia, infected bronchiectasis, lung abscess and post-operative chest infections. Urinary Tract Infections such as acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. Soft-Tissue Infections such as cellulitis, peritonitis and wound infections. Bone and Joint Infections such as osteomyelitis, septic arthritis. Obstetric and Gynaecological Infections such as pelvic inflammatory disease. Gonorrhoea particularly when penicillin has failed or is unsuitable. Other Bacterial Infections such as meningitis and other sensitive infections suitable for parenteral antibiotic therapy PROPHYLAXIS: Prophylaxis of infections in patients with reduced resistance. Pre-operative prophylaxis in patients who are at increased risk from infection.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/856e2b8f-6519-4ee8-ba25-f7241100c53c.json
85748bdb-4bc3-4d49-be9d-9b4747652a3e,LIDOPRI-AVENIR 5 %,off-the-counter,N01BB52,"LIDOCAINE, COMBINATIONS",5577,,,WHO ATC Classification,,ILS,cream,"PRILOCAINE 2.5 %, LIDOCAINE 2.5 %",2025-07-31T12:18:58.747762,IL,ביואבניר,,90.7656,76.92,nan,,,LIDOPRI-AVENIR 5 % 30 G cream,,,,TUBE ALUMINIUM,units,30.0,162 80 35307 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Topical anaesthetic for superficial dermal analgesia in connection with insertion of IV catheters, blood  sampling and superficial surgical procedures.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85748bdb-4bc3-4d49-be9d-9b4747652a3e.json
8588a335-7149-4400-a881-d4b51721b847,HEMLIBRA 150 MG/ML,prescription,B02BX06,EMICIZUMAB,8448,,,WHO ATC Classification,,ILS,solution for injection,EMICIZUMAB/,2025-07-31T03:44:20.170490,IL,רוש,,44882.73472,38036.21755,34578.37959,,7290014774094,HEMLIBRA 150 MG/ML 1 VIAL,,,26632,VIAL GLASS TYPE I,units,1.0,161 19 35415 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8588a335-7149-4400-a881-d4b51721b847.json
858ab2a2-4758-453e-bebc-1c4069235223,TANTUM VERDE,off-the-counter,A01AD02,BENZYDAMINE,5266,,,WHO ATC Classification,,ILS,mouthwash,BENZYDAMINE HYDROCHLORIDE 0.15  %W/V,2025-07-31T13:25:01.604019,IL,רז פרמהצפטי,,45.2648,38.36,nan,,7290015863643,TANTUM VERDE MOUTHWASH 240 ML,20652,,,BOTTLE GLASS TYPE III,units,240.0,140 35 31801 00,valid,nan,local oral,1.4,48,,,,,,,,,,0,,"Locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions of the mouth and throat infcuding: Traumatic conditions, Pharyngitis following tonsillectomy or the use of a naso-gastric tube.Inflammatory conditions : Pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy. Dentistry : For use after dental operations.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/858ab2a2-4758-453e-bebc-1c4069235223.json
858c7b2f-88ad-4ff1-936c-b28d08939668,CAMBIA 50MG 20 gel caps,29C,,,20991,,,,,,capsule,CAMBIA 50MG 20 gel caps,2025-07-31T20:02:56.809958,IL,nan,,,,,,,CAMBIA 50MG 20 gel caps,,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/858c7b2f-88ad-4ff1-936c-b28d08939668.json
85913c8b-9a71-411b-92c7-633e41598b83,ZOFRAN TABLETS 4 MG,prescription,A04AA01,ONDANSETRON,2435,,,WHO ATC Classification,,ILS,tablets,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE,2025-07-31T10:51:47.739562,IL,סנדוז,,186.7026975,158.222625,126.5781,,,ZOFRAN 8MG 10TAB,26076,,8434,BLISTER PVC/ALUMINIUM,units,10.0,049 96 26549 22,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Adults:Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.  Zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). Paediatric Population:Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85913c8b-9a71-411b-92c7-633e41598b83.json
859747e9-d96a-4e3f-890f-8bb4f8f76ca5,ATTENT XR 30 MG,29C,N06BA01,AMFETAMINE,7646,,,WHO ATC Classification,,ILS,capsules extended release,"DEXTROAMPHETAMINE SULFATE 7.5  MG, DEXTROAMPHETAMINE SACCHARATE 7.5  MG, AMPHETAMINE SULFATE 7.5  MG, AMPHETAMINE ASPARTATE MONOHYDRATE 7.5  MG",2025-07-31T13:49:31.264945,IL,nan,,nan,nan,nan,,,AMPHETAMINE MIXED SALTS 5MG 100TAB,,,,BOTTLE HDPE,units,100.0,170 94 35998 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/859747e9-d96a-4e3f-890f-8bb4f8f76ca5.json
859c696c-fea5-4198-8b0c-8c6c9a4dd891,TRUSOPT,prescription,S01EC03,DORZOLAMIDE,3562,,,WHO ATC Classification,,ILS,"eye drops, solution",DORZOLAMIDE AS HYDROCHLORIDE/ML,2025-07-31T09:47:24.475468,IL,רפא,,34.58828862,29.312109,21.3957,,7290004997281,TRUSOPT 2% 5 ML,20147,,53979,DROPER BOTTLE HDPE,units,5.0,106 58 28935 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of eleveated intraocular pressure in patients with ocular hypertension, open-angle glaucoma and in some patients secondary glaucoma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/859c696c-fea5-4198-8b0c-8c6c9a4dd891.json
85aa16f0-8ffd-4b7d-838d-be3d9c968153,HYDROGEN PEROXIDE 3% LIFE,off-the-counter,D08AX01,HYDROGEN PEROXIDE,5562,,,WHO ATC Classification,,ILS,solution,HYDROGEN PEROXIDEW/W,2025-07-31T12:07:11.112819,IL,ליף-פלוריש,,10.9032,9.24,nan,,,HYDROGEN PEROXIDE 3% LIFE 100 ML,,,,BOTTLE POLYETHYLENE,units,100.0,162 73 35786 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,Antiseptic, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85aa16f0-8ffd-4b7d-838d-be3d9c968153.json
85b04b93-954a-4fac-8b3b-6225f4b7ee68,OMEPRADEX - Z,prescription,A02BC01,OMEPRAZOLE,6569,,,WHO ATC Classification,,ILS,caplets,OMEPRAZOLE,2025-07-31T06:07:21.360110,IL,רפא,,53.02060016,44.932712,32.7976,,7290010578511,OMEPRA 40MG 28 CAPSULES,15342,,13853,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,131 25 30841 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85b04b93-954a-4fac-8b3b-6225f4b7ee68.json
85d78e28-5dfb-407b-8ea9-5755ecd12adf,ALDACTONE 25 MG,prescription,C03DA01,SPIRONOLACTONE,9385,,,WHO ATC Classification,,ILS,coated tablets,SPIRONOLACTONE,2025-07-31T06:45:35.702331,IL,אוניפארם,,7849.480695,6652.10258,6047.365982,,,PIRON 801 MG 90 TAB,,,15123,BLISTER PVC/ALUMINIUM,units,90.0,125 97 24826 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Congestive heart failure, cirrhotic ascites.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85d78e28-5dfb-407b-8ea9-5755ecd12adf.json
85e1adef-c2fb-43aa-9958-a9e05763092d,DEFIROX 125 MG,prescription,V03AC03,DEFERASIROX,9121,,,WHO ATC Classification,,ILS,dispersible tablets,DEFERASIROX,2025-07-31T01:45:34.010964,IL,דקסל פארמה,,2067.482216,1752.103573,1491.151977,,,DEFIROX 250 MG  28 TAB,4758,,30194,BLISTER PVC/PCTFE/AL,units,28.0,167 88 35880 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Defirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over). Defirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC] &#8805;5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 µg/l). LIC is the preferred method of iron overload determination and should be used wherever available,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85e1adef-c2fb-43aa-9958-a9e05763092d.json
85f0c9e6-3b8b-4990-af0c-92d11fac9a2c,TALTZ 80 MG,prescription,L04AC13,IXEKIZUMAB,7985,,,WHO ATC Classification,,ILS,solution for injection,IXEKIZUMAB/ML,2025-07-31T09:02:12.353371,IL,אלי לילי,,4286.058141,3632.252823,3302.048021,,7290016021035,TALTZ 80 MG/1 ML 1 PREFILLED PEN,20834,,57247,PRE-FILLED PEN GLASS TYPE I,units,1.0,157 73 34927 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Plaque psoriasis :Taltz is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.Psoriatic arthritis : Taltz, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drug (DMARD) therapies.Ankylosing spondylitis (radiographic axial spondyloarthritis)Taltz is indicated for the treatment of adult patients with active ankylosing spondylitis who have responded inadequately to conventional therapy.Non-radiographic axial spondyloarthritisTaltz is indicated for the treatment of adult patients with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and magnetic resonance imaging (MRI) who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85f0c9e6-3b8b-4990-af0c-92d11fac9a2c.json
85f45ef7-8e6f-40c6-9d19-90fb22ad13db,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7461,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:20:12.827011,IL,צמל,,140.32973,118.9235,95.1388,,,METOJECT 50MG/ML SYRINGE PREFILLED 27.5MG/0.55ML,,,41385,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,25.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85f45ef7-8e6f-40c6-9d19-90fb22ad13db.json
85f8b372-1326-4dfc-a982-3311ac4ce7bb,MENOPUR MULTIDOSE 1200 IU,prescription,G03GA02,HUMAN MENOPAUSAL GONADOTROPHIN,7023,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,MENOTROPHIN,2025-07-31T05:11:40.971296,IL,פרינג,,805.7387265,682.8294596,581.131455,,7046260863804,MENOPUR MULTIDOSE 600 IU 1VIAL,13698,,33846,VIAL GLASS TYPE I,units,1.0,147 67 33343 00,valid,17.5,"s.c, i.m",1.4,36,,,,,,,,,,0,Prescription required,Sterility in females with hypo or normogonadotropic ovarian insufficiency: stimulation of follicle growth. Sterility in males with hypo or normogonadotropic hypogonadism: In combination with HCG to spermatogenesis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/85f8b372-1326-4dfc-a982-3311ac4ce7bb.json
8601e9eb-1544-4deb-99ca-db5bd9cf8e24,VOTRIENT 200 MG,prescription,L01XE11,PAZOPANIB,6703,,,WHO ATC Classification,,ILS,film coated tablets,PAZOPANIB AS HYDROCHLORIDE,2025-07-31T10:21:44.742281,IL,נוברטיס פארמה,,3053.853438,2588.011503,2352.73773,,7290014257719,VOTRIENT 200MG 30TAB,22322,,25188,BOTTLE HDPE,units,30.0,145 09 33192 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Renal cell carcinoma (RCC)Votrient is indicated in adults for the first line treatment of advanced Renal Cell Carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease.Soft tissue sarcoma (STS)Votrient is indicated for the treatment of adult patients with selective subtypes of advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8601e9eb-1544-4deb-99ca-db5bd9cf8e24.json
860241c1-8a8d-449a-81ff-b9c89aacde1a,NORMALOL 100,prescription,C07AB03,ATENOLOL,1775,,,WHO ATC Classification,,ILS,tablets,ATENOLOL,2025-07-31T05:51:15.832086,IL,דקסל פארמה,,20.00881986,16.956627,12.3771,,,NORMALOL 100MG 30TAB,14360,,8314,BLISTER PVC/ALUMINIUM,units,30.0,052 39 26224 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of angina pectoris, acute myocardial infarction, hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/860241c1-8a8d-449a-81ff-b9c89aacde1a.json
860e3906-25dc-4474-9d3c-232c3d53fce3,SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE,prescription,,,7115,,,,,ILS,emulsion for infusion,"FISH OIL/, OLIVE OIL/, TRIGLYCERIDES, MEDIUM-CHAIN/, SOYA BEAN OIL, REFINED/, GLUCOSE MONOHYDRATE/, L- VALINE 6.2 G /, L- TYROSINE 0.40 G /, L- TRYPTOPHAN/, L- THREONINE 4.4 G /, TAURINE/, L- SERINE 6.5 G /, L- PROLINE 11.2 G /, L- PHENYLALANINE 5.1 G /, L- METHIONINE 4.3 G /, L- LYSINE ACETATE 9.3 G /, L-LEUCINE 7.4 G /, L- ISOLEUCINE/, L-HISTIDINE/, GLYCINE/, L-ARGININE/, L- ALANINE/",2025-07-31T08:23:20.290311,IL,ניאופרם,,nan,nan,nan,,,SMOFKABIVEN ELECTROLYTE FREE 1970ML/BAG,,,,BAG POLYPROPYLENE,units,1970.0,172 77 36909 99,valid,nan,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/860e3906-25dc-4474-9d3c-232c3d53fce3.json
86188c11-369a-4fc7-a62f-61871913c889,SIFROL ER 0.75 MG,prescription,N04BC05,PRAMIPEXOLE,6828,,,WHO ATC Classification,,ILS,tablets extended release,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 0.75  MG,2025-07-31T08:10:13.563448,IL,בורינגר אינגלהיים,,39.29297358,33.29913164,24.3059355,,,SIFROL ER 0.375MG 30P.R TAB,9787,,3050,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,144 96 33089 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of signs and symptoms of idiopathic Parkinson's disease, as monotherapy or in combination with levodopa.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86188c11-369a-4fc7-a62f-61871913c889.json
861c2ffb-c409-4a85-a3cb-81a3b1fb3073,EVICEL HUMAN SURGICAL SEALANT,prescription,B05BA10,COMBINATIONS,6855,,,WHO ATC Classification,,ILS,solution,"THROMBIN 800 -/, CALCIUM CHLORIDE 5.6 - 6.20  MG /, PROTEIN CLOTTABLE 50 -/",2025-07-31T02:46:01.029328,IL,אומריקס,,nan,nan,nan,,7290004961862,EVICEL HUMAN SURGICAL SEALANT 2X5ML (ללא אפליקטור),,,19180,VIAL 10 ML GLASS TYPE I,units,2.0,118 61 29895 02,valid,nan,topical in surgery,1.4,24,,,,,,,,,,0,Prescription required,"General haemostasis : Evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. Efficacy has been demonstrated in liver surgery and orthopaedic surgery.Evicel ® is also indicated as suture support for haemostasis for suture line sealing in dura mater closure.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/861c2ffb-c409-4a85-a3cb-81a3b1fb3073.json
862c024c-4e93-4094-8866-c41fcd2a68aa,TADAM 10,prescription,G04BE08,TADALAFIL,8099,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T09:00:34.749086,IL,אוניפארם,,428.767222,363.3620525,309.2443,,,TADAM 20 MG 8 FILM COATED TABLETS,20825,,62139,BLISTER PVC/ALUMINIUM,units,8.0,157 81 34538 01,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/862c024c-4e93-4094-8866-c41fcd2a68aa.json
862d3101-7d66-4929-8d0d-9cc161a88c35,REXTOL 5 MCG/ML,prescription,A11CC07,PARICALCITOL,8430,,,WHO ATC Classification,,ILS,solution for injection,PARICALCITOL/,2025-07-31T07:31:48.638966,IL,לפידות,,302.4876789,256.3454906,218.166375,,,REXTOL 5 MCG/ML 5 VIAL,18597,,37203,AMPOULES GLASS TYPE I,units,5.0,160 03 34789 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Rextol 5 mcg/ml is indicated for the prevention and treatment of secondary hyperparathyrodism in patients with chronic renal failure who are undergoing haemodialysis., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/862d3101-7d66-4929-8d0d-9cc161a88c35.json
86339daf-e575-40b4-9431-a1828fc97ef4,HEPAGAM B,prescription,J06BB04,HEPATITIS B IMMUNOGLOBULIN,7449,,,WHO ATC Classification,,ILS,solution for injection,HEPATITIS B IMMUNOGLOBULIN/ML,2025-07-31T03:44:51.736725,IL,צמל,,5119.683001,4338.7146,3944.286,,7290012240126,HEPAGAM B 312 IU/ML VIAL 5ML (1560UI~31.2ML),8376,,78667,VIAL GLASS TYPE I,units,31.2,140 62 31748 00,valid,10.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,Prevention of hepatitis B recurrence following liver transplantation :   Hepagam B  is indicated for the prevetion of hepatitis B recurrence following liver transplantation  in HBsAg-positive liver transplant patients. Hepagam B should be administered intravenously for this indication.Postexposure prophylaxis :   Hepagam B is indicated for the treatment of acute exposure to blood containing HBsAg  perinatal exposure of infants born to HBsAg-positive mothers  sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection in the following settings:   Acute exposure to blood containing HBsAg   Following either parenteral exposure (needlestick  bite  sharps)  direct mucous membrane contact (accidental splash)  or oral ingestion (pipetting accident)  involving HBsAg - positive materials such as blood  plasma or serum. Perinatal exposure of infants born to HBsAg-positive mothers  Infants born to mothers positive for HBsAg with or without HBeAg.   Perinatal exposure of infants born to HBsAg-positive persons   Sexual partners of HBsAg-positive persons.   Household exposure to persons with acute HBV infection Infants less than 12 months old whose mother or primary caregiver is positive for HBsAg. Other household contacts with an identifiable blood exposure to the index patient.   Hepagam B is indicated for intramuscular use only for these post-exposure prophylaxis indications.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86339daf-e575-40b4-9431-a1828fc97ef4.json
8638da67-e30d-493e-aeac-581a413680b9,RYDAPT ® 25 MG,prescription,L01XE40,MIDOSTAURIN,8107,,,WHO ATC Classification,,ILS,"capsule, soft",MIDOSTAURIN,2025-07-31T07:55:38.938857,IL,נוברטיס פארמה,,29653.91343,25130.43623,22845.85112,,,RYDAPT 25 MG 56 CAPSULES,14626,,10110,BLISTER PACK PA/ALUMINIUM/PVC,units,56.0,160 65 35320 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute myeloid leukaemia (AML) :Rydapt is indicated in combination with standard induction and consolidation chemotherapy followed by single-agent maintenance therapy for adults with newly diagnosed acute myeloid leukaemia (AML) who have an FLT3 mutation.Advanced systemic mastocytosis (advanced SM) :Rydapt is indicated for the treatment of adult patients with advanced systemic mastocytosis (advanced SM).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8638da67-e30d-493e-aeac-581a413680b9.json
8643238b-9420-4bfc-bc18-8f2bb50bea20,RETAVIT 0.025% GEL 20GR,prescription,,,3705,,,,,ILS,tablet,RETAVIT 0.025% GEL 20GR,2025-07-31T19:30:00.111581,IL,כ.צ.ט,,61.6808993,52.27195088,38.863904,,,RETAVIT 0.025% GEL 20GR,18010,,8831,,units,20.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8643238b-9420-4bfc-bc18-8f2bb50bea20.json
86434eb9-2cc3-4935-a229-a16a2926c67b,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,1791,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T11:15:26.137711,IL,פישר,,22.892,19.4,nan,,7290006603036,AZOLINE DROPS 15CC,1378,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,15.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86434eb9-2cc3-4935-a229-a16a2926c67b.json
86645c8f-b9e0-4180-9fd3-8a4773ee767c,FOSTIMON 150 IU,prescription,G03GA04,UROFOLLITROPIN,6065,,,WHO ATC Classification,,ILS,powder for solution for injection,UROFOLLITROPIN/VIAL,2025-07-31T03:19:29.643180,IL,צמל,,721.6880849,611.6000991,520.5107227,,,FOSTIMON 75IU 10 VIALS,6426,,14010,VIAL GLASS TYPE I,units,10.0,137 16 30176 00,valid,17.5,"i.m, s.c",1.4,24,,,,,,,,,,0,Prescription required,"A treatment with FSH followed by the administration of human chronic gonadotrophin (HCG) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. These women belong to the WHO group II and have generally already been treated with clomiphene citrate. Most have polycystic ovarian syndrome. FSH offers good therapeutic prospects for patients whose LH:FSH ratio has to be adjusted, avoiding an exogenous supply of LH FSH may be used alone or in concomitance with human menopausal gonadotropin (HMG) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (IVF-ET,GIFT).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86645c8f-b9e0-4180-9fd3-8a4773ee767c.json
86690d3e-dbc9-4d56-8e2c-04434bbbdda1,NORMALOL 100,prescription,C07AB03,ATENOLOL,1776,,,WHO ATC Classification,,ILS,tablets,ATENOLOL,2025-07-31T05:51:37.352747,IL,דקסל פארמה,,14.339242,12.1519,8.87,,,NORMALOL 50MG 30TAB,14359,,8315,BLISTER PVC/ALUMINIUM,units,30.0,052 39 26224 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of angina pectoris, acute myocardial infarction, hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86690d3e-dbc9-4d56-8e2c-04434bbbdda1.json
86691532-5e21-4712-8584-22d3fa291fc6,ROWACHOL,off-the-counter,N/A,,406,,,WHO ATC Classification,,ILS,capsules,"MENTHOL, MENTHONE, PINENE 3.4  MG, BORNEOL, CAMPHENE, CINEOLE, PINENE 13.6  MG",2025-07-31T13:14:55.637956,IL,מגאפארם,,50.74,43.0,nan,,7290004448202,ROWACHOL 50 CAPS,18091,,,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,107 68 20688 01,valid,nan,per os,1.4,60,,,,,,,,,,0,,An adjuvant in the treatment of gall-bladder stones and liver diseases.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86691532-5e21-4712-8584-22d3fa291fc6.json
86696e8c-d254-4200-8d64-95adeaa4aa9c,ASPIRIN CARDIO,off-the-counter,B01AC06,ACETYLSALICYLIC ACID,5264,,,WHO ATC Classification,,ILS,tablets enteric coated,ACETYLSALICYLIC ACID,2025-07-31T11:14:19.401442,IL,באייר,,18.3136,15.52,nan,,7290013092502,ASPIRIN CARDIO 100MG 30TAB,9407,,,BLISTER POLYPROPYLENE/ALUMINIUM,units,30.0,143 06 31982 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86696e8c-d254-4200-8d64-95adeaa4aa9c.json
8671f839-b218-4192-a5ee-ae94c4408e79,MONUROL,prescription,J01XX01,FOSFOMYCIN,3611,,,WHO ATC Classification,,ILS,powder for oral solution,FOSFOMYCIN AS TROMETAMOL/SACHET,2025-07-31T05:31:21.903758,IL,רפא,,22.20214092,18.8153745,13.73385,,7290008012751,MONUROL 1SACHET,13248,,76690,SACHET ALUMINIUM,units,1.0,107 93 28982 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Monurol is indicated for: - The treatment of acute uncomplicated cystitis in women and female adolescents- Perioperative antibiotic prophylaxis for transrectal prostate biopsy in adult manConsideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8671f839-b218-4192-a5ee-ae94c4408e79.json
86a4a551-d99f-467e-9e79-ac6adb2f6e6c,TORID 40MG 30TAB,prescription,,,4797,,,,,ILS,tablet,TORID 40MG,2025-07-31T19:34:41.080905,IL,אוניפארם,,54.31921494,46.033233,33.6009,,,TORID 40MG 30TAB,20549,,17780,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86a4a551-d99f-467e-9e79-ac6adb2f6e6c.json
86a75674-758a-49ce-acbe-eb72279a526a,VESOMNI,prescription,G04CA53,TAMSULOSIN AND SOLIFENACIN,7307,,,WHO ATC Classification,,ILS,tablets modified release,"TAMSULOSIN HYDROCHLORIDE 0.4  MG, SOLIFENACIN SUCCINATE",2025-07-31T08:27:07.187701,IL,טבע,,164.87196,139.722,111.7776,,,SOLIFENACIN TEVA 5MG 30TAB,9728,,49809,BLISTER PA/ALUMINIUM/PVC,units,30.0,162 69 35421 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic hyperplasia (BPH) in men who are not adequately responding to treatment with monotherapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86a75674-758a-49ce-acbe-eb72279a526a.json
86abeacb-452c-47cf-ab9b-97a67e9ffdee,FLUVASTATIN 40MG TEVA USA   100CAPS,29C,,,20920,,,,,,capsule,FLUVASTATIN 40MG USA,2025-07-31T20:29:18.467319,IL,nan,,,,,,,FLUVASTATIN 40MG TEVA USA   100CAPS,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86abeacb-452c-47cf-ab9b-97a67e9ffdee.json
86b595bf-c8a7-4b51-913d-e5fa3ea32bec,MUSCOL,prescription,M03BC51,"ORPHENADRINE, COMBINATIONS",1606,,,WHO ATC Classification,,ILS,tablets,"PARACETAMOL, ORPHENADRINE (CITRATE)",2025-07-31T05:36:08.310827,IL,טבע,,nan,nan,nan,,,MUSCOL 20TAB,13194,,1403,BLISTER PVC/ALUMINIUM,units,20.0,018 08 20537 01,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of mild to moderate pain of acute musculoskeletal disorders.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86b595bf-c8a7-4b51-913d-e5fa3ea32bec.json
86bdba34-9a64-428e-905a-606450f1b60f,TUMS SMOOTHIES EX PEPPERMINT,off-the-counter,A02AC01,CALCIUM CARBONATE,5158,,,WHO ATC Classification,,ILS,chewable tablets,CALCIUM CARBONATE,2025-07-31T13:30:35.147756,IL,ג.ס.ק,,40.7572,34.54,nan,,7290010140497,TUMS EX 750MG SF 80TAB,20587,,,BOTTLE POLYPROPYLENE,units,80.0,134 94 31175 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For relief from heartburn and acidity,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86bdba34-9a64-428e-905a-606450f1b60f.json
86fdeb6d-37b7-4b8e-85f8-bffcfcb47c96,KALETRA  200 MG/50 MG TABLETS,prescription,J05AE06,LOPINAVIR,6647,,,WHO ATC Classification,,ILS,film coated tablets,"RITONAVIR, LOPINAVIR",2025-07-31T04:20:46.022600,IL,אב-וי,,471.1659071,399.2931593,339.8239654,,8054083003238,KALETRA 100MG/25MG  60 F.C TAB,11218,,4874,BLISTER PVC/ALUMINIUM,units,60.0,137 96 31542 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Kaletra is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86fdeb6d-37b7-4b8e-85f8-bffcfcb47c96.json
86fdec70-3b9a-481e-a496-758aadd8364f,MINIRIN TABLETS 0.1 MG,prescription,H01BA02,DESMOPRESSIN,4410,,,WHO ATC Classification,,ILS,tablets,DESMOPRESSIN ACETATE 0.1  MG,2025-07-31T05:24:51.875166,IL,פרינג,,99.64321672,84.443404,62.7832,,7315372504647,MINIRIN 0.1MG 30TAB,13390,,4060,BOTTLE HDPE,units,30.0,141 99 25705 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Central diabetes insipidus.Nocturnal Enuresis. Treatment of nocturia in adults associated with nocturnal polyuria.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/86fdec70-3b9a-481e-a496-758aadd8364f.json
8702db39-3ea5-4e48-bb8d-bb0336871baa,LITORVA 10,prescription,C10AA05,ATORVASTATIN,7028,,,WHO ATC Classification,,ILS,tablets,ATORVASTATIN AS CALCIUM,2025-07-31T04:50:49.465098,IL,דקסל פארמה,,65.84528738,55.801091,41.4878,,7290010578429,LITORVA 80 MG 30TAB,12464,,34561,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,145 31 33305 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Litorva is indicated as an adjunct to diet for reduction of elevated total cholesterol LDL- cholesterol apolipoprotein B and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Litorva is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable. Pediatric patients (10-17 years of age) : Atorvastatin is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:  1. LDL-C remains >or = 190 mg/dl or   2. LDL-C remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the pediatric patient. Prevention of cardiovascular and/or cerebrovascular event sush as MI or stroke as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor. In patients with clinically evident coronary heart disease, Litorva is indicated to : Reduce the risk of non-fatal myocardial infarction. Reduce the risk of fatal and non fatal stroke. Reduce the risk for revascularization procedures. Reduce the risk of hospitalization for CHF. Reduce the risk of angina.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8702db39-3ea5-4e48-bb8d-bb0336871baa.json
871526aa-5d5d-4e87-bbeb-7f830cf9c5ae,BREXIN TABLETS,prescription,M02AA07,PIROXICAM,6367,,,WHO ATC Classification,,ILS,tablets,PIROXICAM AS BETA-CYCLODEXTRIN,2025-07-31T00:42:13.337413,IL,תרו יבוא,,nan,nan,nan,,,BREXIN 20MG 10 SACHETS WATER SOLUBLE POWDER,2507,,21599,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,136 61 29695 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Piroxicam is indicated for symptomatic relief of osteoarthritis  rheumatoid arthritis or ankylosing spondylitis.   When an NSAID is indicated piroxicam should be considered as a second line option. The desicion to prescribe piroxocam should be based on an assesment of the individual's patient overall risk.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/871526aa-5d5d-4e87-bbeb-7f830cf9c5ae.json
871aecce-7e20-4ea0-9c7d-cb641e60d122,UROCIT-K 10 mEq,prescription,A12BA02,POTASSIUM CITRATE,7919,,,WHO ATC Classification,,ILS,tablets extended release,POTASSIUM CITRATE,2025-07-31T09:54:31.602710,IL,פארמבסט,,nan,nan,nan,,,UROCIT-K 10 mEq 100  SR TAB,85404,,31617,BOTTLE HDPE,units,100.0,156 56 34526 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Urocit®-K is a citrate salt of potassium indicated for the management of:• Renal tubular acidosis (RTA) with calcium stones• Hypocitraturic calcium oxalate nephrolithiasis of any etiologyUric acid lithiasis with or without calcium stones, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/871aecce-7e20-4ea0-9c7d-cb641e60d122.json
872bb383-bd81-404f-b89f-acd5dcd01ac4,JANUET XR 50/1000 MG TABLETS,prescription,A10BA02,METFORMIN,7567,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T04:16:59.470686,IL,מ.ס.ד. ישראל,,nan,nan,nan,,,JANUET XR 50/1000 MG 60TAB,10059,,53751,BOTTLE HDPE,units,60.0,151 32 33933 02,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/872bb383-bd81-404f-b89f-acd5dcd01ac4.json
872e3758-4b78-4aa3-b4dd-abf7435bbc92,HADLIMA 40MG/0.8 ML 2 PF PEN,prescription,,,8826,,,,,ILS,tablet,HADLIMA 40MG/0. 2 PF PEN,2025-07-31T19:10:50.457819,IL,אורגנון,,2331.675847,1975.996569,1796.360517,,,HADLIMA 40MG/0.8 ML 2 PF PEN,,,71428,,units,2.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/872e3758-4b78-4aa3-b4dd-abf7435bbc92.json
87313266-2d56-4714-a23d-f899b7cd02e5,SIMVACOR 40,prescription,C10AA01,SIMVASTATIN,3864,,,WHO ATC Classification,,ILS,film coated tablets,SIMVASTATIN,2025-07-31T08:14:37.672683,IL,אוניפארם,,29.3534145,24.875775,18.1575,,,SIMVACOR 40 40MG 30TAB,19437,,27410,BLISTER PVC/ALUMINIUM,units,30.0,121 95 30222 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia  Simvacor is indicated to: Reduce the risk of total mortality by reducing coronary death Reduce the risk of non-fatal myocardial infarction Reduce the risk for undergoing myocardial revascularization procedures. Reduce the risk of stroke and transient ischemic attacks (TIA). Hyperlipidemia: Simvacor is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvacor therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios.Homozygous familial hypercholesterolemia: Simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Simvacor is indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).   In patients at a high risk of coronary events because of existing coronary heart disease  diabetes  peripheral vessel disease  history of stroke or other cerebrovascular disease  Simvacor is indicated to:  - Reduce the risk of total mortalily by reducing CHD deaths.   - Reduce the risk of non-fatal myocardial infarction and stroke.   - Reduce the need for coronary and non-coronary revascularization procedures.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87313266-2d56-4714-a23d-f899b7cd02e5.json
87316499-7b00-49ef-9163-9eeb6c297e16,ROGARON LEMON SUGAR FREE,off-the-counter,A01AD02,BENZYDAMINE,5578,,,WHO ATC Classification,,ILS,lozenges,BENZYDAMINE HYDROCHLORIDE,2025-07-31T13:14:17.431723,IL,טבע,,35.5062,30.09,nan,,7290110731380,ROGARON LEMON FLAVOR 20 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,164 22 35301 00,valid,nan,per os,1.4,30,,,,,,,,,,0,,Rogaron is used for symptomatic local treatment of acute sore throat in adults and children over 6 years of age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87316499-7b00-49ef-9163-9eeb6c297e16.json
873cac2f-e7b9-44ae-80b3-d149052ad87f,VALETON DROPS,off-the-counter,N05CM09,VALERIAN,1978,,,WHO ATC Classification,,ILS,drops,VALERIAN DRY EXTRACT/,2025-07-31T13:34:20.871210,IL,רקח,,25.9246,21.97,nan,,7290008089654,VALETON DROPS 25ML,22220,,,BOTTLE GLASS TYPE III,units,25.0,147 47 33169 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Relief of mild symptoms of mental stress and to aid sleep for ages 12 and older,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/873cac2f-e7b9-44ae-80b3-d149052ad87f.json
875ced54-1e94-40f1-b3e5-f8a8ebfa2dcc,SIRAN 200 MG EFFERVESCENT TABLETS,29C,R05CB01,ACETYLCYSTEINE,20268,,,WHO ATC Classification,,ILS,tablets effervescent,ACETYLCYSTEINE,2025-07-31T13:42:05.137404,IL,nan,,nan,nan,nan,,7290004448134,ACETYLCYSTEINE FOR INHALATION 20% 100VIAL/10ML,,,,TUBE POLYPROPYLENE,units,100.0,112 05 27057 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Mucolytic in respiratory tract disorders where reduction of sputum viscosity is required.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/875ced54-1e94-40f1-b3e5-f8a8ebfa2dcc.json
8760d2da-670a-4352-85fe-c33494aedda7,AMIFOSTINE 500MG/10ML 3 VIAL,29C,,,20284,,,,,,injection,AMIFOSTINE 500MG/,2025-07-31T19:52:54.797019,IL,nan,,,,,,,AMIFOSTINE 500MG/10ML 3 VIAL,,,,,units,3.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8760d2da-670a-4352-85fe-c33494aedda7.json
879266c5-2b8f-4d37-9b5d-16640e8f6686,RAZALAX CHILDREN,off-the-counter,A06AG04,GLYCEROL,5549,,,WHO ATC Classification,,ILS,enema,GLYCEROL 2.25 G,2025-07-31T12:53:25.498066,IL,רז פרמהצפטי,,22.184,18.8,nan,,7290015863216,RAZALAX ADULT 6 ENEMA,,,,BOTTLE POLYETHYLENE,units,6.0,158 38 34408 00,valid,nan,rectal,1.4,48,,,,,,,,,,0,,Constipation.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/879266c5-2b8f-4d37-9b5d-16640e8f6686.json
87966d69-1166-42b6-88f2-36ce88422a3f,FLEBOGAMMA 5 % DIF,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7147,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T03:07:38.828250,IL,מדיצ'י,,844.8055668,715.9369529,609.308045,,,FLEBOGAMMA 5% 50ML VIAL,,,,BOTTLE GLASS TYPE II,units,50.0,121 04 29877 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Replacement therapy in:Primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- Wiskott Aldrich syndromeMyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.Children with congenital AIDS and recurrent infections.Immunomodulation :Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.Guillain Barré Syndrome.Kawasaki disease.Allogeneic bone marrow transplantation",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87966d69-1166-42b6-88f2-36ce88422a3f.json
879d0db7-edd6-46fc-a455-66eb3a3ac605,EXTRANEAL,prescription,B05AA05,DEXTRAN,9136,,,WHO ATC Classification,,ILS,solution for peritoneal dialysis,"ICODEXTRIN/L, MAGNESIUM CHLORIDE AS HEXAHYDRATE 0.051 G/L, CALCIUM CHLORIDE AS DIHYDRATE 0.257 G/L, SODIUM - (S) - LACTATE 4.5 G/L, SODIUM CHLORIDE 5.4 G/L",2025-07-31T02:50:27.672273,IL,בקסטר,,162.1229737,137.3923567,109.9138853,,,EXTRANEAL 1 BAG 2 L,,,,BAG PVC,units,1.0,116 27 29763 00,valid,25.0,intra-peritoneal,1.4,24,,,,,,,,,,0,Prescription required,Once daily replacement of a single glucose exchange as part of Continuous Ambulatory Peritoneal Dialysis (CAPD) or Automated Peritoneal Dialysis (APD) in the treatment of chronic renal failure.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/879d0db7-edd6-46fc-a455-66eb3a3ac605.json
87a881a6-1da5-4aab-aee1-ea2ac906e2cd,BIFOVIT,off-the-counter,D01AC10,BIFONAZOLE,3785,,,WHO ATC Classification,,ILS,cream,BIFONAZOLE,2025-07-31T11:18:39.677042,IL,ויטאמד,,27.9896,23.72,nan,,7290008084215,BIFOVIT CREAM 1% 15GR,2228,,,TUBE ALUMINIUM,units,15.0,115 32 29687 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Broad spectrum product for the treatment of fungal infections.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87a881a6-1da5-4aab-aee1-ea2ac906e2cd.json
87b2322d-29a8-421b-8998-3a184ad3ecb2,ZOSTRIX,off-the-counter,N01BX04,CAPSAICIN,3188,,,WHO ATC Classification,,ILS,cream,CAPSAICIN 0.025 %,2025-07-31T13:40:06.011644,IL,רפא,,39.9194,33.83,nan,,7290008014182,ZOSTRIX 30GR,26033,,,TUBE ALUMINIUM,units,30.0,101 20 28410 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,For the symptomatic relief of pain associated with arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87b2322d-29a8-421b-8998-3a184ad3ecb2.json
87b42132-eb89-4996-8f9f-5a8977b4c55f,VENORUTON CAPSULES 300 MG,off-the-counter,C05CA02,MONOXERUTIN,1174,,,WHO ATC Classification,,ILS,capsules,OXERUTINES,2025-07-31T13:34:54.383693,IL,דפריס,,44.9462,38.09,nan,,7298120001103,VENORUTON  300MG 20CAPS,22050,,,BLISTER PVC/ALUMINIUM,units,20.0,115 96 22946 01,valid,nan,per os,1.4,60,,,,,,,,,,0,,For the adjunctive treatment of varicose veins in all stages.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87b42132-eb89-4996-8f9f-5a8977b4c55f.json
87b4c14a-29d2-4742-9b9c-aa793fbbd236,IMATINIB - TRIMA 100 MG,prescription,L01XE01,IMATINIB,8435,,,WHO ATC Classification,,ILS,film coated tablets,IMATINIB AS MESYLATE,2025-07-31T03:59:15.294547,IL,תרימה,,3673.604922,3113.22451,2830.2041,,,IMATINIB - TRIMA 100 MG  60 TAB,10575,,49970,BLISTER PVC/ALUMINIUM,units,60.0,157 59 34527 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Imatinib - Trima is indicated for the• Treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia (Ph+ -CML) in chronic phase, accelerated phase or blast crisis.• Treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST). • Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.• Treatment of adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) integrated with chemotherapy. • Treatment of adult patients with relapsed or refractory Ph+ ALL as monotherapy. • Treatment of adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.• Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangements. • Treatment of adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) who have the FIP1L1-PDGFRα fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1- PDGFRα fusion kinase negative. • Treatment of adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-kit mutation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87b4c14a-29d2-4742-9b9c-aa793fbbd236.json
87ccdaaa-f514-4b9d-9d7f-c655b3ae8ab6,BABYZIM DROPS,off-the-counter,A09AC01,PEPSIN AND ACID PREPARATIONS,3313,,,WHO ATC Classification,,ILS,drops,"PEPSIN 0.6 %W/V, NICOTINIC ACID 0.2 %W/V, SODIUM GLYCEROPHOSPHATE 0.8 %W/V",2025-07-31T11:16:03.625604,IL,סם און,,44.8046,37.97,nan,,7290008080118,BABYZIM DROPS 40ML,2096,,,BOTTLE HDPE,units,40.0,025 17 21245 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of constipation and flatulence.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87ccdaaa-f514-4b9d-9d7f-c655b3ae8ab6.json
87d7bc37-debe-4716-86a9-b205543d38a2,FLUTAROL,prescription,L01BC02,FLUOROURACIL,9407,,,WHO ATC Classification,,ILS,cream,FLUOROURACILW/W,2025-07-31T03:14:32.310915,IL,תרו,,127.1503802,107.7545595,80.11491414,,7290017164762,FLUTAROL 5% TUBE 20GR,,,16019,TUBE ALUMINIUM,units,20.0,172 39 37365 99,valid,34.5,topical,1.4,24,,,,,,,,,,0,Prescription required,Antineoplastic agent to treat actinic keratosis multiple and superficial basal cell carcinoma.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87d7bc37-debe-4716-86a9-b205543d38a2.json
87e46cd7-958a-44be-bb1e-a3de2ff32890,RISPERDAL 1 MG,prescription,N05AX08,RISPERIDONE,4613,,,WHO ATC Classification,,ILS,film coated tablets,RISPERIDONE,2025-07-31T07:38:37.420136,IL,יאנסן סילג,,367.0111764,311.0264345,264.7033485,,7290008124744,RISPERDAL CONSTA/DELTOID 37.5MG VIAL,18426,,11176,BLISTER PVC/PE/PVDC/AL,units,1.0,144 78 28260 01,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87e46cd7-958a-44be-bb1e-a3de2ff32890.json
87e6cd11-dbfb-4b63-830d-7ffbd0a0ba6b,ETOPAN XL 500,prescription,M01AB08,ETODOLAC,4869,,,WHO ATC Classification,,ILS,tablets extended release,ETODOLAC,2025-07-31T02:39:32.669787,IL,תרו,,nan,nan,nan,,,ETOPAN 400MG 20 XL TAB,5414,,65843,BOTTLE HDPE,units,20.0,128 08 30651 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the management of signs and symptoms of osteoarthrities and rheumatoid arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87e6cd11-dbfb-4b63-830d-7ffbd0a0ba6b.json
87f15e79-2a40-44c0-a570-541e675f2c8e,ELLA,off-the-counter,G03AD02,ULIPRISTAL,7813,,,WHO ATC Classification,,ILS,tablets,ULIPRISTAL ACETATE,2025-07-31T11:34:36.017622,IL,כ.צ.ט,,110.1176,93.32,nan,,,ELLA 30MG 1TAB,5535,,,BLISTER PVC/PE/PVDC/AL,units,1.0,146 39 33469 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87f15e79-2a40-44c0-a570-541e675f2c8e.json
87f3a7d2-ae35-442b-8d1e-6c841d77b04f,OZEMPIC,prescription,A10BJ06,SEMAGLUTIDE,8389,,,WHO ATC Classification,,ILS,solution for injection,SEMAGLUTIDE 1.34  MG /,2025-07-31T06:23:00.827506,IL,נובו נורדיסק,,399.3061913,338.3950924,287.9958233,,,OZEMPIC 1 prefilled pen 0.25MG/0.19ML,15497,,35411,PRE-FILLED PEN GLASS TYPE I,units,1.0,162 09 35750 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87f3a7d2-ae35-442b-8d1e-6c841d77b04f.json
87f4c1fb-63de-4cb0-ab08-f7b92cd30ab3,CALCIMORE,off-the-counter,A12AA04,CALCIUM CARBONATE,3353,,,WHO ATC Classification,,ILS,chewable tablets,CALCIUM CARBONATE,2025-07-31T11:21:29.524959,IL,תרו,,28.0722,23.79,nan,,,CALCIMORE 60TAB,3158,,,BLISTER PVC/ALUMINIUM,units,60.0,015 95 24731 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,"Antacid, calcium deficiency.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/87f4c1fb-63de-4cb0-ab08-f7b92cd30ab3.json
88128549-0503-4a98-a171-2fbb054a71b1,FOSRENOL ® 750 MG CHEWABLE TABLETS,prescription,V03AE03,LANTHANUM CARBONATE,7954,,,WHO ATC Classification,,ILS,chewable tablets,LANTHANUM AS CARBONATE HYDRATE,2025-07-31T03:18:13.913217,IL,טקדה,,1173.475555,994.4708533,846.358173,,7290008128674,FOSRENOL 1000 MG ORAL POWDER 90 SACHETS,6560,,24742,BOTTLE HDPE,units,90.0,140 51 31998 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in CRF patients on haemodyalisis or continuous ambulatory peritoneal dialysis (CAPD).Fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/L in whom a low phosphate diet alone is insufficient to control serum phosphate levels.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88128549-0503-4a98-a171-2fbb054a71b1.json
881b5344-4dc6-4298-9a9a-87f7ece1a841,ZOELY,prescription,G03CA03,ESTRADIOL,7319,,,WHO ATC Classification,,ILS,film coated tablets,"NOMEGESTROL ACETATE 2.5  MG, ESTRADIOL AS HEMIHYDRATE 1.5  MG",2025-07-31T10:51:05.439476,IL,תרומד,,60.87743154,51.59104598,38.357655,,7290008121897,ZOELY 28TAB,26194,,53749,BLISTER PVC/ALUMINIUM,units,28.0,150 67 33784 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraception,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/881b5344-4dc6-4298-9a9a-87f7ece1a841.json
8825c90f-8a6f-4e1d-8064-3fac40ee2cf4,REPHENIDATE LA 40 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,9145,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:26:24.085042,IL,דקסל פארמה,,159.9873946,135.5825378,108.4660303,,,REPHENIDATE LA 40 MG CAPS,18683,,41268,BLISTER ACLAR/ALUMINIUM,units,30.0,170 58 37010 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention deficit hyperactivity disorder (ADHD),תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8825c90f-8a6f-4e1d-8064-3fac40ee2cf4.json
88266a9e-3802-4515-b905-53f50b8d0ba6,STEROCORT 4 MG,prescription,H02AB08,TRIAMCINOLONE,2103,,,WHO ATC Classification,,ILS,tablets,TRIAMCINOLONE,2025-07-31T08:43:00.263600,IL,תרו,,32.31396887,27.3847206,19.98884715,,7-290000-810379,STEROCORT 4MG 30TAB,19146,,7180,BLISTER PVC/ALUMINIUM,units,30.0,024 58 21653 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Rheumatology: - Active phases of systemic vasculitis: Panarteritis nodosa (in patients with concomitant positive hepatitis B serology, the duration of treatment should be restricted to two weeks), polymyalgia rheumatica (PMR), PMR with giant cell arteritis, arteritis temporalis with acute visual loss;- Active phases of systemic rheumatic disease: systemic lupus erythematosus, mixed connective tissue disease;- Severe progressive forms of active rheumatoid arthritis, e.g. rapidly destructive forms and/or with extra-articular manifestations;- Other forms of inflammatory rheumatic arthritis, provided that the severity of symptoms requires it and non-steroidal anti-inflammatory drugs (NSAIDs) cannot be used:Spondylarthritis (ankylosing spondylitis with involvement of peripheral joints, psoriatic arthritis, enteropathic arthropathy with high inflammatory activity);- Reactive forms of arthritis;- Arthritis in sarcoidosis;- Severe systemic form of juvenile idiopathic arthritis (Still’s disease) or with iridocyclitis refractory to topical treatment.Pulmonary and respiratory tract disorders: - Bronchial asthma:For the long-term treatment of severe chronic asthma (category 4) and for treatment of exacerbations in adults and children.- Chronic obstructive pulmonary disease (COPD):For short-term treatment (max. 14 days) of exacerbations;- Upper respiratory tract disorders:For short-term treatment of severe forms of allergic rhinitis in adults after failure of all other treatment alternatives, including topical glucocorticoids.Dermatology: - Oral initial treatment of extensive, severe, acute skin conditions responsive to glucocorticoids, such as: Allergic skin disease (e.g. acute urticaria, contact dermatitis, drug eruption), atopic eczema (acute exacerbations or extensive weeping eczema), pemphigus vulgaris.Nephrology: - Minimal change glomerulonephritis;- Extracapillary proliferative glomerulonephritis (rapidly progressive glomerulonephritis), generally in combination with cytostatics, tapering and ending treatment in Goodpasture’s syndrome; for all other forms, long-term continuation of treatment;- Idiopathic retroperitoneal fibrosis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88266a9e-3802-4515-b905-53f50b8d0ba6.json
882a6b25-874e-4df6-b6e2-38e3951a9d02,ZOLGENSMA,prescription,M09AX09,ONASEMNOGENE ABEPARVOVEC,8558,,,WHO ATC Classification,,ILS,suspension,ONASEMNOGENE ABEPARVOVEC 2 x 10^13 VG /,2025-07-31T10:53:58.611617,IL,נוברטיס פארמה,,9356370.133,7929127.584,7208297.803,,,ZOLGENSMA 2*10^13VG / 1ML   VIAL,26225,,60707,VIAL GLASS TYPE I,units,1.0,165 75 36125 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Zolgensma is indicated for the treatment of:-	patients with 5q spinal muscular atrophy (SMA) with a bi-allelic mutation in the SMN1 gene and a clinical diagnosis of SMA Type 1, or-	patients with 5q SMA with a bi-allelic mutation in the SMN1 gene and up to 3 copies of the SMN2 gene.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/882a6b25-874e-4df6-b6e2-38e3951a9d02.json
8838a6ec-7036-4258-a519-6e93b8521a26,UROMITEXAN 400 MG,prescription,V03AF01,MESNA,7737,,,WHO ATC Classification,,ILS,solution for injection,MESNA/VIAL,2025-07-31T09:54:45.836890,IL,מגאפארם,,187.29019,158.7205,126.9764,,5413760229225,UROMITEXAN 400MG/VIAL 15X4ML,21123,,35271,AMPOULES GLASS TYPE I,units,15.0,153 48 34007 00,valid,25.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Prevention of urinary passage toxicity of  oxazaphosphorines (Ifosfamide ,Cyclophosphamide, Trofosamide), in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous Ifosfamide, Cyclophosphamide or Trofosamide , urinary passage diseases in anamnesis.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8838a6ec-7036-4258-a519-6e93b8521a26.json
883c2513-931d-458d-b2a9-3b6de4b460bd,ULTOMIRIS 10 MG/ML,prescription,L04AA43,RAVULIZUMAB,8548,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RAVULIZUMAB/ML,2025-07-31T09:51:12.795933,IL,ניאופרם,,22369.44362,18957.15645,17233.77859,,7290111092374,ULTOMIRIS 10MG/1 ML 30 ML VIAL,21147,,3543,VIAL GLASS TYPE I,units,1.0,163 14 36063 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,•	Ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with paroxysmal nocturnal haemoglobinuria (PNH): * In patients with haemolysis with clinical symptom(s) indicative of high disease activity. * In patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. •	Ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with atypical haemolytic uremic syndrome aHUS who are complement inhibitor treatment naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab. •	Ultomiris is indicated in the treatment of adult patients with generalized myasthenia gravis (gMG) who are antiacetylcholine receptor (AChR) antibody-positive.•	Ultomiris is indicated in the treatment of adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin 4 (AQP4) antibody-positive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/883c2513-931d-458d-b2a9-3b6de4b460bd.json
885d05ce-79ae-4bb1-8c03-048d3832a4cb,SAPHNELO,prescription,L04AA51,ANIFROLUMAB,9034,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ANIFROLUMAB/ML,2025-07-31T08:00:29.478267,IL,אסטראזנקה,,4488.190594,3803.55152,3457.774109,,,SAPHNELO 300MG/VIAL,17615,,76805,VIAL GLASS TYPE I,units,1.0,169 50 37020 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Saphnelo is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy.Limitations of UseThe efficacy of SAPHNELO has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. Use of SAPHNELO is not recommended in these situations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/885d05ce-79ae-4bb1-8c03-048d3832a4cb.json
886d923e-f041-4b7f-898f-94b53bc42095,STERONASE AQ NASAL SPRAY,off-the-counter,R01AD11,TRIAMCINOLONE,3728,,,WHO ATC Classification,,ILS,suspension,TRIAMCINOLONE ACETONIDE 0.055 %W/W,2025-07-31T13:20:37.615983,IL,פרמה שלום,,58.4218,49.51,nan,,,STERONASE AQ NASAL SPRAY 16.5 gr120DX55MCG,19256,,,SPRAY METERED DOSE HDPE,units,120.0,069 12 28059 00,valid,nan,nasal,1.4,24,,,,,,,,,,0,,For the treatment of nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 2 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/886d923e-f041-4b7f-898f-94b53bc42095.json
8884c166-7a47-4045-a537-2fa535537951,KETOCONAZOLE HRA 200 MG,prescription,H02CA03,KETOCONAZOLE,8120,,,WHO ATC Classification,,ILS,tablets,KETOCONAZOLE,2025-07-31T04:25:23.095622,IL,כ.צ.ט,,3215.591787,2725.077907,2477.343551,,,KETOCONAZOLE HRA 200 MG 60 TABLETS,11282,,25962,BLISTER PVC/ALUMINIUM,units,60.0,160 67 35337 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of endogenous Cushing's syndrome in adults and adolescents above the age of 12 years.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8884c166-7a47-4045-a537-2fa535537951.json
888da729-7e13-4786-9468-54f7e97cac95,OLUMIANT 2 MG,prescription,L04AA37,BARICITINIB,8308,,,WHO ATC Classification,,ILS,film coated tablets,BARICITINIB,2025-07-31T06:06:31.579314,IL,אלי לילי,,3443.229664,2917.991371,2652.719428,,,OLUMIANT 4 MG 28 TAB,15494,,26043,BLISTER PVC/PE/PCTFE/AL,units,28.0,161 15 35738 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid Arthritis Olumiant is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs. Olumiant may be used as monotherapy or in combination with methotrexate. Atopic Dermatitis Olumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and pediatric patients 2 years of age and older who are candidates for systemic therapy.Alopecia areata Olumiant is indicated for the treatment of severe alopecia areata in adult patients.Juvenile idiopathic arthritis Baricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic disease-modifying antirheumatic drugs (DMARDs): - Polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [RF+] or negative [RF-], extended oligoarticular), - Enthesitis-related arthritis, and - Juvenile psoriatic arthritis. Baricitinib may be used as monotherapy or in combination with Methotrexate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/888da729-7e13-4786-9468-54f7e97cac95.json
88b4f1bd-4956-49fa-b2dc-d21ccbe0ebb9,ZYLET,prescription,S01AA12,TOBRAMYCIN,6495,,,WHO ATC Classification,,ILS,"eye drops, suspension","TOBRAMYCIN/ML, LOTEPREDNOL ETABONATE/ML",2025-07-31T10:56:21.938798,IL,טבע,,nan,nan,nan,,,ZYLET OPHT SUSP 5 ML,26157,,32335,BOTTLE LDPE,units,5.0,142 61 31618 00,valid,nan,ocular,1.4,24,,,,,,,,,,0,Prescription required,"Zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.The use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.The particular anti-infective drug in this product (tobramycin) is active against the following common bacterial eye pathogens:Staphylococci, including S. aureus and S. epidermidis (coagulase-positive and coagulase-negative), including penicillin-resistant strains. Streptococci, including some of the Group A-beta-hemolytic species, some nonhemolytic species, and some Streptococcus pneumoniae. Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, and H. aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus and some Neisseria species.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88b4f1bd-4956-49fa-b2dc-d21ccbe0ebb9.json
88b7c99b-d053-43b6-a3af-3ab89e8da652,BRINAVESS 20 MG/ML,prescription,C01BG11,VERNAKALANT,8360,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,VERNAKALANT HYDROCHLORIDE/ML,2025-07-30T23:43:15.008666,IL,צמל,,824.3063993,698.5647763,594.5232138,,7290013280619,BRINAVESS 20 MG/ML 1 VIAL 10ML,,,,VIAL GLASS TYPE I,units,10.0,148 28 33391 00,valid,17.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults who are hemodynamically stable.- For non-surgery patients: atrial fibrillation ≤ 7 days duration- For post-cardiac surgery patients: atrial fibrillation ≤ 3 days duration,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88b7c99b-d053-43b6-a3af-3ab89e8da652.json
88bf2e6f-ae29-4682-8e28-1f527786d771,FULVESTRANT SANDOZ,prescription,L02BA03,FULVESTRANT,9300,,,WHO ATC Classification,,ILS,solution for injection,FULVESTRANT/ML,2025-07-31T03:22:12.760880,IL,סנדוז,,973.4604421,824.9664764,702.0991288,,,FULVESTRANT SANDOZ 50MG/ML 5ML 2SYR,,,37780,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,167 58 36012 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"MonotherapyFulvestrant Sandoz® is indicated for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women: - Not previously treated with endocrine therapy,or - With disease relapse on or after adjuvant endocrine therapy;or - disease progression on endocrine therapyCombination Therapy Fulvestrant Sandoz® is indicated for the treatment of:- HR-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in men and postmenopausal women in combination with ribociclib as initial endocrine based therapy or following disease progression on endocrine therapy.- HR-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with palbociclib or abemaciclib in women with disease progression after endocrine therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88bf2e6f-ae29-4682-8e28-1f527786d771.json
88c60935-735e-4cc3-8cc3-fa7d1310636f,AMMONAPS 940MG/G FLACON 266G GRANULES,29C,,,20021,,,,,,tablet,AMMONAPS 940MG/G FLACON 266G GRANULES,2025-07-31T19:53:35.192238,IL,nan,,,,,,,AMMONAPS 940MG/G FLACON 266G GRANULES,,,,,units,266.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88c60935-735e-4cc3-8cc3-fa7d1310636f.json
88d5c3c0-3874-4803-b88d-21d4259b522a,TARGIN 10,prescription,V03AB15,NALOXONE,8694,,,WHO ATC Classification,,ILS,tablets prolonged release,"OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (AS DIHYDRATE)",2025-07-31T09:05:40.395552,IL,רפא,,127.5368094,108.0820467,80.358399,,7290008012973,TARGIN 30/15MG 20 SR TAB,20888,,38275,BLISTER PVC/ALUMINIUM,units,20.0,139 95 31636 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Targin is indicated for the relief of moderate to severe pain.The oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. The opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88d5c3c0-3874-4803-b88d-21d4259b522a.json
88d73572-233c-4d89-88bc-cd59969d21f9,SPIRIT WHITFIELD FLORIS,off-the-counter,D01AE12,SALICYLIC ACID,2971,,,WHO ATC Classification,,ILS,spirit,"BENZOIC ACIDW/V, SALICYLIC ACIDW/V",2025-07-31T13:20:07.003287,IL,פלוריש,,13.3458,11.31,nan,,7290008103343,SPIRIT SALICYL 2% 1OOML,19050,,,BOTTLE POLYETHYLENE,units,100.0,060 91 27485 00,valid,nan,topical,1.4,48,,,,,,,,,,0,,"Antifungal, antiseptic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88d73572-233c-4d89-88bc-cd59969d21f9.json
88db6be7-5cb7-4d62-a7c9-079a60110ace,AUGMENTIN ES 600 MG/5 ML,prescription,J01CR02,AMOXICILLIN AND ENZYME INHIBITOR,6799,,,WHO ATC Classification,,ILS,powder for oral suspension,"AMOXICILLIN AS TRIHYDRATE/, CLAVULANIC ACID AS POTASSIUM SALT 42.9  MG /",2025-07-30T23:31:41.741217,IL,ג.ס.ק,,nan,nan,nan,,7290010140855,AUGMENTIN ES 600MG-42.9MG/5ML 100ML,9458,,102,BOTTLE GLASS TYPE III,units,100.0,145 87 33332 01,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,"Augmentin ES is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant Streptococcus pneumoniae:Consideration should be given to official guidance on the appropriate use of antibacterial agents.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/88db6be7-5cb7-4d62-a7c9-079a60110ace.json
890b3bbe-b7c8-47e2-bf87-be72727fe5e8,INCRUSE ELLIPTA 55 MCG,prescription,R03BB07,UMECLIDINIUM BROMIDE,7556,,,WHO ATC Classification,,ILS,powder for inhalation,UMECLIDINIUM AS BROMIDE,2025-07-31T04:04:55.369492,IL,ג.ס.ק,,141.4174476,119.8452999,95.8762399,,,INCRUSE ELLIPTA 55MCG 30 DOSES,9824,,74199,STRIPS ALUMINIUM,units,30.0,153 40 34134 00,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,INCRUSE is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/890b3bbe-b7c8-47e2-bf87-be72727fe5e8.json
890b4217-5d3e-4427-89aa-234cb57b0233,XELJANZ 1 MG/ML,prescription,L04AA29,TOFACITINIB,9288,,,WHO ATC Classification,,ILS,oral solution,TOFACITINIB AS CITRATE/,2025-07-31T10:32:21.127620,IL,פיזר,,6667.666098,5650.564741,5136.877038,,,XELJANZ 10 MG 60 TABS,,,46906,BOTTLE HDPE,units,60.0,176 47 37836 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"XELJANZ 1 MG/ML is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [RF+] or negative [RF-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (PsA) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (DMARDs). XELJANZ 1 MG/ML can be given in combination with methotrexate (MTX) or as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/890b4217-5d3e-4427-89aa-234cb57b0233.json
89346b72-ff5d-4150-bdfe-0780c8618840,LANTUS 100 UNITS/ML,prescription,N/A,,4643,,,WHO ATC Classification,,ILS,solution for injection,INSULIN GLARGINE 100 U/ML,2025-07-31T04:36:14.879145,IL,סאנופי אוונטיס,,161.634258,136.9781908,109.5825527,,7290008880756,LANTUS 100IU/ML VIAL 10ML,12223,,57228,PRE-FILLED PEN GLASS TYPE I,units,10.0,124 36 30365 00,valid,25.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult and pediatric patients, 6 years and over, with type 1 diabetes mellitus or adults patients with type 2 diabetes mellitus who require basal (long acting) insulin for the control of hyperglycemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89346b72-ff5d-4150-bdfe-0780c8618840.json
894053c0-f44b-4c43-a27b-3825e82eab2f,KALOBA ® SYRUP,off-the-counter,R05FB01,COUGH SUPPRESSANTS AND MUCOLYTICS,5532,,,WHO ATC Classification,,ILS,syrup,PELARGONIUM SIDOIDES ROOT DRIED LIQUID EXTRACT (DER 1: 8- 10); EXTRACTING AGENT: ETHANOL(W/W) 2.667 MG/ML,2025-07-31T12:15:39.670860,IL,דר סמואלוב,,50.9288,43.16,nan,,7290014626997,KALOBA ® SYRUP 100ML,,,,BOTTLE GLASS TYPE III,units,100.0,162 31 35357 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Symptomatic treatment of acute bronchitis for adults and children form age of 1 years.  Traditional herbal medicinal product for use in the common cold for adults and children form age of 1 years.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/894053c0-f44b-4c43-a27b-3825e82eab2f.json
8944cc83-f61e-4c47-ac17-9ad07e64bb55,SERDOLECT 16 MG,prescription,N05AE03,SERTINDOLE,6089,,,WHO ATC Classification,,ILS,film coated tablets,SERTINDOLE,2025-07-31T08:04:30.113303,IL,לנדבק,,425.3016308,360.4251269,306.7447888,,,SERDOLECT 16MG 28TAB,19843,,86168,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,137 36 31472 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of schizophrenia.   Due to cardiovascular safety concerns  serntidole should only be used for patients intolerant to at least one other anti-psychotic agent.   Sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8944cc83-f61e-4c47-ac17-9ad07e64bb55.json
89535c6e-9ff0-4d67-bd99-4cf4685ff282,CARBAGLU,prescription,A16AA05,CARGLUMIC ACID,6935,,,WHO ATC Classification,,ILS,tablets dispersible,CARGLUMIC ACID,2025-07-31T00:53:39.395238,IL,מדיסון,,1213.612814,1028.485481,875.3067923,,7290008128599,CARBAGLU 200MG 5 DISP.TAB,9534,,20526,CONTAINER POLYETHYLENE,units,5.0,147 76 33555 05,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Carbaglu is indicated in treatment of :- hyperammonaemia due to N - acetylglutamate synthase primary deficiency.- hyperammonaemia due to isovaleric acidaemia.- hyperammonaemia due to methymalonic acidaemia.- hyperammonaemia due to propionic acidaemia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89535c6e-9ff0-4d67-bd99-4cf4685ff282.json
897744fa-9316-49a2-b3ef-77f53237876e,TIPTIPOT MUCOLIT,off-the-counter,R05CB03,CARBOCISTEINE,3781,,,WHO ATC Classification,,ILS,drops,CARBOCISTEINE/ML,2025-07-31T12:27:42.637560,IL,כ.צ.ט,,41.3708,35.06,nan,,7290008104586,MUCOLIT 375MG 18LOZ LEMON/HONEY,13368,,,BOTTLE GLASS,units,18.0,122 54 30239 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Treatment of disorders of the respiratory tract characterized by excessive or viscous mucus.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/897744fa-9316-49a2-b3ef-77f53237876e.json
897dac52-fa04-4140-9b93-537cabe083f4,RIPALID 0.5 MG,prescription,A10BX02,REPAGLINIDE,8075,,,WHO ATC Classification,,ILS,tablets,REPAGLINIDE 0.5  MG,2025-07-31T07:36:27.743265,IL,פאדאגיס,,58.10739372,49.243554,35.9442,,,RIPALID 2 MG 90 TABLETS,18573,,63288,BLISTER ALUMINIUM /ALUMINIUM,units,90.0,159 05 34990 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Ripalid is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Ripalid is also indicated in combination with metformin in adults with type 2 diabetes mellitus who are not satisfactorily controlled on metformin alone.Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/897dac52-fa04-4140-9b93-537cabe083f4.json
89a0ef83-0600-4c68-8e0a-39a3d6a21a0c,NORMALAX,off-the-counter,,,5290,,,,,ILS,powder for solution,POLYETHYLENE GLYCOL 3350W/W,2025-07-31T12:34:30.666746,IL,תרו,,21.3344,18.08,nan,,7290012066207,NORMALAX 70 GR,,,,BOTTLE HDPE,units,70.0,142 15 32012 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the treatment of constipation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89a0ef83-0600-4c68-8e0a-39a3d6a21a0c.json
89a6b7ec-dd1a-4df4-a618-ed7fc7179982,CINQAIR ®,prescription,R03DX08,RESLIZUMAB,7978,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RESLIZUMAB/,2025-07-31T01:15:17.446220,IL,טבע,,2426.865425,2056.665706,1869.696096,,7290110732714,CINQAIR 10MG/MLVIAL 10ML,,,89850,VIAL GLASS TYPE I,units,1.0,159 19 34975 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,CINQAIR is indicated for the add-on maintenance treatment of patients with severe asthma aged 18 years and older with an eosinophilic phenotype [see Clinical Studies (14)].Limitation of Use:•         CINQAIR is not indicated for treatment of other eosinophilic conditions.•         CINQAIR is not indicated for the relief of acute bronchospasm or status asthmaticus,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89a6b7ec-dd1a-4df4-a618-ed7fc7179982.json
89aa3e57-f7fd-4e8f-9187-ef769b669cfb,ENHERTU,prescription,L01FD01,TRASTUZUMAB,8765,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,TRASTUZUMAB DERUXTECAN,2025-07-31T02:22:17.343658,IL,אסטראזנקה,,7997.21566,6777.301708,6161.183371,,,ENHERTU 100 MG 1 VIAL,5711,,76828,VIAL GLASS TYPE I,units,1.0,167 74 36545 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"HER2-Positive Metastatic Breast CancerENHERTU is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH positive) breast cancer who have received a prior anti-HER2-based regimen either:• in the metastatic setting, or• in the neoadjuvant or adjuvant setting and have developed disease recurrence during or within six months of completing therapy. HER2-Low and HER2-Ultralow Metastatic Breast CancerENHERTU is indicated for the treatment of adult patients with unresectable or metastatic:•Hormone receptor (HR)-positive HER2-low (IHC 1+ or IHC 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining) breast cancer, that has progressed on one or more endocrine therapies in the metastatic setting.•HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy.HER2-Mutant Unresectable or Metastatic Non-Small Cell Lung Cancer ENHERTU is indicated for the treatment of adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC) whose tumors have activating HER2 (ERBB2) mutations, as detected by an approved test, and who have received a prior systemic therapy.HER2-Positive Locally Advanced or Metastatic Gastric CancerENHERTU is indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive (IHC 3+ or IHC 2+/ISH positive) gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen.HER2-Positive (IHC 3+) Unresectable or Metastatic Solid TumorENHERTU is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89aa3e57-f7fd-4e8f-9187-ef769b669cfb.json
89b778fe-2212-4e65-9fb9-4f32bb4a0a40,ETUMIN 40MG/4ML 10AMP,29C,,,20390,,,,,,injection,ETUMIN 40MG/,2025-07-31T20:24:30.904497,IL,nan,,,,,,,ETUMIN 40MG/4ML 10AMP,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89b778fe-2212-4e65-9fb9-4f32bb4a0a40.json
89c0107d-bbf8-4863-92b4-552c1ef32b8d,ETORICOXIB TARO 120 MG,prescription,M01AH05,ETORICOXIB,8212,,,WHO ATC Classification,,ILS,film coated tablets,ETORICOXIB,2025-07-31T02:41:39.139064,IL,תרו יבוא,,36.34265527,30.7988604,22.48092,,,ETORICOXIB TARO 120MG 7TABS,,,74265,BLISTER OPA/ALU/PVC/ALU,units,7.0,160 52 34825 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89c0107d-bbf8-4863-92b4-552c1ef32b8d.json
89c349c5-6e07-425d-b0a1-ff74d757773f,PREGABALIN DEXCEL 100 MG,prescription,N03AX16,PREGABALIN,8081,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:52:03.654444,IL,דקסל פארמה,,168.9678875,143.193125,114.5545,,,PREGABALIN DEXCEL 150 MG 56 CAPSULES,16993,,58334,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,158 75 34730 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of peripheral and central neuropathic pain in adults.Management of FibromyalgiaTreatment of Generalised Anxiety Disorder (GAD) in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89c349c5-6e07-425d-b0a1-ff74d757773f.json
89dd7236-7c94-406a-b1b2-a8e63ad08d11,SPINRAZA,prescription,,,8467,,,,,ILS,solution for injection,NUSINERSEN 2.4  MG /,2025-07-31T08:34:01.841719,IL,מדיסון,,371481.1349,314814.5351,286195.0319,,,SPINRAZA 12MG/5ML (2.4MG/ML) 1X5ML VIAL,10142,,64847,VIAL GLASS TYPE I,units,1.0,162 58 35278 03,valid,10.0,intrathecal,1.4,48,,,,,,,,,,0,Prescription required,Spinraza is indicated for the treatment of 5q Spinal Muscular Atrophy except type 0 and type IV.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89dd7236-7c94-406a-b1b2-a8e63ad08d11.json
89e0db06-d0a7-4f25-866d-ca2bbc52626e,ETORICOXIB TARO 120 MG,prescription,M01AH05,ETORICOXIB,8209,,,WHO ATC Classification,,ILS,film coated tablets,ETORICOXIB,2025-07-31T02:41:49.637332,IL,תרו יבוא,,50.63365793,42.9098796,31.32108,,,ETORICOXIB TARO 30MG  28TABS,,,74261,BLISTER OPA/ALU/PVC/ALU,units,28.0,160 52 34825 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89e0db06-d0a7-4f25-866d-ca2bbc52626e.json
89e79596-edc4-47cc-86d3-31ba22d234dc,FENISTIL DROPS,prescription,R06AB03,DIMETINDENE,2469,,,WHO ATC Classification,,ILS,drops,DIMETINDENE MALEATE/ML,2025-07-31T02:57:22.458868,IL,ג.ס.ק קונסיומר,,19.6983029,16.69347703,12.18501973,,7298120000274,FENISTIL DROPS 20ML,6322,,8387,BOTTLE GLASS TYPE III,units,20.0,034 23 22255 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Antipruritic, antihistaminic and antiallergic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89e79596-edc4-47cc-86d3-31ba22d234dc.json
89f3a19f-8393-4883-a6db-694b6aa133fe,RIVASTIGMINE PATCH DEXCEL 9.5 MG/24 H,prescription,N06DA03,RIVASTIGMINE,8184,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 13.8  MG,2025-07-31T07:45:30.649750,IL,דקסל פארמה,,244.294515,207.02925,165.6234,,,RIVASTIGMINE PATCH DEXCEL 9.5 MG/24 H 30PATCHES,18579,,66787,SACHET PAPER /POLYETHYLENE TEREPHTHALATE/ALUMINUM/POLYACRYLNITRILE,units,30.0,158 88 34452 00,valid,25.0,transdermal,1.4,36,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89f3a19f-8393-4883-a6db-694b6aa133fe.json
89f934f2-3b34-4625-b93a-d8570501a01f,ASSIVAL 5 MG,prescription,N05BA01,DIAZEPAM,1468,,,WHO ATC Classification,,ILS,tablets,DIAZEPAM,2025-07-30T23:28:31.792884,IL,טבע,,11.23537,9.5215,6.95,,,ASSIVAL 2MG 30TAB,1832,,20760,BLISTER PVC/ALUMINIUM,units,30.0,014 61 24381 03,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tension, anxiety, agitation due to acute alcohol withdrawal, adjunct for the relief of skeletal muscle spasm, convulsive disorders.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89f934f2-3b34-4625-b93a-d8570501a01f.json
89fd7014-a7af-4cf1-bcfc-046777b1b63e,PROFEX 150 MG,prescription,C01BC03,PROPAFENONE,4148,,,WHO ATC Classification,,ILS,tablets,PROPAFENONE HYDROCHLORIDE,2025-07-31T06:59:05.695141,IL,תרו,,18.96611286,16.072977,11.7321,,7290000810485,PROFEX 150MG 30TAB,16380,,66471,BLISTER PVC,units,30.0,133 93 29804 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis and treatment of ventricular arrhythmias. Prophylaxis and treatment of atrial fibrillation and flutter. Prophylaxis and treatment of Paroxysmal supraventricular tachycardia (PSVT) associated with disabling symptoms.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/89fd7014-a7af-4cf1-bcfc-046777b1b63e.json
8a0c7f0c-5ce1-4de2-8103-672da05a6d78,PROGRAF 0.5 MG,prescription,L04AA05,TACROLIMUS,8689,,,WHO ATC Classification,,ILS,capsules,TACROLIMUS 0.5   MG,2025-07-31T07:00:00.143537,IL,אסטלס,,2637.900221,2235.508761,2032.280692,,8718692511460,PROGRAF 5 MG/ML 10 AMP,17167,,61808,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,122 07 30215 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in liver  kidney or heart allograft recipients.   Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a0c7f0c-5ce1-4de2-8103-672da05a6d78.json
8a211efa-e507-465e-bfce-94755b0fe912,AUSTEDO 12 MG,prescription,,,8760,,,,,ILS,tablets extended release,DEUTETRABENAZINE,2025-07-31T00:26:28.921319,IL,טבע,,nan,nan,nan,,,AUSTEDO 12 MG 60 SR TAB,,,72483,BOTTLE HDPE,units,60.0,166 59 36156 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,AUSTEDO is indicated in adults for the treatment of: • Chorea associated with Huntington’s disease  • Tardive dyskinesia,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a211efa-e507-465e-bfce-94755b0fe912.json
8a295b22-3411-45f1-985f-fde2764e2d2c,V-MANTINE 10 MG,prescription,N06DX01,MEMANTINE,9150,,,WHO ATC Classification,,ILS,tablets orodispersible,MEMANTINE HYDROCHLORIDE,2025-07-31T10:19:03.333352,IL,ויטאמד,,136.4228171,115.612562,85.9572952,,,V-MANTINE 10 MG 28 TAB,,,42530,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,162 05 34810 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with moderate to severe Alzheimer's disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a295b22-3411-45f1-985f-fde2764e2d2c.json
8a2e309f-5e2b-4bb9-b2ae-62c0ee4364e5,ROPIVACAINE B.BRAUN 10 MG/ML,prescription,N01BB09,ROPIVACAINE,9106,,,WHO ATC Classification,,ILS,solution for injection,ROPIVACAINE HYDROCHLORIDE/ML,2025-07-31T07:48:58.212516,IL,לפידות,,284.0337173,240.7065508,204.856639,,,ROPIVACAINE B.BRAUN 2 MG/ML 20 AMP 10ml,,,45663,AMPOULES LDPE,units,20.0,156 93 34315 00,valid,17.5,"perineural, epidural",1.4,30,,,,,,,,,,0,Prescription required,Ropivacaine B. Braun 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:Surgical anaesthesiaLumbar epidural administration for surgery,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a2e309f-5e2b-4bb9-b2ae-62c0ee4364e5.json
8a3e3a62-5c2b-4bef-8dca-d33be2589451,ESTELLE-35,prescription,N/A,,4808,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.035  MG, CYPROTERONE ACETATE",2025-07-31T02:37:59.178993,IL,תרו יבוא,,65.2012422,55.25529,41.082,,7290000808987,ESTELLE 35 21X3TAB,5408,,11997,BLISTER PVC/PVDC,units,63.0,131 46 30957 11,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of signs of androgenization in women such as pronounced forms of acne, androgenic alopecia and mild forms of hirsutism.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a3e3a62-5c2b-4bef-8dca-d33be2589451.json
8a3e9a97-1982-4eeb-a2b1-d806b9fe760a,ABROLET SUPPOSITORIES,off-the-counter,N02BE05,PROPACETAMOL,3845,,,WHO ATC Classification,,ILS,suppositories,PARACETAMOL,2025-07-31T10:59:18.819101,IL,רקח,,17.7826,15.07,nan,,7290008089500,ABROLET SYRUP SF 115ML,1637,,,FOIL PVC/ALUMINIUM,units,115.0,027 21 24032 00,valid,nan,rectal,1.4,24,,,,,,,,,,0,,"Analgesic, antipyretic pediatric suppositories.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a3e9a97-1982-4eeb-a2b1-d806b9fe760a.json
8a42801e-e729-46c7-ac74-c6582d7a06b2,BACLOFENE BIOINDUSTRIA L.I.M 10 MG/5 ML,prescription,M03BX01,BACLOFEN,8619,,,WHO ATC Classification,,ILS,solution for injection,BACLOFEN/,2025-07-30T23:33:36.963554,IL,פרופארם,,1573.029963,1333.07624,1134.53297,,8059617890117,BACLOFENE BIOINDUSTRIA L.I.M 10 MG/5 ML 5 AMP,,,55689,AMPOULES GLASS TYPE I,units,5.0,160 02 35025 00,valid,17.5,intrathecal,1.4,36,,,,,,,,,,0,Prescription required,"Baclofene Bioindustria L.I.M. 10mg/5ml is indicated in patients with severe chronic spasticity resulting from trauma, multiple sclerosis or other spinal cord disorders, who are unresponsive to oral baclofen or other orally administered antispastic agents and/or those patients who experience unacceptable side effects at effective oral doses.Baclofene Bioindustria L.I.M. 10mg/5ml is effective in adult patients with severe chronic spasticity of cerebral origin, resulting e.g. from cerebral palsy, brain trauma or cerebrovascular accident; however, clinical experience is limited.Pediatric population:Baclofene Bioindustria L.I.M. 10mg/5ml is indicated in patients aged 4 to <18 years with severe chronic spasticity of cerebral origin or of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a42801e-e729-46c7-ac74-c6582d7a06b2.json
8a5e2766-d270-4d31-8b81-fe1190fdadc2,HERCEPTIN  440 MG I.V,prescription,L01FD01,TRASTUZUMAB,7771,,,WHO ATC Classification,,ILS, powder for concentrate for solution for infusion ,TRASTUZUMAB/VIAL,2025-07-31T03:45:58.214440,IL,רוש,,5644.756397,4783.692075,4348.810977,,7290008140478,HERCEPTIN 600 MG / 5 ML S.C. VIAL,,,77302,VIAL GLASS TYPE I,units,1.0,113 91 29676 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress HER2:   1. As a single agent  for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease.    2. In combination with Paclitaxel or Docetaxel  for the treatment of those patients who have not received chemotherapy for their metastatic disease.   3. Herceptin in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer.   Early breast cancer (EBC) :Herceptin is indicated to treat patients with HER2-positive early breast cancer following surgery and  chemotherapy (neoadjuvant or adjuvant)  either alone or in combination with chemotherapy excluding Anthracyclines.  Herceptin should only be used in patients whose tumors have either HER2 overexpression or HER2  gene amplification as determined by an accurate and validated assay.HER2 metastatic gastric cancer (mGC)Herceptin in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.Herceptin should only be used in patients with metastatic gastric cancer whose tumours have HER2 overexpression as defined by IHC2+ and a confirmatory FISH+ result, or IHC 3+, as determined by an accurate and validated assay",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a5e2766-d270-4d31-8b81-fe1190fdadc2.json
8a780af5-2499-4bab-a60b-8f35b4ac4169,ELTROXIN TABLETS 50 MCG,prescription,H03AA01,LEVOTHYROXINE SODIUM,263,,,WHO ATC Classification,,ILS,tablets,LEVOTHYROXINE SODIUM 0.05   MG,2025-07-31T02:17:06.774829,IL,פאדאגיס,,31.78655916,26.937762,19.6626,,7298074011104,ELTROXIN 100MCG 100T,5665,,14586,BOTTLE POLYPROPYLENE,units,100.0,055 82 20571 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of hypothyroidism. Cretinism and juvenile myxoedema.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a780af5-2499-4bab-a60b-8f35b4ac4169.json
8a8c58da-7fdb-4ea5-92c2-7861f5bae4be,RELAXINE,off-the-counter,,,5602,,,,,ILS,film coated tablets,VALERIAN DRY EXTRACT,2025-07-31T12:55:03.451528,IL,ליף- תרימה,,59.5074,50.43,nan,,,RELAXIN LIFE 30 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,115 58 29788 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of mild symptoms of mental stress and to aid sleep.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8a8c58da-7fdb-4ea5-92c2-7861f5bae4be.json
8ad26623-b367-49e7-87de-f349e622b796,NIPRUSS ®,prescription,C02DD01,NITROPRUSSIDE,8817,,,WHO ATC Classification,,ILS,powder for solution for infusion,NITROPRUSSIDE SODIUM ANHYDROUS 52.75  MG,2025-07-31T05:47:24.456243,IL,מדי מרקט,,nan,nan,nan,,7290015841283,NIPRUSS  60 MG 5 AMP,,,67230,AMPOULES GLASS TYPE I,units,5.0,164 33 35970 00,valid,nan,i.v,1.4,60,,,,,,,,,,0,Prescription required,Nipruss is indicated in:• Hypertensive crisis• Controlled intraoperative hypotension Nipruss is not suitable for permanent therapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ad26623-b367-49e7-87de-f349e622b796.json
8adc526d-bafc-4262-a039-4b7267b71c16,ONCOTICE,prescription,L03AX03,BCG VACCINE,8564,,,WHO ATC Classification,,ILS,powder for solution for instillation,BCG STRAIN 200 - 800 MIU,2025-07-31T06:11:45.895604,IL,מ.ס.ד. ישראל,,531.9154194,450.7757992,383.638978,,7290006537195,ONCOTICE  500 MU 1 VIAL,,,10567,VIAL GLASS TYPE I,units,1.0,103 18 28561 00,valid,17.5,intra-vesically,1.4,12,,,,,,,,,,0,Prescription required,OncoTICE is used as a treatment of flat  urothelial cell carcinoma in situ (CIS) of the bladder and as an adjuvant therapy after transurethral resection (TUR) of a primary or relapsing superficial papillary urothelial cell carcinoma of the bladder stage Ta (grade 2 or 3) or T1 (grade 1 2 or 3).   OncoTICE is only recommended for stage Ta grade 1 papillary tumors  when there is judged to be a high risk of tumor recurrence.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8adc526d-bafc-4262-a039-4b7267b71c16.json
8b033c62-7cdf-4f3e-b19a-b4c61d3f2725,PROMEZOLE 2 MG/ML,prescription,A02BC01,OMEPRAZOLE,9540,,,WHO ATC Classification,,ILS,powder for oral suspension,OMEPRAZOLE/BOTTLE,2025-07-31T07:01:44.397179,IL,סופר-פארם,,839.4114651,711.36568,605.4176,,,PROMEZOLE 2 MG/ML 1 BOTTLE,,,,BOTTLE HDPE,units,1.0,177 08 37642 99,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"For Adults : • Treatment of duodenal ulcers • Prevention of relapse of duodenal ulcers • Treatment of gastric ulcers • Prevention of relapse of gastric ulcers • In combination with appropriate antibiotics, Helicobacter pylori (H.pylori) eradication in peptic ulcer disease • Treatment of NSAID-associated gastric and duodenal ulcers • Prevention of NSAID-associated gastric and duodenal ulcers in patients at risk • Treatment of reflux esophagitis • Long-term management of patients with healed reflux esophagitis • Treatment of symptomatic gastro-esophageal reflux diseasePaediatric use (children over 1 month of age) : • Treatment of reflux esophagitis • Symptomatic treatment of heartburn and acid regurgitation in gastroesophagealreflux diseasePaediatric use (children over 4 years of age and adolescents) :• In combination with antibiotics in treatment of duodenal ulcer caused by H. pylori",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b033c62-7cdf-4f3e-b19a-b4c61d3f2725.json
8b14836f-d0bf-4be2-97fb-998ba498f765,PEMETREXED SANDOZ ® 25 MG/ML,prescription,L01BA04,PEMETREXED,8234,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PEMETREXED AS DISODIUM HEMIPENTAHYDRATE/ML,2025-07-31T06:32:27.119617,IL,סנדוז,,1074.694452,910.75801,775.1132,,,PEMETREXED SANDOZ 100	mg VIAL,10381,,25960,VIAL GLASS TYPE I,units,1.0,179 06 37262 99,valid,17.5,i.v,1.4,18,,,,,,,,,,0,Prescription required,Pemetrexed Sandoz in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Pemetrexed Sandoz in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Sandoz is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Sandoz is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b14836f-d0bf-4be2-97fb-998ba498f765.json
8b1c7105-e527-4523-bc50-9d3bf333bbbf,CASPOVIDAE 50 MG,prescription,J02AX04,CASPOFUNGIN,8596,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,CASPOFUNGIN AS ACETATE/VIAL,2025-07-31T00:57:09.895635,IL,SK PHARM(KS KIM),,1274.3241,1079.935726,919.094235,,,CASPOVIDAE 70 MG 1 VIAL,10702,,3782,VIAL GLASS TYPE I,units,1.0,163 22 35317 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Indicated in adults and pediatric patients (3 months and older) for: - Empirical therapy for presumed fungal infections in febrile, neutropenic patients.- Treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. Has not been studied in endocarditis, ostemyelitis, and meningitis due to Candida.- Treatment of esophageal candidiasis.- Treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin B, lipid formulations of amphotericin B, and/or itraconazole). Has not been studied as initial therapy for invasive aspergillosis.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b1c7105-e527-4523-bc50-9d3bf333bbbf.json
8b373c3e-0c0e-4b55-aceb-9a3be989496d,ROSETEMIB S.K. 5/10 MG,prescription,C10BA06,ROSUVASTATIN AND EZETIMIBE,9539,,,WHO ATC Classification,,ILS,film coated tablets,"EZETIMIBE, ROSUVASTATIN AS CALCIUM",2025-07-31T07:50:00.102975,IL,SK PHARM(KS KIM),,110.1714516,93.36564106,69.4168335,,,ROSETEMIB S.K. 5/10 MG 30 TAB,,,58760,BLISTER AL/OPA/AL/PVC,units,30.0,175 16 36802 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary Hypercholesterolaemia/Homozygous Familial Hypercholesterolaemia (HoFH):ROSETEMIB S.K is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b373c3e-0c0e-4b55-aceb-9a3be989496d.json
8b3f108d-a883-4fe3-aa39-be72b7a23bb9,HULIO,prescription,L04AB04,ADALIMUMAB,9096,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/ML,2025-07-31T03:47:28.016510,IL,דקסל פארמה,,2331.675847,1975.996569,1796.360517,,,HULIO 40MG/0.8ML 2 PEN,8489,,72623,PRE-FILLED PEN GLASS TYPE I,units,2.0,167 87 36610 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis: Hulio in combination with methotrexate is indicated for:-The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.-The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.Hulio can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.Axial spondyloarthritis: Ankylosing spondylitis (AS): Hulio is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.Axial spondyloarthritis without radiographic evidence of AS: Hulio is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels , who have had an inadequate response to, or are intolerant to, non-steroidal anti-inflammatory drugs.  Psoriatic arthritis: Hulio is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti rheumatic drug therapy has been inadequate. Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.Psoriasis: Hulio is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.Hidradenitis suppurativa (HS): Hulio is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult patients with an inadequate response to conventional systemic HS therapy.Crohn’s disease:Hulio is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. Hulio is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab. Ulcerative colitis: Hulio is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies. Uveitis: Hulio is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.Intestinal Behcet's disease: Hulio is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b3f108d-a883-4fe3-aa39-be72b7a23bb9.json
8b454e9f-ffd8-4d3b-99d6-0d9242fe4a03,REQUIP MODUTAB 2 MG,prescription,N04BC04,ROPINIROLE,6354,,,WHO ATC Classification,,ILS,film coated tablets - prolonged release,ROPINIROLE AS HYDROCHLORIDE,2025-07-31T07:27:13.658006,IL,ג.ס.ק,,69.38670961,58.80229889,43.71918133,,7290010140510,REQUIP MODUTAB 4MG 28 FILM COATED TABLETS,18408,,81952,BLISTER PVC/PE/PVDC,units,28.0,141 62 31838 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of Parkinson’s disease under the following conditions:•         Initial treatment as monotherapy, in order to delay the introduction of levodopa•         In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).""",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b454e9f-ffd8-4d3b-99d6-0d9242fe4a03.json
8b458d72-c051-4084-8161-34d44d10c784,NUROFEN QUICK 256 MG,off-the-counter,M02AA13,IBUPROFEN,5569,,,WHO ATC Classification,,ILS,tablets,IBUPROFEN SODIUM,2025-07-31T12:39:28.626478,IL,רקיט בנקיזר,,65.3366,55.37,nan,,7290101866961,NUROFEN QUICK 512 MG 24 TAB,14660,,,BLISTER PVC/PVDC,units,24.0,142 71 31929 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"For the symptomatic relief of mild to moderate pain, such as hedache, backache, period pain, dental pain, neuralgia, rheumatic and muscular pain, the pain of non-serious arthritis, migraine, cold and flu symptoms, sore throat and fever.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b458d72-c051-4084-8161-34d44d10c784.json
8b4ebb4e-ff2b-4cae-84d4-92ea77c77593,BUPIVACAINE BAXTER 5 MG/ML,prescription,N01BB01,BUPIVACAINE,8993,,,WHO ATC Classification,,ILS,solution for injection,BUPIVACAINE AS HYDROCHLORIDE ANHYDROUS/,2025-07-30T23:45:52.407927,IL,מרגלית,,102.0441816,86.47812,64.296,,,BUPIVACAINE BAXTER 5 MG/ML 20ML 5 VIAL,,,59061,VIAL GLASS TYPE I,units,5.0,163 50 35009 00,valid,34.5,"caudal, epidural, intercostal, pudental, sacral, paracervical",1.4,36,,,,,,,,,,0,Prescription required,Long acting local anaesthetic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b4ebb4e-ff2b-4cae-84d4-92ea77c77593.json
8b6076b1-e379-4b20-8dd0-b738fa12d834,TADALAMED 10 MG,prescription,G04BE08,TADALAFIL,9320,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T08:59:38.386689,IL,אינובמד,,237.1314725,200.958875,160.7671,,,TADALAMED 20 MG 4 tabs,23572,,2926,BLISTER PVDC/PVC/PE // PAPER/PET/ALU,units,4.0,169 52 37026 99,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of Erectile dysfunction in adult men.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b6076b1-e379-4b20-8dd0-b738fa12d834.json
8b673fd5-b966-4e20-a638-de32f01fc35f,MIOZAC,prescription,C01CA07,DOBUTAMINE,9500,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOBUTAMINE AS HYDROCHLORIDE 12.5 MG/ML,2025-07-31T05:27:18.998344,IL,רז פרמהצפטי,,29.84948888,25.29617814,18.46436361,,7290018490310,MIOZAC 12.5 MG/ML 20ML 1 VIAL,24776,,30489,VIAL GLASS TYPE I,units,1.0,174 22 36662 99,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Dobutamine is indicated for patients who require a positive inotropic support in the short term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures, especially when a low cardiac output is associated with raised pulmonary pressure.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b673fd5-b966-4e20-a638-de32f01fc35f.json
8b8ff1f9-9f18-4ce2-a870-fab3b302daf8,VERMOX SUSPENSION,prescription,P02CA01,MEBENDAZOLE,1432,,,WHO ATC Classification,,ILS,suspension,MEBENDAZOLE/ML,2025-07-31T10:07:07.230560,IL,יאנסן סילג,,30.68330298,26.00280029,18.9801462,,7290008124430,VERMOX SUSP 30ML,1432,,2373,BOTTLE GLASS TYPE III,units,30.0,106 69 21882 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of single or mixed infections of Trichuris trichura (whipworm), Ascaris lumbricoides (large roundworm), Ancylostoma duodenale, Necator americanus (hookworm), Strongyloides stercoralis, Enterobius vermicularis (threadworm/pinworm) and Taenia spp.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b8ff1f9-9f18-4ce2-a870-fab3b302daf8.json
8b9db444-e9eb-449a-8bd4-b192796d059d,SPIRIVA ®,prescription,R03BB04,TIOTROPIUM BROMIDE,7759,,,WHO ATC Classification,,ILS,inhalation powder hard capsules,TIOTROPIUM BROMIDE,2025-07-31T08:34:46.454780,IL,בורינגר אינגלהיים,,149.1034777,126.358885,93.9471264,,9006968012605,SPIRIVA RESPIMAT 2.5MCG 60 ACTUATIONS (30 DOSES),9847,,11472,BLISTER PVC/ALUMINIUM,units,60.0,133 47 31120 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Tiotropium is a bronchodilator for the maintenance treatment of chronic obstructive pulmonary disease (COPD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8b9db444-e9eb-449a-8bd4-b192796d059d.json
8ba39137-89e1-4b40-9119-af6ff65462c8,LACOSAMIDE TEVA ® 100 MG,prescription,N03AX18,LACOSAMIDE,8678,,,WHO ATC Classification,,ILS,film coated tablets,LACOSAMIDE,2025-07-31T04:32:10.629078,IL,טבע,,595.2727296,504.4684149,429.3348212,,,LACOSAMIDE TEVA 200 MG 56 TAB,,,56607,BLISTER OPA/ALU/PVC/ALU,units,56.0,163 97 35488 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Lacosamide Teva is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ba39137-89e1-4b40-9119-af6ff65462c8.json
8ba8e443-8307-4e02-82d8-7d87853e033e,CLOPIXOL ACUPHASE 50,prescription,N05AF05,ZUCLOPENTHIXOL,623,,,WHO ATC Classification,,ILS,solution for injection,ZUCLOPENTHIXOL ACETATE/ML,2025-07-31T01:23:15.042612,IL,לנדבק,,33.90834011,28.73588273,20.97509688,,5702157108244,CLOPIXOL ACUPHASE 50MG 1ML 1AMP,3632,,8221,AMPOULES GLASS TYPE I,units,1.0,047 80 25490 00,valid,37.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Acute psychoses.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ba8e443-8307-4e02-82d8-7d87853e033e.json
8bb09f88-8f03-45c1-95a0-fd951b6e8cc0,TRAMAL INJECTION 100,prescription,N02AX02,TRAMADOL,6960,,,WHO ATC Classification,,ILS,solution for injection,TRAMADOL HYDROCHLORIDE/,2025-07-31T09:33:11.353693,IL,ליברה,,13.054045,11.06275,8.075,,7290008872140,TRAMAL INJECTION 100MG/2ML 5AMP(2ML),20566,,57215,AMPOULES GLASS TYPE I,units,5.0,125 54 30477 00,valid,37.0,"i.v, s.c, i.m",1.4,60,,,,,,,,,,0,Prescription required,Moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8bb09f88-8f03-45c1-95a0-fd951b6e8cc0.json
8bb8c41d-75d4-4eb4-b2e8-465a0938bbca,SMOFKABIVEN PERIPHERAL,prescription,,,7110,,,,,ILS,emulsion for infusion,"GLUCOSE MONOHYDRATE/, SOYA OIL/, TRIGLYCERIDES, MEDIUM-CHAIN/, OLIVE OIL/, FISH OIL/, L- ALANINE 14.0 G /, L-ARGININE 12.0 G /, L-HISTIDINE 3.0 G /, L- ISOLEUCINE 5.0 G /, L- LEUCINE 7.4 G /, L- METHIONINE 4.3 G /, L- PHENYLALANINE 5.1 G /, L- PROLINE 11.2 G /, L- SERINE 6.5 G /, TAURINE 1.0 G /, L- THREONINE 4.4 G /, L- TRYPTOPHAN 2.0 G /, L- TYROSINE 0.4 G /, L- VALINE 6.2 G /, CALCIUM CHLORIDE DIHYDRATE 0.74 G /, SODIUM GLYCEROPHOSPHATE HYDRATE 4.18 G /, MAGNESIUM SULFATE HEPTAHYDRATE 2.47 G /, POTASSIUM CHLORIDE 4.48 G /, SODIUM ACETATE TRIHYDRATE 5.62 G /, ZINC SULFATE HEPTAHYDRATE 0.023 G /, L- LYSINE ACETATE 9.3 G /, AMINOACETIC ACID 11.0 G /, L- LYSINE ACETATE 9.3 G /, AMINOACETIC ACID 11.0 G /",2025-07-31T08:23:33.407846,IL,ניאופרם,,nan,nan,nan,,7290012848247,SMOFKABIVEN PERIPHERAL 1206ML/BAG,,,,BAG PROPYLENE ,units,1206.0,147 83 33337 00,valid,nan,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8bb8c41d-75d4-4eb4-b2e8-465a0938bbca.json
8bc3c185-dcc7-48cb-b050-70c2aef36e26,AMMONAPS 500MG 250TABS,29C,,,20020,,,,,,tablet,AMMONAPS 500MG S,2025-07-31T19:53:13.023512,IL,nan,,,,,,,AMMONAPS 500MG 250TABS,,,,,units,250.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8bc3c185-dcc7-48cb-b050-70c2aef36e26.json
8bd16de5-640a-481d-a55b-d8e6a67e7ab5,HALDOL 2 MG/ML DROPS,prescription,N05AD01,HALOPERIDOL,7313,,,WHO ATC Classification,,ILS,solution  (oral),HALOPERIDOL/ML,2025-07-31T03:42:46.867542,IL,כ.צ.ט,,52.7625908,44.71406,32.638,,7290014577305,HALOPER 5MG 60TAB,8299,,53284,BOTTLE LDPE,units,60.0,029 70 25163 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"HALDOL is indicatedin adult patients aged 18 years and above for:•	Treatment of schizophrenia and schizoaffective disorder.•	Acute treatment of delirium when non-pharmacological treatments have failed.•	Treatment of moderate to severe manic episodes associated with bipolar I disorder when other treatments cannot be used.•	Treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar I disorder.•	Treatment of persistent aggression and psychotic symptoms in patients with moderate to severe Alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.•	Treatment of tic disorders, including Tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.•	Treatment of mild to moderate chorea in Huntington’s disease, when other medicinal products are ineffective or not tolerated.In paediatric patients for:•	Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.•	Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated.  •	Tic disorders, including Tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8bd16de5-640a-481d-a55b-d8e6a67e7ab5.json
8be07b45-71d3-4c92-b16c-84447d4301b9,PEMAZYRE 4.5 MG,prescription,L01EX20,PEMIGATINIB,9027,,,WHO ATC Classification,,ILS,tablets,PEMIGATINIB 4.5  MG,2025-07-31T06:31:48.349710,IL,מדיסון,,34163.00999,28951.70467,26319.73152,,,PEMAZYRE 4.5 MG 14 TABS,,,3034,BLISTER PVC/ALUMINIUM,units,14.0,169 74 36995 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"PEMAZYRE is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as determined by a validated test.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8be07b45-71d3-4c92-b16c-84447d4301b9.json
8be49c97-4173-42eb-9130-eaaf89305b77,KAYEXALATE,prescription,V03AE01,POLYSTYRENE SULFONATE,6263,,,WHO ATC Classification,,ILS,powder for oral suspension,POLYSTYRENE SULPHONATE SODIUM 99.934 %W/W,2025-07-31T04:23:48.874750,IL,סאנופי אוונטיס,,279.3619115,236.7473932,189.3979145,,300241075011,KAYEXALATE 450GR POWDER FOR SUSP.,11165,,28989,BOTTLE HDPE,units,1.0,141 59 21158 01,valid,25.0,"per os, rectal",1.4,48,,,,,,,,,,0,Prescription required,Treatment of hyperkalemia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8be49c97-4173-42eb-9130-eaaf89305b77.json
8bf946a5-4130-4aed-a644-377d3ef41def,REGULAX,off-the-counter,A06AD15,MACROGOL,5477,,,WHO ATC Classification,,ILS,powder for oral solution,POLYETHYLENE GLYCOL 3350 99.973 %W/W,2025-07-31T12:54:35.737685,IL,ליף-ניאופרם,,53.2534,45.13,nan,,7290106953864,REGULAX 250gr,,,,BOTTLE POLYPROPYLENE,units,250.0,150 25 33953 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of constipation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8bf946a5-4130-4aed-a644-377d3ef41def.json
8c1c4975-2f40-4f4b-b650-4df47aa918bc,ORENCIA 125 MG SC,prescription,L04AA24,ABATACEPT,7117,,,WHO ATC Classification,,ILS,solution for injection,ABATACEPT/ML,2025-07-31T06:15:15.851159,IL,ב.מ.ס,,3812.242656,3230.714259,2937.012962,,7290014396074,ORENCIA 125MG SC 125MG/ML 4 SYR PREFILLED (1ML),15427,,47584,SYRINGE PREFILLED  GLASS,units,4.0,149 54 33788 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"ORENCIA is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. ORENCIA may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (DMARDs) other than tumor necrosis factor (TNF) antagonists.ORENCIA is indicated for the treatment of adult patients with active psoriatic arthritis (PsA).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c1c4975-2f40-4f4b-b650-4df47aa918bc.json
8c38089c-02dd-42e6-9cd9-8b9e96467f79,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1822,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:50:08.840113,IL,פישר,,10.8914,9.23,nan,,7290000849188,POLYDINE OINT 15GR,16179,,,BOTTLE HDPE,units,15.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c38089c-02dd-42e6-9cd9-8b9e96467f79.json
8c4874f7-7b6f-475f-85f5-438c8da54a40,CICLODERM,prescription,D01AE14,CICLOPIROX,2726,,,WHO ATC Classification,,ILS,cream,CICLOPIROX OLAMINEW/W,2025-07-31T01:11:27.467547,IL,תרימה,,12.544816,10.6312,7.76,,7290008075114,CICLODERM  CREAM 15GR,3024,,8819,TUBE ALUMINIUM,units,15.0,062 23 26751 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of localized fungal infections of the body and fungal infections of the feet.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c4874f7-7b6f-475f-85f5-438c8da54a40.json
8c48cb7b-8b50-4396-9769-fe880d240066,NICOTINELL LOZENGES 1 MG,off-the-counter,,,5412,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:32:50.360947,IL,ג.ס.ק,,272.4148,230.86,nan,,,NICOTINELL TTS 10 28 PATCHES,,,,BLISTER PVC/PE/PVDC/AL,units,28.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c48cb7b-8b50-4396-9769-fe880d240066.json
8c5b6c28-5f7e-449a-b0e1-e18cce91ae6e,HERZUMA 150 MG,prescription,L01FD01,TRASTUZUMAB,9337,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,TRASTUZUMAB/ 1 VIAL,2025-07-31T03:46:18.785615,IL,פאדאגיס,,4395.045268,3724.614799,3386.013454,,,HERZUMA 420 MG 1 VIAL,,,18497,VIAL GLASS TYPE I,units,1.0,168 26 36465 00,valid,10.0,i.v,1.4,72,,,,,,,,,,0,Prescription required,"Herzuma is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress HER2; 1. As a single agent, for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease.2. In combination with Paclitaxel or Docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease.3. In combination with an aromatase inhibitor for the treatment of postmenopausal patient with hormone-receptor positive metastatic breast cancer.Early Breast Cancer (EBC); Herzuma is indicated to treat patients with HER2-positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding Anthracyclines. Herzuma should only be used in patients whose tumours have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay.HER2 Metastatic Gastric Cancer (mGC);Herzuma in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease. Herzuma should only be used in patients with metastatic gastric cancer whose tumours have HER2 overexpression as defined by IHC2+ and a confirmatory FISH+ result, or IHC 3+, as determined by an accurate and validated assay",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c5b6c28-5f7e-449a-b0e1-e18cce91ae6e.json
8c823fd1-a06f-45a4-8e49-f5a8bdccbd94,PROSULF,prescription,V03AB14,PROTAMINE,6958,,,WHO ATC Classification,,ILS,solution for injection,PROTAMINE SULFATE/,2025-07-31T07:04:27.792490,IL,פרופארם,,509.5387274,431.8125,367.5,,5012727743103,PROSULF 50MG/5ML 10AMP (5ML),,,55443,AMPOULES GLASS TYPE I,units,10.0,126 80 29096 00,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,"To counteract the anticoagulant effect of Heparin, before surgery, after renal dialysis, after open heart surgery, if excessive bleeding occurs and when an overdose has inadvertently been given.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c823fd1-a06f-45a4-8e49-f5a8bdccbd94.json
8c8ec876-e212-4404-8bd3-162cec718494,DOSTINEX,prescription,N04BC06,CABERGOLINE,4363,,,WHO ATC Classification,,ILS,tablets,CABERGOLINE 0.5   MG,2025-07-31T02:03:29.552312,IL,פיזר,,53.20586252,45.089714,32.9122,,7298074000832,DOSTINEX 0.5MG 2TAB,4300,,19418,BOTTLE GLASS TYPE I,units,2.0,112 13 29448 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of hyperprolactinemic disorders.Dostinex is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. Dostinex is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. Inhibition and supression of lactation .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c8ec876-e212-4404-8bd3-162cec718494.json
8c94df16-0f2a-4090-8941-4f37e9f6a50c,CRESTOR ® 5 MG,29C,C10AA07,ROSUVASTATIN,20320,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T14:02:59.499159,IL,nan,,nan,nan,nan,,,CALCIUM ACETAT NEFRO 700MG 200TAB,,,,BLISTER ALUMINIUM /ALUMINIUM,units,200.0,139 22 31615 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c94df16-0f2a-4090-8941-4f37e9f6a50c.json
8c97690f-4ef4-4eba-a3c5-e8959c91cc82,LAMICTAL DISPERSIBLE/CHEWABLE TABLETS 5 MG,prescription,N03AX09,LAMOTRIGINE,8812,,,WHO ATC Classification,,ILS,dispersible chewable tablets,LAMOTRIGINE,2025-07-31T04:33:14.148860,IL,ג.ס.ק,,13.6424874,11.56143,8.439,,7290008105200,LAMICTAL 5MG 30 DISP/CHEWTAB BOTTLE,12599,,67412,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,068 90 28230 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy• Adults and adolescents aged 13 years and above- Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- Seizures associated with Lennox-Gastaut syndrome. Lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome.• Children and adolescents aged 2 to 12 years- Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.- Monotherapy of typical absence seizures.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c97690f-4ef4-4eba-a3c5-e8959c91cc82.json
8c9a5072-de56-48d5-84e4-48f33ae2d58c,TYVASO,prescription,B01AC21,TREPROSTINIL,8925,,,WHO ATC Classification,,ILS,solution for inhalation,TREPROSTINIL AS SODIUM SALT 1.74  MG / 2.9  ML,2025-07-31T07:04:16.961976,IL,פיזר,,307.2281811,260.3628769,221.5854271,,7290008016179,PROSTIN VR 0.5MG/ML 1AMP,,,35608,AMPOULES LDPE,units,1.0,144 71 33077 01,valid,17.5,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of pulmonary arterial hypertension in patients with NYHA class III symptoms, to increase walk distance.Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8c9a5072-de56-48d5-84e4-48f33ae2d58c.json
8cb4f17f-8ead-4ed4-8ae3-05d30cb8adf3,DIFLUCAN 50 MG/5 ML,prescription,J02AC01,FLUCONAZOLE,7101,,,WHO ATC Classification,,ILS,powder for oral suspension,FLUCONAZOLE/,2025-07-31T03:11:11.345612,IL,ביואבניר,,35.2119729,29.840655,21.7815,,7290008094153,FLUCONAZOL 2MG/ML 1VIAL/50ML,6493,,36412,BOTTLE HDPE,units,50.0,106 79 29073 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:•	Cryptococcal meningitis.•	Coccidioidomycosis.•	Invasive candidiasis.•	Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.•	Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.•	Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.•	Candidal balanitis when local therapy is not appropriate.•	Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.•	Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:•	Relapse of cryptococcal meningitis in patients with high risk of recurrence.•	Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•	To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).•	Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.  Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8cb4f17f-8ead-4ed4-8ae3-05d30cb8adf3.json
8cbb51e8-7ba4-47c1-bc17-c62ab5cfa97f,ALCOSEPT,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5206,,,WHO ATC Classification,,ILS,solution,"CHLORHEXIDINE GLUCONATE 0.5 %W/V, ALCOHOLW/V",2025-07-31T11:10:06.858729,IL,פלוריש,,14.9978,12.71,nan,,7290008110181,ALCOSEPT 100ML,9287,,,BOTTLE HDPE,units,100.0,129 67 30806 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Skin antiseptic.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8cbb51e8-7ba4-47c1-bc17-c62ab5cfa97f.json
8cbb9e4f-36de-4383-aa63-10b20faefd45,SALVAKAL,prescription,N07AX01,PILOCARPINE,3230,,,WHO ATC Classification,,ILS,tablets,PILOCARPINE HYDROCHLORIDE,2025-07-31T06:43:09.526023,IL,ויטאמד,,15.66469234,13.275163,9.6899,,7290013834126,PILOCARPINE 2% 10ML,16174,,9378,BOTTLE HDPE,units,10.0,151 93 33938 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of symptoms of xerostomia and salivary gland hypofunction caused by radiotherapy for cancer of the head and neck. Sjogren detected by biopsy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8cbb9e4f-36de-4383-aa63-10b20faefd45.json
8cc10801-cb31-447b-b17d-7f714c197f50,MICROPIRIN 100,off-the-counter,B01AC06,ACETYLSALICYLIC ACID,5466,,,WHO ATC Classification,,ILS,tablets enteric coated,ACETYLSALICYLIC ACID,2025-07-31T12:25:48.189800,IL,דקסל פארמה,,16.6498,14.11,nan,,,MICROPIRIN 75MG 30CAP,,,,BLISTER OPAQUE PVC/PVDC/ALUMINIUM,units,30.0,103 93 28861 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8cc10801-cb31-447b-b17d-7f714c197f50.json
8cc45d60-2bf7-4c81-92f8-444664044d10,PULMOZYME,prescription,R05CB13,DORNASE ALFA (DESOXYRIBONUCLEASE),6554,,,WHO ATC Classification,,ILS,solution for inhalation,RECOMBINANT HUMAN DEOXYRIBONUCLEASE/ML,2025-07-31T07:06:52.740916,IL,רוש,,2626.773808,2226.079598,2023.708725,,7290008140263,PULMOZYME INHALATION SOLUTION 2.5MG/2.5ML 30AMP,16882,,9540,AMPOULES LDPE,units,30.0,101 96 28175 00,valid,10.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,Management of cystic fibrosis not for patients under 5 years of age or with FVC<40% .,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8cc45d60-2bf7-4c81-92f8-444664044d10.json
8ce2f626-227d-4251-a7c8-63f3ca4ec02c,YERVOY 5 MG/ML,prescription,L01XC11,IPILIMUMAB,6932,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,IPILIMUMAB/ML,2025-07-31T10:41:26.884480,IL,ב.מ.ס,,69575.65546,58962.4225,53602.20227,,7290014396005,YERVOY 5MG/ML VIAL40ML,25016,,19808,VIAL GLASS TYPE I,units,40.0,147 62 33522 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Unresectable or Metastatic MelanomaYervoy (ipilimumab) is indicated for the treatment of adult patients with advanced (unresectable or metastatic) melanoma. Yervoy in combination with nivolumab is indicated for the treatment of adult and pediatric patients 12 years and older with advanced (unresectable or metastatic) melanoma . Advanced Renal Cell CarcinomaYERVOY, in combination with nivolumab, is indicated for the first-line treatment of adult patients with intermediate or poor risk, advanced renal cell carcinoma (RCC). Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Metastatic Colorectal Cancer•	YERVOY, in combination with nivolumab, is indicated for the first-line treatment of adult and pediatric patients 12 years and older with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer (CRC).•	YERVOY, in combination with nivolumab, is indicated for the treatment of adult and pediatric patients 12 years of age and older with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.Metastatic Non-Small Cell Lung CancerYERVOY, in combination with nivolumab and 2 cycles of platinum-doublet chemotherapy, is indicated for the first-line treatment of adult patients with metastatic or recurrent non-small cell lung cancer (NSCLC) with no EGFR or ALK genomic tumor aberrations.Hepatocellular CarcinomaYervoy, in combination with nivolumab, is indicated for the treatment of adult patients with hepatocellular carcinoma (HCC) Child-Pugh A who have been previously treated with sorafenib.Malignant Pleural MesotheliomaYERVOY, in combination with nivolumab, is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesotheliomaEsophageal cancerYervoy in combination with nivolumab is indicated for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma with tumour cell PD-L1 expression &#8805; 1%.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ce2f626-227d-4251-a7c8-63f3ca4ec02c.json
8cf4d9e2-3dd9-40eb-a842-b8c01c14486a,VINORELBINE S.K. 20 MG,prescription,L01CA04,VINORELBINE,9185,,,WHO ATC Classification,,ILS,"capsule, soft",VINORELBINE AS TARTRATE,2025-07-31T10:17:35.644590,IL,SK PHARM(KS KIM),,322.3508109,273.1786654,232.4924812,,,VINORELBINE S.K. 30 MG 1CAPSULES,22503,,22222,BLISTER PVC/PVDC/ALUMINIUM,units,1.0,168 46 36145 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Vinorelbine S.K. is indicated :- For the treatment of non small cell lung cancer. - For the treatment of advanced breast cancer,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8cf4d9e2-3dd9-40eb-a842-b8c01c14486a.json
8d05469b-893e-4e5c-a07b-0b182be42acc,PHEBURANE,prescription,A16AX03,SODIUM PHENYLBUTYRATE,7627,,,WHO ATC Classification,,ILS,granules,SODIUM PHENYLBUTYRATE/G,2025-07-31T06:39:08.602274,IL,תרומד,,2391.452322,2026.6546,1724.812426,,7290103847050,PHEBURANE BOTTLE 483MG/G BOTTLE 174G,16945,,77515,BOTTLE HDPE,units,174.0,153 57 34275 00,valid,17.5,oral,1.4,36,,,,,,,,,,0,Prescription required,"PHEBURANE is indicated as adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase.  It is indicated in all patients with neonatal-onset presentation (complete enzyme deficiencies, presenting within the first 28 days of life). It is also indicated in patients with late-onset disease (partial enzyme deficiencies, presenting after the first month of life) who have a history of hyperammonaemic encephalopathy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d05469b-893e-4e5c-a07b-0b182be42acc.json
8d211ee9-e867-45ca-b630-aabf3c0df85a,ATOMIC 100,prescription,N06BA09,ATOMOXETINE,8894,,,WHO ATC Classification,,ILS,coated tablets,ATOMOXETINE AS HYDROCHLORIDE,2025-07-30T23:29:31.806091,IL,אוניפארם,,nan,nan,nan,,,ATOMIC 80 MG 28 TAB,,,66454,BLISTER PVC/ALUMINIUM,units,28.0,167 84 36235 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Atomic is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD. In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Atomic should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD.Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d211ee9-e867-45ca-b630-aabf3c0df85a.json
8d232a66-b0b5-4813-82a6-41b7b1727797,RAZBETEN 21 TAB,off-the-counter,,,5628,,,,,ILS,tablet,RAZBETEN,2025-07-31T19:46:41.207040,IL,רז פרמהצפטי,,38.8338,32.91,,,,RAZBETEN 21 TAB,,,,,units,21.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d232a66-b0b5-4813-82a6-41b7b1727797.json
8d37e876-b325-42ea-8adf-fefb69262354,FLIXOTIDE INHALER CFC FREE 125 MCG,prescription,R03BA05,FLUTICASONE,4031,,,WHO ATC Classification,,ILS,suspension for inhalation,FLUTICASONE PROPIONATE/DOSE,2025-07-31T03:08:54.185276,IL,ג.ס.ק,,139.6515701,118.3487935,87.991668,,,FLIXOTIDE INH CFC FREE 250MCG 120DOSES,6170,,2762,CAN ALUMINIUM,units,120.0,129 81 30973 11,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Prophylactic management of all grades of asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d37e876-b325-42ea-8adf-fefb69262354.json
8d398ac1-d3ed-4608-ad78-fc54a139d2dd,REAGILA 1.5,prescription,N05AX15,CARIPRAZINE,8591,,,WHO ATC Classification,,ILS,"capsule, hard",CARIPRAZINE AS HYDROCHLORIDE 1.5  MG,2025-07-31T07:18:25.784186,IL,דקסל פארמה,,319.1221479,270.4425102,230.1638385,,,REAGILA 6MG 30 CAPS,17047,,3620,BLISTER PVC/PE/PVDC/AL,units,30.0,163 54 35920 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,-Reagila is indicated for the:•	Treatment of schizophrenia in adult patients.•	Acute treatment of manic or mixed episodes associated with bipolar I disorder in adult.•	Treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults.•	Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d398ac1-d3ed-4608-ad78-fc54a139d2dd.json
8d53bbdb-85ff-4435-83f6-acfa6ae16d3d,XEFO 8 MG/2 ML INJECTION,prescription,M01AC05,LORNOXICAM,4680,,,WHO ATC Classification,,ILS,powder for solution for injection,LORNOXICAM/VIAL,2025-07-31T10:31:59.210796,IL,כ.צ.ט,,31.84023028,26.983246,19.6958,,7046264767214,XEFO 8MG 20TAB,24041,,61954,VIAL GLASS TYPE I,units,20.0,127 83 30653 00,valid,37.0,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Short term treatment of moderate postoperative pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d53bbdb-85ff-4435-83f6-acfa6ae16d3d.json
8d5c5a50-00d1-4e0f-b5b2-632ee819e4d6,AVILAC SYRUP,off-the-counter,A06AD11,LACTULOSE,2379,,,WHO ATC Classification,,ILS,syrup,LACTULOSE 66.7 G /,2025-07-31T11:15:14.882672,IL,פאדאגיס,,41.7956,35.42,nan,,7290002925880,AVILAC 300ML,1814,,,BOTTLE HDPE,units,300.0,031 75 25187 00,valid,nan,per os,1.4,30,,,,,,,,,,0,,Constipation. Acute and chronic hepatic encephalopathy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d5c5a50-00d1-4e0f-b5b2-632ee819e4d6.json
8d6cbfb3-ada4-48cc-b3ec-3ac0b10db7f9,COROSAN 75 MG,29C,B01AC07,DIPYRIDAMOLE,20830,,,WHO ATC Classification,,ILS,tablets,DIPYRIDAMOLE,2025-07-31T14:22:03.177548,IL,nan,,nan,nan,nan,,7290015863698,DIPYRIDAMOLE 5MG/ML WEST HARD USA 2ML,,,,BLISTER PVC/PVDC/ALUMINIUM,units,5.0,167 53 35927 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,Corosan is indicated for:• As an adjunct to oral anticoagulation for prophylaxis of thromboembolism associated with prosthetic heart valves.• As an alternative to exercise stress in thallium myocardial imaging particularly in patients unable to exercise or in those for whom exercise may be contraindicated.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d6cbfb3-ada4-48cc-b3ec-3ac0b10db7f9.json
8d889a00-b94b-4095-a21f-aa193e823ac8,ARCOXIA 120 MG TABLETS,prescription,M01AH05,ETORICOXIB,7866,,,WHO ATC Classification,,ILS,film coated tablets,ETORICOXIB,2025-07-30T23:26:40.863442,IL,אורגנון,,45.16670944,38.27687241,27.93932293,,7290006813046,ARCOXIA 90 MG 14TAB,9918,,38663,BLISTER PVC/ALUMINIUM,units,14.0,129 44 30788 11,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Arcoxia 120 mg tablets are indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d889a00-b94b-4095-a21f-aa193e823ac8.json
8d8c9c1f-3686-47c7-baee-91e70eacacba,COLESTID 5G X 50 SACHETS,prescription,,,29,,,,,,tablet,COLESTID 5G X 50 SACHETS,2025-07-31T19:03:57.219989,IL,פיזר,,,,,,,COLESTID 5G X 50 SACHETS,3204,,569,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8d8c9c1f-3686-47c7-baee-91e70eacacba.json
8da8e9c7-b0ab-42c8-b66d-7ad44a9a9ab9,DEFIROX 125 MG,prescription,V03AC03,DEFERASIROX,9120,,,WHO ATC Classification,,ILS,dispersible tablets,DEFERASIROX,2025-07-31T01:45:23.489112,IL,דקסל פארמה,,962.1982231,815.422223,693.97636,,,DEFIROX 125 MG  28 TAB,4757,,30192,BLISTER PVC/PCTFE/AL,units,28.0,167 88 35880 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Defirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over). Defirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC] &#8805;5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 µg/l). LIC is the preferred method of iron overload determination and should be used wherever available,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8da8e9c7-b0ab-42c8-b66d-7ad44a9a9ab9.json
8dba202c-afc7-4056-afe9-cf0390cad727,ADVATE 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,8093,,,WHO ATC Classification,,ILS,powder for solution for injection,OCTOCOG ALFA (ANTIHEMOPHILIC FACTOR RECOMBINANT)/VIAL,2025-07-31T00:10:33.684506,IL,טקדה,,2464.693661,2088.723534,1898.839576,,7291064500602,ADVATE 1000 IU VIAL,,,61636,VIAL GLASS TYPE I,units,1.0,150 79 33664 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8dba202c-afc7-4056-afe9-cf0390cad727.json
8dbafd85-de73-44e1-9881-7db2727ef7f0,ORLADEYO 110 MG,prescription,B06AC06,BEROTRALSTAT,9024,,,WHO ATC Classification,,ILS,capsules,BEROTRALSTAT AS DIHYDROCHLORIDE,2025-07-31T06:16:50.484039,IL,ניאופרם,,nan,nan,nan,,,ORLADEYO 110 MG 28 CAPS,,,,BLISTER PVC/ALUMINIUM,units,28.0,170 35 37012 99,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,ORLADEYO is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years of age and older,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8dbafd85-de73-44e1-9881-7db2727ef7f0.json
8df451d1-31be-4055-bae1-b0b4d00886dd,DIPROGENTA OINTMENT,prescription,N/A,,1237,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS DIPROPIONATE 0.5  MG /, GENTAMICIN AS SULFATE/",2025-07-31T01:58:45.373957,IL,אורגנון,,27.52628871,23.32736435,17.02727325,,72989722,DIPROGENTA OINT 15GR,4436,,8459,TUBE ALUMINIUM,units,15.0,134 12 23893 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of dermatosis complicated by secondary infection caused by organisms sensitive to Gentamicin,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8df451d1-31be-4055-bae1-b0b4d00886dd.json
8e13a872-91bb-42ca-81a0-8fd89c1b222a,IODIFLOR OINTMENT,off-the-counter,D08AG03,IODINE,3378,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:10:34.979099,IL,פלוריש,,25.2048,21.36,nan,,7290006411907,IODIFLOR CLEAN.200ML,,,,BOTTLE HDPE,units,200.0,141 02 31802 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"For the disinfection of skin infections and inflammations, wounds and superficial burns.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8e13a872-91bb-42ca-81a0-8fd89c1b222a.json
8e3cb638-52f3-45c9-ae03-c1d036ba1e2c,TRANXAL 15MG 30CAP,prescription,,,2357,,,,,ILS,tablet,TRANXAL 15MG 30CAP,2025-07-31T19:36:38.434703,IL,כ.צ.ט,,34.54043726,29.271557,21.3661,,,TRANXAL 15MG 30CAP,20450,,7493,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8e3cb638-52f3-45c9-ae03-c1d036ba1e2c.json
8e5b7a92-9da1-4e60-b84e-28c2d90f176d,STEGLUJAN 15/100 MG TABLETS,prescription,A10BD24,SITAGLIPTIN AND ERTUGLIFLOZIN ,8542,,,WHO ATC Classification,,ILS,film coated tablets,"SITAGLIPTIN AS MONOHYDRATE PHOSPHATE, ERTUGLIFLOZIN (L-PGA)",2025-07-31T08:41:47.242203,IL,מ.ס.ד. ישראל,,374.3465117,317.2428206,269.9938899,,,STEGLUJAN 15/100 MG 28 TAB,,,,BLISTER PVC/ALUMINIUM,units,28.0,167 02 36036 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,STEGLUJAN is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:• when metformin and/or a sulphonylurea (SU) and one of the monocomponents of Steglujan do not provide adequate glycaemic control• in patients already being treated with the combination of ertugliflozin and sitagliptin as separate tablets.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8e5b7a92-9da1-4e60-b84e-28c2d90f176d.json
8e5ea0c7-3084-4149-b120-44a91a6d01ca,JANUVIA 100 MG,prescription,A10BH01,SITAGLIPTIN,6108,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS MONOHYDRATE PHOSPHATE,2025-07-31T04:17:21.802906,IL,מ.ס.ד. ישראל,,156.0777531,132.2692823,105.8154258,,,JANUVIA 100MG 28TAB,10042,,86458,BLISTER PVC/PE/PVDC/AL,units,28.0,138 15 31556 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.Important limitations of use:Januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.Januvia has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januvia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8e5ea0c7-3084-4149-b120-44a91a6d01ca.json
8e6618a4-f9e3-4021-96f0-3c1a40c669f5,AZENIL 200 MG/5 ML SUSPENSION,prescription,J01FA10,AZITHROMYCIN,3093,,,WHO ATC Classification,,ILS,powder for oral suspension,AZITHROMYCIN AS DIHYDRATE/,2025-07-30T23:32:54.661127,IL,פיזר,,29.06226484,24.629038,17.9774,,,AZENIL 250MG 6CAPSULES,1984,,68084,BOTTLE POLYETHYLENE,units,6.0,118 26 29828 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Infections caused by susceptible organisms in lower respiratory tract including bronchitis and pneumonia, skin and soft tissue infections, otitis media, upper respiratory tract infections including sinusitis and pharyngitis, tonsilitis, also in the treatment of uncomplicated genital infections due to chlamydia trachomatis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8e6618a4-f9e3-4021-96f0-3c1a40c669f5.json
8e7c622f-f27c-4680-a1a9-0b51b68f8719,TREVICTA,prescription,N05AX13,PALIPERIDONE,7921,,,WHO ATC Classification,,ILS,extended release suspension for injection,PALIPERIDONE AS PALMITATE/,2025-07-31T09:40:07.253157,IL,יאנסן סילג,,1481.087491,1255.158947,1068.22038,,,TREVICTA 175MG/0.875ML SYR PREFILLED,20827,,73576,SYRINGE PREFILLED  CYCLIC OLEFIN COPOLYMER,units,1.0,157 43 34606 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"TREVICTA, a 3 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly paliperidone palmitate injectable product",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8e7c622f-f27c-4680-a1a9-0b51b68f8719.json
8e98a88c-3ce8-464a-80b7-802eb20ad482,IRINOTECAN VENUS 20 MG/ML,prescription,L01XX19,IRINOTECAN,9510,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,IRINOTECAN HYDROCHLORIDE TRIHYDRATE/,2025-07-31T04:12:43.799096,IL,טרוסטפארם,,83.55216024,70.80691861,52.64454915,,,IRINOTECAN VENUS 20 MG/ML 2ML,,,,VIAL GLASS TYPE I,units,1.0,176 15 37137 99,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"IRINOTECAN VENUS 20 MG/ML is indicated for the treatments of patients with metastatic colorectal cancer:- In combination with 5-fluorouracil and folinic acid in patient without prior chemotherapy for metastatic disease.- As a single agent in patients who have failed an established 5-fluorouracil treatment regimen.- For the treatment of patients with small cell lung cancer.- For the treatment of patients with gastric cancer.- Irinotecan in combination with leucovorin, Oxaliplatin and 5- fluorouracil, for the first line treatment of patients with metastatic pancreatic adenocarcinoma.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8e98a88c-3ce8-464a-80b7-802eb20ad482.json
8ea3babf-5f88-4b40-8bb7-aa0094e24709,FEXOFENADINE - TRIMA 120 MG,off-the-counter,R06AX26,FEXOFENADINE,8392,,,WHO ATC Classification,,ILS,film coated tablets,FEXOFENADINE HYDROCHLORIDE,2025-07-31T11:55:21.698033,IL,תרימה,,13.2632,11.24,nan,,,FEXOFENADINE - TRIMA 120 MG 15 TAB,6611,,,BLISTER ALUMINIUM /ALUMINIUM,units,15.0,162 12 35365 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Relief of symptoms associated with seasonal allergic rhinitis., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ea3babf-5f88-4b40-8bb7-aa0094e24709.json
8ea5b212-e8d6-4932-8081-e950f4852063,ACNETRIM,prescription,D10AF02,ERYTHROMYCIN,2163,,,WHO ATC Classification,,ILS,solution,ERYTHROMYCINW/V,2025-07-31T00:06:04.949703,IL,תרימה,,18.43716134,15.624713,11.4049,,,ACNETRIM SOL 25ML,1803,,7781,BOTTLE GLASS TYPE III,units,25.0,035 38 25621 00,valid,37.0,dermal,1.4,15,,,,,,,,,,0,Prescription required,"As a topical antibiotic treatment for all forms of acne, particularly inflamatory acne with papules and pustules.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ea5b212-e8d6-4932-8081-e950f4852063.json
8eaa8c7c-6ada-4e4f-9cc4-3bc2362e1069,FLUTINE 20,prescription,N06AB03,FLUOXETINE,3256,,,WHO ATC Classification,,ILS,capsules,FLUOXETINE AS HYDROCHLORIDE,2025-07-31T03:15:15.154407,IL,טבע,,37.7912582,32.02649,23.377,,7290008093743,FLUTINE 20MG 30CAP,6108,,9346,BLISTER PVDC/ALUMINIUM,units,30.0,062 52 27648 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Adults:Major depressive episodes.Obsessive-compulsive disorder (OCD).Bulimia nervosa: Fluoxetine is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.Children and adolescents aged 8 years and above:Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. Antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8eaa8c7c-6ada-4e4f-9cc4-3bc2362e1069.json
8eb142c7-d562-4d56-8a22-40380bb2b504,ACLASTA ®,prescription,M05BA08,ZOLEDRONIC ACID,6016,,,WHO ATC Classification,,ILS,solution for infusion,ZOLEDRONIC ACID/,2025-07-31T00:05:45.979144,IL,סנדוז,,1129.35666,957.081915,814.5378,,7290006257819,ACLASTA 5MG/100ML 1BOTTLE,1259,,71212,VIAL PLASTIC,units,1.0,135 99 31323 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Paget's disease of the bone.  Treatment of osteoporosis : - in post-menopausal women   - in men   at increased risk of fracture  including those with a recent low-trauma hip fracture.Treatment and prevention of glucocorticoid-induced osteoporosis.Prevention of postmenopausal osteoporosis in women for whom bisphosphonate therapy is indicated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8eb142c7-d562-4d56-8a22-40380bb2b504.json
8ebb5022-f71f-4bb1-b4c2-525c90d3ff0f,LAMISIL ONCE,off-the-counter,,,5068,,,,,ILS,solution,TERBINAFINE AS HYDROCHLORIDE/G,2025-07-31T12:18:00.416552,IL,ג.ס.ק,,55.0352,46.64,nan,,7290011363437,LAMISIL SPRAY 1% 30ML,12220,,,TUBE ALUMINIUM,units,30.0,137 26 31486 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,For the treatment of athlete's foot.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ebb5022-f71f-4bb1-b4c2-525c90d3ff0f.json
8ecdc3c7-d39b-45c7-84b7-fa3d399a2084,IBUFEN 400,prescription,M01AE01,IBUPROFEN,1768,,,WHO ATC Classification,,ILS,caplets,IBUPROFEN,2025-07-31T03:55:54.382533,IL,דקסל פארמה,,12.3718398,10.48461,7.653,,,IBUFEN 600MG 30TAB,9165,,7943,BLISTER PVC/ALUMINIUM,units,30.0,039 70 26008 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the relief of mild to moderate pain such as headache, toothache, primary dysmenorrhea, backache, muscular pain. Anti - inflammatory and relieves pain in reumatoid arthritis and osteo arthritis.For the treatment of pain associated with migraine.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ecdc3c7-d39b-45c7-84b7-fa3d399a2084.json
8ee49e70-70cf-400e-af10-fd48688e51ed,ONGENTYS 50 MG,29C,N04BX04,OPICAPONE,20295,,,WHO ATC Classification,,ILS,"capsule, hard",OPICAPONE,2025-07-31T13:51:34.097660,IL,nan,,nan,nan,nan,,,APO METHYL DOPA 250MG 1TAB,,,,BLISTER OPA/ALU/PVC/ALU,units,30.0,170 17 37081 99,valid,nan,per os,1.4,60,,,,,,,,,,0,,ONGENTYS is indicated as adjunctive therapy to preparations of levodopa/ DOPA decarboxylase inhibitors (DDCI) in adult patients with Parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ee49e70-70cf-400e-af10-fd48688e51ed.json
8ee558dd-ea3d-4a5b-a874-efb9ecab33a4,AMLOW 10,prescription,C08CA01,AMLODIPINE,8077,,,WHO ATC Classification,,ILS,tablets,AMLODIPINE AS MALEATE,2025-07-30T23:22:25.404177,IL,טבע,,19.55552522,16.572479,12.0967,,,AMLODIPINE TEVA 10 MG 	30 TABLETS,,,67877,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,131 66 31035 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate hypertension. Vasospastic angina (Prinzmetal's or variant angina). Chronic stable angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ee558dd-ea3d-4a5b-a874-efb9ecab33a4.json
8ef24685-be64-470e-b5c3-1b53e731c47b,NICOTINELL GUM 2 MG (MINT),off-the-counter,N07BA01,NICOTINE,3906,,,WHO ATC Classification,,ILS,chewing gum,NICOTINE,2025-07-31T12:31:36.352135,IL,ג.ס.ק,,76.287,64.65,nan,,,NICOTINELL GUM 4MG FRUIT 48 tab,14412,,,BLISTER PVC/PVDC/ALUMINIUM,units,48.0,115 78 29638 23,valid,nan,per os,1.4,30,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ef24685-be64-470e-b5c3-1b53e731c47b.json
8f2950d7-e57d-4c84-a1d8-3d291e2b6ee5,FAMCICLOVIR 500MG  30TABS,29C,,,20951,,,,,,tablet,FAMCICLOVIR 500MG S,2025-07-31T20:26:02.000811,IL,nan,,,,,,,FAMCICLOVIR 500MG  30TABS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8f2950d7-e57d-4c84-a1d8-3d291e2b6ee5.json
8f421cc9-ecc3-4a49-81e2-90e2bbfda0a5,VIMPAT 10 MG/ML,prescription,N03AX18,LACOSAMIDE,7183,,,WHO ATC Classification,,ILS,solution for infusion,LACOSAMIDE/,2025-07-31T10:16:24.301013,IL,ניאופרם,,45.63989137,38.67787404,28.23202485,,7290100412688,VIMPAT 50MG 14 F.C.TAB,22412,,46136,VIAL 20 ML GLASS TYPE I,units,14.0,149 13 33552 01,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.בקשה לשינוי משטר מינון: 17/5/20204.2	Posology and method of administrationPosologyLacosamide must be taken twice a day (usually once in the morning and once in the evening).Lacosamide may be taken with or without food.If a dose is missed, the patient should be instructed to take the missed dose immediately, and then to take the next dose of lacosamide at the regularly scheduled time. If the patient notices the missed dose within 6 hours of the next one, he/she should be instructed to wait to take the next dose of lacosamide at the regularly scheduled time. Patients should not take a double dose.Adolescents and children weighing 50 kg or more, and adultsThe following table summarises the recommended posology for adolescents and children weighing 50 kg or more, and for adults. More details are provided in the table below.	Monotherapy	Adjunctive therapyStarting dose	100 mg/day or 200 mg/day	100 mg/daySingle loading dose (if applicable)	200 mg	200 mgTitration (incremental steps)	50 mg twice a day (100 mg/day) at weekly intervals	50 mg twice a day (100 mg/day) at weekly intervalsMaximum recommended dose	up to 600 mg/day	up to 400 mg/dayMonotherapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week.Lacosamide can also be initiated at the dose of 100 mg twice a day based on the physician's assessment of required seizure reduction versus potential side effects.Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 300 mg twice a day (600 mg/day). In patients having reached a dose greater than 400 mg/day and who need an additional antiepileptic medicinal product, the posology that is recommended for adjunctive therapy below should be followed.Adjunctive therapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week. Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 400 mg (200 mg twice a day). Initiation of lacosamide treatment with a loading dose Lacosamide treatment may also be initiated with a single loading dose of 200 mg, followed approximately 12 hours later by a 100 mg twice a day (200 mg/day) maintenance dose regimen. Subsequent dose adjustments should be performed according to individual response and tolerability as described above. A loading dose may be initiated in patients in situations when the physician determines that rapid attainment of lacosamide steady state plasma concentration and therapeutic effect is warranted. It should be administered under medical supervision with consideration of the potential for increased incidence of serious cardiac arrhythmia and central nervous system adverse reactions (see section 4.8). Administration of a loading dose has not been studied in acute conditions such as status epilepticus.DiscontinuationIn accordance with current clinical practice, if lacosamide has to be discontinued, it is recommended this be done gradually (e.g. taper the daily dose by 200 mg/week).In patients who develop serious cardiac arrhythmia, clinical benefit/risk assessment should be performed and if needed lacosamide should be discontinued.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8f421cc9-ecc3-4a49-81e2-90e2bbfda0a5.json
8f593976-d5ec-4b36-8155-813a1c584849,ALPROLIX 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,9003,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR IX (HUMAN- RFIXFC)/VIAL,2025-07-30T23:20:44.859719,IL,מגאפארם,,5511.709207,4670.940213,4246.309285,,,ALPROLIX 1000 IU 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,171 49 36891 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8f593976-d5ec-4b36-8155-813a1c584849.json
8f5b2879-e412-49f3-9ca1-90a7c8b6b214,EUTHYROX 100 MCG,prescription,H03AA01,LEVOTHYROXINE SODIUM,8195,,,WHO ATC Classification,,ILS,tablets,LEVOTHYROXINE SODIUM,2025-07-31T02:43:37.122645,IL,מרק סרונו,,31.78655916,26.937762,19.6626,,,EUTHYROX 100MCG 100TAB,5555,,10936,BLISTER PVC,units,100.0,147 51 33605 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Euthyrox 25 - 200 microgram :- Treatment of benign euthyroid goitre.- Prophylaxis of relapse after surgery for euthyroid goitre, depending on the post - operative hormone status.- Substitution therapy in hypothyroidism.- Suppression therapy in thyroid cancer.Euthyrox 25 - 100 microgram :- Concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism.Euthyrox 100/150/200 microgram :- Diagnostic use for thyroid suppression testing.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8f5b2879-e412-49f3-9ca1-90a7c8b6b214.json
8f7719c6-5d31-494c-bd53-62d59cdea9c0,DIPROSPAN INJECTION,prescription,H02AB01,BETAMETHASONE,4634,,,WHO ATC Classification,,ILS,suspension for injection,"BETAMETHASONE SODIUM PHOSPHATE/ML, BETAMETHASONE AS DIPROPIONATE/ML",2025-07-31T01:59:38.714282,IL,אורגנון,,nan,nan,nan,,,DIPROSPAN 1AMPX2ML,4048,,57660,AMPOULES GLASS TYPE I,units,1.0,047 07 24139 00,valid,nan,"i.m, intradermal, intra-articular, intrabursal, periarticular, soft tissue injection, intralesional",1.4,24,,,,,,,,,,0,Prescription required,"Produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8f7719c6-5d31-494c-bd53-62d59cdea9c0.json
8f77844e-23ec-4c0c-9f64-6c556975d2f1,GRAFALON,prescription,J06BB05,RABIES IMMUNOGLOBULIN,7997,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RABBIT IMMUNOGLOBULIN/ML,2025-07-31T03:39:01.646104,IL,ניאופרם,,18810.92422,15941.46192,14492.23811,,7290012847608,GRAFALON 20MG/ML 5ML10 vials,,,,VIAL GLASS TYPE II,units,10.0,060 25 27341 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,- Prophylaxis and therapy of rejection crises in organ and tissue transplantations.- Prevention of graft-versus-host disease (GVHD) in adults after allogeneic stem cell transplantation (SCT) Grafalon is indicated for prevention of graft-versus-host disease (GVHD) in adults with haematological malignancies following stem cell transplantation from matched unrelated donors in combination with standard Cyclosporin A/methotrexate prophylaxis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8f77844e-23ec-4c0c-9f64-6c556975d2f1.json
8f8c914b-bdf0-4245-9180-d9dc6983b2bb,FASTURTEC 7.5MG/5ML INJECTION,29C,,,20838,,,,,,injection,FASTURTEC 7.5MG/ INJECTION,2025-07-31T20:26:23.560703,IL,nan,,,,,,,FASTURTEC 7.5MG/5ML INJECTION,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8f8c914b-bdf0-4245-9180-d9dc6983b2bb.json
8f90bf5f-870e-411c-840d-ff00ad613f90,EUTHYROX 100 MCG,prescription,H03AA01,LEVOTHYROXINE SODIUM,8196,,,WHO ATC Classification,,ILS,tablets,LEVOTHYROXINE SODIUM,2025-07-31T02:43:57.891034,IL,מרק סרונו,,24.71732902,20.946889,15.2897,,,EUTHYROX 50MCG 100TAB,5556,,10935,BLISTER PVC,units,100.0,147 51 33605 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Euthyrox 25 - 200 microgram :- Treatment of benign euthyroid goitre.- Prophylaxis of relapse after surgery for euthyroid goitre, depending on the post - operative hormone status.- Substitution therapy in hypothyroidism.- Suppression therapy in thyroid cancer.Euthyrox 25 - 100 microgram :- Concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism.Euthyrox 100/150/200 microgram :- Diagnostic use for thyroid suppression testing.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8f90bf5f-870e-411c-840d-ff00ad613f90.json
8fa48bc8-fa99-4918-bd5c-a2c105bf4278,COSENTYX  SOLUTION FOR INJECTION,prescription,L04AC10,SECUKINUMAB,9323,,,WHO ATC Classification,,ILS,solution for injection,SECUKINUMAB/ML,2025-07-31T01:31:04.108028,IL,נוברטיס פארמה,,4640.283045,3932.443433,3574.948575,,7290014257429,COSENTYX  SOLUTION FOR INJECTION 300MG/2ML PEN,23469,,1543,PRE-FILLED PEN GLASS TYPE I,units,1.0,154 20 34342 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"- Plaque psoriasis: Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. - Paediatric plaque psoriasis: Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy. - Psoriatic arthritis: Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous disease modifying anti rheumatic drug (DMARD) therapy has been inadequate. - Axial spondyloarthritis (axSpA) : •Ankylosing spondylitis (AS, radiographic axial spondyloarthritis) Cosentyx is indicated for the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy. •Non-radiographic axial spondyloarthritis (nr-axSpA) Cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to non-steroidal anti-inflammatory drugs (NSAIDs). - Juvenile idiopathic arthritis (JIA) •Enthesitis-related arthritis (ERA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active enthesitisrelated arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. •Juvenile psoriatic arthritis (JPsA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.Hidradenitis suppurativa (HS)Cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic HS therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8fa48bc8-fa99-4918-bd5c-a2c105bf4278.json
8fb3c9d9-9d99-48ba-8bb9-b1d2c6ad5d18,PATANOL 0.1% EYE DROPS 5ML,prescription,,,4866,,,,,ILS,drops,PATANOL 0.1% EYE DROPS,2025-07-31T19:27:58.308654,IL,נוברטיס פארמה,,34.8325946,29.51914797,21.54682333,,,PATANOL 0.1% EYE DROPS 5ML,16703,,65020,,units,5.0,,not-registered,37.0,ophthalmic,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8fb3c9d9-9d99-48ba-8bb9-b1d2c6ad5d18.json
8fde6bfd-f8ff-4997-a5ec-0c2552401c71,VANCOMYCIN LYOMARK 1000 MG,prescription,A07AA09,VANCOMYCIN,8986,,,WHO ATC Classification,,ILS,powder for concentrate for solution for iv infusion/ oral solution,VANCOMYCIN AS HYDROCHLORIDE,2025-07-31T09:58:21.373917,IL,מרגלית,,541.0123,458.485,390.2,,7290001942413,VANCOMYCIN LYOMARK 1000 MG 10 VIALS,,,74586,VIAL GLASS TYPE I,units,10.0,156 97 34033 00,valid,17.5,"i.v, oral",1.4,36,,,,,,,,,,0,Prescription required,Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. It is also indicated for administration to penicillin-allergic patients  as well patients who have failed to respond to  or who cannot receive other drugs  including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected  but when susceptibility data become available  appropriate therapy should be instituted.  Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci  including lower respiratory tract infections  septicemia  skin and skin - structure infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized.  For endocarditis due to Streptococcus viridans or Streptococcus bovis  vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg  Enterococcus fecalis).   Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids  vancomycin hydrochloride has been administered successfully in combination with either rifampin  an aminoglycoside or combined with both drugs.  Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride.  Oral Therapy:Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. Vancomycin hydrochloride is not effective orally when administered for other types of infection.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8fde6bfd-f8ff-4997-a5ec-0c2552401c71.json
8fdf6650-f77e-4f3c-82f3-66e64917f09e,QUILLIVANT XR 600 MG,prescription,N06BA04,METHYLPHENIDATE,9578,,,WHO ATC Classification,,ILS,powder for extended release oral suspension ,METHYLPHENIDATE/BOTTLE,2025-07-31T07:12:18.149129,IL,מדיסון,,nan,nan,nan,,,QUILLIVANT XR 900 MG 1 BOTTLE,,,,BOTTLE GLASS TYPE III,units,1.0,175 92 37654 99,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,QUILLIVANT XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8fdf6650-f77e-4f3c-82f3-66e64917f09e.json
8fe47341-aeea-401e-b885-372b2c466ce2,ALLORIL 100,prescription,M04AA01,ALLOPURINOL,1726,,,WHO ATC Classification,,ILS,tablets,ALLOPURINOL,2025-07-30T23:19:57.935421,IL,דקסל פארמה,,13.7411,11.645,8.5,,7290000806181,ALLORIL 100MG 50TAB,1824,,7938,BLISTER PVC,units,50.0,039 76 26038 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis and/or nephropathy). Management of patients with leukemia, lymphoma, and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8fe47341-aeea-401e-b885-372b2c466ce2.json
8fec6e65-26f5-443a-aaea-481fba6b8afc,LOSEC 20 MG,prescription,A02BC01,OMEPRAZOLE,3266,,,WHO ATC Classification,,ILS,capsules,OMEPRAZOLE,2025-07-31T04:56:12.236282,IL,טבע,,43.6482,36.99,27.0,,,LOSEC 20MG 30CAP,12119,,9333,BOTTLE HDPE,units,30.0,139 78 31879 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8fec6e65-26f5-443a-aaea-481fba6b8afc.json
8ff53695-541e-4532-a886-df98f92fb37c,RIVAR TEVA 2.5 MG,prescription,B01AF01,RIVAROXABAN,9171,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN 2.5  MG,2025-07-31T07:42:04.723099,IL,טבע,,301.1194655,255.1859877,217.179564,,,RIVAR TEVA 2.5 MG 56 TAB,,,38146,BLISTER PVC/PVDC/ALUMINIUM,units,56.0,168 07 36157 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Rivaroxaban Teva 2.5 mg, co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel , is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers. Rivaroxaban Teva 2.5, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ff53695-541e-4532-a886-df98f92fb37c.json
8ff9ba72-2af8-4248-b993-7f8abbde60ee,BENZAC 5 %,off-the-counter,,,3360,,,,,ILS,gel,BENZOYL PEROXIDEW/W,2025-07-31T11:16:53.553296,IL,אמי טכנולוגיות,,66.4104,56.28,nan,,7290008067935,BENZAC AC 10% 60GR,2100,,,TUBE LDPE,units,60.0,103 30 27997 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,For the topical treatment of acne vulgaris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ff9ba72-2af8-4248-b993-7f8abbde60ee.json
8ffbe851-576e-433d-aa38-8872fda55007,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1823,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:50:20.214170,IL,פישר,,35.2938,29.91,nan,,7290000849188,POLYDINE OINT 250GR,16180,,,BOTTLE HDPE,units,250.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/8ffbe851-576e-433d-aa38-8872fda55007.json
9004e506-1d11-496d-b752-d1fb22a1019a,PARAMOL,off-the-counter,N02BE01,PARACETAMOL,5510,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T12:45:12.416330,IL,ליף-דקסון,,22.5026,19.07,nan,,,PARAMOL AF & SHIUL DAY CARE 30 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,30.0,127 96 30764 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9004e506-1d11-496d-b752-d1fb22a1019a.json
900c9297-f0cc-47c4-a628-17ab5b32404e,CAPD 2 PERITONEAL DIALYSIS SOLUTION,29C,B05XA30,COMBINATIONS OF ELECTROLYTES,20847,,,WHO ATC Classification,,ILS,solution for peritoneal dialysis,"MAGNESIUM CHLORIDE 0.1017 G/L, SODIUM CHLORIDE 5.786 G/L, CALCIUM CHLORIDE 0.2573 G/L, GLUCOSE AS MONOHYDRATE 16.5 G/L, LACTIC ACID AS SODIUM 3.925 G/L",2025-07-31T14:42:25.838735,IL,nan,,nan,nan,nan,,,GLUCOSE 20% STEROP BELGIUM 500ML,,,,BAG POLYPROPYLENE,units,10.0,107 95 26735 00,valid,nan,intra-peritoneal,1.4,24,,,,,,,,,,0,,For use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/900c9297-f0cc-47c4-a628-17ab5b32404e.json
90231372-b78d-413e-9e1f-cfbbfb09c84e,MIRENA,prescription,G03AA07,LEVONORGESTREL AND ESTROGEN,3519,,,WHO ATC Classification,,ILS,intrauterine device,LEVONORGESTREL,2025-07-31T05:27:29.229983,IL,באייר,,489.4723162,414.8070661,353.0272903,,7290013092632,MIRENA 1 IDS,13732,,26390,BLISTER ,units,1.0,106 74 28833 00,valid,17.5,intrauterine,1.4,36,,,,,,,,,,0,Prescription required,Contraception and idiopathic menorrhagia.  Protection from endometrial hyperplasia during estrogen replacement therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90231372-b78d-413e-9e1f-cfbbfb09c84e.json
9065613d-7c1d-408d-9aab-5b5a5aed0e32,CABOTRIM 0.5,prescription,,,4989,,,,,ILS,tablets,CABERGOLINE 0.5  MG,2025-07-30T23:47:31.035041,IL,תרימה,,53.20586252,45.089714,32.9122,,7290008075985,CABOTRIM 0.5MG 2TAB,3878,,71197,BOTTLE HDPE,units,2.0,135 73 31180 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of hyperprolactinemic disorders.Cabotrim is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. Cabotrim is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. Inhibition and supression of lactation .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9065613d-7c1d-408d-9aab-5b5a5aed0e32.json
906e094c-0e78-4b5c-8935-994401ca149d,LIPODOX LIPOSOMAL,prescription,L01DB01,DOXORUBICIN,8964,,,WHO ATC Classification,,ILS,liposome concentrate for solution for infusion,DOXORUBICIN HYDROCHLORIDE/,2025-07-31T04:48:41.587285,IL,תרו יבוא,,2119.094584,1795.842947,1528.376976,,7290017164113,LIPODOX LIPOSOMAL 50MG/25ML 1 VIAL,12584,,58505,VIAL GLASS TYPE I,units,1.0,162 74 35191 00,valid,17.5,i.v,1.4,18,,,,,,,,,,0,Prescription required,1. First or second line therapy of AIDS related Kaposis sarcoma in patients with low CD 4 counts and extensive mucocutaneous or visceral disease. 2. The treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. Refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatment. 3. As monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. 4. In combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/906e094c-0e78-4b5c-8935-994401ca149d.json
906f3338-0a78-4c44-803e-f4e09fc46221,OXYCONTIN 10,prescription,N02AA05,OXYCODONE,3198,,,WHO ATC Classification,,ILS,tablets controlled release,OXYCODONE HYDROCHLORIDE,2025-07-31T06:21:46.768552,IL,רפא,,20.34566181,17.24208705,12.585465,,7290008014373,OXYCONTIN 10MG 20TAB (CONTROLLED RELEASE),15028,,9404,BLISTER PVC/ALUMINIUM,units,20.0,100 71 28431 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the relief of moderate to severe chronic pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/906f3338-0a78-4c44-803e-f4e09fc46221.json
90886049-e0c7-4cd4-bf04-0e693ba0b7b4,REPATHA,prescription,C10AX13,EVOLOCUMAB,7838,,,WHO ATC Classification,,ILS,solution for injection,EVOLOCUMAB/ML,2025-07-31T07:25:37.994401,IL,מדיסון,,1035.506488,877.54791,746.8492851,,8715131010492,REPATHA 140MG/ML1 PREFILLED PENS,18536,,58858,PREFILLED PEN GLASS TYPE I,units,1.0,155 71 34521 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Hypercholesterolaemia and mixed dyslipidaemiaRepatha is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, and in paediatric patients aged 10 years and over with heterozygous familial hypercholesterolaemia, as an adjunct to diet:• in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin or, • alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated. Homozygous familial hypercholesterolaemia Repatha is indicated in adults and paediatric patients aged 10 years and over with homozygous familial hypercholesterolaemia in combination with other lipid-lowering therapies.Established atherosclerotic cardiovascular disease Repatha is indicated in adults with established atherosclerotic cardiovascular disease (myocardial infarction, stroke or peripheral arterial disease) to reduce cardiovascular risk by lowering LDL-C levels, as an adjunct to correction of other risk factors:• in combination with the maximum tolerated dose of a statin with or without other lipid-lowering therapies or, • alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90886049-e0c7-4cd4-bf04-0e693ba0b7b4.json
908dc05a-f76e-495c-a716-6c660e30cce7,GLASSIA,prescription,B02AB02,ALFA1 ANTITRYPSIN,6884,,,WHO ATC Classification,,ILS,solution for infusion,ALPHA-1-ANTITRYPSIN ( AAT)/,2025-07-31T03:34:21.264685,IL,קמהדע,,1735.630963,1470.873763,1251.807458,,7290011225414,GLASSIA 1G/50ML 1VIAL,81518,,19644,VIAL GLASS TYPE I,units,1.0,146 60 33208 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Alpha1-Proteinase Inhibitor (Human), GLASSIA® is indicated for chronic augmentation and maintenance therapy in individuals with congenital deficiency of alpha1-proteinase inhibitor (Alpha1-PI), also known as alpha1-antitrypsin (AAT) deficiency and clinical evidence of emphysema.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/908dc05a-f76e-495c-a716-6c660e30cce7.json
909f3932-fc07-4cf8-9cae-266f7072c18e,MAYZENT 0.25 MG,prescription,L04AA42,SIPONIMOD,8722,,,WHO ATC Classification,,ILS,film coated tablets,SIPONIMOD AS FUMARIC ACID 0.25  MG,2025-07-31T05:07:30.083893,IL,נוברטיס פארמה,,6389.913888,5415.181502,4922.892274,,7290018375266,MAYZENT 2 MG 28 TAB,13976,,497,BLISTER PA/ALU/PVC/ALU,units,28.0,165 54 36195 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Mayzent is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease, and active secondary progressive disease, in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/909f3932-fc07-4cf8-9cae-266f7072c18e.json
90a3d3ab-091b-4746-9ad7-bacf517e47b1,HEMLIBRA 150 MG/ML,prescription,B02BX06,EMICIZUMAB,8445,,,WHO ATC Classification,,ILS,solution for injection,EMICIZUMAB/,2025-07-31T03:44:30.763699,IL,רוש,,9078.244795,7693.428134,6994.025576,,7290014774094,HEMLIBRA 30 MG/ML 1 VIAL,,,26626,VIAL GLASS TYPE I,units,1.0,161 19 35415 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90a3d3ab-091b-4746-9ad7-bacf517e47b1.json
90bd3b1a-4aa6-454b-a5c6-048640e59a3b,NUROFEN QUICK 256 MG,off-the-counter,M02AA13,IBUPROFEN,5570,,,WHO ATC Classification,,ILS,tablets,IBUPROFEN SODIUM,2025-07-31T12:39:16.323532,IL,רקיט בנקיזר,,65.3484,55.38,nan,,7290101866961,NUROFEN QUICK 256 MG48 TAB,14681,,,BLISTER PVC/PVDC,units,48.0,142 71 31929 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"For the symptomatic relief of mild to moderate pain, such as hedache, backache, period pain, dental pain, neuralgia, rheumatic and muscular pain, the pain of non-serious arthritis, migraine, cold and flu symptoms, sore throat and fever.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90bd3b1a-4aa6-454b-a5c6-048640e59a3b.json
90c05070-1fbb-4a53-8fd6-eb0a0a4db008,FEMULEN 500MCG 84 TAB,29C,,,20412,,,,,,tablet,FEMULEN 500MCG,2025-07-31T20:27:20.124142,IL,nan,,,,,,,FEMULEN 500MCG 84 TAB,,,,,units,84.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90c05070-1fbb-4a53-8fd6-eb0a0a4db008.json
90c33403-dad4-4cc7-bc10-ec8cac0019ee,VENCLEXTA 10 MG TABLETS,prescription,L01XX52,VENETOCLAX,7987,,,WHO ATC Classification,,ILS,film coated tablets,VENETOCLAX,2025-07-31T10:04:16.255779,IL,אב-וי,,841.5703887,713.1952764,606.9747033,,,VENCLEXTA 50 MG  7 TABLETS,,,60675,BLISTER PVC/PCTFE/AL,units,7.0,158 19 34868 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaVENCLEXTA in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL), who have received at least one prior therapy.VENCLEXTA in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).Acute Myeloid LeukemiaVENCLEXTA in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90c33403-dad4-4cc7-bc10-ec8cac0019ee.json
90e68b69-cca9-4cd3-8b51-cda5ab478622,CLEXANE,prescription,B01AB05,ENOXAPARIN,6482,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/ML  ML,2025-07-31T01:20:20.419119,IL,סאנופי אוונטיס,,50.02725563,42.39598123,30.9459717,,7290012711121,CLEXANE 60MG SAFETY LOCK 2X0.6ML SYR PREFIL,3991,,84288,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,046 77 26037 11,valid,37.0,"i.v, s.c, extracorporeal",1.4,36,,,,,,,,,,0,Prescription required,"Clexane is indicated in adults for: • Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery. • Prevention of thrombus formation in extra corporeal circulation during haemodialysis. • Acute coronary syndrome: - Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid. - Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90e68b69-cca9-4cd3-8b51-cda5ab478622.json
90f1d05d-970f-4291-a670-4b5bb6443537,ARIXTRA 7.5 MG/0.6 ML,prescription,B01AX05,FONDAPARINUX,6282,,,WHO ATC Classification,,ILS,solution for injection,FONDAPARINUX SODIUM 12.5 MG/ML,2025-07-31T00:25:12.404883,IL,פאדאגיס,,714.4744095,605.4868146,515.3079273,,7290010140329,ARIXTRA 7.5MG/0.6ML 10 PREFIL.SYRINGE,9318,,80582,SYRINGE PREFILLED  GLASS TYPE I,units,10.0,139 52 31589 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adults with acute Deep Vein Thrombosis (DVT) and treatment of acute Pulmonary Embolism (PE), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90f1d05d-970f-4291-a670-4b5bb6443537.json
90f5bd21-53dc-426a-be97-f3248ea4e537,AVODART,prescription,G04CB02,DUTASTERIDE,8466,,,WHO ATC Classification,,ILS,"capsule, soft",DUTASTERIDE 0.5   MG,2025-07-31T02:09:02.217795,IL,תרו יבוא,,133.9406064,113.5089885,84.3933,,,DUTASTERIDE TARO 0.5MG 30 TAB,,,35081,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,128 27 30679 01,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Avodart is indicated for : Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90f5bd21-53dc-426a-be97-f3248ea4e537.json
90fa5327-8c5e-4f99-b765-e0ee506b6d86,GLUBEN,prescription,A10BB01,GLIBENCLAMIDE,1756,,,WHO ATC Classification,,ILS,tablets,GLIBENCLAMIDE,2025-07-31T03:36:22.914438,IL,דקסל פארמה,,40.85406856,34.622092,25.2716,,,GLUBEN 5MG 100TAB,7205,,7941,BLISTER PVC,units,100.0,040 08 20814 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Control of hyperglycemia in stable, mild, nonketosis prone Glibenclamide responsive type II diabetes mellitus, which cannot be controlled by proper dietary management or when insulin therapy is inappropriate.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/90fa5327-8c5e-4f99-b765-e0ee506b6d86.json
911059b5-6379-44b2-840f-2ab2b3c91fff,NORMITEN 100,prescription,C07AB03,ATENOLOL,3371,,,WHO ATC Classification,,ILS,tablets,ATENOLOL,2025-07-31T05:51:48.001094,IL,טבע,,12.625646,10.6997,7.81,,,NORMITEN 25MG 30TAB,14089,,9578,BLISTER PVC/ALUMINIUM,units,30.0,045 35 24916 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of angina pectoris, acute myocardial infarction, hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/911059b5-6379-44b2-840f-2ab2b3c91fff.json
9126ff45-51f2-4b7d-94e8-097532462bae,ALPROLIX 250 IU,29C,B02BD04,COAGULATION FACTOR IX,9001,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR IX (HUMAN- RFIXFC)/VIAL,2025-07-31T13:47:25.577629,IL,nan,,nan,nan,nan,,,ALPROLIX 250 IU,,,,VIAL GLASS TYPE I,units,1.0,171 47 37091 00,valid,nan,i.v,1.4,48,,,,,,,,,,0,,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9126ff45-51f2-4b7d-94e8-097532462bae.json
9130becb-7021-453b-b233-572e3abaa48d,BRIVIACT 10 MG FILM COATED TABLETS,prescription,N03AX23,BRIVARACETAM,8364,,,WHO ATC Classification,,ILS,film coated tablets,BRIVARACETAM,2025-07-30T23:44:03.917826,IL,ניאופרם,,409.6748493,347.1820911,295.4741201,,,BRIVIACT 100 MG 56 TABLETS,2627,,64878,BLISTER PVC/PCTFE/AL,units,56.0,159 88 35241 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9130becb-7021-453b-b233-572e3abaa48d.json
9133c7b9-f76e-42b8-ab86-daed81bd16f5,PEMAZYRE 13.5 MG,prescription,L01EX20,PEMIGATINIB,9029,,,WHO ATC Classification,,ILS,tablets,PEMIGATINIB 13.5  MG,2025-07-31T06:31:37.596010,IL,מדיסון,,34163.00999,28951.70467,26319.73152,,,PEMAZYRE 13.5 MG 14 TABS,,,3038,BLISTER PVC/ALUMINIUM,units,14.0,169 76 36997 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"PEMAZYRE is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as determined by a validated test.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9133c7b9-f76e-42b8-ab86-daed81bd16f5.json
9140d9c7-d3a1-4cae-8270-009224c01b84,VAGIFEM  10 MCG,off-the-counter,G03CA03,ESTRADIOL,7196,,,WHO ATC Classification,,ILS,film coated tablets,ESTRADIOL HEMIHYDRATE,2025-07-31T13:33:34.481726,IL,נובו נורדיסק,,140.3846,118.97,nan,,7290015659215,VAGIFEM 10MCG 24PACKS (4 BLISTER CARDS OF 6 APPLICATORS WITH TAB),,,,BLISTER PVC/ALUMINIUM,units,24.0,146 89 33241 00,valid,nan,vaginal,1.4,36,,,,,,,,,,0,,"Treatment of atrophic vaginitis due to estrogen deficiency in postmenopausal women.The experience treating women older than 65 years is limited.שינוי משטר מינון: 1/7/2019שינויים בעלון לרופא בסעיף Posology:4.2	Posology and method of administrationVagifem is administered intravaginally as a local oestrogen therapy by use of an applicator. Initial dose: One vaginal tablet daily for two weeks. Maintenance dose: One vaginal tablet twice a week.Treatment may be started on any convenient day.If a dose is forgotten, it should be taken as soon as the patient remembers. A double dose should be avoided.For initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see also section 4.4) should be used.For oestrogen products for vaginal application of which the systemic exposure to the oestrogen remains within the normal postmenopausal range, such as Vagifem, it is not recommended to add a progestagen (but  see section 4.4, ‘Special warnings and precautions for use’, ‘Endometrial hyperplasia and carcinoma’).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9140d9c7-d3a1-4cae-8270-009224c01b84.json
9144fe93-567e-48b8-8d58-38baf7dce550,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,7243,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T00:04:10.155024,IL,ניאופרם,,1057.051101,895.8060175,762.3881,,,ABSTRAL 200MCG 30TAB SUBLINGUAL,9668,,46852,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,30.0,148 73 33262 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9144fe93-567e-48b8-8d58-38baf7dce550.json
916b7a80-890d-4d7f-beab-e41dc01c0769,EPREX/PROTECS 5000IU/0.5ML 6SYRINGES,prescription,,,4427,,,,,ILS,tablet,EPREX/PROTECS 5000IU/0. 6SYRINGES,2025-07-31T19:09:00.630211,IL,יאנסן סילג,,1163.243136,985.7992675,838.9781,,,EPREX/PROTECS 5000IU/0.5ML 6SYRINGES,5459,,86982,,units,6.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/916b7a80-890d-4d7f-beab-e41dc01c0769.json
918320d0-6429-4505-87a5-37e2fdbe387c,PLAQUENIL,prescription,P01BA02,HYDROXYCHLOROQUINE,481,,,WHO ATC Classification,,ILS,film coated tablets,HYDROXYCHLOROQUINE SULFATE,2025-07-31T06:45:46.173577,IL,סאנופי אוונטיס,,63.8920247,54.14578605,40.25709,,7290012711275,PLAQUENIL 200MG 100TAB,16018,,1720,BOTTLE HDPE,units,100.0,044 96 23782 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Plaquenil is indicated for the suppressive treatment and treatment of acute attacks of malaria due to Plasmodium vivax, p. malaria. p. ovale and susceptible strains of p. falciparum it is also indicated for the treatment of discoid and sustemic lupus erythematosus and rheumatoid arthritis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/918320d0-6429-4505-87a5-37e2fdbe387c.json
918fd553-c947-4cd5-8d4f-2b8861122e03,ELETRIPTAN - TRIMA 40 MG,prescription,N02CC06,ELETRIPTAN,8055,,,WHO ATC Classification,,ILS,film coated tablets,ELETRIPTAN AS HYDROBROMIDE,2025-07-31T02:13:58.414376,IL,תרימה,,80.88321859,68.5451005,50.9629,,,ELETRIPTAN - TRIMA 40 MG 3 TAB,5622,,58067,BLISTER ALUMINIUM /ALUMINIUM,units,3.0,159 03 34741 00,valid,34.5,per os,1.4,30,,,,,,,,,,0,Prescription required,"Acute treatment of the headache phase of migraine attacks, with or without aura",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/918fd553-c947-4cd5-8d4f-2b8861122e03.json
9199ac89-b783-4fa8-98b4-0775287d85d0,BONDORMIN,prescription,N05CD09,BROTIZOLAM,3850,,,WHO ATC Classification,,ILS,tablets,BROTIZOLAM 0.25  MG,2025-07-30T23:44:41.305505,IL,טבע,,15.51936,13.152,9.6,,7290008013932,BROTIZOLAM TEVA 0.25MG 10TAB,2006,,26083,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,120 37 26021 12,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Insomnia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9199ac89-b783-4fa8-98b4-0775287d85d0.json
91b0d94a-233a-439b-be97-ae3f9de4d18b,VPRIV 400,prescription,A16AB10,VELAGLUCERASE ALFA,6707,,,WHO ATC Classification,,ILS,lyophilized powder for solution for infusion,VELAGLUCERASE ALFA 400 U/VIAL,2025-07-31T10:23:07.784969,IL,טקדה,,6779.624976,5745.445151,5223.131955,,7290008128018,VPRIV 400U/VIAL 1 VIAL 20ML,22344,,85677,VIAL 20 ML GLASS TYPE I,units,1.0,146 02 33234 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,VPRIV is a hydrolytic  glucocerebroside – specific enzyme indicated for the long term replacement therapy (ERT) for pediatric and adult patients with type 1 Gaucher disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/91b0d94a-233a-439b-be97-ae3f9de4d18b.json
91b0f417-2454-464f-b0a5-cef76928b60c,IMBRUVICA 140 MG TABLETS,prescription,L01XE27,IBRUTINIB,9155,,,WHO ATC Classification,,ILS,film coated tablets,IBRUTINIB,2025-07-31T04:00:54.832338,IL,יאנסן סילג,,32329.80943,27398.1448,24907.40437,,7290014577688,IMBRUVICA 560 MG 30 FILM COATED TABLETS,9155,,74058,BLISTER PVC/PCTFE/AL,units,30.0,167 61 36458 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"•	Mantle Cell Lymphoma:Imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.•	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma :Imbruvica is indicated for the treatment of adult patients, with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)•	Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) with 17p deletion:Imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)  /Small Lymphocytic Lymphoma (SLL) with 17p deletion.•	Waldenström’s MacroglobulinemiaImbruvica is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).•	Marginal Zone LymphomaIMBRUVICA is indicated for the treatment of adult patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.•	Chronic Graft versus Host DiseaseIMBRUVICA is indicated for the treatment of adult patients with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/91b0f417-2454-464f-b0a5-cef76928b60c.json
91b5ca69-ea62-488e-b63b-3358c7027df0,DULOXETINE S.K. 30 MG,prescription,N06AX21,DULOXETINE,8862,,,WHO ATC Classification,,ILS,gastro resistant capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T02:05:57.716010,IL,SK PHARM(KS KIM),,66.01605934,55.945813,41.5954,,,DULOXETINE S.K. 30 MG 28 CAPS,4732,,70645,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,166 93 35645 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Duloxetine is indicated for:- The treatment of major depressive episodes.- The management of neuropathic pain associated with diabetic peripheral neuropathy.- The treatment of generalized anxiety disorder (GAD).- The management of fibromyalgia.- The management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. This has been established in studies in patients with chronic low back pain (CLBP) and chronic pain due to osteoarthritis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/91b5ca69-ea62-488e-b63b-3358c7027df0.json
91cd9dbd-5cd8-4763-98a0-16a3201a8cea,ENDOXAN 1 G INJECTION,prescription,L01AA01,CYCLOPHOSPHAMIDE,4081,,,WHO ATC Classification,,ILS,powder for solution for injection,CYCLOPHOSPHAMIDE/VIAL,2025-07-31T02:21:45.477217,IL,מגאפארם,,48.93761255,41.47255485,30.27193785,,7290004448271,ENDOXAN 500MG/25ML 1INJ,5065,,26705,VIAL GLASS TYPE I,units,1.0,144 19 29660 02,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Malignant Diseases: Cycophosphamide although effective alone in susceptible melignancies  is more frequently used concurrently or sequentially with other antineoplastic drugs. The following malignancies are often susceptible.  Cycophosphamide treatment:   1) Malignant lymphomas (Stages III and IV of the Ann Arbor staging system)  Hodgkin`s disease  lymphocytic lymphoma (nodular or diffuse)  mixed-cell type lymphoma  histiocytic lymphoma  Burkitt`s lymphoma.   2) Multiple myeloma.   3) Leukemias: Chronic lymphocytic leukemia  chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis)  acute myelogenous and monocytic leukemia  acute lymphoblastic (stemcell) leukemia in children.   4) Mycosis fungoides (advenced disease).   5) Neuroblastoma (disseminated disease).   6) Adenocarcinoma of the ovary.  7) Retinoblastoma.   8) Carcinoma of the breast.   Nonmallgnant Disease Biopsy proven ""Minimal Change"" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. Severe cases of systemic lupus Erythematos as which did not respond to other treatment  especially with nephritis",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/91cd9dbd-5cd8-4763-98a0-16a3201a8cea.json
91e0c3ba-5d70-488a-b51a-1c7166cf62db,BENEFIX 1000 IU/VIAL,prescription,B02BD04,COAGULATION FACTOR IX,6730,,,WHO ATC Classification,,ILS,lyophilized powder for injection,COAGULATION FACTOR IX RECOMBINANT-RFIX/VIAL,2025-07-31T00:30:22.228320,IL,פיזר,,4777.88532,4049.055536,3680.959578,,8470006591734,BENEFIX 2000IU/VIAL I.V 1 VIAL,2634,,74099,VIAL GLASS TYPE I,units,1.0,120 57 30123 01,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (PTP) and previously untreated patients (PUP). Benefix  is not indicated for the treatment of other factor deficiencies (e.g. factors II,VII, and X)' nor for the treatment of hemophilia A patients with inhibitors to factor VIII, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/91e0c3ba-5d70-488a-b51a-1c7166cf62db.json
91e1555e-1dc1-4882-b8b4-3da37e4b48df,TUBERSOL,prescription,,,6970,,,,,ILS,solution for injection,TUBERCULIN PURIFIED PROTEIN 5 TU / 0.1  ML,2025-07-31T09:48:20.740385,IL,סאנופי אוונטיס,,153.20825,129.8375,103.87,,7290101533870,TUBERSOL 5 TU/0.1ML 1VIAL (1ML),,,77963,VIAL GLASS TYPE I,units,1.0,140 77 23830 00,valid,25.0,intradermal,1.4,48,,,,,,,,,,0,Prescription required,An aid in the detection of infection with mycobacterium tuberculosis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/91e1555e-1dc1-4882-b8b4-3da37e4b48df.json
91eaf8f4-b8f4-4fbb-9674-22a1b82b568b,BESPONSA,prescription,L01XC26,INOTUZUMAB OZOGAMICIN ,8286,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,INOTUZUMAB OZOGAMICIN/VIAL,2025-07-30T23:36:09.997160,IL,פיזר,,50769.97361,43025.40328,39114.00298,,7290013592477,BESPONSA 1 VIAL,2673,,25210,VIAL GLASS TYPE I,units,1.0,160 79 35350 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,BESPONSA is indicated as monotherapy for the treatment of adults with relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL). Adult patients with Philadelphia chromosome positive (Ph+) relapsed or refractory B cell precursor ALL should have failed treatment with at least 1 tyrosine kinase inhibitor (TKI).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/91eaf8f4-b8f4-4fbb-9674-22a1b82b568b.json
91ee5580-cd5d-4c15-a77f-acd7e1cbeca1,BENLYSTA I.V. 120 MG,prescription,L04AA26,BELIMUMAB,6839,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BELIMUMAB,2025-07-31T00:30:49.353921,IL,ג.ס.ק,,761.6880637,645.4983878,549.36033,,7290010140893,BENLYSTA 1X120MG POWD FOR CONCENTRATE FOR INF VIAL 5ML,84606,,20519,VIAL GLASS TYPE I,units,1.0,147 37 33499 00,valid,17.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Benlysta is indicated as add-on therapy in patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) with a high degree of disease activity (e.g., positive anti-dsDNA and low complement) despite standard therapy.Benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/91ee5580-cd5d-4c15-a77f-acd7e1cbeca1.json
9200bc1d-740e-4fe7-a94b-924a3097c53a,COMBANTRIN 125MG/2.5ML 15ML 1BOTTLE,29C,,,20339,,,,,,tablet,COMBANTRIN 125MG/2. 1BOTTLE,2025-07-31T20:07:47.658697,IL,nan,,,,,,,COMBANTRIN 125MG/2.5ML 15ML 1BOTTLE,,,,,units,1.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9200bc1d-740e-4fe7-a94b-924a3097c53a.json
9200f2ad-2225-41c9-bbbe-37a620d0d8f1,AVAMYS,prescription,R01AD12,FLUTICASONE FUROATE,6400,,,WHO ATC Classification,,ILS,spray,FLUTICASONE FUROATE 27.5  MCG/ACTUATION,2025-07-31T00:27:06.063702,IL,ג.ס.ק,,36.11394938,30.60504321,22.3394476,,,AVAMYS 27.5MCG/DOSE 120DOSES,9341,,84222,BOTTLE AMBER GLASS TYPE I,units,120.0,141 80 31837 00,valid,37.0,nasal,1.4,36,,,,,,,,,,0,Prescription required,AVAMYS (fluticasone furoate) Nasal Spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9200f2ad-2225-41c9-bbbe-37a620d0d8f1.json
922d0c86-0910-4d68-8da1-570c9769bee2,VENLA 37.5,prescription,N06AX16,VENLAFAXINE,4712,,,WHO ATC Classification,,ILS,tablets,VENLAFAXINE AS HYDROCHLORIDE 37.5   MG,2025-07-31T10:04:27.792345,IL,אוניפארם,,25.28556392,21.428444,15.6412,,,VENLA 37.5MG 28TAB,22241,,59681,BLISTER PVC/ALUMINIUM,units,28.0,129 98 30902 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For treatment of depression.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/922d0c86-0910-4d68-8da1-570c9769bee2.json
922d3aa1-058b-4298-990f-c5ddca879317,MIDODRINE HYDROCHLORIDE MORNINGSIDE 2.5 MG,prescription,C01CA17,MIDODRINE,9156,,,WHO ATC Classification,,ILS,tablets,MIDODRINE HYDROCHLORIDE 2.5  MG,2025-07-31T05:21:52.939037,IL,טרוסטפארם,,267.7532453,226.90954,181.527632,,,MIDODRINE MORNINGSIDE 2.5 MG 100 TABLETS,,,47054,BLISTER PVC/ALUMINIUM,units,100.0,170 54 36873 99,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Midodrine hydrochloride 2.5 mg tablets are indicated in adults for the treatment of severe orthostatic hypotension due to autonomic dysfunction when corrective factors have been ruled out and other forms of treatment are inadequate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/922d3aa1-058b-4298-990f-c5ddca879317.json
923387cf-07ac-4ae8-ba56-6dc6ab6ba3d0,L-THYROXINE SERB,29C,H03AA01,LEVOTHYROXINE SODIUM,20494,,,WHO ATC Classification,,ILS,solution for injection/ concentrate for solution for infusion,LEVOTHYROXINE SODIUM 0.2  MG /,2025-07-31T15:00:30.306107,IL,nan,,nan,nan,nan,,7290015863155,LEVOTHYROXINE 500MCG 1VIAL,,,,AMPOULES GLASS TYPE I,units,1.0,165 27 35356 00,valid,nan,"i.m, i.v",1.4,24,,,,,,,,,,0,,•Myxedema coma•Replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/923387cf-07ac-4ae8-ba56-6dc6ab6ba3d0.json
923a879b-8736-4ca3-a4a2-bd5a11d5831f,BETACORTEN G OINTMENT,prescription,D07AC01,BETAMETHASONE,2172,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS VALERATE 0.1 %W/W, GENTAMICIN AS SULFATE 0.1 %W/W",2025-07-31T00:33:22.956949,IL,תרימה,,15.7763994,13.36983,9.759,,,BETACORTEN TOPICAL SCALP  APPL SOL 30ML,2070,,344,TUBE ALUMINIUM,units,30.0,050 45 23262 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,For local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/923a879b-8736-4ca3-a4a2-bd5a11d5831f.json
923c5c2b-3586-45d4-878c-801997b8de21,LAMISIL ONCE,off-the-counter,,,5219,,,,,ILS,solution,TERBINAFINE AS HYDROCHLORIDE/G,2025-07-31T12:17:24.974654,IL,ג.ס.ק,,49.9612,42.34,nan,,7290011363437,LAMISIL DERMGEL 15GR,12380,,,TUBE ALUMINIUM,units,15.0,137 26 31486 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,For the treatment of athlete's foot.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/923c5c2b-3586-45d4-878c-801997b8de21.json
92480c70-8d41-4e7d-aa94-64670b14f88a,RIZATRIPTAN MELT INOVAMED 10 MG,prescription,N02CC04,RIZATRIPTAN,8043,,,WHO ATC Classification,,ILS,tablets orodispersible,RIZATRIPTAN AS BENZOATE,2025-07-31T07:47:15.254729,IL,אינובמד,,208.210056,176.4492,141.15936,,,RIZATRIPTAN MELT INOVAMED 10 MG 12 TAB,18554,,54752,BLISTER ALU/PVC/ALU,units,12.0,155 09 34154 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the acute treatment of migraine attacks with or without aura in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92480c70-8d41-4e7d-aa94-64670b14f88a.json
92720db6-20f2-412b-a4bf-3608fc0de54d,AMIKACIN - MEDO,prescription,J01GB06,AMIKACIN,8622,,,WHO ATC Classification,,ILS,solution for injection / infusion,AMIKACIN AS SULFATE/,2025-07-30T23:21:53.216004,IL,מדי מרקט,,139.4230475,118.155125,94.5241,,7290015841214,AMIKACIN - MEDO 500mg/2ml 10 amp,,,35613,AMPOULES GLASS TYPE I,units,10.0,163 08 35426 00,valid,25.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"AMIKACIN - MEDO is indicated in the short-term treatment of Gram-negative organisms, including pseudomonas and some Gram-positive organisms.Sensitive Gram-negative organisms include; Pseudomonas aeruginosa, Escherichia coli., indole-positive and indole-negative Proteus spp., Klebsiella, Enterobacter and Serratia spp., Minea-Herralae, Citrobacter freundii, Salmonella, Shigella, Acinetobacter and Providencia spp.The principal Gram-positive organism sensitive to amikacin is Staphylococcus aureus, including some methicillin-resistant strains. AMIKACIN - MEDO has some activity against other Gram-positive organisms including certain strains of Streptococcus pyogenes, Enterococci and Diplococcus pneumoniae.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92720db6-20f2-412b-a4bf-3608fc0de54d.json
92934517-5ac1-46e7-889d-cea08f445087,"DARZALEX 120 MG/ML S.C. 1,800 MG",prescription,L01XC24,DARATUMUMAB,7808,,,WHO ATC Classification,,ILS,solution for injection,DARATUMUMAB/,2025-07-31T01:41:55.400223,IL,יאנסן סילג,,7552.559401,6400.474353,5818.613048,,7290014577657,DARZALEX 20MG/ML VIAL 400MG/20ML,4669,,60535,VIAL GLASS TYPE I,units,20.0,167 14 36565 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"DARZALEX is indicated:Multiple Myeloma• in combination with lenalidomide and dexamethasone or with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.• in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant.• in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.• as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who have demonstrated disease progression on the last therapy.•for the treatment of adult patients with multiple myeloma in combination with pomalidomide and dexamethasone in patients who have received at least one prior line of therapy including lenalidomide and a proteasome inhibitor.Light chain (AL) amyloidosis• in combination with cyclophosphamide, bortezomib and dexamethasone for the treatment of adult patients with newly diagnosed systemic AL amyloidosis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92934517-5ac1-46e7-889d-cea08f445087.json
9295eff0-e6f7-4637-b4fe-52f894bb10b0,NICOTINELL LOZENGES 1 MG,off-the-counter,,,2504,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:29:58.414086,IL,ג.ס.ק,,109.7046,92.97,nan,,,NICOTINEL TTS 30 7S,14481,,,BLISTER PVC/PE/PVDC/AL,units,7.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9295eff0-e6f7-4637-b4fe-52f894bb10b0.json
92a1f1fc-b02d-4d23-9a1c-50e787b542e6,FINASTERIDE TEVA,prescription,G04CB01,FINASTERIDE,7565,,,WHO ATC Classification,,ILS,film coated tablets,FINASTERIDE,2025-07-31T03:04:21.286331,IL,טבע,,465.4588647,394.456665,335.7078,,,FINASTERIDE TEVA 1MG 100TAB,6547,,58972,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,140 59 31427 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Finasteride Teva 1 mg is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92a1f1fc-b02d-4d23-9a1c-50e787b542e6.json
92b0c4b0-a354-4e14-82e0-36c59f38d6bf,RECTOZORIN OINTMENT,off-the-counter,C05AX02,"BISMUTH PREPARATIONS, COMBINATIONS",1669,,,WHO ATC Classification,,ILS,ointment,"ZINC OXIDEW/W, BENZOCAINEW/W, MENTHOL 0.25 %W/W, BISMUTH OXYCHLORIDEW/W, THYMOL BIIODIDEW/W",2025-07-31T12:54:24.877042,IL,טבע,,32.7922,27.79,nan,,7290000802282,RECTOZORIN OINT 50GR,18173,,,TUBE ALUMINIUM,units,50.0,135 34 20466 00,valid,nan,topical annal,1.4,36,,,,,,,,,,0,,"Symptomatic relief of pain and discomfort in irritated anorectal tissues in: hemorrhoids, proctitis, papillitis, cryptitis, fissures and following anorectal surgery.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92b0c4b0-a354-4e14-82e0-36c59f38d6bf.json
92bc804f-19d6-48dc-ad5a-11f73da55a68,ICLUSIG 15 MG,prescription,L01XE24,PONATINIB,7657,,,WHO ATC Classification,,ILS,coated tablets,PONATINIB AS HYDROCHLORIDE,2025-07-31T03:56:37.497410,IL,מדיסון,,22962.71841,19459.93172,17690.84702,,,ICLUSIG 45MG 30 COATED TAB,9803,,67449,BOTTLE HDPE,units,30.0,153 53 34243 02,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Iclusig is indicated in adult patients with:  • chronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (CML) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the T315I mutation  • Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the T315I mutation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92bc804f-19d6-48dc-ad5a-11f73da55a68.json
92c48234-baa3-4ddb-97ce-5096db6e27cb,ONBREZ BREEZHALER 150MCG INHAL 30 HARD CAPS,prescription,,,6656,,,,,ILS,capsule,ONBREZ BREEZHALER 150MCG INHAL 30 HARD CAPS,2025-07-31T19:25:38.459227,IL,נוברטיס פארמה,,137.6686584,116.6683597,86.7422749,,,ONBREZ BREEZHALER 150MCG INHAL 30 HARD CAPS,15380,,24232,,units,30.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92c48234-baa3-4ddb-97ce-5096db6e27cb.json
92cf5ad1-c5e9-42c4-b0a2-491124706be1,DERMACOMBIN CREAM,prescription,D07CB01,TRIAMCINOLONE AND ANTIBIOTICS,2059,,,WHO ATC Classification,,ILS,cream,"NYSTATIN/G, GRAMICIDIN 0.25 MG/G, NEOMYCIN AS SULFATE 2.5 MG/G, TRIAMCINOLONE ACETONIDE/G",2025-07-31T01:48:42.739776,IL,תרו,,nan,nan,nan,,7290000809113,DERMACOMBIN CREAM 5G,4071,,634,TUBE ALUMINIUM,units,5.0,133 54 23775 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,Prescription required,"For the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92cf5ad1-c5e9-42c4-b0a2-491124706be1.json
92e89d48-23ce-4b8d-908f-d2f0f5dc990c,IXIFI,prescription,L04AB02,INFLIXIMAB,8568,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,INFLIXIMAB,2025-07-31T04:15:06.143178,IL,פיזר,,2305.677508,1953.96399,1776.3309,,,IXIFI 100MG/VIAL,,,753,VIAL GLASS TYPE I,units,1.0,162 94 35522 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis:IXIFI, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in:• adult patients with active disease when the response to disease modifying antirheumatic drugs (DMARDs),including methotrexate, has been inadequate.• adult patients with severe, active and progressive disease not previously treated with methotrexate or other DMARDs.In these patient populations, a reduction in the rate of the progression of joint damage, as measured by X ray, has been demonstrated.* Ankylosing spondylitis:IXIFI is indicated for treatment of severe, active ankylosing spondylitis, in adult patients who have responded inadequately to conventional therapy.* Psoriatic arthritis:IXIFI is indicated for treatment of active and progressive psoriatic arthritis in adult patients when the response to previous DMARD therapy has been inadequate.* IXIFI should be administered:• in combination with methotrexate• or alone in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated.Infliximab has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.* Psoriasis:IXIFI is indicated for treatment of moderate to severe plaque psoriasis in adult patients who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or psoralen ultra-violet A (PUVA)* Adult Crohn’s diseaseIXIFI is indicated for treatment :• of moderately to severely active Crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.• treatment of fistulising, active Crohn’s disease, in adult patients who have not responded despite a full and adequate course of therapy with conventional treatment (including antibiotics, drainage and immunosuppressive therapy).* Ulcerative colitis• IXIFI is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6 mercaptopurine (6 MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92e89d48-23ce-4b8d-908f-d2f0f5dc990c.json
92f7e316-169d-4058-940b-635d576a0109,ALPRALID 0.25,prescription,N05BA12,ALPRAZOLAM,3285,,,WHO ATC Classification,,ILS,tablets,ALPRAZOLAM 0.25   MG,2025-07-30T23:20:29.903531,IL,כ.צ.ט,,10.718058,9.0831,6.63,,,ALPRALID 0.25MG 30TAB,1143,,9494,BLISTER PVC/ALUMINIUM,units,30.0,137 10 28371 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of symptoms of tension and anxiety, anxiety accompanied by depression and in panic states with or without phobia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/92f7e316-169d-4058-940b-635d576a0109.json
9300b242-f1fa-436e-9998-0489a9e52a38,M.I.R. 15,prescription,N02AA01,MORPHINE,1864,,,WHO ATC Classification,,ILS,tablets,MORPHINE SULFATE,2025-07-31T05:02:56.924276,IL,רפא,,28.25962168,23.948833,17.4809,,7290008014076,M.I.R 15MG 20TAB,13464,,8342,BLISTER PVC/ALUMINIUM,units,20.0,033 83 25309 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of moderate to severe pain.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9300b242-f1fa-436e-9998-0489a9e52a38.json
93105422-d549-4adb-a378-63cf28a84953,VFEND 200 MG POWDER FOR SOLUTION FOR INFUSION,prescription,J02AC03,VORICONAZOLE,4610,,,WHO ATC Classification,,ILS,powder for solution for infusion,VORICONAZOLE/VIAL,2025-07-31T10:10:16.935343,IL,פיזר,,1740.010498,1474.585168,1254.9661,,7680559450025,VFEND 200MG 14TAB,22084,,55087,VIAL GLASS TYPE I,units,14.0,126 71 30598 12,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of :- invasive aspergillosis  fluconazole-resistant serious invasive Candida infections (including C. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive  possibly life-threatening infections.   - Treatment of candidemia in non neutropenic patients.- Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/93105422-d549-4adb-a378-63cf28a84953.json
93285576-b2f1-499c-ba09-3f6abda7476b,DECAPEPTYL DEPOT 22.5 MG,prescription,L02AE04,TRIPTORELIN,7850,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,TRIPTORELIN AS EMBONATE 22.5  MG,2025-07-31T01:44:24.443031,IL,פרינג,,2488.229422,2108.669096,1916.971905,,7640128545415,DECAPEPTYL DEPOT 22.5 MG VIAL,4646,,33000,VIAL GLASS TYPE I,units,1.0,154 61 34193 00,valid,10.0,i.m,1.4,48,,,,,,,,,,0,Prescription required,"Symptomatic treatment of advanced hormone-dependent prostate cancer. As an alternative treatment, if orchiectomy or the administration of oestrogens are not indicated or are unacceptable to the patient. Treatment of central precocious puberty (CPP) in children 2 years and older with an onset of CPP before 8 years in girls and 10 years in boys.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/93285576-b2f1-499c-ba09-3f6abda7476b.json
932c5d1d-5987-4f0e-9532-ee09133722d0,IFO-CELL 2 G,29C,L01AA06,IFOSFAMIDE,20457,,,WHO ATC Classification,,ILS,solution for infusion,IFOSFAMIDE/,2025-07-31T14:49:14.174026,IL,nan,,nan,nan,nan,,7290016369045,IFO-CELL 40MG/ML (IFOSFAMIDE 40MG/ML) VIAL,,,,VIAL GLASS TYPE I,units,1.0,155 73 34214 00,valid,nan,i.v,1.4,18,,,,,,,,,,0,,"• Testicular tumours For combination chemotherapy in patients with advanced stage II to IV tumours according to the TNM classification (seminomas and non-seminomas), which do not respond or adequately respond to initial chemotherapy.• Cervical cancerPalliative cisplatin/ifosfamide combination chemotherapy (without any other combination partners) of cervical carcinoma, FIGO stage IV B (when curative therapy of the disease is not possible with surgery or radiotherapy) – as an alternative to palliative radiotherapy.• Breast cancerFor palliative therapy in advanced, therapy-refractory or recurrent breast cancer.• Non-small-cell lung cancerFor mono- or combination chemotherapy of patients with inoperable or metastatic tumours.• Small-cell lung cancerFor combination chemotherapy.• Soft-tissue sarcoma (incl. osteosarcoma and rhabdomyosarcoma)For mono- or combination chemotherapy of rhabdomyosarcoma or osteosarcoma after failure of standard therapies. For mono- or combination chemotherapy of other soft-tissue sarcomas after failure of surgery and radiation therapy.• Ewing’s sarcomaFor combination chemotherapy after failure of primary cytostatic therapy.• Non-Hodgkin’s lymphomaFor combination chemotherapy in patients with highly malignant non-Hodgkin’s lymphoma which does not respond, or only insufficiently responds, to the initial therapy. For combination therapy of patients with recurrent tumours.• Hodgkin’s diseaseFor the treatment of patients with primary progressive forms and early relapse of Hodgkin’s disease (duration of complete remission shorter than one year) after failure of primary chemotherapeutic or radiochemotherapeutic treatment – as part of a recognised combination chemotherapy regimen, such as the MINE protocol.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/932c5d1d-5987-4f0e-9532-ee09133722d0.json
932d51f0-d332-41a2-8ca6-3b1e0215b5a5,TIPTIPOT CLEAN-AF,off-the-counter,A12CA01,SODIUM CHLORIDE,3702,,,WHO ATC Classification,,ILS,"nasal drops, solution",SODIUM CHLORIDE 0.9 %W/V,2025-07-31T11:25:26.582351,IL,פלוריש,,15.1984,12.88,nan,,,CLEAN-AF SOL 20ML,3404,,,BOTTLE LDPE,units,20.0,178 01 38142 99,valid,nan,nasal,1.4,36,,,,,,,,,,0,,For the relief of nasal congestion in children and infants.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/932d51f0-d332-41a2-8ca6-3b1e0215b5a5.json
93366a55-4343-49c5-b773-f98a273cbee5,GATTEX,prescription,A16AX08,TEDUGLUTIDE,7377,,,WHO ATC Classification,,ILS,powder for solution for injection,TEDUGLUTIDE/VIAL,2025-07-31T03:28:09.805712,IL,ניאופרם,,94562.62784,80137.82376,72852.56706,,,GATTEX 5MG/VIAL  30 VIAL,7940,,61837,VIAL GLASS TYPE I,units,30.0,152 48 33962 00,valid,10.0,s.c,1.4,48,,,,,,,,,,0,Prescription required,Gattex is indicated for the treatment of patients aged 1 year and above with Short Bowel Syndrome. Patients should be stable following a period of intestinal adaptation after surgery.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/93366a55-4343-49c5-b773-f98a273cbee5.json
933b6ae1-51de-4287-ab50-f7dda9d37731,RYALTRIS,prescription,R01AD59,"MOMETASONE, COMBINATIONS ",9245,,,WHO ATC Classification,,ILS,"nasal spray, suspension","MOMETASONE FUROATE (AS MONOHYDRATE)/DELIVERED DOSE, OLOPATADINE AS HYDROCHLORIDE/DELIVERED DOSE",2025-07-31T07:54:30.936313,IL,SK PHARM(KS KIM),,78.02326727,66.12141588,49.160904,,,RYALTRIS  SUSPENSION 240 DOSES,18714,,53553,BOTTLE METERED DOSE SPRAY HDPE,units,240.0,174 78 37350 99,valid,34.5,nasal,1.4,36,,,,,,,,,,0,Prescription required,Ryaltris is indicated in adults and adolescents 12 years of age and older for the treatment of moderate to severe nasal symptoms associated with allergic rhinitis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/933b6ae1-51de-4287-ab50-f7dda9d37731.json
934a6f93-638f-44e2-b78f-fabf4f0a5583,NORMALOL 100,prescription,C07AB03,ATENOLOL,3333,,,WHO ATC Classification,,ILS,tablets,ATENOLOL,2025-07-31T05:51:26.917009,IL,דקסל פארמה,,12.625646,10.6997,7.81,,,NORMALOL 25MG 30TAB,14081,,9546,BLISTER PVC/ALUMINIUM,units,30.0,052 39 26224 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of angina pectoris, acute myocardial infarction, hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/934a6f93-638f-44e2-b78f-fabf4f0a5583.json
9355aa42-e9a3-4a9f-9eb4-7a8bb61ac2b5,COPAXONE ® 40 MG/ML,prescription,L03AX13,GLATIRAMER ACETATE,6121,,,WHO ATC Classification,,ILS,solution for injection,GLATIRAMER ACETATE,2025-07-31T01:30:01.178839,IL,טבע,,2550.815625,2161.708253,1965.189321,,,COPAXONE 20MG/DOSE 28 PREFILLED SYRINGE,3925,,21055,PREFILLED PEN GLASS TYPE I,units,28.0,151 75 34057 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Copaxone 40 mg/ml is indicated for reducing the frequency of relapses in patients with relapsing-remitting multiple sclerosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9355aa42-e9a3-4a9f-9eb4-7a8bb61ac2b5.json
9366f9d1-df9d-4d3f-8020-e071856d35ca,IMOVAX DT,prescription,J07AM51,"TETANUS TOXOID, COMBINATIONS WITH DIPHTHERIA TOXOID",7532,,,WHO ATC Classification,,ILS,suspension for injection,"DIPHTHERIA TOXOID/ 0.5  ML, TETANUS TOXOID/ 0.5  ML, ALUMINIUM HYDROXIDE 0.6  MG / 0.5  ML",2025-07-31T04:03:52.678753,IL,סאנופי אוונטיס,,82.76034157,70.1358858,52.14564,,7290101534525,IMOVAX POLIO SYRINGE PREFILLED 1X0.5ML,9915,,36907,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,144 62 33232 00,valid,34.5,"i.m, s.c",1.4,36,,,,,,,,,,0,Prescription required,"This vaccine is indicated for adults over 18 years of age in the following cases:- routine booster vaccinations against diphtheria and tetanus. The diphtheria toxoid content is reduced to one tenth of the normal dose to minimize the risks of a severe hypersensitivity reaction.- primary vaccination.- post-exposure prophylaxis following a tetanus-prone wound, if a booster diphtheria injection is required.This adsorbed diphtheria and tetanus vaccine may be administered as a booster vaccination in children over 10 years of age in whom poliomyelitis is prevented by separate administration of poliomyelitis vaccine.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9366f9d1-df9d-4d3f-8020-e071856d35ca.json
937000a1-e8eb-4bd3-a061-69421fd01e5c,LANOXIN ELIXIR,prescription,C01AA05,DIGOXIN,1110,,,WHO ATC Classification,,ILS,elixir,DIGOXIN 0.05  MG /,2025-07-31T04:35:15.562077,IL,פאדאגיס,,23.0893439,19.56724146,14.282658,,7290008105064,LANOXIN PEDI ELX 60ML,12019,,1167,BOTTLE AMBER GLASS,units,60.0,126 96 30673 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Lanoxin is indicated whenever digitalis therapy is required for the treatment of congestive heart failure, atrial fibrilation and/or flutter and supra-ventricular tachycardia.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/937000a1-e8eb-4bd3-a061-69421fd01e5c.json
939eceaa-5a6c-43e3-8cfa-12002b488116,KERENDIA 10 MG,prescription,C03DA05,FINERENON,9212,,,WHO ATC Classification,,ILS,film coated tablets,FINERENON,2025-07-31T04:24:50.606843,IL,באייר,,276.4300432,234.2627589,187.4102071,,,KERENDIA 10 MG 28 F.C.T,,,89209,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,171 38 37226 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Kerendia is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/939eceaa-5a6c-43e3-8cfa-12002b488116.json
93c56eb4-6c82-4174-91e2-d373f673fdbf,RADIAN B SPRAY,off-the-counter,,,5022,,,,,ILS,spray,"MENTHOL 1.4 %, ACETYLSALICYLIC ACID 1.2 %, CAMPHOR 0.6 %, METHYL SALICYLATE 0.6 %",2025-07-31T12:53:14.331977,IL,דפריס,,43.9668,37.26,nan,,5011309143010,RADIAN B SPRAY 100ML,18007,,,BOTTLE HDPE,units,100.0,137 63 24791 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Relief of light muscular and rheumatic pains.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/93c56eb4-6c82-4174-91e2-d373f673fdbf.json
93d5f6a8-9120-4a1d-87ad-37518d4658de,TORID 10MG 3OTAB,prescription,,,4795,,,,,ILS,tablet,TORID 10MG 3OTAB,2025-07-31T19:34:18.384094,IL,אוניפארם,,24.426826,20.7007,15.11,,,TORID 10MG 3OTAB,20547,,17777,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/93d5f6a8-9120-4a1d-87ad-37518d4658de.json
93e67f0f-94f5-40ca-a23c-66105533c90e,SINGULAIR 10 MG TABLETS,prescription,R03DC03,MONTELUKAST,6230,,,WHO ATC Classification,,ILS,tablets,MONTELUKAST AS SODIUM,2025-07-31T08:17:41.018494,IL,אורגנון,,69.59798533,58.9813435,43.8523,,7290004997410,SINGULAIR 4MG PRESCHOOL KIDS 28 CHEWTAB,19444,,3149,BLISTER PVC/OPA/AL,units,28.0,109 91 29317 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.   Singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.Because the benefits of SINGULAIR may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see Warnings and Precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/93e67f0f-94f5-40ca-a23c-66105533c90e.json
93f5adba-980e-47ef-8104-c93c21e39c57,ALINIA 500MG 60TAB,29C,,,20281,,,,,,tablet,ALINIA 500MG,2025-07-31T19:52:17.626067,IL,nan,,,,,,,ALINIA 500MG 60TAB,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/93f5adba-980e-47ef-8104-c93c21e39c57.json
93fc17d0-ab19-41e0-bb25-2a4d0ca67ad3,ENDOMETRIN,prescription,G03DA04,PROGESTERONE,6395,,,WHO ATC Classification,,ILS,vaginal tablets,PROGESTERONE,2025-07-31T02:21:14.529106,IL,פרינג,,235.4553821,199.5384683,159.6307746,,,ENDOMETRIN 100MG 30 VAG.TAB,5016,,52175,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,126 08 29832 00,valid,25.0,vaginal,1.4,36,,,,,,,,,,0,Prescription required,Progesterone supplementation or replacement in cases such as treatment of infertile women and IVF.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/93fc17d0-ab19-41e0-bb25-2a4d0ca67ad3.json
9401bbb8-ee18-41c2-8198-d2e5a1f7e7a8,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,6023,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T02:58:15.977149,IL,רפא,,211.794365,179.48675,143.5894,,,FENTA 75 5 PATCH,6399,,71215,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,5.0,148 73 33262 01,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9401bbb8-ee18-41c2-8198-d2e5a1f7e7a8.json
94055d11-2b58-4bd4-bb57-c5ad7e4bd84c,CIALIS 10 MG,prescription,G04BE08,TADALAFIL,4633,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T01:10:35.605614,IL,אלי לילי,,445.8071683,377.802685,321.5342,,,CIALIS 20MG 8TAB,3743,,57625,BLISTER PVC/PE/PCTFE/AL,units,8.0,128 19 30677 21,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/94055d11-2b58-4bd4-bb57-c5ad7e4bd84c.json
94075faf-d48a-433c-bfcf-82aff30ab253,CANEPHRON (TM),off-the-counter,,,5616,,,,,ILS,coated tablets,"ROSEMARY LEAF, LOVAGE ROOT, CENTAURIUM ERYTHRAEA",2025-07-31T11:22:58.866003,IL,דר סמואלוב,,85.727,72.65,nan,,7290010222414,CANEPHRON (TM)  30 COATED TABLETS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,171 02 36663 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Canephron is a traditional herbal medicinal product for supportive treatment and as an adjuvant to specific measures in cases of mild complaints (such as frequent urination, burning micturition, and the increased urge to urinate) caused by inflammatory diseases of the efferent urinary tract, in adults and children from the age of 12 years.The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/94075faf-d48a-433c-bfcf-82aff30ab253.json
9411f92a-fb00-4b09-914f-cb795d3ce439,JORVEZA 0.5 MG,prescription,A07EA06,BUDESONIDE,9497,,,WHO ATC Classification,,ILS,tablets orodispersible,BUDESONIDE 0.5  MG,2025-07-31T04:19:53.011088,IL,רפא,,1423.762895,1206.578778,1026.875556,,,JORVEZA 0.5 MG 90 TAB ORODISPERSIBLE,,,31289,BLISTER ALUMINIUM /ALUMINIUM,units,90.0,172 53 36975 99,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of eosinophilic esophagitis (EoE) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9411f92a-fb00-4b09-914f-cb795d3ce439.json
9414d524-7954-4200-a632-c71529ea6eeb,EBETAXEL 6 MG/ML,prescription,L01CD01,PACLITAXEL,6131,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PACLITAXEL/ML,2025-07-31T02:10:04.981600,IL,סנדוז,,260.3612475,220.645125,176.5161,,,EBETAXEL 30MG/5ML VIAL,5419,,10323,VIAL GLASS TYPE I,units,1.0,130 95 30965 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Paclitaxel is indicated alone or in combination, for the treatment of advanced carcinoma of the ovary. For the treatment of metastatic breast cancer after failure of combination chemotherapy. Prior therapy should have included an anthracycline unless clinically containdicated. Paclitaxel is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. Advanced non small cell lung cancer: Paclitaxel associated with cisplatinum is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. Kaposis's sarcoma: Paclitaxel is indicated in the second-line treatment of AIDS related Kaposi's sarcoma",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9414d524-7954-4200-a632-c71529ea6eeb.json
94359e3a-d83c-471f-90d1-9b8f4011d1d2,BETNOVATE OINTMENT,prescription,D07AC01,BETAMETHASONE,255,,,WHO ATC Classification,,ILS,ointment,BETAMETHASONE AS VALERATE 0.1 %W/W,2025-07-31T00:34:37.158304,IL,ג.ס.ק,,15.7763994,13.36983,9.759,,7290008102629,BETNOVATE TOPICAL SCALP APPL SOL 30ML,2084,,359,TUBE ALUMINIUM,units,30.0,017 04 24760 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.These include the following:Atopic dermatitis (including infantile atopic dermatitis)Nummular dermatitis (discoid eczema)Prurigo nodularisPsoriasis (excluding widespread plaque psoriasis)Lichen simplex chronicus (neurodermatitis) and lichen planusSeborrhoeic dermatitisIrritant or allergic contact dermatitisDiscoid lupus erythematosusAdjunct to systemic steroid therapy in generalised erythroderma",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/94359e3a-d83c-471f-90d1-9b8f4011d1d2.json
9445e8fb-0e73-46ed-b8f2-02fc841b0cae,GLYCERIN FORTE SUPPOSITORIES,off-the-counter,A06AX01,GLYCEROL,5416,,,WHO ATC Classification,,ILS,suppositories,GLYCERIN 3.2 G,2025-07-31T12:00:01.949622,IL,סם און,,20.2724,17.18,nan,,7290008066198,GLYCERIN FORTE 3.2G 10 SUPP,,,,STRIPS ALUMINIUM FOIL,units,10.0,142 84 32039 00,valid,nan,rectal,1.4,36,,,,,,,,,,0,,For relief of constipation.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9445e8fb-0e73-46ed-b8f2-02fc841b0cae.json
946245aa-9e64-42cf-a9d6-27f81f0ca975,LISSIN 20 MG,prescription,N06BA12,LISDEXAMFETAMINE,9528,,,WHO ATC Classification,,ILS,tablets,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T04:49:24.878028,IL,אוניפארם,,370.28703,313.8025817,267.066027,,,LISSIN 50 MG 30 TAB,,,37689,BLISTER PVDC/ALUMINIUM,units,30.0,176 71 37820 99,valid,17.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Lissin is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Lissin is indicated for the treatment of Moderate to Severe Binge Eating Disorder (BED) for patients over 18 years.Limitation of Use:Lissin is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Lissin for the treatment of obesity have not been established.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/946245aa-9e64-42cf-a9d6-27f81f0ca975.json
946358b4-d8b4-4085-94e4-eaa42998307b,SIGNIFOR 0.3 MG/ 1 ML,prescription,H01CB05,PASIREOTIDE,7121,,,WHO ATC Classification,,ILS,solution for injection,PASIREOTIDE AS DIASPARTATE 0.3 MG/ML,2025-07-31T08:10:49.451543,IL,מדיסון,,18349.85006,15550.72108,14137.01916,,7290014257191,SIGNIFOR 0.6MG/1ML 60AMP (1ML),9689,,48813,AMPOULES GLASS TYPE I,units,60.0,150 59 33762 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/946358b4-d8b4-4085-94e4-eaa42998307b.json
9472a2aa-6045-4d54-9b29-9c83bd6f869d,QVAR 100,prescription,R03BA01,BECLOMETASONE,6087,,,WHO ATC Classification,,ILS,inhaler,BECLOMETASONE DIPROPIONATE/DOSE,2025-07-31T07:13:25.533720,IL,טבע,,97.20436344,82.37658285,61.24653,,502349717614,QVAR 100 MCG/DOSE 200 DOSE AUTOHALER,17018,,86461,AUTOHALER ALUMINIUM,units,200.0,139 29 30661 00,valid,34.5,inhalation,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9472a2aa-6045-4d54-9b29-9c83bd6f869d.json
947bbfa3-24d6-4b1b-a7b6-127ac425eb26,FLIXONASE AQUEOUS NASAL SPRAY,off-the-counter,R01AD08,FLUTICASONE,5529,,,WHO ATC Classification,,ILS,"nasal spray, suspension ",FLUTICASONE PROPIONATE/DOSE,2025-07-31T11:56:23.494578,IL,ג.ס.ק,,47.4006,40.17,nan,,7290014547537,FLIXONASE AQUEOUS NASAL SPRAY 120 doses,,,,BOTTLE METERED DOSE SPRAY GLASS TYPE I,units,120.0,060 33 26912 00,valid,nan,nasal,1.4,24,,,,,,,,,,0,,Self medication:Prophylaxis and treatment of seasonal allergic rhinitis including hay fever in adults.By Physicians prescription:-     Prophylaxis and treatment of seasonal allergic rhinitis including hay fever in children of the age of 4 years and above.-     perennial rhinitis in adults and children of the age of 4 years and above.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/947bbfa3-24d6-4b1b-a7b6-127ac425eb26.json
9494ed69-6fb3-478e-8635-262da6d79d5b,PARACETAMOL ALTAN 10 MG/ML,prescription,N02BE01,PARACETAMOL,9419,,,WHO ATC Classification,,ILS,solution for infusion,PARACETAMOL/,2025-07-31T06:27:50.591862,IL,פרופארם,,462.8137,392.215,333.8,,7290017585796,PARACETAMOL ALTAN 10 MG/ML 100 ML 50 VIAL,,,17136,BAG PVC,units,50.0,163 09 35152 00,valid,17.5,i.v,1.4,12,,,,,,,,,,0,Prescription required,"Paracetamol Altan is indicated for the short-term treatment of moderate pain, especially following surgery, and for the short-term treatment of fever, when intravenous administration is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9494ed69-6fb3-478e-8635-262da6d79d5b.json
949e0e7d-9c75-4078-83a7-faad64312af2,DRONCOR,prescription,C01BD07,DRONEDARONE,8719,,,WHO ATC Classification,,ILS,coated tablets,DRONEDARONE AS HYDROCHLORIDE,2025-07-31T02:05:04.306035,IL,אוניפארם,,314.4900895,266.517025,226.823,,,DRONCOR 400MG 60TAB,,,59876,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,165 80 35478 00,valid,17.5,per os,1.4,18,,,,,,,,,,0,Prescription required,"DRONCOR is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation (AF). Due to its safety profile, DRONCOR should only be prescribed after alternative treatment options have been considered. DRONCOR should not be given to patients with left ventricular systolic dysfunction or to patients with current or previous episodes of heart failure.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/949e0e7d-9c75-4078-83a7-faad64312af2.json
94adb14d-4c56-406d-ad4a-19bf2e20bf85,AETHOXYSKLEROL 0.5% 5AMPX2ML,29C,,,20028,,,,,,injection,AETHOXYSKLEROL 0.5% X,2025-07-31T19:49:46.544213,IL,nan,,,,,,,AETHOXYSKLEROL 0.5% 5AMPX2ML,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/94adb14d-4c56-406d-ad4a-19bf2e20bf85.json
94d79be4-b2d6-44f4-a740-1943b5b1fb31,RISPOND 1,prescription,N05AX08,RISPERIDONE,7943,,,WHO ATC Classification,,ILS,coated tablets,RISPERIDONE,2025-07-31T07:39:46.269591,IL,אוניפארם,,31.1971468,26.43826,19.298,,,RISPOND 1MG 30TAB,18558,,55822,BLISTER PVC/ALUMINIUM,units,30.0,134 58 31403 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/94d79be4-b2d6-44f4-a740-1943b5b1fb31.json
94ea6b20-20ce-4acb-9da7-56abaa05e47a,CHENODEOXYCHOLIC ACID LEADIANT,prescription,A05AA01,CHENODEOXYCHOLIC ACID,8223,,,WHO ATC Classification,,ILS,"capsule, hard",CHENODEOXYCHOLIC ACID,2025-07-31T01:09:01.959352,IL,אמ.בי.איי פארמה,,79238.39674,67151.18667,61046.53333,,5060538130025,CHENODEOXYCHOLIC ACID LEADIANT 250mg 100 caps,,,17072,BLISTER PVC/ALUMINIUM,units,100.0,159 45 35040 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"The treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/94ea6b20-20ce-4acb-9da7-56abaa05e47a.json
94f0de0c-b88d-49b9-93cc-094b6bb336b4,FERROVIN,prescription,B03AC03,IRON-SORBITOL-CITRIC ACID COMPLEX,7260,,,WHO ATC Classification,,ILS,solution for injection,IRON SUCROSE/ML,2025-07-31T03:04:00.424082,IL,לפידות,,341.7328734,289.60413,246.4716,,5212001100121,FERROVIN 20MG/ML AMP 5X5ML,6444,,85909,AMPOULES GLASS TYPE I,units,5.0,141 09 31806 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Ferrovin is indicated for the treatment of iron deficiency in the following indications:• Where there is a clinical need for a rapid iron supply,• In patients who cannot tolerate oral iron therapy or who are non-compliant,• In active inflammatory bowel disease where oral iron preparations are ineffective,• In chronic kidney disease when oral iron preparations are less effective.The diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. Hb (haemoglobin),serum ferritin, TSAT (transferrin saturation), serum iron, etc.).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/94f0de0c-b88d-49b9-93cc-094b6bb336b4.json
95060188-9be8-43e9-8f31-2136ed3ea3a7,RELVAR ELLIPTA 92/22 MCG,prescription,R01AD12,FLUTICASONE FUROATE,7410,,,WHO ATC Classification,,ILS,powder for inhalation,"VILANTEROL AS TRIFENATATE, FLUTICASONE FUROATE",2025-07-31T07:23:04.593834,IL,ג.ס.ק,,149.1338128,126.3845928,101.1076742,,,RELVAR ELLIPTA 92/22MCG 30 DOSES,18508,,53565,PLASTIC INHALER WITH TWO BLISTER STRIP ALUMINIUM,units,30.0,151 45 33982 00,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,AsthmaRelvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate:• patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting beta-2-agonists.• patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2-agonist.COPD (Chronic Obstructive Pulmonary Disease)Relvar Ellipta is indicated for the symptomatic treatment of adults with COPD with a FEV1<70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95060188-9be8-43e9-8f31-2136ed3ea3a7.json
95245d94-8262-4e11-8322-be54aa6b2033,XEPLION 100 MG,prescription,N05AX13,PALIPERIDONE,6716,,,WHO ATC Classification,,ILS,suspension for injection extended release,PALIPERIDONE AS PALMITATE/,2025-07-31T10:33:55.055038,IL,יאנסן סילג,,511.5727577,433.5362546,368.9670252,,7290008099844,XEPLION 100MG/1ML 1 SYRINGE 0.5ML,24059,,1624,SYRINGE PREFILLED  ,units,1.0,169 09 37280 99,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,Xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.Xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95245d94-8262-4e11-8322-be54aa6b2033.json
952a73ce-b793-4b00-96d1-e250a46a0354,DOPRAM 20MG/ML 5VIALX5ML,29C,,,20381,,,,,,injection,DOPRAM 20MG/ML X,2025-07-31T20:18:03.212233,IL,nan,,,,,,,DOPRAM 20MG/ML 5VIALX5ML,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/952a73ce-b793-4b00-96d1-e250a46a0354.json
953e647a-b303-4d32-bfa2-17593155572a,CINACALCET TARO 30 MG,prescription,H05BX01,CINACALCET,7776,,,WHO ATC Classification,,ILS,film coated tablets,CINACALCET AS HYDROCHLORIDE,2025-07-31T01:14:16.872381,IL,טבע,,1030.36361,873.1895,743.14,,,CINACALCET TEVA 30MG 30TAB,9885,,32509,BLISTER PVC/PE/PVDC/AL,units,30.0,160 90 35048 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet Taro may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma. Reduction of hypercalcaemia in patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/953e647a-b303-4d32-bfa2-17593155572a.json
954315e2-c4b3-42be-beb6-6d2f776ec631,LISSIN 20 MG,prescription,N06BA12,LISDEXAMFETAMINE,9529,,,WHO ATC Classification,,ILS,tablets,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T04:49:35.327345,IL,אוניפארם,,432.1597291,366.2370748,311.6911275,,,LISSIN 60 MG 30 TAB,,,,BLISTER PVDC/ALUMINIUM,units,30.0,176 71 37820 99,valid,17.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Lissin is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Lissin is indicated for the treatment of Moderate to Severe Binge Eating Disorder (BED) for patients over 18 years.Limitation of Use:Lissin is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Lissin for the treatment of obesity have not been established.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/954315e2-c4b3-42be-beb6-6d2f776ec631.json
9545b770-789d-4c51-b397-3e12aba2e098,TAMSULIN,prescription,G04CA02,TAMSULOSIN,6154,,,WHO ATC Classification,,ILS,modified release capsules hard,TAMSULOSIN HYDROCHLORIDE 0.4   MG,2025-07-31T09:04:26.917277,IL,רפא,,41.95222494,35.552733,25.9509,,7290008013994,TAMSULIN 0.4MG 30 SR CAPS,20629,,86739,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,138 43 31538 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Treatment of functional symptoms of benign prostatic hyperplasia (BPH).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9545b770-789d-4c51-b397-3e12aba2e098.json
954cb05d-41b7-456d-b7f9-976f6e4048ee,STRATTERA 4 MG/ML ORAL SOLUTION,prescription,N06BA09,ATOMOXETINE,7953,,,WHO ATC Classification,,ILS,solution  (oral),ATOMOXETINE/,2025-07-31T08:44:51.060980,IL,אלי לילי,,197.8850857,167.6992252,134.1593801,,7290016021059,STRATTERA 10MG 28CAPS,9933,,71826,BOTTLE GLASS TYPE III,units,28.0,158 61 35026 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD. Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/954cb05d-41b7-456d-b7f9-976f6e4048ee.json
954e5d31-75c3-4ef9-acb4-60ea25b7bb6c,OVESTIN CREAM,prescription,G03CA04,ESTRIOL,465,,,WHO ATC Classification,,ILS,cream,ESTRIOL 0.1 %W/W,2025-07-31T06:19:38.327220,IL,פאדאגיס,,25.58781768,21.68459222,15.8281695,,7290006537058,OVESTIN VAG CRM 15G,15084,,1332,TUBE ALUMINIUM,units,15.0,065 60 21266 01,valid,37.0,vaginal,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of vulvo-vaginal complaints related to estrogen deficiency.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/954e5d31-75c3-4ef9-acb4-60ea25b7bb6c.json
954eff6a-a1ee-40d4-a62e-b2148ff03987,JANUET XR 50/1000 MG TABLETS,prescription,A10BA02,METFORMIN,6245,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T04:16:37.505757,IL,מ.ס.ד. ישראל,,145.5086668,123.3124295,91.68210368,,,JANUET 50/850 MG 56TAB,10044,,78968,BOTTLE HDPE,units,56.0,151 32 33933 02,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/954eff6a-a1ee-40d4-a62e-b2148ff03987.json
95510266-50fe-48e0-a6c7-4b40cf648811,PANTOAVENIR IV,prescription,A02BC02,PANTOPRAZOLE,7105,,,WHO ATC Classification,,ILS,powder for solution for injection,PANTOPRAZOLE AS SODIUM/VIAL,2025-07-31T06:26:40.529482,IL,ביואבניר,,410.404,347.8,296.0,,7290010286966,PANTOAVENIR IV 40MG/VIAL 20VIALS,16887,,56704,VIAL 10 ML AMBER GLASS TYPE I,units,20.0,145 57 33064 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of duodenal ulcer, gastric ulcer , moderate and severe forms of reflux oesophagitis. Zollinger Ellison Syndrome.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95510266-50fe-48e0-a6c7-4b40cf648811.json
9557b68b-6e4e-466e-8aa7-bd4cc8426943,OXSORALEN 20 MCG/ML,29C,D05AD02,METHOXSALEN,20582,,,WHO ATC Classification,,ILS,solution for blood fraction modification,METHOXSALEN/,2025-07-31T15:30:16.962904,IL,nan,,nan,nan,nan,,,OXSORALEN 10MG 25CAPS,,,,AMPOULES GLASS TYPE I,units,25.0,168 57 35929 00,valid,nan,extracorporeal,1.4,60,,,,,,,,,,0,,Oxsoralen is indicated in adults for extracorporeal use in the palliative treatment of advanced stage cutaneous T-cell lymphoma in patients who have not been responsive to other forms of treatment,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9557b68b-6e4e-466e-8aa7-bd4cc8426943.json
958c48f6-e0a7-46b8-b574-abc83328ace3,EPANUTIN 100 MG,29C,N03AB02,PHENYTOIN,20071,,,WHO ATC Classification,,ILS,capsules,PHENYTOIN SODIUM,2025-07-31T14:29:14.984660,IL,nan,,nan,nan,nan,,,EPANUTIN SYR 30MG/5ML 125ML,,,,BOTTLE HDPE,units,125.0,104 27 24678 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/958c48f6-e0a7-46b8-b574-abc83328ace3.json
958dbfb1-4c14-4474-ad80-2a1260f20ea9,BIMATOL S.K.,prescription,S01ED01,TIMOLOL,8410,,,WHO ATC Classification,,ILS,"eye drops, solution","TIMOLOL AS MALEATE/, BIMATOPROST 0.3  MG /",2025-07-31T00:36:35.024462,IL,טבע,,74.28942119,62.9571366,46.80828,,,BIMATOPROST TEVA BOTTLE  3ML,,,38573,BOTTLE LDPE,units,3.0,176 79 37180 99,valid,34.5,ocular,1.4,24,,,,,,,,,,0,Prescription required,Bimatol S.K. is indicated  for reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/958dbfb1-4c14-4474-ad80-2a1260f20ea9.json
959f5c0a-c611-49d0-8224-0db618aad029,YASMIN,prescription,G03AA12,DROSPIRENONE AND ESTROGEN,7735,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ETHINYLESTRADIOL 0.03   MG",2025-07-31T10:39:33.810894,IL,באייר,,nan,nan,nan,,7-298074-040876,YASMIN PLUS 3X28 F.C.TAB,25019,,24752,BLISTER PVC/ALUMINIUM,units,84.0,122 02 30220 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraception.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/959f5c0a-c611-49d0-8224-0db618aad029.json
95b090a8-1f4c-4182-9587-7e84db4dfeb4,IODO-VIT VETERINARY OINTMENT,off-the-counter,D08AG02,POVIDONE-IODINE,5281,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:12:29.016966,IL,ויטאמד,,45.9846,38.97,nan,,7290008082495,IODO-VIT SOL 1L,9163,,,JAR PLASTIC,units,1000.0,083 26 92362 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Disinfection of wounds, scratches, minor burns and skin infections in farm animals and pets.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95b090a8-1f4c-4182-9587-7e84db4dfeb4.json
95b10d4c-16f1-4520-9878-46b4c72430d2,VIMPAT 10 MG/ML,prescription,N03AX18,LACOSAMIDE,7188,,,WHO ATC Classification,,ILS,solution for infusion,LACOSAMIDE/,2025-07-31T10:16:02.015155,IL,ניאופרם,,465.47578,394.471,335.72,,7290100412688,VIMPAT 150MG 56 F.C.TAB,22414,,46139,VIAL 20 ML GLASS TYPE I,units,56.0,149 13 33552 01,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.בקשה לשינוי משטר מינון: 17/5/20204.2	Posology and method of administrationPosologyLacosamide must be taken twice a day (usually once in the morning and once in the evening).Lacosamide may be taken with or without food.If a dose is missed, the patient should be instructed to take the missed dose immediately, and then to take the next dose of lacosamide at the regularly scheduled time. If the patient notices the missed dose within 6 hours of the next one, he/she should be instructed to wait to take the next dose of lacosamide at the regularly scheduled time. Patients should not take a double dose.Adolescents and children weighing 50 kg or more, and adultsThe following table summarises the recommended posology for adolescents and children weighing 50 kg or more, and for adults. More details are provided in the table below.	Monotherapy	Adjunctive therapyStarting dose	100 mg/day or 200 mg/day	100 mg/daySingle loading dose (if applicable)	200 mg	200 mgTitration (incremental steps)	50 mg twice a day (100 mg/day) at weekly intervals	50 mg twice a day (100 mg/day) at weekly intervalsMaximum recommended dose	up to 600 mg/day	up to 400 mg/dayMonotherapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week.Lacosamide can also be initiated at the dose of 100 mg twice a day based on the physician's assessment of required seizure reduction versus potential side effects.Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 300 mg twice a day (600 mg/day). In patients having reached a dose greater than 400 mg/day and who need an additional antiepileptic medicinal product, the posology that is recommended for adjunctive therapy below should be followed.Adjunctive therapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week. Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 400 mg (200 mg twice a day). Initiation of lacosamide treatment with a loading dose Lacosamide treatment may also be initiated with a single loading dose of 200 mg, followed approximately 12 hours later by a 100 mg twice a day (200 mg/day) maintenance dose regimen. Subsequent dose adjustments should be performed according to individual response and tolerability as described above. A loading dose may be initiated in patients in situations when the physician determines that rapid attainment of lacosamide steady state plasma concentration and therapeutic effect is warranted. It should be administered under medical supervision with consideration of the potential for increased incidence of serious cardiac arrhythmia and central nervous system adverse reactions (see section 4.8). Administration of a loading dose has not been studied in acute conditions such as status epilepticus.DiscontinuationIn accordance with current clinical practice, if lacosamide has to be discontinued, it is recommended this be done gradually (e.g. taper the daily dose by 200 mg/week).In patients who develop serious cardiac arrhythmia, clinical benefit/risk assessment should be performed and if needed lacosamide should be discontinued.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95b10d4c-16f1-4520-9878-46b4c72430d2.json
95b626f7-d182-41a6-b7d0-4cf26741a10c,SAYANA,prescription,G03AC06,MEDROXYPROGESTERONE,6581,,,WHO ATC Classification,,ILS,suspension for injection,MEDROXYPROGESTERONE ACETATE/ 0.65  ML,2025-07-31T08:01:33.565999,IL,פיזר,,95.00896779,80.51607798,59.863255,,7290010355877,SAYANA 104MG/0.65ML SYRINGE,19931,,23645,SYRINGE GLASS TYPE I,units,1.0,143 81 32952 00,valid,34.5,s.c,1.4,60,,,,,,,,,,0,Prescription required,"* SAYANA is indicated for long-term female contraception. Each subcutaneous injection prevents ovulation and provides contraception for at least 13 weeks (+/- 1 week). However, it should be taken into consideration that the return to fertility (ovulation) may be delayed for up to one year .Since loss of bone mineral density may occur in females of all ages who use SAYANA long-term, a risk/benefit assessment, which also takes into consideration the decrease in bone mineral density that occurs during pregnancy and/or lactation, should be considered.* Use in Adolescents (12-18 years)In adolescents, use of SAYANA is only indicated when other contraceptive methods are considered unsuitable or unacceptable, due to unknown long-term effects of bone loss associated with SAYANA during the critical period of bone accretion.SAYANA has not been studied in women under the age of 18 years but data is available for intramuscular medroxyprogesterone acetate in this population.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95b626f7-d182-41a6-b7d0-4cf26741a10c.json
95ba812f-5795-41cc-923f-fae0319c2251,HYDREA 500MG 1000 CAPS,29C,,,20449,,,,,,capsule,HYDREA 500MG,2025-07-31T20:35:59.173204,IL,nan,,,,,,,HYDREA 500MG 1000 CAPS,,,,,units,1000.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95ba812f-5795-41cc-923f-fae0319c2251.json
95c2dba7-3f62-4063-9afc-4aba30a439f6,DUODART,prescription,G04CA02,TAMSULOSIN,7687,,,WHO ATC Classification,,ILS,capsules,"DUTASTERIDE 0.5  MG, TAMSULOSIN HYDROCHLORIDE 0.4  MG",2025-07-31T09:04:44.974562,IL,אינובמד,,58.18806206,49.311917,35.9941,,,TAMSULOSIN INOVAMED 0.4MG 30 P.R.TAB,20794,,58489,BOTTLE HDPE,units,30.0,146 34 33278 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95c2dba7-3f62-4063-9afc-4aba30a439f6.json
95c89204-96c2-4854-a260-a244664e06ab,ADATAR,off-the-counter,D10AD03,ADAPALENE,3990,,,WHO ATC Classification,,ILS,gel,"BENZOYL PEROXIDE AS HYDROUS 2.5 %W/W, ADAPALENE 0.1 %W/W",2025-07-31T11:16:42.244145,IL,ג'ונסון אנד ג'ונסון,,69.8442,59.19,nan,,7290017164199,BEN GAY ULTRA STR 4OZ (117gr),2522,,,CONTAINER PP,units,4.0,163 95 35656 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Cutaneous treatment of acne vulgaris when comedones, papules and pustules are present",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95c89204-96c2-4854-a260-a244664e06ab.json
95cae39c-46f5-4e6c-b93f-a9597b81cd13,ONPATTRO 2 MG/ML,prescription,N07XX12,PATISIRAN,8522,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PATISIRAN  AS SODIUM/,2025-07-31T06:12:52.325226,IL,מדיסון,,40758.59623,34541.18478,31401.07707,,,ONPATTRO 2 MG/ML 5ML 1 VIAL,15507,,3493,VIAL GLASS TYPE I,units,1.0,165 33 36108 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Onpattro is indicated for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95cae39c-46f5-4e6c-b93f-a9597b81cd13.json
95df0ab3-3c44-435c-9832-f82581411e8c,XPOVIO 20 MG,prescription,L01XX66,SELINEXOR,8872,,,WHO ATC Classification,,ILS,tablets,SELINEXOR,2025-07-31T10:36:43.717368,IL,ניאופרם,,34815.42419,29504.59808,26822.36189,,7290111092886,XPOVIO 20 MG 16 TAB,24102,,57377,BLISTER PVC/PCTFE/PVC/ALU,units,16.0,167 04 36451 99,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Multiple Myeloma•	Xpovio® in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.•	XPOVIO in combination with dexamethasone is indicated for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least three prior therapies and whose disease is refractory to at least one proteasome inhibitor (PI), at least one immunomodulatory agent (IMiD), and an anti- CD38 monoclonal antibody (mAb).Diffuse Large B-Cell LymphomaXPOVIO is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95df0ab3-3c44-435c-9832-f82581411e8c.json
95e2ddfe-5c28-49ba-a116-6dce30330856,ADRENALINE SINTETICA 1 MG/ML,prescription,C01CA24,EPINEPHRINE,8822,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE/,2025-07-30T23:15:30.032482,IL,כ.צ.ט,,49.500292,41.9494,30.62,,,ADRENALINE SINTETICA 1 MG/ML 10 amp,,,57072,AMPOULES GLASS TYPE I,units,10.0,166 60 35988 00,valid,37.0,"s.c, i.m, i.v, intracardiac",1.4,24,,,,,,,,,,0,Prescription required,ADRENALINE SINTETICA 1 MG/ML is indicated in the following situations:– Spasm of the airways in acute asthma attacks.– Rapid relief of allergic reactions to drugs or other substances.– Emergency treatment of anaphylactic shock.– Cardiac arrest and cardiopulmonary resuscitation (physical measures should be used first)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95e2ddfe-5c28-49ba-a116-6dce30330856.json
95e77564-64ac-470c-8e46-402cdd6a6acd,PIQRAY 150 MG,prescription,L01XX65,ALPELISIB,8526,,,WHO ATC Classification,,ILS,film coated tablets,ALPELISIB,2025-07-31T06:44:37.758949,IL,נוברטיס פארמה,,18814.77248,15944.72315,14495.20286,,7290018375136,PIQRAY 200 MG 28 TAB,10907,,28445,BLISTER PVC/PCTFE,units,28.0,166 18 36148 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"PIQRAY is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95e77564-64ac-470c-8e46-402cdd6a6acd.json
95fbf518-aea1-4d94-84a0-9bfafe703315,BICALUTAMIDE TEVA ® 150 MG,prescription,L02BB03,BICALUTAMIDE,6272,,,WHO ATC Classification,,ILS,tablets,BICALUTAMIDE,2025-07-30T23:38:42.408273,IL,טבע,,222.6744075,188.707125,150.9657,,,BICALUTAMIDE TEVA 50MG 30TAB,2487,,80699,BLISTER PVDC/ALUMINIUM,units,30.0,140 83 31741 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,In patients with locally advanced prostate cancer (T3-T4  any N  M0  T1-T2  N+  M0)  Bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. The management of patients with locally advanced  non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/95fbf518-aea1-4d94-84a0-9bfafe703315.json
960ef0ba-b3cf-46c9-b78a-6d4eb49ed819,NARAMIG TABLETS 2.5 MG,prescription,N02CC02,NARATRIPTAN,8161,,,WHO ATC Classification,,ILS,film coated tablets,NARATRIPTAN AS HYDROCHLORIDE 2.5   MG,2025-07-31T05:39:13.753988,IL,ג.ס.ק,,18.16712095,15.3958659,11.23785832,,,NARAMIG TABLETS 2.5 MG 2 tab,14624,,54674,BLISTER POLYAMIDE/ALUMINIUM/PVC-ALUMINIUM/PAPER,units,2.0,113 42 29550 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Naramig tablets are indicated for the acute treatment of migraine attacks with or without aura.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/960ef0ba-b3cf-46c9-b78a-6d4eb49ed819.json
962153fa-2884-4a1c-898b-b7afaf6c3983,PEGIL,prescription,L03AA13,PEGFILGRASTIM,8724,,,WHO ATC Classification,,ILS,solution for injection,PEGFILGRASTIM/ML,2025-07-31T06:31:26.897205,IL,אוניפארם,,2716.455979,2302.08144,2092.801309,,7290000812526,PEGIL 6 MG/0.6ML,,,58143,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,165 36 35770 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy, given at intervals of 14 days or more, for malignancy. (with the exception of chronic myeloid leukemia and myelodysplastic syndromes).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/962153fa-2884-4a1c-898b-b7afaf6c3983.json
9621ffa1-b977-4e2f-b9b6-8e47d9a7a09c,PRADAXA 110,prescription,B01AE07,DABIGATRAN ETEXILATE,6319,,,WHO ATC Classification,,ILS,capsules,DABIGATRAN ETEXILATE AS MESILATE,2025-07-31T06:48:11.757335,IL,בורינגר אינגלהיים,,139.4305499,118.1614883,94.5291906,,9006968012391,PRADAXA 110MG 60CAPS,16816,,84209,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,142 96 32974 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with nonvalvular  atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9621ffa1-b977-4e2f-b9b6-8e47d9a7a09c.json
9624dc7a-34a5-453c-ae8c-1075d943bc97,PADCEV 20 MG,prescription,L01XC36,ENFORTUMAB VEDOTIN ,8782,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,ENFORTUMAB VEDOTIN/VIAL,2025-07-31T06:24:48.982763,IL,אסטלס,,3045.251835,2580.722009,2346.110917,,8718692511422,PADCEV 20 MG 1 VIAL,23223,,43087,VIAL GLASS TYPE I,units,1.0,167 37 36604 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"PADCEV, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer (mUC). PADCEV, as a single agent , is indicated for the treatment of adult patients with locally advanced or mUC who: •	have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic settingor:•	are ineligible for cisplatin-containing chemotherapy and have previously received a PD-1/PD-L1 inhibitor.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9624dc7a-34a5-453c-ae8c-1075d943bc97.json
96380f6b-9188-4601-8fae-c470219be63d,LORASTINE SYRUP,off-the-counter,R06AX13,LORATADINE,2915,,,WHO ATC Classification,,ILS,syrup,LORATADINE/,2025-07-31T12:22:28.696037,IL,באייר,,53.3832,45.24,nan,,7290008121040,LORASTINE 10MG 20TAB,12046,,,BOTTLE AMBER GLASS,units,20.0,133 21 28216 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Antihistamine preparation for treatment of allergic rhinitis and urticaria.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96380f6b-9188-4601-8fae-c470219be63d.json
96661d12-dd1d-4510-8cf3-48dd51d9008b,CRESTOR ® 5 MG,prescription,C10AA07,ROSUVASTATIN,6364,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T02:38:09.536942,IL,אוניפארם,,37.7354855,31.979225,23.3425,,,ESTO 10 MG 28TAB,5482,,80978,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,139 22 31615 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96661d12-dd1d-4510-8cf3-48dd51d9008b.json
9679b0e8-4519-43da-889f-c6e078a35406,LORASTINE SYRUP,off-the-counter,R06AX13,LORATADINE,1262,,,WHO ATC Classification,,ILS,syrup,LORATADINE/,2025-07-31T12:22:17.261756,IL,באייר,,26.6562,22.59,nan,,7290008121040,LORASTINE 10MG 10TAB,12287,,,BOTTLE AMBER GLASS,units,10.0,133 21 28216 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Antihistamine preparation for treatment of allergic rhinitis and urticaria.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9679b0e8-4519-43da-889f-c6e078a35406.json
968e303c-9b4b-4799-ace2-1887acefe790,VENORUTON CAPSULES 300 MG,off-the-counter,C05CA02,MONOXERUTIN,1176,,,WHO ATC Classification,,ILS,capsules,OXERUTINES,2025-07-31T13:35:10.223151,IL,ג.ס.ק,,34.8454,29.53,nan,,7298120001103,VENORUTON GEL 2% 40G,22049,,,BLISTER PVC/ALUMINIUM,units,40.0,115 96 22946 01,valid,nan,per os,1.4,60,,,,,,,,,,0,,For the adjunctive treatment of varicose veins in all stages.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/968e303c-9b4b-4799-ace2-1887acefe790.json
969db3f0-8738-45bc-bcb3-c3a283af4e03,ABRAXANE,prescription,L01CD01,PACLITAXEL,7936,,,WHO ATC Classification,,ILS,powder for dispersion for infusion,PACLITAXEL/VIAL,2025-07-31T00:03:45.904924,IL,ניאופרם,,1284.35742,1088.43854,926.3306724,,,ABRAXANE 5MG/ML VIAL 100MG/20ML,9884,,32502,VIAL GLASS TYPE I,units,1.0,155 81 34516 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas. Abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/969db3f0-8738-45bc-bcb3-c3a283af4e03.json
96b33738-3db2-4ffa-a943-5b836fa0a124,TOPAMAX 100,prescription,N03AX11,TOPIRAMATE,3549,,,WHO ATC Classification,,ILS,film coated tablets,TOPIRAMATE,2025-07-31T09:25:33.307076,IL,יאנסן סילג,,57.92099974,49.085593,35.8289,,,TOPAMAX 25MG 60TAB,20156,,52945,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,107 57 29033 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topamax is indicated in adults for the prevention of migraines. The use of Topamax in the acute treatment of migraine has not been studied.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96b33738-3db2-4ffa-a943-5b836fa0a124.json
96cdb629-2b77-473a-96cb-8a2ea75dc7c4,DISEPTYL,prescription,J01EE01,SULFAMETHOXAZOLE AND TRIMETHOPRIM,1931,,,WHO ATC Classification,,ILS,suspension,"SULPHAMETHOXAZOLE, TRIMETHOPRIM 0.8 %",2025-07-31T02:00:15.260548,IL,רקח,,11.3161995,9.59,7.0,,,DISEPTYL SUSP 50ML,4140,,743,BOTTLE GLASS TYPE III,units,50.0,115 02 22578 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Antibacterial for treatment of infections due to susceptible micro-organisms in the upper and lower respiratory tract infections, urinary tract infections, gastro-intestinal tract infections.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96cdb629-2b77-473a-96cb-8a2ea75dc7c4.json
96e25c2e-6d65-4a69-9071-60100b071969,PUREGON SOLUTION FOR INJECTION,prescription,G03GA06,FOLLITROPIN BETA,4965,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN BETA/,2025-07-31T07:07:44.180948,IL,אורגנון,,1339.455989,1135.132245,966.0699956,,7290006537096,PUREGON SOL FOR INJ CART 1X900 IU /1.08ML,16734,,70199,CARTRIDGE GLASS TYPE I,units,1.0,130 52 30898 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Puregon is indicated for the treatment of female infertility in the following clinical situations: Anovulation (including polycystic ovarian disease, PCOD) in women who have beenunresponsive to treatment with clomiphene citrate. Controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)]. In the male : Deficient spermatogenesis due to hypogonadotrophic hypogonadism.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96e25c2e-6d65-4a69-9071-60100b071969.json
96e5c408-7ec9-4ebb-9fbb-08e8daf4c272,ERYTHROCIN LACTOBIONATE I.V.,prescription,J01FA01,ERYTHROMYCIN,6392,,,WHO ATC Classification,,ILS,powder for solution for infusion,ERYTHROMYCIN/VIAL,2025-07-31T02:34:47.372307,IL,ביוטיס,,54.52613974,46.208593,33.7289,,7298120010969,ERYTHROCIN LACTOBIONATE I.V. VIAL 1G/VIAL 20ML,5483,,28909,VIAL GLASS TYPE I,units,1.0,035 49 25602 05,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of bacterial infections susceptible to erythromycin and require I.V. treatment .,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96e5c408-7ec9-4ebb-9fbb-08e8daf4c272.json
96eedcc8-16dd-438a-a322-38e4ede9ef3d,GASPAN ®,off-the-counter,,,5583,,,,,ILS,soft gastro resistant capsules,"CARAWAY OIL, PEPPERMINT OIL (MENTHAE PIPERITAE AETHEROLEUM)",2025-07-31T11:58:27.398645,IL,דר סמואלוב,,51.035,43.25,nan,,7290012024191,GASPAN 14 CAPS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,14.0,165 98 36182 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Herbal medicinal product for the treatment of adult patients with gastrointestinal complaints, particularly with mild cramps, flatulence, fullness and abdominal pain.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96eedcc8-16dd-438a-a322-38e4ede9ef3d.json
96f20972-4c1d-49fe-b7e1-fd9ae5c35a9c,ZODORM 10,prescription,N05CF02,ZOLPIDEM,4415,,,WHO ATC Classification,,ILS,coated tablets,ZOLPIDEM TARTRATE,2025-07-31T10:50:54.953946,IL,אוניפארם,,20.01900444,16.965258,12.3834,,,ZODORM 10MG 20TAB,26106,,4398,BLISTER PVC/ALUMINIUM,units,20.0,123 62 30320 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Zodorm 10 is indicated for the short-term treatment of occasional or transient insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96f20972-4c1d-49fe-b7e1-fd9ae5c35a9c.json
96ff4656-d1b0-46af-9449-6029224a3a09,BRINTELLIX 10 MG,prescription,N06AX26,VORTIOXETINE,7727,,,WHO ATC Classification,,ILS,film coated tablets,VORTIOXETINE AS HYDROBROMIDE,2025-07-31T00:43:11.341288,IL,לנדבק,,192.0881317,162.7865595,130.2292476,,,BRINTELLIX 20MG 28 F.C.TAB,2589,,85112,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,153 73 34155 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Brintellix is indicated for the treatment of major depressive episodes in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/96ff4656-d1b0-46af-9449-6029224a3a09.json
9719d605-e90d-435b-ae65-235b14eea66b,CINACALCET TRIMA 30 MG,prescription,H05BX01,CINACALCET,7786,,,WHO ATC Classification,,ILS,film coated tablets,CINACALCET AS HYDROCHLORIDE,2025-07-31T01:14:45.400417,IL,תרימה,,961.6726565,814.9768275,693.5973,,,CINACALCET TRIMA 30 MG 28TAB,9888,,32088,BLISTER PVC/ALUMINIUM,units,28.0,154 44 34241 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet -Trima  may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with:• parathyroid carcinoma.• primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9719d605-e90d-435b-ae65-235b14eea66b.json
97300cfd-a7fa-4f37-9713-c30014c51446,MCR 100,prescription,N02AA01,MORPHINE,1863,,,WHO ATC Classification,,ILS,tablets controlled release,MORPHINE SULFATE,2025-07-31T05:07:50.974719,IL,רפא,,96.73033775,81.97486614,60.94785587,,7290008014038,MCR 100MG 20TAB,13406,,19088,BLISTER PVC/ALUMINIUM,units,20.0,031 65 25386 00,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Prolonged relief of severe pain.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97300cfd-a7fa-4f37-9713-c30014c51446.json
97350474-761a-4acf-95ab-c90abd00ccc9,CAELYX LIPOSOMAL,prescription,L01DB01,DOXORUBICIN,7295,,,WHO ATC Classification,,ILS,liposome concentrate for solution for infusion,DOXORUBICIN HYDROCHLORIDE 2.0  MG/ML,2025-07-31T00:49:42.486997,IL,בקסטר,,1759.651757,1491.230369,1269.132229,,7290014577183,CAELYX 2MG/ML VIAL 10ML,9673,,47257,VIAL GLASS TYPE I,units,1.0,110 27 28836 02,valid,17.5,i.v,1.4,20,,,,,,,,,,0,Prescription required,First or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease The treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. Refractory is defined as a patient having progressive disease while on treatment  or within 6 months of completing treatmnt. As monotherapy for patients with metastatic breast cancer  where there is an increased cardiac risk.   In combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97350474-761a-4acf-95ab-c90abd00ccc9.json
974238c5-e454-4942-a87a-ac0fb99ae0bb,ROSUVASTATIN INOVAMED 10 MG,prescription,C10AA07,ROSUVASTATIN,9362,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T07:50:33.843955,IL,אינובמד,,177.3783375,150.320625,120.2565,,,ROSUVASTATIN INOVAMED 40 MG 30 TAB,23632,,4912,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,173 65 36557 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/974238c5-e454-4942-a87a-ac0fb99ae0bb.json
977f619f-6a89-4acf-87eb-625d47cc53bd,CIMIDONA 6.5 MG,off-the-counter,G02CX04,CIMICIFUGAE RHIZOMA,8346,,,WHO ATC Classification,,ILS,tablets,DRY EXTRACT FROM CIMICIFUGAE RHIZOMA (BLACK COHOSH) 6.5  MG,2025-07-31T11:24:41.079693,IL,רפא,,nan,nan,nan,,729008012409,CIMIDONA 6.5MG 30 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,153 88 34027 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Alleviation of menopausal complaints.(hot flashes, excessive perspiration, sleep disorders, nervousness and depressive moods).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/977f619f-6a89-4acf-87eb-625d47cc53bd.json
97a8ba21-af18-4f3e-afb1-623ec685a693,ODNATRON,prescription,A04AA01,ONDANSETRON,8072,,,WHO ATC Classification,,ILS,solution for injection,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE/ML,2025-07-31T06:03:08.403872,IL,SK PHARM(KS KIM),,217.707345,184.49775,147.5982,,7290016845013,ODNATRON  8MG/4ML 5 amp,15466,,54623,AMPOULES GLASS TYPE I,units,5.0,150 38 33805 00,valid,25.0,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Adults:Odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.  Odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). Paediatric Population:Odnatron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged &#8805;6 months, and for the prevention and treatment of PONV in children aged &#8805; 1 month.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97a8ba21-af18-4f3e-afb1-623ec685a693.json
97b87109-7748-43ee-995e-2d0ff2a7e460,SOTYKTU 6 MG,prescription,L04AA56,DEUCRAVACITINIB ,9486,,,WHO ATC Classification,,ILS,film coated tablets,DEUCRAVACITINIB,2025-07-31T08:32:26.551196,IL,ב.מ.ס,,3516.057499,2979.709878,2708.827162,,7290014396272,SOTYKTU 6 MG 28 TAB,,,37646,BLISTER PVC/PCTFE/AL,units,28.0,175 38 37671 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,SOTYKTU is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97b87109-7748-43ee-995e-2d0ff2a7e460.json
97bdaa8e-18bc-416f-9ae8-0b9c0265a985,XALACOM EYE DROPS,prescription,,,4591,,,,,ILS,"eye drops, solution","LATANOPROST/ML, TIMOLOL AS MALEATE/ML",2025-07-31T10:27:05.376441,IL,דקסל פארמה,,40.2331325,34.095875,24.8875,,7290006412836,XALACOM  EYE DROPS 2.5ML,24030,,52094,BOTTLE LDPE,units,2.5,124 62 30356 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97bdaa8e-18bc-416f-9ae8-0b9c0265a985.json
97db0050-4326-4d52-af9b-0242779f0fca,SYNTHROID 100 MCG TABLETS,prescription,H03AA01,LEVOTHYROXINE SODIUM,8641,,,WHO ATC Classification,,ILS,tablets,LEVOTHYROXINE SODIUM,2025-07-31T08:56:28.595595,IL,אבוט,,28.6041204,24.24078,17.694,,8002660034762,SYNTHROID 100 MCG 90 TAB,10894,,25498,BOTTLE HDPE,units,90.0,149 74 33763 01,valid,37.0,per os,1.4,15,,,,,,,,,,0,Prescription required,"Hypothyroidism, Pituitary TSH Suppression",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97db0050-4326-4d52-af9b-0242779f0fca.json
97e30560-9e68-42f9-90f7-88db1fe47923,NAROCIN,off-the-counter,M01AE02,NAPROXEN,1607,,,WHO ATC Classification,,ILS,tablets,NAPROXEN SODIUM,2025-07-31T12:29:02.017560,IL,טבע,,43.837,37.15,nan,,,NAROCIN 275MG 20TAB,14333,,,BLISTER PVC/ALUMINIUM,units,20.0,065 82 22014 15,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Mild and moderate analgesic such as relief of toothache, backache and menstrual pain (primary dysmenorrhea). Fever reduction. Non-steroidal anti-inflammatory for the treatment of rheumatic inflammations, tendinitis and musculoskeletal inflammations.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97e30560-9e68-42f9-90f7-88db1fe47923.json
97f1fabf-2871-4c83-acdc-7fed9f2eb4cd,NUEDEXTA,29C,C01BA01,QUINIDINE,20622,,,WHO ATC Classification,,ILS,capsules,"QUINIDINE SULFATE, DEXTROMETHORPHAN HYDROBROMIDE",2025-07-31T15:44:40.703485,IL,nan,,nan,nan,nan,,7290008128308,QUINIDINE GLUCONATE 80MG/10ML,,,,BOTTLE HDPE,units,1.0,149 88 33554 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,For the treatment of Pseudobulbar Affect (PBA) .,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97f1fabf-2871-4c83-acdc-7fed9f2eb4cd.json
97fde813-99e0-45ef-a5ae-78417681833a,DIAMOX 250MG 30 SR CAPS,29C,,,20790,,,,,,capsule,DIAMOX 250MG 30 SR CAPS,2025-07-31T20:14:19.569966,IL,nan,,,,,,,DIAMOX 250MG 30 SR CAPS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97fde813-99e0-45ef-a5ae-78417681833a.json
97fe468f-9029-4e5d-b38d-7f8d4f10cf8f,XCOPRI 100 MG,prescription,N03AX25,CENOBAMATE,9272,,,WHO ATC Classification,,ILS,film coated tablets,CENOBAMATE,2025-07-31T10:31:26.539354,IL,דקסל פארמה,,507.2305939,429.8564546,365.8352805,,,XCOPRI 200 MG 30 TAB,24177,,19218,BLISTER PVC/ALUMINIUM,units,30.0,172 89 37493 99,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Xcopri is indicated for the adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/97fe468f-9029-4e5d-b38d-7f8d4f10cf8f.json
9806b7f8-e601-468e-a0c2-941d413699c9,ISOPTIN 5MG/2ML 5AMP,29C,,,20469,,,,,,injection,ISOPTIN 5MG/,2025-07-31T20:40:53.272740,IL,nan,,,,,,,ISOPTIN 5MG/2ML 5AMP,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9806b7f8-e601-468e-a0c2-941d413699c9.json
9819e078-535c-424a-a949-df421dd54b09,TRAUMAPLANT,off-the-counter,,,5255,,,,,ILS,cream,COMFREY (SYMPHYTUM) CONCENTRATE/,2025-07-31T13:30:01.133341,IL,תרימה,,48.5216,41.12,nan,,7290008075121,TRAUMAPLANT CREAM 50GR,,,,TUBE ALUMINIUM,units,50.0,140 61 31480 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Traumaplant is a phytodrug (extract of plants) for external treatment of ankle sprains  and muscle pains (in case of sports and accidental injuries).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9819e078-535c-424a-a949-df421dd54b09.json
98229d55-ba3b-4f2c-9013-8c0bf8fb4fe0,MESTINON DRAGEES 60 MG,29C,N07AA02,PYRIDOSTIGMINE,20522,,,WHO ATC Classification,,ILS,dragee,PYRIDOSTIGMINE BROMIDE 60.0   MG,2025-07-31T15:09:16.553451,IL,nan,,nan,nan,nan,,,MESTINON 60MG/5ML SYRUP 473ML,,,,BOTTLE AMBER GLASS,units,473.0,130 84 21200 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of myasthenia gravis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98229d55-ba3b-4f2c-9013-8c0bf8fb4fe0.json
98368ac5-ba7c-4a97-bce5-c8524888b361,FEMINET,prescription,G03CA01,ETHINYLESTRADIOL,8051,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.02  MG, DESOGESTREL 0.15  MG",2025-07-31T02:56:39.126299,IL,דקסל פארמה,,74.08455832,62.783524,46.6792,,7290005680557,FEMINET 4X21TAB,10092,,23873,BLISTER PVC/PVDC/ALUMINIUM,units,84.0,128 57 30568 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98368ac5-ba7c-4a97-bce5-c8524888b361.json
984a90b2-2846-4033-a70d-0e1c47ea7ab7,MESTINON DRAGEES 60 MG,29C,N07AA02,PYRIDOSTIGMINE,20106,,,WHO ATC Classification,,ILS,dragee,PYRIDOSTIGMINE BROMIDE 60.0   MG,2025-07-31T15:09:33.020342,IL,nan,,nan,nan,nan,,,MESTINON TIMESPAN 180MG 30 SR TAB,,,,BOTTLE AMBER GLASS,units,30.0,130 84 21200 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of myasthenia gravis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/984a90b2-2846-4033-a70d-0e1c47ea7ab7.json
985390ef-6db9-48a8-a630-ea42fd7d35c2,PHENIDIN 18 MG,prescription,N06BA04,METHYLPHENIDATE,8338,,,WHO ATC Classification,,ILS,tablets prolonged release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T06:39:46.383727,IL,תרימה,,121.5693206,103.024848,76.5984,,,PHENIDIN 18 MG 30 SR TAB,10593,,51712,BOTTLE HDPE,units,30.0,161 08 35114 00,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/985390ef-6db9-48a8-a630-ea42fd7d35c2.json
986cec1f-4d21-4e4e-8f6c-847521f587f7,ALKERAN TABLETS 2 MG,prescription,L01AA03,MELPHALAN,1069,,,WHO ATC Classification,,ILS,tablets,MELPHALAN,2025-07-31T00:16:30.514454,IL,פאדאגיס,,113.5455402,96.22503832,71.54277942,,7290008105453,ALKERAN  2MG 25 TABS,1199,,177,BOTTLE AMBER GLASS,units,25.0,129 55 30948 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of : Multiple myeloma and Advanced ovarian adenocarcinoma,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/986cec1f-4d21-4e4e-8f6c-847521f587f7.json
989258a9-56fa-4af0-b3e6-3daafabb4e2a,SALATAC GEL,off-the-counter,D01AE12,SALICYLIC ACID,1329,,,WHO ATC Classification,,ILS,gel,"SALICYLIC ACIDW/W, LACTIC ACIDW/W",2025-07-31T13:15:18.345985,IL,תרופארם,,68.4754,58.03,nan,,7290103847753,SALATAC GEL 8GR,19680,,,TUBE ALUMINIUM,units,8.0,053 62 26348 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"For topical treatment of warts, corns or callouses.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/989258a9-56fa-4af0-b3e6-3daafabb4e2a.json
989aabf1-6625-4a9c-9b1e-05697071ca74,V-ZOLINE,off-the-counter,S01GA02,TETRYZOLINE,3225,,,WHO ATC Classification,,ILS,"eye drops, solution",TETRYZOLINE HYDROCHLORIDE 0.05 %W/V,2025-07-31T13:38:09.220676,IL,ויטאמד,,21.8182,18.49,nan,,7290008106023,V-ZOLIN 10ML,22071,,,DROPER BOTTLE LDPE,units,10.0,069 78 28589 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,"relief from soreness, burning, itching, irritation redness due to congestion of the eyes.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/989aabf1-6625-4a9c-9b1e-05697071ca74.json
989efe56-2fd4-4b58-a88d-3e9912755b03,JANUET XR 50/1000 MG TABLETS,prescription,A10BA02,METFORMIN,7566,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T04:17:10.722451,IL,מ.ס.ד. ישראל,,nan,nan,nan,,,JANUET XR 50/500 MG 60 TAB,10060,,53752,BOTTLE HDPE,units,60.0,151 32 33933 02,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/989efe56-2fd4-4b58-a88d-3e9912755b03.json
98a083d8-040a-4720-ae8f-bb3364b9ff8c,REKOD TABLETS,prescription,R05DA04,CODEINE,1922,,,WHO ATC Classification,,ILS,tablets,CODEINE PHOSPHATE,2025-07-31T07:20:55.667711,IL,רקח,,nan,nan,nan,,7290008089494,REKOD 20MG 10TAB,18022,,9459,BLISTER PVC/ALUMINIUM,units,10.0,022 09 20913 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated as an analgesic for the relief of mild to moderate pain.For the symptomatic relief of unproductive cough,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98a083d8-040a-4720-ae8f-bb3364b9ff8c.json
98a0d03f-4785-4f31-9c47-0c7fa27d72e0,FLORET,prescription,G03CA01,ETHINYLESTRADIOL,6360,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.03   MG, GESTODENE 0.075   MG",2025-07-31T03:09:52.878558,IL,דקסל פארמה,,66.48917385,56.3467575,41.8935,,7290010577613,FLORET 3X21TAB,6434,,82921,BLISTER PVC/PVDC/ALUMINIUM,units,63.0,140 57 31528 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98a0d03f-4785-4f31-9c47-0c7fa27d72e0.json
98b98606-a15e-4b28-a977-af342d071f3a,GEODON IM 20 MG,prescription,N05AE04,ZIPRASIDONE,4500,,,WHO ATC Classification,,ILS,powder for solution for injection,ZIPRASIDONE MESYLATE TRIHYDRATE 40.93   MG,2025-07-31T03:31:56.414474,IL,דקסל פארמה,,268.4475814,227.4979605,193.6152855,,7290008095341,GEODON 20MG 60CAPS,7596,,29814,VIAL GLASS TYPE I,units,60.0,125 75 30516 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Rapid control of agitation in patients with schizophrenia, when oral therapy is not appropriate, for a maximum of 3 consecutive days.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98b98606-a15e-4b28-a977-af342d071f3a.json
98dc27dc-957f-4dac-9722-51e37a9cf1ec,CODICAL TABLETS,prescription,R05DA04,CODEINE,2005,,,WHO ATC Classification,,ILS,tablets,CODEINE PHOSPHATE,2025-07-31T01:25:13.606441,IL,סם און,,nan,nan,nan,,7290008066440,CODICAL 20MG 10TAB,3568,,7528,BLISTER PVC/ALUMINIUM,units,10.0,044 37 23143 00,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,Indicated as an analgesic for the relief of mild to moderate pain.For the symptomatic relief of unproductive cough,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98dc27dc-957f-4dac-9722-51e37a9cf1ec.json
98e8d019-9912-4b55-8b12-75111e42fe72,ISORDIL SULINGUAL 5MG  100TAB,29C,,,20855,,,,,,tablet,ISORDIL SULINGUAL 5MG,2025-07-31T20:41:40.387603,IL,nan,,,,,,,ISORDIL SULINGUAL 5MG  100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98e8d019-9912-4b55-8b12-75111e42fe72.json
98ef55ad-d97a-46cd-aef8-8d8596e029ae,LEUCOVORIN TEVA 10 MG/ML,prescription,V03AF03,CALCIUM FOLINATE,1387,,,WHO ATC Classification,,ILS,solution for injection,CALCIUM FOLINATE 10.8 MG/ML,2025-07-31T04:41:36.242434,IL,טבע,,62.07338552,52.604564,39.1112,,,LEUCOVORIN 15MG 10TAB,12257,,7799,VIAL GLASS,units,10.0,053 49 26932 05,valid,34.5,"i.v, i.m",1.4,24,,,,,,,,,,0,Prescription required,To diminish the toxicity and counteract the action of folic acid antagonists in cytotoxic therapy. As Leucovorin-Fluorouracil chemotherapy combination for cancer treatment.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98ef55ad-d97a-46cd-aef8-8d8596e029ae.json
98f2f5ed-c25e-451f-bb51-d69303951979,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,6021,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T02:57:54.216749,IL,רפא,,81.65121628,69.195946,51.4468,,,FENTA 25 5 PATCH,6397,,71213,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,5.0,148 73 33262 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/98f2f5ed-c25e-451f-bb51-d69303951979.json
993b061f-6f9c-4eb6-863c-38578ff028b5,VOLTAREN ACTI-GO LIQUID GEL CAPS,off-the-counter,M02AA15,DICLOFENAC,5145,,,WHO ATC Classification,,ILS,gelcaps,DICLOFENAC POTASSIUM 12.5  MG,2025-07-31T13:36:47.976126,IL,ג.ס.ק,,27.9542,23.69,nan,,,VOLTAREN ACTI-GO 20TAB,22095,,,BLISTER PVC/PVDC,units,20.0,150 99 33771 00,valid,nan,oral,1.4,36,,,,,,,,,,0,,"Short term  analgesic and antipyretic in adults and adolescents aged 14 years and over for a maximum of 3 days treatment for the relief of headache dental pain  backache , period pain, rhematic and muscular pain, and fever reduction.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/993b061f-6f9c-4eb6-863c-38578ff028b5.json
997ca092-dec1-418f-8b80-521560cc3c6b,BIMATILOL TEVA ®,prescription,S01ED51,"TIMOLOL, COMBINATIONS",8378,,,WHO ATC Classification,,ILS,"eye drops, solution","TIMOLOL AS MALEATE/, BIMATOPROST 0.3  MG /",2025-07-31T00:36:02.838197,IL,טבע,,52.31551296,44.33518047,32.3614456,,,BIMATILOL TEVA EYE DROPS bottle 3ml,,,30656,BOTTLE LDPE,units,3.0,161 23 35256 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/997ca092-dec1-418f-8b80-521560cc3c6b.json
9997ad53-e7bd-497c-a9a8-f5b4c028b47e,OCTREOTIDE BENDALIS 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,8989,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE AS ACETATE 0.05 MG/ML,2025-07-31T06:02:47.154418,IL,מרגלית,,542.9254399,460.106305,391.5798341,,,OCTREOTIDE BENDALIS 0.5 MG/ML 5 AMPS,,,74013,AMPOULES GLASS TYPE I,units,5.0,164 14 34086 00,valid,17.5,"s.c, i.v",1.4,60,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery. Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy.Octreotide Bendalis treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - Carcinoid tumours with features of the carcinoid syndrome. - VIPomas . - Glucagonomas . - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors or H2- antagonist therapy . - Insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy . - GRFomas. - Octreotide Bendalis is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9997ad53-e7bd-497c-a9a8-f5b4c028b47e.json
999aaaa1-fe9b-4ec5-abfe-574d0c7c1610,BUCCOLAM 2.5 MG,prescription,N05CD08,MIDAZOLAM,7127,,,WHO ATC Classification,,ILS,oromucosal solution,MIDAZOLAM AS HYDROCHLORIDE 2.5  MG,2025-07-31T00:45:04.687075,IL,ניאופרם,,384.8144649,326.1139678,277.5438024,,5060147020052,BUCCOLAM 2.5 MG SYRINGE PREFILLED 4X0.5ML,2548,,40572,SYRINGE PREFILLED  HDPE,units,4.0,149 78 33743 07,valid,17.5,buccal,1.4,18,,,,,,,,,,0,Prescription required,"Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/999aaaa1-fe9b-4ec5-abfe-574d0c7c1610.json
99a7eeec-26e3-4f4d-8e48-a9e442436171,CEFAZOLIN PANPHARMA 1 G,prescription,J01DB04,CEFAZOLIN,7964,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFAZOLIN AS SODIUM,2025-07-31T00:58:47.727095,IL,פארמלוג'יק,,239.47982,202.949,162.3592,,7290006676665,CEFAZOLIN PANPHARMA 1 G 25 VIAL,16907,,43292,VIAL GLASS TYPE III,units,25.0,149 28 33854 01,valid,25.0,"i.v, i.m",1.4,24,,,,,,,,,,0,Prescription required,Cefazolin is indicated for the treatment of infections due to susceptible organisms and also perioperatively for prophylaxis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/99a7eeec-26e3-4f4d-8e48-a9e442436171.json
99c0a1e2-af1b-474f-8317-d9eb8f230867,BESREMI 250 MCG/0.5 ML,prescription,L03AB15,ROPEGINTERFERON ALFA-2B ,8762,,,WHO ATC Classification,,ILS,solution for injection,ROPEGINTERFERON ALFA-2B/ML,2025-07-31T00:31:56.821357,IL,אי.או.פי אורפן,,9249.038048,7838.168185,7125.607441,,4150152036542,BESREMI 250 MCG/0.5 Ml 1 pre-filled pen,,,70821,PRE-FILLED PEN GLASS TYPE I,units,1.0,166 66 36574 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Besremi is indicated as monotherapy in adults for the treatment of polycythaemia vera without symptomatic splenomegaly.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/99c0a1e2-af1b-474f-8317-d9eb8f230867.json
99f0cdb8-08c6-4cba-8d24-30d7b2ae53b7,ELETRIPTAN - TRIMA 40 MG,prescription,N02CC06,ELETRIPTAN,8057,,,WHO ATC Classification,,ILS,film coated tablets,ELETRIPTAN AS HYDROBROMIDE,2025-07-31T02:13:47.632480,IL,תרימה,,250.5675425,212.345375,169.8763,,,ELETRIPTAN - TRIMA 40 MG 10 TAB,5620,,58101,BLISTER ALUMINIUM /ALUMINIUM,units,10.0,159 03 34741 00,valid,25.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Acute treatment of the headache phase of migraine attacks, with or without aura",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/99f0cdb8-08c6-4cba-8d24-30d7b2ae53b7.json
99f91647-c439-4387-a965-ab2aeb92f727,MACLIVAN 250 MG/5 ML,prescription,,,7542,,,,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM 62.5  MG /, AMOXICILLIN AS TRIHYDRATE/",2025-07-31T05:04:12.200843,IL,סנדוז,,14.3885483,12.193685,8.9005,,,MACLIVAN 400 MG+57 MG/5 ML POWDER FOR SUSP 35 ML,13772,,74192,BOTTLE AMBER GLASS TYPE III,units,35.0,120 17 30001 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Maclivan is indicated for the treatment of the following infections in adults and children :• Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/99f91647-c439-4387-a965-ab2aeb92f727.json
9a005855-244c-4dbd-89a8-4626d3b16d22,WAKIX 18 MG,prescription,N07XX11,PITOLISANT ,8552,,,WHO ATC Classification,,ILS,film coated tablets,PITOLISANT  AS HYDROCHLORIDE 17.8  MG,2025-07-31T10:25:16.667045,IL,תרומד,,1379.297303,1168.896072,994.8051675,,3760254600018,WAKIX 18 MG 30 TAB,23083,,89412,BOTTLE HDPE,units,30.0,164 02 36120 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Wakix is indicated•	In adults for the treatment of narcolepsy with or without cataplexy. •	To improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by, or who have not tolerated, OSA primary therapy, such as continuous positive airway pressure (CPAP).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a005855-244c-4dbd-89a8-4626d3b16d22.json
9a04c475-e8d2-4151-92b1-6b89ece39576,GAVRETO,prescription,L01EX23,PRALSETINIB,9015,,,WHO ATC Classification,,ILS,"capsule, hard",PRALSETINIB,2025-07-31T03:28:30.787890,IL,רוש,,15535.9197,13166.03423,11969.12203,,,GAVRETO 60 CAPS 100 MG,,,,BOTTLE HDPE,units,60.0,169 37 36872 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,- GAVRETO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC).- GAVRETO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy.- GAVRETO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a04c475-e8d2-4151-92b1-6b89ece39576.json
9a102df3-bead-4dde-a105-ff4c247615db,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4899,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:22:10.093663,IL,מדיסון,,762.1882162,645.9222458,549.7210603,,8715131005863,ARANESP 100MCG PREFILLED PEN 1X0.5ML,9488,,65751,PRE-FILLED PEN GLASS TYPE I,units,1.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a102df3-bead-4dde-a105-ff4c247615db.json
9a150816-3b34-4655-86ed-61239e42e45c,DURATEARS,off-the-counter,,,5124,,,,,ILS,eye ointment,"MINERAL OIL/G, LANOLIN/G, PETROLATUM/G",2025-07-31T13:25:45.279171,IL,לפידות,,30.0546,25.47,nan,,7290008067690,TEARS NATURAL  2 EYE DROPS 15ML,20091,,,TUBE ALUMINIUM,units,15.0,109 33 24050 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,Eye dryness.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a150816-3b34-4655-86ed-61239e42e45c.json
9a164f5b-a1d9-437c-8604-059300be90cc,AMVUTTRA 25 MG,prescription,N07XX18,VUTRISIRAN,9464,,,WHO ATC Classification,,ILS,solution for injection,VUTRISIRAN AS SODIUM/ML,2025-07-31T00:18:56.701540,IL,מדיסון,,407024.0098,344935.6168,313577.8335,,,AMVUTTRA 25MG/0.5ML 1 PFS,,,30586,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,176 25 37761 99,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Amvuttra is indicated for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a164f5b-a1d9-437c-8604-059300be90cc.json
9a1b9056-c00a-4ec9-9f87-a124ed99c1c3,LEDAGA,prescription,L01AA05,CHLORMETHINE,7823,,,WHO ATC Classification,,ILS,gel,CHLORMETHINE AS HYDROCHLORIDE/G,2025-07-31T04:37:38.084702,IL,רפא,,6181.01838,5238.151403,4761.955821,,7640111932697,LEDAGA 160MCG/G GEL 60G,12511,,32087,TUBE ALUMINIUM,units,60.0,157 12 34556 00,valid,10.0,topical,1.4,60,,,,,,,,,,0,Prescription required,Topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a1b9056-c00a-4ec9-9f87-a124ed99c1c3.json
9a34046d-db81-4257-8085-e6852a56d8f9,HAIRGAIN 5%,off-the-counter,D11AX01,MINOXIDIL,5437,,,WHO ATC Classification,,ILS,solution - external,MINOXIDILW/V,2025-07-31T12:35:11.350011,IL,ליף-פריגו,,193.638,164.1,nan,,7290008856119,NOXIDIL 5% SOLUTION 120ML(2*60),,,,BOTTLE HDPE,units,120.0,138 28 31485 00,valid,nan,topical- scalp,1.4,24,,,,,,,,,,0,,Hair regrowth treatment for men.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a34046d-db81-4257-8085-e6852a56d8f9.json
9a579fa9-1dc7-4084-b8f0-f5791c79c4c5,APIDRA,prescription,A10AB06,INSULIN GLULISINE,6164,,,WHO ATC Classification,,ILS,solution for injection,INSULIN GLULISINE 100 U/ML,2025-07-31T00:21:08.728291,IL,סאנופי אוונטיס,,108.5795729,92.01659126,68.4138225,,7290008880732,APIDRA VIAL 1X10ML,9284,,87578,PRE-FILLED PEN GLASS TYPE I,units,10.0,132 94 31195 00,valid,34.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of adults, adolescents and children, 6 years or older with diabetes mellitus, where treatment with insulin is required.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a579fa9-1dc7-4084-b8f0-f5791c79c4c5.json
9a57cd15-2f3b-4977-ac98-1ba0745c13b2,RAFASSAL 4 GRAM ENEMA,prescription,A07EC02,MESALAZINE,1886,,,WHO ATC Classification,,ILS,enema,MESALAZINE/,2025-07-31T07:15:32.914158,IL,רפא,,85.53203225,72.48477632,53.892027,,7290008013765,RAFASSAL ENEMA 1GR 7X60ML,18218,,8078,BOTTLE POLYETHYLENE,units,420.0,029 58 25321 00,valid,34.5,rectal,1.4,18,,,,,,,,,,0,Prescription required,Treatment and prevention of ulcerative colitis and Crohn's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a57cd15-2f3b-4977-ac98-1ba0745c13b2.json
9a5b2b17-1fe4-4ace-afbd-09923cae3b37,OPTALGIN TABLETS,off-the-counter,N02BB02,METAMIZOLE SODIUM,3026,,,WHO ATC Classification,,ILS,tablets,DIPYRONE,2025-07-31T12:40:38.654476,IL,טבע,,25.4172,21.54,nan,,7290000801834,OPTALGIN 500MG 21CAP,15016,,,BLISTER PVC/ALUMINIUM,units,21.0,016 87 20611 12,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a5b2b17-1fe4-4ace-afbd-09923cae3b37.json
9a7d7d56-c7ce-4eff-ab77-7dce9854f73a,TRANEXAMIC - MEDO INJECTION,prescription,B02AA02,TRANEXAMIC ACID,8623,,,WHO ATC Classification,,ILS,solution for injection,TRANEXAMIC ACID/,2025-07-31T09:34:19.183546,IL,מדי מרקט,,52.27068283,44.29718884,32.33371448,,7290015841177,TRANEXAMIC - MEDO INJECTION 500MG/5ML 10 AMP,,,11431,AMPOULES GLASS TYPE I,units,10.0,162 52 35399 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Prevention and treatment of haemorrhages due to general or local fibrinolysis in adults and children from one year.Specific indications include:- Haemorrhage caused by general or local fibrinolysis such as:    * Menorrhagia and metrorrhagia    * Gastrointestinal bleeding    * Haemorrhagic urinary disorders, further to prostate surgery or surgical procedures affecting the urinary tract- Ear Nose Throat surgery (adenoidectomy, tonsillectomy, dental extractions)- Gynaecological surgery or disorders of obstetric origin- Thoracic and abdominal surgery and other major surgical intervention such as cardiovascular surgery- Management of haemorrhage due to the administration of a fibrinolytic agent.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a7d7d56-c7ce-4eff-ab77-7dce9854f73a.json
9a89c256-3004-452b-bc0e-031e48994207,VOLTAREN EMULGEL 1%,off-the-counter,M02AA15,DICLOFENAC,616,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T13:37:24.363193,IL,ג.ס.ק,,47.9788,40.66,nan,,,VOLTAREN EMULGEL 50G,22205,,,TUBE ALUMINIUM,units,50.0,037 66 25000 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to:  • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :• Pain caused by osteoarthrosis of the peripheral joints,  as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a89c256-3004-452b-bc0e-031e48994207.json
9a95fe3c-71e4-4a95-8d04-af028dd5f14a,ZENALB 20,prescription,B05AA01,ALBUMIN,6899,,,WHO ATC Classification,,ILS,solution for infusion,ALBUMIN HUMAN/ML,2025-07-31T10:46:40.220458,IL,קמהדע,,406.0449646,344.1059175,292.8561,,7290011225063,ZENALB 4.5% SOLUTION 500ML,,,87778,BOTTLE GLASS TYPE II,units,500.0,137 74 31656 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"For restoration and maintenance of circulation blood volume where volume deficiency has been demonstrated and use of a colloid, is appropriate.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a95fe3c-71e4-4a95-8d04-af028dd5f14a.json
9a9d4d2b-53b8-429e-81e1-f9c1d73461a2,ALDACTONE 25 MG,prescription,C03DA01,SPIRONOLACTONE,1448,,,WHO ATC Classification,,ILS,coated tablets,SPIRONOLACTONE,2025-07-31T08:35:03.211843,IL,טבע,,23.60236,20.002,14.6,,,SPIRONOLACTONE TEVA (ALDOSPIRONE) 100MG 20TAB,1189,,33914,BLISTER PVC/ALUMINIUM,units,20.0,125 97 24826 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Congestive heart failure, cirrhotic ascites.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9a9d4d2b-53b8-429e-81e1-f9c1d73461a2.json
9aa76045-2f3d-4cdb-90e0-644f81c1f7fd,QUILLIVANT XR 600 MG,prescription,N06BA04,METHYLPHENIDATE,9577,,,WHO ATC Classification,,ILS,powder for extended release oral suspension ,METHYLPHENIDATE/BOTTLE,2025-07-31T07:12:05.973472,IL,מדיסון,,nan,nan,nan,,,QUILLIVANT XR 600 MG 1 BOTTLE,,,,BOTTLE GLASS TYPE III,units,1.0,175 92 37654 99,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,QUILLIVANT XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9aa76045-2f3d-4cdb-90e0-644f81c1f7fd.json
9abaf9c8-b9d9-43d6-a0f0-b15b0ccd2440,ABACAVIR LAMIVUDINE TARO,prescription,J05AR02,LAMIVUDINE AND ABACAVIR,8963,,,WHO ATC Classification,,ILS,film coated tablets,"LAMIVUDINE, ABACAVIR",2025-07-30T23:00:34.219180,IL,תרו יבוא,,1509.94467,1279.614128,1089.0333,,7290017164205,ABACAVIR LAMIVUDINE TARO 30 TAB,17331,,70235,BLISTER PVC/PE/PVDC/AL,units,30.0,164 76 35411 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"ABACAVIR LAMIVUDINE TARO is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults, adolescents and children weighing at least 25 kg.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9abaf9c8-b9d9-43d6-a0f0-b15b0ccd2440.json
9ac2e03b-32b3-46e0-8d48-bb435866f33b,OCTREOTIDE BENDALIS 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,8988,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE AS ACETATE 0.05 MG/ML,2025-07-31T06:02:25.517963,IL,מרגלית,,91.85508823,77.84329857,57.87605842,,,OCTREOTIDE BENDALIS 0.1 MG/ML 5 AMPS,,,74012,AMPOULES GLASS TYPE I,units,5.0,164 14 34086 00,valid,34.5,"s.c, i.v",1.4,60,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery. Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy.Octreotide Bendalis treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - Carcinoid tumours with features of the carcinoid syndrome. - VIPomas . - Glucagonomas . - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors or H2- antagonist therapy . - Insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy . - GRFomas. - Octreotide Bendalis is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ac2e03b-32b3-46e0-8d48-bb435866f33b.json
9acf8ee7-47bd-46e1-a21c-4f14508f61e8,VFEND 200 MG POWDER FOR SOLUTION FOR INFUSION,prescription,J02AC03,VORICONAZOLE,4943,,,WHO ATC Classification,,ILS,powder for solution for infusion,VORICONAZOLE/VIAL,2025-07-31T10:10:39.564732,IL,פיזר,,1804.978279,1529.642677,1301.823555,,7680559450025,VFEND 40MG/ML PWDR ORAL SUSP 75ML,22270,,69751,VIAL GLASS TYPE I,units,1.0,126 71 30598 12,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of :- invasive aspergillosis  fluconazole-resistant serious invasive Candida infections (including C. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive  possibly life-threatening infections.   - Treatment of candidemia in non neutropenic patients.- Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9acf8ee7-47bd-46e1-a21c-4f14508f61e8.json
9ad87cd8-f0fa-4d02-9899-f853d955393a,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5516,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:00:14.829126,IL,טבע,,59.0,50.0,nan,,7290000800028,ACAMOL FOCUS 50 CAPLIOTS,,,,BLISTER PVC/ALUMINIUM,units,50.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ad87cd8-f0fa-4d02-9899-f853d955393a.json
9ada5b03-9445-4bfd-8446-f11cb8e86d34,TIVICAY 10 MG,prescription,J05AX12,DOLUTEGRAVIR,8156,,,WHO ATC Classification,,ILS,film coated tablets,DOLUTEGRAVIR AS SODIUM,2025-07-31T09:22:40.014153,IL,ג.ס.ק,,696.5177131,590.2692747,502.3568295,,7290014547513,TIVICAY 10 mg 30 film-coated tablets,20848,,69594,BOTTLE HDPE,units,30.0,160 06 35311 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ada5b03-9445-4bfd-8446-f11cb8e86d34.json
9af61d0e-af2c-4493-a329-d8fd3af2434b,EPIVIR ORAL SOLUTION,prescription,J05AF05,LAMIVUDINE,3382,,,WHO ATC Classification,,ILS,solution  (oral),LAMIVUDINE/ML,2025-07-31T02:28:59.339763,IL,ג.ס.ק,,121.4708846,102.9414322,76.5363808,,7290008085519,EPIVIR ORAL SOL 240ML,5018,,9562,BOTTLE HDPE,units,240.0,124 08 28843 21,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Epivir is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9af61d0e-af2c-4493-a329-d8fd3af2434b.json
9afef00f-ef1f-42d9-8f88-0ebce4b64998,ODNATRON,prescription,A04AA01,ONDANSETRON,8069,,,WHO ATC Classification,,ILS,solution for injection,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE/ML,2025-07-31T06:03:19.590986,IL,SK PHARM(KS KIM),,130.226475,110.3614195,82.0531,,7290016845013,ODNATRON 4MG/2ML 5 amp,15467,,54624,AMPOULES GLASS TYPE I,units,5.0,150 38 33805 00,valid,34.5,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Adults:Odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.  Odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). Paediatric Population:Odnatron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged &#8805;6 months, and for the prevention and treatment of PONV in children aged &#8805; 1 month.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9afef00f-ef1f-42d9-8f88-0ebce4b64998.json
9b09539f-53ec-4e74-8e80-d0a071c68565,ORILISSA150 MG,prescription,H01CC03,ELAGOLIX,8780,,,WHO ATC Classification,,ILS,film coated tablets,ELAGOLIX AS SODIUM,2025-07-31T06:16:39.130560,IL,אב-וי,,nan,nan,nan,,,ORILISSA150 MG 28 TAB,,,30777,BLISTER PVC/PE/PCTFE/AL,units,28.0,164 66 35928 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Orilissa is indicated for the management of moderate to severe pain associated with endometriosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b09539f-53ec-4e74-8e80-d0a071c68565.json
9b222216-3131-4e7d-a36d-1e5b39893cf7,TIVICAY 10 MG,prescription,J05AX12,DOLUTEGRAVIR,8157,,,WHO ATC Classification,,ILS,film coated tablets,DOLUTEGRAVIR AS SODIUM,2025-07-31T09:22:53.672608,IL,ג.ס.ק,,1677.000209,1421.186681,1209.52058,,7290014547513,TIVICAY 25 MG 30 film-coated tablets,20849,,69595,BOTTLE HDPE,units,30.0,160 06 35311 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b222216-3131-4e7d-a36d-1e5b39893cf7.json
9b25d048-30e2-4b2d-9bce-f7875394cc71,FEMOSTON CONTI 0.5 MG/2.5 MG,prescription,G03FB08,DYDROGESTERONE AND ESTROGEN,8659,,,WHO ATC Classification,,ILS,film coated tablets,"DYDROGESTERONE 2.5  MG, ESTRADIOL AS HEMIHYDRATE 0.5  MG",2025-07-31T02:57:01.145085,IL,אבוט,,62.72563923,53.15732374,39.52217379,,8002660034946,FEMOSTON CONTI 0.5 MG/2.5 MG 28 TAB,,,69760,BLISTER PVC/ALUMINIUM,units,28.0,164 97 35630 00,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.Femoston is indicated for women with an intact uterus,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b25d048-30e2-4b2d-9bce-f7875394cc71.json
9b294663-1dbb-4b61-961e-0ae376878eda,BUCCOLAM 7.5 MG,prescription,N05CD08,MIDAZOLAM,7129,,,WHO ATC Classification,,ILS,oromucosal solution,MIDAZOLAM AS HYDROCHLORIDE 7.5  MG,2025-07-31T00:45:27.217639,IL,ניאופרם,,389.9489723,330.4652454,281.2470174,,5060147020076,BUCCOLAM 7.5 MG SYRINGE PREFILLED 4X1.5ML,2550,,40575,SYRINGE PREFILLED  HDPE,units,4.0,149 80 33745 07,valid,17.5,buccal,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b294663-1dbb-4b61-961e-0ae376878eda.json
9b4e4f54-59b5-4d0d-857f-227311d1078e,ADEX FORTE 400,off-the-counter,M01AE01,IBUPROFEN,5279,,,WHO ATC Classification,,ILS,caplets,IBUPROFEN,2025-07-31T11:03:43.118986,IL,דקסל פארמה,,57.879,49.05,nan,,,ADEX FORTE 400MG 40CAPLETS,9265,,,BLISTER PVC/ALUMINIUM,units,40.0,110 28 29270 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. For the relief of mild to moderate pain and treatment of primary dysmenorrhea.For the treatment of pain associated with migraine.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b4e4f54-59b5-4d0d-857f-227311d1078e.json
9b51e7db-24aa-4ed0-8b43-5567fc988369,NERIDERM CREAM,prescription,D07AC06,DIFLUCORTOLONE,2768,,,WHO ATC Classification,,ILS,cream,DIFLUCORTOLONE VALERATE 0.1 %W/W /,2025-07-31T05:42:47.677088,IL,פאדאגיס,,24.28556278,20.58098632,15.02261775,,7290002925545,NERIDERM CREAM 30G,14014,,8834,TUBE ALUMINIUM,units,30.0,061 50 24636 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,Corticoid responsive dermatoses in the absence of infection,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b51e7db-24aa-4ed0-8b43-5567fc988369.json
9b530ee6-ed6e-41e4-a927-c3b81abb9a6c,MINOXI 2,off-the-counter,D11AX01,MINOXIDIL,3940,,,WHO ATC Classification,,ILS,solution,MINOXIDILW/V,2025-07-31T12:26:02.254516,IL,תרימה,,147.5,125.0,nan,,7290008075657,MINOXI 2  80ML,13370,,,BOTTLE HDPE,units,80.0,049 97 26155 00,valid,nan,topical- scalp,1.4,36,,,,,,,,,,0,,Androgenetic alopecia in females.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b530ee6-ed6e-41e4-a927-c3b81abb9a6c.json
9b534d3e-7e31-41af-92bc-3421ddf74051,SANDOSTATIN ® 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,948,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE 0.05  MG/ML,2025-07-31T07:59:19.520324,IL,נוברטיס פארמה,,91.85508823,77.84329857,57.87605842,,7298120012734,SANDOSTATIN 0.1MG/ML,19621,,7775,AMPOULES GLASS TYPE I,units,5.0,047 03 25697 00,valid,34.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery.   Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery  or radiotherapy. Sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery  or in the interim period until radiotherapy becomes fully effective.   Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours:   - Carcinoid tumours with features of the carcinoid syndrome    - VIPomas    - Glucagonomas    - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors  or H2- antagonist therapy    - Insulinomas  for pre-operative control of hypoglycaemia and for maintenance therapy   - GRFomas.   Sandostatin is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b534d3e-7e31-41af-92bc-3421ddf74051.json
9b624f5e-0825-4470-9c71-9bb7fbc5c2bd,RISPERDAL 1 MG,prescription,N05AX08,RISPERIDONE,3113,,,WHO ATC Classification,,ILS,film coated tablets,RISPERIDONE,2025-07-31T07:37:23.552325,IL,יאנסן סילג,,20.79804398,17.625461,12.8653,,7290008124744,RISPERDAL 1MG 20TAB,18098,,9231,BLISTER PVC/PE/PVDC/AL,units,20.0,144 78 28260 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b624f5e-0825-4470-9c71-9bb7fbc5c2bd.json
9b753424-2238-4a60-8767-fc1b9fa8b2c2,"DARZALEX 120 MG/ML S.C. 1,800 MG",prescription,L01XC24,DARATUMUMAB,7807,,,WHO ATC Classification,,ILS,solution for injection,DARATUMUMAB/,2025-07-31T01:41:45.098874,IL,יאנסן סילג,,2016.876658,1709.217583,1454.653262,,7290014577657,DARZALEX 20MG/ML VIAL 100MG/5ML,4668,,60534,VIAL GLASS TYPE I,units,5.0,167 14 36565 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"DARZALEX is indicated:Multiple Myeloma• in combination with lenalidomide and dexamethasone or with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.• in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant.• in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.• as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who have demonstrated disease progression on the last therapy.•for the treatment of adult patients with multiple myeloma in combination with pomalidomide and dexamethasone in patients who have received at least one prior line of therapy including lenalidomide and a proteasome inhibitor.Light chain (AL) amyloidosis• in combination with cyclophosphamide, bortezomib and dexamethasone for the treatment of adult patients with newly diagnosed systemic AL amyloidosis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b753424-2238-4a60-8767-fc1b9fa8b2c2.json
9b754111-a904-474a-ad82-c35c8620c551,AMPRES,prescription,N01BA04,CHLOROPROCAINE,8815,,,WHO ATC Classification,,ILS,solution for injection,CHLOROPROCAINE HYDROCHLORIDE/ML,2025-07-30T23:23:10.277878,IL,כ.צ.ט,,582.037656,493.2522728,419.7891683,,7290018609842,AMPRES 10MG/ML  10 AMP 5 ML,,,,AMPOULES GLASS TYPE I,units,10.0,167 11 36305 00,valid,17.5,intrathecal,1.4,24,,,,,,,,,,0,Prescription required,Spinal anaesthesia in adults where the planned surgical procedure should not exceed 40 minutes,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b754111-a904-474a-ad82-c35c8620c551.json
9b77fcc9-4143-46d7-8d90-bd80f1544115,FIRMAGON 120 MG,prescription,L02BX02,DEGARELIX,6673,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,DEGARELIX AS ACETATE,2025-07-31T03:05:30.597250,IL,פרינג,,1058.935508,897.4030129,763.747245,,5015919788876,FIRMAGON 120MG 2VIALS POWDER + 2VIALS SOLV.,6464,,7162,VIAL GLASS TYPE I,units,2.0,145 04 32955 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of adult male patients with advanced hormone-dependent prostate cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b77fcc9-4143-46d7-8d90-bd80f1544115.json
9b8e4ea6-1487-4f93-81d8-5161369363e3,EXELON PATCH 10,prescription,N06DA03,RIVASTIGMINE,3634,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 9.5 MG/DAY,2025-07-31T02:47:46.279937,IL,נוברטיס פארמה,,107.9372426,91.4722395,68.0091,,,EXELON 3MG 28CAPS,5118,,85369,POUCH PAPER/PET/PE/AL/POLYAMIDE,units,28.0,139 70 31675 01,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b8e4ea6-1487-4f93-81d8-5161369363e3.json
9b9c9488-0de9-4a7e-893a-4f1dfa00c080,IRINOTECAN VENUS 20 MG/ML,prescription,L01XX19,IRINOTECAN,9511,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,IRINOTECAN HYDROCHLORIDE TRIHYDRATE/,2025-07-31T04:12:33.232216,IL,טרוסטפארם,,485.4347248,411.38536,350.1152,,,IRINOTECAN VENUS 20 MG/ML 1 VIAL 5ML,,,,VIAL GLASS TYPE I,units,1.0,176 15 37137 99,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"IRINOTECAN VENUS 20 MG/ML is indicated for the treatments of patients with metastatic colorectal cancer:- In combination with 5-fluorouracil and folinic acid in patient without prior chemotherapy for metastatic disease.- As a single agent in patients who have failed an established 5-fluorouracil treatment regimen.- For the treatment of patients with small cell lung cancer.- For the treatment of patients with gastric cancer.- Irinotecan in combination with leucovorin, Oxaliplatin and 5- fluorouracil, for the first line treatment of patients with metastatic pancreatic adenocarcinoma.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9b9c9488-0de9-4a7e-893a-4f1dfa00c080.json
9ba49116-8f41-4cad-a9d2-a5938e3bb363,PREDNISONE 1 MG TABLETS,prescription,H02AB07,PREDNISONE,1984,,,WHO ATC Classification,,ILS,tablets,PREDNISONE,2025-07-31T06:51:52.476463,IL,רקח,,13.433946,11.3847,8.31,,7290008089326,PREDNISONE 5MG 30TAB,16195,,9663,SECURITAINER POLYPROPYLENE,units,30.0,118 06 26041 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Anti-inflammatory.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ba49116-8f41-4cad-a9d2-a5938e3bb363.json
9bca929b-c4ab-41b6-a5cf-2c5c3a1924e6,PLAVIX 75 MG,prescription,B01AC04,CLOPIDOGREL,3779,,,WHO ATC Classification,,ILS,film coated tablets,CLOPIDOGREL AS HYDROGEN SULFATE,2025-07-31T06:45:56.978626,IL,סאנופי אוונטיס,,53.4981438,45.33741,33.093,,7290012711428,PLAVIX 75MG 30TAB,16385,,24639,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,110 70 29307 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Secondary Prevention of atherotrobmotic eventsClopidogrel is indicated in :• Adult Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• Adult Patients suffering from Acute Coronary Syndrome- Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapyPrevention of atherotrobmotic and thromboembolic events in atrial fibrillation: In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with Vitamin K antagonists (VKA) Anti-Thrombin or Anti Factor Xa, and who have a low bleeding risk, clopidogrel is indicated in combination  with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bca929b-c4ab-41b6-a5cf-2c5c3a1924e6.json
9bd1b50a-bb5e-4d2d-a397-d8cefee0926d,CLOPIXOL 10 MG TABLETS,prescription,N05AF05,ZUCLOPENTHIXOL,628,,,WHO ATC Classification,,ILS,film coated tablets,ZUCLOPENTHIXOL AS DIHYDROCHLORIDE,2025-07-31T01:22:54.222410,IL,לנדבק,,15.10712633,12.80265,9.345,,,CLOPIXOL 2MG 50TAB,3628,,8217,CONTAINER HDPE,units,50.0,047 86 25486 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute schizophrenia .Other acute psychoses.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bd1b50a-bb5e-4d2d-a397-d8cefee0926d.json
9bd5822c-c352-46e6-af3e-823de8e69506,TREOSULFAN RAZ 5 G,prescription,L01AB02,TREOSULFAN,9097,,,WHO ATC Classification,,ILS,powder for solution for infusion,TREOSULFAN/VIAL,2025-07-31T09:39:22.053845,IL,רז פרמהצפטי,,15825.7477,13411.65119,12192.41017,,,TREOSULFAN RAZ 5 G 5 VIALS,,,86186,VIAL GLASS TYPE I,units,5.0,167 98 35696 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (alloHSCT) in adult patients with malignant and non-malignant diseases, and in paediatric patients older than one month with malignant diseases.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bd5822c-c352-46e6-af3e-823de8e69506.json
9bd5f02e-e28b-412c-8c38-45386707305b,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4548,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:22:42.544304,IL,מדיסון,,612.4242102,519.003591,441.7051839,,8715131005863,ARANESP 20MCG 4 PREFILLED SYR 0.5ML,9482,,29742,PRE-FILLED PEN GLASS TYPE I,units,4.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bd5f02e-e28b-412c-8c38-45386707305b.json
9bd984ce-f76f-462e-8cbb-446370848c5f,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7454,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:19:40.035842,IL,צמל,,130.485331,110.580789,82.2162,,,METOJECT 50MG/ML SYRINGE PREFILLED 20MG/0.4ML,,,4055,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bd984ce-f76f-462e-8cbb-446370848c5f.json
9bdec17b-a85a-49d2-a76e-9fbc119d11c8,AMIODACORE INJECTION,prescription,C01BD01,AMIODARONE,2309,,,WHO ATC Classification,,ILS,solution for injection,AMIODARONE HYDROCHLORIDE/,2025-07-30T23:22:14.921794,IL,כ.צ.ט,,28.0738756,23.79142,17.366,,7290012711282,AMIODACORE 200MG 30TAB,1235,,206,AMPOULES GLASS TYPE I,units,30.0,043 04 23211 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Treatment should be initiated and normally monitored only under hospital or specialist supervision. Amiodacore injection is indicated for Corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.Amiodacore intravenous can be used where a rapid response is required or where oral administration is not possible.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bdec17b-a85a-49d2-a76e-9fbc119d11c8.json
9becb666-5ec9-4191-a5a3-8821666d9bf4,CIDOFOVIR RAZ 75 MG/ML,prescription,J05AB12,CIDOFOVIR,9160,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,CIDOFOVIR AS DIHYDRATE,2025-07-31T01:12:15.055682,IL,רז פרמהצפטי,,8381.955542,7103.35247,6457.593155,,,CIDOFOVIR RAZ 75 MG/ML 1 VIAL,23276,,77247,VIAL GLASS TYPE I,units,1.0,167 09 35697 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Cidofovir is indicated for the treatment of CMV retinitis in adults with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction. It should be used only when other medicinal products are considered unsuitable.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9becb666-5ec9-4191-a5a3-8821666d9bf4.json
9bf19cbf-ab2b-4f7c-9890-ee0e6b467f55,METADEX XR 10 MG,prescription,N06BA11,DEXMETHYLPHENIDATE,9227,,,WHO ATC Classification,,ILS,capsules extended release,DEXMETHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:16:01.406571,IL,SK PHARM(KS KIM),,nan,nan,nan,,,METADEX XR 30 MG S.K. 100 CAPSULES,,,70904,BOTTLE HDPE,units,100.0,172 56 37337 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Metadex XR extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bf19cbf-ab2b-4f7c-9890-ee0e6b467f55.json
9bfad8fa-91ee-478b-87c9-f42e1dc2a252,NUWIQ 250 IU,prescription,B02BD02,COAGULATION FACTOR VIII,9073,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,SIMOCTOCOG ALFA/VIAL,2025-07-31T05:59:03.635300,IL,דובר מדיקל,,678.5387762,575.0328867,489.3896908,,,NUWIQ 250 IU,,,75583,VIAL GLASS TYPE I,units,1.0,168 20 36549 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients 2 years of age and older with haemophilia A (congenital factor VIII deficiency). Nuwiq does not contain von Willebrand Factor and is thus not indicated to treat von Willebrand’s Disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bfad8fa-91ee-478b-87c9-f42e1dc2a252.json
9bff2002-b642-4ad4-a9d8-d9694c7ab650,TERIL 200,prescription,N03AF01,CARBAMAZEPINE,3271,,,WHO ATC Classification,,ILS,tablets,CARBAMAZEPINE,2025-07-31T09:15:25.552459,IL,תרו,,23.35712178,19.794171,14.4483,,,TERIL CR 200MG 50TAB,20143,,9654,BLISTER PVC/PVDC,units,50.0,129 63 30784 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neurolgia, diabetes insipidus, mania, prophylactic in manic depressive illness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9bff2002-b642-4ad4-a9d8-d9694c7ab650.json
9c0091ed-6914-4eb2-978d-1512f019cf08,KYMRIAH,prescription,,,8481,,,,,ILS,dispersion for infusion,TISAGENLECLEUCEL,2025-07-31T04:31:00.796419,IL,נוברטיס פארמה,,1465444.92,1241902.53,1129002.3,,,KYMRIAH 1.2X10-6X10 1 VIAL,11294,,29274,BAG ETHYLENE VINYL ACETATE (EVA),units,1.0,162 91 35711 00,valid,10.0,i.v,1.4,9,,,,,,,,,,0,Prescription required,"Kymriah is indicated for the treatment of: - Paediatric and young adult patients up to and including 25 years of age with CD19+ B-cell acute lymphoblastic leukaemia (ALL) that is refractory, in relapse post-transplant or in second or later relapse. - Adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. Limitation of Use: KYMRIAH is not indicated for treatment of patients with primary or secondary central nervous system lymphoma- Adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c0091ed-6914-4eb2-978d-1512f019cf08.json
9c04f9aa-47b5-4a52-a12a-53fdf789257e,SECTOR 100,prescription,C09DX04,VALSARTAN AND SACUBITRIL,9292,,,WHO ATC Classification,,ILS,sodium salt complex,SACUBITRIL/VALSARTAN AS SODIUM SALT COMPLEX AS SODIUM SALT COMPLEX 49/51  MG,2025-07-31T08:02:28.909301,IL,אוניפארם,,285.5248431,241.970206,205.9320902,,,SECTOR 50 MG 28 TAB,,,47053,BLISTER PVC/ALUMINIUM,units,28.0,171 72 37119 99,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Sector is indicated for the treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction. Sector has been shown to reduce the rate of cardiovascular death and heart failure hospitalisation compared to angiotensin converting enzyme (ACE) inhibitor therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c04f9aa-47b5-4a52-a12a-53fdf789257e.json
9c21c3c7-eb55-482c-b588-e6a082d178b3,TELEBRIX GASTRO,prescription,P01CB01,MEGLUMINE ANTIMONATE,8695,,,WHO ATC Classification,,ILS,solution,MEGLUMINE IOXITALAMATE 66.03 G /,2025-07-31T09:10:40.677844,IL,ניאופרם,,605.030644,512.7378567,436.372644,,7298120003701,TELEBRIX GASTRO  10 BOTTLEs 100 ML,,,,BOTTLE GLASS TYPE III,units,10.0,117 64 25639 05,valid,17.5,"per os, rectal",1.4,36,,,,,,,,,,0,Prescription required,"Conventional x-ray and CT examinations of the gastrointestinal tract, gastroduodenal radiography, opaque enema examinations, especially in cases in which barium is contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c21c3c7-eb55-482c-b588-e6a082d178b3.json
9c35f8a1-c354-44e4-b2c7-1f4592e822ff,PERGOVERIS ®,prescription,G03GA05,FOLLITROPIN ALFA,6749,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,"FOLLITROPIN ALFA, LUTROPIN ALFA",2025-07-31T06:37:00.486485,IL,מרק סרונו,,397.1376222,336.5573219,286.4317634,,7290000845470,PERGOVERIS 150 IU/75IU VIAL (POWDER+SOLVENT),16839,,32060,VIAL GLASS TYPE I,units,1.0,145 07 33159 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Pergoveris is indicated for the stimulation of follicular development in adult women with sever LH and FSH deficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c35f8a1-c354-44e4-b2c7-1f4592e822ff.json
9c3a4c61-1459-4093-8e95-c9b7a43c8dc4,PARAMOL,off-the-counter,N02BE01,PARACETAMOL,5446,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T12:46:00.087580,IL,ליף-דקסון,,20.296,17.2,nan,,,PARAMOL KAT 20 CHEWABLE TABLETS,,,,BLISTER PVC/ALUMINIUM,units,20.0,127 96 30764 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c3a4c61-1459-4093-8e95-c9b7a43c8dc4.json
9c4da5ff-4119-4073-b6d9-b7fb9c550b4f,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5090,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:00:27.316509,IL,טבע,,35.0106,29.67,nan,,7290000800028,ACAMOL TSIN.LIQUI.GEL 30 DAY CAPSULE,1897,,,BLISTER PVC/ALUMINIUM,units,30.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c4da5ff-4119-4073-b6d9-b7fb9c550b4f.json
9c85912f-94c6-4001-8e66-05222782b207,BITNI TABLETS,off-the-counter,,,5458,,,,,ILS,tablets,BISMUTH SUBSALICYLATE,2025-07-31T11:19:29.321971,IL,כ.צ.ט,,24.6974,20.93,nan,,,BITNI X SUSPENSION 100 ML,,,,BLISTER PVC/ALUMINIUM,units,100.0,140 65 31601 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of diarrhea, nausea, flatulence, convulsive stomach pains, uspet stomach. As a preventative treatment of traveler's diarrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c85912f-94c6-4001-8e66-05222782b207.json
9c992f43-253f-49ab-9763-d342e8798cae,GABAPENTIN INOVAMED 300 MG,prescription,N03AX12,GABAPENTIN,3843,,,WHO ATC Classification,,ILS,capsules,GABAPENTIN,2025-07-31T03:25:47.414873,IL,טבע,,106.9560974,90.6407605,67.3909,,,GABAPENTIN-TEVA 300MG 100CAPS,7534,,2758,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,146 48 33100 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Epilepsy :- Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- Treatment of neuropathic pain- Gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c992f43-253f-49ab-9763-d342e8798cae.json
9c9cd37b-a10a-400b-8344-0b9aa18a93a2,KALYDECO 150 MG FILM COATED TABLETS,prescription,R07AX02,IVACAFTOR,8669,,,WHO ATC Classification,,ILS,film coated tablets,IVACAFTOR,2025-07-31T04:22:06.931952,IL,מדיסון,,52580.82498,44560.02315,40509.11196,,,KALYDECO 50 MG GRANULES 56 SACHETS,11300,,68480,BLISTER PVC/ALUMINIUM,units,56.0,153 89 34269 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Kalydeco tablets are indicated for the treatment of patients with cystic fibrosis (CF) aged 6 years and older and weighing 25 kg or more who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data. Limitations of use : Kalydeco is not effective in patients with CF who are homozygous for the F508del mutation in the CFTR gene.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9c9cd37b-a10a-400b-8344-0b9aa18a93a2.json
9caea017-beab-40bf-94fe-1762b56d20bc,FLOLAN INFUSION OF EPOPROSTENOL 1500 MCG,prescription,B01AC09,EPOPROSTENOL,8256,,,WHO ATC Classification,,ILS,powder for solution for infusion,EPOPROSTENOL AS SODIUM 1.5 MG/VIAL,2025-07-31T03:09:16.239812,IL,ג.ס.ק,,296.3004876,251.1021193,213.7039313,,7290014547483,FLOLAN INFUSION OF EPOPROSTENOL 1500 MCG DIL-PH12,6606,,20047,VIAL GLASS TYPE I,units,1.0,112 41 29467 05,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Flolan is indicated for the treatment of pulmonary arterial hypertension (PAH) (idiopathic or heritable PAH and PAH associated with connective tissue diseases) in patients with WHO Functional Class III-IV symptoms to improve exercise capacity,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9caea017-beab-40bf-94fe-1762b56d20bc.json
9caf80eb-05fa-4296-baa3-c39b375e29db,NOVITROPAN 5 MG TABLETS,prescription,G04BD04,OXYBUTYNIN,8883,,,WHO ATC Classification,,ILS,tablets,OXYBUTYNIN HYDROCHLORIDE,2025-07-31T05:53:28.686039,IL,כ.צ.ט,,9.285797839,7.869320552,5.7440296,,,NOVITROPAN 5 MG  30 TABLETS,,,56320,BLISTER PVC/ALUMINIUM,units,30.0,115 57 25985 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Novitropan is indicated for the symptomatic treatment of urinary incontinence, urgency, and frequency in the unstable bladder, whether due to neurogenic bladder disorders (detrusor hyperreflexia) in conditions such as multiple sclerosis and spina bifida, or to idiopathic detrusor instability (motor urge incontinence). Paediatric population Novitropan is indicated in children of 5 years of age or older for: − Urinary incontinence, urgency, and frequency in unstable bladder conditions due to idiopathic overactive bladder or neurogenic bladder disorders (detrusor overactivity).− Nocturnal enuresis associated with detrusor overactivity, in conjunction with nondrug therapy, when other treatment has failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9caf80eb-05fa-4296-baa3-c39b375e29db.json
9cb42a9c-dd10-42e4-ae17-4f1870684738,RAFASSAL 4 GRAM ENEMA,prescription,A07EC02,MESALAZINE,1887,,,WHO ATC Classification,,ILS,enema,MESALAZINE/,2025-07-31T07:15:14.598455,IL,רפא,,184.7220707,156.5441346,125.2353077,,7290008013765,RAFASSAL ENEMA  7X 4GRX60ML,18179,,7433,BOTTLE POLYETHYLENE,units,7.0,029 58 25321 00,valid,25.0,rectal,1.4,18,,,,,,,,,,0,Prescription required,Treatment and prevention of ulcerative colitis and Crohn's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9cb42a9c-dd10-42e4-ae17-4f1870684738.json
9cb4ece8-da21-40f4-9e67-4b4ff919e1c9,BROMSITE,prescription,S01BC11,BROMFENAC,8299,,,WHO ATC Classification,,ILS,"eye drops, solution",BROMFENAC AS SODIUM SESQUIHYDRATE 0.075 %W/W,2025-07-31T00:44:26.684449,IL,תרו,,nan,nan,nan,,,BROMSITE DROPS 1  BOTTLE 5ML,,,35618,BOTTLE LDPE,units,5.0,166 23 35657 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of postoperative inflammation and prevention of ocular pain in adult patients undergoing cataract surgery,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9cb4ece8-da21-40f4-9e67-4b4ff919e1c9.json
9d021ff1-a97c-4474-8471-35082c5db84d,GABAPENTIN INOVAMED 300 MG,prescription,N03AX12,GABAPENTIN,3844,,,WHO ATC Classification,,ILS,capsules,GABAPENTIN,2025-07-31T03:26:02.599915,IL,טבע,,132.4750783,112.2670155,83.4699,,,GABAPENTIN-TEVA 400MG 100CAPS,7535,,27307,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,146 48 33100 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Epilepsy :- Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- Treatment of neuropathic pain- Gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d021ff1-a97c-4474-8471-35082c5db84d.json
9d323576-ade0-461a-a45c-2e046602cd3b,CEREZYME 400 UNITS,prescription,A16AB02,IMIGLUCERASE,6459,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,IMIGLUCERASE 400 U/VIAL,2025-07-31T01:07:01.540964,IL,סאנופי אוונטיס,,6705.599787,5682.711937,5166.101761,,7290013773012,CEREZYME 400 UNITS POWDER FOR SOL FOR INF,9524,,75687,VIAL GLASS TYPE I,units,1.0,119 65 29980 01,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,For the long term enzyme replacement therapy for patients with a confirmed diagnosis of Type 1 gaucher disease that results in one or more of the following conditions: - Anemia  - Thrombocytopenia  - Bone disease  - Hepatomegaly or splenomegaly.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d323576-ade0-461a-a45c-2e046602cd3b.json
9d3379a8-2950-4fd1-8faf-848883b1a535,SPRYCEL 100MG 30 FC TAB,prescription,,,6627,,,,,ILS,tablet,SPRYCEL 100MG 30 FC TAB,2025-07-31T19:32:32.639843,IL,ב.מ.ס,,6252.333003,5298.587291,4816.897537,,,SPRYCEL 100MG 30 FC TAB,19926,,21587,,units,30.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d3379a8-2950-4fd1-8faf-848883b1a535.json
9d361758-d1e2-4701-aaf9-2bf3683f3080,DOCETAXEL HOSPIRA 10 MG/ML,prescription,L01CD02,DOCETAXEL,7050,,,WHO ATC Classification,,ILS,solution for infusion,DOCETAXEL/,2025-07-31T02:00:58.618148,IL,פיזר,,1318.969408,1117.770685,951.2942,,7290013592651,DOCETAXEL HOSPIRA 10MG/ML VIAL 80MG/8ML,4594,,41876,VIAL GLASS TYPE I,units,1.0,148 24 33345 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Breast cancer:  Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer.  Docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.  Docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. Previous chemotherapy should have included an anthracycline or an alkylating agent.  Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2 and who previously have not received chemotherapy for metastatic disease. Docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Doxorubicin and cyclophosphamide followed by Docetaxel in combination with trastuzumab (AC-TH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high risk node-negative, breast cancer. Docetaxel in combination with trastuzumab, and carboplatin (TCH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high risk node-negative, breast cancer. Non-small cell lung cancer:   Docetaxel is indicated for the treatment of patients with advanced non-small cell lung carcinoma. Ovarian Cancer:   Docetaxel is indicated for treatment of metastatic carcinoma of the ovary after failure of first line or subsequent chemotherapy. Prostate cancer:   Docetaxel in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.Esophageal cancer:   Docetaxel for the treatment of esophageal cancer. Gastric cancer:   Docetaxel for the treatment of advanced gastric cancer. Head and neck (SCCHN):   Docetaxel as monotherapy in the treatment of patients with recurrent and/or metastasis squamos cell carcinoma of the head and neck after failure of a previous chemotherapy regimen.   Docetaxel in combination with cisplatin and 5 fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d361758-d1e2-4701-aaf9-2bf3683f3080.json
9d47014a-b309-4b46-9a24-f743fd2b0007,ENJAYMO,prescription,L04AJ04,SUTIMLIMAB,9207,,,WHO ATC Classification,,ILS,solution for infusion,SUTIMLIMAB/ML,2025-07-31T02:22:28.359285,IL,סאנופי אוונטיס,,4969.555727,4211.488091,3828.625538,,7290012711855,ENJAYMO 50 MG/ML 22 ML (1100 MG)  SOLUTION FOR INFUSION,5757,,72571,VIAL GLASS TYPE I,units,1.0,174 82 37417 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,ENJAYMO is indicated for the reatment of haemolysis in adult patients with cold agglutinin disease (CAD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d47014a-b309-4b46-9a24-f743fd2b0007.json
9d653a30-4c88-4cd1-8354-e195bd6fece5,CLARINASE REPETABS,prescription,R06AX13,LORATADINE,4331,,,WHO ATC Classification,,ILS,tablets prolonged release,"LORATADINE, PSEUDOEPHEDRINE SULFATE",2025-07-31T01:18:30.118303,IL,באייר,,39.76615933,33.70013653,24.5986398,,7290008121521,CLARINASE REPETABS 14,3137,,3680,BLISTER PVC/PCTFE,units,14.0,101 67 28568 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Relief of symptoms of seasonal allergic rhinitis when both the antihistaminic properties and the nasal decongestant activity are desired.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d653a30-4c88-4cd1-8354-e195bd6fece5.json
9d6fa161-03d3-47a3-9db7-c04c6377b137,ABILIFY  MAINTENA 300 MG,prescription,N05AX12,ARIPIPRAZOLE,7884,,,WHO ATC Classification,,ILS,powder and solvent for prolonged-release suspension for injection,ARIPIPRAZOLE AS MONOHYDRATE/VIAL,2025-07-31T00:03:32.890570,IL,לנדבק,,1514.987934,1283.888137,1092.670755,,,ABILIFY  MAINTENA 300 MG VIAL,,,55801,VIAL GLASS TYPE I,units,1.0,153 68 34089 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,Abilify Maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d6fa161-03d3-47a3-9db7-c04c6377b137.json
9d71948c-c6f3-4f86-a9fc-b73ced2e2747,LEVETRIM 1000,prescription,N03AX14,LEVETIRACETAM,6623,,,WHO ATC Classification,,ILS,film coated tablets,LEVETIRACETAM,2025-07-31T04:43:55.819872,IL,תרימה,,91.57201967,77.6034065,57.6977,,,LEVETRIM 250MG 60 FC TAB,12440,,21384,BLISTER PVC/ALUMINIUM,units,60.0,143 77 31941 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,- Levetrim is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetrim is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Levetrim is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Levetrim is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d71948c-c6f3-4f86-a9fc-b73ced2e2747.json
9d75f735-8036-4ad0-ba05-fd6005fdf01e,PREGABALIN TEVA ® 100 MG,prescription,N03AX16,PREGABALIN,8019,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:54:27.748488,IL,טבע,,168.9678875,143.193125,114.5545,,,PREGABALIN TEVA  150 MG 56 TAB,,,56107,BLISTER PVC/ALUMINIUM,units,56.0,157 26 34479 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,PREGABALIN TEVA ® is indicated for the: - Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia. - Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d75f735-8036-4ad0-ba05-fd6005fdf01e.json
9d82ebf9-082d-4eb7-bda0-6d6ca20b4d5c,ENERZAIR BREEZHALER 114 MCG/46 MCG/136 MCG,prescription,R01AD09,MOMETASONE,9012,,,WHO ATC Classification,,ILS,"capsule, hard","MOMETASONE FUROATE, GLYCOPYRRONIUM AS BROMIDE, INDACATEROL AS ACETATE",2025-07-31T02:21:56.424521,IL,נוברטיס פארמה,,271.1666966,229.8022955,183.8418364,,,ENERZAIR BREEZHALER 114 MCG/46 MCG/136 MCG INHALATION 30CAPS,5727,,15011,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,168 70 36695 99,valid,25.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,Enerzair Breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.Important Limitations of Use:Enerzair Breezhaler is not indicated in patients with COPD., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d82ebf9-082d-4eb7-bda0-6d6ca20b4d5c.json
9d871e89-d5d1-4df9-9d40-c8ca7def5487,GYNERA ®,prescription,G03CA01,ETHINYLESTRADIOL,58,,,WHO ATC Classification,,ILS,coated tablets,"ETHINYLESTRADIOL 0.03   MG, GESTODENE 0.075   MG",2025-07-31T03:39:27.253454,IL,באייר,,22.5750107,19.131365,13.9645,,7-298074-040128,GYNERA 1X21TAB,7219,,8191,BLISTER PVC/ALUMINIUM,units,21.0,050 51 25622 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Hormonal contraception.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d871e89-d5d1-4df9-9d40-c8ca7def5487.json
9d93c9b3-e910-4932-a852-61bc897c3727,SELGIN,prescription,N04BD01,SELEGILINE,3096,,,WHO ATC Classification,,ILS,tablets,SELEGILINE HYDROCHLORIDE,2025-07-31T08:03:38.580496,IL,כ.צ.ט,,109.1485173,92.4987435,68.7723,,,SELGIN 5MG 50TAB,19101,,9283,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,069 27 28278 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Parkinson's disease or symptomatic parkinsonism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9d93c9b3-e910-4932-a852-61bc897c3727.json
9da77d51-b608-4482-8a9b-8d9cf007944a,LAVECALM,off-the-counter,,,5625,,,,,ILS,"capsule, soft",LAVENDER OIL,2025-07-31T12:18:10.820877,IL,דר סמואלוב,,91.4736,77.52,nan,,7290019927006,LAVECALM 28 CAPS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,173 95 36643 99,valid,nan,per os,1.4,60,,,,,,,,,,0,,"Lavecalm is a herbal medicinal product for relief of mild symptoms of mental stress and to aid sleep, in adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9da77d51-b608-4482-8a9b-8d9cf007944a.json
9db9f04b-48ef-4365-9b0a-517010d17aac,ALFUZOSIN ER TEVA ® 10 MG,prescription,G04CA01,ALFUZOSIN,6621,,,WHO ATC Classification,,ILS,tablets extended release,ALFUZOSIN HYDROCHLORIDE,2025-07-31T00:15:58.223154,IL,טבע,,76.98752293,65.2436635,48.5083,,7290102064731,ALFUZOSIN ER TEVA 10MG 30 XR TAB,9412,,24006,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,142 46 31943 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of certain functional symptoms of benign prostatic hypertrophy  particularly if surgery has to be delayed for some reason.   Adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9db9f04b-48ef-4365-9b0a-517010d17aac.json
9dc97299-172c-423d-b213-331aa18f29d8,CONCOR 1.25 MG,prescription,C07AB07,BISOPROLOL,9117,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE 1.25  MG,2025-07-31T01:28:17.850257,IL,מרק סרונו,,21.57562858,18.284431,13.3463,,,CONCOR 1.25 MG 30 TAB,,,69385,BLISTER PVC/ALUMINIUM,units,30.0,167 22 35983 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function (ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9dc97299-172c-423d-b213-331aa18f29d8.json
9dd8e7a5-1447-45ce-bbd7-343a4d62d315,TACHOSIL,prescription,B02BB01,HUMAN FIBRINOGEN,7483,,,WHO ATC Classification,,ILS,sealant matrix,"THROMBIN/CM^2, HUMAN FIBRINOGEN 5.5 MG/CM^2",2025-07-31T08:57:14.140528,IL,כ.צ.ט,,1925.151377,1631.48429,1388.497268,,5728300100927,TACHOSIL 2IU/5.5MG 2 SPONGE (4.8x4.8CM),20798,,75909,BLISTER HDPE,units,2.0,139 51 31704 00,valid,17.5,"topical in surgery, epilesional, epilesional",1.4,36,,,,,,,,,,0,Prescription required,"Tachosil is indicated for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for sutute support in vascular surgery where standard techniques are insufficient.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9dd8e7a5-1447-45ce-bbd7-343a4d62d315.json
9dda424b-af8f-4e9a-92d8-543cb64ef5af,MAGNESIUM SULFATE 50 % W/V INOVAMED,29C,A12CC02,MAGNESIUM SULFATE,20866,,,WHO ATC Classification,,ILS,solution for injection / concentrate for solution for inj/inf,MAGNESIUM SULFATE AS HEPTAHYDRATE/,2025-07-31T15:04:58.981847,IL,nan,,nan,nan,nan,,7290104530517,MAGNESIUM SULFATE 40MG/ML VIAL 100ML HOSPIRA USA SOLUTION FOR INJECTION,,,,AMPOULES POLYPROPYLENE,units,1.0,164 55 35842 00,valid,nan,"i.v, i.m",1.4,36,,,,,,,,,,0,,Magnesium Sulfate 50%w/v Inovamed  is indicated for:1.  the treatment of Magnesium deficiency in hypomagnesaemia. 2. the prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutrition. 3. the control and prevention of seizures in severe pre-eclampsia.  4. the control and prevention of recurrent seizures in eclampsia, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9dda424b-af8f-4e9a-92d8-543cb64ef5af.json
9ddb7588-8987-4191-aff2-f1623c152226,FOSAVANCE 70 MG/5600 I.U. TABLETS,prescription,A11CC05,COLECALCIFEROL,6305,,,WHO ATC Classification,,ILS,tablets,"COLECALCIFEROL, ALENDRONIC ACID AS ALENDRONATE SODIUM TRIHYDRATE",2025-07-31T03:17:52.241572,IL,אורגנון,,35.34720013,29.95525568,21.86515013,,,FOSAVANCE 70/5600IU 4 TAB,6435,,82964,BLISTER PA/AL/PVC,units,4.0,140 99 31792 01,valid,37.0,per os,1.4,18,,,,,,,,,,0,Prescription required,"Fosavance is indicated for : - Treatment of Osteoporosis in postmenopausal women:  Fosavance increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). - Treatment to increase bone mass in men with osteoporosis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ddb7588-8987-4191-aff2-f1623c152226.json
9df08fef-4dfe-47e1-9e69-9ff1968cff00,LINEZAN,prescription,J01XX08,LINEZOLID,8594,,,WHO ATC Classification,,ILS,solution for infusion,LINEZOLID/,2025-07-31T04:47:16.399877,IL,SK PHARM(KS KIM),,192.1533904,162.8418563,130.273485,,,LINEZAN 2mg/1ml 1 BAG 300ml,12570,,3780,BAG POLYPROPYLENE,units,1.0,163 64 35325 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Therapy is indicated only when an organism resistant to all other antibiotics is suspected.Linezolid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as:1) Pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (MDRSP). 2) Skin and soft tissue infections including diabetic foot infections. 3) Enterococcal infections. Combination therapy may be indicated if a concomitant Gram negative pathogen is documented or suspected.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9df08fef-4dfe-47e1-9e69-9ff1968cff00.json
9df54a87-c3cd-48d6-921a-ea32d037660d,CHLORPHENICOL SKIN OINTMENT,prescription,D06AX02,CHLORAMPHENICOL,7309,,,WHO ATC Classification,,ILS,ointment,CHLORAMPHENICOL,2025-07-31T01:09:33.647733,IL,רקח,,nan,nan,nan,,7290008090865,CHLORPHENICOL SKIN OINT 3% 10GR,3845,,68579,TUBE ALUMINIUM,units,10.0,140 25 30148 00,valid,nan,topical,1.4,36,,,,,,,,,,0,Prescription required,For treating superficial skin infections caused by microorganisms sensitive to chloramphenicol.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9df54a87-c3cd-48d6-921a-ea32d037660d.json
9e1aa691-43da-4293-8bd2-88b1aab21ca8,ANASTROZOLE TEVA ®,prescription,L02BG03,ANASTROZOLE,6697,,,WHO ATC Classification,,ILS,tablets,ANASTROZOLE,2025-07-31T00:19:13.459450,IL,אינובמד,,179.2306425,151.890375,121.5123,,,ANASTROZOLE INOVAMED 1MG 30TAB,9345,,84771,BLISTER PVDC/ALUMINIUM,units,30.0,141 32 31760 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen.  Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e1aa691-43da-4293-8bd2-88b1aab21ca8.json
9e1fde46-54da-4237-bee2-a3482736e5d4,VENTOLIN DISKUS,prescription,R03AC02,SALBUTAMOL,4151,,,WHO ATC Classification,,ILS,powder for inhalation,SALBUTAMOL AS SULFATE/DOSE,2025-07-31T10:05:31.783079,IL,ג.ס.ק,,18.73946554,15.880903,11.5919,,7290008085410,VENTOLIN INH. CFC FREE 200ACT,22172,,24610,BLISTER LAMINATED,units,200.0,126 97 30674 00,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"Relief of bronchospasm in broncial asthma of all types, chronic, bronchitis and emphysema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e1fde46-54da-4237-bee2-a3482736e5d4.json
9e25f2e1-9f47-4613-abfe-b3fcc7c8554b,SILDAZEN,prescription,G04BE03,SILDENAFIL,9391,,,WHO ATC Classification,,ILS,suspension for oral spray,SILDENAFIL AS CITRATE/,2025-07-31T08:12:15.494455,IL,תרו יבוא,,nan,nan,nan,,7290017164717,SILDAZEN 25MG/ML 30 ML,,,15914,BOTTLE HDPE,units,30.0,170 66 36152 00,valid,nan,oral,1.4,36,,,,,,,,,,0,Prescription required,Sildazen is indicated in the treatment for adult men with erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e25f2e1-9f47-4613-abfe-b3fcc7c8554b.json
9e282449-8b73-45e2-9574-57f6efee73b9,JARDIANCE DUO 12.5 MG/850 MG,prescription,A10BD20,METFORMIN AND EMPAGLIFLOZIN,7853,,,WHO ATC Classification,,ILS,film coated tablets,"EMPAGLIFLOZIN 12.5  MG, METFORMIN HYDROCHLORIDE",2025-07-31T04:18:38.103148,IL,בורינגר אינגלהיים,,206.0035955,174.579326,139.6634608,,,JARDIANCE DUO 5 MG/1000 MG 60 F.C.TAB,10073,,32904,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,155 29 34534 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e282449-8b73-45e2-9574-57f6efee73b9.json
9e73998b-101e-44f3-a1db-a2ffdedd3941,PRAVALIP 10,prescription,C10AA03,PRAVASTATIN,4481,,,WHO ATC Classification,,ILS,tablets,PRAVASTATIN SODIUM,2025-07-31T06:50:45.810801,IL,טבע,,35.4488048,30.04136,21.928,,,PRAVASTATIN-TEVA 20MG 30TAB,16420,,29736,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,132 80 31134 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . Pravastatin should be used in addition to a diet  and other nonpharmacological measures alone has been inadequate.    Primary prevention of coronary events: In hypercholesterolemic patients wihthout clinically evident coronary heart disease  pravastatin is indicated to:   1) Reduce the risk of myocardial infarcton.   2) Reduce the risk for revascularization.   3) Reduce the risk of deaths due to cardiovascular causes with no increase in death non-cardiovascular causes.   Secondary prevention of cardiovascular events:    a) Atherosclerosis: In hypercholesterolemic patients with clinically evident coronary artery disease  including prior MI  pravastatin  is indicated to:      1)Slow the progression of coronary atherosclerosis.      2) Reduce the risk of acute coronary events.     b) Myocardial infarction: in patients with previous myocardial infarction  and normal cholesterol levels. Pravastatin is indicated to:      1) Reduce the risk of recurrent myocardial infarction.       2)Reduce the risk of undergoing myocardial revascularization procedures.       3) Reduce the risk of stroke or transient ischemic attack (TIA).     c) Hypercholesterolemia and mixed dyslipidemia: Pravastatin is indicated as an adjunct to diet to reduce elevated Total-C  LDL-C and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Frederickson Type IIa and IIb).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e73998b-101e-44f3-a1db-a2ffdedd3941.json
9e7f3855-cbc7-40c4-8c62-a10d1e37f8af,ETHYMAL 250MG 50CAPS,29C,,,20076,,,,,,capsule,ETHYMAL 250MG,2025-07-31T20:24:03.629762,IL,nan,,,,,,,ETHYMAL 250MG 50CAPS,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e7f3855-cbc7-40c4-8c62-a10d1e37f8af.json
9e8121ec-478a-4734-ae68-3ed234bf80e7,FLORET,prescription,G03CA01,ETHINYLESTRADIOL,6359,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.03   MG, GESTODENE 0.075   MG",2025-07-31T03:09:37.484017,IL,דקסל פארמה,,22.5750107,19.131365,13.9645,,7290010577613,FLORET 21TAB,6433,,82920,BLISTER PVC/PVDC/ALUMINIUM,units,21.0,140 57 31528 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e8121ec-478a-4734-ae68-3ed234bf80e7.json
9e8cee9f-9fd4-4e20-ae22-9f6d0a94de8a,CHILDREN'S ADVIL GRAPE FLAVOR,off-the-counter,M01AE01,IBUPROFEN,3887,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T11:04:33.527898,IL,ג.ס.ק,,30.857,26.15,nan,,305730171304,ADVIL 200MG 20LIQUI-GELS,1608,,,BOTTLE PLASTIC,units,20.0,122 43 30111 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e8cee9f-9fd4-4e20-ae22-9f6d0a94de8a.json
9e9259a2-901d-407b-b79a-11c15cb3a3ea,DUPLEX 10/160,prescription,C09CA03,VALSARTAN,9182,,,WHO ATC Classification,,ILS,coated tablets,"VALSARTAN, AMLODIPINE AS BESILATE",2025-07-31T02:08:15.498609,IL,אוניפארם,,128.0010887,108.4754989,80.65092857,,,DUPLEX 10/160 30 TABS,,,36969,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,153 26 34298 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of essential hypertension. Duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9e9259a2-901d-407b-b79a-11c15cb3a3ea.json
9ea29ba5-82f9-460d-8763-d186c7f02c24,MONTELUKAST-TRIMA 4MG 28 CHEWTAB,prescription,,,6906,,,,,ILS,tablet,MONTELUKAST-TRIMA 4MG 28 CHEWTAB,2025-07-31T19:20:09.928991,IL,תרימה,,69.59798533,58.9813435,43.8523,,,MONTELUKAST-TRIMA 4MG 28 CHEWTAB,13686,,19110,,units,28.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ea29ba5-82f9-460d-8763-d186c7f02c24.json
9ea6d682-cd03-463c-a417-224dec9f1f98,YENTREVE 20 MG,prescription,N06AX21,DULOXETINE,4891,,,WHO ATC Classification,,ILS,capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T10:40:53.666585,IL,אלי לילי,,226.6706252,192.0937587,153.675007,,7290008139618,YENTREVE 20MG 56CAPS,25010,,66600,BLISTER PVC/PE/PCTFE/AL,units,56.0,132 68 31140 12,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Yentreve is indicated for women for the treatment of moderate to severe Stress Urinary Incontinence (SUI).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ea6d682-cd03-463c-a417-224dec9f1f98.json
9eb39659-03a1-472a-9564-66aecea83f88,REQUIP MODUTAB 2 MG,prescription,N04BC04,ROPINIROLE,6355,,,WHO ATC Classification,,ILS,film coated tablets - prolonged release,ROPINIROLE AS HYDROCHLORIDE,2025-07-31T07:27:27.120703,IL,ג.ס.ק,,134.7438183,114.1896816,84.89939155,,7290010140510,REQUIP MODUTAB 8MG 28 FILM COATED TABLETS,18409,,81953,BLISTER PVC/PE/PVDC,units,28.0,141 62 31838 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of Parkinson’s disease under the following conditions:•         Initial treatment as monotherapy, in order to delay the introduction of levodopa•         In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).""",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9eb39659-03a1-472a-9564-66aecea83f88.json
9ebeb4f6-8adc-4835-9d92-fd90785b9dbe,ARESTIN,prescription,J01AA08,MINOCYCLINE,2859,,,WHO ATC Classification,,ILS,powder soluble,MINOCYCLINE AS HYDROCHLORIDE,2025-07-31T05:26:32.199409,IL,רפא,,45.69497726,38.724557,28.2661,,,MINOCYCLIN 50MG 30CAP,13045,,8961,CARTRIDGE POLYPROPYLENE,units,30.0,144 92 31853 00,valid,37.0,subgingival,1.4,36,,,,,,,,,,0,Prescription required,"Arestin is indicated as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis. Arestin may be used as part of a periodontal maintenance program which includes good oral hygiene, and scaling and root planing.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ebeb4f6-8adc-4835-9d92-fd90785b9dbe.json
9ee33aa6-1114-4b9d-adfd-415a519ef79e,RISPERDAL 1 MG,prescription,N05AX08,RISPERIDONE,3050,,,WHO ATC Classification,,ILS,film coated tablets,RISPERIDONE,2025-07-31T07:37:44.220730,IL,יאנסן סילג,,40.08165708,33.967506,24.7938,,7290008124744,RISPERDAL 2MG 20TAB,18073,,9156,BLISTER PVC/PE/PVDC/AL,units,20.0,144 78 28260 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ee33aa6-1114-4b9d-adfd-415a519ef79e.json
9ee9bb98-cd15-4bd7-88b7-62713f836208,DUORESP ® SPIROMAX ® 160 MCG/4.5 MCG,prescription,R03AK07,FORMOTEROL AND BUDESONIDE,7780,,,WHO ATC Classification,,ILS,powder for inhalation,"FORMOTEROL FUMARATE DIHYDRATE 4.5 MCG/DOSE, BUDESONIDE MICRONIZED/DOSE",2025-07-31T02:07:18.240785,IL,טבע,,231.4303025,196.127375,156.9019,,,DUORESP SPIROMAX 320 MCG/9 MCG 60DOSES,4652,,42653,PACK ,units,60.0,154 58 34443 00,valid,25.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"AsthmaDuoResp Spiromax 160/4.5 mcg/dose is indicated in adults and adolescents (12 years and older), for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long acting β2 adrenoceptor agonist) is appropriate:Patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting β2 adrenoceptor agonists.OrPatients already adequately controlled on both inhaled corticosteroids and long acting β2 adrenoceptor-agonists.Chronic Obstructive Pulmonary Disease (COPD)DuoResp Spiromax  160/4.5 mcg/dose  is indicated in adults, aged 18 years and older, for the Symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV1)< 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9ee9bb98-cd15-4bd7-88b7-62713f836208.json
9effd351-f7cc-4725-93ad-eaa32bbc747e,TUKYSA 150 MG,prescription,L01EH03,TUCATINIB,9038,,,WHO ATC Classification,,ILS,film coated tablets,TUCATINIB,2025-07-31T09:48:44.195060,IL,פיזר,,7774.416949,6588.489233,5989.535666,,5415062123010,TUKYSA 50 MG 88 TABS,,,63175,BLISTER PVC/OPA/AL,units,88.0,170 33 36951 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,TUKYSA is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer who have received at least 2 prior anti-HER2 treatment regimens.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9effd351-f7cc-4725-93ad-eaa32bbc747e.json
9f033eb6-785c-4f18-a604-b62029588be8,REXULTI ® 0.5 MG,prescription,N05AX16,BREXPIPRAZOLE,8635,,,WHO ATC Classification,,ILS,film coated tablets,BREXPIPRAZOLE 0.5  MG,2025-07-31T07:32:12.247500,IL,לנדבק,,319.0059058,270.344,230.08,,5702150153210,REXULTI ® 1 MG 28 TAB,18625,,59878,BLISTER PVC/ALUMINIUM,units,28.0,163 39 35733 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rexulti is indicated for:• Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults• Treatment of schizophrenia in adults and pediatric patients ages 13 years and older• Treatment of agitation associated with dementia due to Alzheimer’s diseaseLimitations of Use:Rexulti is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f033eb6-785c-4f18-a604-b62029588be8.json
9f0bd937-1097-49ad-89bd-d44e679293ca,IODIFLOR OINTMENT,off-the-counter,D08AG03,IODINE,5530,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:10:48.284404,IL,פלוריש,,10.8914,9.23,nan,,7290006411907,IODIFLOR OINTMENT 15 GR,,,,BOTTLE HDPE,units,15.0,141 02 31802 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"For the disinfection of skin infections and inflammations, wounds and superficial burns.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f0bd937-1097-49ad-89bd-d44e679293ca.json
9f545cc1-3ece-4e99-9653-f23335e503b6,NATPARA 50 MCG 2CARTRIDGES,prescription,,,7830,,,,,ILS,tablet,NATPARA 50 MCG 2CARTRIDGES,2025-07-31T19:21:16.809171,IL,ניאופרם,,32623.83451,27647.31861,25133.92601,,,NATPARA 50 MCG 2CARTRIDGES,14667,,54978,,units,2.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f545cc1-3ece-4e99-9653-f23335e503b6.json
9f586d8a-6518-4cc4-bc65-833fcdb83dce,STREFEN HONEY AND LEMON,off-the-counter,S01BC04,FLURBIPROFEN,5599,,,WHO ATC Classification,,ILS,lozenges,FLURBIPROFEN 8.75  MG,2025-07-31T13:22:14.181395,IL,רקיט בנקיזר,,47.6484,40.38,nan,,,STREFEN ORANGE SF 8.75MG 24 LOZENGES,,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,147 77 31684 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the short term relief of symptoms of sore throat such as throat pain and soreness in adults and children over the age of 12 years,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f586d8a-6518-4cc4-bc65-833fcdb83dce.json
9f616393-8008-4107-a0e4-1e99b1f5949a,CILARIL 1,prescription,C09AA08,CILAZAPRIL,9379,,,WHO ATC Classification,,ILS,tablets,CILAZAPRIL,2025-07-31T01:12:46.526673,IL,אוניפארם,,69.19756,58.642,43.6,,,CILARIL 5 MG 30 TAB,,,14027,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,136 01 31495 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Cilaril is indicated for the treatment of hypertension. Cilaril is indicated for the treatment of chronic heart failure.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f616393-8008-4107-a0e4-1e99b1f5949a.json
9f7a40c9-6352-4a1d-94b2-b5f1ad2550ef,FLUDECATE,29C,N05AB02,FLUPHENAZINE,20081,,,WHO ATC Classification,,ILS,solution for injection,FLUPHENAZINE DECANOATE/ML,2025-07-31T14:36:38.629052,IL,nan,,nan,nan,nan,,,FLUPHENAZINE 5MG 100TAB,,,,AMPOULES GLASS TYPE I,units,100.0,025 22 21358 00,valid,nan,i.m,1.4,30,,,,,,,,,,0,,Fludecate is a long acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g. chronic schizophrenics).Fluphenazine Decanoate Injection has not been shown effective in the management of behavioral complications in patients with mental retardation.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f7a40c9-6352-4a1d-94b2-b5f1ad2550ef.json
9f809232-9f57-4cb3-9469-8586b3fdf995,CEFAZOL 1 G.,prescription,J01DB04,CEFAZOLIN,8318,,,WHO ATC Classification,,ILS,powder for solution for injection,CEFAZOLIN AS SODIUM/VIAL,2025-07-31T00:58:12.389587,IL,סנדוז,,103.0721145,87.3492496,64.94368,,,CEFAZOL 1g 10 VIALS,10368,,24378,VIAL GLASS TYPE III,units,10.0,141 70 31813 00,valid,34.5,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis.  Treatment Respiratory tract:  Respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae)  klebsiella species  haemophilus influenzae  staphylococcus aureus (penicillin-sensitive and penicillin-resistant)  and group A B - hemolytic streptococci.   Cefazolin is effective in the eradication of streptococci from the nasopharynx. However  data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.   Urinary tract:   Infections due to escherichia coli  klebsiella species  proteus mirabilis and some strains of Enterobacter and enterococci.   Skin and skin structure:   -hemolytic beta Infections due to Staphylococcus aureus (penicillin-sensitive and penicillin-resistant)  group A streptococci and other strains of streptococci.   Biliary tract:   Infections due to escherichia coli  various strains of streptococci  proteus mirabilis  klebsiella species and staphylococcus aureus.  Bone and joint :Infections due to staphylococcus aureus.   Genital infections (i.e. prostatitis  epididymitis) due to escherichia coli  proteus mirabilis  klebsiella species and some strains of enterococci.Septicemia due to streptococcus pneumoniae (formerly diplococcus pneumoniae)  staphylococcus aureus (penicillin-sensitive and penicillin-resistant) proteus mirabilis  escherichia coli and klebsiella species.Endocarditis caused by staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group A beta-hemolytic streptococci.   Appropriate culture and susceptibility studies should be performed to determine the susceptibility of the causative organism to cefazolin.Perioperative prophylaxis:   The prophylactic administraton of cefazolin perioperatively (preoperatively  intraoperatively and postoperatively) may reduce the incidence of certain postoperative infectons in patients undergoing surgical procedures (e.g. hysterectomy  gastrointestinal surgery and transurethral prostatectomy) that are classified as contaminated or potentially contaminated. The perioperative use of cefazolin may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g. open-heart surgery and prosthetic arthroplasty).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f809232-9f57-4cb3-9469-8586b3fdf995.json
9f903d2e-93b3-44e0-baf7-d83470a46f4e,PUREGON SOLUTION FOR INJECTION,prescription,G03GA06,FOLLITROPIN BETA,4734,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN BETA/,2025-07-31T07:07:25.810499,IL,אורגנון,,894.7009822,758.2212051,645.2946426,,7290006537096,PUREGON  600UI/0.72ML CARTRIDGE,16664,,60467,CARTRIDGE GLASS TYPE I,units,1.0,130 52 30898 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Puregon is indicated for the treatment of female infertility in the following clinical situations: Anovulation (including polycystic ovarian disease, PCOD) in women who have beenunresponsive to treatment with clomiphene citrate. Controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)]. In the male : Deficient spermatogenesis due to hypogonadotrophic hypogonadism.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f903d2e-93b3-44e0-baf7-d83470a46f4e.json
9f9a85ac-42ad-405b-8bd5-80a1d4f6f298,CO-DIOVAN 160/12.5 MG FILM-COATED TABLETS,prescription,C09DA03,VALSARTAN AND DIURETICS,4696,,,WHO ATC Classification,,ILS,film coated tablets,"VALSARTAN, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T01:25:24.010224,IL,נוברטיס פארמה,,37.48151764,31.763998,23.1854,,,CO-DIOVAN 160/12.5MG FCT 28TAB,3749,,59273,BLISTER OPA/AL/PVC,units,28.0,127 62 30611 21,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. This fixed combination should be used as second-line therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f9a85ac-42ad-405b-8bd5-80a1d4f6f298.json
9f9b95b0-c0a8-40d9-9fce-fe73e157de60,LIFE-IBOO 2 % 200ML,off-the-counter,,,5586,,,,,ILS,tablet,LIFE-IBOO 2 %,2025-07-31T19:45:04.978405,IL,ליף-טבע,,40.415,34.25,,,,LIFE-IBOO 2 % 200ML,,,,,units,200.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9f9b95b0-c0a8-40d9-9fce-fe73e157de60.json
9fa6770f-da90-4b6c-9c1d-ee2a8d841b21,HARVONI,prescription,J05AP51,SOFOSBUVIR AND LEDIPASVIR,7822,,,WHO ATC Classification,,ILS,film coated tablets,"LEDIPASVIR, SOFOSBUVIR",2025-07-31T03:43:22.756306,IL,גיליאד,,62183.12533,52697.56618,47906.87835,,5391507141729,HARVONI 90MG/400MG 28 F.C.TAB,8416,,75730,BOTTLE HDPE,units,28.0,156 21 34517 00,valid,10.0,per os,1.4,72,,,,,,,,,,0,Prescription required,Harvoni is indicated for the treatment of chronic hepatitis C (CHC) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9fa6770f-da90-4b6c-9c1d-ee2a8d841b21.json
9fa6eb84-600a-4d95-8f68-0341b4d8058c,PENTASA SLOW RELEASE GRANULES 4 G.,prescription,A07EC02,MESALAZINE,6869,,,WHO ATC Classification,,ILS,granules,MESALAZINE,2025-07-31T06:36:19.364008,IL,פרינג,,357.0415121,302.5775661,257.5128222,,7640128547228,PENTASA SLOW RELEASE GRANULES 2GX60SACHET,16785,,89247,SACHET POLYESTER/ALUMINIUM/POLYETHYLENE,units,60.0,157 47 34816 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate ulcerative colitis or crohn's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9fa6eb84-600a-4d95-8f68-0341b4d8058c.json
9fa9d6bc-1c5b-4736-b1cd-7c323d5e0496,OXALIPLATIN MEDAC 100 MG,prescription,L01XA03,OXALIPLATIN,7434,,,WHO ATC Classification,,ILS,powder for solution for infusion,OXALIPLATIN/VIAL,2025-07-31T06:20:15.868180,IL,צמל,,990.7102646,839.58497,714.5404,,4037353004290,OXALIPLATIN MEDAC 100MG/VIAL,15358,,86828,VIAL GLASS TYPE I,units,1.0,137 25 31504 00,valid,17.5,i.v,1.4,30,,,,,,,,,,0,Prescription required,"Oxaliplatin in combination with 5-fluorouracil (5-FU) and folinic acid (FA) is indicated for: •  Adjuvant treatment of stage III (Duke‘s C) colon cancer after complete resection of primary tumor. •  Treatment of metastatic colorectal cancer. Oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on NCCN guidelines, version 2.2014).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9fa9d6bc-1c5b-4736-b1cd-7c323d5e0496.json
9fae41c7-7b90-430a-a283-f4cc2b5597b1,SEPTAX 1 G,prescription,,,7100,,,,,ILS,powder for solution for inj/inf,CEFTAZIDIME AS PENTAHYDRATE,2025-07-31T08:04:18.664689,IL,ביואבניר,,72.89280493,61.7735635,45.9283,,7290010286119,SEPTAX 2G 1VIAL,19963,,6443,VIAL GLASS TYPE III,units,1.0,135 96 31243 00,valid,34.5,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,"Septax is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• Nosocomial pneumonia• Broncho-pulmonary infections in cystic fibrosis• Bacterial meningitis• Chronic suppurative otitis media• Malignant otitis externa• Complicated urinary tract infections• Complicated skin and soft tissue infections• Complicated intra-abdominal infections• Bone and joint infections• Peritonitis associated with dialysis in patient on CAPD.Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.Ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.Ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (TURP).The selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic Gram negative bacteria.Ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.Consideration should be given to official guidelines on the appropriate use of antibacterial agents.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9fae41c7-7b90-430a-a283-f4cc2b5597b1.json
9fc1ca41-efe0-47c9-bbc9-6a4cff339d88,LOTAN 100,prescription,C09CA01,LOSARTAN,6197,,,WHO ATC Classification,,ILS,tablets,LOSARTAN POTASSIUM,2025-07-31T04:56:22.572117,IL,אוניפארם,,31.35331036,26.570602,19.3946,,,LOTAN 100MG 30TAB,12402,,88090,BLISTER PVC/ALUMINIUM,units,30.0,139 36 31707 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Hypertension: Lotan 100 is indicated for the treatment of hypertension. Heart failure:Lotan 100 is indicated for the treatment of heart failure, when treatment with an ACE inhibitor is not appropriate. Switching patients with heart failure who are stable on an ACE inhibitor to Lotan 100 is not recommended. Renal protection in Type-2 diabetic patients with proteinuria: Lotan 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria. Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Lotan 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy. The benefit of Lotan 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9fc1ca41-efe0-47c9-bbc9-6a4cff339d88.json
9fddb697-4158-4ea4-9a5f-03adfe2ee250,ACERIL 12.5,prescription,,,4538,,,,,ILS,tablets,CAPTOPRIL 12.5  MG,2025-07-30T23:11:54.934600,IL,דקסל פארמה,,37.96245614,32.171573,23.4829,,,ACERIL 25MG 90TAB,1437,,33615,BLISTER ,units,90.0,106 49 29061 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,-HypertensionCongestive Heart Failure-insulin dependent diabetic nephropathy in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl.-improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less or equals to 40% and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9fddb697-4158-4ea4-9a5f-03adfe2ee250.json
9fe5c9cd-c1c0-41df-b81f-dec72ae95203,VECTOR PLUS 160/12.5,prescription,C09CA03,VALSARTAN,9170,,,WHO ATC Classification,,ILS,tablets,"VALSARTAN, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T10:02:05.773791,IL,אוניפארם,,40.1587689,34.032855,24.8415,,,VECTOR PLUS 160/12.5 30TAB,,,35659,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,146 06 33406 01,valid,37.0,per os,1.4,30,,,,,,,,,,0,Prescription required,For the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. This fixed combination should be used as second-line therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9fe5c9cd-c1c0-41df-b81f-dec72ae95203.json
9fecc300-faec-4bc9-999f-d3116129cd85,SUTENT 12.5 MG,prescription,L01XE04,SUNITINIB,6047,,,WHO ATC Classification,,ILS,capsules,SUNITINIB AS MALATE 12.5  MG,2025-07-31T08:53:40.573210,IL,פיזר,,8063.85096,6833.772,6212.52,,,SUTENT 50MG 28CAPS,19815,,75526,BLISTER PVC/ACLAR/ALUMINIUM,units,28.0,136 89 31430 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate.   Sutent is indicated for the treatment of advanced renal cell carcinoma.Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/9fecc300-faec-4bc9-999f-d3116129cd85.json
a002fa1c-bb7b-4c47-b90c-01550418c939,EPANUTIN 100 MG,29C,N03AB02,PHENYTOIN,20593,,,WHO ATC Classification,,ILS,capsules,PHENYTOIN SODIUM,2025-07-31T15:35:12.020500,IL,nan,,nan,nan,nan,,,PHENYTOIN SODIUM 50MG/ML 25AMPX5ML,,,,BOTTLE HDPE,units,25.0,104 27 24678 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a002fa1c-bb7b-4c47-b90c-01550418c939.json
a00e38ca-bd8e-402f-8b0a-424e3bae89f8,TOBREX OPHTHALMIC OINTMENT,prescription,S01AA12,TOBRAMYCIN,756,,,WHO ATC Classification,,ILS,eye ointment,TOBRAMYCIN 0.3 %,2025-07-31T09:24:12.399052,IL,נוברטיס פארמה,,11.89459082,10.08016216,7.3577826,,7290008067188,TOBREX OINT 3.5GR,20444,,7437,TUBE ALUMINIUM,units,3.5,047 16 22795 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic for the treatment of eye infections caused by bacteria sensitive to Tobramycin.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a00e38ca-bd8e-402f-8b0a-424e3bae89f8.json
a0118fac-f2e1-4587-93af-e5668bb0c541,TAZO-PIP AVENIR 4.5 G,prescription,J01CG02,TAZOBACTAM,7104,,,WHO ATC Classification,,ILS,powder for solution for injection,"TAZOBACTAM AS SODIUM SALT, PIPERACILLIN AS SODIUM SALT",2025-07-31T09:08:38.810324,IL,ביואבניר,,60.11909076,50.948382,37.1886,,7290010286263,TAZO-PIP AVENIR 4.5G 1VIAL/50ML,20741,,36415,VIAL GLASS TYPE II,units,1.0,146 80 33342 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms.Tazo-Pip Avenir in combination with an aminoglycoside, is indicated for the treatment of suspected bacterial infections in neutropenic adults and children. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0118fac-f2e1-4587-93af-e5668bb0c541.json
a01cab29-fcde-4757-a899-12fa85c524ac,APO-GEMFIBROZIL 300MG 100TAB,29C,,,20037,,,,,,tablet,APO-GEMFIBROZIL 300MG,2025-07-31T19:55:17.033996,IL,nan,,,,,,,APO-GEMFIBROZIL 300MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a01cab29-fcde-4757-a899-12fa85c524ac.json
a0374f4b-71c8-4eab-96d7-b0e46d54f9cb,HAIRGAINE FOAM 5% 60ML,off-the-counter,,,5501,,,,,ILS,tablet,HAIRGAINE FOAM 5%,2025-07-31T19:43:58.636273,IL,פאדאגיס,,161.365,136.75,,,,HAIRGAINE FOAM 5% 60ML,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0374f4b-71c8-4eab-96d7-b0e46d54f9cb.json
a045f4e2-ebb9-4a17-b74e-1b835b85d98e,CABOTRIM 0.5,prescription,,,4990,,,,,ILS,tablets,CABERGOLINE 0.5  MG,2025-07-30T23:47:36.011835,IL,תרימה,,194.182275,164.56125,131.649,,7290008075985,CABOTRIM 0.5MG 8TAB,3879,,71198,BOTTLE HDPE,units,8.0,135 73 31180 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of hyperprolactinemic disorders.Cabotrim is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. Cabotrim is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. Inhibition and supression of lactation .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a045f4e2-ebb9-4a17-b74e-1b835b85d98e.json
a04f669d-dfb1-4fde-8820-2cc26ebc9fc3,FLEBOGAMMA 5 % DIF,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7148,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T03:06:50.877572,IL,מדיצ'י,,1689.611134,1431.873906,1218.61609,,,FLEBOGAMMA 5% 100ML VIAL,6558,,74378,BOTTLE GLASS TYPE II,units,100.0,121 04 29877 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Replacement therapy in:Primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- Wiskott Aldrich syndromeMyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.Children with congenital AIDS and recurrent infections.Immunomodulation :Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.Guillain Barré Syndrome.Kawasaki disease.Allogeneic bone marrow transplantation",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a04f669d-dfb1-4fde-8820-2cc26ebc9fc3.json
a060ab79-533c-4e60-a501-01eda0f823e5,APIDRA,prescription,A10AB06,INSULIN GLULISINE,4984,,,WHO ATC Classification,,ILS,solution for injection,INSULIN GLULISINE 100 U/ML,2025-07-31T00:20:52.948869,IL,סאנופי אוונטיס,,181.1579731,153.5237128,122.8189703,,7290008880732,APIDRA OPTISET/SOLOSTAR PREFILLED PEN 5X3ML,9250,,15343,PRE-FILLED PEN GLASS TYPE I,units,15.0,132 94 31195 00,valid,25.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of adults, adolescents and children, 6 years or older with diabetes mellitus, where treatment with insulin is required.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a060ab79-533c-4e60-a501-01eda0f823e5.json
a068c7eb-8acc-41fd-9206-0d243e5cdfc5,HISTAFED,off-the-counter,R06AX07,TRIPROLIDINE,5504,,,WHO ATC Classification,,ILS,film coated tablets,"PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE HYDROCHLRIDE 2.5  MG",2025-07-31T12:04:33.008316,IL,תרימה,,30.7626,26.07,nan,,,HISTAFED 30 DRAG,,,,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,027 94 21825 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the symptomatic relief of congestion such as rhinitis and associated allergic conditions.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a068c7eb-8acc-41fd-9206-0d243e5cdfc5.json
a072bf72-10fd-45e2-b574-1698872b45ab,EXJADE 125 MG,prescription,V03AC03,DEFERASIROX,4926,,,WHO ATC Classification,,ILS,tablets dispersible,DEFERASIROX,2025-07-31T02:49:49.295590,IL,נוברטיס פארמה,,2067.482216,1752.103573,1491.151977,,7290006257826,EXJADE 250MG 28 DISPERS TAB,5424,,67379,BLISTER PVC/PE/PVDC,units,28.0,133 99 31337 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).Exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC] &#8805;5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).LIC is the preferred method of iron overload determination and should be used wherever available,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a072bf72-10fd-45e2-b574-1698872b45ab.json
a07544e0-4ac4-42f9-9789-1def3c9c82c5,AMLOW 10,prescription,C08CA01,AMLODIPINE,7941,,,WHO ATC Classification,,ILS,tablets,AMLODIPINE AS MALEATE,2025-07-30T23:22:45.258620,IL,אוניפארם,,19.55552522,16.572479,12.0967,,,AMLOW 10 MG 30 TAB,9952,,55821,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,131 66 31035 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate hypertension. Vasospastic angina (Prinzmetal's or variant angina). Chronic stable angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a07544e0-4ac4-42f9-9789-1def3c9c82c5.json
a0778ebf-1730-493b-b56f-d55791cd73f5,XERMELO 250 MG,prescription,,,8459,,,,,ILS,film coated tablets,TELOTRISTAT ETHYL AS ETIPRATE,2025-07-31T10:34:47.946251,IL,מדיסון,,6011.468973,5094.465458,4631.332235,,7290015666695,XERMELO 250 MG 90 TAB,24097,,26821,BLISTER PVC/PCTFE/PVC/ALU,units,90.0,161 97 35443 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Xermelo is indicated for the treatment of carcinoid syndrome diarrhoea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0778ebf-1730-493b-b56f-d55791cd73f5.json
a0926a29-4660-4212-9685-d8e93e57a032,LACOSAMIDE TEVA ® 100 MG,prescription,N03AX18,LACOSAMIDE,8675,,,WHO ATC Classification,,ILS,film coated tablets,LACOSAMIDE,2025-07-31T04:31:37.796562,IL,טבע,,45.63989137,38.67787404,28.23202485,,,LACOSAMIDE TEVA  50 MG 14 TAB,,,56608,BLISTER OPA/ALU/PVC/ALU,units,14.0,163 97 35488 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Lacosamide Teva is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0926a29-4660-4212-9685-d8e93e57a032.json
a09d822e-3b75-4849-8bfe-372e48abbe5c,CEFUROXIME PANPHARMA 750 MG,prescription,J01DC02,CEFUROXIME,7965,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFUROXIME AS SODIUM/VIAL,2025-07-31T06:26:30.087732,IL,פארמלוג'יק,,145.1439453,123.0033435,91.4523,,7290006676832,PAN-CEFUROXIME 750 MG 10 VIAL,16713,,72438,VIAL GLASS TYPE III,units,10.0,129 73 30873 00,valid,34.5,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,"Infections caused by susceptible microorganisms, prophylaxis against post operative infections in a variety of operations.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a09d822e-3b75-4849-8bfe-372e48abbe5c.json
a09e02ab-92ec-4914-8a26-2805fa41c032,ARCOXIA 120 MG TABLETS,prescription,M01AH05,ETORICOXIB,4762,,,WHO ATC Classification,,ILS,film coated tablets,ETORICOXIB,2025-07-30T23:26:30.783717,IL,אורגנון,,36.34265527,30.7988604,22.48092,,7290006813046,ARCOXIA 120MG 7TAB,1918,,61736,BLISTER PVC/ALUMINIUM,units,7.0,129 44 30788 11,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Arcoxia 120 mg tablets are indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a09e02ab-92ec-4914-8a26-2805fa41c032.json
a0b0b1d8-8e37-4f7e-bb45-ddef5e2215b2,SANDIMMUN NEORAL 100 MG/ML ORAL SOLUTION,prescription,L04AA01,CYCLOSPORIN,3008,,,WHO ATC Classification,,ILS,solution,CICLOSPORIN/ML,2025-07-31T07:58:56.442341,IL,נוברטיס פארמה,,641.2660942,543.4458425,462.5071,,7298120012802,SANDIMMUN NEO SOLUTION 100MG/ML BOTTLE 50ML,19085,,9080,BOTTLE AMBER GLASS,units,50.0,066 79 28141 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of organ rejection in kidney  liver heart allogenic transplants in conjunction with corticosteroids. May also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents.  Bone marrow transplantation.   Endogenous uveitis.   Severe psoriasis above age 16 that did not respond to other treatment.Atopic dermatitis in adults only up to 8 weeks  for severe cases in which conventional therapy is ineffective or inappropriate.   Rheumatoid arthritis: Severe cases in which standard treatments are ineffective or inappropriate.  Nephrotic syndrom type MCD (minimal change disease) in cases where conventional therapy has failed.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0b0b1d8-8e37-4f7e-bb45-ddef5e2215b2.json
a0b5ded7-5c7d-4154-ace3-b35155dd89ea,INTRATECT 100 G/L,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",6897,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T04:10:26.735853,IL,קמהדע,,1689.611134,1431.873906,1218.61609,,,INTRATECT 50MG/ML 1VIAL (5G/100ML),9456,,4132,VIAL GLASS TYPE II,units,100.0,159 72 35202 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, and children and adolescents (0-18 years) in:     -	Primary immunodeficiency syndromes (PID) with impaired antibody production     -	Secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent      infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)*      or serum IgG level of <4 g/l     * PSAF= failure to mount at least a 2-fold rise in IgG antibody titre to pneumococcal         polysaccharide and polypeptide antigen vaccinesImmunomodulation in adults, and children and adolescents (0-18 years) in:     -	Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery      to correct the platelet count     -	Guillain Barré syndrome     -	Kawasaki disease (in conjunction with acetylsalicylic acid)     -	Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)     -	Multifocal motor neuropathy (MMN)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0b5ded7-5c7d-4154-ace3-b35155dd89ea.json
a0cff159-e7de-40d0-bacb-7765d57d1d56,RYBREVANT,prescription,L01FX18,AMIVANTAMAB,9033,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,AMIVANTAMAB/ 7.0  ML,2025-07-31T07:55:16.705914,IL,יאנסן סילג,,6870.832153,5822.739371,5293.399428,,,RYBREVANT 350 MG/7ML,,,88033,VIAL GLASS TYPE I,units,1.0,169 46 36954 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"RYBREVANT is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion mutation, as detected by an approved test whose disease has progressed on or after platinum based chemotherapy.RYBREVANT is indicated in combination with carboplatin and pemetrexed for the first-line treatment of adult patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) with activating epidermal-growth factor receptor (EGFR) Exon 20 insertion mutations.RYBREVANT is indicated in combination with carboplatin and pemetrexed for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal-growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations, whose disease has progressed on or after treatment with an EGFR tyrosine kinase inhibitor (TKI).RYBREVANT in combination with lazertinib, is indicated for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations, as detected by an approved test.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0cff159-e7de-40d0-bacb-7765d57d1d56.json
a0dce7fe-2454-410b-b1d4-3890822bca81,TAFINLAR 50 MG,prescription,L01XE23,DABRAFENIB,7417,,,WHO ATC Classification,,ILS,"capsule, hard",DABRAFENIB AS MESILATE,2025-07-31T09:01:09.608442,IL,נוברטיס פארמה,,5655.099975,4792.457819,4356.779836,,7290014257689,TAFINLAR 75 MG 28 CAPSULES,20785,,53567,BOTTLE HDPE,units,28.0,151 42 33976 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Dabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.Non-small cell lung cancer (NSCLC) :Dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a BRAF V600 mutation.Adjuvant treatment of melanoma :Dabrafenib in combination with trametinib is indicated for the adjuvant treatment of adult patients with Stage III melanoma with BRAF V600 mutation, following complete resection.BRAF V600E Mutation-Positive Locally Advanced or Metastatic Anaplastic Thyroid CancerTAFINLAR is indicated, in combination with trametinib, for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment optionsBRAF V600E Mutation-Positive Unresectable or Metastatic Solid TumorsTafinlar is indicated, in combination with trametinib, for the treatment of adult and pediatric patients 6 years of age and older with unresectable or metastatic solid tumors with BRAF V600E mutation who have progressed following prior treatment and have no satisfactory alternative treatment options. Limitations of Use: Dabrafenib is not indicated for treatment of patients with colorectal cancer because of known intrinsic resistance to BRAF inhibition. Dabrafenib is indicated, in combination with trametinib, for the treatment of pediatric patients 6 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0dce7fe-2454-410b-b1d4-3890822bca81.json
a0deb8c6-3bef-4235-96e6-0d0c600fd640,EPIDUO,prescription,D10AE01,BENZOYL PEROXIDE,9374,,,WHO ATC Classification,,ILS,gel,"BENZOYL PEROXIDE/G, ADAPALENE/G",2025-07-31T02:26:17.180928,IL,אמי טכנולוגיות,,137.9064778,116.8699017,86.8921202,,3499320011709,EPIDUO FORTE 0.3% /2.5 % 30 GR GEL,,,34941,PUMP PP/HDPE/LDPE/EURICAMIDE,units,30.0,156 10 34289 00,valid,34.5,dermal,1.4,24,,,,,,,,,,0,Prescription required,"Cutaneous treatment of Acne vulgaris when comedones, papules and pustules are present.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a0deb8c6-3bef-4235-96e6-0d0c600fd640.json
a10c98fd-e766-4fb6-aba1-50dc06e98d4b,BICALUTAMIDE TEVA ® 150 MG,prescription,L02BB03,BICALUTAMIDE,7683,,,WHO ATC Classification,,ILS,tablets,BICALUTAMIDE,2025-07-31T00:35:46.407947,IL,אינובמד,,207.8294175,176.126625,140.9013,,,BICALUTAMIDE INOVAMED 50 MG 28 F.C.TAB,2543,,39081,BLISTER PVDC/ALUMINIUM,units,28.0,140 83 31741 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,In patients with locally advanced prostate cancer (T3-T4  any N  M0  T1-T2  N+  M0)  Bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. The management of patients with locally advanced  non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a10c98fd-e766-4fb6-aba1-50dc06e98d4b.json
a11bedc5-50e6-40e8-aba7-a1a63cba8708,SOLU CORTEF 500,prescription,H02AB09,HYDROCORTISONE,8129,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,HYDROCORTISONE AS SODIUM SUCCINATE/VIAL,2025-07-31T08:27:56.072689,IL,פיזר,,308.7373624,261.6418325,222.6739,,7290010355556,SOLU CORTEF 100MG 25 VIALS,19717,,54166,VIAL GLASS TYPE I,units,25.0,034 93 22552 00,valid,17.5,"i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,Solu-Cortef is indicated to treat any condition in which IM or IV corticosteroid treatment is required such as: - allergic states- dermatologic diseases- endocrine disorders- gastrointestinal diseases- hematologic disorders- miscellaneous- neoplastic diseases- nervous system disorders- ophthalmic diseases- renal diseases- respiratory diseases- rheumatic disorders- dollagen diseases- certain medical emergencies,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a11bedc5-50e6-40e8-aba7-a1a63cba8708.json
a12a7f93-1a28-4f64-9904-fc4e3cd71bed,CARBAGLU,prescription,A16AA05,CARGLUMIC ACID,6936,,,WHO ATC Classification,,ILS,tablets dispersible,CARGLUMIC ACID,2025-07-31T00:53:49.739479,IL,מדיסון,,13633.77799,11554.04966,10503.68151,,7290008128599,CARBAGLU 200MG 60 DISP.TAB,9535,,22405,CONTAINER POLYETHYLENE,units,60.0,147 76 33555 05,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Carbaglu is indicated in treatment of :- hyperammonaemia due to N - acetylglutamate synthase primary deficiency.- hyperammonaemia due to isovaleric acidaemia.- hyperammonaemia due to methymalonic acidaemia.- hyperammonaemia due to propionic acidaemia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a12a7f93-1a28-4f64-9904-fc4e3cd71bed.json
a1347168-ae48-4fbd-9f5f-e073a6d49673,URSOLIT 100,prescription,A05AA02,URSODEOXYCHOLIC ACID,2675,,,WHO ATC Classification,,ILS,tablets,URSODEOXYCHOLIC ACID,2025-07-31T09:55:31.611864,IL,כ.צ.ט,,77.16490967,65.39399415,48.62007,,,URSOLIT 300MG 30CAPLETS,21029,,8709,BLISTER PVC/ALUMINIUM,units,30.0,019 25 20542 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Dissolution or reductin in size of radiolucent cholesterol in patient with a functioning gallbladder. Treatment of chronic liver diseases including primary billiary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia, chronic hepatitis, and alcohol cirrhosis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a1347168-ae48-4fbd-9f5f-e073a6d49673.json
a19686a8-b2b3-464b-b5b2-b5101cf64871,TRASENTAN 62.5,prescription,C02KX01,BOSENTAN,8224,,,WHO ATC Classification,,ILS,tablets,BOSENTAN AS MONOHYDRATE 62.5  MG,2025-07-31T09:36:13.177835,IL,רפא,,5015.789205,4250.668818,3864.24438,,7290008016858,TRASENTAN 62.5MG 60 TABLETS,,,5368,BLISTER PVC/PCTFE/AL,units,60.0,157 19 34657 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of pulmonary arterial hypertension (PAH) in patients of WHO functional class II-IV. Reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a19686a8-b2b3-464b-b5b2-b5101cf64871.json
a197e87c-4ccc-49d8-8e3b-ca7360238c4d,SUBLOCADE 100 MG,prescription,N02AE01,BUPRENORPHINE,8629,,,WHO ATC Classification,,ILS,extended release solution for injection,BUPRENORPHINE/ 0.5  ML,2025-07-31T08:47:46.067042,IL,נעמי שאקו עזרה,,nan,nan,nan,,,SUBLOCADE 100 MG/0.5 ML  E.R SOL FOR INJ 1 PFS,,,,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,163 66 35771 00,valid,nan,s.c,1.4,24,,,,,,,,,,0,Prescription required,SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder in patients over 15 years of age who have been induced and clinically stabilized on a transmucosal buprenorphine-containing product. SUBLOCADE should be used as part of a complete treatment plan that includes counseling and psychosocial support.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a197e87c-4ccc-49d8-8e3b-ca7360238c4d.json
a1b13cc7-2233-4988-ae8c-39d8c08e521a,V-MANTINE 10 MG,prescription,N06DX01,MEMANTINE,9151,,,WHO ATC Classification,,ILS,tablets orodispersible,MEMANTINE HYDROCHLORIDE,2025-07-31T10:19:13.700675,IL,ויטאמד,,247.3603567,209.6274303,167.7019442,,,V-MANTINE 20 MG 28TAB,,,42531,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,162 05 34810 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with moderate to severe Alzheimer's disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a1b13cc7-2233-4988-ae8c-39d8c08e521a.json
a1c01d6a-2f4d-47be-86b1-2522e976e39a,AETHOXYSKLEROL 1% 5AMPX2ML,29C,,,20029,,,,,,injection,AETHOXYSKLEROL 1% X,2025-07-31T19:50:14.473506,IL,nan,,,,,,,AETHOXYSKLEROL 1% 5AMPX2ML,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a1c01d6a-2f4d-47be-86b1-2522e976e39a.json
a1d8e74e-59fa-471f-a3ea-30450e6b0999,DEPIXOL 20MG/ML  INJECTION  10AMPOULES,29C,,,20916,,,,,,injection,DEPIXOL 20MG/ML INJECTION OULES,2025-07-31T20:12:42.741663,IL,nan,,,,,,,DEPIXOL 20MG/ML  INJECTION  10AMPOULES,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a1d8e74e-59fa-471f-a3ea-30450e6b0999.json
a1f195a1-8462-4ab7-a1b7-88eea50a7ff2,VIREAD,prescription,J05AF07,TENOFOVIR DISOPROXIL,4727,,,WHO ATC Classification,,ILS,film coated tablets,TENOFOVIR DISOPROXIL AS FUMARATE,2025-07-31T10:17:48.589026,IL,גיליאד,,1239.59977,1050.50828,894.0496,,7290006401397,VIREAD 300MG 30TAB,22243,,60430,BOTTLE HDPE,units,30.0,130 43 30944 23,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Viread is indicated for the treatment of :1. HIV 1 infected adults and pediatric patients 12 years of age and older in combination with other antiretroviral medicinal products for the treatment of HIV. 2. Chronic hepatitis B in adults with:   •  Compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis.   • Decompensated liver disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a1f195a1-8462-4ab7-a1b7-88eea50a7ff2.json
a1f1ff1e-4858-4335-b608-5f3acc9f3fa6,PIPERACILLIN /TAZOBACTAM - FRESENIUS 4 G/0.5 G,prescription,J01CG02,TAZOBACTAM,8605,,,WHO ATC Classification,,ILS,powder for solution for infusion,"PIPERACILLIN AS SODIUM SALT 4.0 G/VIAL, TAZOBACTAM AS SODIUM SALT 0.5 G/VIAL",2025-07-31T06:44:04.696115,IL,ניאופרם,,515.6196617,436.965815,371.8858,,,PIPERACILLIN /TAZOBACTAM - FRESENIUS 4 G/0.5 G 10 VIAL,10665,,435,VIAL 50 ML GLASS TYPE II,units,10.0,151 28 33274 03,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,- Treatment of systemic and/or local infections caused by susceptible organisms.- Piperacillin/tazobactam in combination with an aminoglycoside is indicated for the treatment of suspected bacterial infections in neutropenic adults and children above 2 years. - Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a1f1ff1e-4858-4335-b608-5f3acc9f3fa6.json
a20b3b8d-b718-4191-8506-c2c5bdd7f505,ACTEMRA 162 MG S.C.,prescription,L04AC07,TOCILIZUMAB,6415,,,WHO ATC Classification,,ILS,solution for injection,TOCILIZUMAB/ 0.9  ML,2025-07-31T00:06:45.184004,IL,רוש,,594.7969844,504.0652634,428.9917136,,,ACTEMRA 20MG/ML 1X4ML(80MG) CONC. FOR SOLUTION FOR INF.,9339,,84076,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,153 15 34111 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"- Actemra in combination with methotrexate (MTX) is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease modifying anti rheumatic drugs (DMARDs) or tumor necrosis factor (TNF) antagonists. In these patients, Actemra can be given as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate. - Actemra has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function when given in combination with methotrexate. - Actemra in combination with methotrexate (MTX) in indicated for the treatment of severe, active and progressive rheumatoid arthritis (RA) in adults not previously treated with MTX - Actemra (tocilizumab) is indicated for the treatment of giant cell arteritis (GCA) in adult patients.  - Actemra in combination with methotrexate (MTX) is indicated for the treatment of juvenile idiopathic polyarthritis (pJIA; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with MTX. Actemra can be given as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate. - Actemra is indicated for the treatment of active systemic juvenile idiopathic arthritis (sJIA) in patients 1 year of age and older, who have responded inadequately to previous therapy with NSAIDs and systemic corticosteroids. Actemra can be given as monotherapy (in case of intolerance to MTX or where treatment with MTX is inappropriate) or in combination with MTX.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a20b3b8d-b718-4191-8506-c2c5bdd7f505.json
a2115bd4-95ed-416a-a330-5002b8ad2ed6,QULIPTA 10 MG,prescription,N02CD07,ATOGEPANT,9283,,,WHO ATC Classification,,ILS,tablets,ATOGEPANT AS MONOHYDRATE,2025-07-31T07:13:04.424532,IL,אב-וי,,nan,nan,nan,,,QULIPTA 30 MG  30 TABS,,,19684,BLISTER PVC/PE/PCTFE/AL,units,30.0,170 61 37169 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Qulipta is indicated for the preventive treatment of  migraine in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a2115bd4-95ed-416a-a330-5002b8ad2ed6.json
a24adbb2-b421-4c5a-9fa5-4b7120ba15d5,OTEZLA 10 MG,prescription,L04AA32,APREMILAST,9091,,,WHO ATC Classification,,ILS,film coated tablets,APREMILAST,2025-07-30T23:24:46.183463,IL,רפא,,2917.826831,2472.734602,2247.940548,,,APREMIL 30 MG 56 TAB,,,80154,BLISTER PVC,units,56.0,153 91 34274 04,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Otezla is indicated:- For treatment of adult patients with active psoriatic arthritis (PsA).- For adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (PSOR).- For the treatment of adult patients with oral ulcers associated with Behçet’s disease (BD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a24adbb2-b421-4c5a-9fa5-4b7120ba15d5.json
a24eadbd-56c1-4e6e-bb27-539a444937b6,VITAMINE B12 STEROP 1 MG/ML,prescription,B03BA01,CYANOCOBALAMIN,8571,,,WHO ATC Classification,,ILS,solution for injection,CYANOCOBALAMIN (VIT B12)/,2025-07-31T10:18:14.530624,IL,רז פרמהצפטי,,40.0658144,33.95408,24.784,,,VITAMINE B12 STEROP 1 MG/ML 10 AMP,2734,,3334,AMPOULES GLASS TYPE I,units,10.0,163 11 35283 00,valid,37.0,"s.c, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Pernicious anemia and its neurological complications, subacute combined degeneration of the spinal cord. Treatment of vitamin B12 deficiency states and macrocytic anemias associated with nutritional deficiencies, gastrectomy and abnormalities of, or malabsorption from, the gastrointestinal tract such as celiac disease, sprue and accompanying folic acid deficiency. Also suitable for use as the flushing dose in the schilling test for pernicious anemia.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a24eadbd-56c1-4e6e-bb27-539a444937b6.json
a25851f0-0da4-4481-8db3-9add5c6420d6,KETOSPRAY 10 %,prescription,M02AA10,KETOPROFEN,6868,,,WHO ATC Classification,,ILS,spray,KETOPROFEN,2025-07-31T04:25:34.224120,IL,מגאפארם,,nan,nan,nan,,,KETOSPRAY 10 % 25G,11244,,40168,BOTTLE AMBER GLASS TYPE III,units,1.0,144 45 33067 00,valid,nan,dermal,1.4,48,,,,,,,,,,0,Prescription required,"Topical treatment for the symptomatic relief of soft tissue pain and inflammation due to strains, sprains, distortions, and contusions.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a25851f0-0da4-4481-8db3-9add5c6420d6.json
a25f35a1-d997-4aa7-b4a8-b8343fa3f5a7,KOSELUGO 10 MG,prescription,L01EE04,SELUMETINIB,8774,,,WHO ATC Classification,,ILS,"capsule, hard",SELUMETINIB AS HYD-SULFATE,2025-07-31T04:29:32.727791,IL,אסטראזנקה,,24620.96458,20865.22515,18968.3865,,7290013075826,KOSELUGO 10 MG 60 CAPS,11303,,73199,BOTTLE HDPE,units,60.0,167 72 36526 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Koselugo is indicated for the treatment of pediatric patients 2 years of age and older withneurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a25f35a1-d997-4aa7-b4a8-b8343fa3f5a7.json
a28ae9fa-e216-40fc-84ec-b6b513661617,BENERVA 100MG/ML 6AMP,29C,,,20045,,,,,,injection,BENERVA 100MG/ML,2025-07-31T20:00:12.351256,IL,nan,,,,,,,BENERVA 100MG/ML 6AMP,,,,,units,6.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a28ae9fa-e216-40fc-84ec-b6b513661617.json
a2a744e3-f3fe-4466-bbf5-c7662d156aef,VABEN TABLETS,prescription,,,1898,,,,,ILS,tablets,OXAZEPAM,2025-07-31T09:56:05.698843,IL,רפא,,14.54939935,12.33,9.0,,,VABEN 10MG 30TAB,22001,,2332,BLISTER PVC/ALUMINIUM,units,30.0,022 06 21031 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Anxiolytic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a2a744e3-f3fe-4466-bbf5-c7662d156aef.json
a2cdec82-baa4-43c6-82a6-a7ed71839248,XYLOVIT 0.05%,off-the-counter,R01AA07,XYLOMETAZOLINE,5062,,,WHO ATC Classification,,ILS,drops+spray,XYLOMETAZOLINE HYDROCHLORIDE 0.05 %,2025-07-31T13:39:09.692479,IL,ויטאמד,,30.55,25.89,nan,,7290008068970,XYLOVIT 0.05%SPY10ML,24002,,,BOTTLE LDPE,units,10.0,062 58 27663 01,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to 10 hours.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a2cdec82-baa4-43c6-82a6-a7ed71839248.json
a32c16ef-997e-41ea-831d-ea701da814d2,OLANZAPINE ODT TEVA ® 10 MG,prescription,N05AH03,OLANZAPINE,8052,,,WHO ATC Classification,,ILS,tablets orodispersible,OLANZAPINE,2025-07-31T06:05:25.867209,IL,טבע,,133.2598992,112.932118,83.9644,,7290106063143,OLANZAPINE ODT TEVA ® 10 MG NEW FORMULATION 28 TAB,15473,,12693,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,157 16 34591 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia. Olanza ODT Teva is indicated for the management  of the manifestations of psychotic disorders.Olanza ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanza ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanza ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a32c16ef-997e-41ea-831d-ea701da814d2.json
a33b9e80-8cc2-4c96-8ff9-197798966e83,IOPAMIRO 300,prescription,V08AB04,IOPAMIDOL,4658,,,WHO ATC Classification,,ILS,solution for injection,IOPAMIDOL 612.4  MG/ML,2025-07-31T05:27:39.393271,IL,אוניפארם,,52.03221092,44.095094,32.1862,,,MIRO 30MG 30TAB,13492,,57698,BOTTLE GLASS TYPE I,units,30.0,020 40 24483 11,valid,37.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"X-ray contrast medium in neuroradiology, angiography, urography, ct scanning, arthrography and fistulography",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a33b9e80-8cc2-4c96-8ff9-197798966e83.json
a346c615-3c2d-46aa-b846-7eae3a116f7c,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,3962,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:23:25.907383,IL,רקיט בנקיזר,,29.7714,25.23,nan,,7290000852973,STREPSILS ORANGE+VIT C 24 LOZ,19789,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a346c615-3c2d-46aa-b846-7eae3a116f7c.json
a35928a4-f7e3-4753-a3f7-0f8da8bbe7e0,REOLIN EFFERVESCENT TABLETS 200 MG,off-the-counter,R05CB01,ACETYLCYSTEINE,4632,,,WHO ATC Classification,,ILS,tablets effervescent,ACETYLCYSTEINE,2025-07-31T12:56:19.885492,IL,פארמלוג'יק,,30.6564,25.98,nan,,7290006676986,REOLIN EFFER 200MG 30TAB,18286,,,TUBE POLYPROPYLENE,units,30.0,127 37 30626 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Mucolytic in respiratory tract disorders where reduction of sputum viscosity is required.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a35928a4-f7e3-4753-a3f7-0f8da8bbe7e0.json
a3848885-8bf0-46d0-bc3d-42c1468e13ad,ELIGARD 22.5 MG,prescription,,,7881,,,,,ILS,powder and solvent for solution for injection,LEUPRORELIN ACETATE 22.5  MG,2025-07-31T02:15:17.547897,IL,קמהדע,,410.1995303,347.6267361,295.8525413,,8718692510845,ELIGARD 7.5 MG  PREFILLED SYR,5609,,50800,SYRINGE PREFILLED  CYCLIC OLEFIN COPOLYMER,units,1.0,156 79 33678 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,ELIGARD is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3848885-8bf0-46d0-bc3d-42c1468e13ad.json
a388601b-ae51-4ed9-808d-b993ce4241cc,CILARIL 2.5,prescription,C09AA08,CILAZAPRIL,9325,,,WHO ATC Classification,,ILS,tablets,CILAZAPRIL 2.5  MG,2025-07-31T01:12:36.106065,IL,אוניפארם,,27.369038,23.1941,16.93,,,CILARIL 2.5 MG 30 TAB,,,1412,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,135 93 31305 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Cilaril is indicated for the treatment of hypertension. Cilaril is indicated for the treatment of chronic heart failure.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a388601b-ae51-4ed9-808d-b993ce4241cc.json
a3aa7bb1-7a44-439b-870b-93ff3da55368,FELDENE GEL 50GR,off-the-counter,,,2669,,,,,ILS,tablet,FELDENE GEL 50GR,2025-07-31T19:41:45.481648,IL,פיזר,,47.6602,40.39,,,,FELDENE GEL 50GR,6021,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3aa7bb1-7a44-439b-870b-93ff3da55368.json
a3ba2f84-56d9-43ba-9d81-f0473efbbc69,SODIUM CHLORIDE 0.9% IMUNA,prescription,B05CB01,SODIUM CHLORIDE,8888,,,WHO ATC Classification,,ILS,solution for infusion,SODIUM CHLORIDE/ML,2025-07-31T08:25:01.836717,IL,מדי מרקט,,22.42220059,19.00186575,13.869975,,,SODIUM CHLORIDE 0.9% IMUNA 250 ML,,,70778,BAG PLASTIC,units,250.0,167 57 36009 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Short- term intravascular volume substitution. Hypotonic dehydration or isotonic dehydration. Vehicle solution for supplementary medication.Fluid and electrolyte replacement, hypochloremic alkalosis and chloride losses.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3ba2f84-56d9-43ba-9d81-f0473efbbc69.json
a3c6bb7e-2684-42c6-ba87-9ee60a6b751c,SIMVASTATIN TEVA ® 40 MG,prescription,C10AA01,SIMVASTATIN,4133,,,WHO ATC Classification,,ILS,tablets,SIMVASTATIN,2025-07-31T08:15:26.479852,IL,טבע,,23.56533986,19.970627,14.5771,,,SIMVASTATIN-TEVA 20MG 30TAB,19430,,26874,BLISTER PVC/PE/PVDC/AL,units,30.0,129 18 30737 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia  Simvastatin-teva is indicated to:     Reduce the risk of total mortality by reducing coronary death ;Reduce the risk of non-fatal myocardial infarction ;Reduce the risk for undergoing myocardial revascularization procedures.      Reduce the risk of stroke and transient ischemic attacks (TIA).   Hyperlipidemia: Simvastatin-teva is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvastatin-teva therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios.   Homozygous familial hypercholesterolemia: Simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Simvastatin-teva is indicated for the treatment of patients with hypertriglyceridemia ( Fredrickson type IV  hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia): Simvastatin-teva is also indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3c6bb7e-2684-42c6-ba87-9ee60a6b751c.json
a3df4cbe-fd97-4b8b-b708-91f49d163721,ACYCLOVENIR,prescription,J05AB01,ACICLOVIR,7602,,,WHO ATC Classification,,ILS,powder for solution for infusion,ACICLOVIR,2025-07-30T23:13:49.583671,IL,כ.צ.ט,,45.03508114,38.165323,27.8579,,7290010286348,ACYCLO-V 200MG 30TAB,1903,,59112,VIAL GLASS TYPE II,units,30.0,143 05 31907 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,•	indicated for the treatment of Herpes simplex infections in immunocompromised patients and severe initial genital herpes in the non-immunocompromised. •	indicated for the prophylaxis of Herpes simplex infections in immunocompromised patients. •	indicated for the treatment of Varicella zoster infections. •	indicated for the treatment of herpes encephalitis. •	indicated for the treatment of Herpes simplex infections in the neonate and infant up to 3 months of age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3df4cbe-fd97-4b8b-b708-91f49d163721.json
a3dfe4a8-70db-474e-b263-79e8275707bb,DODICILE VETERINARY,29C,,,20303,,,,,ILS,solution for injection,"CYANOCOBALAMIN (VIT B12)/ML, THIAMINE (VIT B1) HYDROCHLORIDE/ML",2025-07-31T13:56:42.895053,IL,nan,,nan,nan,nan,,,B12 DEPOT 1MG/ML AMP,,,,VIAL GLASS TYPE II,units,10.0,083 38 92357 00,valid,nan,"i.m, i.v",1.4,24,,,,,,,,,,0,,"Vitamin B1, 12 supplement in cattle, horses, swine, sheep, dogs and cats.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3dfe4a8-70db-474e-b263-79e8275707bb.json
a3ed8dce-6e7f-410f-8209-558b43bc68df,EDURANT,prescription,J05AG05,RILPIVIRINE,7066,,,WHO ATC Classification,,ILS,tablets,RILPIVIRINE AS HYDROCHLORIDE,2025-07-31T02:11:23.014162,IL,יאנסן סילג,,1112.599378,942.8808709,802.451805,,7290014577084,EDURANT 25MG 30TAB,5561,,77136,BOTTLE HDPE,units,30.0,148 57 33585 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"EDURANT™, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-naïve adult patients with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3ed8dce-6e7f-410f-8209-558b43bc68df.json
a3f888a2-2019-4efd-a864-892ee3d7677a,QULIPTA 10 MG,prescription,N02CD07,ATOGEPANT,9284,,,WHO ATC Classification,,ILS,tablets,ATOGEPANT AS MONOHYDRATE,2025-07-31T07:13:14.919618,IL,אב-וי,,2217.307045,1879.073851,1599.211788,,,QULIPTA 60 MG 30 TABS,,,19711,BLISTER PVC/PE/PCTFE/AL,units,30.0,170 61 37169 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Qulipta is indicated for the preventive treatment of  migraine in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3f888a2-2019-4efd-a864-892ee3d7677a.json
a3fc3ae4-5a82-4813-98ff-a1948eb08f17,FENTADOL 100,prescription,N02AB03,FENTANYL,7889,,,WHO ATC Classification,,ILS,patches,FENTANYL 16.8 MG/PATCH,2025-07-31T02:59:04.340807,IL,סנדוז,,81.65121628,69.195946,51.4468,,7290017585710,FENTADOL 25 5 PATCHES,166027,,59912,SACHET PAPER/PE/ALU/PE,units,5.0,154 87 34320 00,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,"Management of chronic pain and intractable pain requiring opioid analgesia.Fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3fc3ae4-5a82-4813-98ff-a1948eb08f17.json
a3fc6543-1b2c-4804-a0a5-3d0cfd2a479e,ROSETEMIB S.K. 20/10 MG,prescription,C10BA06,ROSUVASTATIN AND EZETIMIBE,9537,,,WHO ATC Classification,,ILS,film coated tablets,"EZETIMIBE, ROSUVASTATIN AS CALCIUM",2025-07-31T07:49:35.076557,IL,SK PHARM(KS KIM),,88.29741199,74.82831857,55.6344376,,,ROSETEMIB S.K. 20/10 MG 30 TAB,,,,BLISTER AL/OPA/AL/PVC,units,30.0,175 18 36804 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary Hypercholesterolaemia/Homozygous Familial Hypercholesterolaemia (HoFH):ROSETEMIB S.K is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or homozygous familial hypercholesterolaemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a3fc6543-1b2c-4804-a0a5-3d0cfd2a479e.json
a4242d0b-369d-495e-a47d-77dc7d6db169,TRAMADOL - KALCEKS 50 MG/ML,prescription,N02AX02,TRAMADOL,8819,,,WHO ATC Classification,,ILS,solution for injection / infusion,TRAMADOL HYDROCHLORIDE/,2025-07-31T09:32:25.570682,IL,מדי מרקט,,26.10464503,22.12258053,16.147869,,,TRAMADOL - KALCEKS 50 MG/ML 10 AMP 2ML,,,65274,AMPOULES GLASS TYPE I,units,10.0,165 16 35762 00,valid,37.0,"s.c, i.m, i.v",1.4,48,,,,,,,,,,0,Prescription required,Moderate to severe pain., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a4242d0b-369d-495e-a47d-77dc7d6db169.json
a424974f-7207-4b99-b6df-e9fb5619a07a,VOLIBRIS 10 MG,prescription,C02KX02,AMBRISENTAN,6242,,,WHO ATC Classification,,ILS,film coated tablets,AMBRISENTAN,2025-07-31T10:19:59.497978,IL,ג.ס.ק,,3974.69666,3368.387,3062.17,,7290010140589,VOLIBRIS 5 MG FC 30 TABLETS,22299,,78755,BLISTER PVC/PVDC,units,30.0,140 09 31884 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Volibris is indicated for treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment with tadalafil.Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a424974f-7207-4b99-b6df-e9fb5619a07a.json
a4419a5a-fbe8-4ead-aca6-3333f3158e93,ESRACAIN INJECTION 2 %,prescription,N01BB02,LIDOCAINE,6606,,,WHO ATC Classification,,ILS,solution for injection,LIDOCAINE HYDROCHLORIDE/ML,2025-07-31T02:37:33.287848,IL,רפא,,234.2171675,198.489125,158.7913,,7290008013369,ESRACAIN INJECTION 2% 50AMP/10ML,5139,,35243,AMPOULES GLASS,units,50.0,020 82 21028 00,valid,25.0,"i.m, i.v, epidural, s.c, intradermal, submucosal, spinal, perineural, i.v regional anaesthesia",1.4,36,,,,,,,,,,0,Prescription required,"Local and regional anaesthesia.Severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be life-threatening.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a4419a5a-fbe8-4ead-aca6-3333f3158e93.json
a4453e73-5f25-45c7-be2d-f5828bc79479,ADVIL COLD & SINUS,off-the-counter,M01AE51,"IBUPROFEN, COMBINATIONS",5217,,,WHO ATC Classification,,ILS,capsules liquid filled,"IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE",2025-07-31T11:05:11.971724,IL,ג.ס.ק,,32.5916,27.62,nan,,305730184168,ADVIL COLD & SINUS 16 CAPS,1791,,,BOX CARTON,units,16.0,135 50 31178 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Temporarily relieves symptoms associated with the common cold, or flu: in the presence of fever or pain with associated congestion.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a4453e73-5f25-45c7-be2d-f5828bc79479.json
a446b3a6-389a-467f-82de-af7d5b9c0ea5,CONCOR 1.25 MG,prescription,C07AB07,BISOPROLOL,2758,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE 1.25  MG,2025-07-31T01:28:28.067293,IL,מרק סרונו,,19.98877402,16.939639,12.3647,,,CONCOR 10MG 30TAB,9356,,8940,BLISTER PVC/ALUMINIUM,units,30.0,167 22 35983 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function (ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a446b3a6-389a-467f-82de-af7d5b9c0ea5.json
a44ac70a-cff0-4244-ab3f-df26ff2b546a,SOOLANTRA,prescription,P02CF01,IVERMECTIN,8946,,,WHO ATC Classification,,ILS,cream,IVERMECTINW/W,2025-07-31T08:31:49.343994,IL,אמי טכנולוגיות,,140.1211999,118.7467849,88.2875724,,,SOOLANTRA CREAM 30G,17541,,74223,TUBE PE/AL/PE,units,30.0,167 59 36606 99,valid,34.5,topical,1.4,24,,,,,,,,,,0,Prescription required,Soolantra is indicated in the topical treatment of inflammatory (papulopustular) lesions caused by rosacea in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a44ac70a-cff0-4244-ab3f-df26ff2b546a.json
a4931ac0-91aa-4f00-9e77-c329009ced2b,MAVENCLAD 10 MG TABLETS,prescription,L01BB04,CLADRIBINE,8148,,,WHO ATC Classification,,ILS,tablets,CLADRIBINE,2025-07-31T05:06:05.029214,IL,מרק סרונו,,7946.966294,6734.717498,6122.470452,,,MAVENCLAD 10 MG 1 TABLET,13830,,64835,BLISTER ALUMINIUM /ALUMINIUM,units,1.0,159 78 35306 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clinical or imaging features,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a4931ac0-91aa-4f00-9e77-c329009ced2b.json
a498653b-5248-4ff8-8ec3-f75b0d1d91f1,PENTASA SLOW RELEASE GRANULES 4 G.,prescription,A07EC02,MESALAZINE,2895,,,WHO ATC Classification,,ILS,granules,MESALAZINE,2025-07-31T06:35:31.835011,IL,פרינג,,155.3883983,131.6850892,105.3480713,,7640128547228,PENTASA 500MG 100 SRTAB,16006,,8993,SACHET POLYESTER/ALUMINIUM/POLYETHYLENE,units,100.0,157 47 34816 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate ulcerative colitis or crohn's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a498653b-5248-4ff8-8ec3-f75b0d1d91f1.json
a4a46066-90e6-4c08-a06f-2b92066ed5d3,NATPARA 75 MCG 2CARTRIDGES,prescription,,,7831,,,,,ILS,tablet,NATPARA 75 MCG 2CARTRIDGES,2025-07-31T19:21:39.122418,IL,ניאופרם,,32623.83451,27647.31861,25133.92601,,,NATPARA 75 MCG 2CARTRIDGES,14668,,54979,,units,2.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a4a46066-90e6-4c08-a06f-2b92066ed5d3.json
a4a65a99-89ca-4306-a903-a62b744f798d,ASTONIN 100MCG 40TAB,29C,,,20786,,,,,,tablet,ASTONIN 100MCG,2025-07-31T19:57:41.856543,IL,nan,,,,,,,ASTONIN 100MCG 40TAB,,,,,units,40.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a4a65a99-89ca-4306-a903-a62b744f798d.json
a4af011d-9962-44f5-82f3-17f15af85270,FABRAZYME 35 MG,prescription,A16AB04,AGALSIDASE BETA,6737,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,AGALSIDASE BETA/VIAL,2025-07-31T02:52:27.011551,IL,סאנופי אוונטיס,,13178.16745,11167.93901,10152.67183,,7290013773029,FABRAZYME 35MG/VIAL,6478,,11481,VIAL GLASS TYPE I,units,1.0,124 94 30313 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease. (alfa - galactosidase A deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a4af011d-9962-44f5-82f3-17f15af85270.json
a4b29f1b-547c-4ba3-914c-14a2683b3bbb,PACLIAVENIR 6MG/ML 10VIAL (30MG/5ML),prescription,,,7275,,,,,ILS,injection,PACLIAVENIR 6MG/ML (30MG/),2025-07-31T19:27:04.550023,IL,ביואבניר,,2291.178329,1941.67655,1765.1605,,,PACLIAVENIR 6MG/ML 10VIAL (30MG/5ML),16683,,10415,,units,10.0,,not-registered,10.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a4b29f1b-547c-4ba3-914c-14a2683b3bbb.json
a502d5a6-6cfa-4766-b4c3-500871ffd3bc,XARELTO 2.5 MG,prescription,B01AF01,RIVAROXABAN,8100,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN 2.5  MG,2025-07-31T10:30:31.233109,IL,באייר,,301.1194655,255.1859877,217.179564,,,XARELTO 2.5 MG 56TAB,24093,,65162,BLISTER PP/ALUMINIUM,units,56.0,151 87 34048 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Xarelto, co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel , is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers.Xarelto, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a502d5a6-6cfa-4766-b4c3-500871ffd3bc.json
a537789e-8404-40d2-b13c-c52dd7ea0d4a,PADCEV 20 MG,prescription,L01XC36,ENFORTUMAB VEDOTIN ,4977,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,ENFORTUMAB VEDOTIN/VIAL,2025-07-31T03:17:16.227814,IL,סנדוז,,72.89280493,61.7735635,45.9283,,8718692511422,FORTUM 2G 1VIAL,6076,,9501,VIAL GLASS TYPE I,units,1.0,167 37 36604 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"PADCEV, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer (mUC). PADCEV, as a single agent , is indicated for the treatment of adult patients with locally advanced or mUC who: •	have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic settingor:•	are ineligible for cisplatin-containing chemotherapy and have previously received a PD-1/PD-L1 inhibitor.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a537789e-8404-40d2-b13c-c52dd7ea0d4a.json
a5390213-a625-4ac1-be38-08b3797c7ef4,UNASYN 1.5 G.,prescription,J01CR01,AMPICILLIN AND ENZYME INHIBITOR,8222,,,WHO ATC Classification,,ILS,powder for solution for injection,"AMPICILLIN AS SODIUM, SULBACTAM AS SODIUM",2025-07-31T09:51:55.774727,IL,פיזר,,35.14191722,29.78128578,21.7381648,,,UNASYN 1.5 G. 1 VIAL,21137,,2899,VIAL GLASS TYPE III,units,1.0,122 47 30258 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,Sulbactam sodium/ampicillin sodium IM/IV is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) Skin and Skin Structure Infections. 2) Intra-Abdominal Infections. 3) Gynecological Infections.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a5390213-a625-4ac1-be38-08b3797c7ef4.json
a53df470-be56-40fd-b8bd-cfac37b24493,REFIXIA 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,9241,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,NONACOG BETA PEGOL/VIAL,2025-07-31T07:20:04.337990,IL,נובו נורדיסק,,9623.514002,8155.520703,7414.10973,,,REFIXIA 1000 IU 1 VIAL,18696,,11589,VIAL GLASS TYPE I,units,1.0,172 35 37303 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in pretreated patients with haemophilia B (congenital factor IX deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a53df470-be56-40fd-b8bd-cfac37b24493.json
a543b1f7-dae3-4348-87ee-f8f2e8666e4a,PITRIYA-T,off-the-counter,D01AE15,TERBINAFINE,5614,,,WHO ATC Classification,,ILS,cream,TERBINAFINE HYDROCHLORIDEW/W,2025-07-31T12:48:49.538262,IL,תרו יבוא,,65.5608,55.56,nan,,,PITRIYA-T TUBE 30 G,,,,TUBE LAMINATED,units,30.0,166 65 36323 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum) Microsporum canis and Epidemophyton floccosum. Yeast infections of the skin principally those caused by the genus Candida (e.g. candida albicans). Pityriasis (tinea versicolor) due to pityrosporum orbiculare (also known as malassezia furfur). For the treatment of plantar-type tinea pedis (Moccasin type).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a543b1f7-dae3-4348-87ee-f8f2e8666e4a.json
a555c018-778f-4ed4-834e-aaba114fb3d7,ODEFSEY,prescription,J05AG05,RILPIVIRINE,8869,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR ALAFENAMIDE AS FUMARATE, EMTRICITABINE, RILPIVIRINE AS HYDROCHLORIDE",2025-07-31T06:02:57.480307,IL,יאנסן סילג,,2888.954266,2448.266436,2225.69676,,,ODEFSEY 30 TAB,,,45193,BOTTLE ,units,30.0,162 38 35353 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"ODEFSEY is indicated for the treatment of adults and  adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus 1 (HIV 1) without known mutations associated with resistance to the non nucleoside reverse transcriptase inhibitor (NNRTI) class, tenofovir or emtricitabine and with a viral load ≤ 100,000 HIV 1 RNA copies/mL", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a555c018-778f-4ed4-834e-aaba114fb3d7.json
a592d13d-2e65-438f-b717-de34c4cc8e19,ROPIVACAINE FRESENIUS 2 MG/ML SOLUTION FOR INJECTION,prescription,N01BB09,ROPIVACAINE,8614,,,WHO ATC Classification,,ILS,solution for injection,ROPIVACAINE AS HYDROCHLORIDE/ML,2025-07-31T07:49:10.314109,IL,ניאופרם,,192.2416882,162.9166922,130.3333538,,,ROPIVACAINE FRESENIUS 2 MG/ML 100ML 5 BAG,18611,,447,AMPOULES PP,units,5.0,158 68 34445 00,valid,25.0,"perineural, epidural",1.4,36,,,,,,,,,,0,Prescription required,"Acute pain management :In adults and adolescents above 12 years of age for:- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.- Field blocks.- Peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a592d13d-2e65-438f-b717-de34c4cc8e19.json
a598eff2-b080-4848-8a19-c165bee77a98,TRULICITY 0.75 MG,prescription,A10BX14,DULAGLUTIDE,7841,,,WHO ATC Classification,,ILS,solution for injection,DULAGLUTIDE 1.5 MG/ML,2025-07-31T09:46:27.861385,IL,אלי לילי,,445.1138004,377.2151018,321.0341292,,7290008139397,TRULICITY 0.75 MG/0.5 ML 4 SYR-PEN,20810,,32988,PRE-FILLED PEN GLASS TYPE I,units,4.0,154 39 34356 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,Type 2 Diabetes MellitusTrulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a598eff2-b080-4848-8a19-c165bee77a98.json
a5b18e98-1520-43ae-b4e0-d6d1cf37abcc,TIPTIPOT AFALPI,off-the-counter,R01BA02,PSEUDOEPHEDRINE,5016,,,WHO ATC Classification,,ILS,drops,PSEUDOEPHEDRINE AS HYDROCHLORIDE/ML,2025-07-31T13:29:05.647047,IL,כ.צ.ט,,26.196,22.2,nan,, 7290008104579,TIPTIPOT NOVIMOL  SUSP 15ML,20602,,,BOTTLE GLASS,units,15.0,121 43 30172 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relief eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a5b18e98-1520-43ae-b4e0-d6d1cf37abcc.json
a5c278bb-d94d-494b-baea-2591b392bad9,LACOSAMIDE TEVA ® 100 MG,prescription,N03AX18,LACOSAMIDE,8676,,,WHO ATC Classification,,ILS,film coated tablets,LACOSAMIDE,2025-07-31T04:31:49.229082,IL,טבע,,297.6099098,252.211788,214.6483302,,,LACOSAMIDE TEVA 100 MG 56 TAB,,,56605,BLISTER OPA/ALU/PVC/ALU,units,56.0,163 97 35488 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Lacosamide Teva is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a5c278bb-d94d-494b-baea-2591b392bad9.json
a5d5c570-372f-4d94-99bb-fb220a6422e9,ATOZET10 MG/10 MG,prescription,C10BA05,ATORVASTATIN AND EZETIMIBE ,7900,,,WHO ATC Classification,,ILS,film coated tablets,"ATORVASTATIN AS CALCIUM TRIHYDRATE, EZETIMIBE",2025-07-30T23:29:56.892508,IL,אורגנון,,129.9606955,110.1361826,81.88563764,,,ATOZET 10 MG/20 MG 30 TAB,9972,,59893,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,156 65 34490 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Prevention of Cardiovascular EventsAtozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaAtozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Atozet is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a5d5c570-372f-4d94-99bb-fb220a6422e9.json
a5d8467c-54fd-4ff0-aff6-e03fc7059f8a,TRAUMAPLANT,off-the-counter,,,5489,,,,,ILS,cream,COMFREY (SYMPHYTUM) CONCENTRATE/,2025-07-31T13:30:01.719571,IL,מכבי קאר,,48.498,41.1,nan,,7290008075121,TRAUMAPLANT CREAM 50GR,,,,TUBE ALUMINIUM,units,50.0,140 61 31480 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Traumaplant is a phytodrug (extract of plants) for external treatment of ankle sprains  and muscle pains (in case of sports and accidental injuries).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a5d8467c-54fd-4ff0-aff6-e03fc7059f8a.json
a5dbbb5b-cb0a-45af-add5-e82f9c7a8837,EMTRICITABINE/TENOFOVIR TEVA ®,prescription,J05AR03,TENOFOVIR DISOPROXIL AND EMTRICITABINE,7351,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR DISOPROXIL AS PHOSPHATE, EMTRICITABINE",2025-07-31T09:12:25.134957,IL,טבע,,1239.59977,1050.50828,894.0496,,,TENOFOVIR TEVA 245MG 30TAB,20782,,51571,BLISTER OPA/ALU/PVC/ALU,units,30.0,162 68 35319 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of HIV-1 infection: Emtricitabine/Tenofovir Teva® is indicated in combination with other anti-retroviral medicinal products for the treatment of HIV-1 infected adults over 18 years of age.Pre-exposure prophylaxis (PrEP): Emtricitabine/Tenofovir Teva® is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection in adults at high risk.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a5dbbb5b-cb0a-45af-add5-e82f9c7a8837.json
a5f052e5-32d6-4d6c-af16-101879033095,PROSTIN E2 VAGINAL GEL 1 MG,prescription,G02AD02,DINOPROSTONE,8928,,,WHO ATC Classification,,ILS,gel,DINOPROSTONE 0.033 %W/W,2025-07-31T07:03:59.279313,IL,פיזר,,250.0039891,211.8677968,169.4942375,,7298074000498,PROSTIN E2 VAGINAL GEL 2 MG/3GR,,,35605,SYRINGE LDPE,units,3.0,056 32 26453 00,valid,25.0,vaginal,1.4,24,,,,,,,,,,0,Prescription required,For labour induction in term and near term pregnant women who have favorable induction features and who have a singleton pregnancy with vertex presentation,תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a5f052e5-32d6-4d6c-af16-101879033095.json
a60c3d24-c969-4688-8141-cd5c85ff590c,JETREA 0.5MG/0.2ML VIAL,prescription,,,7598,,,,,,injection,JETREA 0.5MG/0. VIAL,2025-07-31T19:14:37.251226,IL,לפידות,,,,,,,JETREA 0.5MG/0.2ML VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a60c3d24-c969-4688-8141-cd5c85ff590c.json
a63753f3-51f5-489f-8a44-cc631e321169,AMIKAN,prescription,J01GB06,AMIKACIN,8142,,,WHO ATC Classification,,ILS,solution for injection,AMIKACIN AS SULFATE/,2025-07-30T23:21:58.216731,IL,SK PHARM(KS KIM),,23.27596846,19.725397,14.3981,,7290016845075,AMIKAN 500MG/2ML 1VIAL 2ML,10164,,68392,VIAL GLASS TYPE I,units,1.0,159 82 35008 00,valid,37.0,"i.v, i.m",1.4,24,,,,,,,,,,0,Prescription required,"Amikan is indicated in the short-term treatment of Gram-negative organisms, including pseudomonas and some Gram-positive organisms.Sensitive Gram-negative organisms include; Pseudomonas aeruginosa, Escherichia coli., indole-positive and indole-negative Proteus spp., Klebsiella, Enterobacter and Serratia spp., Minea-Herralae, Citrobacter freundii, Salmonella, Shigella, Acinetobacter and Providencia spp.The principal Gram-positive organism sensitive to amikacin is Staphylococcus aureus, including some methicillin-resistant strains. Amikan has some activity against other Gram-positive organisms including certain strains of Streptococcus pyogenes, Enterococci and Diplococcus pneumoniae.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a63753f3-51f5-489f-8a44-cc631e321169.json
a69cd816-805c-42c1-8069-99cd8a9fdbac,BENDAMUSTINE MEDAC 100 MG,prescription,L01AA09,BENDAMUSTINE ,8661,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BENDAMUSTINE  HYDROCHLORIDE,2025-07-30T23:35:07.468962,IL,צמל,,148.6365493,125.9631774,93.65292,,7290100819029,BENDAMUSTINE MEDAC 25 MG 1 VIAL,2779,,28455,VIAL GLASS TYPE I,units,1.0,163 73 35386 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate.Indolent non-Hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a69cd816-805c-42c1-8069-99cd8a9fdbac.json
a6a492e0-ad45-47c0-a224-1b9cc71f966d,EREMFAT 150MG 1000 TAB,29C,,,20073,,,,,,tablet,EREMFAT 150MG,2025-07-31T20:22:30.985479,IL,nan,,,,,,,EREMFAT 150MG 1000 TAB,,,,,units,1000.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a6a492e0-ad45-47c0-a224-1b9cc71f966d.json
a6ad8050-1c96-4cef-a4b3-4d68d8c4df62,COPAXONE ® 40 MG/ML,prescription,L03AX13,GLATIRAMER ACETATE,8579,,,WHO ATC Classification,,ILS,solution for injection,GLATIRAMER ACETATE,2025-07-31T01:29:50.772553,IL,טבע,,3733.471561,3163.95909,2876.326446,,,COPAXONE ® 40 MG/ML 12 PREFILLED PEN,,,3490,PREFILLED PEN GLASS TYPE I,units,12.0,151 75 34057 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Copaxone 40 mg/ml is indicated for reducing the frequency of relapses in patients with relapsing-remitting multiple sclerosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a6ad8050-1c96-4cef-a4b3-4d68d8c4df62.json
a6d09a5e-f482-44b9-997e-d4f3376ef20d,LOSARDEX 100,prescription,C09CA01,LOSARTAN,6879,,,WHO ATC Classification,,ILS,caplets,LOSARTAN POTASSIUM,2025-07-31T04:54:54.109448,IL,דקסל פארמה,,31.35331036,26.570602,19.3946,,,LOSARDEX 100MG 30TAB,12444,,23422,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,138 20 31492 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hypertension: Losardex 100  is indicated for the treatment of hypertensionHeart failure: Losardex 100 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ACE inhibitor is not appropriate.Switching patients with heart failure who are stable on an ACE inhibitor to Losardex 100 is not recommended.Renal protection in Type-2 diabetic patients with proteinuria: Losardex 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Losardex 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.The benefit of Losardex 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a6d09a5e-f482-44b9-997e-d4f3376ef20d.json
a6d5ed46-5f95-40d1-89fe-d6d0b7f03f5d,SUNOSI 150 MG,prescription,N06BA14,SOLRIAMFETOL,9303,,,WHO ATC Classification,,ILS,film coated tablets,SOLRIAMFETOL AS HYDROCHLORIDE,2025-07-31T08:52:54.149008,IL,ניאופרם,,1536.104973,1301.783933,1107.90122,,,SUNOSI 150 MG 28 FILM COATED TABLETS,23261,,43133,BLISTER PVC/PCTFE,units,28.0,172 81 37285 99,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by primary OSA therapy, such as continuous positive airway pressure (CPAP).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a6d5ed46-5f95-40d1-89fe-d6d0b7f03f5d.json
a6defb4d-559e-4c55-994b-aca866b6802a,AUSTEDO 12 MG,prescription,,,8759,,,,,ILS,tablets extended release,DEUTETRABENAZINE,2025-07-31T00:26:50.562500,IL,טבע,,nan,nan,nan,,,AUSTEDO 9 MG 60 SR TAB,,,72482,BOTTLE HDPE,units,60.0,166 59 36156 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,AUSTEDO is indicated in adults for the treatment of: • Chorea associated with Huntington’s disease  • Tardive dyskinesia,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a6defb4d-559e-4c55-994b-aca866b6802a.json
a6f049e2-3aa2-42a6-abda-d48316da3e50,MARONIL 25MG 30TAB,prescription,,,2246,,,,,ILS,tablet,MARONIL 25MG,2025-07-31T19:17:52.593814,IL,אוניפארם,,15.4272138,13.07391,9.543,,,MARONIL 25MG 30TAB,13044,,2516,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a6f049e2-3aa2-42a6-abda-d48316da3e50.json
a6fdc660-f31b-44eb-84b9-a112355bf271,DESLORATADINE - TRIMA TABLETS,prescription,R06AX27,DESLORATADINE,7304,,,WHO ATC Classification,,ILS,tablets,DESLORATADINE,2025-07-31T01:50:43.312880,IL,תרימה,,29.94783832,25.379524,18.5252,,,DESLORATADINE-TRIMA 5MG 30TAB,7904,,48794,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,149 99 33681 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Desloratadine - Trima tablets are indicated in adults and adolescents aged 12 yars and older for the relief of symptoms associated with: - allergic rhinitis,  - urticaria",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a6fdc660-f31b-44eb-84b9-a112355bf271.json
a706072d-78fd-4a2b-8ffe-c2e84d925a66,KALGARON ORANGE,off-the-counter,R02AD02,LIDOCAINE,5595,,,WHO ATC Classification,,ILS,lozenges,"CETYLPYRIDINIUM CHLORIDE 1.25  MG, LIDOCAINE HYDROCHLORIDE ( AS MONOHYDRATE)",2025-07-31T12:15:04.242163,IL,רפא,,30.621,25.95,nan,,7290017179315,KALGARON  MINT 24 LOZENGES,,,,BLISTER PVDC/ALUMINIUM,units,24.0,163 63 36018 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the relief of severe sore throat.  Relief of mouth and throat infections.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a706072d-78fd-4a2b-8ffe-c2e84d925a66.json
a707243d-f707-45fc-a484-de3957ca80a8,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,3369,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T10:59:29.864953,IL,טבע,,18.1602,15.39,nan,,7290000800028,ACAMOL 21 CAPLETS,1153,,,BLISTER PVC/ALUMINIUM,units,21.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a707243d-f707-45fc-a484-de3957ca80a8.json
a7451743-7d75-4f73-87fc-3d56f352bf31,ADVAGRAF 0.5 MG,prescription,L04AD02,TACROLIMUS,7670,,,WHO ATC Classification,,ILS,capsules prolonged release,TACROLIMUS AS MONOHYDRATE 0.5  MG,2025-07-31T00:09:41.719791,IL,אסטלס,,152.5367679,129.2684531,103.4147625,,8718692510692,ADVAGRAF 0.5MG 50  P.R. CAPS,9817,,74113,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,153 07 34071 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in adult kidney or liver allograft recipients.Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a7451743-7d75-4f73-87fc-3d56f352bf31.json
a7590f01-100e-4595-ba09-1903620b63c6,BOOSTRIX,prescription,J07AM51,"TETANUS TOXOID, COMBINATIONS WITH DIPHTHERIA TOXOID",6404,,,WHO ATC Classification,,ILS,suspension for injection,"DIPHTHERIA TOXOID NLT/ 0.5  ML, TETANUS TOXOID NLT/ 0.5  ML, FILAMENTOUS HAEMAGGLUTININ (FHA)/ 0.5  ML, PERTUSSIS TOXOID (PT)/ 0.5  ML, PERTACTIN (PRN OR 69 KDA OMP) 2.5  MCG / 0.5  ML",2025-07-31T00:40:13.213988,IL,ג.ס.ק,,136.4430887,115.6297413,85.9700679,,,BOOSTRIX SUSP FOR INJ PREFIL SYR 0.5ML,2518,,4164,SYRINGE GLASS TYPE I,units,1.0,121 34 30059 00,valid,34.5,i.m,1.4,48,,,,,,,,,,0,Prescription required,"For Booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years onwards.Boostrix is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy.The administration of Boostrix should be based on official recommendations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a7590f01-100e-4595-ba09-1903620b63c6.json
a764cd07-8c20-4916-a13b-0d47d9d2528a,AFINITOR 10 MG,prescription,L04AA18,EVEROLIMUS,6513,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS,2025-07-30T23:16:24.855060,IL,נוברטיס פארמה,,5159.461319,4372.424847,3974.931679,,7290006257383,AFINITOR 10MG 30TABLETS,9451,,83846,BLISTER PA/AL/PVC,units,30.0,142 87 32046 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"- For the treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection.The effectiveness of Afinitor is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated.- Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease.The safety and effectiveness of AFINITOR® in the treatment of patients with carcinoid tumors have not been established.- For the treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.- Afinitor ® is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Afinitor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes.- Afinitor ® is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.-  Treatment of unresectable, locally advanced  or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a764cd07-8c20-4916-a13b-0d47d9d2528a.json
a76aacd1-3fe3-482b-82fb-86c058e4d69a,ELREXFIO,prescription,L01FX32,ELRANATAMAB,9551,,,WHO ATC Classification,,ILS,solution for injection,ELRANATAMAB/,2025-07-31T02:16:56.562455,IL,פיזר,,17021.26761,14424.8037,13113.45791,,5415062123577,ELREXFIO 44MG/1.1ML 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,177 77 37990 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"ELREXFIO is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and have demonstrated disease progression on the last therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרתתרופה הנרכשת ע'י משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a76aacd1-3fe3-482b-82fb-86c058e4d69a.json
a76d9e83-ec54-49f6-a5f2-9baad6ae6888,RILUTEK,prescription,N07XX02,RILUZOLE,4299,,,WHO ATC Classification,,ILS,film coated tablets,RILUZOLE,2025-07-31T07:35:12.250362,IL,סאנופי אוונטיס,,577.5550868,489.4534851,416.5561575,,7290008880053,RILUTEK 50MG 56TAB,18164,,52899,BLISTER PVC/ALUMINIUM,units,56.0,106 26 29046 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rilutek is indicated to extend life or the time to mechanical ventilation for patients with  amyotrophic lateral sclerosis (ALS).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a76d9e83-ec54-49f6-a5f2-9baad6ae6888.json
a773ae38-9a8a-4784-91f3-b49204d89a44,INCRELEX,prescription,H01AC03,MECASERMIN,8710,,,WHO ATC Classification,,ILS,solution for injection,MECASERMIN/,2025-07-31T04:04:44.832750,IL,מדיסון,,3052.726456,2587.056434,2351.869485,,,INCRELEX 1 VIAL 4 ML,9840,,86573,VIAL GLASS TYPE I,units,1.0,163 53 35755 00,valid,10.0,s.c,1.4,60,,,,,,,,,,0,Prescription required,"For the long-term treatment of growth failure in children and adolescents from 2 to 18 years with confirmed severe primary insulin-like growth factor-1 deficiency (Primary IGFD).Severe Primary IGFD is defined by:* height standard deviation score ≤–3.0and* basal IGF-1 levels below the 2.5th percentile for age and genderand* GH sufficiency.* Exclusion of secondary forms of IGF-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.Severe Primary IGFD includes patients with mutations in the GH receptor (GHR), post-GHR signaling pathway, and IGF-1 gene defects; they are not GH deficient, and therefore, they cannot be expected to respond adequately to exogenous GH treatment.In some cases, when deemed necessary, the physician may decide to assist in the diagnosis by performing an IGF-I generation test.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a773ae38-9a8a-4784-91f3-b49204d89a44.json
a77f1eb0-7d74-49cf-8ac8-e841bc3441ca,INVANZ,prescription,J01DH03,ERTAPENEM,7749,,,WHO ATC Classification,,ILS,lyophilized powder for injection,ERTAPENEM AS SODIUM/VIAL,2025-07-31T04:10:42.714551,IL,מ.ס.ד. ישראל,,1475.627749,1250.532047,1064.282593,,,INVANZ IM/IV 1G/VIAL 20ML 10VIAL,9278,,35593,VIAL 15 ML GLASS TYPE I,units,10.0,127 09 30612 00,valid,17.5,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,Invanz is indicated for the treatment of adult patients and pediatric patients ( 3 months of age and older) with the following moderate to severe infections caused by susceptible isolates of the designated microorganisms. - Complicated intra-abdominal infections. - Complicated skin and skin structure infections including diabetic foot infections without osteomyelitis. - Community acquired pneumonia. - Complicated urinary tract infections including pyelonephritis. Acute pelvic infections including postpartum endomyometritis  septic abortion and post surgical gynecologic infections.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a77f1eb0-7d74-49cf-8ac8-e841bc3441ca.json
a78b9d75-27c5-4487-800c-fa0b24afcf8f,CAFCIT 20MG/ML 10VIAL,29C,,,20318,,,,,,injection,CAFCIT 20MG/ML,2025-07-31T20:01:49.415646,IL,nan,,,,,,,CAFCIT 20MG/ML 10VIAL,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a78b9d75-27c5-4487-800c-fa0b24afcf8f.json
a7cacec5-ae44-43dc-8840-e9e6fd38ee7a,GEODON IM 20 MG,prescription,N05AE04,ZIPRASIDONE,4504,,,WHO ATC Classification,,ILS,powder for solution for injection,ZIPRASIDONE MESYLATE TRIHYDRATE 40.93   MG,2025-07-31T03:32:17.346331,IL,דקסל פארמה,,385.7501244,326.9068997,278.218638,,7290008095341,GEODON 60MG 60CAPS,7600,,29826,VIAL GLASS TYPE I,units,60.0,125 75 30516 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Rapid control of agitation in patients with schizophrenia, when oral therapy is not appropriate, for a maximum of 3 consecutive days.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a7cacec5-ae44-43dc-8840-e9e6fd38ee7a.json
a7dffcd9-1049-4029-bcd6-8a13f714c128,NIPRUSS ®,29C,C02DD01,NITROPRUSSIDE,6808,,,WHO ATC Classification,,ILS,powder for solution for infusion,NITROPRUSSIDE SODIUM ANHYDROUS 52.75  MG,2025-07-31T15:22:58.804187,IL,nan,,nan,nan,nan,,7290015841283,NIPRUSS 60MG 5AMP,,,,AMPOULES GLASS TYPE I,units,5.0,164 33 35970 00,valid,nan,i.v,1.4,60,,,,,,,,,,0,,Nipruss is indicated in:• Hypertensive crisis• Controlled intraoperative hypotension Nipruss is not suitable for permanent therapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a7dffcd9-1049-4029-bcd6-8a13f714c128.json
a7e0cad8-e7ea-48c6-a9c9-1a2a2ef0c5fa,TOPAMAX 100,prescription,N03AX11,TOPIRAMATE,3552,,,WHO ATC Classification,,ILS,film coated tablets,TOPIRAMATE,2025-07-31T09:25:22.093239,IL,יאנסן סילג,,263.1720075,223.027125,178.4217,,,TOPAMAX 200MG 60TAB,20166,,52948,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,107 57 29033 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topamax is indicated in adults for the prevention of migraines. The use of Topamax in the acute treatment of migraine has not been studied.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a7e0cad8-e7ea-48c6-a9c9-1a2a2ef0c5fa.json
a7ea0cf7-91b1-45f0-82a7-09ebb5947a17,ZINDACLIN 1 % GEL,prescription,D10AF01,CLINDAMYCIN,4695,,,WHO ATC Classification,,ILS,gel,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T10:48:48.738458,IL,תרו יבוא,,63.15816837,53.5238715,39.7947,,,ZINDACLIN 1% GEL 30GR,26123,,59634,TUBE HDPE/LDPE,units,30.0,128 65 30648 00,valid,34.5,dermal,1.4,24,,,,,,,,,,0,Prescription required,Zindaclin is indicated for the treatment of acne vulgaris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a7ea0cf7-91b1-45f0-82a7-09ebb5947a17.json
a8135ea6-398c-4806-b6b5-11ad977a06f9,CEFTAZIDIME FRESENIUS  1 G,prescription,J01DD02,CEFTAZIDIME,8606,,,WHO ATC Classification,,ILS,powder for solution for injection,CEFTAZIDIME AS PENTAHYDRATE/VIAL,2025-07-31T01:00:40.357702,IL,ניאופרם,,318.78408,270.156,229.92,,7290008143547,CEFTAZIDIME FRESENIUS  1 G 10 VIAL,10666,,436,VIAL GLASS TYPE II,units,10.0,156 49 34310 00,valid,17.5,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Ceftazidime is indicated for the treatment of the infections listed below in adults and children includingneonates (from birth).•	Nosocomial pneumonia•	Broncho-pulmonary infections in cystic fibrosis•	Bacterial meningitis•	Chronic suppurative otitis media•	Malignant otitis externa•	Complicated urinary tract infections•	Complicated skin and soft tissue infections•	Complicated intra-abdominal infections•	Bone and joint infections•	Peritonitis associated with dialysis in patients on CAPD.Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.Ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.Ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (TURP).The selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic Gram negative bacteria (see sections 4.4 and 5.1).Ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum of activity.Consideration should be given to official guidelines regarding the appropriate use of antibacterial agents",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8135ea6-398c-4806-b6b5-11ad977a06f9.json
a827c011-e187-420b-8f7c-6aabfb7bb7cc,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,1436,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T10:59:53.297451,IL,טבע,,40.5802,34.39,nan,,7290000800028,ACAMOL 500MG 50CAP,1798,,,BLISTER PVC/ALUMINIUM,units,50.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a827c011-e187-420b-8f7c-6aabfb7bb7cc.json
a82a9e4a-3a82-44da-af9f-c890300a4b40,NITRODERM TTS 5,prescription,C01DA02,GLYCERYL TRINITRATE,568,,,WHO ATC Classification,,ILS,patches,GLYCERYL TRINITRATE/PATCH,2025-07-31T05:47:56.342146,IL,סנדוז,,28.80463539,24.41070905,17.8180358,,7298087000560,NITRODERM TTS 10MG/24H 10PATCHES,14053,,2515,POUCH PAPER/POLYETHYLENE/ALUMINIUM/SURLYN,units,10.0,118 55 22967 15,valid,37.0,transdermal,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of angina pectoris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a82a9e4a-3a82-44da-af9f-c890300a4b40.json
a8336565-c1fa-434c-9317-fb7b921ba2f7,ROTATEQ,prescription,,,6033,,,,,ILS,oral solution,"ROTAVIRUS P1A(8) REASSORTANT 1.15 X10^6 IU/ML, ROTAVIRUS G2 REASSORTANT 1.4 X10^6 IU/ML, ROTAVIRUS G4 REASSORTANT 1.0 X10^6   IU/ML, ROTAVIRUS G3 REASSORTANT 1.1 X10^6 IU/ML, ROTAVIRUS G1 REASSORTANT 1.1 X10^6 IU/ML",2025-07-31T07:51:31.547193,IL,nan,,nan,nan,nan,,,ROTATEQ VACCINE,18374,,72706,CONTAINER UNIT DOSE PLASTIC,units,1.0,136 76 31569 00,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,"RotaTeq  is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by types G1, G2, G3, G4, and G9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. The first dose of RotaTeq should be administered between 6 and 12 weeks of age.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8336565-c1fa-434c-9317-fb7b921ba2f7.json
a8387a3c-24c8-4576-88b0-4b3277019d90,DASATINIB TEVA 100 MG,prescription,L01XE06,DASATINIB,9177,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB AS MONOHYDRATE,2025-07-31T01:43:31.301782,IL,טבע,,6621.389314,5611.346876,5101.224433,,,DASATINIB TEVA 70 MG 60 TAB,,,37154,BLISTER OPA/ALU/PVC/ALU,units,60.0,169 90 36435 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with : * Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase. * Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate. * Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8387a3c-24c8-4576-88b0-4b3277019d90.json
a84ea0d8-f477-4150-914b-3a208b09c413,PREGABALIN TARO 100 MG,prescription,N03AX16,PREGABALIN,8173,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:53:55.652664,IL,תרו יבוא,,168.9678875,143.193125,114.5545,,,PREGABALIN TARO 150 MG 56 CAPS,,,59169,BLISTER PVC/ALUMINIUM,units,56.0,158 26 34762 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Pregabalin taro is indicated for the: •	Treatment of peripheral and central neuropathic pain in adults. •	Management of Fibromyalgia. •	Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a84ea0d8-f477-4150-914b-3a208b09c413.json
a8617bbe-165a-462a-b373-362d85529393,N-ALERGYA,off-the-counter,R06AE07,CETIRIZINE,5558,,,WHO ATC Classification,,ILS,tablets,CETIRIZINE DIHYDROCHLORIDE,2025-07-31T12:28:21.135154,IL,ליף- תרימה,,36.2024,30.68,nan,,,N-ALERGYA 10MG 20 TAB,,,,BLISTER PVC/ALUMINIUM,units,20.0,155 16 34652 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antihistaminic drug for the treatment of allergies. For the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in children aged 6 years and over and adults., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8617bbe-165a-462a-b373-362d85529393.json
a874d4f1-32ad-4bfe-b002-058159965bb1,ALCOHOL 70 % VITAMED,off-the-counter,D08AX08,ETHANOL,5542,,,WHO ATC Classification,,ILS,solution - external,ALCOHOL,2025-07-31T11:09:00.689793,IL,ויטאמד,,60.003,50.85,nan,,,ALCOHOL 70 % VITAMED 1 L,,,,BOTTLE HDPE,units,1000.0,128 31 30731 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a874d4f1-32ad-4bfe-b002-058159965bb1.json
a889f92a-44ea-4184-b516-c127a47205fb,BENZAC 5 %,off-the-counter,,,3361,,,,,ILS,gel,BENZOYL PEROXIDEW/W,2025-07-31T11:17:15.100451,IL,אמי טכנולוגיות,,66.4104,56.28,nan,,7290008067935,BENZAC AC 5% 60GR,2098,,,TUBE LDPE,units,60.0,103 30 27997 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,For the topical treatment of acne vulgaris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a889f92a-44ea-4184-b516-c127a47205fb.json
a88f5232-add2-4754-abec-bd811560670b,DIDANOSINE DELAYED 250MG 30CAPS,29C,,,20065,,,,,,capsule,DIDANOSINE DELAYED 250MG,2025-07-31T20:15:50.450826,IL,nan,,,,,,,DIDANOSINE DELAYED 250MG 30CAPS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a88f5232-add2-4754-abec-bd811560670b.json
a8a03377-064f-41a5-a201-7591dba9ed89,EXELON PATCH 10,prescription,N06DA03,RIVASTIGMINE,6223,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 9.5 MG/DAY,2025-07-31T02:48:22.886060,IL,נוברטיס פארמה,,244.294515,207.02925,165.6234,,,EXELON PATCH 10 30 PATCH,5478,,78064,POUCH PAPER/PET/PE/AL/POLYAMIDE,units,30.0,139 70 31675 01,valid,25.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8a03377-064f-41a5-a201-7591dba9ed89.json
a8a468c2-5205-42f8-8927-6b134706630d,HYCOMYCIN,prescription,D07CA01,HYDROCORTISONE AND ANTIBIOTICS,1566,,,WHO ATC Classification,,ILS,ointment,"NEOMYCIN AS SULFATE 0.5 %, HYDROCORTISONE 2.5 %",2025-07-31T03:52:30.863323,IL,טבע,,nan,nan,nan,,,HYCOMYCIN OINT 15GR,8061,,988,TUBE ALUMINIUM,units,15.0,051 45 24387 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Allergic dermatoses and other corticosteroid responsive inflammatory  skin diseases including atopic dermatitis, contact dermatitis, seborrheic dermatitis, anogenital pruritus, infantile eczema and external otitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8a468c2-5205-42f8-8927-6b134706630d.json
a8b375a8-e261-4d10-be31-7e1777e4d3f9,DAKTARIN ORAL GEL,off-the-counter,A01AB09,MICONAZOLE,1359,,,WHO ATC Classification,,ILS,gel,MICONAZOLEW/W,2025-07-31T11:29:03.838350,IL,ג'ונסון אנד ג'ונסון,,21.299,18.05,nan,,7290008124386,DAKTARIN ORAL GEL40G,4005,,,TUBE ALUMINIUM,units,40.0,038 08 20857 00,valid,nan,local oral,1.4,36,,,,,,,,,,0,,"Oral mycosis (thrush) and fungal infections of the upper gastrointestinal tract. Daktarin oral gel can be used for the prevention of oral thrush in patient receiving long-term treatment with antibiotics, steroids, cytotoxic and radiation therapy.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8b375a8-e261-4d10-be31-7e1777e4d3f9.json
a8d63890-7c37-418c-96ea-8889a04c724a,TIPTIPOT AFALPI,off-the-counter,R01BA02,PSEUDOEPHEDRINE,5034,,,WHO ATC Classification,,ILS,drops,PSEUDOEPHEDRINE AS HYDROCHLORIDE/ML,2025-07-31T13:28:48.326933,IL,כ.צ.ט,,25.9836,22.02,nan,, 7290008104579,TIPTIPOT MUCOLIT ORAL DROPS 15ML,20330,,,BOTTLE GLASS,units,15.0,121 43 30172 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relief eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8d63890-7c37-418c-96ea-8889a04c724a.json
a8df89af-72f6-4141-980c-feee5a49430b,VARDENAFIL INOVAMED 10 MG,prescription,G04BE09,VARDENAFIL,9141,,,WHO ATC Classification,,ILS,film coated tablets,VARDENAFIL AS HYDROCHLORIDE TRIHYDRATE,2025-07-31T09:59:43.630747,IL,אינובמד,,107.1596007,90.81322494,67.51912635,,,VARDENAFIL INOVAMED 20 MG 4 TAB,22504,,24492,BLISTER ALU/PVC/PVDC,units,4.0,168 12 36000 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Vardenafil Inovamed to be effective, sexual stimulation is required. Not indicated for use by women",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8df89af-72f6-4141-980c-feee5a49430b.json
a8e43bf2-2a61-4f8d-9835-c1702f655324,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,5539,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:23:58.943032,IL,רקיט בנקיזר,,37.7954,32.03,nan,,7290000852973,STREPSILS SUGAR FREE LEMON 24 LOZENGES,10561,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a8e43bf2-2a61-4f8d-9835-c1702f655324.json
a91f45a0-8409-4db1-b7cc-824ba5473ac1,ZINNAT TABLETS 125 MG,prescription,J01DC02,CEFUROXIME,308,,,WHO ATC Classification,,ILS,tablets,CEFUROXIME AS AXETIL,2025-07-31T10:50:03.757141,IL,סנדוז,,42.92784304,36.379528,26.5544,,,ZINNAT 500MG 10TAB,26061,,7883,BLISTER ALUMINIUM,units,10.0,041 40 25801 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Zinnat is indicated for the treatment of the infections listed below in adults and children from the age of 3 months .• Acute streptococcal tonsillitis and pharyngitis.• Acute bacterial sinusitis.• Acute otitis media.• Acute exacerbations of chronic bronchitis.• Cystitis.• Pyelonephritis.• Uncomplicated skin and soft tissue infections. •Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a91f45a0-8409-4db1-b7cc-824ba5473ac1.json
a929a7dc-9939-4556-91b0-53e04fc32990,HALDOL 2 MG/ML DROPS,prescription,N05AD01,HALOPERIDOL,7314,,,WHO ATC Classification,,ILS,solution  (oral),HALOPERIDOL/ML,2025-07-31T03:42:36.588336,IL,כ.צ.ט,,29.90257352,25.341164,18.4972,,7290014577305,HALOPER 10MG 60TAB,8033,,53285,BOTTLE LDPE,units,60.0,029 70 25163 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"HALDOL is indicatedin adult patients aged 18 years and above for:•	Treatment of schizophrenia and schizoaffective disorder.•	Acute treatment of delirium when non-pharmacological treatments have failed.•	Treatment of moderate to severe manic episodes associated with bipolar I disorder when other treatments cannot be used.•	Treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar I disorder.•	Treatment of persistent aggression and psychotic symptoms in patients with moderate to severe Alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.•	Treatment of tic disorders, including Tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.•	Treatment of mild to moderate chorea in Huntington’s disease, when other medicinal products are ineffective or not tolerated.In paediatric patients for:•	Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.•	Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated.  •	Tic disorders, including Tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a929a7dc-9939-4556-91b0-53e04fc32990.json
a9384227-4717-4d4d-a84d-9c41fe5a6119,SALAZOPIRIN-EN 100TAB,prescription,,,1227,,,,,ILS,tablet,SALAZOPIRIN-EN,2025-07-31T19:31:07.003101,IL,פיזר,,53.28123413,45.15359025,32.958825,,,SALAZOPIRIN-EN 100TAB,19427,,1937,,units,100.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9384227-4717-4d4d-a84d-9c41fe5a6119.json
a93d109e-9923-4227-82c7-c73044593ca1,COTELLIC,prescription,,,7804,,,,,ILS,film coated tablets,COBIMETINIB AS HEMIFUMARATE,2025-07-31T01:32:02.564106,IL,רוש,,24936.8406,21132.91671,19211.74246,,7290014774032,COTELLIC 20 MG 63 F.C.TAB,,,77816,BLISTER PVC/PVDC,units,63.0,156 38 34546 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Cotellic is indicated for use in combination with vemurafenib for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.Cotellic as a single agent, is indicated for the treatment of adult patients with histiocytic neoplasms.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a93d109e-9923-4227-82c7-c73044593ca1.json
a93ff585-0d8e-40a5-aca6-47e28261b2de,KANJINTI 420 MG,prescription,L01XC03,TRASTUZUMAB,8971,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,TRASTUZUMAB/VIAL,2025-07-31T04:23:05.866392,IL,מדיסון,,4395.045268,3724.614799,3386.013454,,8715131022181,KANJINTI 420 MG,,,60698,VIAL GLASS TYPE I,units,1.0,164 57 36491 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Metastatic breast cancer (MBC)KANJINTI is indicated for the treatment of patients with metastatic breast cancer who have tumors that overexpress HER2;1. As a single agent, for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease.2. In combination with Paclitaxel or Docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease.3. In combination with an aromatase inhibitor for the treatment of postmenopausal patient with hormone-receptor positive metastatic breast cancer.Early breast cancer (EBC)KANJINTI is indicated to treat patients with HER2 positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding anthracyclines.Kanjinti should only be used in patients whose tumors have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay.HER2 Metastatic gastric cancer (MGC)KANJINTI in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with HER2-positive metastatic adenocarcinoma of the stomach or gastroesophageal junction who have not received prior anti-cancer treatment for their metastatic disease.KANJINTI should only be used in patients with metastatic gastric cancer (MGC) whose tumours have HER2 overexpression as defined by IHC 2+ and a confirmatory FISH+ result, or IHC 3+, as determined by an accurate and validated assay.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a93ff585-0d8e-40a5-aca6-47e28261b2de.json
a947fdde-e92d-4b59-8cf1-c9c10ca8806b,AUGMENTIN SUSPENSION 400 MG/5 ML,prescription,J01CR02,AMOXICILLIN AND ENZYME INHIBITOR,3818,,,WHO ATC Classification,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM SALT 11.4 MG/ML, AMOXICILLIN AS TRIHYDRATE/ML",2025-07-30T23:31:21.350212,IL,ג.ס.ק,,14.3885483,12.193685,8.9005,,7290010140121,AUGMENTIN 400MG SUSP 35ML,1612,,69743,BOTTLE GLASS TYPE III,units,35.0,112 75 29288 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Augmentin is indicated for the treatment of the following infections in adults and children: • Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.• Recurrent tonsillitis",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a947fdde-e92d-4b59-8cf1-c9c10ca8806b.json
a95a4c81-5f52-4f0c-ace1-63653352c539,OCSAAR 50 MG,prescription,C09CA01,LOSARTAN,6639,,,WHO ATC Classification,,ILS,tablets,LOSARTAN POTASSIUM,2025-07-31T04:55:35.791149,IL,כ.צ.ט,,25.59546614,21.691073,15.8329,,,LOSARTAN 50MG 30TAB,12405,,21066,BLISTER PVC/PE/PVDC,units,30.0,122 79 28344 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hypertension: Ocsaar  50 mg  is indicated for the treatment of hypertensionHeart failure: Ocsaar  50 mg is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ACE inhibitor is not appropriate.Switching patients with heart failure who are stable on an ACE inhibitor to Ocsaar  50 mg is not recommended.Renal protection in Type-2 diabetic patients with proteinuria: Ocsaar 50 mg is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Ocsaar 50 mg is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.The benefit of Ocsaar 50 mg on the primary deposite endpoint was largely driven by reduction in the risk of stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a95a4c81-5f52-4f0c-ace1-63653352c539.json
a98ec3c2-4847-4d6c-965a-48ad4a9d2164,PHENIDIN 18 MG,prescription,N06BA04,METHYLPHENIDATE,8341,,,WHO ATC Classification,,ILS,tablets prolonged release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T06:40:18.477376,IL,תרימה,,233.7339737,198.0796388,158.463711,,,PHENIDIN 54 MG 30 SR TAB,10596,,51733,BOTTLE HDPE,units,30.0,161 08 35114 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a98ec3c2-4847-4d6c-965a-48ad4a9d2164.json
a9930800-8abc-4bd7-a438-1fe31f85268d,BRIVIACT 10 MG FILM COATED TABLETS,prescription,N03AX23,BRIVARACETAM,8362,,,WHO ATC Classification,,ILS,film coated tablets,BRIVARACETAM,2025-07-30T23:44:14.757839,IL,ניאופרם,,409.6748493,347.1820911,295.4741201,,,BRIVIACT 25 MG 56 TABLETS,2625,,64860,BLISTER PVC/PCTFE/AL,units,56.0,159 88 35241 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9930800-8abc-4bd7-a438-1fe31f85268d.json
a9996f3b-08e9-4ff1-9727-b5ecba7886c2,REFIXIA 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,9240,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,NONACOG BETA PEGOL/VIAL,2025-07-31T07:20:25.850855,IL,נובו נורדיסק,,3447.103435,2921.274227,2655.703843,,,REFIXIA 500 IU 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,172 35 37303 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in pretreated patients with haemophilia B (congenital factor IX deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9996f3b-08e9-4ff1-9727-b5ecba7886c2.json
a9c391f1-c7a0-4cba-a9d0-c9d12a8d6885,KIOVIG 100 MG/ML,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7134,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/",2025-07-31T04:26:45.796215,IL,טקדה,,3053.778557,2587.948044,2352.68004,,7290018375280,KIOVIG 10G/100ML VIAL,11297,,37084,VIAL GLASS TYPE I,units,100.0,146 45 33157 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"IVIg can be used in all age ranges, unless otherwise specified below.Replacement therapy in:Primary immunodeficiency syndromes with impaired antibody production.Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.Children and adolescents (age 0-18) with congenital AIDS and recurrent bacterial infections.Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).ImmunomodulationPrimary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.Guillain Barré syndrome.Kawasaki disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9c391f1-c7a0-4cba-a9d0-c9d12a8d6885.json
a9e1289f-840c-4308-8f1e-0f965b0cd6b2,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1818,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:49:57.777490,IL,פישר,,25.2048,21.36,nan,,7290000849188,POLYDINE CLEANSER 200CC,16610,,,BOTTLE HDPE,units,200.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9e1289f-840c-4308-8f1e-0f965b0cd6b2.json
a9e1b6a9-d990-4526-9a6f-418ddc2cce2a,BEPANTHEN PLUS,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5592,,,WHO ATC Classification,,ILS,cream,"DEXPANTHENOL, CHLORHEXIDINE DIHYDROCHLORIDE 0.5 %",2025-07-31T11:17:27.231093,IL,באייר,,95.4384,80.88,nan,,7290008905398,BEPANTHEN PLUS CR 5% 100GR,,,,TUBE ALUMINIUM,units,100.0,127 48 26501 01,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Antiseptic healing treatment of wounds of any kind with an infection risk : such as slight skin irritations, wounds, cuts, burns and skin inflammation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9e1b6a9-d990-4526-9a6f-418ddc2cce2a.json
a9ed6cbf-8278-42c5-b710-a1d0d503d684,GANFORT,prescription,S01ED01,TIMOLOL,6663,,,WHO ATC Classification,,ILS,"eye drops, solution","BIMATOPROST 0.3  MG/ML, TIMOLOL AS MALEATE/ML",2025-07-31T03:27:38.832284,IL,אב-וי,,52.31551296,44.33518047,32.3614456,,7290008127479,GANFORT 3ML EYE DROPS,12445,,23572,BOTTLE LDPE,units,3.0,143 64 31608 01,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9ed6cbf-8278-42c5-b710-a1d0d503d684.json
a9f598de-035f-4769-9c62-2675ce55cb4f,INTELENCE 100 MG,prescription,J05AG04,ETRAVIRINE,6394,,,WHO ATC Classification,,ILS,tablets,ETRAVIRINE,2025-07-31T04:09:17.706906,IL,יאנסן סילג,,1754.628413,1486.973298,1265.50919,,7290008099332,INTELENCE 100MG 120 TAB,9338,,83838,BOTTLE HDPE,units,120.0,141 29 31789 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Intelence is indicated in combination with other antiretroviral medicinal products  for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients  including those with non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance.  Treatment history and when available  resistance testing  should guide the use of Intelence. In patients who have experienced virological failure on an NNRTI- and nucleoside or nucleotide reverse transcriptase inhibitor (N[t]RTI) - containing regimen  Intelence is not recommended for use in combination with N(t)RTIs only.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9f598de-035f-4769-9c62-2675ce55cb4f.json
a9f7bba9-7632-4718-befd-ea5a1a8c34ea,RISEDRONATE S.K.,prescription,M05BA07,RISEDRONIC ACID,8125,,,WHO ATC Classification,,ILS,tablets,RISEDRONIC ACID AS SODIUM HEMIPENTAHYDRATE,2025-07-31T07:37:13.299120,IL,SK PHARM(KS KIM),,nan,nan,nan,,7290016845037,RISEDRONATE S.K. 1 TABLET,18588,,11868,BLISTER PVC/ALUMINIUM,units,1.0,159 63 34827 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of postmenopausal osteoporosis. Prevention of postmenopausal osteoporosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/a9f7bba9-7632-4718-befd-ea5a1a8c34ea.json
aa219206-070a-4ee8-8106-2bcf99a11d4c,FLEBOGAMMA 5 % DIF,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7149,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T03:07:22.775787,IL,מדיצ'י,,3163.527229,2680.955398,2437.23218,,,FLEBOGAMMA 5% 200ML VIAL,6559,,74379,BOTTLE GLASS TYPE II,units,200.0,121 04 29877 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Replacement therapy in:Primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- Wiskott Aldrich syndromeMyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.Children with congenital AIDS and recurrent infections.Immunomodulation :Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.Guillain Barré Syndrome.Kawasaki disease.Allogeneic bone marrow transplantation",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa219206-070a-4ee8-8106-2bcf99a11d4c.json
aa358f79-5163-438f-b0c7-1c3b352ba695,LEVEMIR,prescription,A10AE05,INSULIN DETEMIR,4811,,,WHO ATC Classification,,ILS,solution for injection,INSULIN DETEMIR 100 U/ML,2025-07-31T04:42:35.358361,IL,נובו נורדיסק,,272.3340774,230.7916013,184.633281,,7290008126960,LEVEMIR FLEXPEN CART 5X3ML,12331,,61840,CARTRIDGE GLASS TYPE I,units,15.0,132 40 31119 00,valid,25.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa358f79-5163-438f-b0c7-1c3b352ba695.json
aa404808-7c01-4c96-a403-a07df7a8cbfd,PIPERACILLIN/ TAZOBACTAM PANPHARMA 4G/500MG,prescription,J01CG02,TAZOBACTAM,7967,,,WHO ATC Classification,,ILS,powder for solution for infusion,"PIPERACILLIN AS SODIUM, TAZOBACTAM AS SODIUM",2025-07-31T06:44:16.065346,IL,פארמלוג'יק,,515.6196617,436.965815,371.8858,,7290006676269,PIPERACILLIN/ TAZOBACTAM PANPHARMA 4G/500MG 10 VIAL,16892,,38445,VIAL GLASS TYPE I,units,10.0,148 38 33136 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Pipoeracillin/tazobactam in combination with an aminoglycoside is indicated for suspected bacterial infections in neutropenic adults or children above 2 years .  Appencicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa404808-7c01-4c96-a403-a07df7a8cbfd.json
aa467afe-6a28-4af9-8485-ed767ccafd0f,DORMINOL NIGHT,off-the-counter,N05CM09,VALERIAN,5455,,,WHO ATC Classification,,ILS,film coated tablets,"HOP CONES DRY EXTRACT, VALERIAN ROOT DRY EXTRACT 187.5  MG",2025-07-31T11:33:44.056024,IL,ניאופרם,,49.7252,42.14,nan,,7290012851858,DORMINOL NIGHT 20 tab,,,,BLISTER PVC/ALUMINIUM,units,20.0,149 40 33542 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Herbal medicinal product for  problems falling asleep and staying asleep, as well as restless sleep.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa467afe-6a28-4af9-8485-ed767ccafd0f.json
aa4b85f1-98c2-4e4c-a7ee-b24da3978969,PRIVIGEN,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7137,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/L",2025-07-31T06:57:26.585210,IL,סי אס אל,,1630.995365,1382.199524,1176.34002,,,PRIVIGEN 5G/50ML VIAL,16919,,40633,BOTTLE GLASS TYPE I,units,50.0,146 46 33254 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Replacement therapy in• Primary immunodeficiency syndromes (PID) such as:  – congenital agammaglobulinaemia and hypogammaglobulinaemia  – common variable immunodeficiency  – severe combined immunodeficiency  – Wiskott-Aldrich syndrome• Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections• Children with congenital AIDS and recurrent infectionsImmunomodulation• Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count• Guillain-Barré syndrome• Kawasaki disease• Chronic inflammatory demyelinating polyneuropathy (CIDP)Allogeneic bone marrow transplantation,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa4b85f1-98c2-4e4c-a7ee-b24da3978969.json
aa4e8669-f3f5-4fd6-9138-5c496c23567e,ELETRIPTAN - TRIMA 40 MG,prescription,N02CC06,ELETRIPTAN,8056,,,WHO ATC Classification,,ILS,film coated tablets,ELETRIPTAN AS HYDROBROMIDE,2025-07-31T02:14:09.312994,IL,תרימה,,nan,nan,nan,,,ELETRIPTAN - TRIMA 80 MG 3 TAB,5621,,58069,BLISTER ALUMINIUM /ALUMINIUM,units,3.0,159 03 34741 00,valid,nan,per os,1.4,30,,,,,,,,,,0,Prescription required,"Acute treatment of the headache phase of migraine attacks, with or without aura",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa4e8669-f3f5-4fd6-9138-5c496c23567e.json
aa50eba8-50a5-474c-a060-b65c017042c6,EXELON PATCH 10,prescription,N06DA03,RIVASTIGMINE,3633,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 9.5 MG/DAY,2025-07-31T02:47:36.028327,IL,נוברטיס פארמה,,70.84417625,60.0374375,44.6375,,,EXELON 1.5MG 28CAPS,5117,,85368,POUCH PAPER/PET/PE/AL/POLYAMIDE,units,28.0,139 70 31675 01,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa50eba8-50a5-474c-a060-b65c017042c6.json
aa680f27-5176-49dd-8c45-483e0b8ce485,LIBTAYO,prescription,L01XC33,CEMIPLIMAB,8512,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,CEMIPLIMAB/ML,2025-07-31T04:45:58.314080,IL,מדיסון,,26530.6009,22483.56108,20439.60099,,3664798033717,LIBTAYO 50 MG/1 ML (1 VIAL) 7ML,12563,,51656,VIAL GLASS TYPE I,units,1.0,164 99 36023 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"CCutaneous Squamous Cell CarcinomaLIBTAYO as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation. Basal Cell CarcinomaLIBTAYO as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (laBCC or mBCC) who have progressed on or are intolerant to a hedgehog pathway inhibitor (HHI).Non-Small Cell Lung CancerLIBTAYO as a single agent is indicated for the first-line treatment of adult patients with NSCLC whose tumors have high PD-L1 expression [Tumor Proportion Score (TPS) &#8805; 50%] as determined by an approved test, with no EGFR, ALK or ROS1 aberrations, and is:•	locally advanced where patients are not candidates for surgical resection or definitive chemoradiation or •	metastatic.LIBTAYO in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with non-small cell lung cancer (NSCLC) expressing PD-L1 (in &#8805; 1% of tumour cells), with no EGFR, ALK or ROS1 aberrations and is:•	locally advanced where patients are not candidates for surgical resection or definitive chemoradiation or•	metastatic.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa680f27-5176-49dd-8c45-483e0b8ce485.json
aa682e1f-4baa-4d93-a20c-8b14327ec761,INSTILLAGEL,off-the-counter,C01BB01,LIDOCAINE,5162,,,WHO ATC Classification,,ILS,gel,"CHLORHEXIDINE DIGLUCONATE 0.5  MG /, LIDOCAINE HYDROCHLORIDE 20.0  MG /",2025-07-31T13:21:30.272887,IL,טבע,,38.7158,32.81,nan,,,STILLA SINGLES 20*0.3ML,19803,,,SYRINGE POLYPROPYLENE,units,20.0,160 11 35080 00,valid,nan,"urethral, vaginal",1.4,36,,,,,,,,,,0,,"Local anesthesia prior exploration in urology (ureteroscopy, cystoscopy, urethral dilation, catheterization). For use during gynaecological investigation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa682e1f-4baa-4d93-a20c-8b14327ec761.json
aa74947c-9ac8-4637-b448-ce1c19272164,MORPHINE MARTINDALE 10 MG/ML,prescription,N02AA01,MORPHINE,8953,,,WHO ATC Classification,,ILS,solution for injection,MORPHINE SULFATE/,2025-07-31T05:32:04.217281,IL,אמ.בי.איי פארמה,,36.20688351,30.68380095,22.396935,,,MORPHINE MARTINDALE 10 MG/ML 10AMP,,,88395,AMPOULES GLASS TYPE I,units,10.0,163 86 35125 00,valid,37.0,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Symptomatic relief of moderate to severe pain especially that associated with neoplastic disease myocardial infarction and surgery.Pre-operatively as an adjunct to anesthesia for pain relief and to allay anxiety.Alleviation of the anxiety associated with severe pain. It is useful as a hypnotic wheresleeplessness is due to pain., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa74947c-9ac8-4637-b448-ce1c19272164.json
aa8c448c-013a-4f3b-8a52-b862a5f96101,LAMODEX 100 MG DISPERSIBLE/CHEWABLE TABLETS,prescription,N03AX09,LAMOTRIGINE,4721,,,WHO ATC Classification,,ILS,dispersible/chewable tablets,LAMOTRIGINE,2025-07-31T04:33:25.065706,IL,דקסל פארמה,,66.07271881,55.9938295,41.6311,,,LAMODEX 100MG 30 DISP/CHEW TAB,12311,,60143,BLISTER ACLAR/PVC/ALUMINIUM,units,30.0,129 88 30814 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy • Adults and adolescents aged 13 years and above:   - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.   - Seizures associated with Lennox-Gastaut syndrome. Lamodex is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome. • Children and adolescents aged 2 to 12 years:   - Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.   - Monotherapy of typical absence seizures.Bipolar disorder • Adults aged 18 years and above   - Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamodex is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa8c448c-013a-4f3b-8a52-b862a5f96101.json
aa8cc0e4-0b89-444c-b1fa-80bfe0a13cc2,MIDOLAM 1 MG/ML,prescription,N05CD08,MIDAZOLAM,6228,,,WHO ATC Classification,,ILS,solution for injection,MIDAZOLAM/ML,2025-07-31T05:22:23.931273,IL,רפא,,23.2555993,19.708135,14.3855,,7290017179353,MIDOLAM 5MG/ML5AMPx3ML,13434,,35294,AMPOULES GLASS TYPE I,units,5.0,108 42 29066 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,midazolam is a short-acting sleep-inducing drug that is indicated:In adults• CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia• ANAESTHESIA- Premedication before induction of anaesthesia- Induction of anaesthesia- As a sedative component in combined anaesthesia• SEDATION IN INTENSIVE CARE UNITSIn children• CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia• ANAESTHESIA- Premedication before induction of anaesthesia• SEDATION IN INTENSIVE CARE UNITS,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa8cc0e4-0b89-444c-b1fa-80bfe0a13cc2.json
aa914482-1df5-4e91-9416-e173ca34549d,ALCON AZOPT 1%   DROPS 5ML,prescription,,,4004,,,,,ILS,drops,ALCON AZOPT 1% DROPS,2025-07-31T18:58:30.973338,IL,נוברטיס פארמה,,31.43837122,26.64268747,19.44721713,,,ALCON AZOPT 1%   DROPS 5ML,1611,,22441,,units,5.0,,not-registered,37.0,ophthalmic,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa914482-1df5-4e91-9416-e173ca34549d.json
aa94b65d-5398-471c-b35f-33eb454716ca,DEFERASIROX TEVA ® 125 MG,prescription,V03AC03,DEFERASIROX,8380,,,WHO ATC Classification,,ILS,tablets dispersible,DEFERASIROX,2025-07-31T01:45:02.047499,IL,טבע,,2215.159517,1877.253828,1597.662833,,,DEFERASIROX TEVA  250 MG 30 TAB  DISPERSIBLE,,,59869,BLISTER PVC/PE/PVDC/PE/PVC/ALUMINIUM,units,30.0,161 12 34651 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Deferasirox Teva is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in adult and pediatric patients (aged 2 years and over). Deferasirox Teva is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC] &#8805;5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 μg /l).LIC is the preferred method of iron overload determination and should be used wherever available.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aa94b65d-5398-471c-b35f-33eb454716ca.json
aaaa0d42-ef4c-44de-88c7-a46c056c9c37,RAFASSAL 4 GRAM ENEMA,prescription,A07EC02,MESALAZINE,3019,,,WHO ATC Classification,,ILS,enema,MESALAZINE/,2025-07-31T07:14:20.243113,IL,רפא,,109.89168,93.12854648,69.240555,,7290008013765,RAFASSAL 1GR 30TAB,18071,,9126,BOTTLE POLYETHYLENE,units,30.0,029 58 25321 00,valid,34.5,rectal,1.4,18,,,,,,,,,,0,Prescription required,Treatment and prevention of ulcerative colitis and Crohn's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aaaa0d42-ef4c-44de-88c7-a46c056c9c37.json
aab777f0-a9da-4877-98a7-e03b3042727b,BREXIN TABLETS,prescription,M02AA07,PIROXICAM,6027,,,WHO ATC Classification,,ILS,tablets,PIROXICAM AS BETA-CYCLODEXTRIN,2025-07-30T23:42:54.654883,IL,תרו יבוא,,23.68897584,20.07540414,14.65357967,,,BREXIN 20MG 20TAB,2468,,5853,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,136 61 29695 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Piroxicam is indicated for symptomatic relief of osteoarthritis  rheumatoid arthritis or ankylosing spondylitis.   When an NSAID is indicated piroxicam should be considered as a second line option. The desicion to prescribe piroxocam should be based on an assesment of the individual's patient overall risk.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aab777f0-a9da-4877-98a7-e03b3042727b.json
aae02d5b-c15d-4234-825c-df089c705fd8,GLIVEC ® 400 MG,prescription,L01XX28,IMATINIB,4854,,,WHO ATC Classification,,ILS,film coated tablets,IMATINIB AS MESYLATE,2025-07-31T03:36:02.274445,IL,נוברטיס פארמה,,3673.604922,3113.22451,2830.2041,,,GLIVEC 100MG 60 FCTAB,7708,,62801,BLISTER PVC,units,60.0,129 92 30790 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Glivec is indicated for the treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia (Ph+ -CML) in chronic phase  accelerated phase or blast crisis. Glivec is also indicated for the treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST).   Glivec is also indicated for the treament of :   * Adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) integrated with chemotherapy. * Adult patients with relapsed or refractory Ph + ALL as monotherapy.   * Adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.   * Adult patients with myelodyspiastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet - derived growth factor receptor ) gene re- arrangements.   * Adult patients with hypereosinophilic syndrome (HES) and/or  chronic eosinophilic leukaemia (CEL) who have the FIP1L1- PDGFRalfa fusion kinase (mutational analysis or FISH demonstration for CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFR alfa fusion kinase negative.  * Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-kit mutation. * Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aae02d5b-c15d-4234-825c-df089c705fd8.json
ab08b124-8297-4781-88a7-74f4a796462e,WELLBUTRIN XR 150 MG,prescription,N07BA02,BUPROPION,6240,,,WHO ATC Classification,,ILS,modified release tablets,BUPROPION HYDROCHLORIDE,2025-07-31T10:25:52.248293,IL,ג.ס.ק,,74.89420533,63.46966835,47.1893445,,7290010140374,WELLBUTRIN XR 150MG 30 TABLETS,23067,,78652,BOTTLE HDPE,units,30.0,140 05 31653 00,valid,34.5,per os,1.4,18,,,,,,,,,,0,Prescription required,"Wellbutrin XR is indicated for the treatment of major depressive episodes.Following satisfactory response, continuation with Wellbutrin XR therapy is effective in preventingrelapse.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab08b124-8297-4781-88a7-74f4a796462e.json
ab0be4d9-cbdd-4e6d-85b1-0793a1b9150d,GAZIM X,off-the-counter,,,5119,,,,,ILS,tablets,SIMETHICONE,2025-07-31T11:59:45.669653,IL,כ.צ.ט,,40.238,34.1,nan,,7290008104944,GAZIM X 30TAB,,,,BOTTLE GLASS TYPE III,units,30.0,131 13 30853 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiflatulence.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab0be4d9-cbdd-4e6d-85b1-0793a1b9150d.json
ab376f63-b287-4a48-a508-3ef3005a9087,OXERVATE 20 MCG/ML 7 VIAL,prescription,,,8523,,,,,ILS,injection,OXERVATE 20 MCG/ML,2025-07-31T19:26:47.925537,IL,מינד פארמה אירופה,,533605.2829,452207.8869,411098.079,,,OXERVATE 20 MCG/ML 7 VIAL,,,,,units,7.0,,not-registered,10.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab376f63-b287-4a48-a508-3ef3005a9087.json
ab3cdec6-4575-4938-a505-51deba3c1974,GILENYA 0.5 MG,prescription,L04AA27,FINGOLIMOD,8013,,,WHO ATC Classification,,ILS,"capsule, hard",FINGOLIMOD AS HYDROCHLORIDE 0.5  MG,2025-07-31T03:04:48.180230,IL,טבע,,9623.124731,8155.19045,7413.8095,,,FINGOLIMOD TEVA 0.5MG 30 CAPS,,,62334,BLISTER PVC/PVDC,units,30.0,145 78 33270 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Gilenya is indicated for the treatment of patients with relapsing forms of  multiple sclerosis ( MS )  to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab3cdec6-4575-4938-a505-51deba3c1974.json
ab3cef6c-b713-4842-a98f-48c1c9b198be,ISOVENIR 10 MG,prescription,D10BA01,ISOTRETINOIN,9397,,,WHO ATC Classification,,ILS,"capsule, soft",ISOTRETINOIN,2025-07-31T04:13:14.836086,IL,ביואבניר,,63.74333214,54.019773,40.1634,,,ISOVENIR 10 MG 30 CAPS,,,15529,BLISTER ALU/PVC/TE/PVDC,units,30.0,174 46 36774 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Isovenir is indicated for the treatment of severe cystic acne that does not respond to other treatment,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab3cef6c-b713-4842-a98f-48c1c9b198be.json
ab41d4ae-6008-4baf-96a0-75b043c97b98,DESERNIL 1.65MG 20TAB,29C,,,20364,,,,,,tablet,DESERNIL 1.65MG,2025-07-31T20:13:39.674789,IL,nan,,,,,,,DESERNIL 1.65MG 20TAB,,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab41d4ae-6008-4baf-96a0-75b043c97b98.json
ab70025f-376c-4e48-9262-ba0213ad509d,GONAL-F,prescription,G03GA05,FOLLITROPIN ALFA,6543,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN ALFA/ML,2025-07-31T03:38:35.097259,IL,מרק סרונו,,626.8085455,531.1937063,452.07975,,7290000845364,GONAL-F 600IU/ML PREFILLED PEN 0.75ML (450 IU),7657,,10865,PRE-FILLED PEN GLASS TYPE I,units,1.0,131 55 31061 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"In adult women: • Anovulation (including polycystic ovarian disease, PCOD) in women who have been unresponsive to treatment with clomiphene citrate. • Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). • Follitropin alfa in association with a luteinising hormone (LH) preparation is indicated for the stimulation of follicular development in women with severe LH and FSH deficiency. In adult men: • Follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human Chorionic Gonadotrophin (hCG) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab70025f-376c-4e48-9262-ba0213ad509d.json
ab71657b-620b-43c8-8c53-9e6c9d6f076c,DEXAMETHASONE ROMPHARM 4 MG/ML,prescription,H02AB02,DEXAMETHASONE,8820,,,WHO ATC Classification,,ILS,solution for injection / infusion,DEXAMETHASONE PHOSPHATE (AS SODIUM)/,2025-07-31T01:52:43.919040,IL,מדי מרקט,,78.22734113,66.29435689,49.28948467,,,DEXAMETHASONE ROMPHARM 4 MG/ML 10 AMP 1ML,,,66010,AMPOULES GLASS TYPE I,units,10.0,166 10 35702 00,valid,34.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Dexamethasone Rompharm is indicated in the treatment of:• Endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.• Allergy: Severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.• Ophtalmic: Serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.• Inflammatory Bowel dis.: Systemic treatment in exacerbations of ulcerative colitis and regional enteritis.• Dermatological diseases (pemphigus, Stevens Johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) • Respiratory diseases (symptomatic sarcoidosis, berylliosis, Loeffler's syndrome)• Haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura, pure red cell aplasia• Nephrotic syndrome of the idioplathic type or that due to lupus erythematosus• Cerebral edema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis• Collagen diseases: Active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, Juvenile idiopathic arthritis with severe systemic-onset form (Still's disease) or locally with no control, rheumatic fever with carditis, dermatomyositis, polymyositis, SLE, temporal arteritis.• Infectious Diseases: Bacterial meningitis – adjunct to antibiotics in suspected Pneumococcal meningitis and TB meningitis. Severe infectious diseases with toxic states (eg tuberculosis, typhoid, brucellosis;. Only with simultaneous anti-infective therapy)• Fetal lung maturation• Chemotherapy – associated nausea and vomiting• Multiple Myeloma – part of chemotherapy protocols (eg VAD)• Prevention and treatment of acute mountain sickness/HACE",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab71657b-620b-43c8-8c53-9e6c9d6f076c.json
ab812327-a986-45f6-a091-6199adc6deb9,XANAGIS 0.25 MG,prescription,N05BA12,ALPRAZOLAM,2792,,,WHO ATC Classification,,ILS,tablets,ALPRAZOLAM 0.25   MG,2025-07-31T10:28:23.905524,IL,פאדאגיס,,26.16192278,22.171121,16.1833,,,XANAGIS 0.50MG 50TAB,24017,,8889,BLISTER PVC/PVDC,units,50.0,063 48 26906 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of anxiety accompanied by depression. Treatment of panic states with or without accompanying phobia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab812327-a986-45f6-a091-6199adc6deb9.json
ab8b7261-e512-41af-812f-80fef3dcbc1c,LYRICA 100 MG,prescription,N03AX16,PREGABALIN,7044,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T05:01:22.811377,IL,דקסל פארמה,,192.65624,163.268,130.6144,,,LYRICA 225MG 56 CAPS,12478,,36627,BLISTER PVC,units,56.0,133 01 31188 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,LLyrica is indicated for the:- Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia.- Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab8b7261-e512-41af-812f-80fef3dcbc1c.json
ab96577e-cd3a-43c3-9277-74da920ae11a,LEVETIRACETAM DEXCEL 1000,prescription,N03AX14,LEVETIRACETAM,8084,,,WHO ATC Classification,,ILS,tablets,LEVETIRACETAM,2025-07-31T04:43:34.171547,IL,דקסל פארמה,,147.6547375,125.1311335,93.0343,,,LEVETIRACETAM DEXCEL 500MG 60 TABLETS,12428,,64801,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,149 66 33514 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and    adolescents from 12 years of age with Idiopathic Generalised Epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ab96577e-cd3a-43c3-9277-74da920ae11a.json
aba6d42f-044b-4c08-8b69-b2fa4f513432,HISTAFED,off-the-counter,R06AX07,TRIPROLIDINE,2189,,,WHO ATC Classification,,ILS,film coated tablets,"PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE HYDROCHLRIDE 2.5  MG",2025-07-31T12:04:22.412670,IL,תרימה,,21.1692,17.94,nan,,,HISTAFED 20 DRAG,8049,,,BLISTER ALUMINIUM /ALUMINIUM,units,20.0,027 94 21825 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the symptomatic relief of congestion such as rhinitis and associated allergic conditions.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aba6d42f-044b-4c08-8b69-b2fa4f513432.json
abaa4476-00f9-4a36-8cde-2829b802a7c0,TABRECTA 150 MG,prescription,L01EX17,CAPMATINIB,9133,,,WHO ATC Classification,,ILS,film coated tablets,CAPMATINIB AS DIHYDROCHLORIDE MONOHYDRATE,2025-07-31T08:56:50.505440,IL,נוברטיס פארמה,,42609.32758,36109.60125,32826.91023,,,TABRECTA 150 MG 120 TAB,17959,,18204,BLISTER PVC/PCTFE/AL,units,120.0,169 19 36653 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,TABRECTA is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an approved test.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/abaa4476-00f9-4a36-8cde-2829b802a7c0.json
abc02a0a-c132-4e92-8fc7-6c202eca2236,FOMICYT 2 G.,prescription,J01XX01,FOSFOMYCIN,9458,,,WHO ATC Classification,,ILS,powder for solution for infusion,FOSFOMYCIN AS SODIUM/VIAL,2025-07-31T03:15:47.414416,IL,צמל,,1601.910031,1357.550934,1155.362497,,,FOMICYT 4 G 10 VIALS,,,19095,VIAL GLASS TYPE I,units,10.0,173 51 37318 99,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveConsideration should be given to official guidance on the appropriate use of antibacterial agents.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/abc02a0a-c132-4e92-8fc7-6c202eca2236.json
abc259a0-0b08-4f55-a4fd-dbcf8d8e16a6,EVRA,prescription,G03AA13,NORELGESTROMIN AND ESTROGEN,4724,,,WHO ATC Classification,,ILS,patches,"NORELGESTROMIN/PATCH, ETHINYLESTRADIOL 0.6  MG/PATCH",2025-07-31T02:47:05.189085,IL,תרימה,,153.9220476,130.442419,104.3539352,,7290008099035,EVRA 9 PATCHES,5412,,12926,POUCH LAMINATED,units,9.0,130 21 30818 00,valid,25.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Female contraception. Evra is intended for women of fertile age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/abc259a0-0b08-4f55-a4fd-dbcf8d8e16a6.json
abcfcc18-6551-4cba-ae25-1f6b8f1f4c5f,DEXILANT 30 MG,prescription,A02BC06,DEXLANSOPRAZOLE,7912,,,WHO ATC Classification,,ILS,modified release capsules,DEXLANSOPRAZOLE,2025-07-31T01:53:26.608779,IL,טקדה,,373.495055,316.5212471,269.3797848,,,DEXILANT 60 MG 28  MR CAPS,4658,,48670,BLISTER PVC/PE/PCTFE/AL,units,28.0,155 45 34383 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Dexilant 30 is indicated in adults and in adolescents aged 12 to 17 years for the following:• Maintenance of healed erosive reflux oesophagitis and maintenance of relief of heartburn• Short-term treatment of heartburn and acid regurgitation associated with symptomatic non-erosive gastro-oesophageal reflux disease (GORD).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/abcfcc18-6551-4cba-ae25-1f6b8f1f4c5f.json
abe44af8-2593-4be0-98c2-4cc6caa580ac,PHENERGAN 50 MG/2 ML,prescription,R06AD02,PROMETHAZINE,8816,,,WHO ATC Classification,,ILS,solution for injection,PROMETHAZINE AS HYDROCHLORIDE/,2025-07-31T06:39:19.450826,IL,ביומד,,59.1465442,50.12419,36.587,,7290018609873,PHENERGAN 50 MG/2 ML 5 AMP,,,77729,AMPOULES GLASS TYPE I,units,5.0,167 08 35764 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Phenergan is indicated :As symptomatic treatment for allergic conditions of the upper respiratory tract and skin including allergic rhinitis, urticaria and anaphylactic reactions to drugs and foreign proteins.For sedation and treatment of insomnia in adults.As an adjunct in preoperative sedation in surgery and obstetrics.As a paediatric sedative. For prevention and control of nausea and vomiting associated with certain types of anaesthesia and surgery.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/abe44af8-2593-4be0-98c2-4cc6caa580ac.json
abfc21c1-3b5e-4a1a-80ab-5a333efbe697,ZOKINVY 50 MG,prescription,A16AX20,LONAFARNIB,9044,,,WHO ATC Classification,,ILS,hard gelatin capsules,LONAFARNIB,2025-07-31T10:52:46.013281,IL,ניאופרם,,149862.3838,127002.0258,115456.3871,,7290111098451,ZOKINVY 75 MG 30 CAPS,26231,,43139,BOTTLE HDPE,units,30.0,169 67 36861 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"ZOKINVY is indicated in patients 12 months of age and older with a body surface area (BSA) of0.39 m2 and above:To reduce the risk of mortality in Hutchinson-Gilford Progeria Syndrome (HGPS)• For the treatment of processing-deficient Progeroid Laminopathies with either:o Heterozygous LMNA mutation with progerin-like protein accumulationo Homozygous or compound heterozygous ZMPSTE24 mutationsLimitations of UseZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies. Based upon its mechanism of action, ZOKINVY would not be expected to be effective in these populations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/abfc21c1-3b5e-4a1a-80ab-5a333efbe697.json
ac167bd5-180f-454d-bc1a-983e324df697,NAGLAZYME,prescription,A16AB08,GALSULFASE,7081,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,GALSULFASE/ML,2025-07-31T05:39:08.053763,IL,מדיסון,,6789.17,5753.534154,5230.485594,,7290008128087,NAGLAZYME 1MG/ML VIAL 5ML,14552,,77106,VIAL GLASS TYPE I,units,1.0,143 48 31767 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Naglazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of MPSVI (N-acetylglactosamine 4 sulfatase deficiency  Maroteaux-Lamy syndrome).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac167bd5-180f-454d-bc1a-983e324df697.json
ac206b1e-4073-4b33-be5a-5137ef7e404d,RANIVISIO,prescription,S01LA04,RANIBIZUMAB,9543,,,WHO ATC Classification,,ILS,solution for injection,RANIBIZUMAB/,2025-07-31T07:16:30.051756,IL,דקסל פארמה,,1861.12567,1577.225214,1342.319331,,7290016121018,RANIVISIO 10 MG/ML,,,63055,VIAL GLASS TYPE I,units,1.0,176 24 37973 00,valid,17.5,intravitreal,1.4,36,,,,,,,,,,0,Prescription required,• For treatment of patients with neovascular (wet) age-related macular degeneration (AMD)• For treatment of adult patients with visual impairment due to diabetic macular oedema (DME)• For treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO)• For treatment of visual impairment due to choroidal neovascularization (CNV)• For treatment of proliferative diabetic retinopathy (PDR),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac206b1e-4073-4b33-be5a-5137ef7e404d.json
ac2f0fc7-ca71-4744-8d41-b0fd1b646f09,COLCHICINE 0.5 mg,prescription,M04AC01,COLCHICINE,1852,,,WHO ATC Classification,,ILS,tablets,COLCHICINE,2025-07-31T01:26:05.620404,IL,רפא,,61.53799364,52.15084439,38.773862,,7290008013307,COLCHICINE 0.5MG 30TAB,3201,,538,BLISTER PVC/ALUMINIUM,units,30.0,016 73 24811 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Prevention and treatment of gout and FMF (familial mediterranean fever).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac2f0fc7-ca71-4744-8d41-b0fd1b646f09.json
ac318e45-8931-4a78-b3f4-f5e0fec7ff61,TABRECTA 150 MG,prescription,L01EX17,CAPMATINIB,9134,,,WHO ATC Classification,,ILS,film coated tablets,CAPMATINIB AS DIHYDROCHLORIDE MONOHYDRATE,2025-07-31T08:57:02.266243,IL,נוברטיס פארמה,,42609.32758,36109.60125,32826.91023,,,TABRECTA 200 MG 120 TABS,17958,,18203,BLISTER PVC/PCTFE/AL,units,120.0,169 19 36653 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,TABRECTA is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an approved test.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac318e45-8931-4a78-b3f4-f5e0fec7ff61.json
ac412ffb-6ede-4e57-8dcb-a0579787dafe,ETORICOXIB - TRIMA 90 MG,prescription,M01AH05,ETORICOXIB,8193,,,WHO ATC Classification,,ILS,film coated tablets,ETORICOXIB,2025-07-31T02:42:20.797202,IL,תרימה,,45.16670944,38.27687241,27.93932293,,,ETORICOXIB TRIMA 90MG 14TABS,5645,,19625,BLISTER PVC/ALUMINIUM,units,14.0,160 59 35181 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Etoricoxib -  Trima 90 mg tablets are indicated for the symptomatic relief of rheumatoid arthritis (RA) and ankylosing spondylitis. For the short-term treatment of moderate pain associated with dental surgery.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac412ffb-6ede-4e57-8dcb-a0579787dafe.json
ac56dde8-c589-40f4-9885-013305587136,UNDECYL POWDER,off-the-counter,D01AE04,UNDECYLENIC ACID,5075,,,WHO ATC Classification,,ILS,powder,"UNDECENOIC ACID, ZINC UNDECENOATE",2025-07-31T13:32:44.330390,IL,רקח,,14.42,12.22,nan,,7290008090780,UNDECYL POWDER 30GR,21070,,,SECURITAINER HDPE,units,30.0,029 47 25330 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,Prophylaxis and treatment of mycotic skin infections particulary athlete's  foot.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac56dde8-c589-40f4-9885-013305587136.json
ac574eaf-45ff-43e5-ac43-5a2b798330f0,DICLOVIT,off-the-counter,M02AA15,DICLOFENAC,3757,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T11:33:03.359053,IL,ויטאמד,,41.35,35.04,nan,,7290008106313,DICLOVIT 1% 50GR,4293,,,TUBE ALUMINIUM,units,50.0,111 42 29399 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications:Local treatment of pain, inflammation and swelling due to: • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order:• Pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac574eaf-45ff-43e5-ac43-5a2b798330f0.json
ac5d3a04-4191-4821-a4fd-5cd3507e60ef,EPHEDRIN SINTETICA 50 MG/ML,prescription,R03CA02,EPHEDRINE,7939,,,WHO ATC Classification,,ILS,solution for injection,EPHEDRINE HYDROCHLORIDE/ML,2025-07-31T02:25:39.088005,IL,כ.צ.ט,,97.82246348,82.90039646,61.6359825,,7290016369113,EPHEDRIN SINTETICA 50 MG/ML  10 VIAL,,,,AMPOULES GLASS TYPE I,units,10.0,157 42 34407 00,valid,34.5,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Ephedrine Hydrochloride is used in the prevention and treatment of hypotension from spinal or epidural anaesthesia and during general anaesthesia, with or without a reduction in the heart rate, administered for a surgical or obstetric procedure.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac5d3a04-4191-4821-a4fd-5cd3507e60ef.json
ac7727c9-702a-4871-911a-8641a5c4fa46,FERRO 15 SYRUP,off-the-counter,B03AA02,FERROUS FUMARATE,3164,,,WHO ATC Classification,,ILS,syrup,FERROUS GLUCONATE/ML,2025-07-31T11:54:44.061853,IL,סם און,,42.5154,36.03,nan,,7290008080095,FERRO 15 SYR 120ML,6107,,,BOTTLE GLASS TYPE III,units,120.0,132 96 22885 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the treatment and prevention of anemic states and iron deficiency in infants.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac7727c9-702a-4871-911a-8641a5c4fa46.json
ac813b08-91cd-474b-bc99-5f02ddc35a45,BETACORTEN G OINTMENT,prescription,D07AC01,BETAMETHASONE,2171,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS VALERATE 0.1 %W/W, GENTAMICIN AS SULFATE 0.1 %W/W",2025-07-31T00:33:06.647397,IL,תרימה,,8.454818,7.1651,5.23,,,BETACORTEN OINT 15GR,2069,,341,TUBE ALUMINIUM,units,15.0,050 45 23262 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,For local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac813b08-91cd-474b-bc99-5f02ddc35a45.json
ac9032ba-e54a-4fbb-a29f-4d37943a8050,SYMBICORT TURBUHALER 160/4.5 MCG/DOSE,prescription,R03AK07,FORMOTEROL AND BUDESONIDE,4434,,,WHO ATC Classification,,ILS,powder for inhalation,"BUDESONIDE MICRONIZED/DOSE, FORMOTEROL FUMARATE 4.5 MCG/DOSE",2025-07-31T08:54:19.121284,IL,אסטראזנקה,,146.5232589,124.1722588,92.321382,,,SYMBICORT TURBUHAL 160/4.5MCG/DOSE 120DOSES,19916,,18413,METERED DOSE INHALER ,units,120.0,123 77 30317 00,valid,34.5,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"AsthmaSymbicort Turbuhaler 160/4.5 mcg/dose is indicated in adults and adolescents (12 years and older), for the treatment of asthma, to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations.Chronic Obstructive Pulmonary Disease (COPD)Symbicort Turbuhaler 160/4.5 mcg/dose is indicated in adults, aged 18 years and older, for the Symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV1) < 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac9032ba-e54a-4fbb-a29f-4d37943a8050.json
ac9f6ad6-fd4b-4740-a67b-e1c1d47ecae5,ASSIVAL 5 MG,prescription,N05BA01,DIAZEPAM,1469,,,WHO ATC Classification,,ILS,tablets,DIAZEPAM,2025-07-30T23:28:36.718383,IL,טבע,,17.13596,14.522,10.6,,,ASSIVAL 5MG 30TAB,1823,,20756,BLISTER PVC/ALUMINIUM,units,30.0,014 61 24381 03,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tension, anxiety, agitation due to acute alcohol withdrawal, adjunct for the relief of skeletal muscle spasm, convulsive disorders.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ac9f6ad6-fd4b-4740-a67b-e1c1d47ecae5.json
acb702d0-0cb6-473d-8a4c-c1b5e965149d,VYXEOS LIPOSOMAL,prescription,L01XY01,DAUNORUBICIN AND CYTARABINE,9041,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,"CYTARABINE/VIAL, DAUNORUBICIN AS HCL/VIAL",2025-07-31T10:25:04.974355,IL,מדיסון,,27649.63944,23431.89887,21301.72625,,,VYXEOS 100MG / 44MG 1 VIAL,,,43897,VIAL GLASS TYPE I,units,1.0,169 36 36917 99,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Vyxeos liposomal is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/acb702d0-0cb6-473d-8a4c-c1b5e965149d.json
acc77229-9d85-4c6f-8dd0-599d2c77e532,ANTICUDE  25MG/2ML  2AMP,29C,,,20963,,,,,,injection,ANTICUDE 25MG/,2025-07-31T19:54:48.669584,IL,nan,,,,,,,ANTICUDE  25MG/2ML  2AMP,,,,,units,2.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/acc77229-9d85-4c6f-8dd0-599d2c77e532.json
acdc17b6-d9b2-4e3a-bd98-f7a8f019aa67,BISOPROLOL FUMARATE INOVAMED 10 MG,prescription,C07AB07,BISOPROLOL,7690,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE,2025-07-31T00:39:13.924908,IL,אינובמד,,19.98877402,16.939639,12.3647,,,BISOPROLOL INOVAMED 10 MG 30 F.C.TAB,2579,,71858,BLISTER PVC/ALUMINIUM,units,30.0,152 68 34097 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.- Hypertension. - Coronary heart disease (angina pectoris).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/acdc17b6-d9b2-4e3a-bd98-f7a8f019aa67.json
acdf4211-1aaf-4668-a832-cb85f6dd1585,ANDROGEL 50 MG,prescription,G03BA03,TESTOSTERONE,4677,,,WHO ATC Classification,,ILS,gel,TESTOSTERONEW/W,2025-07-31T00:19:57.363251,IL,כ.צ.ט,,255.6754675,216.674125,173.3393,,7290008098144,ANDROGEL 50MG 30 SACH 5G,1679,,29965,SACHET ALUMINIUM/LDPE,units,30.0,141 18 30760 01,valid,25.0,transdermal,1.4,36,,,,,,,,,,0,Prescription required,Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/acdf4211-1aaf-4668-a832-cb85f6dd1585.json
ace3548a-0a1d-4d89-9d79-00e1958897d5,SANDOSTATIN ® 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,3723,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE 0.05  MG/ML,2025-07-31T08:00:18.320204,IL,נוברטיס פארמה,,2025.065037,1716.156888,1460.559053,,7298120012734,SANDOSTATIN LAR VIAL 30MG,19744,,62753,AMPOULES GLASS TYPE I,units,1.0,047 03 25697 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery.   Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery  or radiotherapy. Sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery  or in the interim period until radiotherapy becomes fully effective.   Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours:   - Carcinoid tumours with features of the carcinoid syndrome    - VIPomas    - Glucagonomas    - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors  or H2- antagonist therapy    - Insulinomas  for pre-operative control of hypoglycaemia and for maintenance therapy   - GRFomas.   Sandostatin is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ace3548a-0a1d-4d89-9d79-00e1958897d5.json
acfd7ba5-f743-475c-85fc-f443a9905554,CAFCIT 20MG/ML 1VIAL,29C,,,20317,,,,,,injection,CAFCIT 20MG/ML,2025-07-31T20:02:05.719465,IL,nan,,,,,,,CAFCIT 20MG/ML 1VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/acfd7ba5-f743-475c-85fc-f443a9905554.json
ad0efa6b-bfc7-40b9-8f3a-c213c364cf47,LORVIQUA 100 MG,prescription,L01XE44,LORLATINIB,8702,,,WHO ATC Classification,,ILS,film coated tablets,LORLATINIB,2025-07-31T04:54:43.483948,IL,פיזר,,17950.00534,15211.86961,13828.97237,,7290013592613,LORVIQUA 25 MG 90 tab,,,58118,BLISTER PVC/ALUMINIUM,units,90.0,164 04 35887 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Lorviqua is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) positive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad0efa6b-bfc7-40b9-8f3a-c213c364cf47.json
ad174095-6d08-474e-827a-efa74c9bd7b1,ACTIQ 1200 MCG,prescription,N02AB03,FENTANYL,6126,,,WHO ATC Classification,,ILS,compressed tablet on a handle,FENTANYL AS CITRATE/DOSE,2025-07-31T00:06:57.457071,IL,טבע,,1110.249384,940.8893507,800.7568942,,7290106061019,ACTIQ 1200MCG 30 COMPRESSED TAB,9267,,86433,BLISTER PVC/ACLAR,units,30.0,138 25 31575 00,valid,17.5,oral transmucosal,1.4,36,,,,,,,,,,0,Prescription required,Actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad174095-6d08-474e-827a-efa74c9bd7b1.json
ad23c51f-89c9-485d-be8b-23c71529a8ed,ELOCTA 2000 IU,prescription,B02BD05,COAGULATION FACTOR VII,9070,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR VIII,2025-07-31T02:16:20.057094,IL,מגאפארם,,5803.33784,4918.083134,4470.984667,,,ELOCTA 2000 IU,,,,VIAL GLASS TYPE I,units,1.0,170 51 36898 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).ELOCTA can be used for all age groups.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad23c51f-89c9-485d-be8b-23c71529a8ed.json
ad47093e-c42a-43f1-af34-0309f3e62994,PRAMIN INJECTION,prescription,A03FA01,METOCLOPRAMIDE,6614,,,WHO ATC Classification,,ILS,solution for injection,METOCLOPRAMIDE HYDROCHLORIDE/ML,2025-07-31T06:49:36.426236,IL,רפא,,124.190575,105.24625,78.25,,7290008013536,PRAMIN INJECTION 10MG/2ML 50AMP,16364,,28702,AMPOULES GLASS TYPE I,units,50.0,051 52 24303 00,valid,34.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Metoclopramide is an antiemetic and stimulates GI motility.   Adult population: Pramin is indicated in adults for:  - Prevention of postoperative nausea and vomiting (PONV) - Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV) - Prevention of nausea and vomiting caused by radiation therapy -Symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. In migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption. - Diabetic gastroparesis  - To faciliate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) (injection only). Pediatric population. Pramin is indicated in children aged 1 to 18 years for:   - Second line-therapy: Treatment of established postoperative nausea and vomiting (PONV) - Second-line therapy: Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV) - To facilitate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) (injection only)",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad47093e-c42a-43f1-af34-0309f3e62994.json
ad6fde54-66dc-430f-86bb-c47c2090f912,SEROQUEL XR 150 MG,prescription,N05AH04,QUETIAPINE,6938,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T08:07:06.337330,IL,צמל,,75.7475217,64.192815,47.727,,,SEROQUEL XR 150MG 30P.R TAB,19961,,19775,BLISTER PVC/ALUMINIUM,units,30.0,146 97 33472 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Seroquel XR is indicated for the treatment of Schizophrenia. Seroquel XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Seroquel XR.  Seroquel XR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Seroquel XR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 Pharmacodynamic properties). Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XR.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad6fde54-66dc-430f-86bb-c47c2090f912.json
ad74c342-47c4-40c1-bf9a-b2217a988b4d,VIBROCIL MICRODOSER,off-the-counter,R06AB03,DIMETINDENE,1181,,,WHO ATC Classification,,ILS,nasal solution,"DIMETINDENE MALEATE 0.025  %W/V, PHENYLEPHRINE 0.25  %W/V",2025-07-31T13:35:22.001059,IL,ג.ס.ק,,28.8038,24.41,nan,,7298120001189,VIBROCIL MICRODOSER 15ML,22068,,,BOTTLE POLYETHYLENE,units,15.0,058 91 27319 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,"Symptomatic treatment of common cold, nasal congestio, acute rhinitis, seasonal (hay fever) and non seasonal allergic rhinitis, acute sinusitis. Adjunctive therapy in case of acute otitis media.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad74c342-47c4-40c1-bf9a-b2217a988b4d.json
ad81d922-c60c-41b3-bc36-1068a15976b1,SLENYTO 1 MG,prescription,N05CH01,MELATONIN,8814,,,WHO ATC Classification,,ILS,tablets prolonged release,MELATONIN,2025-07-31T08:22:16.455425,IL,נעורים,,602.583101,510.6636676,434.6073767,,5060292650012,SLENYTO 5 MG 30 PR TAB,,,69208,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,165 84 36331 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Slenyto is indicated for the treatment of insomnia in children and adolescents aged 2-18 with Autism Spectrum Disorder (ASD) and/or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad81d922-c60c-41b3-bc36-1068a15976b1.json
ad83144b-ade3-4694-b56b-7656a2f0416b,TOPITRIM 100 MG,prescription,N03AX11,TOPIRAMATE,6031,,,WHO ATC Classification,,ILS,tablets,TOPIRAMATE,2025-07-31T09:26:17.119750,IL,תרימה,,263.1720075,223.027125,178.4217,,,TOPITRIM 200MG 60TAB,20609,,72915,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,136 65 31516 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,In adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. In adjunctive therapy of seizures with Lennox-Gastaut syndrome in adults and children. Topitim is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. Topitrim is indicated in adults for the prevention of migraines. The use of Topitrim in the acute treatment of migraine has not been studied.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad83144b-ade3-4694-b56b-7656a2f0416b.json
ad873b29-5c2b-499e-b71e-b491ce7a2701,FLIXOTIDE DISKUS 100 MCG,prescription,R03BA05,FLUTICASONE,3537,,,WHO ATC Classification,,ILS,powder for inhalation,FLUTICASONE PROPIONATE,2025-07-31T03:08:00.614494,IL,ג.ס.ק,,32.7481421,27.75266403,20.257419,,,FLIXOTIDE DISK 100MCG 60DOSES,6055,,47595,BLISTER PVC/OPA/AL,units,60.0,069 97 28478 00,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Prophylactic management of all grades of asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad873b29-5c2b-499e-b71e-b491ce7a2701.json
ad9602ed-f658-42f4-9d82-d0b626afa0a1,TEVAGRASTIM,prescription,L03AA02,FILGRASTIM,6564,,,WHO ATC Classification,,ILS,solution for injection / infusion,FILGRASTIM 0.6 MG/ML,2025-07-31T09:18:02.109118,IL,טבע,,255.2158137,216.2845975,173.027678,,7290102062447,TEVAGRASTIM  0.6MG/ML SYR PREFIL 0.8ML (48MU/0.8ML),20677,,18961,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,143 29 31990 00,valid,25.0,"i.v, s.c",1.4,30,,,,,,,,,,0,Prescription required,Tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy  (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. The safety and efficacy of Tevagrastim are similar in adults and children receiving cytotoxic chemotherapy.   Tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic PBPC).  In patients  children or adults with severe congenital neutropenia  cyclic or idiopathic neutropenia  with an absolute nuetrophil count (ANC) less than or equal to  0.5 x 1000000000 /l   and a history of severe or recurrent infections  long term administration of Tevagrastim is indicated to increase neutophil count and to reduce the incidence and duration of infection-related events.   Tevagrastim in indicated for the treatment of persistent neutopenia (ANC less than or equal to 1.0 x 1000000000/l ) in patients with advanced HIV infection  in order to reduce the risk of bacterial infections when other options to manage neutopenia are inappropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ad9602ed-f658-42f4-9d82-d0b626afa0a1.json
ada8a013-8041-4d93-b152-f61441598f06,NERLYNX,prescription,L01XE45,NERATINIB,8305,,,WHO ATC Classification,,ILS,tablets,NERATINIB AS MALEATE,2025-07-31T05:43:08.847496,IL,מדיסון,,24615.91887,20860.94913,18964.49921,,,NERLYNX  40MG   180TABS,14625,,76013,BOTTLE HDPE,units,180.0,164 61 35663 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Nerlynx is indicated for the extended adjuvant treatment of adult patients with early-stage hormone receptor positive HER2-overexpressed/amplified breast cancer and who are less than one year from the completion of prior adjuvant trastuzumab based therapy.""Nerlynx in combination with capecitabine is indicated for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based regimens in the metastatic setting.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ada8a013-8041-4d93-b152-f61441598f06.json
adac3d45-fbda-417a-b8f1-b4b39234fe68,TYPHIM VI,prescription,J07AP03,"TYPHOID, PURIFIED POLYSACCHARIDE ANTIGEN",4368,,,WHO ATC Classification,,ILS,solution for injection,PURIFIED VI CAPSULAR POLYSACCHARIDE OF S.TYPHI 0.025  MG / 0.5  ML,2025-07-31T09:49:28.780195,IL,סאנופי אוונטיס,,117.8972151,99.91289864,74.284683,,,TYPHIM VI SYRINGE 0.5ML,20804,,20279,SYRINGE 1 ML GLASS TYPE I,units,1.0,125 66 28629 00,valid,34.5,"i.m, s.c",1.4,36,,,,,,,,,,0,Prescription required,Typhim Vi vaccine is indicated for active immunization against typhoid fever for persons two years of age or older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/adac3d45-fbda-417a-b8f1-b4b39234fe68.json
adcf6fa0-97c6-4e90-aa8d-b41c1a38ec45,PIQRAY 150 MG,prescription,L01XX65,ALPELISIB,8525,,,WHO ATC Classification,,ILS,film coated tablets,ALPELISIB,2025-07-31T06:44:26.526415,IL,נוברטיס פארמה,,18814.77745,15944.72736,14495.20669,,7290018375136,PIQRAY 150 MG 56 TAB,10905,,28443,BLISTER PVC/PCTFE,units,56.0,166 18 36148 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"PIQRAY is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/adcf6fa0-97c6-4e90-aa8d-b41c1a38ec45.json
addac415-3847-47cf-bee6-5f5b0c264d50,SERDOLECT 16 MG,prescription,N05AE03,SERTINDOLE,6088,,,WHO ATC Classification,,ILS,film coated tablets,SERTINDOLE,2025-07-31T08:04:41.525568,IL,לנדבק,,143.647972,121.7355749,90.5097211,,,SERDOLECT 4MG 30TAB,19842,,86167,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,137 36 31472 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of schizophrenia.   Due to cardiovascular safety concerns  serntidole should only be used for patients intolerant to at least one other anti-psychotic agent.   Sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/addac415-3847-47cf-bee6-5f5b0c264d50.json
ae05684b-7f66-42ac-87eb-1a0e178caa4e,SAPHRIS 10 MG,prescription,N05AH05,ASENAPINE,6838,,,WHO ATC Classification,,ILS,tablets sublingual,ASENAPINE AS MALEATE,2025-07-31T08:00:40.627340,IL,מ.ס.ד. ישראל,,213.8363455,181.21725,144.9738,,,SAPHRIS 10MG 20 SUBLINGUAL TAB,,,,BLISTER ALUMINIUM,units,20.0,146 05 33229 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Schizophrenia SAPHRIS is indicated for the treatment of schizophrenia in adults. The efficacy of SAPHRIS was established in two 6-week trials and one maintenance trial in adults Bipolar Disorder Monotherapy: SAPHRIS is indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder. Efficacy was established in two 3-week monotherapy trials in adults Adjunctive Therapy: SAPHRIS is indicated as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder. Efficacy was established in one 3-week adjunctive trial in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ae05684b-7f66-42ac-87eb-1a0e178caa4e.json
ae0809f2-76d4-40e5-a72f-33f726012016,STEGLATRO 15 MG,prescription,A10BK04,ERTUGLIFLOZIN,8456,,,WHO ATC Classification,,ILS,film coated tablets,ERTUGLIFLOZIN (L-PGA),2025-07-31T08:41:22.056590,IL,מ.ס.ד. ישראל,,185.2257319,156.9709663,125.576773,,,STEGLATRO 15 MG 28 tab,,,29322,BLISTER ALU/PVC/PA/ALU,units,28.0,161 73 35637 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Steglatro is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:• as monotherapy in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindications.• in addition to other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ae0809f2-76d4-40e5-a72f-33f726012016.json
ae0e4d41-f747-452c-8e58-9634fe4ca358,ADVAGRAF 0.5 MG,prescription,L04AD02,TACROLIMUS,7672,,,WHO ATC Classification,,ILS,capsules prolonged release,TACROLIMUS AS MONOHYDRATE 0.5  MG,2025-07-31T00:10:07.513937,IL,אסטלס,,800.2184776,678.1512823,577.1500275,,8718692510692,ADVAGRAF 3MG 50  P.R. CAPS,9819,,74115,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,153 07 34071 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in adult kidney or liver allograft recipients.Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ae0e4d41-f747-452c-8e58-9634fe4ca358.json
ae174f6e-137a-4723-8dc8-65166e88ad94,AGISTEN ALOEVERA CREAM,off-the-counter,D01AC01,CLOTRIMAZOLE,4216,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T11:08:20.205998,IL,פאדאגיס,,41.7838,35.41,nan,,7290004850432,AGISTEN V 200MG 3 TAB,1157,,,TUBE ALUMINIUM,units,3.0,043 17 22461 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as Malassezia furfur, as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ae174f6e-137a-4723-8dc8-65166e88ad94.json
ae2fca20-1919-4917-9060-ce42a36fe585,IOPAMIRO 300,prescription,V08AB04,IOPAMIDOL,4659,,,WHO ATC Classification,,ILS,solution for injection,IOPAMIDOL 612.4  MG/ML,2025-07-31T05:27:49.632796,IL,אוניפארם,,63.42194439,53.7474105,39.9609,,,MIRO 45MG 30TAB,13493,,57699,BOTTLE GLASS TYPE I,units,30.0,020 40 24483 11,valid,34.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,"X-ray contrast medium in neuroradiology, angiography, urography, ct scanning, arthrography and fistulography",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ae2fca20-1919-4917-9060-ce42a36fe585.json
ae6d4607-9d8a-4c9f-8dae-db52b20b3919,SUNITINIB TEVA  ® 12.5 MG,prescription,L01XE04,SUNITINIB,8978,,,WHO ATC Classification,,ILS,capsules,SUNITINIB AS BASE 12.5  MG,2025-07-31T08:52:03.074338,IL,טבע,,4352.787742,3688.803171,3353.457428,,7290106065529,SUNITINIB TEVA 25 MG 30CAPS,17531,,74039,BLISTER PVC/ACLAR/PVC/ALUMINIUM,units,30.0,163 78 35252 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sunitinib Teva is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to Imatinib Mesylate. Sunitinib Teva is indicated for the treatment of advanced renal cell carcinoma. Treatment of unresectable or metastatic,  well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ae6d4607-9d8a-4c9f-8dae-db52b20b3919.json
ae998aab-01ea-4c6d-b975-a4c0f6e8375d,ANDROCUR 50MG 50TAB,prescription,,,4645,,,,,ILS,tablet,ANDROCUR 50MG,2025-07-31T18:59:21.944336,IL,באייר,,141.631659,120.026835,89.2392825,,,ANDROCUR 50MG 50TAB,1059,,57280,,units,50.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ae998aab-01ea-4c6d-b975-a4c0f6e8375d.json
aed72a26-f255-4a98-825d-abee53438693,REXULTI ® 0.5 MG,prescription,N05AX16,BREXPIPRAZOLE,8638,,,WHO ATC Classification,,ILS,film coated tablets,BREXPIPRAZOLE 0.5  MG,2025-07-31T07:32:47.176670,IL,לנדבק,,911.4989245,772.45675,657.41,,5702150153210,REXULTI ® 4 MG 28 TAB,18628,,59883,BLISTER PVC/ALUMINIUM,units,28.0,163 39 35733 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rexulti is indicated for:• Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults• Treatment of schizophrenia in adults and pediatric patients ages 13 years and older• Treatment of agitation associated with dementia due to Alzheimer’s diseaseLimitations of Use:Rexulti is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aed72a26-f255-4a98-825d-abee53438693.json
aee8d631-fb47-46ab-8aa7-1b6553133097,FLUOROURACIL TEVA,prescription,L01BC02,FLUOROURACIL,8847,,,WHO ATC Classification,,ILS,solution for injection,FLUOROURACIL/ML,2025-07-31T03:14:00.370475,IL,טבע,,83.88013952,71.084864,52.8512,,7290000850795,FLUOROURACIL TEVA 50MG/ML 100 ML 1 VIAL,,,61079,VIAL GLASS TYPE I,units,100.0,035 69 25702 05,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas, in selected patients considered incurable by surgery or other means.As leucovorin-fluorouracil chemotherapy combination for cancer treatment.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aee8d631-fb47-46ab-8aa7-1b6553133097.json
aef321c9-6a8d-4ff4-bb3d-0ad3b327477d,AVONEX SOLUTION FOR INJECTION,prescription,L03AB07,INTERFERON BETA-1A,7370,,,WHO ATC Classification,,ILS,solution for injection,INTERFERON BETA 1A/ 0.5  ML,2025-07-31T00:27:38.192010,IL,מדיסון,,2874.939274,2436.389323,2214.899385,,,AVONEX SOLUTION FOR INJECTION 30MCG/0.5ML 4PEN,9661,,43606,PRE-FILLED PEN GLASS TYPE I,units,4.0,148 95 33434 00,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. Treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of MRI abnormalities characteristic of MS and if they are determined to be at high risk of developing clinically definite multiple sclerosis. Safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aef321c9-6a8d-4ff4-bb3d-0ad3b327477d.json
aef743ea-9151-4fb5-873e-86c19221d5eb,ESRACAIN INJECTION 2 %,off-the-counter,N01BB02,LIDOCAINE,1860,,,WHO ATC Classification,,ILS,solution for injection,LIDOCAINE HYDROCHLORIDE/ML,2025-07-31T11:50:58.464369,IL,רפא,,26.6208,22.56,nan,,7290008013369,ESRACAIN GEL 30GR 2%,5070,,,AMPOULES GLASS,units,30.0,020 82 21028 00,valid,nan,"i.m, i.v, epidural, s.c, intradermal, submucosal, spinal, perineural, i.v regional anaesthesia",1.4,36,,,,,,,,,,0,,"Local and regional anaesthesia.Severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be life-threatening.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aef743ea-9151-4fb5-873e-86c19221d5eb.json
aefd3496-5a23-48bb-ae30-a10bfbe31889,PAXLOVID,prescription,J05AE30,NIRMATRELVIR AND RITONAVIR,9461,,,WHO ATC Classification,,ILS,film coated tablets,"NIRMATRELVIR, RITONAVIR",2025-07-31T06:30:34.937746,IL,פיזר,,4839.166248,4100.988528,3728.17139,,,PAXLOVID  100MG/150MG 30 TAB,,,,BLISTER OPA/AL/PVC,units,30.0,175 58 37720 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Paxlovid is indicated for the treatment of confirmed coronavirus disease 2019 (COVID-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe COVID19,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/aefd3496-5a23-48bb-ae30-a10bfbe31889.json
af023641-6f92-4121-b713-712254226f84,FUNGOFIN,prescription,D01AE16,AMOROLFINE,8566,,,WHO ATC Classification,,ILS,nail lacquer,AMOROLFINE AS HYDROCHLORIDEW/V,2025-07-31T03:22:39.534344,IL,כ.צ.ט,,52.87187296,44.806672,32.7056,,,FUNGOFIN  6.4%W/W 2.5 ML,6593,,65430,BOTTLE GLASS TYPE I,units,2.5,158 02 34380 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,"Topical treatment of onycomycosis caused by dermatophytes, yeast and moulds.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af023641-6f92-4121-b713-712254226f84.json
af077c04-a078-4115-80d9-bdd2def0353c,RETEVMO 120 MG TABLETS,prescription,L01EX22,SELPERCATINIB,9244,,,WHO ATC Classification,,ILS,tablets,SELPERCATINIB,2025-07-31T07:29:52.695696,IL,אלי לילי,,21438.30981,18168.05997,16516.41816,,,RETEVMO 80 MG 60 CAPS,18720,,28957,BOTTLE HDPE,units,60.0,179 73 38201 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Metastatic RET Fusion-Positive Non-Small Cell Lung CancerRETEVMO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC).RET-Mutant Medullary Thyroid CancerRETEVMO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy.RET Fusion-Positive Thyroid CancerRETEVMO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).Other RET Fusion-Positive Solid TumorsRETEVMO is indicated for the treatment of adult patients with locally advanced or metastatic solid tumors with a RET gene fusion that have progressed on or following prior systemic treatment or who have no satisfactory alternative treatment options.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af077c04-a078-4115-80d9-bdd2def0353c.json
af26dea3-90ad-42c1-92b0-bcc5d70f3d6e,RISPOND 1,prescription,N05AX08,RISPERIDONE,7945,,,WHO ATC Classification,,ILS,coated tablets,RISPERIDONE,2025-07-31T07:40:08.235721,IL,אוניפארם,,77.58601834,65.750863,48.8854,,,RISPOND 3 MG 30 TAB,18560,,55824,BLISTER PVC/ALUMINIUM,units,30.0,134 58 31403 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af26dea3-90ad-42c1-92b0-bcc5d70f3d6e.json
af284413-e1bf-4ed4-bee5-27c827a9bce2,FUNGIVERA CREAM,off-the-counter,D01AC01,CLOTRIMAZOLE,5601,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T11:58:16.052404,IL,ליף-פריגו,,25.1104,21.28,nan,,7290113810150,FUNGIVERA CREAM,,,,TUBE ALUMINIUM,units,20.0,165 90 36618 99,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, moulds and other fungi such as Malassezia furfur as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af284413-e1bf-4ed4-bee5-27c827a9bce2.json
af68d654-8930-4de7-ab38-8604f66d6042,DEXEFRIN EYE DROPS,prescription,S01CA01,DEXAMETHASONE AND ANTIINFECTIVES,1800,,,WHO ATC Classification,,ILS,"eye drops, solution","PHENYLEPHRINE HYDROCHLORIDE 0.12 %, DEXAMETHASONE AS SODIUM PHOSPHATE 0.1 %, NEOMYCIN AS SULFATE 0.5 %",2025-07-31T01:53:04.979153,IL,פישר,,24.86330689,21.0706,15.38,,7290000849539,DEXEFRIN DROPS 5CC,4097,,663,BOTTLE LDPE,units,5.0,051 20 24165 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Ocular inflammatory conditions associated with bacterial infection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af68d654-8930-4de7-ab38-8604f66d6042.json
af8041fd-b3d0-4b74-a171-cee8a0d8a085,ZEFFIX ORAL SOLUTION,prescription,J05AF05,LAMIVUDINE,4207,,,WHO ATC Classification,,ILS,oral solution,LAMIVUDINE/ML,2025-07-31T10:45:09.755130,IL,ג.ס.ק,,99.83291517,84.60416916,62.902728,,7290008086462,ZEFFIX ORAL SOL 5MG/ML 240ML,26092,,20905,BOTTLE HDPE,units,240.0,114 12 29545 05,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Zeffix is indicated for the treatment of chronic hepatitis B associated with the evidence of hepatitis B viral (HBV) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af8041fd-b3d0-4b74-a171-cee8a0d8a085.json
af99e249-4f79-4d88-8841-50a56eaaa43e,TIPTIPOT AFALPI,off-the-counter,R01BA02,PSEUDOEPHEDRINE,5056,,,WHO ATC Classification,,ILS,drops,PSEUDOEPHEDRINE AS HYDROCHLORIDE/ML,2025-07-31T13:28:31.384092,IL,כ.צ.ט,,40.6746,34.47,nan,, 7290008104579,TIPTIPOT FERRIPEL 3 DROPS 15ML,20333,,,BOTTLE GLASS,units,15.0,121 43 30172 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relief eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af99e249-4f79-4d88-8841-50a56eaaa43e.json
af9a5416-8de0-460e-962a-3b2084e3e3b2,SUBLOCADE 100 MG,prescription,N02AE01,BUPRENORPHINE,8630,,,WHO ATC Classification,,ILS,extended release solution for injection,BUPRENORPHINE/ 0.5  ML,2025-07-31T08:47:58.094272,IL,נעמי שאקו עזרה,,nan,nan,nan,,,SUBLOCADE 300 MG/1.5 ML E.R SOL FOR INJ 1 PFS,,,,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,163 66 35771 00,valid,nan,s.c,1.4,24,,,,,,,,,,0,Prescription required,SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder in patients over 15 years of age who have been induced and clinically stabilized on a transmucosal buprenorphine-containing product. SUBLOCADE should be used as part of a complete treatment plan that includes counseling and psychosocial support.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af9a5416-8de0-460e-962a-3b2084e3e3b2.json
af9b4afd-50f0-4dbe-bc77-6e06954b29ac,ATTENT XR 30 MG,prescription,N06BA01,AMFETAMINE,8485,,,WHO ATC Classification,,ILS,capsules extended release,"DEXTROAMPHETAMINE SULFATE 7.5  MG, DEXTROAMPHETAMINE SACCHARATE 7.5  MG, AMPHETAMINE SULFATE 7.5  MG, AMPHETAMINE ASPARTATE MONOHYDRATE 7.5  MG",2025-07-30T23:30:39.489189,IL,טבע,,nan,nan,nan,,,ATTENT 30 MG 30 TAB,,,16799,BOTTLE HDPE,units,30.0,170 94 35998 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/af9b4afd-50f0-4dbe-bc77-6e06954b29ac.json
afa34f8d-4761-43ca-95e1-891f21cd8a3e,RESOLOR 1 MG,prescription,A03AE04,PRUCALOPRIDE,7059,,,WHO ATC Classification,,ILS,film coated tablets,PRUCALOPRIDE AS SUCCINATE,2025-07-31T07:27:38.880391,IL,ביוטיס,,247.4681786,209.7188048,167.7750438,,7290014577107,RESOLOR 1MG 28 FC TAB,18504,,48923,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,149 82 33682 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Resolor is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/afa34f8d-4761-43ca-95e1-891f21cd8a3e.json
afa698bd-530a-4b31-b326-5438a7e6706d,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4900,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:22:31.673238,IL,מדיסון,,1227.032268,1039.8579,884.9854472,,8715131005863,ARANESP 150MCG PREFILLED PEN 1X0.3ML,9489,,65752,PRE-FILLED PEN GLASS TYPE I,units,1.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/afa698bd-530a-4b31-b326-5438a7e6706d.json
afced5d4-a7e2-41f0-ae0e-5c1f06f0f477,THEOTRIM 100,prescription,R03DA04,THEOPHYLLINE,2214,,,WHO ATC Classification,,ILS,tablets slow release,THEOPHYLLINE ANHYDROUS,2025-07-31T09:19:05.599036,IL,תרימה,,12.512484,10.6038,7.74,,,THEOTRIM 200 30 SR TAB,20101,,2261,BLISTER PVC/ALUMINIUM,units,30.0,050 47 23896 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Long acting bronchodilator in the symptomatic relief and/or prevention of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/afced5d4-a7e2-41f0-ae0e-5c1f06f0f477.json
b01b103a-bf17-4767-896b-b20e7f73568b,ZEPZELCA,prescription,L01XX69,LURBINECTEDIN,9042,,,WHO ATC Classification,,ILS,lyophilized powder for solution for infusion,LURBINECTEDIN/VIAL,2025-07-31T10:47:25.048810,IL,מגאפארם,,nan,nan,nan,,,ZEPZELCA 4MG/VIAL,,,46910,VIAL GLASS TYPE I,units,1.0,171 62 36588 99,valid,nan,i.v,1.4,60,,,,,,,,,,0,Prescription required,ZEPZELCA is indicated for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b01b103a-bf17-4767-896b-b20e7f73568b.json
b01f3090-3e30-4764-a0a6-e86827170486,QUETIAPINE SANDOZ ® 150 MG PRT,prescription,N05AH04,QUETIAPINE,8839,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:10:59.714141,IL,סנדוז,,150.91315,127.8925,102.314,,,QUETIAPINE SANDOZ  400 MG  30 PRT,17358,,70538,BLISTER PVC/PCTFE/AL,units,30.0,166 02 35776 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Sandoz PRT is indicated for the treatment of Schizophrenia. Quetiapine Sandoz PRT is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Sandoz PRT. Quetiapine Sandoz PRT  is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for the treatment of major depressive episodes in bipolar disorder. Quetiapine Sandoz PRT is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy . Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Sandoz PRT.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b01f3090-3e30-4764-a0a6-e86827170486.json
b022ea77-accb-4873-a43d-695bd1477926,VAXIGRIP,prescription,J07BB02,"INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN ",8715,,,WHO ATC Classification,,ILS,suspension for injection,"B/AUSTRIA/1359417/2021-LIKE STRAIN (B/MICHIGAN/01/2021, WILD TYPE)HA, A/CROATIA/10136RV/2023 (H3N2)-LIKE STRAIN (A/CROATIA/10136RV/2023, X-425A)HA, A/VICTORIA/4897/2022 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/4897/2022, IVR-238)HA",2025-07-31T10:00:48.185672,IL,סאנופי אוונטיס,,719.3046947,609.5802769,518.791725,,,VAXIGRIP TETRA 10PFS,,,,SYRINGE PREFILLED  GLASS TYPE I,units,10.0,179 71 38363 00,valid,17.5,"i.m, s.c",1.4,12,,,,,,,,,,0,Prescription required,"Prevention of influenza disease caused by the two influenza A virus subtypes and the influenza B virus type contained in the vaccine for:- active immunisation of adults, including pregnant women, and children from 6 months of age and older, - passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women The use of Vaxigrip should be based on official recommendations on vaccination against influenza",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b022ea77-accb-4873-a43d-695bd1477926.json
b04f102b-1d57-4232-88e7-b3183f301093,EPIPEN,prescription,C01CA24,EPINEPHRINE,1323,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE/ML,2025-07-31T02:27:49.349596,IL,דקסל פארמה,,269.6624528,228.5275125,194.4915,,7290103846848,EPIPEN JR. 0.15MG/0.3ML AUTO-INJECTOR 2ML,5046,,7085,AUTO-INJECTOR GLASS,units,1.0,019 37 24854 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"EpiPen is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.EpiPen is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. EpiPen is intended for immediate administration as emergency supportive therapy only and  is not a substitute for immediate medical care.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b04f102b-1d57-4232-88e7-b3183f301093.json
b04fd747-f04b-4bf6-864c-7e9de72cfd49,LIPITOR 10 MG,prescription,C10AA05,ATORVASTATIN,4076,,,WHO ATC Classification,,ILS,film coated tablets,ATORVASTATIN AS CALCIUM,2025-07-31T04:47:58.771912,IL,דקסל פארמה,,24.426826,20.7007,15.11,,,LIPITOR 10MG 30TAB,12484,,70539,BLISTER PVC/OPA/AL,units,30.0,126 04 30587 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol  LDL- cholesterol  apolipoprotein B  and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Lipitor is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable.   Pediatric patients (10-17 years of age) :   Atorvastatin is indicated as an adjunct to diet to reduce total -C  LDL-C  and apo B levels in boys and postmenarchal girls  10 to 17 years of age  with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:   1. LDL-C remains >or = 190 mg/dl or   2. LDL-C remains > or = 160 mg/dl and:    there is a positive family history of premature cardiovascular disease or    two or more other CVD risk factors are present in the pediatric patient.   Prevention of cardiovascular and/or cerebrovascular event sush as MI or stroke  as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor.   In patients with clinically evident coronary heart disease  Lipitor is indicated to :    Reduce the risk of non-fatal myocardial infarction.    Reduce the risk of fatal and non fatal stroke.    Reduce the risk for revascularization procedures.    Reduce the risk of hospitalization for CHF.    Reduce the risk of angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b04fd747-f04b-4bf6-864c-7e9de72cfd49.json
b0558463-decc-456b-9a76-250c890aff1f,VINORELBINE S.K. 20 MG,prescription,L01CA04,VINORELBINE,9184,,,WHO ATC Classification,,ILS,"capsule, soft",VINORELBINE AS TARTRATE,2025-07-31T10:17:23.905842,IL,SK PHARM(KS KIM),,221.9904662,188.1275221,150.5020177,,,VINORELBINE S.K. 20 MG 1 CAPSULE,22502,,22220,BLISTER PVC/PVDC/ALUMINIUM,units,1.0,168 46 36145 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Vinorelbine S.K. is indicated :- For the treatment of non small cell lung cancer. - For the treatment of advanced breast cancer,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0558463-decc-456b-9a76-250c890aff1f.json
b0887f76-4f6e-43cf-96c9-7abd3d7433d7,DEPO MEDROL 40 MG/ML,prescription,H02AB04,METHYLPREDNISOLONE,40,,,WHO ATC Classification,,ILS,suspension for injection,METHYLPREDNISOLONE ACETATE/ML,2025-07-31T01:47:51.258778,IL,פיזר,,57.92217728,49.0865931,35.82963,,72982006,DEPO MEDROL+LIDOCAIN 2CC,4054,,619,VIAL GLASS TYPE I,units,1.0,024 49 21841 00,valid,37.0,"periarticular, i.m, intra-articular, intra-lesional, intrabursal, intrarectal instillation, soft tissues",1.4,60,,,,,,,,,,0,Prescription required,For the treatment of conditions responsive to steroid injection therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0887f76-4f6e-43cf-96c9-7abd3d7433d7.json
b0a7c4a2-3a9e-492f-877d-e3d835fd534d,KISQALI 200 MG,prescription,L01EF02,RIBOCICLIB,8115,,,WHO ATC Classification,,ILS,film coated tablets,RIBOCICLIB AS SUCCINATE,2025-07-31T04:27:07.097682,IL,נוברטיס פארמה,,7395.854344,6267.673451,5697.884956,,,KISQALI 200 MG 42 FC TABLETS,11278,,10108,BLISTER PA/ALUMINIUM/PVC,units,42.0,160 68 35298 00,valid,10.0,per os,1.4,12,,,,,,,,,,0,Prescription required,"Kisqali is indicated in combination with:* a non-steroid aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer, as initial endocrine-based therapy.or* fulvestrant for the treatment of men and postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer, as initial endocrine based therapy or following disease progression on endocrine therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0a7c4a2-3a9e-492f-877d-e3d835fd534d.json
b0ab31d7-509c-4673-a02d-b8f91709999c,AZENIL 200 MG/5 ML SUSPENSION,prescription,J01FA10,AZITHROMYCIN,3092,,,WHO ATC Classification,,ILS,powder for oral suspension,AZITHROMYCIN AS DIHYDRATE/,2025-07-30T23:32:49.670999,IL,פיזר,,36.0129982,30.51949,22.277,,,AZENIL 200MG 22.5ML,1074,,9138,BOTTLE POLYETHYLENE,units,22.5,118 26 29828 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Infections caused by susceptible organisms in lower respiratory tract including bronchitis and pneumonia, skin and soft tissue infections, otitis media, upper respiratory tract infections including sinusitis and pharyngitis, tonsilitis, also in the treatment of uncomplicated genital infections due to chlamydia trachomatis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0ab31d7-509c-4673-a02d-b8f91709999c.json
b0bc6b79-1fba-480b-936b-b5e61fe7a642,SOMAVERT 10 MG,prescription,H01AX01,PEGVISOMANT,8164,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,PEGVISOMANT,2025-07-31T08:29:59.873514,IL,פיזר,,9080.58238,7695.409139,6995.82649,,7290010355631,SOMAVERT 10 MG   30 PreFilledSyringe x 1 ml solvent,10269,,76486,VIAL GLASS TYPE I,units,30.0,135 41 31357 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize IGF-I concentrations or was not tolerated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0bc6b79-1fba-480b-936b-b5e61fe7a642.json
b0bd4e27-fc3b-4355-ad62-1c28676f65a6,SOLU CORTEF 500,prescription,H02AB09,HYDROCORTISONE,8219,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,HYDROCORTISONE AS SODIUM SUCCINATE/VIAL,2025-07-31T08:28:08.304277,IL,פיזר,,72.72109573,61.62804997,45.8201115,,7290010355556,SOLU CORTEF 500mg/4 ml 1 VIAL,19851,,86418,VIAL GLASS TYPE I,units,1.0,034 93 22552 00,valid,34.5,"i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,Solu-Cortef is indicated to treat any condition in which IM or IV corticosteroid treatment is required such as: - allergic states- dermatologic diseases- endocrine disorders- gastrointestinal diseases- hematologic disorders- miscellaneous- neoplastic diseases- nervous system disorders- ophthalmic diseases- renal diseases- respiratory diseases- rheumatic disorders- dollagen diseases- certain medical emergencies,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0bd4e27-fc3b-4355-ad62-1c28676f65a6.json
b0c72512-9b87-4171-9e1f-52e027e44e7d,HALDOL 2 MG/ML DROPS,off-the-counter,N05AD01,HALOPERIDOL,2992,,,WHO ATC Classification,,ILS,solution  (oral),HALOPERIDOL/ML,2025-07-31T12:21:31.504774,IL,ויטאמד,,24.249,20.55,nan,,7290014577305,LOPERID 2MG 10CAP,12102,,,BOTTLE LDPE,units,10.0,029 70 25163 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"HALDOL is indicatedin adult patients aged 18 years and above for:•	Treatment of schizophrenia and schizoaffective disorder.•	Acute treatment of delirium when non-pharmacological treatments have failed.•	Treatment of moderate to severe manic episodes associated with bipolar I disorder when other treatments cannot be used.•	Treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar I disorder.•	Treatment of persistent aggression and psychotic symptoms in patients with moderate to severe Alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.•	Treatment of tic disorders, including Tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.•	Treatment of mild to moderate chorea in Huntington’s disease, when other medicinal products are ineffective or not tolerated.In paediatric patients for:•	Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.•	Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated.  •	Tic disorders, including Tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0c72512-9b87-4171-9e1f-52e027e44e7d.json
b0d20bfd-5005-4d53-a180-d9144cd7384c,REBLOZYL 25 MG,prescription,B03XA06,LUSPATERCEPT,8785,,,WHO ATC Classification,,ILS,powder for solution for injection,LUSPATERCEPT,2025-07-31T07:19:10.380903,IL,ב.מ.ס,,18417.02143,15607.64597,14188.76906,,7290014396180,REBLOZYL 75 MG 1 VIAL,,,16535,VIAL GLASS TYPE I,units,1.0,169 03 36646 00,valid,10.0,s.c,1.4,60,,,,,,,,,,0,Prescription required,"Reblozyl is indicated in: •	Adults for the treatment of transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (MDS).•	Adults for the treatment of anaemia associated with transfusion dependent and non-transfusion-dependent beta-thalassaemia",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0d20bfd-5005-4d53-a180-d9144cd7384c.json
b0d94720-2033-4cfb-af6e-fa90efe62307,RIPOL 10 MG/ML,prescription,N01AX10,PROPOFOL,8231,,,WHO ATC Classification,,ILS,emulsion for injection or infusion,PROPOFOL/ML,2025-07-31T07:37:02.666074,IL,רז פרמהצפטי,,85.46214493,72.42554655,53.84799,,7290015863360,RIPOL 20 MG/ML 50 ML 1 VIAL,,,69589,AMPOULES GLASS TYPE I,units,1.0,159 41 34438 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Ripol 10 mg/ml is a short-acting intravenous general anaesthetic for: - Induction and maintenance of general anaesthesia in adults and paediatric patients > 1 month of age- Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and paediatric patients > 1 month of age- Sedation of ventilated patients > 16 years of age in the intensive care unit",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0d94720-2033-4cfb-af6e-fa90efe62307.json
b0da7d05-e982-490e-9453-99442baba6ee,ALCINAL SYRUP,off-the-counter,R06AB54,"CHLORPHENAMINE, COMBINATIONS",1352,,,WHO ATC Classification,,ILS,syrup,"GUAIFENESIN/, DEXTROMETHORPHAN HYDROBROMIDE 7.88  MG /, CHLORPHENIRAMINE MALEATE/",2025-07-31T11:08:48.177640,IL,רקח,,28.2964,23.98,nan,,7290008090230,ALCINAL NEW SYRUP 115CC,1179,,,BOTTLE HDPE,units,115.0,114 85 29581 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the symptomatic relief of cough and nasal congestion associated with colds.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0da7d05-e982-490e-9453-99442baba6ee.json
b0e59be0-1ef6-4453-a602-a3f91e0984ee,RETAVIT 0.025% CREAM 20GR,prescription,,,2762,,,,,ILS,cream,RETAVIT 0.025% CREAM 20GR,2025-07-31T19:29:41.766637,IL,כ.צ.ט,,44.820235,37.98325,27.725,,,RETAVIT 0.025% CREAM 20GR,18069,,8830,,units,20.0,,not-registered,37.0,topical,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b0e59be0-1ef6-4453-a602-a3f91e0984ee.json
b101151c-45f7-4e7a-afd0-0e9b03ff3571,ORFADIN 10 MG HARD CAPSULES,prescription,A16AX04,NITISINONE,6924,,,WHO ATC Classification,,ILS,"capsule, hard",NITISINONE,2025-07-31T06:15:46.962503,IL,מגאפארם,,2647.102794,2243.307453,2039.370412,,7350031443066,ORFADIN 2MG 60CAPS,15417,,38092,CONTAINER HDPE,units,60.0,147 27 33457 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT-1) in  combination with dietary restriction of tyrosine and phenylalanine05/06/2018 בקשה לשינוי משטר מינון Once Daily,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b101151c-45f7-4e7a-afd0-0e9b03ff3571.json
b1105672-6487-48d1-8504-10c2aca6a246,TREMFYA 100 MG/ML S.C,prescription,L04AC16,GUSELKUMAB,8898,,,WHO ATC Classification,,ILS,solution for injection,GUSELKUMAB/ML,2025-07-31T09:38:53.543054,IL,יאנסן סילג,,8722.77407,7392.181744,6720.165222,,,TREMFYA PREFILLED PEN 1 ML 100 MG,20994,,59040,PRE-FILLED PEN GLASS TYPE I,units,1.0,160 54 35346 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Plaque psoriasisTremfya is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.Psoriatic arthritisTremfya, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (DMARD) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1105672-6487-48d1-8504-10c2aca6a246.json
b1252b07-6c01-4a94-8900-36f5d28c0503,FYCOMPA 10 MG FILM COATED TABLETS,prescription,N03AX22,PERAMPANEL,7263,,,WHO ATC Classification,,ILS,film coated tablets,PERAMPANEL AS ANHYDROUS,2025-07-31T03:24:33.822599,IL,אסיי,,364.6421243,309.0187632,262.9946921,,,FYCOMPA 4MG 28 F.C TAB,6530,,51057,BLISTER PVC/ALUMINIUM,units,28.0,150 50 33794 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.Fycompa is indicated for the adjunctive treatment of primary generalised tonic clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalized epilepsy (IGE).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1252b07-6c01-4a94-8900-36f5d28c0503.json
b14bc8e0-8a4d-4575-972f-b5952f0d1a51,ODOMZO  200 MG,29C,L01XX48,SONIDEGIB,20992,,,WHO ATC Classification,,ILS,"capsule, hard",SONIDEGIB AS DIPHOSPHATE,2025-07-31T15:35:56.111651,IL,nan,,nan,nan,nan,,,PHOSPHATE EFFERVESCENT SANDOZ 2G 100 tab,,,,BLISTER PCTFE (ACLAR)/PVC/ALU,units,100.0,156 37 34574 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,Odomzo 200 mg is indicated for the treatment of adult patients with locally advanced basal cell carcinoma which cannot be treated with curative surgery or radiation therapy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b14bc8e0-8a4d-4575-972f-b5952f0d1a51.json
b14c22de-f496-4c35-8197-19e0be622365,ENTECAVIR TEVA ® 0.5 MG,prescription,J05AF10,ENTECAVIR,7811,,,WHO ATC Classification,,ILS,film coated tablets,ENTECAVIR AS MONOHYDRATE 0.5  MG,2025-07-31T02:24:04.020303,IL,טבע,,2281.326898,1933.32788,1757.5708,,,ENTECAVIR TEVA 1 MG 30 F.C.TAB,5595,,75752,BLISTER AL/OPA/AL/PVC,units,30.0,154 78 34441 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Entecavir teva is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with: - Compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. - Decompensated liver disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b14c22de-f496-4c35-8197-19e0be622365.json
b15e8231-2dd1-456a-8279-8985e34f55d8,SOMAVERT 10 MG,prescription,H01AX01,PEGVISOMANT,8166,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,PEGVISOMANT,2025-07-31T08:30:27.812079,IL,פיזר,,17858.26087,15134.12005,13758.29096,,7290010355631,SOMAVERT 20 MG 30 PreFilled Syringe x1 ml solvent,10269,,76488,VIAL GLASS TYPE I,units,30.0,135 41 31357 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize IGF-I concentrations or was not tolerated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b15e8231-2dd1-456a-8279-8985e34f55d8.json
b1667050-fb1a-4569-866e-4a12c1a4dd41,DORZOPT 20 MG/ML,prescription,S01EC03,DORZOLAMIDE,8913,,,WHO ATC Classification,,ILS,"eye drops, solution",DORZOLAMIDE AS HYDROCHLORIDE/,2025-07-31T02:03:14.114469,IL,מדי מרקט,,34.58828862,29.312109,21.3957,,7290015841931,DORZOPT 20 MG/ML EYE DROPS 5 ML,,,71508,BOTTLE LDPE,units,5.0,167 77 35931 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of eleveated intraocular pressure in patients with ocular hypertension, open-angle glaucoma and in some patients secondary glaucoma",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1667050-fb1a-4569-866e-4a12c1a4dd41.json
b16cc10b-b0a1-4460-9fd3-fc003d53b8fc,JANUET XR 100/1000 MG TABLETS,prescription,A10BA02,METFORMIN,8537,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T08:18:51.674780,IL,טבע,,61.09329191,51.7739762,37.7912235,,7290006813640,SITAGLIPTIN 100 MG 10 TAB,,,,BOTTLE HDPE,units,10.0,151 33 33934 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b16cc10b-b0a1-4460-9fd3-fc003d53b8fc.json
b1775bd6-7437-4904-8016-cf5f98f11e5a,SORAFENIB TEVA ®,prescription,L01XE05,SORAFENIB,9286,,,WHO ATC Classification,,ILS,film coated tablets,SORAFENIB AS TOSYLATE,2025-07-31T08:32:02.249892,IL,טבע,,6840.777881,5797.26939,5270.2449,,,SORAFENIB TEVA 200 MG 120 F.C.T,,,43114,BOTTLE HDPE,units,120.0,164 53 35428 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Sorafenib Teva is indicated for the treatment of:•	patients with advanced renal cell carcinoma. •	patients with hepatocellular carcinoma•	patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma, refractory to radioactive iodine.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1775bd6-7437-4904-8016-cf5f98f11e5a.json
b17f1f41-ed82-48cb-b68d-16c901c95d25,WILATE  500,prescription,B02BD02,COAGULATION FACTOR VIII,7716,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,"VON WILLEBRAND FACTOR/VIAL, FACTOR VIII (HUMAN)/VIAL",2025-07-31T10:26:25.320915,IL,דובר מדיקל,,1319.997218,1118.64176,952.03554,,,WILATE 500 1VIAL,,,,VIAL GLASS TYPE I,units,1.0,151 13 33856 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Von Willebrand disease (VWD) :Prevention and treatment of haemorrhage or surgical bleeding in von Willebrand disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or contra-indicated.Haemophilia A :Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital FVIII deficiency).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b17f1f41-ed82-48cb-b68d-16c901c95d25.json
b182c3e5-2ee8-4c64-a0c3-b1bbe5e01de4,SEPTAX 1 G,prescription,,,7099,,,,,ILS,powder for solution for inj/inf,CEFTAZIDIME AS PENTAHYDRATE,2025-07-31T08:04:07.649663,IL,ביואבניר,,37.1688672,31.49904,22.992,,7290010286119,SEPTAX 1G 1VIAL,19962,,6442,VIAL GLASS TYPE III,units,1.0,135 96 31243 00,valid,37.0,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,"Septax is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• Nosocomial pneumonia• Broncho-pulmonary infections in cystic fibrosis• Bacterial meningitis• Chronic suppurative otitis media• Malignant otitis externa• Complicated urinary tract infections• Complicated skin and soft tissue infections• Complicated intra-abdominal infections• Bone and joint infections• Peritonitis associated with dialysis in patient on CAPD.Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.Ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.Ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (TURP).The selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic Gram negative bacteria.Ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.Consideration should be given to official guidelines on the appropriate use of antibacterial agents.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b182c3e5-2ee8-4c64-a0c3-b1bbe5e01de4.json
b1a7f769-db4e-4aec-a960-f6ab492dc526,TRAZIMERA 150 MG,prescription,L01FD01,TRASTUZUMAB,8750,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,TRASTUZUMAB/VIAL,2025-07-31T09:36:56.712647,IL,פיזר,,1600.425768,1356.293084,1154.291986,,,TRAZIMERA 150 MG 1 VIAL,,,,VIAL GLASS TYPE I,units,0.3409,166 30 36300 00,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Metastatic Breast Cancer (MBC)TRAZIMERA is indicated for the treatment of patients with metastatic breast cancer who have tumors that overexpress HER2;1. As a single agent, for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease.2. In combination with Paclitaxel or Docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease.3. In combination with an aromatase inhibitor for the treatment of postmenopausal patient with hormone-receptor positive metastatic breast cancer.Early Breast Cancer (EBC)TRAZIMERA is indicated to treat patients with HER2 positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding anthracyclines.TRAZIMERA should only be used in patients whose tumours have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay.HER2 Metastatic Gastric Cancer (MGC)TRAZIMERA in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.TRAZIMERA should only be used in patients with metastatic gastric cancer whose tumours have HER2 overexpression as defined by IHC2+ and a confirmatory FISH+ result, or IHC 3+, as determined by an accurate and validated assay.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1a7f769-db4e-4aec-a960-f6ab492dc526.json
b1ab0f96-7435-41bf-a519-512c1f11e6e8,ANORO ELLIPTA 55/22 MCG,prescription,R03AL03,VILANTEROL AND UMECLIDINIUM BROMIDE,7557,,,WHO ATC Classification,,ILS,powder for inhalation,"VILANTEROL AS TRIFENATATE, UMECLIDINIUM AS BROMIDE",2025-07-31T00:20:24.310864,IL,ג.ס.ק,,214.6176125,181.8793408,145.5034726,,,ANORO ELLIPTA 55/22 MCG 30 DOSES,9815,,74085,STRIPS ALUMINIUM,units,30.0,153 37 34077 00,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,ANORO is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).ANORO ELLIPTA is NOT indicated for the relief of acute bronchospasm or for the treatment of asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1ab0f96-7435-41bf-a519-512c1f11e6e8.json
b1ac058e-d7ef-4aae-8901-075e68097c9d,TEPADINA 100 MG,prescription,L01AC01,THIOTEPA,9506,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,THIOTEPA/VIAL,2025-07-31T09:13:11.553791,IL,אמ.בי.איי פארמה,,14266.97889,12090.66061,10991.50965,,7290014257528,TEPADINA 400 MG 1 BAG,,,31666,VIAL GLASS TYPE I,units,1.0,154 18 34230 03,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"TEPADINA is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;2.  when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1ac058e-d7ef-4aae-8901-075e68097c9d.json
b1b74e71-6213-4c3e-9c54-90d4def946f1,IBRANCE TABLETS 100 MG,prescription,L01XE33,PALBOCICLIB,7907,,,WHO ATC Classification,,ILS,film coated tablets,PALBOCICLIB,2025-07-31T03:55:22.292264,IL,פיזר,,9598.848156,8134.617443,7395.106767,,5415062107560,IBRANCE 100 MG 21 CAPS,9980,,60193,BLISTER PVC/OPA/AL,units,21.0,173 62 36956 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"IIBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:* an aromatase inhibitor as initial endocrine-based therapy; or* fulvestrant in patients with disease progression following endocrine therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1b74e71-6213-4c3e-9c54-90d4def946f1.json
b1bc6dc5-8508-4d66-8b62-4ace760d33eb,HUMIRA,prescription,L04AB04,ADALIMUMAB,8561,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/,2025-07-31T03:50:23.536410,IL,אב-וי,,2374.023693,2011.884575,1828.985978,,,HUMIRA 80 MG/0.8 ML SOL FOR INJ 1 pf pen,,,4210,PRE-FILLED PEN GLASS TYPE I,units,1.0,157 78 34788 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"• Rheumatoid arthritis:Humira in combination with methotrexate is indicated for:- The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.- The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Humira has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.• Polyarticular juvenile idiopathic arthritis:Humira in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs).  Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. Humira has not been studied in patients aged less than 2 years.• Enthesitis-related arthritis:Humira is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy.• Axial spondyloarthritis :Humira is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.• Axial spondyloarthritis without radiographic evidence of AS:Humira is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels , who have had an inadequate response to, or are intolerant to, non - steroidal anti-inflammatory drugs. • Psoriatic arthritis:Humira is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti rheumatic drug therapy has been inadequate. Humira has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.• Psoriasis:Humira is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.• Paediatric plaque psoriasis:Humira is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.• Hidradenitis suppurativa (HS):Humira is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy.• Crohn’s disease:Humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy.  Humira is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab. • Paediatric Crohn's disease:Humira is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6- years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and corticosteroid, and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies• Ulcerative colitis:Humira is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.  • Uveitis:Humira is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.• Intestinal Behcet's disease:Humira is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.• Paediatric UveitisHumira is indicated for the treatment of chronic non-infectious uveitis in paediatric patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.•	Paediatric ulcerative colitis Humira is indicated for the treatment of moderately to severely active ulcerative colitis in pediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including corticosteroids and/or 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1bc6dc5-8508-4d66-8b62-4ace760d33eb.json
b1d9d458-029a-4286-8a50-3414fa6887ff,GAVISCON PEPPERMINT TABLETS,off-the-counter,,,5482,,,,,ILS,tablets,"CALCIUM CARBONATE, SODIUM BICARBONATE 133.5  MG, ALGINIC ACID AS SODIUM",2025-07-31T11:59:32.777040,IL,רקיט בנקיזר,,44.899,38.05,nan,,,GAVISCON PEPPERMINT 48 TAB,7923,,,BLISTER PVC/PE/PVDC/AL,units,48.0,141 58 31757 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Treatment of symptoms of gastro-oesophageal reflux such as acid regurgatation, heartburn and indigestion (related to reflux), for example, following meals or during pregnancy or in patients with symptoms related to reflux oesophagitis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1d9d458-029a-4286-8a50-3414fa6887ff.json
b1f1366d-4cad-49b7-816b-737c688ffac7,ADVOCIN INJECTABLE SOLUTION 2.5 % VETERINARY,prescription,,,6260,,,,,ILS,solution for injection,DANOFLOXACIN AS MESYLATE/ML,2025-07-31T06:04:53.606615,IL,טבע,,67.72123958,57.390881,42.6698,,,OFLOXACIN-TEVA 200MG 20TAB,15360,,80637,VIAL AMBER GLASS TYPE II,units,20.0,083 84 92073 00,valid,34.5,"i.m, s.c",1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of cattle (calves, beef cattle and non-lactating dairy cattle) with respiratory infections caused by Pasteurella haemolytica and Pasteurella multocida, enteric infections caused by e.coli and salmonela spp.Only after sensitivity to danofloxacin has been confirmed by laboratory tests and after no alternative treatment was found effective (proved resistence to other treatments).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1f1366d-4cad-49b7-816b-737c688ffac7.json
b1f43250-c635-46ad-a796-5d7df002c499,GIVLAARI,prescription,A16AX16,GIVOSIRAN,8769,,,WHO ATC Classification,,ILS,solution for injection,GIVOSIRAN AS SODIUM/,2025-07-31T03:34:11.002828,IL,מדיסון,,205451.1386,174111.1422,158282.8565,,,GIVLAARI 189MG/ML 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,167 60 36561 99,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Givlaari is indicated for the treatment of acute hepatic porphyria (AHP) in adults and adolescents aged 12 years and older,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1f43250-c635-46ad-a796-5d7df002c499.json
b1f842bc-b3eb-47ff-92b5-dc762984f5e4,FLEET ENEMA 133,off-the-counter,A06AG20,COMBINATIONS,1755,,,WHO ATC Classification,,ILS,enema,"SODIUM PHOSPHATE/ML, SODIUM PHOSPHATE/ML",2025-07-31T11:55:59.514674,IL,דקסל פארמה,,14.6202,12.39,nan,,7290008004626,FLEET ENEMA 133 ML,6039,,,BOTTLE POLYETHYLENE,units,133.0,034 95 22406 11,valid,nan,rectal,1.4,36,,,,,,,,,,0,,"Cleaning the colon before surgery, child birth or medical examinations.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b1f842bc-b3eb-47ff-92b5-dc762984f5e4.json
b26f7fd8-e0c8-4d45-99e9-eb9e2b22d338,TESTOVIRON DEPOT,prescription,G03BA03,TESTOSTERONE,143,,,WHO ATC Classification,,ILS,oily solution for injection,TESTOSTERONE ENANTATE/ML,2025-07-31T09:17:00.829911,IL,באייר,,42.33112654,35.87383764,26.18528295,,7298074040425,TESTOVIRON DEP.250MG AMP,20067,,2156,AMPOULES GLASS TYPE I,units,1.0,048 61 23357 00,valid,37.0,i.m,1.4,60,,,,,,,,,,0,Prescription required,"Testosterone replacement therapy for male hypogonadism, when testosterone deficiency has been confirmed by clinical features and biochemical tests .Puberty induction in boys with delayed puberty (pubertas tarda).",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b26f7fd8-e0c8-4d45-99e9-eb9e2b22d338.json
b2919bc0-4654-47aa-a383-f694057d1938,ONUREG 200 MG,prescription,L01BC07,AZACITIDINE,9047,,,WHO ATC Classification,,ILS,film coated tablets,AZACITIDINE,2025-07-31T06:13:02.789164,IL,ב.מ.ס,,35390.90331,29992.29227,27265.72025,,7290014396203,ONUREG 200 MG 7 TAB,,,33375,BLISTER PVC/OPA/AL,units,7.0,169 93 36929 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,ONUREG is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b2919bc0-4654-47aa-a383-f694057d1938.json
b294914f-5bbd-4242-87fa-f47a56d34205,TRIDERM CREAM,prescription,,,3510,,,,,ILS,cream,"CLOTRIMAZOLE/G, BETAMETHASONE AS DIPROPIONATE 0.5 MG/G, GENTAMICIN (AS SULFATE)/G",2025-07-31T09:41:48.115422,IL,אורגנון,,nan,nan,nan,,7290008121132,TRIDERM CREAM 15GR,20123,,33507,TUBE ALUMINIUM,units,15.0,105 13 28792 00,valid,nan,topical,1.4,24,,,,,,,,,,0,Prescription required,Treatment of corticosteroid-responsive dermatoses when complicated by infections caused by bacteria (sensitive to gentamicin) and fungi (sensitive to clotrimazole) or when the possibility of such infections is suspected. The cream is suitable for the use of oozing eczema.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b294914f-5bbd-4242-87fa-f47a56d34205.json
b2a43c26-b5c8-4790-88d6-6423e2679602,CEFUAVENIR 250 MG,prescription,J01DC02,CEFUROXIME,9400,,,WHO ATC Classification,,ILS,tablets,CEFUROXIME AS AXETIL,2025-07-31T01:03:01.527152,IL,ביואבניר,,22.92888444,19.431258,14.1834,,,CEFUAVENIR 250 MG 10 TAB,,,15562,BLISTER PVC/ALUMINIUM,units,10.0,174 07 36745 99,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CefuAvenir is indicated for the treatment of the infections listed below in adults and children from the  age of 3 :months .• Acute streptococcal tonsillitis and pharyngitis.• Acute bacterial sinusitis.• Acute otitis media.• Acute exacerbations of chronic bronchitis.• Cystitis.• Pyelonephritis.• Uncomplicated skin and soft tissue infections. •Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b2a43c26-b5c8-4790-88d6-6423e2679602.json
b2a7ba9b-2a18-4f0a-a490-90bab7a8f1fd,BACTROBAN NASAL,prescription,R01AX06,MUPIROCIN,9437,,,WHO ATC Classification,,ILS,ointment,MUPIROCIN AS CALCIUMW/W,2025-07-31T05:35:57.638748,IL,SK PHARM(KS KIM),,29.60566179,25.08954501,18.3135365,,7290008102582,MUPIROCIN S.K 2% tube 3gr,,,17324,TUBE ALUMINIUM,units,3.0,050 85 26431 21,valid,37.0,nasal,1.4,36,,,,,,,,,,0,Prescription required,"The elimination of nasal carriage of staphylococci, including methycillin-resistant staphylococus aureus (MRSA).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b2a7ba9b-2a18-4f0a-a490-90bab7a8f1fd.json
b2ddb966-c3ac-486d-bd0a-39b19ae5cffe,CYCLOVIR,off-the-counter,D06BB03,ACICLOVIR,5564,,,WHO ATC Classification,,ILS,cream,ACICLOVIRW/W,2025-07-31T11:28:40.785835,IL,לייף-סופרפארם,,30.1608,25.56,nan,,7290106954427,CYCLOVIR 5% CREAM 2G,,,,PACK PUMP POLYPROPYLENE,units,2.0,152 54 34102 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,For the treatment of cold sores (herpes labialis).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b2ddb966-c3ac-486d-bd0a-39b19ae5cffe.json
b2edded7-ebf8-4edc-b132-22f0ece57c2c,CEFAZOLIN - FRESENIUS,prescription,J01DB04,CEFAZOLIN,8608,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFAZOLIN AS SODIUM,2025-07-31T00:58:24.819469,IL,ניאופרם,,103.0721145,87.3492496,64.94368,,,CEFAZOLIN - FRESENIUS 1000MG 10 VIAL,10667,,439,VIAL GLASS TYPE II,units,10.0,149 89 33775 00,valid,34.5,"i.v, i.m",1.4,24,,,,,,,,,,0,Prescription required,Cefazolin - Fresenius is indicated in the treatment of serious infections due to susceptible micro-organisms.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b2edded7-ebf8-4edc-b132-22f0ece57c2c.json
b2ee7f27-b05c-4472-a28b-df8067e48b9d,KEPPRA 1000 MG,prescription,N03AX14,LEVETIRACETAM,4849,,,WHO ATC Classification,,ILS,film coated tablets,LEVETIRACETAM,2025-07-31T04:24:09.454751,IL,כ.צ.ט,,276.859565,234.62675,187.7014,,,KEPPRA 1000MG 60TAB,11193,,63357,BLISTER PVC/ALUMINIUM,units,60.0,132 66 31183 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,- Keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b2ee7f27-b05c-4472-a28b-df8067e48b9d.json
b2f9a090-91f6-43ba-9e57-00399ec887ac,OXALIPLATIN MEDAC 100 MG,prescription,L01XA03,OXALIPLATIN,7435,,,WHO ATC Classification,,ILS,powder for solution for infusion,OXALIPLATIN/VIAL,2025-07-31T06:20:26.380479,IL,צמל,,497.507119,421.6162025,358.8223,,4037353004290,OXALIPLATIN MEDAC 50MG/VIAL,15356,,86829,VIAL GLASS TYPE I,units,1.0,137 25 31504 00,valid,17.5,i.v,1.4,30,,,,,,,,,,0,Prescription required,"Oxaliplatin in combination with 5-fluorouracil (5-FU) and folinic acid (FA) is indicated for: •  Adjuvant treatment of stage III (Duke‘s C) colon cancer after complete resection of primary tumor. •  Treatment of metastatic colorectal cancer. Oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on NCCN guidelines, version 2.2014).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b2f9a090-91f6-43ba-9e57-00399ec887ac.json
b302a863-97be-4dce-8ef8-e44032b724de,BABYAF SALINE NASAL DROPS,off-the-counter,,,3085,,,,,ILS,drops,SODIUM CHLORIDE 0.9 %W/V,2025-07-31T11:15:50.061591,IL,סם און,,13.0862,11.09,nan,,7290008066037,BABY AF DROPS 10ML,2054,,,BOTTLE LDPE,units,10.0,058 90 27441 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Relief of nasal congestion in infants and small children.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b302a863-97be-4dce-8ef8-e44032b724de.json
b3084e44-615d-4435-a330-caec42c71da6,ELIQUIS 2.5 MG,prescription,B01AF02,APIXABAN,6941,,,WHO ATC Classification,,ILS,film coated tablets,APIXABAN 2.5  MG,2025-07-31T02:15:28.175051,IL,פיזר,,273.0354452,231.3859808,196.924239,,,ELIQUIS 2.5MG 60 F.C.TAB,5562,,77578,BLISTER PVC/PVDC,units,60.0,148 31 33496 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age&#8805; 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class &#8805; II).Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3084e44-615d-4435-a330-caec42c71da6.json
b30b8aff-77b3-4cb1-8e77-013c84755e87,ZALDIAR,prescription,N02BE01,PARACETAMOL,8218,,,WHO ATC Classification,,ILS,film coated tablets,"PARACETAMOL, TRAMADOL HYDROCHLORIDE 37.5  MG",2025-07-31T09:32:37.495208,IL,פארמלוג'יק,,26.10464503,22.12258053,16.147869,,7290008872300,TRAMADOL 100MG/2ML  ROTEXMEDICA 10AMPX2ML,,,21039,BLISTER PAPER/PET/ALUMINIUM-PVC,units,10.0,135 90 31296 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of moderate to severe pain.The use of Zaldiar should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b30b8aff-77b3-4cb1-8e77-013c84755e87.json
b320473a-5703-48f2-8ea5-1b3507fc5a82,QUETIAPINE INOVAMED SR 300 MG,prescription,N05AH04,QUETIAPINE,8829,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:09:46.820663,IL,אינובמד,,103.6111807,87.80608535,65.28333483,,7290104530685,QUETIAPINE INOVAMED SR 200 MG 30 TAB,17327,,70058,BLISTER PVC/PCTFE/AL,units,30.0,165 71 35461 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Inovamed SR is indicated for the treatment of Schizophrenia. Quetiapine Inovamed SR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Inovamed SR. Quetiapine Inovamed SR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. Quetiapine Inovamed SR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Inovamed SR.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b320473a-5703-48f2-8ea5-1b3507fc5a82.json
b3206948-4d4f-4aa9-b958-ddceae995900,LITFULO 50 MG,prescription,L04AF08,RITLECITINIB,9478,,,WHO ATC Classification,,ILS,capsules,RITLECITINIB AS TOSYLATE,2025-07-31T04:50:06.796741,IL,פיזר,,5031.734026,4264.181568,3876.528698,,,LITFULO 50 MG 28 CAPS,,,24875,BOTTLE HDPE,units,28.0,176 18 37835 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologicimmunomodulators, cyclosporine or other potent immunosuppressants",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3206948-4d4f-4aa9-b958-ddceae995900.json
b32322ac-d665-4908-bcfe-183595f1a86d,CYSTAGON 150 MG,prescription,A16AA04,MERCAPTAMINE,7659,,,WHO ATC Classification,,ILS,"capsule, hard",CYSTEAMINE AS BITARTRATE,2025-07-31T01:38:06.259982,IL,מדיסון,,1089.046065,922.920435,785.4642,,7290008128995,CYSTAGON 150MG 100CAPS,9539,,35086,BOTTLE HDPE,units,100.0,152 28 34049 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"CYSTAGON is indicated for the treatment of proven nephropathic cystinosis.Cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b32322ac-d665-4908-bcfe-183595f1a86d.json
b32d0f8d-b490-476d-b36a-4e8fa89c61fe,STRIBILD,prescription,J05AR09,"EMTRICITABINE, TENOFOVIR DISOPROXIL, ELVITEGRAVIR AND COBICISTAT ",7426,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR DISOPROXIL AS FUMARATE, EMTRICITABINE, COBICISTATE, ELVITEGRAVIR",2025-07-31T08:47:17.960626,IL,גיליאד,,3423.154819,2900.978789,2637.253445,,5391507140852,STRIBILD 30 F.C.TAB,9723,,50857,BOTTLE HDPE,units,30.0,151 77 33963 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Stribild is indicated for the treatment of human immunodeficiency virus 1 (HIV 1) infection in adults aged 18 years and over who are antiretroviral treatment-naïve or are infected with HIV 1 without known mutations associated with resistance to any of the three antiretroviral agents in Stribild.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b32d0f8d-b490-476d-b36a-4e8fa89c61fe.json
b338f28c-d849-4d3e-afb9-fa81350ef264,LEVOFLOXACIN FRESENIUS 5 MG/ML,prescription,S01AX19,LEVOFLOXACIN,8612,,,WHO ATC Classification,,ILS,solution for infusion,LEVOFLOXACIN AS HEMIHYDRATE/ML,2025-07-31T04:45:47.336901,IL,ניאופרם,,961.1218,814.51,693.2,,,LEVOFLOXACIN FRESENIUS 5 MG/ML 10 BAGS X 100 ML,12567,,445,FREEFLEX BAG SYSTEM POLYOLEFINE,units,10.0,156 84 34212 00,valid,17.5,i.v,1.4,18,,,,,,,,,,0,Prescription required,Levofloxacin solution for infusion is indicated in adults for the treatment of the following infections: -	Acute pyelonephritis and complicated urinary tract infections -	Chronic bacterial prostatitisIn the below-mentioned infections levofloxacin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections:-	Community-acquired pneumonia-	Complicated skin and soft tissue infectionsConsideration should be given to official guidance on the appropriate use of antibacterial agents.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b338f28c-d849-4d3e-afb9-fa81350ef264.json
b33a6a00-1cad-40f0-be1c-a74b7b18ef9e,TYVASO,prescription,B01AC21,TREPROSTINIL,8563,,,WHO ATC Classification,,ILS,solution for inhalation,TREPROSTINIL AS SODIUM SALT 1.74  MG / 2.9  ML,2025-07-31T09:49:59.031363,IL,רפא,,nan,nan,nan,,7290008016179,TYVASO 1.74 / 2.9 ML 4 AMP,,,79160,AMPOULES LDPE,units,4.0,144 71 33077 01,valid,nan,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of pulmonary arterial hypertension in patients with NYHA class III symptoms, to increase walk distance.Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b33a6a00-1cad-40f0-be1c-a74b7b18ef9e.json
b33a9082-b401-44df-a314-06223b6e582a,REXULTI ® 0.5 MG,prescription,N05AX16,BREXPIPRAZOLE,9341,,,WHO ATC Classification,,ILS,film coated tablets,BREXPIPRAZOLE 0.5  MG,2025-07-31T07:32:01.191715,IL,לנדבק,,91.11540695,77.21645,57.41,,5702150153210,REXULTI  0.5 MG  7 TAB,18656,,76817,BLISTER PVC/ALUMINIUM,units,7.0,163 39 35733 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rexulti is indicated for:• Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults• Treatment of schizophrenia in adults and pediatric patients ages 13 years and older• Treatment of agitation associated with dementia due to Alzheimer’s diseaseLimitations of Use:Rexulti is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b33a9082-b401-44df-a314-06223b6e582a.json
b36607bc-7b73-4ada-8ac4-eabd1b315198,PRIZMA,prescription,N06AB03,FLUOXETINE,3607,,,WHO ATC Classification,,ILS,coated tablets,FLUOXETINE AS HYDROCHLORIDE,2025-07-31T06:57:52.938033,IL,אוניפארם,,nan,nan,nan,,,PRIZMA FRTE 60MG 20T,16009,,76251,BLISTER PVC/ALUMINIUM,units,20.0,100 63 28423 01,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,"Adults:Major depressive episodes.Obsessive-compulsive disorder (OCD).Bulimia nervosa: Fluoxetine is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.Children and adolescents aged 8 years and above:Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. Antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b36607bc-7b73-4ada-8ac4-eabd1b315198.json
b37542d3-e523-4c7d-a53b-fa4e320869fb,CERTICAN ® 0.25 MG TABLETS,prescription,L04AA18,EVEROLIMUS,4841,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS 0.25   MG,2025-07-31T01:07:33.008278,IL,נוברטיס פארמה,,744.3132531,630.7739714,536.8289118,,,CERTICAN 0.50MG 60 TAB,3791,,13351,BLISTER PVC/PA/ALUMINIUM,units,60.0,132 60 31066 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Kidney and heart transplantationCertican ® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in adult patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b37542d3-e523-4c7d-a53b-fa4e320869fb.json
b3874099-553b-47ea-a454-b447716a2525,ETUMIN 40MG/4ML 1AMP,29C,,,20403,,,,,,injection,ETUMIN 40MG/,2025-07-31T20:24:41.676944,IL,nan,,,,,,,ETUMIN 40MG/4ML 1AMP,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3874099-553b-47ea-a454-b447716a2525.json
b3903c3d-6c46-4e9c-a1dc-88dfa8d47b0e,EZETIMIBE ® TEVA,prescription,C10AX09,EZETIMIBE,8682,,,WHO ATC Classification,,ILS,tablets,EZETIMIBE,2025-07-31T02:51:43.296876,IL,טבע,,219.15373,185.7235,148.5788,,,EZETIMIBE TEVA 10 MG 30 TAB,,,56609,BLISTER OPA/ALU/PVC/ALU,units,30.0,163 59 35380 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,- Primary hypercholesterolemia: Ezetimibe Teva administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. - Homozygous familial hypercholesterolemia (HoFH): Ezetimibe Teva administered with a statin are indicated for use in patients with HoFH. Patients may also receive adjunctive treatments (e.g. LDL apheresis).- Homozygous sitosterolemia (Phytosterolemia): Ezetimibe Teva is indicated for use in patients with homozygous familial sitosterolemia,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3903c3d-6c46-4e9c-a1dc-88dfa8d47b0e.json
b39c3659-2d6a-4267-986a-092ca34f70a4,TORISEL,prescription,L01XE09,TEMSIROLIMUS,6993,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,TEMSIROLIMUS/ML,2025-07-31T09:27:40.205581,IL,פיזר,,3529.988033,2991.515415,2719.559469,,,TORISEL 25 MG/ML VIAL 1.2ML,20728,,83864,VIAL GLASS TYPE I,units,1.0,143 18 32044 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,First line treatment of patients with advanced renal cell carcinoma.Torisel is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b39c3659-2d6a-4267-986a-092ca34f70a4.json
b3a14680-367c-4f1f-9791-6da4d221612b,XIGDUO XR 10 MG/1000 MG,prescription,A10BD15,METFORMIN AND DAPAGLIFLOZIN,7934,,,WHO ATC Classification,,ILS,tablets extended release,"METFORMIN HYDROCHLORIDE 1005.04  MG, DAPAGLIFLOZIN PROPANEDIOL 12.30  MG",2025-07-31T10:35:25.948969,IL,אסטראזנקה,,nan,nan,nan,,,XIGDUO XR 5 MG/1000 MG 56 E.R. TAB,24091,,43968,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,155 69 34428 01,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3a14680-367c-4f1f-9791-6da4d221612b.json
b3b77ad5-1510-4d6e-bb79-d95d1321bf88,ONBREZ BREEZHALER 300MCG INHAL 30 HARD CAPS,prescription,,,6657,,,,,ILS,capsule,ONBREZ BREEZHALER 300MCG INHAL 30 HARD CAPS,2025-07-31T19:26:07.022140,IL,נוברטיס פארמה,,137.6686584,116.6683597,86.7422749,,,ONBREZ BREEZHALER 300MCG INHAL 30 HARD CAPS,15381,,24233,,units,30.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3b77ad5-1510-4d6e-bb79-d95d1321bf88.json
b3bd7752-a599-4386-84d1-a628869722d4,OPTALGIN TABLETS,off-the-counter,N02BB02,METAMIZOLE SODIUM,1625,,,WHO ATC Classification,,ILS,tablets,DIPYRONE,2025-07-31T12:40:25.831138,IL,טבע,,18.2546,15.47,nan,,7290000801834,OPTALGIN 500MG 20TAB,15036,,,BLISTER PVC/ALUMINIUM,units,20.0,016 87 20611 12,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3bd7752-a599-4386-84d1-a628869722d4.json
b3d4c24f-aed4-4b19-8c47-9d79bda3a592,AGISPOR SOLUTION,off-the-counter,D01AC10,BIFONAZOLE,2367,,,WHO ATC Classification,,ILS,solution,BIFONAZOLEW/V /,2025-07-31T11:06:37.934135,IL,פאדאגיס,,19.6116,16.62,nan,,7290000857329,AGISPOR SOL 15ML,1813,,,BOTTLE GLASS TYPE III,units,15.0,036 83 25609 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Broad spectrum antimycotic agent.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3d4c24f-aed4-4b19-8c47-9d79bda3a592.json
b3de7c26-0df8-4c02-8dc7-e0e3812e4647,VENTOLIN DISKUS,prescription,R03AC02,SALBUTAMOL,4350,,,WHO ATC Classification,,ILS,powder for inhalation,SALBUTAMOL AS SULFATE/DOSE,2025-07-31T10:05:20.690273,IL,ג.ס.ק,,19.35296988,16.40082266,11.9714034,,7290008085410,VENTOLIN DISKUS 200MCG 60DOSE,22158,,21927,BLISTER LAMINATED,units,60.0,126 97 30674 00,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"Relief of bronchospasm in broncial asthma of all types, chronic, bronchitis and emphysema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3de7c26-0df8-4c02-8dc7-e0e3812e4647.json
b3fb85c9-ec34-4d1f-9905-ee8563b296fd,TEPMETKO,prescription,L01EX21,TEPOTINIB,9037,,,WHO ATC Classification,,ILS,film coated tablets,TEPOTINIB AS HYDROCHLORIDE HYDRATE,2025-07-31T09:13:45.931696,IL,מרק סרונו,,33966.3846,28785.07298,26168.24816,,7290000845722,TEPMETKO 225MG 60 TABS,,,76921,BLISTER ALU/PVC-PE-PVDC-PE-PVC,units,60.0,169 25 36977 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,TEPMETKO is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harbouring a MET tyrosine kinase receptor exon 14 (METex14) skipping mutation.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3fb85c9-ec34-4d1f-9905-ee8563b296fd.json
b3fedfa2-5f73-4ade-b189-1890ca4c00c2,ROPIAVENIR 2 MG/ML,prescription,N01BB09,ROPIVACAINE,8275,,,WHO ATC Classification,,ILS,solution for injection / infusion,ROPIVACAINE HYDROCHLORIDE/,2025-07-31T07:48:34.194008,IL,ביואבניר,,395.9889755,335.5838775,285.6033,,,ROPIVACAIN  2MG/ML  200ML  5 BAG,,,42033,POUCH ALUMINIUM,units,5.0,179 58 38443 99,valid,17.5,"perineural, epidural",1.4,24,,,,,,,,,,0,Prescription required,"ROPIAVENIR 2 MG/ML is indicated for:Acute pain management :In adults and adolescents above 12 years of age for:- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain- Field blocks- Peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b3fedfa2-5f73-4ade-b189-1890ca4c00c2.json
b4009c4a-78c5-4563-92c8-be69f3634bc5,EVOXAC 30MG 100CAPS,29C,,,20077,,,,,,capsule,EVOXAC 30MG,2025-07-31T20:24:58.556862,IL,nan,,,,,,,EVOXAC 30MG 100CAPS,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b4009c4a-78c5-4563-92c8-be69f3634bc5.json
b40fcf64-aa88-45d2-b813-c98cd895bba7,ANAFRANIL 25 MG,prescription,N06AA04,CLOMIPRAMINE,516,,,WHO ATC Classification,,ILS,coated tablets,CLOMIPRAMINE HYDROCHLORIDE,2025-07-30T23:23:20.501247,IL,צמל,,15.4272138,13.07391,9.543,,7298087000041,ANAFRANIL 25MG 30TAB,1265,,221,BLISTER PVC/PE/PVDC,units,30.0,108 06 24600 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Adults:Depression of varying originObsessive-compulsive syndromesChildren and adolescents (5-18 years old):Obsessive-compulsive syndromes,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b40fcf64-aa88-45d2-b813-c98cd895bba7.json
b43d9472-af12-4a01-a556-908c9787ab89,CADEX 1 MG,prescription,C02CA04,DOXAZOSIN,3756,,,WHO ATC Classification,,ILS,tablets,DOXAZOSIN AS MESYLATE,2025-07-31T00:49:29.921852,IL,דקסל פארמה,,28.12932498,23.838411,17.4003,,,CADEX 4MG 30CAPL,3574,,51389,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,113 78 29600 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antihypertensive agent. For the treatment of benign prostatic hyperthropy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b43d9472-af12-4a01-a556-908c9787ab89.json
b44cb208-3cea-4f77-9fe0-1aeb9f56409f,ABILIFY  MAINTENA 300 MG,prescription,N05AX12,ARIPIPRAZOLE,8645,,,WHO ATC Classification,,ILS,powder and solvent for prolonged-release suspension for injection,ARIPIPRAZOLE AS MONOHYDRATE/VIAL,2025-07-30T23:26:56.256848,IL,סנדוז,,277.6915072,235.3317858,188.2654286,,,ARIPIPRAZOLE SANDOZ 10 MG 10 TAB,23402,,89164,VIAL GLASS TYPE I,units,30.0,153 68 34089 00,valid,25.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Abilify Maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b44cb208-3cea-4f77-9fe0-1aeb9f56409f.json
b455bd42-6cf7-457b-912e-d626b4c4f3b3,MINIRIN MELT 120 MCG,prescription,H01BA02,DESMOPRESSIN,6064,,,WHO ATC Classification,,ILS,sublingual tablets,DESMOPRESSIN AS ACETATE,2025-07-31T05:25:22.990037,IL,פרינג,,87.866864,74.46344738,55.3631579,,7640128540427,MINIRIN MELT 60MCG 30TAB,13596,,452,BLISTER PVC/ALUMINIUM,units,30.0,137 23 31463 00,valid,34.5,sublingual,1.4,36,,,,,,,,,,0,Prescription required,Nocturnal enuresis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b455bd42-6cf7-457b-912e-d626b4c4f3b3.json
b45c21e0-da11-4102-a448-25614dcc6cb7,ONGENTYS 50 MG,29C,N04BX04,OPICAPONE,20883,,,WHO ATC Classification,,ILS,"capsule, hard",OPICAPONE,2025-07-31T15:28:55.979069,IL,nan,,nan,nan,nan,,,ONGENTYS 25MG CAPSULES,,,,BLISTER OPA/ALU/PVC/ALU,units,10.0,170 17 37081 99,valid,nan,per os,1.4,60,,,,,,,,,,0,,ONGENTYS is indicated as adjunctive therapy to preparations of levodopa/ DOPA decarboxylase inhibitors (DDCI) in adult patients with Parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b45c21e0-da11-4102-a448-25614dcc6cb7.json
b471ca99-b0be-4d94-b64a-37538ba4fc65,ICLUSIG 15 MG,prescription,L01XE24,PONATINIB,7656,,,WHO ATC Classification,,ILS,coated tablets,PONATINIB AS HYDROCHLORIDE,2025-07-31T03:56:16.267283,IL,מדיסון,,14744.37665,12495.23501,11359.30455,,,ICLUSIG 15MG 30 COATED TAB,17205,,67021,BOTTLE HDPE,units,30.0,153 53 34243 02,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Iclusig is indicated in adult patients with:  • chronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (CML) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the T315I mutation  • Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the T315I mutation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b471ca99-b0be-4d94-b64a-37538ba4fc65.json
b47f20b8-29d6-4a5a-ace9-81ed28f02a61,DERMOVATE OINTMENT,prescription,D07AD01,CLOBETASOL,8162,,,WHO ATC Classification,,ILS,ointment,CLOBETASOL 17- PROPIONATE 0.05 %W/W,2025-07-31T01:49:24.049561,IL,ג.ס.ק,,17.45023354,14.78833417,10.7944045,,7290008086127,DERMOVATE OINTMENT 30 GR,4683,,54675,TUBE ALUMINIUM,units,30.0,027 57 22063 00,valid,37.0,topical,1.4,24,,,,,,,,,,0,Prescription required,"Clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. These include the following:• Psoriasis (excluding widespread plaque psoriasis)• Recalcitrant dermatoses  •Lichen planus• Discoid lupus erythematosus • Other skin conditions which do not respond satisfactorily to less potent steroids.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b47f20b8-29d6-4a5a-ace9-81ed28f02a61.json
b485af33-9b54-4c2a-9526-765fdb303537,CLINDAMYCIN INJECTIONS,prescription,J01FF01,CLINDAMYCIN,8877,,,WHO ATC Classification,,ILS,solution for injection,CLINDAMYCIN AS PHOSPHATE/ML,2025-07-31T01:20:42.010863,IL,רפא,,104.5929119,88.63806093,65.90190404,,7290008012218,CLINDAMYCIN INJ 150mg/ml 5 AMP 4ML,,,3908,AMPOULES GLASS TYPE I,units,5.0,120 48 30032 00,valid,34.5,"i.m, i.v",1.4,12,,,,,,,,,,0,Prescription required,The treatment of infections caused by susceptible anaerobic bacteria.,תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b485af33-9b54-4c2a-9526-765fdb303537.json
b4889df5-52b5-4f5f-94a4-7e80f905297c,IOMERON 300,prescription,V08AB10,IOMEPROL,8279,,,WHO ATC Classification,,ILS,solution for injection,IOMEPROL 612.4 MG/ML,2025-07-31T05:13:25.892059,IL,ביואבניר,,467.3339673,396.045735,337.0602,,,MERO AVENIR  0.5G  10VIAL,,,51367,BOTTLE GLASS TYPE I,units,10.0,103 45 28521 11,valid,17.5,"i.v, intra-arterial",1.4,60,,,,,,,,,,0,Prescription required,"Contrast medium for diagnostic radiology. Intravenous urography ( in adults and paediatrics), peripheral phlebography, CT (brain and body), cavernosography,  intravenous DSA, conventional angiography, intraarterial DSA, angiocardiography (in adults and paediatrics), conventional selective coronary arteriography, interventional coronary arteriography, ERCP, arthrography, hysterosalpingography, fistulography, discography, galactography, chloangiography, dacryocystography, sialography, retrograde urethrography, retrograde pyelo-ureterography.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b4889df5-52b5-4f5f-94a4-7e80f905297c.json
b48da70e-a292-4f41-9001-083d54e6091f,VERDYE,prescription,N/A,,8468,,,WHO ATC Classification,,ILS,powder for solution for injection,INDOCYANINE GREEN AS MONOSODIUM SALT/VIAL,2025-07-31T10:06:45.293780,IL,קונספט לרוקחות,,2375.66407,2013.274725,1830.24975,,,VERDYE 25MG 5VIAL,,,,VIAL GLASS TYPE I,units,5.0,129 12 29280 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"In cardiac, ciculatory and micro-circulatory diagnostics: measurement of circulation times, measurement of cardiac output and stroke volume, measurement of end-systolic ventricular volume, measurement of intrathoracic blood volume, measurement of circulationg blood volume,measurement of partial volumes, measurement of organ perfusion-measurement of intra-and extracardiac shunts, measurement of intracardiac valvular insufficiency, measurement of peripheral perfusion (e.g. perfusion of extremities, eyes). In liver function diagnostics: measurement of excretory function of the liver, determination of partial functions of the liver.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b48da70e-a292-4f41-9001-083d54e6091f.json
b49cb892-8009-4b0c-bde9-8a7b6fe8a027,GIOTRIF 20 MG,prescription,L01XE13,AFATINIB,7391,,,WHO ATC Classification,,ILS,film coated tablets,AFATINIB AS DIMALEATE,2025-07-31T03:33:19.624226,IL,בורינגר אינגלהיים,,8756.765492,7420.988035,6746.352759,,,GIOTRIF 30MG 28F.C.TAB,7909,,50940,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,151 47 33984 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,GIOTRIF as monotherapy is indicated for the treatment of: • EGFR TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s);• locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b49cb892-8009-4b0c-bde9-8a7b6fe8a027.json
b4a2397e-64cf-4019-995c-e922674b254a,AZITHROMYCIN INOVAMED 250 MG,prescription,J01FA10,AZITHROMYCIN,8328,,,WHO ATC Classification,,ILS,capsules,AZITHROMYCIN AS DIHYDRATE,2025-07-30T23:33:14.519755,IL,אינובמד,,33.48318086,28.375577,20.7121,,,AZITHROMYCIN INOVAMED 250 MG 6 CAPS,10298,,4219,BLISTER PVC/ALUMINIUM,units,6.0,160 55 35154 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Infections caused by susceptible organisms in lower respiratory tract including bronchitis and pneumonia, skin and soft tissue infections, otitis media, upper respiratory tract infections including sinusitis and pharyngitis, tonsilitis, also in the treatment of uncomplicated genital infections due to chlamydia trachomatis.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b4a2397e-64cf-4019-995c-e922674b254a.json
b4b26920-8375-436e-b354-81a3b891c40c,CHLORACTIL 100MG TABLETS,29C,,,20821,,,,,,tablet,CHLORACTIL 100MG TABLETS,2025-07-31T20:05:19.764300,IL,nan,,,,,,,CHLORACTIL 100MG TABLETS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b4b26920-8375-436e-b354-81a3b891c40c.json
b4d41081-c203-4e11-aaf6-2ae759169ea2,SUBOXONE FILM 4 MG/1 MG,prescription,N02AE01,BUPRENORPHINE,7180,,,WHO ATC Classification,,ILS,sublingual film,"BUPRENORPHINE AS HYDROCHLORIDE, NALOXONE AS HYDROCHLORIDE DIHYDRATE",2025-07-31T08:48:21.365435,IL,נעמי שאקו עזרה,,133.3752814,113.0298995,84.0371,,,SUBOXONE 2MG/0.5MG 28 TAB SUBLINGUAL,19887,,84715,FOIL ALUMINIUM,units,28.0,164 26 35833 00,valid,34.5,"buccal, sublingual",1.4,24,,,,,,,,,,0,Prescription required,Suboxone sublingual film is indicated for treatment of opioid dependence in adults and adolescents over 15 years of age. Suboxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b4d41081-c203-4e11-aaf6-2ae759169ea2.json
b4d871aa-c824-4d70-8131-c37fda5868a5,RIVOTRIL,prescription,N03AE01,CLONAZEPAM,339,,,WHO ATC Classification,,ILS,drops,CLONAZEPAM 2.5 MG/ML,2025-07-31T07:45:47.111889,IL,צמל,,19.01121515,16.1112,11.76,,7290008140072,RIVOTRIL DROPS 10ML,18075,,1909,BOTTLE GLASS TYPE III,units,10.0,061 31 21476 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Anti-epileptic. Panic disorder.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b4d871aa-c824-4d70-8131-c37fda5868a5.json
b4fc2d7a-37de-4a30-b4c5-ec877bf9419e,QUETIAPINE SANDOZ ® 150 MG PRT,prescription,N05AH04,QUETIAPINE,8836,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:10:32.098523,IL,סנדוז,,75.7475217,64.192815,47.727,,,QUETIAPINE SANDOZ  150 MG  30 PRT,17355,,70535,BLISTER PVC/PCTFE/AL,units,30.0,166 02 35776 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Sandoz PRT is indicated for the treatment of Schizophrenia. Quetiapine Sandoz PRT is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Sandoz PRT. Quetiapine Sandoz PRT  is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for the treatment of major depressive episodes in bipolar disorder. Quetiapine Sandoz PRT is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy . Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Sandoz PRT.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b4fc2d7a-37de-4a30-b4c5-ec877bf9419e.json
b501f542-31a0-478b-9bd1-50fbe93b18fd,PREGABALIN TARO 100 MG,prescription,N03AX16,PREGABALIN,8174,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:54:06.611118,IL,תרו יבוא,,200.1721025,169.637375,135.7099,,,PREGABALIN TARO 300 MG  56CAPS,,,59179,BLISTER PVC/ALUMINIUM,units,56.0,158 26 34762 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Pregabalin taro is indicated for the: •	Treatment of peripheral and central neuropathic pain in adults. •	Management of Fibromyalgia. •	Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b501f542-31a0-478b-9bd1-50fbe93b18fd.json
b5060962-9e56-4b62-9c58-f2aaeae05a91,LISSIN 20 MG,prescription,N06BA12,LISDEXAMFETAMINE,9525,,,WHO ATC Classification,,ILS,tablets,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T04:48:52.529050,IL,אוניפארם,,365.0862098,309.3951068,263.3149845,,,LISSIN 20 MG 30 TAB,,,,BLISTER PVDC/ALUMINIUM,units,30.0,176 71 37820 99,valid,17.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Lissin is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Lissin is indicated for the treatment of Moderate to Severe Binge Eating Disorder (BED) for patients over 18 years.Limitation of Use:Lissin is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Lissin for the treatment of obesity have not been established.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5060962-9e56-4b62-9c58-f2aaeae05a91.json
b5136eab-46e9-4c6f-87ce-4f9184e68349,XANAX X.R. 0.5 MG,prescription,N05BA12,ALPRAZOLAM,4309,,,WHO ATC Classification,,ILS,tablets sustained release,ALPRAZOLAM 0.5   MG,2025-07-31T10:29:30.341235,IL,דקסל פארמה,,44.44180944,37.66255204,27.4909139,,7298074000702,XANAX XR 2MG 30 SR TAB,24021,,2497,BLISTER ALUMINIUM,units,30.0,110 49 28804 21,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of anxiety and anxiety associated with depression.Treatment of panic disorder with or without phobic avoidance,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5136eab-46e9-4c6f-87ce-4f9184e68349.json
b5139026-4f93-41de-9d37-7ac72c9327ed,NUCALA POWDER FOR SOLUTION FOR INJECTION,prescription,L04AC06,MEPOLIZUMAB,8934,,,WHO ATC Classification,,ILS,powder for solution for injection,MEPOLIZUMAB,2025-07-31T05:57:38.290939,IL,ג.ס.ק,,4533.902377,3842.290321,3492.991201,,,NUCALA SOL FOR INJ 100MG/ML PEN,14703,,74037,VIAL 10 ML GLASS TYPE I,units,1.0,157 57 34861 00,valid,10.0,s.c,1.4,48,,,,,,,,,,0,Prescription required,Severe eosinophilic asthmaNucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adult patientsChronic rhinosinusitis with nasal polyps (CRSwNP)Nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe CRSwNP for whom therapy with corticosteroids and surgery in the last 10 years do not provide adequate disease control.Eosinophilic Granulomatosis with Polyangiitis (EGPA)Nucala is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).Hypereosinophilic syndrome (HES)Nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5139026-4f93-41de-9d37-7ac72c9327ed.json
b52d17ca-a543-477f-aff4-13f9e660884d,RIAVENIR LA 10 MG MODIFIED RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,8939,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:33:51.519169,IL,ביואבניר,,77.92893605,66.04147123,49.1014656,,,RIAVENIR LA 20 MG 30 CAPSULES,,,76591,BOTTLE HDPE,units,30.0,167 43 36188 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b52d17ca-a543-477f-aff4-13f9e660884d.json
b53185e8-f5c3-44cc-9e97-206112a5a5d5,E-Z-HD POWDER FOR SUSP 340ML/340G,prescription,,,6973,,,,,ILS,tablet,E-Z-HD POWDER FOR SUSP /340G,2025-07-31T19:10:34.101687,IL,אלדן,,72.71527123,61.62311395,45.8164416,,,E-Z-HD POWDER FOR SUSP 340ML/340G,,,,,units,340.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b53185e8-f5c3-44cc-9e97-206112a5a5d5.json
b53e93b5-ad74-41f4-a542-58b43a80d4b5,LUCRIN DEPOT 11.25MG/VIAL,prescription,,,4101,,,,,ILS,injection,LUCRIN DEPOT 11.25MG/VIAL,2025-07-31T19:17:10.903114,IL,אב-וי,,1338.748012,1134.532264,965.5593735,,,LUCRIN DEPOT 11.25MG/VIAL,12358,,68754,,units,1.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b53e93b5-ad74-41f4-a542-58b43a80d4b5.json
b55d6a9f-0d90-4552-9b3d-156f08f1310f,ALCOTINT 70,off-the-counter,D08AX08,ETHANOL,3974,,,WHO ATC Classification,,ILS,solution,ALCOHOL59.7 G /,2025-07-31T11:10:46.101049,IL,ויטאמד,,9.9946,8.47,nan,,7290008068857,ALCOTINT 70% 100ML,1431,,,BOTTLE HDPE,units,100.0,116 46 28135 00,valid,nan,dermal,1.4,48,,,,,,,,,,0,,For cleaning and disinfection of the skin.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b55d6a9f-0d90-4552-9b3d-156f08f1310f.json
b5610082-e2e8-4161-a4cc-b8c2a4e9d094,DUPLEX 10/160,prescription,C09CA03,VALSARTAN,9180,,,WHO ATC Classification,,ILS,coated tablets,"VALSARTAN, AMLODIPINE AS BESILATE",2025-07-31T02:08:25.856304,IL,אוניפארם,,124.885328,105.8350238,78.68775,,,DUPLEX 5/160  30 TABS,,,36968,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,153 26 34298 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of essential hypertension. Duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5610082-e2e8-4161-a4cc-b8c2a4e9d094.json
b566ed0d-c359-474f-9a22-7024abf863e5,NEURONTIN 300 MG,prescription,N03AX12,GABAPENTIN,3334,,,WHO ATC Classification,,ILS,capsules,GABAPENTIN,2025-07-31T05:44:00.777750,IL,דקסל פארמה,,106.9560974,90.6407605,67.3909,,,NEURONTIN 300MG 100CAPS,14090,,9580,BLISTER PVC/ALUMINIUM,units,100.0,125 05 30497 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Epilepsy :- Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults  and adolescents ( age 12 and up ) with epilepsy.- Treatment of neuropathic pain- Gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b566ed0d-c359-474f-9a22-7024abf863e5.json
b57b253e-52a5-4fc0-be12-16a750c8d090,ACROSE 100,prescription,A10BF01,ACARBOSE,6620,,,WHO ATC Classification,,ILS,tablets,ACARBOSE,2025-07-30T23:12:16.608312,IL,רפא,,28.6582765,24.286675,17.7275,,7290008016360,ACROSE 100MG 30TAB,9386,,18666,BLISTER PVC/PE/PVDC/AL,units,30.0,142 79 31979 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Treatment of non-insulin dependent diabetes mellitus (NIDDM) in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b57b253e-52a5-4fc0-be12-16a750c8d090.json
b57e386d-428c-464f-b7f7-324f2e828299,RAXONE IDEBENONE,prescription,N06BX13,IDEBENONE,8368,,,WHO ATC Classification,,ILS,film coated tablets,IDEBENONE,2025-07-31T07:17:33.234812,IL,מגאפארם,,23099.81786,19576.1177,17796.47063,,,RAXONE 150MG  FILM COATED TAB 180TAB,,,77720,BOTTLE HDPE,units,180.0,159 18 34904 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Raxone is indicated for the treatment of visual impairment in adolescent and adult patients with Leber’s Hereditary Optic Neuropathy (LHON).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b57e386d-428c-464f-b7f7-324f2e828299.json
b5a48f44-782c-4e3e-89b9-d770322be76e,CEFOVIT 250,prescription,J01DB01,CEFALEXIN,2276,,,WHO ATC Classification,,ILS,capsules,CEFALEXIN AS MONOHYDRATE,2025-07-31T00:59:56.917608,IL,ויטאמד,,19.5455023,16.563985,12.0905,,,CEFOVIT 250 SUSP 60ML,3590,,7693,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,026 84 25145 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic for the treatment of infections caused by micro-organisms sensitive to Cephalexin.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5a48f44-782c-4e3e-89b9-d770322be76e.json
b5b2bfc0-c7a9-496b-800f-c976c8a6b814,ADAKVEO 10 MG/ML,prescription,B06AX01,CRIZANLIZUMAB,9052,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,CRIZANLIZUMAB/ML,2025-07-31T04:52:08.309082,IL,ליברה,,45.99616245,38.97980042,28.45240907,,,LIZ TABS 1(24+4),,,70496,VIAL GLASS TYPE I,units,28.0,168 71 36562 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,ADAKVEO is indicated to reduce the frequency of vasoocclusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5b2bfc0-c7a9-496b-800f-c976c8a6b814.json
b5c6ca0f-3927-4ac8-bec0-f6a0cd789e31,BETACALCIP TEVA,prescription,D05AX52,"CALCIPOTRIOL, COMBINATIONS",9605,,,WHO ATC Classification,,ILS,ointment,"CALCIPOTRIOL/, BETAMETHASONE AS DIPROPIONATE 0.5  MG /",2025-07-31T00:32:24.492171,IL,טבע,,64.95255423,55.04453993,40.9253085,,,BETACALCIP TEVA OINT TUBE 30 G,,,84543,TUBE ALUMINIUM,units,30.0,168 63 36863 99,valid,34.5,dermal,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5c6ca0f-3927-4ac8-bec0-f6a0cd789e31.json
b5cea117-74a4-4026-9efa-d664871bee30,CRESTOR ® 5 MG,prescription,C10AA07,ROSUVASTATIN,4708,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T01:33:40.265589,IL,אסטראזנקה,,165.553115,140.29925,112.2394,,,CRESTOR 40MG 28TAB,3756,,60451,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,139 22 31615 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5cea117-74a4-4026-9efa-d664871bee30.json
b5d5ebbf-d7ad-49d7-8f24-ba78a976b383,TRAZIMERA 150 MG,prescription,L01FD01,TRASTUZUMAB,8751,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,TRASTUZUMAB/VIAL,2025-07-31T09:37:10.895410,IL,פיזר,,4395.045268,3724.614799,3386.013454,,,TRAZIMERA 420 MG 1 VIAL,,,75587,VIAL GLASS TYPE I,units,1.0,166 30 36300 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Metastatic Breast Cancer (MBC)TRAZIMERA is indicated for the treatment of patients with metastatic breast cancer who have tumors that overexpress HER2;1. As a single agent, for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease.2. In combination with Paclitaxel or Docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease.3. In combination with an aromatase inhibitor for the treatment of postmenopausal patient with hormone-receptor positive metastatic breast cancer.Early Breast Cancer (EBC)TRAZIMERA is indicated to treat patients with HER2 positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding anthracyclines.TRAZIMERA should only be used in patients whose tumours have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay.HER2 Metastatic Gastric Cancer (MGC)TRAZIMERA in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.TRAZIMERA should only be used in patients with metastatic gastric cancer whose tumours have HER2 overexpression as defined by IHC2+ and a confirmatory FISH+ result, or IHC 3+, as determined by an accurate and validated assay.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5d5ebbf-d7ad-49d7-8f24-ba78a976b383.json
b5d67d63-ebce-4f13-b7f9-7546c8ea008f,JEVTANA,prescription,L01CD04,CABAZITAXEL,6712,,,WHO ATC Classification,,ILS,concentrate and solvent for solution for infusion,CABAZITAXEL/ML,2025-07-31T04:19:42.268432,IL,סאנופי אוונטיס,,10986.35855,9310.473349,8464.066681,,7290012711305,JEVTANA 60MG/1.5ML VIAL15ML,10052,,24230,VIAL GLASS TYPE I,units,1.0,145 23 33286 02,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,JEVTANA is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel- containing treatment regimen.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5d67d63-ebce-4f13-b7f9-7546c8ea008f.json
b5dd6c1c-15d8-4f21-98cb-64acebeb9a96,VOLTAREN EMULGEL 1%,off-the-counter,M02AA15,DICLOFENAC,5491,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T13:37:35.497037,IL,ג.ס.ק,,103.3798,87.61,nan,,,VOLTAREN EMULGEL FORTE 100GR,,,,TUBE ALUMINIUM,units,100.0,037 66 25000 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to:  • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :• Pain caused by osteoarthrosis of the peripheral joints,  as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5dd6c1c-15d8-4f21-98cb-64acebeb9a96.json
b5e358eb-41a3-489a-a9fc-59a2ef24656f,PIQRAY 150 MG,prescription,L01XX65,ALPELISIB,8527,,,WHO ATC Classification,,ILS,film coated tablets,ALPELISIB,2025-07-31T06:44:50.254979,IL,נוברטיס פארמה,,nan,nan,nan,,7290018375136,PIQRAY 50 MG 28 TAB,10906,,28444,BLISTER PVC/PCTFE,units,28.0,166 18 36148 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"PIQRAY is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5e358eb-41a3-489a-a9fc-59a2ef24656f.json
b5f057ee-5f1b-4a33-ad56-90ce1976bc70,QARZIBA,29C,L01XC16,DINUTUXIMAB,8117,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DINUTUXIMAB BETA 4.5  MG /,2025-07-31T14:21:17.786890,IL,nan,,nan,nan,nan,,7290015666732,DINUTUXIMAB BETA APEIRON 4.5 MG/ML SOLUTION FOR INFUSION,,,,VIAL GLASS TYPE I,units,1.0,162 50 35299 00,valid,nan,i.v,1.4,48,,,,,,,,,,0,,"Qarziba is indicated for the treatment of high-risk neuroblastoma in patients aged 12 months and above, who have previously received induction chemotherapy and achieved at least a partial response, followed by myeloablative therapy and stem cell transplantation, as well as patients with history of relapsed or refractory neuroblastoma, with or without residual disease. Prior to the treatment of relapsed neuroblastoma, any actively progressing disease should be stabilised by other suitable measures.In patients with a history of relapsed/refractory disease and in patients who have not achieved a complete response after first line therapy, Qarziba should be combined with interleukin-2 (IL-2).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5f057ee-5f1b-4a33-ad56-90ce1976bc70.json
b5fc9330-2439-4f88-987b-b2630d22251a,CIPRALEX 10 MG,prescription,N06AB10,ESCITALOPRAM,6710,,,WHO ATC Classification,,ILS,film coated tablets,ESCITALOPRAM AS OXALATE,2025-07-31T01:15:38.378658,IL,לנדבק,,34.35970138,29.118391,21.2543,,,CIPRALEX 15MG 28TAB,9418,,25297,BLISTER PVC/PE/PVDC/AL,units,28.0,127 01 30558 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of depression and panic disorder.   Treatment of generalized anxiety disorder (GAD)  treatment of social anxiety disorder (social phobia).   Treatment of obsessive - compulsive disorder.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b5fc9330-2439-4f88-987b-b2630d22251a.json
b61ca37a-dbd9-4eb6-a880-9f2cf301c44d,TAGRISSO 40 MG,prescription,L01XE35,OSIMERTINIB,7840,,,WHO ATC Classification,,ILS,tablets,OSIMERTINIB AS MESYLATE,2025-07-31T09:01:37.930884,IL,אסטראזנקה,,25401.12848,21526.38102,19569.4373,,,TAGRISSO 80MG 30TAB,20812,,77850,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,155 86 34627 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Adjuvant Treatment of EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)•	TAGRISSO is indicated as adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations.First-line Treatment of EGFR Mutation-Positive Locally Advanced or Metastatic NSCLC•	TAGRISSO in combination with pemetrexed and platinum-based chemotherapy is indicated for the first line treatment of adult patients with locally advanced or metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations. Locally Advanced, Unresectable (Stage III) EGFR Mutation-Positive NSCLC •	TAGRISSO is indicated for the treatment of adult patients with locally advanced, unresectable (stage III) NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based chemoradiation therapy and whose tumors have EGFR exon 19 deletions or exon 21 L858R mutationsTAGRISSO as monotherapy is indicated for:•	The first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.•	The treatment of adult patients with locally advanced or metastatic EGFR T790M mutation-positive NSCLC.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b61ca37a-dbd9-4eb6-a880-9f2cf301c44d.json
b61e62ea-83aa-4533-9232-3256cd583a28,SIGNIFOR LAR 10 MG,prescription,H01CB05,PASIREOTIDE,9343,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,PASIREOTIDE AS PAMOATE/VIAL,2025-07-31T08:11:13.433272,IL,מדיסון,,14360.6709,12170.06063,11063.69148,,,SIGNIFOR LAR 10 MG 1 VIAL,,,78947,VIAL GLASS TYPE I,units,1.0,172 50 36981 99,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b61e62ea-83aa-4533-9232-3256cd583a28.json
b62ec806-34fa-474c-8177-040e25646029,SWISS RELIEF DUAL RELEASE,off-the-counter,S01BC03,DICLOFENAC,5258,,,WHO ATC Classification,,ILS,capsules,DICLOFENAC SODIUM,2025-07-31T13:24:44.263910,IL,פאדאגיס,,77.1484,65.38,nan,,,SWISS RELIEF SPRAY GEL 25GR,19859,,,BLISTER PVC/PVDC/ALUMINIUM,units,25.0,142 10 31815 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,As a non-steroidal anti-inflamatory analgesic in symptomatic management of rheumatoid arthritis osteoarthritis and ankylosying spondylitis acute musculo-skeletal disorders such as periarthritis  tendenitis tensynovitis bursitis sprains  strains and dislocations relief of pain in fractures low back pain acute gout  psoriatic arthropathy.   In the management of pain and inflammation associated with orthopaedic  dental and minor surgery.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b62ec806-34fa-474c-8177-040e25646029.json
b637aa25-24db-4418-8ce9-42328167595f,DEXAMETHASONE 0.5 MG,prescription,H02AB02,DEXAMETHASONE,1928,,,WHO ATC Classification,,ILS,tablets,DEXAMETHASONE 0.5  MG,2025-07-31T01:52:23.147148,IL,רקח,,23.04657292,19.530994,14.2562,,7290008089159,DEXAMETHASONE 0.5MG 30T,4091,,715,SECURITAINER POLYPROPYLENE,units,30.0,118 05 22579 00,valid,37.0,per os,1.4,18,,,,,,,,,,0,Prescription required,"Indicated in a wide variety of disorders amenable to glucocorticoid therapy, as well as an adjunct in the control of cerebral oedema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b637aa25-24db-4418-8ce9-42328167595f.json
b656e80a-ac6f-4567-ba68-6d7a10d415f8,TRANXAL 5MG 30CAP,prescription,,,2358,,,,,ILS,tablet,TRANXAL 5MG 30CAP,2025-07-31T19:37:01.618705,IL,כ.צ.ט,,14.921218,12.6451,9.23,,,TRANXAL 5MG 30CAP,20449,,7542,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b656e80a-ac6f-4567-ba68-6d7a10d415f8.json
b6594949-1cd9-4a03-8881-607917c82ca3,CAMZYOS 10 MG,prescription,C01EB24,MAVACAMTEN,9502,,,WHO ATC Classification,,ILS,capsules,MAVACAMTEN,2025-07-31T00:51:54.382642,IL,ב.מ.ס,,7718.263193,6540.901302,5946.273911,,,CAMZYOS 5 MG 28 CAPS,,,31532,BLISTER PVC/PCTFE(ACLAR)/ALUMINIUM,units,28.0,174 20 37421 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6594949-1cd9-4a03-8881-607917c82ca3.json
b67353b1-f0ce-4fa3-b838-6195ca5c9b19,DIFLUCAN 50 MG/5 ML,prescription,J02AC01,FLUCONAZOLE,7102,,,WHO ATC Classification,,ILS,powder for oral suspension,FLUCONAZOLE/,2025-07-31T03:11:01.150491,IL,ביואבניר,,69.13899601,58.5923695,43.5631,,7290008094153,FLUCONAZOL 2MG/ML 1VIAL/100ML,6494,,36413,BOTTLE HDPE,units,100.0,106 79 29073 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:•	Cryptococcal meningitis.•	Coccidioidomycosis.•	Invasive candidiasis.•	Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.•	Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.•	Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.•	Candidal balanitis when local therapy is not appropriate.•	Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.•	Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:•	Relapse of cryptococcal meningitis in patients with high risk of recurrence.•	Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•	To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).•	Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.  Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b67353b1-f0ce-4fa3-b838-6195ca5c9b19.json
b6755f42-6384-431e-b099-c4e2987362f3,RIAVENIR LA 10 MG MODIFIED RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,8941,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:34:07.449730,IL,ביואבניר,,159.9873946,135.5825378,108.4660303,,,RIAVENIR LA 40 MG 30 CAPSULES,,,76593,BOTTLE HDPE,units,30.0,167 43 36188 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6755f42-6384-431e-b099-c4e2987362f3.json
b689fa56-0340-45c8-8cd9-4fc9bf1947d6,TECARTUS,prescription,,,8804,,,,,ILS,dispersion for infusion,ANTI-CD19 CAR T CELLS 0.4-2x10^8 CELLS/ BAG,2025-07-31T09:08:43.828770,IL,גיליאד,,1699234.184,1440029.034,1309117.303,,,TECARTUS,,,80264,CRYOGENIC BAG POLYOLEFINE,units,1.0,168 50 36655 00,valid,10.0,i.v,1.4,12,,,,,,,,,,0,Prescription required,Acute Lymphoblastic Leukaemia Tecartus is indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).Mantle Cell Lymphoma Tecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after two or more lines of systemic therapy including a Bruton's tyrosine kinase (BTK) inhibitor unless ineligible to BTK inhibitor •Limitation of Use : TECARTUS is not indicated for the treatment of patients with active central nervous system lymphoma,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b689fa56-0340-45c8-8cd9-4fc9bf1947d6.json
b68e878b-da64-4550-bf4f-8018736f89f4,ISOPTOCARPINE 4% EYE DROP 15ML,29C,,,20854,,,,,,tablet,ISOPTOCARPINE 4% EYE DROP,2025-07-31T20:41:23.477137,IL,nan,,,,,,,ISOPTOCARPINE 4% EYE DROP 15ML,,,,,units,15.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b68e878b-da64-4550-bf4f-8018736f89f4.json
b6ad4e36-998d-4db5-a3cd-291c2fc7e1ac,LAXADIN,prescription,A06AB02,BISACODYL,7207,,,WHO ATC Classification,,ILS,film coated tablets,BISACODYL,2025-07-31T04:37:17.253638,IL,טבע,,29.8723431,25.315545,18.4785,,,LAXADIN 5MG 30 TAB,12492,,41020,BLISTER PVC/ALUMINIUM,units,30.0,018 16 24419 12,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,All types of constipation in ambulatory and bedridden in patients over the age of 6 years . Preparation of patients for abdominal radiography and proctoscopy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6ad4e36-998d-4db5-a3cd-291c2fc7e1ac.json
b6b09ace-9ca3-4a6c-8014-d5e74e10288d,PROPECIA,prescription,G04CB01,FINASTERIDE,6176,,,WHO ATC Classification,,ILS,film coated tablets,FINASTERIDE,2025-07-31T07:02:15.576440,IL,אורגנון,,456.1497651,386.5675975,328.9937,,,PROPECIA 1MG 98TAB,16795,,78305,BLISTER PVC/ALUMINIUM,units,98.0,140 64 29458 11,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Propecia is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6b09ace-9ca3-4a6c-8014-d5e74e10288d.json
b6b7f12e-fe92-4b23-a19b-1496b9cd4934,SERTRALINE TEVA ® 100 MG,prescription,N06AB06,SERTRALINE,4839,,,WHO ATC Classification,,ILS,film coated tablets,SERTRALINE AS HYDROCHLORIDE,2025-07-31T08:08:18.995482,IL,טבע,,46.37508088,39.300916,28.6868,,7290106060715,SERTRALINE TEVA 100MG 30TAB,19807,,71254,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,132 13 30900 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of symptoms of depression in patients with or without a history of mania. Following satisfactory response, continuation with sertaline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6b7f12e-fe92-4b23-a19b-1496b9cd4934.json
b6bb63fd-66d3-4078-8c46-ef3270a9b99e,NIMENRIX,prescription,J07AH02,OTHER MENINGOCOCCAL MONOVALENT PURIFIED POLYSACCHARIDES ANTIGEN,7327,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,"NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W - 135 POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE",2025-07-31T05:46:41.481639,IL,פיזר,,226.1855229,191.6826551,153.3461241,,7290014547124,NIMENRIX 1X0.5ML VIAL POWDER+PRE FILLED SYR SOLVENT,14558,,50290,VIAL GLASS TYPE I,units,1.0,150 74 33816 00,valid,25.0,i.m,1.4,48,,,,,,,,,,0,Prescription required,"Nimenrix is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal diseases caused by Neisseria meningitidis group A, C, W-135 and Y.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6bb63fd-66d3-4078-8c46-ef3270a9b99e.json
b6bd1e69-ad4c-41a4-be5f-220d55402f0d,JORVEZA 0.5 MG,prescription,A07EA06,BUDESONIDE,8511,,,WHO ATC Classification,,ILS,tablets orodispersible,BUDESONIDE 0.5  MG,2025-07-31T04:20:03.668406,IL,רפא,,1969.33746,1668.930125,1420.366064,,,JORVEZA 1 MG 90 TAB,,,25914,BLISTER ALUMINIUM /ALUMINIUM,units,90.0,172 53 36975 99,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of eosinophilic esophagitis (EoE) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6bd1e69-ad4c-41a4-be5f-220d55402f0d.json
b6c16065-a91d-463b-a06f-f8bd2868de97,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7705,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:37:20.088135,IL,סנדוז,,709.2040396,601.0203725,511.5067,,,BINOCRIT 20000 I.U/0.5 ML 1 SYRINGE PREFILLED,2564,,56147,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6c16065-a91d-463b-a06f-f8bd2868de97.json
b6c73d42-f307-40e4-978f-5b319edf3b53,MOXYPEN ® FORTE 500 MG CAPSULES,prescription,J01CA04,AMOXICILLIN,1602,,,WHO ATC Classification,,ILS,capsules,AMOXICILLIN AS TRIHYDRATE,2025-07-31T05:34:07.351070,IL,טבע,,15.03438,12.741,9.3,,7290000801605,MOXYPEN FTE 500MG 10CAPS,13385,,7286,BLISTER PVC/PVDC/ALUMINIUM/PAPER,units,10.0,130 22 30823 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Infections caused by amoxycillin - susceptible organisms. Prevention of bacteremia in patients at risk of developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6c73d42-f307-40e4-978f-5b319edf3b53.json
b6cfc8f6-9989-4ab9-b91f-aa4b61b4bc1b,TRICLONAM SYR 100ML,prescription,,,2359,,,,,,tablet,TRICLONAM SYR,2025-07-31T19:37:23.442313,IL,כ.צ.ט,,,,,,,TRICLONAM SYR 100ML,20186,,2249,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6cfc8f6-9989-4ab9-b91f-aa4b61b4bc1b.json
b6fe1f1b-b14a-465f-95a9-4640af9fa731,MERCAPTIZOL,29C,H03BB02,THIAMAZOLE,20107,,,WHO ATC Classification,,ILS,tablets,METHIMAZOLE,2025-07-31T15:11:25.655802,IL,nan,,nan,nan,nan,,7290012066498,METHIMAZOLE 5MG 100TAB,,,,BLISTER PVC/ALUMINIUM,units,100.0,014 89 24453 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the treatment of hyperthyroidism.בקשה לתוספת משטר מינון: 8/8/2023Adult - The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8-hour intervals. The maintenance dosage is 5 to 15 mg daily. To achieve a required dosage of 5 mg, an intake of 10 mg every other day is suggested.Pediatric - Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8-hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6fe1f1b-b14a-465f-95a9-4640af9fa731.json
b6ff8722-369f-421c-a6ba-25ba430bc1a9,BOTOX 100,prescription,M03AX01,BOTULINUM TOXIN,6719,,,WHO ATC Classification,,ILS,powder for solution for injection,BOTULINUM TOXIN TYPE A 100 U/VIAL,2025-07-31T00:41:24.798873,IL,אב-וי,,894.4015001,757.9674067,645.078644,,7290008127103,BOTOX 100 U 1 VIAL,2553,,10874,VIAL GLASS TYPE I,units,1.0,057 68 27328 00,valid,17.5,"intradermal, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Neurologic disorders:•	•Focal spasticity associated with dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients two years of age or older. •	•	Focal spasticity of the wrist and hand in adult •	Focal spasticity of the lower limb, including ankle and foot in adult. •	•Blepharospasm or VII nerve disorders in patients over 12 years, hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. •	•Reduction of the signs and symptoms of Cervical dystonia (spasmodic torticollis) in adults. •	•Symptom relief in adults fulfilling criteria for chronic migraine (headaches on &#8805;15 days per month of which at least 8 days with migraine) in patients who have responded inadequately or are intolerant of prophylactic migraine medications. Bladder disorders: •Management of overactive bladder with symptoms of urinary incontinence, urgency and frequency in adult patients who have an inadequate response to, or are intolerant of, anticholinergic medication. •Urinary incontinence in adults with neurogenic detrusor overactivity resulting from neurogenic bladder due to stable sub-cervical spinal cord injury, or multiple sclerosis. Skin and skin appendage disorder: •Management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment. •For the temporary improvement in the appearance of: - moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines) and/or, - moderate to severe lateral canthal lines (crow’s feet lines) seen at maximum smile and/or, - moderate to severe forehead lines seen at maximum eyebrow elevation when the severity of the facial lines has an important psychological impact in adult patients.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b6ff8722-369f-421c-a6ba-25ba430bc1a9.json
b703ceb4-4c93-4b50-bd14-31ce235aec52,BUVIDAL 128 MG,29C,N07BC01,BUPRENORPHINE,8497,,,WHO ATC Classification,,ILS,prolonged release solution for injection,BUPRENORPHINE/ML,2025-07-31T14:01:15.975521,IL,nan,,nan,nan,nan,,,BUVIDAL 8 MG /0.16 ML 1 SRINGE,,,,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,168 78 36086 00,valid,nan,s.c,1.4,30,,,,,,,,,,0,,"Treatment of opioid dependence within a framework of medical, social and psychological treatment.Treatment is intended for use in adults and adolescents aged 16 years or over.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b703ceb4-4c93-4b50-bd14-31ce235aec52.json
b716aca6-70b7-4169-8ba9-6a559f30489c,SUGAMAX,prescription,V03AB35,SUGAMMADEX,9295,,,WHO ATC Classification,,ILS,solution for injection,SUGAMMADEX AS SODIUM/,2025-07-31T08:49:18.510683,IL,אוניפארם,,2552.159726,2162.847225,1966.22475,,,SUGAMAX 100MG/ML 10 VIAL2ML,,,52309,VIAL GLASS TYPE I,units,10.0,171 95 36340 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Sugamax is indicated for reversal of neuromuscular blockade induced by rocuronium or vecuronium.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b716aca6-70b7-4169-8ba9-6a559f30489c.json
b76c7746-8b59-4cfc-a3c8-63d43dc4092c,PREFEMIN,off-the-counter,G02CX03,AGNI CASTI FRUCTUS ,5627,,,WHO ATC Classification,,ILS,film coated tablets,AGNI CASTI FRUCTUS,2025-07-31T12:51:54.085952,IL,רפא,,nan,nan,nan,,7290017179407,PREFEMIN 20 MG 30 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,164 38 35417 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the treatment of PMS (premenstrual syndrome) complaints recurring monthly prior to menstruation in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b76c7746-8b59-4cfc-a3c8-63d43dc4092c.json
b777b105-c25e-4515-978b-499f13b0b34c,FUNGILLIN 10MG 1LOZANGE,29C,,,20421,,,,,,tablet,FUNGILLIN 10MG 1LOZANGE,2025-07-31T20:30:24.398306,IL,nan,,,,,,,FUNGILLIN 10MG 1LOZANGE,,,,,units,1.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b777b105-c25e-4515-978b-499f13b0b34c.json
b77d79f2-5a74-4785-b4f7-ad243dd7ee6b,QUETIAPINE TEVA ® 100 MG,prescription,N05AH04,QUETIAPINE,7342,,,WHO ATC Classification,,ILS,film coated tablets,QUETIAPINE AS FUMARATE,2025-07-31T07:11:22.448968,IL,טבע,,54.01189928,45.772796,33.4108,,7290102065721,QUETIAPINE TEVA 100MG 30TAB,17029,,49801,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,150 04 33719 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Ttreatment  of schizophrenia. Treatment of manic episodes associated with bipolar disorder.Treatment of major depressive episodes in bipolar disorders.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b77d79f2-5a74-4785-b4f7-ad243dd7ee6b.json
b78b7d48-2f2a-4f30-8253-cd510f6c4be5,MOXYVIT FORTE 250 SUSPENSION,prescription,J01CA04,AMOXICILLIN,8000,,,WHO ATC Classification,,ILS,powder for oral suspension,AMOXICILLIN AS TRIHYDRATE/ML,2025-07-31T05:35:05.313803,IL,ויטאמד,,24.63326582,20.875649,15.2377,,,MOXYVIT FORTE 250 SUSPENSION 100 ML,13779,,18553,BOTTLE HDPE,units,100.0,045 22 26064 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,•	For the treatment of infections caused by bacteria susceptible to amoxicillin.•	Intended for the prevention of bacterial infections in patients who are at risk for developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b78b7d48-2f2a-4f30-8253-cd510f6c4be5.json
b79db63b-e5c0-44ae-a747-f6e43b5fac8a,CERTICAN ® 0.25 MG TABLETS,prescription,L04AA18,EVEROLIMUS,4840,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS 0.25   MG,2025-07-31T01:07:22.475246,IL,נוברטיס פארמה,,417.2137748,353.5710113,300.911499,,,CERTICAN 0.25MG 60 TAB,3790,,13350,BLISTER PVC/PA/ALUMINIUM,units,60.0,132 60 31066 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Kidney and heart transplantationCertican ® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in adult patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b79db63b-e5c0-44ae-a747-f6e43b5fac8a.json
b7a61f22-7395-4c1e-9905-65c21c0ab013,KEMADRIN TABLETS 5 MG,prescription,N04AA04,PROCYCLIDINE,2470,,,WHO ATC Classification,,ILS,tablets,PROCYCLIDINE HYDROCHLORIDE,2025-07-31T04:23:59.149333,IL,פאדאגיס,,27.39265531,23.2141157,16.94461,,7290008105262,KEMADRIN 5MG 100TAB,11047,,1130,BOTTLE GLASS,units,100.0,018 27 20446 05,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Indicated in all forms of parkinson's disease: idiopathic (paralysis agitans), post encephalitic and arteriosclerotic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7a61f22-7395-4c1e-9905-65c21c0ab013.json
b7a63d2d-dd3a-4091-83ef-7115a52faa4e,METHYLPHENIDATE SANDOZ ® 54 MG PRT,prescription,N06BA04,METHYLPHENIDATE,9355,,,WHO ATC Classification,,ILS,tablets prolonged release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:17:32.136877,IL,סנדוז,,121.5693206,103.024848,76.5984,,,METHYLPHENIDATE SANDOZ  18 MG 30 SR TAB,,,14604,BOTTLE HDPE,units,30.0,169 45 36080 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Methylphenidate Sandoz® PRT is indicated for the treatment of Attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7a63d2d-dd3a-4091-83ef-7115a52faa4e.json
b7b1f8d3-1b8b-444e-ae35-ace7488da3e7,ERDOTIN,prescription,R05CB15,ERDOSTEINE,6766,,,WHO ATC Classification,,ILS,capsules,ERDOSTEINE,2025-07-31T02:33:15.003135,IL,מגאפארם,,52.72930347,44.68585239,32.6174105,,7290004448714,ERDOTIN 300MG 20CAPS,5532,,27740,BLISTER PVC/PVDC,units,20.0,135 02 31112 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Mucolytic agent in acute and chronic respiratory diseases.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7b1f8d3-1b8b-444e-ae35-ace7488da3e7.json
b7b453e1-70cd-4f0a-a378-f784d4b7aa5e,BUDESONIDE STERINEBS TEVA ® 0.5 MG/2 ML,prescription,R01AD05,BUDESONIDE,6522,,,WHO ATC Classification,,ILS,suspension for inhalation,BUDESONIDE 0.25  MG /,2025-07-30T23:45:30.660823,IL,טבע,,88.28815106,74.820467,55.6286,,,BUDESONIDE STERINEBS TEVA 0.5MG/2ML 20UNITS,2502,,11551,AMPOULES POLYETHYLENE,units,20.0,142 43 33002 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Bronchial asthma especially in cases where other therapy is insufficient or insuitable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7b453e1-70cd-4f0a-a378-f784d4b7aa5e.json
b7d66f5b-47fb-47e6-a5f9-52f1e4e51e42,CARGLUMIC  ACID WAYMADE 200 MG,prescription,A16AA05,CARGLUMIC ACID,9498,,,WHO ATC Classification,,ILS,dispersible tablets,CARGLUMIC ACID,2025-07-31T00:55:24.559533,IL,אמ.בי.איי פארמה,,13633.77799,11554.04966,10503.68151,,,CARGLUMIC  ACID WAYMADE 200 MG 60 DISP. TAB,,,11655,BLISTER ALUMINIUM FOIL,units,60.0,173 40 36429 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,CARGLUMIC - ACID WAYMADE 200 MG is indicated for- Hyperammonaemia due to N - acetylglutamate synthase primary deficiency. - Hyperammonaemia due to isovaleric acidaemia. - Hyperammonaemia due to methymalonic acidaemia.- Hyperammonaemia due to propionic acidaemia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7d66f5b-47fb-47e6-a5f9-52f1e4e51e42.json
b7dfcb39-bcc7-4da1-bb1c-5b7f0243aeaa,ORSERDU 345 MG,prescription,L02BA04,ELACESTRANT,9483,,,WHO ATC Classification,,ILS,film coated tablets,ELACESTRANT AS DIHYDROCHLORIDE,2025-07-31T06:17:11.455547,IL,סטמליין ישראל,,48680.14867,41254.36512,37503.96829,,7290019908074,ORSERDU 345 MG 30 TAB,,,63137,BOTTLE HDPE,units,30.0,176 11 37712 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Orserdu is indicated for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7dfcb39-bcc7-4da1-bb1c-5b7f0243aeaa.json
b7e60812-5e1e-46c5-adb3-d1185b5e60fc,NITYR ( NITISINONE) 5 MG 60TAB,prescription,,,8705,,,,,ILS,tablet,NITYR ( NITISINONE) 5 MG,2025-07-31T19:23:13.736415,IL,תרומד,,5322.304479,4510.427525,4100.388659,,,NITYR ( NITISINONE) 5 MG 60TAB,14687,,58131,,units,60.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7e60812-5e1e-46c5-adb3-d1185b5e60fc.json
b7ed84b7-c8b8-4f32-835c-655b43484fe0,KCL 0.3% + NACL 0.9% 1000ML BAXTER UK 1000ML,29C,,,20856,,,,,,tablet,KCL 0.3% + NACL 0.9% BAXTER UK,2025-07-31T20:43:49.227676,IL,nan,,,,,,,KCL 0.3% + NACL 0.9% 1000ML BAXTER UK 1000ML,,,,,units,10.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7ed84b7-c8b8-4f32-835c-655b43484fe0.json
b7f235f1-af85-4440-addb-a7f7d62cd452,VIAGRA 100 MG,prescription,G04BE03,SILDENAFIL,3673,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:12:12.158638,IL,דקסל פארמה,,101.1492159,85.7196745,63.7321,,7290008108812,VIAGRA 100MG 4TAB,22116,,33545,BLISTER PVC/ALUMINIUM,units,4.0,111 38 29461 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7f235f1-af85-4440-addb-a7f7d62cd452.json
b7f5f69c-6bac-4349-9c52-c891828a7cf6,DILANTIN 125,prescription,N03AB02,PHENYTOIN,433,,,WHO ATC Classification,,ILS,suspension,PHENYTOIN/ML,2025-07-31T01:56:14.866982,IL,דקסל פארמה,,nan,nan,nan,,7290013592705,DILANTIN SUSP 237ML,4121,,541,BOTTLE GLASS TYPE III,units,237.0,123 70 24017 01,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,For the control of tonic clonic (Grand- mal) and psychomotor (Temporal lobe seizures).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7f5f69c-6bac-4349-9c52-c891828a7cf6.json
b7fc0203-d310-4c56-9eae-dc65e8830a7f,LORMYX  200 MG,prescription,A07AA11,RIFAXIMIN,7182,,,WHO ATC Classification,,ILS,film coated tablets,RIFAXIMINE,2025-07-31T04:54:22.379471,IL,מגאפארם,,101.7787563,86.25318715,64.12876368,,7290004448707,LORMYX 200MG 12 F.C.TAB,16358,,47006,BLISTER PVC/PE/PVDC/AL,units,12.0,149 55 33667 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"• Casual treatment of diseases of grown-ups and youngsters from 12 years up, caused by bacteria in the gastrointestinal tract, sensitive to Rifaximin:• hepatic encephalopathy • traveller’s diarrhea, caused by not-invasive enteropathogeneous bacteria.• Non-complicated diverticular diseases.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b7fc0203-d310-4c56-9eae-dc65e8830a7f.json
b806714c-7269-4bc5-9bb9-8c6736e0e205,FLUCANOL 100,prescription,J02AC01,FLUCONAZOLE,6610,,,WHO ATC Classification,,ILS,capsules,FLUCONAZOLE,2025-07-31T03:10:40.382993,IL,רפא,,142.1199375,120.440625,96.3525,,7290008012423,FLUCANOL 200MG 7CAPSULES,6336,,57810,BLISTER PVC/PVDC/ALUMINIUM,units,7.0,128 37 30644 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:• Cryptococcal meningitis.• Coccidioidomycosis.• Invasive candidiasis.• Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.• Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.• Candidal balanitis when local therapy is not appropriate.• Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.• Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:• Relapse of cryptococcal meningitis in patients with high risk of recurrence.• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.• To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).• Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis and cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b806714c-7269-4bc5-9bb9-8c6736e0e205.json
b821676a-22ff-4e98-9eb6-5b8be1c71204,ROZLYTREK 100 MG,prescription,L01XE56,ENTRECTINIB,8533,,,WHO ATC Classification,,ILS,"capsule, hard",ENTRECTINIB,2025-07-31T07:52:35.817283,IL,רוש,,27896.08499,23640.75104,21491.59185,,7290014774155,ROZLYTREK 200 MG 90 CAPS,,,,BOTTLE HDPE,units,90.0,164 36 36185 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"NTRK Gene Fusion-Positive Solid TumorsROZLYTREK is indicated for the treatment of adult and pediatric patients older than 1 month of age with solid tumors that:• have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation,• are metastatic or where surgical resection is likely to result in severe morbidity,and• have either progressed following treatment or have no satisfactory alternative therapy.ROS1-Positive Non-Small Cell Lung CancerROZLYTREK is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b821676a-22ff-4e98-9eb6-5b8be1c71204.json
b833e7b4-1af6-4e40-820c-19c182911334,PERMIXON 160 MG,prescription,,,4590,,,,,ILS,capsules,LIPIDOSTEROLIC EXTRACT OF SERENOA REPENS,2025-07-31T06:38:19.989338,IL,פאדאגיס,,82.52611418,69.93738801,51.998058,,7290010137961,PERMIXON 160MG 60CAPS,16131,,53017,BLISTER PVC,units,60.0,113 18 28916 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of moderate micturation troubles related to benign hypertrophy of prostate in adult men.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b833e7b4-1af6-4e40-820c-19c182911334.json
b839959d-ce27-41f2-b596-e6314c778e1c,AMIODACORE INJECTION,prescription,C01BD01,AMIODARONE,6645,,,WHO ATC Classification,,ILS,solution for injection,AMIODARONE HYDROCHLORIDE/,2025-07-30T23:22:19.856483,IL,סאנופי אוונטיס,,16.14663532,13.68358987,9.9880218,,7290012711282,AMIODACORE INJECTION 150MG/3ML 6 AMP,9477,,31743,AMPOULES GLASS TYPE I,units,6.0,043 04 23211 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Treatment should be initiated and normally monitored only under hospital or specialist supervision. Amiodacore injection is indicated for Corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.Amiodacore intravenous can be used where a rapid response is required or where oral administration is not possible.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b839959d-ce27-41f2-b596-e6314c778e1c.json
b844fe0f-c83d-401c-86ab-767582821b93,JARDIANCE DUO 12.5 MG/850 MG,prescription,A10BD20,METFORMIN AND EMPAGLIFLOZIN,7854,,,WHO ATC Classification,,ILS,film coated tablets,"EMPAGLIFLOZIN 12.5  MG, METFORMIN HYDROCHLORIDE",2025-07-31T04:18:27.005775,IL,בורינגר אינגלהיים,,260.5458075,220.8015416,176.6412333,,,JARDIANCE DUO 12.5 MG/850 MG 60 F.C.TAB,10072,,32903,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,155 29 34534 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b844fe0f-c83d-401c-86ab-767582821b93.json
b8487c55-b564-43e6-bfcc-4f71afe3a6fe,DIAMOX SEQUELS 500MG 1000 SR CAPS,29C,,,20368,,,,,,capsule,DIAMOX SEQUELS 500MG 1000 SR CAPS,2025-07-31T20:15:04.593374,IL,nan,,,,,,,DIAMOX SEQUELS 500MG 1000 SR CAPS,,,,,units,1000.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8487c55-b564-43e6-bfcc-4f71afe3a6fe.json
b860a2f0-dac4-4d15-88bc-7daa9faca8bc,DEXAMETHASONE ROMPHARM 4 MG/ML,prescription,H02AB02,DEXAMETHASONE,8821,,,WHO ATC Classification,,ILS,solution for injection / infusion,DEXAMETHASONE PHOSPHATE (AS SODIUM)/,2025-07-31T01:52:54.693034,IL,מדי מרקט,,125.3185505,106.2021662,78.96071835,,,DEXAMETHASONE ROMPHARM 4 MG/ML 10AMP 2ML,,,65909,AMPOULES GLASS TYPE I,units,10.0,166 10 35702 00,valid,34.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Dexamethasone Rompharm is indicated in the treatment of:• Endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.• Allergy: Severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.• Ophtalmic: Serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.• Inflammatory Bowel dis.: Systemic treatment in exacerbations of ulcerative colitis and regional enteritis.• Dermatological diseases (pemphigus, Stevens Johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) • Respiratory diseases (symptomatic sarcoidosis, berylliosis, Loeffler's syndrome)• Haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura, pure red cell aplasia• Nephrotic syndrome of the idioplathic type or that due to lupus erythematosus• Cerebral edema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis• Collagen diseases: Active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, Juvenile idiopathic arthritis with severe systemic-onset form (Still's disease) or locally with no control, rheumatic fever with carditis, dermatomyositis, polymyositis, SLE, temporal arteritis.• Infectious Diseases: Bacterial meningitis – adjunct to antibiotics in suspected Pneumococcal meningitis and TB meningitis. Severe infectious diseases with toxic states (eg tuberculosis, typhoid, brucellosis;. Only with simultaneous anti-infective therapy)• Fetal lung maturation• Chemotherapy – associated nausea and vomiting• Multiple Myeloma – part of chemotherapy protocols (eg VAD)• Prevention and treatment of acute mountain sickness/HACE",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b860a2f0-dac4-4d15-88bc-7daa9faca8bc.json
b8620039-9f8a-4ca4-8a37-fe20f058f0f5,ESRACAIN INJECTION 2 %,off-the-counter,N01BB02,LIDOCAINE,1859,,,WHO ATC Classification,,ILS,solution for injection,LIDOCAINE HYDROCHLORIDE/ML,2025-07-31T11:50:47.136948,IL,רפא,,25.2166,21.37,nan,,7290008013369,ESRACAIN CREAM 20GR 5%,5071,,,AMPOULES GLASS,units,20.0,020 82 21028 00,valid,nan,"i.m, i.v, epidural, s.c, intradermal, submucosal, spinal, perineural, i.v regional anaesthesia",1.4,36,,,,,,,,,,0,,"Local and regional anaesthesia.Severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be life-threatening.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8620039-9f8a-4ca4-8a37-fe20f058f0f5.json
b866e82e-9c40-41a5-a516-a2f147122155,KALETRA  200 MG/50 MG TABLETS,prescription,J05AE06,LOPINAVIR,6648,,,WHO ATC Classification,,ILS,film coated tablets,"RITONAVIR, LOPINAVIR",2025-07-31T04:20:56.997198,IL,אב-וי,,1518.753176,1287.07902,1095.3864,,8054083003238,KALETRA 200MG/50MG 120 F.C.TAB,11205,,70141,BLISTER PVC/ALUMINIUM,units,120.0,137 96 31542 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Kaletra is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b866e82e-9c40-41a5-a516-a2f147122155.json
b874c16c-b811-4dab-9701-eccc87dbfd4b,ESBRIET 267 MG TABLETS,prescription,L04AX05,PIRFENIDONE,8486,,,WHO ATC Classification,,ILS,film coated tablets,PIRFENIDONE,2025-07-31T02:34:59.983021,IL,רוש,,2215.907492,1877.887789,1598.202374,,7290014774131,ESBRIET 267 MG 90 TABLETS,,,3488,BOTTLE HDPE,units,90.0,162 66 35826 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b874c16c-b811-4dab-9701-eccc87dbfd4b.json
b881dda3-fb59-4a25-bee7-39818d61d551,ZEJULA 100 MG,prescription,L01XX54,NIRAPARIB,8457,,,WHO ATC Classification,,ILS,"capsule, hard",NIRAPARIB  AS TOSYLATE MONOHYDRATE,2025-07-31T10:45:21.593614,IL,מדיסון,,20189.73689,17109.94727,15554.49752,,,ZEJULA 100MG   56 HARD CAPSULES,26216,,17241,BLISTER PVC/ALUMINIUM,units,56.0,162 60 35740 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Zejula is indicated as monotherapy for the maintenance treatment of adult patients with Zejula is indicated:•	as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.•	As monotherapy for the maintenance treatment of adult patients with advanced epithelial (FIGO Stages III and IV) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b881dda3-fb59-4a25-bee7-39818d61d551.json
b883677d-0b16-4b7a-bc77-b4a23ea5ec69,LATUDA 60MG TABLETS,29C,,,20859,,,,,,tablet,LATUDA 60MG TABLETS,2025-07-31T20:46:29.342643,IL,nan,,,,,,,LATUDA 60MG TABLETS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b883677d-0b16-4b7a-bc77-b4a23ea5ec69.json
b8a01a85-b122-454d-ba2d-723f1ce74f18,LUNSUMIO,prescription,,,9436,,,,,ILS,concentrate for solution for infusion,MOSUNETUZUMAB/,2025-07-31T04:59:32.377039,IL,רוש,,38850.48754,32924.14345,29931.0395,,,LUNSUMIO 1MG/ML 1 VIAL 30ML,,,,VIAL GLASS TYPE I,units,30.0,172 15 37418 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior systemic therapies.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8a01a85-b122-454d-ba2d-723f1ce74f18.json
b8a1d01e-06bd-4e54-95dc-115ea18314ec,AMLODY 10,prescription,C08CA01,AMLODIPINE,9618,,,WHO ATC Classification,,ILS,tablets,AMLODIPINE AS BESYLATE,2025-07-30T23:22:35.228171,IL,אוניפארם,,19.55552435,16.572479,12.0967,,,AMLODY 10 30 TAB,,,,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,175 06 36807 99,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Amlody is indicated for:Mild to moderate hypertension. Vasospastic angina (Prinzmetal's or variant angina). Chronic stable angina,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8a1d01e-06bd-4e54-95dc-115ea18314ec.json
b8a73ef9-9c6c-4fd0-b9d4-dc46f25bc6d6,ATOMIC 100,prescription,N06BA09,ATOMOXETINE,8145,,,WHO ATC Classification,,ILS,coated tablets,ATOMOXETINE AS HYDROCHLORIDE,2025-07-30T23:29:21.790710,IL,אוניפארם,,380.8937113,322.7912808,274.7159836,,,ATOMIC 40mg 28 tab,,,11114,BLISTER PVC/ALUMINIUM,units,28.0,167 84 36235 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Atomic is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD. In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Atomic should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD.Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8a73ef9-9c6c-4fd0-b9d4-dc46f25bc6d6.json
b8b21e4d-2965-441a-b273-9f097deda0ba,HEXIDYL DENTAL GEL,off-the-counter,A01AB03,CHLORHEXIDINE,5537,,,WHO ATC Classification,,ILS,gel,CHLORHEXIDINE DIGLUCONATEW/W,2025-07-31T12:03:38.924255,IL,פלוריש,,34.4324,29.18,nan,,,HEXIDYL ALCOHOL FREE MOUTHWASH 0.2% 300ml,,,,TUBE ALUMINIUM,units,300.0,175 39 36041 00,valid,nan,local oral,1.4,36,,,,,,,,,,0,,"1) As an aid to maintaining oral hygiene.   2) As an aid in the treatment and prevention of gingivitis.   3) Inhibition of formation of dental plaque.   4) For use in aphtous ulceration and oral candidal infections (e.g., denture stomatitis and thrush).   5) For use in a post- periodontal surgery or treatment regimen to promote gingival healing.   6) As an adjunct to fluoride in the prevention of dental caries in high risk patients.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8b21e4d-2965-441a-b273-9f097deda0ba.json
b8be00f9-7eb7-45f7-8cef-fbe5ee189f4c,CANDOR PLUS,prescription,C09CA06,CANDESARTAN,7548,,,WHO ATC Classification,,ILS,tablets,"HYDROCHLOROTHIAZIDE 12.5  MG, CANDESARTAN CILEXETIL",2025-07-31T00:52:36.430930,IL,אוניפארם,,35.33758272,29.947104,21.8592,,,CANDOR PLUS 16MG/12.5MG 28TAB,9763,,55581,BLISTER PVC/ALUMINIUM,units,28.0,152 75 34056 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Essential hypertension, where monotherapy with candesartan cilexetil or hydrochlorothiazide is not sufficient",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8be00f9-7eb7-45f7-8cef-fbe5ee189f4c.json
b8d840c0-b0c2-425f-a67b-29fbe0b08ea5,SEDURAL,prescription,,,1678,,,,,ILS,tablets,PHENAZOPYRIDINE HYDROCHLORIDE,2025-07-31T08:02:39.898798,IL,רקח,,43.12086508,36.543106,26.6738,,,SEDURAL 100MG 30TAB,19041,,46722,BLISTER PVC/ALUMINIUM,units,30.0,137 47 20755 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Analgesic for the urinary tract.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8d840c0-b0c2-425f-a67b-29fbe0b08ea5.json
b8df2897-3896-477d-9cb8-e765ac6b72bf,NEOSTIGMINE -  HAMELN 2.5 MG/ML INJECTION,prescription,N07AA01,NEOSTIGMINE,8688,,,WHO ATC Classification,,ILS,solution for injection,NEOSTIGMINE METHYLSULFATE 2.5 MG/ML,2025-07-31T05:42:16.306516,IL,פארמהמדיס,,116.1786084,98.4564522,73.2018232,,4260016651313,NEOSTIGMINE -  HAMELN 2.5 MG/ML 10 AMP,,,56152,AMPOULES GLASS TYPE I,units,10.0,151 23 33874 00,valid,34.5,"i.v, i.m, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Myasthenia Gravis, antagonist to non-depolarizing neuromuscular blockade, Paralytic Ileus.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b8df2897-3896-477d-9cb8-e765ac6b72bf.json
b925d25c-dd1e-4729-bc1f-33a1de9aee2c,BETMIGA 25 MG,prescription,G04BD12,MIRABEGRON,7535,,,WHO ATC Classification,,ILS,tablets prolonged release,MIRABEGRON,2025-07-31T00:34:20.779011,IL,אסטלס,,147.1985455,124.7445356,99.7956285,,8718692510739,BETMIGA 50MG 30  P.R.TAB,2585,,85013,BLISTER OPA/AL/PVC,units,30.0,153 46 34104 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b925d25c-dd1e-4729-bc1f-33a1de9aee2c.json
b926060a-f240-481d-be05-c1b4c4656bad,RETAVIT GEL 0.05% 20GR,prescription,,,2344,,,,,,tablet,RETAVIT GEL 0.05% 20GR,2025-07-31T19:30:38.573741,IL,כ.צ.ט,,,,,,,RETAVIT GEL 0.05% 20GR,18196,,19793,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b926060a-f240-481d-be05-c1b4c4656bad.json
b92a59dd-1cce-4c10-8451-9c30b09c95d2,POLYCUTAN,prescription,D01AC20,COMBINATIONS,2401,,,WHO ATC Classification,,ILS,cream,"CLOTRIMAZOLE, NEOMYCIN SULFATE 0.645 %, DEXAMETHASONE ACETATE 0.044 %",2025-07-31T06:47:07.636588,IL,פאדאגיס,,nan,nan,nan,,7290000857206,POLYCUTAN CREAM 15GR,16175,,6792,TUBE ALUMINIUM,units,15.0,048 52 23172 00,valid,nan,topical,1.4,24,,,,,,,,,,0,Prescription required,Treatment of dermatitis involving also a bacterial and/or fungal infection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b92a59dd-1cce-4c10-8451-9c30b09c95d2.json
b964b23f-656d-420d-a30d-4aa9f4ce3864,SYMBICORT TURBUHALER 80/4.5 MCG/DOSE,prescription,R03AK07,FORMOTEROL AND BUDESONIDE,4536,,,WHO ATC Classification,,ILS,powder for inhalation,"BUDESONIDE MICRONIZED/DOSE, FORMOTEROL FUMARATE 4.5 MCG/DOSE",2025-07-31T08:54:40.908645,IL,אסטראזנקה,,170.2958596,144.3185315,115.4548252,,,SYMBICORT TURBUHAL 80/4.5MCG/DOSE 120DOSES,19914,,18403,METERED DOSE INHALER ,units,120.0,123 76 30316 00,valid,25.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"Symbicort turbuhaler is indicated in the regular treatment of asthma  where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate:   - Patients not adequaterly controlled with inhaled corticosteroids and "" as needed"" inhaled short acting beta2- agonists.   - Or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists.   NOTE: Symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b964b23f-656d-420d-a30d-4aa9f4ce3864.json
b9722e64-d2da-43f2-86b5-fd7b29aa83b6,TOCTINO 10 MG,prescription,D11AX19,ALITRETINOIN,6702,,,WHO ATC Classification,,ILS,"capsule, soft",ALITRETINOIN,2025-07-31T09:24:34.581671,IL,ג.ס.ק,,1798.227633,1523.921791,1296.954716,,,TOCTINO 30MG 30CAPS,20718,,26066,BLISTER PVC/PE/PVDC/AL,units,30.0,145 92 33163 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids .Patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx .,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9722e64-d2da-43f2-86b5-fd7b29aa83b6.json
b974d0ae-405c-46b5-9987-acf920c5c112,TREGLUDEC 100U/ML,prescription,A10AE06,INSULIN DEGLUDEC,7420,,,WHO ATC Classification,,ILS,solution for injection,INSULIN DEGLUDEC 100 U/ML,2025-07-31T09:37:50.997973,IL,נובו נורדיסק,,294.5119268,249.5863897,212.4139487,,7290008126724,TREGLUDEC 100U/ML 5X3ML  FLEXTOUCH,9762,,54934,CARTRIDGE GLASS TYPE I,units,15.0,151 66 33908 00,valid,17.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b974d0ae-405c-46b5-9987-acf920c5c112.json
b99aada8-133c-4502-9b5f-54cc43c6c796,PHENERGAN 50 MG/2 ML,prescription,R06AD02,PROMETHAZINE,3439,,,WHO ATC Classification,,ILS,solution for injection,PROMETHAZINE AS HYDROCHLORIDE/,2025-07-31T07:01:23.040198,IL,ויטאמד,,20.21703794,17.133083,12.5059,,7290018609873,PROMETHAZINE 0.1% 100ML,160848,,9500,AMPOULES GLASS TYPE I,units,100.0,167 08 35764 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Phenergan is indicated :As symptomatic treatment for allergic conditions of the upper respiratory tract and skin including allergic rhinitis, urticaria and anaphylactic reactions to drugs and foreign proteins.For sedation and treatment of insomnia in adults.As an adjunct in preoperative sedation in surgery and obstetrics.As a paediatric sedative. For prevention and control of nausea and vomiting associated with certain types of anaesthesia and surgery.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b99aada8-133c-4502-9b5f-54cc43c6c796.json
b99fb764-b819-47e6-9cfe-5bf16c775605,TRIENTINE HCL MEDOMIE 250 MG CAPSULES,prescription,A16AX12,TRIENTINE ,8806,,,WHO ATC Classification,,ILS,"capsule, hard",TRIENTINE  HYDROCHLORIDE,2025-07-31T09:41:59.251333,IL,מדומי פארמה,,19510.44526,16534.27638,15031.16035,,,TRIENTINE HCL MEDOMIE 250 MG 100 CAPSULES,,,75691,BOTTLE HDPE,units,100.0,167 10 36302 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Trientine medomie is indicated for the treatment of Wilson’s disease in patients intolerant to D-Penicillamine therapy, in adults, adolescents and children aged 5 years or older.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b99fb764-b819-47e6-9cfe-5bf16c775605.json
b9ac52cc-4fac-4369-96ce-89fef2e8cab7,JANUET XR 100/1000 MG TABLETS,prescription,A10BA02,METFORMIN,8536,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T08:18:40.632401,IL,טבע,,35.73304274,30.28223961,22.10382453,,7290006813640,SITAGLIPTIN  25 MG 10 TAB,,,,BOTTLE HDPE,units,10.0,151 33 33934 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9ac52cc-4fac-4369-96ce-89fef2e8cab7.json
b9adeb73-0534-4407-8866-34a451d2ff42,KAMRAB,prescription,J06BB05,RABIES IMMUNOGLOBULIN,6889,,,WHO ATC Classification,,ILS,solution for injection,HUMAN-RABIES IMMUNOGLOBULIN/ML,2025-07-31T04:22:28.661815,IL,קמהדע,,7060.581737,5983.544111,5439.585555,,7290008072250,KAMRAB 150IU/ML 1VIAL/10ML,,,,VIAL GLASS TYPE I,units,10.0,138 88 31771 00,valid,10.0,i.m,1.4,30,,,,,,,,,,0,Prescription required,"KamRAB IM is indicated for passive, transient post-exposure prevention of rabies infection when given immediately to individuals in cases of contact with rabid or possibly rabid animal.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9adeb73-0534-4407-8866-34a451d2ff42.json
b9b51439-82c8-45f6-9839-6cac93ccf8f9,LIVIAL 2.5 MG,prescription,G03DC05,TIBOLONE,4568,,,WHO ATC Classification,,ILS,tablets,TIBOLONE 2.5  MG,2025-07-31T04:50:59.817830,IL,אורגנון,,43.24358232,36.64710529,26.74971189,,,LIVIAL 2.5MG  28TAB,12212,,4915,BLISTER PVC/ALUMINIUM,units,28.0,116 52 29486 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"• Complaints resulting from the natural or artificial menopause.Treatment of oestrogen deficiency symptoms in postmenopausal women, more than one year after menopause. Women above 60 years of age should only start with Livial treatment when they are intolerant of, or contraindicated for, other medicinal products approved for the treatment of oestrogen deficiency symptoms.• Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.For all women the decision to prescribe tibolone Livial should be based on an assessment of the individual patient’s overall risks and, particularly in the over 60s, should include consideration of the risk of stroke.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9b51439-82c8-45f6-9839-6cac93ccf8f9.json
b9c9814a-a29e-4e19-b09c-b263af6200f5,RELERT 20 MG,prescription,N02CC06,ELETRIPTAN,4453,,,WHO ATC Classification,,ILS,film coated tablets,ELETRIPTAN HYDROBROMIDE 24.242   MG,2025-07-31T07:22:03.691293,IL,דקסל פארמה,,80.88321859,68.5451005,50.9629,,,RELERT 40MG 3TAB,18031,,28688,BLISTER ALUMINIUM,units,3.0,124 28 30370 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Acute treatment of the headache phase of migraine attacks, with or without aura.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9c9814a-a29e-4e19-b09c-b263af6200f5.json
b9ca0f91-2dc6-4d65-a01f-7e6968a6184d,SPRYCEL 20 MG  60 FILM COATED TAB,prescription,,,6377,,,,,ILS,tablet,SPRYCEL 20 MG 60 FILM COATED TAB,2025-07-31T19:32:55.946980,IL,ב.מ.ס,,4389.218971,3719.677094,3381.524631,,,SPRYCEL 20 MG  60 FILM COATED TAB,19870,,81977,,units,60.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9ca0f91-2dc6-4d65-a01f-7e6968a6184d.json
b9d0f054-33a3-4783-b3ee-4fd0372a077a,FLUORESCEINE SERB,prescription,S01JA01,FLUORESCEIN,6002,,,WHO ATC Classification,,ILS,solution for injection,FLUORESCEIN SODIUM/ML,2025-07-31T03:13:27.575928,IL,טרדיס גת,,142.3836346,120.6641025,96.531282,,7290008127547,FLUORESCEINE  SERB 10 AMP X5ML,55446,,28961,AMPOULES GLASS TYPE I,units,10.0,113 59 25293 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,For examination of the retina by Fluorescent Angiography.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9d0f054-33a3-4783-b3ee-4fd0372a077a.json
b9d8bdc8-87f1-48d8-93f7-b36736f5d054,MOUNJARO 10 MG KWIKPEN,prescription,A10BX16,TIRZEPATIDE,9230,,,WHO ATC Classification,,ILS,solution for injection,TIRZEPATIDE 16.7 MG/ML,2025-07-31T05:32:59.029622,IL,אלי לילי,,nan,nan,nan,,,MOUNJARO 5 MG/0.5 ML SOL FOR INJ 4 PF PEN,,,,PRE-FILLED PEN GLASS TYPE I,units,4.0,177 53 38072 99,valid,nan,s.c,1.4,24,,,,,,,,,,0,Prescription required,"T2DMMounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise•	as monotherapy when metformin is considered inappropriate due to intolerance or contraindications•	in addition to other medicinal products for the treatment of diabetes.Weight managementMounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of•	&#8805; 30 kg/m2 (obesity) or•	&#8805; 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).For trial results with respect to obstructive sleep apnoea (OSA) in adults with obesity, see section 5.1.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9d8bdc8-87f1-48d8-93f7-b36736f5d054.json
b9dc9b84-825a-4949-9715-c7d593f8ab59,RESYL SYRUP 2% 100ML,off-the-counter,,,582,,,,,ILS,tablet,RESYL SYRUP 2%,2025-07-31T19:47:10.210938,IL,ג.ס.ק,,44.427,37.65,,,,RESYL SYRUP 2% 100ML,18205,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9dc9b84-825a-4949-9715-c7d593f8ab59.json
b9e69b2a-88e6-440b-8476-fbf01d74278c,REMICADE,prescription,L04AB02,INFLIXIMAB,4184,,,WHO ATC Classification,,ILS,powder for concentrate for infusion,INFLIXIMAB 100.0 MG/VIAL,2025-07-31T07:23:14.954334,IL,יאנסן סילג,,2305.677508,1953.96399,1776.3309,,7290008121279,REMICADE 100MG/VIAL 20ML,18291,,23349,VIAL 20 ML GLASS TYPE I,units,1.0,137 18 29865 05,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"- Adult :- Crohn's disease: Treatment of  moderate to severe active Crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. Treatment of fistulising Crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. - Paediatric Crohn's disease: Remicade is indicated for:  Treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. Remicade has been studied only in combination with conventional immunosuppressive therapy - Ankylosing spondylitis: Remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional therapy. - Psoriatic arthritis : Remicade is indicated for : Treatment of active and progressive psoriatic arthritis in adults when the response to previous DMARD therapy has been inadequate. Remicade should be administered : either in combination with methotrexate or alone in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated. - Remicade has been shown to improve physical function in patients with psoriatic arthritis and to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease. - Rheumatoid arthritis: Remicade in combination with methotrexate is indicated for the reduction of signs and symptoms as well as the improvement in physical function in: Patients with active disease when the response to disease-modifying drugs including methotrexate has been inadequate. Patients with severe active and progressive disease not previously treated with methotrexate or other DMARDs. In this these patient populations a reduction in the rate of the progression of joint damage as measured by x-ray has been demonstrated - Psoriasis: Remicade is indicated for: Treatment of moderate to severe plaque psoriasis in adults who failed to respond to or who have a contraindication to or are intolerant to other systemic therapy including cyclosporine methotrexate or PUVA. - Ulcerative colitis: Remicade is indicated for: Treatment of moderately to severely active ulcerative colitis in patients who have had an inadequate response to convential therapy including corticosteroids and 6-MP or AZA or who are intolerant to or have medical contraindications for such therapies.- Paediatric ulcerative colitis: Remicade is indicated for treatment of severely active ulcerative colitis, in paediatric patients aged 6 to 17 years, who have had an inadequate response to conventional therapy including corticosteroids and 6 MP or AZA, or who are intolerant to or have medical contraindications for such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9e69b2a-88e6-440b-8476-fbf01d74278c.json
b9ec2e32-1b5b-4559-bb7a-3f385555e570,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1821,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:51:01.898821,IL,פישר,,35.2938,29.91,nan,,7290000849188,POLYDINE SOL 200CC,,,,BOTTLE HDPE,units,200.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/b9ec2e32-1b5b-4559-bb7a-3f385555e570.json
ba0b2b5e-4dab-45cb-987d-512cb0486383,CLARISCAN,prescription,V08CA02,GADOTERIC ACID,9060,,,WHO ATC Classification,,ILS,solution for injection,GADOTERIC ACID 279.3  MG /,2025-07-31T01:19:02.371186,IL,אלדן,,842.646884,714.1075605,607.7511153,,,CLARISCAN 279.3MG/ML100ML,,,,BOTTLE GLASS TYPE I,units,100.0,163 65 35367 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Enhancement of contrast in magnetic resonance imaging.Encephalic and spinal pathologies: brain tumours, tumours of the spine and the surrounding tissue, intervertebral disk prolapse infectious diseases.Abdominal pathologies: primary and secondary liver tumours.Osteo-articular pathology: bone and soft tissue tumours synovial diseases.Magnetic resonance imaging for angiography.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba0b2b5e-4dab-45cb-987d-512cb0486383.json
ba28392f-ed2e-433d-9f81-bc970dad126e,AROMASIN,prescription,L02BG06,EXEMESTANE,4011,,,WHO ATC Classification,,ILS,coated tablets,EXEMESTANE,2025-07-30T23:28:01.301631,IL,פיזר,,301.1369853,255.200835,217.1922,,,AROMASIN 25MG 30TAB,1054,,25921,BLISTER ,units,30.0,119 48 30005 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Aromasin is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. Aromasin is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies.   Aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer  following 2-3 years of initial adjuvant tamoxifen therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba28392f-ed2e-433d-9f81-bc970dad126e.json
ba2e2118-0722-4106-a312-7daf5e361697,CHAMPIX 0.5 MG,prescription,N07BA03,VARENICLINE,6091,,,WHO ATC Classification,,ILS,film coated tablets,VARENICLINE AS TARTRATE 0.5  MG,2025-07-31T01:08:40.819043,IL,פיזר,,306.8850173,260.0720601,221.3379235,,7290010355747,CHAMPIX 1MG 56TAB,3911,,16669,BLISTER ACLAR/PVC/ALUMINIUM,units,56.0,137 66 31510 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Champix is indicated as an aid to smoking cessation treatment adults over 18 years of age.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba2e2118-0722-4106-a312-7daf5e361697.json
ba3235cb-d3f4-4677-ba4c-03e5467b69ac,SIMVACOR 80,prescription,C10AA01,SIMVASTATIN,3865,,,WHO ATC Classification,,ILS,film coated tablets,SIMVASTATIN,2025-07-31T08:14:49.217546,IL,אוניפארם,,119.5687811,101.3294755,75.3379,,,SIMVACOR 80 80MG 30TAB,19450,,4394,BLISTER PVC/ALUMINIUM,units,30.0,121 96 30223 01,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia  Simvacor is indicated to: Reduce the risk of total mortality by reducing coronary death Reduce the risk of non-fatal myocardial infarction Reduce the risk for undergoing myocardial revascularization procedures. Reduce the risk of stroke and transient ischemic attacks (TIA). Hyperlipidemia: Simvacor is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvacor therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Simvacor is indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).   In patients at a high risk of coronary events because of existing coronary heart disease  diabetes  peripheral vessel disease  history of stroke or other cerebrovascular disease  Simvacor is indicated to:   - Reduce the risk of total mortalily by reducing CHD deaths.   - Reduce the risk of non-fatal myocardial infarction and stroke.   - Reduce the need for coronary and non-coronary revascularization procedures., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba3235cb-d3f4-4677-ba4c-03e5467b69ac.json
ba339e0c-d3b6-4cf5-a62e-66398342e79f,FLUARIX TETRA,prescription,J07BB02,"INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN ",7676,,,WHO ATC Classification,,ILS,suspension for injection,"B/PHUKET/3073/2013 (B/YAMAGATA LINEAGE)-LIKE VIRUSHA /, B/AUSTRIA/1359417/2021 (B/VICTORIA LINEAGE)-LIKE VIRUSHA /, A/VICTORIA/4897/2022 (H1N1)PDM09-LIKE VIRUSHA /, A/THAILAND/8/2022 (H3N2)-LIKE VIRUSHA /",2025-07-31T03:10:08.735260,IL,ג.ס.ק,,61.99085356,52.534624,39.0592,,,FLUARIX TETRA SYRINGE 1X0.5ML,6563,,62174,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,152 47 34024 00,valid,34.5,i.m,1.4,12,,,,,,,,,,0,Prescription required,Fluarix Tetra is indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba339e0c-d3b6-4cf5-a62e-66398342e79f.json
ba595ba4-44da-4514-9209-daefad4f683d,NOVORAPID,prescription,A10AB05,INSULIN ASPART,4342,,,WHO ATC Classification,,ILS,solution for injection,INSULIN ASPART 100 U/ML,2025-07-31T05:56:01.466795,IL,נובו נורדיסק,,92.54451796,78.42756108,58.31045433,,7290008126458,NOVORAPID VIAL 10MLX100IU/ML,9094,,3646,VIAL GLASS TYPE I,units,10.0,118 94 29983 02,valid,34.5,"i.v, s.c",1.4,30,,,,,,,,,,0,Prescription required,"Treatment of patients with diabetes mellitus in adults, adolescents and children aged 2 years and above.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba595ba4-44da-4514-9209-daefad4f683d.json
ba59d27f-f88d-4742-a465-4ef1ff528b9a,SUMATRIDEX 100,prescription,N02CC01,SUMATRIPTAN,6183,,,WHO ATC Classification,,ILS,caplets,SUMATRIPTAN AS SUCCINATE,2025-07-31T08:50:46.024369,IL,דקסל פארמה,,55.43450728,46.978396,34.2908,,7290010577347,SUMATRIDEX 50MG 6CAPLETS,19828,,7829,BLISTER ALUMINIUM /ALUMINIUM,units,6.0,131 31 30967 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sumatridex caplets are indicated for the acute relief of migraine attacks, with or without aura. Sumatridex should only be used where there is a clear diagnosis of migraine.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba59d27f-f88d-4742-a465-4ef1ff528b9a.json
ba63bf35-2eda-47b8-aa5d-d3ce9f7d1b70,VFEND 200 MG POWDER FOR SOLUTION FOR INFUSION,prescription,J02AC03,VORICONAZOLE,4611,,,WHO ATC Classification,,ILS,powder for solution for infusion,VORICONAZOLE/VIAL,2025-07-31T10:10:27.674505,IL,פיזר,,3257.891866,2760.92531,2509.9321,,7680559450025,VFEND 200MG 28TAB,22086,,55088,VIAL GLASS TYPE I,units,28.0,126 71 30598 12,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of :- invasive aspergillosis  fluconazole-resistant serious invasive Candida infections (including C. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive  possibly life-threatening infections.   - Treatment of candidemia in non neutropenic patients.- Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba63bf35-2eda-47b8-aa5d-d3ce9f7d1b70.json
ba8f6ff5-3829-48ce-8d77-d16a1f8bd7e1,ALCOXIDINE,off-the-counter,D08AC02,CHLORHEXIDINE,5280,,,WHO ATC Classification,,ILS,solution - external,"ALCOHOLV/V, CHLORHEXIDINE GLUCONATE 0.5 %W/V",2025-07-31T11:11:18.783790,IL,ויטאמד,,35.02,29.68,nan,,7290008083089,ALCOXIDINE 500ML,1132,,,BOTTLE HDPE,units,500.0,116 50 28130 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Disinfection of hands and skin,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba8f6ff5-3829-48ce-8d77-d16a1f8bd7e1.json
ba91fcda-7038-4080-beb1-f1a6d0ac6ee4,DASATINIB SANDOZ ® 100 MG,prescription,L01XE06,DASATINIB,9351,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB,2025-07-31T01:42:27.419656,IL,סנדוז,,6399.316607,5423.149667,4930.136061,,,DASATINIB SANDOZ  50 MG 60 TAB,,,14589,BLISTER OPA/ALU/PVC/ALU,units,60.0,173 10 36531 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with :  Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase.  Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate.  Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ba91fcda-7038-4080-beb1-f1a6d0ac6ee4.json
bab6427a-1206-4531-a67e-0e3a1e2e8589,HYDRALAZINE (APO) 10MG 100TAB,29C,,,20088,,,,,,tablet,HYDRALAZINE (APO) 10MG,2025-07-31T20:35:20.482602,IL,nan,,,,,,,HYDRALAZINE (APO) 10MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bab6427a-1206-4531-a67e-0e3a1e2e8589.json
bacfd10f-906d-4536-9851-551cf6f72677,RIVAROXABAN TARO 10 MG,prescription,B01AX06,RIVAROXABAN,9297,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:44:13.899021,IL,תרו יבוא,,277.807105,235.42975,188.3438,,,RIVAROXABAN TARO 15 MG 30 TAB,,,24896,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,162 53 35228 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"*  Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.*  Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bacfd10f-906d-4536-9851-551cf6f72677.json
bad4d465-0808-4848-ac49-6aec2192cffb,FLUCANOL 100,prescription,J02AC01,FLUCONAZOLE,6609,,,WHO ATC Classification,,ILS,capsules,FLUCONAZOLE,2025-07-31T03:10:29.735193,IL,רפא,,21.66502656,18.360192,13.4016,,7290008012423,FLUCANOL 150MG 1 CAPSULE,6129,,57190,BLISTER PVC/PVDC/ALUMINIUM,units,1.0,128 37 30644 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:• Cryptococcal meningitis.• Coccidioidomycosis.• Invasive candidiasis.• Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.• Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.• Candidal balanitis when local therapy is not appropriate.• Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.• Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:• Relapse of cryptococcal meningitis in patients with high risk of recurrence.• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.• To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).• Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis and cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bad4d465-0808-4848-ac49-6aec2192cffb.json
baeb0681-f739-4a17-98dd-3677506a6dd5,SALBUTRIM,prescription,R03AC02,SALBUTAMOL,7305,,,WHO ATC Classification,,ILS,inhaler,SALBUTAMOL AS SULFATE/DOSE,2025-07-31T07:57:25.859589,IL,תרימה,,18.73946554,15.880903,11.5919,,7290008143127,SALBUTRIM INHALER CFC FREE 100MCG/DOSE 200ACT.,9705,,49886,METERED DOSE INHALER ALUMINIUM,units,200.0,149 19 33272 00,valid,37.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"Salbutrim is a short-acting (4 to 6 hour)  bronchodilator with fast  (within 5 minutes) onset in reversible airways obstruction.  It is particularly suitable for the relief and prevention of asthma symptoms It should be used to relieve symptoms when they occur, and to prevent them in those circumstances recognized by the patient to precipitate an asthma attack (e.g. before exercise or unavoidable allergen exposure).Salbutrim is particularly valuable as relief medication in mild, moderate or severe asthma, provided that reliance on it does not delay the introduction and use of regular inhaled corticosteroid therapy.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/baeb0681-f739-4a17-98dd-3677506a6dd5.json
bb066e29-9f0b-44ad-938c-a469bc9ee2ee,ROWATINEX,off-the-counter,,,408,,,,,ILS,capsules,"CAMPHENE, CINEOLE, FENCHONE, BORNEOL, ANETHOLE, PINENE BETA 6.2  MG, PINENE ALFA 24.8  MG",2025-07-31T13:15:06.595148,IL,מגאפארם,,50.74,43.0,nan,,,ROWATINEX  50CAPS,18093,,,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,107 67 20546 01,valid,nan,per os,1.4,60,,,,,,,,,,0,,As an adjuvant in infections of kidenys and urinary tract.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb066e29-9f0b-44ad-938c-a469bc9ee2ee.json
bb0cdf9e-b365-4ff5-b023-d2e5ed56694c,LATANO-AVENIR,prescription,S01EE01,LATANOPROST,8277,,,WHO ATC Classification,,ILS,"eye drops, solution",LATANOPROST 0.05 MG/ML,2025-07-31T04:36:41.106364,IL,ביואבניר,,36.8932369,31.265455,22.8215,,7290010286461,LATANO-AVENIR 0.05 MG/ML   2.5ML  VIAL,,,37852,VIAL PLASTIC,units,2.5,154 66 34068 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb0cdf9e-b365-4ff5-b023-d2e5ed56694c.json
bb1814f5-c9c4-4597-9b74-b9a493630250,CYMEVENE 500 MG,prescription,J05AB06,GANCICLOVIR,3472,,,WHO ATC Classification,,ILS,powder for solution for infusion,GANCICLOVIR AS SODIUM,2025-07-31T01:37:13.673036,IL,צמל,,510.9294896,432.9911121,368.5030742,,7290013280541,CYMEVENE 500MG 5VIAL,3042,,9645,VIAL 10 ML GLASS TYPE I,units,5.0,110 89 26101 01,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Cymevene IV is indicated for the treatment of CMV retinitis in immunocompromised patiens, including patients with acquired immunodeficiency syndrome (AIDS). Cymevene IV is also indicated for the prevention of CMV disease in transplant recipients at risk for CMV disease.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb1814f5-c9c4-4597-9b74-b9a493630250.json
bb34d46c-a382-4d19-b453-e318c563979e,DECAPEPTYL DEPOT 11.25 MG,prescription,L02AE04,TRIPTORELIN,4991,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,TRIPTORELIN AS EMBONATE 11.25  MG,2025-07-31T01:44:13.816905,IL,פרינג,,1348.213263,1142.553663,972.3860964,,7046260200104,DECAPEPTYL DEPOT 11.25MG VIAL,4497,,70319,VIAL GLASS TYPE I,units,1.0,135 83 31300 00,valid,17.5,i.m,1.4,48,,,,,,,,,,0,Prescription required,- Lowering of sexual hormones and- treatment of advanced hormone-dependent prostate cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb34d46c-a382-4d19-b453-e318c563979e.json
bb44fbae-93e0-4181-90d8-1cf092611f1e,NOCDURNA 50MCG 10 SUBLINGUAL TAB,prescription,,,8708,,,,,ILS,tablet,NOCDURNA 50MCG 10 SUBLINGUAL TAB,2025-07-31T19:23:59.566475,IL,פרינג,,61.13985296,51.81343702,38.5230015,,,NOCDURNA 50MCG 10 SUBLINGUAL TAB,,,,,units,10.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb44fbae-93e0-4181-90d8-1cf092611f1e.json
bb46c927-9b14-40f1-b281-63359d8e20ad,COUMADIN 1 MG,prescription,B01AA03,WARFARIN,3708,,,WHO ATC Classification,,ILS,tablets,WARFARIN SODIUM,2025-07-31T01:32:33.237207,IL,תרו,,18.59089917,15.755,11.5,,7290000808048,COUMADIN 2MG 30TAB,3592,,17840,BOTTLE HDPE,units,30.0,111 43 29373 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. Coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. Coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb46c927-9b14-40f1-b281-63359d8e20ad.json
bb483fe8-7a8f-4cae-be43-e491a2dafdcf,LEVEMIR,prescription,A10AE05,INSULIN DETEMIR,6587,,,WHO ATC Classification,,ILS,solution for injection,INSULIN DETEMIR 100 U/ML,2025-07-31T04:42:50.943045,IL,נובו נורדיסק,,255.4567929,216.4888172,173.1910538,,7290008126960,LEVEMIR PENFILL 5X3ML,9402,,20875,CARTRIDGE GLASS TYPE I,units,15.0,132 40 31119 00,valid,25.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb483fe8-7a8f-4cae-be43-e491a2dafdcf.json
bb6babb2-4971-4344-9c07-58f25b5a1308,MYOCHOLINE-GLENWOOD 25 MG,29C,N07AB02,BETHANECHOL,20925,,,WHO ATC Classification,,ILS,tablets,BETHANECHOL CHLORIDE,2025-07-31T13:58:54.963037,IL,nan,,nan,nan,nan,,7290018609880,BETHANECHOL  5MG  100TABS USE ONLY,,,,BLISTER PVC/ALUMINIUM,units,100.0,167 20 35286 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Myocholine Glenwood is indicated in cases of postoperative urinary retention due to atony of the bladder in adults in diseases in which a stimulation of the bladder muscle is needed.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb6babb2-4971-4344-9c07-58f25b5a1308.json
bb70214c-72d5-406c-af50-81f78c8611a6,LITFULO 50 MG,29C,L04AF08,RITLECITINIB,20420,,,WHO ATC Classification,,ILS,capsules,RITLECITINIB AS TOSYLATE,2025-07-31T14:39:07.843353,IL,nan,,nan,nan,nan,,,FUL GLO 0.6MG 300 OPHTALMIC STRIPS,,,,BOTTLE HDPE,units,300.0,176 18 37835 99,valid,nan,per os,1.4,36,,,,,,,,,,0,,"LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologicimmunomodulators, cyclosporine or other potent immunosuppressants",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb70214c-72d5-406c-af50-81f78c8611a6.json
bb7d53b4-b676-4eba-aaf9-47189baaa0dd,V-OPTIC 0.5%,prescription,S01ED01,TIMOLOL,3240,,,WHO ATC Classification,,ILS,drops,TIMOLOL AS MALEATE/ML,2025-07-31T10:20:21.880224,IL,ויטאמד,,18.77891058,15.914331,11.6163,,7-290008-083720,V-OPTIC 0.5% 5ML,22101,,9644,DROPER BOTTLE LDPE,units,5.0,069 79 28590 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"For the reduction of elevated intraocular pressure.may be used in patients with chronic open angle glaucoma, aphakic glaucoma, some patients with secondary glaucoma and patients with ocular hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb7d53b4-b676-4eba-aaf9-47189baaa0dd.json
bb96d973-6790-4f07-97af-fad6dd94b1a9,IBRANCE TABLETS 100 MG,prescription,L01XE33,PALBOCICLIB,7908,,,WHO ATC Classification,,ILS,film coated tablets,PALBOCICLIB,2025-07-31T03:55:32.772520,IL,פיזר,,9598.848156,8134.617443,7395.106767,,5415062107560,IBRANCE 125 MG 21 CAPS,9956,,56882,BLISTER PVC/OPA/AL,units,21.0,173 62 36956 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"IIBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:* an aromatase inhibitor as initial endocrine-based therapy; or* fulvestrant in patients with disease progression following endocrine therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb96d973-6790-4f07-97af-fad6dd94b1a9.json
bb9cc423-a688-489f-b21b-0c027ed43c46,IBOO 2 % FOR CHILDREN,off-the-counter,M02AA13,IBUPROFEN,5519,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/ML,2025-07-31T12:07:55.858966,IL,טבע,,44.899,38.05,nan,,7290110730642,IBOO 2 % FOR CHILDREN SYR 200 ML,,,,BOTTLE PET,units,200.0,153 81 34080 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years (i.e. weighing about 40 kg).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bb9cc423-a688-489f-b21b-0c027ed43c46.json
bba0f4e6-5345-4b04-adda-b8995ee20bfe,KALOBA TABLETS ®,off-the-counter,R05FB01,COUGH SUPPRESSANTS AND MUCOLYTICS,5521,,,WHO ATC Classification,,ILS,film coated tablets,PELARGONIUM SIDOIDES ROOT DRIED LIQUID EXTRACT (DER 1: 8- 10); EXTRACTING AGENT: ETHANOL(W/W),2025-07-31T12:15:50.773627,IL,דר סמואלוב,,61.0178,51.71,nan,,,KALOBA TABLETS 21 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,21.0,160 53 34993 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,- Symptomatic treatment of acute bronchitis.- Traditional herbal medicinal product for use in the common cold.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bba0f4e6-5345-4b04-adda-b8995ee20bfe.json
bbaae8ad-980b-49d3-b9c6-855f93c3d3ac,MEMOX 10,prescription,N06DX01,MEMANTINE,6827,,,WHO ATC Classification,,ILS,tablets,MEMANTINE HYDROCHLORIDE,2025-07-31T05:10:48.733823,IL,אוניפארם,,147.1755,124.725,99.78,,,MEMOX 20MG 28 F.C.TAB,13670,,3403,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,133 16 31117 02,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of patient with moderate  to severe Alzheimer's disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bbaae8ad-980b-49d3-b9c6-855f93c3d3ac.json
bbb36bcf-e39f-49e3-b95f-bca3726d84ac,TOBI PODHALER 28 MG,prescription,J01GB01,TOBRAMYCIN,6965,,,WHO ATC Classification,,ILS,inhalation powder hard capsules,TOBRAMYCIN,2025-07-31T09:23:43.914994,IL,דקסל פארמה,,10960.26369,9288.359469,8443.963154,,7290006257543,TOBI PODHALER 28MG 224INH HARD CAPS,20720,,26220,BLISTER PVC/PA/AL/PVC,units,224.0,147 05 33412 00,valid,10.0,inhalation,1.4,48,,,,,,,,,,0,Prescription required,Suppressive therapy of chronic pulmonary infection due to Pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bbb36bcf-e39f-49e3-b95f-bca3726d84ac.json
bbb50922-08ea-48b2-8ce4-d82d60732395,PROGRAF 0.5 MG,prescription,L04AA05,TACROLIMUS,6132,,,WHO ATC Classification,,ILS,capsules,TACROLIMUS 0.5   MG,2025-07-31T06:59:27.014433,IL,אסטלס,,214.0166,181.37,145.096,,8718692511460,PROGRAF 0.5 MG 50 CAPSULES,16772,,86607,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,122 07 30215 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in liver  kidney or heart allograft recipients.   Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bbb50922-08ea-48b2-8ce4-d82d60732395.json
bbbb03d0-d6f6-4cda-a444-5868a01713a8,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,1747,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:32:11.422138,IL,דקסל פארמה,,26.0308,22.06,nan,,,DEXAMOL SINUS DAY 30 CAPLETS,4003,,,BLISTER PVC/ALUMINIUM,units,30.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bbbb03d0-d6f6-4cda-a444-5868a01713a8.json
bbc73db4-ea16-4b30-80de-d18d3ed4f21b,JELMYTO,prescription,L01DC03,MITOMYCIN,9309,,,WHO ATC Classification,,ILS,powder and hydrogel for pyelocalyceal solution,MITOMYCIN/VIAL,2025-07-31T04:19:00.027940,IL,ניאופרם,,nan,nan,nan,,372493103033,JELMYTO 40 MG/VIAL,17869,,88142,VIAL GLASS TYPE I,units,1.0,170 82 36971 99,valid,nan,", , , , , , pyelocalyceal",1.4,36,,,,,,,,,,0,Prescription required,For the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC).,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bbc73db4-ea16-4b30-80de-d18d3ed4f21b.json
bbe6b8bf-2e0d-4348-be9a-c25813a758ce,AFINITOR 10 MG,prescription,L04AA18,EVEROLIMUS,6901,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS,2025-07-30T23:16:29.977784,IL,נוברטיס פארמה,,3115.894118,2640.588235,2400.534759,,7290006257383,AFINITOR 2.5MG 30TABLETS,9597,,37075,BLISTER PA/AL/PVC,units,30.0,142 87 32046 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"- For the treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection.The effectiveness of Afinitor is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated.- Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease.The safety and effectiveness of AFINITOR® in the treatment of patients with carcinoid tumors have not been established.- For the treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.- Afinitor ® is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Afinitor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes.- Afinitor ® is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.-  Treatment of unresectable, locally advanced  or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bbe6b8bf-2e0d-4348-be9a-c25813a758ce.json
bc0445a9-93bd-4dd2-b057-6b01090a49e5,BACTROBAN NASAL,prescription,R01AX06,MUPIROCIN,977,,,WHO ATC Classification,,ILS,ointment,MUPIROCIN AS CALCIUMW/W,2025-07-31T00:28:17.956229,IL,ג.ס.ק,,29.73800364,25.201698,18.3954,,7290008102582,BACTROBAN 15GR OINT,2352,,20699,TUBE ALUMINIUM,units,15.0,050 85 26431 21,valid,37.0,nasal,1.4,36,,,,,,,,,,0,Prescription required,"The elimination of nasal carriage of staphylococci, including methycillin-resistant staphylococus aureus (MRSA).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc0445a9-93bd-4dd2-b057-6b01090a49e5.json
bc1430c4-614a-4cdf-bbd4-053b6cc9e9f4,BALVERSA 3 MG,prescription,L01EX16,ERDAFITINIB,8492,,,WHO ATC Classification,,ILS,film coated tablets,ERDAFITINIB,2025-07-30T23:34:18.613125,IL,יאנסן סילג,,nan,nan,nan,,7290014577572,BALVERSA 5 MG 28 TAB,2749,,433,BOTTLE HDPE,units,28.0,165 77 36132 00,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,"BALVERSA is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has:- Susceptible FGFR3 or FGFR2 genetiic alterations, and- Progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc1430c4-614a-4cdf-bbd4-053b6cc9e9f4.json
bc27e896-9d44-47bc-9886-3900c51d2daf,HUMAN ALBUMIN 20% BEHRING,prescription,B05AA01,ALBUMIN,9328,,,WHO ATC Classification,,ILS,solution for infusion,ALBUMIN HUMAN/ML,2025-07-31T03:49:40.009757,IL,סי אס אל,,175.9130352,149.07885,119.26308,,7290000689975,HUMAN ALBUMIN 20% BEHRING 50ML,8341,,28817,VIAL GLASS TYPE II,units,50.0,039 05 20131 00,valid,25.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Hypoalbuminemia (liver cirrhosis nephrosis) toxic processes ( pregnancy toxicosis, hyperbilirubinemia ) ,volume substitution therapy.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc27e896-9d44-47bc-9886-3900c51d2daf.json
bc2b23f7-73d9-4e96-bff1-372bdf292add,PIRFENIDONE SANDOZ ® 267 MG,prescription,L04AX05,PIRFENIDONE,9524,,,WHO ATC Classification,,ILS,film coated tablets,PIRFENIDONE,2025-07-31T06:45:13.801057,IL,סנדוז,,7326.181982,6208.629074,5644.208249,,,PIRFENIDONE SANDOZ 801MG 84 TAB,,,,BLISTER PVC/PE/PVDC,units,84.0,175 20 37557 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Pirfenidone Sandoz is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc2b23f7-73d9-4e96-bff1-372bdf292add.json
bc2fdbd1-4322-47bd-a09b-fc6aa5be1931,IDACIO,prescription,L04AB04,ADALIMUMAB,8871,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/ML,2025-07-31T03:56:48.028961,IL,ניאופרם,,2331.675847,1975.996569,1796.360517,,,IDACIO 40MG/0.8 ML 2 PFP,17302,,69151,PRE-FILLED PEN GLASS TYPE I,units,2.0,165 83 36283 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"• Rheumatoid arthritis: Idacio in combination with methotrexate is indicated for:- The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.- The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. Idacio can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. Adalimumab has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.• Axial spondyloarthritis:-Ankylosing spondylitis (AS): Idacio is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.-Axial spondyloarthritis without radiographic evidence of AS: Idacio is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels, who have had an inadequate response to, or are intolerant to, non-steroidal anti-inflammatory drugs.• Psoriatic arthritis: Idacio is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti rheumatic drug therapy has been inadequate. Adalimumab has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.• Psoriasis: Idacio is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.• Hidradenitis suppurativa (HS): Idacio is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult patients with an inadequate response to conventional systemic HS therapy.• Crohn’s disease: Idacio is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. Idacio is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab. • Ulcerative colitis: Idacio is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies. • Uveitis:Idacio is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.• Intestinal Behcet's disease: Idacio is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc2fdbd1-4322-47bd-a09b-fc6aa5be1931.json
bc3161ff-72ae-466b-8cd7-c1e73e4fed64,RECITAL 20,prescription,N06AB04,CITALOPRAM,4617,,,WHO ATC Classification,,ILS,tablets,CITALOPRAM AS HYDROBROMIDE,2025-07-31T07:19:31.505784,IL,אוניפארם,,49.65888046,42.083797,30.7181,,,RECITAL 40MG 28TAB,18062,,56393,BLISTER PVC/ALUMINIUM,units,28.0,123 22 30309 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of states of depression or panic disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc3161ff-72ae-466b-8cd7-c1e73e4fed64.json
bc39d993-1809-43bc-a004-e420b64076ae,TRITACE 1.25 MG,prescription,,,2658,,,,,ILS,tablets,RAMIPRIL 1.25  MG,2025-07-31T09:43:33.419623,IL,סאנופי אוונטיס,,14.11809112,11.964484,8.7332,,,TRITACE 1.25MG 28TAB,20026,,4868,BLISTER PVC/ALUMINIUM,units,28.0,124 59 30412 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Hypertension  congestive heart failure  reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction  stoke  cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI  unstable angina or multivessel CABG or multivessel PTCA)  stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction  stroke  cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings :  hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg)  high total cholesterol (>5.2 mmol/L)  low HDL ( <0.9 mmol/L)  current smoker  known microalbuminuria  clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc39d993-1809-43bc-a004-e420b64076ae.json
bc3e2002-4e46-4643-bcd8-c9dd99c6b2d2,MUCOLESS SOLUTION,off-the-counter,R05CB02,BROMHEXINE,5423,,,WHO ATC Classification,,ILS,solution,BROMHEXINE HYDROCHLORIDE/ML,2025-07-31T12:27:20.100772,IL,מכבי קאר,,19.2104,16.28,nan,,7290008082648,MUCOLESS SOL INHALATION 50ML,,,,BOTTLE GLASS TYPE III,units,50.0,135 11 31423 00,valid,nan,"per os, inhalation",1.4,36,,,,,,,,,,0,,Bronchial mucolytic. It can also be given by inhalation as an aerosol solution.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc3e2002-4e46-4643-bcd8-c9dd99c6b2d2.json
bc4a7f98-298f-4965-9214-fda5edfa343f,MOXYVIT FORTE 250 SUSPENSION,prescription,J01CA04,AMOXICILLIN,2291,,,WHO ATC Classification,,ILS,powder for oral suspension,AMOXICILLIN AS TRIHYDRATE/ML,2025-07-31T05:35:15.809775,IL,ויטאמד,,13.33695,11.3025,8.25,,,MOXYVIT SUSP 60ML,13430,,7924,BOTTLE HDPE,units,60.0,045 22 26064 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,•	For the treatment of infections caused by bacteria susceptible to amoxicillin.•	Intended for the prevention of bacterial infections in patients who are at risk for developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc4a7f98-298f-4965-9214-fda5edfa343f.json
bc6d2214-d564-4e05-9a94-a5916ad96cc5,VERRUMAL SOLUTION,prescription,,,908,,,,,ILS,solution,"SALICYLIC ACID/, FLUOROURACIL 0.5 G /",2025-07-31T10:08:08.734271,IL,ניאופרם,,133.6950821,113.300917,84.2386,,,VERRUMAL SOL 13ML,22062,,2375,BOTTLE GLASS TYPE III,units,13.0,010 34 24061 00,valid,34.5,topical,1.4,36,,,,,,,,,,0,Prescription required,"Common warts ( special form : plantar warts, on areas of the sole of the foot that are subjected to pressure), plane juvenile warts of the extremities.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc6d2214-d564-4e05-9a94-a5916ad96cc5.json
bc97949a-d85e-4e79-b8af-149ddc37a6ec,SANDOSTATIN ® 0.05 MG/ML,prescription,H01CB02,OCTREOTIDE,949,,,WHO ATC Classification,,ILS,solution for injection / infusion,OCTREOTIDE 0.05  MG/ML,2025-07-31T07:59:08.385490,IL,נוברטיס פארמה,,90.41345712,76.62157724,56.96771542,,7298120012734,SANDOSTATIN 0.05MG/ML 5 VIALS,19655,,8201,AMPOULES GLASS TYPE I,units,5.0,047 03 25697 00,valid,34.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Prevention of complications following pancreatic surgery.   Symptomatic control and reduction of GH and IGF-1plasma levels in patients with acromegaly who are inadequately controlled by surgery  or radiotherapy. Sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery  or in the interim period until radiotherapy becomes fully effective.   Relief of symptoms associated with functional gastroenteropancreatic endocrine tumours:   - Carcinoid tumours with features of the carcinoid syndrome    - VIPomas    - Glucagonomas    - Gastrinomas / zollinger-Ellison syndrome usually in conjunction with proton pump inhibitors  or H2- antagonist therapy    - Insulinomas  for pre-operative control of hypoglycaemia and for maintenance therapy   - GRFomas.   Sandostatin is not an antitumour therapy and is not curative in these patients.Emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bc97949a-d85e-4e79-b8af-149ddc37a6ec.json
bca20f78-6c6f-48b0-9cc4-acf4856d0415,SANDIMMUN ® NEORAL ® 100 MG CAPSULES,prescription,L04AA01,CYCLOSPORIN,3007,,,WHO ATC Classification,,ILS,capsules,CICLOSPORIN,2025-07-31T07:58:31.633778,IL,נוברטיס פארמה,,169.1189275,143.321125,114.6569,,7298120012772,SANDIMMUN NEO 25MG 50CAPS,19071,,9078,BLISTER PVC/PA/ALUMINIUM,units,50.0,066 78 28140 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of organ rejection in kidney  liver heart allogenic transplants in conjunction with corticosteroids. May also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents.  Bone marrow transplantation.   Endogenous uveitis.   Severe psoriasis above age 16 that did not respond to other treatment. Atopic dermatitis in adults only up to 8 weeks  for severe cases in which conventional therapy is ineffective or inappropriate.   Rheumatoid arthritis: Severe cases in which standard treatments are ineffective or inappropriate.  Nephrotic syndrom type MCD (minimal change disease) in cases where conventional therapy has failed.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bca20f78-6c6f-48b0-9cc4-acf4856d0415.json
bcb3ea35-42fa-435b-8064-e7181724afda,PROPOFOL-LIPURO 2%,prescription,N01AX10,PROPOFOL,8288,,,WHO ATC Classification,,ILS,emulsion for injection or infusion,PROPOFOL/ML,2025-07-31T07:02:50.695674,IL,לפידות,,746.6023814,632.7138825,538.4799,,4030539096416,PROPOFOL LIPURO 2 % 50ML 10 AMP,,,25161,BOTTLE GLASS TYPE II,units,10.0,141 66 31763 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Propofol-Lipuro 2% is a short-acting intravenous general anaesthetic for● induction and maintenance of general anaesthesia in adults and children > 3 years● sedation of ventilated patients >16 years of age in the intensive care unit● sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 3 years.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bcb3ea35-42fa-435b-8064-e7181724afda.json
bcbe9d47-b5cf-4d01-855e-777bf3a1d1e0,TYGACIL,prescription,J01AA12,TIGECYCLINE,6981,,,WHO ATC Classification,,ILS,powder for solution for infusion,TIGECYCLINE/VIAL,2025-07-31T09:48:58.313392,IL,פיזר,,1535.509308,1301.279132,1107.471602,,,TYGACIL 50MG/DOSE 10 VIALS 5ML,20891,,30484,VIAL GLASS TYPE I,units,10.0,136 43 31352 01,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"TYGACIL is   indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:Complicated Skin and Skin Structure Infections:Complicated skin and skin structure infections caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates ), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Streptococcus pyogenes, Enterobacter cloacae, Klebsiella pneumoniae, and Bacteroides fragilis .Complicated Intra-abdominal Infections:Complicated intra-abdominal infections caused by Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Bacteroides fragilis, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, Clostridium perfringens, and Peptostreptococcus micros.Community-Acquired Bacterial Pneumonia:Community-acquired bacterial pneumonia caused by Streptococcus pneumoniae (penicillin susceptible isolates), including cases with concurrent bacteremia, Haemophilus influenzae (beta-lactamase negative isolates), and Legionella pneumophila.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bcbe9d47-b5cf-4d01-855e-777bf3a1d1e0.json
bcc25871-ca14-41df-aac4-28743525390a,ENSTILAR,prescription,D05AX52,"CALCIPOTRIOL, COMBINATIONS",8625,,,WHO ATC Classification,,ILS,cutaneous foam,"BETAMETHASONE AS DIPROPIONATE 0.5  MG /, CALCIPOTRIOL AS MONOHYDRATE/",2025-07-31T02:22:49.322435,IL,דקסל פארמה,,196.6130869,166.6212675,133.297014,,,ENSTILAR FOAM 60 GR,5667,,24709,CAN ALUMINIUM,units,60.0,163 91 35848 00,valid,25.0,topical,1.4,24,,,,,,,,,,0,Prescription required,Topical treatment of psoriasis vulgaris in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bcc25871-ca14-41df-aac4-28743525390a.json
bccbc110-c768-4f36-bdab-cf9b9247a9b1,CANDOR 16,prescription,C09CA06,CANDESARTAN,7323,,,WHO ATC Classification,,ILS,tablets,CANDESARTAN CILEXETIL,2025-07-31T00:52:25.832044,IL,אוניפארם,,24.02073608,20.356556,14.8588,,,CANDOR 8MG 28TAB,9685,,48770,BLISTER PVC/ALUMINIUM,units,28.0,150 71 33815 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Hypertension. Treatment of patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction < or = 40 % ) as add-on therapy to ACE inhibitors or when ACE inhibitors are not tolerated,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bccbc110-c768-4f36-bdab-cf9b9247a9b1.json
bce4a5ab-adc5-456c-ae25-b6a86c26db02,DIACOMIT 250MG 60CAPS,29C,,,20063,,,,,,capsule,DIACOMIT 250MG,2025-07-31T20:13:56.238957,IL,nan,,,,,,,DIACOMIT 250MG 60CAPS,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bce4a5ab-adc5-456c-ae25-b6a86c26db02.json
bd1115a3-0560-4902-a000-08bbd8a0499f,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,5392,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:23:47.517369,IL,רקיט בנקיזר,,37.7954,32.03,nan,,7290000852973,STREPSILS STRAW S. FREE 24LOZ,19821,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd1115a3-0560-4902-a000-08bbd8a0499f.json
bd349ef5-8a79-4acc-9857-f030c7c56e6d,LIPITOR 10 MG,prescription,C10AA05,ATORVASTATIN,4077,,,WHO ATC Classification,,ILS,film coated tablets,ATORVASTATIN AS CALCIUM,2025-07-31T04:48:09.509581,IL,דקסל פארמה,,32.64788364,27.667698,20.1954,,,LIPITOR 20MG 30TAB,12482,,69510,BLISTER PVC/OPA/AL,units,30.0,126 04 30587 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol  LDL- cholesterol  apolipoprotein B  and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Lipitor is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable.   Pediatric patients (10-17 years of age) :   Atorvastatin is indicated as an adjunct to diet to reduce total -C  LDL-C  and apo B levels in boys and postmenarchal girls  10 to 17 years of age  with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:   1. LDL-C remains >or = 190 mg/dl or   2. LDL-C remains > or = 160 mg/dl and:    there is a positive family history of premature cardiovascular disease or    two or more other CVD risk factors are present in the pediatric patient.   Prevention of cardiovascular and/or cerebrovascular event sush as MI or stroke  as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor.   In patients with clinically evident coronary heart disease  Lipitor is indicated to :    Reduce the risk of non-fatal myocardial infarction.    Reduce the risk of fatal and non fatal stroke.    Reduce the risk for revascularization procedures.    Reduce the risk of hospitalization for CHF.    Reduce the risk of angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd349ef5-8a79-4acc-9857-f030c7c56e6d.json
bd39585d-ce62-45bc-9940-f6808da0654e,CYMBALTA 30 MG,prescription,N06AX21,DULOXETINE,4823,,,WHO ATC Classification,,ILS,gastro resistant capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T01:36:53.238909,IL,אלי לילי,,66.01605934,55.945813,41.5954,,,CYMBALTA 30MG 28CAPS,3789,,13277,BLISTER PVC/PE/PCTFE/AL,units,28.0,132 70 31142 12,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Cymbalta is indicated for the treatment of major depressive episodes.- Cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy.- Cymbalta is indicated for the treatment of generalized anxiety disorder (GAD).- Cymbalta is indicated for the management of fibromyalgia.- Cymbalta is indicated for the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. This has been established in studies in patients with chronic low back pain (CLBP) and chronic pain due to osteoarthritis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd39585d-ce62-45bc-9940-f6808da0654e.json
bd3aee83-d5ee-404a-89c3-271ea495d69a,MYFORTIC 180 MG,prescription,L04AA06,MYCOPHENOLIC ACID,4699,,,WHO ATC Classification,,ILS,gastro resistant tablets,MYCOPHENOLIC ACID,2025-07-31T05:38:05.137632,IL,נוברטיס פארמה,,861.6881783,730.2442189,621.4844416,,7290100419984,MYFORTIC 360MG 120TAB,13508,,59276,BLISTER PA/ALUMINIUM/PVC,units,120.0,128 30 30715 01,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Myfortic is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd3aee83-d5ee-404a-89c3-271ea495d69a.json
bd42b6dd-a890-4d58-94b7-3be52c93000e,LIVTENCITY,prescription,J05AX10,MARIBAVIR,9220,,,WHO ATC Classification,,ILS,film coated tablets,MARIBAVIR,2025-07-31T04:51:26.322244,IL,טקדה,,58525.68414,49598.03961,45089.12692,,,LIVTENCITY 200 MG 56 TAB,12662,,24943,BOTTLE POLYETHYLENE,units,56.0,173 33 37360 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"LIVTENCITY is indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd42b6dd-a890-4d58-94b7-3be52c93000e.json
bd4782eb-fcc1-4b11-b14d-a532339216d7,PLUVITON 30TAB,off-the-counter,,,2032,,,,,ILS,tablet,PLUVITON,2025-07-31T19:46:29.923851,IL,סם און,,42.067,35.65,,,,PLUVITON 30TAB,16163,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd4782eb-fcc1-4b11-b14d-a532339216d7.json
bd5addc7-7a73-42bf-aa96-a5f61403adae,FLUMIST,prescription,J07BB02,"INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN ",7584,,,WHO ATC Classification,,ILS,"nasal spray, suspension ","B/AUSTRIA/1359417/2021 (B/VICTORIA LINEAGE)-LIKE VIRUS 10^7.0±0.5 FFU / 0.2  ML, A/VICTORIA/4897/2022 (H1N1)PDM09-LIKE VIRUS 10^7.0±0.5 FFU / 0.2  ML, A/THAILAND/8/2022 (H3N2)-LIKE VIRUS 10^7.0±0.5 FFU / 0.2  ML",2025-07-31T03:13:16.842101,IL,אסטראזנקה,,1205.567173,1021.667141,869.50395,,7290019949015,FLUMIST QUADRIVALENT 0.2ML 10 UNIT DOSE,6602,,81270,PREFILED SPRAYER GLASS,units,10.0,177 71 38099 00,valid,17.5,intranasal,1.4,15,,,,,,,,,,0,Prescription required,FluMist is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FluMist is approved for use in persons 2 through 49 years of age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd5addc7-7a73-42bf-aa96-a5f61403adae.json
bd7603e2-f280-491c-8c45-12a643c7cc7d,ABIVENIR 250 MG,prescription,L02BX03,ABIRATERONE,9522,,,WHO ATC Classification,,ILS,tablets,ABIRATERONE ACETATE,2025-07-30T23:10:31.203955,IL,סנדוז,,3304.85753,2800.726845,2546.115313,,,ABIRATERONE SANDOZ 500MG 60 TAB,,,,BOTTLE HDPE,units,60.0,172 52 37297 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,AbiVenir is a CYP17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd7603e2-f280-491c-8c45-12a643c7cc7d.json
bd796842-c861-4e27-b51b-8aaa2fe5bdbd,CALCILESS TABLETS,prescription,,,2001,,,,,ILS,tablets,"SODIUM PHOSPHATE DIBASIC, POTASSIUM PHOSPHATE MONOBASIC",2025-07-31T00:49:52.958459,IL,סם און,,215.5712404,182.6875,146.15,,7290008066273,CALCILESS 200TAB,3012,,417,JAR HDPE,units,200.0,046 29 23142 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Prevention and treatment of calcium oxalate stones.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd796842-c861-4e27-b51b-8aaa2fe5bdbd.json
bd7c1717-0aa9-4831-93b1-6aef8d642736,PROVIRON 25MG 50TAB,prescription,,,134,,,,,ILS,tablet,PROVIRON 25MG,2025-07-31T19:29:19.108233,IL,באייר,,45.62862593,38.66832878,28.2250575,,,PROVIRON 25MG 50TAB,16827,,17912,,units,50.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd7c1717-0aa9-4831-93b1-6aef8d642736.json
bd884b0d-2196-4fb1-9bc6-2cabc02a70be,PAPAVERINE HCL STEROP 40 MG/2 ML,prescription,A03AD01,PAPAVERINE,8567,,,WHO ATC Classification,,ILS,solution for injection,PAPAVERINE HYDROCHLORIDE/,2025-07-31T06:27:39.740742,IL,רז פרמהצפטי,,38.59631421,32.70874085,23.87499332,,7290015863537,PAPAVERINE HCL STEROP 40 MG/2 ML 10 AMP,,,49006,AMPOULES GLASS TYPE I,units,10.0,161 86 35093 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Antispasmodic in visceral spasm, e.g. gastrointestinal colic, biliary and urinary tract spasms. Peripheral vascular disease with vasospastic element. Vascular spasm associated with acute myocardial infarction, angina pectoris, peripheral and pulmonary embolism.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd884b0d-2196-4fb1-9bc6-2cabc02a70be.json
bd9e3778-c77b-462d-b840-08c0841536e9,ACTOS 15 MG,prescription,A10BG03,PIOGLITAZONE,7093,,,WHO ATC Classification,,ILS,tablets,PIOGLITAZONE AS HYDROCHLORIDE,2025-07-30T23:13:44.589980,IL,צמל,,151.0019832,127.9677881,102.3742305,,,ACTOS 45MG 28TAB,9528,,33619,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,149 69 33828 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bd9e3778-c77b-462d-b840-08c0841536e9.json
bdc04752-e798-48e3-9b60-561074a01b93,CEREBONIN FORTE 240 MG,prescription,N06DP01,GINKGO BILOBA ,9615,,,WHO ATC Classification,,ILS,film coated tablets,DRY EXTRACT FROM GINKGO BILOBA LEAVES (35-67:1),2025-07-31T01:06:50.738057,IL,דר סמואלוב,,181.0491313,153.4314741,122.7451793,,,CEREBONIN FORTE 240 MG 30 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,177 41 36979 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Herbal medicine for the improvement of (age-associated) cognitive impairment and of quality of life in mild dementia in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bdc04752-e798-48e3-9b60-561074a01b93.json
bdd055ac-624a-4bc3-8e69-18db06663460,MACRODANTIN 100MG 30CAPS,29C,,,20100,,,,,,capsule,MACRODANTIN 100MG,2025-07-31T20:49:33.976395,IL,nan,,,,,,,MACRODANTIN 100MG 30CAPS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bdd055ac-624a-4bc3-8e69-18db06663460.json
bdd1f523-314d-438e-9d04-a6b5b364951d,CAVERJECT 10 MCG,prescription,G04BE01,ALPROSTADIL,3158,,,WHO ATC Classification,,ILS,powder for solution for injection,ALPROSTADIL,2025-07-31T00:57:41.288877,IL,פיזר,,54.07682511,45.82781993,33.45096345,,,CAVERJECT 10MCG V+DS,3009,,22284,VIAL GLASS TYPE I,units,1.0,101 08 28542 00,valid,37.0,intracavernosal,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of erectile dysfunction in adult males, due to neurogenic, vasculogenic, psychogenic or mixed etiology. Useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bdd1f523-314d-438e-9d04-a6b5b364951d.json
bde8f879-e13b-494a-8988-eab95bdb699b,SMOFLIPID 200 MG/ML,prescription,B05BA10,COMBINATIONS,7109,,,WHO ATC Classification,,ILS,emulsion for infusion,"TRIGLYCERIDES, MEDIUM-CHAIN/L, SOYA OIL/L, REFINED OLIVE OIL/L, PURIFIED FISH OIL/L",2025-07-31T08:23:58.081997,IL,ניאופרם,,3082.4097,2612.211727,2374.737933,,,SMOFLIPID 200 MG/ML  10 BOTTLES 500ML,,,35597,BOTTLE GLASS TYPE II,units,5000.0,137 75 31387 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Supply of energy and essential fatty acids and omega-3 fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bde8f879-e13b-494a-8988-eab95bdb699b.json
be09194b-c29f-4bb1-9d29-e458ad0adee7,STIMOFIL 300 MCG/0.5 ML,prescription,L03AA02,FILGRASTIM,8744,,,WHO ATC Classification,,ILS,solution for injection / infusion,FILGRASTIM/ 0.5  ML,2025-07-31T08:43:47.858570,IL,צמל,,167.9440789,142.3254969,113.8603976,,7290015245999,STIMOFIL 300 MCG/0.5 ML 1 SYR PREFILLED,,,51640,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,164 19 36445 00,valid,25.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Stimofil is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia.The safety and efficacy of Stimofil  are similar in adults and children receiving cytotoxic chemotherapy.Stimofil  is indicated for the mobilisation of peripheral blood progenitor cells (PBPCs).In patients, children or adults with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of less or equal to 0.5 x 109 /L, and a history of severe or recurrent infections, long term administration of Stimofil  is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.Stimofil  is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 x 109 /L) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be09194b-c29f-4bb1-9d29-e458ad0adee7.json
be0a58c9-7da1-4b50-ade1-84ce9936c8a6,AGISTEN ALOEVERA CREAM,off-the-counter,D01AC01,CLOTRIMAZOLE,5042,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T11:07:05.042071,IL,פאדאגיס,,34.69,29.4,nan,,7290004850432,AGISTEN BABY PASTE 30GR,2061,,,TUBE ALUMINIUM,units,30.0,043 17 22461 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as Malassezia furfur, as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be0a58c9-7da1-4b50-ade1-84ce9936c8a6.json
be301d9a-6656-4f42-9663-34bbe5377b4e,DIFOLTA,prescription,L01BA05,PRALATREXATE,7090,,,WHO ATC Classification,,ILS,solution for injection,PRALATREXATE/ML,2025-07-31T01:55:47.455847,IL,רפא,,nan,nan,nan,,7290008013963,DIFOLTA 20MG/ML VIAL(1ML),22363,,40912,VIAL GLASS TYPE I,units,1.0,149 31 33684 00,valid,nan,i.v,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be301d9a-6656-4f42-9663-34bbe5377b4e.json
be41b231-dd1f-4fb4-8248-b83e925a67ae,VOLTAREN EMULGEL 1%,off-the-counter,M02AA15,DICLOFENAC,5273,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T13:37:11.799152,IL,ג.ס.ק,,111.8522,94.79,nan,,,VOLTAREN EMULGEL 150G,22318,,,TUBE ALUMINIUM,units,150.0,037 66 25000 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to:  • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :• Pain caused by osteoarthrosis of the peripheral joints,  as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be41b231-dd1f-4fb4-8248-b83e925a67ae.json
be42311b-472b-4288-9698-b2e7c1539127,ALCOHOL 70%  FLORIS,off-the-counter,D08AX08,ETHANOL,2968,,,WHO ATC Classification,,ILS,solution,ALCOHOLV/V,2025-07-31T11:09:11.573716,IL,פלוריש,,12.2012,10.34,nan,,,ALCOHOL 70% 100ML,1878,,,BOTTLE HDPE,units,100.0,057 39 27018 00,valid,nan,topical,1.4,48,,,,,,,,,,0,,Antiseptic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be42311b-472b-4288-9698-b2e7c1539127.json
be4560ad-0fcd-4ea5-b033-4d8e16eceac7,DEPO MEDROL 40 MG/ML,prescription,H02AB04,METHYLPREDNISOLONE,8560,,,WHO ATC Classification,,ILS,suspension for injection,METHYLPREDNISOLONE ACETATE/ML,2025-07-31T05:18:35.870519,IL,דקסל פארמה,,1024.993696,868.638725,739.267,,72982006,METHYLPREDNISOLONE MYLAN 500MG 10 VIALS,13974,,59192,VIAL GLASS TYPE I,units,10.0,024 49 21841 00,valid,17.5,"periarticular, i.m, intra-articular, intra-lesional, intrabursal, intrarectal instillation, soft tissues",1.4,60,,,,,,,,,,0,Prescription required,For the treatment of conditions responsive to steroid injection therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be4560ad-0fcd-4ea5-b033-4d8e16eceac7.json
be5eedb8-b299-4be3-8482-8129778efb36,SPIRIT WHITFIELD FLORIS,off-the-counter,D01AE12,SALICYLIC ACID,2972,,,WHO ATC Classification,,ILS,spirit,"BENZOIC ACIDW/V, SALICYLIC ACIDW/V",2025-07-31T13:20:18.497008,IL,פלוריש,,17.7944,15.08,nan,,7290008103343,SPIRIT WHITFIELD  100ML,19050,,,BOTTLE POLYETHYLENE,units,100.0,060 91 27485 00,valid,nan,topical,1.4,48,,,,,,,,,,0,,"Antifungal, antiseptic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be5eedb8-b299-4be3-8482-8129778efb36.json
be5ff59a-cdff-44e6-9358-214e1485520b,RISPERDAL 1 MG,prescription,N05AX08,RISPERIDONE,3052,,,WHO ATC Classification,,ILS,film coated tablets,RISPERIDONE,2025-07-31T07:38:05.434506,IL,יאנסן סילג,,69.66321514,59.036623,43.8934,,7290008124744,RISPERDAL 4MG 20TAB,18078,,9158,BLISTER PVC/PE/PVDC/AL,units,20.0,144 78 28260 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be5ff59a-cdff-44e6-9358-214e1485520b.json
be7537d4-2678-423f-9f44-ed4ee75e8628,SINUFED TABLETS,off-the-counter,R01BA02,PSEUDOEPHEDRINE,5244,,,WHO ATC Classification,,ILS,tablets,PSEUDOEPHEDRINE HYDROCHLORIDE,2025-07-31T13:18:13.211014,IL,תרימה,,13.1688,11.16,nan,,,SINUFED 10 TAB,19874,,,BLISTER PVC/ALUMINIUM,units,10.0,030 06 25464 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,"Symptomatic treatment of nasal congestion, to relieve eustachian tube congestion.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be7537d4-2678-423f-9f44-ed4ee75e8628.json
be762882-7e63-43b0-a35f-a78a7f5be2c4,MACLIVAN 250 MG/5 ML,prescription,,,7543,,,,,ILS,powder for oral suspension,"CLAVULANIC ACID AS POTASSIUM 62.5  MG /, AMOXICILLIN AS TRIHYDRATE/",2025-07-31T05:04:00.816300,IL,סנדוז,,24.93055856,21.127592,15.4216,,,MACLIVAN 400 MG + 57MG/5 ML POWDER FOR SUSP 70 ML,13773,,74193,BOTTLE AMBER GLASS TYPE III,units,70.0,120 17 30001 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Maclivan is indicated for the treatment of the following infections in adults and children :• Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be762882-7e63-43b0-a35f-a78a7f5be2c4.json
be79cb28-afe5-4400-af80-1eab0c55bc26,ALBUNORM 20 %,prescription,B05AA01,ALBUMIN,7721,,,WHO ATC Classification,,ILS,solution for infusion,"ALBUMIN HUMAN/, PLASMA PROTEIN FRACTION",2025-07-31T00:14:46.821315,IL,דובר מדיקל,,215.9813641,183.0350625,146.42805,,,ALBUNORM 5% VIAL 250ML,,,13718,BOTTLE GLASS TYPE II,units,250.0,150 28 33713 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on the official recommendations",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be79cb28-afe5-4400-af80-1eab0c55bc26.json
be7b5d13-ddfc-4e6f-8e6e-1d76bc3005dd,ADVAGRAF 0.5 MG,prescription,L04AD02,TACROLIMUS,7673,,,WHO ATC Classification,,ILS,capsules prolonged release,TACROLIMUS AS MONOHYDRATE 0.5  MG,2025-07-31T00:10:20.929177,IL,אסטלס,,1276.607156,1081.870519,920.7408675,,8718692510692,ADVAGRAF 5MG 50  P.R. CAPS,9820,,74123,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,153 07 34071 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in adult kidney or liver allograft recipients.Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be7b5d13-ddfc-4e6f-8e6e-1d76bc3005dd.json
be96725e-4ad0-451b-9984-d2ddfa47de43,NERIDERM OINTMENT,prescription,D07AC06,DIFLUCORTOLONE,3686,,,WHO ATC Classification,,ILS,ointment,DIFLUCORTOLONE VALERATE 0.1 G /,2025-07-31T05:42:57.932895,IL,פאדאגיס,,24.29550365,20.58941079,15.028767,,7290002925521,NERIDERM OINT 30G,14016,,8836,TUBE ALUMINIUM,units,30.0,061 51 24637 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,Corticoid responsive dermatoses in the absence of infection,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/be96725e-4ad0-451b-9984-d2ddfa47de43.json
bea15c12-6462-4436-9837-ce973ecd2e61,MALARONE TABLETS FOR ADULTS,prescription,P01BB51,"PROGUANIL, COMBINATIONS",4648,,,WHO ATC Classification,,ILS,film coated tablets,"ATOVAQUONE, PROGUANIL HYDROCHLORIDE",2025-07-31T05:05:06.482923,IL,ג.ס.ק,,113.2359265,95.96265381,71.347698,,,MALARONE ADULTS 12TAB,13499,,59161,BLISTER PVC/ALUMINIUM,units,12.0,128 46 30733 01,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Prevention of malaria: For the prophylaxis of P.falciparum malaria, including in areas where chloroquine resistance has been reported. Treatment of malaria: For the treatment of acute, uncomplicated P.flaciparum malaria. Malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bea15c12-6462-4436-9837-ce973ecd2e61.json
bea29f33-72ca-4bdf-8274-babdf62fa64f,TREPROSTINIL S.K 2.5 MG/ML,prescription,B01AC21,TREPROSTINIL,8598,,,WHO ATC Classification,,ILS,solution for injection / infusion,TREPROSTINIL 2.5  MG /,2025-07-31T09:39:33.509407,IL,SK PHARM(KS KIM),,15698.12655,13303.49767,12094.08879,,7290016845136,TREPROSTINIL S.K 2.5 MG/ML 20ML 1 VIAL,20956,,3784,VIAL GLASS TYPE I,units,1.0,162 29 35640 00,valid,10.0,"s.c, i.v",1.4,24,,,,,,,,,,0,Prescription required,Treprostinil s.k. is indicated for the treatment of:* Primary pulmonary arterial hypertension.* Pulmonary arterial hypertension associated with connective tissue disorders. * Pulmonary hypertension associated with congenital systemic to pulmonary shunts.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bea29f33-72ca-4bdf-8274-babdf62fa64f.json
beabab9a-e2a8-4b60-88ed-d0edd36ec600,TEMO 100 MG,prescription,L01AX03,TEMOZOLOMIDE,6798,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T09:11:15.236214,IL,פאדאגיס,,2505.715923,2123.48807,1930.4437,,7298074050721,TEMO 250 MG 5CAPS,20704,,32100,BOTTLE GLASS TYPE III,units,5.0,145 26 33258 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/beabab9a-e2a8-4b60-88ed-d0edd36ec600.json
beac4d25-37d5-491c-bcdc-2915511c6ba5,LUNSUMIO,prescription,,,9222,,,,,ILS,concentrate for solution for infusion,MOSUNETUZUMAB/,2025-07-31T04:59:21.904982,IL,רוש,,1383.312814,1172.299047,997.7013167,,,LUNSUMIO 1MG/1ML 1VIAL 1ML,,,,VIAL GLASS TYPE I,units,1.0,172 15 37418 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior systemic therapies.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/beac4d25-37d5-491c-bcdc-2915511c6ba5.json
beadd836-f442-4b51-b6b3-56e43abeac25,EZATOR S.K. 10/10 MG,prescription,C10BA05,ATORVASTATIN AND EZETIMIBE ,9335,,,WHO ATC Classification,,ILS,film coated tablets,"EZETIMIBE, ATORVASTATIN AS CALCIUM TRIHYDRATE",2025-07-31T02:51:00.834289,IL,SK PHARM(KS KIM),,143.1975503,121.3538562,90.22591541,,,EZATOR S.K. 10/40 MG 30 TAB,5744,,13717,BLISTER OPA/ALU/PVC/ALU,units,30.0,170 85 36878 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Prevention of Cardiovascular EventsEzator S.K. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaEzator S.K. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Ezator S.K. is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/beadd836-f442-4b51-b6b3-56e43abeac25.json
bebb437e-aab0-414a-8632-ac371dc15c16,ACCOFIL 300 MCG/0.5 ML,prescription,L03AA02,FILGRASTIM,8439,,,WHO ATC Classification,,ILS,solution for injection / infusion,FILGRASTIM/ 0.5  ML,2025-07-31T00:05:33.355359,IL,צמל,,255.2158137,216.2845975,173.027678,,,ACCOFIL 480 MCG/0.5 ML 1PFS,,,,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,160 35 34790 00,valid,25.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"ACCOFIL is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia.The safety and efficacy of ACCOFIL are similar in adults and children receiving cytotoxic chemotherapy.ACCOFIL is indicated for the mobilisation of peripheral blood progenitor cells (PBPCs).In patients, children or adults with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of less or equal to 0.5 x 109 /L, and a history of severe or recurrent infections, long term administration of ACCOFIL is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.ACCOFIL is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 x 109 /L) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bebb437e-aab0-414a-8632-ac371dc15c16.json
bebd5843-ccff-4ea0-bdd2-c0143f606cbf,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,3963,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:22:52.225437,IL,רקיט בנקיזר,,29.7714,25.23,nan,,7290000852973,STREPSILS HONEY AND LEMON 24 LOZ,19746,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bebd5843-ccff-4ea0-bdd2-c0143f606cbf.json
bebd7e87-287e-421e-9354-4ede2aed4dca,DOGMATIL 100MG/2ML 6 AMP,29C,,,20378,,,,,,injection,DOGMATIL 100MG/,2025-07-31T20:17:46.699099,IL,nan,,,,,,,DOGMATIL 100MG/2ML 6 AMP,,,,,units,6.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bebd7e87-287e-421e-9354-4ede2aed4dca.json
bebdbc1f-08c4-4d4b-a68e-da210f001e4e,TEPKINLY 4 MG / 0.8 ML,prescription,,,9471,,,,,ILS,solution for injection,EPCORITAMAB/ML,2025-07-31T09:13:23.185812,IL,אב-וי,,3031.310736,2568.907518,2335.370471,,8054083027029,TEPKINLY 4 MG / 0.8 ML 1 VIAL,,,17434,VIAL GLASS TYPE I,units,1.0,176 07 37755 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"TEPKINLY is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B cell lymphoma after two or more lines of systemic therapy.Tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bebdbc1f-08c4-4d4b-a68e-da210f001e4e.json
bec315e3-bfa1-44f0-bd73-b538b6befd62,PREGABALIN TEVA ® 100 MG,prescription,N03AX16,PREGABALIN,8016,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:54:38.494497,IL,טבע,,43.82877422,37.143029,27.1117,,,PREGABALIN TEVA  25 MG 56 TAB,16982,,55993,BLISTER PVC/ALUMINIUM,units,56.0,157 26 34479 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,PREGABALIN TEVA ® is indicated for the: - Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia. - Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bec315e3-bfa1-44f0-bd73-b538b6befd62.json
bec8c4ad-4c7b-42d7-9ac2-992b7f8a1e3a,ERLEADA,prescription,L02BB05,APALUTAMIDE,8301,,,WHO ATC Classification,,ILS,film coated tablets,APALUTAMIDE,2025-07-31T02:34:10.132042,IL,יאנסן סילג,,13190.76761,11178.61712,10162.3792,,7290014577480,ERLEADA 60MG  120 TAB,2647,,26049,BOTTLE HDPE,units,120.0,162 84 35698 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Erleada is indicated in adult men for the treatment of• metastatic hormone‐sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT)• non-metastatic castration-resistant prostate cancer (nm-CRPC).""",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bec8c4ad-4c7b-42d7-9ac2-992b7f8a1e3a.json
bed60ccf-1275-4c0b-9be2-fd47b01e4149,NOVONORM 0.5 MG,prescription,A10BX02,REPAGLINIDE,3809,,,WHO ATC Classification,,ILS,tablets,REPAGLINIDE 0.5  MG,2025-07-31T05:55:04.489169,IL,נובו נורדיסק,,33.54962312,28.431884,20.7532,,,NOVONORM 1MG 90TAB,14214,,20253,BLISTER ALUMINIUM,units,90.0,114 47 29661 12,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Repaglinide is also indicated in combination with metformin in adults with type 2diabetes mellitus who are not satisfactorily controlled on metformin alone.Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bed60ccf-1275-4c0b-9be2-fd47b01e4149.json
bedda9f9-8633-4049-b96a-44bd22a71b1b,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7706,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:37:47.105939,IL,סנדוז,,976.5919511,827.6202975,704.3577,,,BINOCRIT 30000 I.U/0.75 ML 1 SYRINGE PREFILLED,2568,,56402,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bedda9f9-8633-4049-b96a-44bd22a71b1b.json
beeb76df-f93f-4844-aa14-be704cb2aad7,ELELYSO,prescription,A16AB11,TALIGLUCERASE ALFA,7154,,,WHO ATC Classification,,ILS,powder for solution for infusion,TALIGLUCERASE ALFA 200 U/VIAL,2025-07-31T02:13:36.802845,IL,פיזר,,nan,nan,nan,,7290013823007,ELELYSO 200 U/VIAL,5557,,26152,VIAL GLASS TYPE I,units,1.0,148 67 33413 00,valid,nan,i.v,1.4,24,,,,,,,,,,0,Prescription required,ELELYSO™ (taliglucerase alfa) for injection is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for adults and pediatric patients with a confirmed diagnosis of Type 1 Gaucher disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/beeb76df-f93f-4844-aa14-be704cb2aad7.json
bef08473-7b5c-4ce6-baa7-fd7ed4e3ab45,REFIXIA 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,9242,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,NONACOG BETA PEGOL/VIAL,2025-07-31T07:20:15.347788,IL,נובו נורדיסק,,19161.7124,16238.74004,14762.49095,,,REFIXIA 2000 IU 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,172 35 37303 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in pretreated patients with haemophilia B (congenital factor IX deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bef08473-7b5c-4ce6-baa7-fd7ed4e3ab45.json
bef13582-98d1-40ce-8313-3addad46183a,MARCAINE 0.5 %,prescription,N01BB01,BUPIVACAINE,8366,,,WHO ATC Classification,,ILS,solution for injection,BUPIVACAINE HYDROCHLORIDE/ML,2025-07-31T05:05:28.168059,IL,פאדאגיס,,102.0441816,86.47812,64.296,,6091403219001,MARCAINE 0.5 % 5 VIALS,13530,,5998,VIAL 20 ML GLASS TYPE I,units,5.0,046 89 23721 01,valid,34.5,"epidural, caudal, pudental, sacral, intercostal, paracervical",1.4,36,,,,,,,,,,0,Prescription required,Long acting local anaesthetic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bef13582-98d1-40ce-8313-3addad46183a.json
befc5a3e-f343-45f9-b120-9559df4e59ea,FERINJECT,prescription,,,6674,,,,,ILS,solution for injection / infusion,FERRIC CARBOXYMALTOSE/VIAL,2025-07-31T03:03:03.211152,IL,כ.צ.ט,,569.0828231,482.2736004,410.4456173,,,FERINJECT 500MG/10ML SOL FOR INJ/INF,69,,25671,VIAL GLASS TYPE I,units,1.0,146 42 33331 03,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Ferinject is indicated for treatment of iron deficiency when oral iron preparations are ineffective or cannot be used. The diagnosis must be based on laboratory tests.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/befc5a3e-f343-45f9-b120-9559df4e59ea.json
bf291814-50f5-4374-ad2e-da3bdd0e442b,CRESTOR ® 5 MG,off-the-counter,C10AA07,ROSUVASTATIN,5231,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T11:21:45.826703,IL,ג.ס.ק,,81.7386,69.27,nan,,,CALCIUM D SANDOZ 60 TAB EFF,3948,,,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,139 22 31615 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf291814-50f5-4374-ad2e-da3bdd0e442b.json
bf2d8561-f63f-4e41-b729-d24f29a4d22a,LUTATHERA 370 MBq/ML SOLUTION FOR INFUSION,prescription,V10XX04,LUTETIUM (177LU) OXODOTREOTIDE,8801,,,WHO ATC Classification,,ILS,solution for infusion,LUTETIUM (177LU) OXODOTREOTIDE 370 MBQ/ML,2025-07-31T05:00:03.967362,IL,נוברטיס פארמה,,98504.01122,83477.97932,75889.07211,,7290018070802,LUTATHERA 370 MBq/ML SOLUTION FOR INFUSION 1VIAL,,,76863,VIAL GLASS TYPE I,units,1.0,162 24 35598 00,valid,10.0,i.v,1.4,72,,,,,,,,,,0,Prescription required,"Lutathera is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (G1 and G2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (GEP NETs) in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf2d8561-f63f-4e41-b729-d24f29a4d22a.json
bf592c88-baf0-42db-89ff-7550d4825043,HYQVIA,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",8154,,,WHO ATC Classification,,ILS,solution for infusion,HUMAN NORMAL IMMUNOGLOBULIN/,2025-07-31T03:53:41.996447,IL,טקדה,,3404.488306,2885.159709,2622.872463,,7290018375235,HYQVIA 1vial normal  10g/100ml + 1vial recombinant 5ml,8472,,59754,VIAL GLASS TYPE I,units,100.0,160 21 35267 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, children and adolescents (0-18 years) in:• Primary immunodeficiency syndromes with impaired antibody production • Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (CLL), in whom prophylactic antibiotics have failed or are contra-indicated.• Hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (MM) patients.• Hypogammaglobulinaemia in patients pre- and post-allogeneic hematopoietic stem cell transplantation (HSCT).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf592c88-baf0-42db-89ff-7550d4825043.json
bf598520-83d5-4f66-a1fd-3889b2eb1c54,ADAKVEO 10 MG/ML,prescription,B06AX01,CRIZANLIZUMAB,9053,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,CRIZANLIZUMAB/ML,2025-07-31T04:52:18.693284,IL,ליברה,,135.4704493,114.8054706,85.3572272,,,LIZ TABS 3(24+4),,,70497,VIAL GLASS TYPE I,units,84.0,168 71 36562 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,ADAKVEO is indicated to reduce the frequency of vasoocclusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf598520-83d5-4f66-a1fd-3889b2eb1c54.json
bf5cef1d-4233-48c8-8259-f7f292a96b99,ZOFRAN TABLETS 4 MG,prescription,A04AA01,ONDANSETRON,2704,,,WHO ATC Classification,,ILS,tablets,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE,2025-07-31T10:51:36.101900,IL,סנדוז,,136.8453169,115.9706075,86.2235,,,ZOFRAN 4MG 10TAB,26008,,8773,BLISTER PVC/ALUMINIUM,units,10.0,049 96 26549 22,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Adults:Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.  Zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). Paediatric Population:Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf5cef1d-4233-48c8-8259-f7f292a96b99.json
bf7688d8-09b2-470e-8045-848ebf92db97,RYBELSUS 14 MG,prescription,A10BJ06,SEMAGLUTIDE,8787,,,WHO ATC Classification,,ILS,tablets,SEMAGLUTIDE,2025-07-31T07:54:54.396017,IL,נובו נורדיסק,,507.0941789,429.7408487,365.7368925,,,RYBELSUS 7 MG 30 TAB,18634,,69366,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,166 74 36541 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in combination with other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf7688d8-09b2-470e-8045-848ebf92db97.json
bf7b2171-c9b9-46d2-9d33-dfc00716b809,MAALOX PLUS SUSPENSION,off-the-counter,,,1307,,,,,ILS,suspension,"ALUMINIUM HYDROXIDE/, MAGNESIUM HYDROXIDE/, SIMETHICONE/",2025-07-31T12:24:31.851433,IL,פרמה שלום,,34.1846,28.97,nan,,7290008880299,MAALOX SUSP 355ML,13007,,,BOTTLE PET,units,355.0,107 65 20354 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Antacid, antiflatulent, relief of sensation of heatburn.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf7b2171-c9b9-46d2-9d33-dfc00716b809.json
bf874649-eaee-461d-b83a-8acff07aa5bc,ISOKET RETARD 40MG 56TAB,29C,,,20467,,,,,,tablet,ISOKET RETARD 40MG,2025-07-31T20:39:37.798449,IL,nan,,,,,,,ISOKET RETARD 40MG 56TAB,,,,,units,56.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf874649-eaee-461d-b83a-8acff07aa5bc.json
bf8f7e80-97d4-4820-91cd-64f9fe84832c,LICARBIUM,prescription,,,1949,,,,,ILS,tablets,LITHIUM CARBONATE,2025-07-31T04:46:08.668232,IL,רקח,,86.92657797,73.6665915,54.7707,,7290008089258,LICARBIUM 300MG 100T,12050,,1205,BLISTER PVC/ALUMINIUM,units,100.0,022 10 20683 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of manic depressive states.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf8f7e80-97d4-4820-91cd-64f9fe84832c.json
bf9262cc-3ada-4086-bcf3-f2d3ab6eee7f,ONGLYZA 5 MG 30 FC TAB,prescription,,,6579,,,,,ILS,tablet,ONGLYZA 5 MG 30 FC TAB,2025-07-31T19:26:30.430686,IL,אסטראזנקה,,133.9795122,113.5419645,84.4178175,,,ONGLYZA 5 MG 30 FC TAB,15394,,22696,,units,30.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bf9262cc-3ada-4086-bcf3-f2d3ab6eee7f.json
bfa369f6-d2aa-4af4-818f-270b88d21003,OMEPRADEX - Z,off-the-counter,A02BC01,OMEPRAZOLE,5169,,,WHO ATC Classification,,ILS,caplets,OMEPRAZOLE,2025-07-31T12:40:03.442525,IL,דקסל פארמה,,32.332,27.4,nan,,7290010578511,OMEPRADEX Z 20MG 14 CAPLETS,15323,,,BLISTER ALUMINIUM /ALUMINIUM,units,14.0,131 25 30841 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bfa369f6-d2aa-4af4-818f-270b88d21003.json
bfa3bacf-fe0b-4be2-8df5-8be925020acc,CINACALCET TRIMA 30 MG,prescription,H05BX01,CINACALCET,7787,,,WHO ATC Classification,,ILS,film coated tablets,CINACALCET AS HYDROCHLORIDE,2025-07-31T01:14:56.402331,IL,תרימה,,1804.073869,1528.87616,1301.1712,,,CINACALCET TRIMA 60 MG 28TAB,9889,,32090,BLISTER PVC/ALUMINIUM,units,28.0,154 44 34241 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet -Trima  may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with:• parathyroid carcinoma.• primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bfa3bacf-fe0b-4be2-8df5-8be925020acc.json
bfae4306-32b3-4789-8a03-286bcd89a88d,STRATTERA 4 MG/ML ORAL SOLUTION,prescription,N06BA09,ATOMOXETINE,7948,,,WHO ATC Classification,,ILS,solution  (oral),ATOMOXETINE/,2025-07-31T08:46:04.674372,IL,אלי לילי,,305.3196711,258.745484,220.2089225,,7290016021059,STRATTERA 80MG 28 CAPS,9810,,71834,BOTTLE GLASS TYPE III,units,28.0,158 61 35026 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD. Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bfae4306-32b3-4789-8a03-286bcd89a88d.json
bfe5b7ce-4ba7-46d9-bac1-16e99bab7f71,DIMETINDENE INOVAMED GEL,off-the-counter,D04AA13,DIMETINDENE,5522,,,WHO ATC Classification,,ILS,gel,DIMETINDENE MALEATE 0.1 %W/W,2025-07-31T13:27:58.045928,IL,תרימה,,43.0346,36.47,nan,,,TINDEN GEL 30g,,,,TUBE ALUMINIUM,units,30.0,167 86 35712 00,valid,nan,topical,1.4,18,,,,,,,,,,0,,"Urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bfe5b7ce-4ba7-46d9-bac1-16e99bab7f71.json
bff7c5fb-f10b-408f-b241-b4601e1a4a07,SIMPONI,prescription,L04AB06,GOLIMUMAB,6698,,,WHO ATC Classification,,ILS,solution for injection,GOLIMUMAB/ML,2025-07-31T08:13:48.907402,IL,יאנסן סילג,,3929.702142,3330.256201,3027.505637,,7290014577299,SIMPONI 50MG/0.5ML (0.5ML) PREFILLED PEN,6698,,29028,AUTO - INJECTOR PEN GLASS TYPE I,units,1.0,147 32 33213 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid Arthritis:Simponi, in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis when the response to disease-modifying anti-rheumatic drug (DMARD) therapy including MTX has been inadequate.Juvenile idiopathic arthritis: Polyarticular juvenile idiopathic arthritis (pJIA)Simponi in combination with MTX is indicated for the treatment of polyarticular juvenile idiopathic arthritis in children with a body weight of at least 40 kg, who have responded inadequately to previous therapy with MTX.Simponi 100 mg is not recommended in children aged less than 18.Psoriatic Arthritis:Simponi, alone or in combination with methotrexate, is indicated for the treatment of adult patients with active and progressive  psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.Axial spondyloarthritis:* Ankylosing SpondylitisSimponi is indicated for the treatment of adult patients with severe active ankylosing spondylitis who have responded inadequately to conventional therapy.* Non-radiographic axial spondyloarthritis (nr-Axial SpA)Simponi is indicated for the treatment of adults with severe, active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to, or are intolerant to nonsteroidal anti-inflammatory drugs (NSAIDS).Ulcerative colitis (UC):Simponi is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/bff7c5fb-f10b-408f-b241-b4601e1a4a07.json
c005e101-09bb-4a58-a341-6f1941a43850,DUAVIVE,prescription,G03CC07,CONJUGATED ESTROGENS AND BAZEDOXIFENE,7999,,,WHO ATC Classification,,ILS,tablets modified release,"BAZEDOXIFENE ACETATE, ESTROGENS CONJUGATED 0.45  MG",2025-07-31T02:05:25.153391,IL,פיזר,,165.2007691,140.000658,112.0005264,,7290013592286,DUAVIVE 28 SR TAB,4670,,56619,BLISTER PVC/ACLAR/PVC/ALUMINIUM,units,28.0,157 37 34551 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of the following conditions in women with a uterus:• Treatment of moderate to severe vasomotor symptoms associated with menopause• Prevention of postmenopausal osteoporosis, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c005e101-09bb-4a58-a341-6f1941a43850.json
c016083e-4a93-4cec-8108-897d312d6965,RASAGILINE INOVAMED,prescription,N04BD02,RASAGILINE,8867,,,WHO ATC Classification,,ILS,tablets,RASAGILINE AS HEMITARTRATE,2025-07-31T07:17:12.001512,IL,אינובמד,,294.5612318,249.6281625,212.4495,,,RASAGILINE INOVAMED 1MG 30 TAB,18667,,2920,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,165 93 35792 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Rasagiline Inovamed  is indicated for the treatment of idiopathic Parkinson's disease (PD) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c016083e-4a93-4cec-8108-897d312d6965.json
c0209687-fb1c-451a-a29e-72ee2640d79e,NEUPOGEN 30 MU PRE-FILLED SYRINGE,prescription,L03AA02,FILGRASTIM,2843,,,WHO ATC Classification,,ILS,solution for injection,FILGRASTIM 30 MU / 0.5  ML,2025-07-31T05:43:50.488117,IL,מדיסון,,1229.752408,1042.163104,886.9473225,,8715131009762,NEUPOGEN 5VIAL 30MU./1ML,14608,,25519,SYRINGE PREFILLED  GLASS TYPE I,units,5.0,117 22 29875 00,valid,17.5,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Neupogen is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia.The safety and efficacy of Neupogen are similar in adults and children receiving cytotoxic chemotherapy.Neupogen is indicated for the mobilisation of peripheral blood progenitor cells (PBPCs).In patients, children or adults, with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of ≤ 0.5 × 109/l, and a history of severe or recurrent infections, long term administration of Neupogen is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.Neupogen is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 × 109/l) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0209687-fb1c-451a-a29e-72ee2640d79e.json
c028ed51-df9e-44cd-9da9-51f19f29d7e3,PEN-RAFA VK 500,prescription,J01CE02,PHENOXYMETHYLPENICILLIN,6204,,,WHO ATC Classification,,ILS,caplets,PHENOXYMETHYLPENICILLIN AS POTASSIUM,2025-07-31T06:34:45.911092,IL,רפא,,27.51407813,23.3170164,17.01972,,7290008016520,PEN-RAFA VK 500 40 CAPLETS,16780,,88078,BLISTER PVC/PVDC/ALUMINIUM,units,40.0,137 52 28678 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"For susceptible microorganisms. To treat group A haemolytic infections of the upper respiratory tract using a twice daily regimen (1 G. bid in adults, 0.5 G bid in children).",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c028ed51-df9e-44cd-9da9-51f19f29d7e3.json
c06f7fa9-7c6e-4420-950a-771834d1a344,NUROFEN GEL 5 %,off-the-counter,M02AA13,IBUPROFEN,5497,,,WHO ATC Classification,,ILS,gel,IBUPROFENW/W,2025-07-31T12:37:08.596879,IL,רקיט בנקיזר,,49.383,41.85,nan,,5000158100800,NUROFEN FOR CHILDREN ORANGE SYR 200ML,14579,,,TUBE ALUMINIUM,units,200.0,134 23 31074 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c06f7fa9-7c6e-4420-950a-771834d1a344.json
c06fcc77-0913-4013-8324-397d6839ad47,FUSID TABLETS,29C,C03CA01,FUROSEMIDE,20424,,,WHO ATC Classification,,ILS,tablets,FUROSEMIDE,2025-07-31T14:40:15.183251,IL,nan,,nan,nan,nan,,7290102064144,FUROSEMIDE ROXANE ORAL SOL 10MG/ML 120ML,,,,BLISTER PVC/ALUMINIUM,units,120.0,020 20 20472 12,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Adjunctive therapy in acute pulmonary edema. Treatment of hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c06fcc77-0913-4013-8324-397d6839ad47.json
c075fad8-5baa-4b48-9758-5096747bb108,PEGLAX NEUTRAL,off-the-counter,A06AD15,MACROGOL,5292,,,WHO ATC Classification,,ILS,powder for oral solution,POLYETHYLENE GLYCOL 3350 99.973 %W/W,2025-07-31T12:46:54.537340,IL,ניאופרם,,63.6374,53.93,nan,,7290013166562,PEGLAX ORANGE 250 GR,,,,BOTTLE POLYPROPYLENE,units,250.0,144 49 33236 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of constipation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c075fad8-5baa-4b48-9758-5096747bb108.json
c07bc069-02f4-4247-86af-7d50f2d2abfc,DAPSON-FATOL 50MG 100 tab,29C,,,21007,,,,,,tablet,DAPSON-FATOL 50MG,2025-07-31T20:11:01.855064,IL,nan,,,,,,,DAPSON-FATOL 50MG 100 tab,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c07bc069-02f4-4247-86af-7d50f2d2abfc.json
c080c17e-0f5c-412e-8f25-88a277a83e4f,L-THYROXINE SERB,29C,H03AA01,LEVOTHYROXINE SODIUM,20495,,,WHO ATC Classification,,ILS,solution for injection/ concentrate for solution for infusion,LEVOTHYROXINE SODIUM 0.2  MG /,2025-07-31T15:00:40.968531,IL,nan,,nan,nan,nan,,7290015863155,LEVOTHYROXINE SODIUM 125MCG 100TAB,,,,AMPOULES GLASS TYPE I,units,100.0,165 27 35356 00,valid,nan,"i.m, i.v",1.4,24,,,,,,,,,,0,,•Myxedema coma•Replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c080c17e-0f5c-412e-8f25-88a277a83e4f.json
c0851593-9a0a-42d0-9160-d41038df8cc1,BISOPROLOL FUMARATE INOVAMED 10 MG,prescription,C07AB07,BISOPROLOL,7689,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE,2025-07-31T00:39:35.520491,IL,אינובמד,,15.19604,12.878,9.4,,,BISOPROLOL INOVAMED 5 MG 30 F.C.TAB,2578,,71856,BLISTER PVC/ALUMINIUM,units,30.0,152 68 34097 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.- Hypertension. - Coronary heart disease (angina pectoris).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0851593-9a0a-42d0-9160-d41038df8cc1.json
c0966181-db76-4071-9d73-0f6afa3cdab5,PAROTIN 20,prescription,N06AB05,PAROXETINE,4911,,,WHO ATC Classification,,ILS,coated tablets,PAROXETINE AS HYDROCHLORIDE,2025-07-31T06:29:12.141420,IL,כ.צ.ט,,37.18163834,31.509863,22.9999,,,PAROTIN 20MG 30TAB,16735,,70512,BLISTER PVC/ALUMINIUM,units,30.0,133 48 31068 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of (in adults):* Major Depressive Disorder* Obsessive Compulsive Disorder (OCD)* Panic Disorder with and without agoraphobia* Social Anxiety Disorders/Social phobia* Generalised Anxiety Disorder* Post-Traumatic Stress Disorder,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0966181-db76-4071-9d73-0f6afa3cdab5.json
c097232f-6d03-4c16-ab11-134716223669,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,1745,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:31:45.521559,IL,דקסל פארמה,,22.9982,19.49,nan,,,DEXAMOL PLUS 20 CAPLETS,4422,,,BLISTER PVC/ALUMINIUM,units,20.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c097232f-6d03-4c16-ab11-134716223669.json
c0a057c7-48c7-46f9-8264-da2149f82208,CEREBONIN 120 MG,prescription,N06DX02,GINKGO BILOBA,7803,,,WHO ATC Classification,,ILS,film coated tablets,DRY EXTRACT FROM GINKGO BILOBA LEAVES (35-67:1),2025-07-31T01:06:40.098632,IL,דר סמואלוב,,107.4908493,91.09394413,67.7278395,,7290014626492,CEREBONIN 120 MG 30F.C.TAB,9944,,54718,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,155 61 34325 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"•	For the symptomatic treatment of mental losses due to organic brain syndrome within the framework of a general therapeutic concept for dementia syndromes having as major symptoms: Deficient memory, disturbances of concentration, depressive mood, dizziness, tinnitus and headache.The primary target group includes patients with demential syndrome in primary degenerative dementia, vascular dementia and mixed forms of both.•	Vertigo of vascular and involutional origin.•	Adjuvant treatment in case of tinnitus of vascular and involutional origin.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0a057c7-48c7-46f9-8264-da2149f82208.json
c0b5b16f-8e65-48f1-af57-98daf5a251da,BUPIVACAIN HYPERBAR SINTETICA 5 MG/ML,prescription,N01BB01,BUPIVACAINE,9125,,,WHO ATC Classification,,ILS,solution for injection,BUPIVACAINE HYDROCHLORIDE ( AS MONOHYDRATE)/ML,2025-07-31T00:46:15.242627,IL,אמ.בי.איי פארמה,,189.685,160.75,128.6,,,BUPIVACAINE AGUETTANT 5 MG/ML 20ML 10 VIALS,,,88397,AMPOULES GLASS TYPE I,units,10.0,174 92 37021 99,valid,25.0,spinal,1.4,36,,,,,,,,,,0,Prescription required,"BUPIVACAIN HYPERBAR  SINTETICA 5 MG/ML is indicated for spinal anaesthesia for surgery, e.g. urological and lower limb surgery, lasting 2-3 hours, abdominal surgery lasting 45-60 minutes.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0b5b16f-8e65-48f1-af57-98daf5a251da.json
c0b6304f-f87e-4b1d-903b-4f0474a2baa2,PRADAXA 110,prescription,B01AE07,DABIGATRAN ETEXILATE,6685,,,WHO ATC Classification,,ILS,capsules,DABIGATRAN ETEXILATE AS MESILATE,2025-07-31T06:48:22.630601,IL,בורינגר אינגלהיים,,145.629002,123.414414,91.7579286,,9006968012391,PRADAXA 150MG 60CAPS,16833,,26096,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,142 96 32974 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with nonvalvular  atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0b6304f-f87e-4b1d-903b-4f0474a2baa2.json
c0bbb7f4-f23f-4598-852d-dd55fa3cc052,LOTAN PLUS,prescription,,,6100,,,,,ILS,tablets,"LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE 12.5   MG",2025-07-31T04:56:53.735301,IL,אוניפארם,,24.79444084,21.012238,15.3374,,,LOTAN PLUS 30TAB,12396,,15983,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,137 95 31535 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Lotan plus is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. To reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0bbb7f4-f23f-4598-852d-dd55fa3cc052.json
c0d129b6-bd2b-47da-ab88-c012e1911f6c,PERICATE,prescription,N05AD01,HALOPERIDOL,4483,,,WHO ATC Classification,,ILS,solution for injection,HALOPERIDOL AS DECANOATE/ML,2025-07-31T06:37:59.513268,IL,אוניפארם,,294.7793282,249.81299,212.6068,,7290000812489,PERICATE 5AMP,16099,,29202,AMPOULES GLASS,units,5.0,026 04 25277 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,indicated for the maintenance treatment of schizophrenia and schizoaffective disorder in adult patients currently stabilized with oral haloperidol..,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0d129b6-bd2b-47da-ab88-c012e1911f6c.json
c0d96f48-fdf2-486e-9589-e5558c928e1a,VOXZOGO 0.4 MG,prescription,M05BX07,VOSORITIDE,9491,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,VOSORITIDE 0.4 MG/VIAL,2025-07-31T10:22:38.298071,IL,מדיסון,,34813.91266,29503.31713,26821.19739,,,VOXZOGO 0.56 MG 10 VIAL,,,26102,VIAL GLASS TYPE I,units,10.0,175 72 37698 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Voxzogo is indicated for the treatment of achondroplasia in paediatric patients whose epiphyses are not closed. The diagnosis of achondroplasia should be confirmed by appropriate genetic testing.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0d96f48-fdf2-486e-9589-e5558c928e1a.json
c0da2a4a-4563-4350-9226-c4e8e969b24e,NIFEDILONG 30,prescription,C08CA05,NIFEDIPINE,6238,,,WHO ATC Classification,,ILS,tablets prolonged release,NIFEDIPINE,2025-07-31T05:46:25.634558,IL,כ.צ.ט,,60.78238174,51.510493,37.5989,,,NIFEDILONG 60MG 30SRTAB,14470,,87932,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,137 89 31415 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Chronic stable angina, hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0da2a4a-4563-4350-9226-c4e8e969b24e.json
c0e2d529-7a93-48ff-b50c-47ea4f5aa204,SITAGLIPTIN S.K. 100 MG,prescription,A10BH01,SITAGLIPTIN,9444,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE,2025-07-31T08:19:28.409952,IL,SK PHARM(KS KIM),,105.22473,89.1735,66.3,,,SITAGLIPTIN S.K. 25 MG 30 TAB,,,22232,BLISTER PVC/PE/PVDC/AL,units,30.0,171 99 36508 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Sitagliptin S.K. is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: Sitagliptin S.K. should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. Sitagliptin S.K. has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitagliptin S.K..,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0e2d529-7a93-48ff-b50c-47ea4f5aa204.json
c0ed6423-da5d-4700-b811-d049e367fc8b,CLOFARABINE S.K. 1MG/1ML 1 VIAL 20 ML,prescription,,,8728,,,,,ILS,injection,CLOFARABINE S.K. 1MG/,2025-07-31T19:02:48.392881,IL,SK PHARM(KS KIM),,5865.324163,4970.613698,4518.739725,,,CLOFARABINE S.K. 1MG/1ML 1 VIAL 20 ML,17081,,59393,,units,1.0,,not-registered,10.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0ed6423-da5d-4700-b811-d049e367fc8b.json
c0f2335c-fa19-4a69-be08-602bec3bff81,MODAFINIL MEDOCHEMIE,prescription,N06BA07,MODAFINIL,8587,,,WHO ATC Classification,,ILS,tablets,MODAFINIL,2025-07-31T05:28:47.931971,IL,דפריס,,150.471004,127.5178,102.01424,,,MODAFINIL MEDOCHEMIE 100 MG 30 TAB,13975,,489,BLISTER PVC/ALUMINIUM,units,30.0,163 27 35354 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"To improve wakefulness in patients with excessive sleepiness associated with narcolepsy (with or without cataplexy), obstructive sleep apnea/hypopnea syndrome   (OSAHS ) and shift work sleep disorder (SWDS).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c0f2335c-fa19-4a69-be08-602bec3bff81.json
c107e95c-1c1c-4826-ab4c-369a1564afbe,ZITHROMAX I.V.,prescription,J01FA10,AZITHROMYCIN,8658,,,WHO ATC Classification,,ILS,powder for solution for infusion,AZITHROMYCIN AS DIHYDRATE/VIAL,2025-07-31T10:50:44.692406,IL,פיזר,,57.75413429,48.9441816,35.72568,,7290008097994,ZITHROMAX I.V. 1 VIAL,,,64994,VIAL GLASS TYPE I,units,1.0,124 14 30374 01,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c107e95c-1c1c-4826-ab4c-369a1564afbe.json
c10c20bb-3671-4220-8bf1-228d919c9472,INTRAROSA,prescription,G03XX01,PRASTERONE,8626,,,WHO ATC Classification,,ILS,vaginal pessaries,PRASTERONE 6.5  MG,2025-07-31T04:09:44.052440,IL,דקסל פארמה,,122.2177009,103.5743274,77.00693485,,7290015912655,INTRAROSA 6.5 MG VAGINAL PESSARIES,10861,,24707,BLISTER PVC/PE,units,28.0,163 84 36058 00,valid,34.5,intravaginal,1.4,36,,,,,,,,,,0,Prescription required,Intrarosa is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c10c20bb-3671-4220-8bf1-228d919c9472.json
c1125554-55e5-44de-a210-9dc0367ae44b,NUSSIDEX,off-the-counter,R01BA52,"PSEUDOEPHEDRINE, COMBINATIONS",5589,,,WHO ATC Classification,,ILS,tablets,"DEXCHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE AS HYDROCHLORIDE",2025-07-31T12:39:50.684807,IL,טבע,,29.6534,25.13,nan,,7290000801803,NUSSIDEX 30 TAB,,,,BLISTER PVC/ALUMINIUM,units,30.0,057 17 21688 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Symptomatic treatment of the common cold and allergic rhinitis (hay fever).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1125554-55e5-44de-a210-9dc0367ae44b.json
c118f5c5-7686-46c4-ba26-21ffa55746f6,RONEXINE 100 MG TABLETS,prescription,,,7318,,,,,ILS,tablets,LEVOMEPROMAZINE AS MALEATE,2025-07-31T07:48:11.733358,IL,רקח,,47.9669469,40.649955,29.6715,,7290008089845,RONEXINE 100MG 30TAB,18379,,25181,BLISTER PVC/ALUMINIUM,units,30.0,030 40 21109 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Therapeutic indications  Neuroleptic drug - Acute psychotic states. Chronic psychotic states (schizophrenia, chronic non-schizophrenic delirium: paranoid delirium, chronic hallucinatory psychoses). - In association with an antidepressant – short-duration treatment of certain severe forms of major depressive episodes.This association can be done only during the initial period of the treatment, namely, during the period from 4 to 6 weeks.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c118f5c5-7686-46c4-ba26-21ffa55746f6.json
c11cdec4-dd9b-436b-b717-cd90cb495b5b,PADCEV 20 MG,prescription,L01XC36,ENFORTUMAB VEDOTIN ,8783,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,ENFORTUMAB VEDOTIN/VIAL,2025-07-31T06:24:59.566136,IL,אסטלס,,4567.227774,3870.532184,3518.665622,,8718692511422,PADCEV 30 MG 1 VIAL,23224,,43088,VIAL GLASS TYPE I,units,1.0,167 37 36604 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"PADCEV, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer (mUC). PADCEV, as a single agent , is indicated for the treatment of adult patients with locally advanced or mUC who: •	have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic settingor:•	are ineligible for cisplatin-containing chemotherapy and have previously received a PD-1/PD-L1 inhibitor.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c11cdec4-dd9b-436b-b717-cd90cb495b5b.json
c131da37-9e0e-4356-908f-51c3d240cda3,VESANOID,prescription,L01XX14,TRETINOIN,7344,,,WHO ATC Classification,,ILS,capsules,TRETINOIN,2025-07-31T10:08:59.774823,IL,צמל,,1941.944727,1645.715943,1400.609313,,7290013280626,VESANOID 10MG 100CAPSULES,22360,,9659,BOTTLE GLASS TYPE II,units,100.0,101 07 28446 04,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Induction of remission in acute promyelocytic leukemia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c131da37-9e0e-4356-908f-51c3d240cda3.json
c138735d-2d58-42a5-87a7-4daac11de6b9,DEKINET,prescription,N04AA02,BIPERIDEN,1855,,,WHO ATC Classification,,ILS,tablets,BIPERIDEN HYDROCHLORIDE,2025-07-31T01:46:04.895977,IL,רפא,,14.54939935,12.33,9.0,,7290008014571,DEKINET 2MG 30TAB,4036,,676,BLISTER PVC/ALUMINIUM,units,30.0,015 32 24634 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,All types of Parkinson's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c138735d-2d58-42a5-87a7-4daac11de6b9.json
c15e78c1-05d4-4a33-8931-c4c3abd180f8,SPRAVATO,prescription,N06AX27,ESKETAMINE,8738,,,WHO ATC Classification,,ILS,solution for spray,ESKETAMINE AS HYDROCHLORIDE/VIAL,2025-07-31T08:35:57.564839,IL,יאנסן סילג,,2907.981308,2464.391049,2240.355499,,7290014577619,SPRAVATO NASAL SPRAY 28MG 3 VIALS,10683,,425,VIAL GLASS TYPE I,units,3.0,164 65 36113 00,valid,10.0,nasal,1.4,48,,,,,,,,,,0,Prescription required,"Spravato, in combination with a SSRI or SNRI, is indicated for adults with treatment-resistant Major Depressive Disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.Spravato, co-administered with oral antidepressant therapy, is indicated in adults with a moderate to severe episode of Major Depressive Disorder, as acute short-term treatment, for the rapid reduction of depressive symptoms, which according to clinical judgement constitute a psychiatric emergency.Limitations of Use: The effectiveness of SPRAVATO in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. Use of SPRAVATO does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of SPRAVATO.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c15e78c1-05d4-4a33-8931-c4c3abd180f8.json
c15f65af-cfe7-49e8-ac8d-76730052085f,EBIXA TABLETS 10 MG,prescription,N06DX01,MEMANTINE,4731,,,WHO ATC Classification,,ILS,film coated tablets,MEMANTINE HYDROCHLORIDE,2025-07-31T02:10:36.527337,IL,לנדבק,,155.9268225,132.141375,105.7131,,,EBIXA 10MG 56TAB,5401,,59111,BLISTER PP/ALUMINIUM,units,56.0,129 83 30891 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Treatment of patient with moderate to severe Alzheimer's disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c15f65af-cfe7-49e8-ac8d-76730052085f.json
c16069a4-5112-4ba3-a37e-97082d91ea01,SYNTHROID 100 MCG TABLETS,prescription,H03AA01,LEVOTHYROXINE SODIUM,8642,,,WHO ATC Classification,,ILS,tablets,LEVOTHYROXINE SODIUM,2025-07-31T08:56:39.157151,IL,אבוט,,22.2460326,18.85257,13.761,,8002660034762,SYNTHROID 50 MCG 90 TAB,10893,,25481,BOTTLE HDPE,units,90.0,149 74 33763 01,valid,37.0,per os,1.4,15,,,,,,,,,,0,Prescription required,"Hypothyroidism, Pituitary TSH Suppression",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c16069a4-5112-4ba3-a37e-97082d91ea01.json
c165a6ad-d7d3-4e9e-a2c4-2e20e6734488,TOPISALEN,prescription,D07XB01,FLUMETASONE,2224,,,WHO ATC Classification,,ILS,ointment,"SALICYLIC ACIDW/W, FLUMETASONE PIVALATE 0.02 %W/W",2025-07-31T09:25:55.357693,IL,תרימה,,25.74904314,21.821223,15.9279,,,TOPISALEN OINT 15GR,20162,,2217,TUBE ALUMINIUM,units,15.0,023 58 21362 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of corticosteroid responsive dermatoses especially in hyperkeratotic conditions.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c165a6ad-d7d3-4e9e-a2c4-2e20e6734488.json
c16f7245-e40a-4487-8ea5-067b02253e24,GEMCITABINE TEVA ® CONCENTRATE,prescription,L01BC05,GEMCITABINE,7353,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,GEMCITABINE AS HYDROCHLORIDE/ML,2025-07-31T03:29:43.893305,IL,טבע,,260.6854525,220.919875,176.7359,,7290106061309,GEMCITABINE TEVA CONCENTRATE 40MG/ML (1000MG/25ML),7917,,43116,VIAL 10 ML GLASS TYPE I,units,1.0,150 90 33868 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"GEMCITABINE TEVA®  CONCENTRATE is indicated for the palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer.GEMCITABINE TEVA®  CONCENTRATE is indicated for the treatment of patients with bladder cancer at the invasive stage.Breast cancer:GEMCITABINE TEVA®  CONCENTRATE in combination with paclitaxel,is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant /neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.Ovarian cancer:GEMCITABINE TEVA®  CONCENTRATE in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma who have relapsed at least 6 months after platinum-based therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c16f7245-e40a-4487-8ea5-067b02253e24.json
c17b691c-b03a-4a44-bda6-1bc6884b821d,AGISERC 16,prescription,N07CA01,BETAHISTINE,2714,,,WHO ATC Classification,,ILS,tablets,BETAHISTINE DIHYDROCHLORIDE,2025-07-30T23:16:57.111370,IL,פאדאגיס,,15.737601,13.33695,9.735,,7-290002-925422,AGISERC 16MG 30TAB,1042,,8774,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,056 87 27365 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Meniere's syndrom. Symptomatic treatment of peripheral vertigo.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c17b691c-b03a-4a44-bda6-1bc6884b821d.json
c1806b6d-24ee-4218-b0f0-240a516be397,SEBOSEL,off-the-counter,D01AE13,SELENIUM SULFIDE,2100,,,WHO ATC Classification,,ILS,suspension,SELENIUM SULFIDE/ML,2025-07-31T13:15:57.579223,IL,תרו,,32.2848,27.36,nan,,,SEBOSEL SHAMP 100ML,19032,,,BOTTLE HDPE,units,100.0,016 79 21210 00,valid,nan,topical- scalp,1.4,48,,,,,,,,,,0,,"For the treatment of dandruff, seborrheic dermatitis of the scalp and tinea versicolor.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1806b6d-24ee-4218-b0f0-240a516be397.json
c18e987a-e511-4c6c-9400-f81d93d2dd9a,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1826,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:50:40.833469,IL,פישר,,40.3324,34.18,nan,,7290000849188,POLYDINE SOL 1000CC,16182,,,BOTTLE HDPE,units,1000.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c18e987a-e511-4c6c-9400-f81d93d2dd9a.json
c193d0a6-8870-4e15-a6f7-663d246d086f,AJOVY,prescription,,,8464,,,,,ILS,solution for injection,FREMANEZUMAB/ML,2025-07-30T23:17:35.834021,IL,טבע,,2425.231885,2055.281349,1749.175617,,7290110733261,AJOVY 225MG/1.5ML,,,4192,PREFILLED PEN GLASS TYPE I,units,1.0,162 86 35836 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,AJOVY is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c193d0a6-8870-4e15-a6f7-663d246d086f.json
c195f95f-f400-4f88-a769-d9e0757f8e71,NEBIDO ®,prescription,G03BA03,TESTOSTERONE,7745,,,WHO ATC Classification,,ILS,solution for injection,TESTOSTERONE UNDECANOATE/ML,2025-07-31T05:41:01.276294,IL,באייר,,468.231114,396.8060464,337.7072736,,7290013092823,NEBIDO 1000MG/4ML 1VIAL (250 MG/ML IM VIAL4ML),14570,,62423,VIAL GLASS TYPE I,units,1.0,134 77 31162 11,valid,17.5,i.m,1.4,60,,,,,,,,,,0,Prescription required,Testosterone replacement therpay in primary and secondary male hypogonadism.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c195f95f-f400-4f88-a769-d9e0757f8e71.json
c1a1c605-8fa5-4ddc-8f70-b095410118cc,QVAR 100,prescription,R03BA01,BECLOMETASONE,7251,,,WHO ATC Classification,,ILS,inhaler,BECLOMETASONE DIPROPIONATE/DOSE,2025-07-31T07:13:37.400479,IL,טבע,,97.20436344,82.37658285,61.24653,,502349717614,QVAR 100MCG/DODE PMD INHALER 200DOSES,17025,,43073,AUTOHALER ALUMINIUM,units,200.0,139 29 30661 00,valid,34.5,inhalation,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis and treatment of bronchial asthma in adults and children 5 years of age and obove.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1a1c605-8fa5-4ddc-8f70-b095410118cc.json
c1a788f5-8347-4615-a457-44c79b5bbe6d,METHYLPHENIDATE SANDOZ ® 54 MG PRT,prescription,N06BA04,METHYLPHENIDATE,9357,,,WHO ATC Classification,,ILS,tablets prolonged release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:17:53.670296,IL,סנדוז,,170.9435144,144.8673851,115.8939081,,,METHYLPHENIDATE SANDOZ  36 MG 30 SR TAB,,,14623,BOTTLE HDPE,units,30.0,169 45 36080 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Methylphenidate Sandoz® PRT is indicated for the treatment of Attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1a788f5-8347-4615-a457-44c79b5bbe6d.json
c1a88423-a84a-4f78-924a-a76d7824ed13,HISTAFED EXPECTORANT SYRUP,off-the-counter,R06AX07,TRIPROLIDINE,2192,,,WHO ATC Classification,,ILS,syrup,"GUAIFENESIN/, PSEUDOEPHEDRINE HYDROCHLORIDE/, TRIPROLIDINE HYDROCHLRIDE 1.25  MG /",2025-07-31T12:04:45.251450,IL,תרימה,,23.1162,19.59,nan,,7290000843698,HISTAFED EXPECT 115ML,8253,,,BOTTLE GLASS,units,115.0,050 31 26252 00,valid,nan,per os,1.4,18,,,,,,,,,,0,,"Histafed expectorant is a proven combination for providing an effective antiallergic action, decongestion with an added expectorant effect.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1a88423-a84a-4f78-924a-a76d7824ed13.json
c1aad767-3702-44e4-88a4-c16f4008c997,TICOVAC 0.5 ML,prescription,J07BA01,"ENCEPHALITIS, TICK BORNE, INACTIVATED, WHOLE VIRUS",8416,,,WHO ATC Classification,,ILS,suspension for injection,"ENCEPHALITIS, TICK BORNE, INACTIVATED, WHOLE VIRUS 2.4  MCG / 0.5  ML",2025-07-31T09:20:18.721655,IL,פיזר,,200.1093914,169.5842375,135.66739,,7290013592392,TICOVAC 0.5 ML  1 PREFILLED SYRINGE,20889,,45684,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,162 33 35413 00,valid,25.0,i.m,1.4,30,,,,,,,,,,0,Prescription required,Ticovac 0.5 ml is indicated for the active (prophylactic) immunization of adolescents from 16 years of age and adults against tick-borne encephalitis (TBE).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1aad767-3702-44e4-88a4-c16f4008c997.json
c1b166a9-6486-4fc2-a953-c5685f40252f,MEROKEN,prescription,A06AD10,MINERAL SALTS IN COMBINATION,2800,,,WHO ATC Classification,,ILS,powder for solution,"MACROGOLS 315.0  G/CONTAINER, POTASSIUM CHLORIDE 1.1175  G/CONTAINER, SODIUM BICARBONATE 4.2840  G/CONTAINER, SODIUM CHLORIDE 8.4240  G/CONTAINER",2025-07-31T05:13:52.080014,IL,תרו,,nan,nan,nan,,7290000808758,MEROKEN POWDER FOR SOL 3 L,13035,,8917,BOTTLE HDPE,units,1.0,062 36 27922 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Bowel cleansing prior to colonoscopy and barium enema x-ray examinations.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1b166a9-6486-4fc2-a953-c5685f40252f.json
c1b1b8ea-f002-4bd1-b5ab-9d25694cefb7,SERETIDE DISKUS 50/100 MCG,prescription,R03AK06,SALMETEROL AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,4126,,,WHO ATC Classification,,ILS,powder for inhalation,"FLUTICASONE PROPIONATE, SALMETEROL AS XINAFOATE",2025-07-31T08:05:19.128936,IL,ג.ס.ק,,106.3312402,90.11122055,66.99719,,7290008086509,SERETIDE DISKUS 50/100MCG 60DISK,19395,,21197,BLISTER PVC,units,60.0,114 13 29551 01,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"Seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1b1b8ea-f002-4bd1-b5ab-9d25694cefb7.json
c1b46846-56f2-4c17-b415-2c2d3dfedfae,CARVEDILOL TEVA ® 12.5 MG,prescription,C07AG02,CARVEDILOL,6110,,,WHO ATC Classification,,ILS,tablets,CARVEDILOL 12.5   MG,2025-07-31T00:56:28.489807,IL,טבע,,18.24575509,15.462505,11.2865,,7290102066797,CARVEDILOL TEVA 12.5MG 30TAB,3933,,42314,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,135 46 31073 11,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of symptomatic congestive heart failure. Carvedilol Teva  may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ACE inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1b46846-56f2-4c17-b415-2c2d3dfedfae.json
c1c975d6-0481-4143-b980-9ef57ffa61ff,MOVIPREP  ®,prescription,B05XA31,ELECTROLYTES IN COMBINATION WITH OTHER DRUGS,6679,,,WHO ATC Classification,,ILS,powder for solution,"POTASSIUM CHLORIDE 1.015 G, SODIUM ASCORBATE 5.9 G, MACROGOLS, SODIUM CHLORIDE 2.691 G, SODIUM SULFATE ANHYDROUS 7.5 G, ASCORBIC ACID 4.7 G",2025-07-31T05:33:20.433229,IL,פאדאגיס,,97.70174892,82.79809599,61.55992267,,7290012596186,MOVIPREP 4 SACHETS,13652,,25189,SACHET PAPER/POLYETHYLENE /ALUMINIUM,units,4.0,145 38 33156 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For bowel cleansing prior to any clinical procedures requiring a clean bowel e.g. bowel endoscopy or radiology.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1c975d6-0481-4143-b980-9ef57ffa61ff.json
c1d344c0-6e62-44c5-b079-c7d30246177a,DALACIN 2 % VAGINAL CREAM,prescription,G01AA10,CLINDAMYCIN,33,,,WHO ATC Classification,,ILS,cream,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T01:39:52.447023,IL,פיזר,,14.89212638,12.62044665,9.212004853,,7298074000054,DALACIN C 150MG 16CAPS,4007,,8468,TUBE PLASTIC,units,16.0,064 17 27818 00,valid,37.0,vaginal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1d344c0-6e62-44c5-b079-c7d30246177a.json
c1db91bc-304f-4aaa-80e5-6f4694e7643e,BESREMI 250 MCG/0.5 ML,prescription,L03AB15,ROPEGINTERFERON ALFA-2B ,8763,,,WHO ATC Classification,,ILS,solution for injection,ROPEGINTERFERON ALFA-2B/ML,2025-07-31T00:32:07.659430,IL,אי.או.פי אורפן,,10163.37135,8613.026953,7830.024503,,4150152036542,BESREMI 500 MCG/0.5 mL 1 pre-filled pen,,,,PRE-FILLED PEN GLASS TYPE I,units,1.0,166 66 36574 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Besremi is indicated as monotherapy in adults for the treatment of polycythaemia vera without symptomatic splenomegaly.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1db91bc-304f-4aaa-80e5-6f4694e7643e.json
c1e5595d-0184-40e7-b2be-3bbb768ed97b,TRULICITY 1.5 MG,prescription,A10BX14,DULAGLUTIDE,7842,,,WHO ATC Classification,,ILS,solution for injection,DULAGLUTIDE/ML,2025-07-31T09:46:39.319251,IL,אלי לילי,,443.4039306,375.7660596,319.8009018,,,TRULICITY 1.5 MG/0.5ML 4 SYR-PEN,20811,,32989,PRE-FILLED PEN GLASS TYPE I,units,4.0,154 40 34357 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,Type 2 Diabetes MellitusTrulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1e5595d-0184-40e7-b2be-3bbb768ed97b.json
c1f6396e-17e2-41a1-985c-d7f442b22fab,PNEUMOVAX 23,prescription,J07AL01,"PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN",1205,,,WHO ATC Classification,,ILS,solution for injection,PNEUMOCOCCAL VACCINE POLYVALENT/ 0.5  ML,2025-07-31T06:46:47.051347,IL,מ.ס.ד. ישראל,,132.210235,112.042577,83.30303125,,,PNEUMOVAX 23 25MCG/0.5ML,,,11122,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,136 52 23874 00,valid,34.5,"i.m, s.c",1.4,28,,,,,,,,,,0,Prescription required,For vaccination against pneumococcal disease caused by those pneumococcal types included in the vaccine.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1f6396e-17e2-41a1-985c-d7f442b22fab.json
c1fda98c-58a9-44aa-bd12-1cd6d0aba825,XENPOZYME,prescription,A16AB25,OLIPUDASE ALFA,9277,,,WHO ATC Classification,,ILS, powder for concentrate for solution for infusion ,OLIPUDASE ALFA/VIAL,2025-07-31T10:33:17.223635,IL,סאנופי אוונטיס,,16646.93637,14107.57382,12825.06711,,,XENPOZYME 1 VIAL,,,30222,VIAL GLASS TYPE I,units,1.0,173 41 37455 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-Central Nervous System (CNS) manifestations of Acid Sphingomyelinase Deficiency (ASMD) in paediatric and adult patients with type A/B or type B,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c1fda98c-58a9-44aa-bd12-1cd6d0aba825.json
c2045fa5-0556-40e7-8ad0-66802d0e3e40,GLAUTAN,prescription,S01EE01,LATANOPROST,6220,,,WHO ATC Classification,,ILS,"eye drops, solution",LATANOPROST/ML,2025-07-31T03:34:36.929891,IL,אוניפארם,,36.8932369,31.265455,22.8215,,7290008546393,GLAUTAN 2.5 ML EYE DROPS,7832,,89273,BOTTLE LDPE,units,2.5,139 75 31597 00,valid,37.0,ocular,1.4,18,,,,,,,,,,0,Prescription required,Reduction of elevated intraocular pressure as a first line treatment in patients with open-angle glaucoma and ocular hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2045fa5-0556-40e7-8ad0-66802d0e3e40.json
c204b24e-422f-4c1b-871e-32b81b007646,IRINOTECAN HCL SEACROSS 20 MG/ML,prescription,L01XX19,IRINOTECAN,7917,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,IRINOTECAN HYDROCHLORIDE TRIHYDRATE/,2025-07-31T04:12:11.878099,IL,טבע,,2372.165352,2010.30962,1827.5542,,,IRINOTECAN ACTAVIS 20MG/ML(500mg/25ml) VIAL,9958,,61638,VIAL GLASS TYPE I,units,1.0,168 44 36042 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Irinotecan HCl seacross is indicated for the treatment of patients with metastatic colorectal cancer: In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. For the treatment of patients with small cell lung cancer. For the treatment of patients with gastric cancer. Irinotecan in combination with leucovorin, Oxaliplatin and 5-fluorouracil for the first-line treatment of patients with metastatic pancreatic adenocarcinoma",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c204b24e-422f-4c1b-871e-32b81b007646.json
c207be78-8825-456d-adc4-630a2aee0b4f,DUTASTAMED,prescription,G04CA02,TAMSULOSIN,8923,,,WHO ATC Classification,,ILS,"capsule, hard","DUTASTERIDE 0.5  MG, TAMSULOSIN HYDROCHLORIDE 0.4  MG",2025-07-31T02:08:46.422128,IL,אינובמד,,69.4047233,58.81756473,43.7305314,,,DUTASTAMED 30 CAP,4740,,72745,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,166 79 36462 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c207be78-8825-456d-adc4-630a2aee0b4f.json
c2129767-6c10-4781-b6dc-f13f4c864dca,REVOLADE 25 MG,prescription,B02BX05,ELTROMBOPAG,6326,,,WHO ATC Classification,,ILS,film coated tablets,ELTROMBOPAG AS OLAMINE,2025-07-31T07:31:25.767584,IL,נוברטיס פארמה,,3892.964809,3299.122866,2999.202606,,7290014547254,REVOLADE 25MG 28TAB,18440,,24682,BLISTER POLYAMIDE/ALUMINIUM/PVC,units,28.0,143 55 32036 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (ITP) who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).Revolade is indicated for the treatment of paediatric patients aged 6 year and above with primary immune thrombocytopenia (ITP) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).Revolade is indicated for the treatment of adult patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.Revolade is indicated for the treatment of thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.Revolade is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 6 years and older with severe aplastic anemia.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2129767-6c10-4781-b6dc-f13f4c864dca.json
c2139a32-b226-4d24-8b79-5baf35785251,DAPTOMYCIN S.K. 350 MG,prescription,J01XX09,DAPTOMYCIN,9435,,,WHO ATC Classification,,ILS,lyophilized powder for solution for  injection or infusion ,DAPTOMYCIN/VIAL,2025-07-31T01:41:15.909188,IL,SK PHARM(KS KIM),,472.8307388,400.7040159,341.0246944,,,DAPTOMYCIN S.K. 500 MG 1 VIAL,,,11588,VIAL GLASS TYPE I,units,1.0,171 75 36924 99,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Daptomycin S.K. is indicated for the treatment of the infections listed below. • Complicated Skin and Skin Structure Infections Complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only).• Staphylococcus aureus Bloodstream Infections (Bacteremia), Including Those with Right-Sided Infective Endocarditis, Caused by Methicillin-Susceptible and Methicillin-Resistant Isolates Staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.• Combination therapy may be clinically indicated if the documented or presumed pathogens include Gram negative or anaerobic organisms.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2139a32-b226-4d24-8b79-5baf35785251.json
c2172457-f3a7-48e9-ac64-50cacbecd8d1,SEREVENT DISKUS,prescription,R03AC12,SALMETEROL,3541,,,WHO ATC Classification,,ILS,powder for inhalation,SALMETEROL AS XINAFOATE,2025-07-31T08:05:56.830527,IL,ג.ס.ק,,103.6895851,87.87253369,65.3327388,,7290008085328,SEREVENT DISK 50MCG 60DOSES,19103,,9291,BLISTER ,units,60.0,067 16 28303 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Salmeterol is a selective beta-2-agonist indicated for reversible airways obstruction in patients with asthma and chronic obstructive pulmonary disease (COPD).In asthma (including nocturnal asthma and exercise induced symptoms) it is indicated for those treated with inhaled corticosteroids who require a long-acting beta agonist in accordance with current treatment guidelines.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2172457-f3a7-48e9-ac64-50cacbecd8d1.json
c21dc043-1da4-4fab-9ea2-2ddeb1abba4c,BYLVAY 1200 MICROGRAMS,prescription,A05AX05,ODEVIXIBAT,9198,,,WHO ATC Classification,,ILS,"capsule, hard",ODEVIXIBAT AS SESQUIHYDRATE,2025-07-31T00:48:06.966062,IL,מדיסון,,33884.75799,28715.89788,26105.36171,,,BYLVAY 400 MCG 30 HARD CAPS,,,25877,BOTTLE HDPE,units,30.0,171 44 37200 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older.Bylvay is indicated for the treatment of cholestatic pruritus in patients 12 months of age and older with Alagille syndrome (ALGS).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c21dc043-1da4-4fab-9ea2-2ddeb1abba4c.json
c223bee3-2df8-43d0-8cbc-9c30700ba025,PARAMOL,off-the-counter,N02BE01,PARACETAMOL,5511,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T12:45:24.427112,IL,ליף-דקסון,,11.8944,10.08,nan,,,PARAMOL AF & SHIUL NIGHT CARE 20 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,20.0,127 96 30764 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c223bee3-2df8-43d0-8cbc-9c30700ba025.json
c22508bf-7331-43f7-ac49-436457961b4e,NOXAFIL 100 MG GASTRO-RESISTANT TABLETS,prescription,J02AC04,POSACONAZOLE,8005,,,WHO ATC Classification,,ILS,gastro resistant tablets,POSACONAZOLE,2025-07-31T05:56:44.978017,IL,מ.ס.ד. ישראל,,1809.553485,1533.519971,1305.123379,,7290006813893,NOXAFIL 100 MG GASTRO-RESISTANT 24 TABLETS,14611,,77256,BLISTER PVC/ACLAR/ALUMINIUM,units,24.0,156 42 34550 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Noxafil gastro-resistant tablets are indicated for use in the treatment of the following fungal infections in adults:- Invasive aspergillosis in patients with disease that is refractory to amphotericin B or itraconazole or in patients who are intolerant of these medicinal products;- Fusariosis in patients with disease that is refractory to amphotericin B or in patients who are intolerant of amphotericin B;- Chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole;- Coccidioidomycosis in patients with disease that is refractory to amphotericin B, itraconazole or fluconazole or in patients who are intolerant of these medicinal products.- Zygomycosis in patients intolerant of or with disease that is refractory to alternative therapy.Refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.Noxafil gastro-resistant tablets are also indicated for prophylaxis of invasive fungal infections in the following patients:- Patients receiving remission-induction chemotherapy for acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS) expected to result in prolonged neutropenia and who are at high risk of developing invasive fungal infections;- Hematopoietic stem cell transplant (HSCT) recipients who are undergoing high-dose immunosuppressive therapy for graft versus host disease and who are at high risk of developing invasive fungal infections.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c22508bf-7331-43f7-ac49-436457961b4e.json
c235249d-4f61-4b81-bc1b-67e7ca6fdad5,NUROFEN GEL 5 %,off-the-counter,M02AA13,IBUPROFEN,5494,,,WHO ATC Classification,,ILS,gel,IBUPROFENW/W,2025-07-31T12:37:45.031530,IL,רקיט בנקיזר,,49.383,41.85,nan,,5000158100800,NUROFEN FOR CHILDREN STRABERRY SYR 200ML,14575,,,TUBE ALUMINIUM,units,200.0,134 23 31074 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c235249d-4f61-4b81-bc1b-67e7ca6fdad5.json
c23ca38d-69f8-4808-9653-c6cd7f1a8679,BLEOMYCIN PFI,prescription,L01DC01,BLEOMYCIN,6846,,,WHO ATC Classification,,ILS,powder for solution for injection,BLEOMYCIN SULFATE/VIAL,2025-07-31T00:39:56.651693,IL,מגאפארם,,935.5503298,792.8392978,674.7568492,,9088880084885,BLEOMYCIN PFI 15000 IU/VIAL 10 VIALS,2268,,26707,VIAL GLASS TYPE I,units,10.0,133 57 25199 00,valid,17.5,"intrapleural, intra-arterial, i.v, s.c, i.m, intra-tumoral, intra-cavitary",1.4,42,,,,,,,,,,0,Prescription required,"Bleomycin is useful in the management of the following neoplasms: Squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. Well differentiated tumors usually respond better than anaplastic ones.Hodgkin's disease and other malignant lymphomas, including mycosis fungoides. Testicular carcinoma (seminoma and no seminoma) .Malignant effusions of serous cavities (intrapleural and intraperitoneal).Secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. Local treatment of refractory warts. Bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c23ca38d-69f8-4808-9653-c6cd7f1a8679.json
c283904c-0f18-4b0a-a3ad-bd13486dae4a,RESTASIS,prescription,L04AA01,CYCLOSPORIN,7088,,,WHO ATC Classification,,ILS,"eye drops, emulsion",CICLOSPORIN 0.05 %,2025-07-31T07:28:10.573790,IL,אב-וי,,nan,nan,nan,,7290104780028,RESTASIS 0.05% EYE DRPS 30X0.4ML,18467,,4125,VIAL LDPE,units,30.0,136 03 31306 00,valid,nan,ocular,1.4,24,,,,,,,,,,0,Prescription required,To increase tear production in patients whose tear production is presumed to be supressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c283904c-0f18-4b0a-a3ad-bd13486dae4a.json
c2944527-dd61-4cf0-a254-1ff40bb330e2,XULTOPHY,prescription,A10AE56,INSULIN DEGLUDEC AND LIRAGLUTIDE,7886,,,WHO ATC Classification,,ILS,solution for injection,"INSULIN DEGLUDEC 100 U/ML, LIRAGLUTIDE 3.6 MG/ML",2025-07-31T10:37:33.564105,IL,נובו נורדיסק,,894.494732,758.0464168,645.1458866,,,XULTOPHY 5X3ML PRE FILLED PEN,24092,,52675,PRE-FILLED PEN GLASS TYPE I,units,15.0,155 72 34607 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Xultophy® is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to other oral medicinal products for the treatment of diabetes. For study results with respect to combinations, effects on glycaemic control, and the population studied, see sections 4.4, 4.5 and 5.1",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2944527-dd61-4cf0-a254-1ff40bb330e2.json
c2a45df9-1ee1-4a1b-8bd9-8fbc93281a09,KENALOG 40MG/ML 5 PREFILLED SYR.,29C,,,20477,,,,,,tablet,KENALOG 40MG/ML 5 PREFILLED SYR.,2025-07-31T20:44:08.756420,IL,nan,,,,,,,KENALOG 40MG/ML 5 PREFILLED SYR.,,,,,units,5.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2a45df9-1ee1-4a1b-8bd9-8fbc93281a09.json
c2b2cb6b-6ff6-45ea-9948-4433584a3b6d,LOPRESOR DIVITABS 200 MG,29C,C07AB02,METOPROLOL,20870,,,WHO ATC Classification,,ILS,tablets slow release,METOPROLOL TARTRATE,2025-07-31T15:12:58.548126,IL,nan,,nan,nan,nan,,7298087000386,METOPROLOL TARTRATE 25MG CITRON USA TABLETS,,,,BLISTER PVC/PE/PVDC,units,100.0,045 04 22324 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,"Hypertension, angina pectoris, arrhythmia, prophylaxis of migrain, prophylaxis of reinfarction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2b2cb6b-6ff6-45ea-9948-4433584a3b6d.json
c2c294ad-6df4-4cff-97b7-7a2da071c50c,IOPIDINE 0.5 %,prescription,S01EA03,APRACLONIDINE,3028,,,WHO ATC Classification,,ILS,"eye drops, solution",APRACLONIDINE AS HYDROCHLORIDE/ML,2025-07-31T04:11:29.503534,IL,נוברטיס פארמה,,66.03542789,55.96222951,41.60760558,,7290016369267,IOPIDINE 0.5% 5ML,9085,,9152,BOTTLE LDPE,units,5.0,068 60 28209 00,valid,34.5,ocular,1.4,24,,,,,,,,,,0,Prescription required,Short term adjunctive therapy of chronic glaucoma in patients on maximally tolerated medical therapy who require additional intraocular pressure (IOP) reduction to delay laser treatment or glaucoma surgery.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2c294ad-6df4-4cff-97b7-7a2da071c50c.json
c2c49fb4-88bf-4113-91a4-fbf11f5bc1c8,HUMALOG,prescription,A10AB04,INSULIN LISPRO,3436,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO 100 U/ML,2025-07-31T03:47:48.812903,IL,אלי לילי,,144.137873,122.1507453,97.7205962,,7290008067676,HUMALOG CART 3MLX5,9208,,9621,CARTRIDGE GLASS TYPE I,units,15.0,102 83 28580 00,valid,25.0,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilization of diabetes mellitus.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2c49fb4-88bf-4113-91a4-fbf11f5bc1c8.json
c2e18bb1-6fa6-4b19-9ed8-e33cb2324e1c,IMOVANE,prescription,N05CF01,ZOPICLONE,9348,,,WHO ATC Classification,,ILS,film coated tablets,ZOPICLONE 7.5  MG,2025-07-31T04:03:19.563803,IL,סאנופי אוונטיס,,14.824222,12.5629,9.17,,3587080000382,IMOVANE 7.5MG 14 TAB,23385,,89039,BLISTER PVC/ALUMINIUM,units,14.0,101 19 24581 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Imovane is indicated for the short-term treatment of insomnia in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2e18bb1-6fa6-4b19-9ed8-e33cb2324e1c.json
c2edf2d0-b613-48bb-b814-8b75f23defdd,VESICARE 10MG 30TAB,prescription,,,6001,,,,,ILS,tablet,VESICARE 10MG,2025-07-31T19:38:13.115297,IL,כ.צ.ט,,217.034745,183.92775,147.1422,,,VESICARE 10MG 30TAB,22293,,75667,,units,30.0,,not-registered,25.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2edf2d0-b613-48bb-b814-8b75f23defdd.json
c2f728c6-a4f3-41a0-b5a0-b5ce61171d36,DACARBAZINE MEDAC 1000 MG,prescription,L01AX04,DACARBAZINE,7442,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,DACARBAZINE AS CITRATE/VIAL,2025-07-31T01:38:26.936281,IL,צמל,,221.6463325,187.835875,150.2687,,,DACARBAZINE MEDAC 1000MG VIAL,4525,,86832,VIAL GLASS,units,1.0,134 90 31172 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. Further indications for dacarbazine as part of a combination chemotherapy in advanced Hodgkin's disease as a second line.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2f728c6-a4f3-41a0-b5a0-b5ce61171d36.json
c2f82348-0d2b-4014-802f-bdc35d97712f,FAMPRIDINE S.K. 10 MG,prescription,N07XX07,FAMPRIDINE,9409,,,WHO ATC Classification,,ILS,tablets prolonged release,FAMPRIDINE,2025-07-31T02:52:53.428685,IL,SK PHARM(KS KIM),,757.681556,642.1030136,546.4706499,,,FAMPRIDINE S.K. 10 MG 56 TAB,6689,,15298,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,173 05 37639 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,FAMPRIDINE S.K. is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (EDSS 4-7).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c2f82348-0d2b-4014-802f-bdc35d97712f.json
c30ff113-a962-4840-a6bd-995cd054e5e5,THEOTRIM 100,prescription,R03DA04,THEOPHYLLINE,2212,,,WHO ATC Classification,,ILS,tablets slow release,THEOPHYLLINE ANHYDROUS,2025-07-31T09:18:52.788022,IL,תרימה,,10.637228,9.0146,6.58,,,THEOTRIM 100 30 SR TAB,20099,,2256,BLISTER PVC/ALUMINIUM,units,30.0,050 47 23896 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Long acting bronchodilator in the symptomatic relief and/or prevention of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c30ff113-a962-4840-a6bd-995cd054e5e5.json
c33414a9-bfb3-47de-a0a2-baef83e507a7,OPTI GENTA,prescription,S01AA11,GENTAMICIN,3234,,,WHO ATC Classification,,ILS,drops,GENTAMICIN AS SULFATE 0.3 %W/V,2025-07-31T06:14:27.365160,IL,ויטאמד,,13.82192939,11.7135,8.55,,7-290008-083850,OPTI-GENTA 5ML,15024,,9371,DROPER BOTTLE LDPE,units,5.0,069 76 28591 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Infection of external eye and its adnexa caused by susceptible bacteria.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c33414a9-bfb3-47de-a0a2-baef83e507a7.json
c33a72e8-a796-4083-942f-f3eacde73bc3,PITRION,off-the-counter,D01AC02,MICONAZOLE,3021,,,WHO ATC Classification,,ILS,cream,MICONAZOLE NITRATE,2025-07-31T12:48:16.771129,IL,רפא,,26.1724,22.18,nan,,7290008015400,PITRION CR 2% 15GR,16107,,,TUBE ALUMINIUM,units,15.0,067 41 27977 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,Skin and nail infections due to dermatophytes or candida.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c33a72e8-a796-4083-942f-f3eacde73bc3.json
c3485ce2-53fe-4794-9350-54d5cb4b38b6,REAGILA 4.5,prescription,N05AX15,CARIPRAZINE,8590,,,WHO ATC Classification,,ILS,"capsule, hard",CARIPRAZINE AS HYDROCHLORIDE 4.5  MG,2025-07-31T07:18:15.414872,IL,דקסל פארמה,,319.1221479,270.4425102,230.1638385,,7290015912617,REAGILA 4.5 MG 30CAPS,17046,,3611,BLISTER PVC/PE/PVDC/AL,units,30.0,163 56 35922 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Reagila is indicated for the:•	Treatment of schizophrenia in adult patients.•	Acute treatment of manic or mixed episodes associated with bipolar I disorder in adult.•	Treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults.•	Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3485ce2-53fe-4794-9350-54d5cb4b38b6.json
c34e9e29-33b4-4b32-a070-8bf8c1379abd,GENOTROPIN 12 MG,prescription,H01AC01,SOMATROPIN,8386,,,WHO ATC Classification,,ILS,powder for solution for injection,SOMATROPIN,2025-07-31T03:30:15.424074,IL,פיזר,,1144.463147,969.8840664,825.433248,,7317961351113,GENOTROPIN 12 MG 1 prefilled pen,7429,,30739,CARTRIDGE GLASS TYPE I,units,1.0,121 35 27540 22,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Children:   Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome. Short stature in children with renal insufficiency.   Growth disturbance (height SDS<2.5 and parenteral adjusted height SDS < -1) in short children born SGA (SGA - small for gestational age  i.e. born small in relation to the length of the fetus development)  with a birth witght and/or length < 2 SD  who failed to show catch up growth (HV SDS < 0 during the last year) by 4 years of age or later.   Prader willi syndrome  for improvement of growth and body composition.  Adults:    For adults who have suffered from growth-hormone deficiency since childhood.   For adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c34e9e29-33b4-4b32-a070-8bf8c1379abd.json
c35c96d4-5b71-47bf-ac98-bee1ba47892d,OPTI GENTA,prescription,S01AA11,GENTAMICIN,8850,,,WHO ATC Classification,,ILS,drops,GENTAMICIN AS SULFATE 0.3 %W/V,2025-07-31T03:31:25.468998,IL,טבע,,48.31680124,40.94644355,29.887915,,7-290008-083850,GENTAMICIN TEVA 80 MG/2 ML 10 AMP,,,48819,DROPER BOTTLE LDPE,units,10.0,069 76 28591 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Infection of external eye and its adnexa caused by susceptible bacteria.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c35c96d4-5b71-47bf-ac98-bee1ba47892d.json
c3618724-963a-40f7-bb68-04f276039b4f,CRESTOR ® 5 MG,prescription,C10AA07,ROSUVASTATIN,4706,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T01:33:19.858252,IL,אסטראזנקה,,84.76098002,71.831339,53.4062,,,CRESTOR 10MG 28TAB,3754,,60449,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,139 22 31615 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Adults with:•	primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.•	Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3618724-963a-40f7-bb68-04f276039b4f.json
c36e57cd-5575-4c75-b2a3-11fa441115d2,TEGRETOL 200 MG,prescription,N03AF01,CARBAMAZEPINE,602,,,WHO ATC Classification,,ILS,tablets,CARBAMAZEPINE,2025-07-31T09:09:39.677342,IL,נוברטיס פארמה,,19.74693066,16.734687,12.2151,,7298087000836,TEGRETOL 200MG 50TAB,20035,,2128,BLISTER PVC/PE/PVDC,units,50.0,015 41 24602 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic depressive illness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c36e57cd-5575-4c75-b2a3-11fa441115d2.json
c3918555-5921-4f25-8e06-2ab0f89d4ace,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7451,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:18:56.968476,IL,צמל,,90.54278532,76.731174,57.0492,,,METOJECT 50MG/ML SYRINGE PREFILLED 10MG/0.2ML,,,3995,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3918555-5921-4f25-8e06-2ab0f89d4ace.json
c3b5b96d-89fe-4e22-a2e3-a81fb3eb4a6d,TREPROSTINIL S.K. 10 MG/ML,prescription,B01AC21,TREPROSTINIL,8600,,,WHO ATC Classification,,ILS,solution for injection / infusion,TREPROSTINIL/,2025-07-31T09:39:44.848789,IL,SK PHARM(KS KIM),,47984.62452,40664.93784,36968.12531,,7290016845150,TREPROSTINIL S.K. 10 MG/ML 20 ML 1VIAL,20936,,55045,VIAL GLASS TYPE I,units,1.0,162 27 35642 00,valid,10.0,"s.c, i.v",1.4,24,,,,,,,,,,0,Prescription required,Treprostinil s.k. is indicated for the treatment of:* Primary pulmonary arterial hypertension.* Pulmonary arterial hypertension associated with connective tissue disorders. * Pulmonary hypertension associated with congenital systemic to pulmonary shunts.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3b5b96d-89fe-4e22-a2e3-a81fb3eb4a6d.json
c3c6fb49-a7a1-40d3-a6db-294b50a8cb49,BIMATOL S.K.,prescription,S01ED01,TIMOLOL,8250,,,WHO ATC Classification,,ILS,"eye drops, solution","TIMOLOL AS MALEATE/, BIMATOPROST 0.3  MG /",2025-07-31T00:36:19.122427,IL,SK PHARM(KS KIM),,74.28942119,62.9571366,46.80828,,,BIMATOPROST S.K. 0.3 MG/1 ML OPHT SOL 3ML,2642,,24958,BOTTLE LDPE,units,3.0,176 79 37180 99,valid,34.5,ocular,1.4,24,,,,,,,,,,0,Prescription required,Bimatol S.K. is indicated  for reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3c6fb49-a7a1-40d3-a6db-294b50a8cb49.json
c3d0c84f-4ec7-4342-b561-280dff93b150,ETHYOL 500MG/VIAL 3VIALX10ML,29C,,,20004,,,,,,injection,ETHYOL 500MG/VIAL X,2025-07-31T20:24:19.876760,IL,nan,,,,,,,ETHYOL 500MG/VIAL 3VIALX10ML,,,,,units,3.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3d0c84f-4ec7-4342-b561-280dff93b150.json
c3e47ae3-bdc2-4d6c-830c-9cc355ccd522,FLAME,prescription,G03CA01,ETHINYLESTRADIOL,6361,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.02   MG, GESTODENE 0.075   MG",2025-07-31T03:06:19.785723,IL,דקסל פארמה,,23.02636542,19.513869,14.2437,,7290010577606,FLAME 21TAB,6431,,82918,BLISTER PVC/PVDC/ALUMINIUM,units,21.0,140 58 31529 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3e47ae3-bdc2-4d6c-830c-9cc355ccd522.json
c3ef33e9-d82c-4fb6-b4a6-8cb8d09a3b62,ULTIVA 5 MG,prescription,N01AH06,REMIFENTANIL,8269,,,WHO ATC Classification,,ILS,powder for concentrate for solution for injection / infusion,REMIFENTANIL AS HYDROCHLORIDE/VIAL,2025-07-31T07:23:47.604688,IL,ביואבניר,,386.66712,327.684,278.88,,7290008086189,REMIFENTANIL  5MG  5VIAL 6ML,,,20082,VIAL GLASS TYPE I,units,5.0,108 35 29195 22,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Ultiva is indicated as an analgesic agent  for use during induction and/or maintenance of general anaesthesia under close supervision . Ultiva is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3ef33e9-d82c-4fb6-b4a6-8cb8d09a3b62.json
c3f4a6f2-b4e3-45fd-b212-cf97e81b7cf8,ALCOHOL 70%  FLORIS,off-the-counter,D08AX08,ETHANOL,5476,,,WHO ATC Classification,,ILS,solution,ALCOHOLV/V,2025-07-31T11:09:35.207369,IL,ויטאמד,,20.1662,17.09,nan,,,ALCOHOL 70% 200ML,,,,BOTTLE HDPE,units,200.0,057 39 27018 00,valid,nan,topical,1.4,48,,,,,,,,,,0,,Antiseptic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c3f4a6f2-b4e3-45fd-b212-cf97e81b7cf8.json
c40e6b99-8ad9-480d-9dc9-fd4827ae94b6,NEUPOGEN 30 MU PRE-FILLED SYRINGE,prescription,L03AA02,FILGRASTIM,4134,,,WHO ATC Classification,,ILS,solution for injection,FILGRASTIM 30 MU / 0.5  ML,2025-07-31T05:43:24.546187,IL,מדיסון,,167.9440789,142.3254969,113.8603976,,8715131009762,NEUPOGEN 1 PREFIL.SYR. 30MU/0.5ML,14607,,3757,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,117 22 29875 00,valid,25.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Neupogen is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia.The safety and efficacy of Neupogen are similar in adults and children receiving cytotoxic chemotherapy.Neupogen is indicated for the mobilisation of peripheral blood progenitor cells (PBPCs).In patients, children or adults, with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (ANC) of ≤ 0.5 × 109/l, and a history of severe or recurrent infections, long term administration of Neupogen is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.Neupogen is indicated for the treatment of persistent neutropenia (ANC less than or equal to 1.0 × 109/l) in patients with advanced HIV infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c40e6b99-8ad9-480d-9dc9-fd4827ae94b6.json
c4153d6e-ec61-429f-8968-53c23f73fb0f,NITYR ( NITISINONE) 10 MG 60TAB,prescription,,,8706,,,,,ILS,tablet,NITYR ( NITISINONE) 10 MG,2025-07-31T19:22:39.377961,IL,תרומד,,9674.326236,8198.581556,7453.25596,,,NITYR ( NITISINONE) 10 MG 60TAB,14688,,58132,,units,60.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4153d6e-ec61-429f-8968-53c23f73fb0f.json
c415ca4f-9390-49c9-977d-3766b8f1a5df,ENALADEX 10 MG,prescription,C09AA02,ENALAPRIL,3771,,,WHO ATC Classification,,ILS,tablets,ENALAPRIL MALEATE,2025-07-31T02:19:16.528659,IL,דקסל פארמה,,18.93588244,16.047358,11.7134,,,ENALADEX 20MG 30TAB,5152,,22584,BLISTER ALUMINIUM,units,30.0,115 85 29810 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. To retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c415ca4f-9390-49c9-977d-3766b8f1a5df.json
c4210791-04d1-45c6-8188-05ddbfa2f0bb,BUCCOLAM 10 MG,prescription,N05CD08,MIDAZOLAM,7128,,,WHO ATC Classification,,ILS,oromucosal solution,MIDAZOLAM AS HYDROCHLORIDE,2025-07-31T00:45:16.531482,IL,ניאופרם,,389.9489723,330.4652454,281.2470174,,5060147020083,BUCCOLAM 5 MG SYRINGE PREFILLED 4X1ML,2549,,40574,SYRINGE PREFILLED  HDPE,units,4.0,149 81 33746 07,valid,17.5,buccal,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4210791-04d1-45c6-8188-05ddbfa2f0bb.json
c43da09b-6a41-4281-964e-e480f6ff953e,MICROGYNON ® 30,prescription,,,87,,,,,ILS,coated tablets,"LEVONORGESTREL, ETHINYLESTRADIOL",2025-07-31T05:21:09.995649,IL,באייר,,27.41693906,23.23469516,16.9596315,,7298074040173,MICROGYNON 3X21TAB,13127,,1334,BLISTER PVC/ALUMINIUM,units,63.0,027 43 21707 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Oral contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c43da09b-6a41-4281-964e-e480f6ff953e.json
c43e758b-8847-4a0c-b168-44e351bbfd82,ZINNAT SUSPENSION 125 MG/5 ML,prescription,J01DC02,CEFUROXIME,309,,,WHO ATC Classification,,ILS,granules for suspension,CEFUROXIME AS AXETIL/ML,2025-07-31T10:50:15.775417,IL,סנדוז,,22.74953971,19.2792718,14.07246117,,7290008086301,ZINNAT SUSP 125MG/5ML 50ML,26071,,8422,BOTTLE GLASS TYPE III,units,50.0,055 83 26733 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Zinnat is indicated for the treatment of the infections listed below in adults and children from the age of 3 months.• Acute streptococcal tonsillitis and pharyngitis.• Acute bacterial sinusitis.• Acute otitis media.• Acute exacerbations of chronic bronchitis.• Cystitis.• Pyelonephritis.• Uncomplicated skin and soft tissue infections. • Treatment of early Lyme disease.Consideration should be given to official guidance on the appropriate use of antibacterial agents.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c43e758b-8847-4a0c-b168-44e351bbfd82.json
c43f13bf-8a93-4583-b3d0-3132688f4cbf,CRUSIA,prescription,B01AB05,ENOXAPARIN,8441,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/,2025-07-31T01:34:27.648498,IL,צמל,,38.175199,32.351865,23.6145,,,CRUSIA 40MG/0.4ML 2 SYR,10625,,55058,SYRINGE 0.5 ML GLASS TYPE I,units,2.0,162 88 35673 00,valid,37.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Crusia is indicated in adults for:•Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery.•Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism.•Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE ikely to require thrombolytic therapy or surgery. Prevention of thrombus formation in extra corporeal circulation during haemodialysis.•Acute coronary syndrome:-Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid.-Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c43f13bf-8a93-4583-b3d0-3132688f4cbf.json
c4730cba-404e-4853-b9b4-b8e64722d9a5,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,577,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T12:43:55.430652,IL,ג.ס.ק,,18.6676,15.82,nan,,7290006603036,OTRIVIN PED DPS 0.05% 10ML,15080,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,10.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4730cba-404e-4853-b9b4-b8e64722d9a5.json
c47be477-491f-4e13-80a1-a7999621fbbf,JANUET XR 100/1000 MG TABLETS,prescription,A10BA02,METFORMIN,8538,,,WHO ATC Classification,,ILS,tablets extended release,"SITAGLIPTIN AS PHOSPHATE SALT, METFORMIN HYDROCHLORIDE",2025-07-31T08:19:04.432257,IL,טבע,,43.198205,36.60864831,26.7216411,,7290006813640,SITAGLIPTIN 50 MG 10 TAB,,,,BOTTLE HDPE,units,10.0,151 33 33934 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c47be477-491f-4e13-80a1-a7999621fbbf.json
c47f1f4f-84ba-4ae4-9aad-c08ca0f68cd6,GENTAMICIN B. BRAUN 1 MG/ML,prescription,S01AA11,GENTAMICIN,9110,,,WHO ATC Classification,,ILS,solution for infusion,GENTAMICIN AS SULFATE 0.1 G /,2025-07-31T03:30:58.572821,IL,לפידות,,300.5407076,254.6955263,216.76215,,4030539126922,GENTAMICIN B. BRAUN 1 MG/ML 20 AMP 80ML,,,50869,CONTAINER POLYETHYLENE,units,20.0,149 06 33562 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment of serious infections caused by susceptible microorganisms.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c47f1f4f-84ba-4ae4-9aad-c08ca0f68cd6.json
c493a1af-baf4-4add-9fe4-6ec95b51613c,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1824,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:50:30.488978,IL,פישר,,20.1662,17.09,nan,,7290000849188,POLYDINE OINT 50GR,16527,,,BOTTLE HDPE,units,50.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c493a1af-baf4-4add-9fe4-6ec95b51613c.json
c494aac5-2c40-4651-9de5-1f555e97c188,FYCOMPA 10 MG FILM COATED TABLETS,prescription,N03AX22,PERAMPANEL,7266,,,WHO ATC Classification,,ILS,film coated tablets,PERAMPANEL AS ANHYDROUS,2025-07-31T03:24:01.281162,IL,אסיי,,510.7466894,432.8361967,368.3712312,,,FYCOMPA 10MG 28 F.C TAB,6527,,51053,BLISTER PVC/ALUMINIUM,units,28.0,150 50 33794 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.Fycompa is indicated for the adjunctive treatment of primary generalised tonic clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalized epilepsy (IGE).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c494aac5-2c40-4651-9de5-1f555e97c188.json
c4a05ed1-925c-4605-b285-94fb7e941f9f,DILANTIN 125,29C,N03AB02,PHENYTOIN,20067,,,WHO ATC Classification,,ILS,suspension,PHENYTOIN/ML,2025-07-31T14:20:59.929884,IL,nan,,nan,nan,nan,,7290013592705,DILANTIN INFATABS 50MG 100TAB,,,,BOTTLE GLASS TYPE III,units,100.0,123 70 24017 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the control of tonic clonic (Grand- mal) and psychomotor (Temporal lobe seizures).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4a05ed1-925c-4605-b285-94fb7e941f9f.json
c4a85093-ddde-4447-8c9f-1cf774cae1b6,CAMZYOS 2.5 MG,prescription,C01EB24,MAVACAMTEN,9200,,,WHO ATC Classification,,ILS,capsules,MAVACAMTEN 2.5  MG,2025-07-31T00:51:43.593367,IL,ב.מ.ס,,8269.567707,7008.108538,6371.007761,,,CAMZYOS 2.5 MG 30CAPS,,,70796,BLISTER PVC/PCTFE(ACLAR)/ALUMINIUM,units,30.0,174 18 37419 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4a85093-ddde-4447-8c9f-1cf774cae1b6.json
c4adfa9f-e245-4af5-8e21-65736726c9ae,ZAPPA ODT 10,prescription,N05AH03,OLANZAPINE,7298,,,WHO ATC Classification,,ILS,tablets orodispersible,OLANZAPINE,2025-07-31T10:43:51.099396,IL,אוניפארם,,96.35934811,81.6604645,60.7141,,,ZAPPA ODT 5MG 30 O.D.TAB,26184,,47259,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,150 21 33756 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia. Zappa ODT is indicated for the management of the manifestations of psychotic disorders. Zappa ODT is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Zappa ODT is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zappa ODT with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4adfa9f-e245-4af5-8e21-65736726c9ae.json
c4aebb7b-697c-4a78-ac9b-8121de49ee71,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5481,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:01:40.424267,IL,טבע,,30.7154,26.03,nan,,7290000800028,ACAMOL TSINUN CLASSIC DAY 35 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,35.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4aebb7b-697c-4a78-ac9b-8121de49ee71.json
c4bb01f2-8335-4d76-ad30-ec7a9aa5e8e3,LICARBIUM,29C,,,20926,,,,,ILS,tablets,LITHIUM CARBONATE,2025-07-31T15:02:52.748202,IL,nan,,nan,nan,nan,,7290008089258,LITHIUM CARBONATE 450MG  50 ER TABS  GLENMARK USA,,,,BLISTER PVC/ALUMINIUM,units,50.0,022 10 20683 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Treatment of manic depressive states.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4bb01f2-8335-4d76-ad30-ec7a9aa5e8e3.json
c4e0cf81-af17-4bf4-ab36-baa12d7967a1,TAKHZYRO,prescription,B06AC05,LANADELUMAB,9116,,,WHO ATC Classification,,ILS,solution for injection,LANADELUMAB/ML,2025-07-31T09:02:00.697600,IL,טקדה,,131846.303,111734.16,101576.5091,,,TAKHZYRO 300 MG/2 ML 2 PFS,,,86372,PRE-FILLED SYRINGE  GLASS TYPE I,units,2.0,163 47 35885 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE)in patients aged 2 years and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4e0cf81-af17-4bf4-ab36-baa12d7967a1.json
c4fdf48f-0b26-44a9-8494-ee1b32301818,GABAPENTIN INOVAMED 300 MG,prescription,N03AX12,GABAPENTIN,7682,,,WHO ATC Classification,,ILS,capsules,GABAPENTIN,2025-07-31T03:25:32.083960,IL,אינובמד,,132.4750783,112.2670155,83.4699,,,GABAPENTIN INOVAMED 400 MG 100CAPS,7865,,8565,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,146 48 33100 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Epilepsy :- Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- Treatment of neuropathic pain- Gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c4fdf48f-0b26-44a9-8494-ee1b32301818.json
c5126812-e0ad-4b41-91c4-41719240dad0,EPI-CELL 50 MG/25ML 1VIAL,29C,,,9260,,,,,,injection,EPI-CELL 50 MG/,2025-07-31T20:22:19.382829,IL,nan,,,,,,,EPI-CELL 50 MG/25ML 1VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c5126812-e0ad-4b41-91c4-41719240dad0.json
c52a7a4e-8d04-4fa1-9fdd-338e981c0a51,FOSTER 100/6,prescription,R03AK08,FORMOTEROL AND BECLOMETASONE,9447,,,WHO ATC Classification,,ILS,pressurised solution,"FORMOTEROL FUMARATE DIHYDRATE/DOSE, BECLOMETASONE DIPROPIONATE ANHYDROUS/DOSE",2025-07-31T03:18:57.426228,IL,קמהדע,,142.7786933,120.998898,96.7991184,,7290011225544,FOSTER 200/6 120  ACTUATIONS,,,28022,INHALER ALUMINIUM,units,120.0,150 73 33783 00,valid,25.0,inhalation,1.4,21,,,,,,,,,,0,Prescription required,"Foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.COPD :Symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c52a7a4e-8d04-4fa1-9fdd-338e981c0a51.json
c54286fc-b848-41f7-82fd-bf76c7f3f0d3,PROAVENIR,prescription,G04CB01,FINASTERIDE,7743,,,WHO ATC Classification,,ILS,film coated tablets,FINASTERIDE,2025-07-31T06:58:25.458927,IL,ביואבניר,,456.1497651,386.5675975,328.9937,,7290010286973,PROAVENIR 1MG 98 F.C.TAB,16937,,55452,BLISTER ALUMINIUM /ALUMINIUM,units,98.0,150 83 33638 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,ProAvenir is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c54286fc-b848-41f7-82fd-bf76c7f3f0d3.json
c54e1486-a86d-4c68-a256-7affd3b1cbdf,LEVITRA 20MG 4TAB,prescription,,,4683,,,,,ILS,tablet,LEVITRA 20MG,2025-07-31T19:16:17.826172,IL,באייר,,107.1596007,90.81322494,67.51912635,,,LEVITRA 20MG 4TAB,12316,,60182,,units,4.0,,not-registered,34.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c54e1486-a86d-4c68-a256-7affd3b1cbdf.json
c54e515d-3258-45ea-999c-bdf5bc40b876,RAMIPRIL INOVAMED 2.5,prescription,C09AA05,RAMIPRIL,8919,,,WHO ATC Classification,,ILS,tablets,RAMIPRIL 2.5  MG,2025-07-31T07:15:57.303065,IL,אינובמד,,16.48932,13.974,10.2,,,RAMIPRIL INOVAMED 2.5MG 30TAB,,,72749,BLISTER PVC/ALUMINIUM,units,30.0,166 47 35580 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hypertension congestive heart failure reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction, stroke, cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction, stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) high total cholesterol (>5.2 mmol/L) low HDL ( <0.9 mmol/L) current smoker known microalbuminuria clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c54e515d-3258-45ea-999c-bdf5bc40b876.json
c55574b3-bf70-4365-8d17-084b9694455d,OPDUALAG,prescription,L01XC17,NIVOLUMAB,9285,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,"RELATLIMAB/ML, NIVOLUMAB/ML",2025-07-31T06:13:50.726929,IL,ב.מ.ס,,34777.26112,29472.2565,26792.96045,,7290014396227,OPDUALAG (12 MG /4 MG)/ML  (240 MG/80 MG)/1 VIAL20 ML,,,14127,VIAL GLASS TYPE I,units,1.0,171 74 37423 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Opdualag is indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c55574b3-bf70-4365-8d17-084b9694455d.json
c5580258-9357-4906-a421-d2c1b25f6869,KEPPRA 1000 MG,prescription,N03AX14,LEVETIRACETAM,6215,,,WHO ATC Classification,,ILS,film coated tablets,LEVETIRACETAM,2025-07-31T04:24:19.621623,IL,כ.צ.ט,,251.7825,213.375,170.7,,,KEPPRA 100MG/ML 300ML,11215,,78584,BLISTER PVC/ALUMINIUM,units,300.0,132 66 31183 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,- Keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c5580258-9357-4906-a421-d2c1b25f6869.json
c57956da-4298-4513-aeaa-e536316061d1,CALCITONIN SALMON 200IU/DOSE 30 DOSE 3.7 ML  SPRAY,29C,,,20989,,,,,,spray,CALCITONIN SALMON 200IU/DOSE 30 DOSE 3. SPRAY,2025-07-31T20:02:34.662269,IL,nan,,,,,,,CALCITONIN SALMON 200IU/DOSE 30 DOSE 3.7 ML  SPRAY,,,,,units,30.0,,not-registered,,inhalation,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c57956da-4298-4513-aeaa-e536316061d1.json
c5af2218-b124-4197-a4dc-f765278e1a8b,SOLIFENACIN TRIMA 10,prescription,G04BD08,SOLIFENACIN,7516,,,WHO ATC Classification,,ILS,tablets,SOLIFENACIN SUCCINATE,2025-07-31T08:27:19.815886,IL,תרימה,,217.034745,183.92775,147.1422,,7290000843889,SOLIFENACIN TRIMA 10MG 30TAB,9814,,71846,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,152 33 33869 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c5af2218-b124-4197-a4dc-f765278e1a8b.json
c5d54f63-e937-4e16-96cf-9652415d0a66,EFFERAMOL,off-the-counter,N02BE01,PARACETAMOL,5624,,,WHO ATC Classification,,ILS,tablets effervescent,PARACETAMOL,2025-07-31T11:34:25.326328,IL,ליף-טרי אוף ליף,,30.2552,25.64,nan,,7290017312026,EFFERAMOL 500MG 20 EFF TAB,,,,TUBE POLYPROPYLENE,units,20.0,158 67 34469 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c5d54f63-e937-4e16-96cf-9652415d0a66.json
c5d83147-e66a-47a1-9dbd-4cb845efbf3c,NICOTINELL GUM 2 MG (MINT),off-the-counter,N07BA01,NICOTINE,5260,,,WHO ATC Classification,,ILS,chewing gum,NICOTINE,2025-07-31T12:30:35.827957,IL,ג.ס.ק,,212.8012,180.34,nan,,,NICOTINELL GUM 2 MG MINT 204 UNITS,14497,,,BLISTER PVC/PVDC/ALUMINIUM,units,204.0,115 78 29638 23,valid,nan,per os,1.4,30,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c5d83147-e66a-47a1-9dbd-4cb845efbf3c.json
c5f24240-10e5-4af3-8e7a-7a227d4d759f,VOLTAREN EMULGEL 1%,off-the-counter,M02AA15,DICLOFENAC,5487,,,WHO ATC Classification,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T13:36:36.921632,IL,ג.ס.ק,,31.8954,27.03,nan,,,VOLTAREN ACTI-GO 12.5MG 20 LIQUID GEL  CAPS,,,,TUBE ALUMINIUM,units,20.0,037 66 25000 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications: Local treatment of pain, inflammation and swelling due to:  • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order :• Pain caused by osteoarthrosis of the peripheral joints,  as of the knee or fingers",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c5f24240-10e5-4af3-8e7a-7a227d4d759f.json
c5f531e9-b657-4fa7-8913-03dd2657b133,DOSTINEX,prescription,N04BC06,CABERGOLINE,4064,,,WHO ATC Classification,,ILS,tablets,CABERGOLINE 0.5   MG,2025-07-31T02:03:45.107898,IL,פיזר,,194.182275,164.56125,131.649,,7298074000832,DOSTINEX 0.5MG 8TAB,4236,,33391,BOTTLE GLASS TYPE I,units,8.0,112 13 29448 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of hyperprolactinemic disorders.Dostinex is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. Dostinex is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. Inhibition and supression of lactation .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c5f531e9-b657-4fa7-8913-03dd2657b133.json
c6108958-209c-48fa-b5af-5aa2edfaef7b,INFANRIX IPV HIB,prescription,J07CA06,DIPHTHERIA-HEMOPHILUS INFLUENZAE B-PERTUSSIS-POLIOMYELITIS-TETANUS,4089,,,WHO ATC Classification,,ILS,powder and suspension for suspension for injection,"DIPHTHERIA TOXOID NLT/ 0.5  ML, INACTIVATED POLIO VIRUS (IPV) TYPE 3 32 DU / 0.5  ML, INACTIVATED POLIO VIRUS (IPV) TYPE 2 8 DU / 0.5  ML, INACTIVATED POLIO VIRUS (IPV) TYPE 1 40 DU / 0.5  ML, PERTUSSIS TOXOID (PT)/ 0.5  ML, FILLAMENTOUS HAEMAGGLUTININ (FHA)/ 0.5  ML, PERTACTIN/ 0.5  ML, TETANUS TOXOID NLT/ 0.5  ML, HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/VIAL",2025-07-31T04:05:34.045229,IL,ג.ס.ק,,195.1436299,165.3759649,132.3007719,,7290008102483,INFANRIX POLIO HIB (IPV-HIB) INJ 0.5ML,9189,,51658,VIAL + SYRINGE GLASS TYPE I,units,1.0,112 53 29413 00,valid,25.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Active immunisation in infants from the age of 2 months to 5  years against diptheria, tetanus, pertussis, poliomyelitis and Haemophilus influenza type b. Booster dose for children who have previously been immunised with DTP, Polio  and Hib antigens",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6108958-209c-48fa-b5af-5aa2edfaef7b.json
c62d6056-9f47-46f7-8bbb-f35643a90f1a,LEVEBON 100 MG/ML,prescription,N03AX14,LEVETIRACETAM,8698,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,LEVETIRACETAM/,2025-07-31T04:42:19.754347,IL,מדי מרקט,,454.6116916,385.2641454,327.8843791,,7290015841337,LEVEBON 100 MG/ML 5ML 10 VIAL,,,70231,VIAL GLASS TYPE I,units,10.0,165 29 35845 00,valid,17.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,"LEVEBON is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.LEVEBON is indicated as adjunctive therapy.  • in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.LEVEBON concentrate is an alternative for patients when oral administration is temporarily not feasible.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c62d6056-9f47-46f7-8bbb-f35643a90f1a.json
c6343c57-6890-41c0-b9bd-6b52c0911ca8,ANTROLIN,prescription,N01BB52,"LIDOCAINE, COMBINATIONS",8387,,,WHO ATC Classification,,ILS,cream,"LIDOCAINE HYDROCHLORIDE 1.5 %W/W, NIFEDIPINE 0.3 %W/W",2025-07-31T00:20:36.954570,IL,סופר-פארם,,60.24171528,51.05230335,37.264455,,,ANTROLIN CREAM 1 TUBE 30GR,10305,,5162,TUBE ALUMINIUM,units,30.0,160 31 34663 00,valid,37.0,rectal,1.4,36,,,,,,,,,,0,Prescription required,Treatment of anal fissures and proctologies generally associated with anal sphincter hypertonia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6343c57-6890-41c0-b9bd-6b52c0911ca8.json
c637e703-f053-46f8-aab9-1ad885236f4f,CHLORAMPHENICOL FISIOPHARMA 1G,prescription,J01BA01,CHLORAMPHENICOL,9418,,,WHO ATC Classification,,ILS,powder for solution for injection,CHLORAMPHENICOL,2025-07-31T01:09:12.550467,IL,פרופארם,,5535.576446,4691.166479,4264.696799,,7290018375129,CHLORAMPHENICOL FISIOPHARMA 1G 10 VIALS,,,17135,VIAL GLASS TYPE III,units,10.0,165 65 35172 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Chloramphenicol is active against several bacteria in the following infections:- Typhoid fever and salmonellosis (Salmonella typhi);- Bacterial meningitis (Haemophilus influenzae, Neisseria meningitidis);- Rickettiosis (Rickettsia);- Brucellosis (Brucella);- Psittacosis (Chlamydophila psittaci);- Lymphogranuloma Venereum (Lymphogranuloma-psittacosis);- Urinary infection caused by gram-negative bacteria;- Infections caused by anaerobic bacteria (Cocci gram-positive cocci, Clostridium).and is indicated when oral administration is contraindicated or not feasible due to vomiting, diarrhea or severe sepsis .",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c637e703-f053-46f8-aab9-1ad885236f4f.json
c649d3a5-02e3-426f-a6be-fef0cbcf0585,LOSARDEX 100,prescription,C09CA01,LOSARTAN,6178,,,WHO ATC Classification,,ILS,caplets,LOSARTAN POTASSIUM,2025-07-31T04:55:14.993740,IL,דקסל פארמה,,25.59546614,21.691073,15.8329,,,LOSARDEX 50MG 30TAB,12400,,86890,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,138 20 31492 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hypertension: Losardex 100  is indicated for the treatment of hypertensionHeart failure: Losardex 100 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ACE inhibitor is not appropriate.Switching patients with heart failure who are stable on an ACE inhibitor to Losardex 100 is not recommended.Renal protection in Type-2 diabetic patients with proteinuria: Losardex 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Losardex 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.The benefit of Losardex 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c649d3a5-02e3-426f-a6be-fef0cbcf0585.json
c64d3f6d-7e0c-400b-b709-440436315cba,TADAM 10,prescription,G04BE08,TADALAFIL,8096,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T09:00:47.275183,IL,אוניפארם,,506.6883833,429.396935,365.4442,,,TADAM 5 MG 28 FILM COATED TABLETS,20823,,62136,BLISTER PVC/ALUMINIUM,units,28.0,157 81 34538 01,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c64d3f6d-7e0c-400b-b709-440436315cba.json
c6553766-004d-437c-adfc-46a1792bab38,ARMONIA PLUS,prescription,G04CA52,TAMSULOSIN AND DUTASTERIDE,8811,,,WHO ATC Classification,,ILS,"capsule, hard","TAMSULOSIN HYDROCHLORIDE 0.4  MG, DUTASTERIDE 0.5  MG",2025-07-30T23:27:54.308280,IL,אוניפארם,,69.4047233,58.81756473,43.7305314,,,ARMONIA PLUS 30 CAPS,,,67313,BOTTLE HDPE,units,30.0,166 88 36264 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6553766-004d-437c-adfc-46a1792bab38.json
c656dcc7-ad6d-4e69-acc3-d4cc46923969,DESLORATADINE - TRIMA TABLETS,prescription,R06AX27,DESLORATADINE,7303,,,WHO ATC Classification,,ILS,tablets,DESLORATADINE,2025-07-31T01:50:27.835888,IL,תרימה,,15.30063402,12.966639,9.4647,,,DESLORATADINE-TRIMA 5MG 15TAB,16041,,48793,BLISTER ALUMINIUM /ALUMINIUM,units,15.0,149 99 33681 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Desloratadine - Trima tablets are indicated in adults and adolescents aged 12 yars and older for the relief of symptoms associated with: - allergic rhinitis,  - urticaria",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c656dcc7-ad6d-4e69-acc3-d4cc46923969.json
c662715d-ba8f-4490-9493-1a84133ada97,VERZENIO 100 MG,prescription,L01EF03,ABEMACICLIB,8335,,,WHO ATC Classification,,ILS,film coated tablets,ABEMACICLIB,2025-07-31T10:08:32.983480,IL,אלי לילי,,2286.926905,1938.073734,1761.885213,,7290016021103,VERZENIO 150 MG 14 TAB,22445,,26047,BLISTER PVC/ALUMINIUM,units,14.0,161 44 35391 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"VERZENIO™ (abemaciclib) is indicated: • in combination with a non-steroidal aromatase inhibitor as initial endocrine-based therapy for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy. • as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy in the metastatic setting and prior chemotherapy in the metastatic setting including taxane in adjuvant or metastatic setting. Verzenio should not be used in adult patients after prior treatment with cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) inhibitor. • Verzenio in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) negative, node positive early breast cancer at high risk of recurrence. In pre- or perimenopausal women and in men, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c662715d-ba8f-4490-9493-1a84133ada97.json
c67d10d9-e193-4c81-83a2-ec29a71c4c91,XCOPRI 100 MG,prescription,N03AX25,CENOBAMATE,9274,,,WHO ATC Classification,,ILS,film coated tablets,CENOBAMATE,2025-07-31T10:31:37.564592,IL,דקסל פארמה,,463.7123283,392.9765669,334.448142,,,XCOPRI 25 MG 14TAB+ 12.5 MG 14TAB,24174,,19212,BLISTER PVC/ALUMINIUM,units,28.0,172 89 37493 99,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Xcopri is indicated for the adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c67d10d9-e193-4c81-83a2-ec29a71c4c91.json
c67f904b-d3e3-42b4-acc6-7c6472e19d1c,GAVRETO,prescription,L01EX23,PRALSETINIB,9017,,,WHO ATC Classification,,ILS,"capsule, hard",PRALSETINIB,2025-07-31T03:28:20.389493,IL,רוש,,31071.8394,26332.06846,23938.24405,,,GAVRETO 120 CAPS 100 MG,,,,BOTTLE HDPE,units,120.0,169 37 36872 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,- GAVRETO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC).- GAVRETO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy.- GAVRETO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c67f904b-d3e3-42b4-acc6-7c6472e19d1c.json
c68567be-bb9d-45f3-9617-4cd3d3a474e5,ZYPREXA VELOTAB 10 MG,prescription,N05AH03,OLANZAPINE,4791,,,WHO ATC Classification,,ILS,tablets orodispersible,OLANZAPINE,2025-07-31T10:57:41.586777,IL,אלי לילי,,89.93540215,76.2164425,56.6665,,,ZYPREXA VELOTAB 5MG 28TAB,26134,,12648,BLISTER ALUMINIUM,units,28.0,130 76 30741 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia.   Zyprexa is indicated for the management of the manifestations of psychotic disorders.   Zyprexa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment  Zyprexa is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c68567be-bb9d-45f3-9617-4cd3d3a474e5.json
c694c686-44a2-4124-868c-18133f77a626,GLIMEPIRIDE TEVA ®  2 MG,prescription,A10BB12,GLIMEPIRIDE,7469,,,WHO ATC Classification,,ILS,tablets,GLIMEPIRIDE,2025-07-31T03:35:04.101991,IL,טבע,,27.68605326,23.462757,17.1261,,7290106061255,GLIMEPIRIDE TEVA  4 MG 30 TAB,7915,,53409,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,151 16 33859 00,valid,37.0,per os,1.4,18,,,,,,,,,,0,Prescription required,"Non-insulin-dependent diabetes mellitus (adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c694c686-44a2-4124-868c-18133f77a626.json
c6a0a7c6-3851-4037-a18f-5bceef343ff2,ACADIONE 250MG 120 TAB,29C,,,20263,,,,,,tablet,ACADIONE 250MG,2025-07-31T19:48:23.952232,IL,nan,,,,,,,ACADIONE 250MG 120 TAB,,,,,units,120.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6a0a7c6-3851-4037-a18f-5bceef343ff2.json
c6a8a079-04be-401b-bf5b-5dbda3efdc82,NUEDEXTA,prescription,C01BA01,QUINIDINE,6919,,,WHO ATC Classification,,ILS,capsules,"QUINIDINE SULFATE, DEXTROMETHORPHAN HYDROBROMIDE",2025-07-31T05:57:49.864138,IL,מדיסון,,nan,nan,nan,,7290008128308,NUEDEXTA 60 CAPSULES,14530,,35015,BOTTLE HDPE,units,60.0,149 88 33554 00,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of Pseudobulbar Affect (PBA) .,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6a8a079-04be-401b-bf5b-5dbda3efdc82.json
c6b90b5e-139c-4bec-8195-42c131d087d5,NEOTIGASON 10 MG,prescription,D05BB02,ACITRETIN,4540,,,WHO ATC Classification,,ILS,capsules,ACITRETIN,2025-07-31T05:42:26.666459,IL,טבע,,103.0012029,87.289155,64.899,,5690528199024,NEOTIGASON 10MG 30CAPS,14484,,61640,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,100 62 28448 11,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Severe disorders of keratinization  such as erythrodermic psoriasis  local or generalized pustular psoriasis  congenital ichthyosis  pityriasis rubra pilaris  darier's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6b90b5e-139c-4bec-8195-42c131d087d5.json
c6be9c0f-3366-462a-ba8b-3c40e1a508a7,LATARO,prescription,S01EE01,LATANOPROST,8176,,,WHO ATC Classification,,ILS,"eye drops, solution",LATANOPROST 0.05  MG /,2025-07-31T04:36:57.329957,IL,תרו יבוא,,36.8932369,31.265455,22.8215,,,LATARO EYES DROPS  0.05 MG/1 ML 2.5 ML,,,57675,BOTTLE LDPE,units,2.5,156 63 34215 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,Reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6be9c0f-3366-462a-ba8b-3c40e1a508a7.json
c6cb9fc4-f48e-4447-8a95-423fb50ad139,ACAMOLI ® FORTE 50 MG/ML SYRUP STRAWBERRY FLAVOUR,off-the-counter,N02BE01,PARACETAMOL,5167,,,WHO ATC Classification,,ILS,syrup,PARACETAMOL/,2025-07-31T11:02:19.236298,IL,טבע,,20.8388,17.66,nan,,,ACAMOLI FRUIT SYR 100ML + SYRINGE,1929,,,BOTTLE PET,units,100.0,140 18 31762 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Analgesic, antipyretic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6cb9fc4-f48e-4447-8a95-423fb50ad139.json
c6d44b75-608a-46f0-bd73-bb4b14dcb439,DOXYLIN 100,prescription,J01AA02,DOXYCYCLINE,1754,,,WHO ATC Classification,,ILS,tablets,DOXYCYCLINE AS HYCLATE,2025-07-31T02:04:53.268182,IL,דקסל פארמה,,12.0145712,10.18184,7.432,,,DOXYLIN 100MG 10TAB,4173,,727,BLISTER PVC/ALUMINIUM,units,10.0,015 94 24790 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Doxycycline has been found clinically effective in the treatment of a variety of infections caused by susceptible strains of Gram-positive and Gram-negative bacteria and certain other microorganisms.-Respiratory tract infections: Pneumonia and other lower respiratory tract infections due to susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Moraxella catarrhalis and other organisms. Mycoplasma pneumonia. Treatment of chronic bronchitis, sinusitis.-Urinary tract infections: Infections caused by susceptible strains of Klebsiella species, Enterobacter species, Escherichia coli, Streptococcus faecalis and other organisms.-Sexually transmitted diseases: Infections due to Chlamdyia trachomatis including uncomplicated urethral, endocervical or rectal infections. Non-gonococcal urethritis caused by Ureaplasma urealiticum (T-mycoplasma). Doxylin 100 is also indicated in infections due to Calymmatobacterium granulomatis. Doxylin is an alternative drug in the treatment of gonorrhoea and syphilis.Since Doxycycline is a member of the tetracycline series of antibiotics, it may be expected to be useful in the treatment of infections which respond to other tetracyclines, such as:-Ophthalmic infections: Treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis may be treated with oral Doxycycline alone or in combination with topical agents.-Rickettsial infections: Rocky Mountain spotted fever, typhus group, Q fever, Coxiella endocarditis. -Other infections: Psittocosis, brucellosis (in combination with streptomycin), cholera, bubonic plague, louse and tick-borne relapsing fever including stage 1 and stage 2 Lyme disease, leptospirosis, tularaemia glanders, chloroquine-resistant falciparum malaria and acute intestinal amoebiasis (as an adjunct to amoebicides). Infections due to susceptible strains of Bacteroides species, and Listeria species.   -Doxylin is an alternative drug in the treatment of leptospirosis, gas gangrene and tetanus. -Doxylin is indicated for prophylaxis in the following conditions: Scrub typhus, traveller's diarrhoea    (enterotoxigenic Escherichia coli), leptospirosis, malaria and cholera.   -Anthrax due to Bacillus anthracis, including inhalational anthrax (post exposure): to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6d44b75-608a-46f0-bd73-bb4b14dcb439.json
c6e9a80a-3cce-492b-a001-2d792392a1c4,XYLO-POS 0.1% 15 ml,off-the-counter,,,5268,,,,,ILS,tablet,XYLO-POS 0.1%,2025-07-31T19:48:05.799082,IL,קיוומא,,48.7222,41.29,,,,XYLO-POS 0.1% 15 ml,,,,,units,15.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c6e9a80a-3cce-492b-a001-2d792392a1c4.json
c71b8d1d-7e98-4789-84c8-48e3dd176f02,XANAGIS 0.25 MG,prescription,N05BA12,ALPRAZOLAM,2793,,,WHO ATC Classification,,ILS,tablets,ALPRAZOLAM 0.25   MG,2025-07-31T10:28:37.531280,IL,פאדאגיס,,39.61979446,33.576097,24.5081,,,XANAGIS 1MG 50TAB,24018,,8890,BLISTER PVC/PVDC,units,50.0,063 48 26906 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of anxiety accompanied by depression. Treatment of panic states with or without accompanying phobia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c71b8d1d-7e98-4789-84c8-48e3dd176f02.json
c733d835-ce15-4e1d-a5df-35f151e7dfc3,ESPERAL 500MG 20TAB,29C,,,20793,,,,,,tablet,ESPERAL 500MG,2025-07-31T20:23:25.787431,IL,nan,,,,,,,ESPERAL 500MG 20TAB,,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c733d835-ce15-4e1d-a5df-35f151e7dfc3.json
c736957e-a9fd-4def-b3e1-8b8a9c5e4b24,GALAFOLD 123 MG,prescription,,,7981,,,,,ILS,"capsule, hard",MIGALASTAT AS HYDROCHLORIDE,2025-07-31T03:26:13.046105,IL,תרומד,,83279.9471,70576.22949,64160.20863,,7290103847746,GALAFOLD 123 MG 14 CAPS,7945,,64788,BLISTER PVC/PCTFE/PVC,units,14.0,158 80 35012 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Galafold is indicated for long-term treatment of adults and adolescents aged 12 years and older with a confirmed diagnosis of Fabry disease (α-galactosidase A deficiency) and who have an amenable mutation.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c736957e-a9fd-4def-b3e1-8b8a9c5e4b24.json
c736c719-2825-48e4-882b-57ff8562c2e8,AUVELITY ®,prescription,N07XX59,"DEXTROMETHORPHAN, COMBINATIONS",9518,,,WHO ATC Classification,,ILS,tablets extended release,"BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE",2025-07-31T00:46:48.004034,IL,אופק פארמה,,100.8479005,85.46432625,63.54225,,,BUPROPION HCL 300 MG XR 30 TAB,,,4271,BOTTLE HDPE,units,30.0,177 80 37881 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,AUVELITY is indicated for the treatment of major depressive disorder (MDD) in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c736c719-2825-48e4-882b-57ff8562c2e8.json
c73b4308-9025-4247-bf68-fb1f7eccef0c,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,3961,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:22:24.749622,IL,רקיט בנקיזר,,29.7714,25.23,nan,,7290000852973,STREPSILS  MENTHOL&EUCA 24LOZ,19747,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c73b4308-9025-4247-bf68-fb1f7eccef0c.json
c73fbe9e-8b0b-4d81-92bd-0bdb27fc4a82,RINGER LACTATED SOLUTION/VIOSER,prescription,B05BB01,ELECTROLYTES,9442,,,WHO ATC Classification,,ILS,solution for infusion,"SODIUM LACTATE 3.14 G/L, CALCIUM CHLORIDE DIHYDRATE 0.26 G/L, POTASSIUM CHLORIDE 0.41 G/L, SODIUM CHLORIDE 6.02 G/L",2025-07-31T08:25:49.996544,IL,רז פרמהצפטי,,nan,nan,nan,,7290111096761,SODIUM CHLORIDE MONICO 0.45 %  BAG 500 ML,,,68102,BOTTLE LDPE,units,500.0,169 66 36052 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,Prescription required,Source of water and electrolytes. Regulation or maintenance of metabolic acidosis (except lactic acidosis),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c73fbe9e-8b0b-4d81-92bd-0bdb27fc4a82.json
c75194e6-d404-475f-8209-49d00bea5519,PENTASA SLOW RELEASE GRANULES 4 G.,prescription,A07EC02,MESALAZINE,699,,,WHO ATC Classification,,ILS,granules,MESALAZINE,2025-07-31T06:35:42.585079,IL,פרינג,,126.9853985,107.6147493,80.010966,,7640128547228,PENTASA ENEMA 7X1OOML,16544,,7900,SACHET POLYESTER/ALUMINIUM/POLYETHYLENE,units,700.0,157 47 34816 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate ulcerative colitis or crohn's disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c75194e6-d404-475f-8209-49d00bea5519.json
c761ae88-3daa-41d7-a877-b6260f9c9204,CEFUROXIME - FRESENIUS 1500 MG,prescription,J01DC02,CEFUROXIME,8609,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CEFUROXIME AS SODIUM SALT,2025-07-31T01:03:56.717770,IL,ניאופרם,,145.1439453,123.0033435,91.4523,,,CEFUROXIME  FRESENIUS 750 MG 10 VIAL,10668,,440,VIAL 20 ML GLASS,units,10.0,149 08 33470 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Cefuroxime -Fresenius is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth).•	Community acquired pneumonia•	 Acute exacerbations of chronic bronchitis•	 Complicated urinary tract infections, including pyelonephritis•	 Soft-tissue infections: cellulitis, erysipelas and wound infections•	 Intra-abdominal infections •	 Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section)•	 Nose infections for example, sinusitis•	 Septic arthritis",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c761ae88-3daa-41d7-a877-b6260f9c9204.json
c76b3f6d-2984-43ed-9ff5-f2dba1530a2a,DIFICLIR,prescription,A07AA12,FIDAXOMICIN,7536,,,WHO ATC Classification,,ILS,film coated tablets,FIDAXOMICIN,2025-07-31T01:55:21.210579,IL,טרדיס גת,,6948.57168,5888.62033,5353.291209,,7290008127592,DIFICLIR 200MG 20 F.C.TAB,4645,,32909,BLISTER ALUMINIUM,units,20.0,155 60 34282 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,DIFICLIR is indicated for the treatment of Clostridium difficile infections (CDI) also known as C. difficile associated diarrhoea (CDAD) in adult and paediatric patients aged 6 years and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c76b3f6d-2984-43ed-9ff5-f2dba1530a2a.json
c7712d3c-1b46-4955-befa-ed8ced5bff08,SERETIDE DISKUS 50/100 MCG,prescription,R03AK06,SALMETEROL AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,4127,,,WHO ATC Classification,,ILS,powder for inhalation,"FLUTICASONE PROPIONATE, SALMETEROL AS XINAFOATE",2025-07-31T08:05:30.821450,IL,ג.ס.ק,,133.3809242,113.0346815,84.0406554,,7290008086509,SERETIDE DISKUS 50/250MCG 60DISK,19396,,21198,BLISTER PVC,units,60.0,114 13 29551 01,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"Seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c7712d3c-1b46-4955-befa-ed8ced5bff08.json
c783acb9-e076-43bd-9613-7c59f3fcb5ff,SYMDEKO 100 MG/150 MG & 150 MG,prescription,R07AX31,IVACAFTOR AND TEZACAFTOR,8312,,,WHO ATC Classification,,ILS,film coated tablets,"IVACAFTOR, TEZACAFTOR, IVACAFTOR",2025-07-31T08:54:52.551634,IL,מדיסון,,nan,nan,nan,,,SYMDEKO 100 MG/150 MG & 150 MG 56 TAB,10333,,12459,BLISTER ACLAR/PVC/ALUMINIUM,units,56.0,162 71 35683 00,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,"SYMDEKO is a combination of tezacaftor and ivacaftor, indicated for the treatment of patients with cystic fibrosis (CF) aged 12 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence.If the patient’s genotype is unknown, a health authority cleared CF mutation test should be used to detect the presence of a CFTR mutation followed by verification with bi-directional sequencing when recommended by the mutation test instructions for use.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c783acb9-e076-43bd-9613-7c59f3fcb5ff.json
c7b82dc9-7541-41b9-b90f-328bfa399095,ARTHRYL GO,off-the-counter,M01AX05,GLUCOSAMINE,5612,,,WHO ATC Classification,,ILS,powder for solution,GLUCOSAMINE SULFATE (CRYSTALLINE),2025-07-31T11:13:40.252608,IL,דקסל פארמה,,93.9988,79.66,nan,,7290008015295,ARTHRYL GO 1500 MG 30 SACHET,17522,,,SACHET ALUMINIUM,units,30.0,154 70 34599 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of symptoms in mild to moderate osteoarthritis of the knee.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c7b82dc9-7541-41b9-b90f-328bfa399095.json
c7c16301-19e9-4427-8cea-5c4bc312d432,IMITREX INJECTION,prescription,N02CC01,SUMATRIPTAN,268,,,WHO ATC Classification,,ILS,solution for injection,SUMATRIPTAN AS SUCCINATE/ 0.5  ML,2025-07-31T04:02:00.280224,IL,ג.ס.ק,,140.3453772,118.9367656,88.428822,,7290008085953,IMITREX INJ 2 PREFILLED +AUTO INJ,9183,,8415,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,055 92 26920 00,valid,34.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache.Imitrex should only be used where there is a clear diagnosis of migraine or cluster headache.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c7c16301-19e9-4427-8cea-5c4bc312d432.json
c7e565d8-e0f5-46e9-a742-5bb790af43bb,NICOTINELL GUM 2 MG (MINT),off-the-counter,N07BA01,NICOTINE,5620,,,WHO ATC Classification,,ILS,chewing gum,NICOTINE,2025-07-31T12:31:11.136796,IL,ג.ס.ק,,152.574,129.3,nan,,,NICOTINELL GUM 4 MG (FRUIT) 96 GUMS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,96.0,115 78 29638 23,valid,nan,per os,1.4,30,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c7e565d8-e0f5-46e9-a742-5bb790af43bb.json
c7e9f826-763e-4c80-a539-39151ca62134,MIDOLAM 1 MG/ML,prescription,N05CD08,MIDAZOLAM,6229,,,WHO ATC Classification,,ILS,solution for injection,MIDAZOLAM/ML,2025-07-31T05:22:03.420666,IL,רפא,,16.5830828,14.05346,10.258,,7290017179353,MIDOLAM 1MG/MLx5ML 5AMP,13259,,35298,AMPOULES GLASS TYPE I,units,5.0,108 42 29066 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,midazolam is a short-acting sleep-inducing drug that is indicated:In adults• CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia• ANAESTHESIA- Premedication before induction of anaesthesia- Induction of anaesthesia- As a sedative component in combined anaesthesia• SEDATION IN INTENSIVE CARE UNITSIn children• CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia• ANAESTHESIA- Premedication before induction of anaesthesia• SEDATION IN INTENSIVE CARE UNITS,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c7e9f826-763e-4c80-a539-39151ca62134.json
c7eb2000-d41c-4703-af03-a54afb661273,RAMITENS 10,prescription,C09AA05,RAMIPRIL,4888,,,WHO ATC Classification,,ILS,capsules,RAMIPRIL,2025-07-31T07:16:19.813675,IL,רפא,,33.9526415,28.773425,21.0025,,7290008012485,RAMITENS 10MG 30CAPS,18343,,65592,BLISTER PVC/PVDC/TE/ALUMINIUM,units,30.0,131 58 30972 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Hypertension  congestive heart failure  reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction  stroke  cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI  unstable angina or multivessel CABG or multivessel PTCA)  stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction  stroke  cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings :  - hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg)  - high total cholesterol (>5.2 mmol/L)  - low HDL ( <0.9 mmol/L)  - current smoker  - known microalbuminuria  - clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c7eb2000-d41c-4703-af03-a54afb661273.json
c7fa04e5-4e93-4593-bf5f-1f319359a4c9,CIBINQO 100 MG,prescription,D11AH08,ABROCITINIB,9204,,,WHO ATC Classification,,ILS,film coated tablets,ABROCITINIB,2025-07-31T01:11:17.265676,IL,פיזר,,5248.004525,4447.46166,4043.146964,,,CIBINQO 50 MG 28 F.C.T,,,,BLISTER PVC/ALUMINIUM,units,28.0,171 31 37239 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c7fa04e5-4e93-4593-bf5f-1f319359a4c9.json
c8046932-87f5-4f84-9820-5bc04ee98208,SANDIMMUN ® NEORAL ® 100 MG CAPSULES,prescription,L04AA01,CYCLOSPORIN,3006,,,WHO ATC Classification,,ILS,capsules,CICLOSPORIN,2025-07-31T07:58:44.388588,IL,נוברטיס פארמה,,309.0002428,261.8646125,222.8635,,7298120012772,SANDIMMUN NEO 50MG 50CAPS,19076,,9079,BLISTER PVC/PA/ALUMINIUM,units,50.0,066 78 28140 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of organ rejection in kidney  liver heart allogenic transplants in conjunction with corticosteroids. May also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents.  Bone marrow transplantation.   Endogenous uveitis.   Severe psoriasis above age 16 that did not respond to other treatment. Atopic dermatitis in adults only up to 8 weeks  for severe cases in which conventional therapy is ineffective or inappropriate.   Rheumatoid arthritis: Severe cases in which standard treatments are ineffective or inappropriate.  Nephrotic syndrom type MCD (minimal change disease) in cases where conventional therapy has failed.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8046932-87f5-4f84-9820-5bc04ee98208.json
c833eb6f-ed3f-4c47-864e-6f686dea578c,TRICAN 200 MG CAPSULES,prescription,J02AC01,FLUCONAZOLE,3367,,,WHO ATC Classification,,ILS,capsules,FLUCONAZOLE,2025-07-31T09:41:13.217518,IL,פיזר,,142.1199375,120.440625,96.3525,,7290010355372,TRICAN 200MG 7CAPS,20640,,89715,BLISTER PVC/ALUMINIUM,units,7.0,118 50 29947 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections.Fluconazole is indicated in adults for the treatment of:•	Cryptococcal meningitis.•	Coccidioidomycosis.•	Invasive candidiasis.•	Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.•	Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.•	Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.•	Candidal balanitis when local therapy is not appropriate.•	Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.•	Tinea unguinium (onychomycosis) when other agents are not considered appropriate.Fluconazole is indicated in adults for the prophylaxis of:•	Relapse of cryptococcal meningitis in patients with high risk of recurrence.•	Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•	To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).•	Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).Fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.  Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c833eb6f-ed3f-4c47-864e-6f686dea578c.json
c84fbbe1-4df1-4f38-aafd-580af6ddac82,MIGLUSTAT DIPHARMA,prescription,A16AX06,MIGLUSTAT,8950,,,WHO ATC Classification,,ILS,"capsule, hard",MIGLUSTAT,2025-07-31T05:23:38.773219,IL,אמ.בי.איי פארמה,,14442.63548,12239.52213,11126.8383,,,MIGLUSTAT DIPHARMA 100MG 84 CAPS,,,74612,BLISTER OPA/AL/PVC,units,84.0,165 46 36284 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Miglustat Dipharma is indicated for the oral treatment of mild to moderate type I Gaucher disease. Miglustat Dipharma may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable. Miglustat Dipharma is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with Niemann-Pick type C disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c84fbbe1-4df1-4f38-aafd-580af6ddac82.json
c856b4f4-d4ad-48a9-9c09-f61271de9880,HYDRAPRES 20MG/ML 5AMP,29C,,,20447,,,,,,injection,HYDRAPRES 20MG/ML,2025-07-31T20:35:42.269556,IL,nan,,,,,,,HYDRAPRES 20MG/ML 5AMP,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c856b4f4-d4ad-48a9-9c09-f61271de9880.json
c85d809d-a0ab-42b8-a7fe-a330e8351ee0,LUCENTIS,prescription,S01LA04,RANIBIZUMAB,8634,,,WHO ATC Classification,,ILS,solution for injection,RANIBIZUMAB/ML,2025-07-31T04:58:08.361084,IL,נוברטיס פארמה,,1861.12567,1577.225214,1342.319331,,7290014257351,LUCENTIS 1 VIAL 0.23 ML,,,40768,SYRINGE PREFILLED  GLASS,units,1.0,136 75 31520 00,valid,17.5,intravitreal,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of patients with neovascular (wet) age-related macular degeneration (AMD). Treatment of adult patients with visual impairment due to diabetic macular oedema (DME) . The treatment of visual impairement due to macular oedema secondary to retinal vein occlusion (RVO). The treatment of visual impaiment due to choroidal neovascularization (CNV) . Lucentis is indicated in preterm infants for: the treatment of retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 3+) or AP-ROP (aggressive posterior ROP) disease.The treatment of proliferative diabetic retinopathy (PDR)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c85d809d-a0ab-42b8-a7fe-a330e8351ee0.json
c867e97b-666e-4441-bc2b-4cf89291b76c,INSTILLAGEL,off-the-counter,C01BB01,LIDOCAINE,5517,,,WHO ATC Classification,,ILS,gel,"CHLORHEXIDINE DIGLUCONATE 0.5  MG /, LIDOCAINE HYDROCHLORIDE 20.0  MG /",2025-07-31T13:21:13.611513,IL,טבע,,20.1662,17.09,nan,,,STILLA SINGLES 10*0.3ML EYES DROPS,,,,SYRINGE POLYPROPYLENE,units,10.0,160 11 35080 00,valid,nan,"urethral, vaginal",1.4,36,,,,,,,,,,0,,"Local anesthesia prior exploration in urology (ureteroscopy, cystoscopy, urethral dilation, catheterization). For use during gynaecological investigation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c867e97b-666e-4441-bc2b-4cf89291b76c.json
c87115f7-d6fe-4867-a657-1eb16a079e86,RUCONEST - POWDER FOR SOLUTION FOR INJECTION,prescription,B06AC04,CONESTAT ALFA,7411,,,WHO ATC Classification,,ILS,powder for solution for injection,CONESTAT ALFA 2100 U/VIAL,2025-07-31T07:53:24.372151,IL,קמהדע,,4361.108785,3695.855067,3359.868243,,8718309680039,RUCONEST - POWDER FOR SOL FOR INJ VIAL 25ML,18509,,53952,VIAL GLASS TYPE I,units,1.0,151 22 33442 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Ruconest is indicated for treatment of acute angioedema attacks in adults and adolescents aged 12 years and above with hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c87115f7-d6fe-4867-a657-1eb16a079e86.json
c8729c4e-21fa-452f-a486-ef1c11d1bf3f,DESFERAL 0.5 G.,prescription,V03AC01,DEFEROXAMINE,528,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,DEFEROXAMINE MESYLATE 0.5 G/VIAL,2025-07-31T01:50:11.230776,IL,נוברטיס פארמה,,152.8933002,129.5705992,103.6564793,,,DESFERAL 500MG 10 VIALS,4085,,651,VIAL GLASS TYPE I,units,10.0,107 07 21532 00,valid,25.0,"i.m, i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,Treatment of chronic iron overload  e.g.: Transfusional haemosiderosis especially in thalassaemia major  sideroblastic anaemia  autoimmune haemolytic anaemia and other chronic anaemias  Idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia  cardiac disease  hypoproteinaemia) preclude phlebotomy  Iron overload associated with porphyria cutanea tarda. Treatment of acute iron poisoning. Treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease  and/or dialysis encephalopathy  and/or aluminium-related anaemia. Diagnosis of iron overload.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8729c4e-21fa-452f-a486-ef1c11d1bf3f.json
c89192c8-703a-4297-ac78-e0cd46c0ebed,RIBONE 150,prescription,M05BA07,RISEDRONIC ACID,6783,,,WHO ATC Classification,,ILS,tablets,RISEDRONIC ACID AS SODIUM,2025-07-31T07:35:01.708198,IL,אוניפארם,,64.88255252,54.985214,40.8812,,7290008546591,RIBONE 35MG 4TAB,18460,,31859,BLISTER PVC/ALUMINIUM,units,4.0,147 68 33575 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of postmenopausal osteoporosis.Prevention of postmenopausal osteoporosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c89192c8-703a-4297-ac78-e0cd46c0ebed.json
c89707e7-3bc4-4ddc-9faf-1ca7aa2863bd,GLIADEL,prescription,L01AD01,CARMUSTINE,8570,,,WHO ATC Classification,,ILS,wafer,CARMUSTINE 7.7   MG,2025-07-31T00:55:35.164953,IL,רז פרמהצפטי,,6445.181814,5462.01873,4965.471572,,3161379010015,CARMUSTINE 100 MG/VIAL 1VIAL,,,48999,POUCH LAMINATED,units,1.0,110 34 29392 00,valid,10.0,implant,1.4,48,,,,,,,,,,0,Prescription required,For use as an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated.   Gliadel implant is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation.   Gliadel implant is indicated for use as an adjunct to surgery in patients with Recurrent histogically proved glioblastoma multiforme for whom surgical resection is indicated.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c89707e7-3bc4-4ddc-9faf-1ca7aa2863bd.json
c89befb7-f827-4d73-ac6c-082f9aae201c,LACROMYCIN EYE DROPS,prescription,S01AA11,GENTAMICIN,1807,,,WHO ATC Classification,,ILS,"eye drops, solution",GENTAMICIN AS SULFATE 0.3 %,2025-07-31T04:32:21.307445,IL,פישר,,13.82192939,11.7135,8.55,,7290000849560,LACROMYCIN DROPS 5CC,12008,,1162,BOTTLE LDPE,units,5.0,050 96 24707 00,valid,37.0,ocular,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of eye infections susceptible to treatment with Gentamycin.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c89befb7-f827-4d73-ac6c-082f9aae201c.json
c8a4a025-f8df-4859-9fb8-13472194a6ba,THALIDOMIDE BMS 50 MG HARD CAPSULES,prescription,L04AX02,THALIDOMIDE,4827,,,WHO ATC Classification,,ILS,"capsule, hard",THALIDOMIDE,2025-07-31T09:18:42.156320,IL,ניאופרם,,1456.664084,1234.461143,1050.605228,,7290006401694,THALIDOMIDE PHARMION 50MG 28HARD CAPS,20556,,12876,BLISTER PVC/PCTFE,units,28.0,131 42 31004 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Multiple myeloma :  *  For the treatment of multiple myeloma after failure of standard therapies.  *  Thalidomide BMS 50 mg hard capsules  in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma.   *  Thalidomide BMS in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma > or = 65 years or ineligible for high dose chemotherapy.  Erythema Nodosum Leprosum:  For the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). Thalidomide is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. It is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8a4a025-f8df-4859-9fb8-13472194a6ba.json
c8a84cb4-8bf6-4d64-a5c4-f31ace9bc8f8,TERIFLUNOMIDE TEVA,prescription,L04AA31,TERIFLUNOMIDE,8383,,,WHO ATC Classification,,ILS,film coated tablets,TERIFLUNOMIDE,2025-07-31T09:14:53.405181,IL,טבע,,4017.629682,3404.770917,3095.246288,,,TERIFLUNOMIDE TEVA  14 MG 28 TAB,,,30663,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,161 57 35259 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Teriflunomide Teva is indicated for the treatment of adult patients with relapsing remitting forms of Multiple Sclerosis (MS) to reduce the frequency of clinical relapses and to delay the progression of physical disability.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8a84cb4-8bf6-4d64-a5c4-f31ace9bc8f8.json
c8afa60b-ee27-46d3-aaf0-d864897e9452,TRODELVY,prescription,,,9256,,,,,ILS, powder for concentrate for solution for infusion ,SACITUZUMAB GOVITECAN,2025-07-31T09:45:25.643165,IL,גיליאד,,5401.056711,4577.166908,4161.060825,,5391507147523,TRODELVY 200MG 1 VIAL,,,89205,VIAL GLASS TYPE I,units,1.0,170 64 37173 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mTNBC) who have received two or more prior systemic therapies, including at least one of them for advanced disease.Trodelvy is indicated for the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+ or IHC 2+/ISH–) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8afa60b-ee27-46d3-aaf0-d864897e9452.json
c8dece7e-d0d2-4daf-9e50-8a7c6a4d6803,LOSARDEX 12.5,prescription,C09CA01,LOSARTAN,6177,,,WHO ATC Classification,,ILS,tablets,LOSARTAN POTASSIUM 12.5   MG,2025-07-31T04:55:04.766868,IL,דקסל פארמה,,40.33513996,34.182322,24.9506,,,LOSARDEX 12.5MG 30TAB,12399,,86889,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,138 18 31490 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Heart failure: Losardex 12.5 mg is indicated for the treatment of heart failure, when treatment with an ACE inhibitor is no longer considered appropriate. Switching patients with heart failure who are stable on an ACE inhibitor to Losardex 12.5 mg is not recommended.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8dece7e-d0d2-4daf-9e50-8a7c6a4d6803.json
c8e44ada-1d24-4d98-8896-14110947878a,AKLIEF,prescription,D10AD06,TRIFAROTENE,9505,,,WHO ATC Classification,,ILS,cream,TRIFAROTENE 0.005 %W/W,2025-07-31T00:12:44.313504,IL,אמי טכנולוגיות,,79.74791718,67.58298367,50.2475715,,,AKLIEF 50 MCG 30 GR,,,,BOTTLE HDPE,units,30.0,176 48 37123 99,valid,34.5,topical,1.4,24,,,,,,,,,,0,Prescription required,"Aklief is indicated for the cutaneous treatment of Acne Vulgaris of the face and/or the trunk in patients from 12 years of age and older, when many comedones, papules and pustules are present.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8e44ada-1d24-4d98-8896-14110947878a.json
c8eaa5ed-60c2-4ddc-9d00-f1c0cab4c140,SAXENDA,prescription,A10BX07,LIRAGLUTIDE,7758,,,WHO ATC Classification,,ILS,solution for injection,LIRAGLUTIDE/,2025-07-31T08:01:22.316799,IL,נובו נורדיסק,,1081.380478,916.4241744,779.9354676,,,SAXENDA 6MG/ML 5X3ML,9877,,30911,PRE-FILLED PEN GLASS TYPE I,units,5.0,155 64 34553 00,valid,17.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"AdultsSaxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial Body Mass Index (BMI) of •&#8805;30 kg/m² (obesity), or •&#8805;27 kg/m² to < 30 kg/m² (overweight) in the presence of at least one weight-related comorbidity such as dysglycaemia (pre-diabetes or type 2 diabetes mellitus), hypertension or dyslipidaemia, and who have failed a previous weight management intervention. Treatment with Saxenda should be discontinued after 12 weeks on the 3.0 mg/day dose if patients have not lost at least 5% of their initial body weight.Adolescents (&#8805;12 years)Saxenda can be used as an adjunct to a healthy nutrition and increased physical activity for weight management in adolescent patients from the age of 12 years and above with:• obesity (BMI corresponding to &#8805;30 kg/m2 for adults by international cut-off points)* and• body weight above 60 kg. Treatment with Saxenda should be discontinued and re-evaluated if patients have not lost at least 4% of their BMI or BMI z score after 12 weeks on the 3.0 mg/day or maximum tolerated dose. Re-evaluation should be performed periodically", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8eaa5ed-60c2-4ddc-9d00-f1c0cab4c140.json
c8f3e620-ef7e-4e22-9a93-ec3861d8f0e6,PEGLAX NEUTRAL,off-the-counter,A06AD15,MACROGOL,5291,,,WHO ATC Classification,,ILS,powder for oral solution,POLYETHYLENE GLYCOL 3350 99.973 %W/W,2025-07-31T12:46:43.693353,IL,ניאופרם,,63.6374,53.93,nan,,7290013166562,PEGLAX NEUTRAL 250GR,,,,BOTTLE POLYPROPYLENE,units,250.0,144 49 33236 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of constipation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c8f3e620-ef7e-4e22-9a93-ec3861d8f0e6.json
c91390b5-17c1-400c-9d30-988c2e324d07,IMBRUVICA 140 MG TABLETS,prescription,L01XE27,IBRUTINIB,9153,,,WHO ATC Classification,,ILS,film coated tablets,IBRUTINIB,2025-07-31T04:00:32.254882,IL,יאנסן סילג,,16278.99302,13795.75741,12541.59765,,7290014577688,IMBRUVICA 280 MG 30 FILM COATED TABLETS,9153,,74056,BLISTER PVC/PCTFE/AL,units,30.0,167 61 36458 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"•	Mantle Cell Lymphoma:Imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.•	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma :Imbruvica is indicated for the treatment of adult patients, with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)•	Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) with 17p deletion:Imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)  /Small Lymphocytic Lymphoma (SLL) with 17p deletion.•	Waldenström’s MacroglobulinemiaImbruvica is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).•	Marginal Zone LymphomaIMBRUVICA is indicated for the treatment of adult patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.•	Chronic Graft versus Host DiseaseIMBRUVICA is indicated for the treatment of adult patients with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c91390b5-17c1-400c-9d30-988c2e324d07.json
c9139d1a-48de-45ed-9a0f-6ddba307e9f9,BEXSERO,prescription,J07AH06,"MENINGOCOCCUS B, OUTER MEMBRANE VESICLE VACCINE",7867,,,WHO ATC Classification,,ILS,suspension for injection,"NEISSERIA MENINGITIDES GROUP B STRAIN NZ98/254, NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN, NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN, NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN",2025-07-31T00:34:52.941697,IL,ג.ס.ק,,426.2361084,361.2170571,307.418772,,,BEXSERO 1X0.5ML SYRINGE,2635,,69300,SYRINGE GLASS TYPE I,units,1.0,155 59 34399 00,valid,17.5,i.m,1.4,48,,,,,,,,,,0,Prescription required,Bexsero is indicated for active immunization of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c9139d1a-48de-45ed-9a0f-6ddba307e9f9.json
c9203bfd-9d3a-4002-85c7-b2ac78d309c1,ZAVEDOS 10 MG,prescription,L01DB06,IDARUBICIN,8197,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,IDARUBICIN HYDROCHLORIDE/VIAL,2025-07-31T10:44:02.005441,IL,פיזר,,395.6162558,335.2680283,285.3344922,,72982228,ZAVEDOS 10MG VIAL IV,26127,,64898,VIAL GLASS TYPE I,units,1.0,059 92 27176 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Antimitotic and cytotoxic agent. Acute non-limphocytic Leukemia (ANLL) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients.Acute limphocytic leukemia (ALL) as second line treatment in adults and children.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c9203bfd-9d3a-4002-85c7-b2ac78d309c1.json
c921b36e-e16f-4431-8b75-35c23cf6a350,ANHYDROL FORTE,off-the-counter,D09AA08,ALUMINIUM CHLOROHYDRATE,5037,,,WHO ATC Classification,,ILS,solution,ALUMINIUM CHLORIDE HEXAHYDRATEW/V,2025-07-31T11:13:16.473284,IL,תרופארם,,67.968,57.6,nan,,5016379105005,ANHYDROL FORTE 60ML,1602,,,BOTTLE HDPE,units,60.0,060 38 27252 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"For the topical treatment of hyperhydrosis specifically involving axillae, hands or feet.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c921b36e-e16f-4431-8b75-35c23cf6a350.json
c9401a65-d142-4a79-87d2-ba3308f7b34c,MINULET,prescription,G03CA01,ETHINYLESTRADIOL,371,,,WHO ATC Classification,,ILS,tablets,"GESTODENE 0.075  MG, ETHINYLESTRADIOL 0.030  MG",2025-07-31T05:27:03.153348,IL,פיזר,,66.48917385,56.3467575,41.8935,,,MINULET 3X21TAB,13456,,29928,BLISTER PVC/ALUMINIUM,units,63.0,050 50 25757 06,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraception.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c9401a65-d142-4a79-87d2-ba3308f7b34c.json
c9428890-ebdf-4ea5-aff3-5c860574d308,BACLOSAL 10,prescription,,,9377,,,,,ILS,tablets,BACLOFEN,2025-07-30T23:33:47.263717,IL,אוניפארם,,60.563736,51.3252,38.16,,,BACLOSAL 25MG 60TAB,,,14056,BLISTER ALU/PVC/PVDC,units,60.0,046 07 23779 02,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Muscle spasticity of various origins.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c9428890-ebdf-4ea5-aff3-5c860574d308.json
c9460885-9f1f-40da-876f-3212f787650c,ATROVENT ®,prescription,R03BB01,IPRATROPIUM BROMIDE,4715,,,WHO ATC Classification,,ILS,inhaler,IPRATROPIUM BROMIDE 0.02   MG,2025-07-31T00:26:02.191102,IL,בורינגר אינגלהיים,,23.79869917,20.16838913,14.72145192,,7920000800462,ATROVENT INHALER 20MCG 200DOSES,1906,,59982,INHALER ,units,200.0,130 01 30934 00,valid,37.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"For the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c9460885-9f1f-40da-876f-3212f787650c.json
c9511c9c-d7ab-4ab7-b761-af41e40ff151,TERIL 200,prescription,N03AF01,CARBAMAZEPINE,3272,,,WHO ATC Classification,,ILS,tablets,CARBAMAZEPINE,2025-07-31T09:15:44.270798,IL,תרו,,23.9951938,20.33491,14.843,,,TERIL CR 400MG 30TAB,20144,,9652,BLISTER PVC/PVDC,units,30.0,129 63 30784 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neurolgia, diabetes insipidus, mania, prophylactic in manic depressive illness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c9511c9c-d7ab-4ab7-b761-af41e40ff151.json
c96d0cec-e7d1-4169-9b7d-36068c8c08c4,HAIRGAIN 5%,off-the-counter,D11AX01,MINOXIDIL,3701,,,WHO ATC Classification,,ILS,solution - external,MINOXIDILW/V,2025-07-31T12:26:23.883632,IL,תרימה,,196.175,166.25,nan,,7290008856119,MINOXI 5 SOL 80ML,13136,,,BOTTLE HDPE,units,80.0,138 28 31485 00,valid,nan,topical- scalp,1.4,24,,,,,,,,,,0,,Hair regrowth treatment for men.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c96d0cec-e7d1-4169-9b7d-36068c8c08c4.json
c9f34780-980d-4d7e-a9da-354cf371f502,BOSENTAN TEVA ® 125 MG,prescription,C02KX01,BOSENTAN,8409,,,WHO ATC Classification,,ILS,film coated tablets,BOSENTAN AS MONOHYDRATE,2025-07-30T23:41:43.480354,IL,טבע,,5598.665923,4744.632138,4313.301944,,,BOSENTAN TEVA ® 125 MG 60 tab,,,38558,BLISTER PVC/ACLAR/PVC/ALUMINIUM,units,60.0,162 02 34906 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of pulmonary arterial hypertension (PAH) in patients of WHO functional class II-IV.Reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/c9f34780-980d-4d7e-a9da-354cf371f502.json
ca06e460-7af2-493d-b17a-fa4dc8ae7363,TOUJEO,prescription,A10AE04,INSULIN GLARGINE,7862,,,WHO ATC Classification,,ILS,solution for injection,INSULIN GLARGINE 300 U/ML,2025-07-31T09:28:01.674344,IL,סאנופי אוונטיס,,194.786095,165.0729692,132.0583754,,,TOUJEO 300 U/ML PER FILLED PEN 3X1.5ML,20807,,27283,PRE-FILLED PEN GLASS TYPE I,units,4.5,155 31 34440 00,valid,25.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca06e460-7af2-493d-b17a-fa4dc8ae7363.json
ca19188d-7763-411b-ad0d-1a6516e54345,ISOKET RETARD 40MG 50TAB,29C,,,20768,,,,,,tablet,ISOKET RETARD 40MG,2025-07-31T20:39:20.061078,IL,nan,,,,,,,ISOKET RETARD 40MG 50TAB,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca19188d-7763-411b-ad0d-1a6516e54345.json
ca253832-b42b-4619-8742-3ed3468c939f,AVCAMOL 250 MG,prescription,N02BE01,PARACETAMOL,8213,,,WHO ATC Classification,,ILS,granules,PARACETAMOL/STICK PACK,2025-07-31T06:28:40.417445,IL,תרו יבוא,,105.9557483,89.793007,66.7606,,,PARACETAMOL TARO IV 10MG/ML 10VIAL 100ML,,,,STICK PACKS POLYESTER/ALUMINIUM/POLYETHYLENE,units,10.0,148 51 33446 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Analgesic, Antipyretic .",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca253832-b42b-4619-8742-3ed3468c939f.json
ca385018-bbc2-4cdc-929f-25748242a278,ACERIL 12.5,prescription,,,4537,,,,,ILS,tablets,CAPTOPRIL 12.5  MG,2025-07-30T23:11:50.030785,IL,דקסל פארמה,,17.80878892,15.092194,11.0162,,,ACERIL 12.5MG 90TAB,1426,,33614,BLISTER ,units,90.0,106 49 29061 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,-HypertensionCongestive Heart Failure-insulin dependent diabetic nephropathy in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl.-improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less or equals to 40% and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca385018-bbc2-4cdc-929f-25748242a278.json
ca3b1890-a8ed-42eb-9516-c604b51d9b11,ZAVESCA,prescription,A16AX06,MIGLUSTAT,7846,,,WHO ATC Classification,,ILS,capsules,MIGLUSTAT,2025-07-31T10:44:12.521085,IL,יאנסן סילג,,14442.63548,12239.52213,11126.8383,,7640111932543,ZAVESCA 100 MG 84 CAPSULES,26204,,77007,BLISTER PVC/ALUMINIUM,units,84.0,128 34 30714 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Zavesca is indicated for the oral treatment of mild to moderate type I Gaucher disease. Zavesca may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable.Zavesca is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with Niemann-Pick type C disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca3b1890-a8ed-42eb-9516-c604b51d9b11.json
ca491b93-24c8-4411-9dac-ca9d009c9e2d,ALDACTONE 25 MG,prescription,C03DA01,SPIRONOLACTONE,9384,,,WHO ATC Classification,,ILS,coated tablets,SPIRONOLACTONE,2025-07-31T06:45:25.054179,IL,אוניפארם,,2215.907492,1877.887789,1598.202374,,,PIRON 267 MG 90 TAB,,,15124,BLISTER PVC/ALUMINIUM,units,90.0,125 97 24826 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Congestive heart failure, cirrhotic ascites.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca491b93-24c8-4411-9dac-ca9d009c9e2d.json
ca4bb053-f213-4b66-8533-a8fcb97bbd88,DEFERASIROX TEVA ® 125 MG,prescription,V03AC03,DEFERASIROX,8381,,,WHO ATC Classification,,ILS,tablets dispersible,DEFERASIROX,2025-07-31T01:45:12.926298,IL,טבע,,3725.628502,3157.31229,2870.2839,,,DEFERASIROX TEVA  500 MG 30 DIS TAB,,,59870,BLISTER PVC/PE/PVDC/PE/PVC/ALUMINIUM,units,30.0,161 12 34651 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Deferasirox Teva is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in adult and pediatric patients (aged 2 years and over). Deferasirox Teva is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. Chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [LIC] &#8805;5 mg Fe/g dry weight [dw] or serum ferritin consistently >800 μg /l).LIC is the preferred method of iron overload determination and should be used wherever available.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca4bb053-f213-4b66-8533-a8fcb97bbd88.json
ca50188c-70de-40f5-a188-573963f334fc,FENTAMED 100 MCG,prescription,N01AH01,FENTANYL,9363,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE MICRONIZED,2025-07-31T02:59:36.101981,IL,אינובמד,,1037.509631,879.24545,748.294,,7290104531170,FENTAMED 100 MCG 30 TAB SUBLINGUAL,23634,,5010,BLISTER PA/AL/PVC//ALU/PET,units,30.0,173 43 36706 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fentamed is indicated for management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca50188c-70de-40f5-a188-573963f334fc.json
ca6aac77-6961-4fcc-a94c-50ca4181af65,ASPIRIN 500,29C,B01AC06,ACETYLSALICYLIC ACID,20985,,,WHO ATC Classification,,ILS,tablets,ACETYLSALICYLIC ACID,2025-07-31T13:54:43.029733,IL,nan,,nan,nan,nan,,7298074020014,ASPIRIN 500MG INJECTION,,,,BLISTER PP/ALUMINIUM,units,20.0,025 43 21130 00,valid,nan,per os,1.4,48,,,,,,,,,,0,,"Pain relief, fever reduction .",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ca6aac77-6961-4fcc-a94c-50ca4181af65.json
caa38a7b-c4d2-4c0c-9a2c-ccb34dd8d272,DOCITON 1MG/ML 10AMPX1ML,29C,,,20377,,,,,,injection,DOCITON 1MG/ML X,2025-07-31T20:17:23.834447,IL,nan,,,,,,,DOCITON 1MG/ML 10AMPX1ML,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/caa38a7b-c4d2-4c0c-9a2c-ccb34dd8d272.json
caab0c9c-7da1-4ddb-9894-ffa71d5a285b,BUTRANS 10,prescription,,,8258,,,,,ILS,patches matrix,BUPRENORPHINE,2025-07-31T00:46:58.436549,IL,רפא,,110.3693945,93.53338936,69.54155343,,7290008012546,BUTRANS  15MG 2 PATCHES,2617,,25325,POUCH ALUMINIUM,units,2.0,135 71 31152 00,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/caab0c9c-7da1-4ddb-9894-ffa71d5a285b.json
cab6b0e2-c89a-46c3-84a4-c589322ad6e2,"VINORELBIN ""EBEWE"" 10 MG/ML",prescription,N/A,,7970,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,VINORELBINE AS TARTRATE/ML,2025-07-31T10:17:12.882293,IL,סנדוז,,404.2013536,342.54352,291.5264,,,VINORELBIN EBEWE 10 MG/ML VIAL 5ML,22277,,71242,VIAL GLASS,units,1.0,136 44 31351 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of non small cell lung cancer. For the treatment of advanced breast cancer. Hormone- refractory prostate cancer, especially in combination with low dose oral corticoid therapy or Estramustin.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cab6b0e2-c89a-46c3-84a4-c589322ad6e2.json
cabcd90a-866b-4a5a-8b94-04634d1fe776,ALIMTA 100MG/VIAL VIAL 10ML,prescription,,,7336,,,,,ILS,injection,ALIMTA 100MG/VIAL VIAL,2025-07-31T18:58:47.969389,IL,אלי לילי,,1074.694452,910.75801,775.1132,,,ALIMTA 100MG/VIAL VIAL 10ML,9610,,80343,,units,1.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cabcd90a-866b-4a5a-8b94-04634d1fe776.json
cac28698-95a2-42a3-bc06-6fd9290ae693,SPASMEX 15,prescription,G04BD09,TROSPIUM,6333,,,WHO ATC Classification,,ILS,film coated tablets,TROSPIUM CHLORIDE,2025-07-31T08:33:00.274469,IL,ליברה,,74.92422627,63.49510701,47.208258,,4028305000521,SPASMEX 30MG 30TAB,19923,,21296,BLISTER PVC,units,30.0,132 49 30583 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,For the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cac28698-95a2-42a3-bc06-6fd9290ae693.json
cac4a70b-7202-4f11-bec4-a2aeedae8202,DETHAMYCIN,prescription,S01CA01,DEXAMETHASONE AND ANTIINFECTIVES,3236,,,WHO ATC Classification,,ILS,solution,"NEOMYCIN SULFATE 0.5 %W/V, DEXAMETHASONE SODIUM PHOSPHATE 0.1 %W/V",2025-07-31T01:51:51.979592,IL,ויטאמד,,nan,nan,nan,,,DETHAMYCIN 10ML,4196,,9369,BOTTLE LDPE,units,10.0,101 62 28764 00,valid,nan,"nasal, ocular, otic",1.4,24,,,,,,,,,,0,Prescription required,For the treatment of inflammations with probable secondary bacterial infections.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cac4a70b-7202-4f11-bec4-a2aeedae8202.json
cac97948-ae9d-4a3f-8800-cdd0b5754372,TERROSA,prescription,H05AA02,TERIPARATIDE,8672,,,WHO ATC Classification,,ILS,solution for injection,TERIPARATIDE/ML,2025-07-31T09:15:57.109693,IL,טבע,,1100.798471,932.8800598,793.9404764,,7290015912679,TERIPARATIDE 250 MCG/ML 1 PREFILLED PEN,,,28025,CARTRIDGE GLASS TYPE I,units,1.0,163 82 35787 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Terrosa is indicated* For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis Terrosa reduces the risk of vertebral and nonvertebral fractures . * To increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, or who have failed or are intolerant to other available osteoporosis therapy. * For the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cac97948-ae9d-4a3f-8800-cdd0b5754372.json
caddcbd0-5ac7-416d-8a12-f96c31808579,TYKERB,prescription,,,6192,,,,,ILS,film coated tablets,LAPATINIB AS DITOSYLATE MONOHYDRATE,2025-07-31T09:49:09.572769,IL,נוברטיס פארמה,,4039.038869,3422.914448,3111.740407,,7290014257702,TYKERB 250 MG 70 TAB,20666,,78015,BOTTLE HDPE,units,70.0,139 23 31609 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress HER2 (ErbB2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting .• Tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the HER2 receptor for whom hormonal therapy is indicated. Tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/caddcbd0-5ac7-416d-8a12-f96c31808579.json
cae5a882-0e98-4f39-95db-af7e8bb59ed3,LANSOPRAZOLE TEVA ® 30 MG,prescription,A02BC03,LANSOPRAZOLE,6114,,,WHO ATC Classification,,ILS,capsules,LANSOPRAZOLE,2025-07-31T04:35:26.010120,IL,טבע,,44.72275402,37.900639,27.6647,,7290102063147,LANSOPRAZOLE TEVA 30MG 30CAPS,12404,,84718,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,133 19 30999 00,valid,37.0,per os,1.4,18,,,,,,,,,,0,Prescription required,• Treatment of duodenal and gastric ulcer                                                                             • Treatment of reflux oesophagitis• Prophylaxis of reflux oesophagitis• Eradication of Helicobacter pylori (H. pylori) concurrently given with appropriate antibiotic therapy for treatment of H.pylori-associated ulcers• Treatment of NSAID-associated benign gastric and duodenal ulcers in patients requiring continued NSAID treatment• Prophylaxis of NSAID-associated gastric ulcers and duodenal ulcers in patients at risk requiring continued therapy• Symptomatic gastroesophageal reflux disease• Zollinger-Ellison syndrome.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cae5a882-0e98-4f39-95db-af7e8bb59ed3.json
caed6ace-7d1c-49d4-91db-7c420aa3cf0c,VECTOR 160,prescription,C09CA03,VALSARTAN,9166,,,WHO ATC Classification,,ILS,tablets,VALSARTAN,2025-07-31T10:01:54.387142,IL,אוניפארם,,30.10901334,25.516113,18.6249,,,VECTOR 80 MG 30TAB,,,35628,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,145 44 33076 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For treatment of hypertension. Valsartan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan significantly reduced hospitalizations for heart failure. There is no evidence that Valsartan provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/caed6ace-7d1c-49d4-91db-7c420aa3cf0c.json
cb04f604-8bfd-4d78-920f-3731e84f7c7d,ARIPLY 10,prescription,N05AX12,ARIPIPRAZOLE,7201,,,WHO ATC Classification,,ILS,tablets,ARIPIPRAZOLE,2025-07-30T23:27:17.162611,IL,אוניפארם,,259.17874,219.643,175.7144,,,ARIPLY 10MG 28TAB,9642,,40538,BLISTER PVC/ALUMINIUM,units,28.0,149 03 33529 01,valid,25.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Ariply is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.Ariply  is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD). Efficacy was established in two 6-week trials in adults with MDD who had an inadequate response to antidepressant therapy during the current episode.Ariply  is indicated for the treatment of irritability associated with autistic disorder. Efficacy was established in two 8-week trials in pediatric patients (aged 6 to 17 years) with irritability associated with autistic disorder (including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb04f604-8bfd-4d78-920f-3731e84f7c7d.json
cb075ea5-989f-4348-bb1b-8095e39cdda3,ORILISSA150 MG,prescription,H01CC03,ELAGOLIX,8781,,,WHO ATC Classification,,ILS,film coated tablets,ELAGOLIX AS SODIUM,2025-07-31T06:16:28.585925,IL,אב-וי,,nan,nan,nan,,,ORILISSA 200 MG 56 TAB,,,30806,BLISTER PVC/PE/PCTFE/AL,units,56.0,164 66 35928 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Orilissa is indicated for the management of moderate to severe pain associated with endometriosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb075ea5-989f-4348-bb1b-8095e39cdda3.json
cb17399c-c6e5-43dd-8bf3-1e7c0200ddbd,ADCETRIS  50 MG,prescription,L01XC12,BRENTUXIMAB VEDOTIN,7193,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BRENTUXIMAB VEDOTIN/VIAL,2025-07-30T23:14:24.837192,IL,טקדה,,14583.06939,12358.53393,11235.03085,,7290019217817,ADCETRIS 50MG/VIAL 1 VIAL,9722,,50844,VIAL GLASS TYPE I,units,1.0,152 09 33991 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"ADCETRIS is indicated for the treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL): 1. following autologous stem cell transplant (ASCT) or 2. following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option. ADCETRIS is indicated for the treatment of adult patients with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL). ADCETRIS is indicated for the treatment of adult patients with CD30+ HL at increased risk of relapse or progression following ASCT. ADCETRIS is indicated for the treatment of adult patients with CD30+ cutaneous T-cell lymphoma (CTCL) after at least 1 prior systemic therapy . ADCETRIS is indicated for the treatment of adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma (cHL), in combination with doxorubicin, vinblastine, and dacarbazine.ADCETRIS is indicated for the treatment of adult patients with previously untreated systemic anaplastic large cell lymphoma (sALCL) or other CD30-expressing peripheral T-cell lymphomas (PTCL), including angioimmunoblastic T-cell lymphoma and PTCL not otherwise specified, in combination with cyclophosphamide, doxorubicin, and prednisone.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb17399c-c6e5-43dd-8bf3-1e7c0200ddbd.json
cb1a4e6a-2455-411f-a02b-fd2acaf24ac5,LEMOCIN CHERRY,off-the-counter,R02AD02,LIDOCAINE,3899,,,WHO ATC Classification,,ILS,lozenges,"LIDOCAINE, TYROTHRICIN, CETRIMONIUM BROMIDE",2025-07-31T12:18:22.493302,IL,דפריס,,30.6446,25.97,nan,,7290011363185,LEMOCIN CHERRY 24LOZ,12374,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,117 79 29907 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of pain associated with severe sore throat and mouth infections.This medicine is intended for adults and children over 12 years old.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb1a4e6a-2455-411f-a02b-fd2acaf24ac5.json
cb2462ed-3081-4e09-b054-c62a03f5c58a,LAEVOLAC,off-the-counter,A06AD11,LACTULOSE,5177,,,WHO ATC Classification,,ILS,solution  (oral),LACTULOSE/ML,2025-07-31T12:16:41.047379,IL,מגאפארם,,39.707,33.65,nan,,9088880170823,LAEVOLAC 300ML,12306,,,BOTTLE PET,units,300.0,115 98 29714 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Constipation. Acute and chronic hepatic encephalopathy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb2462ed-3081-4e09-b054-c62a03f5c58a.json
cb257230-3280-48d2-b13d-ac25c8c0abac,NICOTINELL LOZENGES 1 MG,off-the-counter,,,3993,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:31:54.438341,IL,ג.ס.ק,,61.0296,51.72,nan,,,NICOTINELL GUM MINT 2GR 48 tab,14409,,,BLISTER PVC/PE/PVDC/AL,units,48.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb257230-3280-48d2-b13d-ac25c8c0abac.json
cb3b9ee3-84ff-417c-943c-11173d881165,JANESS,prescription,G03AC03,LEVONORGESTREL,7957,,,WHO ATC Classification,,ILS,intrauterine delivery system,LEVONORGESTREL 13.5  MG,2025-07-31T04:16:04.849114,IL,באייר,,518.375422,439.3012246,373.8733827,,,JANESS 13.5 MG INTRAUTERINE SYSTEM,10070,,32527,BLISTER PETG/PE,units,1.0,153 52 34106 00,valid,17.5,intrauterine,1.4,36,,,,,,,,,,0,Prescription required,Contraception for up to 3 years.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb3b9ee3-84ff-417c-943c-11173d881165.json
cb50dd80-fa55-457c-8e25-931670950438,STALEVO 125/31.25/200 MG,prescription,N04BA01,LEVODOPA,6458,,,WHO ATC Classification,,ILS,film coated tablets,"LEVODOPA, ENTACAPONE, CARBIDOPA AS MONOHYDRATE 31.25  MG",2025-07-31T08:38:38.120368,IL,אינובמד,,76.9512565,65.21293213,48.4854514,,,STALEVO 125/31.25/200MG 30TAB,19925,,21390,BOTTLE HDPE,units,30.0,144 31 32963 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa/decarboxylase (DDC) inhibitor treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb50dd80-fa55-457c-8e25-931670950438.json
cb641463-9fb1-412f-a93b-0c5f9a376743,REKOVELLE,prescription,G03GA10,FOLLITROPIN DELTA,8344,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN DELTA 33.3 MCG/ML,2025-07-31T07:21:18.659088,IL,פרינג,,316.9007295,268.5599522,228.5616614,,7640128548768,REKOVELLE 12 1 PREFFILED PEN,,,28161,PEN GLASS,units,1.0,159 60 35096 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb641463-9fb1-412f-a93b-0c5f9a376743.json
cb762565-d6af-46b5-9009-4e44ac7b76d6,PRASUGREL TEVA 10 MG,prescription,B01AC22,PRASUGREL,8861,,,WHO ATC Classification,,ILS,film coated tablets,PRASUGREL AS HYDROBROMIDE,2025-07-31T06:49:57.877226,IL,טבע,,109.4064808,92.71735661,68.93483763,,,PRASUGREL TEVA 10 MG 28 TAB,,,68123,BLISTER OPA/AL/PE+DESICCANT - AL/PE,units,28.0,166 41 35678 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Prasugrel Teva, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI] undergoing primary or delayed percutaneous coronary intervention (PCI). The increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had TIA/CVA in the past and in those above the age of 75 or weight below 60 kg.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb762565-d6af-46b5-9009-4e44ac7b76d6.json
cb84d7f0-96e4-4a93-b904-2c1af85e065a,IBUPRO LIQUI - GELS 200,off-the-counter,M01AE01,IBUPROFEN,5554,,,WHO ATC Classification,,ILS,capsules liquid filled,IBUPROFEN,2025-07-31T12:09:00.404764,IL,ליף-דקסון,,45.1468,38.26,nan,,,IBUPRO LIQUI - GELS 200 40 CAPS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,40.0,131 18 31017 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of mild to moderate pain such as headache, toothache, menstrual pain, backache, muscular pain, anti - inflammatory for rheumatic disease, reduction of fever.For the treatment of pain associated with migraine.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb84d7f0-96e4-4a93-b904-2c1af85e065a.json
cb8af328-b400-43f0-9db0-34b9072fdb46,DIPYRONE KALCEKS 500 MG/ML,29C,N02BB02,METAMIZOLE SODIUM,20801,,,WHO ATC Classification,,ILS,solution for injection,METAMIZOLE SODIUM MONOHYDRATE/,2025-07-31T15:09:43.394028,IL,nan,,nan,nan,nan,,,METAMIZOLE 5MG 100TAB,,,,AMPOULES GLASS TYPE I,units,100.0,163 58 35578 00,valid,nan,"i.m, i.v",1.4,48,,,,,,,,,,0,,"As an analgesic: Dypirone Kalceks, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. As an antipyretic: Dypirone Kalceks by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. Hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb8af328-b400-43f0-9db0-34b9072fdb46.json
cb9a3e6c-892a-4536-b9ba-9099c282fcfe,ROKACET,prescription,N02BE01,PARACETAMOL,6018,,,WHO ATC Classification,,ILS,caplets,"PARACETAMOL, CAFFEINE, CODEINE PHOSPHATE",2025-07-31T07:47:58.720387,IL,תרו,,nan,nan,nan,,,ROKACET PLUS 24 CAPLETS,18370,,72116,BLISTER PVC/PVDC,units,24.0,027 84 21960 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of pain and coughs and for the reduction of fever accompanied by pain.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cb9a3e6c-892a-4536-b9ba-9099c282fcfe.json
cba2b9fd-ba84-4a07-9e29-e9f02293ded4,BUVIDAL 128 MG,29C,N07BC01,BUPRENORPHINE,8495,,,WHO ATC Classification,,ILS,prolonged release solution for injection,BUPRENORPHINE/ML,2025-07-31T14:01:04.750993,IL,nan,,nan,nan,nan,,,BUVIDAL 32 MG/0.64 ML 1 syringe,,,,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,168 78 36086 00,valid,nan,s.c,1.4,30,,,,,,,,,,0,,"Treatment of opioid dependence within a framework of medical, social and psychological treatment.Treatment is intended for use in adults and adolescents aged 16 years or over.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cba2b9fd-ba84-4a07-9e29-e9f02293ded4.json
cbb0a020-08a5-441b-91eb-afd878908533,CHILDREN'S ADVIL GRAPE FLAVOR,off-the-counter,M01AE01,IBUPROFEN,3888,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T11:04:46.597609,IL,ג.ס.ק,,59.8024,50.68,nan,,305730171304,ADVIL 200MG 40LIQUI-GELS,1609,,,BOTTLE PLASTIC,units,40.0,122 43 30111 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbb0a020-08a5-441b-91eb-afd878908533.json
cbb8ad1f-2ca6-4869-b79a-60240fdabadf,NORVASC 10 MG TABLETS,prescription,C08CA01,AMLODIPINE,8040,,,WHO ATC Classification,,ILS,tablets,AMLODIPINE AS BESYLATE,2025-07-31T05:52:30.786636,IL,דקסל פארמה,,19.55552522,16.572479,12.0967,,,NORVASC 10 MG 30 TABLETS,14613,,27185,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,129 49 30947 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Mild to moderate hypertension.  Vasospastic angina ( Prinzmetal's or variant angina). Chronic stable angina., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbb8ad1f-2ca6-4869-b79a-60240fdabadf.json
cbbb0021-9afd-42bc-b3ae-440009cdac4b,LENALIDOMIDE TEVA ® 10 MG,prescription,L04AX04,LENALIDOMIDE,8425,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE AS HYDROCHLORIDE HYDRATE,2025-07-31T04:39:05.770791,IL,טבע,,24330.36379,20618.95236,18744.50215,,,LENALIDOMIDE TEVA  25 MG 21 CAPS,,,45711,BLISTER OPA/ALU/PVC/ALU,units,21.0,161 82 35502 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM): Lenalidomide Teva is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes: Lenalidomide Teva is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Lenalidomide Teva 7.5 mg is not indicated for treatment in MDS.Mantle Cell Lymphoma:Lenalidomide Teva is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphoma:Lenalidomide Teva in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbbb0021-9afd-42bc-b3ae-440009cdac4b.json
cbcd6d89-c8b8-45c4-bc10-ce78d16774ff,METOCLOPRAMIDE S.A.L.F 10 MG/2 ML,prescription,A03FA01,METOCLOPRAMIDE,8229,,,WHO ATC Classification,,ILS,solution for injection,METOCLOPRAMIDE HYDROCHLORIDE/ML,2025-07-31T05:18:46.513227,IL,רז פרמהצפטי,,15.03438,12.741,9.3,,7290015863100,METOCLOPRAMIDE S.A.L.F  10MG/2 ML 5 AMP,,,52751,AMPOULES GLASS TYPE I,units,5.0,158 39 34558 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"METOCLOPRAMIDE S.A.L.F 10 MG/2 ML is indicated in adults for: - Prevention of postoperative nausea and vomiting (PONV) - Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV) - Prevention of nausea and vomiting caused by radiation therapy - Symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. In migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption. - Diabetic gastroparesis - To faciliate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) Pediatric population. METOCLOPRAMIDE S.A.L.F 10 MG/2 ML is indicated in children aged 1 to 18 years for: - Second line-therapy: Treatment of established postoperative nausea and vomiting (PONV) - Second-line therapy: Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV) - To facilitate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbcd6d89-c8b8-45c4-bc10-ce78d16774ff.json
cbd5e9e2-7649-4e86-ac2c-94fbd303573a,RYTMONORM 150 MG,prescription,,,7781,,,,,ILS,film coated tablets,PROPAFENONE HYDROCHLORIDE,2025-07-31T07:55:49.578788,IL,אבוט,,18.96611286,16.072977,11.7321,,8002660018632,RYTMONORM 150 MG 30 F.C.TAB,20911,,31084,BLISTER PVC/ALUMINIUM,units,30.0,103 99 27103 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis and treatment of ventricular arrhythmias. Prophylaxis and treatment of atrial fibrillation and flutter. Prophylaxis and treatment of Paroxysmal supraventricular tachycardia (PSVT) associated with Disabling symptoms.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbd5e9e2-7649-4e86-ac2c-94fbd303573a.json
cbd81762-2d5b-498a-beb9-10fdeeee9534,STALEVO ® 50/12.5/200 MG,prescription,N04BA02,LEVODOPA AND DECARBOXYLASE INHIBITOR,4844,,,WHO ATC Classification,,ILS,film coated tablets,"LEVODOPA, CARBIDOPA 12.5   MG, ENTACAPONE",2025-07-31T08:39:18.237278,IL,אינובמד,,66.74305086,56.56191002,42.0534647,,7290100418246,STALEVO 50/12.5/200MG 30TAB,19737,,61885,BOTTLE HDPE,units,30.0,132 34 31105 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbd81762-2d5b-498a-beb9-10fdeeee9534.json
cbe02bde-3379-4703-993b-aaec6adc63cd,COSENTYX  SOLUTION FOR INJECTION,prescription,L04AC10,SECUKINUMAB,7754,,,WHO ATC Classification,,ILS,solution for injection,SECUKINUMAB/ML,2025-07-31T01:31:25.755746,IL,נוברטיס פארמה,,5267.194295,4463.724177,4057.93107,,7290014257429,COSENTYX 150MG SOL FOR INJ 2 PREFILLED SYRINGES,9850,,18478,PRE-FILLED PEN GLASS TYPE I,units,2.0,154 20 34342 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"- Plaque psoriasis: Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. - Paediatric plaque psoriasis: Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy. - Psoriatic arthritis: Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous disease modifying anti rheumatic drug (DMARD) therapy has been inadequate. - Axial spondyloarthritis (axSpA) : •Ankylosing spondylitis (AS, radiographic axial spondyloarthritis) Cosentyx is indicated for the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy. •Non-radiographic axial spondyloarthritis (nr-axSpA) Cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to non-steroidal anti-inflammatory drugs (NSAIDs). - Juvenile idiopathic arthritis (JIA) •Enthesitis-related arthritis (ERA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active enthesitisrelated arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. •Juvenile psoriatic arthritis (JPsA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.Hidradenitis suppurativa (HS)Cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic HS therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbe02bde-3379-4703-993b-aaec6adc63cd.json
cbeb3ea6-23b8-44ba-807f-6a44e017e48b,V-OPTIC 0.25%,prescription,S01ED01,TIMOLOL,3239,,,WHO ATC Classification,,ILS,drops,TIMOLOL AS MALEATE 2.5 MG/ML,2025-07-31T10:20:10.057903,IL,ויטאמד,,19.6538145,16.655775,12.1575,,7-290008-083614,V-OPTIC 0.25% 5ML,22097,,9643,DROPER BOTTLE LDPE,units,5.0,069 80 28592 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,"For the reduction of elevated intraocular pressure.may be used in patients with chronic open angle glaucoma, aphakic glaucoma, some patients with secondary glaucoma and patients with ocular hypertension.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbeb3ea6-23b8-44ba-807f-6a44e017e48b.json
cbf47b53-a4f9-49ba-bd8c-4e0c79f07f1e,VYVANSE 30 MG,prescription,N06BA12,LISDEXAMFETAMINE,7380,,,WHO ATC Classification,,ILS,capsules,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T10:24:28.957056,IL,מדיסון,,385.3381468,326.557766,277.921503,,7290008128957,VYVANSE 70MG 30CAPS,22407,,32835,BOTTLE HDPE,units,30.0,153 19 33994 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Vyvanse is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Vyvanse is indicated for the treatment of  Moderate to Severe Binge Eating Disorder (BED) for patient over 18 years.Limitation of Use:Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbf47b53-a4f9-49ba-bd8c-4e0c79f07f1e.json
cbfc0b5e-776b-4149-a4e1-6fa98dc726ab,OCTAGAM,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7143,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T06:01:22.423354,IL,דובר מדיקל,,844.8055668,715.9369529,609.308045,,,OCTAGAM 5% 50ML VIAL,,,,BOTTLE GLASS TYPE II,units,50.0,143 22 31778 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Replacement therapy in:   • Primary immunodeficiency syndromes such as:      - congenital agammaglobulinaemia and hypogammaglobulinaemia       - common variable immunodeficiency       - severe combined immunodeficiency       - Wiskott Aldrich syndrome.  • Children with congenital AIDS and recurrent bacterial infections.      Immunomodulatory effect:   • Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.   • Guillain barre syndrome.   • Kawasaki disease.      Allogeneic bone marrow transplantation.• Myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cbfc0b5e-776b-4149-a4e1-6fa98dc726ab.json
cc0bf727-fbcf-4440-8dd3-1304cbf9af43,HUMAN ALBUMIN 20% BEHRING,prescription,B05AA01,ALBUMIN,9186,,,WHO ATC Classification,,ILS,solution for infusion,ALBUMIN HUMAN/ML,2025-07-31T03:49:29.351662,IL,טקדה,,175.9130352,149.07885,119.26308,,7290000689975,HUMAN ALBUMIN 20% 1VIAL/50 ML,,,59453,VIAL GLASS TYPE II,units,50.0,039 05 20131 00,valid,25.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Hypoalbuminemia (liver cirrhosis nephrosis) toxic processes ( pregnancy toxicosis, hyperbilirubinemia ) ,volume substitution therapy.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc0bf727-fbcf-4440-8dd3-1304cbf9af43.json
cc16e671-c8c8-45cf-92ca-5d48e70159c0,DEXIMUNE 100,prescription,L04AA01,CYCLOSPORIN,4437,,,WHO ATC Classification,,ILS,capsules,CICLOSPORIN,2025-07-31T01:53:37.046531,IL,דקסל פארמה,,594.259446,503.6097,428.604,,,DEXIMUNE 100MG 50 CAPSULES,4538,,10444,BLISTER ALUMINIUM /ALUMINIUM,units,50.0,124 48 30358 11,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of organ rejection in kidney  liver heart allogenic transplants in conjunction with corticosteroids. May also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents.  Bone marrow transplantation.   Endogenous uveitis.   Severe psoriasis above age 16 that did not respond to other treatment.   Atopic dermatitis in adults only up to 8 weeks  for severe cases in which conventional therapy is ineffective or inappropriate.   Rheumatoid arthritis: Severe cases in which standard treatments are ineffective or inappropriate. Nephrotic syndrom type MCD (minimal change disease) in cases where conventional therapy has failed.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc16e671-c8c8-45cf-92ca-5d48e70159c0.json
cc23b9ca-5582-4c47-bac4-cefe8527b283,OFEV 100 MG,prescription,,,7620,,,,,ILS,"capsule, soft",NINTEDANIB AS ESILATE,2025-07-31T06:04:01.783734,IL,בורינגר אינגלהיים,,10645.65622,9021.742965,8201.584513,,,OFEV 150MG 60CAPS,15461,,30881,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,154 74 34335 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Idiopathic Pulmonary Fibrosis OFEV is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adults. Systemic Sclerosis-Associated Interstitial Lung DiseaseOFEV is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD).Chronic Fibrosing Interstitial Lung Diseases with a Progressive PhenotypeOFEV is indicated in adults for the treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc23b9ca-5582-4c47-bac4-cefe8527b283.json
cc257b5d-5b87-45bb-bd3a-05912f4cda17,LOTAN 12.5,prescription,C09CA01,LOSARTAN,6098,,,WHO ATC Classification,,ILS,tablets,LOSARTAN POTASSIUM 12.5   MG,2025-07-31T04:56:32.941120,IL,אוניפארם,,40.33513996,34.182322,24.9506,,,LOTAN 12.5MG 30TAB,12394,,15981,BLISTER PVC/ALUMINIUM,units,30.0,137 93 31629 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Heart failure: Lotan 12.5  is indicated for the treatment of heart failure, when treatment with an ACE inhibitor is no longer considered appropriate. Switching patients with heart failure who are stable on an ACE inhibitor to Lotan 12.5 mg is not recommended",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc257b5d-5b87-45bb-bd3a-05912f4cda17.json
cc2ffd08-51f1-41d2-b3fc-f129ffd45384,PEMETREXED TEVA ® 100 MG,prescription,L01BA04,PEMETREXED,7904,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,PEMETREXED,2025-07-31T06:33:33.557541,IL,טבע,,4932.985268,4180.49599,3800.4509,,7290106064980,PEMETREXED TEVA ® 500 MG 1 VIAL,16960,,52425,VIAL GLASS TYPE I,units,1.0,156 39 34393 01,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Malignant pleural mesothelioma :Pemetrexed Teva in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Non-small cell lung cancer: Pemetrexed Teva in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. Pemetrexed Teva is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc2ffd08-51f1-41d2-b3fc-f129ffd45384.json
cc3c0505-d1e4-4166-b150-74fa48b9d8fa,ROSUVASTATIN SANDOZ 10 MG,prescription,C10AA07,ROSUVASTATIN,8432,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T07:51:09.804206,IL,סנדוז,,132.9169269,112.6414635,83.7483,,,ROSUVASTATIN SANDOZ 20 MG 30 TAB,18614,,14826,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,162 39 35574 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc3c0505-d1e4-4166-b150-74fa48b9d8fa.json
cc3e941f-5dd4-4c16-a349-873c3d474f06,PREDNISONE 1 MG TABLETS,prescription,H02AB07,PREDNISONE,1983,,,WHO ATC Classification,,ILS,tablets,PREDNISONE,2025-07-31T06:51:41.343887,IL,רקח,,30.93024614,26.212073,19.1329,,7290008089326,PREDNISONE 20MG 30TAB,16196,,9664,SECURITAINER POLYPROPYLENE,units,30.0,118 06 26041 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Anti-inflammatory.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc3e941f-5dd4-4c16-a349-873c3d474f06.json
cc526f38-d2f2-4742-a7b3-a9268c086cf6,CALMANERVIN S ELIXIR,off-the-counter,N05CM09,VALERIAN,3645,,,WHO ATC Classification,,ILS,elixir,"PASSIFLORA LIQ. EXTR./ML, VALERIAN LIQUID EXTRACT/ML",2025-07-31T11:22:35.540855,IL,סם און,,63.8144,54.08,nan,,7290008066044,CALMANERVIN 30TAB,3065,,,BOTTLE HDPE,units,30.0,035 48 25445 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,relief of mild symptoms of mental stress and to aid sleep           .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc526f38-d2f2-4742-a7b3-a9268c086cf6.json
cc555562-35af-46e4-8244-4ba2d0a921b8,FOLIC ACID 5 MG,off-the-counter,B03BB01,FOLIC ACID,5456,,,WHO ATC Classification,,ILS,tablets,FOLIC ACID,2025-07-31T11:56:48.380514,IL,כ.צ.ט,,19.8004,16.78,nan,,,FOLI 5 30 TAB,,,,BLISTER PVC/ALUMINIUM,units,30.0,128 85 21928 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the treatment of megaloblastic anemias caused by folic acid deficiency.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc555562-35af-46e4-8244-4ba2d0a921b8.json
cc7287fe-19d9-49c4-80c6-1dd93f4c561c,OMNIC 0.4MG 30 M.R. CAPS,prescription,,,3727,,,,,ILS,capsule,OMNIC 0.4MG 30 M.R. CAPS,2025-07-31T19:24:46.104412,IL,כ.צ.ט,,41.95222494,35.552733,25.9509,,,OMNIC 0.4MG 30 M.R. CAPS,15117,,17665,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc7287fe-19d9-49c4-80c6-1dd93f4c561c.json
cc788a36-3a1c-47d3-8a93-cf5c72baeb57,METADEX XR 10 MG,prescription,N06BA11,DEXMETHYLPHENIDATE,9223,,,WHO ATC Classification,,ILS,capsules extended release,DEXMETHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:16:22.845820,IL,SK PHARM(KS KIM),,nan,nan,nan,,,METADEX XR 5 MG S.K.100 CAPSULES,,,,BOTTLE HDPE,units,100.0,172 56 37337 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Metadex XR extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc788a36-3a1c-47d3-8a93-cf5c72baeb57.json
cc794584-2744-4c11-9066-45d976695aea,CYRAMZA 10 MG/ML,prescription,L01XC21,RAMUCIRUMAB ,7805,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RAMUCIRUMAB/ML,2025-07-31T01:37:24.174181,IL,אלי לילי,,2326.619597,1971.711611,1678.052435,,7290008139793,CYRAMZA 10 MG/ML VIAL 10ML,10640,,47395,VIAL GLASS TYPE I,units,10.0,156 19 34510 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Gastric cancerCyramza in combination with paclitaxel is indicated for the treatment of adult patients with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum and fluoropyrimidine chemotherapy. Cyramza monotherapy is indicated for the treatment of adult patients with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum or fluoropyrimidine chemotherapy, for whom treatment in combination with paclitaxel is not appropriate.Colorectal cancerCyramza, in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil), is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin and a fluoropyrimidine.Non-small cell lung cancerCyramza in combination with erlotinib is indicated for the first-line treatment of adult patients with metastatic non-small cell lung adenocarcinoma with activating epidermal growth factor receptor (EGFR) mutations.Cyramza in combination with docetaxel is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with disease progression after platinum-based chemotherapy.Hepatocellular carcinomaCyramza monotherapy is indicated for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have a serum alpha fetoprotein (AFP) of &#8805; 400 ng/ml and who have been previously treated with sorafenib.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc794584-2744-4c11-9066-45d976695aea.json
cc7dd79e-a43a-4693-a9b0-c01665432a64,RASAGILINE - TRIMA,prescription,N04BD02,RASAGILINE,7868,,,WHO ATC Classification,,ILS,tablets,RASAGILINE AS MESYLATE,2025-07-31T07:17:01.516449,IL,תרימה,,294.5612318,249.6281625,212.4495,,,RASAGILINE - TRIMA 1MG 30TAB,18551,,42654,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,155 62 34403 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of idiopathic Parkinson's disease (PD) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc7dd79e-a43a-4693-a9b0-c01665432a64.json
cc8b9396-9be4-4ba7-b148-a3697979975d,SIRAN 200 MG EFFERVESCENT TABLETS,29C,R05CB01,ACETYLCYSTEINE,20267,,,WHO ATC Classification,,ILS,tablets effervescent,ACETYLCYSTEINE,2025-07-31T13:42:41.429306,IL,nan,,nan,nan,nan,,7290004448134,ACETYLCYSTEINE FOR INHALATION 20% 3VIAL/10ML,,,,TUBE POLYPROPYLENE,units,3.0,112 05 27057 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Mucolytic in respiratory tract disorders where reduction of sputum viscosity is required.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cc8b9396-9be4-4ba7-b148-a3697979975d.json
ccaaab25-c9c4-4c84-991b-80cadaad9eb5,KATADOLON 100MG 50TAB,29C,,,20096,,,,,,tablet,KATADOLON 100MG,2025-07-31T20:43:19.021335,IL,nan,,,,,,,KATADOLON 100MG 50TAB,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ccaaab25-c9c4-4c84-991b-80cadaad9eb5.json
ccc96679-43de-46b9-a207-b2b674017610,TEMO 100 MG,prescription,L01AX03,TEMOZOLOMIDE,6795,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T09:10:52.821209,IL,פאדאגיס,,1381.639624,1170.881038,996.4945,,7298074050721,TEMO 100 MG 5CAPS,20703,,32099,BOTTLE GLASS TYPE III,units,5.0,145 26 33258 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ccc96679-43de-46b9-a207-b2b674017610.json
ccee6da1-ea6f-404c-8769-7c85b98bd122,GLUCOSE 10 %,prescription,B05CX01,GLUCOSE,9112,,,WHO ATC Classification,,ILS,solution for infusion,GLUCOSE AS MONOHYDRATE,2025-07-31T03:37:14.712750,IL,לפידות,,95.1743928,80.65626867,59.967486,,,GLUCOSE 10 % 500ML 10 BOTTLE,,,42915,BOTTLE POLYETHYLENE,units,10.0,116 96 27991 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Carbohydrate infusion therapy : - hypoglycaemic situations,  - hypertonic dehydration  , - hypertonic electrolyte disturbances. Vehicle solution for supplementary medication.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ccee6da1-ea6f-404c-8769-7c85b98bd122.json
ccef0f0f-bd1c-4ab1-b276-a160d65367e7,CORSODYL DENTAL GEL,off-the-counter,S02AA09,CHLORHEXIDINE,3891,,,WHO ATC Classification,,ILS,gel,CHLORHEXIDINE DIGLUCONATEW/W,2025-07-31T11:26:46.805003,IL,ג.ס.ק,,34.9044,29.58,nan,,7290008102933,CORSODYL DENTAL GEL 1% 50GR,3697,,,TUBE ALUMINIUM,units,50.0,114 62 29571 21,valid,nan,local oral,1.4,36,,,,,,,,,,0,,1. As an aid to maintaining oral hygiene.2. As an aid in the treatment and  prevention of gingivitis.3. Inhibition of formation of dental plaque.4. For use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush).5. For use in a post- periodontal  surgery or treatment regimen to promote gingival healing.6. As an adjunct to fluoride in the prevention of dental caries in high risk patients.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ccef0f0f-bd1c-4ab1-b276-a160d65367e7.json
ccf4e527-8bcc-4878-9bc9-a64e6e496fb9,EASYLAX TABLETS,prescription,A06AB04,PHENOLPHTHALEIN,2007,,,WHO ATC Classification,,ILS,tablets,PHENOLPHTALEIN YELLOW,2025-07-31T02:09:54.675982,IL,סם און,,nan,nan,nan,,7290008066051,EASYLAX 120MG 20TAB,5005,,762,BOTTLE HDPE,units,20.0,035 84 22447 00,valid,nan,per os,1.4,24,,,,,,,,,,0,Prescription required,Laxative.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ccf4e527-8bcc-4878-9bc9-a64e6e496fb9.json
cd0e0caa-0ffa-49e7-91ce-8a7586a29f10,DECAPEPTYL DEPOT 3.75 MG,prescription,L02AE04,TRIPTORELIN,4021,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,TRIPTORELIN AS EMBONATE 3.75  MG  ML,2025-07-31T01:44:34.910011,IL,פרינג,,470.9415618,399.1030362,339.6621585,,4031925098021,DECAPEPTYL DEPOT 3.75MG/2ML VIAL+SOLV,4539,,17581,VIAL GLASS TYPE I,units,1.0,132 28 28860 01,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,- Lowering of sexual hormones and - treatment of advanced hormone-dependent prostate cancer. - Central precocious puberty.- As adjuvant treatment in combination with tamoxifen or an aromatase inhibitor of hormone receptor-positive  early stage breast cancer in women at high risk of recurrence and who are confirmed as pre-menopausal after completion of chemotherapy and in men at high risk of recurrence,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd0e0caa-0ffa-49e7-91ce-8a7586a29f10.json
cd0e4987-ac60-4355-b63a-55bde47f074d,HYPERHEP B S/D,prescription,J06BB04,HEPATITIS B IMMUNOGLOBULIN,8931,,,WHO ATC Classification,,ILS,solution for injection,HEPATITIS B IMMUNOGLOBULIN/ML,2025-07-31T03:53:31.088212,IL,פאדאגיס,,nan,nan,nan,,,HYPERHEP B S/D 1ML,,,,SYRINGE 0.5 ML GLASS TYPE I,units,1.0,127 10 27800 00,valid,nan,i.m,1.4,36,,,,,,,,,,0,Prescription required,"For post-exposure prophylaxis such as: - acute exposure to blood containing HBsAG, - perinatal exposure of infants born to HBsAg-positive mothers, - sexual exposure to HBsAg positive persons, - household exposure to persons with acute HBV infections.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd0e4987-ac60-4355-b63a-55bde47f074d.json
cd160b93-157f-4b26-9432-1d39d9e32869,TAKHZYRO,prescription,B06AC05,LANADELUMAB,9455,,,WHO ATC Classification,,ILS,solution for injection,LANADELUMAB/ML,2025-07-31T09:01:49.232135,IL,טקדה,,64545.33421,54699.43821,49726.76201,,,TAKHZYRO 150MG/ML 1 PFS,,,18907,PRE-FILLED SYRINGE  GLASS TYPE I,units,1.0,163 47 35885 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE)in patients aged 2 years and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd160b93-157f-4b26-9432-1d39d9e32869.json
cd185dc8-aad7-457f-bf28-d6f6acf6c110,DEPALEPT ORAL SOLUTION,prescription,N03AG01,VALPROIC ACID,2314,,,WHO ATC Classification,,ILS,solution  (oral),VALPROIC ACID AS SODIUM/ML,2025-07-31T01:46:58.161990,IL,כ.צ.ט,,26.98678727,22.87015871,16.6935465,,7290008005098,DEPALEPT ORAL SOL 50ML,4043,,595,BOTTLE GLASS TYPE III,units,50.0,116 68 23129 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd185dc8-aad7-457f-bf28-d6f6acf6c110.json
cd2dd4ab-3b2e-4e6d-9fee-694a9253f7ea,CRYSVITA 10 MG,prescription,M05BX05,BUROSUMAB,8296,,,WHO ATC Classification,,ILS,solution for injection,BUROSUMAB/ML,2025-07-31T01:35:19.895828,IL,מדיסון,,39543.90132,33511.78227,30465.25661,,7290015666664,CRYSVITA 30 MG  1 VIAL,10382,,25966,VIAL GLASS TYPE I,units,1.0,164 58 35724 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and paediatric patients 6 months of age and olderTumor-induced OsteomalaciaCRYSVITA is indicated for the treatment of FGF23 - related hypophosphatemia in tumor - induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd2dd4ab-3b2e-4e6d-9fee-694a9253f7ea.json
cd3a703d-8a4d-4777-a049-5da9dfdaf517,ENBREL 25 MG SOLUTION FOR INJECTION,prescription,L04AB01,ETANERCEPT,4638,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ML,2025-07-31T02:20:10.219778,IL,פיזר,,1395.715685,1182.809955,1006.64677,,,ENBREL  25MG/VIAL 4 VIALS,5211,,28907,SYRINGE PREFILLED  GLASS TYPE I,units,4.0,142 52 31949 00,valid,17.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"* Rheumatoid arthritis:- Enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs)  including methotrexate (unless contraindicated)  has been inadequate..   Enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.  - Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.Enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.* Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Enbrel has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.   * Plaque psoriasis Treatment of adults patients (18 years or older) with moderate to severe plaque psoriasis  who  are candidates for systemic therapy or phototherapy.* Paediatric plaque psoriasis Treatment of chronic severe plaque psoriasis in children and adolescents from the age of  6 years  who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.* Juvenile idiopathic arthritis- Treatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. - Treatment of psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.Treatment of enthesitis-related arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, conventional therapy. Enbrel has not been studied in children aged less than 2 years.* Axial spondyloarthritis- Ankylosing spondylitis(AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.- Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to nonsteroidal anti-inflammatory drugs (NSAIDs)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd3a703d-8a4d-4777-a049-5da9dfdaf517.json
cd3e6595-44fa-4922-b87f-819a96427891,SOMAVERT 10 MG,prescription,H01AX01,PEGVISOMANT,8090,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,PEGVISOMANT,2025-07-31T08:30:49.669759,IL,פיזר,,26785.51293,22699.58824,20635.98931,,7290010355631,SOMAVERT 30 MG 	30 VIALS,10136,,64600,VIAL GLASS TYPE I,units,30.0,135 41 31357 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize IGF-I concentrations or was not tolerated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd3e6595-44fa-4922-b87f-819a96427891.json
cd43646a-dc73-434c-a1dc-608230f1de3e,EXELON PATCH 10,prescription,N06DA03,RIVASTIGMINE,4565,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 9.5 MG/DAY,2025-07-31T02:48:12.329244,IL,נוברטיס פארמה,,117.9535894,99.960669,74.3202,,,EXELON 6MG 28CAPS,5202,,30605,POUCH PAPER/PET/PE/AL/POLYAMIDE,units,28.0,139 70 31675 01,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd43646a-dc73-434c-a1dc-608230f1de3e.json
cd45301c-f299-458c-9bb2-b45ff063cf2b,CARDILOC 1.25,prescription,C07AB07,BISOPROLOL,3842,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL HEMIFUMARATE 1.25  MG,2025-07-31T00:54:31.789536,IL,אוניפארם,,19.98877402,16.939639,12.3647,,,CARDILOC 10MG 30TAB,3686,,24787,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,148 63 33513 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function (ejection fraction < 35%, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd45301c-f299-458c-9bb2-b45ff063cf2b.json
cd4ae478-f7cf-4df8-8e84-eb0ded88a470,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4895,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:23:25.476508,IL,מדיסון,,303.1697203,256.9235032,218.6583006,,8715131005863,ARANESP 40MCG PREFILLED PEN 1X0.4ML,9491,,65748,PRE-FILLED PEN GLASS TYPE I,units,1.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd4ae478-f7cf-4df8-8e84-eb0ded88a470.json
cd4f51b2-a3fd-4a7f-85c4-b23e2be910fd,ABIRATERONE MEDOMIE 250 MG,prescription,L02BX03,ABIRATERONE,9410,,,WHO ATC Classification,,ILS,tablets,ABIRATERONE ACETATE,2025-07-30T23:10:16.288342,IL,מדומי פארמה,,17160.87617,14543.1154,13221.014,,,ABIRATERONE MEDOMIE 250 MG 120 TAB,,,16192,BOTTLE HDPE,units,120.0,171 35 37168 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,a CYP17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd4f51b2-a3fd-4a7f-85c4-b23e2be910fd.json
cd59cd1f-c377-447c-8737-d158a9d1b178,XEOMIN 50,prescription,M03AX01,BOTULINUM TOXIN,8427,,,WHO ATC Classification,,ILS,powder for solution for injection,BOTULINUM TOXIN TYPE A 0.2 - 0.4 NG 50 LD50 UNITS / VIAL,2025-07-31T10:33:43.399086,IL,אלפאמדיקיס,,504.0709669,427.1788045,363.5564293,,,XEOMIN 50 1 VIAL,,,3508,VIAL GLASS TYPE I,units,1.0,161 95 35383 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. Xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd59cd1f-c377-447c-8737-d158a9d1b178.json
cd6583e2-dfee-49a8-b17a-baa6c7f67649,ROCURIM,prescription,M03AC09,ROCURONIUM BROMIDE,8143,,,WHO ATC Classification,,ILS,solution for injection,ROCURONIUM BROMIDE/,2025-07-31T07:47:26.076435,IL,אוניפארם,,183.1164563,155.1834375,124.14675,,,ROCURIM 50mg/5ml 10 vials,,,67822,AMPOULES GLASS TYPE I,units,10.0,159 40 34871 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Rocurim is indicated in adult and paediatric patients (from term neonates to adolescents [0 to <18 years]) as an adjunct to general anaesthesia to facilitate tracheal intubation during routine sequence induction and to provide skeletal muscle relaxation during surgery. In adults Rocurim is also indicated to facilitate tracheal intubation during rapid sequence induction and as an adjunct in the intensive care unit (ICU) to facilitate intubation and mechanical ventilation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd6583e2-dfee-49a8-b17a-baa6c7f67649.json
cd65ba2d-c48e-4c4c-9a5e-917b8bd606f5,ALKINDI 0.5 MG,prescription,H02AB09,HYDROCORTISONE,9085,,,WHO ATC Classification,,ILS,granules in capsules for opening,HYDROCORTISONE 0.5  MG,2025-07-30T23:19:38.068654,IL,מדומי פארמה,,208.3923678,176.6037094,141.2829675,,,ALKINDI 0.5 MG 50 CAPSULES,,,83370,BOTTLE HDPE,units,50.0,164 46 35964 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Alkindi is indicated for replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old)", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd65ba2d-c48e-4c4c-9a5e-917b8bd606f5.json
cd6bb1a7-6691-4092-8440-de6c59d3e54c,TECENTRIQ,prescription,,,8103,,,,,ILS,concentrate for solution for infusion,ATEZOLIZUMAB/ML,2025-07-31T09:08:54.846439,IL,רוש,,19172.77439,16248.11461,14771.01328,,7290014774049,TECENTRIQ 1200 MG / 20 ML vial,,,77818,VIAL GLASS TYPE I,units,1.0,158 66 34982 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Urothelial Carcinoma• TECENTRIQ (atezolizumab) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin-containing chemotherapy and whose tumours have a PD-L1 expression &#8805; 5%.• TECENTRIQ is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following any platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant chemotherapy.- Non-Small Cell Lung Cancer •TECENTRIQ, as a single agent, is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (PD-L1 stained &#8805; 50% of tumor cells [TC &#8805; 50%] or PD-L1 stained tumor-infiltrating immune cells [IC] covering &#8805; 10% of the tumor area [IC &#8805; 10%]), as determined by an approved test, with no EGFR or ALK genomic tumor aberrations.•TECENTRIQ, in combination with paclitaxel protein-bound and carboplatin, is indicated for the first-line treatment of adult patients with metastatic non-squamous NSCLC with no EGFR or ALK genomic tumor aberrations.• TECENTRIQ, in combination with bevacizumab, paclitaxel, and carboplatin, is indicated for the first-line treatment of adult patients with metastatic non-squamous non-small cell lung cancer (NSCLC). In patients with EGFR mutant or ALK-positive NSCLC, TECENTRIQ, in combination with bevacizumab, paclitaxel, and carboplatin, is indicated only after failure of appropriate targeted therapies.• TECENTRIQ is indicated for the treatment of patients with metastatic NSCLC who are naïve to anti-PD-L1 or anti-PD-1 therapies and have disease progression during or following platinum-containing chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on approved therapy for NSCLC harboring these aberrations prior to receiving TECENTRIQ.• TECENTRIQ as monotherapy, is indicated as adjuvant treatment following complete resection and no progression after platinum-based adjuvant chemotherapy for adult patients with Stage II to IIIA NSCLC whose tumors have PD-L1 expression on &#8805; 50% of tumor cells (TCs).- Locally Advanced or Metastatic Triple-Negative Breast Cancer Tecentriq, in combination with nab-paclitaxel, is indicated for the treatment of patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) whose tumors have PD-L1 expression &#8805;1% and who have not received prior chemotherapy for metastatic disease.-  Small Cell Lung CancerTECENTRIQ, in combination with carboplatin and etoposide, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).""- Hepatocellular CarcinomaTECENTRIQ, in combination with bevacizumab, is indicated for the treatment of patients with unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy.- MelanomaTECENTRIQ, in combination with cobimetinib and vemurafenib, is indicated for the treatment of patients with BRAF V600 mutation-positive unresectable or metastatic melanoma.- Alveolar Soft Part Sarcoma TECENTRIQ, as a single agent, is indicated for the treatment of adult and pediatric patients 2 years of age and older with unresectable or metastatic alveolar soft part sarcoma (ASPS).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd6bb1a7-6691-4092-8440-de6c59d3e54c.json
cd6d625c-3b01-4d5a-b0f6-ff8c8e4e6bd7,TRELEGY ELLIPTA 184 / 55 / 22 MCG,prescription,R03AL08,"VILANTEROL, UMECLIDINIUM BROMIDE AND FLUTICASONE FUROATE",8257,,,WHO ATC Classification,,ILS,powder for inhalation pre-dispensed,"VILANTEROL AS TRIFENATATE/INH, UMECLIDINIUM AS BROMIDE/INH, FLUTICASONE FUROATE/INH",2025-07-31T09:38:35.822095,IL,ג.ס.ק,,274.572198,232.6883137,198.0326074,,,TRELEGY ELLIPTA 92/55/22 MCG PWDR FOR INH 30DOSES,20860,,20049,PLASTIC INHALER WITH TWO BLISTER STRIP ALUMINIUM,units,30.0,168 61 36629 99,valid,17.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,"AsthmaTrelegy Ellipta 184/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older. Trelegy Ellipta 184/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ICS/LABA.Important Limitations of UseTrelegy Ellipta 184/55/22 mcg is NOT indicated for the relief of acute asthma.Trelegy Ellipta 184/55/22 mcg is not indicated for patients with COPD.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd6d625c-3b01-4d5a-b0f6-ff8c8e4e6bd7.json
cd7c3aa9-41a6-49ae-a670-a5e8b2ecd56b,NORDITROPIN 10 MG,prescription,H01AC01,SOMATROPIN,8086,,,WHO ATC Classification,,ILS,solution for injection,SOMATROPIN 6.667 MG/ML,2025-07-31T05:50:44.181932,IL,נובו נורדיסק,,1092.074287,925.4867254,787.648277,,7290008126878,NORDITROPIN 10 MG/1.5ML NORDIFLEX,14622,,76430,PRE-FILLED PEN GLASS TYPE I,units,1.0,118 74 29921 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,Children: * Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome.* Short stature in children with renal insufficiency.   * Growth disturbance (current height SDS < - 2.5 and parental adjusted height SDS < - 1) in short children born small for gestational age (SGA)  with a birth weight and/or length below - 2 SD  who failed to show catch-up growth (HV SDS < during the last year)  by 4 years of age or later.* Children with short stature associated with Noonan syndrome.Adults: Treatment of adults with Hypothalamic-pituitary disease  resulting from organic disease or  pituitary tumors treated medically  surgically or radiotherapy or patients with childhood onset of G.H. deficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd7c3aa9-41a6-49ae-a670-a5e8b2ecd56b.json
cd8be6b0-e37d-42ff-aa0f-f0b13782ef0c,PRAVALIP 10,prescription,C10AA03,PRAVASTATIN,4482,,,WHO ATC Classification,,ILS,tablets,PRAVASTATIN SODIUM,2025-07-31T06:51:02.545926,IL,טבע,,47.2516014,40.04373,29.229,,,PRAVASTATIN-TEVA 40MG 30TAB,16422,,29737,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,132 80 31134 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . Pravastatin should be used in addition to a diet  and other nonpharmacological measures alone has been inadequate.    Primary prevention of coronary events: In hypercholesterolemic patients wihthout clinically evident coronary heart disease  pravastatin is indicated to:   1) Reduce the risk of myocardial infarcton.   2) Reduce the risk for revascularization.   3) Reduce the risk of deaths due to cardiovascular causes with no increase in death non-cardiovascular causes.   Secondary prevention of cardiovascular events:    a) Atherosclerosis: In hypercholesterolemic patients with clinically evident coronary artery disease  including prior MI  pravastatin  is indicated to:      1)Slow the progression of coronary atherosclerosis.      2) Reduce the risk of acute coronary events.     b) Myocardial infarction: in patients with previous myocardial infarction  and normal cholesterol levels. Pravastatin is indicated to:      1) Reduce the risk of recurrent myocardial infarction.       2)Reduce the risk of undergoing myocardial revascularization procedures.       3) Reduce the risk of stroke or transient ischemic attack (TIA).     c) Hypercholesterolemia and mixed dyslipidemia: Pravastatin is indicated as an adjunct to diet to reduce elevated Total-C  LDL-C and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Frederickson Type IIa and IIb).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd8be6b0-e37d-42ff-aa0f-f0b13782ef0c.json
cd97c57a-6dfb-4f4b-bcc4-b4f2159446c6,ELTROXIN TABLETS 50 MCG,prescription,H03AA01,LEVOTHYROXINE SODIUM,2458,,,WHO ATC Classification,,ILS,tablets,LEVOTHYROXINE SODIUM 0.05   MG,2025-07-31T02:17:17.047520,IL,פאדאגיס,,24.71732902,20.946889,15.2897,,7298074011104,ELTROXIN 50MCG 100T,5664,,14585,BOTTLE POLYPROPYLENE,units,100.0,055 82 20571 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of hypothyroidism. Cretinism and juvenile myxoedema.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd97c57a-6dfb-4f4b-bcc4-b4f2159446c6.json
cd9f1f28-aaf9-46f8-a75d-677cb6298654,MENTAX CREAM,prescription,D01AE23,BUTENAFINE,4281,,,WHO ATC Classification,,ILS,cream,BUTENAFINE HYDROCHLORIDE,2025-07-31T05:11:51.241107,IL,פאדאגיס,,nan,nan,nan,,7290004850098,MENTAX CREAM 1% 10GR,13252,,33372,TUBE ALUMINIUM,units,10.0,110 63 28947 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Interdigital tinea pedis, tinea coporis, tinea cruris . (Treatment in tinea coporis and tinea cruris is limited to up to 4 weeks).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cd9f1f28-aaf9-46f8-a75d-677cb6298654.json
cdac4746-060c-411e-bfe9-718a660021fe,TYVASO,prescription,B01AC21,TREPROSTINIL,8742,,,WHO ATC Classification,,ILS,solution for inhalation,TREPROSTINIL AS SODIUM SALT 1.74  MG / 2.9  ML,2025-07-31T09:50:18.196982,IL,רפא,,nan,nan,nan,,7290008016179,TYVASO 1.74 MG/ 2.9 ML 28 AMP,,,79161,AMPOULES LDPE,units,28.0,144 71 33077 01,valid,nan,inhalation,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of pulmonary arterial hypertension in patients with NYHA class III symptoms, to increase walk distance.Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cdac4746-060c-411e-bfe9-718a660021fe.json
cdc4e9bd-f2d4-41e3-87c3-53f630cd4665,FLUCONAZOLE MBI 2 MG/ ML,prescription,J02AC01,FLUCONAZOLE,9128,,,WHO ATC Classification,,ILS,solution for infusion,FLUCONAZOLE/,2025-07-31T03:11:43.769644,IL,אמ.בי.איי פארמה,,5654.088,4791.6,4356.0,,,FLUCONAZOLE MBI 2 MG/ ML 200ML 50 BAG,,,84873,BAG PVC,units,10000.0,161 92 35274 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections (see section 5.1). Fluconazole is indicated in adults for the treatment of:•	Cryptococcal meningitis (see section 4.4).•	Coccidioidomycosis (see section 4.4).•	Invasive candidiasis.•	Mucosal candidiasis (including oropharyngeal candidiasis, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis).•	Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.Fluconazole is indicated in adults for the prophylaxis of:•	Relapse of cryptococcal meningitis in patients with high risk of recurrence.•	Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•	Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Haematopoetic Stem Cell Transplantation (see section 5.1)).Fluconazole is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence (see section 4.4).Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cdc4e9bd-f2d4-41e3-87c3-53f630cd4665.json
cdd18882-5ef5-49df-bd4c-3ec35343c89a,ABECMA,prescription,L01XL07,IDECABTAGENE VICLEUCEL,9546,,,WHO ATC Classification,,ILS,dispersion for infusion,IDECABTAGENE VICLEUCEL,2025-07-30T23:00:40.202184,IL,ב.מ.ס,,1569759.536,1330304.751,1209367.955,,,ABECMA 1 BAG,,,,BAG ETHYLENE VINYL ACETATE (EVA),units,1.0,171 53 37039 00,valid,10.0,i.v,1.4,12,,,,,,,,,,0,Prescription required,"Abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody and have demonstrated disease progression on the last therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cdd18882-5ef5-49df-bd4c-3ec35343c89a.json
cde97b67-a827-41dd-9c6b-6c44db283508,CRUSIA,prescription,B01AB05,ENOXAPARIN,8443,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/,2025-07-31T01:34:48.425645,IL,צמל,,58.98382271,49.98629265,36.486345,,,CRUSIA 80MG/0.8ML 2 SYR,10627,,55141,SYRINGE 0.5 ML GLASS TYPE I,units,2.0,162 88 35673 00,valid,37.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Crusia is indicated in adults for:•Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery.•Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism.•Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE ikely to require thrombolytic therapy or surgery. Prevention of thrombus formation in extra corporeal circulation during haemodialysis.•Acute coronary syndrome:-Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid.-Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cde97b67-a827-41dd-9c6b-6c44db283508.json
cdf5b66b-0237-4661-94be-54c3055ceebb,CIBINQO 100 MG,prescription,D11AH08,ABROCITINIB,9205,,,WHO ATC Classification,,ILS,film coated tablets,ABROCITINIB,2025-07-31T01:10:56.361086,IL,פיזר,,5195.618546,4403.06676,4002.787964,,,CIBINQO 100 MG  28 F.C.T,,,46907,BLISTER PVC/ALUMINIUM,units,28.0,171 31 37239 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cdf5b66b-0237-4661-94be-54c3055ceebb.json
ce086e7d-876b-4c4c-89c9-3f1ec789d3fe,KEPPRA 1000 MG,prescription,N03AX14,LEVETIRACETAM,4847,,,WHO ATC Classification,,ILS,film coated tablets,LEVETIRACETAM,2025-07-31T04:24:29.839139,IL,כ.צ.ט,,91.57201967,77.6034065,57.6977,,,KEPPRA 250MG 60TAB,11203,,69504,BLISTER PVC/ALUMINIUM,units,60.0,132 66 31183 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,- Keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce086e7d-876b-4c4c-89c9-3f1ec789d3fe.json
ce1215e8-0e83-4f3d-ad8a-26956d39f7bc,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,7610,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T00:04:47.588484,IL,ניאופרם,,663.9244957,562.6478777,478.8492576,,,ABSTRAL 800MCG 30 TAB SUBLINGUAL,9794,,62430,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,30.0,148 73 33262 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce1215e8-0e83-4f3d-ad8a-26956d39f7bc.json
ce349cfa-aa63-4e1a-a0dc-bb25cad28afa,PHENYLEPHRINE SINTETICA 0.1 MG/ML,prescription,C01CA06,PHENYLEPHRINE,8754,,,WHO ATC Classification,,ILS,solution for infusion,PHENYLEPHRINE HYDROCHLORIDE 0.1  MG /,2025-07-31T06:41:29.317726,IL,כ.צ.ט,,702.1829091,595.0702619,506.4427761,,,PHENYLEPHRINE SINTETICA 10 MG/ML 10 AMP,,,,AMPOULES GLASS TYPE I,units,10.0,177 43 37116 99,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of hypotensive states, e.g. septic shock, circulatory failure, during spinal anaesthesia or drug-induced hypotension.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce349cfa-aa63-4e1a-a0dc-bb25cad28afa.json
ce485c0b-3ad8-4593-9327-e7671ff5af55,ESOPRIM CONTROL 20 MG,off-the-counter,A02BC05,ESOMEPRAZOLE,5604,,,WHO ATC Classification,,ILS,"capsule, hard",ESOMEPRAZOLE AS SODIUM,2025-07-31T11:35:11.169772,IL,SK PHARM(KS KIM),,40.238,34.1,nan,,,ESOPRIM CONTROL 20 MG 14 CAPS,,,,BLISTER ALUMINIUM /ALUMINIUM,units,14.0,164 75 36169 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Esoprim Control 20mg is indicated for the short-term treatment of reflux symptoms (e.g. heartburn and  Acid regurgitation) in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce485c0b-3ad8-4593-9327-e7671ff5af55.json
ce50f16a-1284-409a-9fec-94e4a692e2fc,DEPO MEDROL 40 MG/ML,prescription,H02AB04,METHYLPREDNISOLONE,84,,,WHO ATC Classification,,ILS,suspension for injection,METHYLPREDNISOLONE ACETATE/ML,2025-07-31T05:08:11.616384,IL,פיזר,,12.32770769,10.44721037,7.625701,,72982006,MEDROL 4MG 30TAB,13061,,1089,VIAL GLASS TYPE I,units,30.0,024 49 21841 00,valid,37.0,"periarticular, i.m, intra-articular, intra-lesional, intrabursal, intrarectal instillation, soft tissues",1.4,60,,,,,,,,,,0,Prescription required,For the treatment of conditions responsive to steroid injection therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce50f16a-1284-409a-9fec-94e4a692e2fc.json
ce531a31-52c1-4843-a6b9-70275e39ea5d,FAMOTIDINE TEVA ® 20 MG,off-the-counter,A02BA03,FAMOTIDINE,5277,,,WHO ATC Classification,,ILS,tablets,FAMOTIDINE,2025-07-31T11:53:02.989398,IL,טבע,,28.2846,23.97,nan,,,FAMOTIDINE TEVA 20MG 30TAB,6132,,,BLISTER PVC/ALUMINIUM,units,30.0,111 66 29371 12,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce531a31-52c1-4843-a6b9-70275e39ea5d.json
ce57cdc5-9ffd-4ac4-9f19-3fd139c800b3,AKEEGA 100/500,prescription,L01XX54,NIRAPARIB,9462,,,WHO ATC Classification,,ILS,film coated tablets,"ABIRATERONE ACETATE, NIRAPARIB AS TOSYLATE MONOHYDRATE",2025-07-30T23:17:46.965750,IL,יאנסן סילג,,26541.13163,22492.48544,20447.71403,,,AKEEGA 50/500 56 TAB,,,,BLISTER PVDC/PE/PVC/AL,units,56.0,175 83 37789 99,valid,10.0,per os,1.4,30,,,,,,,,,,0,Prescription required,Akeega is indicated with prednisone or prednisolone for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC) and BRCA 1/2 mutations (germline and/or somatic) in whom chemotherapy is not clinically indicated.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce57cdc5-9ffd-4ac4-9f19-3fd139c800b3.json
ce65ecfb-4336-4636-ac10-09585f576e53,KYPROLIS,prescription,L01XX45,CARFILZOMIB,7400,,,WHO ATC Classification,,ILS,powder for solution for injection,CARFILZOMIB/ML,2025-07-31T04:31:11.117925,IL,מדיסון,,5443.32946,4612.991273,4193.62843,,7290008128391,KYPROLIS 60MG/VIAL,11251,,50848,VIAL GLASS TYPE I,units,1.0,151 21 33948 01,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Kyprolis is indicated: - for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy in combination with:      •	Lenalidomide and dexamethasone; or      •	Dexamethasone; or      •	Daratumumab (I.V or S.C) and dexamethasone.- as a single agent for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy. Approval is based on response rate. Clinical benefit, such as improvement in survival or symptoms, has not been verified.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce65ecfb-4336-4636-ac10-09585f576e53.json
ce70c108-b8b9-4933-a209-15a44240d4d7,HISTADEX,off-the-counter,R01BA52,"PSEUDOEPHEDRINE, COMBINATIONS",2882,,,WHO ATC Classification,,ILS,syrup,"DEXCHLORPHENIRAMINE MALEATE/, PSEUDOEPHEDRINE HYDROCHLORIDE/",2025-07-31T12:04:11.057255,IL,ויטאמד,,28.7684,24.38,nan,,,HISTADEX 115ML,8047,,,BOTTLE HDPE,units,115.0,063 16 28042 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of congestion in the respiratory tract due to allergy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce70c108-b8b9-4933-a209-15a44240d4d7.json
ce73c62f-38c2-4260-be38-17d4ea828424,GRISEOFULVIN ORAL SUSP 120ML,29C,,,20086,,,,,,tablet,GRISEOFULVIN ORAL SUSP,2025-07-31T20:33:05.712652,IL,nan,,,,,,,GRISEOFULVIN ORAL SUSP 120ML,,,,,units,120.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce73c62f-38c2-4260-be38-17d4ea828424.json
ce8f0298-b801-46bd-b9bd-b6de4ee47e6c,SOLODENT ALCOHOL FREE MOUTHWASH,off-the-counter,A01AB03,CHLORHEXIDINE,5630,,,WHO ATC Classification,,ILS,solution,CHLORHEXIDINE GLUCONATE 0.2 %W/V,2025-07-31T13:19:15.418498,IL,סופר-פארם,,27.0338,22.91,nan,,,SOLODENT ALCOHOL FREE MOUTHWASH  300ML,,,,BOTTLE PET,units,300.0,172 54 37476 99,valid,nan,local oral,1.4,24,,,,,,,,,,0,,"Antibacterial solution for the disinfection of the mouth:1) As an aid to maintaining oral hygiene. 2) As an aid in the treatment and prevention of gingivitis. 3) Inhibition of formation of dental plaque. 4) For use in aphtous ulceration and oral candidal infections (e.g., denture stomatitis and thrush). 5) For use in a post- periodontal surgery or treatment regimen to promote gingival healing.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce8f0298-b801-46bd-b9bd-b6de4ee47e6c.json
ce8f9a6b-2d30-41a8-a028-99788615133e,ZEPOSIA 0.23 MG,prescription,L04AA38,OZANIMOD,8799,,,WHO ATC Classification,,ILS,capsules,OZANIMOD AS HYDROCHLORIDE 0.23  MG,2025-07-31T10:47:03.802887,IL,ב.מ.ס,,nan,nan,nan,,7290014396159,ZEPOSIA 0.46 MG 3 CAPS,,,,BLISTER PVC/PCTFE/AL,units,3.0,167 33 36599 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Zeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease as defined by clinical or imaging features.ZEPOSIA is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ce8f9a6b-2d30-41a8-a028-99788615133e.json
cef617bf-96dc-4ae6-90c4-41c4d5a4f56d,SUXAMETHONIUM CHLORID VUAB 100 MG,prescription,M03AB01,SUXAMETHONIUM,8996,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,SUXAMETHONIUM CHLORIDE,2025-07-31T08:53:46.113512,IL,מרגלית,,37.73433146,31.97824842,23.34178717,,8594159933569,SUXAMETHONIUM CHLORID VUAB 100 MG,,,68394,VIAL GLASS TYPE II,units,1.0,166 27 35120 00,valid,37.0,"intraosseous, intralingual, i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Suxamethonium chlorid VUAB is used as a muscle relaxant during general anesthesia.It is used as a muscle relaxant to facilitate endotracheal intubation, particularly rapid intubation, for mechanical ventilation and for a wide range of surgical and obstetric procedures. It is also used in severe laryngospasm and to reduce the intensity of muscular contractions associated with pharmacologically or electrically induced convulsions.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cef617bf-96dc-4ae6-90c4-41c4d5a4f56d.json
cf1ef6ce-43a6-4851-a5cd-b91f1871fd20,RYBELSUS 14 MG,prescription,A10BJ06,SEMAGLUTIDE,8788,,,WHO ATC Classification,,ILS,tablets,SEMAGLUTIDE,2025-07-31T07:55:05.360800,IL,נובו נורדיסק,,507.0941789,429.7408487,365.7368925,,,RYBELSUS14 MG 30 TAB,18635,,69367,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,166 74 36541 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in combination with other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cf1ef6ce-43a6-4851-a5cd-b91f1871fd20.json
cf369a5f-9503-4c78-bf71-b89f03555bc2,PHENIDIN 18 MG,prescription,N06BA04,METHYLPHENIDATE,8339,,,WHO ATC Classification,,ILS,tablets prolonged release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T06:39:56.907664,IL,תרימה,,160.12128,135.696,108.5568,,,PHENIDIN 27 MG 30SR TAB,10594,,51714,BOTTLE HDPE,units,30.0,161 08 35114 00,valid,25.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cf369a5f-9503-4c78-bf71-b89f03555bc2.json
cf373b1d-8924-4fa6-8bf9-1be1b9559bf5,CLOBETASOL PROPIONATE - TRIMA CREAM,prescription,D07AD01,CLOBETASOL,7479,,,WHO ATC Classification,,ILS,cream,CLOBETASOL PROPIONATE 0.05 %W/W,2025-07-31T01:20:52.990346,IL,תרימה,,16.4448635,13.936325,10.1725,,7290000843469,CLOBETASOL PROPIONATE TRIMA CREAM 25G,9747,,53865,TUBE ALUMINIUM,units,25.0,150 92 33656 00,valid,37.0,dermal,1.4,24,,,,,,,,,,0,Prescription required,"Clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids.These include the following:- Psoriasis (excluding widespread plaque psoriasis)- Recalcitrant dermatoses- Lichen planus- Discoid lupus erythematosus- Other skin conditions which do not respond satisfactorily to less potent steroids.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cf373b1d-8924-4fa6-8bf9-1be1b9559bf5.json
cf3eaaec-bd08-49f9-b6b9-c20304155d19,PHENOBARBITONE REKAH 100 MG,prescription,N03AA02,PHENOBARBITAL,1955,,,WHO ATC Classification,,ILS,tablets,PHENOBARBITAL,2025-07-31T06:40:44.685786,IL,רקח,,20.33472642,17.232819,12.5787,,7290008089319,PHENOBARBITONE 100MG 30TAB,16130,,7045,BLISTER PVC/ALUMINIUM,units,30.0,028 67 21938 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sedative, hypnotic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cf3eaaec-bd08-49f9-b6b9-c20304155d19.json
cf402054-224a-45dd-a98d-0417533c22df,ADIZEM CD 180,prescription,,,3496,,,,,ILS,capsules controlled release,DILTIAZEM HYDROCHLORIDE,2025-07-31T00:08:51.539568,IL,רפא,,32.54643165,27.58172297,20.1326445,,7290008013475,ADIZEM CD 120MG 30CAP,1079,,53940,BLISTER PVC/ALUMINIUM,units,30.0,102 96 27681 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Calcium channel blocker that is indicated for the treatment of hypertension and angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cf402054-224a-45dd-a98d-0417533c22df.json
cf5104a0-58a0-4f3f-bc4c-f05e141edad3,LAMODEX 100 MG DISPERSIBLE/CHEWABLE TABLETS,prescription,N03AX09,LAMOTRIGINE,4718,,,WHO ATC Classification,,ILS,dispersible/chewable tablets,LAMOTRIGINE,2025-07-31T04:34:07.658898,IL,דקסל פארמה,,13.6424874,11.56143,8.439,,,LAMODEX 5MG 30DISP/CHEW TAB,12308,,60140,BLISTER ACLAR/PVC/ALUMINIUM,units,30.0,129 88 30814 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy • Adults and adolescents aged 13 years and above:   - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.   - Seizures associated with Lennox-Gastaut syndrome. Lamodex is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome. • Children and adolescents aged 2 to 12 years:   - Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.   - Monotherapy of typical absence seizures.Bipolar disorder • Adults aged 18 years and above   - Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamodex is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cf5104a0-58a0-4f3f-bc4c-f05e141edad3.json
cf741862-7292-4a4b-9b9c-5605eaa0d414,NOVONORM 0.5 MG,prescription,A10BX02,REPAGLINIDE,3808,,,WHO ATC Classification,,ILS,tablets,REPAGLINIDE 0.5  MG,2025-07-31T05:54:53.973148,IL,נובו נורדיסק,,29.80169768,25.255676,18.4348,,,NOVONORM 0.5MG 90TAB,14215,,20252,BLISTER ALUMINIUM,units,90.0,114 47 29661 12,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Repaglinide is indicated in adults with type 2 diabetes mellitus whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Repaglinide is also indicated in combination with metformin in adults with type 2diabetes mellitus who are not satisfactorily controlled on metformin alone.Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cf741862-7292-4a4b-9b9c-5605eaa0d414.json
cfb7bc4a-0c81-4de3-a1e5-fc338b02f93b,DIPROSPAN INJECTION,prescription,H02AB01,BETAMETHASONE,1252,,,WHO ATC Classification,,ILS,suspension for injection,"BETAMETHASONE SODIUM PHOSPHATE/ML, BETAMETHASONE AS DIPROPIONATE/ML",2025-07-31T01:59:22.048485,IL,אורגנון,,22.93028986,19.4324499,14.18427,,,DIPROSPAN 1AMPX1ML,4137,,702,AMPOULES GLASS TYPE I,units,1.0,047 07 24139 00,valid,37.0,"i.m, intradermal, intra-articular, intrabursal, periarticular, soft tissue injection, intralesional",1.4,24,,,,,,,,,,0,Prescription required,"Produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cfb7bc4a-0c81-4de3-a1e5-fc338b02f93b.json
cfd1be99-6481-4185-8a15-c36ee4488d5c,MIDAZOLAM KALCEKS 1 MG/ML,prescription,N05CD08,MIDAZOLAM,8910,,,WHO ATC Classification,,ILS,solution for injection / infusion,MIDAZOLAM/,2025-07-31T05:21:31.512056,IL,מדי מרקט,,31.394372,26.6054,19.42,,,MIDAZOLAM KALCEKS 5 MG/ML 1ML X 10AMP,,,71511,AMPOULES GLASS TYPE I,units,10.0,171 77 37234 99,valid,37.0,"i.m, i.v",1.4,24,,,,,,,,,,0,Prescription required,Midazolam is a short-acting sleep-inducing drug that is indicated: In adults * CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia * ANAESTHESIA* Premedication before induction of anaesthesia* Induction of anaesthesia* As a sedative component in combined anaesthesia * SEDATION IN INTENSIVE CARE UNITSIn children * CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia * ANAESTHESIA* Premedication before induction of anaesthesia * SEDATION IN INTENSIVE CARE UNITS,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cfd1be99-6481-4185-8a15-c36ee4488d5c.json
cffed0c1-40fb-4317-af0d-68506d21d37a,GLYCERINE 2.35GR 20 SUP ADULT,off-the-counter,,,2019,,,,,ILS,tablet,GLYCERINE 2.35GR 20 SUP ADULT,2025-07-31T19:42:53.693269,IL,סם און,,20.1662,17.09,,,,GLYCERINE 2.35GR 20 SUP ADULT,7181,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/cffed0c1-40fb-4317-af0d-68506d21d37a.json
d00e9ff6-375a-4d4a-9b94-991ceb7a9542,SIMVAXON 10,prescription,C10AA01,SIMVASTATIN,6180,,,WHO ATC Classification,,ILS,caplets,SIMVASTATIN,2025-07-31T08:16:27.114083,IL,דקסל פארמה,,23.56533986,19.970627,14.5771,,,SIMVAXON 20MG 30TAB,19846,,86335,BLISTER ACLAR COATED PVC/ALUMINIUM,units,30.0,132 83 31147 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Coronary Heart Disease :   In patients with coronary heart disease and hypercholesterolemia  Simvaxon is indicated to:    - Reduce the risk of total mortality by reducing coronary death    - Reduce the risk of non-fatal myocardial infarction    - Reduce the risk for undergoing myocardial revascularization procedures    - Reduce the risk of stroke and transient ischemic attacks (TIA's).   Hyperlipidemia:   Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb)  Simvaxon therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia:   Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia):   Simvaxon is indicated for the treatment of patients with hypertriglyceridemia (Fredrickson type IV hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia):  Simvaxon is indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d00e9ff6-375a-4d4a-9b94-991ceb7a9542.json
d0140243-a336-42eb-a6ff-b0284e8fdcdc,IODIFLOR OINTMENT,off-the-counter,D08AG03,IODINE,5531,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:10:59.922111,IL,פלוריש,,37.3116,31.62,nan,,7290006411907,IODIFLOR OINTMENT 250MG,,,,BOTTLE HDPE,units,250.0,141 02 31802 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"For the disinfection of skin infections and inflammations, wounds and superficial burns.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0140243-a336-42eb-a6ff-b0284e8fdcdc.json
d028e460-f552-4cd4-bab6-940e2b1b2a95,MELIANE ®,prescription,G03AA10,GESTODENE AND ESTROGEN,4109,,,WHO ATC Classification,,ILS,coated tablets,"GESTODENE 0.075   MG, ETHINYLESTRADIOL 0.020   MG",2025-07-31T05:09:35.093722,IL,באייר,,67.81852881,57.4733295,42.7311,,7298074040029,MELIANE 3X21TAB,13250,,85171,BLISTER PVC/ALUMINIUM,units,63.0,109 12 29094 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d028e460-f552-4cd4-bab6-940e2b1b2a95.json
d0324985-a9a1-44b9-be5d-1942f796112c,TIGECYCLINE S.K.,prescription,J01AA12,TIGECYCLINE,9561,,,WHO ATC Classification,,ILS,powder for solution for infusion,TIGECYCLINE/VIAL,2025-07-31T09:20:30.559667,IL,SK PHARM(KS KIM),,1535.509308,1301.279132,1107.471602,,,TIGECYCLINE S.K. 50MG/VIAL,,,,VIAL GLASS TYPE I,units,10.0,176 70 36901 99,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"TIGECYCLINE S.K. is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:Complicated Skin and Skin Structure Infections:Complicated skin and skin structure infections caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates ), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Streptococcus pyogenes, Enterobacter cloacae, Klebsiella pneumoniae, and Bacteroides fragilis .Complicated Intra-abdominal Infections: Complicated intra-abdominal infections caused by Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Bacteroides fragilis, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, Clostridium perfringens, and Peptostreptococcus micros.Community-Acquired Bacterial Pneumonia: Community-acquired bacterial pneumonia caused by Streptococcus pneumoniae (penicillin susceptible isolates), including cases with concurrent bacteremia, Haemophilus influenzae (beta-lactamase negative isolates), and Legionella pneumophila.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0324985-a9a1-44b9-be5d-1942f796112c.json
d037244c-3727-4bff-b07f-ca57744dcf8c,GASTRO 10,prescription,A02BA03,FAMOTIDINE,3630,,,WHO ATC Classification,,ILS,tablets,FAMOTIDINE,2025-07-31T02:52:42.284488,IL,טבע,,49.0096539,41.533605,30.3165,,,FAMOTIDINE-T 40MG 30TAB,6133,,35693,BLISTER PVC/ALUMINIUM,units,30.0,107 36 28578 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d037244c-3727-4bff-b07f-ca57744dcf8c.json
d0410078-0073-4641-83c4-ab9e1e948533,OXOPURIN 400,prescription,C04AD03,PENTOXIFYLLINE,1778,,,WHO ATC Classification,,ILS,caplets prolonged release,PENTOXIFYLLINE,2025-07-31T06:21:14.702052,IL,דקסל פארמה,,45.18623324,38.293418,27.9514,,7290000806655,OXOPURIN 400MG 50SR CAPLETS,15089,,2570,BLISTER PVC/ALUMINIUM,units,50.0,011 41 23858 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the improvement of blood flow in the peripheral blood vessels.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0410078-0073-4641-83c4-ab9e1e948533.json
d043f426-cee5-41ce-a5a5-a6e3aa78d8c8,TRAMADEX OD 100,prescription,N02AX02,TRAMADOL,3218,,,WHO ATC Classification,,ILS,tablets prolonged release,TRAMADOL HYDROCHLORIDE,2025-07-31T09:30:48.369256,IL,דקסל פארמה,,nan,nan,nan,,,TRAMADEX 100MG 10TAB,20137,,47622,BLISTER PVC/PE/PCTFE/AL,units,10.0,139 25 31580 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d043f426-cee5-41ce-a5a5-a6e3aa78d8c8.json
d0572a2a-fb83-425f-aed5-5dd83fc9a382,OPTIVATE 1000 I.U,prescription,B02BD06,VON WILLEBRAND FACTOR AND COAGULA-TION FACTOR VIII IN COMBINATION,6890,,,WHO ATC Classification,,ILS,powder for solution for injection,"FACTOR VIII/VIAL, VON WILLEBRAND FACTOR/VIAL",2025-07-31T06:14:54.117221,IL,קמהדע,,4686.364083,3971.495162,3610.450148,,7290011225384,OPTIVATE 1000 I.U 1VIAL/10ML,15355,,78316,VIAL GLASS TYPE I,units,1.0,140 03 31687 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding with haemophilia A (congenital factor VIII deficiency).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0572a2a-fb83-425f-aed5-5dd83fc9a382.json
d05ea8b4-fd3b-4c3c-a58c-0c6c0102516a,TEMODAL 100 MG,prescription,L01AX03,TEMOZOLOMIDE,4196,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T09:12:13.601976,IL,מ.ס.ד. ישראל,,91.10303162,77.205959,57.4022,,7290008121972,TEMODAL 5MG 5CAP,20751,,38958,SACHET POLYETHYLENE,units,5.0,120 30 30116 23,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d05ea8b4-fd3b-4c3c-a58c-0c6c0102516a.json
d0601cd2-7537-4e92-8377-a12d8132198f,ETOPOSIDE TEVA,prescription,L01CB01,ETOPOSIDE,7563,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ETOPOSIDE/ML,2025-07-31T02:40:14.747871,IL,טבע,,311.8084599,264.2444575,224.8889,,7290106061774,ETOPOSIDE 20MG/ML 50ML (1000MG),5589,,75921,VIAL GLASS TYPE I,units,50.0,106 48 28897 05,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Hodgkin's disease. Malignant (non-Hodgkin's) Lymphomas, especially of the Histiocytic variety.Acute Non-Lymphocytic leukemia.  Management of refractory testicular tumors and of small cell lung cancer.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0601cd2-7537-4e92-8377-a12d8132198f.json
d06dc7b4-129b-4a1c-99f7-35ecb6f87bf0,ACTEMRA 162 MG S.C.,prescription,L04AC07,TOCILIZUMAB,6416,,,WHO ATC Classification,,ILS,solution for injection,TOCILIZUMAB/ 0.9  ML,2025-07-31T00:06:31.284205,IL,רוש,,1469.066683,1244.971821,1059.550486,,,ACTEMRA 20MG/ML 1X10ML(200MG) CONC. FOR SOLUTION FOR INF.,9340,,84077,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,153 15 34111 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"- Actemra in combination with methotrexate (MTX) is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease modifying anti rheumatic drugs (DMARDs) or tumor necrosis factor (TNF) antagonists. In these patients, Actemra can be given as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate. - Actemra has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function when given in combination with methotrexate. - Actemra in combination with methotrexate (MTX) in indicated for the treatment of severe, active and progressive rheumatoid arthritis (RA) in adults not previously treated with MTX - Actemra (tocilizumab) is indicated for the treatment of giant cell arteritis (GCA) in adult patients.  - Actemra in combination with methotrexate (MTX) is indicated for the treatment of juvenile idiopathic polyarthritis (pJIA; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with MTX. Actemra can be given as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate. - Actemra is indicated for the treatment of active systemic juvenile idiopathic arthritis (sJIA) in patients 1 year of age and older, who have responded inadequately to previous therapy with NSAIDs and systemic corticosteroids. Actemra can be given as monotherapy (in case of intolerance to MTX or where treatment with MTX is inappropriate) or in combination with MTX.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d06dc7b4-129b-4a1c-99f7-35ecb6f87bf0.json
d071941f-7c65-4417-b7c7-dda5cb34241d,ACTIVELLE,prescription,G03AA05,NORETHISTERONE AND ESTROGEN,3811,,,WHO ATC Classification,,ILS,film coated tablets,"ESTRADIOL AS HEMIHYDRATE, NORETHISTERONE ACETATE 0.5   MG",2025-07-30T23:13:28.971781,IL,נובו נורדיסק,,39.56835503,33.53250576,24.47628157,,7290008126403,ACTIVELLE 28TAB,1599,,20255,DISPENSER PACK POLYPROPYLENE,units,28.0,114 30 29629 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in women more than one year after menopause. Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of , or contraindicated for, other medicinal products approved for the prevention of osteoporosis.The experience treating women older than 65 years is limited.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d071941f-7c65-4417-b7c7-dda5cb34241d.json
d0841bc9-c87c-4c12-8620-eb6796be2c76,TADAIR,prescription,G04BE08,TADALAFIL,8022,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T19:33:51.250074,IL,אוניפארם,,2921.459352,2475.81301,2250.7391,,,TADAIR 56 TAB,20822,,62104,BLISTER PVC/ALUMINIUM,units,56.0,157 90 35176 01,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Tadair is indicated in adults for the treatment of pulmonary arterial hypertension (PAH) classified as WHO functional class II and III, to improve exercise capacity. Efficacy has been shown in idiopathic PAH (IPAH) and in PAH related to collagen vascular disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0841bc9-c87c-4c12-8620-eb6796be2c76.json
d09282fe-582d-49ed-8285-b4634ba8799e,ZEMPLAR 1 MICROGRAM,prescription,H05BX02,PARICALCITOL,6302,,,WHO ATC Classification,,ILS,"capsule, soft",PARICALCITOL,2025-07-31T10:46:06.449010,IL,אב-וי,,548.573604,464.8929054,395.6535365,,,ZEMPLAR 5MCG/ML 5AMPX2ML,,,,BLISTER PVC/PVDC/ALUMINIUM,units,5.0,141 12 31816 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d09282fe-582d-49ed-8285-b4634ba8799e.json
d093c7a7-7444-4333-8a27-f9e0ee64f1cd,PROQUAD,prescription,J07BD54,"MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED",7893,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,"MEASLES VIRUS ENDERS EDMONSTON STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED)",2025-07-31T07:03:15.255239,IL,מ.ס.ד. ישראל,,421.4102399,357.1273378,303.9381599,,7290006813831,PROQUAD 1 vial,16958,,47562,VIAL 3 ML GLASS TYPE I,units,1.0,154 72 34392 00,valid,17.5,"s.c, i.m",1.4,18,,,,,,,,,,0,Prescription required,"ProQuad is indicated for simultaneous vaccination against measles, mumps, rubella, and varicella in individuals from 12 months of age to 12 years of age.ProQuad can be administered to individuals from 9 months of age under special circumstances: outbreak situations, or travel to a region with high prevalence of measles.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d093c7a7-7444-4333-8a27-f9e0ee64f1cd.json
d0a55269-e3eb-4de9-b812-f1ea525dfcd4,PREVYMIS 240 MG FILM-COATED TABLETS,prescription,J05AX18,LETERMOVIR,8529,,,WHO ATC Classification,,ILS,film coated tablets,LETERMOVIR,2025-07-31T06:56:05.195457,IL,מ.ס.ד. ישראל,,21447.62252,18175.9521,16523.59281,,7290017512037,PREVYMIS 240 MG 28 TAB,,,74621,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,166 13 35974 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,PREVYMIS is indicated for prophylaxis of cytomegalovirus (CMV) reactivation and disease in adult CMV-seropositive recipients [R+] of an allogeneic haematopoietic stem cell transplant (HSCT).Consideration should be given to official guidance on the appropriate use of antiviral agents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0a55269-e3eb-4de9-b812-f1ea525dfcd4.json
d0b20dbb-4def-426c-b8d9-278d58342c99,TAMBOCOR 100 MG TABLETS,prescription,C01BC04,FLECAINIDE,4189,,,WHO ATC Classification,,ILS,tablets,FLECAINIDE ACETATE,2025-07-31T09:02:58.342926,IL,דקסל פארמה,,56.77407222,48.11362266,35.1194326,,7290008107464,TAMBOCOR 50MG 60TAB,20220,,34018,BLISTER PVDC/ALUMINIUM,units,60.0,123 99 23293 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Serious sustained life threatening ventricular arrhytmias that have not responsed to other drugs. Paroxymal atrial flutter.,תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0b20dbb-4def-426c-b8d9-278d58342c99.json
d0bb185b-796b-4ad1-88bb-a4876f2e8e5a,FOSTIMON 150 IU,prescription,G03GA04,UROFOLLITROPIN,6066,,,WHO ATC Classification,,ILS,powder for solution for injection,UROFOLLITROPIN/VIAL,2025-07-31T03:19:19.152546,IL,צמל,,1881.452124,1594.451024,1356.979595,,,FOSTIMON 150 IU 10 VIALS,6427,,14011,VIAL GLASS TYPE I,units,10.0,137 16 30176 00,valid,17.5,"i.m, s.c",1.4,24,,,,,,,,,,0,Prescription required,"A treatment with FSH followed by the administration of human chronic gonadotrophin (HCG) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. These women belong to the WHO group II and have generally already been treated with clomiphene citrate. Most have polycystic ovarian syndrome. FSH offers good therapeutic prospects for patients whose LH:FSH ratio has to be adjusted, avoiding an exogenous supply of LH FSH may be used alone or in concomitance with human menopausal gonadotropin (HMG) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (IVF-ET,GIFT).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0bb185b-796b-4ad1-88bb-a4876f2e8e5a.json
d0df045f-372a-4af0-8e8a-94629b135394,ACYCLOVENIR,prescription,J05AB01,ACICLOVIR,7603,,,WHO ATC Classification,,ILS,powder for solution for infusion,ACICLOVIR,2025-07-30T23:13:54.553128,IL,כ.צ.ט,,38.39069348,32.534486,23.7478,,7290010286348,ACYCLO-V 400MG 30TAB,1904,,59113,VIAL GLASS TYPE II,units,30.0,143 05 31907 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,•	indicated for the treatment of Herpes simplex infections in immunocompromised patients and severe initial genital herpes in the non-immunocompromised. •	indicated for the prophylaxis of Herpes simplex infections in immunocompromised patients. •	indicated for the treatment of Varicella zoster infections. •	indicated for the treatment of herpes encephalitis. •	indicated for the treatment of Herpes simplex infections in the neonate and infant up to 3 months of age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0df045f-372a-4af0-8e8a-94629b135394.json
d0ed759a-1a15-4696-81b6-50bb1790ce2c,PROTHIAZINE EXPECTORANT SYRUP,prescription,R05CA10,COMBINATIONS,2340,,,WHO ATC Classification,,ILS,syrup,"PROMETHAZINE HYDROCHLORIDE/, GUAIFENESIN/, IPECACUANHA/",2025-07-31T07:04:48.852240,IL,כ.צ.ט,,nan,nan,nan,,7290008005265,PROTHIAZINE EXP110ML,16278,,1823,BOTTLE GLASS TYPE III,units,110.0,117 30 23206 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"For temporary relief of cough due to colds, allergies.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0ed759a-1a15-4696-81b6-50bb1790ce2c.json
d0f7c28f-7874-4bfd-bc53-f2cb7d89c270,CHLORAMPHENICOL VUAB 1 G.,29C,S01AA01,CHLORAMPHENICOL,20332,,,WHO ATC Classification,,ILS,powder for concentrate for solution for injection,CHLORAMPHENICOL AS SODIUM SUCCINATE,2025-07-31T14:07:26.337150,IL,nan,,nan,nan,nan,,8594159933460,CHLORAMPHENICOL 1G 80 VIALS,,,,VIAL 20 ML GLASS TYPE I,units,80.0,159 56 34926 00,valid,nan,"i.m, i.v",1.4,36,,,,,,,,,,0,,"Typhus and parathyphus, salmonellosis with septic development, meningitis, epiglottis, pertussis and parapertussis, serious infections with aerobe and anaerobe flora (pulmonary, abdominal, gynecologic) and other infections caused by bacteria susceptible to chloramphenicol.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0f7c28f-7874-4bfd-bc53-f2cb7d89c270.json
d0fed5f9-22d1-4a64-9db4-35dd326edc2a,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7703,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:38:52.442845,IL,סנדוז,,1854.476471,1571.59023,1337.5236,,,BINOCRIT 8000 I.U/0.8 ML 6 SYRINGE PREFILLED,2562,,56140,SYRINGE PREFILLED  GLASS TYPE I,units,6.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d0fed5f9-22d1-4a64-9db4-35dd326edc2a.json
d10a20b7-5836-4784-9e2a-23097e11a9af,CLASTEON 800 MG,prescription,M05BA02,CLODRONIC ACID,8283,,,WHO ATC Classification,,ILS,film coated tablets,CLODRONIC ACID AS DISODIUM TETRATHYDRATE,2025-07-31T01:19:12.659883,IL,ביואבניר,,402.154325,340.80875,290.05,,,CLASTEON 800MG  30TABS,,,12470,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,158 03 34600 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Treatment of hypercalcemia due to malignancy. Palliative treatment of osteolysis due to malignancy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d10a20b7-5836-4784-9e2a-23097e11a9af.json
d10df7e4-b64c-45fb-91ba-6390ff3d00a1,EPANUTIN 100 MG,29C,N03AB02,PHENYTOIN,20592,,,WHO ATC Classification,,ILS,capsules,PHENYTOIN SODIUM,2025-07-31T15:35:01.594698,IL,nan,,nan,nan,nan,,,PHENYTOIN 50MG/ML (100MG/2ML) 25AMP,,,,BOTTLE HDPE,units,25.0,104 27 24678 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d10df7e4-b64c-45fb-91ba-6390ff3d00a1.json
d11d4515-ffd4-4997-9758-ba5d3fc26b82,ELOCOM LOTION,off-the-counter,D07AC13,MOMETASONE,3594,,,WHO ATC Classification,,ILS,lotion,MOMETASONE FUROATE/G,2025-07-31T12:23:48.736338,IL,פלוריש,,17.7944,15.08,nan,,7290008121538,LOTIO ZINCI 100ML,12065,,,BOTTLE LDPE,units,100.0,137 48 28715 22,valid,nan,topical,1.4,24,,,,,,,,,,0,,"The relief of the inflammatory and pruritic manifestations of corticosteroid - responsive dermatoses, such as psoriasis and atopic dermatitis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d11d4515-ffd4-4997-9758-ba5d3fc26b82.json
d12d77a1-1d1d-4131-bfee-23eacd12fe61,ALPROLIX 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,9004,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR IX (HUMAN- RFIXFC)/VIAL,2025-07-30T23:20:49.801677,IL,מגאפארם,,11369.63977,9635.288368,8759.353062,,,ALPROLIX 2000 IU 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,171 49 36891 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d12d77a1-1d1d-4131-bfee-23eacd12fe61.json
d13b4a40-eb5d-4e52-b37e-651dc23436f4,ARGATROBAN 250MG/2.5ML 1 VIAL,29C,,,21012,,,,,,injection,ARGATROBAN 250MG/2.,2025-07-31T19:56:45.168871,IL,nan,,,,,,,ARGATROBAN 250MG/2.5ML 1 VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d13b4a40-eb5d-4e52-b37e-651dc23436f4.json
d141a6cf-8ed3-43fc-ad7d-9b50938b77fe,ADEMPAS 0.5 MG,prescription,C02KX05,RIOCIGUAT,7578,,,WHO ATC Classification,,ILS,film coated tablets,RIOCIGUAT 0.5  MG,2025-07-30T23:14:34.920730,IL,באייר,,4588.78771,3888.803317,3535.275742,,,ADEMPAS 1MG 42TAB,9870,,28789,BLISTER PP/ALUMINIUM,units,42.0,153 76 34132 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Chronic thromboembolic pulmonary hypertension (CTEPH) Adempas is indicated for the treatment of adult patients with WHO Functional Class (FC) II to III with	• inoperable CTEPH, • persistent or recurrent CTEPH after surgical treatment, to improve exercise capacity. Pulmonary arterial hypertension (PAH)Adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH) with WHO Functional Class (FC) II to III to improve exercise capacity.Efficacy has been shown in a PAH population including aetiologies of idiopathic or heritable PAH or PAH associated with connective tissue disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d141a6cf-8ed3-43fc-ad7d-9b50938b77fe.json
d14cc9de-d287-4a09-a821-8a288262f73e,RENNIE ICE,off-the-counter,A02AC10,COMBINATIONS,5597,,,WHO ATC Classification,,ILS,chewable tablets,"CALCIUM CARBONATE, MAGNESIUM CARBONATE",2025-07-31T12:56:08.552597,IL,באייר,,42.1614,35.73,nan,,7290013092380,RENNIE SPEARMINT 60 FREE SUGAR TAB,,,,BLISTER PVC/ALUMINIUM,units,60.0,147 91 33516 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of hyperacidity and heartburn.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d14cc9de-d287-4a09-a821-8a288262f73e.json
d14f7578-2b55-4d9a-923d-a80c32be71e1,PARKAL,prescription,H05BX02,PARICALCITOL,8649,,,WHO ATC Classification,,ILS,solution for injection,PARICALCITOL 0.005  MG /,2025-07-31T06:29:01.759388,IL,אוניפארם,,302.4876789,256.3454906,218.166375,,7290000812502,PARKAL 5MCG/ML 5 VIALS,,,89580,AMPOULES GLASS,units,5.0,164 82 34696 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Paricalcitol is indicated in adults for the prevention and treatment of secondary hyperparathyroidism in patients with chronic renal failure who are undergoing haemodialysis., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d14f7578-2b55-4d9a-923d-a80c32be71e1.json
d1558b0f-796b-4bda-8c9d-375d9b89fe66,DERMACOMBIN OINTMENT,prescription,D07CB01,TRIAMCINOLONE AND ANTIBIOTICS,2076,,,WHO ATC Classification,,ILS,ointment,"TRIAMCINOLONE ACETONIDE/G, NEOMYCIN AS SULFATE 2.5 MG/G, GRAMICIDIN 0.25 MG/G, NYSTATIN/G",2025-07-31T05:59:40.725683,IL,תרו,,19.06213805,16.154355,11.7915,,7-290000-809120,NYSTATIN RM SUSP 30ML,14356,,7907,TUBE ALUMINIUM,units,30.0,015 28 24536 00,valid,37.0,dermal,1.4,36,,,,,,,,,,0,Prescription required,"For the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d1558b0f-796b-4bda-8c9d-375d9b89fe66.json
d1729825-b63e-477f-8dae-19b57a93a800,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,3916,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:30:43.544367,IL,דקסל פארמה,,40.2498,34.11,nan,,,DEXAMOL COLD D30&N20,4203,,,BLISTER PVC/ALUMINIUM,units,50.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d1729825-b63e-477f-8dae-19b57a93a800.json
d181a791-7de8-4b82-b485-2831e57458bd,EUCREAS 50/1000 MG,prescription,A10BA02,METFORMIN,7015,,,WHO ATC Classification,,ILS,film coated tablets,"METFORMIN HYDROCHLORIDE, VILDAGLIPTIN",2025-07-31T02:43:26.783191,IL,נוברטיס פארמה,,nan,nan,nan,,,EUCREAS 500/50MG 30 FC TAB,5537,,34571,BLISTER ,units,30.0,147 90 33627 01,valid,nan,per os,1.4,18,,,,,,,,,,0,Prescription required,Eucreas is indicated in the treatment of type 2 diabetes mellitus:- Eucreas is indicated in the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.- Eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea.- Eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in adult patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d181a791-7de8-4b82-b485-2831e57458bd.json
d18b8bc0-b418-4312-b7d0-c947bfb92054,SUBOXONE FILM 4 MG/1 MG,29C,N02AE01,BUPRENORPHINE,20919,,,WHO ATC Classification,,ILS,sublingual film,"BUPRENORPHINE AS HYDROCHLORIDE, NALOXONE AS HYDROCHLORIDE DIHYDRATE",2025-07-31T15:18:30.770509,IL,nan,,nan,nan,nan,,,NALOXONE INRESA 0.4MG/ML   10AMP,,,,FOIL ALUMINIUM,units,10.0,164 26 35833 00,valid,nan,"buccal, sublingual",1.4,24,,,,,,,,,,0,,Suboxone sublingual film is indicated for treatment of opioid dependence in adults and adolescents over 15 years of age. Suboxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d18b8bc0-b418-4312-b7d0-c947bfb92054.json
d1900ead-7549-48eb-84cb-af3d44ec0e09,CLEXANE,prescription,B01AB05,ENOXAPARIN,6480,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/ML  ML,2025-07-31T01:19:55.622489,IL,סאנופי אוונטיס,,20.1654675,17.08938,12.474,,7290012711121,CLEXANE 20MG SAFETY LOCK 2X0.2ML SYR PREFIL,3989,,84286,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,046 77 26037 11,valid,37.0,"i.v, s.c, extracorporeal",1.4,36,,,,,,,,,,0,Prescription required,"Clexane is indicated in adults for: • Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery. • Prevention of thrombus formation in extra corporeal circulation during haemodialysis. • Acute coronary syndrome: - Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid. - Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d1900ead-7549-48eb-84cb-af3d44ec0e09.json
d1a7b52c-6b12-4c15-af45-c053f5ea9435,LISINOPRIL 20MG 1A PHARMA TABLETS,29C,,,20864,,,,,,tablet,LISINOPRIL 20MG 1A PHARMA TABLETS,2025-07-31T20:48:30.665482,IL,nan,,,,,,,LISINOPRIL 20MG 1A PHARMA TABLETS,,,,,units,28.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d1a7b52c-6b12-4c15-af45-c053f5ea9435.json
d1c8ad0e-339f-44b9-aa4e-48ea5b534385,SOOLANTRA,prescription,P02CF01,IVERMECTIN,8791,,,WHO ATC Classification,,ILS,cream,IVERMECTINW/W,2025-07-31T08:31:20.595901,IL,אמי טכנולוגיות,,70.06059996,59.37339244,44.1437862,,,SOOLANTRA 10 MG/G CREAM 15 GR,,,,TUBE PE/AL/PE,units,15.0,167 59 36606 99,valid,34.5,topical,1.4,24,,,,,,,,,,0,Prescription required,Soolantra is indicated in the topical treatment of inflammatory (papulopustular) lesions caused by rosacea in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d1c8ad0e-339f-44b9-aa4e-48ea5b534385.json
d1d49c34-8870-44e8-b6be-cb24dea5ee23,NUROFEN FORTE FOR CHILDREN  STRAWBERRY 40MG/1ML SUSPENSION,off-the-counter,M01AE01,IBUPROFEN,5576,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T12:36:33.604699,IL,רקיט בנקיזר,,121.0208,102.56,nan,,,NUROFEN FOR CHILDREN FORTE STRAWBERRY 200MG/5ML100 ML SUSPENSION,14701,,,BOTTLE PET,units,100.0,165 24 35419 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years (i.e. weighing about 40 kg)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d1d49c34-8870-44e8-b6be-cb24dea5ee23.json
d2237412-344a-4b8e-80a4-a3d58811efca,CIPRODEX 250,prescription,J01MA02,CIPROFLOXACIN,4574,,,WHO ATC Classification,,ILS,tablets,CIPROFLOXACIN AS HYDROCHLORIDE,2025-07-31T01:16:26.304934,IL,דקסל פארמה,,19.1138701,16.198195,11.8235,,,CIPRODEX 250MG 10TAB,3605,,4880,BLISTER PVC/ALUMINIUM,units,10.0,123 59 30427 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,CIPRODEX caplets are indicated for the treatment of the following infections:Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Adults • Lower respiratory tract infections due to Gram-negative bacteria - exacerbations of chronic obstructive pulmonary disease o In exacerbation of chronic obstructive pulmonary disease CIPRODEX should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis - pneumonia • Chronic suppurative otitis media • Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria • Uncomplicated acute cystitis - In uncomplicated acute cystitis CIPRODEX should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. • Acute pyelonephritis • Complicated urinary tract infections • Bacterial prostatitis • Genital tract infections - gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae - epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae - pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae • Infections of the gastro-intestinal tract (e.g. travellers’ diarrhoea) • Intra-abdominal infections • Infections of the skin and soft tissue caused by Gram-negative bacteria • Malignant external otitis • Infections of the bones and joints • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Children and adolescents • Broncho-pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis • Complicated urinary tract infections and acute pyelonephritis • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary. Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d2237412-344a-4b8e-80a4-a3d58811efca.json
d22b5c6d-6fd0-412d-b4a1-41ca7b542b60,SOMATULINE AUTOGEL 120 MG,prescription,H01CB03,LANREOTIDE,6250,,,WHO ATC Classification,,ILS,solution for injection,LANREOTIDE AS ACETATE/DOSE,2025-07-31T08:29:46.679418,IL,מדיסון,,3289.349162,2787.584159,2534.167418,,7290008128667,SOMATULINE AUTOGEL 90MG 1 PREFIL SYR,19920,,68865,SYRINGE PREFILLED  POLYPROPYLENE,units,1.0,127 27 30485 00,valid,10.0,deep s.c.,1.4,36,,,,,,,,,,0,Prescription required,"Somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of Growth Hormone (GH) and/or insulin like growth factor-1 (IGF-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .The goal of treatment in acromegaly is to reduce GH and IGF-1 levels and where possible to normalize these values. Somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.Somatuline autogel is also indicated for the treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumors (GEP-NETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d22b5c6d-6fd0-412d-b4a1-41ca7b542b60.json
d23e87cc-7540-46a9-949b-9e8a83cd4389,EVRA,prescription,G03AA13,NORELGESTROMIN AND ESTROGEN,4723,,,WHO ATC Classification,,ILS,patches,"NORELGESTROMIN/PATCH, ETHINYLESTRADIOL 0.6  MG/PATCH",2025-07-31T02:46:55.031572,IL,תרימה,,56.23285472,47.65496375,34.78464507,,7290008099035,EVRA 3 PATCHES,5404,,60282,POUCH LAMINATED,units,3.0,130 21 30818 00,valid,37.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Female contraception. Evra is intended for women of fertile age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d23e87cc-7540-46a9-949b-9e8a83cd4389.json
d24d1bec-4861-4cb0-bd78-18c2d2bf968c,XARELTO 1 MG/ML GRANULES FOR ORAL SUSPENSION,prescription,B01AF01,RIVAROXABAN,6949,,,WHO ATC Classification,,ILS,granules for oral suspension,RIVAROXABAN 19.7 MG/G,2025-07-31T10:30:41.810138,IL,באייר,,259.285825,219.73375,175.787,,,XARELTO 20MG 28 F.C.TAB,24071,,34118,BOTTLE GLASS TYPE I,units,28.0,174 12 37097 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of venous thromboembolism (VTE) and prevention of VTE recurrence in term   neonates, infants and toddlers, children, and adolescents aged less than 18 years after at least 5 days of initial parenteral anticoagulation treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d24d1bec-4861-4cb0-bd78-18c2d2bf968c.json
d25f7b51-cf0c-48ec-8f02-759f376a6741,FELBATOL 600MG/5ML ORAL SUSP 237ML,29C,,,20078,,,,,,tablet,FELBATOL 600MG/ ORAL SUSP,2025-07-31T20:27:00.055886,IL,nan,,,,,,,FELBATOL 600MG/5ML ORAL SUSP 237ML,,,,,units,237.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d25f7b51-cf0c-48ec-8f02-759f376a6741.json
d2756ecc-d871-4968-bf41-d9b50ca42d2a,NORMALAX,off-the-counter,,,5289,,,,,ILS,powder for solution,POLYETHYLENE GLYCOL 3350W/W,2025-07-31T12:34:19.655575,IL,תרו,,63.0592,53.44,nan,,7290012066207,NORMALAX 240 GR,,,,BOTTLE HDPE,units,240.0,142 15 32012 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the treatment of constipation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d2756ecc-d871-4968-bf41-d9b50ca42d2a.json
d28446fb-6279-4ed7-86d7-23aa3feaf173,BUDESONIDE STERINEBS TEVA ® 0.5 MG/2 ML,prescription,R01AD05,BUDESONIDE,8133,,,WHO ATC Classification,,ILS,suspension for inhalation,BUDESONIDE 0.25  MG /,2025-07-31T00:45:37.723789,IL,רפא,,355.610931,301.3652092,256.4810291,,,BUDESON 9MG GRANULES 30 SACHETS,,,64696,AMPOULES POLYETHYLENE,units,30.0,142 43 33002 00,valid,17.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Bronchial asthma especially in cases where other therapy is insufficient or insuitable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d28446fb-6279-4ed7-86d7-23aa3feaf173.json
d2850d4b-4d9e-4a71-9516-80ebd67a24e6,DIPHANTOINE 250MG/5ML 5 AMP,29C,,,20068,,,,,,injection,DIPHANTOINE 250MG/,2025-07-31T20:16:29.131066,IL,nan,,,,,,,DIPHANTOINE 250MG/5ML 5 AMP,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d2850d4b-4d9e-4a71-9516-80ebd67a24e6.json
d28a5ddb-cd15-46d5-b382-c9290f341bd0,TARDYFERON,off-the-counter,,,5223,,,,,ILS,tablets,FERROUS SULFATE 247.25  MG,2025-07-31T13:25:12.408156,IL,פאדאגיס,,25.9836,22.02,nan,,7290012162398,TARDYFERON 30TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,135 66 31400 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Prevention and treatment of Iron deficiency anemia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d28a5ddb-cd15-46d5-b382-c9290f341bd0.json
d28eb7cc-ef1b-4965-82e3-19c6efc212d9,DOCETAXEL VENUS PHARMA 20 MG/ML,prescription,L01CD02,DOCETAXEL,9513,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOCETAXEL/ML,2025-07-31T02:01:20.662476,IL,טרוסטפארם,,1318.969408,1117.770685,951.2942,,,DOCETAXEL VENUS PHARMA 20 MG/ML 1VIAL 4ML,,,37265,VIAL GLASS TYPE I,units,1.0,175 12 37136 99,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Breast cancer: Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. Docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. Docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy.Previous chemotherapy should have included an anthracycline or an alkylating agent. Docetaxel in combination with trastuzumab is indicated for treatment of patients with metastatic breast cancer whose tumors overexpressed HER2 and who previously have not received chemotherapy for metastatic disease.Docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Doxorubicin and cyclophosphamide followed by Docetaxel in combination with trastuzumab (AC-TH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node positive or high-risk node-negative, breast cancer. Docetaxel in combination with trastuzumab, and carboplatin (TCH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high-risk node-negative, breast cancer.Non-small cell lung cancer: Docetaxel is indicated for the treatment of patients with advanced non-small cell lung carcinoma.Ovarian cancer: Docetaxel is indicated for the treatment of metastatic carcinoma of the ovary after failure first line or subsequent chemotherapy.Prostate cancer: Docetaxel in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.Esophageal cancer: Docetaxel for the treatment of esophageal cancer.Gastric cancer: Docetaxel for the treatment of advanced gastric cancer.Head and neck (SCCHN): Docetaxel as monotherapy in the treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after failure of a previous chemotherapy regimen.Docetaxel in combination with cisplatin and 5 fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d28eb7cc-ef1b-4965-82e3-19c6efc212d9.json
d29794c1-2c7f-40ec-a4b0-69479cda6a94,PLEGRIDY 125,prescription,L03AB13,PEGINTERFERON BETA-1A,7630,,,WHO ATC Classification,,ILS,solution for injection,PEGINTERFERON BETA 1A/ 0.5  ML,2025-07-31T06:46:19.802006,IL,מדיסון,,2934.667858,2487.00677,2260.915245,,7290015666091,PLEGRIDY 94 MCG & 63 MCG/0.5ML 1+1 PRE FILLED PEN,16977,,4468,PRE-FILLED PEN GLASS TYPE I,units,2.0,155 04 34292 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Plegridy is indicated in adult patients for the treatment of relapsing remitting multiple sclerosis,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d29794c1-2c7f-40ec-a4b0-69479cda6a94.json
d2a69dba-42f5-4cd2-9544-5555658cf883,FAVOXIL 100,prescription,N06AB08,FLUVOXAMINE,2857,,,WHO ATC Classification,,ILS,tablets,FLUVOXAMINE MALEATE,2025-07-31T02:54:59.404446,IL,פאדאגיס,,54.50560892,46.191194,33.7162,,7290002925866,FAVOXIL 100MG 30TAB,6048,,9006,BLISTER PVC/PVDC,units,30.0,041 91 25728 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. Treatment of obsessive compulsive disorders (OCD).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d2a69dba-42f5-4cd2-9544-5555658cf883.json
d2a80c27-5125-4a3d-8b8f-49cdf8ccffa6,THEOTRIM 100,prescription,R03DA04,THEOPHYLLINE,2216,,,WHO ATC Classification,,ILS,tablets slow release,THEOPHYLLINE ANHYDROUS,2025-07-31T09:19:16.120714,IL,תרימה,,15.0877278,12.78621,9.333,,,THEOTRIM 300 30 SR TAB,20103,,2267,BLISTER PVC/ALUMINIUM,units,30.0,050 47 23896 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Long acting bronchodilator in the symptomatic relief and/or prevention of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d2a80c27-5125-4a3d-8b8f-49cdf8ccffa6.json
d2b84f2f-d04b-4c08-8ab3-224f5d96bb66,EPIVIR 150 MG,prescription,J05AF05,LAMIVUDINE,4776,,,WHO ATC Classification,,ILS,film coated tablets,LAMIVUDINE,2025-07-31T02:28:48.885169,IL,ג.ס.ק,,337.0993974,285.6774681,243.1297601,,7290008085502,EPIVIR 300MG 30TAB,5411,,12897,BOTTLE HDPE,units,30.0,102 54 28844 22,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Epivir is indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d2b84f2f-d04b-4c08-8ab3-224f5d96bb66.json
d2ffdcfd-ddef-4ff1-bbdd-c75429cd4464,TIPTIPOT MUCOLIT,off-the-counter,R05CB03,CARBOCISTEINE,2328,,,WHO ATC Classification,,ILS,drops,CARBOCISTEINE/ML,2025-07-31T12:27:54.229450,IL,כ.צ.ט,,45.8312,38.84,nan,,7290008104586,MUCOLIT 375MG 20 CAPS,13402,,,BOTTLE GLASS,units,20.0,122 54 30239 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Treatment of disorders of the respiratory tract characterized by excessive or viscous mucus.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d2ffdcfd-ddef-4ff1-bbdd-c75429cd4464.json
d3089536-2780-4ff2-960a-e1a62d419d92,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7701,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:38:25.419001,IL,סנדוז,,1163.243136,985.7992675,838.9781,,,BINOCRIT 5000 IU/0.5ML 6 SYRINGE PREFILLED,2560,,56137,SYRINGE PREFILLED  GLASS TYPE I,units,6.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3089536-2780-4ff2-960a-e1a62d419d92.json
d31a9e17-e7ff-4e36-9b3b-174256489f99,HUMIRA,prescription,L04AB04,ADALIMUMAB,8028,,,WHO ATC Classification,,ILS,solution for injection,ADALIMUMAB/,2025-07-31T03:50:01.952027,IL,אב-וי,,2303.621878,1952.222018,1661.465547,,,HUMIRA 40 MG/0.4 ML SOL FOR INJ 2 PEN,8437,,73628,PRE-FILLED PEN GLASS TYPE I,units,2.0,157 78 34788 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"• Rheumatoid arthritis:Humira in combination with methotrexate is indicated for:- The treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate.- The treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.Humira has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.• Polyarticular juvenile idiopathic arthritis:Humira in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs).  Humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. Humira has not been studied in patients aged less than 2 years.• Enthesitis-related arthritis:Humira is indicated for the treatment of active enthesitis-related arthritis in patients, 6 years of age and older, who have had an inadequate response to, or who are intolerant of, conventional therapy.• Axial spondyloarthritis :Humira is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.• Axial spondyloarthritis without radiographic evidence of AS:Humira is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS, but with objective signs of inflammation by radiological and/or laboratory tests including MRI and serum CRP levels , who have had an inadequate response to, or are intolerant to, non - steroidal anti-inflammatory drugs. • Psoriatic arthritis:Humira is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti rheumatic drug therapy has been inadequate. Humira has been shown to reduce the rate of progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease and to improve physical function.• Psoriasis:Humira is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.• Paediatric plaque psoriasis:Humira is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.• Hidradenitis suppurativa (HS):Humira is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adult and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy.• Crohn’s disease:Humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy.  Humira is indicated for reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab. • Paediatric Crohn's disease:Humira is indicated for the treatment of moderately to severely active Crohn's disease in paediatric patients (from 6- years of age) who have had an inadequate response to conventional therapy including primary nutrition therapy and corticosteroid, and/or an immunomodulator, or who are intolerant to or have contraindications for such therapies• Ulcerative colitis:Humira is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.  • Uveitis:Humira is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.• Intestinal Behcet's disease:Humira is indicated for the treatment of intestinal Behcet’s disease in patients who have had an inadequate response to conventional therapy.• Paediatric UveitisHumira is indicated for the treatment of chronic non-infectious uveitis in paediatric patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate.•	Paediatric ulcerative colitis Humira is indicated for the treatment of moderately to severely active ulcerative colitis in pediatric patients (from 6 years of age) who have had an inadequate response to conventional therapy including corticosteroids and/or 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d31a9e17-e7ff-4e36-9b3b-174256489f99.json
d3308866-e2a4-4c9f-bd44-02d81eee7dfe,TENOVAMED INOVAMED,prescription,J05AR03,TENOFOVIR DISOPROXIL AND EMTRICITABINE,9313,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR DISOPROXIL AS FUMARATE, EMTRICITABINE",2025-07-31T09:12:35.997627,IL,אינובמד,,2203.263857,1867.17276,1589.0832,,,TENOVAMED INOVAMED 30 TAB,23433,,254,BLISTER OPA/ALU/PVC/ALU,units,30.0,171 61 36295 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Tenovamed Inovamed is indicated in combination with other anti-retroviral medicinal products for the treatment of HIV-1 infected adults over 18 years of age. Tenovamed Inovamed is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection in adults at high risk,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3308866-e2a4-4c9f-bd44-02d81eee7dfe.json
d33f07c9-3d2f-41fb-8a13-5b52194759e4,HEXIDYL DENTAL GEL,off-the-counter,A01AB03,CHLORHEXIDINE,5536,,,WHO ATC Classification,,ILS,gel,CHLORHEXIDINE DIGLUCONATEW/W,2025-07-31T12:04:00.690410,IL,פלוריש,,34.4324,29.18,nan,,,HEXIDYL MOUTHWASH 0.2% 300ml,,,,TUBE ALUMINIUM,units,300.0,175 39 36041 00,valid,nan,local oral,1.4,36,,,,,,,,,,0,,"1) As an aid to maintaining oral hygiene.   2) As an aid in the treatment and prevention of gingivitis.   3) Inhibition of formation of dental plaque.   4) For use in aphtous ulceration and oral candidal infections (e.g., denture stomatitis and thrush).   5) For use in a post- periodontal surgery or treatment regimen to promote gingival healing.   6) As an adjunct to fluoride in the prevention of dental caries in high risk patients.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d33f07c9-3d2f-41fb-8a13-5b52194759e4.json
d3498774-49fe-41ff-916d-3b835101c221,RHOPHYLAC 300,prescription,J06BB01,ANTI-D (RH) IMMUNOGLOBULIN,9326,,,WHO ATC Classification,,ILS,solution for injection,ANTI-D IMMUNOGLOBULINS/ML,2025-07-31T07:33:27.218677,IL,סי אס אל,,355.6246958,301.3768742,256.4909568,,7290011714925,RHOPHYLAC 300 150MCG/ML 2 ML,18472,,83471,SYRINGE GLASS TYPE I,units,1.0,127 75 30675 00,valid,17.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of Rh (D) immunisation in Rh (D)-negative women:    Anti-D immune globulin is administered for the prevention of Rh (D) immunization if it has been demonstrated  or if it is  suspected  that fetal erythrocytes have entered the circulation of the mother. Treatment is not necessary when it is assured that the child or the father are Rh (D)- negative. Criteria for a rhesus-incompatible pregnancy and the administration of anti-D immune globulin are : a) the mother is Rh (D) -negative  b) the child is either Rh (D)-positive Rh (D)weak - positive or its rhesus type is not known.    Routine antepartum prophylaxis : To prevent Rh (D) immunisation due to spontaneous fetomaternal haemorrhage (FMH) during the last trimester of pregnancy.   Postpartum prophylaxis To prevent Rh (D) immunisation of the Rh (D)-negative mother following delivery of a Rh (D)-positive child.    Complications of pregnancy: Interventions during pregnancy  such as invasive prenatal diagnosis (e.g. amniocentesis  chorionic villus sampling  fetal blood sampling) or other intrauterine procedures (e.g. insertion of shunts  embryo reduction)  external version of the fetus and therapeutic abortion. Incidents during pregnancy  such as antepartum haemorrhage  spontaneous abortion  ruptured tubal pregnancy  ectopic pregnancy  stillbirths  intrauterine death and abdominal trauma.   Treatment of Rh (D) -negative persons after incompatible transfusions of Rh (D)-positive blood or erythrocyte concentrate:    Prevention of Rh (D) immunisation in Rh (D)-negative persons who for any reason have been given blood or blood components containing Rh (D)-positive red cells.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3498774-49fe-41ff-916d-3b835101c221.json
d3583692-6816-4f66-bf32-eb2d4121aaf5,VITA-MERFEN OINTMENT,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5216,,,WHO ATC Classification,,ILS,ointment,"VITAMIN A PALMITATE 0.2 %W/W, BENZOXONIUM CHLORIDE 0.1 %W/W, CHLORHEXIDINE AS GLUCONATE 0.5 %W/W",2025-07-31T13:36:17.634454,IL,מדיטרנד,,51.0704,43.28,nan,,7290011363406,VITA-MERFEN OINT 40GR,22295,,,TUBE ALUMINIUM,units,40.0,118 17 27599 00,valid,nan,dermal,1.4,30,,,,,,,,,,0,,"Vita-Merfen ointment is indicated for the treatment of all kinds of small wounds (such as scratches, abrasions, cuts),cracks, chapped skin, minor burns (first degree).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3583692-6816-4f66-bf32-eb2d4121aaf5.json
d393f720-1052-4d2f-8db2-091c83c8bad3,VIAGRA 100 MG,prescription,G04BE03,SILDENAFIL,3678,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:12:23.143103,IL,דקסל פארמה,,188.0098425,159.330375,127.4643,,7290008108812,VIAGRA 100MG 8TAB,22119,,33853,BLISTER PVC/ALUMINIUM,units,8.0,111 38 29461 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d393f720-1052-4d2f-8db2-091c83c8bad3.json
d39e4f70-6aa7-47d2-9711-182ed2684690,PHAREPA 25000 I.U/ 5 ML,prescription,C05BA03,HEPARIN,9420,,,WHO ATC Classification,,ILS,solution for injection / infusion,HEPARIN SODIUM/ML,2025-07-31T06:38:52.189317,IL,פרופארם,,147.6488324,125.1261347,100.1009078,,,PHAREPA 25000 I.U/ 5 ML 5 VIALS,,,17137,VIAL GLASS TYPE I,units,5.0,165 22 35978 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"•As part of the treatment of venous or arterial thromboembolic disorders (including the early treatment of heart attacks as well as unstable angina pectoris)•For anticoagulation during treatment or operation with an extracorporeal circulation (e.g. heart/lung machine, hemodialysis)", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d39e4f70-6aa7-47d2-9711-182ed2684690.json
d3abea0c-a61f-4f3d-82ad-d044b3185bfb,ZEPOSIA 0.23 MG,prescription,L04AA38,OZANIMOD,8800,,,WHO ATC Classification,,ILS,capsules,OZANIMOD AS HYDROCHLORIDE 0.23  MG,2025-07-31T10:47:14.488960,IL,ב.מ.ס,,6089.52895,5160.617983,4691.470894,,7290014396159,ZEPOSIA 0.92 MG 28 CAPS,,,72976,BLISTER PVC/PCTFE/AL,units,28.0,167 33 36599 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Zeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease as defined by clinical or imaging features.ZEPOSIA is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3abea0c-a61f-4f3d-82ad-d044b3185bfb.json
d3cedf8a-70e6-460d-ad6a-537314aacaf7,TRAMADEX OD 100,prescription,N02AX02,TRAMADOL,6206,,,WHO ATC Classification,,ILS,tablets prolonged release,TRAMADOL HYDROCHLORIDE,2025-07-31T09:31:50.226417,IL,דקסל פארמה,,37.2941537,31.605215,23.0695,,,TRAMADEX OD 100MG 30 P.R.TAB,20641,,80022,BLISTER PVC/PE/PCTFE/AL,units,30.0,139 25 31580 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3cedf8a-70e6-460d-ad6a-537314aacaf7.json
d3deeb4f-e23a-4eb7-8270-ae28bc0eb610,SEGLUROMET 2.5/1000 MG 56 TAB,prescription,,,8309,,,,,ILS,tablet,SEGLUROMET 2.5/1000 MG,2025-07-31T19:31:54.354561,IL,מ.ס.ד. ישראל,,197.7871739,167.6162565,134.0930052,,,SEGLUROMET 2.5/1000 MG 56 TAB,,,29323,,units,56.0,,not-registered,25.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3deeb4f-e23a-4eb7-8270-ae28bc0eb610.json
d3e6d41c-e24a-4fee-bf9b-aad3166ac51b,EZETROL 10 MG TABLETS,prescription,C10AX09,EZETIMIBE,4668,,,WHO ATC Classification,,ILS,tablets,EZETIMIBE,2025-07-31T02:51:53.555422,IL,אורגנון,,219.15373,185.7235,148.5788,,,EZETROL 10MG 30TAB,5398,,58364,BLISTER PVC/ALUMINIUM,units,30.0,128 41 30721 11,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Primary hypercholesterolemia:   Ezetrol administered with an HMG-CoA reductase inhibitor  (statin) or alone  are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia.   Homozygous familial hypercholesterolemia (HoFH):   Ezetrol administered with a statin  are indicated for use in patients with HoFH.Patients may also receive adjunctive treatments (e.g. LDL apheresis).Homozygous sitosterolemia (Phytosterolemia):   Ezetrol are indicated for use in patients with homozygous familial sitosterolemia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3e6d41c-e24a-4fee-bf9b-aad3166ac51b.json
d3f7609d-ebfc-4c19-a2bf-15067fd20dee,SITAR 50,prescription,A10BH01,SITAGLIPTIN,9382,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS HYDROCHLORIDE,2025-07-31T08:20:44.348906,IL,אוניפארם,,118.746822,100.6329,74.82,,,SITAR 50 50 MG 28 TAB,,,14548,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,172 97 36637 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,SITAR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: SITAR should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. SITAR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using SITAR.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d3f7609d-ebfc-4c19-a2bf-15067fd20dee.json
d409948e-3e8e-4d86-be56-c4b426ac9eef,GAMUNEX ® - C,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7069,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN 0.1 G/ML",2025-07-31T03:26:56.314267,IL,פאדאגיס,,3053.778557,2587.948044,2352.68004,,7298074020687,GAMUNEX C 0.1G/ML 10GR 100ML,7924,,35532,VIAL GLASS,units,100.0,132 95 31058 00,valid,10.0,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Gamunex is indicated as replacement therapy of primary immunodeficiency (PI) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, X-limked immunodeficiency with hyper IgM, Wiskott- Aldrich syndrom, and severed combined immunodeficiencies. Gamunex is also indicated in Idiopathic Thrombocytopenia Purpura (ITP) to raise platelet counts to prevent bleeding or to allow a patient with ITP to undergo surgery.Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d409948e-3e8e-4d86-be56-c4b426ac9eef.json
d420895e-eedf-4379-be9f-815b2266038e,AZADINE,prescription,L01BC07,AZACITIDINE,8407,,,WHO ATC Classification,,ILS,lyophilized powder for suspension for sc injection / solution for infusion,AZACITIDINE/VIAL,2025-07-30T23:32:34.397017,IL,SK PHARM(KS KIM),,1789.972551,1516.925891,1291.000758,,7290016845129,AZADINE 100 MG/VIAL,10459,,38473,VIAL GLASS TYPE I,units,1.0,162 37 35330 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Azadine is indicated for treatment of patients with the following French-American- British (FAB) myelodysplastic syndrome subtypes: refractory anemia (RA) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d420895e-eedf-4379-be9f-815b2266038e.json
d4269b17-003e-410f-b273-a91db01d7c68,GRANUPAS,prescription,J04AA01,4-AMINOSALICYLIC ACID ,7982,,,WHO ATC Classification,,ILS,gastro resistant granules,4 - AMINOSALICYLIC ACID/SACHET,2025-07-31T03:39:11.887011,IL,תרומד,,2425.46241,2055.47671,1749.341881,,,GRANUPAS 30 SACHETS,7949,,20106,SACHET POLYETHYLENE/ALUMINIUM/LDPE,units,30.0,160 83 34974 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,GRANUPAS is indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adults and paediatric patients from 28 days of age and older when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4269b17-003e-410f-b273-a91db01d7c68.json
d430cddd-4ce9-43db-9f23-70183df11888,MULTAQ,prescription,C01BD07,DRONEDARONE,6412,,,WHO ATC Classification,,ILS,film coated tablets,DRONEDARONE,2025-07-31T05:35:36.868785,IL,סאנופי אוונטיס,,314.4900895,266.517025,226.823,,7290012711251,MULTAQ 400MG  60 F.C. TABLETS,13636,,83861,BLISTER PVC/ALUMINIUM,units,60.0,142 42 32977 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"MULTAQ is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation (AF). Due to its safety profile, Multaq should only be prescribed after alternative treatment options have been considered.MULTAQ should not be given to patients with left ventricular systolic dysfunction or to patients with current or previous episodes of heart failure.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d430cddd-4ce9-43db-9f23-70183df11888.json
d440e2a9-a106-4f0a-a55d-3ebfda6a0602,LIFE- IBOO 2 %  100 ML,off-the-counter,,,5585,,,,,ILS,tablet,LIFE- IBOO 2 %,2025-07-31T19:44:42.654215,IL,ליף-טבע,,23.5292,19.94,,,,LIFE- IBOO 2 %  100 ML,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d440e2a9-a106-4f0a-a55d-3ebfda6a0602.json
d4414783-1627-4a8a-b97b-9632ddb05a17,PEN-RAFA VK FORTE,prescription,J01CE02,PHENOXYMETHYLPENICILLIN,6205,,,WHO ATC Classification,,ILS,powder for syrup,PHENOXYMETHYLPENICILLIN AS POTASSIUM/,2025-07-31T06:34:58.069414,IL,רפא,,58.24950967,49.36399344,36.032112,,7290008016506,PEN-RAFA VK FORTE 60ML,16781,,88079,BOTTLE GLASS TYPE III,units,60.0,137 38 31570 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of infections caused by susceptible micro-organisms.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4414783-1627-4a8a-b97b-9632ddb05a17.json
d44da3db-eec4-45ab-a54a-065595c32ca9,XOLAIR ® 150 MG,prescription,R03DX05,OMALIZUMAB,4966,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,OMALIZUMAB/DOSE,2025-07-31T10:36:08.900215,IL,נוברטיס פארמה,,2221.1481,1882.328982,1601.982113,,9319099316550,XOLAIR 150MG/VIAL 1 VIAL,24043,,13355,VIAL GLASS TYPE I,units,1.0,132 61 31124 00,valid,17.5,s.c,1.4,48,,,,,,,,,,0,Prescription required,"Allergic asthma Xolair is indicated for patients 6 to 12 years of age with severe persistent asthma and for patients 12 years of age and older with moderate to severe persistent asthma, who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. Xolair has been shown to decrease the incidence of asthma exacerbations in these patients. Limitations of use: Xolair is not indicated for the relief of acute bronchospasm or status asthmaticus. Xolair is not indicated for the treatment of other allergic conditions.Chronic rhinosinusitis with nasal polyps (CRSwNP) Xolair is indicated as an add-on therapy with intranasal corticosteroids (INC) for the treatment of adults (18 years and above) with severe CRSwNP for whom therapy with INC does not provide adequate disease control.Chronic spontaneous urticaria (CSU) Xolair is indicated as add-on therapy for the treatment of chronic spontaneous urticaria in adult and adolescent (12 years and above) patients with inadequate response to H1 antihistamine treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d44da3db-eec4-45ab-a54a-065595c32ca9.json
d4751ca3-12a7-4275-a8c0-b24896774539,ISTURISA 1 MG,prescription,H02CA02,OSILODROSTAT ,9211,,,WHO ATC Classification,,ILS,film coated tablets,OSILODROSTAT  AS PHOSPHATE,2025-07-31T04:14:29.133304,IL,מדיסון,,28163.92511,23867.73421,21697.94019,,,ISTURISA 5 MG 60 F.C.T,23566,,3011,BLISTER PVC/ALUMINIUM,units,60.0,171 12 37207 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Isturisa is indicated for the treatment of endogenous Cushing’s syndrome in adult patients for whom surgery is not an option or has not been curative,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4751ca3-12a7-4275-a8c0-b24896774539.json
d4a876ab-b67d-413a-82f6-82febd8e2af7,LAMZEDE,prescription,A16AB15,VELMANASE ALFA,8776,,,WHO ATC Classification,,ILS,powder for solution for infusion,VELMANASE ALFA/VIAL,2025-07-31T04:34:59.886293,IL,קמהדע,,4685.287437,3970.58275,3609.620682,,7290008072076,LAMZEDE 10 MG/VIAL 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,168 14 36602 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Enzyme replacement therapy for the treatment of non-neurological manifestations in patients with mild to moderate alpha mannosidosis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4a876ab-b67d-413a-82f6-82febd8e2af7.json
d4ac2642-6949-44ac-9d77-16641b45d245,VECTOR PLUS 80/12.5,prescription,C09CA03,VALSARTAN,9168,,,WHO ATC Classification,,ILS,film coated tablets,"VALSARTAN, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T10:02:29.200323,IL,אוניפארם,,28.92517716,24.512862,17.8926,,,VECTOR PLUS 80/12.5 30 TAB,,,35639,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,145 46 33145 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of hypertension for patients in whom combination therapy is appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4ac2642-6949-44ac-9d77-16641b45d245.json
d4b51959-f2ad-40a3-b219-28d3533ab6f6,MENOPUR MULTIDOSE 1200 IU,prescription,G03GA02,HUMAN MENOPAUSAL GONADOTROPHIN,7024,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,MENOTROPHIN,2025-07-31T05:11:30.506971,IL,פרינג,,1732.727691,1468.413363,1249.7135,,7046260863804,MENOPUR MULTIDOSE 1200 IU 1VIAL,13697,,33836,VIAL GLASS TYPE I,units,1.0,147 67 33343 00,valid,17.5,"s.c, i.m",1.4,36,,,,,,,,,,0,Prescription required,Sterility in females with hypo or normogonadotropic ovarian insufficiency: stimulation of follicle growth. Sterility in males with hypo or normogonadotropic hypogonadism: In combination with HCG to spermatogenesis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4b51959-f2ad-40a3-b219-28d3533ab6f6.json
d4beb2f7-fe9e-4291-9e3e-52bece919192,PERPHENAN 4 MG,prescription,N05AB03,PERPHENAZINE,2088,,,WHO ATC Classification,,ILS,film coated tablets,PERPHENAZINE,2025-07-31T06:38:40.980094,IL,תרו,,24.2888764,20.58379448,15.0246675,,7-290000-809823,PERPHENAN 8MG 20TAB,16120,,1682,BLISTER PVC/ALUMINIUM,units,20.0,015 38 24729 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tranquilizer,antiemetic.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4beb2f7-fe9e-4291-9e3e-52bece919192.json
d4c2a4f8-14d2-4722-a0e4-dacfe0a7e7fe,DICLOPLAST,off-the-counter,M02AA15,DICLOFENAC,5033,,,WHO ATC Classification,,ILS,patches,DICLOFENAC SODIUM/PATCH,2025-07-31T11:32:37.485886,IL,כ.צ.ט,,67.6612,57.34,nan,,,DICLOPLAST PACK 5,4286,,,POUCH PAPER/POLYETHYLENE/ALUMINIUM/ETHYLENE,units,5.0,129 72 28525 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4c2a4f8-14d2-4722-a0e4-dacfe0a7e7fe.json
d4cfc8c7-6773-424f-a4c2-7648f9fd0501,JARDIANCE DUO 12.5 MG/850 MG,prescription,A10BD20,METFORMIN AND EMPAGLIFLOZIN,7852,,,WHO ATC Classification,,ILS,film coated tablets,"EMPAGLIFLOZIN 12.5  MG, METFORMIN HYDROCHLORIDE",2025-07-31T04:18:49.168482,IL,בורינגר אינגלהיים,,266.2731348,225.655209,180.5241672,,,JARDIANCE DUO 5 MG/850 MG 60 F.C.TAB,10074,,32905,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,155 29 34534 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4cfc8c7-6773-424f-a4c2-7648f9fd0501.json
d4d18067-27ce-4b33-be86-9a406ad1f718,SKYRIZI 150 MG,prescription,L04AC18,RISANKIZUMAB,9258,,,WHO ATC Classification,,ILS,solution for injection,RISANKIZUMAB/,2025-07-31T08:21:21.719535,IL,אב-וי,,12694.92875,10758.41467,9780.376973,,,SKYRIZI 150 MG 1 PF PEN,,,73688,PRE-FILLED PEN GLASS TYPE I,units,1.0,169 73 36871 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Plaque PsoriasisSkyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who arecandidates for systemic therapy.Psoriatic ArthritisSkyrizi, alone or in combination with methotrexate (MTX), is indicated for the treatment of activepsoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (DMARDs).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4d18067-27ce-4b33-be86-9a406ad1f718.json
d4d428ef-95e0-41bb-969c-5d5577252eb7,EFMODY 10 MG,prescription,H02AB09,HYDROCORTISONE,9290,,,WHO ATC Classification,,ILS,modified release capsules hard,HYDROCORTISONE,2025-07-31T02:12:16.012389,IL,מדומי פארמה,,863.6611965,731.9163008,622.90749,,,EFMODY 5 MG 50 M.R CAPS,,,47544,BOTTLE HDPE,units,50.0,173 55 37411 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4d428ef-95e0-41bb-969c-5d5577252eb7.json
d4e5ea62-2ba7-448f-b4e3-5dc5b42b5c3f,DOPAMINE HYDROCHLORIDE S.A.L.F. 40 MG/1 ML,29C,C01CA04,DOPAMINE,20380,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOPAMINE HYDROCHLORIDE/,2025-07-31T14:23:44.434811,IL,nan,,nan,nan,nan,,7290015863551,DOPAMINE HCL 40MG/ML 10AMPX5ML,,,,AMPOULES GLASS TYPE I,units,10.0,164 32 35059 00,valid,nan,i.v,1.4,24,,,,,,,,,,0,,"DOPAMINE HYDROCHLORIDE S.A.L.F. is used for the treatment of states of shock of different nature:- post myocardial infarction cardiogenic shock, a shock caused by a heart attack,- surgical shock, caused by a surgical operation,- hypovolemic or haemorrhagic shock, caused by a decrease in blood volume due to a hemorrhage,A shock is characterized by a sharp decrease in blood pressure in response to a reduced blood flow in the organism.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4e5ea62-2ba7-448f-b4e3-5dc5b42b5c3f.json
d4f3d781-1c03-4d79-8c12-c9ac24a5b6bd,CARDILOC 1.25,prescription,C07AB07,BISOPROLOL,7063,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL HEMIFUMARATE 1.25  MG,2025-07-31T00:54:20.727555,IL,אוניפארם,,21.57562858,18.284431,13.3463,,,CARDILOC 1.25MG 30 F.C.TAB,9602,,38162,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,148 63 33513 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function (ejection fraction < 35%, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d4f3d781-1c03-4d79-8c12-c9ac24a5b6bd.json
d50c63ae-34fb-4615-ad76-fe3a46442277,LOSEC 20 MG,off-the-counter,A02BC01,OMEPRAZOLE,5221,,,WHO ATC Classification,,ILS,capsules,OMEPRAZOLE,2025-07-31T12:23:20.403487,IL,טבע,,29.0988,24.66,nan,,,LOSEC 20 MG 14 CAPS (OTC),12413,,,BOTTLE HDPE,units,14.0,139 78 31879 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d50c63ae-34fb-4615-ad76-fe3a46442277.json
d50ee7bf-2f11-44a0-9954-4fe6597d0274,COLPERMIN,off-the-counter,,,5105,,,,,ILS,capsules,PEPPERMINT OIL (MENTHAE PIPERITAE AETHEROLEUM),2025-07-31T11:26:23.314214,IL,טרדיס גת,,38.3264,32.48,nan,,7290008127370,COLPERMIN 20 CAPS,3774,,,BLISTER PVC/ALUMINIUM,units,20.0,109 07 26971 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the treatment of symptoms of discomfort abdominal colic and distension following irritable bowel syndrome,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d50ee7bf-2f11-44a0-9954-4fe6597d0274.json
d511b6f7-de7f-4312-95f1-e0708a8fa8a3,HEPARIN SODIUM B.BRAUN 5000 IU/ML,29C,B01AB01,HEPARIN,8942,,,WHO ATC Classification,,ILS,solution for injection / infusion,HEPARIN SODIUM,2025-07-31T14:45:08.389745,IL,nan,,nan,nan,nan,,,HEPARIN BICHSEL 5000 IU/ML 5ML 10 AMP,,,,VIAL GLASS TYPE II,units,10.0,172 47 36469 00,valid,nan,"i.v, s.c",1.4,36,,,,,,,,,,0,,"-	Prevention of thromboembolic disorders. -	As part of the treatment of venous and arterial thromboembolic disorders (including early treatment of heart attacks as well as unstable angina pectoris). -	For the anticoagulation in case of treatment or operation with extracorporeal circulation (e.g. heart-lung machine, hemodialysis).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d511b6f7-de7f-4312-95f1-e0708a8fa8a3.json
d512ba21-7e83-4373-b320-2dc4082b75d3,FENTADOL 100,prescription,N02AB03,FENTANYL,7888,,,WHO ATC Classification,,ILS,patches,FENTANYL 16.8 MG/PATCH,2025-07-31T02:58:53.177722,IL,סנדוז,,56.36017244,47.762858,34.8634,,7290017585710,FENTADOL 12 5 PATCHES,166026,,59911,SACHET PAPER/PE/ALU/PE,units,5.0,154 87 34320 00,valid,37.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,"Management of chronic pain and intractable pain requiring opioid analgesia.Fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d512ba21-7e83-4373-b320-2dc4082b75d3.json
d513bacc-20c5-4a94-b699-4e94102ef914,CIMIDONA FORTE 13 MG,prescription,G02CX04,CIMICIFUGAE RHIZOMA,9306,,,WHO ATC Classification,,ILS,tablets,DRY EXTRACT FROM CIMICIFUGAE RHIZOMA (BLACK COHOSH),2025-07-31T01:13:17.863119,IL,רפא,,nan,nan,nan,,,CIMIDONA FORTE 13 MG,,,69836,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,163 70 35388 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Alleviation of menopausal complaints (hot flashes, excessive perspiration, sleep disorders, nervousness and depressive moods).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d513bacc-20c5-4a94-b699-4e94102ef914.json
d526642a-ca2f-4e69-9936-2a6707d9d5ff,DIMETHYL FUMARATE DEXCEL 120 MG,prescription,L04AX07,DIMETHYL FUMARATE,8671,,,WHO ATC Classification,,ILS,capsules delayed release,DIMETHYL FUMARATE,2025-07-31T01:56:47.563272,IL,טבע,,2491.803221,2111.697645,1919.725132,,,DIMETHYL FUMARATE  240 MG 60 CAPS,,,28621,BLISTER PVC/PE/PVDC/AL,units,60.0,173 49 37560 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Dimethyl Fumarate Dexcel is indicated for the treatment in adult patients with relapsing remitting multiple sclerosis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d526642a-ca2f-4e69-9936-2a6707d9d5ff.json
d5269f12-9967-44cb-a8a7-df095711327d,MAVENCLAD 10 MG TABLETS,prescription,L01BB04,CLADRIBINE,8150,,,WHO ATC Classification,,ILS,tablets,CLADRIBINE,2025-07-31T05:06:16.618056,IL,מרק סרונו,,47681.79776,40408.30499,36734.82271,,,MAVENCLAD 10 MG 6 TABLETS,13832,,64837,BLISTER ALUMINIUM /ALUMINIUM,units,6.0,159 78 35306 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clinical or imaging features,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5269f12-9967-44cb-a8a7-df095711327d.json
d526db06-8769-4962-9d36-f492e95dc31c,THYROGEN,prescription,V04CJ01,THYROTROPIN,4197,,,WHO ATC Classification,,ILS,powder for solution for injection,THYROTROPIN ALFA 0.9 MG/ML,2025-07-31T09:19:54.020840,IL,סאנופי אוונטיס,,3234.670142,2741.246005,2492.041823,,7290013773036,THYROGEN 0.9MG/ML 2VIALS,20104,,24675,VIAL GLASS TYPE I,units,2.0,117 91 29910 00,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without  radioiodine imaging in the follow up of patients with well-differentiated thyroid cancer  who have previously undergone thyroidectomy. Adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well differentiated thyroid cancer and who do not have evidence of metastatic thyroid cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d526db06-8769-4962-9d36-f492e95dc31c.json
d52cb344-3e1a-42aa-ac77-d3704b335e04,CAMZYOS 10 MG,prescription,C01EB24,MAVACAMTEN,9203,,,WHO ATC Classification,,ILS,capsules,MAVACAMTEN,2025-07-31T00:51:22.263410,IL,ב.מ.ס,,8269.567707,7008.108538,6371.007761,,,CAMZYOS 15 MG 30 CAPS,,,70953,BLISTER PVC/PCTFE(ACLAR)/ALUMINIUM,units,30.0,174 20 37421 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d52cb344-3e1a-42aa-ac77-d3704b335e04.json
d52ede14-2655-471b-9159-51dadbffe776,ABSTRAL 100 MCG,prescription,N01AH01,FENTANYL,7245,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE,2025-07-31T00:04:35.573398,IL,ניאופרם,,1050.17725,889.98072,757.4304,,,ABSTRAL 600MCG 30TAB SUBLINGUAL,9670,,46854,BLISTER PVC/ALUMINIUM-ALUMINIUM,units,30.0,148 73 33262 01,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d52ede14-2655-471b-9159-51dadbffe776.json
d54f358d-d2df-4987-9555-ff7032858126,VORICONAZOLE-TRIMA 200MG,prescription,J02AC03,VORICONAZOLE,7481,,,WHO ATC Classification,,ILS,tablets,VORICONAZOLE,2025-07-31T10:20:57.763676,IL,תרימה,,1740.010498,1474.585168,1254.9661,,7290000843971,VORICONAZOLE-TRIMA 200MG 14TAB,22384,,53867,BLISTER PVC/ALUMINIUM,units,14.0,151 41 33937 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of: invasive aspergillosis, Candidemia in non-neutropenic patients, Fluconazole-resistant serious invasive Candida infections (including C. krusei), serious fungal infections caused by Scedosporium spp. and Fusarium spp. Voriconazole should be administered primarily to immunocompromised patients with progressive, possibly life-threatening infections. Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d54f358d-d2df-4987-9555-ff7032858126.json
d562db93-8d90-45aa-bd75-66ce6168db78,EPREX/PROTECS 40000 IU/ML 1 SYRINGE,prescription,,,4726,,,,,ILS,tablet,EPREX/PROTECS 40000 IU/ML 1 SYRINGE,2025-07-31T19:08:15.920612,IL,יאנסן סילג,,1299.158264,1100.98158,937.0056,,,EPREX/PROTECS 40000 IU/ML 1 SYRINGE,5463,,86986,,units,1.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d562db93-8d90-45aa-bd75-66ce6168db78.json
d596308f-cfa4-42bf-acc9-84ed51799f73,VUMERITY 231 MG,prescription,,,8796,,,,,ILS,capsules delayed release,DIROXIMEL FUMARATE,2025-07-31T10:23:19.300921,IL,מדיסון,,4777.222732,4048.494021,3680.44911,,,VUMERITY 231 MG 120 CAPS,22483,,62573,BOTTLE HDPE,units,120.0,168 83 36412 00,valid,10.0,per os,1.4,32,,,,,,,,,,0,Prescription required,Vumerity is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d596308f-cfa4-42bf-acc9-84ed51799f73.json
d5a031f4-c227-4507-945b-c8318dcab0da,MONOCORD 20,prescription,C01DA14,ISOSORBIDE MONONITRATE,2779,,,WHO ATC Classification,,ILS,tablets,ISOSORBIDE MONONITRATE,2025-07-31T05:29:29.528259,IL,דקסל פארמה,,20.14994904,17.076228,12.4644,,7290008113427,MONOCORD 20MG 60TAB,13033,,8885,BLISTER PVC/ALUMINIUM,units,60.0,052 51 23128 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of angina pectoris and prevention of anginal attacks. Treatment of congestive heart failure.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5a031f4-c227-4507-945b-c8318dcab0da.json
d5ac1ba2-2ff7-4a34-ab66-2e2866164739,RELVAR ELLIPTA 184/22 MCG,prescription,R01AD12,FLUTICASONE FUROATE,7409,,,WHO ATC Classification,,ILS,powder for inhalation,"VILANTEROL AS TRIFENATATE, FLUTICASONE FUROATE",2025-07-31T07:22:53.533753,IL,ג.ס.ק,,174.763522,148.1046863,118.483749,,,RELVAR ELLIPTA 184/22MCG 30 DOSES,18507,,53564,PLASTIC INHALER WITH TWO BLISTER STRIP ALUMINIUM,units,30.0,151 46 33981 00,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,AsthmaRelvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate:	• patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting beta-2-agonists.• patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2-agonist.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5ac1ba2-2ff7-4a34-ab66-2e2866164739.json
d5aff401-db3a-432c-893c-2f5cf2c0576f,CRYSVITA 10 MG,prescription,M05BX05,BUROSUMAB,8753,,,WHO ATC Classification,,ILS,solution for injection,BUROSUMAB/ML,2025-07-31T01:35:09.253393,IL,מדיסון,,25475.52561,21589.42944,19626.75404,,7290015666664,CRYSVITA 20 MG 1 VIAL,10383,,25967,VIAL GLASS TYPE I,units,1.0,164 58 35724 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and paediatric patients 6 months of age and olderTumor-induced OsteomalaciaCRYSVITA is indicated for the treatment of FGF23 - related hypophosphatemia in tumor - induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5aff401-db3a-432c-893c-2f5cf2c0576f.json
d5b8642a-5a7e-4d75-a66b-a2f4aaff5deb,ZOELY,29C,G03CA03,ESTRADIOL,20104,,,WHO ATC Classification,,ILS,film coated tablets,"NOMEGESTROL ACETATE 2.5  MG, ESTRADIOL AS HEMIHYDRATE 1.5  MG",2025-07-31T15:07:32.551661,IL,nan,,nan,nan,nan,,7290008121897,MEGESTROL 40MG 100TAB,,,,BLISTER PVC/ALUMINIUM,units,100.0,150 67 33784 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Oral contraception,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5b8642a-5a7e-4d75-a66b-a2f4aaff5deb.json
d5c63b24-035d-4e6a-819e-9eb3d982a7a8,VABYSMO,prescription,S01LA09,FARICIMAB,9261,,,WHO ATC Classification,,ILS,solution for injection,FARICIMAB/ML,2025-07-31T09:56:18.759058,IL,רוש,,4484.956495,3800.810758,3455.282507,,,VABYSMO 240MG/2 ML (6 MG/0.05 ML) 1 VIAL,,,,PRE-FILLED SYRINGE  GLASS TYPE I,units,1.0,172 14 37335 00,valid,10.0,intravitreal,1.4,24,,,,,,,,,,0,Prescription required,Vabysmo is a vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2) inhibitor indicated for the treatment of patients with:•	Neovascular (Wet) Age-Related Macular Degeneration (nAMD) •	Diabetic Macular Edema (DME)•	visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5c63b24-035d-4e6a-819e-9eb3d982a7a8.json
d5d430c0-5d39-4ac9-8008-67964983b7af,ATTENT XR 30 MG,29C,N06BA01,AMFETAMINE,7649,,,WHO ATC Classification,,ILS,capsules extended release,"DEXTROAMPHETAMINE SULFATE 7.5  MG, DEXTROAMPHETAMINE SACCHARATE 7.5  MG, AMPHETAMINE SULFATE 7.5  MG, AMPHETAMINE ASPARTATE MONOHYDRATE 7.5  MG",2025-07-31T13:49:15.083616,IL,nan,,nan,nan,nan,,,AMPHETAMINE MIXED SALTS 30MG 100TAB,,,,BOTTLE HDPE,units,100.0,170 94 35998 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5d430c0-5d39-4ac9-8008-67964983b7af.json
d5d729e4-21aa-4f1f-8fb6-886bd01de700,PRAVALIP 20,prescription,C10AA03,PRAVASTATIN,4836,,,WHO ATC Classification,,ILS,tablets,PRAVASTATIN SODIUM,2025-07-31T06:50:19.510713,IL,אוניפארם,,35.4488048,30.04136,21.928,,,PRAVALIP 20 30TAB,16697,,13198,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,132 79 31135 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . Pravastatin should be used in addition to a diet  and other nonpharmacological measures alone has been inadequate.    Primary prevention of coronary events: In hypercholesterolemic patients wihthout clinically evident coronary heart disease  pravastatin is indicated to:   1) Reduce the risk of myocardial infarcton.   2) Reduce the risk for revascularization.   3) Reduce the risk of deaths due to cardiovascular causes with no increase in death non-cardiovascular causes.   Secondary prevention of cardiovascular events:   a) Atherosclerosis: In hypercholesterolemic patients with clinically evident coronary artery disease  including prior MI  pravastatin  is indicated to:      1)Slow the progression of coronary atherosclerosis.      2) Reduce the risk of acute coronary events.    b) Myocardial infarction: in patients with previous myocardial infarction  and normal cholesterol levels.   Pravastatin is indicated to:      1) Reduce the risk of recurrent myocardial infarction.       2)Reduce the risk of undergoing myocardial revascularization procedures.  3) Reduce the risk of stroke or transient ischemic attack (TIA).   c) Hypercholesterolemia and mixed dyslipidemia: Pravastatin is indicated as an adjunct to diet to reduce elevated Total-C  LDL-C and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Frederickson Type IIa and IIb).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5d729e4-21aa-4f1f-8fb6-886bd01de700.json
d5dc3cf1-caec-4b30-a30b-ad6820f68f92,NEXOBRID 2 G POWDER AND 20 G GEL,prescription,B06AA11,BROMELAINS,8711,,,WHO ATC Classification,,ILS,powder and gel,CONCENTRATE OF PROTEOLYTIC ENZYMES ENRICHED IN BROMELAIN,2025-07-31T05:45:09.308726,IL,מדיוונד,,2366.060571,2005.136166,1706.498865,,,NEXOBRID 2 G POWDER AND 20 G GEL  VIAL,,,,VIAL GLASS TYPE II,units,2.0,152 30 33685 00,valid,17.5,topical,1.4,36,,,,,,,,,,0,Prescription required,.NexoBrid is indicated for removal of eschar in all age groups with deep partial- and full-thickness thermal burns,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5dc3cf1-caec-4b30-a30b-ad6820f68f92.json
d5ece98b-a637-4874-aed5-e0dcc925d921,DOCETAXEL VENUS PHARMA 20 MG/ML,prescription,L01CD02,DOCETAXEL,9512,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOCETAXEL/ML,2025-07-31T02:01:09.919974,IL,טרוסטפארם,,336.406495,285.09025,242.63,,,DOCETAXEL VENUS PHARMA 20 MG/ML 1 VIAL 1 ML,,,37252,VIAL GLASS TYPE I,units,1.0,175 12 37136 99,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Breast cancer: Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. Docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. Docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy.Previous chemotherapy should have included an anthracycline or an alkylating agent. Docetaxel in combination with trastuzumab is indicated for treatment of patients with metastatic breast cancer whose tumors overexpressed HER2 and who previously have not received chemotherapy for metastatic disease.Docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Doxorubicin and cyclophosphamide followed by Docetaxel in combination with trastuzumab (AC-TH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node positive or high-risk node-negative, breast cancer. Docetaxel in combination with trastuzumab, and carboplatin (TCH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high-risk node-negative, breast cancer.Non-small cell lung cancer: Docetaxel is indicated for the treatment of patients with advanced non-small cell lung carcinoma.Ovarian cancer: Docetaxel is indicated for the treatment of metastatic carcinoma of the ovary after failure first line or subsequent chemotherapy.Prostate cancer: Docetaxel in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.Esophageal cancer: Docetaxel for the treatment of esophageal cancer.Gastric cancer: Docetaxel for the treatment of advanced gastric cancer.Head and neck (SCCHN): Docetaxel as monotherapy in the treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after failure of a previous chemotherapy regimen.Docetaxel in combination with cisplatin and 5 fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5ece98b-a637-4874-aed5-e0dcc925d921.json
d5fd49e1-5f1c-4039-8ab3-7bc6df56e7c7,BRAMITOB,prescription,S01AA12,TOBRAMYCIN,6881,,,WHO ATC Classification,,ILS,solution for inhalation,TOBRAMYCIN/,2025-07-30T23:42:31.022446,IL,קמהדע,,6687.733271,5667.570821,5152.33711,,,BRAMITOB 300MG/4ML 56AMP (4ML),,,29855,AMPOULES POLYETHYLENE,units,56.0,144 24 32986 00,valid,10.0,nebulisation,1.4,24,,,,,,,,,,0,Prescription required,Management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d5fd49e1-5f1c-4039-8ab3-7bc6df56e7c7.json
d60fd014-60e9-4393-8629-11a022406461,FERRIFOL,off-the-counter,B03AD01,FERROUS AMINO ACID COMPLEX,3529,,,WHO ATC Classification,,ILS,tablets,"FOLIC ACID 0.4  MG, FERROUS AS IRON III HYDROXIDE POLYMALTOSE COMPL.",2025-07-31T11:54:20.890716,IL,כ.צ.ט,,53.5956,45.42,nan,,7290008104371,FERRIFOL 3 30CHEWTAB,6346,,,BLISTER PVC/PE/PVDC,units,30.0,131 01 30647 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d60fd014-60e9-4393-8629-11a022406461.json
d622f1ac-392d-47b8-9d88-bbffa5459fd7,AMPHO-MORONAL 10MG 20TAB,29C,,,20288,,,,,,tablet,AMPHO-MORONAL 10MG,2025-07-31T19:53:58.082643,IL,nan,,,,,,,AMPHO-MORONAL 10MG 20TAB,,,,,units,20.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d622f1ac-392d-47b8-9d88-bbffa5459fd7.json
d6244587-6854-4cf5-be8b-33c538c45f35,NUROFEN QUICK 256 MG,off-the-counter,M02AA13,IBUPROFEN,5409,,,WHO ATC Classification,,ILS,tablets,IBUPROFEN SODIUM,2025-07-31T12:39:05.331327,IL,רקיט בנקיזר,,32.6624,27.68,nan,,7290101866961,NUROFEN QUICK 256 MG 24 TAB,14544,,,BLISTER PVC/PVDC,units,24.0,142 71 31929 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"For the symptomatic relief of mild to moderate pain, such as hedache, backache, period pain, dental pain, neuralgia, rheumatic and muscular pain, the pain of non-serious arthritis, migraine, cold and flu symptoms, sore throat and fever.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6244587-6854-4cf5-be8b-33c538c45f35.json
d62fee78-51a1-4827-88f7-4add087e47bc,NINLARO 2.3 MG,prescription,L01XX50,IXAZOMIB,7817,,,WHO ATC Classification,,ILS,capsules,IXAZOMIB AS CITRATE 2.3  MG,2025-07-31T05:47:02.610896,IL,טקדה,,21135.14134,17911.13752,16282.85229,,7290014257856,NINLARO 3 MG 3CAPS,14602,,56196,BLISTER PVC/ALUMINIUM,units,3.0,156 81 34609 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"NINLARO is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d62fee78-51a1-4827-88f7-4add087e47bc.json
d64c2869-bf36-4d08-ad84-dc90bf889140,ADRENALINE S.A.L.F 1 MG/ML,prescription,C01CA24,EPINEPHRINE,8252,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE/ML,2025-07-30T23:15:25.052150,IL,רז פרמהצפטי,,24.750146,20.9747,15.31,,7290015863124,ADRENALINE S.A.L.F 1 MG/ML 5 AMP,,,76348,AMPOULES GLASS TYPE I,units,5.0,160 10 34515 00,valid,37.0,"i.m, i.v, s.c, intracardiac",1.4,18,,,,,,,,,,0,Prescription required,Adrenalin S.A.L.F 1 mg/ml is indicated in the following situations:– Spasm of the airways in acute asthma attacks.– Rapid relief of allergic reactions to drugs or other substances.– Emergency treatment of anaphylactic shock.– Cardiac arrest and cardiopulmonary resuscitation (physical measures should be used first)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d64c2869-bf36-4d08-ad84-dc90bf889140.json
d65685f7-d2e1-44cd-80a8-24ad7f466a31,HALDOL 2 MG/ML DROPS,prescription,N05AD01,HALOPERIDOL,7258,,,WHO ATC Classification,,ILS,solution  (oral),HALOPERIDOL/ML,2025-07-31T03:42:15.992736,IL,יאנסן סילג,,11.46514493,9.71622495,7.092135,,7290014577305,HALDOL DROPS 30ML,8410,,57906,BOTTLE LDPE,units,30.0,029 70 25163 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"HALDOL is indicatedin adult patients aged 18 years and above for:•	Treatment of schizophrenia and schizoaffective disorder.•	Acute treatment of delirium when non-pharmacological treatments have failed.•	Treatment of moderate to severe manic episodes associated with bipolar I disorder when other treatments cannot be used.•	Treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar I disorder.•	Treatment of persistent aggression and psychotic symptoms in patients with moderate to severe Alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.•	Treatment of tic disorders, including Tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.•	Treatment of mild to moderate chorea in Huntington’s disease, when other medicinal products are ineffective or not tolerated.In paediatric patients for:•	Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.•	Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated.  •	Tic disorders, including Tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d65685f7-d2e1-44cd-80a8-24ad7f466a31.json
d657c8a8-4047-4883-a65f-0730081b1f0a,CADEX 1 MG,prescription,C02CA04,DOXAZOSIN,3754,,,WHO ATC Classification,,ILS,tablets,DOXAZOSIN AS MESYLATE,2025-07-30T23:47:40.952897,IL,דקסל פארמה,,28.69852984,24.320788,17.7524,,,CADEX 1MG 30TAB,3572,,51387,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,113 78 29600 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antihypertensive agent. For the treatment of benign prostatic hyperthropy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d657c8a8-4047-4883-a65f-0730081b1f0a.json
d6780982-5464-429d-93c2-7d2f55bb0772,URAMOX,prescription,S01EC01,ACETAZOLAMIDE,2113,,,WHO ATC Classification,,ILS,tablets,ACETAZOLAMIDE,2025-07-31T09:54:20.842221,IL,תרו,,22.97668062,19.47176411,14.2129665,,7290012066573,URAMOX 250MG 30TAB,21122,,27127,BOTTLE HDPE,units,30.0,016 94 21225 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For adjunctive treatment of drug induced edema and edema due to congestive heart failure. Chronic simple (open angle) glaucoma, secondary glaucoma and pre operatively in acute angle closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acute mountain sickness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6780982-5464-429d-93c2-7d2f55bb0772.json
d6afbb34-6932-4ae1-bead-e89586c06aa8,TERBULIN RESPIRATORY SOLUTION,prescription,R03CC03,TERBUTALINE,3132,,,WHO ATC Classification,,ILS,solution for inhalation,TERBUTALINE SULFATE/,2025-07-31T09:14:18.042275,IL,ויטאמד,,nan,nan,nan,,7290008068833,TERBULIN RESP 15ML,20130,,9307,BOTTLE BROWN GLASS,units,15.0,065 67 28096 00,valid,nan,inhalation with nebuliser,1.4,24,,,,,,,,,,0,Prescription required,Bronchodilator for the treatment of acute attacks of Asthma.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6afbb34-6932-4ae1-bead-e89586c06aa8.json
d6b208d4-8ecd-4bd2-87e5-46785cbc4e00,ZYVOXID I.V. 2 MG/ML,prescription,J01XX08,LINEZOLID,8621,,,WHO ATC Classification,,ILS,solution for infusion,LINEZOLID/ML,2025-07-31T10:58:17.261545,IL,פיזר,,1806.241871,1530.71345,1302.734851,,,ZYVOXID I.V. 2 MG/ML 300 ML 10 BAG,,,,BAG EXEL - FILM,units,10.0,125 81 30502 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Therapy is indicated only when an organism resistant to all other antibiotics is suspected. Zyvoxid is indicated in adult and pediatric patients for the treatment of  infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as:   1) Pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (MDRSP).   2) Skin and soft tissue infections including diabetic foot infections.   3) Enterococcal infections.   Combination therapy may be indicated if a concomitant Gram negative pathogen is documented or suspected.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6b208d4-8ecd-4bd2-87e5-46785cbc4e00.json
d6b243d2-254d-4527-a069-6ce2cbaab986,ACULAR EYE DROPS 0.5% 5ML,29C,,,20804,,,,,,drops,ACULAR EYE DROPS 0.5%,2025-07-31T19:48:51.850724,IL,nan,,,,,,,ACULAR EYE DROPS 0.5% 5ML,,,,,units,5.0,,not-registered,,ophthalmic,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6b243d2-254d-4527-a069-6ce2cbaab986.json
d6b66c94-751d-4b04-ac6e-3b2e04fa1cc1,TRIBEMIN TABLETS,off-the-counter,A11HA02,PYRIDOXINE (VIT B6),2043,,,WHO ATC Classification,,ILS,tablets,"PYRIDOXINE (VIT B6) HYDROCHLORIDE, THIAMINE (VIT B1) HYDROCHLORIDE, CYANOCOBALAMIN (VIT B12) 0.25  MG",2025-07-31T13:30:22.877357,IL,סם און,,33.158,28.1,nan,,7290008066075,TRIBEMIN 20TAB,20182,,,BLISTER PVC/ALUMINIUM,units,20.0,040 39 22836 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the treatment of neurologic pain and metabolic disorders. Vitamin B supplement.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6b66c94-751d-4b04-ac6e-3b2e04fa1cc1.json
d6b6ad40-72cc-4fbc-839d-3061a8a9a1e4,INSULATARD VIAL,prescription,A10AC01,INSULIN (HUMAN),2576,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN (HUMAN)/ML,2025-07-31T04:09:07.068165,IL,נובו נורדיסק,,132.2497228,112.0760412,83.3279117,,7290008126045,INSULATARD HM P3MLX5,9191,,8535,VIAL GLASS TYPE I,units,15.0,049 88 26013 00,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,Insulatard is indicated for treatment of diabetes mellitus.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6b6ad40-72cc-4fbc-839d-3061a8a9a1e4.json
d6d5fb87-8259-45a6-abcc-d64e7bc727e2,GIOTRIF 20 MG,prescription,L01XE13,AFATINIB,7393,,,WHO ATC Classification,,ILS,film coated tablets,AFATINIB AS DIMALEATE,2025-07-31T03:33:40.150065,IL,בורינגר אינגלהיים,,9822.888298,8324.481978,7567.710889,,,GIOTRIF 50MG 28 F.C.TAB,7911,,50944,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,151 47 33984 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,GIOTRIF as monotherapy is indicated for the treatment of: • EGFR TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s);• locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6d5fb87-8259-45a6-abcc-d64e7bc727e2.json
d6dc5aa3-66ab-4dd6-b7dd-7501cae74c2d,HYQVIA,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",8152,,,WHO ATC Classification,,ILS,solution for infusion,HUMAN NORMAL IMMUNOGLOBULIN/,2025-07-31T03:53:52.812756,IL,טקדה,,909.1531271,770.468786,655.7181158,,7290018375235,HYQVIA 1vial normal 2.5g/25ml + 1vial recombinant 1.25ml,8470,,59752,VIAL GLASS TYPE I,units,25.0,160 21 35267 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, children and adolescents (0-18 years) in:• Primary immunodeficiency syndromes with impaired antibody production • Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (CLL), in whom prophylactic antibiotics have failed or are contra-indicated.• Hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (MM) patients.• Hypogammaglobulinaemia in patients pre- and post-allogeneic hematopoietic stem cell transplantation (HSCT).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6dc5aa3-66ab-4dd6-b7dd-7501cae74c2d.json
d6e30492-949a-414d-a9a0-a5c022328112,TAMOXIFEN TEVA ® 20 MG,prescription,L02BA01,TAMOXIFEN,6527,,,WHO ATC Classification,,ILS,tablets,TAMOXIFEN AS CITRATE,2025-07-31T09:03:53.618020,IL,טבע,,35.77115484,30.314538,22.1274,,,TAMOXIFEN TEVA 20MG 30TAB,20644,,11644,BLISTER PVDC/ALUMINIUM,units,30.0,142 98 33084 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the palliative treatment of breast cancer generally in post menopausal women, either alone or in combination with other modalities.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6e30492-949a-414d-a9a0-a5c022328112.json
d6fcc450-a410-4f47-af69-66af283c4ee6,STATOR 10,prescription,C10AA07,ROSUVASTATIN,6519,,,WHO ATC Classification,,ILS,film coated tablets,ROSUVASTATIN AS CALCIUM,2025-07-31T08:41:10.107084,IL,אוניפארם,,72.28431079,61.2578905,45.5449,,,STATOR 5MG 28 FC TAB,19896,,2810,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,143 13 31932 02,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as  an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise  weight reduction ) is inadequate.  Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d6fcc450-a410-4f47-af69-66af283c4ee6.json
d700bce0-8b40-4bbd-b5c0-7bfed66e1e40,ARAVA 10 MG,prescription,L04AA13,LEFLUNOMIDE,4008,,,WHO ATC Classification,,ILS,film coated tablets,LEFLUNOMIDE,2025-07-30T23:26:15.339258,IL,סאנופי אוונטיס,,135.7282614,115.0239555,85.5196695,,,ARAVA 10MG 30TAB,1649,,27276,BOTTLE HDPE,units,30.0,121 78 30132 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Arava is indicated in adults for the treatment of active rheumatoid arthritis (RA) :   1. to reduce signs and symptoms    2. to inhibit structural damage as evidenced by X-ray erosions and joint space narrowing    3. to imptove physical function.   Arava is indicated for the treatment of adult patients with active psoriatic arthritis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d700bce0-8b40-4bbd-b5c0-7bfed66e1e40.json
d70385c4-e060-4dc2-baf2-002c79aacc5c,OCTAGAM,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7144,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T06:00:51.231326,IL,דובר מדיקל,,1689.611134,1431.873906,1218.61609,,,OCTAGAM 5% 100ML VIAL,,,,BOTTLE GLASS TYPE II,units,100.0,143 22 31778 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Replacement therapy in:   • Primary immunodeficiency syndromes such as:      - congenital agammaglobulinaemia and hypogammaglobulinaemia       - common variable immunodeficiency       - severe combined immunodeficiency       - Wiskott Aldrich syndrome.  • Children with congenital AIDS and recurrent bacterial infections.      Immunomodulatory effect:   • Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.   • Guillain barre syndrome.   • Kawasaki disease.      Allogeneic bone marrow transplantation.• Myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d70385c4-e060-4dc2-baf2-002c79aacc5c.json
d703e926-136c-4ff9-ab24-77bb391a0784,EXELON PATCH 10,prescription,N06DA03,RIVASTIGMINE,6221,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 9.5 MG/DAY,2025-07-31T02:48:43.708265,IL,נוברטיס פארמה,,210.1366125,178.081875,142.4655,,,EXELON PATCH 5 30 PATCH,5477,,78063,POUCH PAPER/PET/PE/AL/POLYAMIDE,units,30.0,139 70 31675 01,valid,25.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d703e926-136c-4ff9-ab24-77bb391a0784.json
d72a07fb-49e1-4e7e-bd05-a828d73bd023,PERJETA,prescription,L01FD02,PERTUZUMAB,7116,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,PERTUZUMAB/,2025-07-31T06:38:09.751181,IL,רוש,,10867.5569,9209.794393,8372.540357,,7290008140935,PERJETA 420MG/14ML 1VIAL(14ML),16988,,77202,VIAL GLASS TYPE I,units,1.0,149 26 33749 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Early breast cancer Perjeta is indicated for use in combination with trastuzumab and chemotherapy for: •	The neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer. • the adjuvant treatment of patients with HER2-positive early breast cancer (node positive) at high risk of recurrence .Metastatic Breast CancerPerjeta is indicated for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d72a07fb-49e1-4e7e-bd05-a828d73bd023.json
d734ba26-094c-4898-baa1-f37dca6d1b71,HYQVIA,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",8153,,,WHO ATC Classification,,ILS,solution for infusion,HUMAN NORMAL IMMUNOGLOBULIN/,2025-07-31T03:54:15.443881,IL,טקדה,,1818.306254,1540.937572,1311.436232,,7290018375235,HYQVIA 1vial normal 5g/50ml + 1vial recombinant 2.5ml,8471,,59753,VIAL GLASS TYPE I,units,50.0,160 21 35267 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, children and adolescents (0-18 years) in:• Primary immunodeficiency syndromes with impaired antibody production • Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (CLL), in whom prophylactic antibiotics have failed or are contra-indicated.• Hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (MM) patients.• Hypogammaglobulinaemia in patients pre- and post-allogeneic hematopoietic stem cell transplantation (HSCT).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d734ba26-094c-4898-baa1-f37dca6d1b71.json
d742b783-191d-4f8d-885f-26201fe27f03,DOXORUBICIN TEVA,prescription,L01DB01,DOXORUBICIN,7448,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOXORUBICIN HYDROCHLORIDE/ML,2025-07-31T02:04:32.427929,IL,טבע,,2119.094584,1795.842947,1528.376976,,7290102064281,DOXORUBICIN TEVA 2MG/ML VIAL 25ML,,,86193,VIAL GLASS TYPE I,units,1.0,061 78 27503 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"To produce regression in disseminated neoplastic conditions such as: - acute lymphoblastic leukemia, - acute myeloblastic leukemia, - Wilms' tumor neuroblastoma, - soft tissue and bone sarcomas, - breast carcinoma, - lymphomas of both Hodgkin's and non-Hodgkin's types, - bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types, - gastric carcinoma.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d742b783-191d-4f8d-885f-26201fe27f03.json
d76254d0-73dd-46ec-8858-7717d4720d25,IBOO 4 % FOR CHILDREN,off-the-counter,M01AE01,IBUPROFEN,5520,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T12:08:09.560597,IL,טבע,,36.3086,30.77,nan,,7290110730659,IBOO 4 % FOR CHILDREN 30 ML,,,,BOTTLE PET,units,30.0,160 27 34833 02,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years (i.e. weighing about 40 kg),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d76254d0-73dd-46ec-8858-7717d4720d25.json
d769fd9b-6716-4b08-87ba-5c070f9a0b56,LOSARDEX PLUS,prescription,C09DA01,LOSARTAN AND DIURETICS,6525,,,WHO ATC Classification,,ILS,tablets,"HYDROCHLOROTHIAZIDE 12.5   MG, LOSARTAN POTASSIUM",2025-07-31T04:55:25.452583,IL,דקסל פארמה,,24.79444084,21.012238,15.3374,,,LOSARDEX PLUS 30 TAB,12424,,82005,BLISTER PVC/PE/PVDC/AL,units,30.0,141 56 31892 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Losardex plus is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. To reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d769fd9b-6716-4b08-87ba-5c070f9a0b56.json
d76e5b43-971d-4ad3-a566-49da00a05914,BANOPHEN 12.5MG/5ML SYRUP 300 ML,29C,,,20811,,,,,,tablet,BANOPHEN 12.5MG/ SYRUP,2025-07-31T19:59:25.027432,IL,nan,,,,,,,BANOPHEN 12.5MG/5ML SYRUP 300 ML,,,,,units,300.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d76e5b43-971d-4ad3-a566-49da00a05914.json
d7700774-96c4-44cc-9a0d-d17d7ff2af3f,PRIZMA SOLUTION,prescription,N06AB03,FLUOXETINE,8663,,,WHO ATC Classification,,ILS,solution  (oral),FLUOXETINE AS HYDROCHLORIDE/ML,2025-07-31T06:58:03.316943,IL,אוניפארם,,63.5807944,53.88203155,40.06099,,7290000812656,PRIZMA SOLUTION 120 ML,,,60615,BOTTLE GLASS TYPE III,units,120.0,162 93 35206 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Adults:Major depressive episodes.Obsessive-compulsive disorder (OCD).Bulimia nervosa: Fluoxetine is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.Children and adolescents aged 8 years and above:Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. Antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d7700774-96c4-44cc-9a0d-d17d7ff2af3f.json
d781fa8a-0aac-4bcf-b238-fb70653dd526,ELONVA 100 MCG / 0.5 ML,prescription,G03GA09,CORIFOLLITROPIN ALFA,6676,,,WHO ATC Classification,,ILS,solution for injection,CORIFOLLITROPIN ALFA/ 0.5  ML,2025-07-31T02:16:46.200328,IL,אורגנון,,2397.209991,2031.533981,1846.849074,,7290008121804,ELONVA 150MCG/0.5ML 1 SYRINGE PREFILLED,5529,,19933,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,147 30 33282 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Controlled Ovarian Stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d781fa8a-0aac-4bcf-b238-fb70653dd526.json
d7821c77-991a-4426-bf4c-145688b94669,BRIVIACT 10 MG FILM COATED TABLETS,prescription,N03AX23,BRIVARACETAM,8363,,,WHO ATC Classification,,ILS,film coated tablets,BRIVARACETAM,2025-07-30T23:44:19.759455,IL,ניאופרם,,409.6748493,347.1820911,295.4741201,,,BRIVIACT 50 MG 56 TABLETS,2626,,64864,BLISTER PVC/PCTFE/AL,units,56.0,159 88 35241 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d7821c77-991a-4426-bf4c-145688b94669.json
d7a32fc6-2e21-40e0-9c89-3e254781f072,SEPTADINE,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",3596,,,WHO ATC Classification,,ILS,solution - external,"CHLORHEXIDINE DICLUCONATE 0.5  %W/V, ALCOHOLV/V",2025-07-31T13:16:42.919590,IL,פלוריש,,44.8282,37.99,nan,,7290008103565,SEPTADINE SOL 1LITER,,,,BOTTLE HDPE,units,1000.0,108 58 29253 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,"For quick disinfection of hands, also before invasive procedures.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d7a32fc6-2e21-40e0-9c89-3e254781f072.json
d7a3475d-1652-4cfd-b301-98d4c107777d,BEVACIZUMAB KAMADA,prescription,L01FG01,BEVACIZUMAB,9532,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BEVACIZUMAB/ML,2025-07-30T23:38:04.986853,IL,קמהדע,,944.0973032,800.0824959,680.9212731,,7290008072137,BEVACIZUMAB KAMADA 25MG/ML 4 ML,,,,VIAL GLASS TYPE I,units,1.0,170 95 36978 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"- Bevacizumab Kamada in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of patients with metastatic carcinoma of the colon or rectum.- Bevacizumab Kamada in addition to platinum - based chemotherapy is indicated for first - line treatment of patients with unresectable advanced metastatic or recurrent non- small cell lung cancer other than predominantly squamous cell histology. - Bevacizumab Kamada in combination with interferon alfa-2a is indicated for first line treatment of patients with advanced and /or metastatic renal cell cancer.- Bevacizumab Kamada in combination with paclitaxel is indicated for first-line treatment of patients with metastatic breast cancer.- Bevacizumab Kamada as a single agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.- Bevacizumab Kamada in combination with carboplatin and paclitaxel, is indicated for the front-line treatment of advanced (FIGO stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are at high risk for recurrence (residual disease after debulking).- Bevacizumab Kamada in combination with carboplatin and gemcitabine, is indicated for the treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor-targeted agents.- Bevacizumab Kamada in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents - Bevacizumab Kamada in combination with paclitaxel and cisplatin or paclitaxel and topotecan is indicated for treatment of patients with persistent, recurrent, or metastatic carcinoma of the cervix.- Bevacizumab Kamada in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d7a3475d-1652-4cfd-b301-98d4c107777d.json
d7e064aa-6afc-4c03-8904-7c9c4d87470b,DIAMOX INJ 500MG/VIAL,29C,,,20791,,,,,,injection,DIAMOX INJ 500MG/VIAL,2025-07-31T20:14:35.880115,IL,nan,,,,,,,DIAMOX INJ 500MG/VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d7e064aa-6afc-4c03-8904-7c9c4d87470b.json
d7eb52b5-dd5c-4123-8491-746379361b40,KALBETEN TABLETS,off-the-counter,,,3127,,,,,ILS,tablets,BISMUTH SUBSALICYLATE,2025-07-31T12:13:50.138401,IL,סם און,,20.709,17.55,nan,,7290008080903,KALBETEN 10TAB,11178,,,BLISTER PVC/ALUMINIUM,units,10.0,114 90 29652 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Kalbeten Tablets is indicated for relief of diarrhea, nausea, flatulence, convulsive stomach pains, upset stomach, indigestion. Kalbeten Tablets is indicated as a preventative treatment of traveler's diarrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d7eb52b5-dd5c-4123-8491-746379361b40.json
d7f4d86e-792f-4ae0-82da-2dbe3d82d7f2,"GEMCITABINE ""EBEWE"" 40MG/ML",prescription,L01BC05,GEMCITABINE,7741,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,GEMCITABINE AS HYDROCHLORIDE/,2025-07-31T03:29:22.888558,IL,סנדוז,,502.9835167,426.2572175,362.7721,,7290016369724,GEMCITABINE  EBEWE  2000MG/50ML,7863,,3561,VIAL GLASS TYPE I,units,1.0,145 95 33400 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d7f4d86e-792f-4ae0-82da-2dbe3d82d7f2.json
d7f8d265-728d-4a59-bca4-f41d2703472a,STIVARGA,prescription,L01XE21,REGORAFENIB,7404,,,WHO ATC Classification,,ILS,film coated tablets,REGORAFENIB,2025-07-31T08:44:25.288602,IL,באייר,,11793.7437,9994.698494,9086.08954,,,STIVARGA 40MG 3X28 F.C.TAB,9761,,51051,BOTTLE HDPE,units,84.0,150 87 33823 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Stivarga is indicated as monotherapy for the treatment of adults patients:- with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy,and if   KRAS wild- type, an anti-EGFR therapy.- with locally advanced, unresectable or metastatic   gastrointestinal stromal tumors (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.- hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d7f8d265-728d-4a59-bca4-f41d2703472a.json
d80e9194-95b3-47c6-8329-9a0c0af152a9,ZOLADEX,prescription,L02AE03,GOSERELIN,4313,,,WHO ATC Classification,,ILS,implant,GOSERELIN AS ACETATE 3.6  MG/UNIT,2025-07-31T10:53:18.787491,IL,אסטראזנקה,,1264.122858,1071.290605,911.7366852,,5000455018204,ZOLADEX LA 10.8MG SINGLE DOSE SYR,26130,,12202,SYRINGE PREFILLED  POLYETHYLENE,units,1.0,140 16 25142 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of prostate cancer suitable for hormonal manipulation.   Breast cancer in pre-menopausal women suitable for hormone manipulation.Endometriosis.   Assisted reproduction: pituitary down regulation in preparion for superovulation.   Endometrial thinning: Zoladex is indicated for the prethinning of the utetine endometrium prior ro endometrial ablation or resection.  Uterine Fibroids: For reduction of fibroid size prior to surgery.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d80e9194-95b3-47c6-8329-9a0c0af152a9.json
d80f6796-0ca7-4b86-af04-fcebca47dc67,DDAVP 0.004MG/ML 10AMP,29C,,,20360,,,,,,injection,DDAVP 0.004MG/ML,2025-07-31T20:12:02.582925,IL,nan,,,,,,,DDAVP 0.004MG/ML 10AMP,,,,,units,10.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d80f6796-0ca7-4b86-af04-fcebca47dc67.json
d818ef72-088e-4ddd-8c86-005b1b99682d,SLENYTO 1 MG,prescription,N05CH01,MELATONIN,8813,,,WHO ATC Classification,,ILS,tablets prolonged release,MELATONIN,2025-07-31T08:22:04.006923,IL,נעורים,,254.1263324,215.3613083,172.2890466,,5060292650012,SLENYTO 1 MG 60 PR TAB,,,69207,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,165 84 36331 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Slenyto is indicated for the treatment of insomnia in children and adolescents aged 2-18 with Autism Spectrum Disorder (ASD) and/or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d818ef72-088e-4ddd-8c86-005b1b99682d.json
d81add1c-2a26-4542-bb59-d7401ba10fce,FENTORA ® 100 MCG,prescription,N01AH01,FENTANYL,7613,,,WHO ATC Classification,,ILS,tablets,FENTANYL AS CITRATE,2025-07-31T03:02:30.813915,IL,טבע,,594.9798932,504.2202709,429.1236348,,,FENTORA 400MCG 28 BUCCAL TAB,6584,,76298,BLISTER PVC/ALU/POLYAMIDE/PVC,units,28.0,152 90 34050 00,valid,17.5,buccal,1.4,36,,,,,,,,,,0,Prescription required,"Fentora is indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.                                      Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d81add1c-2a26-4542-bb59-d7401ba10fce.json
d83a3e11-fe51-4982-be6f-1f04b38070d4,MENTAX CREAM,prescription,D01AE23,BUTENAFINE,9544,,,WHO ATC Classification,,ILS,cream,BUTENAFINE HYDROCHLORIDE,2025-07-31T05:12:01.658335,IL,פאדאגיס,,nan,nan,nan,,7290004850098,MENTAX CREAM 1% 15 GR,,,63092,TUBE ALUMINIUM,units,15.0,110 63 28947 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,"Interdigital tinea pedis, tinea coporis, tinea cruris . (Treatment in tinea coporis and tinea cruris is limited to up to 4 weeks).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d83a3e11-fe51-4982-be6f-1f04b38070d4.json
d8618f3a-4c89-4853-8067-e9a4e8f5310e,HOLOXAN 1 G,prescription,L01AA06,IFOSFAMIDE,8007,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,IFOSFAMIDE/VIAL,2025-07-31T03:47:17.660481,IL,מגאפארם,,1301.739534,1103.169145,938.8673578,,,HOLOXAN 2G PWD FOR SOL FOR INJ 1VIAL,8435,,73448,VIAL GLASS,units,1.0,156 22 34017 00,valid,17.5,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Testicular tumourFor combination chemotherapy in patients with advanced stage II to IV tumours according to the TNM classification (seminomas and non-seminomas), which do not respond or adequately respond to initial chemotherapy.Cervical cancerPalliative cisplatin/ifosfamide combination chemotherapy (without any other combination partners) of cervical carcinoma, FIGO stage IV B (when curative therapy of the disease is not possible with surgery or radiotherapy) – as an alternative to palliative radiotherapy.Breast cancerFor palliative therapy in advanced, therapy-refractory or recurrent breast cancer.Non-small-cell lung cancerFor mono- or combination chemotherapy of patients with inoperable or metastatic tumours.Small-cell lung cancerFor combination chemotherapy.Soft-tissue sarcoma (incl. osteosarcoma and rhabdomyosarcoma)For mono- or combination chemotherapy of rhabdomyosarcoma or osteosarcoma after failure of standard therapies. For mono- or combination chemotherapy of other soft-tissue sarcomas after failure of surgery and radiation therapy.Ewing’s sarcomaFor combination chemotherapy after failure of primary cytostatic therapy.Non-Hodgkin’s lymphomaFor combination chemotherapy in patients with highly malignant non-Hodgkin’s lymphoma which does not respond, or only insufficiently responds, to the initial therapy. For combination therapy of patients with recurrent tumours.Hodgkin’s lymphomaFor the treatment of patients with primary progressive forms and early relapse of Hodgkin’s lymphoma (duration of complete remission shorter than one year) after failure of primary chemotherapeutic or radio-chemotherapeutic treatment – as part of a recognised combination chemotherapy regimen, such as the MINE protocol.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8618f3a-4c89-4853-8067-e9a4e8f5310e.json
d8764252-053f-4a78-9d75-1a896613f3f0,SEROQUEL XR 150 MG,prescription,N05AH04,QUETIAPINE,6439,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T08:07:29.562904,IL,צמל,,122.873282,104.1299,77.42,,,SEROQUEL XR 300MG 30 TAB EXTENDED RELEASE,19877,,83219,BLISTER PVC/ALUMINIUM,units,30.0,146 97 33472 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Seroquel XR is indicated for the treatment of Schizophrenia. Seroquel XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Seroquel XR.  Seroquel XR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Seroquel XR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate.Seroquel XR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 Pharmacodynamic properties). Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XR.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8764252-053f-4a78-9d75-1a896613f3f0.json
d87f2389-80ba-4988-a3a9-5f7ffc59198f,TRACLEER 125 MG,prescription,C02KX01,BOSENTAN,4661,,,WHO ATC Classification,,ILS,film coated tablets,BOSENTAN AS MONOHYDRATE,2025-07-31T09:28:37.316943,IL,יאנסן סילג,,5598.665923,4744.632138,4313.301944,,7640111932420,TRACLEER 125MG 60TAB,20534,,57711,BOTTLE HDPE,units,60.0,125 58 30488 01,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Treatment of pulmonary arterial hypertension (PAH) in patients of WHO functional class II-IV.Reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d87f2389-80ba-4988-a3a9-5f7ffc59198f.json
d890bfd3-a7a1-474f-ab7e-d050d0cf3754,VANCOAVENIR 1 G,prescription,A07AA09,VANCOMYCIN,4863,,,WHO ATC Classification,,ILS,powder for solution for injection,VANCOMYCIN AS HYDROCHLORIDE/VIAL,2025-07-31T09:58:53.427648,IL,דקסל פארמה,,61.93610137,52.4882215,39.0247,,7290010287147,VANCOMYCIN MYLAN 1G/VIAL,22279,,29144,VIAL GLASS TYPE I,units,1.0,153 18 34020 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci.It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside.Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. Vancomycin hydrochloride is not effective orally when administered for other types of infection.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d890bfd3-a7a1-474f-ab7e-d050d0cf3754.json
d8a9b797-be0b-45f4-97b0-ce28877a96aa,VITA-MERFEN OINTMENT,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",1186,,,WHO ATC Classification,,ILS,ointment,"VITAMIN A PALMITATE 0.2 %W/W, BENZOXONIUM CHLORIDE 0.1 %W/W, CHLORHEXIDINE AS GLUCONATE 0.5 %W/W",2025-07-31T13:36:04.705654,IL,מדיטרנד,,32.686,27.7,nan,,7290011363406,VITA-MERFEN OINT 20GR,22091,,,TUBE ALUMINIUM,units,20.0,118 17 27599 00,valid,nan,dermal,1.4,30,,,,,,,,,,0,,"Vita-Merfen ointment is indicated for the treatment of all kinds of small wounds (such as scratches, abrasions, cuts),cracks, chapped skin, minor burns (first degree).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8a9b797-be0b-45f4-97b0-ce28877a96aa.json
d8b5588f-cbaf-46a7-9928-1720734fc2a3,ALDURAZYME ®,prescription,A16AB05,LARONIDASE,7126,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,LARONIDASE 500 UNITS /,2025-07-30T23:19:00.704424,IL,סאנופי אוונטיס,,2722.898942,2307.541579,2097.765072,,7290013773135,ALDURAZYME 500U/5ML 1VIAL(5ML),9726,,50914,VIAL GLASS TYPE I,units,1.0,130 42 30779 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Aldurazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis I (MPS I  alfa-l-iduronidase deficiency) to treat the non-neurological manifestations of the disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8b5588f-cbaf-46a7-9928-1720734fc2a3.json
d8bb2ec7-7fb7-4111-b3d5-87694289cab1,PROMETHAZINE EXPECTORANS SYRUP,prescription,,,2880,,,,,ILS,syrup,"IPECACUANHA/, PROMETHAZINE HYDROCHLORIDE/, GUAIACOLSULFONATE AS POTASSIUM/",2025-07-31T07:01:33.576326,IL,ויטאמד,,nan,nan,nan,,7-290008-084383,PROMETHAZINE EX100ML,16149,,9068,BOTTLE GLASS TYPE III,units,100.0,062 83 28044 01,valid,nan,per os,1.4,18,,,,,,,,,,0,Prescription required,"For temporary relief of cough, increases the output of upper resperatory tract fluids.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8bb2ec7-7fb7-4111-b3d5-87694289cab1.json
d8c7900d-f4ce-40af-8a6e-094ebc2f8921,FLAGYL 250 MG TABLETS,prescription,J01XD01,METRONIDAZOLE,807,,,WHO ATC Classification,,ILS,film coated tablets,METRONIDAZOLE,2025-07-31T03:06:08.890880,IL,סאנופי אוונטיס,,102.3053153,86.69942361,64.460538,,3582910013679,FLAGYL SUSP 4% 120ML,6441,,83833,BLISTER PVC/ALUMINIUM,units,120.0,106 97 21742 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Trichomonias, acute intestinal amebiasis. Infections due to anaerobic bacteria, lambliasis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8c7900d-f4ce-40af-8a6e-094ebc2f8921.json
d8d03a43-d7a1-4b87-bb73-1921d34a046f,CLONNIRIT,prescription,N02CX02,CLONIDINE,1850,,,WHO ATC Classification,,ILS,tablets,CLONIDINE HYDROCHLORIDE,2025-07-31T01:21:51.744008,IL,רפא,,21.25812834,18.015363,13.1499,,7290008013093,CLONNIRIT 25MCG 30T,3183,,504,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,044 54 22183 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prophylaxis of migraine and recurrent vascular headache, but not acute attacks.Treatment of menopausal flushing.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8d03a43-d7a1-4b87-bb73-1921d34a046f.json
d8db0fc9-d461-407d-b45f-8240a9c211e5,ANAFRANIL 25 MG,29C,N06AA04,CLOMIPRAMINE,20292,,,WHO ATC Classification,,ILS,coated tablets,CLOMIPRAMINE HYDROCHLORIDE,2025-07-31T13:50:08.545867,IL,nan,,nan,nan,nan,,7298087000041,ANAFRANIL 25MG/2ML 6AMP,,,,BLISTER PVC/PE/PVDC,units,6.0,108 06 24600 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,Adults:Depression of varying originObsessive-compulsive syndromesChildren and adolescents (5-18 years old):Obsessive-compulsive syndromes,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8db0fc9-d461-407d-b45f-8240a9c211e5.json
d8dbb2dc-8c1c-4fed-b294-d28a1582d475,RITALIN ® LA 10 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,6845,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:40:56.417202,IL,נוברטיס פארמה,,51.24029545,43.42397919,31.69633518,,7290003257192,RITALIN LA 10MG 30CAPS,18473,,10222,BOTTLE HDPE,units,30.0,146 50 33288 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD) .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8dbb2dc-8c1c-4fed-b294-d28a1582d475.json
d8e35ace-e2e0-40da-abe1-dfc662d0a277,OPTALGIN TEVA,prescription,N02BB02,METAMIZOLE SODIUM,8690,,,WHO ATC Classification,,ILS,solution for injection,DIPYRONE/,2025-07-31T06:14:12.036665,IL,טבע,,34.07881069,28.88034804,21.08054601,,7290106062870,Optalgin Teva  1 G/2 ML 10 AMP,,,25981,AMPOULES GLASS TYPE I,units,10.0,160 24 34798 00,valid,37.0,"i.v, i.m",1.4,48,,,,,,,,,,0,Prescription required,"As an analgesic: Optalgin Teva injection, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. As an antipyretic: Optalgin injection by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. Hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8e35ace-e2e0-40da-abe1-dfc662d0a277.json
d8f3dc5b-e5a7-4eae-a5fa-fae917dfef8a,VERMOX TABLETS,prescription,P02CA01,MEBENDAZOLE,4335,,,WHO ATC Classification,,ILS,tablets,MEBENDAZOLE,2025-07-31T10:06:56.271295,IL,יאנסן סילג,,27.47427744,23.283287,16.9951,,,VERMOX 100MG 6 CHEW/TAB,4335,,20436,BLISTER PVC/ALUMINIUM,units,6.0,130 12 30986 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of trichuris trichiura (whipworm). Ascaris lumbricoides (roundworm). Ancylostoma duodenale (common hookworm). Necator americanus (american hookworm), strongyloidiasis, enterobius vermicularis (pinworm) and teniasis in single or mixed infections.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8f3dc5b-e5a7-4eae-a5fa-fae917dfef8a.json
d8fd2f4b-c1a6-462f-97c3-8d5dcf050581,BINOCRIT 1000 IU/ 0.5 ML,prescription,B03XA01,ERYTHROPOIETIN,7707,,,WHO ATC Classification,,ILS,solution for injection,EPOETIN ALFA/ 0.5  ML,2025-07-31T00:38:14.594885,IL,סנדוז,,1299.158264,1100.98158,937.0056,,,BINOCRIT 40000 I.U/1 ML 1 SYRINGE PREFILLED,2567,,56150,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,147 08 33360 00,valid,17.5,"i.v, s.c",1.4,24,,,,,,,,,,0,Prescription required,"Binocrit® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis  .- in adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients. 	Binocrit® is indicated in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.Binocrit® is indicated in adults in a predonation programme  to increase the yield of autologous blood.Treatment should only be given to patients with moderate anaemia (haemoglobin (Hb) concentration range between 10 13 g/dl (6.2 8.1 mmol/l), no iron deficiency), if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).Binocrit® is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.Use should be restricted to patients with moderate anaemia (e.g. Hb concentration range between 10 13 g/dl or 6.2 8.1 mmol/l) who do not have an autologous predonation programme available and with an expected blood loss (900 to 1800 ml).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d8fd2f4b-c1a6-462f-97c3-8d5dcf050581.json
d906b8f3-db21-497f-8c5c-dfd5b4ccf485,TEMODAL 100 MG,prescription,L01AX03,TEMOZOLOMIDE,4193,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T09:11:38.536903,IL,מ.ס.ד. ישראל,,1381.639624,1170.881038,996.4945,,7290008121972,TEMODAL 100MG 5CAP,20748,,38954,SACHET POLYETHYLENE,units,5.0,120 30 30116 23,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d906b8f3-db21-497f-8c5c-dfd5b4ccf485.json
d91472b3-3299-4f78-ab32-8369d0a6bd8c,CLOPIXOL 10 MG TABLETS,prescription,N05AF05,ZUCLOPENTHIXOL,626,,,WHO ATC Classification,,ILS,film coated tablets,ZUCLOPENTHIXOL AS DIHYDROCHLORIDE,2025-07-31T01:23:41.263038,IL,לנדבק,,79.12804118,67.057665,49.857,,,CLOPIXOL DEPOT INJECTION 500MG 1AMP,3638,,8271,CONTAINER HDPE,units,1.0,047 86 25486 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute schizophrenia .Other acute psychoses.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d91472b3-3299-4f78-ab32-8369d0a6bd8c.json
d92d547d-7724-49ba-9911-da78f48bbcde,EPINEPHRINE INJECTION MYLAN 0.3 MG,prescription,R01AA14,EPINEPHRINE,8628,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE/ML,2025-07-31T02:26:49.570743,IL,תרופארם,,269.6624528,228.5275125,194.4915,,,EPINEPHRINE INJECTION MYLAN 0.3 MG 1 syr,5641,,6502,AUTO-INJECTOR GLASS TYPE I,units,1.0,161 59 35821 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"Epinephrine is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera which includes bees,wasps,hornets,yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs,diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise induced anaphylaxis.Epinephrine is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.Epinephrine is intended for immediate administration as emergency supportive therapy only, and is not a substitute for immediate medical care", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d92d547d-7724-49ba-9911-da78f48bbcde.json
d92e8c6b-45ce-4477-9fc7-3711e5c0e0df,FOMICYT 2 G.,prescription,J01XX01,FOSFOMYCIN,9457,,,WHO ATC Classification,,ILS,powder for solution for infusion,FOSFOMYCIN AS SODIUM/VIAL,2025-07-31T03:15:36.508962,IL,צמל,,995.1802146,843.3731007,717.764341,,,FOMICYT 2 G. 10 VIALS,,,19056,VIAL GLASS TYPE I,units,10.0,173 51 37318 99,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveConsideration should be given to official guidance on the appropriate use of antibacterial agents.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d92e8c6b-45ce-4477-9fc7-3711e5c0e0df.json
d93a14a1-f09e-4d3b-a8d3-023025c124ed,COD-ACAMOL 15/325,prescription,N02BE51,"PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS",1502,,,WHO ATC Classification,,ILS,tablets,"PARACETAMOL, CODEINE PHOSPHATE 15.0   MG",2025-07-31T01:24:36.925375,IL,טבע,,nan,nan,nan,,7290102063215,COD-ACAMOL FORTE 10TAB,3184,,84093,BLISTER PVC/ALUMINIUM,units,10.0,040 04 22978 01,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of mild to moderate pain. Relief of fever and cough associated with fever.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d93a14a1-f09e-4d3b-a8d3-023025c124ed.json
d948cffe-4ea1-4ec4-a291-c64ba0a1071c,TROGARZO 200MG/VIAL 2 VIAL,prescription,,,8794,,,,,,injection,TROGARZO 200MG/VIAL,2025-07-31T19:37:34.836579,IL,שטרן,,,,,,,TROGARZO 200MG/VIAL 2 VIAL,,,,,units,2.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d948cffe-4ea1-4ec4-a291-c64ba0a1071c.json
d949ec82-1913-4736-bb5f-62783a6f179c,CONTROLOC 20 MG,prescription,A02BC02,PANTOPRAZOLE,4017,,,WHO ATC Classification,,ILS,tablets,PANTOPRAZOLE,2025-07-31T01:29:19.569594,IL,טקדה,,22.93995681,19.44064223,14.1902498,,7298074020434,CONTROLOC 20MG 30TAB,3667,,24331,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,116 36 29745 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of reflux oesophagitis and associated symptoms (e.g. heartburn, acid regurgitation, pain on swallowing).For long-term management and prevention of relapse in reflux oesophagitis.Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAIDs treatment.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d949ec82-1913-4736-bb5f-62783a6f179c.json
d95ff3b2-e42c-4cce-83f6-a6aa8751642c,ZOELY,prescription,G03CA03,ESTRADIOL,7320,,,WHO ATC Classification,,ILS,film coated tablets,"NOMEGESTROL ACETATE 2.5  MG, ESTRADIOL AS HEMIHYDRATE 1.5  MG",2025-07-31T10:51:25.600925,IL,תרומד,,169.7326158,143.8412063,115.072965,,7290008121897,ZOELY 3X28TAB,26195,,53750,BLISTER PVC/ALUMINIUM,units,84.0,150 67 33784 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraception,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d95ff3b2-e42c-4cce-83f6-a6aa8751642c.json
d972e3f6-d7fa-445e-91dd-df23c214dd48,XCOPRI 100 MG,prescription,N03AX25,CENOBAMATE,9271,,,WHO ATC Classification,,ILS,film coated tablets,CENOBAMATE,2025-07-31T10:31:14.086232,IL,דקסל פארמה,,507.2305939,429.8564546,365.8352805,,,XCOPRI 100 MG 30 TAB,24176,,19217,BLISTER PVC/ALUMINIUM,units,30.0,172 89 37493 99,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Xcopri is indicated for the adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d972e3f6-d7fa-445e-91dd-df23c214dd48.json
d9754646-b39f-4671-bb9f-196cf95be01c,DERMACOMBIN CREAM,prescription,D07CB01,TRIAMCINOLONE AND ANTIBIOTICS,2060,,,WHO ATC Classification,,ILS,cream,"NYSTATIN/G, GRAMICIDIN 0.25 MG/G, NEOMYCIN AS SULFATE 2.5 MG/G, TRIAMCINOLONE ACETONIDE/G",2025-07-31T01:48:32.434332,IL,תרו,,nan,nan,nan,,7290000809113,DERMACOMBIN CREAM 15G,4070,,636,TUBE ALUMINIUM,units,15.0,133 54 23775 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,Prescription required,"For the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d9754646-b39f-4671-bb9f-196cf95be01c.json
d98d3865-c757-423e-ab09-29ee9b901665,ANGELIQ ®,prescription,G03CA03,ESTRADIOL,4865,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ESTRADIOL AS HEMIHYDRATE",2025-07-31T00:20:13.342314,IL,באייר,,74.33726466,62.99768472,46.8384273,,,ANGELIQ 1X28TAB,1964,,64687,BLISTER PVC/ALUMINIUM,units,28.0,132 92 31057 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Angeliq is indicated for hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women more than 1 year post menopause. Prevention of postmenopausal osteoporosis in women with an increased risk of future osteoporosis fractures.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d98d3865-c757-423e-ab09-29ee9b901665.json
d99fc639-da50-4cb4-90c1-f1d4be2ed6f1,ROXO 150,prescription,J01FA06,ROXITHROMYCIN,6488,,,WHO ATC Classification,,ILS,tablets,ROXITHROMYCIN,2025-07-31T07:51:58.497274,IL,אוניפארם,,49.01806022,41.540729,30.3217,,,ROXO 150MG 20TAB,18423,,84743,BLISTER PVC/ALUMINIUM,units,20.0,134 98 30273 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"For the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ENT bronchopulmonary, genital and skin manifestations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d99fc639-da50-4cb4-90c1-f1d4be2ed6f1.json
d9b55f65-0b08-4e47-bfcd-6ec7b1af48fa,TRAMADEX OD 100,prescription,N02AX02,TRAMADOL,7372,,,WHO ATC Classification,,ILS,tablets prolonged release,TRAMADOL HYDROCHLORIDE,2025-07-31T09:32:13.283406,IL,דקסל פארמה,,47.52028032,40.271424,29.3952,,,TRAMADEX OD 300MG 10 P.R.TAB,20650,,80862,BLISTER PVC/PE/PCTFE/AL,units,10.0,139 25 31580 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d9b55f65-0b08-4e47-bfcd-6ec7b1af48fa.json
d9c18c3a-c334-4ccf-8283-db89b4872e98,ISOKET SPRAY 1.25MG/0.05ML 15 ml,29C,,,20852,,,,,,spray,ISOKET SPRAY 1.25MG/0.,2025-07-31T20:40:18.248537,IL,nan,,,,,,,ISOKET SPRAY 1.25MG/0.05ML 15 ml,,,,,units,15.0,,not-registered,,inhalation,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d9c18c3a-c334-4ccf-8283-db89b4872e98.json
d9cb0446-cbfd-4052-88be-4b475ace5e79,BRONCHICLEAR   ® TABLETS,off-the-counter,R05CA10,COMBINATIONS,5607,,,WHO ATC Classification,,ILS,film coated tablets,"PRIMULA ROOT DRY EXTRACT (6-7:1);                      EXTRACTING AGENT : ETHANOL 47.4 % (V/V), THYME HERB DRY EXTRACT (6-10:1);                  EXTRACTING AGENT: ETHANOL 70.0 % (V/V)",2025-07-31T11:19:58.443349,IL,דר סמואלוב,,48.7694,41.33,nan,,7290014626713,BRONCHICLEAR ORAL LIQUID BOTTLE 100 ML,,,,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,159 49 34894 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the relief of symptoms in acute bronchitis with coughs and colds associated with viscous mucus in children from 12 years of age, adolescents and adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d9cb0446-cbfd-4052-88be-4b475ace5e79.json
d9ecc19b-9a4e-47e9-b67d-884c6070a4cf,DIMETHYL FUMARATE TEVA 120 MG,prescription,L04AX07,DIMETHYL FUMARATE,8857,,,WHO ATC Classification,,ILS,gastro resistant hard capsule,DIMETHYL FUMARATE,2025-07-31T01:57:19.994651,IL,טבע,,669.8656411,567.682772,483.134274,,7290106065352,DIMETHYL FUMARATE TEVA 120 MG 14 CAPS,,,64129,BOTTLE HDPE,units,14.0,165 74 36525 99,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Dimethyl fumarate Teva is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d9ecc19b-9a4e-47e9-b67d-884c6070a4cf.json
d9f1391f-ee8f-433d-9c13-308412d776c0,TROSMOLYT 20 MG,prescription,G04BD09,TROSPIUM,4412,,,WHO ATC Classification,,ILS,film coated tablets,TROSPIUM CHLORIDE,2025-07-31T06:17:38.871734,IL,באייר,,35.90727256,30.429892,22.2116,,7290010038480,OSMO ADALAT 30MG 30 SR TAB,15382,,27863,BLISTER PVC/ALUMINIUM,units,30.0,159 44 35071 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Symptomatic treatment of urge incontinence and /or increased urinary frequency and urgency as may occur in patients with overactive bladder (e.g. idiopathic or neurologic detrusor overactivity), ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d9f1391f-ee8f-433d-9c13-308412d776c0.json
d9f5b7cc-5279-4777-9f39-4c5c1278a459,BINOSTO,prescription,M05BA04,ALENDRONIC ACID,8054,,,WHO ATC Classification,,ILS,tablets effervescent,ALENDRONIC ACID AS TRIHYDRATE,2025-07-31T00:39:03.035861,IL,צמל,,64.00409267,54.2407565,40.3277,,7290100819098,BINOSTO 70MG 4 TAB EFF,,,64781,BLISTER PAPER/POLYETHYLENE /ALUMINIUM,units,4.0,158 96 34539 00,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"For the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures).Treatment to increase bone mass in men with osteoporosis",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/d9f5b7cc-5279-4777-9f39-4c5c1278a459.json
da002958-65ed-4821-93ef-20e9cbceda09,MABTHERA 10 MG/ML I.V,prescription,L01XC02,RITUXIMAB,4945,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,RITUXIMAB/ML,2025-07-31T05:03:38.378335,IL,רוש,,3920.040699,3322.068537,3020.062306,,7290008140119,MABTHERA 500MG/50ML 1VIAL,13544,,9770,VIAL GLASS TYPE I,units,1.0,112 51 29472 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"MabThera is indicated for the following indications: * Non-Hodgkin’s lymphoma (NHL)MabThera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma.MabThera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy MabThera is indicated for the treatment of patients with CD20 positive diffuse large B-cell non-Hodgkin's lymphoma in combination with CHOP chemotherapy. MabThera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * Chronic lymphocytic leukaemia (CLL)MabThera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including MabThera or patients refractory to previous MabThera plus chemotherapy.* Rheumatoid arthritisMabThera is indicated, in combination with methotrexate, to reduce signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more TNF antagonist therapies.* Granulomatosis with polyangiitis and Microscopic polyangiitisMabThera, in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis (WG) and Microscopic polyangiitis (MPA). *Pemphigus vulgarisMabThera is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da002958-65ed-4821-93ef-20e9cbceda09.json
da06f391-bd14-4c72-8745-5ce448d4f033,SEVELAMER TARO 2.4 G,prescription,V03AE02,SEVELAMER,8175,,,WHO ATC Classification,,ILS,powder for oral suspension,SEVELAMER CARBONATE ANHYDROUS 2.4 G,2025-07-31T08:09:07.524714,IL,תרו יבוא,,727.4207085,616.4582275,524.6453,,7290017164229,SEVELAMER TARO 800 MG 180TAB,,,54683,SACHET PET/AL/LDPE,units,180.0,164 79 35536 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. Also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus &#8805; 1.78 mmol/l. Should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da06f391-bd14-4c72-8745-5ce448d4f033.json
da07902a-c8cb-4b89-a228-2561918b27b1,SOMATULINE AUTOGEL 120 MG,prescription,H01CB03,LANREOTIDE,6256,,,WHO ATC Classification,,ILS,solution for injection,LANREOTIDE AS ACETATE/DOSE,2025-07-31T08:29:21.959305,IL,מדיסון,,3953.655957,3350.556045,3045.960041,,7290008128667,SOMATULINE AUTOGEL 120MG 1 PREFIL SYR,19918,,68866,SYRINGE PREFILLED  POLYPROPYLENE,units,1.0,127 27 30485 00,valid,10.0,deep s.c.,1.4,36,,,,,,,,,,0,Prescription required,"Somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of Growth Hormone (GH) and/or insulin like growth factor-1 (IGF-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .The goal of treatment in acromegaly is to reduce GH and IGF-1 levels and where possible to normalize these values. Somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.Somatuline autogel is also indicated for the treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumors (GEP-NETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da07902a-c8cb-4b89-a228-2561918b27b1.json
da119473-23f5-4e5d-92cd-647fc67e1035,OPSUMIT ®,prescription,C02KX04,MACITENTAN,7664,,,WHO ATC Classification,,ILS,film coated tablets,MACITENTAN,2025-07-31T06:14:01.063202,IL,יאנסן סילג,,9950.370504,8432.517751,7665.925229,,,OPSUMIT 10MG 30 F.C.TAB,15446,,68449,BLISTER PVC/PE/PVDC/AL,units,30.0,152 72 34061 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Opsumit ® is an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression. Disease progression included: death, initiation of intravenous (IV) or subcutaneous prostanoids or clinical worsening of PAH (decreased 6-minute walk distance, worsened PAH symptoms and need for additional PAH treatment). Opsumit also reduced hospitalization for PAH.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da119473-23f5-4e5d-92cd-647fc67e1035.json
da134ae7-6f8a-443c-9744-1296df3fddd4,EPINEPHRINE INJECTION MYLAN 0.3 MG,prescription,R01AA14,EPINEPHRINE,8517,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE/ML,2025-07-31T02:27:00.404009,IL,דקסל פארמה,,539.3249055,457.055025,388.983,,,EPINEPHRINE INJECTION MYLAN 0.3 MG 2 SYR,5652,,28568,AUTO-INJECTOR GLASS TYPE I,units,2.0,161 59 35821 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"Epinephrine is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera which includes bees,wasps,hornets,yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs,diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise induced anaphylaxis.Epinephrine is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.Epinephrine is intended for immediate administration as emergency supportive therapy only, and is not a substitute for immediate medical care", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da134ae7-6f8a-443c-9744-1296df3fddd4.json
da2099ff-febc-407d-bdab-25a5f056f77e,CAMPTO,prescription,L01XX19,IRINOTECAN,6136,,,WHO ATC Classification,,ILS,solution for infusion,IRINOTECAN HYDROCHLORIDE/ML,2025-07-31T00:50:14.494704,IL,פיזר,,485.4347248,411.38536,350.1152,,7290010355754,CAMPTO 100MG/5ML 1 VIAL,3013,,10487,VIAL POLYPROPYLENE,units,1.0,106 12 29047 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Campto is indicated for the treatment of patients with metastatic colorectal cancer:   In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease.   As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.   For the treatment of patients with small cell lung cancer.  For the treatment of patients with gastric cancer.Irinotecan in combination with leucovorin, Oxaliplatin and 5-fluorouracil for the first-line treatment of patients with metastatic pancreatic adenocarcinoma.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da2099ff-febc-407d-bdab-25a5f056f77e.json
da5eb7c5-7e17-4707-922d-cf8e68ee440c,PREDNISONE 1 MG TABLETS,prescription,H02AB07,PREDNISONE,1982,,,WHO ATC Classification,,ILS,tablets,PREDNISONE,2025-07-31T06:51:29.414898,IL,רקח,,25.3385884,21.47338,15.674,,7290008089326,PREDNISONE 1MG 100TAB,16568,,8003,SECURITAINER POLYPROPYLENE,units,100.0,118 06 26041 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Anti-inflammatory.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da5eb7c5-7e17-4707-922d-cf8e68ee440c.json
da7b1800-d9f0-4cc8-b6fa-9a0a55e0fc95,CARNITINE SOLUTION  30%,prescription,A16AA01,LEVOCARNITINE,174,,,WHO ATC Classification,,ILS,solution,LEVOCARNITINE,2025-07-31T00:55:56.999211,IL,טבע,,45.2648,38.36,28.0,,7290008096669,CARNITINE 30% 20ML,3609,,27559,BOTTLE GLASS TYPE III,units,20.0,119 07 23815 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Systemic and myopathic carnitine deficiency.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da7b1800-d9f0-4cc8-b6fa-9a0a55e0fc95.json
da91c699-c785-46aa-8c0f-f841548db291,REMODULIN 10 MG/ML,prescription,B01AC21,TREPROSTINIL,6724,,,WHO ATC Classification,,ILS,solution for injection,TREPROSTINIL AS SODIUM/ML,2025-07-31T07:23:57.945806,IL,רפא,,47984.62452,40664.93784,36968.12531,,7290008016629,REMODULIN 10MG/ML VIAL 1X20ML,,,55070,VIAL GLASS,units,1.0,135 55 31251 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Remodulin is indicated as a continuous subcutaneous infusion or  intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders.   Pulmonary hypertension associated with congenital systemic to pulmonary shunts.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da91c699-c785-46aa-8c0f-f841548db291.json
da934fb1-2a67-4a4c-8597-9f27e9a5f216,DES-LORATADIM,off-the-counter,R06AX27,DESLORATADINE,5065,,,WHO ATC Classification,,ILS,tablets,DESLORATADINE,2025-07-31T12:22:52.660552,IL,כ.צ.ט,,59.0,50.0,nan,,,LORATADIM 10MG 20TAB,12074,,,BLISTER ALU/PVC/TE/PVDC,units,20.0,152 01 32034 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Des-Loratadim is indicated for the relief of symptoms associated with allergic rhinitis, urticaria.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da934fb1-2a67-4a4c-8597-9f27e9a5f216.json
da9d9c5e-287a-41f7-a83e-f8c48179be54,NUROFEN GEL 5 %,off-the-counter,M02AA13,IBUPROFEN,5198,,,WHO ATC Classification,,ILS,gel,IBUPROFENW/W,2025-07-31T12:37:25.121416,IL,רקיט בנקיזר,,26.137,22.15,nan,,5000158100800,NUROFEN FOR CHILDREN STRABERRY SYR 100ML,14459,,,TUBE ALUMINIUM,units,100.0,134 23 31074 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/da9d9c5e-287a-41f7-a83e-f8c48179be54.json
daaf105f-80b9-4cdf-8dae-1f3efe1e1ed7,DULOXETINE SANDOZ ® 30 MG GRC,prescription,N06AX21,DULOXETINE,9065,,,WHO ATC Classification,,ILS,gastro resistant capsules,DULOXETINE AS HYDROCHLORIDE,2025-07-31T02:06:20.399603,IL,סנדוז,,66.01605934,55.945813,41.5954,,,DULOXETINE SANDOZ 30 MG 28 CAPS,,,,BLISTER PVC/PE/PCTFE/AL,units,28.0,167 67 35796 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Duloxetine Sandoz is indicated for - The treatment of major depressive episodes.- The management of neuropathic pain associated with diabetic peripheral neuropathy.- The treatment of generalized anxiety disorder (GAD).- The management of fibromyalgia.- The management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. This has been established in studies in patients with chronic low back pain (CLBP) and chronic pain due to osteoarthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/daaf105f-80b9-4cdf-8dae-1f3efe1e1ed7.json
dab0acc7-7b12-4bd7-bc74-87ad9195b6ff,SEVORANE,prescription,N01AB08,SEVOFLURANE,7995,,,WHO ATC Classification,,ILS,liquid for inhalation,SEVOFLURANE,2025-07-31T08:09:26.732880,IL,אב-וי,,669.1693076,567.0926588,482.63205,,8054083015781,SEVORANE BOTTLE 250 ML,,,77626,BOTTLE AMBER PEN,units,250.0,106 99 28917 01,valid,17.5,inhalation,1.4,36,,,,,,,,,,0,Prescription required,Sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dab0acc7-7b12-4bd7-bc74-87ad9195b6ff.json
dad5c3ae-dd07-4d6c-99ea-342090f7eb1a,PEMETREXED TARO 100 MG,prescription,L01BA04,PEMETREXED,8476,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,PEMETREXED/VIAL,2025-07-31T06:32:38.211582,IL,תרו,,1074.694452,910.75801,775.1132,,7290017164151,PEMETREXED TARO 100 MG VIAL,,,68641,VIAL GLASS TYPE I,units,1.0,163 33 35358 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,1.Pemetrexed Taro in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. 2.Pemetrexed Taro in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. 3.Pemetrexed Taro is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.4.Pemetrexed Taro is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dad5c3ae-dd07-4d6c-99ea-342090f7eb1a.json
dae64050-e884-4ed4-96ae-444e0f2df170,NUROFEN GEL 5 %,off-the-counter,M02AA13,IBUPROFEN,5197,,,WHO ATC Classification,,ILS,gel,IBUPROFENW/W,2025-07-31T12:38:14.247214,IL,רקיט בנקיזר,,40.8516,34.62,nan,,5000158100800,NUROFEN GEL 5% 50GR,14446,,,TUBE ALUMINIUM,units,50.0,134 23 31074 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dae64050-e884-4ed4-96ae-444e0f2df170.json
db062860-85b8-452a-9c6b-1a4d53b6d342,BRIVIACT 10 MG FILM COATED TABLETS,prescription,N03AX23,BRIVARACETAM,8361,,,WHO ATC Classification,,ILS,film coated tablets,BRIVARACETAM,2025-07-30T23:43:58.910632,IL,ניאופרם,,120.5195942,102.1352539,75.93699171,,,BRIVIACT 10 MG 14 TABLETS,2624,,64856,BLISTER PVC/PCTFE/AL,units,14.0,159 88 35241 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/db062860-85b8-452a-9c6b-1a4d53b6d342.json
db29e31b-0774-4d35-9b8f-cb184e8bdb31,IMBRUVICA 140 MG TABLETS,prescription,L01XE27,IBRUTINIB,7394,,,WHO ATC Classification,,ILS,film coated tablets,IBRUTINIB,2025-07-31T04:00:20.367447,IL,יאנסן סילג,,24997.89414,21184.65699,19258.77908,,7290014577688,IMBRUVICA 140MG 90CAPSULES,9757,,51487,BLISTER PVC/PCTFE/AL,units,90.0,167 61 36458 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"•	Mantle Cell Lymphoma:Imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.•	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma :Imbruvica is indicated for the treatment of adult patients, with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)•	Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) with 17p deletion:Imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)  /Small Lymphocytic Lymphoma (SLL) with 17p deletion.•	Waldenström’s MacroglobulinemiaImbruvica is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).•	Marginal Zone LymphomaIMBRUVICA is indicated for the treatment of adult patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.•	Chronic Graft versus Host DiseaseIMBRUVICA is indicated for the treatment of adult patients with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/db29e31b-0774-4d35-9b8f-cb184e8bdb31.json
db2bb610-24ed-4700-a4d1-57c134365ec8,CLOPIXOL DROPS,prescription,N05AF05,ZUCLOPENTHIXOL,627,,,WHO ATC Classification,,ILS,solution,ZUCLOPENTHIXOL AS DIHYDROCHLORIDE/ML,2025-07-31T01:23:52.078990,IL,לנדבק,,41.00059536,34.7462688,25.36224,,,CLOPIXOL DROPS 20ML,3864,,8220,BOTTLE GLASS TYPE III,units,20.0,047 87 25488 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute schizophrenia and other acute psychoses.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/db2bb610-24ed-4700-a4d1-57c134365ec8.json
db2ef4c7-bc78-42e7-ba6a-09b031cf7a38,OTRIVIN,off-the-counter,R01AA07,XYLOMETAZOLINE,5411,,,WHO ATC Classification,,ILS,nasal solution,XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V,2025-07-31T12:42:09.554154,IL,ג.ס.ק,,40.5802,34.39,nan,,7290006603036,OTRIVIN COMPLETE NASAL SPRAY 10ML,,,,BOTTLE METERED DOSE SPRAY POLYETHYLENE,units,10.0,115 43 22229 00,valid,nan,nasal,1.4,36,,,,,,,,,,0,,Rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/db2ef4c7-bc78-42e7-ba6a-09b031cf7a38.json
db333406-bb8c-469c-86e5-0016327725be,LITORVA 10,prescription,C10AA05,ATORVASTATIN,6759,,,WHO ATC Classification,,ILS,tablets,ATORVASTATIN AS CALCIUM,2025-07-31T04:50:39.052660,IL,דקסל פארמה,,54.31921494,46.033233,33.6009,,7290010578429,LITORVA 40MG 30 TAB,12451,,26469,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,145 31 33305 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Litorva is indicated as an adjunct to diet for reduction of elevated total cholesterol LDL- cholesterol apolipoprotein B and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Litorva is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable. Pediatric patients (10-17 years of age) : Atorvastatin is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present:  1. LDL-C remains >or = 190 mg/dl or   2. LDL-C remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the pediatric patient. Prevention of cardiovascular and/or cerebrovascular event sush as MI or stroke as an adjunct to correction of other risk factors such as hypertension in patients with three or more additional risk factors or diabetes with one additional risk factor. In patients with clinically evident coronary heart disease, Litorva is indicated to : Reduce the risk of non-fatal myocardial infarction. Reduce the risk of fatal and non fatal stroke. Reduce the risk for revascularization procedures. Reduce the risk of hospitalization for CHF. Reduce the risk of angina.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/db333406-bb8c-469c-86e5-0016327725be.json
db527814-d4f1-41bb-a3d0-6bde771ae13c,ALCOSEPT,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5238,,,WHO ATC Classification,,ILS,solution,"CHLORHEXIDINE GLUCONATE 0.5 %W/V, ALCOHOLW/V",2025-07-31T11:10:29.240333,IL,פלוריש,,35.5888,30.16,nan,,7290008110181,ALCOSEPT 500ML,,,,BOTTLE HDPE,units,500.0,129 67 30806 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,Skin antiseptic.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/db527814-d4f1-41bb-a3d0-6bde771ae13c.json
db55de44-5095-419c-9c06-bc47ff979a2f,AQUIMOD CREAM 5 %,prescription,D06BB10,IMIQUIMOD,6876,,,WHO ATC Classification,,ILS,cream,IMIQUIMOD,2025-07-31T00:21:46.282137,IL,תרו,,268.385985,227.44575,181.9566,,7290012066337,AQUIMOD CREAM 5 % 12SACHET (0.25G),9502,,19683,SACHET ALUMINIUM,units,12.0,144 90 33114 00,valid,25.0,dermal,1.4,24,,,,,,,,,,0,Prescription required,Indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients. For the treatment of actinic keratoses in adults with normal immune systems. For the treatment of superficial basal cell carcinoma in adults with normal immune systems when surgical methods are less appropriate.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/db55de44-5095-419c-9c06-bc47ff979a2f.json
db7901ad-7c49-494c-9789-e2349a878964,CLOXACILLIN - MEDO 1 GR,prescription,J01CF02,CLOXACILLIN,8624,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,CLOXACILLIN AS SODIUM/VIAL,2025-07-31T01:24:03.120748,IL,מדי מרקט,,79.96440079,67.76644436,50.3839735,,,CLOXACILLIN - MEDO 500 MG 10 VIALS,,,11432,VIAL GLASS TYPE III,units,10.0,170 15 36456 99,valid,34.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Cloxacillin is indicated for the treatment of sensitive staphylococcal infections: respiratory infections, otorhinolaryngologic infections, renal infections, urogenital infections, neuro-meningeal infections, bone and joint infections, endocarditis, and treatment of skin infections caused by sensitive staphylococci and/or streptococci. Cloxacillin is also indicated as preventive treatment of postoperative infections in neurosurgery.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/db7901ad-7c49-494c-9789-e2349a878964.json
dbb809df-e16f-4446-b95f-da114c98880f,RUPAFIN TABLETS,prescription,R06AX28,RUPATADINE,8535,,,WHO ATC Classification,,ILS,tablets,RUPATADINE AS FUMARATE,2025-07-31T07:53:45.528839,IL,קמהדע,,31.02879108,26.29558683,19.193859,,7290011225797,RUPAFIN 10 MG 30 TAB,,,31015,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,164 90 35494 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Rupafin is indicated for symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (over 12 years of age),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dbb809df-e16f-4446-b95f-da114c98880f.json
dbbef2d4-3fd7-4723-8d1a-f2ec74c9e619,SUNOSI 150 MG,prescription,N06BA14,SOLRIAMFETOL,9302,,,WHO ATC Classification,,ILS,film coated tablets,SOLRIAMFETOL AS HYDROCHLORIDE,2025-07-31T08:53:06.893374,IL,ניאופרם,,1123.030431,951.7207466,809.9751035,,,SUNOSI 75 MG 28 FILM COATED TABLETS,23260,,43132,BLISTER PVC/PCTFE,units,28.0,172 81 37285 99,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy).Sunosi is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by primary OSA therapy, such as continuous positive airway pressure (CPAP).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dbbef2d4-3fd7-4723-8d1a-f2ec74c9e619.json
dbefe14f-09c9-4cfc-be7b-e017022fa86e,ESRACAIN INJECTION 1%,prescription,N01BB02,LIDOCAINE,4254,,,WHO ATC Classification,,ILS,solution for injection,LIDOCAINE HYDROCHLORIDE/ML,2025-07-31T02:37:17.574667,IL,רפא,,236.361965,200.30675,160.2454,,7290008013352,ESRACAIN 1% 50AMP/10ML,5139,,35241,AMPOULES GLASS,units,50.0,019 20 21029 00,valid,25.0,"i.m, epidural, s.c, intradermal, submucosal, spinal, perineural, i.v regional anaesthesia",1.4,36,,,,,,,,,,0,Prescription required,Local and regional anesthesia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dbefe14f-09c9-4cfc-be7b-e017022fa86e.json
dbf7e055-a1f1-4076-a06f-0e794e50f522,ENSPRYNG,prescription,L04AC19,SATRALIZUMAB,8766,,,WHO ATC Classification,,ILS,solution for injection,SATRALIZUMAB/,2025-07-31T02:22:38.904280,IL,רוש,,35867.92035,30396.54402,27633.22184,,,ENSPRYNG 120MG/ML 1 PREF SYR,,,,SYRINGE PREFILLED  POLYMER,units,1.0,169 11 36563 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Enspryng is indicated as a monotherapy or in combination with immunosuppressive therapy (IST) for the treatment of neuromyelitis optica spectrum disorders (NMOSD) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 IgG (AQP4-IgG) seropositive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dbf7e055-a1f1-4076-a06f-0e794e50f522.json
dc0c6e8e-8c9b-4da0-beea-057124028d25,CAMZYOS 10 MG,prescription,C01EB24,MAVACAMTEN,9503,,,WHO ATC Classification,,ILS,capsules,MAVACAMTEN,2025-07-31T00:50:47.703582,IL,ב.מ.ס,,7718.263193,6540.901302,5946.273911,,,CAMZYOS 10 MG 28 CAPS,,,,BLISTER PVC/PCTFE(ACLAR)/ALUMINIUM,units,28.0,174 20 37421 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc0c6e8e-8c9b-4da0-beea-057124028d25.json
dc111cab-4475-4d38-8419-a5c4d16918d0,LISSIN 20 MG,prescription,N06BA12,LISDEXAMFETAMINE,9526,,,WHO ATC Classification,,ILS,tablets,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T04:49:03.072452,IL,אוניפארם,,351.5754452,297.9453058,253.570473,,,LISSIN 30 MG 30 TAB,,,37686,BLISTER PVDC/ALUMINIUM,units,30.0,176 71 37820 99,valid,17.5,per os,1.4,18,,,,,,,,,,0,Prescription required,Lissin is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Lissin is indicated for the treatment of Moderate to Severe Binge Eating Disorder (BED) for patients over 18 years.Limitation of Use:Lissin is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Lissin for the treatment of obesity have not been established.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc111cab-4475-4d38-8419-a5c4d16918d0.json
dc13bae6-e2fa-43a0-ba34-ea38a77df0b5,KEPPRA 1000 MG,prescription,N03AX14,LEVETIRACETAM,4848,,,WHO ATC Classification,,ILS,film coated tablets,LEVETIRACETAM,2025-07-31T04:24:40.105465,IL,כ.צ.ט,,147.6547375,125.1311335,93.0343,,,KEPPRA 500MG 60TAB,11192,,63356,BLISTER PVC/ALUMINIUM,units,60.0,132 66 31183 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,- Keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. - Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - Keppra is indicated as adjunctive therapy in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc13bae6-e2fa-43a0-ba34-ea38a77df0b5.json
dc37f833-3ddf-4cae-b9d8-30bc17b10156,LEPONEX 100 MG TABLETS,prescription,,,3301,,,,,ILS,tablets,CLOZAPINE,2025-07-31T04:39:47.288765,IL,דקסל פארמה,,101.4582243,85.981546,63.9268,,8904182702795,LEPONEX 100MG 50TAB,12020,,23379,BLISTER PVC/PE/PVDC,units,50.0,047 98 23148 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"For treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for diath.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc37f833-3ddf-4cae-b9d8-30bc17b10156.json
dc417880-7c97-48cd-a1eb-392b6d4dec6e,MVASI,prescription,L01FG01,BEVACIZUMAB,8967,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BEVACIZUMAB/,2025-07-31T05:36:29.458662,IL,מדיסון,,3537.913711,2998.232092,2725.665538,,8715131022426,MVASI 400MG 25MG/ML VIAL 16ML,,,60700,VIAL GLASS TYPE I,units,1.0,164 30 35864 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"MVASI in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum.MVASI in addition to platinum - based chemotherapy is indicated for first - line treatment of adult patients with unresectable advanced metastatic or recurrent non- small cell lung cancer other than predominantly squamous cell histology.MVASI in combination with interferon alfa-2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer.MVASI in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer. MVASI as a single agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.MVASI in combination with carboplatin and paclitaxel, is indicated for the front-line treatment of advanced (FIGO stages IIIB, IIIC and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients who are at high risk for recurrence (residual disease after debulking).MVASI  in combination with carboplatin and gemcitabine, is indicated for the treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor-targeted agents.MVASI in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin isindicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents.MVASI in combination with paclitaxel and cisplatin or paclitaxel and topotecan is indicated, in patients who cannot receive platinum therapy, for treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.MVASI, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc417880-7c97-48cd-a1eb-392b6d4dec6e.json
dc4de08e-069e-45e5-8522-3ad6bc0bb70e,SOOLANTRA,prescription,P02CF01,IVERMECTIN,8790,,,WHO ATC Classification,,ILS,cream,IVERMECTINW/W,2025-07-31T08:31:31.455144,IL,אמי טכנולוגיות,,9.515045547,8.063598279,5.88583816,,,SOOLANTRA 10 MG/G CREAM 2 G,,,,TUBE PE/AL/PE,units,2.0,167 59 36606 99,valid,37.0,topical,1.4,24,,,,,,,,,,0,Prescription required,Soolantra is indicated in the topical treatment of inflammatory (papulopustular) lesions caused by rosacea in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc4de08e-069e-45e5-8522-3ad6bc0bb70e.json
dc52d696-9c36-4957-8545-68983d61a6da,XENAZINE 25 MG,prescription,N07XX06,TETRABENAZINE,4873,,,WHO ATC Classification,,ILS,tablets,TETRABENAZINE,2025-07-31T10:32:54.120802,IL,ניאופרם,,581.4777826,492.7778038,419.3853649,,7290111091919,XENAZINE 25MG 112TAB,24029,,61821,BOTTLE HDPE,units,112.0,132 07 31010 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Movement disorders, associated with organic central nervous system conditions, e.g. Huntington's chorea, hemiballismus and senile chorea.Moderate to severe tardive dyskinesia, which is disabling and/or socially embarrassing. The condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc52d696-9c36-4957-8545-68983d61a6da.json
dc576fbf-bc2b-41a3-bd78-d47282a36617,PECFENT 100,prescription,N01AH01,FENTANYL,8350,,,WHO ATC Classification,,ILS,"nasal spray, solution",FENTANYL AS CITRATE/SPRAY,2025-07-31T06:31:05.968279,IL,מדיסון,,858.8772787,727.8621329,619.4571344,,,PECFENT 100 4 BOTTLE *8 doses,16934,,77041,BOTTLE GLASS TYPE I,units,32.0,152 59 33975 01,valid,17.5,nasal,1.4,36,,,,,,,,,,0,Prescription required,"PecFent is indicated for the management of breakthrough pain (BTP) in adults who are already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain  that occurs on a background of otherwise controlled persistent pain.Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc576fbf-bc2b-41a3-bd78-d47282a36617.json
dc58ec13-011d-447e-9094-f82837aaee7d,EKLIRA GENUAIR INHALER 60 DOSES (322MCG/DOSE),prescription,,,7363,,,,,ILS,tablet,EKLIRA GENUAIR INHALER 60 DOSES (322MCG/DOSE),2025-07-31T19:05:32.442961,IL,אסטראזנקה,,164.3343727,139.2664238,111.413139,,,EKLIRA GENUAIR INHALER 60 DOSES (322MCG/DOSE),5624,,53969,,units,60.0,,not-registered,25.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc58ec13-011d-447e-9094-f82837aaee7d.json
dc5f89eb-7f18-4c54-ad0a-cc7f46a135f7,ZEBINIX 200 MG,prescription,N03AF04,ESLICARBAZEPINE,9311,,,WHO ATC Classification,,ILS,tablets,ESLICARBAZEPINE ACETATE,2025-07-31T10:44:34.293051,IL,תרומד,,352.0548475,298.3515789,253.9162374,,,ZEBINIX 200 MG 60 TAB,,,2587,BLISTER PVC/ALUMINIUM,units,60.0,170 76 37082 99,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Zebinix is indicated as:• monotherapy in the treatment of partial-onset seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;• adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc5f89eb-7f18-4c54-ad0a-cc7f46a135f7.json
dc64bccb-dcb9-4117-8dc9-eacc8fbfe12f,MAXIBONE 70,prescription,M05BA04,ALENDRONIC ACID,4788,,,WHO ATC Classification,,ILS,tablets,ALENDRONATE AS SODIUM,2025-07-31T05:06:37.247163,IL,אוניפארם,,44.52940866,37.736787,27.5451,,,MAXIBONE 70MG  4TAB,13528,,11422,BLISTER PVDC/ALUMINIUM,units,4.0,131 98 31048 02,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Maxibone is indicated for the treatment of osteoporosis in postmenopausal women to prevent  fractures, including those of the hip and spine (vertebral compression fractures).Treatment to increase bone mass in men with osteoporosis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc64bccb-dcb9-4117-8dc9-eacc8fbfe12f.json
dc80ed15-4cb0-4290-87f0-19579e360e8f,ZYVOXID 600 MG,prescription,J01XX08,LINEZOLID,4399,,,WHO ATC Classification,,ILS,tablets,LINEZOLID,2025-07-31T10:58:04.465744,IL,פיזר,,936.8429725,793.9347577,675.6891555,,7298074160208,ZYVOXID 600MG 10TAB,26116,,54453,BLISTER PVC/ALUMINIUM,units,10.0,122 61 30245 01,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Therapy is indicated only when an organism resistant to all other antibiotics is suspected. Zyvoxid is indicated in adult and pediatric patients for the treatment of  infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as:   1) Pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (MDRSP).   2) Skin and soft tissue infections including diabetic foot infections.   3) Enterococcal infections.   Combination therapy may be indicated if a concomitant Gram negative pathogen is documented or suspected.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc80ed15-4cb0-4290-87f0-19579e360e8f.json
dc92d3e1-acc6-436e-a4ea-8cad422a9b20,SYNTHOMYCINE 3 %,prescription,D10AF03,CHLORAMPHENICOL,1423,,,WHO ATC Classification,,ILS,ointment,CHLORAMPHENICOL,2025-07-31T08:56:17.792925,IL,רקח,,nan,nan,nan,,7290008001311,SYNTHOMYCINE 5% OINT 3.6G,19207,,2089,TUBE ALUMINIUM,units,3.6,025 11 20849 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dc92d3e1-acc6-436e-a4ea-8cad422a9b20.json
dca4e421-4a0a-4cb1-b345-826f0fe01bdf,ALCOHOL 70 % VITAMED,off-the-counter,D08AX08,ETHANOL,3748,,,WHO ATC Classification,,ILS,solution - external,ALCOHOL,2025-07-31T11:09:22.862605,IL,פלוריש,,59.5192,50.44,nan,,,ALCOHOL 70% 1L,1007,,,BOTTLE HDPE,units,1000.0,128 31 30731 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dca4e421-4a0a-4cb1-b345-826f0fe01bdf.json
dcac97ce-d3f1-46e7-9b2a-6b7c0031ef79,SIMVACOR 20,prescription,C10AA01,SIMVASTATIN,3863,,,WHO ATC Classification,,ILS,film coated tablets,SIMVASTATIN,2025-07-31T08:14:25.421961,IL,אוניפארם,,23.56533986,19.970627,14.5771,,,SIMVACOR 20 20MG 30TAB,19433,,2765,BLISTER PVC/ALUMINIUM,units,30.0,121 26 30128 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia  Simvacor is indicated to: Reduce the risk of total mortality by reducing coronary death Reduce the risk of non-fatal myocardial infarction Reduce the risk for undergoing myocardial revascularization procedures.Reduce the risk of stroke and transient ischemic attacks (TIA).Hyperlipidemia: Simvacor is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvacor therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios.Homozygous familial hypercholesterolemia: Simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Simvacor is indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dcac97ce-d3f1-46e7-9b2a-6b7c0031ef79.json
dcb2a028-014d-4d08-b4ef-456dfc92c03a,PREGABALIN TARO 100 MG,prescription,N03AX16,PREGABALIN,8172,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:54:17.151996,IL,תרו יבוא,,123.5665273,104.717396,77.8568,,,PREGABALIN TARO 75 MG 56CAPS,,,59197,BLISTER PVC/ALUMINIUM,units,56.0,158 26 34762 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Pregabalin taro is indicated for the: •	Treatment of peripheral and central neuropathic pain in adults. •	Management of Fibromyalgia. •	Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dcb2a028-014d-4d08-b4ef-456dfc92c03a.json
dd0620b1-fa0b-43b7-a674-84c5ad68a02c,IMPAVIDO 10 MG,prescription,L01XX09,MILTEFOSINE,7591,,,WHO ATC Classification,,ILS,"capsule, hard",MILTEFOSINE,2025-07-31T04:04:03.147427,IL,מגאפארם,,4353.761298,3689.628382,3354.20762,,7290014573154,IMPAVIDO 10MG 56CAPS,9902,,32907,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,154 05 34311 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,-Treatment of visceral Leishmaniasis caused by Leishmania donovani. -Treatment of cutaneous Leishmaniasis caused by Leishmania brasiliensis complex or Leishmania mexicana complex.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dd0620b1-fa0b-43b7-a674-84c5ad68a02c.json
dd1ffa4a-9e78-4586-8eaa-2ae12263c5ef,COLUMVI,29C,L01FX28,GLOFITAMAB,21018,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,GLOFITAMAB/,2025-07-31T14:10:09.096549,IL,nan,,nan,nan,nan,,7290014774278,COLUMVI 1MG/ML VIAL 10 ML,,,,VIAL GLASS TYPE I,units,10.0,176 69 37772 00,valid,nan,i.v,1.4,30,,,,,,,,,,0,,"Columvi is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B cell lymphoma after two or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dd1ffa4a-9e78-4586-8eaa-2ae12263c5ef.json
dd316d7a-ae9c-4443-bfba-b59930815852,ENALAPRILAT 1.25MG/ML INJECTION,29C,,,21010,,,,,,injection,ENALAPRILAT 1.25MG/ML INJECTION,2025-07-31T20:21:17.388162,IL,nan,,,,,,,ENALAPRILAT 1.25MG/ML INJECTION,,,,,units,1.25,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dd316d7a-ae9c-4443-bfba-b59930815852.json
dd424b6c-0df1-49e9-8036-69642e4e4017,XROFEN ORANGE SUGAR FREE,29C,S01BC04,FLURBIPROFEN,20840,,,WHO ATC Classification,,ILS,lozenges,FLURBIPROFEN 8.75  MG,2025-07-31T14:37:02.628249,IL,nan,,nan,nan,nan,,,FLURBIPROFEN 100MG MYLAN USA   100TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,176 33 36543 99,valid,nan,per os,1.4,24,,,,,,,,,,0,,XROFEN ORANGE SUGAR FREE is indicated for the short term relief of symptoms of sore throat such as throat pain and soreness in adults and children over the age of 12 years.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dd424b6c-0df1-49e9-8036-69642e4e4017.json
dd45b88b-f177-457e-b6d8-d47bf9b80365,FULVENIR,prescription,L02BA03,FULVESTRANT,9087,,,WHO ATC Classification,,ILS,solution for injection,FULVESTRANT/ML,2025-07-31T03:21:39.936155,IL,ביואבניר,,973.4604421,824.9664764,702.0991288,,,FULVENIR  250 MG/5 ML 2 PFS,,,81403,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,168 64 36677 99,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Monotherapy :FulVenir is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:not previously treated with endocrine therapy, or with disease relapse on or after adjuvant endocrine therapy; or disease progression on endocrine therapy. Combination Therapy with Palbociclib: FulVenir is indicated for the treatment of HR-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dd45b88b-f177-457e-b6d8-d47bf9b80365.json
dd570a1e-4d37-410b-83ac-e90bfb50b814,VIAGRA 100 MG,prescription,G04BE03,SILDENAFIL,3716,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:12:56.663384,IL,דקסל פארמה,,80.65023231,68.3476545,50.8161,,7290008108812,VIAGRA 50MG 4TAB,22108,,33393,BLISTER PVC/ALUMINIUM,units,4.0,111 38 29461 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dd570a1e-4d37-410b-83ac-e90bfb50b814.json
dd915d06-7afb-448f-b827-41f46a9b14cc,METADEX XR 10 MG,prescription,N06BA11,DEXMETHYLPHENIDATE,9228,,,WHO ATC Classification,,ILS,capsules extended release,DEXMETHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:16:12.168065,IL,SK PHARM(KS KIM),,nan,nan,nan,,,METADEX XR 40 MG S.K. 100 CAPSULES,,,,BOTTLE HDPE,units,100.0,172 56 37337 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Metadex XR extended-release capsules are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dd915d06-7afb-448f-b827-41f46a9b14cc.json
ddb4f581-6c62-4807-bb7d-caf03d25003c,POLYDINE TINCTURE,off-the-counter,D08AG02,POVIDONE-IODINE,1829,,,WHO ATC Classification,,ILS,tincture,POVIDONE-IODINEW/V,2025-07-31T12:51:25.590776,IL,פישר,,58.9056,49.92,nan,,7290000849188,POLYDINE TINCTURE 1L,16184,,,BOTTLE HDPE,units,1000.0,044 36 23412 00,valid,nan,dermal,1.4,60,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ddb4f581-6c62-4807-bb7d-caf03d25003c.json
ddd68ee1-d990-44ad-bde5-05442144aae2,VYNDAQEL,prescription,N07XX08,TAFAMIDIS,7750,,,WHO ATC Classification,,ILS,capsules soft gelatin,TAFAMIDIS AS MEGLUMINE 12.2  MG,2025-07-31T10:23:54.859582,IL,פיזר,,43939.52482,37236.88709,33851.71554,,7290013592163,VYNDAQEL 20MG 30 CAPS,22417,,60532,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,154 10 34016 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of transthyretin amyloidosis in adult patients with stage 1 symptomatic polyneuropathy to delay peripheral neurologic impairment.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ddd68ee1-d990-44ad-bde5-05442144aae2.json
dde143ee-20d1-4b10-8fb9-af26c83b3885,REVLIMID ® 10 MG,prescription,L04AX04,LENALIDOMIDE,6277,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE,2025-07-31T07:31:04.336167,IL,ניאופרם,,24330.36379,20618.95236,18744.50215,,7640133681382,REVLIMID 25MG 21CAPS,18464,,83867,BLISTER PVC/PCTFE,units,21.0,140 46 31661 11,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM) Revlimid is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes REVLIMID is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Revlimid 7.5 mg is not indicated for treatment in MDS.Mantle Cell LymphomaREVLIMID is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphomaRevlimid in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dde143ee-20d1-4b10-8fb9-af26c83b3885.json
dde4caae-c395-4f29-b070-0e2130b9b366,ENTRESTO 100 MG,prescription,C09DX04,VALSARTAN AND SACUBITRIL,7789,,,WHO ATC Classification,,ILS,film coated tablets,SACUBITRIL/VALSARTAN AS SODIUM SALT COMPLEX 49/51  MG,2025-07-31T02:24:35.630589,IL,נוברטיס פארמה,,285.5248431,241.970206,205.9320902,,290014257498,ENTRESTO 50 MG 28 F.C.TAB,5596,,32618,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,154 98 34485 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Entresto is indicated for the treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction. Entresto has been shown to reduce the rate of cardiovascular death and heart failure hospitalisation compared to angiotensin converting enzyme (ACE) inhibitor therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dde4caae-c395-4f29-b070-0e2130b9b366.json
dde77e2c-f9d5-428b-9153-96858131fdd7,ABEVMY,prescription,L01FG01,BEVACIZUMAB,9534,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BEVACIZUMAB/,2025-07-30T23:09:42.674178,IL,דקסל פארמה,,944.0973032,800.0824959,680.9212731,,7290015912839,ABEVMY 100MG/4ML 1 VIAL,,,38716,VIAL GLASS TYPE I,units,1.0,175 88 37178 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Abevmy in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of patients with metastatic carcinoma of the colon or rectum.Abevmy in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer.Abevmy, in addition to platinum-based chemotherapy, is indicated for first-line treatment of patients with unresectable advanced, metastatic or recurrent non-small cell lung cancer other than predominantly squamous cell histology.Bevacizumab in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations.Abevmy in combination with interferon alfa-2a is indicated for first line treatment of patients with advanced and/or metastatic renal cell cancer.Abevmy, as a single agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.Abevmy, in combination with carboplatin and paclitaxel is indicated for the front-line treatment of advanced ([FIGO] stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are at high risk for recurrence (residual disease after debulking).Abevmy, in combination with carboplatin and gemcitabine, is indicated for treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents.Bevacizumab in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents .Abevmy, (bevacizumab) in combination with paclitaxel and cisplatin or, paclitaxel and topotecan, is indicated for the treatment of patients with persistent, recurrent, or metastatic carcinoma of the cervix.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dde77e2c-f9d5-428b-9153-96858131fdd7.json
ddf17dc5-a049-47ea-bc9b-6cf7980ee516,BUTRANS 10,prescription,,,6617,,,,,ILS,patches matrix,BUPRENORPHINE,2025-07-31T00:47:22.663944,IL,רפא,,68.46879074,58.02440151,43.14081897,,7290008012546,BUTRANS 10MG 2 PATCHES,2476,,14909,POUCH ALUMINIUM,units,2.0,135 71 31152 00,valid,34.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ddf17dc5-a049-47ea-bc9b-6cf7980ee516.json
de05a6b2-c06e-4cd3-a70b-564d86e72fd9,TRASENTAN 125,prescription,C02KX01,BOSENTAN,8225,,,WHO ATC Classification,,ILS,tablets,BOSENTAN AS MONOHYDRATE,2025-07-31T09:36:01.102015,IL,רפא,,5598.665923,4744.632138,4313.301944,,7290008016865,TRASENTAN 125MG 60 TABLETS,,,5271,BLISTER PVC/PCTFE/AL,units,60.0,157 20 34656 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of pulmonary arterial hypertension (PAH) in patients of WHO functional class II-IV. Reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de05a6b2-c06e-4cd3-a70b-564d86e72fd9.json
de1baae1-84a2-4996-b993-6ca703ce06af,LOJUXTA 10 MG,prescription,C10AX12,LOMITAPIDE,8960,,,WHO ATC Classification,,ILS,"capsule, hard",LOMITAPIDE AS MESYLATE,2025-07-31T04:53:06.588618,IL,מדיסון,,113841.3214,96475.70035,87705.18214,,7290008128629,LOJUXTA 20 MG 28 tab,,,44057,BOTTLE HDPE,units,28.0,152 86 33998 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"An adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de1baae1-84a2-4996-b993-6ca703ce06af.json
de1d1d91-1575-4ffe-a554-7ab25b2479ba,EPANUTIN 100 MG,prescription,N03AB02,PHENYTOIN,437,,,WHO ATC Classification,,ILS,capsules,PHENYTOIN SODIUM,2025-07-31T02:25:17.959822,IL,דקסל פארמה,,24.752784,20.97693653,15.3116325,,,EPANUTIN 100MG 100CAPS,5023,,6906,BOTTLE HDPE,units,100.0,104 27 24678 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of epilepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de1d1d91-1575-4ffe-a554-7ab25b2479ba.json
de1f439b-4275-4022-a0e5-6c21082a1d15,RIVASTIGMINE DEXCEL 1.5 MG,prescription,N06DA03,RIVASTIGMINE,7554,,,WHO ATC Classification,,ILS,"capsule, hard",RIVASTIGMINE AS HYDROGEN TARTRATE 1.5  MG,2025-07-31T07:45:08.507169,IL,דקסל פארמה,,117.9535894,99.960669,74.3202,,,RIVASTIGMINE DEXCEL 6 MG 28 CAPSULES,18513,,58853,BLISTER PVC/ALUMINIUM,units,28.0,152 77 33949 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of patients with mild to moderately severe dementia of the Alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.Symptomatic treatment of mild to moderately severe alzheimer's dementia.Symptomatic treatment of mild to moderately severe dementiaassociated with Parkinson's disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de1f439b-4275-4022-a0e5-6c21082a1d15.json
de2176dd-8719-4c4a-bc50-e3358edca563,FEMARA,prescription,L02BG04,LETROZOLE,3637,,,WHO ATC Classification,,ILS,film coated tablets,LETROZOLE 2.5  MG,2025-07-31T02:55:51.864967,IL,נוברטיס פארמה,,229.99616,194.912,155.9296,,7298120015308,FEMARA 2.5MG 30TAB,6094,,85227,BLISTER PVC/PE/PVDC/AL,units,30.0,109 86 29281 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Femara (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined  locally advanced or metastatic breast cancer. Femara is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.  Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy.   Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de2176dd-8719-4c4a-bc50-e3358edca563.json
de5a8bd5-3411-414a-8ecb-8c662030fb80,NOCTURNO FORTE 7.5,prescription,N05CF01,ZOPICLONE,3627,,,WHO ATC Classification,,ILS,tablets,ZOPICLONE 7.5  MG,2025-07-31T05:50:06.257302,IL,אוניפארם,,21.1742268,17.94426,13.098,,,NOCTURNO 7.5MG 20TAB,14152,,33365,BLISTER PVC/ALUMINIUM,units,20.0,111 24 29356 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Short-term treatment of insomnia in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de5a8bd5-3411-414a-8ecb-8c662030fb80.json
de5c48c9-37af-4a27-8e77-bc34c64e1593,INSPRA 25 MG,prescription,C03DA04,EPLERENONE,4958,,,WHO ATC Classification,,ILS,film coated tablets,EPLERENONE,2025-07-31T04:08:30.021764,IL,דקסל פארמה,,82.64640097,70.03932597,52.07384831,,,INSPRA 25MG 28TAB,9237,,65824,BLISTER PVC/ALUMINIUM,units,28.0,134 67 31192 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (LVEF < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.Inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with NYHA class II (chronic) heart failure and left ventricular systolic dysfunction (LVEF < or = 30%).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de5c48c9-37af-4a27-8e77-bc34c64e1593.json
de624cdd-eb29-43c6-8437-270187962f35,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5479,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:01:27.819979,IL,טבע,,19.9892,16.94,nan,,7290000800028,ACAMOL TSINUN CLASSIC DAY 21 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,21.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de624cdd-eb29-43c6-8437-270187962f35.json
de66b99b-e111-449f-8a7a-b30311ec50c3,DANTRIUM 25MG 50CAPS,29C,,,20059,,,,,,capsule,DANTRIUM 25MG,2025-07-31T20:10:24.034527,IL,nan,,,,,,,DANTRIUM 25MG 50CAPS,,,,,units,50.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de66b99b-e111-449f-8a7a-b30311ec50c3.json
de6fad41-911c-4a15-91bb-4d1d525921a7,CLOPIDEXCEL 75,prescription,B01AC04,CLOPIDOGREL,6631,,,WHO ATC Classification,,ILS,film coated tablets,CLOPIDOGREL AS BESYLATE,2025-07-31T01:22:12.532982,IL,דקסל פארמה,,53.4981438,45.33741,33.093,,7290010578368,CLOPIDEXCEL 75MG 30 FC TAB,9403,,30171,BLISTER PVC/PE/PVDC/AL,units,30.0,144 29 33118 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Secondary prevention of atherotrombotic eventsClopidogrel is indicated in:•   Adult Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.•   Adult Patients suffering from Acute Coronary Syndrome     -  Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).    -  ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.Prevention of atherothrobmotic and thromboembolic events in atrial fibrillation:In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with Vitamin K antagonists (VKA) Anti-Thrombin or Anti Factor Xa, and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de6fad41-911c-4a15-91bb-4d1d525921a7.json
de751729-e62d-4ebc-94f1-47f0c5f1648f,NORADRENALINE SINTETICA 4 MG/4 ML,prescription,C01CA03,NOREPINEPHRINE,8246,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,NOREPINEPHRINE AS BITARTRATE/ML,2025-07-31T05:50:33.515723,IL,כ.צ.ט,,109.2670736,92.59921904,68.847003,,7290016369359,NORADRENALINE SINTETICA 4MG/4ML  10 AMP,,,,AMPOULES GLASS TYPE I,units,10.0,158 56 34555 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"For blood pressure control in certain acute hypotensive states (e.g., pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, septicemia, blood transfusion, and drug reactions). As an adjunct in the treatment of cardiac arrest and profound hypotension.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de751729-e62d-4ebc-94f1-47f0c5f1648f.json
de7cb8bb-c2e8-4509-b83f-660e788ef104,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,3915,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:32:00.122391,IL,דקסל פארמה,,39.8486,33.77,nan,,,DEXAMOL SINUS D30&N20,4202,,,BLISTER PVC/ALUMINIUM,units,50.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de7cb8bb-c2e8-4509-b83f-660e788ef104.json
de957354-7264-4081-a5b0-df01181d51bb,CORDAMIL 40 MG,prescription,C08DA01,VERAPAMIL,9123,,,WHO ATC Classification,,ILS,film coated tablets,VERAPAMIL HYDROCHLORIDE,2025-07-31T01:30:11.504614,IL,טרוסטפארם,,25.54228,21.646,15.8,,5944708138700,CORDAMIL 40 MG 60TAB,23211,,30322,BLISTER PVC/ALUMINIUM,units,60.0,169 31 36504 99,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Cordamil is indicated for treatment of coronary heart disease, including:- chronic stable angina pectoris (effort angina), - unstable angina pectoris: - aggravated angina, resting angina, vasospastic angina (Prinzmetal angina)   - post heart-attack angina in patients without heart failure, when adrenergic beta-blockers are contraindicated. Prevention of ventricular fast heart rate disorders not controlled by tonic-cardiac glycosides or beta-blockers (for example supraventricular paroxysmal tachycardia, atrial fibrillation/ flutter with rapid ventricular response, except for Wolff-Parkinson-White syndrome.) Moderate to mild essential hypertension",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de957354-7264-4081-a5b0-df01181d51bb.json
de9e486a-7485-4759-abbf-2fdc06bd1fc3,NGENLA 24 MG,prescription,H01AC08,SOMATROGON,9236,,,WHO ATC Classification,,ILS,solution for injection,SOMATROGON/ML,2025-07-31T05:46:04.206471,IL,פיזר,,2322.4237,1968.155766,1675.026184,,5415062383872,NGENLA 60 MG/ 1.2 ML SOL FOR INJ 1 PEN,,,17853,PRE-FILLED PEN GLASS TYPE I,units,1.0,175 08 37406 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Ngenla is indicated for the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/de9e486a-7485-4759-abbf-2fdc06bd1fc3.json
decfe9bd-a31c-4322-bb2f-60073839b439,ATOZET10 MG/10 MG,prescription,C10BA05,ATORVASTATIN AND EZETIMIBE ,7902,,,WHO ATC Classification,,ILS,film coated tablets,"ATORVASTATIN AS CALCIUM TRIHYDRATE, EZETIMIBE",2025-07-30T23:30:06.844076,IL,אורגנון,,145.8326912,123.5870265,98.86962118,,,ATOZET 10 MG/80 MG 30 TAB,9974,,59898,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,156 65 34490 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Prevention of Cardiovascular EventsAtozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaAtozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Atozet is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/decfe9bd-a31c-4322-bb2f-60073839b439.json
dee0e13f-89ee-4795-a9f5-74441cb93eb8,LASEA ®,prescription,,,7861,,,,,ILS,"capsule, soft",LAVENDER OIL,2025-07-31T04:36:25.382392,IL,דר סמואלוב,,90.53278685,76.72270413,57.0429027,,,LASEA 80MG 28 CAPSULES SOFT,12527,,54717,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,155 33 34385 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of anxiety in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dee0e13f-89ee-4795-a9f5-74441cb93eb8.json
dee6400a-63d3-4293-b26c-4f6e1563048b,SALIKAREN,off-the-counter,D01AE12,SALICYLIC ACID,1976,,,WHO ATC Classification,,ILS,ointment,SALICYLIC ACID,2025-07-31T13:15:29.623099,IL,רקח,,16.4492,13.94,nan,,7290008089661,SALIKAREN OINT 20GR,19004,,,TUBE ALUMINIUM,units,20.0,018 38 20047 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including dandruff, keratosis palmaris and plantaris, psoriasis - keratin of scalp, hands, legs and elbows.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dee6400a-63d3-4293-b26c-4f6e1563048b.json
dee9155c-aca6-4218-8af3-47a564364701,PREGABALIN DEXCEL 100 MG,prescription,N03AX16,PREGABALIN,8082,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:52:26.326578,IL,דקסל פארמה,,200.1721025,169.637375,135.7099,,,PREGABALIN DEXCEL 300 MG 56 CAPSULES,16994,,58335,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,158 75 34730 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of peripheral and central neuropathic pain in adults.Management of FibromyalgiaTreatment of Generalised Anxiety Disorder (GAD) in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dee9155c-aca6-4218-8af3-47a564364701.json
df0458aa-2972-4c8f-83b2-7c8992c698ef,EZATOR S.K. 10/10 MG,prescription,C10BA05,ATORVASTATIN AND EZETIMIBE ,9333,,,WHO ATC Classification,,ILS,film coated tablets,"EZETIMIBE, ATORVASTATIN AS CALCIUM TRIHYDRATE",2025-07-31T02:50:38.364711,IL,SK PHARM(KS KIM),,118.5487397,100.4650337,74.69519232,,,EZATOR S.K. 10/10 MG 30 TAB,5742,,13733,BLISTER OPA/ALU/PVC/ALU,units,30.0,170 85 36878 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"- Prevention of Cardiovascular EventsEzator S.K. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaEzator S.K. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Ezator S.K. is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df0458aa-2972-4c8f-83b2-7c8992c698ef.json
df0599d9-5b7d-4e16-8547-44455793eb9b,FULVENIR,prescription,L02BA03,FULVESTRANT,8823,,,WHO ATC Classification,,ILS,solution for injection,FULVESTRANT/ML,2025-07-31T03:21:51.211781,IL,SK PHARM(KS KIM),,973.4604421,824.9664764,702.0991288,,,FULVESTRANT 250 MG/5 ML S.K. 2 PFS,6639,,69320,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,168 64 36677 99,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"Monotherapy :FulVenir is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:not previously treated with endocrine therapy, or with disease relapse on or after adjuvant endocrine therapy; or disease progression on endocrine therapy. Combination Therapy with Palbociclib: FulVenir is indicated for the treatment of HR-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df0599d9-5b7d-4e16-8547-44455793eb9b.json
df144855-0700-4555-bdcf-ec1f6511eaaa,LEVITRA 20MG 8TAB,prescription,,,6950,,,,,ILS,tablet,LEVITRA 20MG,2025-07-31T19:16:29.992332,IL,באייר,,199.1814139,168.7978159,135.0382527,,,LEVITRA 20MG 8TAB,12459,,18582,,units,8.0,,not-registered,25.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df144855-0700-4555-bdcf-ec1f6511eaaa.json
df30d6cf-58b0-445f-8bf7-5e47b47547eb,FROBEN 200MG 30 SR CAPS,29C,,,20417,,,,,,capsule,FROBEN 200MG 30 SR CAPS,2025-07-31T20:30:08.436936,IL,nan,,,,,,,FROBEN 200MG 30 SR CAPS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df30d6cf-58b0-445f-8bf7-5e47b47547eb.json
df3d70f1-fc72-4f97-9993-a83324d022db,ONDANSETRON INOVAMED 4 MG,prescription,A04AA01,ONDANSETRON,7784,,,WHO ATC Classification,,ILS,film coated tablets,ONDANSETRON AS HYDROCHLORIDE DIHYDRATE,2025-07-31T06:12:19.103071,IL,אינובמד,,186.7026975,158.222625,126.5781,,,ONDANSETRON INOVAMED 8 MG 10 F.C.TAB,15450,,79260,BLISTER PVC/ALUMINIUM,units,10.0,152 95 34231 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Adults : Ondansetron Inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. For prevention and treatment of post operative nausea and vomiting (PONV).Pediatric population : Ondansetron Inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df3d70f1-fc72-4f97-9993-a83324d022db.json
df68a5f8-28b5-49b3-9c10-486da59d3d23,CATAPRESAN-TTS-2 5MG 2PATCHES,29C,,,20325,,,,,,tablet,CATAPRESAN-TTS-2 5MG 2PATCHES,2025-07-31T20:03:46.668412,IL,nan,,,,,,,CATAPRESAN-TTS-2 5MG 2PATCHES,,,,,units,2.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df68a5f8-28b5-49b3-9c10-486da59d3d23.json
df7bdd6e-2af1-4f32-8901-8eb323536506,IDELVION 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,8413,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,ALBUTREPENONACOG ALFA,2025-07-31T03:57:30.583866,IL,סי אס אל,,15158.22289,12845.95218,11678.13834,,,IDELVION 2000 IU VIAL,,,,VIAL GLASS TYPE I,units,1.0,159 31 35015 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df7bdd6e-2af1-4f32-8901-8eb323536506.json
df823fa4-5f2a-45a3-bed1-e51ab25ab24f,URSOLIT 100,prescription,A05AA02,URSODEOXYCHOLIC ACID,6497,,,WHO ATC Classification,,ILS,tablets,URSODEOXYCHOLIC ACID,2025-07-31T09:55:19.651620,IL,כ.צ.ט,,nan,nan,nan,,,URSOLIT 100MG 60 TAB,21110,,84927,BLISTER PVC/ALUMINIUM,units,60.0,019 25 20542 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Dissolution or reductin in size of radiolucent cholesterol in patient with a functioning gallbladder. Treatment of chronic liver diseases including primary billiary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia, chronic hepatitis, and alcohol cirrhosis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df823fa4-5f2a-45a3-bed1-e51ab25ab24f.json
df8f9d92-d95f-4790-b767-f4c400056b88,OVALEAP,prescription,G03GA05,FOLLITROPIN ALFA,8026,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN ALFA/,2025-07-31T06:19:00.767329,IL,תרומד,,445.2916435,377.3658164,321.1623969,,,OVALEAP 300IU/0.5 ML 1 CARTRIDGE,15475,,23875,CARTRIDGE GLASS TYPE I,units,1.0,157 82 34716 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,"In adult women:• Anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate.• Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra fallopian transfer (ZIFT).• Ovaleap in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/L.In adult men:• Ovaleap is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotropic hypogonadism with concomitant human chorionic gonadotropin (hCG) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/df8f9d92-d95f-4790-b767-f4c400056b88.json
dfa850c4-3129-48c4-a548-a214a4ccdfdd,AGIOLAX,prescription,,,2920,,,,,ILS,granules,"ISPAGHULA HUSKS 2.2  G /, SENNA 6.74 - 13.15 G /, ISPAGHULA SEED/",2025-07-31T00:11:33.920063,IL,מגאפארם,,71.00559703,60.17423745,44.73921,,,AGIOLAX GRANULES 200GR,1034,,9047,CONTAINER PVC/PVDC,units,200.0,140 20 22366 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For short - term treatment of constipation.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dfa850c4-3129-48c4-a548-a214a4ccdfdd.json
dfac2938-9068-4a05-8043-92fb3a56843d,ABROLET SUPPOSITORIES,off-the-counter,N02BE05,PROPACETAMOL,3101,,,WHO ATC Classification,,ILS,suppositories,PARACETAMOL,2025-07-31T10:58:59.335673,IL,רקח,,24.7446,20.97,nan,,7290008089500,ABROLET FTE 250MG 12 SUP,1091,,,FOIL PVC/ALUMINIUM,units,12.0,027 21 24032 00,valid,nan,rectal,1.4,24,,,,,,,,,,0,,"Analgesic, antipyretic pediatric suppositories.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dfac2938-9068-4a05-8043-92fb3a56843d.json
dfc3da9f-05c3-41db-990a-a9c16ce9abbe,CLOTHREE-TEVA 200MG 3 VAG+APPLICA,off-the-counter,,,4605,,,,,ILS,tablet,CLOTHREE- 200MG 3 VAG+APPLICA,2025-07-31T19:41:26.587529,IL,טבע,,41.7838,35.41,,,,CLOTHREE-TEVA 200MG 3 VAG+APPLICA,3924,,,,units,3.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dfc3da9f-05c3-41db-990a-a9c16ce9abbe.json
dfd0e8b7-ee3a-4dea-b0e8-f1390835a6f9,ABILIFY  MAINTENA 300 MG,prescription,N05AX12,ARIPIPRAZOLE,8647,,,WHO ATC Classification,,ILS,powder and solvent for prolonged-release suspension for injection,ARIPIPRAZOLE AS MONOHYDRATE/VIAL,2025-07-30T23:27:07.044736,IL,סנדוז,,412.2076384,349.3285071,297.3008571,,,ARIPIPRAZOLE SANDOZ 30 MG 30 TAB,23401,,89166,VIAL GLASS TYPE I,units,30.0,153 68 34089 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,Abilify Maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dfd0e8b7-ee3a-4dea-b0e8-f1390835a6f9.json
dfeab6cb-1d1e-41c8-94b1-dea7efc81cfc,AMLODY 10,prescription,C08CA01,AMLODIPINE,9617,,,WHO ATC Classification,,ILS,tablets,AMLODIPINE AS BESYLATE,2025-07-30T23:22:40.220741,IL,אוניפארם,,14.53000015,12.31356,8.988,,,AMLODY 5 30 TAB,,,,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,175 06 36807 99,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Amlody is indicated for:Mild to moderate hypertension. Vasospastic angina (Prinzmetal's or variant angina). Chronic stable angina,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dfeab6cb-1d1e-41c8-94b1-dea7efc81cfc.json
dfef7571-2bde-48df-8820-651d39e078f8,TRAMADOL MEDOCHEMIE 100 MG/2 ML,prescription,N02AX02,TRAMADOL,8620,,,WHO ATC Classification,,ILS,solution for injection / infusion,TRAMADOL HYDROCHLORIDE/,2025-07-31T09:32:48.600128,IL,דפריס,,26.10464503,22.12258053,16.147869,,5290931000636,TRAMADOL MEDOCHEMIE 100 MG/2 ML 10 AMP,20959,,9932,AMPOULES GLASS TYPE I,units,10.0,162 36 35276 00,valid,37.0,"s.c, i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,Moderate to severe pain, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dfef7571-2bde-48df-8820-651d39e078f8.json
dff11d35-ed69-4aae-aa20-416d7d065dd9,STERODEX EYE DROPS,prescription,S01BA01,DEXAMETHASONE,1833,,,WHO ATC Classification,,ILS,"eye drops, solution",DEXAMETHASONE AS SODIUM PHOSPHATE 0.1 %,2025-07-31T08:43:12.318017,IL,פישר,,14.4111807,12.212865,8.9145,,7290000849652,STERODEX DROPS 5CC,19149,,2041,BOTTLE LDPE,units,5.0,053 35 24706 00,valid,37.0,ocular,1.4,42,,,,,,,,,,0,Prescription required,For the treatment of conjuctivitis and cornea inflammation.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dff11d35-ed69-4aae-aa20-416d7d065dd9.json
dff9a756-a61e-4d82-a80d-60e5941fccdb,HISTAZINE,off-the-counter,R06AE07,CETIRIZINE,5462,,,WHO ATC Classification,,ILS,syrup,CETIRIZINE DIHYDROCHLORIDE 0.1  %W/V,2025-07-31T12:05:10.044293,IL,תרימה,,22.1486,18.77,nan,,7290008075459,HISTAZINE 10MG 10TAB,,,,BOTTLE GLASS,units,10.0,109 59 29304 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antihistaminic drug for the treatment of allergies for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic uriticaria in children aged over 2 years and adults., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dff9a756-a61e-4d82-a80d-60e5941fccdb.json
dffa0242-3235-40d4-ab78-697c729fd6e1,QUETIAPINE INOVAMED SR 300 MG,prescription,N05AH04,QUETIAPINE,8830,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:09:58.504161,IL,אינובמד,,122.873282,104.1299,77.42,,7290104530685,QUETIAPINE INOVAMED SR 300 MG 30 TAB,17328,,70059,BLISTER PVC/PCTFE/AL,units,30.0,165 71 35461 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Inovamed SR is indicated for the treatment of Schizophrenia. Quetiapine Inovamed SR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Inovamed SR. Quetiapine Inovamed SR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. Quetiapine Inovamed SR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Inovamed SR.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dffa0242-3235-40d4-ab78-697c729fd6e1.json
dffafb73-70fd-4b12-be5c-da23a444a760,VYVGART S.C. 180 MG/ML,prescription,L04AA58,EFGARTIGIMOD,9575,,,WHO ATC Classification,,ILS,solution for injection,EFGARTIGIMOD ALFA/,2025-07-31T10:24:52.047388,IL,מדיסון,,79530.69088,67398.89357,61271.72143,,,VYVGART S.C. 180 MG/ML 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,177 82 38001 00,valid,10.0,s.c,1.4,18,,,,,,,,,,0,Prescription required,Vyvgart is indicated as an add-on to standard therapy for the treatment of adult patients with generalised Myasthenia Gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dffafb73-70fd-4b12-be5c-da23a444a760.json
dffef102-4b9b-4a33-8be9-be8772508ae7,LENALIDOMIDE S.K. 10 MG,prescription,L04AX04,LENALIDOMIDE,8731,,,WHO ATC Classification,,ILS,"capsule, hard",LENALIDOMIDE,2025-07-31T04:38:11.218211,IL,SK PHARM(KS KIM),,22606.81805,19158.32038,17416.65489,,7290016845327,LENALIDOMIDE S.K. 15 MG 21 CAPS,12587,,59401,BLISTER PVC/ACLAR/ALUMINIUM,units,21.0,164 86 36219 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Multiple Myeloma (MM)Lenalidomide S.K. is indicated for the treatment of multiple myeloma. Myelodysplastic Syndromes Lenalidomide S.K. is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Lenalidomide S.K. 7.5 mg is not indicated for treatment in MDS. Mantle Cell Lymphoma Lenalidomide S.K. is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL). Follicular lymphomaLenalidomide S.K. in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dffef102-4b9b-4a33-8be9-be8772508ae7.json
dfff7b1d-b779-4a85-a214-96a7d366bac3,METHYLPHENIDATE SANDOZ ® 54 MG PRT,prescription,N06BA04,METHYLPHENIDATE,9358,,,WHO ATC Classification,,ILS,tablets prolonged release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T05:18:04.326732,IL,סנדוז,,233.7339737,198.0796388,158.463711,,,METHYLPHENIDATE SANDOZ  54 MG 30 SR TAB,,,14624,BOTTLE HDPE,units,30.0,169 45 36080 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Methylphenidate Sandoz® PRT is indicated for the treatment of Attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dfff7b1d-b779-4a85-a214-96a7d366bac3.json
dfff7e45-121a-4bf0-8f80-1fc7707880b8,CIALIS 10 MG,prescription,G04BE08,TADALAFIL,4630,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T01:10:04.465894,IL,אלי לילי,,289.4992589,245.338355,208.7986,,,CIALIS 10MG 4TAB,3741,,57623,BLISTER PVC/PE/PCTFE/AL,units,4.0,128 19 30677 21,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/dfff7e45-121a-4bf0-8f80-1fc7707880b8.json
e00cfda7-d629-45a5-b26b-a607b906aeaf,SIGNIFOR LAR 10 MG,prescription,H01CB05,PASIREOTIDE,7793,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,PASIREOTIDE AS PAMOATE/VIAL,2025-07-31T08:12:03.045963,IL,מדיסון,,13574.80616,11504.07353,10458.24866,,,SIGNIFOR LAR 60 MG 1VIAL,14593,,41061,VIAL GLASS TYPE I,units,1.0,172 50 36981 99,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e00cfda7-d629-45a5-b26b-a607b906aeaf.json
e012711f-cf55-47d5-a52b-20ee26ce21d9,IODIFLOR OINTMENT,off-the-counter,D08AG03,IODINE,5461,,,WHO ATC Classification,,ILS,ointment,POVIDONE-IODINE,2025-07-31T12:11:23.718737,IL,פלוריש,,41.7956,35.42,nan,,7290006411907,IODIFLOR SOL 1 LITER,,,,BOTTLE HDPE,units,1000.0,141 02 31802 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"For the disinfection of skin infections and inflammations, wounds and superficial burns.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e012711f-cf55-47d5-a52b-20ee26ce21d9.json
e0415fdc-e5bb-4a1d-aff0-b4ed70bfe758,DIAMOX SEQUELS 500MG 100CAPS,29C,,,20064,,,,,,capsule,DIAMOX SEQUELS 500MG,2025-07-31T20:15:27.389088,IL,nan,,,,,,,DIAMOX SEQUELS 500MG 100CAPS,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e0415fdc-e5bb-4a1d-aff0-b4ed70bfe758.json
e04232a8-0657-4a9b-b62b-135aca2ff340,OMVOH 100 MG / ML,prescription,L04AC24,MIRIKIZUMAB,9480,,,WHO ATC Classification,,ILS,solution for injection,MIRIKIZUMAB/,2025-07-31T06:10:22.094943,IL,אלי לילי,,6803.783001,5765.918054,5241.743685,,7290016021394,OMVOH 300 MG/15 ML,15572,,22154,PRE-FILLED PEN GLASS TYPE I,units,1.0,174 95 37706 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e04232a8-0657-4a9b-b62b-135aca2ff340.json
e043c23e-c7d3-4ec0-8a3b-7342e51719b5,CONTALAX,prescription,A06AB02,BISACODYL,1797,,,WHO ATC Classification,,ILS,suppositories,BISACODYL 0.566 %,2025-07-31T01:29:09.295948,IL,פישר,,103.4446386,87.664948,65.1784,,7290000849348,CONTALAX 10MG 25SUPP,3225,,535,BLISTER PVC/PE,units,25.0,118 13 23519 01,valid,34.5,rectal,1.4,36,,,,,,,,,,0,Prescription required,Laxative for the relief of constipation.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e043c23e-c7d3-4ec0-8a3b-7342e51719b5.json
e05ae27e-8938-4b8d-81a2-f0b5a7ffee24,SEVELAMER TARO 2.4 G,prescription,V03AE02,SEVELAMER,8961,,,WHO ATC Classification,,ILS,powder for oral suspension,SEVELAMER CARBONATE ANHYDROUS 2.4 G,2025-07-31T08:08:55.110993,IL,תרו יבוא,,524.5506625,444.5344597,378.3271998,,7290017164229,SEVELAMER TARO 2.4 G 60 SACHETS,17156,,61625,SACHET PET/AL/LDPE,units,60.0,164 79 35536 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. Also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus &#8805; 1.78 mmol/l. Should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e05ae27e-8938-4b8d-81a2-f0b5a7ffee24.json
e062cf9e-3ce9-40fa-9522-e595d805735e,PICO - SALAX ORANGE,prescription,A09AB04,CITRIC ACID,8159,,,WHO ATC Classification,,ILS,powder for solution,"SODIUM PICOSULFATE, CITRIC ACID ANHYDROUS, MAGNESIUM OXIDE 3.5 G",2025-07-31T06:42:09.127243,IL,פרינג,,63.08532048,53.462136,39.7488,,5015919705590,PICO SALAX CRANBERRY   2SACHETS    2*16.1 G,,,76226,SACHET PAPER/POLYETHYLENE /ALUMINIUM,units,2.0,144 04 32928 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"To clean the bowel Prior to X-ray examination, endoscopy or surgery.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e062cf9e-3ce9-40fa-9522-e595d805735e.json
e06f7f7c-cafa-48dc-97a2-7be2789bf43d,DIDANOSINE DELAYED 400MG 30CAPS,29C,,,20066,,,,,,capsule,DIDANOSINE DELAYED 400MG,2025-07-31T20:16:11.940131,IL,nan,,,,,,,DIDANOSINE DELAYED 400MG 30CAPS,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e06f7f7c-cafa-48dc-97a2-7be2789bf43d.json
e076d739-f91e-475f-a9e2-18e00670588a,SUBOXONE FILM 4 MG/1 MG,prescription,N02AE01,BUPRENORPHINE,9077,,,WHO ATC Classification,,ILS,sublingual film,"BUPRENORPHINE AS HYDROCHLORIDE, NALOXONE AS HYDROCHLORIDE DIHYDRATE",2025-07-31T08:48:32.856755,IL,נעמי שאקו עזרה,,693.3460654,587.5814375,500.0693085,,,SUBOXONE 8 MG/2 MG 30 FILMS,10322,,10233,FOIL ALUMINIUM,units,30.0,164 26 35833 00,valid,17.5,"buccal, sublingual",1.4,24,,,,,,,,,,0,Prescription required,Suboxone sublingual film is indicated for treatment of opioid dependence in adults and adolescents over 15 years of age. Suboxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e076d739-f91e-475f-a9e2-18e00670588a.json
e078a954-e8d1-444d-ba81-1a9b370d36a8,AZITHROVENIR,prescription,J01FA10,AZITHROMYCIN,8840,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,AZITHROMYCIN AS DIHYDRATE/VIAL,2025-07-30T23:33:04.504471,IL,טבע,,24.00861158,20.346281,14.8513,,7290010286287,AZITHRO TEVA 200 MG / 5 ML 15 ML,,,15244,VIAL GLASS TYPE II,units,15.0,159 58 34834 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment of infections caused by susceptible strains of the designated microorganism in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e078a954-e8d1-444d-ba81-1a9b370d36a8.json
e08158ce-1f9c-4575-b61c-be5faafef4b9,EUCARBON,prescription,A07BA51,"MEDICINAL CHARCOAL, COMBINATIONS",1316,,,WHO ATC Classification,,ILS,tablets,"SENNAE FOLIUM, RHUBARB, SULFUR PURIFIED, MEDICINAL CHARCOAL",2025-07-31T02:42:46.675311,IL,תרופארם,,nan,nan,nan,,,EUCARBON 30TAB,5381,,8107,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,120 36 25951 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Mild laxative, anti-flatulant.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e08158ce-1f9c-4575-b61c-be5faafef4b9.json
e081cefd-d678-4a2b-85ba-23f98b59e6cf,SIGNIFOR 0.3 MG/ 1 ML,prescription,H01CB05,PASIREOTIDE,7122,,,WHO ATC Classification,,ILS,solution for injection,PASIREOTIDE AS DIASPARTATE 0.3 MG/ML,2025-07-31T08:11:01.297002,IL,מדיסון,,18998.29863,16100.25379,14636.59436,,7290014257191,SIGNIFOR 0.9MG/1ML 60AMP (1ML),9690,,48814,AMPOULES GLASS TYPE I,units,60.0,150 59 33762 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e081cefd-d678-4a2b-85ba-23f98b59e6cf.json
e0919254-a136-45c4-a311-86593f3f68b9,LEVITRA 10MG 4 ORODISPERSIBLE TAB,prescription,,,6916,,,,,,tablet,LEVITRA 10MG 4 ORODISPERSIBLE TAB,2025-07-31T19:15:55.713778,IL,באייר,,,,,,,LEVITRA 10MG 4 ORODISPERSIBLE TAB,12462,,28999,,units,4.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e0919254-a136-45c4-a311-86593f3f68b9.json
e0990cc4-90a8-4bb5-87a6-ea5a3f194e0e,STRATTERA 4 MG/ML ORAL SOLUTION,prescription,N06BA09,ATOMOXETINE,7950,,,WHO ATC Classification,,ILS,solution  (oral),ATOMOXETINE/,2025-07-31T08:45:42.378894,IL,אלי לילי,,380.8937113,322.7912808,274.7159836,,7290016021059,STRATTERA 40MG 28CAPS,9808,,71830,BOTTLE GLASS TYPE III,units,28.0,158 61 35026 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD. Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e0990cc4-90a8-4bb5-87a6-ea5a3f194e0e.json
e09e396e-e4c9-46b2-880f-72824d9b2c11,ZYBAN,prescription,N07BA02,BUPROPION,4212,,,WHO ATC Classification,,ILS,tablets prolonged release,BUPROPION HYDROCHLORIDE,2025-07-31T10:56:04.275271,IL,ג.ס.ק,,158.1349259,134.012655,107.210124,,,ZYBAN 150MG 60TAB SUSTAINED RELEASE,26101,,25889,BLISTER PVC/PA/ALUMINIUM,units,60.0,118 33 29919 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Zyban is indicated as an aid to smoking cessation in combination with motivational support in nicotine-dependent patients.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e09e396e-e4c9-46b2-880f-72824d9b2c11.json
e0bda09c-9864-4edb-b96f-cbdf8a93e615,DOGMATIL 100MG/2ML 12AMP,29C,,,20379,,,,,,injection,DOGMATIL 100MG/,2025-07-31T20:17:34.978761,IL,nan,,,,,,,DOGMATIL 100MG/2ML 12AMP,,,,,units,12.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e0bda09c-9864-4edb-b96f-cbdf8a93e615.json
e0c819a7-716e-4232-84ff-10c985e672b1,NUVARING,prescription,G03CA01,ETHINYLESTRADIOL,4937,,,WHO ATC Classification,,ILS,vaginal ring,"ETHINYLESTRADIOL 2.7  MG, ETONOGESTREL 11.7  MG",2025-07-31T05:58:26.340919,IL,אורגנון,,61.04096179,51.72963094,37.7588547,,7290006537140,NUVARING 1VAGINAL RING,14434,,67994,SACHET ALUMINIUM LAMINATE,units,1.0,132 14 30926 01,valid,37.0,vaginal,1.4,40,,,,,,,,,,0,Prescription required,Contraception. The safety and efficacy has been established in women aged 18 to 40 years.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e0c819a7-716e-4232-84ff-10c985e672b1.json
e0d61d49-5586-45dd-93fe-6cc46d3240ef,MINOCLIN 100MG 10CAPS,prescription,,,6863,,,,,ILS,capsule,MINOCLIN 100MG,2025-07-31T19:19:25.023941,IL,רקח,,21.92481418,18.580351,13.5623,,,MINOCLIN 100MG 10CAPS,13674,,16516,,units,10.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e0d61d49-5586-45dd-93fe-6cc46d3240ef.json
e0e48f4d-831e-4992-8d58-e3451eabb4fb,SUGAMEDIN,prescription,V03AB35,SUGAMMADEX,9499,,,WHO ATC Classification,,ILS,solution for injection,SUGAMMADEX AS SODIUM/,2025-07-31T08:49:30.769037,IL,SK PHARM(KS KIM),,2552.159726,2162.847225,1966.22475,,,SUGAMEDIN 100MG/ML 2ML 10 VIAL,,,31332,VIAL GLASS TYPE I,units,10.0,175 54 36854 99,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Sugamedin is indicated for reversal of neuromuscular blockade induced by rocuronium or vecuronium,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e0e48f4d-831e-4992-8d58-e3451eabb4fb.json
e0ea61c4-b84f-4d11-9644-62ed5c5d3ca8,SIMVASTATIN TEVA ® 40 MG,prescription,C10AA01,SIMVASTATIN,4687,,,WHO ATC Classification,,ILS,tablets,SIMVASTATIN,2025-07-31T08:16:03.890484,IL,טבע,,119.5687811,101.3294755,75.3379,,,SIMVASTATIN-TEVA 80MG 30TAB,19715,,59806,BLISTER PVC/PE/PVDC/AL,units,30.0,129 18 30737 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia  Simvastatin-teva is indicated to:     Reduce the risk of total mortality by reducing coronary death ;Reduce the risk of non-fatal myocardial infarction ;Reduce the risk for undergoing myocardial revascularization procedures.      Reduce the risk of stroke and transient ischemic attacks (TIA).   Hyperlipidemia: Simvastatin-teva is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvastatin-teva therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios.   Homozygous familial hypercholesterolemia: Simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Simvastatin-teva is indicated for the treatment of patients with hypertriglyceridemia ( Fredrickson type IV  hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia): Simvastatin-teva is also indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e0ea61c4-b84f-4d11-9644-62ed5c5d3ca8.json
e102af18-c496-4205-b90a-2aaed7dd8aef,CREON 10000,off-the-counter,A09AA02,"MULTIENZYMES (LIPASE, PROTEASE ETC.)",9104,,,WHO ATC Classification,,ILS,capsules,PANCREATIN,2025-07-31T11:27:22.627019,IL,אבוט,,30.1254,25.53,nan,,,CREON 10000 (150MG) 20CAPS,,,,BLISTER ALUMINIUM /ALUMINIUM,units,20.0,103 48 28837 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Pancreatic exocrine insufficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e102af18-c496-4205-b90a-2aaed7dd8aef.json
e103088a-b810-40d4-a7bf-60b454c688e7,CLOPIXOL ACUPHASE 50,prescription,N05AF05,ZUCLOPENTHIXOL,624,,,WHO ATC Classification,,ILS,solution for injection,ZUCLOPENTHIXOL ACETATE/ML,2025-07-31T01:23:04.545929,IL,לנדבק,,nan,nan,nan,,5702157108244,CLOPIXOL ACUPHASE 100MG 2ML,3633,,8222,AMPOULES GLASS TYPE I,units,1.0,047 80 25490 00,valid,nan,i.m,1.4,36,,,,,,,,,,0,Prescription required,Acute psychoses.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e103088a-b810-40d4-a7bf-60b454c688e7.json
e11cd57b-1286-43b3-aabf-ff7d079343f3,CIALIS 10 MG,prescription,G04BE08,TADALAFIL,6219,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T01:10:45.821040,IL,אלי לילי,,506.6883833,429.396935,365.4442,,,CIALIS 5MG 28TAB,3946,,89211,BLISTER PVC/PE/PCTFE/AL,units,28.0,128 19 30677 21,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e11cd57b-1286-43b3-aabf-ff7d079343f3.json
e13c6ba5-80fc-4428-8f56-b7346ed2dae5,ATAZANAVIR TEVA  ® 150 MG,prescription,J05AE08,ATAZANAVIR,8852,,,WHO ATC Classification,,ILS,capsules,ATAZANAVIR AS SULFATE,2025-07-30T23:29:01.712944,IL,טבע,,985.9845657,835.5801776,711.132066,,,ATAZANAVIR TEVA  300 MG 30 CAPS,,,55690,BLISTER OPA/ALU/PVC/ALU,units,30.0,160 95 35017 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Atazanavir Teva ® is indicated in combination with other antiretroviral agents for  for the treatment of HIV-1 infection.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e13c6ba5-80fc-4428-8f56-b7346ed2dae5.json
e14965f1-0c48-42b3-be81-9535ad0ffe6c,DICLOFTIL ® 0.1 %,prescription,M02AA15,DICLOFENAC,6259,,,WHO ATC Classification,,ILS,solution,DICLOFENAC SODIUM 0.1 %V/V,2025-07-31T01:55:10.663223,IL,ביואבניר,,90.11506858,76.36870558,56.77970675,,7290010286089,DICLOFTIL 0.1% SOL 30x0.5ML,4526,,89979,BAG PET/PE/AL,units,15.0,138 87 31465 00,valid,34.5,ocular,1.4,36,,,,,,,,,,0,Prescription required,Post-operative inflammation following cataract extraction. Control of ocular pain and discomfort associated with corneal epithelial defects after laser excimer PRK or accidental trauma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e14965f1-0c48-42b3-be81-9535ad0ffe6c.json
e14e2f56-3e8b-47aa-8220-26b14ffc8307,IDELVION 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,8412,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,ALBUTREPENONACOG ALFA,2025-07-31T03:57:19.968917,IL,סי אס אל,,8726.904187,7395.681843,6723.34713,,,IDELVION 1000 IU VIAL,17079,,59390,VIAL GLASS TYPE I,units,1.0,159 31 35015 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e14e2f56-3e8b-47aa-8220-26b14ffc8307.json
e153a949-4438-4c19-a4c3-0ed075453f51,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7455,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:19:50.825984,IL,צמל,,143.734918,121.8092525,90.5645,,,METOJECT 50MG/ML SYRINGE PREFILLED 22.5MG/0.45ML,,,4090,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e153a949-4438-4c19-a4c3-0ed075453f51.json
e17e13f0-e3f9-4158-aefb-d59a4e6183d0,JAKAVI 10 MG,prescription,L01XE18,RUXOLITINIB,7170,,,WHO ATC Classification,,ILS,tablets,RUXOLITINIB AS PHOSPHATE,2025-07-31T04:15:48.593084,IL,נוברטיס פארמה,,7608.957055,6448.268978,5862.062707,,7290016369212,JAKAVI 5MG 56TAB,10062,,76460,BLISTER PVC/PCTFE,units,56.0,158 58 34859 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"* Myelofibrosis (MF) Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. * Polycythaemia vera (PV) Jakavi is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.*Graft versus host disease (GvHD)Jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e17e13f0-e3f9-4158-aefb-d59a4e6183d0.json
e1a8bc50-0a8b-404c-9418-641d8bb21b2a,ORFADIN 10 MG HARD CAPSULES,prescription,A16AX04,NITISINONE,6926,,,WHO ATC Classification,,ILS,"capsule, hard",NITISINONE,2025-07-31T06:15:36.761697,IL,מגאפארם,,9674.326236,8198.581556,7453.25596,,7350031443066,ORFADIN 10MG 60CAPS,15419,,38096,CONTAINER HDPE,units,60.0,147 27 33457 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT-1) in  combination with dietary restriction of tyrosine and phenylalanine05/06/2018 בקשה לשינוי משטר מינון Once Daily,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e1a8bc50-0a8b-404c-9418-641d8bb21b2a.json
e1b6f237-69fe-4b62-8913-575b77345bfb,LANTON 15,prescription,A02BC03,LANSOPRAZOLE,4833,,,WHO ATC Classification,,ILS,capsules,LANSOPRAZOLE,2025-07-31T04:35:36.492127,IL,רפא,,28.7552725,24.368875,17.7875,,7290008013888,LANTON 15 28CAPS,12320,,61767,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,131 08 30988 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,• Treatment of duodenal and gastric ulcer• Treatment of reflux oesophagitis• Prophylaxis of reflux oesophagitis• Eradication of Helicobacter pylori (H. pylori) concurrently given with appropriate antibiotic therapy for treatment of H.pylori-associated ulcers• Treatment of NSAID-associated benign gastric and duodenal ulcers in patients requiring continued NSAID treatment• Prophylaxis of NSAID-associated gastric ulcers and duodenal ulcers in patients at risk requiring continued therapy• Symptomatic gastroesophageal reflux disease• Zollinger-Ellison syndrome.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e1b6f237-69fe-4b62-8913-575b77345bfb.json
e1beb145-e5ef-4961-83e4-15f4071af482,STREPSILS ORANGE WITH 100 MG VITAMIN C,off-the-counter,R02AA03,DICHLOROBENZYL ALCOHOL,5460,,,WHO ATC Classification,,ILS,lozenges,"DICHLOROBENZYL ALCOHOL 1.2  MG, AMYLMETACRESOL 0.6  MG, ASCORBIC ACID",2025-07-31T13:22:41.496790,IL,רקיט בנקיזר,,29.7714,25.23,nan,,7290000852973,STREPSILS GINGER 24 tab,9743,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,066 33 25662 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antiseptic. To relieve throat pain in children and adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e1beb145-e5ef-4961-83e4-15f4071af482.json
e1c628bf-79ed-49e8-b427-944bb6427483,ZOLEDRONIC ACID FRESENIUS 4 MG/5 ML,prescription,M05BA08,ZOLEDRONIC ACID,8613,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,ZOLEDRONIC ACID AS MONOHYDRATE,2025-07-31T10:53:30.021915,IL,ניאופרם,,4311.0474,3653.43,3321.3,,,ZOLEDRONIC ACID FRESENIUS 4 MG/5 ML 10 VIAL X 5 ML,26219,,446,VIAL POLYPROPYLENE,units,10.0,156 91 34402 00,valid,10.0,i.v,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of hypercalcaemia of malignancy. Treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e1c628bf-79ed-49e8-b427-944bb6427483.json
e1c7a612-b4c8-46a0-83cf-c1db230524a1,ADEMPAS 0.5 MG,prescription,C02KX05,RIOCIGUAT,7574,,,WHO ATC Classification,,ILS,film coated tablets,RIOCIGUAT 0.5  MG,2025-07-30T23:14:29.859846,IL,באייר,,4588.795159,3888.80963,3535.281482,,,ADEMPAS 1.5MG 42TAB,9871,,28790,BLISTER PP/ALUMINIUM,units,42.0,153 76 34132 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Chronic thromboembolic pulmonary hypertension (CTEPH) Adempas is indicated for the treatment of adult patients with WHO Functional Class (FC) II to III with	• inoperable CTEPH, • persistent or recurrent CTEPH after surgical treatment, to improve exercise capacity. Pulmonary arterial hypertension (PAH)Adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH) with WHO Functional Class (FC) II to III to improve exercise capacity.Efficacy has been shown in a PAH population including aetiologies of idiopathic or heritable PAH or PAH associated with connective tissue disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e1c7a612-b4c8-46a0-83cf-c1db230524a1.json
e1d02212-255d-4acf-9ad5-556564ad61e3,VALSARTAN -MEDO 160 MG,prescription,C09CA03,VALSARTAN,8905,,,WHO ATC Classification,,ILS,film coated tablets,VALSARTAN,2025-07-31T09:57:17.421314,IL,מדי מרקט,,30.10901334,25.516113,18.6249,,,VALSARTAN -MEDO 80 MG 30TAB,,,71509,BLISTER PVC/PCTFE/AL,units,30.0,167 40 35704 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For treatment of hypertension. Valsartan-Medo is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan-Medo signicantly reduced hospitalisations for heart failure. There is no evidence that Valsartan-Medo provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan-Medo is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e1d02212-255d-4acf-9ad5-556564ad61e3.json
e1e7d01c-5ae4-498d-a738-83a384bbd03e,CERAZETTE,prescription,G03AC09,DESOGESTREL,4758,,,WHO ATC Classification,,ILS,film coated tablets,DESOGESTREL 0.075   MG,2025-07-31T01:05:57.095578,IL,אורגנון,,21.8814893,18.543635,13.5355,,7290006537133,CERAZETTE 0.075MG 1X28TAB,3766,,61777,BLISTER PVC/ALUMINIUM,units,28.0,131 09 30977 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e1e7d01c-5ae4-498d-a738-83a384bbd03e.json
e1fcb75a-852e-47e1-bf8c-82d92569dcac,FOROL TABLETS,off-the-counter,,,5503,,,,,ILS,tablets,"FOLIC ACID, FERROUS FUMARATE",2025-07-31T11:57:43.506707,IL,סם און,,41.3826,35.07,nan,,,FOROL 30 TABLETS,,,,BLISTER PVC/ALUMINIUM,units,30.0,154 68 34101 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the prevention and treatment of iron deficiency anemia and for maintaining the level of folic acid particular in pregnancy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e1fcb75a-852e-47e1-bf8c-82d92569dcac.json
e205306c-3ff9-4062-a114-2cac51ad308f,ELOCOM LOTION,prescription,D07AC13,MOMETASONE,3509,,,WHO ATC Classification,,ILS,lotion,MOMETASONE FUROATE/G,2025-07-31T02:15:59.543545,IL,אורגנון,,17.15212524,14.5357,10.61,,7290008121538,ELOCOM LOTION 20ML,5053,,82906,BOTTLE LDPE,units,20.0,137 48 28715 22,valid,37.0,topical,1.4,24,,,,,,,,,,0,Prescription required,"The relief of the inflammatory and pruritic manifestations of corticosteroid - responsive dermatoses, such as psoriasis and atopic dermatitis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e205306c-3ff9-4062-a114-2cac51ad308f.json
e20e43b8-b4bf-47fc-9d42-52a54f0bd5af,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8031,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:53:05.700503,IL,יאנסן סילג,,30216.34412,25607.07243,23279.15675,,7640111932642,UPTRAVI ® 200 MCG 140 TAB,21124,,22333,BLISTER ALUMINIUM /ALUMINIUM,units,140.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e20e43b8-b4bf-47fc-9d42-52a54f0bd5af.json
e21e49c7-a179-4c1e-8344-cefb19714dc5,VAZKEPA,prescription,,,9304,,,,,ILS,"capsule, soft",ICOSAPENT ETHYL,2025-07-31T10:01:19.623993,IL,ניאופרם,,935.5822326,792.8663341,674.7798588,,,VAZKEPA 120 CAPS,22514,,43134,BLISTER PVC/PCTFE/AL,units,120.0,172 61 37268 99,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"Vazkepa is indicated to reduce the risk of cardiovascular events in adult statin-treated patients at highcardiovascular risk with elevated triglycerides (&#8805; 150 mg/dL [&#8805; 1.7 mmol/L]) and• established cardiovascular disease, or• diabetes, and at least one other cardiovascular risk factor.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e21e49c7-a179-4c1e-8344-cefb19714dc5.json
e22b5e60-6704-4678-89fb-29fa8400f577,MOUNJARO 10 MG KWIKPEN,prescription,A10BX16,TIRZEPATIDE,9234,,,WHO ATC Classification,,ILS,solution for injection,TIRZEPATIDE 16.7 MG/ML,2025-07-31T05:32:37.199938,IL,אלי לילי,,nan,nan,nan,,,MOUNJARO 15 MG/0.5 ML SOL FOR INJ 4 PF PEN,,,,PRE-FILLED PEN GLASS TYPE I,units,4.0,177 53 38072 99,valid,nan,s.c,1.4,24,,,,,,,,,,0,Prescription required,"T2DMMounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise•	as monotherapy when metformin is considered inappropriate due to intolerance or contraindications•	in addition to other medicinal products for the treatment of diabetes.Weight managementMounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of•	&#8805; 30 kg/m2 (obesity) or•	&#8805; 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).For trial results with respect to obstructive sleep apnoea (OSA) in adults with obesity, see section 5.1.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e22b5e60-6704-4678-89fb-29fa8400f577.json
e23049a5-d6aa-479c-921b-69fd8e2402b1,STREFEN HONEY AND LEMON,off-the-counter,S01BC04,FLURBIPROFEN,5567,,,WHO ATC Classification,,ILS,lozenges,FLURBIPROFEN 8.75  MG,2025-07-31T13:21:57.612221,IL,רקיט בנקיזר,,47.6484,40.38,nan,,,STREFEN HONEY AND LEMON 8.75 MG 24 LOZENGES,17036,,,BLISTER PVC/PVDC/ALUMINIUM,units,24.0,147 77 31684 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the short term relief of symptoms of sore throat such as throat pain and soreness in adults and children over the age of 12 years,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e23049a5-d6aa-479c-921b-69fd8e2402b1.json
e2416b3b-7fbb-4b44-bb94-48d462e5b294,ERAXIS 100 MG,prescription,J02AX06,ANIDULAFUNGIN,6403,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,ANIDULAFUNGIN/VIAL,2025-07-31T02:32:44.347451,IL,פיזר,,1114.095732,944.148925,803.531,,7290010355907,ERAXIS 100MG 30ML VIAL LYOPHILIZED POWDER FOR INJ.,5494,,21260,VIAL GLASS TYPE I,units,1.0,139 84 31584 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment of invasive candidiasis in adults and paediatric patients aged 1 month to < 18 years,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2416b3b-7fbb-4b44-bb94-48d462e5b294.json
e2486753-1b53-4417-8ff0-3091ae0a16df,RIVASTIGMINE DEXCEL 1.5 MG,prescription,N06DA03,RIVASTIGMINE,7551,,,WHO ATC Classification,,ILS,"capsule, hard",RIVASTIGMINE AS HYDROGEN TARTRATE 1.5  MG,2025-07-31T07:44:35.631712,IL,דקסל פארמה,,70.84417625,60.0374375,44.6375,,,RIVASTIGMINE DEXCEL 1.5 MG 28 CAPSULES,18510,,58796,BLISTER PVC/ALUMINIUM,units,28.0,152 77 33949 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of patients with mild to moderately severe dementia of the Alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.Symptomatic treatment of mild to moderately severe alzheimer's dementia.Symptomatic treatment of mild to moderately severe dementiaassociated with Parkinson's disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2486753-1b53-4417-8ff0-3091ae0a16df.json
e2494b23-202a-4a69-8fad-b56b32992d2c,BEOVU 120 MG/ML,prescription,S01LA06,BROLUCIZUMAB,8761,,,WHO ATC Classification,,ILS,solution for injection,BROLUCIZUMAB/,2025-07-30T23:35:46.004984,IL,נוברטיס פארמה,,3134.873317,2656.672421,2415.156746,,7290018609828,BEOVU 120 MG/ML 1 VIAL,2832,,64495,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,166 75 36377 00,valid,10.0,intravitreal,1.4,24,,,,,,,,,,0,Prescription required,Beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (AMD).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2494b23-202a-4a69-8fad-b56b32992d2c.json
e250f5b5-fca9-4551-a9a0-cb8fff27323e,CYPROHEPTADINE SYRUP RISING USA 2MG/5ML,29C,,,20827,,,,,,tablet,CYPROHEPTADINE SYRUP RISING USA 2MG/,2025-07-31T20:09:24.035493,IL,nan,,,,,,,CYPROHEPTADINE SYRUP RISING USA 2MG/5ML,,,,,units,1.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e250f5b5-fca9-4551-a9a0-cb8fff27323e.json
e25afff3-69f5-482b-ae83-84a1992e0641,ETOMIDATE-LIPURO,prescription,N01AX07,ETOMIDATE,8685,,,WHO ATC Classification,,ILS,emulsion for injection,ETOMIDATE/,2025-07-31T02:39:01.692839,IL,לפידות,,122.6029774,103.9008329,77.2496899,,,ETOMIDATE-LIPURO 20 MG/10 ML 10 AMP,,,,AMPOULES GLASS TYPE I,units,10.0,113 84 29554 00,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Induction of general anaesthesia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e25afff3-69f5-482b-ae83-84a1992e0641.json
e26cc886-ce99-4222-a6fc-9f4d6450af56,ZOVIRAX,off-the-counter,D06BB03,ACICLOVIR,5082,,,WHO ATC Classification,,ILS,cream,ACICLOVIRW/W,2025-07-31T13:40:33.035666,IL,ג.ס.ק,,35.695,30.25,nan,,7290008086950,ZOVIRAX CREAM  5% 2G TUBES,26122,,,PACK PUMP POLYPROPYLENE,units,2.0,126 38 30532 00,valid,nan,topical,1.4,24,,,,,,,,,,0,,For the treatment of cold sores (herpes labialis).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e26cc886-ce99-4222-a6fc-9f4d6450af56.json
e281ad69-e158-425d-be29-19b93536010a,FANAPT TABLETS 1 MG,prescription,N05AX14,ILOPERIDONE,6944,,,WHO ATC Classification,,ILS,tablets,ILOPERIDONE,2025-07-31T02:54:17.610725,IL,מגאפארם,,nan,nan,nan,,7290014573062,FANAPT 4MG 60TAB,6508,,43874,BLISTER ALUMINIUM,units,60.0,148 32 33482 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,FANAPT is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e281ad69-e158-425d-be29-19b93536010a.json
e287bf3c-2487-46c8-a92c-899a7ae6299b,CICLODERM,prescription,D01AE14,CICLOPIROX,3338,,,WHO ATC Classification,,ILS,cream,CICLOPIROX OLAMINEW/W,2025-07-31T01:12:03.491771,IL,תרימה,,nan,nan,nan,,7290008075114,CICLODERM SPRAY 30ML,3008,,9660,TUBE ALUMINIUM,units,30.0,062 23 26751 00,valid,nan,topical,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of localized fungal infections of the body and fungal infections of the feet.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e287bf3c-2487-46c8-a92c-899a7ae6299b.json
e29d8a79-3bbd-4f90-81e7-6aaa1a36ccd5,TRITACE COMP 2.5 MG/12.5 MG,prescription,C09BA05,RAMIPRIL AND DIURETICS,4606,,,WHO ATC Classification,,ILS,tablets,"RAMIPRIL 2.5  MG, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T09:44:08.438803,IL,סאנופי אוונטיס,,15.00075472,12.712504,9.2792,,7290008880947,TRITACE COMP 2.5MG/12.5MG 28TAB,20317,,27928,BLISTER PVC/ALUMINIUM,units,28.0,122 27 30187 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Essential hypertension.Tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone or hydrochlorothiazide alone.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e29d8a79-3bbd-4f90-81e7-6aaa1a36ccd5.json
e2aa3a0e-86fc-4f7d-b95e-178c4b01067f,VERAPRESS 240 SR,prescription,C08DA01,VERAPAMIL,3042,,,WHO ATC Classification,,ILS,caplets,VERAPAMIL HYDROCHLORIDE,2025-07-31T10:06:33.693527,IL,דקסל פארמה,,32.7789899,27.778805,20.2765,,,VERAPRESS 240 30 SR CAPLETS,22031,,9121,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,068 63 26427 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,The treatment of mild to moderate hypertension.The treatment and prophylaxis of angina pectoris.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2aa3a0e-86fc-4f7d-b95e-178c4b01067f.json
e2b435cb-e916-49e1-b024-6d4defc7bf79,CABAZITAXEL S.K.,prescription,L01CD04,CABAZITAXEL,9183,,,WHO ATC Classification,,ILS,concentrate and solvent for solution for infusion,CABAZITAXEL/ML,2025-07-30T23:47:02.946670,IL,SK PHARM(KS KIM),,10986.35855,9310.473349,8464.066681,,,CABAZITAXEL S.K.  40 MG/ML (60 MG/1.5 ML) 1 VIAL,23141,,31559,VIAL GLASS TYPE I,units,1.0,169 69 36260 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,CABAZITAXEL S.K. is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel- containing treatment regimen.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2b435cb-e916-49e1-b024-6d4defc7bf79.json
e2ba10fa-c7d6-4e81-ae0c-ddab10ea1142,PARICALCITOL INOVAMED 5 MCG/ML,prescription,H05BX02,PARICALCITOL,8329,,,WHO ATC Classification,,ILS,solution for injection,PARICALCITOL 0.005 MG/ML,2025-07-31T06:28:51.164170,IL,אינובמד,,302.4876789,256.3454906,218.166375,,7290104530401,PARICALCITOL INOVAMED 5 MCG/ML 5 AMP,10299,,4220,AMPOULES GLASS TYPE I,units,5.0,159 87 34513 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Paricalcitol is indicated in adults for the prevention and treatment of secondary hyperparathyroidism in patients with chronic renal failure who are undergoing haemodialysis., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2ba10fa-c7d6-4e81-ae0c-ddab10ea1142.json
e2ca1efe-0b7d-46a0-b3c0-059dd21d9ea8,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7462,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:20:23.337754,IL,צמל,,142.579105,120.82975,96.6638,,,METOJECT 50MG/ML SYRINGE PREFILLED 30MG/0.6ML,,,41386,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,25.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2ca1efe-0b7d-46a0-b3c0-059dd21d9ea8.json
e2cf10e2-bea8-4d9b-a03c-baed65c3d58c,RUBRACA 200 MG,prescription,L01XX55,RUCAPARIB,8460,,,WHO ATC Classification,,ILS,film coated tablets,RUCAPARIB AS CAMSYLATE,2025-07-31T07:52:46.265340,IL,ניאופרם,,12564.09898,10647.54198,9679.583619,,7290111090660,RUBRACA 200MG  60TABS,18608,,54993,BOTTLE HDPE,units,60.0,162 81 35664 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube,or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2cf10e2-bea8-4d9b-a03c-baed65c3d58c.json
e2dbd9bf-9b2f-4d12-bd30-32ff2ae99a33,ADVAGRAF 0.5 MG,prescription,L04AD02,TACROLIMUS,7671,,,WHO ATC Classification,,ILS,capsules prolonged release,TACROLIMUS AS MONOHYDRATE 0.5  MG,2025-07-31T00:09:54.809642,IL,אסטלס,,270.0772381,228.8790255,194.79066,,8718692510692,ADVAGRAF 1MG 50  P.R. CAPS,9818,,74114,BLISTER PVC/PVDC/ALUMINIUM,units,50.0,153 07 34071 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in adult kidney or liver allograft recipients.Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2dbd9bf-9b2f-4d12-bd30-32ff2ae99a33.json
e2e95678-483d-4893-9a6e-b4b3c16ad913,AMBISOME,prescription,J02AA01,AMPHOTERICIN B,7809,,,WHO ATC Classification,,ILS,powder for concentrate for infusion,AMPHOTERICIN B/VIAL,2025-07-31T00:18:09.836666,IL,גיליאד,,5135.377364,4352.014909,3956.37719,,7290008142151,AMBISOME 50MG/VIAL 10VIALS,9446,,2505,VIAL 15 ML GLASS TYPE I,units,10.0,066 56 28192 01,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Antifungal antibiotic for the treatment of severe systemic and/or deep mycoses where toxicity precludes the use of conventional systemic amphotericin B in effective dosages. This drug should not be used to treat the common clinically inapparent forms of fungal disease which show only positive skin or serologic tests. Ambisome is also indicated for the treatment of systemic fungal infections in immunocompromised patients (e.g. patients with AIDS or cancer). Ambisome is also indicated for the primary therapy of visceral leishmaniasis in immunocompetent patients and immunocompromised patients (e.g. HIV positive). Empirical treatment of presumed fungal infection in febrile neutropenic patients.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2e95678-483d-4893-9a6e-b4b3c16ad913.json
e2f6848a-6a7f-4163-aa4a-8bee50c52201,ZETO 250,prescription,J01FA10,AZITHROMYCIN,3315,,,WHO ATC Classification,,ILS,coated tablets,AZITHROMYCIN AS DIHYDRATE,2025-07-31T10:47:47.232119,IL,אוניפארם,,33.48318086,28.375577,20.7121,,,ZETO 250 6TAB,26040,,9601,BLISTER PVC/ALUMINIUM,units,6.0,103 83 28422 01,valid,37.0,per os,1.4,27,,,,,,,,,,0,Prescription required,"Zeto is indicated for infections caused by susceptible organisms, in low respiratory tract infections including bronchitis and pneumonia, skin and soft tissue infections, otitis media and in upper respiratory tract infections including sinusitis and pharyngitis/tonsilitis.It is also used for the treatment of uncomplicated genital infections due to chlamydia trachomatis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e2f6848a-6a7f-4163-aa4a-8bee50c52201.json
e3086765-27dc-4adc-9bc3-8f170f4497c0,CEFTAZIDINE PANPHARMA 1G 10VIAL,prescription,,,8215,,,,,ILS,injection,CEFTAZIDINE PANPHARMA 1G,2025-07-31T19:00:47.939884,IL,פארמלוג'יק,,318.78408,270.156,229.92,,,CEFTAZIDINE PANPHARMA 1G 10VIAL,,,66929,,units,10.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3086765-27dc-4adc-9bc3-8f170f4497c0.json
e30bbe8f-e7eb-4eba-90e1-81aac3f52a28,DEPO-PROVERA 150 MG/ML,prescription,G03AC06,MEDROXYPROGESTERONE,42,,,WHO ATC Classification,,ILS,suspension for injection,MEDROXYPROGESTERONE ACETATE/ML,2025-07-31T01:48:22.062115,IL,פיזר,,32.76557277,27.76743578,20.2682013,,7298074000511,DEPO-PROVERA 3.3MLx150MG/ML,4058,,626,SYRINGE GLASS TYPE I,units,1.0,069 69 24309 00,valid,37.0,i.m,1.4,60,,,,,,,,,,0,Prescription required,For contraception where medically indicated and oral administration is inapplicable.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e30bbe8f-e7eb-4eba-90e1-81aac3f52a28.json
e317786f-5d8f-4cab-b6d9-5fe7d6d53fa5,ZIDOVAL 7.5 MG/G VAGINAL GEL,prescription,G01AF01,METRONIDAZOLE,4211,,,WHO ATC Classification,,ILS,gel,METRONIDAZOLE 7.5 MG/G,2025-07-31T10:48:15.992255,IL,מגאפארם,,40.73831819,34.524,25.2,,7290008107310,ZIDOVAL VAG. GEL 7.5MG/G 40G + APPLICATORS,26029,,25306,TUBE ALUMINIUM,units,40.0,118 72 29887 01,valid,37.0,vaginal,1.4,36,,,,,,,,,,0,Prescription required,Zidoval vaginal gel is indicated for the treatment of bacterial vaginosis (formally called non-specific vaginitis gardnella vaginalis vaginitis or haemophilus vaginitis).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e317786f-5d8f-4cab-b6d9-5fe7d6d53fa5.json
e31ad6d7-9859-4f12-a82f-c6e62c16572d,ELOCTA 3000 IU,prescription,B02BD05,COAGULATION FACTOR VII,9071,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR VIII/VIAL,2025-07-31T02:16:25.173306,IL,מגאפארם,,8527.690121,7226.856356,6569.869415,,,ELOCTA 3000 IU,,,,VIAL GLASS TYPE I,units,1.0,170 52 36899 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e31ad6d7-9859-4f12-a82f-c6e62c16572d.json
e32120ee-05ee-48c7-9e4a-eb13f37421fc,ADENOHARDT,prescription,C01EB10,ADENOSINE,8331,,,WHO ATC Classification,,ILS,solution for injection,ADENOSINE/,2025-07-31T00:08:39.054518,IL,פרופארם,,97.194004,82.3678,61.24,,5012727911731,ADENOHARDT 3MG/ML 6 VIALS 2ML,,,55446,VIAL GLASS TYPE I,units,6.0,157 77 34595 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Rapid conversion to a normal sinus rhythm of paroxymal supraventicular tachycardias including those associated with accessory bypass tracts (wolf parkinson-white syndrome).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e32120ee-05ee-48c7-9e4a-eb13f37421fc.json
e326266e-755f-47e7-9284-b0244d577f49,BENEFIX 1000 IU/VIAL,prescription,B02BD04,COAGULATION FACTOR IX,6729,,,WHO ATC Classification,,ILS,lyophilized powder for injection,COAGULATION FACTOR IX RECOMBINANT-RFIX/VIAL,2025-07-31T00:30:11.538086,IL,פיזר,,2397.421027,2031.712825,1847.011659,,8470006591734,BENEFIX 1000IU/VIAL I.V 1 VIAL,2571,,37884,VIAL GLASS TYPE I,units,1.0,120 57 30123 01,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (PTP) and previously untreated patients (PUP). Benefix  is not indicated for the treatment of other factor deficiencies (e.g. factors II,VII, and X)' nor for the treatment of hemophilia A patients with inhibitors to factor VIII, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e326266e-755f-47e7-9284-b0244d577f49.json
e333987d-4e77-44df-99ce-9b5fef141fa8,LIXIANA15 MG,prescription,B01AF03,EDOXABAN,8520,,,WHO ATC Classification,,ILS,film coated tablets,EDOXABAN AS TOSYLATE,2025-07-31T04:51:58.099039,IL,מדיסון,,300.5514786,254.7046542,216.7699185,,,LIXIANA 60 MG 30 TAB,12608,,73227,BLISTER PVC/ALUMINIUM,units,30.0,166 82 36013 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,"• Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with  one or more risk factors, such as congestive heart failure, hypertension, age &#8805; 75 years,diabetes mellitus, prior stroke or transient ischaemic attack (TIA).• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e333987d-4e77-44df-99ce-9b5fef141fa8.json
e33419f4-a4db-41c0-8e8f-86b13dbb5c7d,METHADONE,prescription,N02AC52,"METHADONE, COMB. EXCL. PSYCHOLEPTICS",6611,,,WHO ATC Classification,,ILS,solution,METHADONE HYDROCHLORIDE/ML,2025-07-31T05:17:00.310797,IL,רפא,,nan,nan,nan,,7290008014120,METHADONE 5% 50MG/ML 25 BOTTLE/ 200ML,13138,,35291,BOTTLE GLASS TYPE III,units,25.0,105 67 29097 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of severe pain.  Detoxification and withdrawal treatment in narcotic addiction.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e33419f4-a4db-41c0-8e8f-86b13dbb5c7d.json
e34ba806-822b-42a9-b77f-9fe4613fa85e,RENNIE PEPPERMINT,off-the-counter,,,1313,,,,,ILS,chewable tablets,"CALCIUM CARBONATE, MAGNESIUM CARBONATE",2025-07-31T12:55:40.704270,IL,באייר,,29.2404,24.78,nan,,,RENNIE PEPPERMINT 48TAB,18226,,,BLISTER PVC/ALUMINIUM,units,48.0,134 20 28413 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,Relief of hyperacidity and heartburn.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e34ba806-822b-42a9-b77f-9fe4613fa85e.json
e34c4207-4181-40ae-98e1-fac39f5ab61b,RENVELA 2.4 G POWDER,prescription,V03AE02,SEVELAMER,6691,,,WHO ATC Classification,,ILS,powder for oral suspension,SEVELAMER CARBONATE ANHYDROUS 2.4 G/SACHET,2025-07-31T07:25:16.507085,IL,סאנופי אוונטיס,,524.5506625,444.5344597,378.3271998,,7290013773067,RENVELA 2.4G POWDER 60SACHET,18459,,21577,SACHET FOIL,units,60.0,145 75 33193 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.Also indicated for the control of hyperphosphataemia in adult patients with chronic kidney diseasenot on dialysis with serum phosphorus &#8805; 1.78 mmol/l.Should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e34c4207-4181-40ae-98e1-fac39f5ab61b.json
e34d9816-6976-4961-b550-e069e5b5fad6,OTRIVINI SALINE FOR BABIES MD 15ML,off-the-counter,,,5021,,,,,ILS,tablet,OTRIVINI SALINE FOR BABIES MD,2025-07-31T19:45:55.921567,IL,ג.ס.ק,,24.1074,20.43,,,,OTRIVINI SALINE FOR BABIES MD 15ML,15322,,,,units,15.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e34d9816-6976-4961-b550-e069e5b5fad6.json
e36125d0-f04a-402d-a674-86031fe1e6f4,RAFASSAL 4 GRAM ENEMA,prescription,A07EC02,MESALAZINE,2488,,,WHO ATC Classification,,ILS,enema,MESALAZINE/,2025-07-31T07:14:42.998784,IL,רפא,,78.57027396,66.58498089,49.505562,,7290008013765,RAFASSAL 500MG 30SUPP,18233,,8300,BOTTLE POLYETHYLENE,units,30.0,029 58 25321 00,valid,34.5,rectal,1.4,18,,,,,,,,,,0,Prescription required,Treatment and prevention of ulcerative colitis and Crohn's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e36125d0-f04a-402d-a674-86031fe1e6f4.json
e3622065-89cf-4e96-8e4a-2d299715cdf5,HERCEPTIN  440 MG I.V,prescription,L01FD01,TRASTUZUMAB,4915,,,WHO ATC Classification,,ILS, powder for concentrate for solution for infusion ,TRASTUZUMAB/VIAL,2025-07-31T03:45:47.386655,IL,רוש,,4395.045268,3724.614799,3386.013454,,7290008140478,HERCEPTIN 440MG MULTIDOSE VIAL,8324,,35510,VIAL GLASS TYPE I,units,1.0,113 91 29676 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"Herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress HER2:   1. As a single agent  for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease.    2. In combination with Paclitaxel or Docetaxel  for the treatment of those patients who have not received chemotherapy for their metastatic disease.   3. Herceptin in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer.   Early breast cancer (EBC) :Herceptin is indicated to treat patients with HER2-positive early breast cancer following surgery and  chemotherapy (neoadjuvant or adjuvant)  either alone or in combination with chemotherapy excluding Anthracyclines.  Herceptin should only be used in patients whose tumors have either HER2 overexpression or HER2  gene amplification as determined by an accurate and validated assay.HER2 metastatic gastric cancer (mGC)Herceptin in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.Herceptin should only be used in patients with metastatic gastric cancer whose tumours have HER2 overexpression as defined by IHC2+ and a confirmatory FISH+ result, or IHC 3+, as determined by an accurate and validated assay",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3622065-89cf-4e96-8e4a-2d299715cdf5.json
e36e6cb9-f976-4a54-a3ae-8469c770cc81,BETAREN 100 S.R.,prescription,M01AB05,DICLOFENAC,3857,,,WHO ATC Classification,,ILS,tablets slow release,DICLOFENAC SODIUM,2025-07-31T00:33:59.927469,IL,דקסל פארמה,,20.33472642,17.232819,12.5787,,,BETAREN 100MG 20 S.R.TAB,2265,,25870,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,015 73 24619 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis, osteoarthritis, low back pain and other acute musculoskeletal disorders such as periarthritis, tendinitis, tenosynovitis, bursitis, sprains, strains and dislocation, ankylosing spondylitis and acute gout.Control of pain and inflammation in orthopedic, dental, and other minor surgery.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e36e6cb9-f976-4a54-a3ae-8469c770cc81.json
e3740d05-e8cc-4fa9-9f13-bfe94f50dba0,GRISEOFULVIN ORAL SUSP 100ML,29C,,,20436,,,,,,tablet,GRISEOFULVIN ORAL SUSP,2025-07-31T20:32:49.180532,IL,nan,,,,,,,GRISEOFULVIN ORAL SUSP 100ML,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3740d05-e8cc-4fa9-9f13-bfe94f50dba0.json
e383cfe9-329a-4b98-83fc-40562ecf5ed1,PRIMENE 10 %,prescription,B05XB03,LYSINE,9092,,,WHO ATC Classification,,ILS,solution for infusion,"L- VALINE 0.76 G /, L- TYROSINE 0.045 G /, L- TRYPTOPHAN 0.2 G /, L- THREONINE 0.37 G /, TAURINE 0.06 G /, L- SERINE 0.4 G /, L- PROLINE 0.3 G /, L- PHENYLALANINE 0.42 G /, L- ORNITHINE HYDROCHLORIDE 0.318 G /, L- METHIONINE 0.24 G /, L- LYSINE 1.1 G /, L- LEUCINE 1.0 G /, L- ISOLEUCINE 0.67 G /, L-HISTIDINE 0.38 G /, GLYCINE 0.4 G /, L- GLUTAMIC ACID 1.0 G /, L- CYSTEINE 0.189 G /, L- ASPARTIC ACID 0.6 G /, L-ARGININE 0.84 G /, L- ALANINE 0.8 G /",2025-07-31T06:56:55.360674,IL,סופר-פארם,,105.4999165,89.40671291,66.4733925,,,PRIMENE 10 % BOTTLE 100 ML,,,,BOTTLE GLASS TYPE II,units,100.0,123 47 30286 20,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Primene 10 % is indicated in   1) children and infants   2) neonates  at term or premature  of normal or low birth weight when oral or enteral nutrition is impossible  insufficient or contraindicated.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e383cfe9-329a-4b98-83fc-40562ecf5ed1.json
e386e4d1-b4b1-414e-ada3-aac397faaab1,DERMAX,off-the-counter,,,1798,,,,,ILS,solution,TRICLOSANV/V,2025-07-31T11:29:31.047480,IL,פישר,,33.4648,28.36,nan,,7290000849386,DERMAX 200ML,4077,,,BOTTLE HDPE,units,200.0,022 58 24975 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,For treatment and disinfection of skin infections .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e386e4d1-b4b1-414e-ada3-aac397faaab1.json
e3956b86-fa21-4f76-9ad7-914c28d19938,TESTOMAX 25 MG,prescription,G03BA03,TESTOSTERONE,6034,,,WHO ATC Classification,,ILS,gel,TESTOSTERONE/DOSE,2025-07-31T09:16:32.102693,IL,פאדאגיס,,142.0149175,120.351625,96.2813,,7290004850463,TESTOMAX 25MG 30SACHX2.5G,20621,,75520,SACHET ALUMINIUM,units,30.0,136 20 31297 00,valid,25.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3956b86-fa21-4f76-9ad7-914c28d19938.json
e39d4cbc-1fdc-4947-b24f-a622e7274535,SINUCLEAR EXTRACT TABLETS,off-the-counter,,,5629,,,,,ILS,coated tablets,"NATIVE DRY EXTRACT (3-6:1) DERIVED FROM GENTIAN ROOT, PRIMULA FLOWERS, SORREL HERB, ELDER FLOWERS, VERBENA HERB (1:3:3:3:3), 1. EXTRACTING AGENT: ETHANOL(M/M)",2025-07-31T13:17:49.387861,IL,דר סמואלוב,,60.416,51.2,nan,,,SINUCLEAR EXTRACT  20 TABLETS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,177 48 36980 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Herbal medicinal product for the symptomatic relief of nasal congestion and headaches in those suffering from acute uncomplicated inflammations of the paranasal sinuses (acute uncomplicated rhinosinusitis) in adults and children from the age of 12 years.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e39d4cbc-1fdc-4947-b24f-a622e7274535.json
e3be0e90-7995-4c78-bbc3-251db2b05dd3,MACCABIMOL KID,off-the-counter,N02BE01,PARACETAMOL,5513,,,WHO ATC Classification,,ILS,suppositories,PARACETAMOL,2025-07-31T12:24:42.327742,IL,מכבי קאר,,12.7204,10.78,nan,,7290008091145,MACCABIMOL KID 12 SUPPOSITORIES,,,,FOIL ALUMINIUM,units,12.0,135 30 31435 00,valid,nan,rectal,1.4,24,,,,,,,,,,0,,"Analgesic, antipyretic pediatric suppositories.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3be0e90-7995-4c78-bbc3-251db2b05dd3.json
e3d53217-5266-4c45-9d87-e5e5941ebf8c,CARVEDEXXON 12.5,prescription,C07AG02,CARVEDILOL,4603,,,WHO ATC Classification,,ILS,tablets,CARVEDILOL 12.5  MG,2025-07-31T00:56:07.637522,IL,דקסל פארמה,,18.2457559,15.462505,11.2865,,,CARVEDEXXON 12.5MG 30TAB,3730,,53251,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,127 20 30615 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of symptomatic congestive heart failure. Carvedexxon may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ACE inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3d53217-5266-4c45-9d87-e5e5941ebf8c.json
e3e3ea74-dbeb-4df0-bb18-74202b1c1b7e,TRIKAFTA 100MG/50MG/75MG&150MG,prescription,R07AX32,"IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR",8956,,,WHO ATC Classification,,ILS,film coated tablets,"IVACAFTOR, TEZACAFTOR, ELEXACAFTOR, IVACAFTOR",2025-07-31T09:42:32.922560,IL,מדיסון,,nan,nan,nan,,,TRIKAFTA 100MG/50MG/75MG/150MG,17194,,64957,BLISTER PVC/ACLAR,units,84.0,167 03 36448 99,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,Trikafta is indicated for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene or a mutation in the CFTR gene that is responsive based on in vitro data.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3e3ea74-dbeb-4df0-bb18-74202b1c1b7e.json
e3e823cd-aaf8-470f-9e49-f333d77be1e4,AGISTEN ALOEVERA CREAM,off-the-counter,D01AC01,CLOTRIMAZOLE,2371,,,WHO ATC Classification,,ILS,cream,CLOTRIMAZOLEW/W,2025-07-31T11:07:40.368496,IL,פאדאגיס,,34.692,29.4,nan,,7290004850432,AGISTEN CREAM 30GR,1833,,,TUBE ALUMINIUM,units,30.0,043 17 22461 00,valid,nan,dermal,1.4,24,,,,,,,,,,0,,"For the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, molds and other fungi such as Malassezia furfur, as well as skin infections caused by Corynebacterium minutissimum.Indicated also for Candida Vulvitis and Candida balanitis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3e823cd-aaf8-470f-9e49-f333d77be1e4.json
e3f82191-873b-4901-9fbf-ad2c1b88f43a,EPREX/PROTECS 6000 IU/0.6ML 6SYRINGES,prescription,,,4428,,,,,ILS,tablet,EPREX/PROTECS 6000 IU/0. 6SYRINGES,2025-07-31T19:09:22.215152,IL,יאנסן סילג,,1393.624669,1181.037855,1005.1386,,,EPREX/PROTECS 6000 IU/0.6ML 6SYRINGES,5460,,86983,,units,6.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3f82191-873b-4901-9fbf-ad2c1b88f43a.json
e3f82755-7af0-4bcd-9935-9b72d2c4efe9,LIPANOR,prescription,C10AB08,CIPROFIBRATE,3427,,,WHO ATC Classification,,ILS,capsules,CIPROFIBRATE,2025-07-31T04:47:37.778129,IL,כ.צ.ט,,25.02145103,21.20462046,15.47782515,,,LIPANOR 100MG 30CAP,2067,,9595,BLISTER PVC/ALUMINIUM,units,30.0,105 56 28758 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of primary hyperlipidaemia resistant to appropriate dietary management, including hypercholesterolaemia, hypertriglyceridaemia and combined hyperlipidaemia.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3f82755-7af0-4bcd-9935-9b72d2c4efe9.json
e3fe2001-2165-4fea-af60-a55703f4d278,HISTAZINE,off-the-counter,R06AE07,CETIRIZINE,3602,,,WHO ATC Classification,,ILS,syrup,CETIRIZINE DIHYDROCHLORIDE 0.1  %W/V,2025-07-31T12:05:44.964438,IL,תרימה,,31.5886,26.77,nan,,7290008075459,HISTAZINE SYRUP 115ML,8003,,,BOTTLE GLASS,units,115.0,109 59 29304 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antihistaminic drug for the treatment of allergies for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic uriticaria in children aged over 2 years and adults., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e3fe2001-2165-4fea-af60-a55703f4d278.json
e41529ba-a6cf-4a77-b920-37fd1df1b0fc,ABITREN TEVA ® 75 MG/3 ML,prescription,M01AB05,DICLOFENAC,1346,,,WHO ATC Classification,,ILS,solution for injection,DICLOFENAC SODIUM/,2025-07-30T23:10:41.084462,IL,טבע,,12.997464,11.0148,8.04,,7290110730482,ABITREN 50MG 10SUPP,1009,,7107,AMPOULES GLASS TYPE I,units,10.0,159 38 34860 00,valid,37.0,i.m,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of: - Exacerbations of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondylarthritis, non-articular rheumatism.- Treatment of painful conditions due to inflammation of non rheumatic origin.- Renal colic and biliary colic - Post-traumatic and post-operative pain, inflammation and swelling",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e41529ba-a6cf-4a77-b920-37fd1df1b0fc.json
e4343b36-bb2e-4e97-a5e0-98724a110181,TEPADINA 100 MG,prescription,L01AC01,THIOTEPA,7762,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,THIOTEPA/VIAL,2025-07-31T09:12:58.978187,IL,אמ.בי.איי פארמה,,538.5851926,456.4281496,388.449489,,7290014257528,TEPADINA 15MG VIAL,,,,VIAL GLASS TYPE I,units,1.0,154 18 34230 03,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"TEPADINA is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients;2.  when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4343b36-bb2e-4e97-a5e0-98724a110181.json
e453f111-02bd-4253-b168-bbc4ecae990a,TACROCEL 0.5 MG,prescription,L04AD02,TACROLIMUS,7079,,,WHO ATC Classification,,ILS,capsules,TACROLIMUS AS MONOHYDRATE 0.5  MG,2025-07-31T08:57:47.765556,IL,פאדאגיס,,725.8682444,615.14258,523.5256,,,TACROCEL 1 MG 100 CAPSULES,20746,,38113,BLISTER PVC/PE/PVDC/AL,units,100.0,148 54 33452 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Prophylaxis of transplant rejection in liver kidney or heart allograft recipients.Treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e453f111-02bd-4253-b168-bbc4ecae990a.json
e45b3e5c-9b18-4b2d-8055-4be29e2df360,EVIPLERA,prescription,J05AG05,RILPIVIRINE,7167,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR DISOPROXIL AS FUMARATE, RILPIVIRINE AS HYDROCHLORIDE, EMTRICITABINE",2025-07-31T02:46:12.052444,IL,יאנסן סילג,,2485.419062,2106.287434,1914.806759,,,EVIPLERA 30 F.C.TAB,5567,,77155,BOTTLE HDPE,units,30.0,149 30 33766 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"EVIPLERA, a combination of two nucleoside analog HIV 1 reverse transcriptase inhibitors (emtricitabine and tenofovir disoproxil fumarate) and one non-nucleoside reverse transcriptase inhibitor (rilpivirine), is indicated for use as a complete regimen for the treatment of HIV-1 infection in adult patients with no antiretroviral treatment history and with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy, and in certain virologically-suppressed (HIV-1 RNA <50 copies/mL) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see below).The following points should be considered when initiating therapy with EVIPLERA in adult patients with no antiretroviral treatment history: • More rilpivirine-treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA &#8805;50 copies/mL) compared to rilpivirine-treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL [See Clinical Studies (14)]. • Regardless of HIV-1 RNA level at the start of therapy, more rilpivirine-treated subjects with CD4+ cell count less than 200 cells/mm3 experienced virologic failure compared to rilpivirine-treated subjects with CD4+ cell count greater than or equal to 200 cells/mm3 [See Clinical Studies (14)]. •  The observed virologic failure rate in rilpivirine-treated subjects conferred a higher rate of overall treatment resistance and cross-resistance to the NNRTI class compared to efavirenz [See Microbiology (12.4)]• More subjects treated with rilpivirine developed tenofovir and lamivudine/emtricitabine  associated resistance compared to efavirenz [See Microbiology (12.4)].",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e45b3e5c-9b18-4b2d-8055-4be29e2df360.json
e4636073-106e-4afc-83f3-ff318b78cd6c,ANASTROZOLE TEVA ®,prescription,L02BG03,ANASTROZOLE,6347,,,WHO ATC Classification,,ILS,tablets,ANASTROZOLE,2025-07-30T23:23:35.332566,IL,טבע,,179.2306425,151.890375,121.5123,,,ANASTROZOLE 1MG 30TAB,9332,,79385,BLISTER PVDC/ALUMINIUM,units,30.0,141 32 31760 01,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen.  Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4636073-106e-4afc-83f3-ff318b78cd6c.json
e46d88e1-aa2c-4cce-b463-7542d463b07f,MICROLET,off-the-counter,A06AG20,COMBINATIONS,1771,,,WHO ATC Classification,,ILS,enema,"GLYCEROL 12.5 %W/V, SODIUM CITRATEW/V, LAURYLSULPHOACETATE SODIUM 0.9 %W/V",2025-07-31T12:25:25.429506,IL,דקסל פארמה,,37.4178,31.71,nan,,7290008004961,MICROLET 12 TUBES,13125,,,TUBE PLASTIC,units,12.0,047 20 23432 03,valid,nan,rectal,1.4,36,,,,,,,,,,0,,Constipation.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e46d88e1-aa2c-4cce-b463-7542d463b07f.json
e470397c-5a9a-49a9-a5cc-121e2d54cdeb,FENTAMED 100 MCG,prescription,N01AH01,FENTANYL,9367,,,WHO ATC Classification,,ILS,tablets sublingual,FENTANYL AS CITRATE MICRONIZED,2025-07-31T03:00:41.581094,IL,אינובמד,,663.9244957,562.6478777,478.8492576,,7290104531170,FENTAMED 800 MCG 30 TAB SUBLINGUAL,23638,,5095,BLISTER PA/AL/PVC//ALU/PET,units,30.0,173 43 36706 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Fentamed is indicated for management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Breakthrough pain is a transient exacerbation of otherwise controlled chronic background pain.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e470397c-5a9a-49a9-a5cc-121e2d54cdeb.json
e47f339e-1db6-4098-bfbf-ee3cf4dfcfb6,DESCOVY 200 MG/10 MG,prescription,J05AR03,TENOFOVIR DISOPROXIL AND EMTRICITABINE,7979,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR ALAFENAMIDE FUMARATE, EMTRICITABINE",2025-07-31T01:49:50.552268,IL,גיליאד,,2419.632909,2050.536455,1745.137408,,5391507143198,DESCOVY 200 MG/10 MG 30 TAB,4667,,62099,BOTTLE HDPE,units,30.0,158 05 34949 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (HIV 1)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e47f339e-1db6-4098-bfbf-ee3cf4dfcfb6.json
e47f44b4-60d2-4bd1-a58b-1c0edba1477f,FLUCONAZOLE MBI 2 MG/ ML,prescription,J02AC01,FLUCONAZOLE,8952,,,WHO ATC Classification,,ILS,solution for infusion,FLUCONAZOLE/,2025-07-31T03:11:54.164378,IL,אמ.בי.איי פארמה,,2827.044,2395.8,2178.0,,,FLUCONAZOLE MBI 200MG/100ML 50  VIAL,,,84872,BAG PVC,units,5000.0,161 92 35274 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Fluconazole is indicated in the following fungal infections (see section 5.1). Fluconazole is indicated in adults for the treatment of:•	Cryptococcal meningitis (see section 4.4).•	Coccidioidomycosis (see section 4.4).•	Invasive candidiasis.•	Mucosal candidiasis (including oropharyngeal candidiasis, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis).•	Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.Fluconazole is indicated in adults for the prophylaxis of:•	Relapse of cryptococcal meningitis in patients with high risk of recurrence.•	Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.•	Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Haematopoetic Stem Cell Transplantation (see section 5.1)).Fluconazole is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old:Fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence (see section 4.4).Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e47f44b4-60d2-4bd1-a58b-1c0edba1477f.json
e4801a92-1dfa-49a0-bc2c-5969dfa2cb1e,DEXAMOL,off-the-counter,N02BE01,PARACETAMOL,2701,,,WHO ATC Classification,,ILS,caplets,PARACETAMOL,2025-07-31T11:30:59.785504,IL,דקסל פארמה,,26.3494,22.33,nan,,,DEXAMOL COLD DAY 30 CAPLIOTS,4010,,,BLISTER PVC/ALUMINIUM,units,30.0,039 64 25921 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4801a92-1dfa-49a0-bc2c-5969dfa2cb1e.json
e48ebaad-c64c-4ae5-893c-ad6cb62c7c14,SINGULAIR 10 MG TABLETS,prescription,R03DC03,MONTELUKAST,4748,,,WHO ATC Classification,,ILS,tablets,MONTELUKAST AS SODIUM,2025-07-31T08:17:27.504988,IL,אורגנון,,68.24952151,57.83858012,43.0026618,,7290004997410,SINGULAIR 4MG 28SACHETS GRANULES,19723,,11252,BLISTER PVC/OPA/AL,units,28.0,109 91 29317 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms of the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.   Singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Singulair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.Because the benefits of SINGULAIR may not outweigh the risk of neuropsychiatric symptoms in patients with seasonal rhinitis [see Warnings and Precautions (5.1)], reserve use for patients who have an intolerance to alternative therapies.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e48ebaad-c64c-4ae5-893c-ad6cb62c7c14.json
e497bb74-ed41-411a-a5ff-fa81b04a091d,DAIVOBET,prescription,D05AX52,"CALCIPOTRIOL, COMBINATIONS",4703,,,WHO ATC Classification,,ILS,ointment,"BETAMETHASONE AS DIPROPIONATE 0.5 MG/G, CALCIPOTRIOL AS HYDRATE/G",2025-07-31T01:39:21.034009,IL,דקסל פארמה,,64.95255423,55.04453993,40.9253085,,,DAIVOBET OINT 30GR,4460,,59736,TUBE ALUMINIUM,units,30.0,127 60 30600 00,valid,34.5,dermal,1.4,24,,,,,,,,,,0,Prescription required,Topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e497bb74-ed41-411a-a5ff-fa81b04a091d.json
e4a23fa2-b8c7-4452-a935-45ef91a57c6f,CEFOVIT 250,prescription,J01DB01,CEFALEXIN,2275,,,WHO ATC Classification,,ILS,capsules,CEFALEXIN AS MONOHYDRATE,2025-07-31T00:59:30.789690,IL,ויטאמד,,13.33695,11.3025,8.25,,,CEFOVIT 125 SUSP 60ML,3588,,7692,BLISTER PVC/PVDC/ALUMINIUM,units,60.0,026 84 25145 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic for the treatment of infections caused by micro-organisms sensitive to Cephalexin.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4a23fa2-b8c7-4452-a935-45ef91a57c6f.json
e4a67e89-12ab-452c-b47b-7ac5a5625024,NICOTINELL GUM 2 MG (MINT),off-the-counter,N07BA01,NICOTINE,5617,,,WHO ATC Classification,,ILS,chewing gum,NICOTINE,2025-07-31T12:30:21.564721,IL,ג.ס.ק,,122.0592,103.44,nan,,,NICOTINELL GUM 2 MG (MINT) 96 GUMS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,96.0,115 78 29638 23,valid,nan,per os,1.4,30,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4a67e89-12ab-452c-b47b-7ac5a5625024.json
e4ac777d-4f45-405f-a8c5-b927c2cb1f5e,GAMUNEX ® - C,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7053,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN 0.1 G/ML",2025-07-31T03:27:28.464012,IL,פאדאגיס,,1630.995365,1382.199524,1176.34002,,7298074020687,GAMUNEX C 0.1G/ML 5GR 50ML SOLUTION FOR INJECTION,7926,,35530,VIAL GLASS,units,50.0,132 95 31058 00,valid,17.5,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Gamunex is indicated as replacement therapy of primary immunodeficiency (PI) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, X-limked immunodeficiency with hyper IgM, Wiskott- Aldrich syndrom, and severed combined immunodeficiencies. Gamunex is also indicated in Idiopathic Thrombocytopenia Purpura (ITP) to raise platelet counts to prevent bleeding or to allow a patient with ITP to undergo surgery.Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4ac777d-4f45-405f-a8c5-b927c2cb1f5e.json
e4aded3c-215f-443e-98a8-7264759b5769,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4555,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:22:20.996641,IL,מדיסון,,4494.50006,3808.898525,3462.635023,,8715131005863,ARANESP 150MCG 4 PREFILLED SYR 0.3ML,9481,,29749,PRE-FILLED PEN GLASS TYPE I,units,4.0,124 46 30400 00,valid,10.0,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4aded3c-215f-443e-98a8-7264759b5769.json
e4c99d00-294a-41ee-b2af-a9af7d14bdb1,LOSEC 20 MG,prescription,A02BC01,OMEPRAZOLE,1388,,,WHO ATC Classification,,ILS,capsules,OMEPRAZOLE,2025-07-31T04:56:01.915725,IL,טבע,,29.0988,24.66,18.0,,,LOSEC 20MG 14CAPS,12271,,78360,BOTTLE HDPE,units,14.0,139 78 31879 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4c99d00-294a-41ee-b2af-a9af7d14bdb1.json
e4d362af-1c1b-481d-a61b-f406490a7d77,ULTIBRO BREEZHALER 110/50 MCG,prescription,R03AC18,INDACATEROL,7421,,,WHO ATC Classification,,ILS,inhalation powder hard capsules,"INDACATEROL AS MALEATE, GLYCOPYRRONIUM AS BROMIDE",2025-07-31T09:51:02.171123,IL,נוברטיס פארמה,,203.0474105,172.0740844,137.6592675,,7290014257269,ULTIBRO BREEZHALER 110/50 MCG 30 CAPSULES,21119,,52780,BLISTER PVC/OPA/AL,units,30.0,151 39 33990 00,valid,25.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Ultibro Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4d362af-1c1b-481d-a61b-f406490a7d77.json
e4dd2c36-2571-48e5-a15e-6a15071823ba,HUMULIN N,prescription,A10AC01,INSULIN (HUMAN),3322,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN (HUMAN)/ML,2025-07-31T03:51:28.937454,IL,אלי לילי,,123.3448146,104.5295086,77.71710675,,7290008139816,HUMULIN REGUL CART 5x3ML,9091,,9473,VIAL GLASS TYPE I,units,15.0,054 12 22715 22,valid,34.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4dd2c36-2571-48e5-a15e-6a15071823ba.json
e4e12a63-32d2-4d11-b1c6-b7dbaf73a2bb,CALAMINE LOTION FLORIS,off-the-counter,D09AB01,ZINC BANDAGE WITHOUT SUPPLEMENTS,3331,,,WHO ATC Classification,,ILS,lotion,"CALAMINE, ZINC OXIDE",2025-07-31T11:21:17.580053,IL,פלוריש,,13.4992,11.44,nan,,7290008103503,CALAMINE LOTION 100ML,3145,,,BOTTLE POLYETHYLENE,units,100.0,125 47 28879 00,valid,nan,dermal,1.4,48,,,,,,,,,,0,,For relief of skin irritations.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4e12a63-32d2-4d11-b1c6-b7dbaf73a2bb.json
e4e8b041-7a82-446e-804e-f7238508819a,COSENTYX  SOLUTION FOR INJECTION,prescription,L04AC10,SECUKINUMAB,7755,,,WHO ATC Classification,,ILS,solution for injection,SECUKINUMAB/ML,2025-07-31T01:31:14.805364,IL,נוברטיס פארמה,,5267.194295,4463.724177,4057.93107,,7290014257429,COSENTYX 150MG SOL FOR INJ 2 PREFILLED PENS,9851,,18479,PRE-FILLED PEN GLASS TYPE I,units,2.0,154 20 34342 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"- Plaque psoriasis: Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. - Paediatric plaque psoriasis: Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy. - Psoriatic arthritis: Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous disease modifying anti rheumatic drug (DMARD) therapy has been inadequate. - Axial spondyloarthritis (axSpA) : •Ankylosing spondylitis (AS, radiographic axial spondyloarthritis) Cosentyx is indicated for the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy. •Non-radiographic axial spondyloarthritis (nr-axSpA) Cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to non-steroidal anti-inflammatory drugs (NSAIDs). - Juvenile idiopathic arthritis (JIA) •Enthesitis-related arthritis (ERA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active enthesitisrelated arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. •Juvenile psoriatic arthritis (JPsA) Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.Hidradenitis suppurativa (HS)Cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic HS therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4e8b041-7a82-446e-804e-f7238508819a.json
e4fa57e3-37b1-4a7d-a838-15c92e424ef0,YESCARTA,prescription,,,8696,,,,,ILS,dispersion for infusion,AXICABTAGENE CILOLEUCEL,2025-07-31T10:41:37.640173,IL,גיליאד,,1630045.851,1381394.85,1255813.5,,NA,YESCARTA 1 bag,,,3485,BAG ,units,1.0,162 57 35695 00,valid,10.0,i.v,1.4,12,,,,,,,,,,0,Prescription required,"Yescarta is indicated for the treatment of adult patients with diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy.YESCARTA is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), after two or more lines of systemic therapy. Limitation of Use :YESCARTA is not indicated for the treatment of patients with primary or secondary central nervous system lymphoma.Yescarta is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4fa57e3-37b1-4a7d-a838-15c92e424ef0.json
e4fb4889-d17d-4251-b9b9-d3c5f677b301,REKOVELLE,prescription,G03GA10,FOLLITROPIN DELTA,8123,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN DELTA 33.3 MCG/ML,2025-07-31T07:21:29.379881,IL,פרינג,,939.9477162,796.5658966,677.9284227,,7640128548768,REKOVELLE 36 MCG/1.08 ML 1 PREFFILLED PEN,,,65874,PEN GLASS,units,1.0,159 60 35096 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e4fb4889-d17d-4251-b9b9-d3c5f677b301.json
e500fc6e-ce1b-4fe9-96a5-536e63b7fb20,PAXXET 20,prescription,N06AB05,PAROXETINE,3774,,,WHO ATC Classification,,ILS,tablets,PAROXETINE AS HYDROCHLORIDE,2025-07-31T06:30:45.092336,IL,אוניפארם,,37.18163834,31.509863,22.9999,,,PAXXET 20MG 30TAB,16374,,21832,BLISTER PVC/ALUMINIUM,units,30.0,117 10 29855 02,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. Treatment of symptoms and prevention of relapse of obsessive compulsive disorder (OCD). Treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.Treatment of symptoms of social phobia.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e500fc6e-ce1b-4fe9-96a5-536e63b7fb20.json
e5013a5c-7132-4ddf-aa0d-e57fea942f13,WELIREG 40 MG FILM-COATED TABLETS,prescription,L01XX74,BELZUTIFAN,9270,,,WHO ATC Classification,,ILS,film coated tablets,BELZUTIFAN,2025-07-31T10:25:40.451002,IL,מ.ס.ד. ישראל,,75647.10445,64107.71849,58279.74408,,,WELIREG 40 MG 90 FILM-COATED TABLETS,,,2012,BOTTLE HDPE,units,90.0,173 89 37469 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for VHL associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumours (pNET), and for whom localised procedures are unsuitable or undesirable.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e5013a5c-7132-4ddf-aa0d-e57fea942f13.json
e50b3207-a07f-4462-b238-b0d72fb4108c,BOTOX 100,prescription,M03AX01,BOTULINUM TOXIN,7037,,,WHO ATC Classification,,ILS,powder for solution for injection,BOTULINUM TOXIN TYPE A 100 U/VIAL,2025-07-30T23:42:21.013994,IL,אב-וי,,504.0709669,427.1788045,363.5564293,,7290008127103,BOTOX 50 UNITS 1 VIAL,2552,,40891,VIAL GLASS TYPE I,units,1.0,057 68 27328 00,valid,17.5,"intradermal, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Neurologic disorders:•	•Focal spasticity associated with dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients two years of age or older. •	•	Focal spasticity of the wrist and hand in adult •	Focal spasticity of the lower limb, including ankle and foot in adult. •	•Blepharospasm or VII nerve disorders in patients over 12 years, hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. •	•Reduction of the signs and symptoms of Cervical dystonia (spasmodic torticollis) in adults. •	•Symptom relief in adults fulfilling criteria for chronic migraine (headaches on &#8805;15 days per month of which at least 8 days with migraine) in patients who have responded inadequately or are intolerant of prophylactic migraine medications. Bladder disorders: •Management of overactive bladder with symptoms of urinary incontinence, urgency and frequency in adult patients who have an inadequate response to, or are intolerant of, anticholinergic medication. •Urinary incontinence in adults with neurogenic detrusor overactivity resulting from neurogenic bladder due to stable sub-cervical spinal cord injury, or multiple sclerosis. Skin and skin appendage disorder: •Management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment. •For the temporary improvement in the appearance of: - moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines) and/or, - moderate to severe lateral canthal lines (crow’s feet lines) seen at maximum smile and/or, - moderate to severe forehead lines seen at maximum eyebrow elevation when the severity of the facial lines has an important psychological impact in adult patients.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e50b3207-a07f-4462-b238-b0d72fb4108c.json
e50d9568-71c7-45ac-a6ab-fe5c1a08aab6,DEPO-PROVERA 150 MG/ML,prescription,G03AC06,MEDROXYPROGESTERONE,128,,,WHO ATC Classification,,ILS,suspension for injection,MEDROXYPROGESTERONE ACETATE/ML,2025-07-31T07:05:42.531410,IL,פיזר,,23.67730646,20.06551484,14.6463612,,7298074000511,PROVERA 5MG 24TAB,16282,,1826,SYRINGE GLASS TYPE I,units,24.0,069 69 24309 00,valid,37.0,i.m,1.4,60,,,,,,,,,,0,Prescription required,For contraception where medically indicated and oral administration is inapplicable.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e50d9568-71c7-45ac-a6ab-fe5c1a08aab6.json
e50dc10e-871e-4986-996a-d32d8491cefb,ARTHRYL,off-the-counter,M01AX05,GLUCOSAMINE,6161,,,WHO ATC Classification,,ILS,powder for solution,GLUCOSAMINE SULFATE (CRYSTALLINE),2025-07-31T11:13:28.926663,IL,דקסל פארמה,,93.9988,79.66,nan,,7290008016346,ARTHRYL 1500MG 30 SACHETS,17523,,,SACHET ALUMINIUM,units,30.0,136 92 31267 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Treatment of osteoarthritis symptoms ( i.e. pain and function limitation).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e50dc10e-871e-4986-996a-d32d8491cefb.json
e53215c2-9feb-40e4-bae1-7ae74899bb3e,ISADERM VETERINARY,prescription,,,8586,,,,,ILS,gel,"BETAMETHASONE AS VALERATE 0.1 %, FUSIDIC ACID AS HEMIHYDRATE 0.5 %",2025-07-31T03:23:50.688519,IL,טבע,,30.87819162,26.167959,19.1007,,5701170099003,FUSID TEVA 20 MG / 2 ML 10 AMP,,,61649,TUBE ALUMINIUM,units,10.0,082 41 92173 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,"For the topical treatment of surface pyoderma in dogs such as acute moist dermatitis (""hot spots"") and intertrigo (skin fold dermatitis) in dogs.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e53215c2-9feb-40e4-bae1-7ae74899bb3e.json
e55b922f-8ad4-4d81-b11f-8ecc52461f06,RUBRACA 200 MG,prescription,L01XX55,RUCAPARIB,8471,,,WHO ATC Classification,,ILS,film coated tablets,RUCAPARIB AS CAMSYLATE,2025-07-31T07:53:07.444668,IL,ניאופרם,,13786.793,11683.7234,10621.56673,,7290111090660,RUBRACA 300 MG 60 TAB,18610,,54995,BOTTLE HDPE,units,60.0,162 81 35664 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube,or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e55b922f-8ad4-4d81-b11f-8ecc52461f06.json
e564cc59-b2f2-4aa4-b194-cddd80f1c178,CAMZYOS 10 MG,prescription,C01EB24,MAVACAMTEN,9504,,,WHO ATC Classification,,ILS,capsules,MAVACAMTEN,2025-07-31T00:51:10.848292,IL,ב.מ.ס,,7718.263193,6540.901302,5946.273911,,,CAMZYOS 15 MG 28 CAPS,,,31543,BLISTER PVC/PCTFE(ACLAR)/ALUMINIUM,units,28.0,174 20 37421 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e564cc59-b2f2-4aa4-b194-cddd80f1c178.json
e5856052-7eab-4046-94f6-41e11e78106b,OMEPRADEX - Z,prescription,A02BC01,OMEPRAZOLE,4413,,,WHO ATC Classification,,ILS,caplets,OMEPRAZOLE,2025-07-31T06:07:31.837017,IL,דקסל פארמה,,28.34594938,24.021991,17.5343,,7290010578511,OMEPRADEX 10MG 30CAPLETS,15013,,28204,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,131 25 30841 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e5856052-7eab-4046-94f6-41e11e78106b.json
e58e2b19-385a-4f15-87e1-323a39e10800,ADEX 200,off-the-counter,M01AE01,IBUPROFEN,5102,,,WHO ATC Classification,,ILS,caplets,IBUPROFEN,2025-07-31T11:04:20.589596,IL,דקסל פארמה,,50.327,42.65,nan,,,ADEX LIQUIGEL 400MG 20CAPS,9274,,,BLISTER PVC/ALUMINIUM,units,20.0,039 71 26007 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"For the relief of mild to moderate pain such as headache, toothache, primary dysmenorrhea, backache, muscular pain. Anti - inflammatory and relieves pain in reumatoid arthritis and osteo arthritis. For the reduction of fever.For the treatment of pain associated with migraine.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e58e2b19-385a-4f15-87e1-323a39e10800.json
e59ad42b-f90f-4ea3-a385-98e2980a443e,ENTEAVENIR 0.5 MG,prescription,J05AF10,ENTECAVIR,8935,,,WHO ATC Classification,,ILS,film coated tablets,ENTECAVIR AS MONOHYDRATE 0.5  MG,2025-07-31T02:23:10.320627,IL,ביואבניר,,2274.594984,1927.622868,1640.5301,,,ENTEAVENIR 0.5 MG 10 TAB,,,70663,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,166 96 36713 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Enteavenir is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with: -  Compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. -  Decompensated liver disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e59ad42b-f90f-4ea3-a385-98e2980a443e.json
e5a2c77f-8d97-4d44-8c0f-653eb88dc00d,LORVIQUA 100 MG,prescription,L01XE44,LORLATINIB,8633,,,WHO ATC Classification,,ILS,film coated tablets,LORLATINIB,2025-07-31T04:54:33.009993,IL,פיזר,,20675.12959,17521.29704,15928.45185,,7290013592613,LORVIQUA 100 MG 30 TAB,,,551,BLISTER PVC/ALUMINIUM,units,30.0,164 04 35887 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Lorviqua is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) positive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e5a2c77f-8d97-4d44-8c0f-653eb88dc00d.json
e5bd4121-edbb-4e18-904a-635fa29da321,HUMULIN N,prescription,A10AC01,INSULIN (HUMAN),3321,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN (HUMAN)/ML,2025-07-31T03:51:12.172190,IL,אלי לילי,,143.3387242,121.4735005,90.31487025,,7290008139816,HUMULIN NPH CART 5x3ML,9106,,9474,VIAL GLASS TYPE I,units,15.0,054 12 22715 22,valid,34.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e5bd4121-edbb-4e18-904a-635fa29da321.json
e5cf86ff-8f47-4b2d-ba39-1c3f0109db7f,TARGIN 10,prescription,V03AB15,NALOXONE,6235,,,WHO ATC Classification,,ILS,tablets prolonged release,"OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (AS DIHYDRATE)",2025-07-31T09:05:20.045039,IL,רפא,,76.13868334,64.52431078,47.97346527,,7290008012973,TARGIN 20/10 MG 20 TABLETS P. R.,20639,,89486,BLISTER PVC/ALUMINIUM,units,20.0,139 95 31636 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Targin is indicated for the relief of moderate to severe pain.The oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. The opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e5cf86ff-8f47-4b2d-ba39-1c3f0109db7f.json
e5feb081-42dc-45dd-b7b2-7900970279ce,FOSCAVIR 24 MG/ML,prescription,J05AD01,FOSCARNET,6786,,,WHO ATC Classification,,ILS,solution for infusion,FOSCARNET TRISODIUM HEXAHYDRATE/ML,2025-07-31T03:18:02.669341,IL,מגאפארם,,565.5822992,479.3070545,407.9208975,,506022922011,FOSCAVIR 24MG/ML 250ML,6498,,83426,BOTTLE GLASS TYPE I,units,1.0,068 16 28118 02,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment of CMV retinitis in patients with aquired immunodeficiency syndrome (AIDS).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e5feb081-42dc-45dd-b7b2-7900970279ce.json
e60ace29-2850-4972-b9b1-387e0c9d174f,NOCDURNA 25MCG 10 SUBLINGUAL TAB,prescription,,,8707,,,,,ILS,tablet,NOCDURNA 25MCG 10 SUBLINGUAL TAB,2025-07-31T19:23:37.292971,IL,פרינג,,59.52376304,50.44386923,36.8203425,,,NOCDURNA 25MCG 10 SUBLINGUAL TAB,,,,,units,10.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e60ace29-2850-4972-b9b1-387e0c9d174f.json
e60f446b-3021-4a59-92a0-6749fd9d72aa,BACLOSAL 10,prescription,,,9161,,,,,ILS,tablets,BACLOFEN,2025-07-31T00:28:07.276929,IL,אוניפארם,,30.214254,25.6053,18.69,,,BACLOSAL 10 MG 60 TABS,,,35158,BLISTER ALU/PVC/PVDC,units,60.0,046 07 23779 02,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Muscle spasticity of various origins.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e60f446b-3021-4a59-92a0-6749fd9d72aa.json
e6159f27-d946-425d-a985-1e7665468de8,ARANESP 100 MCG,prescription,B03XA02,DARBEPOETIN ALFA,4897,,,WHO ATC Classification,,ILS,solution for injection,DARBEPOETIN ALFA/ 0.5  ML,2025-07-31T00:24:08.316248,IL,מדיסון,,447.6325591,379.3496432,322.8507602,,8715131005863,ARANESP 60MCG PREFILLED PEN 1X0.3ML,9493,,65749,PRE-FILLED PEN GLASS TYPE I,units,1.0,124 46 30400 00,valid,17.5,"s.c, i.v",1.4,36,,,,,,,,,,0,Prescription required,Aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients &#8805; 1 year of age,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6159f27-d946-425d-a985-1e7665468de8.json
e61b236a-4e24-459c-b513-cb34b7f8d272,ALUNBRIG 30 MG,prescription,L01XE43,BRIGATINIB,8108,,,WHO ATC Classification,,ILS,film coated tablets,BRIGATINIB,2025-07-31T00:17:45.900811,IL,טקדה,,4353.100238,3689.068162,3353.69833,,7290016369434,ALUNBRIG 30 MG 30 FILM COATED TABLETS,,,64844,BOTTLE HDPE,units,30.0,161 05 35334 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e61b236a-4e24-459c-b513-cb34b7f8d272.json
e6201c94-2120-4b98-a3d6-619e2c5b078e,XCOPRI 100 MG,prescription,N03AX25,CENOBAMATE,9275,,,WHO ATC Classification,,ILS,film coated tablets,CENOBAMATE,2025-07-31T10:31:48.210955,IL,דקסל פארמה,,497.3859812,421.5135621,358.7349465,,,XCOPRI 50 MG 30 TAB,24175,,19214,BLISTER PVC/ALUMINIUM,units,30.0,172 89 37493 99,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Xcopri is indicated for the adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6201c94-2120-4b98-a3d6-619e2c5b078e.json
e6308d52-2381-4bec-8eef-eddf6a0e5813,NICOTINELL GUM 2 MG (MINT),off-the-counter,N07BA01,NICOTINE,5259,,,WHO ATC Classification,,ILS,chewing gum,NICOTINE,2025-07-31T12:30:46.558154,IL,ג.ס.ק,,212.8012,180.34,nan,,,NICOTINELL GUM 2MG FRUIT 204 UNITS,14498,,,BLISTER PVC/PVDC/ALUMINIUM,units,204.0,115 78 29638 23,valid,nan,per os,1.4,30,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6308d52-2381-4bec-8eef-eddf6a0e5813.json
e64a7620-3eca-419a-87e5-dee17531bd01,IMOVAX DT,prescription,J07AM51,"TETANUS TOXOID, COMBINATIONS WITH DIPHTHERIA TOXOID",7531,,,WHO ATC Classification,,ILS,suspension for injection,"DIPHTHERIA TOXOID/ 0.5  ML, TETANUS TOXOID/ 0.5  ML, ALUMINIUM HYDROXIDE 0.6  MG / 0.5  ML",2025-07-31T04:03:36.246696,IL,סאנופי אוונטיס,,51.7311977,43.84,32.0,,7290101534525,IMOVAX DT SYRINGE PREFILLED 1X0.5ML,,,60987,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,144 62 33232 00,valid,37.0,"i.m, s.c",1.4,36,,,,,,,,,,0,Prescription required,"This vaccine is indicated for adults over 18 years of age in the following cases:- routine booster vaccinations against diphtheria and tetanus. The diphtheria toxoid content is reduced to one tenth of the normal dose to minimize the risks of a severe hypersensitivity reaction.- primary vaccination.- post-exposure prophylaxis following a tetanus-prone wound, if a booster diphtheria injection is required.This adsorbed diphtheria and tetanus vaccine may be administered as a booster vaccination in children over 10 years of age in whom poliomyelitis is prevented by separate administration of poliomyelitis vaccine.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e64a7620-3eca-419a-87e5-dee17531bd01.json
e663f8b6-8ddb-4a81-b8e6-a9d533aa15f5,EVETOR 2.5,prescription,L04AA18,EVEROLIMUS,9055,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS 2.5  MG,2025-07-31T02:45:02.223621,IL,אוניפארם,,3115.894118,2640.588235,2400.534759,,,EVETOR 2.5MG 30 TABS,,,75162,BLISTER ALU-PA/AI/PVC,units,30.0,168 87 36324 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Evetor is indicated for:- Treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of Evetor is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. - Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. The safety and effectiveness of EVETOR in the treatment of patients with carcinoid tumors have not been established. - Treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non – steroidal aromatase inhibitor. - Treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Evetor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes. - Treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.- Treatment of unresectable, locally advanced or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e663f8b6-8ddb-4a81-b8e6-a9d533aa15f5.json
e66451aa-0b44-4044-9eb4-7f8dc63a4a78,ATOMIC 100,prescription,N06BA09,ATOMOXETINE,8144,,,WHO ATC Classification,,ILS,coated tablets,ATOMOXETINE AS HYDROCHLORIDE,2025-07-30T23:29:16.765104,IL,אוניפארם,,372.6599572,315.8135231,268.7774664,,,ATOMIC 25mg 28 tab,,,11107,BLISTER PVC/ALUMINIUM,units,28.0,167 84 36235 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Atomic is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD. In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Atomic should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD.Based on clinical judgment, patients should have ADHD of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e66451aa-0b44-4044-9eb4-7f8dc63a4a78.json
e6830773-d209-4b85-82b0-d82afcf8f7a3,VECTOR 160,prescription,C09CA03,VALSARTAN,9167,,,WHO ATC Classification,,ILS,tablets,VALSARTAN,2025-07-31T10:01:43.255315,IL,אוניפארם,,43.39293886,36.773677,26.8421,,,VECTOR 160 30 TAB,,,35643,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,145 44 33076 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For treatment of hypertension. Valsartan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan significantly reduced hospitalizations for heart failure. There is no evidence that Valsartan provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6830773-d209-4b85-82b0-d82afcf8f7a3.json
e6a2ae13-f929-4f13-8f56-ed670aa47320,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8035,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:52:17.339832,IL,יאנסן סילג,,13039.06554,11050.05603,10045.50548,,7640111932642,UPTRAVI ® 1000 MCG 60 TAB,21129,,22743,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6a2ae13-f929-4f13-8f56-ed670aa47320.json
e6a3572a-c3ce-4adc-9f5d-459de2cb4976,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8034,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:53:52.784931,IL,יאנסן סילג,,13039.06554,11050.05603,10045.50548,,7640111932642,UPTRAVI ® 800 MCG 60tab,21128,,22561,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6a3572a-c3ce-4adc-9f5d-459de2cb4976.json
e6af0535-5585-4653-8262-eceed581f438,ACTIQ 1200 MCG,prescription,N02AB03,FENTANYL,6124,,,WHO ATC Classification,,ILS,compressed tablet on a handle,FENTANYL AS CITRATE/DOSE,2025-07-31T00:07:47.205527,IL,טבע,,986.1891881,835.7535864,711.279648,,7290106061019,ACTIQ 600MCG 30 COMPRESSED TAB,9271,,86431,BLISTER PVC/ACLAR,units,30.0,138 25 31575 00,valid,17.5,oral transmucosal,1.4,36,,,,,,,,,,0,Prescription required,Actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6af0535-5585-4653-8262-eceed581f438.json
e6c170c4-a7d2-44d4-8828-c48be11b9c18,VALTREX TABLETS 500 MG,prescription,J05AB11,VALACICLOVIR,3383,,,WHO ATC Classification,,ILS,film coated tablets,VALACICLOVIR AS HYDROCHLORIDE,2025-07-31T09:57:29.025160,IL,ג.ס.ק,,46.85245835,39.70547495,28.9820985,,,VALTREX 500MG 10TAB,22016,,9566,BLISTER PVC/ALUMINIUM,units,10.0,100 39 28426 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Varicella zoster virus (VZV) infections – herpes zoster:Valtrex is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults.Valtrex is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression.Herpes simplex virus (HSV) infections:Valtrex is indicated for the treatment and suppression of HSV infections of the skin and mucous membranes including- treatment of first-episode of genital herpes in immunocompetent adults and adolescents and in immunocompromised adults- treatment of recurrences of genital herpes in immunocompetent adults and adolescents, and in immunocompromised adults- suppression of recurrent genital herpes in immunocompetent adults and adolescents and in immunocompromised adultsTreatment and suppression of recurrent ocular HSV infections in immunocompetent adults and adolescents and in immunocompromised adults Clinical studies have not been conducted in HSV-infected patients immunocompromised for other causes than HIV-infection.Cytomegalovirus (CMV) infections:Valtrex is indicated for the prophylaxis of CMV infection and disease following solid organ transplantation in adults and adolescents",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6c170c4-a7d2-44d4-8828-c48be11b9c18.json
e6ebbe54-f899-4a93-a542-8dfd1ab223fd,AMLOW 10,prescription,C08CA01,AMLODIPINE,8076,,,WHO ATC Classification,,ILS,tablets,AMLODIPINE AS MALEATE,2025-07-30T23:22:30.339661,IL,טבע,,14.5300008,12.31356,8.988,,,AMLODIPINE TEVA 5 MG 30 TABLETS,,,67878,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,131 66 31035 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Mild to moderate hypertension. Vasospastic angina (Prinzmetal's or variant angina). Chronic stable angina.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6ebbe54-f899-4a93-a542-8dfd1ab223fd.json
e6f036f5-1287-4568-ade6-916d6b70e280,SYLVANT 100 MG,prescription,L04AC11,SILTUXIMAB,7796,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,SILTUXIMAB,2025-07-31T08:54:08.629108,IL,מדיסון,,11396.25977,9657.847695,8779.861541,,7290014577275,SYLVANT 400 MG 1VIAL,,,38796,VIAL GLASS TYPE I,units,1.0,153 85 34217 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Sylvant is indicated for the treatment of adult patients with multicentric Castleman’s disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e6f036f5-1287-4568-ade6-916d6b70e280.json
e701f7d0-e57d-4a95-8c3f-2c13240ec197,FENTANYL-PIRAMAL,prescription,N01AH01,FENTANYL,9148,,,WHO ATC Classification,,ILS,solution for injection,FENTANYL AS CITRATE 0.05 MG/ML,2025-07-31T03:01:58.592580,IL,פארמהמדיס,,23.50827388,19.922266,14.5418,,5056162500679,FENTANYL-PIRAMAL 0.05 MG/ML 2 amp 10ML,,,,AMPOULES GLASS TYPE I,units,10.0,025 41 21376 00,valid,37.0,"epidural, i.v",1.4,36,,,,,,,,,,0,Prescription required,For analgesic action of short duration during anesthtic periods (premedication dinduction and maintenance) and in the immediate postoperative period  as need arises. As a narcotic analgesic supplement in general or regional anesthesia. For administration with neuroleptics (such as droperidol) as an anesthetic premedication  for the induction of anesthesia  and as an adjunct in the maintenance of general or regional anesthesia. For use as an anesthetic agent with oxygen in selected  high-risk patients (open heart surgery or certain neurological or orthopedic procedures). By the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections  and as adjunct to general anesthesia.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e701f7d0-e57d-4a95-8c3f-2c13240ec197.json
e7235531-8bd6-4646-9005-cb5af322ad2c,DIPROSALIC LOTION,prescription,,,1244,,,,,ILS,lotion,"SALICYLIC ACID/G, BETAMETHASONE AS DIPROPIONATE 0.5 MG/G",2025-07-31T01:58:55.734607,IL,אורגנון,,18.0097315,15.262485,11.1405,,72989579,DIPROSALIC LOTION 30ML,4133,,696,BOTTLE PLASTIC,units,30.0,134 10 24243 21,valid,37.0,dermal,1.4,18,,,,,,,,,,0,Prescription required,"Provides anti-inflammatory, antipruritic, anti-allergic and keratinolytic activity in the topical management of subacute and chronic hyperkeratotic and dry dermatoses responsive to corticosteroid therapy",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e7235531-8bd6-4646-9005-cb5af322ad2c.json
e7263c2b-46b3-4f6f-860d-f1ab1faffbd5,STALEVO ® 100/25/200 MG,prescription,N04BA01,LEVODOPA,4845,,,WHO ATC Classification,,ILS,film coated tablets,"LEVODOPA, CARBIDOPA, ENTACAPONE",2025-07-31T08:38:24.345653,IL,אינובמד,,69.45706855,58.86192512,43.7635131,,7290104530586,STALEVO 100/25/200MG 30TAB,19738,,13353,BOTTLE HDPE,units,30.0,132 35 31106 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e7263c2b-46b3-4f6f-860d-f1ab1faffbd5.json
e74ed8a4-e290-4168-a877-d879907202dc,MERONEM 500 MG,prescription,J01DH02,MEROPENEM,6436,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,MEROPENEM AS TRIHYDRATE/VIAL,2025-07-31T05:14:14.454428,IL,פיזר,,467.3339673,396.045735,337.0602,,,MERONEM 500MG 10VIAL POWDER FOR SOL. FOR INJ.,13633,,83475,VIAL GLASS TYPE I,units,10.0,104 08 28622 02,valid,17.5,i.v,1.4,48,,,,,,,,,,0,Prescription required,Meronem is indicated for treatment  in adults and children  of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem:  - Pneumonias and nosocomial pneumonias.   - Pulmonary infections in patients with cystic fibrosis.   - Urinary tract infections.   - Intra-abdominal infections.  - Gynecological infections  such as endometritis and pelvic inflammatory disease.   - Skin and skin structure infections.   - Meningitis.   - Septicemia.   Meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections.   There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e74ed8a4-e290-4168-a877-d879907202dc.json
e750f406-9810-48ce-8287-c9f31dd75302,TRITACE COMP 2.5 MG/12.5 MG,prescription,C09BA05,RAMIPRIL AND DIURETICS,2659,,,WHO ATC Classification,,ILS,tablets,"RAMIPRIL 2.5  MG, HYDROCHLOROTHIAZIDE 12.5  MG",2025-07-31T09:43:44.409868,IL,סאנופי אוונטיס,,15.390032,13.0424,9.52,,7290008880947,TRITACE 2.5MG 28TAB,20027,,4869,BLISTER PVC/ALUMINIUM,units,28.0,122 27 30187 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Essential hypertension.Tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone or hydrochlorothiazide alone.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e750f406-9810-48ce-8287-c9f31dd75302.json
e76a219f-5493-4122-af31-a2d5b7bbafd1,TRAMADEX OD 100,prescription,N02AX02,TRAMADOL,7371,,,WHO ATC Classification,,ILS,tablets prolonged release,TRAMADOL HYDROCHLORIDE,2025-07-31T09:32:01.390221,IL,דקסל פארמה,,21.9970762,18.64159,13.607,,,TRAMADEX OD 200MG 10 P.R.TAB,20649,,80663,BLISTER PVC/PE/PCTFE/AL,units,10.0,139 25 31580 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of moderate to severe pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e76a219f-5493-4122-af31-a2d5b7bbafd1.json
e781d1ac-6660-4361-9d55-1d9cf26b54ae,TADAM 10,prescription,G04BE08,TADALAFIL,8097,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T09:00:13.556503,IL,אוניפארם,,289.4992589,245.338355,208.7986,,,TADAM 10 MG 4 FILM COATED TABLETS,20824,,62137,BLISTER PVC/ALUMINIUM,units,4.0,157 81 34538 01,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e781d1ac-6660-4361-9d55-1d9cf26b54ae.json
e78c1590-1a58-40a7-a4ee-34c34197ef41,UMAN ALBUMIN,prescription,B05AA01,ALBUMIN,8718,,,WHO ATC Classification,,ILS,solution for infusion,ALBUMIN HUMAN/ML,2025-07-31T09:51:44.166829,IL,קמהדע,,175.9130352,149.07885,119.26308,,7290008072106,UMAN ALBUMIN 200MG/ML  VIAL 50ML,,,16762,VIAL GLASS TYPE II,units,50.0,143 85 31992 00,valid,25.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,For restoration and maintenance of circulating blood volume where volume deficiency has been demontrated  and use of a colloid  such as albumin  is appropriate.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e78c1590-1a58-40a7-a4ee-34c34197ef41.json
e7a6d42b-a1c7-4872-b43f-4c2b5cd7c8a2,TAMBOCOR 100 MG TABLETS,prescription,C01BC04,FLECAINIDE,2869,,,WHO ATC Classification,,ILS,tablets,FLECAINIDE ACETATE,2025-07-31T09:02:46.913318,IL,דקסל פארמה,,61.14810414,51.82042954,38.5282004,,7290008107464,TAMBOCOR 100MG 60TAB,20437,,9002,BLISTER PVDC/ALUMINIUM,units,60.0,123 99 23293 00,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Serious sustained life threatening ventricular arrhytmias that have not responsed to other drugs. Paroxymal atrial flutter.,תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e7a6d42b-a1c7-4872-b43f-4c2b5cd7c8a2.json
e7bc5051-a47c-420b-bd3a-1538643a16a1,KALGARON ORANGE,off-the-counter,R02AD02,LIDOCAINE,5594,,,WHO ATC Classification,,ILS,lozenges,"CETYLPYRIDINIUM CHLORIDE 1.25  MG, LIDOCAINE HYDROCHLORIDE ( AS MONOHYDRATE)",2025-07-31T12:15:29.107049,IL,רפא,,30.621,25.95,nan,,7290017179315,KALGARON STRAWBERY 24 LOZENGES,,,,BLISTER PVDC/ALUMINIUM,units,24.0,163 63 36018 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For the relief of severe sore throat.  Relief of mouth and throat infections.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e7bc5051-a47c-420b-bd3a-1538643a16a1.json
e7d22155-a509-416f-b3b8-a1e86d9b52d5,IMPAVIDO 10 MG,prescription,L01XX09,MILTEFOSINE,7593,,,WHO ATC Classification,,ILS,"capsule, hard",MILTEFOSINE,2025-07-31T04:04:13.679993,IL,מגאפארם,,13696.85491,11607.50468,10552.27698,,7290014573154,IMPAVIDO 50MG 56CAPS,9903,,32908,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,154 05 34311 00,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,-Treatment of visceral Leishmaniasis caused by Leishmania donovani. -Treatment of cutaneous Leishmaniasis caused by Leishmania brasiliensis complex or Leishmania mexicana complex.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e7d22155-a509-416f-b3b8-a1e86d9b52d5.json
e7e208eb-1b91-462b-81b3-d56acf8e0a4a,DIGOXIN KERN PHARMA 0.25 MG,prescription,C01AA05,DIGOXIN,7731,,,WHO ATC Classification,,ILS,tablets,DIGOXIN 0.25   MG,2025-07-31T01:55:59.401232,IL,תרימה,,20.5025295,17.375025,12.6825,,7290016981100,DIGOXIN KERN PHARMA 0.25MG 50TAB,4621,,6700,BLISTER PVC/ALUMINIUM,units,50.0,151 20 33918 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Cardiac failure:Digoxin KERN PHARMA is indicated for the treatment of chronic cardiac failure where the principal cause is systolic dysfunction. The greatest therapeutic benefit is achieved in patients with ventricular dilatation.Digoxin KERN PHARMA is specifically indicated where cardiac failure is accompanied by atrial fibrilation.Supraventricular arrhythmias:Digoxin KERN PHARMA is indicated for the treatment of certain supraventricular arrhythmias, particularly atrial fibrillation and flutter, where its principal beneficial effect is to reduce the ventricular rate.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e7e208eb-1b91-462b-81b3-d56acf8e0a4a.json
e7e34c74-f097-40a1-8c4d-deb8edb00882,ROGARON LEMON SUGAR FREE,off-the-counter,A01AD02,BENZYDAMINE,5579,,,WHO ATC Classification,,ILS,lozenges,BENZYDAMINE HYDROCHLORIDE,2025-07-31T13:14:34.726093,IL,טבע,,35.5062,30.09,nan,,7290110731380,ROGARON ORANGE - HONEY FLAVOR 20 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,164 22 35301 00,valid,nan,per os,1.4,30,,,,,,,,,,0,,Rogaron is used for symptomatic local treatment of acute sore throat in adults and children over 6 years of age.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e7e34c74-f097-40a1-8c4d-deb8edb00882.json
e7f59ebe-ab4f-43a2-acec-466a000216d5,ABEVMY,prescription,L01FG01,BEVACIZUMAB,9535,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BEVACIZUMAB/,2025-07-30T23:09:47.592936,IL,דקסל פארמה,,3537.913711,2998.232092,2725.665538,,7290015912839,ABEVMY 400MG/16 ML 1 VIAL,,,38719,VIAL GLASS TYPE I,units,1.0,175 88 37178 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Abevmy in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of patients with metastatic carcinoma of the colon or rectum.Abevmy in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer.Abevmy, in addition to platinum-based chemotherapy, is indicated for first-line treatment of patients with unresectable advanced, metastatic or recurrent non-small cell lung cancer other than predominantly squamous cell histology.Bevacizumab in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations.Abevmy in combination with interferon alfa-2a is indicated for first line treatment of patients with advanced and/or metastatic renal cell cancer.Abevmy, as a single agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.Abevmy, in combination with carboplatin and paclitaxel is indicated for the front-line treatment of advanced ([FIGO] stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are at high risk for recurrence (residual disease after debulking).Abevmy, in combination with carboplatin and gemcitabine, is indicated for treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents.Bevacizumab in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents .Abevmy, (bevacizumab) in combination with paclitaxel and cisplatin or, paclitaxel and topotecan, is indicated for the treatment of patients with persistent, recurrent, or metastatic carcinoma of the cervix.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e7f59ebe-ab4f-43a2-acec-466a000216d5.json
e810c938-2774-41cc-b581-3f34c8e7bdae,XAMIOL,prescription,D07AC01,BETAMETHASONE,6652,,,WHO ATC Classification,,ILS,gel,"BETAMETHASONE AS DIPROPIONATE 0.5  MG /, CALCIPOTRIOL AS HYDRATE/",2025-07-31T10:28:00.704239,IL,דקסל פארמה,,138.7536984,117.5878853,87.425937,,,XAMIOL GEL 60GR,24057,,24890,BOTTLE POLYETHYLENE,units,60.0,144 25 32996 01,valid,34.5,topical,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e810c938-2774-41cc-b581-3f34c8e7bdae.json
e813ab50-df8c-457a-99a9-8866b5de2590,VALTREX TABLETS 500 MG,prescription,J05AB11,VALACICLOVIR,3166,,,WHO ATC Classification,,ILS,film coated tablets,VALACICLOVIR AS HYDROCHLORIDE,2025-07-31T09:57:39.235178,IL,ג.ס.ק,,179.5440922,152.1560171,121.7248137,,,VALTREX 500MG 42TAB,22074,,9310,BLISTER PVC/ALUMINIUM,units,42.0,100 39 28426 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Varicella zoster virus (VZV) infections – herpes zoster:Valtrex is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults.Valtrex is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression.Herpes simplex virus (HSV) infections:Valtrex is indicated for the treatment and suppression of HSV infections of the skin and mucous membranes including- treatment of first-episode of genital herpes in immunocompetent adults and adolescents and in immunocompromised adults- treatment of recurrences of genital herpes in immunocompetent adults and adolescents, and in immunocompromised adults- suppression of recurrent genital herpes in immunocompetent adults and adolescents and in immunocompromised adultsTreatment and suppression of recurrent ocular HSV infections in immunocompetent adults and adolescents and in immunocompromised adults Clinical studies have not been conducted in HSV-infected patients immunocompromised for other causes than HIV-infection.Cytomegalovirus (CMV) infections:Valtrex is indicated for the prophylaxis of CMV infection and disease following solid organ transplantation in adults and adolescents",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e813ab50-df8c-457a-99a9-8866b5de2590.json
e81590f2-73ea-4b50-b1e2-a171d4963a90,GIOTRIF 20 MG,prescription,L01XE13,AFATINIB,7390,,,WHO ATC Classification,,ILS,film coated tablets,AFATINIB AS DIMALEATE,2025-07-31T03:33:09.402844,IL,בורינגר אינגלהיים,,9859.29703,8355.336838,7595.760761,,,GIOTRIF 20MG 28F.C.TAB,7908,,50939,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,151 47 33984 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,GIOTRIF as monotherapy is indicated for the treatment of: • EGFR TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s);• locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e81590f2-73ea-4b50-b1e2-a171d4963a90.json
e83076d9-8b81-4774-9db4-a014241dd33c,PHYSICARE GEL,off-the-counter,,,5389,,,,,ILS,gel,DICLOFENAC SODIUMW/W,2025-07-31T12:47:42.471726,IL,מכבי קאר,,34.9988,29.66,nan,,7290008082617,PHYSICARE GEL 100 GR,,,,TUBE ALUMINIUM,units,100.0,136 05 31442 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Self medication for the following indications:Local treatment of pain, inflammation and swelling due to: • Pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • Localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.By Physicians order:• Pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e83076d9-8b81-4774-9db4-a014241dd33c.json
e832c6cb-2c60-48e4-99f6-464c1c040030,LAMICTAL DISPERSIBLE/CHEWABLE TABLETS 5 MG,prescription,N03AX09,LAMOTRIGINE,3467,,,WHO ATC Classification,,ILS,dispersible chewable tablets,LAMOTRIGINE,2025-07-31T04:32:42.389480,IL,ג.ס.ק,,118.7379342,100.625368,74.8144,,7290008105200,LAMICTAL 200MG 30 DISP/CHEWTAB,12199,,21350,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,068 90 28230 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Epilepsy• Adults and adolescents aged 13 years and above- Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.- Seizures associated with Lennox-Gastaut syndrome. Lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome.• Children and adolescents aged 2 to 12 years- Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.- Monotherapy of typical absence seizures.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e832c6cb-2c60-48e4-99f6-464c1c040030.json
e833f76e-9536-4dda-ba4b-3484248d3949,ALPROLIX 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,9005,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,COAGULATION FACTOR IX (HUMAN- RFIXFC)/VIAL,2025-07-30T23:20:55.721895,IL,מגאפארם,,16527.93057,14006.72144,12733.38313,,,ALPROLIX 3000 IU 1 VIAL,,,,VIAL GLASS TYPE I,units,1.0,171 49 36891 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e833f76e-9536-4dda-ba4b-3484248d3949.json
e8350a12-4e60-4768-99ba-fa64ce05593c,ENALADEX 10 MG,prescription,C09AA02,ENALAPRIL,3769,,,WHO ATC Classification,,ILS,tablets,ENALAPRIL MALEATE,2025-07-31T02:19:27.410124,IL,דקסל פארמה,,14.614064,12.3848,9.04,,,ENALADEX 5MG 30TAB,5028,,22582,BLISTER ALUMINIUM,units,30.0,115 85 29810 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. To retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e8350a12-4e60-4768-99ba-fa64ce05593c.json
e83f1ebc-c55f-48ca-aeda-31d88c1a4c05,AMPISULVENIR 1.5 G,prescription,J01CG01,SULBACTAM,8265,,,WHO ATC Classification,,ILS,powder for solution for injection,"AMPICILLIN AS SODIUM SALT, SULBACTAM AS SODIUM SALT",2025-07-30T23:23:00.358475,IL,ביואבניר,,301.399655,255.4234364,217.381648,,7290010286294,AMPISULVENIR  1.5G  10VIAL  20ML,,,18443,VIAL GLASS TYPE I,units,10.0,152 55 33564 00,valid,17.5,"i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Antibiotic for the treatment of bacterial infections caused by susceptible beta-lactamase producing strains of microorganisms, in the following conditions: 1. Skin and Skin Structure Infections ;2. Intra- Abdominal Infections ;3. Gynecological Infections .",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e83f1ebc-c55f-48ca-aeda-31d88c1a4c05.json
e84029b9-369f-4225-bd0f-63f99672524d,PECFENT 100,prescription,N01AH01,FENTANYL,8351,,,WHO ATC Classification,,ILS,"nasal spray, solution",FENTANYL AS CITRATE/SPRAY,2025-07-31T06:31:16.414599,IL,מדיסון,,971.6105983,823.3988487,700.7649776,,,PECFENT 400 4 BOTTLES*8 doses,16935,,77055,BOTTLE GLASS TYPE I,units,32.0,152 59 33975 01,valid,17.5,nasal,1.4,36,,,,,,,,,,0,Prescription required,"PecFent is indicated for the management of breakthrough pain (BTP) in adults who are already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain  that occurs on a background of otherwise controlled persistent pain.Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e84029b9-369f-4225-bd0f-63f99672524d.json
e844a04e-bae7-4786-b96e-d63dafbf1376,DEPALEPT CHRONO 500 MG,prescription,N03AG01,VALPROIC ACID,4243,,,WHO ATC Classification,,ILS,tablets prolonged release,"VALPROIC ACID, VALPROIC ACID AS SODIUM",2025-07-31T01:46:47.672803,IL,סאנופי אוונטיס,,19.55189201,16.56940075,12.0944531,,7290012711527,DEPALEPT CHRONO 500MG 30 SR TAB,4295,,17714,BLISTER ALU/PVC/ALU,units,30.0,119 33 27953 02,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Epilepsy:Treatment of generalized or partial epilepsy  secondary epilepsy and mixed forms of epilepsy.   Bipolar disorders: Treatment of manic episode in bipolar disorder when lithium is contraindicated or not tolerated. The continuation of treatment after manic episode could be considered in patients who have responded to valproic acid for acute mania.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e844a04e-bae7-4786-b96e-d63dafbf1376.json
e853af9c-d48f-42ef-828f-c44eddd07087,TEVIMBRA,prescription,A01FF09,TISLELIZUMAB,9545,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,TISLELIZUMAB/ML,2025-07-31T09:18:13.643625,IL,בייגין,,10254.19954,8690.0,7900.0,,7290020225009,TEVIMBRA 10MG/ML 1 VIAL,24838,,63052,VIAL GLASS TYPE I,units,1.0,177 72 37815 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Oesophageal squamous cell carcinoma (OSCC)Tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.Non-small cell lung cancer (NSCLC)Tevimbra in combination with carboplatin and either paclitaxel or nab-paclitaxel is indicated for the first-line treatment of adult patients with squamous non-small cell lung cancer who have: • locally advanced NSCLC and are not candidates for surgical resection or platinum-based chemoradiation, or • metastatic NSCLC.  Tevimbra as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer after prior platinum-based therapy. Patients with EGFR mutant or ALK positive NSCLC should also have received targeted therapies before receiving tislelizumab.Gastric CancerTevimbra, in combination with platinum and fluoropyrimidine-based chemotherapy, is indicated for the first-line treatment of adults with unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G/GEJ) whose tumors express PD-L1 (&#8805;1).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e853af9c-d48f-42ef-828f-c44eddd07087.json
e8571868-e020-4be0-bea5-76ad97156ccd,HYCAMTIN 0.25 MG,prescription,L01XX17,TOPOTECAN,3401,,,WHO ATC Classification,,ILS,hard gelatin capsules,TOPOTECAN AS HYDROCHLORIDE 0.25   MG,2025-07-31T03:52:20.672970,IL,סנדוז,,923.452948,782.5872788,666.0317267,,,HYCAMTIN 4MG 1VIAL,8318,,75309,BLISTER PVC/PCTFE,units,1.0,141 37 31862 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of patients with relapsed small cell lung cancer (SCLC) for whom re-treatment with the first-line regimen is not considered appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e8571868-e020-4be0-bea5-76ad97156ccd.json
e8610dc8-f375-4a05-9c01-91ccb06f36e5,DERMEDAL 12 SACHETSX2.5GR,29C,,,20363,,,,,,tablet,DERMEDAL 12 SACHETSX2.5GR,2025-07-31T20:13:21.942390,IL,nan,,,,,,,DERMEDAL 12 SACHETSX2.5GR,,,,,units,12.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e8610dc8-f375-4a05-9c01-91ccb06f36e5.json
e86207a4-abb6-4cc0-8972-fcc4af9a232c,EPREX/PROTECS 2000 IU/0.5ML 6 SYRINGES,prescription,,,4571,,,,,ILS,tablet,EPREX/PROTECS 2000 IU/0. 6 SYRINGES,2025-07-31T19:06:44.924625,IL,יאנסן סילג,,486.8870836,412.6161725,351.1627,,,EPREX/PROTECS 2000 IU/0.5ML 6 SYRINGES,5456,,86978,,units,6.0,,not-registered,17.5,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e86207a4-abb6-4cc0-8972-fcc4af9a232c.json
e86c7146-c345-4619-bd13-f4443c13582b,COLIRACIN,prescription,J01XB01,COLISTIN,1853,,,WHO ATC Classification,,ILS,powder for concentrate for infusion,COLISTIMETHATE SODIUM 1000000 U/VIAL,2025-07-31T01:26:37.467492,IL,רפא,,50.32337082,42.64692632,31.1291433,,7290008012195,COLIRACIN 1 VIAL,3206,,520,VIAL GLASS TYPE I,units,1.0,119 27 22678 11,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,Antibiotic for treatment of infections caused by micro-organisms sensitive to colistin.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e86c7146-c345-4619-bd13-f4443c13582b.json
e88581a7-ef2e-4024-9a03-ad5122271734,DASATINIB TEVA 100 MG,prescription,L01XE06,DASATINIB,9175,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB AS MONOHYDRATE,2025-07-31T01:43:09.998672,IL,טבע,,4389.218971,3719.677094,3381.524631,,,DASATINIB TEVA 20 MG 60TAB,,,37216,BLISTER OPA/ALU/PVC/ALU,units,60.0,169 90 36435 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with : * Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase. * Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate. * Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e88581a7-ef2e-4024-9a03-ad5122271734.json
e8ad3c70-44ef-42cc-8aa9-46fc437ae961,MOXYVIT FORTE 250 SUSPENSION,prescription,J01CA04,AMOXICILLIN,2290,,,WHO ATC Classification,,ILS,powder for oral suspension,AMOXICILLIN AS TRIHYDRATE/ML,2025-07-31T05:34:43.750455,IL,ויטאמד,,15.03438,12.741,9.3,,,MOXYVIT FORTE 10 CAPS,13429,,7922,BOTTLE HDPE,units,10.0,045 22 26064 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,•	For the treatment of infections caused by bacteria susceptible to amoxicillin.•	Intended for the prevention of bacterial infections in patients who are at risk for developing bacterial endocarditis.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e8ad3c70-44ef-42cc-8aa9-46fc437ae961.json
e8f378b8-0ff6-4d9e-90cc-ec8ec7da80b2,SKYRIZI 150 MG,prescription,L04AC18,RISANKIZUMAB,9259,,,WHO ATC Classification,,ILS,solution for injection,RISANKIZUMAB/,2025-07-31T08:21:33.166746,IL,אב-וי,,12694.92875,10758.41467,9780.376973,,,SKYRIZI 150 MG 1 PFS,,,73693,PRE-FILLED PEN GLASS TYPE I,units,1.0,169 73 36871 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Plaque PsoriasisSkyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who arecandidates for systemic therapy.Psoriatic ArthritisSkyrizi, alone or in combination with methotrexate (MTX), is indicated for the treatment of activepsoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (DMARDs).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e8f378b8-0ff6-4d9e-90cc-ec8ec7da80b2.json
e9015663-9fff-4d0f-b90d-95dfca502b5f,BICALUTAMIDE TEVA ® 150 MG,prescription,L02BB03,BICALUTAMIDE,7684,,,WHO ATC Classification,,ILS,tablets,BICALUTAMIDE,2025-07-31T00:35:30.466305,IL,אינובמד,,467.7712694,396.41633,337.3756,,,BICALUTAMIDE INOVAMED 150 MG 28 F.C.TAB,2544,,39082,BLISTER PVDC/ALUMINIUM,units,28.0,140 83 31741 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,In patients with locally advanced prostate cancer (T3-T4  any N  M0  T1-T2  N+  M0)  Bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. The management of patients with locally advanced  non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e9015663-9fff-4d0f-b90d-95dfca502b5f.json
e9476fb5-e3ce-4109-a46c-03d74e76e615,BONDORMIN,prescription,N05CD09,BROTIZOLAM,7692,,,WHO ATC Classification,,ILS,tablets,BROTIZOLAM 0.25  MG,2025-07-30T23:40:57.369311,IL,רפא,,31.03872,26.304,19.2,,7290008013932,BONDORMIN 0.25MG 20TAB,2572,,61426,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,120 37 26021 12,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Insomnia.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e9476fb5-e3ce-4109-a46c-03d74e76e615.json
e949f1fd-a4a5-4454-b6ed-9ec5aed6520e,CATHEJELL WITH LIDOCAINE,prescription,D04AB01,LIDOCAINE,8747,,,WHO ATC Classification,,ILS,gel,"LIDOCAINE HYDROCHLORIDEW/W, CHLORHEXIDINE DIHYDROCHLORIDE 0.05 %W/W",2025-07-31T00:57:31.004133,IL,לפידות,,294.63125,249.6875,212.5,,9001505000817,CATHEJELL WITH LIDOCAINE 25 SYR,,,72436,SYRINGE POLYPROPYLENE,units,25.0,134 65 31156 00,valid,17.5,urethral,1.4,36,,,,,,,,,,0,Prescription required,Instillation into the urethra prior to the instillation of catheters or other instruments and manipulations which require the use of a local anesthetic.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e949f1fd-a4a5-4454-b6ed-9ec5aed6520e.json
e979c8d9-a556-4188-a499-42acad73d46f,PIOGLITAZONE INOVAMED 15,prescription,A10BG03,PIOGLITAZONE,8921,,,WHO ATC Classification,,ILS,tablets,PIOGLITAZONE AS HYDROCHLORIDE,2025-07-31T06:43:31.321360,IL,אינובמד,,161.7878392,137.1083444,109.6866755,,7290104530869,PIOGLITAZONE INOVAMED 45MG 30TAB,17477,,72748,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,167 54 35972 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e979c8d9-a556-4188-a499-42acad73d46f.json
e9826aa4-fd3e-4e20-a90c-899d8faeca7f,DANYELZA,prescription,,,9010,,,,,ILS,concentrate for solution for infusion,NAXITAMAB/,2025-07-31T01:41:05.282094,IL,טקדה,,nan,nan,nan,,7290018609866,DANYELZA 40MG/10ML 1 VIAL,,,71514,VIAL GLASS TYPE I,units,1.0,170 45 36843 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,Prescription required,"DANYELZA is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), for the treatment of pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e9826aa4-fd3e-4e20-a90c-899d8faeca7f.json
e98bb1c3-0b6c-4604-9232-79983e765529,STALEVO 75/18.75/200,prescription,N04BA01,LEVODOPA,6457,,,WHO ATC Classification,,ILS,film coated tablets,"CARBIDOPA AS MONOHYDRATE 18.75  MG, ENTACAPONE, LEVODOPA",2025-07-31T08:39:32.805996,IL,אינובמד,,63.14912338,53.51620863,39.7890027,,7290006257475,STALEVO 75/18.75/200MG 30TAB,19924,,21389,BOTTLE HDPE,units,30.0,144 30 32962 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa/decarboxylase (DDC) inhibitor treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e98bb1c3-0b6c-4604-9232-79983e765529.json
e98c1eac-1b97-4064-ae7e-3215b080d282,RIVAROXABAN S.K. 10 MG,prescription,B01AF01,RIVAROXABAN,9331,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:43:28.808259,IL,SK PHARM(KS KIM),,259.28671,219.7345,175.7876,,,RIVAROXABAN S.K. 15 MG 28 TAB,18699,,8622,BLISTER ALU-PVC/PE/PVDC ,units,28.0,170 37 36327 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e98c1eac-1b97-4064-ae7e-3215b080d282.json
e99005b8-b4ae-426d-8c78-af6d265b8574,ENDOXAN 1 G INJECTION,29C,L01AA01,CYCLOPHOSPHAMIDE,20070,,,WHO ATC Classification,,ILS,powder for solution for injection,CYCLOPHOSPHAMIDE/VIAL,2025-07-31T14:27:52.722527,IL,nan,,nan,nan,nan,,7290004448271,ENDOXAN 50MG 50TAB,,,,VIAL GLASS TYPE I,units,50.0,144 19 29660 02,valid,nan,i.v,1.4,36,,,,,,,,,,0,,"Malignant Diseases: Cycophosphamide although effective alone in susceptible melignancies  is more frequently used concurrently or sequentially with other antineoplastic drugs. The following malignancies are often susceptible.  Cycophosphamide treatment:   1) Malignant lymphomas (Stages III and IV of the Ann Arbor staging system)  Hodgkin`s disease  lymphocytic lymphoma (nodular or diffuse)  mixed-cell type lymphoma  histiocytic lymphoma  Burkitt`s lymphoma.   2) Multiple myeloma.   3) Leukemias: Chronic lymphocytic leukemia  chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis)  acute myelogenous and monocytic leukemia  acute lymphoblastic (stemcell) leukemia in children.   4) Mycosis fungoides (advenced disease).   5) Neuroblastoma (disseminated disease).   6) Adenocarcinoma of the ovary.  7) Retinoblastoma.   8) Carcinoma of the breast.   Nonmallgnant Disease Biopsy proven ""Minimal Change"" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. Severe cases of systemic lupus Erythematos as which did not respond to other treatment  especially with nephritis",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e99005b8-b4ae-426d-8c78-af6d265b8574.json
e993cad8-1b6b-4d52-8d35-f23edd4fad35,SITAR PLUS 50/850,prescription,A10BD07,METFORMIN AND SITAGLIPTIN,9129,,,WHO ATC Classification,,ILS,film coated tablets,"METFORMIN HYDROCHLORIDE, SITAGLIPTIN AS HYDROCHLORIDE",2025-07-31T08:21:08.917217,IL,אוניפארם,,145.5086668,123.3124295,91.68210368,,,SITAR PLUS 50/850 56 tab,,,5824,BLISTER OPAQUE PVC/PVDC/ALUMINIUM,units,56.0,168 97 36684 99,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,"Sitar plus is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use: Sitar plus should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. Sitar plus has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitar plus.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e993cad8-1b6b-4d52-8d35-f23edd4fad35.json
e9a4ead8-6c66-46ef-980d-05e7f8e24305,BUDICORT TURBUHALER 100 MCG/DOSE,prescription,R03BA02,BUDESONIDE,6530,,,WHO ATC Classification,,ILS,powder for inhalation,BUDESONIDE/DOSE,2025-07-31T00:45:59.083659,IL,אסטראזנקה,,59.44644511,50.37834555,36.772515,,7290013075024,BUDICORT TURBUHALER 200MCG/DOSE 100DOSES,2499,,84647,POWDER INHALER LDPE,units,100.0,057 98 26940 00,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Bronchial asthma.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e9a4ead8-6c66-46ef-980d-05e7f8e24305.json
e9d2489f-a14a-45db-a22c-a048c7244854,ENBREL 25 MG SOLUTION FOR INJECTION,prescription,L04AB01,ETANERCEPT,7335,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ML,2025-07-31T02:20:31.936743,IL,פיזר,,2418.646751,2049.700727,1863.364298,,,ENBREL 50MG 4 PREFIL.SYR,5507,,15837,SYRINGE PREFILLED  GLASS TYPE I,units,4.0,142 52 31949 00,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,"* Rheumatoid arthritis:- Enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs)  including methotrexate (unless contraindicated)  has been inadequate..   Enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.  - Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.Enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.* Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Enbrel has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.   * Plaque psoriasis Treatment of adults patients (18 years or older) with moderate to severe plaque psoriasis  who  are candidates for systemic therapy or phototherapy.* Paediatric plaque psoriasis Treatment of chronic severe plaque psoriasis in children and adolescents from the age of  6 years  who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.* Juvenile idiopathic arthritis- Treatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. - Treatment of psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.Treatment of enthesitis-related arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, conventional therapy. Enbrel has not been studied in children aged less than 2 years.* Axial spondyloarthritis- Ankylosing spondylitis(AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.- Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to nonsteroidal anti-inflammatory drugs (NSAIDs)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e9d2489f-a14a-45db-a22c-a048c7244854.json
e9f6753c-18c3-4a9b-bf9b-75a6894431fe,WAKIX 4.5 MG,prescription,N07XX11,PITOLISANT ,8551,,,WHO ATC Classification,,ILS,film coated tablets,PITOLISANT  AS HYDROCHLORIDE 4.45  MG,2025-07-31T10:25:28.148632,IL,תרומד,,1380.462515,1169.883539,995.645565,,3760254600001,WAKIX 4.5 MG 30 TAB,23084,,89418,BOTTLE HDPE,units,30.0,164 01 36119 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Wakix is indicated•	In adults for the treatment of narcolepsy with or without cataplexy. •	To improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by, or who have not tolerated, OSA primary therapy, such as continuous positive airway pressure (CPAP).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/e9f6753c-18c3-4a9b-bf9b-75a6894431fe.json
ea04e27f-727b-47c0-bf2b-bb5168f4dd7e,PARACETAMOL FRESENIUS 10 MG/ML,prescription,N02BE01,PARACETAMOL,8611,,,WHO ATC Classification,,ILS,solution for infusion,PARACETAMOL/ML,2025-07-31T06:28:01.647416,IL,ניאופרם,,105.954796,89.7922,66.76,,,PARACETAMOL FRESENIUS 10 MG/ML 10 VIAL X 100 ML,10670,,443,VIAL GLASS TYPE II,units,10.0,153 99 34200 02,valid,34.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Paracetamol – Fresenius is indicated for:- the short-term treatment of moderate pain, especially following surgery- the short-term treatment of fever.when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea04e27f-727b-47c0-bf2b-bb5168f4dd7e.json
ea0a909b-eca6-45dc-a21b-8a07610a9aa7,GILENYA 0.5 MG,prescription,L04AA27,FINGOLIMOD,6713,,,WHO ATC Classification,,ILS,"capsule, hard",FINGOLIMOD AS HYDROCHLORIDE 0.5  MG,2025-07-31T03:32:38.203057,IL,נוברטיס פארמה,,8981.583169,7611.51116,6919.5556,,,GILENYA 0.5MG 28 HARD CAPSULES,7857,,31878,BLISTER PVC/PVDC,units,28.0,145 78 33270 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Gilenya is indicated for the treatment of patients with relapsing forms of  multiple sclerosis ( MS )  to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea0a909b-eca6-45dc-a21b-8a07610a9aa7.json
ea23a6d7-1cb9-4fef-8f76-73f28d112e3a,XAMIOL,prescription,D07AC01,BETAMETHASONE,6651,,,WHO ATC Classification,,ILS,gel,"BETAMETHASONE AS DIPROPIONATE 0.5  MG /, CALCIPOTRIOL AS HYDRATE/",2025-07-31T10:27:49.664687,IL,דקסל פארמה,,69.37684922,58.79394263,43.7129685,,,XAMIOL GEL 30GR,24056,,24879,BOTTLE POLYETHYLENE,units,30.0,144 25 32996 01,valid,34.5,topical,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea23a6d7-1cb9-4fef-8f76-73f28d112e3a.json
ea28d6ff-6ac3-4e36-9d00-d31c1875498f,ZOSTAVAX (ZOSTER VACCINE LIVE) VIAL 0.65ML,prescription,,,7064,,,,,ILS,injection,ZOSTAVAX (ZOSTER VACCINE LIVE) VIAL 0.,2025-07-31T19:40:17.044059,IL,מ.ס.ד. ישראל,,775.0074684,656.7860194,558.966825,,,ZOSTAVAX (ZOSTER VACCINE LIVE) VIAL 0.65ML,26182,,65806,,units,1.0,,not-registered,17.5,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea28d6ff-6ac3-4e36-9d00-d31c1875498f.json
ea2b4333-1cac-43b1-8d27-f456d7a82eab,URALYT-U,off-the-counter,A12BA02,POTASSIUM CITRATE,3747,,,WHO ATC Classification,,ILS,granules,POTASSIUM SODIUM HYDROGEN CITRATE 2.427 G / 2.5 G,2025-07-31T12:06:59.415170,IL,פלוריש,,28.7448,24.36,nan,,7290008097796,HYDROGEN PEROXIDE 3% 1L,8005,,,CONTAINER POLYPROPYLENE,units,1000.0,063 87 22365 00,valid,nan,per os,1.4,60,,,,,,,,,,0,,To dissolve uric acid stones in the urinary tract. Prevention of further stone formation.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea2b4333-1cac-43b1-8d27-f456d7a82eab.json
ea31abda-fe21-462d-976a-cdfa09882c23,MOTILIUM,29C,A03FA03,DOMPERIDONE,20874,,,WHO ATC Classification,,ILS,tablets,DOMPERIDONE,2025-07-31T15:16:23.013379,IL,nan,,nan,nan,nan,,,MOTILIUM 1MG/ML ORAL SUSPENSION JANSEEN FRANCE 200ML,,,,BLISTER PVC/ALUMINIUM,units,200.0,013 03 24314 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Motilium is indicated for the relief of the symptoms of nausea and vomiting.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea31abda-fe21-462d-976a-cdfa09882c23.json
ea389d4a-a2ea-4221-b96f-fbf8760dcc7a,ACTILYSE 20 MG,prescription,,,7365,,,,,ILS,powder and solvent for solution for injection/infusion,ALTEPLASE/VIAL,2025-07-30T23:12:50.551385,IL,בורינגר אינגלהיים,,2376.737276,2014.184221,1714.199337,,,ACTILYSE 50 MG 1VIAL/50ML,9711,,47794,VIAL GLASS TYPE I,units,1.0,136 78 31438 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Acute myocardial infarction :Actilyse is indicated for use in the management of acute myocardial infraction (AMI) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infract size, improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with AMI. Treatment should be initiated as soon as possible after the onset of AMI symptoms.Acute massive pulmonary embolism with hemodynamic deprivation:Actylise is indicated in the management of acute massive pulmonary embolism (PE) in adults:- for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and- for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. The diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. For fibrinolytic treatment of acute ischaemic stroke.Treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging techniques (e.g. cranial computerised tomography or other diagnostic imaging method sensitive for the presence of haemorrhage). The treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome. This treatment is restricted to a prescription by a specialist in neurology.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea389d4a-a2ea-4221-b96f-fbf8760dcc7a.json
ea4296ae-3c14-4d23-b186-343a8fa2dc3e,PROVOCHOLINE ®,prescription,,,4985,,,,,ILS,powder for solution for inhalation,METHACHOLINE CHLORIDE/VIAL,2025-07-31T07:06:14.833402,IL,קמהדע,,1506.420127,1276.627283,1086.491305,,628777101005,PROVOCHOLINE 100MG/VIAL 6VIALS,16791,,70226,VIAL GLASS,units,6.0,134 45 31127 00,valid,17.5,inhalation,1.4,36,,,,,,,,,,0,Prescription required,For the diagnosis of bronchial airway hyperactivity in subjects who do not have clinically apparent asthma.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea4296ae-3c14-4d23-b186-343a8fa2dc3e.json
ea4c86e2-94c7-4578-b1b1-9226319ee6a3,QUETIAPINE INOVAMED SR 300 MG,prescription,N05AH04,QUETIAPINE,8828,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:09:35.455770,IL,אינובמד,,75.7475217,64.192815,47.727,,7290104530685,QUETIAPINE INOVAMED SR 150 MG 30 TAB,17326,,69635,BLISTER PVC/PCTFE/AL,units,30.0,165 71 35461 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Inovamed SR is indicated for the treatment of Schizophrenia. Quetiapine Inovamed SR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Inovamed SR. Quetiapine Inovamed SR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. Quetiapine Inovamed SR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Inovamed SR.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea4c86e2-94c7-4578-b1b1-9226319ee6a3.json
ea4d7077-85f8-46bb-adaa-06416b8f73a0,ANAFRANIL 25 MG,prescription,N06AA04,CLOMIPRAMINE,1876,,,WHO ATC Classification,,ILS,coated tablets,CLOMIPRAMINE HYDROCHLORIDE,2025-07-31T06:49:26.025271,IL,רפא,,15.03438,12.741,9.3,,7298087000041,PRAMIN 5AMP 10MG/2ML,16425,,1744,BLISTER PVC/PE/PVDC,units,5.0,108 06 24600 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Adults:Depression of varying originObsessive-compulsive syndromesChildren and adolescents (5-18 years old):Obsessive-compulsive syndromes,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea4d7077-85f8-46bb-adaa-06416b8f73a0.json
ea552d59-a716-46a7-b98c-ab86c2233103,ETORICOXIB DEXCEL 120 MG,prescription,M01AH05,ETORICOXIB,8182,,,WHO ATC Classification,,ILS,tablets,ETORICOXIB,2025-07-31T02:40:56.509143,IL,דקסל פארמה,,36.34265527,30.7988604,22.48092,,,ETORICOXIB DEXCEL 120 MG 7 tabs,5630,,74265,BLISTER ALUMINIUM /ALUMINIUM,units,7.0,160 18 34751 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea552d59-a716-46a7-b98c-ab86c2233103.json
ea667ef5-54aa-416b-8464-166037bac8af,GLUCAGEN HYPOKIT 1 MG,prescription,H04AA01,GLUCAGON,642,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,GLUCAGON AS HYDROCHLORIDE/VIAL,2025-07-31T03:36:43.518304,IL,נובו נורדיסק,,85.55350386,72.5029726,53.90555583,,7290008126205,GLUCAGEN KIT 1MG,9656,,9656,VIAL GLASS TYPE I,units,1.0,102 38 28662 05,valid,34.5,"s.c, i.m",1.4,36,,,,,,,,,,0,Prescription required,Treatment of severe hypoglycaemia reactions which may occur in the management of insulin treated persons with diabetes.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea667ef5-54aa-416b-8464-166037bac8af.json
ea69f3c2-29dc-4456-8f1b-9dcae8f5bd82,AUBAGIO,prescription,L04AK02,TERIFLUNOMIDE,7381,,,WHO ATC Classification,,ILS,film coated tablets,TERIFLUNOMIDE,2025-07-30T23:31:05.757113,IL,סאנופי אוונטיס,,4017.629682,3404.770917,3095.246288,,,AUBAGIO 14MG 28TAB,9749,,77451,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,151 36 33946 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Aubagio ®  is indicated for the treatment of adult patients with relapsing remitting forms of Multiple Sclerosis (MS) ) to reduce the frequency of clinical relapses and to delay the progression of physical disability.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea69f3c2-29dc-4456-8f1b-9dcae8f5bd82.json
ea8d5967-3523-450b-b22c-25092cc4a441,CHILDREN'S ADVIL GRAPE FLAVOR,off-the-counter,M01AE01,IBUPROFEN,5104,,,WHO ATC Classification,,ILS,suspension,IBUPROFEN/,2025-07-31T12:09:21.248069,IL,ליף-דקסון,,28.497,24.15,nan,,305730171304,IBUPRO LIQUIGEL 200MG 20CA,,,,BOTTLE PLASTIC,units,20.0,122 43 30111 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years .,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ea8d5967-3523-450b-b22c-25092cc4a441.json
eaa9a1d2-e626-4be9-b88e-b7ceccf79731,OMEPRADEX - Z,prescription,A02BC01,OMEPRAZOLE,4414,,,WHO ATC Classification,,ILS,caplets,OMEPRAZOLE,2025-07-31T06:08:03.263603,IL,דקסל פארמה,,182.71002,154.839,123.8712,,7290010578511,OMEPRADEX 40MG 30CAPLETS,15009,,28205,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,131 25 30841 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eaa9a1d2-e626-4be9-b88e-b7ceccf79731.json
eaa9a54c-e5c0-4da2-843e-b569cb6feb28,IMBRUVICA 140 MG TABLETS,prescription,L01XE27,IBRUTINIB,7487,,,WHO ATC Classification,,ILS,film coated tablets,IBRUTINIB,2025-07-31T04:00:10.065977,IL,יאנסן סילג,,33330.52551,28246.20932,25678.37211,,7290014577688,IMBRUVICA 140MG 120CAPSULES,9718,,50838,BLISTER PVC/PCTFE/AL,units,120.0,167 61 36458 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"•	Mantle Cell Lymphoma:Imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.•	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma :Imbruvica is indicated for the treatment of adult patients, with chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)•	Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) with 17p deletion:Imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)  /Small Lymphocytic Lymphoma (SLL) with 17p deletion.•	Waldenström’s MacroglobulinemiaImbruvica is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).•	Marginal Zone LymphomaIMBRUVICA is indicated for the treatment of adult patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy.•	Chronic Graft versus Host DiseaseIMBRUVICA is indicated for the treatment of adult patients with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eaa9a54c-e5c0-4da2-843e-b569cb6feb28.json
eab0cae6-1934-4c9d-b618-5dc2f10a40be,TAVNEOS,prescription,L04AA59,AVACOPAN,9254,,,WHO ATC Classification,,ILS,"capsule, hard",AVACOPAN,2025-07-31T09:08:25.826553,IL,כ.צ.ט,,31107.85177,26362.58742,23965.98856,,,TAVNEOS 10 MG 180 CAPS,,,17575,BOTTLE HDPE,units,180.0,173 80 37474 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eab0cae6-1934-4c9d-b618-5dc2f10a40be.json
ead3318f-afad-4785-8fb7-1ae4b4fbfef6,NORDITROPIN 10 MG,prescription,H01AC01,SOMATROPIN,8087,,,WHO ATC Classification,,ILS,solution for injection,SOMATROPIN 6.667 MG/ML,2025-07-31T05:50:54.807004,IL,נובו נורדיסק,,2329.840369,1974.441078,1794.946435,,7290008126878,NORDITROPIN 15 MG/1.5 ML NORDIFLEX,14623,,76431,PRE-FILLED PEN GLASS TYPE I,units,1.0,118 74 29921 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Children: * Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome.* Short stature in children with renal insufficiency.   * Growth disturbance (current height SDS < - 2.5 and parental adjusted height SDS < - 1) in short children born small for gestational age (SGA)  with a birth weight and/or length below - 2 SD  who failed to show catch-up growth (HV SDS < during the last year)  by 4 years of age or later.* Children with short stature associated with Noonan syndrome.Adults: Treatment of adults with Hypothalamic-pituitary disease  resulting from organic disease or  pituitary tumors treated medically  surgically or radiotherapy or patients with childhood onset of G.H. deficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ead3318f-afad-4785-8fb7-1ae4b4fbfef6.json
eafd7588-ff98-4975-83ad-a54385bf2f1f,DIAZEPAM GRINDEKS 5 MG,prescription,N05BA01,DIAZEPAM,9629,,,WHO ATC Classification,,ILS,tablets,DIAZEPAM,2025-07-31T01:54:43.045178,IL,מדי מרקט,,17.13595924,14.522,10.6,,,DIAZEPAM GRINDEKS 5 MG,,,,BLISTER PVC/ALUMINIUM,units,30.0,173 32 36670 99,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Diazepam Grindeks 5 mg is indicated for tension, anxiety, agitation due to acute alcohol withdrawal, adjunct for the relief of skeletal muscle spasm, convulsive disorders.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eafd7588-ff98-4975-83ad-a54385bf2f1f.json
eb05eda8-d744-4509-a64f-d86fe88491e0,FERRIPEL-3 SYRUP,off-the-counter,,,3699,,,,,ILS,syrup,FERROUS AS IRON III HYDROXIDE POLYMALTOSE COMPL./,2025-07-31T11:54:31.740647,IL,כ.צ.ט,,48.4508,41.06,nan,,7290008104425,FERRIPEL 3 SYR 110ML,6131,,,BOTTLE GLASS,units,110.0,107 47 28826 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Prevention and treatment of iron deficiency anaemia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eb05eda8-d744-4509-a64f-d86fe88491e0.json
eb0b4789-c327-452f-892c-b47b36ee5b0f,CODABROL 10TAB,prescription,,,1921,,,,,,tablet,CODABROL,2025-07-31T19:03:06.111980,IL,רקח,,,,,,,CODABROL 10TAB,3185,,506,,units,10.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eb0b4789-c327-452f-892c-b47b36ee5b0f.json
eb0ef1c7-db69-4b39-80c3-b792ebe15857,CRYSVITA 10 MG,prescription,M05BX05,BUROSUMAB,8875,,,WHO ATC Classification,,ILS,solution for injection,BUROSUMAB/ML,2025-07-31T01:34:58.773260,IL,מדיסון,,12774.49214,10825.84127,9841.673886,,7290015666664,CRYSVITA 10 MG 1 VIAL,,,25968,VIAL GLASS TYPE I,units,1.0,164 58 35724 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and paediatric patients 6 months of age and olderTumor-induced OsteomalaciaCRYSVITA is indicated for the treatment of FGF23 - related hypophosphatemia in tumor - induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eb0ef1c7-db69-4b39-80c3-b792ebe15857.json
eb2b6592-744e-4ea7-a998-a17ef9d60e69,KARIN 250,prescription,J01FA09,CLARITHROMYCIN,3885,,,WHO ATC Classification,,ILS,coated tablets,CLARITHROMYCIN,2025-07-31T04:23:37.957256,IL,אוניפארם,,54.34411058,46.054331,33.6163,,,KARIN 500MG 14TAB,11016,,76163,BLISTER PVC/ALUMINIUM,units,14.0,104 96 28719 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Karin is indicated in the treatment of infections caused by one or more susceptible organisms. Indications include:* Lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia.* Upper respiratory tract infections, for example, sinusitis and pharyngitis.Karin is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section.Karin is also indicated in:* skin and soft tissue infections of mild to moderate severity.* combination with proton pump inhibitor for the eradication of H. Pylori in patients with proven duodenal ulcer.* treatment of Mycobacterium Avium Complex infection in AIDS patients.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eb2b6592-744e-4ea7-a998-a17ef9d60e69.json
eb33ff92-1358-42c5-a355-3e1af905a63a,BIMZELX ®,prescription,L04AC21,BIMEKIZUMAB,9195,,,WHO ATC Classification,,ILS,solution for injection,BIMEKIZUMAB/,2025-07-31T00:36:46.202431,IL,ניאופרם,,8493.186252,7197.615788,6543.28708,,7290111099267,BIMZELX  160 MG 2 pfpen,2918,,88149,PRE-FILLED PEN GLASS TYPE I,units,2.0,172 46 37409 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,"Plaque psoriasisBimzelx  is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.Psoriatic arthritisBimzelx, alone or in combination with a conventional non-biologic disease-modifying antirheumatic drug (cDMARD) (e.g., methotrexate), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (DMARDs).Axial spondyloarthritisNon-radiographic axial spondyloarthritis (nr-axSpA)Bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (NSAIDs).Ankylosing spondylitis (AS, radiographic axial spondyloarthritis)Bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eb33ff92-1358-42c5-a355-3e1af905a63a.json
eb6f9476-e91d-4199-a5cf-0a87b69dfd22,RIVAROXABAN DEXCEL 10 MG,prescription,B01AF01,RIVAROXABAN,9394,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:42:38.623616,IL,דקסל פארמה,,259.28671,219.7345,175.7876,,7290015912952,RIVAROXABAN DEXCEL 15 MG 28 TAB,18709,,16668,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,172 93 36479 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), adults (following completion of at least 6 months therapy for DVT or PE).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eb6f9476-e91d-4199-a5cf-0a87b69dfd22.json
eb9248b8-69b1-42ee-8c75-401a89546a81,LIVMARLI,prescription,A05AX04,MARALIXIBAT CHLORIDE,9219,,,WHO ATC Classification,,ILS,solution  (oral),MARALIXIBAT CHLORIDE/ML,2025-07-31T04:51:15.800637,IL,ניאופרם,,150421.6421,127475.9736,115887.2487,,,LIVMARLI ORAL SOLUTION 10 MG/ML 30ML,12628,,88146,BOTTLE PET,units,30.0,170 65 37132 99,valid,10.0,oral,1.4,30,,,,,,,,,,0,Prescription required,Livamrli ® is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 2 months of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eb9248b8-69b1-42ee-8c75-401a89546a81.json
eb944502-5775-465f-b714-e82957f3f239,CLOPIXOL 10 MG TABLETS,prescription,N05AF05,ZUCLOPENTHIXOL,629,,,WHO ATC Classification,,ILS,film coated tablets,ZUCLOPENTHIXOL AS DIHYDROCHLORIDE,2025-07-31T01:22:33.040389,IL,לנדבק,,26.64492234,22.58044366,16.48207567,,,CLOPIXOL 10MG 50TAB,3629,,8218,CONTAINER HDPE,units,50.0,047 86 25486 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute schizophrenia .Other acute psychoses.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eb944502-5775-465f-b714-e82957f3f239.json
eba9da26-4230-40aa-9c53-ccbb9432a30e,SOMAVERT 10 MG,prescription,H01AX01,PEGVISOMANT,8089,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,PEGVISOMANT,2025-07-31T08:30:41.971703,IL,פיזר,,22607.92608,19159.26024,17417.50931,,7290010355631,SOMAVERT 25 MG 30 VIALS,10135,,64599,VIAL GLASS TYPE I,units,30.0,135 41 31357 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize IGF-I concentrations or was not tolerated.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eba9da26-4230-40aa-9c53-ccbb9432a30e.json
ebd0287b-c479-4dec-9ade-edc160e897d6,PIOGLITAZONE TEVA 30 MG,prescription,A10BG03,PIOGLITAZONE,9583,,,WHO ATC Classification,,ILS,tablets,PIOGLITAZONE AS HYDROCHLORIDE,2025-07-31T06:43:47.363814,IL,טבע,,123.804804,104.91933,78.00693684,,,PIOGLITAZONE TEVA 30 MG,,,17329,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,165 41 36344 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Pioglitazone Teva is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.Pioglitazone Teva is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ebd0287b-c479-4dec-9ade-edc160e897d6.json
ebd88ea9-cf31-4e1e-9dda-99139c01ff0a,APO GO PEN 10 MG/ML,prescription,N04BC07,APOMORPHINE,6042,,,WHO ATC Classification,,ILS,solution for injection,APOMORPHINE HYDROCHLORIDE/ML,2025-07-31T00:21:19.662523,IL,טבע,,624.2878886,529.0575563,450.26175,,,APO GO PEN 10MG/ML 5X3ML,9800,,65941,PEN INJECTOR ,units,5.0,136 82 31425 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,Treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson's disease which are not sufficiently controlled by oral anti-Parkinson medication.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ebd88ea9-cf31-4e1e-9dda-99139c01ff0a.json
ebe1639b-37fe-4496-8fbd-3f335fe42277,NOXAFIL SUSPENSION,prescription,J02AC04,POSACONAZOLE,6101,,,WHO ATC Classification,,ILS,suspension,POSACONAZOLE/ML,2025-07-31T05:56:55.515640,IL,מ.ס.ד. ישראל,,2082.328831,1764.685528,1501.860024,,7290008121460,NOXAFIL SUSPENSION 40 MG/ML 105ML,14509,,89495,BOTTLE GLASS TYPE III,units,105.0,138 37 31627 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Noxafil is indicated for use in the treatment of the following fungal infections in adults :   - Invasive aspergillosis in patients with disease that is refractory to amphotericin B or itraconazole or in patients who are intolerant of these medicinal products    - Fusariosis in patients with disease that is refractory to amphotericin B or in patients who are intolerant of amphotericin B   - Chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole     - Coccidioidomycosis in patients with disease that is refractory to amphotericin B  itraconazole or fluconazole or in patients who are intolerant of these medicinal products    - Oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised  in whom response to topical therapy is expected to be poor.   Refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.   Noxafil is also indicated for prophylaxis of invasive fungal infections in the following patients :   - Patients receiving remission- induction chemotherapy for acute myelogenous leukemia  ( AML) or myelodysplastic syndromes ( MDS ) expected to result in prologed neutropenia and who are at high risk of developing invasive fungal infections     - Hematopoietic stem cell transplant ( HSCT) recipients who are undergoing high - dose immunosuppressive therapy for graft versus host disease and who are at high risk of developing invasive fungal infections.   Zygomycosis in patients intolerant of  or with disease that is refractory to  alternative therapy, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ebe1639b-37fe-4496-8fbd-3f335fe42277.json
ec1071c3-9931-455f-a033-01be7ac554bc,BISOPROLOL FUMARATE INOVAMED 2.5 MG,prescription,C07AB07,BISOPROLOL,7688,,,WHO ATC Classification,,ILS,film coated tablets,BISOPROLOL FUMARATE 2.5  MG,2025-07-31T00:39:24.774231,IL,אינובמד,,17.80878892,15.092194,11.0162,,,BISOPROLOL INOVAMED 2.5 MG 30 F.C.TAB,2577,,71854,BLISTER PVC/ALUMINIUM,units,30.0,152 66 34099 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ACE inhibitors and diuretics, and optionally cardiac glycosides.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ec1071c3-9931-455f-a033-01be7ac554bc.json
ec243e18-7d17-43a4-bfb5-2ec2f74faedf,SONOVUE,prescription,V08DA05,SULFUR HEXAFLUORIDE,8188,,,WHO ATC Classification,,ILS,powder and solvent for dispersion for injection,SULPHUR HEXAFLUORIDE 8 MCL/ML,2025-07-31T08:31:08.495037,IL,דקסל פארמה,,382.008463,323.736,275.52,,,SONOVUE  8 MCL/ML 1VIAL 25MG PWDR,10374,,25131,VIAL GLASS TYPE I,units,1.0,153 03 34004 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"This medicinal product is for diagnostic use only. SonoVue is for use with ultrasound imaging to enhance the echogenicity of the blood, which results in an improved signal to noise ratio. SonoVue should only be used in patients where study without contrast enhancement is inconclusive.Echocardiography: SonoVue is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation.Doppler of macrovasculature: SonoVue increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid or peripheral arteries by improving the Doppler signal to noise ratio. SonoVue increases the quality of the Doppler flow image and the duration of clinically useful signal enhancement in portal vein assessment.Doppler of microvasculature: SonoVue improves display of the vascularity of liver and breast lesions during Doppler sonography, leading to more specific lesion characterisation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ec243e18-7d17-43a4-bfb5-2ec2f74faedf.json
ec3fa4f4-99ac-4851-ae71-20f8fcb3e733,PLAVIX 75 MG,prescription,B01AC04,CLOPIDOGREL,6198,,,WHO ATC Classification,,ILS,film coated tablets,CLOPIDOGREL AS HYDROGEN SULFATE,2025-07-31T01:22:22.764111,IL,טבע,,53.4981438,45.33741,33.093,,7290012711428,CLOPIDOGREL 75MG 30TAB,3941,,80638,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,110 70 29307 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Secondary Prevention of atherotrobmotic eventsClopidogrel is indicated in :• Adult Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• Adult Patients suffering from Acute Coronary Syndrome- Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapyPrevention of atherotrobmotic and thromboembolic events in atrial fibrillation: In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with Vitamin K antagonists (VKA) Anti-Thrombin or Anti Factor Xa, and who have a low bleeding risk, clopidogrel is indicated in combination  with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ec3fa4f4-99ac-4851-ae71-20f8fcb3e733.json
ec40f1a6-8552-4926-a838-c5357c9c0f4f,SUNITINIB TARO 12.5 MG,prescription,L01XE04,SUNITINIB,9404,,,WHO ATC Classification,,ILS,"capsule, hard",SUNITINIB 12.5  MG,2025-07-31T08:51:41.676944,IL,תרו,,8063.85096,6833.772,6212.52,,7290017164410,SUNITINIB TARO 50 MG 28 CAPS,,,15976,BLISTER OPA/ALU/PVC/ALU,units,28.0,167 94 36017 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Sunitinib taro is indicated for:• Treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • Treatment of advanced renal cell carcinoma.• Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ec40f1a6-8552-4926-a838-c5357c9c0f4f.json
ec4cdfab-11f0-44ba-a70f-02a9b88f4b40,XELJANZ 1 MG/ML,prescription,L04AA29,TOFACITINIB,7422,,,WHO ATC Classification,,ILS,oral solution,TOFACITINIB AS CITRATE/,2025-07-31T10:32:31.507211,IL,פיזר,,3489.614698,2957.300723,2688.455203,,,XELJANZ 5 MG 60TAB,24083,,57630,BOTTLE HDPE,units,60.0,176 47 37836 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"XELJANZ 1 MG/ML is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [RF+] or negative [RF-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (PsA) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (DMARDs). XELJANZ 1 MG/ML can be given in combination with methotrexate (MTX) or as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ec4cdfab-11f0-44ba-a70f-02a9b88f4b40.json
ec85e404-c745-4f51-8519-0383ce9e29cb,BICALUTAMIDE TEVA ® 150 MG,prescription,L02BB03,BICALUTAMIDE,6271,,,WHO ATC Classification,,ILS,tablets,BICALUTAMIDE,2025-07-30T23:38:37.498192,IL,טבע,,501.1834237,424.731715,361.4738,,,BICALUTAMIDE TEVA 150MG 30TAB,2488,,80700,BLISTER PVDC/ALUMINIUM,units,30.0,140 83 31741 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,In patients with locally advanced prostate cancer (T3-T4  any N  M0  T1-T2  N+  M0)  Bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. The management of patients with locally advanced  non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ec85e404-c745-4f51-8519-0383ce9e29cb.json
ecbcf294-4dcd-418b-b790-5bf2beb51db4,AMBRISENTAN S.K. 10 MG,prescription,C02KX02,AMBRISENTAN,8983,,,WHO ATC Classification,,ILS,film coated tablets,AMBRISENTAN,2025-07-30T23:21:37.505097,IL,טבע,,3974.69666,3368.387,3062.17,,,AMBRISENTAN TEVA 5 MG 30 TAB,17582,,74858,BLISTER PVC/PE/PVDC/AL,units,30.0,176 63 36826 99,valid,10.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"AMBRISENTAN S.K. is indicated for treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment with tadalafil.Efficacy has been  shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ecbcf294-4dcd-418b-b790-5bf2beb51db4.json
ecde0ef5-95ec-421f-bf52-58b60141e62b,PROLIA 60 MG,prescription,M05BX04,DENOSUMAB,6726,,,WHO ATC Classification,,ILS,solution for injection,DENOSUMAB/,2025-07-31T07:00:33.883405,IL,מדיסון,,855.5619382,725.0525222,617.0659763,,,PROLIA 60MG/ML PREFIL SYRINGE,16845,,3486,PREFILLED SYRINGE (BLISTERED) GLASS TYPE I,units,1.0,146 25 33253 00,valid,17.5,s.c,1.4,48,,,,,,,,,,0,Prescription required,"Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal women Prolia significantly reduces the risk of vertebral, non vertebral and hip fractures. Treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures. In men with prostate cancer receiving hormone ablation, Prolia significantly reduces the risk of vertebral fractures.Treatment of bone loss associated with long-term systemic glucocorticoid therapy of a daily dosage equivalent to 7.5 mg or greater of prednisone and expected to remain on glucocorticoids for at least 3 months, in adult patients at high risk of fracture.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ecde0ef5-95ec-421f-bf52-58b60141e62b.json
ed01a547-c6ec-49e1-84b6-6bd7c23f342b,INTRATECT 100 G/L,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",8881,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T04:09:54.806312,IL,קמהדע,,3053.778557,2587.948044,2352.68004,,,INTRATECT 100 G/L 1 VIAL 100ML,,,51390,VIAL GLASS TYPE II,units,100.0,159 72 35202 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, and children and adolescents (0-18 years) in:     -	Primary immunodeficiency syndromes (PID) with impaired antibody production     -	Secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent      infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)*      or serum IgG level of <4 g/l     * PSAF= failure to mount at least a 2-fold rise in IgG antibody titre to pneumococcal         polysaccharide and polypeptide antigen vaccinesImmunomodulation in adults, and children and adolescents (0-18 years) in:     -	Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery      to correct the platelet count     -	Guillain Barré syndrome     -	Kawasaki disease (in conjunction with acetylsalicylic acid)     -	Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)     -	Multifocal motor neuropathy (MMN)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed01a547-c6ec-49e1-84b6-6bd7c23f342b.json
ed13f640-990e-4648-93f7-0d4136fe84d8,LACRIMOL EYE DROPS,off-the-counter,S01AX18,POVIDONE-IODINE,1805,,,WHO ATC Classification,,ILS,"eye drops, solution","HYDROXYETHYLCELLULOSE 0.31 %, POVIDONE 1.6 %",2025-07-31T12:16:29.051192,IL,פישר,,20.3904,17.28,nan,,7290000849553,LACRIMOL DROPS 15CC,12006,,,BOTTLE LDPE,units,15.0,026 72 22083 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,A lubricating tear substitute for dry eyes when tear production is insufficient.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed13f640-990e-4648-93f7-0d4136fe84d8.json
ed1e6e84-fa5b-498d-9878-70efa7d3481c,CIRCADIN,prescription,N05CH01,MELATONIN,6752,,,WHO ATC Classification,,ILS,tablets prolonged release,MELATONIN,2025-07-31T01:17:47.342855,IL,נעורים,,103.0990859,87.37211057,64.960677,,,CIRCADIN 2MG 30 PR TAB,9422,,26470,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,139 92 31648 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed1e6e84-fa5b-498d-9878-70efa7d3481c.json
ed4995dd-047d-4555-b791-2d59bd22a1af,COUMADIN 2.5 MG,prescription,B01AA03,WARFARIN,3709,,,WHO ATC Classification,,ILS,tablets,WARFARIN SODIUM 2.5  MG,2025-07-31T01:32:23.020233,IL,תרו,,nan,nan,nan,,7-290000-808239,COUMADIN 2.5MG 30TAB,3596,,17842,BOTTLE HDPE,units,30.0,111 45 29375 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. Coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. Coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed4995dd-047d-4555-b791-2d59bd22a1af.json
ed4eeb40-a648-490c-93c7-c7d98c071e18,LOPRESOR DIVITABS 200 MG,prescription,C07AB02,METOPROLOL,556,,,WHO ATC Classification,,ILS,tablets slow release,METOPROLOL TARTRATE,2025-07-31T04:54:00.145308,IL,נוברטיס פארמה,,11.61006083,9.839035038,7.1817774,,7298087000386,LOPRESOR 200MG 14SR DIVITAB,12099,,6872,BLISTER PVC/PE/PVDC,units,14.0,045 04 22324 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Hypertension, angina pectoris, arrhythmia, prophylaxis of migrain, prophylaxis of reinfarction.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed4eeb40-a648-490c-93c7-c7d98c071e18.json
ed734aa8-366c-4a8b-948f-f041325ba1e6,ABILIFY  MAINTENA 300 MG,prescription,N05AX12,ARIPIPRAZOLE,8646,,,WHO ATC Classification,,ILS,powder and solvent for prolonged-release suspension for injection,ARIPIPRAZOLE AS MONOHYDRATE/VIAL,2025-07-30T23:27:01.213701,IL,סנדוז,,272.548415,230.9732331,196.5729643,,,ARIPIPRAZOLE SANDOZ 15 MG 10 TAB,23400,,89165,VIAL GLASS TYPE I,units,30.0,153 68 34089 00,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,Abilify Maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed734aa8-366c-4a8b-948f-f041325ba1e6.json
ed7b4088-9a49-48de-94ee-ee0cf3da044d,MERFEN SPRAY FIRST AID,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",3992,,,WHO ATC Classification,,ILS,solution,"BENZOXONIUM CHLORIDE/ML, CHLORHEXIDINE GLUCONATE/ML",2025-07-31T12:25:03.913688,IL,מדיטרנד,,36.6154,31.03,nan,,7290010859290,MERFEN SPRAY 30ML,13540,,,BOTTLE PLASTIC,units,30.0,121 68 30135 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"To disinfect wounds and injuries, such as cuts, scratches, mild burns and insect stings.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed7b4088-9a49-48de-94ee-ee0cf3da044d.json
ed7f6a94-3139-41e1-b4fa-6c3e35755817,XYNTHA 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,7494,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,MOROCTOCOG ALFA/VIAL,2025-07-31T10:38:32.697081,IL,פיזר,,787.7048571,667.5465188,568.1246968,,35894014012,XYNTHA 500 IU 1VIAL,24082,,56698,VIAL 10 ML GLASS TYPE I,units,1.0,137 80 31593 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed7f6a94-3139-41e1-b4fa-6c3e35755817.json
ed820f5c-fd65-4a31-8f55-7f72142834ec,DESLORATADINE - TRIMA SYRUP 0.5 MG/ML,prescription,R06AX27,DESLORATADINE,7311,,,WHO ATC Classification,,ILS,syrup,DESLORATADINE 0.5 MG/ML,2025-07-31T01:51:04.359474,IL,תרימה,,15.3835656,13.03692,9.516,,7290000843551,DESLORATADINE-TRIMA SYRUP 0.5MG/ML 120ML,4606,,50861,BOTTLE GLASS TYPE III,units,120.0,150 37 33827 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the relief of symptoms associated with allergic rhinitis and/or chronic idiopathic  urticaria in adults and children 1 year of age and above.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed820f5c-fd65-4a31-8f55-7f72142834ec.json
ed850df0-1a57-40d7-ba00-2954111ec93f,SKYRIZI 360 MG,prescription,L04AC18,RISANKIZUMAB,9315,,,WHO ATC Classification,,ILS,solution for injection,RISANKIZUMAB/ML,2025-07-31T08:21:39.026226,IL,אב-וי,,11637.16161,9862.001804,8965.456185,,300741070011,SKYRIZI 360 MG,23146,,31579,CARTRIDGE GLASS TYPE I,units,1.0,172 09 37477 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Crohn's disease Skyrizi is indicated for the treatment of patients 16 years and older with moderately to severely active Crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy, or if such therapies are not advisable.Ulcerative colitisSkyrizi is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy, or a biological therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed850df0-1a57-40d7-ba00-2954111ec93f.json
ed87ba41-a8d3-4379-9df2-5c3d41bb6f9e,CIALIS 10 MG,prescription,G04BE08,TADALAFIL,4631,,,WHO ATC Classification,,ILS,film coated tablets,TADALAFIL,2025-07-31T01:10:25.340157,IL,אלי לילי,,237.1314725,200.958875,160.7671,,,CIALIS 20MG 4TAB,3742,,57624,BLISTER PVC/PE/PCTFE/AL,units,4.0,128 19 30677 21,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of erectile dysfunction in adult men.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed87ba41-a8d3-4379-9df2-5c3d41bb6f9e.json
ed9c8687-c29f-47a0-9ee7-259319c1cd76,FLIXOTIDE DISKUS 100 MCG,prescription,R03BA05,FLUTICASONE,3540,,,WHO ATC Classification,,ILS,powder for inhalation,FLUTICASONE PROPIONATE,2025-07-31T03:08:32.911873,IL,ג.ס.ק,,28.96771589,24.54891287,17.9189145,,,FLIXOTIDE DISK 50MCG 60DOSES,6111,,47594,BLISTER PVC/OPA/AL,units,60.0,069 97 28478 00,valid,37.0,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Prophylactic management of all grades of asthma.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ed9c8687-c29f-47a0-9ee7-259319c1cd76.json
eda37e04-3a46-46fb-9fbb-4150976588f0,UPTRAVI ® 1000 microgram,prescription,B01AC27,SELEXIPAG,8032,,,WHO ATC Classification,,ILS,film coated tablets,SELEXIPAG,2025-07-31T09:53:31.264737,IL,יאנסן סילג,,13039.06554,11050.05603,10045.50548,,7640111932642,UPTRAVI ® 400 MCG 60 TAB,21126,,22558,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,158 11 34942 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (ERA) and/or a phosphodiesterase type 5 (PDE-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies.Efficacy has been shown in a PAH population including idiopathic and heritable PAH, PAH associated with connective tissue disorders, and PAH associated with corrected simple congenital heart disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eda37e04-3a46-46fb-9fbb-4150976588f0.json
eda981ca-861d-4767-b1ed-8c50c71dd43c,ZUTECTRA,prescription,J06BB04,HEPATITIS B IMMUNOGLOBULIN,8357,,,WHO ATC Classification,,ILS,solution for injection,HUMAN HEPATITIS B IMMUNOGLOBULIN,2025-07-31T10:55:53.641580,IL,קמהדע,,7065.716647,5987.89573,5443.541573,,4036124022440,ZUTECTRA 500IU 5 PREF SYR,,,53578,SYRINGE PREFILLED  GLASS TYPE I,units,5.0,150 26 33639 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Prevention of hepatitis B virus (HBV) re-infection in HBsAg and HBV-DNA negative adult patients at least one week after liver transplantation for hepatitis B induced liver failure.HBV-DNA negative status should be confirmed within the last 3 months prior to OLT. Patients should be HBsAg negative before treatment start.The concomitant use of adequate virostatic agents should be considered as standard of hepatitis B re-infection prophylaxis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eda981ca-861d-4767-b1ed-8c50c71dd43c.json
edc1df7d-3b78-412c-9f65-a602ac2a995d,MIDOLAM 1 MG/ML,prescription,N05CD08,MIDAZOLAM,6227,,,WHO ATC Classification,,ILS,solution for injection,MIDAZOLAM/ML,2025-07-31T05:22:13.615020,IL,רפא,,79.87826687,67.6934465,50.3297,,7290017179353,MIDOLAM 5MG/ML5AMPx10ML,13258,,35297,AMPOULES GLASS TYPE I,units,5.0,108 42 29066 00,valid,34.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,midazolam is a short-acting sleep-inducing drug that is indicated:In adults• CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia• ANAESTHESIA- Premedication before induction of anaesthesia- Induction of anaesthesia- As a sedative component in combined anaesthesia• SEDATION IN INTENSIVE CARE UNITSIn children• CONSCIOUS SEDATION before and during diagnostic or therapeutic procedures with or without local anaesthesia• ANAESTHESIA- Premedication before induction of anaesthesia• SEDATION IN INTENSIVE CARE UNITS,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/edc1df7d-3b78-412c-9f65-a602ac2a995d.json
edc41a86-b3bb-411c-8ed3-db973762cb79,REPHENIDATE LA 10 MG MODIFIED-RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,9142,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:26:00.108070,IL,דקסל פארמה,,51.24029545,43.42397919,31.69633518,,,REPHENIDATE LA 10 MG 30 CAPS,18680,,41263,BLISTER ACLAR/ALUMINIUM,units,30.0,170 55 37007 99,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention deficit hyperactivity disorder (ADHD),תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/edc41a86-b3bb-411c-8ed3-db973762cb79.json
eddefd9a-cf6b-4de7-a8e1-1291523cf2c1,MONOCORD 20,prescription,C01DA14,ISOSORBIDE MONONITRATE,1773,,,WHO ATC Classification,,ILS,tablets,ISOSORBIDE MONONITRATE,2025-07-31T05:29:39.811210,IL,דקסל פארמה,,16.8465886,14.27677,10.421,,7290008113427,MONOCORD 40MG 30TAB,13454,,8268,BLISTER PVC/ALUMINIUM,units,30.0,052 51 23128 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of angina pectoris and prevention of anginal attacks. Treatment of congestive heart failure.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eddefd9a-cf6b-4de7-a8e1-1291523cf2c1.json
ede18210-1959-40f4-ac2f-5371ce141767,CISATRACURIUM 2MG/ML 10ML NORMON SPAIN solution for injection/infusion,29C,,,20824,,,,,,injection,CISATRACURIUM 2MG/ML NORMON SPAIN solution for injection/infusion,2025-07-31T20:06:57.992087,IL,nan,,,,,,,CISATRACURIUM 2MG/ML 10ML NORMON SPAIN solution for injection/infusion,,,,,units,5.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ede18210-1959-40f4-ac2f-5371ce141767.json
ee025128-c328-44f1-b25f-7f36092cef3f,KOATE DVI 1000,prescription,B02BD02,COAGULATION FACTOR VIII,7055,,,WHO ATC Classification,,ILS,powder for solution for injection,FACTOR VIII (HUMAN)/VIAL,2025-07-31T04:28:44.789215,IL,פאדאגיס,,787.7048571,667.5465188,568.1246968,,7298074020335,KOATE DVI 500IU/VIAL,,,,VIAL GLASS TYPE I,units,1.0,117 90 29931 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"For the treatment of classical hemophilia (hemophilia A)  in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor VIII . Koate-DVI provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee025128-c328-44f1-b25f-7f36092cef3f.json
ee080e90-47dc-453e-8043-9ba9516211cf,RELESTAT,prescription,S01GX10,EPINASTINE,4942,,,WHO ATC Classification,,ILS,"eye drops, solution",EPINASTINE HYDROCHLORIDE 0.05 %W/V,2025-07-31T07:22:42.888587,IL,אב-וי,,33.05383468,28.01172555,20.446515,,7290008127455,RELESTAT EYE DROPS 0.05% 5ML,18352,,68144,BOTTLE LDPE,units,5.0,133 58 31028 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Treatment of the symptoms of seasonal allergic conjunctivitis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee080e90-47dc-453e-8043-9ba9516211cf.json
ee0b4129-622c-450b-b165-7fc1b05d1c80,HURRICAINE,off-the-counter,D04AB04,BENZOCAINE,5496,,,WHO ATC Classification,,ILS,gel,BENZOCAINEW/W,2025-07-31T12:05:58.297228,IL,לוי דנטל,,42.9166,36.37,nan,,,HURRICAINE oral gel 5.25 GR,,,,BOTTLE HDPE,units,5.25,142 11 32950 00,valid,nan,local oral,1.4,36,,,,,,,,,,0,,"Hurricaine is designed for any dental procedure in which topical anesthesia is desired. Hurricaine is also used for temporary relief of occasional minor irritation and pain associated with: canker sores, sore mouth and throat , minor injury of the mouth and gums caused by dentures or orthodentic appliances.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee0b4129-622c-450b-b165-7fc1b05d1c80.json
ee0ee889-3a57-45f0-852b-3b7faf8ad66a,TRITTICO 100 MG,prescription,N06AX05,TRAZODONE,9316,,,WHO ATC Classification,,ILS,tablets,TRAZODONE HYDROCHLORIDE,2025-07-31T09:44:31.728401,IL,רז פרמהצפטי,,48.32591725,40.95416898,29.893554,,7290015863629,TRITTICO 100 MG 30 tabs,,,77179,BLISTER PVC/ALUMINIUM,units,30.0,173 31 36296 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of depression with or without anxiety.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee0ee889-3a57-45f0-852b-3b7faf8ad66a.json
ee14e563-dee9-41a4-8bfe-db9bd8b0424d,MYCOPHENOLIC ACID INOVAMED 180 MG,prescription,L04AA06,MYCOPHENOLIC ACID,9368,,,WHO ATC Classification,,ILS,tablets delayed release,MYCOPHENOLIC ACID,2025-07-31T05:37:22.027318,IL,אינובמד,,423.581428,358.9673118,305.5040952,,,MYCOPHENOLIC INOVAMED 180 MG 120 TAB,23639,,5102,BOTTLE HDPE,units,120.0,173 70 37504 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Mycophenolic Inovamed is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee14e563-dee9-41a4-8bfe-db9bd8b0424d.json
ee1ad3d1-2051-454f-b049-8bbc873d0544,DOVATO,prescription,J05AR25,LAMIVUDINE AND DOLUTEGRAVIR,8505,,,WHO ATC Classification,,ILS,film coated tablets,"LAMIVUDINE, DOLUTEGRAVIR AS SODIUM",2025-07-31T02:04:11.237007,IL,ג.ס.ק,,2960.391373,2508.80636,2280.733055,,7290014547612,DOVATO 50 MG/ 300 MG 30 TAB,4723,,60960,BOTTLE HDPE,units,30.0,165 26 36147 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Dovato is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine and viral load ≤500,000 c/mL.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee1ad3d1-2051-454f-b049-8bbc873d0544.json
ee1adc42-6495-49ad-a612-40b8a866774e,SOLU MEDROL 1000 MG,prescription,H02AB04,METHYLPREDNISOLONE,8221,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,METHYLPREDNISOLONE AS SODIUM SUCCINATE 62.5  MG/ML,2025-07-31T08:28:55.691932,IL,פיזר,,117.3291441,99.43147808,73.9267495,,7298074000658,SOLU MEDROL 500 MG/8ML 1 VIAL,10378,,75594,VIAL GLASS TYPE I,units,1.0,114 10 22489 00,valid,34.5,"i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,"Solu Medrol is indicated to treat any condition in which IM or IV corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee1adc42-6495-49ad-a612-40b8a866774e.json
ee31e6a0-8a00-475c-8266-e1c345301158,ERGAMISOL 50MG 36TAB,29C,,,20075,,,,,,tablet,ERGAMISOL 50MG,2025-07-31T20:23:14.999937,IL,nan,,,,,,,ERGAMISOL 50MG 36TAB,,,,,units,36.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee31e6a0-8a00-475c-8266-e1c345301158.json
ee37a493-c5e8-4677-8d4c-315a706946da,TRAJENTA-DUO 2.5MG/1000MG 60 F.C.TAB,prescription,,,7289,,,,,ILS,tablet,TRAJENTA-DUO 2.5MG/1000MG 60 F.C.TAB,2025-07-31T19:35:20.899121,IL,בורינגר אינגלהיים,,212.6566494,180.2175075,144.174006,,,TRAJENTA-DUO 2.5MG/1000MG 60 F.C.TAB,20776,,50204,,units,60.0,,not-registered,25.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee37a493-c5e8-4677-8d4c-315a706946da.json
ee516194-93aa-4f84-87dd-94cb1a55df31,URSOFALK 500,prescription,A05AA02,URSODEOXYCHOLIC ACID,4884,,,WHO ATC Classification,,ILS,film coated tablets,URSODEOXYCHOLIC ACID,2025-07-31T09:54:56.650580,IL,רפא,,135.4749584,114.8092919,85.36006833,,729000812294,URSOFALK 250MG 100CAPS,21092,,65322,BLISTER PVC/PVDC/ALUMINIUM,units,100.0,150 68 33832 01,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"For the symptomatic treatment of primary biliary cholangitis (PBC), in patients without decompensated hepatic cirrhosis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee516194-93aa-4f84-87dd-94cb1a55df31.json
ee5e0b57-665b-4621-958a-64265577d4a0,VERQUVO 10 MG,prescription,C01DX22,VERICIGUAT,9089,,,WHO ATC Classification,,ILS,film coated tablets,VERICIGUAT,2025-07-31T10:07:56.868130,IL,באייר,,236.0680162,200.0576498,160.0461198,,,VERQUVO 5 MG 14 TAB,,,14335,BLISTER PP/ALUMINIUM,units,14.0,169 18 36994 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Verquvo is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee5e0b57-665b-4621-958a-64265577d4a0.json
ee6cdcb7-9e1b-4932-9b1e-8faa3cbbb018,EUCARB0N 100TAB,prescription,,,1315,,,,,,tablet,EUCARB0N,2025-07-31T19:10:10.916387,IL,תרופארם,,,,,,,EUCARB0N 100TAB,5382,,8108,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee6cdcb7-9e1b-4932-9b1e-8faa3cbbb018.json
ee7a4d40-3691-42c8-8fae-e683b9c5388d,PROTHIAZINE 25 MG,prescription,R06AD02,PROMETHAZINE,2342,,,WHO ATC Classification,,ILS,tablets,PROMETHAZINE HYDROCHLORIDE,2025-07-31T07:04:38.155925,IL,כ.צ.ט,,44.64493231,37.83469008,27.6165621,,,PROTHIAZINE 25MG 30TAB,16277,,1821,BLISTER PVC/ALUMINIUM,units,30.0,109 46 25265 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Antihistaminic, antiemetic, sedative.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee7a4d40-3691-42c8-8fae-e683b9c5388d.json
ee8debf7-73ac-492c-98b2-04ba7989ca1b,VANCOMYCIN LYOMARK 1000 MG,prescription,A07AA09,VANCOMYCIN,8985,,,WHO ATC Classification,,ILS,powder for concentrate for solution for iv infusion/ oral solution,VANCOMYCIN AS HYDROCHLORIDE,2025-07-31T09:58:36.270900,IL,מרגלית,,290.0558,245.81,209.2,,7290001942413,VANCOMYCIN LYOMARK 500 MG 10 VIAL,,,74585,VIAL GLASS TYPE I,units,10.0,156 97 34033 00,valid,17.5,"i.v, oral",1.4,36,,,,,,,,,,0,Prescription required,Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. It is also indicated for administration to penicillin-allergic patients  as well patients who have failed to respond to  or who cannot receive other drugs  including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected  but when susceptibility data become available  appropriate therapy should be instituted.  Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci  including lower respiratory tract infections  septicemia  skin and skin - structure infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized.  For endocarditis due to Streptococcus viridans or Streptococcus bovis  vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg  Enterococcus fecalis).   Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids  vancomycin hydrochloride has been administered successfully in combination with either rifampin  an aminoglycoside or combined with both drugs.  Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride.  Oral Therapy:Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. Vancomycin hydrochloride is not effective orally when administered for other types of infection.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee8debf7-73ac-492c-98b2-04ba7989ca1b.json
ee8f7796-970c-4304-bcb2-e3e0eb8b28dc,KALURIL,29C,C03EA01,HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS,20033,,,WHO ATC Classification,,ILS,tablets,"AMILORIDE AS HYDROCHLORIDE ANHYDROUS, HYDROCHLOROTHIAZIDE",2025-07-31T13:48:16.847494,IL,nan,,nan,nan,nan,,7-290000-803425,AMILORIDE HCL 5MG 28TAB,,,,BLISTER PVC/ALUMINIUM,units,28.0,117 57 23150 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Hypertension: Kaluril is indicated in the management of hypertension  either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of the disease.   Edema: Edema associated with congestive heart failure and hepatic cirrhosis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee8f7796-970c-4304-bcb2-e3e0eb8b28dc.json
ee9f8f2f-12f4-4692-8067-ccb602682598,FLUVASTATIN 20MG 100 CAPSULES SANDOZ UK,29C,,,20841,,,,,,capsule,FLUVASTATIN 20MG ULES UK,2025-07-31T20:28:55.540081,IL,nan,,,,,,,FLUVASTATIN 20MG 100 CAPSULES SANDOZ UK,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ee9f8f2f-12f4-4692-8067-ccb602682598.json
eea455b1-c632-43b9-9955-07dec03c7d93,MYCOPHENOLIC ACID INOVAMED 180 MG,prescription,L04AA06,MYCOPHENOLIC ACID,9369,,,WHO ATC Classification,,ILS,tablets delayed release,MYCOPHENOLIC ACID,2025-07-31T05:37:32.781361,IL,אינובמד,,861.6881783,730.2442189,621.4844416,,,MYCOPHENOLIC INOVAMED 360 MG 120 TAB,23640,,5105,BOTTLE HDPE,units,120.0,173 70 37504 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Mycophenolic Inovamed is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eea455b1-c632-43b9-9955-07dec03c7d93.json
eeb30d46-e685-47d9-b49c-f6d7a7fea9e8,ATROPINE SULPHATE S.A.L.F. 1 MG/ML,prescription,A03BA01,ATROPINE,8251,,,WHO ATC Classification,,ILS,solution for injection,ATROPINE SULFATE/ML,2025-07-30T23:30:17.823456,IL,רז פרמהצפטי,,30.47291,25.8245,18.85,,7290015863131,ATROPINE SULPHATE S.A.L.F. 1 MG/ML 5 amp,,,52753,AMPOULES GLASS TYPE I,units,5.0,159 21 34594 00,valid,37.0,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. Treatment of sinus bradycardia, particularly if complicated by hypotension.Antidote in poisoning by organophosphorus.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eeb30d46-e685-47d9-b49c-f6d7a7fea9e8.json
eec34ec6-b60e-462c-9ec3-2206af5a7134,TUSSOPHEDRINE,off-the-counter,R05DA20,COMBINATIONS,5187,,,WHO ATC Classification,,ILS,syrup,"EPHEDRINE HYDROCHLORIDE 1.2 MG/ML, DEXTROMETHORPHAN HYDROBROMIDE/ML, GUAIACOLSULFONATE POTASSIUM/ML, BENZOIC ACID SODIUM/ML",2025-07-31T13:32:06.071709,IL,תרימה,,31.7892,26.94,nan,,7290000843629,TUSSOPHEDRINE NEW FORMULA 115ML,20557,,,BOTTLE GLASS TYPE III,units,115.0,131 32 31021 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of cough in adults and adolescents from the age of 12 years and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eec34ec6-b60e-462c-9ec3-2206af5a7134.json
eeca8a2b-41df-4456-9e75-343f58382d94,LENVIMA 10 MG,prescription,L01XE29,LENVATINIB,7824,,,WHO ATC Classification,,ILS,"capsule, hard",LENVATINIB AS MESILATE,2025-07-31T04:39:36.944416,IL,אסיי,,6770.967464,5738.108275,5216.462069,,5036519001691,LENVIMA 4 MG 30CAPS,12518,,32836,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,155 37 34530 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"LENVIMA is indicated for the treatment of adult patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma (DTC), refractory to radioactive iodine (RAI).LENVIMA is indicated in combination with everolimus for the treatment of adult patients with advanced clear cell renal cell carcinoma (RCC) following one prior vascular endothelial growth factor (VEGF)-targeted therapy.LENVIMA is indicated as monotherapy for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have received no prior systemic therapy.Lenvima, in combination with pembrolizumab, is indicated for the treatment of adult patients with advanced or recurrent endometrial carcinoma who have disease progression on or following prior treatment with a platinum containing therapy and who are not candidates for curative surgery or radiation.LENVIMA is indicated in combination with pembrolizumab for the first-line treatment of adult patients with advanced RCC.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eeca8a2b-41df-4456-9e75-343f58382d94.json
eed76858-fa24-42a3-a906-1a6f8847eae0,DOLESTINE 50MG/ML 10 AMP,prescription,,,8583,,,,,ILS,injection,DOLESTINE 50MG/ML,2025-07-31T19:04:42.151845,IL,טבע,,41.98558108,35.58100249,25.97153467,,,DOLESTINE 50MG/ML 10 AMP,,,48732,,units,10.0,,not-registered,37.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eed76858-fa24-42a3-a906-1a6f8847eae0.json
eef48193-ef7f-465e-920e-67e4a3bfbea1,LONSURF 15 MG/6.14 MG,prescription,L01BC59,"TRIFLURIDINE, COMBINATIONS",8803,,,WHO ATC Classification,,ILS,film coated tablets,"TIPIRACIL AS HYDROCHLORIDE 6.14  MG, TRIFLURIDINE",2025-07-31T04:53:49.795839,IL,מדיסון,,3493.824894,2960.868686,2691.698805,,,LONSURF 20 MG/8.19MG 20 TAB,12531,,26562,BLISTER ALUMINIUM /ALUMINIUM,units,20.0,163 89 35314 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Colorectal cancerLonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (CRC) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR agents.LONSURF in combination with bevacizumab, is indicated for the treatment of adult patients with metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapyGastric cancerLonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eef48193-ef7f-465e-920e-67e4a3bfbea1.json
eef88cfa-fb13-4520-a956-1f7a4a9d69e9,NOTENSYL TABLETS,prescription,A03AA07,DICYCLOVERINE,2333,,,WHO ATC Classification,,ILS,tablets,DICYCLOMINE HYDROCHLORIDE,2025-07-31T05:53:18.197628,IL,כ.צ.ט,,nan,nan,nan,,,NOTENSYL SYRUP 110ML,14160,,1514,BLISTER PVC/ALUMINIUM,units,110.0,117 85 23254 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"Adjunctive therapy in irritable bowel syndrome, neurogenic bowel disturbance.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/eef88cfa-fb13-4520-a956-1f7a4a9d69e9.json
ef00e1e9-171f-4268-9156-888efdba11ae,KALBETEN TABLETS,off-the-counter,,,5044,,,,,ILS,tablets,BISMUTH SUBSALICYLATE,2025-07-31T12:14:04.539687,IL,סם און,,37.0284,31.38,nan,,7290008080903,KALBETEN 20TAB,11037,,,BLISTER PVC/ALUMINIUM,units,20.0,114 90 29652 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Kalbeten Tablets is indicated for relief of diarrhea, nausea, flatulence, convulsive stomach pains, upset stomach, indigestion. Kalbeten Tablets is indicated as a preventative treatment of traveler's diarrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef00e1e9-171f-4268-9156-888efdba11ae.json
ef20c71c-4491-4817-8989-3767e93bf9bb,BLASTOVIN TEVA,prescription,L01CA01,VINBLASTINE,1478,,,WHO ATC Classification,,ILS,solution for injection,VINBLASTINE SULFATE/,2025-07-30T23:40:36.892993,IL,טבע,,75.86338,64.291,47.8,,7290102065196,BLASTOVIN 1VIAL 10MG/10ML,2101,,29639,VIAL GLASS TYPE I,units,1.0,146 63 33376 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:Frequently Responsive Malignancies :• Generalized Hodgkin's disease (Stages III and IV, Ann Arbor modification of Rye staging system)• Non-Hodgkin's lymphoma:   - Reticulum-cell sarcoma   - Lymphosarcoma• Mycosis fungoides.• Neuroblastoma.• Histiocytosis X.Less Frequently Responsive Malignancies :• Choriocarcinoma resistant to other chemotherapeutic agents.• Embryonal carcinoma of the testis.• Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef20c71c-4491-4817-8989-3767e93bf9bb.json
ef28eb85-dc20-4f15-8b55-0cb18b7d1298,ZYPREXA VELOTAB 10 MG,prescription,N05AH03,OLANZAPINE,4792,,,WHO ATC Classification,,ILS,tablets orodispersible,OLANZAPINE,2025-07-31T10:57:30.143751,IL,אלי לילי,,133.2598992,112.932118,83.9644,,,ZYPREXA VELOTAB 10MG 28TAB,26132,,12646,BLISTER ALUMINIUM,units,28.0,130 76 30741 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia.   Zyprexa is indicated for the management of the manifestations of psychotic disorders.   Zyprexa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment  Zyprexa is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef28eb85-dc20-4f15-8b55-0cb18b7d1298.json
ef374438-1185-4f68-8783-4c9274e1286d,REAGILA 1.5,prescription,N05AX15,CARIPRAZINE,8588,,,WHO ATC Classification,,ILS,"capsule, hard",CARIPRAZINE AS HYDROCHLORIDE 1.5  MG,2025-07-31T07:17:53.848163,IL,דקסל פארמה,,316.4599619,268.1864204,228.243762,,,REAGILA 1.5 30CAPS,17044,,3609,BLISTER PVC/PE/PVDC/AL,units,30.0,163 54 35920 00,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,-Reagila is indicated for the:•	Treatment of schizophrenia in adult patients.•	Acute treatment of manic or mixed episodes associated with bipolar I disorder in adult.•	Treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults.•	Adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef374438-1185-4f68-8783-4c9274e1286d.json
ef3c426a-00bd-4606-9aff-89a8ef2ebaa4,ABACAVIR LAMIVUDINE TARO,prescription,J05AR02,LAMIVUDINE AND ABACAVIR,8963,,,WHO ATC Classification,,ILS,film coated tablets,"LAMIVUDINE, ABACAVIR",2025-07-30T23:09:32.479752,IL,תרו יבוא,,1509.94467,1279.614128,1089.0333,,7290017164205,ABACAVIR LAMIVUDINE TARO 30 TAB,17331,,70235,BLISTER PVC/PE/PVDC/AL,units,30.0,164 76 35411 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"ABACAVIR LAMIVUDINE TARO is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults, adolescents and children weighing at least 25 kg.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef3c426a-00bd-4606-9aff-89a8ef2ebaa4.json
ef402513-47c1-47df-a0c6-726a40c67a54,PROVIGIL,prescription,N06BA07,MODAFINIL,6836,,,WHO ATC Classification,,ILS,caplets,MODAFINIL,2025-07-31T07:05:53.048235,IL,טבע,,150.471004,127.5178,102.01424,,,PROVIGIL 100MG 30TAB,16423,,29835,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,124 37 30383 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"To improve wakefulness in patients with excessive sleepiness associated with narcolepsy (with or without cataplexy), obstructive sleep apnea/hypopnea syndrome ( OSAHS ) and shift work sleep disorder (SWDS).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef402513-47c1-47df-a0c6-726a40c67a54.json
ef533486-819b-4ec3-830b-6c7088bd36b9,ABILIFY  MAINTENA 300 MG,prescription,N05AX12,ARIPIPRAZOLE,8644,,,WHO ATC Classification,,ILS,powder and solvent for prolonged-release suspension for injection,ARIPIPRAZOLE AS MONOHYDRATE/VIAL,2025-07-30T23:27:12.228249,IL,סנדוז,,263.3328563,223.1634375,178.53075,,,ARIPIPRAZOLE SANDOZ 5 MG 10 TAB,23403,,89167,VIAL GLASS TYPE I,units,30.0,153 68 34089 00,valid,25.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Abilify Maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef533486-819b-4ec3-830b-6c7088bd36b9.json
ef5ca950-2307-4d57-ba42-2cbbe5925183,ALCOHOL 70 % VITAMED,off-the-counter,D08AX08,ETHANOL,3749,,,WHO ATC Classification,,ILS,solution - external,ALCOHOL,2025-07-31T11:09:45.627669,IL,פלוריש,,183.5136,155.52,nan,,,ALCOHOL 70% 5L,1021,,,BOTTLE HDPE,units,5000.0,128 31 30731 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Skin disinfection.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef5ca950-2307-4d57-ba42-2cbbe5925183.json
ef6411c2-57a7-4bf8-bbed-9d6d1d119ed3,DEPO MEDROL 40 MG/ML,prescription,H02AB04,METHYLPREDNISOLONE,36,,,WHO ATC Classification,,ILS,suspension for injection,METHYLPREDNISOLONE ACETATE/ML,2025-07-31T01:47:29.501124,IL,פיזר,,44.73856125,37.91403664,27.6744793,,72982006,DEPO MEDROL 40MG/ML 2ML,4052,,621,VIAL GLASS TYPE I,units,1.0,024 49 21841 00,valid,37.0,"periarticular, i.m, intra-articular, intra-lesional, intrabursal, intrarectal instillation, soft tissues",1.4,60,,,,,,,,,,0,Prescription required,For the treatment of conditions responsive to steroid injection therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef6411c2-57a7-4bf8-bbed-9d6d1d119ed3.json
ef721c14-7a96-41a7-93cc-9ef8effd099f,PROCTO-GLYVENOL SUPPOSITORIES,off-the-counter,C05AX05,TRIBENOSIDE,580,,,WHO ATC Classification,,ILS,suppositories,"TRIBENOSIDE, LIDOCAINE",2025-07-31T12:52:26.923689,IL,ג.ס.ק,,52.1914,44.23,nan,,7298087020124,PROCTO-GLYVENOL 10 SUPP,16239,,,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,067 40 23920 00,valid,nan,rectal,1.4,36,,,,,,,,,,0,,Local relief of haemorrhoids.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef721c14-7a96-41a7-93cc-9ef8effd099f.json
ef7415d7-d443-4eb3-8b7b-2eaf114012c7,TOCTINO 10 MG,prescription,D11AX19,ALITRETINOIN,6701,,,WHO ATC Classification,,ILS,"capsule, soft",ALITRETINOIN,2025-07-31T09:24:23.505705,IL,ג.ס.ק,,1475.572159,1250.484936,1064.242499,,,TOCTINO 10MG 30CAPS,20719,,26067,BLISTER PVC/PE/PVDC/AL,units,30.0,145 92 33163 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids .Patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx .,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef7415d7-d443-4eb3-8b7b-2eaf114012c7.json
ef959ace-676f-4e8c-a399-a6cd2b17946a,ONDEXXYA,29C,V03AB38,ANDEXANET ALFA,9279,,,WHO ATC Classification,,ILS,powder for solution for infusion,ANDEXANET ALFA/VIAL,2025-07-31T15:28:44.683913,IL,nan,,nan,nan,nan,,7290111096570,ONDEXXYA 4 VIAL,,,,VIAL GLASS TYPE I,units,4.0,171 23 36933 00,valid,nan,i.v,1.4,48,,,,,,,,,,0,,For adult patients treated with a direct factor Xa (FXa) inhibitor (apixaban or rivaroxaban) when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ef959ace-676f-4e8c-a399-a6cd2b17946a.json
efca9144-0e3c-4022-987f-b8945d239c60,VYVANSE 30 MG,prescription,N06BA12,LISDEXAMFETAMINE,7378,,,WHO ATC Classification,,ILS,capsules,LISDEXAMFETAMINE DIMESYLATE,2025-07-31T10:24:07.357433,IL,מדיסון,,351.5754452,297.9453058,253.570473,,7290008128957,VYVANSE 30MG 30CAPS,22405,,32833,BOTTLE HDPE,units,30.0,153 19 33994 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Vyvanse is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.Vyvanse is indicated for the treatment of  Moderate to Severe Binge Eating Disorder (BED) for patient over 18 years.Limitation of Use:Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/efca9144-0e3c-4022-987f-b8945d239c60.json
efcede36-8233-4114-b49f-2f5384760618,ACTIQ 1200 MCG,prescription,N02AB03,FENTANYL,6125,,,WHO ATC Classification,,ILS,compressed tablet on a handle,FENTANYL AS CITRATE/DOSE,2025-07-31T00:07:59.361719,IL,טבע,,1214.85643,1029.539348,876.2037,,7290106061019,ACTIQ 800MCG 30 COMPRESSED TAB,9272,,86432,BLISTER PVC/ACLAR,units,30.0,138 25 31575 00,valid,17.5,oral transmucosal,1.4,36,,,,,,,,,,0,Prescription required,Actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/efcede36-8233-4114-b49f-2f5384760618.json
efdf6064-4aaf-477c-a30f-566c5fab67d5,TEGRETOL 200 MG,prescription,N03AF01,CARBAMAZEPINE,604,,,WHO ATC Classification,,ILS,tablets,CARBAMAZEPINE,2025-07-31T09:10:03.479667,IL,נוברטיס פארמה,,23.9951938,20.33491,14.843,,7298087000836,TEGRETOL CR 400 30T,20480,,7898,BLISTER PVC/PE/PVDC,units,30.0,015 41 24602 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic depressive illness.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/efdf6064-4aaf-477c-a30f-566c5fab67d5.json
efe8343d-6188-4512-a535-be081943d393,HERITY,prescription,L01FD01,TRASTUZUMAB,8723,,,WHO ATC Classification,,ILS,powder and solvent for concentrate for solution for infusion,TRASTUZUMAB/VIAL,2025-07-31T03:46:08.420699,IL,אוניפארם,,4395.045268,3724.614799,3386.013454,,,HERITY 1 vial,,,58142,VIAL GLASS TYPE I,units,1.0,164 96 35475 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Herity is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress HER2:1. As a single agent for the treatment of those patients who have received one or more chemotherapy regiments for their metastatic disease.2. In combination with Paclitaxel or Docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease.3. Herity in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer.Early breast cancer (EBC) :Herity is indicated to treat patients with HER2-positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding Anthracyclines.Herity should only be used in patients whose tumors have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay.HER2 metastatic gastric cancer (mGC). Herity in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.Herity should only be used in patients with metastatic gastric cancer whose tumours have HER2 overexpression as defined by IHC2+ and a confirmatory FISH+ result, or IHC 3+, as determined by an accurate and validated assay.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/efe8343d-6188-4512-a535-be081943d393.json
efeb160e-5344-45b1-a3cd-475123aa82b2,SINUCLEAR EXTRACT TABLETS,off-the-counter,,,5507,,,,,ILS,coated tablets,"NATIVE DRY EXTRACT (3-6:1) DERIVED FROM GENTIAN ROOT, PRIMULA FLOWERS, SORREL HERB, ELDER FLOWERS, VERBENA HERB (1:3:3:3:3), 1. EXTRACTING AGENT: ETHANOL(M/M)",2025-07-31T13:17:36.006288,IL,דר סמואלוב,,46.5982,39.49,nan,,,SINUCLEAR 20 TAB,,,,BLISTER PVC/PVDC/ALUMINIUM,units,20.0,177 48 36980 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Herbal medicinal product for the symptomatic relief of nasal congestion and headaches in those suffering from acute uncomplicated inflammations of the paranasal sinuses (acute uncomplicated rhinosinusitis) in adults and children from the age of 12 years.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/efeb160e-5344-45b1-a3cd-475123aa82b2.json
f00ef5c3-3276-4b5d-86b4-d839036172d7,HEPARIN SODIUM B.BRAUN 5000 IU/ML,prescription,B01AB01,HEPARIN,8217,,,WHO ATC Classification,,ILS,solution for injection / infusion,HEPARIN SODIUM,2025-07-31T03:45:04.300397,IL,פארמלוג'יק,,693.9495121,588.092833,500.5045388,,,HEPARIN INJECTION BP 5000 UNITS/ML	   5ML  25VIAL,,,54678,VIAL GLASS TYPE II,units,25.0,172 47 36469 00,valid,17.5,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"-	Prevention of thromboembolic disorders. -	As part of the treatment of venous and arterial thromboembolic disorders (including early treatment of heart attacks as well as unstable angina pectoris). -	For the anticoagulation in case of treatment or operation with extracorporeal circulation (e.g. heart-lung machine, hemodialysis).",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f00ef5c3-3276-4b5d-86b4-d839036172d7.json
f02b47c6-9bad-453e-a302-f966eb62145f,RENVELA 800 MG TABLETS,prescription,V03AE02,SEVELAMER,6690,,,WHO ATC Classification,,ILS,film coated tablets,SEVELAMER CARBONATE ANHYDROUS,2025-07-31T07:25:26.931416,IL,סאנופי אוונטיס,,727.4207085,616.4582275,524.6453,,,RENVELA 800MG 180TAB,18458,,27620,BOTTLE HDPE,units,180.0,145 74 33197 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"For the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.Also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus &#8805; 1.78 mmol/l.Should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f02b47c6-9bad-453e-a302-f966eb62145f.json
f0448147-cc92-4f77-afe7-797b637d657f,FORADIL CAPSULES FOR INHALATION,prescription,R03AC13,FORMOTEROL,3216,,,WHO ATC Classification,,ILS,powder for inhalation,FORMOTEROL FUMARATE DIHYDRATE,2025-07-31T03:16:39.792911,IL,סנדוז,,70.04469532,59.35991393,44.133765,,7298120003664,FORADIL 12MCG 60CAPS,6112,,47600,BLISTER ALUMINIUM /ALUMINIUM,units,60.0,101 97 28552 00,valid,34.5,inhalation,1.4,24,,,,,,,,,,0,Prescription required,Foradil is indicated in asthma ( including nocturnal asthma and exercise-induced symptoms) in those treated with inhaled corticosteroids who also require a long-acting beta agonist in accordance with current treatment guidelines.Prophylaxis and treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0448147-cc92-4f77-afe7-797b637d657f.json
f0723338-01bc-4a1e-a15a-42caf6c46dd5,TISSEEL FROZEN,prescription,B02BC30,COMBINATIONS,8965,,,WHO ATC Classification,,ILS,solutions for sealant,"CALCIUM CHLORIDE DIHYDRATE 40 MCMOL/ML, HUMAN THROMBIN/, APROTININ ACETATE 3000 KIU /, HUMAN FIBRINOGEN/",2025-07-31T09:22:07.520555,IL,בקסטר,,758.5619153,642.8491094,547.105625,,,TISSEEL FROZEN PREF SYR 2ML,,,,SYRINGE POLYPROPYLENE,units,1.0,162 87 35322 00,valid,17.5,epilesional,1.4,24,,,,,,,,,,0,Prescription required,"Supportive treatment in adults and children from 1 month of age where standard surgical techniques appear insufficient: * For improvement of Hemostasis.* As a tissue glue to improve wound healing or to support sutures in vascular surgery and in gastrointestinal anastomoses.* For tissue sealing, to improve adhesion of the separated tissue (e.g. tissue flaps, grafts, split skin grafts [mesh grafts]).Efficacy in fully heparinized patients has been proven.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0723338-01bc-4a1e-a15a-42caf6c46dd5.json
f079b0da-0c21-4a1c-9a80-0d362a0cb55b,IRON CARE,off-the-counter,B03AB04,FERRIC HYDROXIDE,5572,,,WHO ATC Classification,,ILS,syrup,IRON AS IRON III HYDROXIDE POLYMALTOSE COMPL./,2025-07-31T12:13:38.671671,IL,סם און,,48.4508,41.06,nan,,7290013834256,IRON CARE 50 MG/5 ML,,,,BOTTLE GLASS TYPE III,units,110.0,162 45 34473 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,Prevention and treatment of iron deficiency anemia., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f079b0da-0c21-4a1c-9a80-0d362a0cb55b.json
f084cb76-d1e5-4db9-afd1-0245c0dae5a1,XYNTHA 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,8131,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,MOROCTOCOG ALFA/VIAL,2025-07-31T10:38:07.633603,IL,פיזר,,5803.33784,4918.083134,4470.984667,,35894014012,XYNTHA 2000 IU LYOPHILIZED POWDER FOR INJECTION,24094,,65445,VIAL 10 ML GLASS TYPE I,units,1.0,137 80 31593 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f084cb76-d1e5-4db9-afd1-0245c0dae5a1.json
f0a7cf4b-d4c5-4256-a884-4c3b1d7e7c11,RIBONE 150,prescription,M05BA07,RISEDRONIC ACID,7011,,,WHO ATC Classification,,ILS,tablets,RISEDRONIC ACID AS SODIUM,2025-07-31T07:34:50.398689,IL,אוניפארם,,nan,nan,nan,,7290008546591,RIBONE 150MG 1 TAB,18481,,26032,BLISTER PVC/ALUMINIUM,units,1.0,147 68 33575 01,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of postmenopausal osteoporosis.Prevention of postmenopausal osteoporosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0a7cf4b-d4c5-4256-a884-4c3b1d7e7c11.json
f0a84a30-a47f-4c6d-9b40-9f6058c5e86c,MELIANE ®,prescription,G03AA10,GESTODENE AND ESTROGEN,4108,,,WHO ATC Classification,,ILS,coated tablets,"GESTODENE 0.075   MG, ETHINYLESTRADIOL 0.020   MG",2025-07-31T05:09:19.808393,IL,באייר,,23.02636542,19.513869,14.2437,,7298074040029,MELIANE 21TAB,13249,,85170,BLISTER PVC/ALUMINIUM,units,21.0,109 12 29094 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Oral contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0a84a30-a47f-4c6d-9b40-9f6058c5e86c.json
f0b06ff2-d056-43f9-b304-fd3f74a975cd,CHLORAMPHENICOL VUAB 1 G.,prescription,S01AA01,CHLORAMPHENICOL,8994,,,WHO ATC Classification,,ILS,powder for concentrate for solution for injection,CHLORAMPHENICOL AS SODIUM SUCCINATE,2025-07-31T01:09:23.069329,IL,מרגלית,,591.3002112,501.1018739,426.4696799,,8594159933460,CHLORAMPHENICOL VUAB 1 G 1 VIAL,,,87370,VIAL 20 ML GLASS TYPE I,units,1.0,159 56 34926 00,valid,17.5,"i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"Typhus and parathyphus, salmonellosis with septic development, meningitis, epiglottis, pertussis and parapertussis, serious infections with aerobe and anaerobe flora (pulmonary, abdominal, gynecologic) and other infections caused by bacteria susceptible to chloramphenicol.",תרופה אשפוזית לפי החלטת משרד הבריאות ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0b06ff2-d056-43f9-b304-fd3f74a975cd.json
f0b15cf6-a74a-48d4-a6ea-5b2be901cf3f,VERQUVO 2.5 MG,prescription,C01DX22,VERICIGUAT,9088,,,WHO ATC Classification,,ILS,film coated tablets,VERICIGUAT 2.5  MG,2025-07-31T10:07:45.538923,IL,באייר,,236.4179222,200.3541803,160.2833442,,,VERQUVO 2.5 MG 14 TAB,,,14333,BLISTER PP/ALUMINIUM,units,14.0,169 16 36992 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Verquvo is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0b15cf6-a74a-48d4-a6ea-5b2be901cf3f.json
f0bae55d-19ca-469d-99aa-de337cd847a3,STRENSIQ ® 100 MG/ML,prescription,A16AB13,ASFOTASE ALFA,7975,,,WHO ATC Classification,,ILS,solution for injection,ASFOTASE ALFA/,2025-07-31T08:46:15.655123,IL,ניאופרם,,247419.9054,209677.8952,190616.2684,,,STRENSIQ ® 100 MG/ML 12 VIAL  0.8ML,9988,,62121,VIAL GLASS TYPE I,units,12.0,155 44 34545 00,valid,10.0,s.c,1.4,30,,,,,,,,,,0,Prescription required,Strensiq is indicated for long-term enzyme replacement therapy in patients with paediatric-onset hypophosphatasia to treat the bone manifestations of the disease.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0bae55d-19ca-469d-99aa-de337cd847a3.json
f0c276ad-0ace-4515-b903-039c02b94123,FEMOSTON CONTI 0.5 MG/2.5 MG,prescription,G03FB08,DYDROGESTERONE AND ESTROGEN,8660,,,WHO ATC Classification,,ILS,film coated tablets,"DYDROGESTERONE 2.5  MG, ESTRADIOL AS HEMIHYDRATE 0.5  MG",2025-07-31T02:57:12.105016,IL,אבוט,,60.76789881,51.49822162,37.58994279,,8002660034946,FEMOSTON CONTI 1 MG/5 MG 28 TAB,,,69762,BLISTER PVC/ALUMINIUM,units,28.0,164 97 35630 00,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.Femoston is indicated for women with an intact uterus,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0c276ad-0ace-4515-b903-039c02b94123.json
f0d52de7-cf7c-4741-8122-f38cbd06ede3,LETROZOLE DEXCEL,prescription,L02BG04,LETROZOLE,6784,,,WHO ATC Classification,,ILS,film coated tablets,LETROZOLE 2.5  MG,2025-07-31T04:41:09.999158,IL,דקסל פארמה,,229.99616,194.912,155.9296,,,LETROZOLE DEXCEL 2.5MG 30TAB,12449,,32136,BLISTER PVC/ALUMINIUM,units,30.0,145 49 33275 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0d52de7-cf7c-4741-8122-f38cbd06ede3.json
f0da3a5d-9145-4452-9c1b-6bc2b50f6a53,SIRAN 200 MG EFFERVESCENT TABLETS,29C,R05CB01,ACETYLCYSTEINE,20265,,,WHO ATC Classification,,ILS,tablets effervescent,ACETYLCYSTEINE,2025-07-31T13:41:47.632713,IL,nan,,nan,nan,nan,,7290004448134,ACETYLCYSTEINE 200MG/ML (20%) 10 AMPX10ML,,,,TUBE POLYPROPYLENE,units,10.0,112 05 27057 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Mucolytic in respiratory tract disorders where reduction of sputum viscosity is required.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0da3a5d-9145-4452-9c1b-6bc2b50f6a53.json
f0e7f24d-dec3-4d95-907d-f9c69c617be2,AVCAMOL 250 MG,off-the-counter,N02BE01,PARACETAMOL,5428,,,WHO ATC Classification,,ILS,granules,PARACETAMOL/STICK PACK,2025-07-31T11:14:43.735754,IL,טבע,,28.8392,24.44,nan,,,AVCAMOL 500 MG STRAW/VANILLA 10 SACHETS,,,,STICK PACKS POLYESTER/ALUMINIUM/POLYETHYLENE,units,10.0,148 51 33446 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Analgesic, Antipyretic .",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f0e7f24d-dec3-4d95-907d-f9c69c617be2.json
f10bf1a5-a530-405b-9584-6a0280bbcc1f,PROPECIA,prescription,G04CB01,FINASTERIDE,3726,,,WHO ATC Classification,,ILS,film coated tablets,FINASTERIDE,2025-07-31T07:02:05.280488,IL,אורגנון,,148.55079,125.8905,100.7124,,,PROPECIA 1MG 30TAB,16356,,89878,BLISTER PVC/ALUMINIUM,units,30.0,140 64 29458 11,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Propecia is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f10bf1a5-a530-405b-9584-6a0280bbcc1f.json
f10ca266-193f-4af4-978c-1b6723054b1c,SUNITINIB TARO 12.5 MG,prescription,L01XE04,SUNITINIB,9403,,,WHO ATC Classification,,ILS,"capsule, hard",SUNITINIB 12.5  MG,2025-07-31T08:51:29.041517,IL,תרו יבוא,,4062.601892,3442.88296,3129.8936,,7290017164410,SUNITINIB TARO 25 MG 28 CAPS,,,15972,BLISTER OPA/ALU/PVC/ALU,units,28.0,167 94 36017 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Sunitinib taro is indicated for:• Treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • Treatment of advanced renal cell carcinoma.• Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f10ca266-193f-4af4-978c-1b6723054b1c.json
f12b5439-78ba-42c9-8408-2bcd62bd2aa0,NUROFEN FORTE LIQUID CAPSULES 400 MG,off-the-counter,M02AA13,IBUPROFEN,5391,,,WHO ATC Classification,,ILS,capsules liquid filled,IBUPROFEN,2025-07-31T12:38:27.708031,IL,רקיט בנקיזר,,20.001,16.95,nan,,,NUROFEN LIQUID 200MG 10 CAPS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,10.0,148 44 31886 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Relief of mild to moderate pain such as headache, toothache, menstrual pain, backache, muscular pain, anti-inflammatory for rheumatic disease, reduction of fever.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f12b5439-78ba-42c9-8408-2bcd62bd2aa0.json
f139cdda-8bce-44db-a738-cb69ef96c047,NITISINONE DIPHARMA 10 MG,prescription,A16AX04,NITISINONE,9126,,,WHO ATC Classification,,ILS,"capsule, hard",NITISINONE,2025-07-31T05:47:45.739201,IL,אמ.בי.איי פארמה,,5322.304478,4510.427524,4100.388658,,,NITISINONE DIPHARMA 5 MG 60 caps,,,84875,BOTTLE HDPE,units,60.0,167 25 35824 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f139cdda-8bce-44db-a738-cb69ef96c047.json
f150ad2a-dcac-44e8-ba4d-8031927a513e,METFORMIN INOVAMED,prescription,A10BA02,METFORMIN,8631,,,WHO ATC Classification,,ILS,film coated tablets,METFORMIN HYDROCHLORIDE,2025-07-31T05:16:33.495066,IL,אינובמד,,15.03438,12.741,9.3,,7290104530470,METFORMIN INOVAMED 850MG 30 TAB,13986,,15539,BLISTER PVC/ALUMINIUM,units,30.0,162 59 35148 02,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.• In adults, Metformin may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin.• In children from 10 years of age and adolescents, Metformin may be used as monotherapy or in combination with insulin.A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f150ad2a-dcac-44e8-ba4d-8031927a513e.json
f1601753-8ac4-4440-bcc5-3426d13d2b84,VOTUBIA 2 MG 30 TAB DISPERSIBLE,prescription,,,8314,,,,,ILS,tablet,VOTUBIA 2 MG DISPERSIBLE,2025-07-31T19:39:09.440396,IL,נוברטיס פארמה,,3474.354931,2944.368717,2676.698834,,,VOTUBIA 2 MG 30 TAB DISPERSIBLE,22457,,45467,,units,30.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f1601753-8ac4-4440-bcc5-3426d13d2b84.json
f16fa46c-4241-4e2c-bb32-e3737b2e180b,METFORMIN TEVA ®,prescription,A10BA02,METFORMIN,6209,,,WHO ATC Classification,,ILS,tablets,METFORMIN HYDROCHLORIDE,2025-07-31T05:16:44.092675,IL,טבע,,15.03438,12.741,9.3,,7291064976490,METFORMIN TEVA 850MG 30TAB,13536,,12493,BLISTER PVDC/ALUMINIUM,units,30.0,130 25 30822 18,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. •In adults, Metformin Teva  may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin.•In children from 10 years of age and adolescents, Metformin Teva may be used as monotherapy or in combination with insulin.A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f16fa46c-4241-4e2c-bb32-e3737b2e180b.json
f184df21-b689-45a6-a6a1-ff7afe320bbd,ASACOL 1600,prescription,A07EC02,MESALAZINE,1288,,,WHO ATC Classification,,ILS,modified release tablets,MESALAZINE,2025-07-30T23:28:11.432946,IL,טרדיס גת,,153.0000509,129.6610658,103.7288527,,,ASACOL 400MG 100TAB,1816,,7858,BLISTER PVC/ALUMINIUM,units,100.0,174 09 36782 99,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,ASACOL 1600 is indicated for:Ulcerative colitis-For the treatment of mild to moderate acute disease-For the maintenance of remission,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f184df21-b689-45a6-a6a1-ff7afe320bbd.json
f1a158cb-0330-4bae-a913-fc81da90efa1,CLEXANE,prescription,B01AB05,ENOXAPARIN,6481,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/ML  ML,2025-07-31T01:20:09.577217,IL,סאנופי אוונטיס,,38.175199,32.351865,23.6145,,7290012711121,CLEXANE 40MG SAFETY LOCK 2X0.4ML SYR PREFIL,3990,,84287,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,046 77 26037 11,valid,37.0,"i.v, s.c, extracorporeal",1.4,36,,,,,,,,,,0,Prescription required,"Clexane is indicated in adults for: • Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery. • Prevention of thrombus formation in extra corporeal circulation during haemodialysis. • Acute coronary syndrome: - Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid. - Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f1a158cb-0330-4bae-a913-fc81da90efa1.json
f1aaf400-f899-4cb1-b357-af4cd36940e3,ATTENT XR 30 MG,prescription,N06BA01,AMFETAMINE,9190,,,WHO ATC Classification,,ILS,capsules extended release,"DEXTROAMPHETAMINE SULFATE 7.5  MG, DEXTROAMPHETAMINE SACCHARATE 7.5  MG, AMPHETAMINE SULFATE 7.5  MG, AMPHETAMINE ASPARTATE MONOHYDRATE 7.5  MG",2025-07-30T23:30:55.872987,IL,טבע,,nan,nan,nan,,,ATTENT XR 30 MG 30 CAPS,,,16707,BOTTLE HDPE,units,30.0,170 94 35998 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of Attention Deficit Hyperactivity Disorder (ADHD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f1aaf400-f899-4cb1-b357-af4cd36940e3.json
f1b81b2a-ed58-4a73-97e6-c843c992b679,XEPLION 100 MG,prescription,N05AX13,PALIPERIDONE,6715,,,WHO ATC Classification,,ILS,suspension for injection extended release,PALIPERIDONE AS PALMITATE/,2025-07-31T10:34:36.907894,IL,יאנסן סילג,,789.8406898,669.3565466,569.665146,,7290008099844,XEPLION 100MG/1ML 1 SYRINGE 1ML,24061,,1630,SYRINGE PREFILLED  ,units,1.0,169 09 37280 99,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,Xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.Xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f1b81b2a-ed58-4a73-97e6-c843c992b679.json
f20072cf-27c1-4602-b2f9-7bf6ba9b9d4f,BENEFIX 1000 IU/VIAL,prescription,B02BD04,COAGULATION FACTOR IX,6728,,,WHO ATC Classification,,ILS,lyophilized powder for injection,COAGULATION FACTOR IX RECOMBINANT-RFIX/VIAL,2025-07-31T00:30:33.084423,IL,פיזר,,1289.525633,1092.818381,930.058197,,8470006591734,BENEFIX 500 IU/VIAL I.V 1 VIAL,54960,,37886,VIAL GLASS TYPE I,units,1.0,120 57 30123 01,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (PTP) and previously untreated patients (PUP). Benefix  is not indicated for the treatment of other factor deficiencies (e.g. factors II,VII, and X)' nor for the treatment of hemophilia A patients with inhibitors to factor VIII, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f20072cf-27c1-4602-b2f9-7bf6ba9b9d4f.json
f2192227-2349-4b0e-9cab-e38a9f4fca98,AMISULPRIDE MEDO 100 MG,prescription,N05AL05,AMISULPRIDE,7857,,,WHO ATC Classification,,ILS,tablets,AMISULPRIDE,2025-07-31T06:56:26.781037,IL,אוניפארם,,72.05195935,61.0609825,45.3985,,,PRIDE 100 MG 30 F.C.TAB,9905,,42441,BLISTER PVC/ALUMINIUM,units,30.0,178 82 37379 99,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of schizophrenia .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2192227-2349-4b0e-9cab-e38a9f4fca98.json
f21a8c41-f128-4889-9a35-440ef2e779cd,PREGABALIN INOVAMED 150 MG,prescription,N03AX16,PREGABALIN,8324,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:53:33.029613,IL,אינובמד,,75.57087747,64.0431165,47.6157,,7290104530364,PREGABALIN INOVAMED 50 MG 56 CAPS,10301,,4214,BLISTER PVC/ALUMINIUM,units,56.0,156 17 34774 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Pregabalin Inovamed is indicated for the:* treatment of peripheral and central neuropathic pain in adults. * Management of Fibromyalgia.* Treatment of Generalised Anxiety Disorder (GAD) in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f21a8c41-f128-4889-9a35-440ef2e779cd.json
f232a18f-2ed7-4e4a-979a-d04967c5b32c,MAGNESIUM SULFATE KALCEKS 50 %,prescription,A12CC02,MAGNESIUM SULFATE,8909,,,WHO ATC Classification,,ILS,solution for injection / concentrate for solution for inj/inf,MAGNESIUM SULFATE HEPTAHYDRATE/,2025-07-31T05:04:56.119872,IL,מדי מרקט,,119.0207787,100.8650712,74.992618,,,MAGNESIUM SULFATE KALCEKS 50 % 2ML 10 AMP,,,,AMPOULES GLASS TYPE I,units,10.0,165 51 35894 00,valid,34.5,"i.m, i.v",1.4,48,,,,,,,,,,0,Prescription required,Magnesium Sulfate Kalceks 50% solution for injection or infusion is indicated for: the treatment of Magnesium deficiency in hypomagnesaemiathe prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutritionthe control and prevention of seizures in severe pre-eclampsiathe control and prevention of recurrent seizures in eclampsia, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f232a18f-2ed7-4e4a-979a-d04967c5b32c.json
f241323d-d456-466d-baf0-34ddb9e61876,IG VENA,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",8652,,,WHO ATC Classification,,ILS,solution for infusion,HUMAN NORMAL IMMUNOGLOBULIN/ML,2025-07-31T03:58:07.798091,IL,קמהדע,,1689.611134,1431.873906,1218.61609,,,IG VENA 1VIAL 5% 100ML,,,40762,VIAL GLASS TYPE I,units,100.0,164 11 35926 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, and children and adolescents (0-18 years) in:• Primary immunodeficiency syndromes (PID) with impaired antibody production• Secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)* or serum IgG level of <4 g/l*  PSAF  =  failure  to  mount  at  least  a  2-fold  rise  in  IgG  antibody  titre  to  pneumococcal polysaccharide and polypeptide antigen vaccines.Immunomodulation in adults, and children and adolescents (0-18 years) in:• Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count• Guillain Barré syndrome• Kawasaki disease (in conjunction with acetylsalicylic acid)• Chronic inflammatory demyelinating poliradiculoneuropathy (CIDP)• Multifocal motor neuropathy (MMN)",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f241323d-d456-466d-baf0-34ddb9e61876.json
f248851d-85b7-4178-8c5a-849dc531c250,GASTROGRAFIN 76% SOL FOR INJ 100ML,29C,,,20425,,,,,,injection,GASTROGRAFIN 76% SOL FOR INJ,2025-07-31T20:31:15.213464,IL,nan,,,,,,,GASTROGRAFIN 76% SOL FOR INJ 100ML,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f248851d-85b7-4178-8c5a-849dc531c250.json
f249b01a-cd14-428e-aeb0-d4e2f54b6c81,VERZENIO 100 MG,prescription,L01EF03,ABEMACICLIB,8336,,,WHO ATC Classification,,ILS,film coated tablets,ABEMACICLIB,2025-07-31T10:08:47.896625,IL,אלי לילי,,2286.926905,1938.073734,1761.885213,,7290016021103,VERZENIO 50 MG 14 TAB,22443,,26045,BLISTER PVC/ALUMINIUM,units,14.0,161 44 35391 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"VERZENIO™ (abemaciclib) is indicated: • in combination with a non-steroidal aromatase inhibitor as initial endocrine-based therapy for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy. • as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy in the metastatic setting and prior chemotherapy in the metastatic setting including taxane in adjuvant or metastatic setting. Verzenio should not be used in adult patients after prior treatment with cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) inhibitor. • Verzenio in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) negative, node positive early breast cancer at high risk of recurrence. In pre- or perimenopausal women and in men, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f249b01a-cd14-428e-aeb0-d4e2f54b6c81.json
f2515ff0-03cb-453b-97b0-c7257ab62bd1,BIAFINE,off-the-counter,,,3003,,,,,ILS,cream,TROLAMINE 0.67  %W/W,2025-07-31T11:18:28.269904,IL,ג'ונסון אנד ג'ונסון,,44.0612,37.34,nan,,7290008099110,BIAFINE 93GR,2457,,,TUBE ALUMINIUM,units,93.0,067 13 28323 01,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Soothes burns, sunburns, sores and wounds.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2515ff0-03cb-453b-97b0-c7257ab62bd1.json
f2537411-dc12-4e4b-b068-24622be6aaaf,TARIOL,prescription,D07AC01,BETAMETHASONE,9451,,,WHO ATC Classification,,ILS,gel,"CALCIPOTRIOL AS MONOHYDRATE/, BETAMETHASONE AS DIPROPIONATE 0.5  MG /",2025-07-31T09:06:50.162841,IL,תרו יבוא,,138.7536984,117.5878853,87.425937,,7290017164496,TARIOL  GEL 60 GR,,,73685,BOTTLE HDPE,units,60.0,168 51 36732 99,valid,34.5,topical,1.4,24,,,,,,,,,,0,Prescription required,Topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2537411-dc12-4e4b-b068-24622be6aaaf.json
f2562fd9-53a3-4653-9733-06ed38f07ea3,GLIMEPIRIDE TEVA ®  2 MG,prescription,A10BB12,GLIMEPIRIDE,7468,,,WHO ATC Classification,,ILS,tablets,GLIMEPIRIDE,2025-07-31T03:35:36.056902,IL,טבע,,26.0337264,22.06248,16.104,,7290106061255,GLIMEPIRIDE TEVA 3 MG 30 TAB,7914,,53407,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,151 16 33859 00,valid,37.0,per os,1.4,18,,,,,,,,,,0,Prescription required,"Non-insulin-dependent diabetes mellitus (adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2562fd9-53a3-4653-9733-06ed38f07ea3.json
f2570396-c41d-4621-9aa4-1afbb0176ce7,ETOPAN XL 500,prescription,M01AB08,ETODOLAC,4418,,,WHO ATC Classification,,ILS,tablets extended release,ETODOLAC,2025-07-31T02:40:04.310136,IL,תרו,,80.7214931,68.408045,50.861,,,ETOPAN XL 600MG 20  TAB,5183,,4665,BOTTLE HDPE,units,20.0,128 08 30651 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the management of signs and symptoms of osteoarthrities and rheumatoid arthritis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2570396-c41d-4621-9aa4-1afbb0176ce7.json
f26dd8c0-8677-4a33-8277-bfc42c30e73e,ICATIBANT TEVA ®,prescription,B06AC02,ICATIBANT,8377,,,WHO ATC Classification,,ILS,solution for injection,ICATIBANT AS ACETATE/,2025-07-31T03:56:04.925046,IL,טבע,,7496.296871,6352.793959,5775.267235,,7290106065345,ICATIBANT TEVA 30mg/3ml 1 syr,,,30653,SYRINGE GLASS TYPE I,units,1.0,160 88 35235 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Icatibant Teva is indicated for symptomatic treatment of acute attacks of hereditary angioedima (HAE) in adults, adolescents and children aged 2 years and older, with C1-esterase-inhibitor deficiency.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f26dd8c0-8677-4a33-8277-bfc42c30e73e.json
f27ad89c-9230-4fb1-bf16-647aba80bb79,HIPREX 1000MG 60 TAB,29C,,,20770,,,,,,tablet,HIPREX 1000MG,2025-07-31T20:34:20.765406,IL,nan,,,,,,,HIPREX 1000MG 60 TAB,,,,,units,60.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f27ad89c-9230-4fb1-bf16-647aba80bb79.json
f282433b-79e0-4474-94b1-82749229cd5f,DARAPRIM 25MG 30TAB,29C,,,20062,,,,,,tablet,DARAPRIM 25MG,2025-07-31T20:11:12.444588,IL,nan,,,,,,,DARAPRIM 25MG 30TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f282433b-79e0-4474-94b1-82749229cd5f.json
f293a624-c62c-4556-9272-48245298e572,ZYPREXA 10 MG,prescription,N05AH03,OLANZAPINE,4752,,,WHO ATC Classification,,ILS,tablets,OLANZAPINE,2025-07-31T10:57:15.927962,IL,אלי לילי,,108.4711343,91.92469414,68.3454975,,,ZYPREXA INJ 10MG,26176,,22688,BLISTER ALUMINIUM,units,1.0,104 86 28859 21,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia.   Zyprexa is indicated for the management of the manifestations of psychotic disorders.   Zyprexa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment  Zyprexa is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f293a624-c62c-4556-9272-48245298e572.json
f2a0ced6-a5eb-4002-8ac4-fd7ee94a8c4f,RIVAROXABAN TARO 10 MG,prescription,B01AX06,RIVAROXABAN,9298,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:44:24.815747,IL,תרו יבוא,,277.807105,235.42975,188.3438,,,RIVAROXABAN TARO 20 MG 30 TAB,,,24899,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,162 53 35228 00,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"*  Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.*  Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), in adults (following completion of at least 6 months therapy for DVT or PE).", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2a0ced6-a5eb-4002-8ac4-fd7ee94a8c4f.json
f2b5cee1-edb1-4e96-acc3-9f83af7c7b76,VERQUVO 10 MG,prescription,C01DX22,VERICIGUAT,9090,,,WHO ATC Classification,,ILS,film coated tablets,VERICIGUAT,2025-07-31T10:07:34.701491,IL,באייר,,449.1765569,380.658116,323.964354,,,VERQUVO 10 MG 28 TAB,,,14347,BLISTER PP/ALUMINIUM,units,28.0,169 18 36994 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Verquvo is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2b5cee1-edb1-4e96-acc3-9f83af7c7b76.json
f2b61630-1f3b-4d1b-9b16-c7d339f2d943,NUROFEN FOR CHILDREN SUPPOSITORIES 125 MG,off-the-counter,M02AA13,IBUPROFEN,5262,,,WHO ATC Classification,,ILS,suppositories,IBUPROFEN,2025-07-31T12:36:09.678046,IL,רקיט בנקיזר,,20.3432,17.24,nan,,,NUROFEN FOR CHILDREN 60MG 10 SUPP,14501,,,BLISTER PE/ALUMINIUM,units,10.0,142 89 32016 01,valid,nan,rectal,1.4,36,,,,,,,,,,0,,For the symptomatic treatment of muld to moderate pain.   For the symptomatic treatment of fever.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2b61630-1f3b-4d1b-9b16-c7d339f2d943.json
f2faf3f1-8bbc-4191-8e72-d3b9424edde7,RIZALT 10 MG TABLETS,prescription,N02CC04,RIZATRIPTAN,7569,,,WHO ATC Classification,,ILS,tablets,RIZATRIPTAN AS BENZOATE,2025-07-31T07:46:19.649298,IL,אורגנון,,155.34759,131.6505,105.3204,,,RIZALT 10MG 12 TAB,18514,,61224,BLISTER PVC/ALUMINIUM,units,12.0,112 36 29508 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f2faf3f1-8bbc-4191-8e72-d3b9424edde7.json
f31100c9-6161-4200-a1c6-9d17b72a7d3d,HYDREA 500MG 100CAPS,29C,,,20448,,,,,,capsule,HYDREA 500MG,2025-07-31T20:36:15.488111,IL,nan,,,,,,,HYDREA 500MG 100CAPS,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f31100c9-6161-4200-a1c6-9d17b72a7d3d.json
f31956c9-dd7d-4c6f-8380-8ba42f5da2f8,ISONIAZIDE 300MG 100TAB,29C,,,20092,,,,,,tablet,ISONIAZIDE 300MG,2025-07-31T20:40:42.048781,IL,nan,,,,,,,ISONIAZIDE 300MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f31956c9-dd7d-4c6f-8380-8ba42f5da2f8.json
f342f7ac-06a5-4d72-9fbe-e6fe5c347bb9,FLORINEF 0.1MG 100 TAB,29C,,,20414,,,,,,tablet,FLORINEF 0.1MG,2025-07-31T20:27:48.513926,IL,nan,,,,,,,FLORINEF 0.1MG 100 TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f342f7ac-06a5-4d72-9fbe-e6fe5c347bb9.json
f3441ca1-4829-4318-97da-5cf6c0de18a1,SITAR 100,prescription,A10BH01,SITAGLIPTIN,9383,,,WHO ATC Classification,,ILS,film coated tablets,SITAGLIPTIN AS HYDROCHLORIDE,2025-07-31T08:20:20.216300,IL,אוניפארם,,156.077125,132.26875,105.815,,,SITAR 100 MG 28 TAB,,,14549,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,172 98 36638 99,valid,25.0,per os,1.4,24,,,,,,,,,,0,Prescription required,SITAR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: SITAR should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. SITAR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using SITAR.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f3441ca1-4829-4318-97da-5cf6c0de18a1.json
f344de3d-5f35-4dbc-b53d-7560a35ab435,MIRO 30,29C,N06AX11,MIRTAZAPINE,20981,,,WHO ATC Classification,,ILS,tablets,MIRTAZAPINE,2025-07-31T15:15:37.179127,IL,nan,,nan,nan,nan,,,MIRTAZAPINE 7.5MG 100 tab,,,,BLISTER PVC/ALUMINIUM,units,100.0,128 62 30738 02,valid,nan,per os,1.4,36,,,,,,,,,,0,,Episode of major depression,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f344de3d-5f35-4dbc-b53d-7560a35ab435.json
f359c683-58a8-4f36-b952-f7050b2e857e,BYLVAY 1200 MICROGRAMS,prescription,A05AX05,ODEVIXIBAT,9199,,,WHO ATC Classification,,ILS,"capsule, hard",ODEVIXIBAT AS SESQUIHYDRATE,2025-07-31T00:48:18.943581,IL,מדיסון,,50792.94543,43044.87092,39131.70084,,,BYLVAY 600 MCG  30 HARD CAPS,,,25916,BOTTLE HDPE,units,30.0,171 44 37200 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older.Bylvay is indicated for the treatment of cholestatic pruritus in patients 12 months of age and older with Alagille syndrome (ALGS).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f359c683-58a8-4f36-b952-f7050b2e857e.json
f35e92eb-14de-43df-874e-dd7140f1e698,LERCANAPRIL TEVA 10 /10,prescription,C09BB02,ENALAPRIL AND LERCANIDIPINE,8680,,,WHO ATC Classification,,ILS,film coated tablets,"LERCANIDIPINE HYDROCHLORIDE, ENALAPRIL MALEATE",2025-07-31T04:40:20.779622,IL,טבע,,39.33209679,33.33228541,24.33013534,,,LERCANAPRIL TEVA 10 MG /10 MG  30 TAB,,,56612,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,164 44 35533 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under Lercanidipine monotherapy.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f35e92eb-14de-43df-874e-dd7140f1e698.json
f3758ac5-4918-49b6-8ca6-864a9a3259ca,SPIRIT SALICYL 2%,off-the-counter,D01AE12,SALICYLIC ACID,2924,,,WHO ATC Classification,,ILS,spirit,SALICYLIC ACID/,2025-07-31T13:19:56.488691,IL,ויטאמד,,12.2602,10.39,nan,,7290008068840,SPIRIT SALICYL 2% 100ML,19063,,,BOTTLE HDPE,units,100.0,064 30 28131 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,Keratolytic - for the treatment of acne.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f3758ac5-4918-49b6-8ca6-864a9a3259ca.json
f376f1ce-2581-48ba-aaca-70ddfb20ad60,BUSULFAN RAZ 6 MG/ML,prescription,L01AB01,BUSULFAN,9318,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,BUSULFAN/ML,2025-07-30T23:46:08.994965,IL,רז פרמהצפטי,,9991.451002,8467.331734,7697.574304,,,BUSULFAN RAZ 6 MG/ML 8 VIAL,,,50989,VIAL GLASS TYPE I,units,8.0,171 90 36140 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,BUSULFAN RAZ is indicated for use in combination with other chemotherapeutic agents and/or radiotherapy as a conditioning regimen prior to hematopoietic progenitor cell transplantation.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f376f1ce-2581-48ba-aaca-70ddfb20ad60.json
f37be5a0-1983-4263-895e-e3d4bc169e1a,SAVIOR,off-the-counter,D08AC52,"CHLORHEXIDINE, COMBINATIONS",5335,,,WHO ATC Classification,,ILS,cream,"CETRIMIDE 0.5  %W/W, CHLORHEXIDINE HYDROCHLORIDE 0.1  %W/W",2025-07-31T13:15:41.106490,IL,טבע,,16.579,14.05,nan,,7290000802923,SAVIOR 10GR,,,,TUBE ALUMINIUM,units,10.0,126 25 21373 00,valid,nan,topical,1.4,30,,,,,,,,,,0,,"First aid antiseptic for external use in treatment for minor injuries, wounds and burns.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f37be5a0-1983-4263-895e-e3d4bc169e1a.json
f39f828f-f355-4823-a752-b021d3ab5400,HADLIMA 40mg/0.8 ml 2 PFS,prescription,,,8825,,,,,ILS,tablet,HADLIMA 40mg/0. 2 PFS,2025-07-31T19:11:09.732247,IL,אורגנון,,2331.675847,1975.996569,1796.360517,,,HADLIMA 40mg/0.8 ml 2 PFS,,,71429,,units,2.0,,not-registered,10.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f39f828f-f355-4823-a752-b021d3ab5400.json
f3a38c8c-598c-41c0-a5ad-a4f0f018e158,SLEEP AID,off-the-counter,R06AA09,DOXYLAMINE,5106,,,WHO ATC Classification,,ILS,tablets,DOXYLAMINE SUCCINATE,2025-07-31T13:18:49.339581,IL,פאדאגיס,,60.416,51.2,nan,,0370030993734,SLEEP AID 16 CAPLIOTS,19822,,,BLISTER PVC,units,16.0,131 07 30938 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Aid to the relief of temporary sleep disturbance.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f3a38c8c-598c-41c0-a5ad-a4f0f018e158.json
f3b260a9-a85d-4cf5-8291-7a4be2cb855b,"MITOXANTRON ""EBEWE"" 2 MG/ML",prescription,L01DB07,MITOXANTRONE,7963,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,MITOXANTRONE AS HYDROCHLORIDE/ML,2025-07-31T05:28:10.838739,IL,סנדוז,,706.0516932,598.3488925,509.2331,,7290016369755,MITOXANTRON EBEWE 2 MG/ML VIAL 20MG/10ML,13556,,60514,VIAL GLASS TYPE I,units,1.0,129 78 30863 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Treatment of advanced breast cancer, non-Hodgkin's lymphomas, acute non lymphocytic leukemia palliation of non resectable primary hepatocellular carcinoma. Mitoxantrone in combination with corticosterolds is indicated for inital chemotherapy in patients with pain due to advanced hormone-refractory prostate cancer. For reduction of neurologic disability and/or frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remmitting multiple sclerosis (patients whose neurologic status is significantly abnormal between relapses), for patients 18-55 years old.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f3b260a9-a85d-4cf5-8291-7a4be2cb855b.json
f3c25162-cad0-49b9-8818-608b5d57c19c,ACTOS 15 MG,prescription,A10BG03,PIOGLITAZONE,7092,,,WHO ATC Classification,,ILS,tablets,PIOGLITAZONE AS HYDROCHLORIDE,2025-07-30T23:13:39.204107,IL,צמל,,123.804804,104.91933,78.00693684,,,ACTOS 30MG 28TAB,9527,,33610,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,149 69 33828 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f3c25162-cad0-49b9-8818-608b5d57c19c.json
f3e69c26-b579-4ecc-bac2-808c9189fa76,XATRAL XL 10 MG,prescription,G04CA01,ALFUZOSIN,4360,,,WHO ATC Classification,,ILS,tablets prolonged release,ALFUZOSIN HYDROCHLORIDE,2025-07-31T10:31:03.603201,IL,סאנופי אוונטיס,,76.98752293,65.2436635,48.5083,,7290012711367,XATRAL XL 10MG 30TAB,24065,,26593,BLISTER PVC/ALUMINIUM,units,30.0,123 01 30140 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of certain functional symptoms of benign prostatic hypertrophy  particularly if surgery has to be delayed for some reason. Adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f3e69c26-b579-4ecc-bac2-808c9189fa76.json
f3f3d649-1a63-411d-9bc2-292338bf6548,HUMULIN N,prescription,A10AC01,INSULIN (HUMAN),3317,,,WHO ATC Classification,,ILS,suspension for injection,INSULIN (HUMAN)/ML,2025-07-31T03:50:39.537183,IL,אלי לילי,,147.1741976,124.7239018,92.7315255,,7290008139816,HUMULIN 70/30CART 5*3ML,9108,,9476,VIAL GLASS TYPE I,units,15.0,054 12 22715 22,valid,34.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f3f3d649-1a63-411d-9bc2-292338bf6548.json
f3ff5c7c-6d01-45f8-bf76-51a848156136,YAZ,prescription,G03AA12,DROSPIRENONE AND ESTROGEN,6485,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ETHINYLESTRADIOL 0.02   MG",2025-07-31T10:39:50.820357,IL,באייר,,45.99616245,38.97980042,28.45240907,,,YAZ 1X28TABLETS,25012,,2269,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,141 04 32023 01,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,- Oral contraception.   - Treatment of moderate acne vulgaris in women who seek oral contraception.   - Treatment of symptoms of premenstrual dysphoric disorder (PMDD ) in women who have chosen oral contraceptives as their method of birth control. The efficacy of Yaz for PMDD was not assessed beyond 3 cycles. Yaz has not been evaluated for treatment of PMS ( premenstrual syndrome ).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f3ff5c7c-6d01-45f8-bf76-51a848156136.json
f41cba7a-956e-47af-98ee-4e476b2ac627,DOLESTINE 100MG/2ML 10 AMP,prescription,,,8584,,,,,ILS,injection,DOLESTINE 100MG/,2025-07-31T19:04:31.352576,IL,טבע,,47.81923684,40.52477879,29.5801305,,,DOLESTINE 100MG/2ML 10 AMP,,,48729,,units,10.0,,not-registered,37.0,intramuscular,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f41cba7a-956e-47af-98ee-4e476b2ac627.json
f4278a84-5bf9-4608-b207-176b4809d291,SIGNIFOR LAR 10 MG,prescription,H01CB05,PASIREOTIDE,7795,,,WHO ATC Classification,,ILS,powder and solvent for suspension for injection,PASIREOTIDE AS PAMOATE/VIAL,2025-07-31T08:11:51.091160,IL,מדיסון,,13266.56875,11242.85537,10220.77761,,,SIGNIFOR LAR 40 MG 1VIAL,9922,,41060,VIAL GLASS TYPE I,units,1.0,172 50 36981 99,valid,10.0,i.m,1.4,36,,,,,,,,,,0,Prescription required,Treatment of adult patients with Cushing’s disease for whom surgery is not an option or for whom surgery has failed.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f4278a84-5bf9-4608-b207-176b4809d291.json
f4316429-dcaf-4c3c-9cf5-70e1b6418240,HUMALOG,prescription,A10AB04,INSULIN LISPRO,3323,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO 100 U/ML,2025-07-31T03:49:18.712770,IL,אלי לילי,,105.3697902,89.29643636,66.3914025,,7290008067676,HUMALOG VIALS 10ML,9239,,69988,CARTRIDGE GLASS TYPE I,units,10.0,102 83 28580 00,valid,34.5,"s.c, i.v, i.m",1.4,36,,,,,,,,,,0,Prescription required,Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Humalog is also indicated for the initial stabilization of diabetes mellitus.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f4316429-dcaf-4c3c-9cf5-70e1b6418240.json
f43b63e9-4b5e-4ff8-b329-672e8ed68bf1,EFRIN-10 DROPS 5CC,prescription,,,1802,,,,,ILS,drops,EFRIN-10 DROPS 5CC,2025-07-31T19:05:04.327721,IL,פישר,,13.4986094,11.4395,8.35,,,EFRIN-10 DROPS 5CC,5011,,750,,units,5.0,,not-registered,37.0,ophthalmic,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f43b63e9-4b5e-4ff8-b329-672e8ed68bf1.json
f43f04bf-31a9-4f0b-9665-871e3b7fcca9,ISOVENIR 10 MG,prescription,D10BA01,ISOTRETINOIN,9399,,,WHO ATC Classification,,ILS,"capsule, soft",ISOTRETINOIN,2025-07-31T04:13:36.113204,IL,ביואבניר,,202.56588,171.666,137.3328,,,ISOVENIR 40 MG 30 CAPS,,,15538,BLISTER ALU/PVC/TE/PVDC,units,30.0,174 46 36774 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Isovenir is indicated for the treatment of severe cystic acne that does not respond to other treatment,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f43f04bf-31a9-4f0b-9665-871e3b7fcca9.json
f441e560-2fbe-4a61-81ca-7c5e4a34293c,REPHENIDATE 10 MG,prescription,N06BA04,METHYLPHENIDATE,7991,,,WHO ATC Classification,,ILS,tablets,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:25:49.368519,IL,דקסל פארמה,,30.27018836,25.652702,18.7246,,,REPHENIDATE 10 MG 30 TAB,10084,,12920,BLISTER PVC/ALUMINIUM,units,30.0,157 18 34355 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD). Narcolepsy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f441e560-2fbe-4a61-81ca-7c5e4a34293c.json
f449e1d3-02e9-41ca-b045-e092e58c757f,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5091,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:00:50.556579,IL,טבע,,11.6702,9.89,nan,,7290000800028,ACAMOL TSIN.LIQUI.GEL.10NIGHT CAPSULE,1898,,,BLISTER PVC/ALUMINIUM,units,10.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f449e1d3-02e9-41ca-b045-e092e58c757f.json
f4517961-e355-4d53-9393-4fb8a2681c8f,GASTRO 10,prescription,A02BA03,FAMOTIDINE,7519,,,WHO ATC Classification,,ILS,tablets,FAMOTIDINE,2025-07-31T03:27:59.481167,IL,אוניפארם,,49.0096539,41.533605,30.3165,,,GASTRO 40MG 30TAB,,,40128,BLISTER PVC/ALUMINIUM,units,30.0,107 36 28578 01,valid,37.0,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f4517961-e355-4d53-9393-4fb8a2681c8f.json
f45a43fa-562f-4d98-a758-6ec3ed833fec,SMOFKABIVEN,prescription,,,7114,,,,,ILS,emulsion for infusion,"FISH OIL/, OLIVE OIL/, TRIGLYCERIDES, MEDIUM-CHAIN/, SOYBEAN OIL/, ZINC SULFATE HEPTAHYDRATE 0.023 G /, SODIUM ACETATE TRIHYDRATE 5.62 G /, POTASSIUM CHLORIDE 4.48 G /, MAGNESIUM SULFATE HEPTAHYDRATE 2.47 G /, SODIUM GLYCEROPHOSPHATE HYDRATE 4.18 G /, CALCIUM CHLORIDE DIHYDRATE 0.74 G /, L- VALINE 6.2 G /, L- TYROSINE 0.40 G /, L- TRYPTOPHAN 2.0 G /, L- THREONINE 4.4 G /, TAURINE 1.0 G /, L- SERINE 6.5 G /, L- PROLINE 11.2 G /, L- PHENYLALANINE 5.1 G /, L- METHIONINE 4.3 G /, L- LEUCINE 7.4 G /, L- ISOLEUCINE 5.0 G /, L-HISTIDINE 3.0 G /, L-ARGININE 12.0 G /, L- ALANINE 14.0 G /, GLUCOSE MONOHYDRATE/, L- LYSINE ACETATE 9.3 G /, AMINOACETIC ACID 11.0 G /",2025-07-31T08:23:07.432143,IL,ניאופרם,,679.529843,575.8727739,490.1044884,,,SMOFKABIVEN 2463ML/BAG,,,,BAG POLYPROPYLENE,units,2463.0,147 81 33335 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Parenteral nutrition for adults and children aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f45a43fa-562f-4d98-a758-6ec3ed833fec.json
f46ace02-9540-4e7c-b741-7ba8bde0f512,YAZ,prescription,G03AA12,DROSPIRENONE AND ESTROGEN,6486,,,WHO ATC Classification,,ILS,film coated tablets,"DROSPIRENONE, ETHINYLESTRADIOL 0.02   MG",2025-07-31T10:40:08.669089,IL,באייר,,135.4704493,114.8054706,85.3572272,,,YAZ 3X28TABLETS,25013,,2270,BLISTER PVC/PVDC/ALUMINIUM,units,84.0,141 04 32023 01,valid,34.5,per os,1.4,60,,,,,,,,,,0,Prescription required,- Oral contraception.   - Treatment of moderate acne vulgaris in women who seek oral contraception.   - Treatment of symptoms of premenstrual dysphoric disorder (PMDD ) in women who have chosen oral contraceptives as their method of birth control. The efficacy of Yaz for PMDD was not assessed beyond 3 cycles. Yaz has not been evaluated for treatment of PMS ( premenstrual syndrome ).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f46ace02-9540-4e7c-b741-7ba8bde0f512.json
f479ab3d-212c-4a22-a854-44766cd52d18,INFLUVAC,prescription,J07BB02,"INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN ",8414,,,WHO ATC Classification,,ILS,suspension for injection,"B/WASHINGTON/02/2019 (B/VICTORIA LINEAGE)-LIKE VIRUS/DOSE / 0.5  ML, A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN/ 0.5  ML, A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN/ 0.5  ML",2025-07-31T04:05:50.454332,IL,אבוט,,82.50008892,69.9153327,51.98166,,7290014257290,INFLUVAC TETRA 1 syr 0.5ml,,,10267,SYRINGE GLASS TYPE I,units,1.0,033 66 22645 00,valid,34.5,"i.m, deep s.c.",1.4,12,,,,,,,,,,0,Prescription required,Influenza virus vaccine.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f479ab3d-212c-4a22-a854-44766cd52d18.json
f4868433-7c24-447c-b66d-fe2228748c03,CYSTADROPS  3.8 MG/ML,prescription,A16AA04,MERCAPTAMINE,8501,,,WHO ATC Classification,,ILS,"eye drops, solution",MERCAPTAMINE AS HYDROCHLORIDE 3.8  MG,2025-07-31T01:37:55.922548,IL,מדיסון,,nan,nan,nan,,7290015666619,CYSTADROPS 3.8 MG / 1 VIAL 5 ML,10662,,3494,VIAL GLASS TYPE I,units,1.0,164 69 35476 00,valid,nan,ocular,1.4,6,,,,,,,,,,0,Prescription required,Cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f4868433-7c24-447c-b66d-fe2228748c03.json
f4874e57-3fff-48b6-95bd-2500628a25c6,LUXTURNA,prescription,,,8480,,,,,ILS,concentrate and solvent for solution for injection,VORETIGENE NEPARVOVEC 5X10^12 VECTOR GENOMES/ML,2025-07-31T05:00:30.188487,IL,נוברטיס פארמה,,1696041.494,1437323.364,1306657.603,,7290017585789,LUXTURNA 5X10 1 VIAL,12566,,3507,VIAL GLASS TYPE I,units,1.0,162 92 35759 00,valid,10.0,subretinal injection,1.4,36,,,,,,,,,,0,Prescription required,Luxturna is indicated for the treatment of adult and paediatric patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f4874e57-3fff-48b6-95bd-2500628a25c6.json
f48b589e-2fd3-40a5-800a-02ccf2f87211,MAGNESIUM SULFATE 50 % W/V INOVAMED,29C,A12CC02,MAGNESIUM SULFATE,20798,,,WHO ATC Classification,,ILS,solution for injection / concentrate for solution for inj/inf,MAGNESIUM SULFATE AS HEPTAHYDRATE/,2025-07-31T15:05:21.319825,IL,nan,,nan,nan,nan,,7290104530517,MAGNESIUM SULFATE 5G/10ML 50VIAL,,,,AMPOULES POLYPROPYLENE,units,50.0,164 55 35842 00,valid,nan,"i.v, i.m",1.4,36,,,,,,,,,,0,,Magnesium Sulfate 50%w/v Inovamed  is indicated for:1.  the treatment of Magnesium deficiency in hypomagnesaemia. 2. the prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutrition. 3. the control and prevention of seizures in severe pre-eclampsia.  4. the control and prevention of recurrent seizures in eclampsia, ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f48b589e-2fd3-40a5-800a-02ccf2f87211.json
f4ec88d0-536c-4d76-870a-44d02b4d7e08,CUROSURF,prescription,,,8686,,,,,ILS,suspension,PHOSPHOLIPIDS FRACTION FROM PORCINE LUNG/ML,2025-07-31T01:36:32.725674,IL,טבע,,3513.803187,2977.799444,2707.090403,,7290000801940,CUROSURF 240 MG/3 ML 1 VIAL,,,61746,VIAL GLASS TYPE I,units,1.0,068 79 28250 00,valid,10.0,endotracheopulmonary instillation,1.4,18,,,,,,,,,,0,Prescription required,Treatment of preterm babies with respiratory distress syndrome (RDS). Prophylactic use in premature infants at high risk of RDS.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f4ec88d0-536c-4d76-870a-44d02b4d7e08.json
f4f20677-9e59-4e59-8f1d-09ee45288cf5,OLANZAPINE ODT TEVA ® 10 MG,prescription,N05AH03,OLANZAPINE,6815,,,WHO ATC Classification,,ILS,tablets orodispersible,OLANZAPINE,2025-07-31T06:05:49.052207,IL,טבע,,87.88597992,74.479644,55.3752,,7290106063143,OLANZAPINE TEVA 5MG 28 F.C.TAB,15391,,2389,BLISTER ALUMINIUM /ALUMINIUM,units,28.0,157 16 34591 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia. Olanza ODT Teva is indicated for the management  of the manifestations of psychotic disorders.Olanza ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanza ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanza ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f4f20677-9e59-4e59-8f1d-09ee45288cf5.json
f503277a-d469-4249-97f8-535d58409923,GONAL-F,prescription,G03GA05,FOLLITROPIN ALFA,6542,,,WHO ATC Classification,,ILS,solution for injection,FOLLITROPIN ALFA/ML,2025-07-31T03:38:24.284940,IL,מרק סרונו,,445.2916435,377.3658164,321.1623969,,7290000845364,GONAL-F 600IU/ML PREFILLED PEN 0.5ML (300IU),7656,,10864,PRE-FILLED PEN GLASS TYPE I,units,1.0,131 55 31061 00,valid,17.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,"In adult women: • Anovulation (including polycystic ovarian disease, PCOD) in women who have been unresponsive to treatment with clomiphene citrate. • Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). • Follitropin alfa in association with a luteinising hormone (LH) preparation is indicated for the stimulation of follicular development in women with severe LH and FSH deficiency. In adult men: • Follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human Chorionic Gonadotrophin (hCG) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f503277a-d469-4249-97f8-535d58409923.json
f505dd16-d6b0-4f1b-9b3e-611a4fbdf2ae,NICOTINELL LOZENGES 1 MG,off-the-counter,,,2502,,,,,ILS,lozenges,NICOTINE,2025-07-31T12:29:47.552072,IL,ג.ס.ק,,109.7046,92.97,nan,,,NICOTINEL TTS 20 7S,14480,,,BLISTER PVC/PE/PVDC/AL,units,7.0,136 54 31154 01,valid,nan,per os,1.4,24,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f505dd16-d6b0-4f1b-9b3e-611a4fbdf2ae.json
f509b7e5-3485-4760-a7fc-1527b109fab9,ENBREL 25 MG SOLUTION FOR INJECTION,prescription,L04AB01,ETANERCEPT,7550,,,WHO ATC Classification,,ILS,solution for injection,ETANERCEPT/ML,2025-07-31T02:20:20.772344,IL,פיזר,,1395.715685,1182.809955,1006.64677,,,ENBREL 25MG/DOSE 4 PRE-FILLED SYR,5507,,15838,SYRINGE PREFILLED  GLASS TYPE I,units,4.0,142 52 31949 00,valid,17.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"* Rheumatoid arthritis:- Enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (DMARDs)  including methotrexate (unless contraindicated)  has been inadequate..   Enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.  - Reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.Enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function.* Psoriatic arthritisTreatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drug therapy has been inadequate. Enbrel has been shown to improve physical function in patients with psoriatic arthritis, and to reduce the rate of progression of peripheral joint damage as measured by X ray in patients with polyarticular symmetrical subtypes of the disease.   * Plaque psoriasis Treatment of adults patients (18 years or older) with moderate to severe plaque psoriasis  who  are candidates for systemic therapy or phototherapy.* Paediatric plaque psoriasis Treatment of chronic severe plaque psoriasis in children and adolescents from the age of  6 years  who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.* Juvenile idiopathic arthritis- Treatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. - Treatment of psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.Treatment of enthesitis-related arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, conventional therapy. Enbrel has not been studied in children aged less than 2 years.* Axial spondyloarthritis- Ankylosing spondylitis(AS)Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.- Non-radiographic axial spondyloarthritisTreatment of adults with severe non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to nonsteroidal anti-inflammatory drugs (NSAIDs)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f509b7e5-3485-4760-a7fc-1527b109fab9.json
f50dbfa9-615b-4eda-9e56-b562d4753fca,EXFORGE 10 MG/160 MG,prescription,C08CA01,AMLODIPINE,6146,,,WHO ATC Classification,,ILS,film coated tablets,"AMLODIPINE AS BESYLATE, VALSARTAN",2025-07-31T02:49:16.591002,IL,נוברטיס פארמה,,116.5596395,98.7793555,73.4419,,7290006257963,EXFORGE 5MG/160MG 28TAB,5466,,87350,BLISTER PVC/PA/ALUMINIUM,units,28.0,138 42 31568 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of essential hypertension. Exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f50dbfa9-615b-4eda-9e56-b562d4753fca.json
f51eb7e1-2d83-42ae-9e44-5ed6e979b366,VELPHORO,prescription,V03AE05,SUCROFERRIC OXYHYDROXIDE,7843,,,WHO ATC Classification,,ILS,chewable tablets,IRON AS SUCROFERRIC OXYHYDROXIDE,2025-07-31T10:03:05.918023,IL,כ.צ.ט,,774.5300161,656.3813987,558.622467,,,VELPHORO 500MG 90 CHEWTAB,22411,,54625,BOTTLE HDPE,units,90.0,156 48 34557 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Velphoro is indicated for the control of serum phosphorus levels in adult chronic kidney disease (CKD) patients on haemodialysis (HD) or peritoneal dialysis (PD).Velphoro should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin D3 or one of its analogues, or calcimimetics to control the development of renal bone disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f51eb7e1-2d83-42ae-9e44-5ed6e979b366.json
f5337201-8fb1-4604-a1d6-276b3076b491,ATARAX 25MG 25TAB,29C,,,20041,,,,,,tablet,ATARAX 25MG,2025-07-31T19:58:33.111831,IL,nan,,,,,,,ATARAX 25MG 25TAB,,,,,units,25.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5337201-8fb1-4604-a1d6-276b3076b491.json
f5407984-446a-4627-aa13-da9424e7a0ac,EPIPEN,prescription,C01CA24,EPINEPHRINE,7547,,,WHO ATC Classification,,ILS,solution for injection,EPINEPHRINE/ML,2025-07-31T02:27:33.515334,IL,דקסל פארמה,,539.3249055,457.055025,388.983,,7290103846848,EPIPEN 0.3MG/0.3ML AUTO-INJECTOR 2X2ML כולל מזרק תרגול,5577,,53692,AUTO-INJECTOR GLASS,units,2.0,019 37 24854 00,valid,17.5,i.m,1.4,24,,,,,,,,,,0,Prescription required,"EpiPen is indicated in the emergency treatment of severe allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.EpiPen is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. EpiPen is intended for immediate administration as emergency supportive therapy only and  is not a substitute for immediate medical care.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5407984-446a-4627-aa13-da9424e7a0ac.json
f560636e-35c1-442f-89ac-b5c368a5bc8a,ROZLYTREK 100 MG,prescription,L01XE56,ENTRECTINIB,8532,,,WHO ATC Classification,,ILS,"capsule, hard",ENTRECTINIB,2025-07-31T07:52:24.385726,IL,רוש,,4952.001727,4196.61182,3815.101654,,7290014774155,ROZLYTREK 100 MG 30 CAPS,,,,BOTTLE HDPE,units,30.0,164 36 36185 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"NTRK Gene Fusion-Positive Solid TumorsROZLYTREK is indicated for the treatment of adult and pediatric patients older than 1 month of age with solid tumors that:• have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known acquired resistance mutation,• are metastatic or where surgical resection is likely to result in severe morbidity,and• have either progressed following treatment or have no satisfactory alternative therapy.ROS1-Positive Non-Small Cell Lung CancerROZLYTREK is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f560636e-35c1-442f-89ac-b5c368a5bc8a.json
f565feac-9515-4077-94d7-3942edd4610d,INSTILLAGEL,off-the-counter,C01BB01,LIDOCAINE,5450,,,WHO ATC Classification,,ILS,gel,"CHLORHEXIDINE DIGLUCONATE 0.5  MG /, LIDOCAINE HYDROCHLORIDE 20.0  MG /",2025-07-31T13:20:54.913322,IL,טבע,,24.5558,20.81,nan,,,STILLA EYE DROPS 10ml,,,,SYRINGE POLYPROPYLENE,units,10.0,160 11 35080 00,valid,nan,"urethral, vaginal",1.4,36,,,,,,,,,,0,,"Local anesthesia prior exploration in urology (ureteroscopy, cystoscopy, urethral dilation, catheterization). For use during gynaecological investigation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f565feac-9515-4077-94d7-3942edd4610d.json
f57907ea-538c-48b7-ab27-9fc67fbd5356,CERAZETTE,prescription,G03AC09,DESOGESTREL,4759,,,WHO ATC Classification,,ILS,film coated tablets,DESOGESTREL 0.075   MG,2025-07-31T01:06:13.057337,IL,אורגנון,,64.44657615,54.6157425,40.6065,,7290006537133,CERAZETTE 0.075MG 3X28TAB,3767,,61778,BLISTER PVC/ALUMINIUM,units,84.0,131 09 30977 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f57907ea-538c-48b7-ab27-9fc67fbd5356.json
f57b58fb-1000-4bf6-90d4-bb10ed782416,QULIPTA 10 MG,prescription,N02CD07,ATOGEPANT,9282,,,WHO ATC Classification,,ILS,tablets,ATOGEPANT AS MONOHYDRATE,2025-07-31T07:12:53.165108,IL,אב-וי,,2217.307045,1879.073851,1599.211788,,,QULIPTA 10 MG 30 TABS,,,19682,BLISTER PVC/PE/PCTFE/AL,units,30.0,170 61 37169 99,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Qulipta is indicated for the preventive treatment of  migraine in adults,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f57b58fb-1000-4bf6-90d4-bb10ed782416.json
f57f4692-b839-40da-9b2e-075fe569555e,INDOVIS 25MG 30CAP,prescription,,,2321,,,,,ILS,tablet,INDOVIS 25MG 30CAP,2025-07-31T19:12:48.819810,IL,כ.צ.ט,,14.9251814,12.64845938,9.2324521,,,INDOVIS 25MG 30CAP,9172,,8033,,units,30.0,,not-registered,37.0,oral,1.4,,,,,,,,active,,,0,Prescription required. Dispense according to physician instructions.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f57f4692-b839-40da-9b2e-075fe569555e.json
f58a21e7-4573-40a3-b11a-e4b1ed944db7,INTRATECT 100 G/L,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",8882,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN/ML",2025-07-31T04:10:05.628903,IL,קמהדע,,1630.995365,1382.199524,1176.34002,,,INTRATECT 100 G/L 1 VIAL 50ML,,,51381,VIAL GLASS TYPE II,units,50.0,159 72 35202 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Replacement therapy in adults, and children and adolescents (0-18 years) in:     -	Primary immunodeficiency syndromes (PID) with impaired antibody production     -	Secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent      infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)*      or serum IgG level of <4 g/l     * PSAF= failure to mount at least a 2-fold rise in IgG antibody titre to pneumococcal         polysaccharide and polypeptide antigen vaccinesImmunomodulation in adults, and children and adolescents (0-18 years) in:     -	Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery      to correct the platelet count     -	Guillain Barré syndrome     -	Kawasaki disease (in conjunction with acetylsalicylic acid)     -	Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)     -	Multifocal motor neuropathy (MMN)",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f58a21e7-4573-40a3-b11a-e4b1ed944db7.json
f58b9a83-9c1d-46c2-a64c-6fa3d24f3aa3,GAMUNEX ® - C,prescription,J06BA02,"IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.",7052,,,WHO ATC Classification,,ILS,solution for infusion,"IMMUNOGLOBULINS, NORMAL HUMAN 0.1 G/ML",2025-07-31T03:27:12.465760,IL,פאדאגיס,,815.4976827,691.0997618,588.1700101,,7298074020687,GAMUNEX C 0.1G/ML 2.5GR 25ML SOLUTION FOR INJECTION,7925,,35514,VIAL GLASS,units,25.0,132 95 31058 00,valid,17.5,"i.v, s.c",1.4,36,,,,,,,,,,0,Prescription required,"Gamunex is indicated as replacement therapy of primary immunodeficiency (PI) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, X-limked immunodeficiency with hyper IgM, Wiskott- Aldrich syndrom, and severed combined immunodeficiencies. Gamunex is also indicated in Idiopathic Thrombocytopenia Purpura (ITP) to raise platelet counts to prevent bleeding or to allow a patient with ITP to undergo surgery.Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f58b9a83-9c1d-46c2-a64c-6fa3d24f3aa3.json
f58c8117-1d06-48d4-81c3-b8b10a593bd5,FANAPT TABLETS 1 MG,prescription,N05AX14,ILOPERIDONE,7252,,,WHO ATC Classification,,ILS,tablets,ILOPERIDONE,2025-07-31T02:53:56.449998,IL,מגאפארם,,nan,nan,nan,,7290014573062,FANAPT 1MG*2TAB + 2MG*2TAB + 4MG*2TAB + 6MG*2TAB,6536,,53735,BLISTER ALUMINIUM,units,8.0,148 32 33482 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,FANAPT is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f58c8117-1d06-48d4-81c3-b8b10a593bd5.json
f5a4d160-8b34-4d51-bc83-996aae309c75,VITRAKVI  100 MG,prescription,L01XE53,LAROTRECTINIB,8737,,,WHO ATC Classification,,ILS,capsules,LAROTRECTINIB AS SULFATE,2025-07-31T10:18:41.035318,IL,באייר,,10450.66915,8856.499674,8051.36334,,,VITRAKVI  20 MG/ML ORAL SOLUTION 100ML,,,14797,BOTTLE HDPE,units,100.0,164 41 36178 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Vitrakvi as monotherapy is indicated for the treatment of adult and paediatric patients with solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion:• Who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and• Who have no satisfactory treatment options",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5a4d160-8b34-4d51-bc83-996aae309c75.json
f5b6f8a5-2039-4a7a-935b-77d701c51b9e,SUMATRIDEX 100,prescription,N02CC01,SUMATRIPTAN,6182,,,WHO ATC Classification,,ILS,caplets,SUMATRIPTAN AS SUCCINATE,2025-07-31T08:50:34.843015,IL,דקסל פארמה,,75.50294959,63.9855505,47.5729,,7290010577347,SUMATRIDEX 100MG 6CAPLETS,19829,,7830,BLISTER ALUMINIUM /ALUMINIUM,units,6.0,131 31 30967 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Sumatridex caplets are indicated for the acute relief of migraine attacks, with or without aura. Sumatridex should only be used where there is a clear diagnosis of migraine.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5b6f8a5-2039-4a7a-935b-77d701c51b9e.json
f5b9d5f4-897f-4662-bcf6-60d0da7e8bb8,DOCETAXEL VENUS PHARMA 20 MG/ML,prescription,L01CD02,DOCETAXEL,9514,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,DOCETAXEL/ML,2025-07-31T02:01:31.395069,IL,טרוסטפארם,,2349.430351,1991.04267,1694.5044,,,DOCETAXEL VENUS PHARMA 20 MG/ML 1VIAL 8ML,,,37266,VIAL GLASS TYPE I,units,1.0,175 12 37136 99,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Breast cancer: Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. Docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. Docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy.Previous chemotherapy should have included an anthracycline or an alkylating agent. Docetaxel in combination with trastuzumab is indicated for treatment of patients with metastatic breast cancer whose tumors overexpressed HER2 and who previously have not received chemotherapy for metastatic disease.Docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline. Doxorubicin and cyclophosphamide followed by Docetaxel in combination with trastuzumab (AC-TH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node positive or high-risk node-negative, breast cancer. Docetaxel in combination with trastuzumab, and carboplatin (TCH) is indicated for the adjuvant treatment of patients with HER2 over-expressing, node-positive or high-risk node-negative, breast cancer.Non-small cell lung cancer: Docetaxel is indicated for the treatment of patients with advanced non-small cell lung carcinoma.Ovarian cancer: Docetaxel is indicated for the treatment of metastatic carcinoma of the ovary after failure first line or subsequent chemotherapy.Prostate cancer: Docetaxel in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.Esophageal cancer: Docetaxel for the treatment of esophageal cancer.Gastric cancer: Docetaxel for the treatment of advanced gastric cancer.Head and neck (SCCHN): Docetaxel as monotherapy in the treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after failure of a previous chemotherapy regimen.Docetaxel in combination with cisplatin and 5 fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5b9d5f4-897f-4662-bcf6-60d0da7e8bb8.json
f5caed6e-96e6-44fb-8327-66a3bce273d0,MELPHALAN RAZ 50 MG,prescription,L01AA03,MELPHALAN,8870,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection/infusion,MELPHALAN AS HYDROCHLORIDE,2025-07-31T05:10:06.157774,IL,רז פרמהצפטי,,388.3475407,329.1081,280.092,,7290015863469,MELPHALAN RAZ 50 MG 1 VIAL,17350,,70515,VIAL GLASS TYPE I,units,1.0,166 16 35540 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,For the palliative treatment of multiple myeloma and for the palliation of non resectable epithelial cancer of the ovary.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5caed6e-96e6-44fb-8327-66a3bce273d0.json
f5e3cb1b-4c31-4e97-ae95-e37def006c3f,LAMOGINE 100 MG,prescription,N03AX09,LAMOTRIGINE,4422,,,WHO ATC Classification,,ILS,tablets,LAMOTRIGINE,2025-07-31T04:34:49.332434,IL,תרימה,,38.73325102,32.824789,23.9597,,,LAMOGINE 50MG 30TAB,12080,,30856,BLISTER PVC/ALUMINIUM,units,30.0,123 89 30354 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"EpilepsyAdults and adolescents aged 13 years and above- 	Adjunctive or monotherapy treatment of partial seizures and generalised seizures,                including tonic-clonic seizures.- 	Seizures associated with Lennox-Gastaut syndrome. Lamogine is given as adjunctive               therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-              Gastaut syndrome.Children and adolescents aged 2 to 12 years- 	Adjunctive treatment of partial seizures and generalised seizures, including tonic-             clonic seizures and the seizures associated with Lennox-Gastaut syndrome.-	 Monotherapy of typical absence seizures.Bipolar disorderAdults aged 18 years and above-	 Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamogine is not indicated for the acute treatment of manic or depressive episodes.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5e3cb1b-4c31-4e97-ae95-e37def006c3f.json
f5ef7339-a098-4c01-97f5-6ee6191ed894,LYUMJEV 200 UNITS/ML,prescription,A10AB04,INSULIN LISPRO,9162,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO AS ZINC CRYSTALS 200 UNITS/ML,2025-07-31T05:02:30.705977,IL,אלי לילי,,105.3697902,89.29643636,66.3914025,,,LYUMJEV 100 UNITS/ML VIAL 10 ML,12634,,31731,PREFILLED PEN GLASS TYPE I,units,10.0,169 14 36424 00,valid,34.5,s.c,1.4,24,,,,,,,,,,0,Prescription required,Treatment of diabetes mellitus in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5ef7339-a098-4c01-97f5-6ee6191ed894.json
f5f3d378-5fe3-419e-9a64-038fb904d736,PERCOCET 10,prescription,N02BE01,PARACETAMOL,6210,,,WHO ATC Classification,,ILS,tablets,"OXYCODONE HYDROCHLORIDE, PARACETAMOL",2025-07-31T06:36:29.631194,IL,תרו,,nan,nan,nan,,,PERCOCET 10MG/325MG 20TAB,16786,,89257,BLISTER PVC/ALUMINIUM,units,20.0,139 21 31414 00,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,For the relief of moderate to moderately severe pain.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f5f3d378-5fe3-419e-9a64-038fb904d736.json
f612b3f1-bfc7-43f2-af91-502af9442789,YERVOY 5 MG/ML,prescription,L01XC11,IPILIMUMAB,6931,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,IPILIMUMAB/ML,2025-07-31T10:41:15.070104,IL,ב.מ.ס,,17393.91386,14740.60563,13400.55057,,7290014396005,YERVOY 5MG/ML VIAL10ML,25015,,19807,VIAL GLASS TYPE I,units,10.0,147 62 33522 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Unresectable or Metastatic MelanomaYervoy (ipilimumab) is indicated for the treatment of adult patients with advanced (unresectable or metastatic) melanoma. Yervoy in combination with nivolumab is indicated for the treatment of adult and pediatric patients 12 years and older with advanced (unresectable or metastatic) melanoma . Advanced Renal Cell CarcinomaYERVOY, in combination with nivolumab, is indicated for the first-line treatment of adult patients with intermediate or poor risk, advanced renal cell carcinoma (RCC). Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Metastatic Colorectal Cancer•	YERVOY, in combination with nivolumab, is indicated for the first-line treatment of adult and pediatric patients 12 years and older with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer (CRC).•	YERVOY, in combination with nivolumab, is indicated for the treatment of adult and pediatric patients 12 years of age and older with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.Metastatic Non-Small Cell Lung CancerYERVOY, in combination with nivolumab and 2 cycles of platinum-doublet chemotherapy, is indicated for the first-line treatment of adult patients with metastatic or recurrent non-small cell lung cancer (NSCLC) with no EGFR or ALK genomic tumor aberrations.Hepatocellular CarcinomaYervoy, in combination with nivolumab, is indicated for the treatment of adult patients with hepatocellular carcinoma (HCC) Child-Pugh A who have been previously treated with sorafenib.Malignant Pleural MesotheliomaYERVOY, in combination with nivolumab, is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesotheliomaEsophageal cancerYervoy in combination with nivolumab is indicated for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma with tumour cell PD-L1 expression &#8805; 1%.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f612b3f1-bfc7-43f2-af91-502af9442789.json
f628f051-b0eb-4b58-a2a8-39e426f3155a,CIMZIA,prescription,L04AB05,CERTOLIZUMAB PEGOL,7383,,,WHO ATC Classification,,ILS,solution for injection,CERTOLIZUMAB PEGOL/ML,2025-07-31T01:13:28.582419,IL,ניאופרם,,3344.136609,2834.014202,2576.376547,,,CIMZIA 200MG/ML 2 SYRINGE PREFILLED,10085,,13383,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,152 53 33883 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Rheumatoid arthritis:Cimzia, in combination with methotrexate (MTX), is indicated for: the treatment of moderate to severe, active rheumatoid arthritis (RA) in adult patients when the response to disease-modifying antirheumatic drugs (DMARDs) including methotrexate, has been inadequate. Cimzia can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. Cimzia has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with methotrexate.Axial spondyloarthritis:Cimzia is indicated for the treatment of adult patients with severe active axial spondyloarthritis, comprising: Ankylosing spondylitis (AS): Adults with severe active ankylosing spondylitis who have had an inadequate response to, or are intolerant to nonsteroidal anti-inflammatory drugs (NSAIDs). Axial spondyloarthritis without radiographic evidence of AS Adults with severe active axial spondyloarthritis without radiographic evidence of AS but with objective signs of inflammation by elevated C reactive protein (CRP) and /or magnetic resonance imaging (MRI), who have had an inadequate response to, or are intolerant to NSAIDs. Crohn's Disease :CIMZIA is indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.Plaque psoriasis:Cimzia is indicated for the treatment of moderate to severe plaque psoriasis in adults who arecandidates for systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f628f051-b0eb-4b58-a2a8-39e426f3155a.json
f6340e65-f0f7-45cd-ad2d-30ea806beae2,LYRICA 100 MG,prescription,N03AX16,PREGABALIN,4878,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T05:02:04.109908,IL,דקסל פארמה,,123.5665273,104.717396,77.8568,,,LYRICA 75MG 56CAPS,12337,,65301,BLISTER PVC,units,56.0,133 01 31188 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,LLyrica is indicated for the:- Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia.- Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f6340e65-f0f7-45cd-ad2d-30ea806beae2.json
f66663d1-5617-4deb-a0e5-68ec4d6d3c0d,HALDOL 2 MG/ML DROPS,prescription,N05AD01,HALOPERIDOL,2877,,,WHO ATC Classification,,ILS,solution  (oral),HALOPERIDOL/ML,2025-07-31T03:42:05.567857,IL,יאנסן סילג,,294.7793282,249.81299,212.6068,,7290014577305,HALDOL DECANOATE 100MG/ML 5 AMP,8023,,8763,BOTTLE LDPE,units,5.0,029 70 25163 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"HALDOL is indicatedin adult patients aged 18 years and above for:•	Treatment of schizophrenia and schizoaffective disorder.•	Acute treatment of delirium when non-pharmacological treatments have failed.•	Treatment of moderate to severe manic episodes associated with bipolar I disorder when other treatments cannot be used.•	Treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar I disorder.•	Treatment of persistent aggression and psychotic symptoms in patients with moderate to severe Alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.•	Treatment of tic disorders, including Tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.•	Treatment of mild to moderate chorea in Huntington’s disease, when other medicinal products are ineffective or not tolerated.In paediatric patients for:•	Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.•	Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated.  •	Tic disorders, including Tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f66663d1-5617-4deb-a0e5-68ec4d6d3c0d.json
f666d695-b83a-4400-8dbb-625bc024868b,FLAME,prescription,G03CA01,ETHINYLESTRADIOL,6362,,,WHO ATC Classification,,ILS,tablets,"ETHINYLESTRADIOL 0.02   MG, GESTODENE 0.075   MG",2025-07-31T03:06:35.018525,IL,דקסל פארמה,,67.81852881,57.4733295,42.7311,,7290010577606,FLAME 3X21TAB,6432,,82919,BLISTER PVC/PVDC/ALUMINIUM,units,63.0,140 58 31529 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f666d695-b83a-4400-8dbb-625bc024868b.json
f6813676-ae22-4551-bceb-ce810ff1ff0e,EVOREL 50,prescription,G03CA03,ESTRADIOL,3553,,,WHO ATC Classification,,ILS,patches,ESTRADIOL AS HEMIHYDRATE 3.2  MG,2025-07-31T02:46:34.417020,IL,תרומד,,34.11026,28.907,21.1,,7290103848538,EVOREL 50 8PATCH,5085,,52949,POUCH ALUMINIUM,units,8.0,103 09 28671 00,valid,37.0,transdermal,1.4,24,,,,,,,,,,0,Prescription required,"Deficiency symptoms by absence of Estrogen after the menopause or after surgical removal of the ovarians. They comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis. In women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f6813676-ae22-4551-bceb-ce810ff1ff0e.json
f68b5721-a11b-4018-be6a-894d00f0bc42,SOLU MEDROL 1000 MG,prescription,H02AB04,METHYLPREDNISOLONE,139,,,WHO ATC Classification,,ILS,powder for solution for inj/inf,METHYLPREDNISOLONE AS SODIUM SUCCINATE 62.5  MG/ML,2025-07-31T08:28:31.567360,IL,פיזר,,24.27502306,20.57205435,15.01609807,,7298074000658,SOLU MEDROL 125MG VIAL2ML,19109,,2021,VIAL GLASS TYPE I,units,1.0,114 10 22489 00,valid,37.0,"i.m, i.v",1.4,60,,,,,,,,,,0,Prescription required,"Solu Medrol is indicated to treat any condition in which IM or IV corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f68b5721-a11b-4018-be6a-894d00f0bc42.json
f6948b65-a55e-4e8e-89fb-7d1daca9ac77,SUBOXONE FILM 4 MG/1 MG,29C,N02AE01,BUPRENORPHINE,20540,,,WHO ATC Classification,,ILS,sublingual film,"BUPRENORPHINE AS HYDROCHLORIDE, NALOXONE AS HYDROCHLORIDE DIHYDRATE",2025-07-31T15:18:14.410309,IL,nan,,nan,nan,nan,,,NALOXONE HYDROCHLORIDE 0.4MG/ML 10AMP,,,,FOIL ALUMINIUM,units,10.0,164 26 35833 00,valid,nan,"buccal, sublingual",1.4,24,,,,,,,,,,0,,Suboxone sublingual film is indicated for treatment of opioid dependence in adults and adolescents over 15 years of age. Suboxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f6948b65-a55e-4e8e-89fb-7d1daca9ac77.json
f696a7ad-2ecd-4d76-9ff0-4666631942a9,SODIUM CHLORIDE 0.9% IMUNA,prescription,B05CB01,SODIUM CHLORIDE,8889,,,WHO ATC Classification,,ILS,solution for infusion,SODIUM CHLORIDE/ML,2025-07-31T08:25:13.911771,IL,מדי מרקט,,44.84440118,38.0037315,27.73995,,,SODIUM CHLORIDE 0.9% IMUNA 500 ML,,,70779,BAG PLASTIC,units,500.0,167 57 36009 00,valid,37.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,"Short- term intravascular volume substitution. Hypotonic dehydration or isotonic dehydration. Vehicle solution for supplementary medication.Fluid and electrolyte replacement, hypochloremic alkalosis and chloride losses.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f696a7ad-2ecd-4d76-9ff0-4666631942a9.json
f6975b56-f88d-494f-a3ff-10b66e76b098,KANUMA ®,prescription,A16AB14,SEBELIPASE ALFA,8012,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,SEBELIPASE ALFA/,2025-07-31T04:23:16.374435,IL,ניאופרם,,35284.5957,29902.20108,27183.81916,,7290111097362,KANUMA 2MG/ML VIAL,11270,,62010,VIAL 10 ML GLASS TYPE I,units,1.0,157 74 34903 00,valid,10.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,KANUMA is indicated for long-term enzyme replacement therapy (ERT) in patients of all ages with lysosomal acid lipase (LAL) deficiency.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f6975b56-f88d-494f-a3ff-10b66e76b098.json
f6b565f9-5b21-4b8a-9c32-6a38555096b5,BETACALCIP TEVA,prescription,D05AX52,"CALCIPOTRIOL, COMBINATIONS",9606,,,WHO ATC Classification,,ILS,ointment,"CALCIPOTRIOL/, BETAMETHASONE AS DIPROPIONATE 0.5  MG /",2025-07-31T00:32:35.243563,IL,טבע,,129.9051085,110.0890799,81.850617,,,BETACALCIP TEVA OINT TUBE 60GR,,,85011,TUBE ALUMINIUM,units,60.0,168 63 36863 99,valid,34.5,dermal,1.4,36,,,,,,,,,,0,Prescription required,Topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f6b565f9-5b21-4b8a-9c32-6a38555096b5.json
f6b8f597-115c-4cee-b571-e705c8f6bae6,DAYVIGO ® 10 MG,prescription,N05CM21,LEMBOREXANT,9412,,,WHO ATC Classification,,ILS,film coated tablets,LEMBOREXANT,2025-07-31T01:43:42.779504,IL,אסיי,,nan,nan,nan,,5036519004678,DAYVIGO  10 MG 28 TAB,4791,,14311,BLISTER PVC/ALUMINIUM,units,28.0,172 65 37069 99,valid,nan,per os,1.4,36,,,,,,,,,,0,Prescription required,"DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f6b8f597-115c-4cee-b571-e705c8f6bae6.json
f6cc48fb-89a5-47d4-a9c1-13a7adcc78ec,INREBIC,prescription,L01XE57,FEDRATINIB,8773,,,WHO ATC Classification,,ILS,capsules,FEDRATINIB AS DIHYDROCHLORIDE MONOHYDRATE,2025-07-31T04:06:53.399725,IL,ב.מ.ס,,17378.04018,14727.15335,13388.32123,,7290014396173,INREBIC 100 MG 120 CAPS,,,84739,BOTTLE HDPE,units,120.0,168 28 36598 99,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,INREBIC® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f6cc48fb-89a5-47d4-a9c1-13a7adcc78ec.json
f6ef3199-adad-4725-b735-664eaa344c87,DALACIN 2 % VAGINAL CREAM,prescription,G01AA10,CLINDAMYCIN,3511,,,WHO ATC Classification,,ILS,cream,CLINDAMYCIN PHOSPHATEW/W,2025-07-31T01:40:13.382515,IL,פיזר,,24.23898247,20.54151148,14.993804,,7298074000054,DALACIN C 300MG 16CAPS,4177,,75856,TUBE PLASTIC,units,16.0,064 17 27818 00,valid,37.0,vaginal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f6ef3199-adad-4725-b735-664eaa344c87.json
f7058ba1-bde2-48e0-a108-cde3281befc0,PERTUSSOL SYRUP,off-the-counter,,,3982,,,,,ILS,syrup,"GUAIACOLSULFONATE AS POTASSIUM/, EPHEDRINE HYDROCHLORIDE/, BENZOIC ACID AS SODIUM/, CODEINE PHOSPHATE/",2025-07-31T12:47:30.375535,IL,רקח,,25.1222,21.29,nan,,7290008090971,PERTUSSOL SYRUP 115ML,16654,,,BOTTLE HDPE,units,115.0,141 79 30275 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,For relief of cough.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f7058ba1-bde2-48e0-a108-cde3281befc0.json
f70b4dc7-e44c-4243-a575-130e8f289d8e,LABETALOL S.A.L.F. 5 MG/ML,prescription,C07AG01,LABETALOL,9424,,,WHO ATC Classification,,ILS,solution for injection,LABETALOL HYDROCHLORIDE/,2025-07-31T04:31:27.229523,IL,רז פרמהצפטי,,182.8748465,154.9786835,123.9829468,,7290015863476,LABETALOL S.A.L.F. 5 MG/ML 5 AMP 20 ML,12556,,38274,AMPOULES GLASS TYPE I,units,5.0,165 81 35551 00,valid,25.0,i.v,1.4,24,,,,,,,,,,0,Prescription required,Treatment of hypertension when rapid control of blood pressure is essential.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f70b4dc7-e44c-4243-a575-130e8f289d8e.json
f716fb8d-32fc-447c-9c61-bf5bfd3cf531,VIAGRA 100 MG,prescription,G04BE03,SILDENAFIL,3675,,,WHO ATC Classification,,ILS,film coated tablets,SILDENAFIL AS CITRATE,2025-07-31T10:13:09.474335,IL,דקסל פארמה,,149.907495,127.04025,101.6322,,7290008108812,VIAGRA 50MG 8TAB,22118,,33852,BLISTER PVC/ALUMINIUM,units,8.0,111 38 29461 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Treatment of erectile dysfunction.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f716fb8d-32fc-447c-9c61-bf5bfd3cf531.json
f71e86ab-a243-47e7-be13-2b4b825d80de,FLUDECATE,prescription,N05AB02,FLUPHENAZINE,2239,,,WHO ATC Classification,,ILS,solution for injection,FLUPHENAZINE DECANOATE/ML,2025-07-31T03:12:28.278105,IL,אוניפארם,,89.02012158,75.440781,56.0898,,,FLUDECATE 1ML 5AMP,6052,,893,AMPOULES GLASS TYPE I,units,5.0,025 22 21358 00,valid,34.5,i.m,1.4,30,,,,,,,,,,0,Prescription required,Fludecate is a long acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g. chronic schizophrenics).Fluphenazine Decanoate Injection has not been shown effective in the management of behavioral complications in patients with mental retardation.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f71e86ab-a243-47e7-be13-2b4b825d80de.json
f743dd6d-94e0-460d-a3dd-939b19152348,ZYPREXA 10 MG,prescription,N05AH03,OLANZAPINE,3357,,,WHO ATC Classification,,ILS,tablets,OLANZAPINE,2025-07-31T10:56:32.312901,IL,אלי לילי,,143.4005325,121.525875,97.2207,,,ZYPREXA 10MG 28TAB,26039,,9516,BLISTER ALUMINIUM,units,28.0,104 86 28859 21,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia.   Zyprexa is indicated for the management of the manifestations of psychotic disorders.   Zyprexa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment  Zyprexa is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f743dd6d-94e0-460d-a3dd-939b19152348.json
f77df083-bea1-449e-be3d-e3a904187395,OCSAAR 50 MG,prescription,C09CA01,LOSARTAN,6640,,,WHO ATC Classification,,ILS,tablets,LOSARTAN POTASSIUM,2025-07-31T04:55:51.580676,IL,כ.צ.ט,,24.79444084,21.012238,15.3374,,,LOSARTAN PLUS 30TAB,12406,,21067,BLISTER PVC/PE/PVDC,units,30.0,122 79 28344 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hypertension: Ocsaar  50 mg  is indicated for the treatment of hypertensionHeart failure: Ocsaar  50 mg is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ACE inhibitor is not appropriate.Switching patients with heart failure who are stable on an ACE inhibitor to Ocsaar  50 mg is not recommended.Renal protection in Type-2 diabetic patients with proteinuria: Ocsaar 50 mg is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Ocsaar 50 mg is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.The benefit of Ocsaar 50 mg on the primary deposite endpoint was largely driven by reduction in the risk of stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f77df083-bea1-449e-be3d-e3a904187395.json
f782bf74-0ffa-43fb-a014-82652648c676,TREVICTA,prescription,N05AX13,PALIPERIDONE,7923,,,WHO ATC Classification,,ILS,extended release suspension for injection,PALIPERIDONE AS PALMITATE/,2025-07-31T09:40:23.411924,IL,יאנסן סילג,,2399.005347,2033.05547,1848.232245,,,TREVICTA E.R SUSP FOR INJ 350MG/1.750ML,20829,,73580,SYRINGE PREFILLED  CYCLIC OLEFIN COPOLYMER,units,1.0,157 43 34606 00,valid,10.0,i.m,1.4,24,,,,,,,,,,0,Prescription required,"TREVICTA, a 3 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly paliperidone palmitate injectable product",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f782bf74-0ffa-43fb-a014-82652648c676.json
f7843e2c-bd86-43a4-af2f-5a73a1fd9a96,BENLYSTA I.V. 120 MG,prescription,L04AA26,BELIMUMAB,8337,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,BELIMUMAB,2025-07-31T00:31:18.077119,IL,ג.ס.ק,,4324.321854,3664.6797,3331.527,,7290010140893,BENLYSTA 200 MG 4 PREFILLED SYR,2647,,26816,VIAL GLASS TYPE I,units,4.0,147 37 33499 00,valid,10.0,i.v,1.4,60,,,,,,,,,,0,Prescription required,"Benlysta is indicated as add-on therapy in patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) with a high degree of disease activity (e.g., positive anti-dsDNA and low complement) despite standard therapy.Benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f7843e2c-bd86-43a4-af2f-5a73a1fd9a96.json
f7ab258e-ab99-43e5-86c0-603791eff1fd,RISPERIDEX 1 MG,prescription,N05AX08,RISPERIDONE,8048,,,WHO ATC Classification,,ILS,tablets,RISPERIDONE,2025-07-31T07:39:24.983459,IL,דקסל פארמה,,77.58601834,65.750863,48.8854,,7290010577439,RISPERIDEX 3MG 30TAB,10088,,16124,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,134 54 31353 00,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,"Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients.  Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as   elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f7ab258e-ab99-43e5-86c0-603791eff1fd.json
f7d4d87e-acf5-4081-9b2a-553c5e2abdf7,RIAVENIR LA 10 MG MODIFIED RELEASE CAPSULES,prescription,N06BA04,METHYLPHENIDATE,8938,,,WHO ATC Classification,,ILS,modified release capsules,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T07:33:40.021236,IL,ביואבניר,,51.24029545,43.42397919,31.69633518,,,RIAVENIR LA 10 MG 30 CAPSULES,,,76590,BOTTLE HDPE,units,30.0,167 43 36188 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Attention Deficit Hyperactivity Disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f7d4d87e-acf5-4081-9b2a-553c5e2abdf7.json
f7ea02bc-ffdf-4298-8771-eedada1abaec,MAXITROL OPHTHALMIC SUSPENSION,prescription,S01AA18,POLYMYXIN B,742,,,WHO ATC Classification,,ILS,"eye drops, suspension","DEXAMETHASONE 1.0  MG/ML, NEOMYCIN AS SULFATE 3,500  IU/ML, POLYMYXIN B SULFATE/ML",2025-07-31T05:06:58.297574,IL,נוברטיס פארמה,,17.00406287,14.41022341,10.51841125,,7290008067195,MAXITROL OPHT SUSPENSION  5ML,13394,,7438,DROPER BOTTLE POLYETHYLENE,units,5.0,116 23 22787 00,valid,37.0,ocular,1.4,24,,,,,,,,,,0,Prescription required,Maxitrol is indicated in ocular inflammation when concurrent use of antimicrobial in judged necessary.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f7ea02bc-ffdf-4298-8771-eedada1abaec.json
f7f3d29c-d9d1-449c-ab8e-7e4d5f115c58,METOJECT 50 MG/ML S.C,prescription,L01BA01,METHOTREXATE,7453,,,WHO ATC Classification,,ILS,solution for injection,METHOTREXATE/ML,2025-07-31T05:19:17.918824,IL,צמל,,105.5719875,89.467786,66.5188,,,METOJECT 50MG/ML SYRINGE PREFILLED 15MG/0.3ML,,,4024,SYRINGE PREFILLED  GLASS TYPE I,units,1.0,145 34 33074 04,valid,34.5,s.c,1.4,30,,,,,,,,,,0,Prescription required,"Psoriasis in adult patients :because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis  which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis in patients 3 years of age and above when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequateCrohn’s Disease: Mild to moderate Crohn's disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f7f3d29c-d9d1-449c-ab8e-7e4d5f115c58.json
f7f6bf92-7ace-4383-92ef-47adc29a7417,CINACALCET TARO 30 MG,prescription,H05BX01,CINACALCET,8475,,,WHO ATC Classification,,ILS,film coated tablets,CINACALCET AS HYDROCHLORIDE,2025-07-31T01:14:00.658730,IL,תרו יבוא,,2490.261675,2110.39125,1918.5375,,,CINACALCET TARO 90 MG 28 TAB,,,45480,BLISTER PVC/PE/PVDC/AL,units,28.0,160 90 35048 00,valid,10.0,per os,1.4,30,,,,,,,,,,0,Prescription required,"Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet Taro may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma. Reduction of hypercalcaemia in patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f7f6bf92-7ace-4383-92ef-47adc29a7417.json
f7faefcd-ef85-4909-8009-6a0c09fc1628,SYLVANT 100 MG,prescription,L04AC11,SILTUXIMAB,7797,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,SILTUXIMAB,2025-07-31T08:53:57.032685,IL,מדיסון,,2752.560341,2332.678359,2120.61669,,7290014577275,SYLVANT 100 MG 1VIAL,,,38794,VIAL GLASS TYPE I,units,1.0,153 85 34217 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Sylvant is indicated for the treatment of adult patients with multicentric Castleman’s disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f7faefcd-ef85-4909-8009-6a0c09fc1628.json
f812e908-3a32-4fcf-acd0-9afdf971840e,CALMANERVIN S ELIXIR,off-the-counter,N05CM09,VALERIAN,2003,,,WHO ATC Classification,,ILS,elixir,"PASSIFLORA LIQ. EXTR./ML, VALERIAN LIQUID EXTRACT/ML",2025-07-31T11:22:47.637296,IL,סם און,,31.683,26.85,nan,,7290008066044,CALMANERVIN ELIXIR 120 ML,3572,,,BOTTLE HDPE,units,120.0,035 48 25445 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,relief of mild symptoms of mental stress and to aid sleep           .,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f812e908-3a32-4fcf-acd0-9afdf971840e.json
f8261154-01d7-407a-ac9b-5dc17e680452,LARIAM 250MG 8TAB,29C,,,2425,,,,,,tablet,LARIAM 250MG,2025-07-31T20:46:01.748966,IL,nan,,,,,,,LARIAM 250MG 8TAB,,,,,units,8.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8261154-01d7-407a-ac9b-5dc17e680452.json
f834fc10-9b63-4cc0-a21c-6cce4a664250,ADVATE 1000 IU,off-the-counter,B02BD02,COAGULATION FACTOR VIII,1945,,,WHO ATC Classification,,ILS,powder for solution for injection,OCTOCOG ALFA (ANTIHEMOPHILIC FACTOR RECOMBINANT)/VIAL,2025-07-31T12:03:18.013850,IL,רקח,,30.149,25.55,nan,,7291064500602,HEMO 20SUPP,8018,,,VIAL GLASS TYPE I,units,20.0,150 79 33664 00,valid,nan,i.v,1.4,24,,,,,,,,,,0,,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f834fc10-9b63-4cc0-a21c-6cce4a664250.json
f83d04ad-c443-4c91-9325-b204ea860cb0,PEPTOLITE CHEWABLE TABLETS 30 TAB,off-the-counter,,,5563,,,,,ILS,tablet,PEPTOLITE CHEWABLE TABLETS,2025-07-31T19:46:18.399603,IL,ליף-פריגו,,34.8926,29.57,,,,PEPTOLITE CHEWABLE TABLETS 30 TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f83d04ad-c443-4c91-9325-b204ea860cb0.json
f8479751-7aea-45bf-9547-83b8a133a1d6,GLUCOSE 20 %,prescription,B05CX01,GLUCOSE,9113,,,WHO ATC Classification,,ILS,solution for infusion,GLUCOSE AS MONOHYDRATE,2025-07-31T03:37:25.565945,IL,לפידות,,135.2396957,114.6099167,85.211834,,,GLUCOSE 20 % 500ML 10 BOTTLES,,,42916,BOTTLE LDPE,units,10.0,137 53 27992 00,valid,34.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,High caloric carbohydrate infusion  hypoglycaemia.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8479751-7aea-45bf-9547-83b8a133a1d6.json
f848fd30-3d5f-475f-a20f-168ddce8dcbd,QUETIAPINE SANDOZ ® 150 MG PRT,prescription,N05AH04,QUETIAPINE,8835,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:11:10.883074,IL,סנדוז,,46.978396,39.8122,29.06,,,QUETIAPINE SANDOZ  50 MG  30 PRT,17354,,70534,BLISTER PVC/PCTFE/AL,units,30.0,166 02 35776 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Sandoz PRT is indicated for the treatment of Schizophrenia. Quetiapine Sandoz PRT is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Sandoz PRT. Quetiapine Sandoz PRT  is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for the treatment of major depressive episodes in bipolar disorder. Quetiapine Sandoz PRT is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. Quetiapine Sandoz PRT is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy . Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Sandoz PRT.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f848fd30-3d5f-475f-a20f-168ddce8dcbd.json
f850d8a2-204b-467b-9571-55b65810f5f4,LYUMJEV 200 UNITS/ML,prescription,A10AB04,INSULIN LISPRO,9163,,,WHO ATC Classification,,ILS,solution for injection,INSULIN LISPRO AS ZINC CRYSTALS 200 UNITS/ML,2025-07-31T05:02:46.735384,IL,אלי לילי,,184.235775,156.1320197,124.9056158,,,LYUMJEV PFS 100 UNITS/ML 5X3ML,12633,,31730,PREFILLED PEN GLASS TYPE I,units,15.0,169 14 36424 00,valid,25.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,Treatment of diabetes mellitus in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f850d8a2-204b-467b-9571-55b65810f5f4.json
f8548223-a64c-433c-ad6a-84e293e46317,TEMODAL 100 MG,prescription,L01AX03,TEMOZOLOMIDE,1870,,,WHO ATC Classification,,ILS,capsules,TEMOZOLOMIDE,2025-07-31T05:28:58.131113,IL,רפא,,21.21787406,17.98125,13.125,,7290008121972,MODAL 50MG 30CAP,13154,,1369,SACHET POLYETHYLENE,units,30.0,120 30 30116 23,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8548223-a64c-433c-ad6a-84e293e46317.json
f86c080c-f3a5-4445-a62e-255557b21f1e,MEKINIST 0.5 MG,prescription,L01EE01,TRAMETINIB,7848,,,WHO ATC Classification,,ILS,film coated tablets,TRAMETINIB AS DIMETHYL SULFOXIDE 0.5  MG,2025-07-31T05:08:48.203239,IL,נוברטיס פארמה,,5165.58642,4377.615805,3979.650732,,7290014257627,MEKINIST 0.5 MG 30 F.C.TAB,13800,,56399,BOTTLE HDPE,units,30.0,154 95 34309 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,"Trametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. Trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior BRAF inhibitor therapy. Non-small cell lung cancer (NSCLC) :Trametinib in combination with dabrafenib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a BRAF V600 mutation.Adjuvant treatment of melanoma :Trametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with Stage III melanoma with a BRAF V600 mutation, following complete resection.BRAF V600E Mutation-Positive Locally Advanced or Metastatic Anaplastic Thyroid CancerTAFINLAR is indicated, in combination with trametinib, for the treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment optionsBRAF V600E Mutation-Positive Unresectable or Metastatic Solid TumorsMekinist is indicated, in combination with dabrafenib, for the treatment of adult and pediatric patients 6 years of age and older with unresectable or metastatic solid tumors with BRAF V600E mutation who have progressed following prior treatment and have no satisfactory alternative treatment options. Limitations of Use: Trametinib is not indicated for treatment of patients with colorectal cancer because of known intrinsic resistance to BRAF inhibitionTrametinib is indicated, in combination with dabrafenib, for the treatment of pediatric patients 6 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f86c080c-f3a5-4445-a62e-255557b21f1e.json
f885d6bd-7480-4fdc-b5b2-03b90a75f60b,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5163,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:00:03.731993,IL,טבע,,42.362,35.9,nan,,7290000800028,ACAMOL FOCUS 30CAPLIOTS,1851,,,BLISTER PVC/ALUMINIUM,units,30.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f885d6bd-7480-4fdc-b5b2-03b90a75f60b.json
f894d7a7-2373-4956-857c-c91f35e0d46e,BRONCHO D,off-the-counter,R06AA52,"DIPHENHYDRAMINE, COMBINATIONS",1995,,,WHO ATC Classification,,ILS,syrup,"DIPHENHYDRAMINE HYDROCHLORIDE/, AMMONIUM CHLORIDE/",2025-07-31T11:20:15.543513,IL,סם און,,32.981,27.95,nan,,7290008066013,BRONCHO D SYROP 120ML,2342,,,BOTTLE HDPE,units,120.0,058 88 27178 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,For the relief of coughs and congestion in the respiratory tract.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f894d7a7-2373-4956-857c-c91f35e0d46e.json
f8b64943-4b7e-4079-9939-0eaccb81e8af,CANESTEN V,off-the-counter,G01AF02,CLOTRIMAZOLE,5486,,,WHO ATC Classification,,ILS,vaginal tablets,CLOTRIMAZOLE,2025-07-31T11:23:24.733513,IL,באייר,,41.7012,35.34,nan,,7290013092489,CANESTEN V 200MG 3 VAG. TAB,,,,BLISTER PE/ALUMINIUM,units,3.0,149 92 33642 02,valid,nan,intravaginal,1.4,48,,,,,,,,,,0,,Infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (e.g. Candida albicans) in adults and children 12 years of age and older.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8b64943-4b7e-4079-9939-0eaccb81e8af.json
f8b7ff08-6f06-42f5-b6fd-c4e682a0011f,DECAPEPTYL 0.1,prescription,L02AE04,TRIPTORELIN,631,,,WHO ATC Classification,,ILS,solution for injection,TRIPTORELIN ACETATE 0.1 MG/ML,2025-07-31T01:44:03.423521,IL,פרינג,,146.7502835,124.3646526,99.49172205,,7640128540304,DECAPEPTYL 0.1MG 7AMP,4513,,13756,SYRINGE PREFILLED  GLASS TYPE I,units,7.0,136 67 24855 00,valid,25.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,IVF,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8b7ff08-6f06-42f5-b6fd-c4e682a0011f.json
f8c4f485-85f1-49ea-9d42-e453f9ece700,TOVIAZ 4 MG,prescription,G04BD11,FESOTERODINE,6262,,,WHO ATC Classification,,ILS,tablets sustained release,FESOTERODINE FUMARATE,2025-07-31T09:28:12.638943,IL,פיזר,,68.27988432,57.86431132,43.0217928,,,TOVIAZ 4MG 28 S.R.TAB,20647,,80261,BLISTER ALU/PVC/PA/ALU,units,28.0,139 55 31658 00,valid,34.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8c4f485-85f1-49ea-9d42-e453f9ece700.json
f8d2789f-25ce-4b3b-8ee6-bd7ef25527e0,SEROQUEL 100 MG,prescription,N05AH04,QUETIAPINE,4130,,,WHO ATC Classification,,ILS,film coated tablets,QUETIAPINE AS FUMARATE,2025-07-31T08:06:32.710208,IL,צמל,,94.47514299,80.0636805,59.5269,,,SEROQUEL 200MG 30TAB,19420,,25352,BLISTER PVC/ALUMINIUM,units,30.0,109 40 29314 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of schizophrenia.   Treatment of manic episodes associated with bipolar disorder. Treatment of major depressive episodes in bipolar disorders.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8d2789f-25ce-4b3b-8ee6-bd7ef25527e0.json
f8e43f76-d969-4b4a-bae3-24d6a7987869,HISTAZINE,off-the-counter,R06AE07,CETIRIZINE,3414,,,WHO ATC Classification,,ILS,syrup,CETIRIZINE DIHYDROCHLORIDE 0.1  %W/V,2025-07-31T12:05:21.609307,IL,תרימה,,44.2854,37.53,nan,,7290008075459,HISTAZINE 10MG 20TAB,8132,,,BOTTLE GLASS,units,20.0,109 59 29304 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Antihistaminic drug for the treatment of allergies for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic uriticaria in children aged over 2 years and adults., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8e43f76-d969-4b4a-bae3-24d6a7987869.json
f8f22e11-0e77-4607-83d3-a4e038c4b3ca,KETOROLAC TROMETAMOL ROMPHARM 30 MG/ML,29C,M01AB15,KETOROLAC,20481,,,WHO ATC Classification,,ILS,solution for injection,KETOROLAC TROMETAMOL/,2025-07-31T14:57:49.884889,IL,nan,,nan,nan,nan,,,KETOROLAC TROMETHAMINE 30MG/ML 25AMP,,,,AMPOULES GLASS TYPE I,units,25.0,165 53 35519 00,valid,nan,"i.m, i.v",1.4,36,,,,,,,,,,0,,"Ketorolac Trometamol 30 mg/ml, solution for injection is indicated for the short-term management of moderate to severe acute post-operative pain.      The maximum duration of treatment is two days.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f8f22e11-0e77-4607-83d3-a4e038c4b3ca.json
f9135785-ee18-4532-a6d9-990baae1143d,LINEZO - AVENIR,prescription,J01XX08,LINEZOLID,9086,,,WHO ATC Classification,,ILS,film coated tablets,LINEZOLID,2025-07-31T04:47:27.523187,IL,ביואבניר,,936.8429725,793.9347577,675.6891555,,,LINEZO - AVENIR 600 mg 10 tabs,,,81404,BLISTER ALUMINIUM /ALUMINIUM,units,10.0,168 94 35977 00,valid,17.5,per os,1.4,30,,,,,,,,,,0,Prescription required,Therapy is indicated only when an organism resistant to all other antibiotics is suspected.Linezo-Avenir  is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as:1) Pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (MDRSP). 2) Skin and soft tissue infections including diabetic foot infections. 3) Enterococcal infections. Combination therapy may be indicated if a concomitant Gram negative pathogen is documented or suspected.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9135785-ee18-4532-a6d9-990baae1143d.json
f92656b1-7cc1-4820-9c5b-f275453987c0,HYCAMTIN 0.25 MG,prescription,L01XX17,TOPOTECAN,6352,,,WHO ATC Classification,,ILS,hard gelatin capsules,TOPOTECAN AS HYDROCHLORIDE 0.25   MG,2025-07-31T03:52:09.635816,IL,סנדוז,,1992.739868,1688.762675,1437.24483,,,HYCAMTIN 1MG 10 CAPS,8364,,81955,BLISTER PVC/PCTFE,units,10.0,141 37 31862 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Indicated for the treatment of patients with relapsed small cell lung cancer (SCLC) for whom re-treatment with the first-line regimen is not considered appropriate.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f92656b1-7cc1-4820-9c5b-f275453987c0.json
f933970b-3a54-414c-b2ac-52f9aaa888ac,STABILANOL,prescription,J02AC01,FLUCONAZOLE,6070,,,WHO ATC Classification,,ILS,solution for infusion,FLUCONAZOLE/ML,2025-07-31T08:38:12.855896,IL,תרימה,,35.2119729,29.840655,21.7815,,7290000843407,STABILANOL 2 MG/ML IV  SOL. FOR INFUSION 50 ML,19830,,13566,VIAL GLASS TYPE I,units,50.0,134 81 31179 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Stabilanol is indicated in the following fungal infections .Stabilanol is indicated in adults for the treatment of: • Cryptococcal meningitis .• Coccidioidomycosis. Invasive candidiasis.• Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.Stabilanol is indicated in adults for the prophylaxis of: • Relapse of crytopcoccal meningitis in patients with high risk of recurrence.• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse.• Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation ).Stabilanol is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old: Stabilanol is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. stabilanol can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.Consideration should be given to official guidance on the appropriate use of antifungals.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f933970b-3a54-414c-b2ac-52f9aaa888ac.json
f93c9357-f636-4948-ac89-480eedac708b,LOSEC 20 MG,off-the-counter,A02BC01,OMEPRAZOLE,5222,,,WHO ATC Classification,,ILS,capsules,OMEPRAZOLE,2025-07-31T12:23:31.557110,IL,טבע,,50.1146,42.47,nan,,,LOSEC 20 MG 28 CAPS (OTC),12414,,,BOTTLE HDPE,units,28.0,139 78 31879 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f93c9357-f636-4948-ac89-480eedac708b.json
f9459dc2-ea8d-4c0b-89ac-2a4bbbba6650,NICOTINELL GUM 2 MG (MINT),off-the-counter,N07BA01,NICOTINE,5619,,,WHO ATC Classification,,ILS,chewing gum,NICOTINE,2025-07-31T12:31:24.278716,IL,ג.ס.ק,,152.574,129.3,nan,,,NICOTINELL GUM 4 MG (MINT) 96 GUMS,,,,BLISTER PVC/PVDC/ALUMINIUM,units,96.0,115 78 29638 23,valid,nan,per os,1.4,30,,,,,,,,,,0,,As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms.   In smokers currently unable or not ready to stop smoking abruptly  the gum may also be used as part of a program to reduce smoking prior to stopping completely.,תרופה שאושרה לשימוש כללי בקופ'חתרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9459dc2-ea8d-4c0b-89ac-2a4bbbba6650.json
f945d892-79a9-4dd3-97e6-5dea097b318f,RIVAROXABAN DEXCEL 10 MG,prescription,B01AF01,RIVAROXABAN,9395,,,WHO ATC Classification,,ILS,film coated tablets,RIVAROXABAN,2025-07-31T07:43:05.181349,IL,דקסל פארמה,,259.285825,219.73375,175.787,,7290015912952,RIVAROXABAN DEXCEL 20 MG 28 TAB,18710,,16671,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,172 93 36479 99,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.Prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE), adults (following completion of at least 6 months therapy for DVT or PE).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f945d892-79a9-4dd3-97e6-5dea097b318f.json
f94a424b-71d2-4550-a6f6-e26758f332ac,ZAVICEFTA,prescription,,,8185,,,,,ILS,powder for concentrate for solution for infusion,"CEFTAZIDIME AS PENTAHYDRATE/VIAL, AVIBACTAM AS SODIUM 0.5 G/VIAL",2025-07-31T10:44:23.629236,IL,פיזר,,5616.909465,4760.092979,4327.357253,,7290013592514,ZAVICEFTA 2G/0.5G POWDER FOR CONCENTRATION FOR SOLUTION VIAL 20ML,26217,,28700,VIAL GLASS TYPE I,units,10.0,160 61 35394 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Zavicefta® is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:•	Complicated intra-abdominal infection (cIAI), used in combination with Metronidazole•	Complicated urinary tract infection (cUTI), including pyelonephritis •	Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP)Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.Zavicefta® is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f94a424b-71d2-4550-a6f6-e26758f332ac.json
f94aa8d9-c2d6-4ba5-a5f4-03cb6d26ce5c,OPTI GENTA,29C,S01AA11,GENTAMICIN,20428,,,WHO ATC Classification,,ILS,drops,GENTAMICIN AS SULFATE 0.3 %W/V,2025-07-31T14:41:27.096441,IL,nan,,nan,nan,nan,,7-290008-083850,GENTAMICIN 80 MG/2ML 5AMP,,,,DROPER BOTTLE LDPE,units,5.0,069 76 28591 00,valid,nan,ocular,1.4,36,,,,,,,,,,0,,Infection of external eye and its adnexa caused by susceptible bacteria.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f94aa8d9-c2d6-4ba5-a5f4-03cb6d26ce5c.json
f951f47c-0c67-4e71-b826-5b94baa18aaa,GENOTROPIN 12 MG,prescription,H01AC01,SOMATROPIN,4042,,,WHO ATC Classification,,ILS,powder for solution for injection,SOMATROPIN,2025-07-31T03:30:35.909957,IL,פיזר,,1144.463147,969.8840664,825.433248,,7317961351113,GENOTROPIN 36UI CARTRIDGE,7429,,18549,CARTRIDGE GLASS TYPE I,units,1.0,121 35 27540 22,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Children:   Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome. Short stature in children with renal insufficiency.   Growth disturbance (height SDS<2.5 and parenteral adjusted height SDS < -1) in short children born SGA (SGA - small for gestational age  i.e. born small in relation to the length of the fetus development)  with a birth witght and/or length < 2 SD  who failed to show catch up growth (HV SDS < 0 during the last year) by 4 years of age or later.   Prader willi syndrome  for improvement of growth and body composition.  Adults:    For adults who have suffered from growth-hormone deficiency since childhood.   For adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f951f47c-0c67-4e71-b826-5b94baa18aaa.json
f962009a-edd3-4bd5-b43c-c11eba32d290,INSTILLAGEL,prescription,C01BB01,LIDOCAINE,8687,,,WHO ATC Classification,,ILS,gel,"CHLORHEXIDINE DIGLUCONATE 0.5  MG /, LIDOCAINE HYDROCHLORIDE 20.0  MG /",2025-07-31T04:08:56.228792,IL,פרופארם,,134.9035,114.325,85.0,,,INSTILLAGEL 10 SYR *11ML,,,36796,SYRINGE POLYPROPYLENE,units,10.0,160 11 35080 00,valid,34.5,"urethral, vaginal",1.4,36,,,,,,,,,,0,Prescription required,"Local anesthesia prior exploration in urology (ureteroscopy, cystoscopy, urethral dilation, catheterization). For use during gynaecological investigation.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f962009a-edd3-4bd5-b43c-c11eba32d290.json
f96263fa-5b36-43e8-97b2-3d4c54acc374,MIFEGYNE,prescription,G03XB01,MIFEPRISTONE,7310,,,WHO ATC Classification,,ILS,tablets,MIFEPRISTONE,2025-07-31T05:22:44.770670,IL,לפידות,,310.5217435,263.1540316,223.960878,,,MIFEGYNE 200 MG 3TAB,13694,,30969,BLISTER PVC/ALUMINIUM,units,3.0,115 52 29641 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Medical termination of developing intra-uterine pregnancy.- In sequential use with a prostaglandin analogue up to 63 days of amenorrhea.- Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.- Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reasons (beyond the first trimester).- Labour induction in foetal death in utero.In patients where prostaglandin or oxytocin cannot be use.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f96263fa-5b36-43e8-97b2-3d4c54acc374.json
f962e6c0-e20e-4475-a4c9-3f63ae2c39e1,MONTAIR 4 MG,prescription,R03DC03,MONTELUKAST,7864,,,WHO ATC Classification,,ILS,chewable tablets,MONTELUKAST AS SODIUM,2025-07-31T05:30:01.914248,IL,כ.צ.ט,,74.56925866,63.194287,46.9846,,,MONTAIR 4 MG 30 CHEWTAB,13790,,33175,BLISTER PA/ALUMINIUM/PVC,units,30.0,145 58 31866 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Montair is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction.Montair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma.Montair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.Montair is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f962e6c0-e20e-4475-a4c9-3f63ae2c39e1.json
f9715a28-9786-48ba-aa41-112d896fec40,PREGABALIN DEXCEL 100 MG,prescription,N03AX16,PREGABALIN,8079,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T06:52:37.266135,IL,דקסל פארמה,,75.57087747,64.0431165,47.6157,,,PREGABALIN DEXCEL 50 MG 56 CAPSULES,16991,,58329,BLISTER ALUMINIUM /ALUMINIUM,units,56.0,158 75 34730 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of peripheral and central neuropathic pain in adults.Management of FibromyalgiaTreatment of Generalised Anxiety Disorder (GAD) in adults,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9715a28-9786-48ba-aa41-112d896fec40.json
f98752e3-7f2c-4cd1-8f1e-de4ef19f76bd,DANTAMACRIN 50MG 100 HARD CAPS,29C,,,20355,,,,,,capsule,DANTAMACRIN 50MG 100 HARD CAPS,2025-07-31T20:10:08.023331,IL,nan,,,,,,,DANTAMACRIN 50MG 100 HARD CAPS,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f98752e3-7f2c-4cd1-8f1e-de4ef19f76bd.json
f99f8216-202c-48a5-a8bd-f0f2c7f0c075,SYNTHOMYCINE 3 %,prescription,D10AF03,CHLORAMPHENICOL,1422,,,WHO ATC Classification,,ILS,ointment,CHLORAMPHENICOL,2025-07-31T08:56:00.766607,IL,טבע,,nan,nan,nan,,7290008001311,SYNTHOMYCINE 3% OINT 10G,19206,,2090,TUBE ALUMINIUM,units,10.0,025 11 20849 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,Prescription required,Antibiotic.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f99f8216-202c-48a5-a8bd-f0f2c7f0c075.json
f9a46edd-6620-466a-b544-4e20b68620cc,CAPD 2 PERITONEAL DIALYSIS SOLUTION,off-the-counter,B05XA30,COMBINATIONS OF ELECTROLYTES,3223,,,WHO ATC Classification,,ILS,solution for peritoneal dialysis,"MAGNESIUM CHLORIDE 0.1017 G/L, SODIUM CHLORIDE 5.786 G/L, CALCIUM CHLORIDE 0.2573 G/L, GLUCOSE AS MONOHYDRATE 16.5 G/L, LACTIC ACID AS SODIUM 3.925 G/L",2025-07-31T11:03:20.745697,IL,ויטאמד,,23.3,19.75,nan,,,ACID BORIC 1.9% 10ML,1087,,,BAG POLYPROPYLENE,units,10.0,107 95 26735 00,valid,nan,intra-peritoneal,1.4,24,,,,,,,,,,0,,For use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9a46edd-6620-466a-b544-4e20b68620cc.json
f9a84181-d4a6-4269-b51c-373460e0e7d0,FELBATOL 600MG 100TAB,29C,,,20411,,,,,,tablet,FELBATOL 600MG,2025-07-31T20:26:34.474918,IL,nan,,,,,,,FELBATOL 600MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9a84181-d4a6-4269-b51c-373460e0e7d0.json
f9afd6dc-52fb-4ff8-940c-5376c999d6cb,MINESSE,prescription,G03AA10,GESTODENE AND ESTROGEN,4509,,,WHO ATC Classification,,ILS,film coated tablets,"ETHINYLESTRADIOL 0.015  MG, GESTODENE 0.06  MG",2025-07-31T05:24:41.526070,IL,פיזר,,141.0048838,119.4956696,88.844364,,7290008142946,MINESSE 84TAB,13118,,30848,BLISTER PVC/ALUMINIUM,units,84.0,122 57 30271 11,valid,34.5,per os,1.4,34,,,,,,,,,,0,Prescription required,Contraceptive.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9afd6dc-52fb-4ff8-940c-5376c999d6cb.json
f9c1b9ec-4f13-40a0-b65c-bc011e36a2ff,VORTIMAL,prescription,J02AC03,VORICONAZOLE,8128,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,VORICONAZOLE/VIAL,2025-07-31T10:21:21.571982,IL,SK PHARM(KS KIM),,501.920085,425.3560043,362.00511,,7290016845068,VORTIMAL 200MG 1VIAL,22428,,66788,VIAL 25 ML GLASS TYPE I,units,1.0,159 55 34932 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Vortimal is a broad spectrum, triazole antifungal agent and is indicated as follows:-       Treatment of invasive aspergillosis.-       Treatment of candidaemia in non-neutropenic patients.-       Treatment of fluconazole-resistant serious invasive Candida infections (including C. krusei).-       Treatment of serious fungal infections caused by Scedosporium spp. and Fusarium spp.Vortimal should be administered primarily to immunocompromised  patients with progressive, possibly life-threatening infections.Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9c1b9ec-4f13-40a0-b65c-bc011e36a2ff.json
f9d64f91-812e-4b6b-88e6-e98b04f40ebe,ROVAMYCIN,prescription,J01FA02,SPIRAMYCIN,825,,,WHO ATC Classification,,ILS,film coated tablets,SPIRAMYCIN 1.5 MIU,2025-07-31T07:51:47.597631,IL,סאנופי אוונטיס,,84.4155484,71.53860352,53.1885528,,7290008880435,ROVAMYCIN 1.5MIU 16TAB,18368,,1895,BLISTER PVC/ALUMINIUM,units,16.0,046 59 23868 01,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Respiratory tract infections, infections caused by clamydia, cryptosporidiosis pregnancy toxoplasmosis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9d64f91-812e-4b6b-88e6-e98b04f40ebe.json
f9d95c35-2b39-4954-85f5-3ac20f5780af,BOTOX 100,prescription,M03AX01,BOTULINUM TOXIN,7255,,,WHO ATC Classification,,ILS,powder for solution for injection,BOTULINUM TOXIN TYPE A 100 U/VIAL,2025-07-31T00:41:40.833546,IL,אב-וי,,1812.623325,1536.12153,1307.337473,,7290008127103,BOTOX 200 U 1 VIAL,2606,,57830,VIAL GLASS TYPE I,units,1.0,057 68 27328 00,valid,17.5,"intradermal, i.m",1.4,36,,,,,,,,,,0,Prescription required,"Neurologic disorders:•	•Focal spasticity associated with dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients two years of age or older. •	•	Focal spasticity of the wrist and hand in adult •	Focal spasticity of the lower limb, including ankle and foot in adult. •	•Blepharospasm or VII nerve disorders in patients over 12 years, hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. •	•Reduction of the signs and symptoms of Cervical dystonia (spasmodic torticollis) in adults. •	•Symptom relief in adults fulfilling criteria for chronic migraine (headaches on &#8805;15 days per month of which at least 8 days with migraine) in patients who have responded inadequately or are intolerant of prophylactic migraine medications. Bladder disorders: •Management of overactive bladder with symptoms of urinary incontinence, urgency and frequency in adult patients who have an inadequate response to, or are intolerant of, anticholinergic medication. •Urinary incontinence in adults with neurogenic detrusor overactivity resulting from neurogenic bladder due to stable sub-cervical spinal cord injury, or multiple sclerosis. Skin and skin appendage disorder: •Management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment. •For the temporary improvement in the appearance of: - moderate to severe vertical lines between the eyebrows seen at maximum frown (glabellar lines) and/or, - moderate to severe lateral canthal lines (crow’s feet lines) seen at maximum smile and/or, - moderate to severe forehead lines seen at maximum eyebrow elevation when the severity of the facial lines has an important psychological impact in adult patients.",תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9d95c35-2b39-4954-85f5-3ac20f5780af.json
f9f08d1d-6a59-4f02-8189-3c21f6c41e84,AKYNZEO 300mg/0.50mg,prescription,A04AA55,"PALONOSETRON, COMBINATIONS",3612,,,WHO ATC Classification,,ILS,capsules,"NETUPITANT, PALONOSETRON AS HYDROCHLORIDE 0.50  MG",2025-07-31T08:08:43.598371,IL,פאדאגיס,,231.358175,196.06625,156.853,,7290017179254,SETRON 1MG 10TAB,19246,,85049,BLISTER ALUMINIUM /ALUMINIUM,units,10.0,155 79 34343 00,valid,25.0,per os,1.4,60,,,,,,,,,,0,Prescription required,"Prevention of Acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9f08d1d-6a59-4f02-8189-3c21f6c41e84.json
f9fa4712-8115-4dd2-be9c-a8f4692e3f1d,ZYPREXA 7.5 MG,prescription,N05AH03,OLANZAPINE,8580,,,WHO ATC Classification,,ILS,tablets,OLANZAPINE 7.5   MG,2025-07-31T10:56:58.401716,IL,אלי לילי,,127.28542,107.869,80.2,,,ZYPREXA 7.5 MG 28 tab,26212,,4658,BLISTER ALUMINIUM,units,28.0,104 85 28858 21,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute and maintenance treatment of schizophrenia.   Zyprexa is indicated for the management of the manifestations of psychotic disorders.   Zyprexa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment  Zyprexa is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/f9fa4712-8115-4dd2-be9c-a8f4692e3f1d.json
fa037127-4454-44d5-b9ce-de6ab06b5213,BORTEZOMIB TEVA ® 3.5 MG,prescription,L01XX32,BORTEZOMIB,8059,,,WHO ATC Classification,,ILS,powder for solution for injection,BORTEZOMIB 3.5  MG,2025-07-31T00:40:46.893924,IL,טבע,,5218.217134,4422.21791,4020.1981,,7290110733483,BORTEZOMIB TEVA 3.5 MG PWDR FOR INJ 1VIAL,,,40331,VIAL GLASS TYPE I,units,1.0,158 86 34239 00,valid,10.0,"s.c, i.v",1.4,24,,,,,,,,,,0,Prescription required,"Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa037127-4454-44d5-b9ce-de6ab06b5213.json
fa099987-1532-44a9-ab74-b49d327edafe,RAFASSAL 4 GRAM ENEMA,prescription,A07EC02,MESALAZINE,8354,,,WHO ATC Classification,,ILS,enema,MESALAZINE/,2025-07-31T07:14:31.830957,IL,רפא,,411.8025382,348.9852174,297.0086957,,7290008013765,RAFASSAL 3 GRAM GRANULES 50 sachets,18527,,76634,BOTTLE POLYETHYLENE,units,50.0,029 58 25321 00,valid,17.5,rectal,1.4,18,,,,,,,,,,0,Prescription required,Treatment and prevention of ulcerative colitis and Crohn's disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa099987-1532-44a9-ab74-b49d327edafe.json
fa2a575f-94c2-435a-9c55-8d5b4b1fb3a5,SIRAN 200 MG EFFERVESCENT TABLETS,29C,R05CB01,ACETYLCYSTEINE,20269,,,WHO ATC Classification,,ILS,tablets effervescent,ACETYLCYSTEINE,2025-07-31T13:43:00.198213,IL,nan,,nan,nan,nan,,7290004448134,ACETYLCYSTEINE FOR INHALATION 20% 3VIALSX20ML,,,,TUBE POLYPROPYLENE,units,3.0,112 05 27057 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,Mucolytic in respiratory tract disorders where reduction of sputum viscosity is required.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa2a575f-94c2-435a-9c55-8d5b4b1fb3a5.json
fa361f29-5715-41b3-ab7b-c6fdbc209c9b,ZOMIG 2.5 MG,prescription,N02CC03,ZOLMITRIPTAN,3617,,,WHO ATC Classification,,ILS,film coated tablets,ZOLMITRIPTAN 2.5   MG,2025-07-31T10:54:11.079677,IL,ניאופרם,,31.84990753,26.99144826,19.70178705,,,ZOMIG 2.5MG 3TAB,26047,,76315,BLISTER PVC/ALUMINIUM,units,3.0,108 67 29181 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Acute treatment of migraine with or without aura.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa361f29-5715-41b3-ab7b-c6fdbc209c9b.json
fa442aa9-b260-4418-998b-794d447bf678,KADCYLA,prescription,L01FD03,TRASTUZUMAB EMTANSINE,7398,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,TRASTUZUMAB EMTANSINE/ML,2025-07-31T04:20:24.256439,IL,רוש,,7502.003945,6357.630744,5779.664313,,7290008140959,KADCYLA  20MG/ML VIAL15ML 100MG,,,77757,VIAL 15 ML GLASS TYPE I,units,100.0,151 63 33939 00,valid,10.0,i.v,1.4,48,,,,,,,,,,0,Prescription required,"""Early Breast Cancer (EBC):KADCYLA, as a single agent, is indicated for the adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and trastuzumab -based treatment.""Metastatic Breast Cancer (MBC)Kadcyla, as a single agent, is indicated for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either:•	Received prior therapy for metastatic disease, or•	Developed disease recurrence during or within six months of completing adjuvant therapy.""",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa442aa9-b260-4418-998b-794d447bf678.json
fa5813d7-2d06-450b-a45d-c0c412813848,TRANSLARNA 1000 MG,prescription,M09AX03,ATALUREN,7637,,,WHO ATC Classification,,ILS,granules for oral suspension,ATALUREN,2025-07-31T09:34:55.178553,IL,מדיסון,,31882.78137,27019.30745,24563.00677,,,TRANSLARNA 250MG 30 SACHETS,9849,,16015,SACHET ALUMINIUM,units,30.0,154 28 34267 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Translarna is indicated for the treatment of Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older.  The presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa5813d7-2d06-450b-a45d-c0c412813848.json
fa58e905-719f-4c3e-b98a-aaa1667111d6,ATACAND PLUS ®,prescription,C09DA06,CANDESARTAN AND DIURETICS,6445,,,WHO ATC Classification,,ILS,tablets,"CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE 12.5   MG",2025-07-30T23:28:56.685612,IL,צמל,,35.33758272,29.947104,21.8592,,,ATACAND PLUS 28TAB,9319,,80658,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,121 44 30145 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Essential hypertension, where monotherapy with candesartan cilexetil or hydrochlorothiazide is not sufficient.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa58e905-719f-4c3e-b98a-aaa1667111d6.json
fa5f9d46-3a78-440c-8968-47163676fa9d,XANAX X.R. 0.5 MG,prescription,N05BA12,ALPRAZOLAM,4307,,,WHO ATC Classification,,ILS,tablets sustained release,ALPRAZOLAM 0.5   MG,2025-07-31T10:28:56.574366,IL,דקסל פארמה,,20.77330908,17.6045,12.85,,7298074000702,XANAX XR 0.50MG 30 SR TAB,24019,,2495,BLISTER ALUMINIUM,units,30.0,110 49 28804 21,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,For the treatment of anxiety and anxiety associated with depression.Treatment of panic disorder with or without phobic avoidance,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa5f9d46-3a78-440c-8968-47163676fa9d.json
fa6af314-0291-491f-a3da-70d2d0ab7f1f,MICROPIRIN 100,off-the-counter,B01AC06,ACETYLSALICYLIC ACID,5498,,,WHO ATC Classification,,ILS,tablets enteric coated,ACETYLSALICYLIC ACID,2025-07-31T12:25:36.805952,IL,דקסל פארמה,,16.0362,13.59,nan,,,MICROPIRIN 100MG 30TAB,,,,BLISTER OPAQUE PVC/PVDC/ALUMINIUM,units,30.0,103 93 28861 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa6af314-0291-491f-a3da-70d2d0ab7f1f.json
fa6c3a2e-62c7-430a-984e-eb6f23d9bb85,NUSSIDEX,off-the-counter,R01BA52,"PSEUDOEPHEDRINE, COMBINATIONS",1622,,,WHO ATC Classification,,ILS,tablets,"DEXCHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE AS HYDROCHLORIDE",2025-07-31T12:39:40.260080,IL,טבע,,20.0246,16.97,nan,,7290000801803,NUSSIDEX  20TAB,14193,,,BLISTER PVC/ALUMINIUM,units,20.0,057 17 21688 01,valid,nan,per os,1.4,36,,,,,,,,,,0,,Symptomatic treatment of the common cold and allergic rhinitis (hay fever).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa6c3a2e-62c7-430a-984e-eb6f23d9bb85.json
fa7ddb22-e400-4957-98d1-c262d1fd1801,CRINONE 8 %,prescription,G03DA04,PROGESTERONE,6538,,,WHO ATC Classification,,ILS,gel,PROGESTERONEW/W,2025-07-31T01:33:56.495092,IL,מרק סרונו,,187.3168972,158.7431403,126.9945122,,7290000845166,CRINONE 8 % VAG GEL 15*1.45 G,3745,,58548,APPLICATOR POLYETHYLENE,units,15.0,120 01 29994 00,valid,25.0,vaginal,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of infertility due to inadequete luteal phase. For use during in-vitro fertilisation, where infertility is mainly due to tubal idiopathic or endometriosis linked sterility associated with normal obulatory.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fa7ddb22-e400-4957-98d1-c262d1fd1801.json
faa3a08f-68ce-4cff-b4f6-a47413ce03b5,OCSAAR 50 MG,prescription,C09CA01,LOSARTAN,3577,,,WHO ATC Classification,,ILS,tablets,LOSARTAN POTASSIUM,2025-07-31T06:00:24.933576,IL,אורגנון,,25.59546614,21.691073,15.8329,,,OCSAAR 50MG 30 TAB,15021,,9314,BLISTER PVC/PE/PVDC,units,30.0,122 79 28344 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Hypertension: Ocsaar  50 mg  is indicated for the treatment of hypertensionHeart failure: Ocsaar  50 mg is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ACE inhibitor is not appropriate.Switching patients with heart failure who are stable on an ACE inhibitor to Ocsaar  50 mg is not recommended.Renal protection in Type-2 diabetic patients with proteinuria: Ocsaar 50 mg is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Ocsaar 50 mg is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.The benefit of Ocsaar 50 mg on the primary deposite endpoint was largely driven by reduction in the risk of stroke.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/faa3a08f-68ce-4cff-b4f6-a47413ce03b5.json
faa47107-e30a-4bc4-8093-92b107c1525f,VIMPAT 10 MG/ML,prescription,N03AX18,LACOSAMIDE,7186,,,WHO ATC Classification,,ILS,solution for infusion,LACOSAMIDE/,2025-07-31T10:15:50.178525,IL,ניאופרם,,297.6099098,252.211788,214.6483302,,7290100412688,VIMPAT 100MG 56 F.C.TAB,22413,,46138,VIAL 20 ML GLASS TYPE I,units,56.0,149 13 33552 01,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.בקשה לשינוי משטר מינון: 17/5/20204.2	Posology and method of administrationPosologyLacosamide must be taken twice a day (usually once in the morning and once in the evening).Lacosamide may be taken with or without food.If a dose is missed, the patient should be instructed to take the missed dose immediately, and then to take the next dose of lacosamide at the regularly scheduled time. If the patient notices the missed dose within 6 hours of the next one, he/she should be instructed to wait to take the next dose of lacosamide at the regularly scheduled time. Patients should not take a double dose.Adolescents and children weighing 50 kg or more, and adultsThe following table summarises the recommended posology for adolescents and children weighing 50 kg or more, and for adults. More details are provided in the table below.	Monotherapy	Adjunctive therapyStarting dose	100 mg/day or 200 mg/day	100 mg/daySingle loading dose (if applicable)	200 mg	200 mgTitration (incremental steps)	50 mg twice a day (100 mg/day) at weekly intervals	50 mg twice a day (100 mg/day) at weekly intervalsMaximum recommended dose	up to 600 mg/day	up to 400 mg/dayMonotherapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week.Lacosamide can also be initiated at the dose of 100 mg twice a day based on the physician's assessment of required seizure reduction versus potential side effects.Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 300 mg twice a day (600 mg/day). In patients having reached a dose greater than 400 mg/day and who need an additional antiepileptic medicinal product, the posology that is recommended for adjunctive therapy below should be followed.Adjunctive therapy The recommended starting dose is 50 mg twice a day which should be increased to an initial therapeutic dose of 100 mg twice a day after one week. Depending on response and tolerability, the maintenance dose can be further increased at weekly intervals by 50 mg twice a day (100 mg/day), up to a maximum recommended daily dose of 400 mg (200 mg twice a day). Initiation of lacosamide treatment with a loading dose Lacosamide treatment may also be initiated with a single loading dose of 200 mg, followed approximately 12 hours later by a 100 mg twice a day (200 mg/day) maintenance dose regimen. Subsequent dose adjustments should be performed according to individual response and tolerability as described above. A loading dose may be initiated in patients in situations when the physician determines that rapid attainment of lacosamide steady state plasma concentration and therapeutic effect is warranted. It should be administered under medical supervision with consideration of the potential for increased incidence of serious cardiac arrhythmia and central nervous system adverse reactions (see section 4.8). Administration of a loading dose has not been studied in acute conditions such as status epilepticus.DiscontinuationIn accordance with current clinical practice, if lacosamide has to be discontinued, it is recommended this be done gradually (e.g. taper the daily dose by 200 mg/week).In patients who develop serious cardiac arrhythmia, clinical benefit/risk assessment should be performed and if needed lacosamide should be discontinued.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/faa47107-e30a-4bc4-8093-92b107c1525f.json
fabd2305-a25b-41d6-a8c4-91cad1b6cb88,VYVGART IV 20 MG/ML,prescription,L04AA58,EFGARTIGIMOD,9264,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,EFGARTIGIMOD ALFA/ML,2025-07-31T10:24:40.115289,IL,מדיסון,,39288.85856,33295.64433,30268.76757,,,VYVGART 400 MG/20 ML VIAL,22523,,3086,VIAL GLASS TYPE I,units,20.0,172 67 37436 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Vyvgart is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fabd2305-a25b-41d6-a8c4-91cad1b6cb88.json
fabe7a37-1d28-41c3-9481-ede087fa8685,RIVASTIGMINE DEXCEL 1.5 MG,prescription,N06DA03,RIVASTIGMINE,7552,,,WHO ATC Classification,,ILS,"capsule, hard",RIVASTIGMINE AS HYDROGEN TARTRATE 1.5  MG,2025-07-31T07:44:47.054537,IL,דקסל פארמה,,107.9372426,91.4722395,68.0091,,,RIVASTIGMINE DEXCEL 3 MG 28 CAPSULES,18511,,58798,BLISTER PVC/ALUMINIUM,units,28.0,152 77 33949 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of patients with mild to moderately severe dementia of the Alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.Symptomatic treatment of mild to moderately severe alzheimer's dementia.Symptomatic treatment of mild to moderately severe dementiaassociated with Parkinson's disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fabe7a37-1d28-41c3-9481-ede087fa8685.json
fabf17ae-2d24-40d4-bfb6-7ebbffe4b4f2,NICORETTE QUICK MIST SPRAY 1 MG,off-the-counter,N07BA01,NICOTINE,5631,,,WHO ATC Classification,,ILS,"oromucosal spray, solution",NICOTINE/SPRAY,2025-07-31T12:29:25.354985,IL,ג'ונסון אנד ג'ונסון,,134.1424,113.68,nan,,,NICORETTE QUICK MIST SPRAY 1 MG 13.2 ML,,,,BOTTLE PET,units,1.0,175 35 36908 99,valid,nan,oromucosal,1.4,24,,,,,,,,,,0,,"Nicorette Quick Mist relieves and/or prevents craving and nicotine withdrawal symptoms in nicotine dependence, such as those arising from the use of tobacco or electronic cigarettes.It is indicated in adults, to aid quitting or reduction prior to quitting, to assist those who are unwilling or unable to use such products, and as a safer alternative to smoking tobacco for smokers and those around them.Nicorette Quick Mist is indicated in pregnant and lactating women making a quit attempt.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fabf17ae-2d24-40d4-bfb6-7ebbffe4b4f2.json
facbbce0-6604-4bb0-8b14-043ac618fd44,EASOTIC VETERINARY,29C,,,20451,,,,,ILS,ear drops suspension,"MICONAZOLE AS NITRATE 15.1 MG/ML, GENTAMICIN AS SULFATE/ML, HYDROCORTISONE ACEPONATE 1.11 MG/ML",2025-07-31T14:47:53.660957,IL,nan,,nan,nan,nan,,,HYDROCORTISONE 5MG 50TAB,,,,CONTAINER POLYPROPYLENE,units,50.0,159 84 34886 00,valid,nan,otic,1.4,18,,,,,,,,,,0,,"In dogs: treatment of acute otitis externa, and acute exacerbation of recurrent otitis externa associated with bacteria susceptible to gentamicin and fungi susceptible to miconazole in particular Malassezia pachydermatis.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/facbbce0-6604-4bb0-8b14-043ac618fd44.json
faeeaa84-3832-41e8-8df8-2225f475de16,RECORLEV,prescription,,,9239,,,,,ILS,tablets,LEVOKETOCONAZOLE,2025-07-31T07:19:42.141118,IL,ניאופרם,,nan,nan,nan,,,RECORLEV 150MG 50 TABS,18684,,43135,BOTTLE HDPE,units,50.0,174 69 37497 99,valid,nan,per os,1.4,60,,,,,,,,,,0,Prescription required,RECORLEV is indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative.RECORLEV is not approved for the treatment of fungal infections. The safety and effectiveness of RECORLEV for the treatment of fungal infections have not been established.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/faeeaa84-3832-41e8-8df8-2225f475de16.json
faf748aa-fc23-4b51-a335-9219a715292e,ACAMOL,off-the-counter,N02BE01,PARACETAMOL,5483,,,WHO ATC Classification,,ILS,tablets,PARACETAMOL,2025-07-31T11:01:04.220100,IL,טבע,,30.7744,26.08,nan,,7290000800028,ACAMOL TSINUN & SHAPA'AT DAY 35 CAPLETS,,,,BLISTER PVC/ALUMINIUM,units,35.0,020 16 20534 00,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/faf748aa-fc23-4b51-a335-9219a715292e.json
fb0bf92c-40b4-4fab-bdf4-25dbde4814b9,CALAMINE LOTION FLORIS,off-the-counter,D09AB01,ZINC BANDAGE WITHOUT SUPPLEMENTS,2927,,,WHO ATC Classification,,ILS,lotion,"CALAMINE, ZINC OXIDE",2025-07-31T11:21:05.417319,IL,ויטאמד,,13.0862,11.09,nan,,7290008103503,CALAMINE LOT 100ML,3048,,,BOTTLE POLYETHYLENE,units,100.0,125 47 28879 00,valid,nan,dermal,1.4,48,,,,,,,,,,0,,For relief of skin irritations.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb0bf92c-40b4-4fab-bdf4-25dbde4814b9.json
fb289ff1-3368-4388-8766-e5c25f9c4354,KALBETEN FORTE SUSPENSION,off-the-counter,,,3254,,,,,ILS,suspension,BISMUTH SUBSALICYLATE/ML,2025-07-31T12:14:43.023433,IL,סם און,,25.3346,21.47,nan,,7290008080309,KALBETEN SUSP 100ML,11015,,,BOTTLE HDPE,units,100.0,131 72 30868 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,"Kalbeten Forte Suspension is indicated for relief of diarrhea, nausea, flatulence, convulsive stomach pains, upset stomach, indigestion. Kalbeten Forte Suspension is indicated as a preventative treatment of traveler's diarrhea.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb289ff1-3368-4388-8766-e5c25f9c4354.json
fb2aecd9-1cf4-446d-af28-c33c6030d1d4,EVEROLIMUS TEVA ® 10 MG,prescription,L04AA18,EVEROLIMUS,8981,,,WHO ATC Classification,,ILS,tablets,EVEROLIMUS,2025-07-31T02:44:41.505193,IL,טבע,,3931.799305,3332.033309,3029.12119,,,EVEROLIMUS TEVA 5 MG  30TAB,5697,,74041,BLISTER OPA/ALU/PVC/ALU,units,30.0,163 31 35379 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"• For the treatment of patients with SEGA associated with tuberous sclerosis Complex (TSC) who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of Everolimus is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. • Treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. The safety and effectiveness of Everolimus in the treatment of patients with carcinoid tumors have not been established.• For the treatment of hormone receptor – positive, HER2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression follwing a non – steroidal aromatase inhibitor.• Everolimus Teva is indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. The effectiveness of Everolimus in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. Further follow-up of patients is required to determine long-term outcomes.• Everolimus Teva is indicated for the treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with VEGF-targeted therapy.•Treatment of unresectable, locally advanced or metastatic, well-differentiated (Grade 1 or Grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb2aecd9-1cf4-446d-af28-c33c6030d1d4.json
fb2e5ffc-8f1e-4b36-a21d-3e3261356913,LACOSAMIDE TEVA ® 100 MG,prescription,N03AX18,LACOSAMIDE,8677,,,WHO ATC Classification,,ILS,film coated tablets,LACOSAMIDE,2025-07-31T04:31:59.961138,IL,טבע,,465.47578,394.471,335.72,,,LACOSAMIDE TEVA 150 MG 56 TAB,,,56606,BLISTER OPA/ALU/PVC/ALU,units,56.0,163 97 35488 00,valid,17.5,per os,1.4,24,,,,,,,,,,0,Prescription required,Lacosamide Teva is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb2e5ffc-8f1e-4b36-a21d-3e3261356913.json
fb2ef6fa-e624-40a5-ae24-efab987f2ff3,FLAGYL 250 MG TABLETS,prescription,J01XD01,METRONIDAZOLE,806,,,WHO ATC Classification,,ILS,film coated tablets,METRONIDAZOLE,2025-07-31T03:05:52.515801,IL,סאנופי אוונטיס,,13.9641908,11.83406,8.638,,3582910013679,FLAGYL 250MG 20TAB,6420,,89581,BLISTER PVC/ALUMINIUM,units,20.0,106 97 21742 01,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Trichomonias, acute intestinal amebiasis. Infections due to anaerobic bacteria, lambliasis.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb2ef6fa-e624-40a5-ae24-efab987f2ff3.json
fb2f8594-0834-4166-bae4-2b414caa2086,SPIOLTO RESPIMAT,prescription,R03AL03,VILANTEROL AND UMECLIDINIUM BROMIDE,7839,,,WHO ATC Classification,,ILS,solution for inhalation,"OLODATEROL AS HYDROCHLORIDE 2.5  MCG, TIOTROPIUM BROMIDE AS MONOHYDRATE 2.5  MCG",2025-07-31T08:34:14.680018,IL,בורינגר אינגלהיים,,222.9924976,188.9767013,151.181361,,9006968013251,SPIOLTO RESPIMAT INHALER 60 ACTUATIONS (30 DOSES),9910,,33283,INHALER POLYETHYLENE,units,60.0,155 58 34508 00,valid,25.0,inhalation,1.4,36,,,,,,,,,,0,Prescription required,Spiolto Respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb2f8594-0834-4166-bae4-2b414caa2086.json
fb2fc7c4-5458-4a49-bd85-6e7f3a46f720,ALUNBRIG 30 MG,prescription,L01XE43,BRIGATINIB,8110,,,WHO ATC Classification,,ILS,film coated tablets,BRIGATINIB,2025-07-31T00:17:58.280647,IL,טקדה,,12861.83286,10899.85884,9908.962585,,7290016369434,ALUNBRIG 90 MG 30 FILM COATED TABLETS,10148,,64845,BOTTLE HDPE,units,30.0,161 05 35334 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb2fc7c4-5458-4a49-bd85-6e7f3a46f720.json
fb44a399-59e8-418b-bbb2-4fd41e021162,NEURONTIN 300 MG,prescription,N03AX12,GABAPENTIN,3335,,,WHO ATC Classification,,ILS,capsules,GABAPENTIN,2025-07-31T05:44:11.592725,IL,דקסל פארמה,,132.4750783,112.2670155,83.4699,,,NEURONTIN 400MG 100CAPS,14101,,9581,BLISTER PVC/ALUMINIUM,units,100.0,125 05 30497 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Epilepsy :- Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults  and adolescents ( age 12 and up ) with epilepsy.- Treatment of neuropathic pain- Gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb44a399-59e8-418b-bbb2-4fd41e021162.json
fb5f0250-d0a3-4f88-924e-8288c7a60d2f,CURATANE 10 MG,prescription,,,7456,,,,,ILS,capsules soft gelatin,ISOTRETINOIN,2025-07-31T01:36:22.215601,IL,תרו יבוא,,38.68782456,32.786292,23.9316,,,CURATANE 5 MG 30 CAPS,9742,,51569,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,136 12 30295 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of severe cystic acne that does not respond to other treatment.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb5f0250-d0a3-4f88-924e-8288c7a60d2f.json
fb6057d5-b832-418e-8a1a-5d32abf56203,OMEPRADEX - Z,prescription,A02BC01,OMEPRAZOLE,3710,,,WHO ATC Classification,,ILS,caplets,OMEPRAZOLE,2025-07-31T06:07:52.375459,IL,דקסל פארמה,,43.6482,36.99,27.0,,7290010578511,OMEPRADEX 20MG 30CAPLETS,15308,,59980,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,131 25 30841 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb6057d5-b832-418e-8a1a-5d32abf56203.json
fb62f294-0b60-4f8c-9d42-87cf7899fdb9,CLEXANE,prescription,B01AB05,ENOXAPARIN,6483,,,WHO ATC Classification,,ILS,solution for injection,ENOXAPARIN SODIUM/ML  ML,2025-07-31T01:20:31.289632,IL,סאנופי אוונטיס,,58.98382271,49.98629265,36.486345,,7290012711121,CLEXANE 80MG SAFETY LOCK 2X0.8ML SYR PREFIL,3992,,84289,SYRINGE PREFILLED  GLASS TYPE I,units,2.0,046 77 26037 11,valid,37.0,"i.v, s.c, extracorporeal",1.4,36,,,,,,,,,,0,Prescription required,"Clexane is indicated in adults for: • Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery. • Prevention of thrombus formation in extra corporeal circulation during haemodialysis. • Acute coronary syndrome: - Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid. - Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb62f294-0b60-4f8c-9d42-87cf7899fdb9.json
fb713a3f-f53d-4e1f-be34-9e7124ee65f1,VOXZOGO 1.2 MG,prescription,M05BX07,VOSORITIDE,9492,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,VOSORITIDE 1.2 MG/VIAL,2025-07-31T10:22:49.391281,IL,מדיסון,,34813.91266,29503.31713,26821.19739,,,VOXZOGO 1.2 MG 10 VIAL,,,26103,VIAL GLASS TYPE I,units,10.0,175 74 37700 00,valid,10.0,s.c,1.4,36,,,,,,,,,,0,Prescription required,Voxzogo is indicated for the treatment of achondroplasia in paediatric patients whose epiphyses are not closed. The diagnosis of achondroplasia should be confirmed by appropriate genetic testing.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb713a3f-f53d-4e1f-be34-9e7124ee65f1.json
fb7bc738-93c8-4543-9c23-f6d80e4cd9fe,KALYDECO 150 MG FILM COATED TABLETS,prescription,R07AX02,IVACAFTOR,7599,,,WHO ATC Classification,,ILS,film coated tablets,IVACAFTOR,2025-07-31T04:21:56.026658,IL,מדיסון,,52580.81505,44560.01473,40509.1043,,,KALYDECO 150MG 56TAB,11256,,56073,BLISTER PVC/ALUMINIUM,units,56.0,153 89 34269 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,Kalydeco tablets are indicated for the treatment of patients with cystic fibrosis (CF) aged 6 years and older and weighing 25 kg or more who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data. Limitations of use : Kalydeco is not effective in patients with CF who are homozygous for the F508del mutation in the CFTR gene.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb7bc738-93c8-4543-9c23-f6d80e4cd9fe.json
fb8ccec5-8e28-42b7-a317-207eac192a14,PHENYLEPHRINE ALTAN 10 MG/ML,prescription,C01CA06,PHENYLEPHRINE,9413,,,WHO ATC Classification,,ILS,solution for injection / infusion,PHENYLEPHRINE HYDROCHLORIDE/,2025-07-31T06:41:16.827094,IL,פרופארם,,702.1829091,595.0702619,506.4427761,,7290017585192,PHENYLEPHRINE ALTAN 10 MG/ML 10 AMP,,,17127,AMPOULES GLASS TYPE I,units,10.0,162 16 35141 00,valid,17.5,"s.c, i.m, i.v",1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of hypotensive states, e.g. septic shock, circulatory failure, during spinal anaesthesia or drug-induced hypotension.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fb8ccec5-8e28-42b7-a317-207eac192a14.json
fba5d550-149e-41f6-834c-67387d249df0,IMATINIB - TRIMA 100 MG,prescription,L01XE01,IMATINIB,8434,,,WHO ATC Classification,,ILS,film coated tablets,IMATINIB AS MESYLATE,2025-07-31T03:59:26.171004,IL,תרימה,,7205.710061,6106.53395,5551.3945,,,IMATINIB - TRIMA 400 MG 30 TAB,10576,,49971,BLISTER PVC/ALUMINIUM,units,30.0,157 59 34527 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Imatinib - Trima is indicated for the• Treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia (Ph+ -CML) in chronic phase, accelerated phase or blast crisis.• Treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST). • Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.• Treatment of adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) integrated with chemotherapy. • Treatment of adult patients with relapsed or refractory Ph+ ALL as monotherapy. • Treatment of adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.• Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangements. • Treatment of adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) who have the FIP1L1-PDGFRα fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1- PDGFRα fusion kinase negative. • Treatment of adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-kit mutation.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fba5d550-149e-41f6-834c-67387d249df0.json
fbb288f4-a096-4090-9f7e-0f84b0131f11,OZURDEX,prescription,R01AD03,DEXAMETHASONE,6947,,,WHO ATC Classification,,ILS,implant in applicator,DEXAMETHASONE 0.7  MG,2025-07-31T06:23:49.718209,IL,אב-וי,,4988.809424,4227.804785,3843.458895,,7290104780011,OZURDEX 0.7MG IMPLANT IN APPLICATOR,15410,,3401,APPLICATOR STAINLESS STEEL,units,1.0,147 03 33284 00,valid,10.0,intravitreal,1.4,36,,,,,,,,,,0,Prescription required,Ozurdex is indicated for the treatment of adult patients with:• diabetic macular oedema (DME)• macular oedema following either Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO).• inflammation of the posterior segment of the eye presenting as non-infectious uveitis.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fbb288f4-a096-4090-9f7e-0f84b0131f11.json
fbc0cda8-1241-48dc-ac94-6d5c23fa6d67,TARGIN 10,prescription,V03AB15,NALOXONE,6234,,,WHO ATC Classification,,ILS,tablets prolonged release,"OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (AS DIHYDRATE)",2025-07-31T09:05:01.637381,IL,רפא,,38.56046559,32.67836212,23.85281907,,7290008012973,TARGIN 10/5 MG 20 TABLETS,20638,,89485,BLISTER PVC/ALUMINIUM,units,20.0,139 95 31636 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Targin is indicated for the relief of moderate to severe pain.The oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. The opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fbc0cda8-1241-48dc-ac94-6d5c23fa6d67.json
fbc5b0e8-e7ed-4809-be7c-fb8b4e13af96,ENCYPALMED,off-the-counter,A09AC02,MULTIENZYMES AND ACID PREPARATIONS,3920,,,WHO ATC Classification,,ILS,dragee,"PANCREATIN, OX BILE EXTRACT",2025-07-31T11:34:59.293643,IL,תרימה,,52.9702,44.89,nan,,,ENCYPALMED 60 DRAGEES,5137,,,BLISTER PVC/ALUMINIUM,units,60.0,027 66 22433 00,valid,nan,per os,1.4,12,,,,,,,,,,0,,"Regulation of digestive disturbances, indigestion fermentative dyspepsia, gastroenteritis, meteorism, epigastric fullness and post prandial distress.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fbc5b0e8-e7ed-4809-be7c-fb8b4e13af96.json
fbdd44b0-6524-4a4e-836f-3915a3e636ca,RINGER LACTATED SOLUTION/VIOSER,29C,B05BB01,ELECTROLYTES,20990,,,WHO ATC Classification,,ILS,solution for infusion,"SODIUM LACTATE 3.14 G/L, CALCIUM CHLORIDE DIHYDRATE 0.26 G/L, POTASSIUM CHLORIDE 0.41 G/L, SODIUM CHLORIDE 6.02 G/L",2025-07-31T15:38:29.589021,IL,nan,,nan,nan,nan,,7290111096761,POTASSIUM IODATE 85MG 44 tab,,,,BOTTLE LDPE,units,44.0,169 66 36052 00,valid,nan,i.v,1.4,36,,,,,,,,,,0,,Source of water and electrolytes. Regulation or maintenance of metabolic acidosis (except lactic acidosis),,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fbdd44b0-6524-4a4e-836f-3915a3e636ca.json
fbf7c60b-9e60-4c5c-91f4-a639f2179a92,NOROCILLIN VETERINARY,29C,,,20814,,,,,ILS,suspension for injection,PROCAINE BENZYLPENICILLIN/ML,2025-07-31T13:58:26.279312,IL,nan,,nan,nan,nan,,,BENZYLPENICILLIN 1200MG GENUS UK POWDER FOR INJECTION,,,,VIAL GLASS TYPE II,units,1.0,083 40 92360 00,valid,nan,i.m,1.4,24,,,,,,,,,,0,,"Norocillin is recommended in the treatment of diseases caused by susceptible organisms to penicillin in Cattle, sheep and pigs.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fbf7c60b-9e60-4c5c-91f4-a639f2179a92.json
fc018c24-09fb-4ad2-81b2-f966c4a3fa83,ESPEROCT 1000 IU,prescription,,,9208,,,,,ILS,powder and solvent for solution for injection,TUROCTOCOG ALFA PEGOL/VIAL,2025-07-31T02:37:07.127464,IL,נובו נורדיסק,,3070.142136,2601.815486,2365.286805,,,ESPEROCT 1000 IU 1 VIAL,5740,,3085,VIAL GLASS TYPE I,units,1.0,172 44 37440 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Treatment and prophylaxis of bleeding in previously treated patients with haemophilia A (congenital factor VIII disorder).Esperoct® does not contain pharmacologically active quantities of von Willebrand factor and is, therefore, unsuitable for the treatment of von Willebrand disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc018c24-09fb-4ad2-81b2-f966c4a3fa83.json
fc029fda-9aad-4a6e-96f8-40e78633ded7,GENTAMICIN B. BRAUN 1 MG/ML,prescription,S01AA11,GENTAMICIN,9111,,,WHO ATC Classification,,ILS,solution for infusion,GENTAMICIN AS SULFATE 0.1 G /,2025-07-31T03:31:09.569220,IL,לפידות,,620.233333,525.621492,447.33744,,4030539126922,GENTAMICIN B. BRAUN 3 MG/ML 80 ML 20 CONTAINER,,,50870,CONTAINER POLYETHYLENE,units,20.0,149 06 33562 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment of serious infections caused by susceptible microorganisms.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc029fda-9aad-4a6e-96f8-40e78633ded7.json
fc0d7d96-7037-4660-8d0b-dfdd62ca51d0,XYNTHA 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,7493,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,MOROCTOCOG ALFA/VIAL,2025-07-31T10:38:20.457717,IL,פיזר,,678.5387762,575.0328867,489.3896908,,35894014012,XYNTHA 250 IU 1VIAL,24081,,56697,VIAL 10 ML GLASS TYPE I,units,1.0,137 80 31593 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc0d7d96-7037-4660-8d0b-dfdd62ca51d0.json
fc34fce3-d1f2-41aa-bbe9-c54ad0d298e3,FYCOMPA 10 MG FILM COATED TABLETS,prescription,N03AX22,PERAMPANEL,7265,,,WHO ATC Classification,,ILS,film coated tablets,PERAMPANEL AS ANHYDROUS,2025-07-31T03:24:54.787172,IL,אסיי,,428.8215271,363.4080899,309.2834808,,,FYCOMPA 8MG 28 F.C TAB,6532,,51059,BLISTER PVC/ALUMINIUM,units,28.0,150 50 33794 01,valid,17.5,per os,1.4,60,,,,,,,,,,0,Prescription required,Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.Fycompa is indicated for the adjunctive treatment of primary generalised tonic clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalized epilepsy (IGE).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc34fce3-d1f2-41aa-bbe9-c54ad0d298e3.json
fc4b9363-b077-4205-b5c2-c12bea4d840f,BETMIGA 25 MG,prescription,G04BD12,MIRABEGRON,7534,,,WHO ATC Classification,,ILS,tablets prolonged release,MIRABEGRON,2025-07-31T00:34:10.378684,IL,אסטלס,,215.1023834,182.2901635,145.8321308,,8718692510739,BETMIGA 25MG 30 P.R.TAB,2584,,85010,BLISTER OPA/AL/PVC,units,30.0,153 46 34104 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc4b9363-b077-4205-b5c2-c12bea4d840f.json
fc52649a-9641-4334-941c-043f9bfb71b5,XYNTHA 1000 IU,prescription,B02BD02,COAGULATION FACTOR VIII,7495,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,MOROCTOCOG ALFA/VIAL,2025-07-31T10:37:56.513646,IL,פיזר,,2464.693661,2088.723534,1898.839576,,35894014012,XYNTHA 1000 IU 1VIAL,24080,,56696,VIAL 10 ML GLASS TYPE I,units,1.0,137 80 31593 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency),תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc52649a-9641-4334-941c-043f9bfb71b5.json
fc69c106-257a-4c9c-bdbc-42e4ff0ec1d3,FOSALAN ONCE-WEEKLY 70 MG,prescription,M05BA04,ALENDRONIC ACID,4037,,,WHO ATC Classification,,ILS,tablets,ALENDRONATE AS SODIUM,2025-07-31T03:17:36.737776,IL,אורגנון,,44.52940866,37.736787,27.5451,,,FOSALAN ONCE-WEEKLY 70MG 4TAB,6172,,27168,BLISTER PVC/ALUMINIUM,units,4.0,122 08 30219 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Fosalan is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures). Treatment to increase bone mass in men with osteoporosis.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc69c106-257a-4c9c-bdbc-42e4ff0ec1d3.json
fc7add91-4261-41b0-b0cb-0ce88d597cdf,DONEPEZIL TEVA 10 MG,prescription,N06DA02,DONEPEZIL,6369,,,WHO ATC Classification,,ILS,film coated tablets,DONEPEZIL HYDROCHLORIDE ( AS MONOHYDRATE),2025-07-31T02:02:13.790355,IL,טבע,,75.67691159,64.13297877,47.6825121,,7291064976285,DONEPEZIL TEVA 5MG 30TAB,4531,,76342,BLISTER OPA/ALU/PVC/ALU,units,30.0,159 51 34714 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Treatment of mild to moderately severe Alzheimer's dementia.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc7add91-4261-41b0-b0cb-0ce88d597cdf.json
fc862f0e-fe3c-4767-82a0-8ee761a9e21d,PHESGO 1200 MG / 600 MG,prescription,L01FY01,PERTUZUMAB AND TRASTUZUMAB,9030,,,WHO ATC Classification,,ILS,solution for injection,"TRASTUZUMAB/ML, PERTUZUMAB/ML",2025-07-31T06:41:51.890178,IL,רוש,,21091.16415,17873.86871,16248.97156,,,PHESGO 600 MG / 600 MG (VIAL 10 ML),,,88140,VIAL GLASS TYPE I,units,1.0,168 67 36651 00,valid,10.0,s.c,1.4,18,,,,,,,,,,0,Prescription required,"Early Breast Cancer (EBC)Phesgo is indicated for use in combination with chemotherapy for:•The neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer .•The adjuvant treatment of patients with HER2-positive early breast cancer (node positive) at high risk of recurrence.Metastatic Breast Cancer (MBC)Phesgo is indicated for use in combination with docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc862f0e-fe3c-4767-82a0-8ee761a9e21d.json
fc88bde7-21df-4a91-bb34-f2c58204484c,BRINTELLIX 10 MG,prescription,N06AX26,VORTIOXETINE,7724,,,WHO ATC Classification,,ILS,film coated tablets,VORTIOXETINE AS HYDROBROMIDE,2025-07-31T00:43:22.950500,IL,לנדבק,,70.17595644,59.47115217,44.21647001,,,BRINTELLIX 5MG 28 F.C.TAB,2586,,85109,BLISTER PVC/PVDC/ALUMINIUM,units,28.0,153 73 34155 00,valid,34.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Brintellix is indicated for the treatment of major depressive episodes in adults.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc88bde7-21df-4a91-bb34-f2c58204484c.json
fc900a00-b673-4ce0-bcf4-1b5bde91b7f5,AZILECT,prescription,N04BD02,RASAGILINE,4803,,,WHO ATC Classification,,ILS,tablets,RASAGILINE AS MESYLATE,2025-07-30T23:32:59.562517,IL,טבע,,294.5612318,249.6281625,212.4495,,,AZILECT 1MG 30TAB,1938,,12446,BLISTER ALUMINIUM /ALUMINIUM,units,30.0,132 17 31000 00,valid,17.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Azilect is indicated for the treatment of idiopathic Parkinson's disease (PD) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc900a00-b673-4ce0-bcf4-1b5bde91b7f5.json
fc9859cd-e2fd-4625-a5a0-3ce5a4d85879,CAVERJECT 10 MCG,prescription,G04BE01,ALPROSTADIL,3010,,,WHO ATC Classification,,ILS,powder for solution for injection,ALPROSTADIL,2025-07-31T00:57:51.520106,IL,פיזר,,59.12375543,50.10487971,36.5729049,,,CAVERJECT 20MCG V+DS,3010,,9322,VIAL GLASS TYPE I,units,1.0,101 08 28542 00,valid,37.0,intracavernosal,1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of erectile dysfunction in adult males, due to neurogenic, vasculogenic, psychogenic or mixed etiology. Useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fc9859cd-e2fd-4625-a5a0-3ce5a4d85879.json
fcb1c761-e875-45ba-a5b3-c396c5f4aced,DAPSONE 100MG 28TAB,29C,,,20061,,,,,,tablet,DAPSONE 100MG,2025-07-31T20:10:45.780748,IL,nan,,,,,,,DAPSONE 100MG 28TAB,,,,,units,28.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcb1c761-e875-45ba-a5b3-c396c5f4aced.json
fcb64b39-73b7-43ed-a6cb-3c852aba0fa1,ORACORT E,off-the-counter,A01AC01,TRIAMCINOLONE,2079,,,WHO ATC Classification,,ILS,paste,"LIDOCAINE HYDROCHLORIDE MONOHYDRATE/, TRIAMCINOLONE ACETONIDE 0.1 G /",2025-07-31T12:41:35.074315,IL,תרו יבוא,,22.4672,19.04,nan,,7290000808222,ORACORT PASTE 5G,15047,,,TUBE ALUMINIUM,units,5.0,037 10 22812 00,valid,nan,local oral,1.4,36,,,,,,,,,,0,,Adjunctive treatment and temporary relief of pain and symptoms associated with oral inflammatory and ulcerative lesions.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcb64b39-73b7-43ed-a6cb-3c852aba0fa1.json
fcbadc1d-5b98-48e5-aa95-d656bf7f78ee,EXELON PATCH 10,prescription,N06DA03,RIVASTIGMINE,7369,,,WHO ATC Classification,,ILS,patches,RIVASTIGMINE 9.5 MG/DAY,2025-07-31T02:48:33.248985,IL,נוברטיס פארמה,,361.4046883,306.2751596,260.6597103,,,EXELON PATCH 15MG 30PATCHES,5571,,50169,POUCH PAPER/PET/PE/AL/POLYAMIDE,units,30.0,139 70 31675 01,valid,17.5,transdermal,1.4,24,,,,,,,,,,0,Prescription required,Treatment of mild to moderate dementia of the Alzheimer's type.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcbadc1d-5b98-48e5-aa95-d656bf7f78ee.json
fcbcfd8f-895a-4e3e-a52e-4310cf042d8d,CYNOMEL 25MCG 30TAB,29C,,,20348,,,,,,tablet,CYNOMEL 25MCG,2025-07-31T20:09:02.231638,IL,nan,,,,,,,CYNOMEL 25MCG 30TAB,,,,,units,30.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcbcfd8f-895a-4e3e-a52e-4310cf042d8d.json
fcc32e4a-15df-42d3-9828-cd9eccecf2ac,DUODART,prescription,G04CA02,TAMSULOSIN,8854,,,WHO ATC Classification,,ILS,capsules,"DUTASTERIDE 0.5  MG, TAMSULOSIN HYDROCHLORIDE 0.4  MG",2025-07-31T09:04:05.768299,IL,טבע,,58.18806206,49.311917,35.9941,,,TAMSU P.R TEVA 30 TABS,,,58507,BOTTLE HDPE,units,30.0,146 34 33278 01,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcc32e4a-15df-42d3-9828-cd9eccecf2ac.json
fcd5f01d-ab6c-4739-9b5a-7c43683e104a,IRINOTECAN HCL SEACROSS 20 MG/ML,prescription,L01XX19,IRINOTECAN,7916,,,WHO ATC Classification,,ILS,concentrate for solution for infusion,IRINOTECAN HYDROCHLORIDE TRIHYDRATE/,2025-07-31T04:11:55.820083,IL,טבע,,485.4347248,411.38536,350.1152,,,IRINOTECAN ACTAVIS 20MG/ML(100MG/5ML) VIAL,9957,,61637,VIAL GLASS TYPE I,units,1.0,168 44 36042 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Irinotecan HCl seacross is indicated for the treatment of patients with metastatic colorectal cancer: In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. For the treatment of patients with small cell lung cancer. For the treatment of patients with gastric cancer. Irinotecan in combination with leucovorin, Oxaliplatin and 5-fluorouracil for the first-line treatment of patients with metastatic pancreatic adenocarcinoma",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcd5f01d-ab6c-4739-9b5a-7c43683e104a.json
fcf373f3-ad2b-47ad-9902-067ab42b3ca6,OZEMPIC,prescription,A10BJ06,SEMAGLUTIDE,8391,,,WHO ATC Classification,,ILS,solution for injection,SEMAGLUTIDE 1.34  MG /,2025-07-31T06:23:33.852053,IL,נובו נורדיסק,,398.3715594,337.6030314,287.3217289,,,OZEMPIC 1 prefilled pen 1MG/0.74ML,15499,,35433,PRE-FILLED PEN GLASS TYPE I,units,1.0,162 09 35750 00,valid,17.5,s.c,1.4,36,,,,,,,,,,0,Prescription required,Ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcf373f3-ad2b-47ad-9902-067ab42b3ca6.json
fcf3819f-b84a-4ab1-acb7-1756f7aa310f,APO-GEMFIBROZIL 600MG 100TAB,29C,,,20038,,,,,,tablet,APO-GEMFIBROZIL 600MG,2025-07-31T19:55:33.304281,IL,nan,,,,,,,APO-GEMFIBROZIL 600MG 100TAB,,,,,units,100.0,,not-registered,,oral,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcf3819f-b84a-4ab1-acb7-1756f7aa310f.json
fcf66836-55cc-4b9a-a6aa-0fe355c62abe,GIROFLOX,prescription,J01MA02,CIPROFLOXACIN,8617,,,WHO ATC Classification,,ILS,solution for infusion,CIPROFLOXACIN/,2025-07-31T01:17:20.991727,IL,פרופארם,,1781.186636,1509.4802,1284.664,,7290010286041,CIPROFLOXACIN I.V G.E.S. 2 MG/ML 200 ML 20 BAGS,,,50070,BOTTLE PLASTIC,units,4000.0,133 31 30984 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,* Adults :Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens.* Children and adolescents:• Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa• Complicated urinary tract infections and pyelonephritis• Inhalation anthrax (post-exposure prophylaxis and curative treatment)Ciprofloxacin may also be used to treat severe infections in children and adolescents when there is no otheralternative .Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fcf66836-55cc-4b9a-a6aa-0fe355c62abe.json
fd0091d5-b4d5-44c1-84e2-64c477695ef6,ANAFRANIL 25 MG,prescription,N06AA04,CLOMIPRAMINE,1880,,,WHO ATC Classification,,ILS,coated tablets,CLOMIPRAMINE HYDROCHLORIDE,2025-07-31T06:49:15.663543,IL,רפא,,14.54939935,12.33,9.0,,7298087000041,PRAMIN 10MG 30TAB,16202,,1748,BLISTER PVC/PE/PVDC,units,30.0,108 06 24600 00,valid,37.0,per os,1.4,60,,,,,,,,,,0,Prescription required,Adults:Depression of varying originObsessive-compulsive syndromesChildren and adolescents (5-18 years old):Obsessive-compulsive syndromes,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd0091d5-b4d5-44c1-84e2-64c477695ef6.json
fd058fa4-ac72-420b-a9ac-114519dc601a,MONOCORD 20,prescription,C01DA14,ISOSORBIDE MONONITRATE,1774,,,WHO ATC Classification,,ILS,tablets,ISOSORBIDE MONONITRATE,2025-07-31T05:29:50.097441,IL,דקסל פארמה,,39.79115406,33.721317,24.6141,,7290008113427,MONOCORD 50MG SR 30TAB,13460,,8313,BLISTER PVC/ALUMINIUM,units,30.0,052 51 23128 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of angina pectoris and prevention of anginal attacks. Treatment of congestive heart failure.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd058fa4-ac72-420b-a9ac-114519dc601a.json
fd4f02fb-ca93-4c14-ad28-036e2dd6a823,ENTUMIN ®,prescription,N05AX09,CLOTIAPINE,922,,,WHO ATC Classification,,ILS,tablets,CLOTIAPINE,2025-07-31T02:24:46.262665,IL,תרו יבוא,,22.55108502,19.111089,13.9497,,7298120014271,ENTUMIN 40MG 30TAB,5080,,807,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,023 40 21411 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of severe mental and emotional disorders (Neuroleptic).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd4f02fb-ca93-4c14-ad28-036e2dd6a823.json
fd559f2c-1bbb-4882-89b0-7f051cc2d83b,GENDEVRA,prescription,J05AR18,"EMTRICITABINE, TENOFOVIR ALAFENAMIDE, ELVITEGRAVIR AND COBICISTAT",7973,,,WHO ATC Classification,,ILS,film coated tablets,"TENOFOVIR ALAFENAMIDE, EMTRICITABINE, COBICISTATE, ELVITEGRAVIR",2025-07-31T03:30:04.908866,IL,גיליאד,,3691.032191,3127.993521,2843.630474,,5391507142764,GENDEVRA 30 TAB,7942,,73726,BOTTLE HDPE,units,30.0,157 46 34742 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Gendevra is indicated for the treatment of human immunodeficiency virus 1 (HIV 1) infection without any known mutations associated with resistance to the integrase inhibitor class, emtricitabine or tenofovir as follows:• In adults and adolescents aged from 12 years and with body weight at least 35 kg• In children aged from 6 years and with body weight at least 25 kg for whom alternative regimens are unsuitable due to toxicities.תוספת התוויה: 2/7/2019Addition of new info to posology section: precaution in pregnant women",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd559f2c-1bbb-4882-89b0-7f051cc2d83b.json
fd60dcab-74d6-434d-adcf-ca375d59db10,TALZENNA 0.25 MG,prescription,L01XX60,TALAZOPARIB,8545,,,WHO ATC Classification,,ILS,"capsule, hard",TALAZOPARIB AS TOSYLATE 0.25  MG,2025-07-31T09:02:35.912335,IL,פיזר,,23486.39946,19903.72924,18094.29931,,7290013592620,TALZENNA 1 MG 30 TAB,,,549,BLISTER PVC/PVDC/ALUMINIUM,units,30.0,164 07 36019 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,TALZENNA is indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA) mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd60dcab-74d6-434d-adcf-ca375d59db10.json
fd6d0db3-c7dd-4735-baea-8205c8ff9a95,SALAGEN,prescription,N07AX01,PILOCARPINE,3255,,,WHO ATC Classification,,ILS,tablets,PILOCARPINE HYDROCHLORIDE,2025-07-31T07:56:21.791638,IL,מגאפארם,,408.1982172,345.9306925,294.4091,,,SALAGEN 5MG 100TAB,19018,,9410,BOTTLE HDPE,units,100.0,101 65 28557 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,For the treatment of symptoms of xerostomia and salivary gland hypofunction caused by radiotherapy for cancer of the head and neck. Sjogren detected by biopsy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd6d0db3-c7dd-4735-baea-8205c8ff9a95.json
fd70ce6d-d8a8-4f89-9ddd-77474e84f2a5,BETNESOL TABLETS,prescription,H02AB01,BETAMETHASONE,6015,,,WHO ATC Classification,,ILS,tablets,BETAMETHASONE 0.5  MG,2025-07-30T23:37:44.034240,IL,דפריס,,14.87272,12.604,9.2,,,BETNESOL 0.50MG 30TAB,2074,,349,BLISTER ALUMINIUM/LDPE,units,30.0,135 65 22066 00,valid,37.0,per os,1.4,24,,,,,,,,,,0,Prescription required,Diseases responsive to oral glucocorticosteroid therapy.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd70ce6d-d8a8-4f89-9ddd-77474e84f2a5.json
fd71be9c-d080-45d7-81fc-4499db19dd79,VARDENAFIL INOVAMED 10 MG,prescription,G04BE09,VARDENAFIL,9140,,,WHO ATC Classification,,ILS,film coated tablets,VARDENAFIL AS HYDROCHLORIDE TRIHYDRATE,2025-07-31T09:59:32.839992,IL,אינובמד,,70.93703925,60.11613763,44.69601311,,,VARDENAFIL INOVAMED 10MG  4 TAB,22505,,24493,BLISTER ALU/PVC/PVDC,units,4.0,168 12 36000 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Vardenafil Inovamed to be effective, sexual stimulation is required. Not indicated for use by women",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd71be9c-d080-45d7-81fc-4499db19dd79.json
fd739354-e58f-4ef2-b493-efb6ddd43b41,CETRIMIDE SHAMPOO VITAMED,off-the-counter,D11AC01,CETRIMIDE,2928,,,WHO ATC Classification,,ILS,shampoo,CETRIMIDE,2025-07-31T11:24:16.214474,IL,ויטאמד,,20.6736,17.52,nan,,7290008083416,CETRIMIDE SHAMP 100ML,3051,,,BOTTLE POLYETHYLENE,units,100.0,063 64 28092 00,valid,nan,topical- scalp,1.4,36,,,,,,,,,,0,,For the treatment of dandruff.,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd739354-e58f-4ef2-b493-efb6ddd43b41.json
fd7c6dce-b25b-4637-a381-2102415e9c09,NUROFEN GEL 5 %,off-the-counter,M02AA13,IBUPROFEN,5584,,,WHO ATC Classification,,ILS,gel,IBUPROFENW/W,2025-07-31T12:35:46.679688,IL,רקיט בנקיזר,,30.1608,25.56,nan,,5000158100800,NUROFEN FOR  CHILDREN CHEWABLE  12 CAPSULE 100 MG,14702,,,TUBE ALUMINIUM,units,12.0,134 23 31074 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,"Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains, sports injuries.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd7c6dce-b25b-4637-a381-2102415e9c09.json
fd816f48-f4ce-4864-baa8-1f9887002501,JAKAVI 10 MG,prescription,L01XE18,RUXOLITINIB,7172,,,WHO ATC Classification,,ILS,tablets,RUXOLITINIB AS PHOSPHATE,2025-07-31T04:15:37.749035,IL,נוברטיס פארמה,,15076.44155,12776.64595,11615.13268,,7290016369212,JAKAVI 20MG 56TAB,10064,,76462,BLISTER PVC/PCTFE,units,56.0,158 58 34859 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"* Myelofibrosis (MF) Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. * Polycythaemia vera (PV) Jakavi is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.*Graft versus host disease (GvHD)Jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fd816f48-f4ce-4864-baa8-1f9887002501.json
fdcbe2b8-8be3-421e-b43e-ea488a3b99da,LIPIODOL ULTRA FLUID,29C,,,20862,,,,,ILS,solution for injection,IODINE AS ETHYL ESTERS OF IODIZED FATTY ACIDS OF POPPY SEED OIL/ML,2025-07-31T15:01:53.028853,IL,nan,,nan,nan,nan,,7-298120-003749,LIPIODOL GUERBET PORTUGAL/GERMANY 4.8G/10ML VIALS 10ML,,,,AMPOULES GLASS,units,1.0,056 03 21367 00,valid,nan,"intra-lymphatic, intra-arterial",1.4,36,,,,,,,,,,0,,"- Lymphography.- Visualisation, localisation and vectorisation during Trans-Arterial Chemo-Embolisation (TACE) of hepatocellular carcinoma, in adults.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fdcbe2b8-8be3-421e-b43e-ea488a3b99da.json
fdd886e4-5c80-484d-a91d-a2c8f8b924c4,NEXOBRID 2 G POWDER AND 20 G GEL,prescription,B06AA11,BROMELAINS,8712,,,WHO ATC Classification,,ILS,powder and gel,CONCENTRATE OF PROTEOLYTIC ENZYMES ENRICHED IN BROMELAIN,2025-07-31T05:45:20.155111,IL,מדיוונד,,5441.781251,4611.679232,4192.435665,,,NEXOBRID 5 G POWDER AND 50 G GEL  VIAL,,,,VIAL GLASS TYPE II,units,5.0,152 30 33685 00,valid,10.0,topical,1.4,36,,,,,,,,,,0,Prescription required,.NexoBrid is indicated for removal of eschar in all age groups with deep partial- and full-thickness thermal burns,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fdd886e4-5c80-484d-a91d-a2c8f8b924c4.json
fde46cd3-9a65-4703-9740-995a4880893e,MESNA-CELL 100 MG/ML,29C,V03AF01,MESNA,20519,,,WHO ATC Classification,,ILS,solution for injection,MESNA/,2025-07-31T15:09:06.030504,IL,nan,,nan,nan,nan,,7290014257535,MESNA-CELL 1000MG 1AMP,,,,AMPOULES GLASS,units,1.0,154 04 34131 00,valid,nan,i.v,1.4,60,,,,,,,,,,0,,"Prevention of urinary tract toxicity of oxazaphosphorines (the active components of Ifosfamide, Cyclophosphamide , Trofosfamide) in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous ifosfamide, Cyclophosphamide or Trofosfamide, urinary passage diseases in anamnesis.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fde46cd3-9a65-4703-9740-995a4880893e.json
fde81813-b1bd-4f47-97a9-4346b3554132,TUKYSA 150 MG,prescription,L01EH03,TUCATINIB,9039,,,WHO ATC Classification,,ILS,film coated tablets,TUCATINIB,2025-07-31T09:48:33.536280,IL,פיזר,,22028.30624,18668.05697,16970.96088,,5415062123010,TUKYSA 150 MG 84 TABS,,,63176,BLISTER PVC/OPA/AL,units,84.0,170 33 36951 99,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,TUKYSA is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer who have received at least 2 prior anti-HER2 treatment regimens.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fde81813-b1bd-4f47-97a9-4346b3554132.json
fdf75622-407e-4883-860d-9519adc8e9cc,HALDOL 2 MG/ML DROPS,prescription,N05AD01,HALOPERIDOL,4260,,,WHO ATC Classification,,ILS,solution  (oral),HALOPERIDOL/ML,2025-07-31T03:41:39.673400,IL,יאנסן סילג,,15.36829115,13.02397613,9.506551917,,7290014577305,HALDOL 5AMPX5MG/ML,8054,,27937,BOTTLE LDPE,units,5.0,029 70 25163 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"HALDOL is indicatedin adult patients aged 18 years and above for:•	Treatment of schizophrenia and schizoaffective disorder.•	Acute treatment of delirium when non-pharmacological treatments have failed.•	Treatment of moderate to severe manic episodes associated with bipolar I disorder when other treatments cannot be used.•	Treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar I disorder.•	Treatment of persistent aggression and psychotic symptoms in patients with moderate to severe Alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.•	Treatment of tic disorders, including Tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.•	Treatment of mild to moderate chorea in Huntington’s disease, when other medicinal products are ineffective or not tolerated.In paediatric patients for:•	Schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.•	Persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated.  •	Tic disorders, including Tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fdf75622-407e-4883-860d-9519adc8e9cc.json
fe0116d9-c096-477e-9b80-bdfc378f87ae,KUFFEX,off-the-counter,R05DA09,DEXTROMETHORPHAN,5546,,,WHO ATC Classification,,ILS,syrup,"DEXTROMETHORPHAN HYDROBROMIDE/, GUAIFENESIN/",2025-07-31T12:16:17.781087,IL,ליף-פריגו,,35.0224,29.68,nan,,7290103447373,KUFFEX DM 118ML,,,,BOTTLE POLYETHYLENE,units,118.0,148 29 33671 00,valid,nan,per os,1.4,24,,,,,,,,,,0,,For relief of cough and expecctorant.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe0116d9-c096-477e-9b80-bdfc378f87ae.json
fe178abe-2b07-4f4e-b7f4-28f6b1254ef0,ENLON 10MG/ML 1 VIAL,29C,,,20389,,,,,,injection,ENLON 10MG/ML,2025-07-31T20:21:28.958947,IL,nan,,,,,,,ENLON 10MG/ML 1 VIAL,,,,,units,1.0,,not-registered,,intramuscular,1.4,,,,,,,,active,,,0,Available over-the-counter.,,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe178abe-2b07-4f4e-b7f4-28f6b1254ef0.json
fe383b57-62b4-4ab1-9ff4-bca593962b55,DEPO-PROVERA 150 MG/ML,prescription,G03AC06,MEDROXYPROGESTERONE,3048,,,WHO ATC Classification,,ILS,suspension for injection,MEDROXYPROGESTERONE ACETATE/ML,2025-07-31T01:48:06.872677,IL,פיזר,,18.29474841,15.50402477,11.3168064,,7298074000511,DEPO-PROVERA 150MG1ML SOL FOR INJ,4163,,9278,SYRINGE GLASS TYPE I,units,1.0,069 69 24309 00,valid,37.0,i.m,1.4,60,,,,,,,,,,0,Prescription required,For contraception where medically indicated and oral administration is inapplicable.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe383b57-62b4-4ab1-9ff4-bca593962b55.json
fe3aa24c-41c7-4b5a-834a-7d40b1d69662,GLUCOMIN,prescription,A10BA02,METFORMIN,3197,,,WHO ATC Classification,,ILS,caplets,METFORMIN HYDROCHLORIDE,2025-07-31T03:36:53.878133,IL,דקסל פארמה,,15.03438,12.741,9.3,,,GLUCOMIN  850MG 30T,7057,,34013,BLISTER PVC,units,30.0,112 20 29498 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.• In adults, Glucomin may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin.• In children from 10 years of age and adolescents, Glucomin may be used as monotherapy or in combination with insulin.A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe3aa24c-41c7-4b5a-834a-7d40b1d69662.json
fe4de2e6-0f89-401b-9136-e5bdb0902233,IDELVION 1000 IU,prescription,B02BD04,COAGULATION FACTOR IX,8411,,,WHO ATC Classification,,ILS,powder and solvent for solution for injection,ALBUTREPENONACOG ALFA,2025-07-31T03:57:41.466888,IL,סי אס אל,,4384.468595,3715.651517,3377.865015,,,IDELVION 500 IU VIAL,17078,,59389,VIAL GLASS TYPE I,units,1.0,159 31 35015 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe4de2e6-0f89-401b-9136-e5bdb0902233.json
fe6ec396-44b1-4f69-a24e-f310622ecda0,CABOMETYX 20 MG,prescription,L01XE26,CABOZANTINIB,8113,,,WHO ATC Classification,,ILS,film coated tablets,CABOZANTINIB AS (S) MALATE,2025-07-31T00:48:56.913714,IL,מדיסון,,21894.46497,18554.63215,16867.84741,,7290015666565,CABOMETYX 40 MG 30 FC TABLETS,10144,,64850,BOTTLE HDPE,units,30.0,160 99 35263 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,"Renal Cell Carcinoma (RCC)Cabometyx is indicated as monotherapy for advanced renal cell carcinoma- as first-line treatment of adult patients with intermediate or poor risk, per IMDC criteria.- in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy.Cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults.Hepatocellular Carcinoma (HCC)Cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (HCC), in adults with Child-Pugh Class A hepatic impairment who have previously been treated with sorafenib.Differentiated thyroid carcinoma (DTC)Cabometyx is indicated as monotherapy for the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma (DTC), refractory or not eligible to radioactive iodine (RAI) who have progressed during or after prior systemic therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe6ec396-44b1-4f69-a24e-f310622ecda0.json
fe742794-bb1d-4db7-98f5-53cacd000f25,RIPOL 10 MG/ML,prescription,N01AX10,PROPOFOL,8230,,,WHO ATC Classification,,ILS,emulsion for injection or infusion,PROPOFOL/ML,2025-07-31T07:36:51.901475,IL,רז פרמהצפטי,,49.46565635,41.92004775,30.598575,,7290015863360,RIPOL 10 MG/ML 5 VIALS 20 ml,,,69587,AMPOULES GLASS TYPE I,units,5.0,159 41 34438 00,valid,37.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Ripol 10 mg/ml is a short-acting intravenous general anaesthetic for: - Induction and maintenance of general anaesthesia in adults and paediatric patients > 1 month of age- Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and paediatric patients > 1 month of age- Sedation of ventilated patients > 16 years of age in the intensive care unit",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe742794-bb1d-4db7-98f5-53cacd000f25.json
fe898167-505b-430c-af66-464f21b6bc77,DIMETINDENE INOVAMED GEL,off-the-counter,D04AA13,DIMETINDENE,5523,,,WHO ATC Classification,,ILS,gel,DIMETINDENE MALEATE 0.1 %W/W,2025-07-31T13:27:47.269265,IL,תרימה,,81.7386,69.27,nan,,,TINDEN GEL 100 G,,,,TUBE ALUMINIUM,units,100.0,167 86 35712 00,valid,nan,topical,1.4,18,,,,,,,,,,0,,"Urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe898167-505b-430c-af66-464f21b6bc77.json
fe96f589-1ca5-4184-9b83-b67d40283863,TREMFYA 100 MG/ML S.C,prescription,L04AC16,GUSELKUMAB,8201,,,WHO ATC Classification,,ILS,solution for injection,GUSELKUMAB/ML,2025-07-31T09:39:09.471208,IL,יאנסן סילג,,8722.77407,7392.181744,6720.165222,,,TREMFYA SYRRINGE PREFILLED 1ML,20856,,4221,PRE-FILLED PEN GLASS TYPE I,units,1.0,160 54 35346 00,valid,10.0,s.c,1.4,24,,,,,,,,,,0,Prescription required,"Plaque psoriasisTremfya is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.Psoriatic arthritisTremfya, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (DMARD) therapy.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fe96f589-1ca5-4184-9b83-b67d40283863.json
fea932f0-7465-4d31-b55c-73837fbe64ff,SIMVAXON 10,prescription,C10AA01,SIMVASTATIN,6179,,,WHO ATC Classification,,ILS,caplets,SIMVASTATIN,2025-07-31T08:16:15.558263,IL,דקסל פארמה,,15.9121938,13.48491,9.843,,,SIMVAXON 10MG 30TAB,19845,,86334,BLISTER ACLAR COATED PVC/ALUMINIUM,units,30.0,132 83 31147 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Coronary Heart Disease :   In patients with coronary heart disease and hypercholesterolemia  Simvaxon is indicated to:    - Reduce the risk of total mortality by reducing coronary death    - Reduce the risk of non-fatal myocardial infarction    - Reduce the risk for undergoing myocardial revascularization procedures    - Reduce the risk of stroke and transient ischemic attacks (TIA's).   Hyperlipidemia:   Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb)  Simvaxon therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia:   Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia):   Simvaxon is indicated for the treatment of patients with hypertriglyceridemia (Fredrickson type IV hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia):  Simvaxon is indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fea932f0-7465-4d31-b55c-73837fbe64ff.json
feb456e3-36f3-4bc3-8ba7-e7091be3b611,INOVELON 100 MG TABLETS,prescription,N03AF03,RUFINAMIDE,6671,,,WHO ATC Classification,,ILS,film coated tablets,RUFINAMIDE,2025-07-31T04:06:43.036264,IL,אסיי,,637.8877019,540.5828222,460.070487,,5036519000519,INOVELON 400 MG 60TAB,9421,,25919,BLISTER PA/ALUMINIUM/PVC,units,60.0,145 35 33202 00,valid,17.5,per os,1.4,48,,,,,,,,,,0,Prescription required,Inovelon is indicated as adjunctive therapy in the treatment of seizures associated with Lennox Gastaut syndrome in patients 1 year of age and older.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/feb456e3-36f3-4bc3-8ba7-e7091be3b611.json
feb73f9d-5698-4006-8649-fbb57e08c1b1,QUETIAPINE INOVAMED SR 300 MG,prescription,N05AH04,QUETIAPINE,8831,,,WHO ATC Classification,,ILS,tablets prolonged release,QUETIAPINE AS FUMARATE,2025-07-31T07:10:09.569212,IL,אינובמד,,150.91315,127.8925,102.314,,7290104530685,QUETIAPINE INOVAMED SR 400 MG 30 TAB,17329,,70060,BLISTER PVC/PCTFE/AL,units,30.0,165 71 35461 00,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Quetiapine Inovamed SR is indicated for the treatment of Schizophrenia. Quetiapine Inovamed SR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Inovamed SR. Quetiapine Inovamed SR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. Quetiapine Inovamed SR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Inovamed SR.", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/feb73f9d-5698-4006-8649-fbb57e08c1b1.json
fecc1cec-53c8-4c78-acc1-ee4e64b9b90e,XALKORI 200 MG,prescription,L01XE16,CRIZOTINIB,6927,,,WHO ATC Classification,,ILS,capsules,CRIZOTINIB,2025-07-31T10:27:26.325359,IL,פיזר,,17822.49716,15103.81182,13730.73802,,7290013592064,XALKORI 200MG 60CAPS,34072,,20593,BLISTER PVC/ALUMINIUM,units,60.0,147 40 33588 00,valid,10.0,per os,1.4,48,,,,,,,,,,0,Prescription required,XALKORI is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive.  Xalkori is indicated for the treatment of patients with metastatic NSCLC whose tumors are ROS1-positive.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fecc1cec-53c8-4c78-acc1-ee4e64b9b90e.json
fee66c90-6369-4181-babc-3fd7127d9d55,TRIKAFTA 100MG/50MG/75MG&150MG,prescription,R07AX32,"IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR",9576,,,WHO ATC Classification,,ILS,film coated tablets,"IVACAFTOR, TEZACAFTOR, ELEXACAFTOR, IVACAFTOR",2025-07-31T09:42:46.715652,IL,מדיסון,,nan,nan,nan,,,TRIKAFTA 50 MG/25 MG/37.5 MG &75 MG 84 TAB,,,,BLISTER PVC/ACLAR,units,84.0,167 03 36448 99,valid,nan,per os,1.4,48,,,,,,,,,,0,Prescription required,Trikafta is indicated for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene or a mutation in the CFTR gene that is responsive based on in vitro data.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fee66c90-6369-4181-babc-3fd7127d9d55.json
feff269b-755d-4602-a9c4-7afbeb30c2a6,INLYTA 1 MG,prescription,L01XE17,AXITINIB,7169,,,WHO ATC Classification,,ILS,film coated tablets,AXITINIB,2025-07-31T04:06:11.656390,IL,פיזר,,15186.42008,12869.84809,11699.8619,,,INLYTA 5MG 60 F.C.TAB,9683,,77409,BLISTER ALUMINIUM,units,60.0,149 67 33736 00,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,For the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/feff269b-755d-4602-a9c4-7afbeb30c2a6.json
ff0043a9-3d2d-4f2f-8314-2f36983a60b8,VANCOAVENIR 1 G,prescription,A07AA09,VANCOMYCIN,8271,,,WHO ATC Classification,,ILS,powder for solution for injection,VANCOMYCIN AS HYDROCHLORIDE/VIAL,2025-07-31T09:57:55.639706,IL,ביואבניר,,290.0558,245.81,209.2,,7290010287147,VANCOAVENIR 0.5G 10 VIALS,,,67041,VIAL GLASS TYPE I,units,10.0,153 18 34020 00,valid,17.5,i.v,1.4,24,,,,,,,,,,0,Prescription required,Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci.It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside.Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. Vancomycin hydrochloride is not effective orally when administered for other types of infection.,תרופה מוגבלת לשימוש בבתי חולים או אשפוז יום ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff0043a9-3d2d-4f2f-8314-2f36983a60b8.json
ff264a68-c851-466e-97fa-c364d0889218,SIMVAXON 10,prescription,C10AA01,SIMVASTATIN,7730,,,WHO ATC Classification,,ILS,caplets,SIMVASTATIN,2025-07-31T08:16:49.810593,IL,דקסל פארמה,,119.5687811,101.3294755,75.3379,,,SIMVAXON 80MG 30TAB,9782,,58772,BLISTER ACLAR COATED PVC/ALUMINIUM,units,30.0,132 83 31147 00,valid,34.5,per os,1.4,36,,,,,,,,,,0,Prescription required,Coronary Heart Disease :   In patients with coronary heart disease and hypercholesterolemia  Simvaxon is indicated to:    - Reduce the risk of total mortality by reducing coronary death    - Reduce the risk of non-fatal myocardial infarction    - Reduce the risk for undergoing myocardial revascularization procedures    - Reduce the risk of stroke and transient ischemic attacks (TIA's).   Hyperlipidemia:   Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb)  Simvaxon therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia:   Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia):   Simvaxon is indicated for the treatment of patients with hypertriglyceridemia (Fredrickson type IV hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia):  Simvaxon is indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff264a68-c851-466e-97fa-c364d0889218.json
ff27817f-4770-4d9a-ad51-ec4979e17974,CILOXAN,prescription,S01AX13,CIPROFLOXACIN,2782,,,WHO ATC Classification,,ILS,solution,CIPROFLOXACIN AS HYDROCHLORIDE 0.3 %W/V,2025-07-31T01:13:12.783555,IL,נוברטיס פארמה,,21.15741416,17.930012,13.0876,,7290016369243,CILOXAN 0.3% EYE DROPS 5ML,3033,,8860,BOTTLE LDPE,units,5.0,061 17 27635 00,valid,37.0,"ocular, otic",1.4,24,,,,,,,,,,0,Prescription required,"Corneal ulcers and conjunctivitis caused by susceptible gram positive and gram negative microorganisms for adults and pediatric patients above the age of 1 year. For localized or diffuse otitis externa accompanied by a strong inflammatory reaction and of which the strains are susceptible to ciprofloxacin, and for the acute flare-up of a chronic otitis media. In this case, a mucopurulent secretion comes through the perforated eardrum. Pseudomonas aeruginosa is one of the organisms most likely to be found in this case. Also in other infections of the ear in which Pseudomonas aeruginosa and/or other susceptible strains may be demonstrated or suspected (for example with suppurating tympanic tubes), Ciloxan can be used under the strict supervision of an ear specialist. It must be understood that this is not a routine treatment and that improper use must be avoided.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff27817f-4770-4d9a-ad51-ec4979e17974.json
ff43520c-164a-49f4-a57b-a9d7c19381ab,LYRICA 100 MG,prescription,N03AX16,PREGABALIN,6773,,,WHO ATC Classification,,ILS,capsules,PREGABALIN,2025-07-31T05:01:33.153462,IL,דקסל פארמה,,43.82877422,37.143029,27.1117,,,LYRICA 25MG 56 CAPSULES,12454,,32210,BLISTER PVC,units,56.0,133 01 31188 00,valid,37.0,per os,1.4,36,,,,,,,,,,0,Prescription required,LLyrica is indicated for the:- Treatment of peripheral and central neuropathic pain in adults. - Management of Fibromyalgia.- Treatment of Generalised Anxiety Disorder (GAD) in adults.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff43520c-164a-49f4-a57b-a9d7c19381ab.json
ff4a1aec-2543-4d0d-b03c-0b238efe52b3,RADIAN B MUSCLE RUB,off-the-counter,,,3473,,,,,ILS,cream,"MENTHOL 2.54 %W/W, CAMPHOR 1.43 %W/W, CAPSICUM OLEORESIN 0.005 %W/W, METHYL SALICYLATE 0.42 %W/W",2025-07-31T12:52:51.016091,IL,דפריס,,24.2018,20.51,nan,,5011309145915,RADIAN B CREAM 40GR,18005,,,TUBE ALUMINIUM,units,40.0,137 01 22841 00,valid,nan,topical,1.4,36,,,,,,,,,,0,,Relief of rheumatic pains and mild muscle pains.,,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff4a1aec-2543-4d0d-b03c-0b238efe52b3.json
ff5490e6-0def-4e2e-bcc0-54bd4f0c7639,ADEMPAS 0.5 MG,prescription,C02KX05,RIOCIGUAT,7768,,,WHO ATC Classification,,ILS,film coated tablets,RIOCIGUAT 0.5  MG,2025-07-30T23:14:40.272564,IL,באייר,,9177.590319,7777.61926,7070.562964,,,ADEMPAS 2.5MG 84TAB,9873,,29094,BLISTER PP/ALUMINIUM,units,84.0,153 76 34132 01,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Chronic thromboembolic pulmonary hypertension (CTEPH) Adempas is indicated for the treatment of adult patients with WHO Functional Class (FC) II to III with	• inoperable CTEPH, • persistent or recurrent CTEPH after surgical treatment, to improve exercise capacity. Pulmonary arterial hypertension (PAH)Adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH) with WHO Functional Class (FC) II to III to improve exercise capacity.Efficacy has been shown in a PAH population including aetiologies of idiopathic or heritable PAH or PAH associated with connective tissue disease.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff5490e6-0def-4e2e-bcc0-54bd4f0c7639.json
ff5dae31-6a54-48ba-a650-aae22e507f2a,ABIRATERONE S.K 250 MG,prescription,L02BX03,ABIRATERONE,8824,,,WHO ATC Classification,,ILS,tablets,ABIRATERONE ACETATE,2025-07-30T23:10:21.261072,IL,SK PHARM(KS KIM),,17160.87617,14543.1154,13221.014,,7290016845549,ABIRATERONE S.K 250 MG 120 TAB,17312,,69319,BOTTLE HDPE,units,120.0,166 38 36143 00,valid,10.0,per os,1.4,24,,,,,,,,,,0,Prescription required,• Abiraterone S.K. is CYP 17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. • Abiraterone S.K. is indicated for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT)., ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff5dae31-6a54-48ba-a650-aae22e507f2a.json
ff6883c0-fb5e-48f4-bb33-317b810c27ff,ROZEX,prescription,D06BX01,METRONIDAZOLE,2910,,,WHO ATC Classification,,ILS,gel,METRONIDAZOLE 0.75 %W/W,2025-07-31T07:52:08.882242,IL,אמי טכנולוגיות,,36.04322862,30.545109,22.2957,,6009626120363,ROZEX GEL 30GR,18111,,9036,TUBE ALUMINIUM,units,30.0,062 18 26970 00,valid,37.0,topical,1.4,36,,,,,,,,,,0,Prescription required,"Topical application for the treatment of inflammatory papules, pustules and erythema of rosacea.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff6883c0-fb5e-48f4-bb33-317b810c27ff.json
ff90a1d6-ee09-4561-8ab0-0f890d8007bc,TECENTRIQ,prescription,,,8720,,,,,ILS,concentrate for solution for infusion,ATEZOLIZUMAB/ML,2025-07-31T09:09:05.297455,IL,רוש,,14088.45624,11939.37022,10853.97293,,7290014774049,TECENTRIQ 840MG/14ML 1 VIAL,,,3489,VIAL GLASS TYPE I,units,1.0,158 66 34982 00,valid,10.0,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Urothelial Carcinoma• TECENTRIQ (atezolizumab) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin-containing chemotherapy and whose tumours have a PD-L1 expression &#8805; 5%.• TECENTRIQ is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following any platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant chemotherapy.- Non-Small Cell Lung Cancer •TECENTRIQ, as a single agent, is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (PD-L1 stained &#8805; 50% of tumor cells [TC &#8805; 50%] or PD-L1 stained tumor-infiltrating immune cells [IC] covering &#8805; 10% of the tumor area [IC &#8805; 10%]), as determined by an approved test, with no EGFR or ALK genomic tumor aberrations.•TECENTRIQ, in combination with paclitaxel protein-bound and carboplatin, is indicated for the first-line treatment of adult patients with metastatic non-squamous NSCLC with no EGFR or ALK genomic tumor aberrations.• TECENTRIQ, in combination with bevacizumab, paclitaxel, and carboplatin, is indicated for the first-line treatment of adult patients with metastatic non-squamous non-small cell lung cancer (NSCLC). In patients with EGFR mutant or ALK-positive NSCLC, TECENTRIQ, in combination with bevacizumab, paclitaxel, and carboplatin, is indicated only after failure of appropriate targeted therapies.• TECENTRIQ is indicated for the treatment of patients with metastatic NSCLC who are naïve to anti-PD-L1 or anti-PD-1 therapies and have disease progression during or following platinum-containing chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on approved therapy for NSCLC harboring these aberrations prior to receiving TECENTRIQ.• TECENTRIQ as monotherapy, is indicated as adjuvant treatment following complete resection and no progression after platinum-based adjuvant chemotherapy for adult patients with Stage II to IIIA NSCLC whose tumors have PD-L1 expression on &#8805; 50% of tumor cells (TCs).- Locally Advanced or Metastatic Triple-Negative Breast Cancer Tecentriq, in combination with nab-paclitaxel, is indicated for the treatment of patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) whose tumors have PD-L1 expression &#8805;1% and who have not received prior chemotherapy for metastatic disease.-  Small Cell Lung CancerTECENTRIQ, in combination with carboplatin and etoposide, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC).""- Hepatocellular CarcinomaTECENTRIQ, in combination with bevacizumab, is indicated for the treatment of patients with unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy.- MelanomaTECENTRIQ, in combination with cobimetinib and vemurafenib, is indicated for the treatment of patients with BRAF V600 mutation-positive unresectable or metastatic melanoma.- Alveolar Soft Part Sarcoma TECENTRIQ, as a single agent, is indicated for the treatment of adult and pediatric patients 2 years of age and older with unresectable or metastatic alveolar soft part sarcoma (ASPS).",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff90a1d6-ee09-4561-8ab0-0f890d8007bc.json
ff9188c2-6765-4ed3-a825-b318eca6f5ff,REKAMBYS,prescription,J05AG05,RILPIVIRINE,9040,,,WHO ATC Classification,,ILS,suspension for injection prolonged release,RILPIVIRINE/,2025-07-31T07:20:42.065534,IL,ג.ס.ק,,2327.034715,1972.063406,1678.351835,,,REKAMBYS INJECTION 900MG/3ML 1 VIAL,,,89154,VIAL GLASS TYPE I,units,1.0,170 12 36949 99,valid,17.5,i.m,1.4,36,,,,,,,,,,0,Prescription required,"REKAMBYS is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA < 50 copies/mL) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the NNRTI and INI class.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff9188c2-6765-4ed3-a825-b318eca6f5ff.json
ff948613-2a26-4fbd-9c4f-36bf394b074b,LOANA,off-the-counter,N01BB52,"LIDOCAINE, COMBINATIONS",5565,,,WHO ATC Classification,,ILS,cream,"PRILOCAINE/, LIDOCAINE/",2025-07-31T12:21:09.870356,IL,לייף-סופרפארם,,90.7656,76.92,nan,,7290111592638,LOANA LIFE 30 G CREAM,,,,TUBE ALUMINIUM,units,30.0,160 64 35545 00,valid,nan,dermal,1.4,36,,,,,,,,,,0,,"Topical anaesthetic for superficial dermal analgesia in connection with insertion of IV catheters, blood sampling and superficial surgical procedures", ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ff948613-2a26-4fbd-9c4f-36bf394b074b.json
ffad8fd3-7b0c-4e5c-a452-3986d9bc8b74,NAROCIN,off-the-counter,M01AE02,NAPROXEN,3606,,,WHO ATC Classification,,ILS,tablets,NAPROXEN SODIUM,2025-07-31T12:28:50.881236,IL,טבע,,24.0012,20.34,nan,,,NAROCIN 275MG 10TAB,14212,,,BLISTER PVC/ALUMINIUM,units,10.0,065 82 22014 15,valid,nan,per os,1.4,36,,,,,,,,,,0,,"Mild and moderate analgesic such as relief of toothache, backache and menstrual pain (primary dysmenorrhea). Fever reduction. Non-steroidal anti-inflammatory for the treatment of rheumatic inflammations, tendinitis and musculoskeletal inflammations.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ffad8fd3-7b0c-4e5c-a452-3986d9bc8b74.json
ffb1fa5b-8af2-4a95-b05e-0b0057a6e902,CYTOTEC 200 MCG TABLETS,prescription,A02BB01,MISOPROSTOL,1078,,,WHO ATC Classification,,ILS,tablets,MISOPROSTOL,2025-07-31T01:38:16.528730,IL,פיזר,,39.5577682,33.52353386,24.46973275,,,CYTOTEC 200MCG 28TAB,3643,,8146,BLISTER ALUMINIUM LAMINATE,units,28.0,037 78 25161 00,valid,37.0,"per os, rectal, buccal, sublingual, vaginal",1.4,36,,,,,,,,,,0,Prescription required,"For the treatment of duodenal and gastric ulcer.Treatment and prevention NSAID induced ulcers lesions, erosions, while NSAID therapy continues.Use in conjunction with Mifepristone subject to the approval of a committee for the termination of pregnancy according to the Israeli penal law 1977.First-trimester pregnancy failure: Use is intended for emptying the uterus in states of first trimester pregnancy failure, including: presentation of a pregnancy sac in the uterus with no fetal echo, missed abortion (until week 11+6 and a fetus 40 mm in length) or incomplete abortion. The preparation is to be used after location of the sac in the uterus has been proved and the diagnosis of pregnancy failure is certain. The preparation can be used for this purpose in an ambulatory setting. The dosage and route of administration will be similar to the use of Cytotec in pregnancy termination after using Mifegyne. Informed consent and medical surveillance are required.Softening and dilation of the cervix for performing intrauterine procedures, such as: curettage, hysteroscopy, IUD insertion and others, according to clinical judgment. The preparation can be used for this purpose in an ambulatory setting. The route of administration (vaginal, sublingual, buccal, oral or rectal) and the dosage are according to the decision of the attending doctor.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ffb1fa5b-8af2-4a95-b05e-0b0057a6e902.json
ffba5b15-cf1b-4893-904b-0e35fafe69ea,CONCERTA 18 MG,prescription,N06BA04,METHYLPHENIDATE,4982,,,WHO ATC Classification,,ILS,tablets extended release,METHYLPHENIDATE HYDROCHLORIDE,2025-07-31T01:27:46.665630,IL,יאנסן סילג,,160.12128,135.696,108.5568,,7290008124966,CONCERTA 27MG XR 30TAB,3858,,69989,BOTTLE HDPE,units,30.0,126 85 30589 24,valid,25.0,per os,1.4,36,,,,,,,,,,0,Prescription required,Concerta is indicated for the treatment of Attention deficit hyperactivity disorder (ADHD).,תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ffba5b15-cf1b-4893-904b-0e35fafe69ea.json
ffbdfea9-0270-4d61-8229-0dfc6e5d1ad7,DASATINIB SANDOZ ® 100 MG,prescription,L01XE06,DASATINIB,9354,,,WHO ATC Classification,,ILS,film coated tablets,DASATINIB,2025-07-31T01:42:48.771282,IL,סנדוז,,5707.264313,4836.664887,4396.968079,,,DASATINIB SANDOZ 140 MG 30 TAB,,,14603,BLISTER OPA/ALU/PVC/ALU,units,30.0,173 10 36531 99,valid,10.0,per os,1.4,36,,,,,,,,,,0,Prescription required,"Treatment of adult patients with :  Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase.  Chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate.  Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.",,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ffbdfea9-0270-4d61-8229-0dfc6e5d1ad7.json
ffd8db71-15ff-42f0-9b00-d8dab6fafff7,PEMETREXED TEVA ® 100 MG,prescription,L01BA04,PEMETREXED,7903,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,PEMETREXED,2025-07-31T06:33:11.752972,IL,טבע,,1074.694452,910.75801,775.1132,,7290106064980,PEMETREXED TEVA ® 100 MG 1 VIAL,16959,,52424,VIAL GLASS TYPE I,units,1.0,156 39 34393 01,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,Malignant pleural mesothelioma :Pemetrexed Teva in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Non-small cell lung cancer: Pemetrexed Teva in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. Pemetrexed Teva is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ffd8db71-15ff-42f0-9b00-d8dab6fafff7.json
ffeed955-64b3-465f-8d61-d23af0fd0399,TEEJEL GEL,off-the-counter,N02BA03,CHOLINE SALICYLATE,2681,,,WHO ATC Classification,,ILS,gel,"CETALKONIUM CHLORIDE 0.01 %W/W, CHOLINE SALICYLATE 8.7 %W/W",2025-07-31T13:26:09.394912,IL,רפא,,26.2196,22.22,nan,,7290008015158,TEEJEL GEL 10GR,20509,,,TUBE ALUMINIUM,units,10.0,042 17 25901 00,valid,nan,local oral,1.4,24,,,,,,,,,,0,,"As an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.",תרופה שאושרה לשימוש כללי בקופ'ח ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/ffeed955-64b3-465f-8d61-d23af0fd0399.json
fffb671e-85ed-4854-ad41-c638be284a33,MYCAMINE 100 MG,prescription,J02AX05,MICAFUNGIN,7828,,,WHO ATC Classification,,ILS,powder for concentrate for solution for infusion,MICAFUNGIN AS SODIUM,2025-07-31T05:36:39.957314,IL,אסטלס,,1349.0605,1143.271661,972.997158,,8718692510883,MYCAMINE 100 MG VIAL,13788,,33077,VIAL GLASS TYPE I,units,1.0,155 91 34429 00,valid,17.5,i.v,1.4,36,,,,,,,,,,0,Prescription required,"Adults, adolescents &#8805; 16 years of age and elderly:- Treatment of invasive candidiasis.- Treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate.- Prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.Children (including neonates) and adolescents < 16 years of age:- Treatment of invasive candidiasis.- Prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation.The decision to use Mycamine should take into account a potential risk for the development of liver tumours. Mycamine should therefore only be used if other antifungals are not appropriate.",תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ,https://github.com/FormidableCare/OpenMed/tree/main/catalog/fffb671e-85ed-4854-ad41-c638be284a33.json
